*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1aj8_c02 CITRATE SYNTHASE user 1 4 # 1 A 193 SER A 83 SER~? 4.31 CL CL A2020 A 223 HIS A 79 HIS~? -3.92 CL CL A2020s A 262 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 28.44 32.05 73.53 28.64 31.12 71.24 109.33 86.01 47.44 108.27 87.28 49.22 coo 29.33 36.13 69.70 30.07 34.20 70.11 103.72 86.36 44.76 104.87 88.01 44.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 98.48 94.83 47.66 98.07 96.39 49.01 coo 30.62 37.23 61.07 30.08 35.73 62.49 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 2 4 # 2 A 193 SER B 83 SER~? 7.75 CL CL B2010 A 223 HIS B 79 HIS~? 5.08 CL CL B2010 A 262 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 28.44 32.05 73.53 28.64 31.12 71.24 7.70 61.77 7.67 8.73 59.61 7.20 coo 29.33 36.13 69.70 30.07 34.20 70.11 13.46 62.96 8.26 12.78 63.30 6.30 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.73 57.29 2.23 19.89 55.80 0.75 coo 30.62 37.23 61.07 30.08 35.73 62.49 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 3 4 # 3 A 193 SER C 83 SER~? 3.84 CL CL C2021 A 223 HIS C 79 HIS~? -4.32 CL CL C2021s A 262 HIS C 125 HIS.? 6.65 CL CL C2011 A 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 28.44 32.05 73.53 28.64 31.12 71.24 99.03 9.95 70.83 97.44 9.06 69.22 coo 29.33 36.13 69.70 30.07 34.20 70.11 92.85 10.89 71.99 93.43 9.18 73.06 coo 38.54 36.60 66.38 37.88 34.77 67.15 86.57 4.11 67.63 86.24 2.65 66.14 coo 30.62 37.23 61.07 30.08 35.73 62.49 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 4 4 # 4 A 193 SER D 83 SER~? 4.15 CL CL D2022 A 223 HIS D 79 HIS~? -4.57 CL CL D2022s A 262 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 28.44 32.05 73.53 28.64 31.12 71.24 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 29.33 36.13 69.70 30.07 34.20 70.11 3.57 52.49 87.96 2.52 51.97 89.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.12 57.04 95.76 9.45 58.59 97.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 5 4 # 5 A 193 SER E 83 SER~? 3.98 CL CL E2032 A 223 HIS E 79 HIS~? -4.18 CL CL E2032s A 262 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 28.44 32.05 73.53 28.64 31.12 71.24 6.89 98.81 51.94 8.26 99.71 50.10 coo 29.33 36.13 69.70 30.07 34.20 70.11 12.36 98.35 54.34 11.69 100.32 54.60 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.41 104.46 50.06 20.14 105.76 48.58 coo 30.62 37.23 61.07 30.08 35.73 62.49 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 6 4 # 6 A 193 SER F 83 SER~? 4.14 CL CL F2023 A 223 HIS F 79 HIS~? -4.63 CL CL F2023s A 262 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 28.44 32.05 73.53 28.64 31.12 71.24 107.41 36.26 21.11 106.31 38.05 19.96 coo 29.33 36.13 69.70 30.07 34.20 70.11 101.04 34.65 20.79 101.93 33.69 19.16 coo 38.54 36.60 66.38 37.88 34.77 67.15 96.50 38.92 12.23 96.44 40.22 10.57 coo 30.62 37.23 61.07 30.08 35.73 62.49 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 7 4 # 7 A 193 SER G 83 SER~? 4.16 CL CL G2033 A 223 HIS G 79 HIS~? -4.46 CL CL G2033s A 262 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 28.44 32.05 73.53 28.64 31.12 71.24 -0.88 18.73 43.69 0.20 17.85 45.68 coo 29.33 36.13 69.70 30.07 34.20 70.11 5.20 17.85 42.65 4.12 16.10 42.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.81 10.31 48.06 9.47 8.80 49.48 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 8 4 # 8 A 193 SER H 83 SER~? 4.17 CL CL H2024 A 223 HIS H 79 HIS~? 4.82 CL CL H2024 A 262 HIS H 125 HIS.? 7.36 CL CL H2014 A 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 28.44 32.05 73.53 28.64 31.12 71.24 100.86 60.76 97.52 99.44 59.04 98.47 coo 29.33 36.13 69.70 30.07 34.20 70.11 95.19 63.20 96.60 95.96 63.87 98.43 coo 38.54 36.60 66.38 37.88 34.77 67.15 88.12 60.23 103.63 87.33 59.09 105.21 coo 30.62 37.23 61.07 30.08 35.73 62.49 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 9 4 # 9 A 193 SER I 83 SER~? 4.12 CL CL I2025 A 223 HIS I 79 HIS~? -4.56 CL CL I2025s A 262 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 28.44 32.05 73.53 28.64 31.12 71.24 222.83 204.85 161.89 221.39 205.66 163.52 coo 29.33 36.13 69.70 30.07 34.20 70.11 216.99 204.94 159.50 218.07 206.60 158.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 211.42 212.80 162.96 211.20 214.50 164.16 coo 30.62 37.23 61.07 30.08 35.73 62.49 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 10 4 # 10 A 193 SER J 83 SER~? 3.90 CL CL J2026 A 223 HIS J 79 HIS~? -4.36 CL CL J2026s A 262 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 28.44 32.05 73.53 28.64 31.12 71.24 120.35 177.35 126.19 121.76 175.49 125.60 coo 29.33 36.13 69.70 30.07 34.20 70.11 126.45 179.07 126.46 125.69 179.71 124.61 coo 38.54 36.60 66.38 37.88 34.77 67.15 132.43 173.86 119.73 132.77 172.30 118.36 coo 30.62 37.23 61.07 30.08 35.73 62.49 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 11 4 # 11 A 193 SER K 83 SER~? 3.98 CL CL K2027 A 223 HIS K 79 HIS~? -4.34 CL CL K2027s A 262 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 28.44 32.05 73.53 28.64 31.12 71.24 216.96 127.03 182.22 215.88 126.06 180.30 coo 29.33 36.13 69.70 30.07 34.20 70.11 211.01 127.65 183.80 211.70 125.86 184.65 coo 38.54 36.60 66.38 37.88 34.77 67.15 204.92 120.38 179.37 204.44 118.90 177.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 12 4 # 12 A 193 SER L 83 SER~? 3.95 CL CL L2028 A 223 HIS L 79 HIS~? -4.09 CL CL L2028s A 262 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 28.44 32.05 73.53 28.64 31.12 71.24 115.00 167.12 206.00 116.47 168.85 206.74 coo 29.33 36.13 69.70 30.07 34.20 70.11 120.65 164.52 206.19 119.64 164.06 207.98 coo 38.54 36.60 66.38 37.88 34.77 67.15 126.56 168.90 213.47 127.02 170.42 214.85 coo 30.62 37.23 61.07 30.08 35.73 62.49 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 13 4 # 13 A 193 SER M 83 SER~? 4.48 CL CL M2029 A 223 HIS M 79 HIS~? -4.31 CL CL M2029s A 262 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 28.44 32.05 73.53 28.64 31.12 71.24 119.79 211.86 171.05 121.18 212.22 169.09 coo 29.33 36.13 69.70 30.07 34.20 70.11 125.50 211.59 173.52 124.72 213.49 173.99 coo 38.54 36.60 66.38 37.88 34.77 67.15 132.19 217.95 169.15 132.87 219.15 167.56 coo 30.62 37.23 61.07 30.08 35.73 62.49 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 14 4 # 14 A 193 SER N 83 SER~? 3.82 CL CL N2030 A 223 HIS N 79 HIS~? -4.33 CL CL N2030s A 262 HIS N 125 HIS.? 9.29 CL CL N2030 A 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 28.44 32.05 73.53 28.64 31.12 71.24 221.50 155.10 133.13 220.51 157.01 132.05 coo 29.33 36.13 69.70 30.07 34.20 70.11 215.64 153.98 132.96 216.60 153.22 131.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 210.43 158.18 125.05 210.19 159.49 123.43 coo 30.62 37.23 61.07 30.08 35.73 62.49 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 15 4 # 15 A 193 SER O 83 SER~? 7.53 CL CL O2018 A 223 HIS O 79 HIS~? 5.21 CL CL O2018 A 262 HIS O 125 HIS.? 7.09 CL CL O2018 A 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 28.44 32.05 73.53 28.64 31.12 71.24 115.90 131.94 160.39 117.13 130.87 162.21 coo 29.33 36.13 69.70 30.07 34.20 70.11 121.98 131.53 158.56 121.09 129.74 157.92 coo 38.54 36.60 66.38 37.88 34.77 67.15 126.97 124.39 163.68 126.90 122.97 165.24 coo 30.62 37.23 61.07 30.08 35.73 62.49 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 4 1aj8_c02 CITRATE SYNTHASE user 16 4 # 16 A 193 SER P 83 SER~? 8.38 CL CL P2019 A 223 HIS P 79 HIS~? 5.38 CL CL P2019 A 262 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 28.44 32.05 73.53 28.64 31.12 71.24 218.12 176.21 210.92 216.94 174.20 211.47 coo 29.33 36.13 69.70 30.07 34.20 70.11 212.25 178.47 210.26 213.09 179.27 212.01 coo 38.54 36.60 66.38 37.88 34.77 67.15 205.78 175.00 217.63 205.21 173.76 219.23 coo 30.62 37.23 61.07 30.08 35.73 62.49 207.19 183.81 214.61 207.22 185.89 215.11 1aj8_c02 source 1aj8 CITRATE SYNTHASE : 16 hits 1aj8_c02 naa= 4 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 1 4 # 1 B 193 SER A 83 SER~? 4.31 CL CL A2020 B 223 HIS A 79 HIS~? -3.92 CL CL A2020s B 262 HIS A 125 HIS.? 6.10 O2 GOL A3040 B 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 24.20 33.47 87.18 22.82 34.14 89.12 109.33 86.01 47.44 108.27 87.28 49.22 coo 23.86 29.50 91.20 24.12 31.58 91.00 103.72 86.36 44.76 104.87 88.01 44.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 98.48 94.83 47.66 98.07 96.39 49.01 coo 20.42 28.25 99.26 20.25 29.62 97.63 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 2 4 # 2 B 193 SER B 83 SER~? 7.75 CL CL B2010 B 223 HIS B 79 HIS~? 5.08 CL CL B2010 B 262 HIS B 125 HIS.? 5.37 C1 GOL B3023 B 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 24.20 33.47 87.18 22.82 34.14 89.12 7.70 61.77 7.67 8.73 59.61 7.20 coo 23.86 29.50 91.20 24.12 31.58 91.00 13.46 62.96 8.26 12.78 63.30 6.30 coo 29.35 31.42 99.15 28.72 33.09 98.04 19.73 57.29 2.23 19.89 55.80 0.75 coo 20.42 28.25 99.26 20.25 29.62 97.63 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 3 4 # 3 B 193 SER C 83 SER~? 3.84 CL CL C2021 B 223 HIS C 79 HIS~? -4.32 CL CL C2021s B 262 HIS C 125 HIS.? 6.65 CL CL C2011 B 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 24.20 33.47 87.18 22.82 34.14 89.12 99.03 9.95 70.83 97.44 9.06 69.22 coo 23.86 29.50 91.20 24.12 31.58 91.00 92.85 10.89 71.99 93.43 9.18 73.06 coo 29.35 31.42 99.15 28.72 33.09 98.04 86.57 4.11 67.63 86.24 2.65 66.14 coo 20.42 28.25 99.26 20.25 29.62 97.63 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 4 4 # 4 B 193 SER D 83 SER~? 4.15 CL CL D2022 B 223 HIS D 79 HIS~? -4.57 CL CL D2022s B 262 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 24.20 33.47 87.18 22.82 34.14 89.12 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 23.86 29.50 91.20 24.12 31.58 91.00 3.57 52.49 87.96 2.52 51.97 89.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.12 57.04 95.76 9.45 58.59 97.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 5 4 # 5 B 193 SER E 83 SER~? 3.98 CL CL E2032 B 223 HIS E 79 HIS~? -4.18 CL CL E2032s B 262 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 24.20 33.47 87.18 22.82 34.14 89.12 6.89 98.81 51.94 8.26 99.71 50.10 coo 23.86 29.50 91.20 24.12 31.58 91.00 12.36 98.35 54.34 11.69 100.32 54.60 coo 29.35 31.42 99.15 28.72 33.09 98.04 19.41 104.46 50.06 20.14 105.76 48.58 coo 20.42 28.25 99.26 20.25 29.62 97.63 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 6 4 # 6 B 193 SER F 83 SER~? 4.14 CL CL F2023 B 223 HIS F 79 HIS~? -4.63 CL CL F2023s B 262 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 24.20 33.47 87.18 22.82 34.14 89.12 107.41 36.26 21.11 106.31 38.05 19.96 coo 23.86 29.50 91.20 24.12 31.58 91.00 101.04 34.65 20.79 101.93 33.69 19.16 coo 29.35 31.42 99.15 28.72 33.09 98.04 96.50 38.92 12.23 96.44 40.22 10.57 coo 20.42 28.25 99.26 20.25 29.62 97.63 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 7 4 # 7 B 193 SER G 83 SER~? 4.16 CL CL G2033 B 223 HIS G 79 HIS~? -4.46 CL CL G2033s B 262 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 24.20 33.47 87.18 22.82 34.14 89.12 -0.88 18.73 43.69 0.20 17.85 45.68 coo 23.86 29.50 91.20 24.12 31.58 91.00 5.20 17.85 42.65 4.12 16.10 42.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.81 10.31 48.06 9.47 8.80 49.48 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 8 4 # 8 B 193 SER H 83 SER~? 4.17 CL CL H2024 B 223 HIS H 79 HIS~? 4.82 CL CL H2024 B 262 HIS H 125 HIS.? 7.36 CL CL H2014 B 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 24.20 33.47 87.18 22.82 34.14 89.12 100.86 60.76 97.52 99.44 59.04 98.47 coo 23.86 29.50 91.20 24.12 31.58 91.00 95.19 63.20 96.60 95.96 63.87 98.43 coo 29.35 31.42 99.15 28.72 33.09 98.04 88.12 60.23 103.63 87.33 59.09 105.21 coo 20.42 28.25 99.26 20.25 29.62 97.63 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 9 4 # 9 B 193 SER I 83 SER~? 4.12 CL CL I2025 B 223 HIS I 79 HIS~? -4.56 CL CL I2025s B 262 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 24.20 33.47 87.18 22.82 34.14 89.12 222.83 204.85 161.89 221.39 205.66 163.52 coo 23.86 29.50 91.20 24.12 31.58 91.00 216.99 204.94 159.50 218.07 206.60 158.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 211.42 212.80 162.96 211.20 214.50 164.16 coo 20.42 28.25 99.26 20.25 29.62 97.63 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 10 4 # 10 B 193 SER J 83 SER~? 3.90 CL CL J2026 B 223 HIS J 79 HIS~? -4.36 CL CL J2026s B 262 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 24.20 33.47 87.18 22.82 34.14 89.12 120.35 177.35 126.19 121.76 175.49 125.60 coo 23.86 29.50 91.20 24.12 31.58 91.00 126.45 179.07 126.46 125.69 179.71 124.61 coo 29.35 31.42 99.15 28.72 33.09 98.04 132.43 173.86 119.73 132.77 172.30 118.36 coo 20.42 28.25 99.26 20.25 29.62 97.63 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 11 4 # 11 B 193 SER K 83 SER~? 3.98 CL CL K2027 B 223 HIS K 79 HIS~? -4.34 CL CL K2027s B 262 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 24.20 33.47 87.18 22.82 34.14 89.12 216.96 127.03 182.22 215.88 126.06 180.30 coo 23.86 29.50 91.20 24.12 31.58 91.00 211.01 127.65 183.80 211.70 125.86 184.65 coo 29.35 31.42 99.15 28.72 33.09 98.04 204.92 120.38 179.37 204.44 118.90 177.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 12 4 # 12 B 193 SER L 83 SER~? 3.95 CL CL L2028 B 223 HIS L 79 HIS~? -4.09 CL CL L2028s B 262 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 24.20 33.47 87.18 22.82 34.14 89.12 115.00 167.12 206.00 116.47 168.85 206.74 coo 23.86 29.50 91.20 24.12 31.58 91.00 120.65 164.52 206.19 119.64 164.06 207.98 coo 29.35 31.42 99.15 28.72 33.09 98.04 126.56 168.90 213.47 127.02 170.42 214.85 coo 20.42 28.25 99.26 20.25 29.62 97.63 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 13 4 # 13 B 193 SER M 83 SER~? 4.48 CL CL M2029 B 223 HIS M 79 HIS~? -4.31 CL CL M2029s B 262 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 24.20 33.47 87.18 22.82 34.14 89.12 119.79 211.86 171.05 121.18 212.22 169.09 coo 23.86 29.50 91.20 24.12 31.58 91.00 125.50 211.59 173.52 124.72 213.49 173.99 coo 29.35 31.42 99.15 28.72 33.09 98.04 132.19 217.95 169.15 132.87 219.15 167.56 coo 20.42 28.25 99.26 20.25 29.62 97.63 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 14 4 # 14 B 193 SER N 83 SER~? 3.82 CL CL N2030 B 223 HIS N 79 HIS~? -4.33 CL CL N2030s B 262 HIS N 125 HIS.? 9.29 CL CL N2030 B 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 24.20 33.47 87.18 22.82 34.14 89.12 221.50 155.10 133.13 220.51 157.01 132.05 coo 23.86 29.50 91.20 24.12 31.58 91.00 215.64 153.98 132.96 216.60 153.22 131.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 210.43 158.18 125.05 210.19 159.49 123.43 coo 20.42 28.25 99.26 20.25 29.62 97.63 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 15 4 # 15 B 193 SER O 83 SER~? 7.53 CL CL O2018 B 223 HIS O 79 HIS~? 5.21 CL CL O2018 B 262 HIS O 125 HIS.? 7.09 CL CL O2018 B 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 24.20 33.47 87.18 22.82 34.14 89.12 115.90 131.94 160.39 117.13 130.87 162.21 coo 23.86 29.50 91.20 24.12 31.58 91.00 121.98 131.53 158.56 121.09 129.74 157.92 coo 29.35 31.42 99.15 28.72 33.09 98.04 126.97 124.39 163.68 126.90 122.97 165.24 coo 20.42 28.25 99.26 20.25 29.62 97.63 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 4 1aj8_c03 CITRATE SYNTHASE user 16 4 # 16 B 193 SER P 83 SER~? 8.38 CL CL P2019 B 223 HIS P 79 HIS~? 5.38 CL CL P2019 B 262 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 24.20 33.47 87.18 22.82 34.14 89.12 218.12 176.21 210.92 216.94 174.20 211.47 coo 23.86 29.50 91.20 24.12 31.58 91.00 212.25 178.47 210.26 213.09 179.27 212.01 coo 29.35 31.42 99.15 28.72 33.09 98.04 205.78 175.00 217.63 205.21 173.76 219.23 coo 20.42 28.25 99.26 20.25 29.62 97.63 207.19 183.81 214.61 207.22 185.89 215.11 1aj8_c03 source 1aj8 CITRATE SYNTHASE : 16 hits 1aj8_c03 naa= 4 ULMN 4 1al6_c01 CITRATE SYNTHASE user 1 4 # 1 244 SER A 83 SER~? 4.31 CL CL A2020 274 HIS A 79 HIS~? -3.92 CL CL A2020s 320 HIS A 125 HIS.? 6.10 O2 GOL A3040 375 ASP A 127 ASP.? 12.37 CL CL A2020 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 109.33 86.01 47.44 108.27 87.28 49.22 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 103.72 86.36 44.76 104.87 88.01 44.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 98.48 94.83 47.66 98.07 96.39 49.01 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 4 1al6_c01 CITRATE SYNTHASE user 2 4 # 2 244 SER B 83 SER~? 7.75 CL CL B2010 274 HIS B 79 HIS~? 5.08 CL CL B2010 320 HIS B 125 HIS.? 5.37 C1 GOL B3023 375 ASP B 127 ASP.? 11.35 CL CL B2010 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 7.70 61.77 7.67 8.73 59.61 7.20 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 13.46 62.96 8.26 12.78 63.30 6.30 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.73 57.29 2.23 19.89 55.80 0.75 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 4 1al6_c01 CITRATE SYNTHASE user 3 4 # 3 244 SER C 81 SER~? 9.13 CL CL C2021 274 HIS C 79 HIS~? -4.32 CL CL C2021s 320 HIS C 125 HIS.? 6.65 CL CL C2011 375 ASP C 127 ASP.? 10.87 CL CL C2011 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 97.80 14.60 67.87 97.00 16.56 66.71 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 92.85 10.89 71.99 93.43 9.18 73.06 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 86.57 4.11 67.63 86.24 2.65 66.14 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1al6_c01 CITRATE SYNTHASE user 4 4 # 4 244 SER C 83 SER~? 3.84 CL CL C2021 274 HIS C 79 HIS~? -4.32 CL CL C2021s 320 HIS C 125 HIS.? 6.65 CL CL C2011 375 ASP C 127 ASP.? 10.87 CL CL C2011 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 99.03 9.95 70.83 97.44 9.06 69.22 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 92.85 10.89 71.99 93.43 9.18 73.06 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 86.57 4.11 67.63 86.24 2.65 66.14 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1al6_c01 CITRATE SYNTHASE user 5 4 # 5 244 SER D 83 SER~? 4.15 CL CL D2022 274 HIS D 79 HIS~? -4.57 CL CL D2022s 320 HIS D 125 HIS.? -3.96 O3 GOL D3018s 375 ASP D 127 ASP.? 11.17 CL CL D2012 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 3.57 52.49 87.96 2.52 51.97 89.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.12 57.04 95.76 9.45 58.59 97.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 4 1al6_c01 CITRATE SYNTHASE user 6 4 # 6 244 SER E 83 SER~? 3.98 CL CL E2032 274 HIS E 79 HIS~? -4.18 CL CL E2032s 320 HIS E 125 HIS.? 5.41 C3 GOL E3022 375 ASP E 127 ASP.? 11.39 CL CL E2013 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 6.89 98.81 51.94 8.26 99.71 50.10 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 12.36 98.35 54.34 11.69 100.32 54.60 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.41 104.46 50.06 20.14 105.76 48.58 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 4 1al6_c01 CITRATE SYNTHASE user 7 4 # 7 244 SER F 83 SER~? 4.14 CL CL F2023 274 HIS F 79 HIS~? -4.63 CL CL F2023s 320 HIS F 125 HIS.? 6.27 C1 GOL F3039 375 ASP F 127 ASP.? 10.85 CL CL F2034 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 107.41 36.26 21.11 106.31 38.05 19.96 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 101.04 34.65 20.79 101.93 33.69 19.16 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 96.50 38.92 12.23 96.44 40.22 10.57 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 4 1al6_c01 CITRATE SYNTHASE user 8 4 # 8 244 SER G 83 SER~? 4.16 CL CL G2033 274 HIS G 79 HIS~? -4.46 CL CL G2033s 320 HIS G 125 HIS.? 6.66 C2 GOL G3038 375 ASP G 127 ASP.? 12.80 CL CL G2033 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 -0.88 18.73 43.69 0.20 17.85 45.68 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 5.20 17.85 42.65 4.12 16.10 42.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.81 10.31 48.06 9.47 8.80 49.48 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 4 1al6_c01 CITRATE SYNTHASE user 9 4 # 9 244 SER H 83 SER~? 4.17 CL CL H2024 274 HIS H 79 HIS~? 4.82 CL CL H2024 320 HIS H 125 HIS.? 7.36 CL CL H2014 375 ASP H 127 ASP.? 11.27 CL CL H2014 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 100.86 60.76 97.52 99.44 59.04 98.47 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 95.19 63.20 96.60 95.96 63.87 98.43 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 88.12 60.23 103.63 87.33 59.09 105.21 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 4 1al6_c01 CITRATE SYNTHASE user 10 4 # 10 244 SER I 81 SER~? 9.15 CL CL I2025 274 HIS I 79 HIS~? -4.56 CL CL I2025s 320 HIS I 125 HIS.? 6.50 O2 GOL I3031 375 ASP I 127 ASP.? 10.93 CL CL I2015 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 220.47 200.38 164.21 219.13 198.61 165.10 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 216.99 204.94 159.50 218.07 206.60 158.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 211.42 212.80 162.96 211.20 214.50 164.16 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 4 1al6_c01 CITRATE SYNTHASE user 11 4 # 11 244 SER I 83 SER~? 4.12 CL CL I2025 274 HIS I 79 HIS~? -4.56 CL CL I2025s 320 HIS I 125 HIS.? 6.50 O2 GOL I3031 375 ASP I 127 ASP.? 10.93 CL CL I2015 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 222.83 204.85 161.89 221.39 205.66 163.52 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 216.99 204.94 159.50 218.07 206.60 158.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 211.42 212.80 162.96 211.20 214.50 164.16 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 4 1al6_c01 CITRATE SYNTHASE user 12 4 # 12 244 SER J 83 SER~? 3.90 CL CL J2026 274 HIS J 79 HIS~? -4.36 CL CL J2026s 320 HIS J 125 HIS.? -4.00 O3 GOL J3030s 375 ASP J 127 ASP.? 11.08 CL CL J2016 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 120.35 177.35 126.19 121.76 175.49 125.60 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 126.45 179.07 126.46 125.69 179.71 124.61 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 132.43 173.86 119.73 132.77 172.30 118.36 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 4 1al6_c01 CITRATE SYNTHASE user 13 4 # 13 244 SER K 83 SER~? 3.98 CL CL K2027 274 HIS K 79 HIS~? -4.34 CL CL K2027s 320 HIS K 125 HIS.? -4.02 O1 GOL K3041s 375 ASP K 127 ASP.? 12.37 CL CL K2027 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 216.96 127.03 182.22 215.88 126.06 180.30 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 211.01 127.65 183.80 211.70 125.86 184.65 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 204.92 120.38 179.37 204.44 118.90 177.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 4 1al6_c01 CITRATE SYNTHASE user 14 4 # 14 244 SER L 81 SER~? 8.97 CL CL L2028 274 HIS L 79 HIS~? -4.09 CL CL L2028s 320 HIS L 125 HIS.? 5.88 O2 GOL L3027 375 ASP L 127 ASP.? 11.05 CL CL L2009 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 117.25 168.62 201.10 118.49 169.09 199.06 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 120.65 164.52 206.19 119.64 164.06 207.98 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.56 168.90 213.47 127.02 170.42 214.85 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 4 1al6_c01 CITRATE SYNTHASE user 15 4 # 15 244 SER L 83 SER~? 3.95 CL CL L2028 274 HIS L 79 HIS~? -4.09 CL CL L2028s 320 HIS L 125 HIS.? 5.88 O2 GOL L3027 375 ASP L 127 ASP.? 11.05 CL CL L2009 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 115.00 167.12 206.00 116.47 168.85 206.74 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 120.65 164.52 206.19 119.64 164.06 207.98 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.56 168.90 213.47 127.02 170.42 214.85 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 4 1al6_c01 CITRATE SYNTHASE user 16 4 # 16 244 SER M 83 SER~? 4.48 CL CL M2029 274 HIS M 79 HIS~? -4.31 CL CL M2029s 320 HIS M 125 HIS.? 4.98 C3 GOL M3043 375 ASP M 127 ASP.? 9.06 CL CL M2017 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 119.79 211.86 171.05 121.18 212.22 169.09 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 125.50 211.59 173.52 124.72 213.49 173.99 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 132.19 217.95 169.15 132.87 219.15 167.56 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 4 1al6_c01 CITRATE SYNTHASE user 17 4 # 17 244 SER N 83 SER~? 3.82 CL CL N2030 274 HIS N 79 HIS~? -4.33 CL CL N2030s 320 HIS N 125 HIS.? 9.29 CL CL N2030 375 ASP N 127 ASP.? 12.60 CL CL N2030 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 221.50 155.10 133.13 220.51 157.01 132.05 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 215.64 153.98 132.96 216.60 153.22 131.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 210.43 158.18 125.05 210.19 159.49 123.43 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 4 1al6_c01 CITRATE SYNTHASE user 18 4 # 18 244 SER O 83 SER~? 7.53 CL CL O2018 274 HIS O 79 HIS~? 5.21 CL CL O2018 320 HIS O 125 HIS.? 7.09 CL CL O2018 375 ASP O 127 ASP.? 11.33 CL CL O2018 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 115.90 131.94 160.39 117.13 130.87 162.21 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 121.98 131.53 158.56 121.09 129.74 157.92 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.97 124.39 163.68 126.90 122.97 165.24 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 4 1al6_c01 CITRATE SYNTHASE user 19 4 # 19 244 SER P 83 SER~? 8.38 CL CL P2019 274 HIS P 79 HIS~? 5.38 CL CL P2019 320 HIS P 125 HIS.? 6.57 O3 GOL P3034 375 ASP P 127 ASP.? 11.05 CL CL P2019 coo 7.28 -2.66 -2.02 9.55 -2.28 -2.78 218.12 176.21 210.92 216.94 174.20 211.47 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 212.25 178.47 210.26 213.09 179.27 212.01 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 205.78 175.00 217.63 205.21 173.76 219.23 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 207.19 183.81 214.61 207.22 185.89 215.11 1al6_c01 source 1al6 CITRATE SYNTHASE : 19 hits 1al6_c01 naa= 4 ULMN 4 1dco_c01 DCOH user 1 4 # 1 B 62 HIS C 79 HIS~? -4.32 CL CL C2021s B 63 HIS C 76 HIS~? -4.98 CL CL C2011s B 80 HIS C 125 HIS.? 6.65 CL CL C2011 B 89 ASP C 127 ASP.? 10.87 CL CL C2011 coo 30.13 28.91 18.82 29.78 26.89 19.27 92.85 10.89 71.99 93.43 9.18 73.06 coo 30.80 33.19 23.94 30.03 35.03 23.38 89.28 12.80 65.47 90.23 11.67 63.98 coo 25.47 25.21 25.04 27.09 24.88 26.31 86.57 4.11 67.63 86.24 2.65 66.14 coo 32.70 23.27 17.35 31.06 23.48 18.68 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1dco_c01 DCOH user 2 4 # 2 B 62 HIS F 79 HIS~? -4.63 CL CL F2023s B 63 HIS F 76 HIS~? -4.65 CL CL F2034s B 80 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 89 ASP F 127 ASP.? 10.85 CL CL F2034 coo 30.13 28.91 18.82 29.78 26.89 19.27 101.04 34.65 20.79 101.93 33.69 19.16 coo 30.80 33.19 23.94 30.03 35.03 23.38 97.24 41.20 21.57 98.43 42.65 20.63 coo 25.47 25.21 25.04 27.09 24.88 26.31 96.50 38.92 12.23 96.44 40.22 10.57 coo 32.70 23.27 17.35 31.06 23.48 18.68 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 4 1dco_c01 DCOH user 3 4 # 3 B 62 HIS I 79 HIS~? -4.56 CL CL I2025s B 63 HIS I 76 HIS~? 4.17 O3 GOL I3031s B 80 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 89 ASP I 127 ASP.? 10.93 CL CL I2015 coo 30.13 28.91 18.82 29.78 26.89 19.27 216.99 204.94 159.50 218.07 206.60 158.77 coo 30.80 33.19 23.94 30.03 35.03 23.38 212.11 203.51 165.19 213.01 204.42 166.85 coo 25.47 25.21 25.04 27.09 24.88 26.31 211.42 212.80 162.96 211.20 214.50 164.16 coo 32.70 23.27 17.35 31.06 23.48 18.68 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 4 1dco_c01 DCOH user 4 4 # 4 B 62 HIS K 79 HIS~? -4.34 CL CL K2027s B 63 HIS K 76 HIS~? -6.12 C3 GOL K3041s B 80 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 89 ASP K 127 ASP.? 12.37 CL CL K2027 coo 30.13 28.91 18.82 29.78 26.89 19.27 211.01 127.65 183.80 211.70 125.86 184.65 coo 30.80 33.19 23.94 30.03 35.03 23.38 207.10 129.51 177.50 208.14 128.55 175.95 coo 25.47 25.21 25.04 27.09 24.88 26.31 204.92 120.38 179.37 204.44 118.90 177.95 coo 32.70 23.27 17.35 31.06 23.48 18.68 205.42 123.70 188.60 205.51 122.74 190.54 1dco_c01 source 1dco DCOH : 4 hits 1dco_c01 naa= 4 ULMN 4 1dco_c07 DCOH user 1 4 # 1 H 62 HIS C 79 HIS~? -4.32 CL CL C2021s H 63 HIS C 76 HIS~? -4.98 CL CL C2011s H 80 HIS C 125 HIS.? 6.65 CL CL C2011 H 89 ASP C 127 ASP.? 10.87 CL CL C2011 coo 25.41 62.31 81.97 26.41 62.87 83.70 92.85 10.89 71.99 93.43 9.18 73.06 coo 27.91 57.00 79.64 28.08 57.36 77.58 89.28 12.80 65.47 90.23 11.67 63.98 coo 32.94 62.32 86.32 31.68 60.75 86.87 86.57 4.11 67.63 86.24 2.65 66.14 coo 22.93 64.49 87.27 24.97 64.23 86.95 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 4 1dco_c07 DCOH user 2 4 # 2 H 62 HIS F 79 HIS~? -4.63 CL CL F2023s H 63 HIS F 76 HIS~? -4.65 CL CL F2034s H 80 HIS F 125 HIS.? 6.27 C1 GOL F3039 H 89 ASP F 127 ASP.? 10.85 CL CL F2034 coo 25.41 62.31 81.97 26.41 62.87 83.70 101.04 34.65 20.79 101.93 33.69 19.16 coo 27.91 57.00 79.64 28.08 57.36 77.58 97.24 41.20 21.57 98.43 42.65 20.63 coo 32.94 62.32 86.32 31.68 60.75 86.87 96.50 38.92 12.23 96.44 40.22 10.57 coo 22.93 64.49 87.27 24.97 64.23 86.95 96.13 30.12 15.93 96.25 28.10 15.23 1dco_c07 source 1dco DCOH : 2 hits 1dco_c07 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU A 59 GLU.? 24.46 O1 GOL A3040 A 136 ARG A 108 ARG~? 22.68 O1 GOL A3040 A 275 ASP A 54 ASP~? 22.76 O3 GOL B3003 A 435 GLU A 56 GLU.? 25.60 O3 GOL B3003 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 73.55 78.44 42.57 74.34 76.74 41.50 coo -4.99 57.22 1.82 -7.93 56.43 2.21 77.54 80.61 37.36 78.31 77.83 38.52 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 63.60 81.91 35.55 61.73 81.46 36.38 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 66.40 88.57 34.15 65.18 90.26 34.28 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 2 4 # 2 A 132 GLU C 59 GLU.? 17.71 C3 GOL C3021 A 136 ARG C 108 ARG~? 20.30 O3 GOL C3021 A 275 ASP C 54 ASP~? 14.99 CL CL C2006 A 435 GLU C 56 GLU~? 17.52 CL CL C2004 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 64.70 25.06 67.52 64.51 27.14 67.22 coo -4.99 57.22 1.82 -7.93 56.43 2.21 67.42 22.77 74.41 69.21 25.29 74.04 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 53.32 23.86 72.39 51.93 24.66 71.07 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 54.66 16.88 74.36 53.19 15.44 73.98 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 3 4 # 3 A 132 GLU D 59 GLU.? 17.18 O2 GOL D3019 A 136 ARG D 108 ARG~? 19.71 O3 GOL D3019 A 275 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 435 GLU D 56 GLU~? 9.22 O1 GOL D3005 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 34.38 48.89 80.62 34.75 48.54 78.54 coo -4.99 57.22 1.82 -7.93 56.43 2.21 29.84 43.62 83.53 28.05 43.26 81.00 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 43.67 42.20 85.12 45.49 43.03 84.45 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 40.62 42.19 92.06 41.92 42.65 93.65 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 4 4 # 4 A 132 GLU E 59 GLU.? 18.54 O2 GOL E3035 A 136 ARG E 108 ARG~? 18.65 O1 GOL E3035 A 275 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 435 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 39.30 83.55 59.19 38.26 82.82 60.97 coo -4.99 57.22 1.82 -7.93 56.43 2.21 36.12 87.73 64.17 35.30 85.24 62.51 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 50.61 86.23 65.01 52.31 85.22 64.30 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 5 4 # 5 A 132 GLU F 59 GLU.? -3.47 CL CL F2035s A 136 ARG F 108 ARG~? -3.40 CL CL F2035s A 275 ASP F 54 ASP~? 17.55 CL CL F2035 A 435 GLU F 56 GLU~? 19.98 CL CL F2035 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 70.01 37.30 28.39 71.62 37.24 29.74 coo -4.99 57.22 1.82 -7.93 56.43 2.21 74.01 31.91 26.65 74.85 33.96 28.84 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 59.85 34.12 24.67 58.32 35.47 25.18 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 6 4 # 6 A 132 GLU G 59 GLU.? 19.70 CL CL C2006 A 136 ARG G 108 ARG~? 22.05 O2 GOL G3001 A 275 ASP G 54 ASP~? 15.07 CL CL C2006 A 435 GLU G 56 GLU.? 17.83 CL CL C2004 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 36.26 26.21 43.47 36.13 28.17 44.46 coo -4.99 57.22 1.82 -7.93 56.43 2.21 32.32 22.84 38.36 31.62 25.53 39.73 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 46.65 21.52 40.60 48.29 22.27 41.77 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 43.97 14.81 40.22 44.85 13.00 40.58 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 7 4 # 7 A 132 GLU H 59 GLU.? 16.22 O2 GOL H3016 A 136 ARG H 108 ARG~? 14.48 O2 GOL H3016 A 275 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 435 GLU H 56 GLU.? 8.74 O3 GOL H3006 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 68.06 65.41 81.65 68.51 66.61 79.97 coo -4.99 57.22 1.82 -7.93 56.43 2.21 71.22 70.92 84.57 72.18 68.95 82.36 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 56.87 71.80 83.08 55.07 70.98 82.33 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 58.45 73.39 90.18 56.86 73.32 91.53 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 8 4 # 8 A 132 GLU K 59 GLU.? 18.15 O3 GOL K3010 A 136 ARG K 108 ARG~? 18.77 O3 GOL K3010 A 275 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 435 GLU K 56 GLU~? 9.32 O1 GOL K3011 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 181.67 140.70 183.14 183.47 141.86 183.25 coo -4.99 57.22 1.82 -7.93 56.43 2.21 185.36 137.67 187.99 186.54 140.01 186.30 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 171.09 138.55 186.41 169.55 139.29 185.16 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 172.89 131.40 187.88 171.30 130.10 187.44 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 9 4 # 9 A 132 GLU M 59 GLU.? 20.39 CL CL I2007 A 136 ARG M 108 ARG~? 23.14 O1 GOL M3043 A 275 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 435 GLU M 56 GLU~? 9.79 O1 GOL M3007 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 154.66 198.25 177.60 153.49 196.88 176.48 coo -4.99 57.22 1.82 -7.93 56.43 2.21 150.62 202.12 182.01 149.56 199.68 180.53 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 164.95 201.02 181.99 166.71 200.19 181.24 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 163.29 208.10 182.55 164.69 209.62 182.16 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 10 4 # 10 A 132 GLU O 59 GLU.? 16.38 CL CL O2036 A 136 ARG O 108 ARG~? 13.39 CL CL O2036 A 275 ASP O 54 ASP~? 15.16 CL CL K2003 A 435 GLU O 56 GLU.? 16.78 CL CL O2036 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 151.76 141.44 158.93 151.52 142.12 156.88 coo -4.99 57.22 1.82 -7.93 56.43 2.21 148.81 138.28 154.16 147.06 140.78 153.42 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 162.95 137.35 154.91 164.67 137.97 155.90 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 11 4 # 11 A 132 GLU P 59 GLU.? 23.07 O3 GOL P3014 A 136 ARG P 108 ARG~? 21.30 O3 GOL P3014 A 275 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 435 GLU P 56 GLU.? 24.16 O3 GOL M3007 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 183.91 180.18 196.89 184.59 182.10 196.19 coo -4.99 57.22 1.82 -7.93 56.43 2.21 187.53 185.71 199.97 188.17 183.79 197.64 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 172.77 185.90 199.12 171.10 184.95 198.29 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 174.58 187.04 206.13 173.17 186.75 207.60 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 11 hits 1dl2_c00 naa= 4 ULMN 4 1kzh_c01 PHOSPHOFRUCTOKINASE user 1 4 # 1 B 146 ARG B 37 ARG~? -4.23 C1 GOL B3003s B 203 LYS B 22 LYS~? 21.36 O2 GOL B3003 B 204 THR B 25 THR~? 18.37 C1 GOL B3003 B 206 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 30.44 48.99 84.53 31.72 50.36 82.10 62.11 68.41 8.30 60.04 68.85 10.44 coo 41.12 55.31 79.75 37.30 52.17 81.04 65.01 54.92 6.02 70.07 53.87 9.73 coo 38.33 54.75 77.25 36.67 56.16 77.22 62.90 57.03 1.60 64.66 58.25 2.10 coo 33.88 56.54 74.67 32.88 54.78 75.26 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 4 1kzh_c01 PHOSPHOFRUCTOKINASE user 2 4 # 2 B 146 ARG E 37 ARG~? -4.52 O1 GOL E3004s B 203 LYS E 22 LYS~? 21.81 O1 GOL E3004 B 204 THR E 25 THR~? 18.78 O1 GOL E3004 B 206 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 30.44 48.99 84.53 31.72 50.36 82.10 58.59 99.11 69.23 56.48 96.91 69.19 coo 41.12 55.31 79.75 37.30 52.17 81.04 64.37 100.86 56.32 69.54 97.12 56.69 coo 38.33 54.75 77.25 36.67 56.16 77.22 62.03 105.38 57.79 63.36 104.90 59.41 coo 33.88 56.54 74.67 32.88 54.78 75.26 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 4 1kzh_c01 PHOSPHOFRUCTOKINASE user 3 4 # 3 B 146 ARG P 37 ARG~? -21.37 O3 GOL M3007s B 203 LYS P 22 LYS~? 16.49 O1 GOL L3028 B 204 THR P 25 THR~? 25.98 O1 GOL L3028 B 206 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 30.44 48.99 84.53 31.72 50.36 82.10 165.27 191.94 211.53 167.28 191.57 209.25 coo 41.12 55.31 79.75 37.30 52.17 81.04 160.29 179.27 215.80 155.06 178.69 212.33 coo 38.33 54.75 77.25 36.67 56.16 77.22 162.77 181.61 219.73 161.27 183.01 219.06 coo 33.88 56.54 74.67 32.88 54.78 75.26 167.75 181.83 222.09 168.94 183.53 222.37 1kzh_c01 source 1kzh PHOSPHOFRUCTOKINASE : 3 hits 1kzh_c01 naa= 4 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 1 4 # 1 E 218 ASN A 148 ASN~? 19.52 O3 GOL A3037 E 223 CYH A 153 CYH.? 14.43 O2 GOL A3037 E 464 HIS A 151 HIS~? -11.70 O3 GOL A3037s E 481 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 54.97 60.81 42.57 56.18 59.30 41.66 94.75 68.19 45.57 92.70 67.63 45.54 coo 52.64 53.08 37.81 53.81 50.54 38.32 101.61 70.42 52.87 102.62 71.46 50.52 coo 58.30 58.47 34.64 57.49 60.07 35.72 94.27 72.58 51.14 93.29 74.44 51.00 coo 54.45 64.64 33.82 56.13 63.43 34.32 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 2 4 # 2 E 218 ASN B 148 ASN~? 9.53 C1 GOL B3024 E 223 CYH B 153 CYH~? 8.68 O3 GOL B3015 E 464 HIS B 151 HIS~? -4.11 O3 GOL B3015s E 481 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 54.97 60.81 42.57 56.18 59.30 41.66 18.41 65.45 28.07 17.76 65.23 30.07 coo 52.64 53.08 37.81 53.81 50.54 38.32 10.51 59.26 25.83 10.35 61.25 24.02 coo 58.30 58.47 34.64 57.49 60.07 35.72 18.48 59.01 25.15 19.77 58.54 23.56 coo 54.45 64.64 33.82 56.13 63.43 34.32 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 3 4 # 3 E 218 ASN C 148 ASN~? 11.79 O3 GOL C3036 E 223 CYH C 153 CYH.? 7.56 CL CL C2031 E 464 HIS C 151 HIS~? -4.28 C2 GOL C3036s E 481 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 54.97 60.81 42.57 56.18 59.30 41.66 88.30 30.82 70.17 86.43 31.75 69.70 coo 52.64 53.08 37.81 53.81 50.54 38.32 96.07 27.08 64.55 96.20 25.81 66.95 coo 58.30 58.47 34.64 57.49 60.07 35.72 88.24 26.50 64.44 86.75 25.04 64.52 coo 54.45 64.64 33.82 56.13 63.43 34.32 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 4 4 # 4 E 218 ASN D 148 ASN~? 21.41 O2 GOL D3020 E 223 CYH D 153 CYH.? 14.75 O1 GOL D3020 E 464 HIS D 151 HIS~? -13.00 O2 GOL D3020s E 481 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 54.97 60.81 42.57 56.18 59.30 41.66 12.38 49.18 69.99 12.27 49.48 67.83 coo 52.64 53.08 37.81 53.81 50.54 38.32 5.67 57.11 70.86 4.62 54.95 72.38 coo 58.30 58.47 34.64 57.49 60.07 35.72 13.06 55.69 73.24 14.03 55.94 75.08 coo 54.45 64.64 33.82 56.13 63.43 34.32 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 5 4 # 5 E 218 ASN E 148 ASN~? 10.65 O1 GOL E3002 E 223 CYH E 153 CYH~? 8.85 O1 GOL E3002 E 464 HIS E 151 HIS~? -4.12 O1 GOL E3002s E 481 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 54.97 60.81 42.57 56.18 59.30 41.66 16.50 78.61 57.58 15.95 76.60 57.32 coo 52.64 53.08 37.81 53.81 50.54 38.32 10.10 80.75 49.90 9.59 82.62 51.85 coo 58.30 58.47 34.64 57.49 60.07 35.72 17.87 81.44 51.19 19.31 82.95 50.96 coo 54.45 64.64 33.82 56.13 63.43 34.32 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 6 4 # 6 E 218 ASN F 148 ASN~? 20.16 CL CL F2035 E 223 CYH F 153 CYH~? 17.48 CL CL F2034 E 464 HIS F 151 HIS~? 14.76 O3 GOL F3039s E 481 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 54.97 60.81 42.57 56.18 59.30 41.66 92.36 36.84 38.84 92.17 37.47 40.85 coo 52.64 53.08 37.81 53.81 50.54 38.32 100.56 42.65 36.94 101.15 40.25 35.75 coo 58.30 58.47 34.64 57.49 60.07 35.72 93.09 42.58 34.58 92.14 42.76 32.71 coo 54.45 64.64 33.82 56.13 63.43 34.32 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 7 4 # 7 E 218 ASN G 148 ASN~? 12.10 C1 GOL G3001 E 223 CYH G 153 CYH~? 9.03 O3 GOL G3001 E 464 HIS G 151 HIS~? -4.14 C3 GOL G3001s E 481 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 54.97 60.81 42.57 56.18 59.30 41.66 14.30 36.21 40.84 16.27 36.90 41.19 coo 52.64 53.08 37.81 53.81 50.54 38.32 6.06 35.44 46.92 5.44 33.82 44.74 coo 58.30 58.47 34.64 57.49 60.07 35.72 13.55 33.19 47.26 14.46 31.35 47.64 coo 54.45 64.64 33.82 56.13 63.43 34.32 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 8 4 # 8 E 218 ASN H 148 ASN~? 6.95 O1 GOL H3016 E 223 CYH H 153 CYH.? 12.27 O1 GOL H3016 E 464 HIS H 151 HIS~? 4.32 C1 GOL H3016s E 481 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 54.97 60.81 42.57 56.18 59.30 41.66 90.74 62.26 76.80 90.93 61.43 74.87 coo 52.64 53.08 37.81 53.81 50.54 38.32 97.03 55.04 80.47 97.67 57.42 81.76 coo 58.30 58.47 34.64 57.49 60.07 35.72 89.33 56.65 80.95 87.93 56.76 82.51 coo 54.45 64.64 33.82 56.13 63.43 34.32 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 9 4 # 9 E 218 ASN I 148 ASN~? 10.15 O1 GOL I3032 E 223 CYH I 153 CYH~? 13.03 O3 GOL I3032 E 464 HIS I 151 HIS~? 3.98 O3 GOL I3032s E 481 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 54.97 60.81 42.57 56.18 59.30 41.66 209.21 186.01 159.54 209.28 184.02 160.30 coo 52.64 53.08 37.81 53.81 50.54 38.32 216.28 188.21 166.60 217.09 189.60 164.27 coo 58.30 58.47 34.64 57.49 60.07 35.72 208.71 190.07 165.44 207.65 191.87 165.52 coo 54.45 64.64 33.82 56.13 63.43 34.32 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 10 4 # 10 E 218 ASN J 148 ASN~? 20.55 O1 GOL J3033 E 223 CYH J 153 CYH.? 14.69 O1 GOL J3033 E 464 HIS J 151 HIS~? -12.73 O1 GOL J3033s E 481 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 54.97 60.81 42.57 56.18 59.30 41.66 132.19 180.35 145.70 132.98 179.70 147.44 coo 52.64 53.08 37.81 53.81 50.54 38.32 124.53 173.82 143.70 124.14 176.01 142.05 coo 58.30 58.47 34.64 57.49 60.07 35.72 132.36 173.99 142.63 133.63 173.58 141.01 coo 54.45 64.64 33.82 56.13 63.43 34.32 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 11 4 # 11 E 218 ASN K 148 ASN~? 12.08 C1 GOL K3009 E 223 CYH K 153 CYH.? 10.08 C1 GOL K3009 E 464 HIS K 151 HIS~? -4.18 C2 GOL K3009s E 481 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 54.97 60.81 42.57 56.18 59.30 41.66 205.46 147.19 182.80 205.92 149.13 182.14 coo 52.64 53.08 37.81 53.81 50.54 38.32 213.02 144.07 176.61 213.41 142.76 178.95 coo 58.30 58.47 34.64 57.49 60.07 35.72 205.25 143.04 176.89 203.95 141.38 176.70 coo 54.45 64.64 33.82 56.13 63.43 34.32 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 12 4 # 12 E 218 ASN L 148 ASN~? 21.20 O3 GOL L3028 E 223 CYH L 153 CYH.? 17.58 CL CL L2028 E 464 HIS L 151 HIS~? -15.32 O3 GOL L3028s E 481 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 54.97 60.81 42.57 56.18 59.30 41.66 128.43 161.78 187.33 130.41 161.66 186.63 coo 52.64 53.08 37.81 53.81 50.54 38.32 121.51 169.13 188.69 120.63 167.06 190.29 coo 58.30 58.47 34.64 57.49 60.07 35.72 129.06 168.07 190.57 130.17 168.32 192.34 coo 54.45 64.64 33.82 56.13 63.43 34.32 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 13 4 # 13 E 218 ASN M 148 ASN~? 20.35 O3 GOL M3042 E 223 CYH M 153 CYH~? 14.73 C2 GOL M3042 E 464 HIS M 151 HIS~? -11.81 O3 GOL M3042s E 481 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 54.97 60.81 42.57 56.18 59.30 41.66 131.01 191.89 175.87 130.74 189.82 175.52 coo 52.64 53.08 37.81 53.81 50.54 38.32 124.18 194.08 168.46 123.60 195.77 170.58 coo 58.30 58.47 34.64 57.49 60.07 35.72 131.91 195.13 169.59 133.22 196.76 169.40 coo 54.45 64.64 33.82 56.13 63.43 34.32 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 14 4 # 14 E 218 ASN N 148 ASN~? 8.14 O1 GOL N3029 E 223 CYH N 153 CYH.? 9.71 O1 GOL N3012 E 464 HIS N 151 HIS~? 3.39 O2 GOL N3012s E 481 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 54.97 60.81 42.57 56.18 59.30 41.66 207.66 155.05 151.71 208.13 155.55 153.68 coo 52.64 53.08 37.81 53.81 50.54 38.32 215.62 161.14 149.48 216.18 158.76 148.20 coo 58.30 58.47 34.64 57.49 60.07 35.72 207.96 160.84 147.59 206.93 161.03 145.77 coo 54.45 64.64 33.82 56.13 63.43 34.32 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 15 4 # 15 E 218 ASN O 148 ASN~? 8.79 O3 GOL O3026 E 223 CYH O 153 CYH.? 10.07 O3 GOL O3013 E 464 HIS O 151 HIS~? 4.32 O2 GOL O3026s E 481 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 54.97 60.81 42.57 56.18 59.30 41.66 129.87 150.23 157.24 129.64 152.28 157.66 coo 52.64 53.08 37.81 53.81 50.54 38.32 121.90 148.90 163.71 121.42 147.29 161.55 coo 58.30 58.47 34.64 57.49 60.07 35.72 129.65 146.92 163.60 130.73 145.15 163.91 coo 54.45 64.64 33.82 56.13 63.43 34.32 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 4 1nbf_c02 UBIQUITIN CARBOXYL-TERMINAL HYDROLASuser 16 4 # 16 E 218 ASN P 148 ASN~? 11.59 O1 GOL P3014 E 223 CYH P 153 CYH.? 9.50 O2 GOL P3014 E 464 HIS P 151 HIS~? -4.15 C3 GOL P3014s E 481 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 54.97 60.81 42.57 56.18 59.30 41.66 206.51 178.28 190.78 206.84 177.74 188.77 coo 52.64 53.08 37.81 53.81 50.54 38.32 213.41 171.20 193.92 214.01 173.48 195.24 coo 58.30 58.47 34.64 57.49 60.07 35.72 205.70 172.52 194.71 204.41 172.45 196.35 coo 54.45 64.64 33.82 56.13 63.43 34.32 200.75 174.15 199.66 202.28 173.10 198.62 1nbf_c02 source 1nbf UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 7 : 16 hits 1nbf_c02 naa= 4 ULMN 4 1oqz_c02 GLUTARYL ACYLASE user 1 4 # 1 A 170 SER B 83 SER~? 7.75 CL CL B2010 A 192 HIS B 79 HIS~? 5.08 CL CL B2010 A 413 ASN B 84 ASN~? 10.19 CL CL B2010 A 624 GLU B 93 GLU~? 9.70 CL CL B2010 coo 80.14 40.76 52.28 77.73 40.59 51.94 7.70 61.77 7.67 8.73 59.61 7.20 coo 81.57 42.83 49.15 82.94 43.59 50.55 13.46 62.96 8.26 12.78 63.30 6.30 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.47 57.99 9.65 6.63 56.79 8.31 coo 83.99 48.41 48.69 83.76 47.49 50.58 11.87 67.96 6.38 12.21 67.44 4.38 ULMN 4 1oqz_c02 GLUTARYL ACYLASE user 2 4 # 2 A 170 SER E 83 SER~? 3.98 CL CL E2032 A 192 HIS E 79 HIS~? -4.18 CL CL E2032s A 413 ASN E 84 ASN~? 6.86 CL CL E2032 A 624 GLU E 93 GLU~? 8.42 CL CL E2032 coo 80.14 40.76 52.28 77.73 40.59 51.94 6.89 98.81 51.94 8.26 99.71 50.10 coo 81.57 42.83 49.15 82.94 43.59 50.55 12.36 98.35 54.34 11.69 100.32 54.60 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.48 96.99 47.72 6.68 98.41 46.68 coo 83.99 48.41 48.69 83.76 47.49 50.58 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 4 1oqz_c02 GLUTARYL ACYLASE user 3 4 # 3 A 170 SER N 83 SER~? 3.82 CL CL N2030 A 192 HIS N 79 HIS~? -4.33 CL CL N2030s A 413 ASN N 84 ASN~? 6.35 CL CL N2030 A 624 GLU N 93 GLU~? 8.57 CL CL N2030 coo 80.14 40.76 52.28 77.73 40.59 51.94 221.50 155.10 133.13 220.51 157.01 132.05 coo 81.57 42.83 49.15 82.94 43.59 50.55 215.64 153.98 132.96 216.60 153.22 131.26 coo 81.75 35.21 52.13 80.92 37.12 51.69 223.39 159.28 134.52 222.37 160.07 132.83 coo 83.99 48.41 48.69 83.76 47.49 50.58 217.47 148.79 132.22 217.76 148.97 130.14 1oqz_c02 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c02 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 103 ALA.? 23.54 C1 GOL A3040 A 458 ALA A 104 ALA.? 27.75 C1 GOL A3040 B 193 ALA A 135 ALA.? 20.01 CL CL A2020 B 194 GLY A 100 GLY.? 15.80 C1 GOL A3040 coo 43.27 124.32 20.47 43.79 125.29 21.53 85.79 84.63 30.26 86.09 85.81 29.49 coo 39.57 123.53 20.89 38.42 124.25 20.20 83.99 82.31 27.78 84.56 81.91 26.40 coo 47.95 129.15 20.31 47.81 128.95 18.79 92.96 83.99 31.70 93.11 82.79 32.66 coo 50.40 126.23 20.48 50.46 127.00 20.75 92.24 84.14 36.91 92.61 83.48 36.62 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA A 103 ALA.? 23.54 C1 GOL A3040 A 458 ALA A 107 ALA~? 23.39 C1 GOL A3040 B 193 ALA A 135 ALA.? 20.01 CL CL A2020 B 194 GLY A 100 GLY.? 15.80 C1 GOL A3040 coo 43.27 124.32 20.47 43.79 125.29 21.53 85.79 84.63 30.26 86.09 85.81 29.49 coo 39.57 123.53 20.89 38.42 124.25 20.20 82.20 83.48 33.36 81.08 83.84 32.41 coo 47.95 129.15 20.31 47.81 128.95 18.79 92.96 83.99 31.70 93.11 82.79 32.66 coo 50.40 126.23 20.48 50.46 127.00 20.75 92.24 84.14 36.91 92.61 83.48 36.62 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA C 103 ALA.? 23.74 CL CL C2011 A 458 ALA C 104 ALA.? 27.63 CL CL C2011 B 193 ALA C 135 ALA.? 18.18 CL CL C2011 B 194 GLY C 100 GLY.? 14.66 CL CL C2011 coo 43.27 124.32 20.47 43.79 125.29 21.53 72.83 17.21 82.55 72.76 16.04 83.42 coo 39.57 123.53 20.89 38.42 124.25 20.20 71.27 19.91 84.79 71.83 20.32 86.13 coo 47.95 129.15 20.31 47.81 128.95 18.79 80.29 16.27 82.51 80.76 17.49 81.72 coo 50.40 126.23 20.48 50.46 127.00 20.75 80.63 15.92 77.56 81.07 16.49 77.86 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA C 103 ALA.? 23.74 CL CL C2011 A 458 ALA C 107 ALA~? 24.66 O3 GOL C3021 B 193 ALA C 135 ALA.? 18.18 CL CL C2011 B 194 GLY C 100 GLY.? 14.66 CL CL C2011 coo 43.27 124.32 20.47 43.79 125.29 21.53 72.83 17.21 82.55 72.76 16.04 83.42 coo 39.57 123.53 20.89 38.42 124.25 20.20 70.53 18.97 78.69 69.18 18.83 79.43 coo 47.95 129.15 20.31 47.81 128.95 18.79 80.29 16.27 82.51 80.76 17.49 81.72 coo 50.40 126.23 20.48 50.46 127.00 20.75 80.63 15.92 77.56 81.07 16.49 77.86 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 457 ALA D 103 ALA.? 22.75 O3 GOL D3018 A 458 ALA D 104 ALA.? 25.39 O3 GOL D3005 B 193 ALA D 135 ALA.? 17.96 CL CL D2012 B 194 GLY D 100 GLY.? 14.37 CL CL D2012 coo 43.27 124.32 20.47 43.79 125.29 21.53 21.54 37.81 88.92 21.25 37.31 90.31 coo 39.57 123.53 20.89 38.42 124.25 20.20 22.98 34.70 87.10 22.19 33.47 86.79 coo 47.95 129.15 20.31 47.81 128.95 18.79 14.36 39.19 88.01 14.38 39.77 86.62 coo 50.40 126.23 20.48 50.46 127.00 20.75 15.06 44.22 87.32 14.69 43.84 86.72 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 457 ALA D 103 ALA.? 22.75 O3 GOL D3018 A 458 ALA D 107 ALA~? 22.02 O1 GOL D3005 B 193 ALA D 135 ALA.? 17.96 CL CL D2012 B 194 GLY D 100 GLY.? 14.37 CL CL D2012 coo 43.27 124.32 20.47 43.79 125.29 21.53 21.54 37.81 88.92 21.25 37.31 90.31 coo 39.57 123.53 20.89 38.42 124.25 20.20 25.02 40.65 87.20 26.22 39.76 87.79 coo 47.95 129.15 20.31 47.81 128.95 18.79 14.36 39.19 88.01 14.38 39.77 86.62 coo 50.40 126.23 20.48 50.46 127.00 20.75 15.06 44.22 87.32 14.69 43.84 86.72 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 457 ALA E 103 ALA.? 22.77 O1 GOL E3022 A 458 ALA E 104 ALA.? 25.00 O3 GOL E3004 B 193 ALA E 135 ALA.? 17.76 CL CL E2013 B 194 GLY E 100 GLY.? 14.41 CL CL E2013 coo 43.27 124.32 20.47 43.79 125.29 21.53 29.75 94.87 69.28 29.73 96.24 69.72 coo 39.57 123.53 20.89 38.42 124.25 20.20 30.68 92.74 72.36 29.80 92.61 73.57 coo 47.95 129.15 20.31 47.81 128.95 18.79 22.68 95.82 67.83 22.19 94.52 67.17 coo 50.40 126.23 20.48 50.46 127.00 20.75 23.21 94.72 62.80 22.71 94.23 63.20 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 457 ALA E 103 ALA.? 22.77 O1 GOL E3022 A 458 ALA E 107 ALA~? 22.09 O1 GOL E3004 B 193 ALA E 135 ALA.? 17.76 CL CL E2013 B 194 GLY E 100 GLY.? 14.41 CL CL E2013 coo 43.27 124.32 20.47 43.79 125.29 21.53 29.75 94.87 69.28 29.73 96.24 69.72 coo 39.57 123.53 20.89 38.42 124.25 20.20 32.73 92.45 66.43 33.92 92.84 67.38 coo 47.95 129.15 20.31 47.81 128.95 18.79 22.68 95.82 67.83 22.19 94.52 67.17 coo 50.40 126.23 20.48 50.46 127.00 20.75 23.21 94.72 62.80 22.71 94.23 63.20 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 457 ALA F 103 ALA.? 17.16 CL CL F2035 A 458 ALA F 104 ALA.? 17.42 CL CL F2035 B 193 ALA F 135 ALA.? 17.61 CL CL F2034 B 194 GLY F 100 GLY.? 14.35 CL CL F2034 coo 43.27 124.32 20.47 43.79 125.29 21.53 80.38 24.48 22.19 80.56 23.71 20.93 coo 39.57 123.53 20.89 38.42 124.25 20.20 78.22 22.26 24.45 78.62 20.87 24.89 coo 47.95 129.15 20.31 47.81 128.95 18.79 87.72 24.37 22.89 88.08 25.22 24.08 coo 50.40 126.23 20.48 50.46 127.00 20.75 88.10 29.47 22.82 88.41 29.13 23.45 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 457 ALA F 103 ALA.? 17.16 CL CL F2035 A 458 ALA F 107 ALA~? 11.99 CL CL F2035 B 193 ALA F 135 ALA.? 17.61 CL CL F2034 B 194 GLY F 100 GLY.? 14.35 CL CL F2034 coo 43.27 124.32 20.47 43.79 125.29 21.53 80.38 24.48 22.19 80.56 23.71 20.93 coo 39.57 123.53 20.89 38.42 124.25 20.20 77.64 28.24 23.39 76.33 27.50 23.08 coo 47.95 129.15 20.31 47.81 128.95 18.79 87.72 24.37 22.89 88.08 25.22 24.08 coo 50.40 126.23 20.48 50.46 127.00 20.75 88.10 29.47 22.82 88.41 29.13 23.45 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 457 ALA G 103 ALA.? 23.43 O3 GOL G3038 A 458 ALA G 104 ALA.? 27.56 O3 GOL G3038 B 193 ALA G 135 ALA.? 19.98 C3 GOL G3038 B 194 GLY G 100 GLY.? 15.63 C3 GOL G3038 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.93 17.13 31.78 25.80 15.78 31.20 coo 39.57 123.53 20.89 38.42 124.25 20.20 28.07 19.00 29.20 27.65 19.27 27.79 coo 47.95 129.15 20.31 47.81 128.95 18.79 18.49 17.87 31.65 18.29 19.28 32.20 coo 50.40 126.23 20.48 50.46 127.00 20.75 18.20 18.81 36.73 17.92 19.38 36.23 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 457 ALA G 103 ALA.? 23.43 O3 GOL G3038 A 458 ALA G 107 ALA~? 23.34 O3 GOL G3038 B 193 ALA G 135 ALA.? 19.98 C3 GOL G3038 B 194 GLY G 100 GLY.? 15.63 C3 GOL G3038 coo 43.27 124.32 20.47 43.79 125.29 21.53 25.93 17.13 31.78 25.80 15.78 31.20 coo 39.57 123.53 20.89 38.42 124.25 20.20 28.71 19.00 35.28 30.01 18.45 34.61 coo 47.95 129.15 20.31 47.81 128.95 18.79 18.49 17.87 31.65 18.29 19.28 32.20 coo 50.40 126.23 20.48 50.46 127.00 20.75 18.20 18.81 36.73 17.92 19.38 36.23 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 457 ALA H 103 ALA.? 22.00 O2 GOL H3016 A 458 ALA H 104 ALA.? 23.11 O2 GOL H3016 B 193 ALA H 135 ALA.? 17.80 CL CL H2014 B 194 GLY H 100 GLY.? 14.46 CL CL H2014 coo 43.27 124.32 20.47 43.79 125.29 21.53 78.03 77.34 90.28 78.09 78.05 91.59 coo 39.57 123.53 20.89 38.42 124.25 20.20 77.04 79.94 87.64 77.82 81.14 87.32 coo 47.95 129.15 20.31 47.81 128.95 18.79 85.12 76.02 91.45 85.59 75.06 90.35 coo 50.40 126.23 20.48 50.46 127.00 20.75 84.43 70.85 91.47 84.93 71.17 90.93 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 457 ALA H 103 ALA.? 22.00 O2 GOL H3016 A 458 ALA H 107 ALA~? 19.88 O2 GOL H3016 B 193 ALA H 135 ALA.? 17.80 CL CL H2014 B 194 GLY H 100 GLY.? 14.46 CL CL H2014 coo 43.27 124.32 20.47 43.79 125.29 21.53 78.03 77.34 90.28 78.09 78.05 91.59 coo 39.57 123.53 20.89 38.42 124.25 20.20 74.84 74.21 88.46 73.65 75.20 88.59 coo 47.95 129.15 20.31 47.81 128.95 18.79 85.12 76.02 91.45 85.59 75.06 90.35 coo 50.40 126.23 20.48 50.46 127.00 20.75 84.43 70.85 91.47 84.93 71.17 90.93 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 457 ALA I 103 ALA.? 22.10 O1 GOL I3032 A 458 ALA I 104 ALA.? 23.01 O1 GOL I3032 B 193 ALA I 135 ALA.? 17.77 CL CL I2015 B 194 GLY I 100 GLY.? 14.37 CL CL I2015 coo 43.27 124.32 20.47 43.79 125.29 21.53 198.53 202.47 145.78 198.83 203.71 144.96 coo 39.57 123.53 20.89 38.42 124.25 20.20 196.91 200.10 143.15 197.60 199.68 141.94 coo 47.95 129.15 20.31 47.81 128.95 18.79 205.79 202.14 146.97 205.93 200.92 147.82 coo 50.40 126.23 20.48 50.46 127.00 20.75 205.29 202.15 152.01 205.70 201.55 151.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 457 ALA I 103 ALA.? 22.10 O1 GOL I3032 A 458 ALA I 107 ALA~? 19.76 O1 GOL I3032 B 193 ALA I 135 ALA.? 17.77 CL CL I2015 B 194 GLY I 100 GLY.? 14.37 CL CL I2015 coo 43.27 124.32 20.47 43.79 125.29 21.53 198.53 202.47 145.78 198.83 203.71 144.96 coo 39.57 123.53 20.89 38.42 124.25 20.20 195.26 201.05 149.03 194.08 201.40 148.06 coo 47.95 129.15 20.31 47.81 128.95 18.79 205.79 202.14 146.97 205.93 200.92 147.82 coo 50.40 126.23 20.48 50.46 127.00 20.75 205.29 202.15 152.01 205.70 201.55 151.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 A 457 ALA J 103 ALA.? 22.78 O3 GOL J3030 A 458 ALA J 104 ALA.? 27.25 CL CL J2016 B 193 ALA J 135 ALA.? 17.65 CL CL J2016 B 194 GLY J 100 GLY.? 14.25 CL CL J2016 coo 43.27 124.32 20.47 43.79 125.29 21.53 146.20 190.71 129.38 146.25 191.31 128.01 coo 39.57 123.53 20.89 38.42 124.25 20.20 147.96 193.37 131.52 147.53 194.84 131.67 coo 47.95 129.15 20.31 47.81 128.95 18.79 138.91 190.36 128.97 138.50 189.71 130.36 coo 50.40 126.23 20.48 50.46 127.00 20.75 138.71 185.34 129.72 138.30 185.82 130.25 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 A 457 ALA J 103 ALA.? 22.78 O3 GOL J3030 A 458 ALA J 107 ALA~? 22.98 O1 GOL J3030 B 193 ALA J 135 ALA.? 17.65 CL CL J2016 B 194 GLY J 100 GLY.? 14.25 CL CL J2016 coo 43.27 124.32 20.47 43.79 125.29 21.53 146.20 190.71 129.38 146.25 191.31 128.01 coo 39.57 123.53 20.89 38.42 124.25 20.20 148.84 187.30 131.57 150.17 188.07 131.20 coo 47.95 129.15 20.31 47.81 128.95 18.79 138.91 190.36 128.97 138.50 189.71 130.36 coo 50.40 126.23 20.48 50.46 127.00 20.75 138.71 185.34 129.72 138.30 185.82 130.25 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 A 457 ALA K 103 ALA.? 22.71 O1 GOL K3041 A 458 ALA K 104 ALA.? 24.94 C3 GOL K3011 B 193 ALA K 135 ALA.? 19.10 O1 GOL K3041 B 194 GLY K 100 GLY.? 14.95 O1 GOL K3041 coo 43.27 124.32 20.47 43.79 125.29 21.53 191.37 132.16 195.10 191.41 130.94 195.93 coo 39.57 123.53 20.89 38.42 124.25 20.20 189.66 134.67 197.47 190.20 135.04 198.78 coo 47.95 129.15 20.31 47.81 128.95 18.79 198.59 131.76 194.84 198.93 133.01 194.07 coo 50.40 126.23 20.48 50.46 127.00 20.75 198.88 131.68 189.78 199.27 132.26 190.18 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 A 457 ALA K 103 ALA.? 22.71 O1 GOL K3041 A 458 ALA K 107 ALA~? 22.22 O1 GOL K3011 B 193 ALA K 135 ALA.? 19.10 O1 GOL K3041 B 194 GLY K 100 GLY.? 14.95 O1 GOL K3041 coo 43.27 124.32 20.47 43.79 125.29 21.53 191.37 132.16 195.10 191.41 130.94 195.93 coo 39.57 123.53 20.89 38.42 124.25 20.20 188.69 133.89 191.46 187.37 133.63 192.25 coo 47.95 129.15 20.31 47.81 128.95 18.79 198.59 131.76 194.84 198.93 133.01 194.07 coo 50.40 126.23 20.48 50.46 127.00 20.75 198.88 131.68 189.78 199.27 132.26 190.18 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 A 457 ALA M 103 ALA.? 23.16 C1 GOL M3043 A 458 ALA M 104 ALA.? 24.70 O2 GOL M3007 B 193 ALA M 135 ALA.? 17.94 CL CL M2017 B 194 GLY M 100 GLY.? 14.53 CL CL M2017 coo 43.27 124.32 20.47 43.79 125.29 21.53 143.77 208.24 187.66 143.68 209.57 188.29 coo 39.57 123.53 20.89 38.42 124.25 20.20 145.12 206.09 190.53 144.39 205.96 191.83 coo 47.95 129.15 20.31 47.81 128.95 18.79 136.61 208.69 186.51 136.19 207.38 185.80 coo 50.40 126.23 20.48 50.46 127.00 20.75 136.99 208.10 181.48 136.55 207.56 181.91 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 A 457 ALA M 103 ALA.? 23.16 C1 GOL M3043 A 458 ALA M 107 ALA~? 21.92 O2 GOL M3007 B 193 ALA M 135 ALA.? 17.94 CL CL M2017 B 194 GLY M 100 GLY.? 14.53 CL CL M2017 coo 43.27 124.32 20.47 43.79 125.29 21.53 143.77 208.24 187.66 143.68 209.57 188.29 coo 39.57 123.53 20.89 38.42 124.25 20.20 146.87 206.02 184.65 148.06 206.37 185.60 coo 47.95 129.15 20.31 47.81 128.95 18.79 136.61 208.69 186.51 136.19 207.38 185.80 coo 50.40 126.23 20.48 50.46 127.00 20.75 136.99 208.10 181.48 136.55 207.56 181.91 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 23 4 # 23 A 457 ALA N 103 ALA.? 21.96 O2 GOL N3029 A 458 ALA N 104 ALA.? 23.34 O2 GOL N3029 B 193 ALA N 135 ALA.? 17.79 O2 GOL N3029 B 194 GLY N 100 GLY.? 15.00 O2 GOL N3029 coo 43.27 124.32 20.47 43.79 125.29 21.53 195.39 142.61 135.23 195.50 141.92 133.92 coo 39.57 123.53 20.89 38.42 124.25 20.20 193.52 140.18 137.52 194.08 138.86 137.96 coo 47.95 129.15 20.31 47.81 128.95 18.79 202.74 142.87 135.54 203.09 143.71 136.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 202.89 147.88 135.58 203.22 147.52 136.22 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 24 4 # 24 A 457 ALA N 103 ALA.? 21.96 O2 GOL N3029 A 458 ALA N 107 ALA~? 20.05 O2 GOL N3029 B 193 ALA N 135 ALA.? 17.79 O2 GOL N3029 B 194 GLY N 100 GLY.? 15.00 O2 GOL N3029 coo 43.27 124.32 20.47 43.79 125.29 21.53 195.39 142.61 135.23 195.50 141.92 133.92 coo 39.57 123.53 20.89 38.42 124.25 20.20 192.58 146.26 136.61 191.34 145.47 136.19 coo 47.95 129.15 20.31 47.81 128.95 18.79 202.74 142.87 135.54 203.09 143.71 136.74 coo 50.40 126.23 20.48 50.46 127.00 20.75 202.89 147.88 135.58 203.22 147.52 136.22 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 25 4 # 25 A 457 ALA O 103 ALA.? 8.47 CL CL O2036 A 458 ALA O 104 ALA.? 12.70 CL CL O2036 B 193 ALA O 135 ALA.? 13.72 CL CL O2036 B 194 GLY O 100 GLY.? 12.06 CL CL O2036 coo 43.27 124.32 20.47 43.79 125.29 21.53 141.96 132.42 146.77 141.81 131.11 146.18 coo 39.57 123.53 20.89 38.42 124.25 20.20 143.88 134.49 144.18 143.39 134.64 142.75 coo 47.95 129.15 20.31 47.81 128.95 18.79 134.59 132.69 147.05 134.19 133.97 147.77 coo 50.40 126.23 20.48 50.46 127.00 20.75 134.51 133.33 152.18 134.16 133.89 151.73 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 26 4 # 26 A 457 ALA O 103 ALA.? 8.47 CL CL O2036 A 458 ALA O 107 ALA~? 7.32 CL CL O2036 B 193 ALA O 135 ALA.? 13.72 CL CL O2036 B 194 GLY O 100 GLY.? 12.06 CL CL O2036 coo 43.27 124.32 20.47 43.79 125.29 21.53 141.96 132.42 146.77 141.81 131.11 146.18 coo 39.57 123.53 20.89 38.42 124.25 20.20 144.83 134.27 150.21 146.04 133.75 149.40 coo 47.95 129.15 20.31 47.81 128.95 18.79 134.59 132.69 147.05 134.19 133.97 147.77 coo 50.40 126.23 20.48 50.46 127.00 20.75 134.51 133.33 152.18 134.16 133.89 151.73 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 27 4 # 27 A 457 ALA P 103 ALA.? 22.96 O2 GOL P3034 A 458 ALA P 104 ALA.? 27.15 C3 GOL M3007 B 193 ALA P 135 ALA.? 17.74 CL CL P2019 B 194 GLY P 100 GLY.? 14.36 CL CL P2019 coo 43.27 124.32 20.47 43.79 125.29 21.53 193.97 192.06 205.68 194.07 192.84 206.95 coo 39.57 123.53 20.89 38.42 124.25 20.20 192.65 194.69 203.24 193.36 195.93 203.02 coo 47.95 129.15 20.31 47.81 128.95 18.79 201.29 191.04 206.34 201.72 190.19 205.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 200.81 185.95 206.27 201.28 186.23 205.69 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 28 4 # 28 A 457 ALA P 103 ALA.? 22.96 O2 GOL P3034 A 458 ALA P 107 ALA~? 23.00 O2 GOL P3034 B 193 ALA P 135 ALA.? 17.74 CL CL P2019 B 194 GLY P 100 GLY.? 14.36 CL CL P2019 coo 43.27 124.32 20.47 43.79 125.29 21.53 193.97 192.06 205.68 194.07 192.84 206.95 coo 39.57 123.53 20.89 38.42 124.25 20.20 190.95 188.80 203.91 189.77 189.77 204.20 coo 47.95 129.15 20.31 47.81 128.95 18.79 201.29 191.04 206.34 201.72 190.19 205.13 coo 50.40 126.23 20.48 50.46 127.00 20.75 200.81 185.95 206.27 201.28 186.23 205.69 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 28 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 135 ALA.? 20.01 CL CL A2020 A 194 GLY A 100 GLY.? 15.80 C1 GOL A3040 B 457 ALA A 103 ALA.? 23.54 C1 GOL A3040 B 458 ALA A 104 ALA.? 27.75 C1 GOL A3040 coo 61.89 87.20 13.50 62.59 88.00 12.38 92.96 83.99 31.70 93.11 82.79 32.66 coo 59.34 89.99 13.88 59.24 89.18 13.73 92.24 84.14 36.91 92.61 83.48 36.62 coo 65.50 91.13 17.77 64.65 89.88 18.00 85.79 84.63 30.26 86.09 85.81 29.49 coo 68.56 91.15 20.03 69.95 90.68 19.64 83.99 82.31 27.78 84.56 81.91 26.40 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA A 135 ALA.? 20.01 CL CL A2020 A 194 GLY A 100 GLY.? 15.80 C1 GOL A3040 B 457 ALA A 103 ALA.? 23.54 C1 GOL A3040 B 458 ALA A 107 ALA~? 23.39 C1 GOL A3040 coo 61.89 87.20 13.50 62.59 88.00 12.38 92.96 83.99 31.70 93.11 82.79 32.66 coo 59.34 89.99 13.88 59.24 89.18 13.73 92.24 84.14 36.91 92.61 83.48 36.62 coo 65.50 91.13 17.77 64.65 89.88 18.00 85.79 84.63 30.26 86.09 85.81 29.49 coo 68.56 91.15 20.03 69.95 90.68 19.64 82.20 83.48 33.36 81.08 83.84 32.41 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA C 135 ALA.? 18.18 CL CL C2011 A 194 GLY C 100 GLY.? 14.66 CL CL C2011 B 457 ALA C 103 ALA.? 23.74 CL CL C2011 B 458 ALA C 104 ALA.? 27.63 CL CL C2011 coo 61.89 87.20 13.50 62.59 88.00 12.38 80.29 16.27 82.51 80.76 17.49 81.72 coo 59.34 89.99 13.88 59.24 89.18 13.73 80.63 15.92 77.56 81.07 16.49 77.86 coo 65.50 91.13 17.77 64.65 89.88 18.00 72.83 17.21 82.55 72.76 16.04 83.42 coo 68.56 91.15 20.03 69.95 90.68 19.64 71.27 19.91 84.79 71.83 20.32 86.13 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA C 135 ALA.? 18.18 CL CL C2011 A 194 GLY C 100 GLY.? 14.66 CL CL C2011 B 457 ALA C 103 ALA.? 23.74 CL CL C2011 B 458 ALA C 107 ALA~? 24.66 O3 GOL C3021 coo 61.89 87.20 13.50 62.59 88.00 12.38 80.29 16.27 82.51 80.76 17.49 81.72 coo 59.34 89.99 13.88 59.24 89.18 13.73 80.63 15.92 77.56 81.07 16.49 77.86 coo 65.50 91.13 17.77 64.65 89.88 18.00 72.83 17.21 82.55 72.76 16.04 83.42 coo 68.56 91.15 20.03 69.95 90.68 19.64 70.53 18.97 78.69 69.18 18.83 79.43 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 193 ALA D 135 ALA.? 17.96 CL CL D2012 A 194 GLY D 100 GLY.? 14.37 CL CL D2012 B 457 ALA D 103 ALA.? 22.75 O3 GOL D3018 B 458 ALA D 104 ALA.? 25.39 O3 GOL D3005 coo 61.89 87.20 13.50 62.59 88.00 12.38 14.36 39.19 88.01 14.38 39.77 86.62 coo 59.34 89.99 13.88 59.24 89.18 13.73 15.06 44.22 87.32 14.69 43.84 86.72 coo 65.50 91.13 17.77 64.65 89.88 18.00 21.54 37.81 88.92 21.25 37.31 90.31 coo 68.56 91.15 20.03 69.95 90.68 19.64 22.98 34.70 87.10 22.19 33.47 86.79 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 193 ALA D 135 ALA.? 17.96 CL CL D2012 A 194 GLY D 100 GLY.? 14.37 CL CL D2012 B 457 ALA D 103 ALA.? 22.75 O3 GOL D3018 B 458 ALA D 107 ALA~? 22.02 O1 GOL D3005 coo 61.89 87.20 13.50 62.59 88.00 12.38 14.36 39.19 88.01 14.38 39.77 86.62 coo 59.34 89.99 13.88 59.24 89.18 13.73 15.06 44.22 87.32 14.69 43.84 86.72 coo 65.50 91.13 17.77 64.65 89.88 18.00 21.54 37.81 88.92 21.25 37.31 90.31 coo 68.56 91.15 20.03 69.95 90.68 19.64 25.02 40.65 87.20 26.22 39.76 87.79 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 193 ALA E 135 ALA.? 17.76 CL CL E2013 A 194 GLY E 100 GLY.? 14.41 CL CL E2013 B 457 ALA E 103 ALA.? 22.77 O1 GOL E3022 B 458 ALA E 104 ALA.? 25.00 O3 GOL E3004 coo 61.89 87.20 13.50 62.59 88.00 12.38 22.68 95.82 67.83 22.19 94.52 67.17 coo 59.34 89.99 13.88 59.24 89.18 13.73 23.21 94.72 62.80 22.71 94.23 63.20 coo 65.50 91.13 17.77 64.65 89.88 18.00 29.75 94.87 69.28 29.73 96.24 69.72 coo 68.56 91.15 20.03 69.95 90.68 19.64 30.68 92.74 72.36 29.80 92.61 73.57 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 8 4 # 8 A 193 ALA E 135 ALA.? 17.76 CL CL E2013 A 194 GLY E 100 GLY.? 14.41 CL CL E2013 B 457 ALA E 103 ALA.? 22.77 O1 GOL E3022 B 458 ALA E 107 ALA~? 22.09 O1 GOL E3004 coo 61.89 87.20 13.50 62.59 88.00 12.38 22.68 95.82 67.83 22.19 94.52 67.17 coo 59.34 89.99 13.88 59.24 89.18 13.73 23.21 94.72 62.80 22.71 94.23 63.20 coo 65.50 91.13 17.77 64.65 89.88 18.00 29.75 94.87 69.28 29.73 96.24 69.72 coo 68.56 91.15 20.03 69.95 90.68 19.64 32.73 92.45 66.43 33.92 92.84 67.38 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 9 4 # 9 A 193 ALA F 135 ALA.? 17.61 CL CL F2034 A 194 GLY F 100 GLY.? 14.35 CL CL F2034 B 457 ALA F 103 ALA.? 17.16 CL CL F2035 B 458 ALA F 104 ALA.? 17.42 CL CL F2035 coo 61.89 87.20 13.50 62.59 88.00 12.38 87.72 24.37 22.89 88.08 25.22 24.08 coo 59.34 89.99 13.88 59.24 89.18 13.73 88.10 29.47 22.82 88.41 29.13 23.45 coo 65.50 91.13 17.77 64.65 89.88 18.00 80.38 24.48 22.19 80.56 23.71 20.93 coo 68.56 91.15 20.03 69.95 90.68 19.64 78.22 22.26 24.45 78.62 20.87 24.89 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 10 4 # 10 A 193 ALA F 135 ALA.? 17.61 CL CL F2034 A 194 GLY F 100 GLY.? 14.35 CL CL F2034 B 457 ALA F 103 ALA.? 17.16 CL CL F2035 B 458 ALA F 107 ALA~? 11.99 CL CL F2035 coo 61.89 87.20 13.50 62.59 88.00 12.38 87.72 24.37 22.89 88.08 25.22 24.08 coo 59.34 89.99 13.88 59.24 89.18 13.73 88.10 29.47 22.82 88.41 29.13 23.45 coo 65.50 91.13 17.77 64.65 89.88 18.00 80.38 24.48 22.19 80.56 23.71 20.93 coo 68.56 91.15 20.03 69.95 90.68 19.64 77.64 28.24 23.39 76.33 27.50 23.08 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 11 4 # 11 A 193 ALA G 135 ALA.? 19.98 C3 GOL G3038 A 194 GLY G 100 GLY.? 15.63 C3 GOL G3038 B 457 ALA G 103 ALA.? 23.43 O3 GOL G3038 B 458 ALA G 104 ALA.? 27.56 O3 GOL G3038 coo 61.89 87.20 13.50 62.59 88.00 12.38 18.49 17.87 31.65 18.29 19.28 32.20 coo 59.34 89.99 13.88 59.24 89.18 13.73 18.20 18.81 36.73 17.92 19.38 36.23 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.93 17.13 31.78 25.80 15.78 31.20 coo 68.56 91.15 20.03 69.95 90.68 19.64 28.07 19.00 29.20 27.65 19.27 27.79 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 12 4 # 12 A 193 ALA G 135 ALA.? 19.98 C3 GOL G3038 A 194 GLY G 100 GLY.? 15.63 C3 GOL G3038 B 457 ALA G 103 ALA.? 23.43 O3 GOL G3038 B 458 ALA G 107 ALA~? 23.34 O3 GOL G3038 coo 61.89 87.20 13.50 62.59 88.00 12.38 18.49 17.87 31.65 18.29 19.28 32.20 coo 59.34 89.99 13.88 59.24 89.18 13.73 18.20 18.81 36.73 17.92 19.38 36.23 coo 65.50 91.13 17.77 64.65 89.88 18.00 25.93 17.13 31.78 25.80 15.78 31.20 coo 68.56 91.15 20.03 69.95 90.68 19.64 28.71 19.00 35.28 30.01 18.45 34.61 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 13 4 # 13 A 193 ALA H 135 ALA.? 17.80 CL CL H2014 A 194 GLY H 100 GLY.? 14.46 CL CL H2014 B 457 ALA H 103 ALA.? 22.00 O2 GOL H3016 B 458 ALA H 104 ALA.? 23.11 O2 GOL H3016 coo 61.89 87.20 13.50 62.59 88.00 12.38 85.12 76.02 91.45 85.59 75.06 90.35 coo 59.34 89.99 13.88 59.24 89.18 13.73 84.43 70.85 91.47 84.93 71.17 90.93 coo 65.50 91.13 17.77 64.65 89.88 18.00 78.03 77.34 90.28 78.09 78.05 91.59 coo 68.56 91.15 20.03 69.95 90.68 19.64 77.04 79.94 87.64 77.82 81.14 87.32 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 14 4 # 14 A 193 ALA H 135 ALA.? 17.80 CL CL H2014 A 194 GLY H 100 GLY.? 14.46 CL CL H2014 B 457 ALA H 103 ALA.? 22.00 O2 GOL H3016 B 458 ALA H 107 ALA~? 19.88 O2 GOL H3016 coo 61.89 87.20 13.50 62.59 88.00 12.38 85.12 76.02 91.45 85.59 75.06 90.35 coo 59.34 89.99 13.88 59.24 89.18 13.73 84.43 70.85 91.47 84.93 71.17 90.93 coo 65.50 91.13 17.77 64.65 89.88 18.00 78.03 77.34 90.28 78.09 78.05 91.59 coo 68.56 91.15 20.03 69.95 90.68 19.64 74.84 74.21 88.46 73.65 75.20 88.59 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 15 4 # 15 A 193 ALA I 135 ALA.? 17.77 CL CL I2015 A 194 GLY I 100 GLY.? 14.37 CL CL I2015 B 457 ALA I 103 ALA.? 22.10 O1 GOL I3032 B 458 ALA I 104 ALA.? 23.01 O1 GOL I3032 coo 61.89 87.20 13.50 62.59 88.00 12.38 205.79 202.14 146.97 205.93 200.92 147.82 coo 59.34 89.99 13.88 59.24 89.18 13.73 205.29 202.15 152.01 205.70 201.55 151.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 198.53 202.47 145.78 198.83 203.71 144.96 coo 68.56 91.15 20.03 69.95 90.68 19.64 196.91 200.10 143.15 197.60 199.68 141.94 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 16 4 # 16 A 193 ALA I 135 ALA.? 17.77 CL CL I2015 A 194 GLY I 100 GLY.? 14.37 CL CL I2015 B 457 ALA I 103 ALA.? 22.10 O1 GOL I3032 B 458 ALA I 107 ALA~? 19.76 O1 GOL I3032 coo 61.89 87.20 13.50 62.59 88.00 12.38 205.79 202.14 146.97 205.93 200.92 147.82 coo 59.34 89.99 13.88 59.24 89.18 13.73 205.29 202.15 152.01 205.70 201.55 151.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 198.53 202.47 145.78 198.83 203.71 144.96 coo 68.56 91.15 20.03 69.95 90.68 19.64 195.26 201.05 149.03 194.08 201.40 148.06 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 17 4 # 17 A 193 ALA J 135 ALA.? 17.65 CL CL J2016 A 194 GLY J 100 GLY.? 14.25 CL CL J2016 B 457 ALA J 103 ALA.? 22.78 O3 GOL J3030 B 458 ALA J 104 ALA.? 27.25 CL CL J2016 coo 61.89 87.20 13.50 62.59 88.00 12.38 138.91 190.36 128.97 138.50 189.71 130.36 coo 59.34 89.99 13.88 59.24 89.18 13.73 138.71 185.34 129.72 138.30 185.82 130.25 coo 65.50 91.13 17.77 64.65 89.88 18.00 146.20 190.71 129.38 146.25 191.31 128.01 coo 68.56 91.15 20.03 69.95 90.68 19.64 147.96 193.37 131.52 147.53 194.84 131.67 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 18 4 # 18 A 193 ALA J 135 ALA.? 17.65 CL CL J2016 A 194 GLY J 100 GLY.? 14.25 CL CL J2016 B 457 ALA J 103 ALA.? 22.78 O3 GOL J3030 B 458 ALA J 107 ALA~? 22.98 O1 GOL J3030 coo 61.89 87.20 13.50 62.59 88.00 12.38 138.91 190.36 128.97 138.50 189.71 130.36 coo 59.34 89.99 13.88 59.24 89.18 13.73 138.71 185.34 129.72 138.30 185.82 130.25 coo 65.50 91.13 17.77 64.65 89.88 18.00 146.20 190.71 129.38 146.25 191.31 128.01 coo 68.56 91.15 20.03 69.95 90.68 19.64 148.84 187.30 131.57 150.17 188.07 131.20 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 19 4 # 19 A 193 ALA K 135 ALA.? 19.10 O1 GOL K3041 A 194 GLY K 100 GLY.? 14.95 O1 GOL K3041 B 457 ALA K 103 ALA.? 22.71 O1 GOL K3041 B 458 ALA K 104 ALA.? 24.94 C3 GOL K3011 coo 61.89 87.20 13.50 62.59 88.00 12.38 198.59 131.76 194.84 198.93 133.01 194.07 coo 59.34 89.99 13.88 59.24 89.18 13.73 198.88 131.68 189.78 199.27 132.26 190.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 191.37 132.16 195.10 191.41 130.94 195.93 coo 68.56 91.15 20.03 69.95 90.68 19.64 189.66 134.67 197.47 190.20 135.04 198.78 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 20 4 # 20 A 193 ALA K 135 ALA.? 19.10 O1 GOL K3041 A 194 GLY K 100 GLY.? 14.95 O1 GOL K3041 B 457 ALA K 103 ALA.? 22.71 O1 GOL K3041 B 458 ALA K 107 ALA~? 22.22 O1 GOL K3011 coo 61.89 87.20 13.50 62.59 88.00 12.38 198.59 131.76 194.84 198.93 133.01 194.07 coo 59.34 89.99 13.88 59.24 89.18 13.73 198.88 131.68 189.78 199.27 132.26 190.18 coo 65.50 91.13 17.77 64.65 89.88 18.00 191.37 132.16 195.10 191.41 130.94 195.93 coo 68.56 91.15 20.03 69.95 90.68 19.64 188.69 133.89 191.46 187.37 133.63 192.25 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 21 4 # 21 A 193 ALA M 135 ALA.? 17.94 CL CL M2017 A 194 GLY M 100 GLY.? 14.53 CL CL M2017 B 457 ALA M 103 ALA.? 23.16 C1 GOL M3043 B 458 ALA M 104 ALA.? 24.70 O2 GOL M3007 coo 61.89 87.20 13.50 62.59 88.00 12.38 136.61 208.69 186.51 136.19 207.38 185.80 coo 59.34 89.99 13.88 59.24 89.18 13.73 136.99 208.10 181.48 136.55 207.56 181.91 coo 65.50 91.13 17.77 64.65 89.88 18.00 143.77 208.24 187.66 143.68 209.57 188.29 coo 68.56 91.15 20.03 69.95 90.68 19.64 145.12 206.09 190.53 144.39 205.96 191.83 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 22 4 # 22 A 193 ALA M 135 ALA.? 17.94 CL CL M2017 A 194 GLY M 100 GLY.? 14.53 CL CL M2017 B 457 ALA M 103 ALA.? 23.16 C1 GOL M3043 B 458 ALA M 107 ALA~? 21.92 O2 GOL M3007 coo 61.89 87.20 13.50 62.59 88.00 12.38 136.61 208.69 186.51 136.19 207.38 185.80 coo 59.34 89.99 13.88 59.24 89.18 13.73 136.99 208.10 181.48 136.55 207.56 181.91 coo 65.50 91.13 17.77 64.65 89.88 18.00 143.77 208.24 187.66 143.68 209.57 188.29 coo 68.56 91.15 20.03 69.95 90.68 19.64 146.87 206.02 184.65 148.06 206.37 185.60 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 23 4 # 23 A 193 ALA N 135 ALA.? 17.79 O2 GOL N3029 A 194 GLY N 100 GLY.? 15.00 O2 GOL N3029 B 457 ALA N 103 ALA.? 21.96 O2 GOL N3029 B 458 ALA N 104 ALA.? 23.34 O2 GOL N3029 coo 61.89 87.20 13.50 62.59 88.00 12.38 202.74 142.87 135.54 203.09 143.71 136.74 coo 59.34 89.99 13.88 59.24 89.18 13.73 202.89 147.88 135.58 203.22 147.52 136.22 coo 65.50 91.13 17.77 64.65 89.88 18.00 195.39 142.61 135.23 195.50 141.92 133.92 coo 68.56 91.15 20.03 69.95 90.68 19.64 193.52 140.18 137.52 194.08 138.86 137.96 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 24 4 # 24 A 193 ALA N 135 ALA.? 17.79 O2 GOL N3029 A 194 GLY N 100 GLY.? 15.00 O2 GOL N3029 B 457 ALA N 103 ALA.? 21.96 O2 GOL N3029 B 458 ALA N 107 ALA~? 20.05 O2 GOL N3029 coo 61.89 87.20 13.50 62.59 88.00 12.38 202.74 142.87 135.54 203.09 143.71 136.74 coo 59.34 89.99 13.88 59.24 89.18 13.73 202.89 147.88 135.58 203.22 147.52 136.22 coo 65.50 91.13 17.77 64.65 89.88 18.00 195.39 142.61 135.23 195.50 141.92 133.92 coo 68.56 91.15 20.03 69.95 90.68 19.64 192.58 146.26 136.61 191.34 145.47 136.19 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 25 4 # 25 A 193 ALA O 135 ALA.? 13.72 CL CL O2036 A 194 GLY O 100 GLY.? 12.06 CL CL O2036 B 457 ALA O 103 ALA.? 8.47 CL CL O2036 B 458 ALA O 104 ALA.? 12.70 CL CL O2036 coo 61.89 87.20 13.50 62.59 88.00 12.38 134.59 132.69 147.05 134.19 133.97 147.77 coo 59.34 89.99 13.88 59.24 89.18 13.73 134.51 133.33 152.18 134.16 133.89 151.73 coo 65.50 91.13 17.77 64.65 89.88 18.00 141.96 132.42 146.77 141.81 131.11 146.18 coo 68.56 91.15 20.03 69.95 90.68 19.64 143.88 134.49 144.18 143.39 134.64 142.75 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 26 4 # 26 A 193 ALA O 135 ALA.? 13.72 CL CL O2036 A 194 GLY O 100 GLY.? 12.06 CL CL O2036 B 457 ALA O 103 ALA.? 8.47 CL CL O2036 B 458 ALA O 107 ALA~? 7.32 CL CL O2036 coo 61.89 87.20 13.50 62.59 88.00 12.38 134.59 132.69 147.05 134.19 133.97 147.77 coo 59.34 89.99 13.88 59.24 89.18 13.73 134.51 133.33 152.18 134.16 133.89 151.73 coo 65.50 91.13 17.77 64.65 89.88 18.00 141.96 132.42 146.77 141.81 131.11 146.18 coo 68.56 91.15 20.03 69.95 90.68 19.64 144.83 134.27 150.21 146.04 133.75 149.40 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 27 4 # 27 A 193 ALA P 135 ALA.? 17.74 CL CL P2019 A 194 GLY P 100 GLY.? 14.36 CL CL P2019 B 457 ALA P 103 ALA.? 22.96 O2 GOL P3034 B 458 ALA P 104 ALA.? 27.15 C3 GOL M3007 coo 61.89 87.20 13.50 62.59 88.00 12.38 201.29 191.04 206.34 201.72 190.19 205.13 coo 59.34 89.99 13.88 59.24 89.18 13.73 200.81 185.95 206.27 201.28 186.23 205.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 193.97 192.06 205.68 194.07 192.84 206.95 coo 68.56 91.15 20.03 69.95 90.68 19.64 192.65 194.69 203.24 193.36 195.93 203.02 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 28 4 # 28 A 193 ALA P 135 ALA.? 17.74 CL CL P2019 A 194 GLY P 100 GLY.? 14.36 CL CL P2019 B 457 ALA P 103 ALA.? 22.96 O2 GOL P3034 B 458 ALA P 107 ALA~? 23.00 O2 GOL P3034 coo 61.89 87.20 13.50 62.59 88.00 12.38 201.29 191.04 206.34 201.72 190.19 205.13 coo 59.34 89.99 13.88 59.24 89.18 13.73 200.81 185.95 206.27 201.28 186.23 205.69 coo 65.50 91.13 17.77 64.65 89.88 18.00 193.97 192.06 205.68 194.07 192.84 206.95 coo 68.56 91.15 20.03 69.95 90.68 19.64 190.95 188.80 203.91 189.77 189.77 204.20 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 28 hits 1pix_c03 naa= 4 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 1 4 # 1 A 62 GLU D 63 GLU~? 9.36 O3 GOL D3019 A 75 GLN D 166 GLN~? 21.13 O1 GOL D3020 A 84 GLU D 62 GLU~? 6.84 O2 GOL D3019 A 202 ASN D 165 ASN~? 17.10 CL CL D2022 coo 31.58 50.21 48.39 31.33 50.18 50.48 26.38 54.52 74.49 25.00 56.17 74.76 coo 15.01 67.80 50.45 13.17 67.90 51.59 2.69 48.18 70.17 3.26 49.63 68.68 coo 31.72 45.69 48.66 33.65 44.89 48.92 28.24 57.03 78.84 28.94 58.69 77.75 coo 11.82 69.95 45.33 12.39 70.17 47.37 -1.38 47.13 75.34 -2.60 46.72 77.02 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 2 4 # 2 A 62 GLU D 63 GLU~? 9.36 O3 GOL D3019 A 75 GLN D 166 GLN~? 21.13 O1 GOL D3020 A 84 GLU D 62 GLU~? 6.84 O2 GOL D3019 A 202 ASN D 169 ASN~? 20.20 CL CL D2022 coo 31.58 50.21 48.39 31.33 50.18 50.48 26.38 54.52 74.49 25.00 56.17 74.76 coo 15.01 67.80 50.45 13.17 67.90 51.59 2.69 48.18 70.17 3.26 49.63 68.68 coo 31.72 45.69 48.66 33.65 44.89 48.92 28.24 57.03 78.84 28.94 58.69 77.75 coo 11.82 69.95 45.33 12.39 70.17 47.37 2.51 43.08 73.92 0.74 42.93 75.11 1qrg_c00 source 1qrg CARBONIC ANHYDRASE : 2 hits 1qrg_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 54 ASP~? 22.76 O3 GOL B3003 A 100 ARG A 51 ARG~? 16.54 O3 GOL B3003 A 116 GLN A 49 GLN~? -17.97 O3 GOL B3003s coo 32.24 20.09 5.34 30.38 19.04 5.27 63.60 81.91 35.55 61.73 81.46 36.38 coo 26.40 25.34 6.28 26.15 22.33 7.25 61.69 79.67 29.64 62.00 76.91 30.99 coo 26.74 21.94 13.78 27.57 20.97 12.08 57.39 88.29 28.43 56.26 87.37 26.90 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 100 ARG B 51 ARG~? 11.52 O3 GOL B3003 A 116 GLN B 49 GLN~? -3.84 O2 GOL B3003s coo 32.24 20.09 5.34 30.38 19.04 5.27 53.08 65.82 20.87 54.46 64.71 21.90 coo 26.40 25.34 6.28 26.15 22.33 7.25 56.02 71.46 21.90 55.03 71.54 24.81 coo 26.74 21.94 13.78 27.57 20.97 12.08 62.15 70.11 14.96 63.42 71.58 15.87 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP C 54 ASP~? 14.99 CL CL C2006 A 100 ARG C 51 ARG~? 15.50 O3 GOL D3005 A 116 GLN C 49 GLN~? -17.03 O3 GOL D3005s coo 32.24 20.09 5.34 30.38 19.04 5.27 53.32 23.86 72.39 51.93 24.66 71.07 coo 26.40 25.34 6.28 26.15 22.33 7.25 50.80 26.41 78.15 53.63 27.50 78.75 coo 26.74 21.94 13.78 27.57 20.97 12.08 44.73 18.97 77.96 43.48 20.16 79.23 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 100 ARG D 51 ARG~? -12.62 C3 GOL D3005s A 116 GLN D 49 GLN~? -3.86 C1 GOL D3005s coo 32.24 20.09 5.34 30.38 19.04 5.27 43.67 42.20 85.12 45.49 43.03 84.45 coo 26.40 25.34 6.28 26.15 22.33 7.25 44.97 36.17 83.73 45.77 36.49 80.75 coo 26.74 21.94 13.78 27.57 20.97 12.08 49.64 36.42 92.77 50.82 34.75 92.16 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP F 54 ASP~? 17.55 CL CL F2035 A 100 ARG F 51 ARG~? 18.26 CL CL F2035 A 116 GLN F 49 GLN~? -27.01 O1 GOL B3017s coo 32.24 20.09 5.34 30.38 19.04 5.27 59.85 34.12 24.67 58.32 35.47 25.18 coo 26.40 25.34 6.28 26.15 22.33 7.25 56.56 29.17 27.33 58.39 29.67 29.78 coo 26.74 21.94 13.78 27.57 20.97 12.08 52.39 28.58 18.18 51.03 27.30 19.18 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP G 54 ASP~? 15.07 CL CL C2006 A 100 ARG G 51 ARG~? 21.90 CL CL C2006 A 116 GLN G 49 GLN~? -23.35 CL CL C2006s coo 32.24 20.09 5.34 30.38 19.04 5.27 46.65 21.52 40.60 48.29 22.27 41.77 coo 26.40 25.34 6.28 26.15 22.33 7.25 49.60 22.70 34.88 49.12 25.71 35.34 coo 26.74 21.94 13.78 27.57 20.97 12.08 53.91 14.01 36.43 55.26 14.63 34.91 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 100 ARG H 51 ARG~? -11.05 O1 GOL H3006s A 116 GLN H 49 GLN~? -4.02 C2 GOL H3006s coo 32.24 20.09 5.34 30.38 19.04 5.27 56.87 71.80 83.08 55.07 70.98 82.33 coo 26.40 25.34 6.28 26.15 22.33 7.25 55.75 78.18 80.83 58.67 78.05 79.79 coo 26.74 21.94 13.78 27.57 20.97 12.08 49.55 79.01 88.02 48.67 80.55 86.81 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 8 3 # 8 A 46 ASP I 54 ASP~? 15.17 CL CL I2007 A 100 ARG I 51 ARG~? 21.58 CL CL I2007 A 116 GLN I 49 GLN~? -23.38 CL CL I2007s coo 32.24 20.09 5.34 30.38 19.04 5.27 176.64 198.53 151.72 174.93 197.89 152.71 coo 26.40 25.34 6.28 26.15 22.33 7.25 174.23 196.17 146.19 174.71 193.30 147.29 coo 26.74 21.94 13.78 27.57 20.97 12.08 169.91 205.02 145.21 168.70 204.10 143.69 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 9 3 # 9 A 46 ASP J 54 ASP~? 19.87 CL CL J2002 A 100 ARG J 51 ARG~? 27.44 CL CL J2002 A 116 GLN J 49 GLN~? 24.01 CL CL J2002 coo 32.24 20.09 5.34 30.38 19.04 5.27 166.52 182.87 136.75 168.05 181.78 137.64 coo 26.40 25.34 6.28 26.15 22.33 7.25 168.80 189.12 137.91 166.15 189.45 139.46 coo 26.74 21.94 13.78 27.57 20.97 12.08 174.68 187.74 130.59 175.97 189.20 131.45 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 10 3 # 10 A 46 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 100 ARG K 51 ARG~? -10.79 O3 GOL K3011s A 116 GLN K 49 GLN~? -3.60 C1 GOL K3011s coo 32.24 20.09 5.34 30.38 19.04 5.27 171.09 138.55 186.41 169.55 139.29 185.16 coo 26.40 25.34 6.28 26.15 22.33 7.25 168.73 140.32 192.51 171.31 141.97 192.79 coo 26.74 21.94 13.78 27.57 20.97 12.08 162.94 132.97 191.99 161.75 134.08 193.36 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 11 3 # 11 A 46 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 100 ARG L 51 ARG~? 16.39 O3 GOL K3011 A 116 GLN L 49 GLN~? -17.16 O3 GOL K3011s coo 32.24 20.09 5.34 30.38 19.04 5.27 161.13 155.54 200.38 162.83 156.50 199.58 coo 26.40 25.34 6.28 26.15 22.33 7.25 163.01 149.53 198.74 162.90 150.47 195.82 coo 26.74 21.94 13.78 27.57 20.97 12.08 167.81 149.67 207.40 169.07 148.12 206.67 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 12 3 # 12 A 46 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 100 ARG M 51 ARG~? -9.68 O2 GOL M3007s A 116 GLN M 49 GLN~? -4.12 C1 GOL M3007s coo 32.24 20.09 5.34 30.38 19.04 5.27 164.95 201.02 181.99 166.71 200.19 181.24 coo 26.40 25.34 6.28 26.15 22.33 7.25 166.66 199.07 188.11 163.90 199.62 189.28 coo 26.74 21.94 13.78 27.57 20.97 12.08 172.36 207.31 187.85 173.41 206.43 189.48 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 13 3 # 13 A 46 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 100 ARG N 51 ARG~? 10.93 O1 GOL N3008 A 116 GLN N 49 GLN~? -3.60 O2 GOL N3008s coo 32.24 20.09 5.34 30.38 19.04 5.27 174.60 151.44 139.08 172.92 152.56 139.62 coo 26.40 25.34 6.28 26.15 22.33 7.25 172.16 145.36 140.78 174.78 144.98 142.37 coo 26.74 21.94 13.78 27.57 20.97 12.08 167.06 145.69 132.62 165.84 144.32 133.61 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 14 3 # 14 A 46 ASP O 54 ASP~? 15.16 CL CL K2003 A 100 ARG O 51 ARG~? 16.43 O1 GOL N3008 A 116 GLN O 49 GLN~? -17.97 O1 GOL N3008s coo 32.24 20.09 5.34 30.38 19.04 5.27 162.95 137.35 154.91 164.67 137.97 155.90 coo 26.40 25.34 6.28 26.15 22.33 7.25 165.78 138.84 148.96 164.30 141.49 149.44 coo 26.74 21.94 13.78 27.57 20.97 12.08 170.33 130.25 149.83 171.69 131.01 148.34 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 15 3 # 15 A 46 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 100 ARG P 51 ARG~? 14.75 O3 GOL M3007 A 116 GLN P 49 GLN~? -16.44 O3 GOL M3007s coo 32.24 20.09 5.34 30.38 19.04 5.27 172.77 185.90 199.12 171.10 184.95 198.29 coo 26.40 25.34 6.28 26.15 22.33 7.25 171.10 192.14 197.11 173.97 192.46 196.07 coo 26.74 21.94 13.78 27.57 20.97 12.08 165.46 192.43 204.59 164.40 193.94 203.51 12as_c00 source 12as ASPARAGINE SYNTHETASE : 15 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 54 ASP~? 22.76 O3 GOL B3003 B 100 ARG A 51 ARG~? 16.54 O3 GOL B3003 B 116 GLN A 49 GLN~? -17.97 O3 GOL B3003s coo 32.18 48.37 12.48 33.96 49.46 12.97 63.60 81.91 35.55 61.73 81.46 36.38 coo 39.04 43.25 11.37 38.30 45.35 13.56 61.69 79.67 29.64 62.00 76.91 30.99 coo 37.43 42.63 19.41 36.76 44.08 17.97 57.39 88.29 28.43 56.26 87.37 26.90 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP C 54 ASP~? 14.99 CL CL C2006 B 100 ARG C 51 ARG~? 15.50 O3 GOL D3005 B 116 GLN C 49 GLN~? -17.03 O3 GOL D3005s coo 32.18 48.37 12.48 33.96 49.46 12.97 53.32 23.86 72.39 51.93 24.66 71.07 coo 39.04 43.25 11.37 38.30 45.35 13.56 50.80 26.41 78.15 53.63 27.50 78.75 coo 37.43 42.63 19.41 36.76 44.08 17.97 44.73 18.97 77.96 43.48 20.16 79.23 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP H 54 ASP~? 12.64 O3 GOL H3006 B 100 ARG H 51 ARG~? -11.05 O1 GOL H3006s B 116 GLN H 49 GLN~? -4.02 C2 GOL H3006s coo 32.18 48.37 12.48 33.96 49.46 12.97 56.87 71.80 83.08 55.07 70.98 82.33 coo 39.04 43.25 11.37 38.30 45.35 13.56 55.75 78.18 80.83 58.67 78.05 79.79 coo 37.43 42.63 19.41 36.76 44.08 17.97 49.55 79.01 88.02 48.67 80.55 86.81 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP J 54 ASP~? 19.87 CL CL J2002 B 100 ARG J 51 ARG~? 27.44 CL CL J2002 B 116 GLN J 49 GLN~? 24.01 CL CL J2002 coo 32.18 48.37 12.48 33.96 49.46 12.97 166.52 182.87 136.75 168.05 181.78 137.64 coo 39.04 43.25 11.37 38.30 45.35 13.56 168.80 189.12 137.91 166.15 189.45 139.46 coo 37.43 42.63 19.41 36.76 44.08 17.97 174.68 187.74 130.59 175.97 189.20 131.45 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP K 54 ASP~? 13.11 O1 GOL K3011 B 100 ARG K 51 ARG~? -10.79 O3 GOL K3011s B 116 GLN K 49 GLN~? -3.60 C1 GOL K3011s coo 32.18 48.37 12.48 33.96 49.46 12.97 171.09 138.55 186.41 169.55 139.29 185.16 coo 39.04 43.25 11.37 38.30 45.35 13.56 168.73 140.32 192.51 171.31 141.97 192.79 coo 37.43 42.63 19.41 36.76 44.08 17.97 162.94 132.97 191.99 161.75 134.08 193.36 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP M 54 ASP~? 13.03 O2 GOL M3007 B 100 ARG M 51 ARG~? -9.68 O2 GOL M3007s B 116 GLN M 49 GLN~? -4.12 C1 GOL M3007s coo 32.18 48.37 12.48 33.96 49.46 12.97 164.95 201.02 181.99 166.71 200.19 181.24 coo 39.04 43.25 11.37 38.30 45.35 13.56 166.66 199.07 188.11 163.90 199.62 189.28 coo 37.43 42.63 19.41 36.76 44.08 17.97 172.36 207.31 187.85 173.41 206.43 189.48 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 7 3 # 7 B 46 ASP N 54 ASP~? 13.04 O3 GOL N3008 B 100 ARG N 51 ARG~? 10.93 O1 GOL N3008 B 116 GLN N 49 GLN~? -3.60 O2 GOL N3008s coo 32.18 48.37 12.48 33.96 49.46 12.97 174.60 151.44 139.08 172.92 152.56 139.62 coo 39.04 43.25 11.37 38.30 45.35 13.56 172.16 145.36 140.78 174.78 144.98 142.37 coo 37.43 42.63 19.41 36.76 44.08 17.97 167.06 145.69 132.62 165.84 144.32 133.61 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 8 3 # 8 B 46 ASP O 54 ASP~? 15.16 CL CL K2003 B 100 ARG O 51 ARG~? 16.43 O1 GOL N3008 B 116 GLN O 49 GLN~? -17.97 O1 GOL N3008s coo 32.18 48.37 12.48 33.96 49.46 12.97 162.95 137.35 154.91 164.67 137.97 155.90 coo 39.04 43.25 11.37 38.30 45.35 13.56 165.78 138.84 148.96 164.30 141.49 149.44 coo 37.43 42.63 19.41 36.76 44.08 17.97 170.33 130.25 149.83 171.69 131.01 148.34 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 9 3 # 9 B 46 ASP P 54 ASP~? 21.88 O3 GOL M3007 B 100 ARG P 51 ARG~? 14.75 O3 GOL M3007 B 116 GLN P 49 GLN~? -16.44 O3 GOL M3007s coo 32.18 48.37 12.48 33.96 49.46 12.97 172.77 185.90 199.12 171.10 184.95 198.29 coo 39.04 43.25 11.37 38.30 45.35 13.56 171.10 192.14 197.11 173.97 192.46 196.07 coo 37.43 42.63 19.41 36.76 44.08 17.97 165.46 192.43 204.59 164.40 193.94 203.51 12as_c01 source 12as ASPARAGINE SYNTHETASE : 9 hits 12as_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 114 ARG~? 18.99 O2 GOL A3040 265 HIS A 131 HIS.? 23.28 O2 GOL A3040 274 TYR A 75 TYR~? 11.96 CL CL A2020 coo -15.18 55.46 8.55 -14.82 52.98 10.38 86.11 90.82 36.33 86.92 90.68 33.36 coo -14.48 45.59 11.18 -14.02 47.49 10.42 92.67 90.69 28.54 93.68 90.74 26.70 coo 0.94 52.26 9.16 1.95 54.78 9.91 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 114 ARG~? 18.99 O2 GOL A3040 265 HIS A 131 HIS.? 23.28 O2 GOL A3040 274 TYR A 143 TYR~? 16.38 O1 GOL A3040 coo -15.18 55.46 8.55 -14.82 52.98 10.38 86.11 90.82 36.33 86.92 90.68 33.36 coo -14.48 45.59 11.18 -14.02 47.49 10.42 92.67 90.69 28.54 93.68 90.74 26.70 coo 0.94 52.26 9.16 1.95 54.78 9.91 92.99 77.44 39.76 93.75 79.76 38.42 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG A 122 ARG.? -4.29 O1 GOL A3040s 265 HIS A 125 HIS.? 6.10 O2 GOL A3040 274 TYR A 157 TYR.? -3.90 O2 GOL A3037s coo -15.18 55.46 8.55 -14.82 52.98 10.38 89.32 88.48 50.81 89.57 85.85 52.38 coo -14.48 45.59 11.18 -14.02 47.49 10.42 98.48 94.83 47.66 98.07 96.39 49.01 coo 0.94 52.26 9.16 1.95 54.78 9.91 100.57 80.52 55.08 97.88 80.73 54.34 ULMN 3 1a41_c01 TOPOISOMERASE I user 4 3 # 4 223 ARG B 114 ARG~? 18.19 O1 GOL B3023 265 HIS B 131 HIS.? 20.97 CL CL B2010 274 TYR B 75 TYR~? 10.15 CL CL B2010 coo -15.18 55.46 8.55 -14.82 52.98 10.38 33.27 67.19 7.11 33.19 70.17 6.41 coo -14.48 45.59 11.18 -14.02 47.49 10.42 28.04 75.38 3.45 27.81 77.14 2.33 coo 0.94 52.26 9.16 1.95 54.78 9.91 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1a41_c01 TOPOISOMERASE I user 5 3 # 5 223 ARG B 114 ARG~? 18.19 O1 GOL B3023 265 HIS B 131 HIS.? 20.97 CL CL B2010 274 TYR B 143 TYR~? 10.77 O2 GOL B3024 coo -15.18 55.46 8.55 -14.82 52.98 10.38 33.27 67.19 7.11 33.19 70.17 6.41 coo -14.48 45.59 11.18 -14.02 47.49 10.42 28.04 75.38 3.45 27.81 77.14 2.33 coo 0.94 52.26 9.16 1.95 54.78 9.91 23.25 68.41 18.58 23.33 69.19 15.92 ULMN 3 1a41_c01 TOPOISOMERASE I user 6 3 # 6 223 ARG C 114 ARG~? 19.78 CL CL C2011 265 HIS C 131 HIS.? 21.65 CL CL C2011 274 TYR C 75 TYR~? 10.50 CL CL C2011 coo -15.18 55.46 8.55 -14.82 52.98 10.38 73.29 10.73 76.57 73.51 10.59 79.63 coo -14.48 45.59 11.18 -14.02 47.49 10.42 77.67 9.26 85.52 77.97 8.68 87.52 coo 0.94 52.26 9.16 1.95 54.78 9.91 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1a41_c01 TOPOISOMERASE I user 7 3 # 7 223 ARG C 114 ARG~? 19.78 CL CL C2011 265 HIS C 131 HIS.? 21.65 CL CL C2011 274 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo -15.18 55.46 8.55 -14.82 52.98 10.38 73.29 10.73 76.57 73.51 10.59 79.63 coo -14.48 45.59 11.18 -14.02 47.49 10.42 77.67 9.26 85.52 77.97 8.68 87.52 coo 0.94 52.26 9.16 1.95 54.78 9.91 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1a41_c01 TOPOISOMERASE I user 8 3 # 8 223 ARG D 94 ARG~? 15.71 CL CL D2012 265 HIS D 79 HIS~? -4.57 CL CL D2022s 274 TYR D 143 TYR~? 15.16 CL CL D2012 coo -15.18 55.46 8.55 -14.82 52.98 10.38 3.39 42.85 90.39 4.96 40.19 90.49 coo -14.48 45.59 11.18 -14.02 47.49 10.42 3.57 52.49 87.96 2.52 51.97 89.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 9 3 # 9 223 ARG D 114 ARG~? 18.11 O3 GOL D3018 265 HIS D 131 HIS.? 21.16 CL CL D2012 274 TYR D 75 TYR~? 10.03 CL CL D2012 coo -15.18 55.46 8.55 -14.82 52.98 10.38 21.28 44.89 93.84 20.52 41.96 94.27 coo -14.48 45.59 11.18 -14.02 47.49 10.42 14.37 37.50 95.10 13.27 35.76 95.49 coo 0.94 52.26 9.16 1.95 54.78 9.91 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1a41_c01 TOPOISOMERASE I user 10 3 # 10 223 ARG D 114 ARG~? 18.11 O3 GOL D3018 265 HIS D 131 HIS.? 21.16 CL CL D2012 274 TYR D 143 TYR~? 15.16 CL CL D2012 coo -15.18 55.46 8.55 -14.82 52.98 10.38 21.28 44.89 93.84 20.52 41.96 94.27 coo -14.48 45.59 11.18 -14.02 47.49 10.42 14.37 37.50 95.10 13.27 35.76 95.49 coo 0.94 52.26 9.16 1.95 54.78 9.91 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1a41_c01 TOPOISOMERASE I user 11 3 # 11 223 ARG E 114 ARG~? 18.39 O3 GOL E3022 265 HIS E 131 HIS.? 21.62 CL CL E2013 274 TYR E 75 TYR~? 10.13 CL CL E2013 coo -15.18 55.46 8.55 -14.82 52.98 10.38 31.03 99.62 62.12 30.45 100.18 65.09 coo -14.48 45.59 11.18 -14.02 47.49 10.42 25.00 102.72 69.75 24.26 103.67 71.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1a41_c01 TOPOISOMERASE I user 12 3 # 12 223 ARG E 114 ARG~? 18.39 O3 GOL E3022 265 HIS E 131 HIS.? 21.62 CL CL E2013 274 TYR E 143 TYR~? 15.23 CL CL E2013 coo -15.18 55.46 8.55 -14.82 52.98 10.38 31.03 99.62 62.12 30.45 100.18 65.09 coo -14.48 45.59 11.18 -14.02 47.49 10.42 25.00 102.72 69.75 24.26 103.67 71.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 20.79 87.99 61.33 20.74 90.64 62.13 ULMN 3 1a41_c01 TOPOISOMERASE I user 13 3 # 13 223 ARG F 114 ARG~? 18.29 CL CL F2035 265 HIS F 131 HIS.? 21.33 CL CL F2034 274 TYR F 75 TYR~? 9.99 CL CL F2034 coo -15.18 55.46 8.55 -14.82 52.98 10.38 81.94 30.32 15.98 81.85 27.28 16.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.97 21.37 16.19 87.42 19.33 15.94 coo 0.94 52.26 9.16 1.95 54.78 9.91 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1a41_c01 TOPOISOMERASE I user 14 3 # 14 223 ARG F 114 ARG~? 18.29 CL CL F2035 265 HIS F 131 HIS.? 21.33 CL CL F2034 274 TYR F 143 TYR~? 15.09 CL CL F2034 coo -15.18 55.46 8.55 -14.82 52.98 10.38 81.94 30.32 15.98 81.85 27.28 16.31 coo -14.48 45.59 11.18 -14.02 47.49 10.42 86.97 21.37 16.19 87.42 19.33 15.94 coo 0.94 52.26 9.16 1.95 54.78 9.91 89.42 31.84 29.55 89.79 30.44 27.17 ULMN 3 1a41_c01 TOPOISOMERASE I user 15 3 # 15 223 ARG G 114 ARG~? 19.08 O3 GOL G3038 265 HIS G 131 HIS.? 23.01 C3 GOL G3038 274 TYR G 75 TYR~? 12.69 CL CL G2033 coo -15.18 55.46 8.55 -14.82 52.98 10.38 24.45 12.48 38.95 24.54 11.96 35.94 coo -14.48 45.59 11.18 -14.02 47.49 10.42 19.23 10.55 30.25 18.64 9.92 28.33 coo 0.94 52.26 9.16 1.95 54.78 9.91 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1a41_c01 TOPOISOMERASE I user 16 3 # 16 223 ARG G 114 ARG~? 19.08 O3 GOL G3038 265 HIS G 131 HIS.? 23.01 C3 GOL G3038 274 TYR G 143 TYR~? 15.53 C3 GOL G3001 coo -15.18 55.46 8.55 -14.82 52.98 10.38 24.45 12.48 38.95 24.54 11.96 35.94 coo -14.48 45.59 11.18 -14.02 47.49 10.42 19.23 10.55 30.25 18.64 9.92 28.33 coo 0.94 52.26 9.16 1.95 54.78 9.91 16.97 25.90 37.77 16.51 23.33 36.84 ULMN 3 1a41_c01 TOPOISOMERASE I user 17 3 # 17 223 ARG H 114 ARG~? 20.07 CL CL H2014 265 HIS H 131 HIS.? 21.54 CL CL H2014 274 TYR H 75 TYR~? 10.27 CL CL H2014 coo -15.18 55.46 8.55 -14.82 52.98 10.38 76.88 71.50 96.54 77.56 74.47 96.38 coo -14.48 45.59 11.18 -14.02 47.49 10.42 83.28 79.38 97.87 84.13 81.25 98.32 coo 0.94 52.26 9.16 1.95 54.78 9.91 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1a41_c01 TOPOISOMERASE I user 18 3 # 18 223 ARG H 114 ARG~? 20.07 CL CL H2014 265 HIS H 131 HIS.? 21.54 CL CL H2014 274 TYR H 143 TYR~? 11.30 O2 GOL H3016 coo -15.18 55.46 8.55 -14.82 52.98 10.38 76.88 71.50 96.54 77.56 74.47 96.38 coo -14.48 45.59 11.18 -14.02 47.49 10.42 83.28 79.38 97.87 84.13 81.25 98.32 coo 0.94 52.26 9.16 1.95 54.78 9.91 86.77 67.99 85.16 86.88 69.36 87.57 ULMN 3 1a41_c01 TOPOISOMERASE I user 19 3 # 19 223 ARG I 94 ARG~? 17.03 CL CL I2015 265 HIS I 79 HIS~? -4.56 CL CL I2025s 274 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo -15.18 55.46 8.55 -14.82 52.98 10.38 216.21 203.80 147.44 213.68 202.45 146.18 coo -14.48 45.59 11.18 -14.02 47.49 10.42 216.99 204.94 159.50 218.07 206.60 158.77 coo 0.94 52.26 9.16 1.95 54.78 9.91 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 20 3 # 20 223 ARG I 114 ARG~? 18.68 O1 GOL I3031 265 HIS I 131 HIS.? 21.12 CL CL I2015 274 TYR I 75 TYR~? 10.32 CL CL I2015 coo -15.18 55.46 8.55 -14.82 52.98 10.38 198.65 208.42 151.97 199.12 208.35 148.94 coo -14.48 45.59 11.18 -14.02 47.49 10.42 205.05 208.81 144.12 206.00 208.92 142.25 coo 0.94 52.26 9.16 1.95 54.78 9.91 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1a41_c01 TOPOISOMERASE I user 21 3 # 21 223 ARG I 114 ARG~? 18.68 O1 GOL I3031 265 HIS I 131 HIS.? 21.12 CL CL I2015 274 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo -15.18 55.46 8.55 -14.82 52.98 10.38 198.65 208.42 151.97 199.12 208.35 148.94 coo -14.48 45.59 11.18 -14.02 47.49 10.42 205.05 208.81 144.12 206.00 208.92 142.25 coo 0.94 52.26 9.16 1.95 54.78 9.91 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 22 3 # 22 223 ARG J 114 ARG~? 18.34 O3 GOL J3030 265 HIS J 131 HIS.? 21.32 CL CL J2016 274 TYR J 75 TYR~? 10.17 CL CL J2016 coo -15.18 55.46 8.55 -14.82 52.98 10.38 145.85 183.80 124.31 145.72 186.84 123.92 coo -14.48 45.59 11.18 -14.02 47.49 10.42 140.93 192.25 121.78 140.50 194.18 121.08 coo 0.94 52.26 9.16 1.95 54.78 9.91 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1a41_c01 TOPOISOMERASE I user 23 3 # 23 223 ARG J 114 ARG~? 18.34 O3 GOL J3030 265 HIS J 131 HIS.? 21.32 CL CL J2016 274 TYR J 143 TYR~? 15.18 CL CL J2016 coo -15.18 55.46 8.55 -14.82 52.98 10.38 145.85 183.80 124.31 145.72 186.84 123.92 coo -14.48 45.59 11.18 -14.02 47.49 10.42 140.93 192.25 121.78 140.50 194.18 121.08 coo 0.94 52.26 9.16 1.95 54.78 9.91 136.50 183.91 136.49 136.50 184.93 133.88 ULMN 3 1a41_c01 TOPOISOMERASE I user 24 3 # 24 223 ARG K 114 ARG~? 18.18 O1 GOL K3041 265 HIS K 131 HIS.? 21.27 O1 GOL K3041 274 TYR K 75 TYR~? 12.36 CL CL K2027 coo -15.18 55.46 8.55 -14.82 52.98 10.38 191.56 126.17 188.91 191.90 126.17 191.97 coo -14.48 45.59 11.18 -14.02 47.49 10.42 196.99 124.95 197.52 197.50 124.37 199.47 coo 0.94 52.26 9.16 1.95 54.78 9.91 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1a41_c01 TOPOISOMERASE I user 25 3 # 25 223 ARG K 114 ARG~? 18.18 O1 GOL K3041 265 HIS K 131 HIS.? 21.27 O1 GOL K3041 274 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo -15.18 55.46 8.55 -14.82 52.98 10.38 191.56 126.17 188.91 191.90 126.17 191.97 coo -14.48 45.59 11.18 -14.02 47.49 10.42 196.99 124.95 197.52 197.50 124.37 199.47 coo 0.94 52.26 9.16 1.95 54.78 9.91 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1a41_c01 TOPOISOMERASE I user 26 3 # 26 223 ARG L 114 ARG~? 18.80 O1 GOL L3027 265 HIS L 131 HIS.? 20.79 CL CL L2009 274 TYR L 75 TYR~? 10.07 CL CL L2009 coo -15.18 55.46 8.55 -14.82 52.98 10.38 138.87 157.00 210.52 138.32 154.00 210.96 coo -14.48 45.59 11.18 -14.02 47.49 10.42 131.63 149.73 212.78 130.46 148.21 213.64 coo 0.94 52.26 9.16 1.95 54.78 9.91 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1a41_c01 TOPOISOMERASE I user 27 3 # 27 223 ARG L 114 ARG~? 18.80 O1 GOL L3027 265 HIS L 131 HIS.? 20.79 CL CL L2009 274 TYR L 143 TYR~? 15.30 CL CL L2009 coo -15.18 55.46 8.55 -14.82 52.98 10.38 138.87 157.00 210.52 138.32 154.00 210.96 coo -14.48 45.59 11.18 -14.02 47.49 10.42 131.63 149.73 212.78 130.46 148.21 213.64 coo 0.94 52.26 9.16 1.95 54.78 9.91 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1a41_c01 TOPOISOMERASE I user 28 3 # 28 223 ARG M 114 ARG~? 18.40 O3 GOL M3043 265 HIS M 131 HIS.? 21.22 CL CL M2017 274 TYR M 75 TYR~? 10.36 CL CL M2017 coo -15.18 55.46 8.55 -14.82 52.98 10.38 144.35 213.37 180.84 143.79 213.88 183.80 coo -14.48 45.59 11.18 -14.02 47.49 10.42 137.94 216.13 188.51 137.11 217.01 190.24 coo 0.94 52.26 9.16 1.95 54.78 9.91 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1a41_c01 TOPOISOMERASE I user 29 3 # 29 223 ARG M 114 ARG~? 18.40 O3 GOL M3043 265 HIS M 131 HIS.? 21.22 CL CL M2017 274 TYR M 143 TYR~? 15.40 CL CL M2017 coo -15.18 55.46 8.55 -14.82 52.98 10.38 144.35 213.37 180.84 143.79 213.88 183.80 coo -14.48 45.59 11.18 -14.02 47.49 10.42 137.94 216.13 188.51 137.11 217.01 190.24 coo 0.94 52.26 9.16 1.95 54.78 9.91 134.88 201.35 179.85 134.66 203.97 180.76 ULMN 3 1a41_c01 TOPOISOMERASE I user 30 3 # 30 223 ARG N 114 ARG~? 21.90 O2 GOL N3029 265 HIS N 131 HIS.? 24.11 CL CL N2030 274 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo -15.18 55.46 8.55 -14.82 52.98 10.38 196.45 148.76 129.28 196.55 145.72 129.25 coo -14.48 45.59 11.18 -14.02 47.49 10.42 201.51 139.96 128.80 202.02 137.96 128.37 coo 0.94 52.26 9.16 1.95 54.78 9.91 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1a41_c01 TOPOISOMERASE I user 31 3 # 31 223 ARG N 114 ARG~? 21.90 O2 GOL N3029 265 HIS N 131 HIS.? 24.11 CL CL N2030 274 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo -15.18 55.46 8.55 -14.82 52.98 10.38 196.45 148.76 129.28 196.55 145.72 129.25 coo -14.48 45.59 11.18 -14.02 47.49 10.42 201.51 139.96 128.80 202.02 137.96 128.37 coo 0.94 52.26 9.16 1.95 54.78 9.91 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1a41_c01 TOPOISOMERASE I user 32 3 # 32 223 ARG O 94 ARG~? 17.23 CL CL O2018 265 HIS O 79 HIS~? 5.21 CL CL O2018 274 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo -15.18 55.46 8.55 -14.82 52.98 10.38 124.05 130.93 146.77 126.63 131.98 145.39 coo -14.48 45.59 11.18 -14.02 47.49 10.42 121.98 131.53 158.56 121.09 129.74 157.92 coo 0.94 52.26 9.16 1.95 54.78 9.91 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1a41_c01 TOPOISOMERASE I user 33 3 # 33 223 ARG O 114 ARG~? 4.95 CL CL O2036 265 HIS O 131 HIS.? 12.83 CL CL O2036 274 TYR O 75 TYR~? 10.24 CL CL O2018 coo -15.18 55.46 8.55 -14.82 52.98 10.38 141.08 127.21 153.72 140.82 126.86 150.69 coo -14.48 45.59 11.18 -14.02 47.49 10.42 136.08 125.57 145.21 136.18 124.88 143.24 coo 0.94 52.26 9.16 1.95 54.78 9.91 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1a41_c01 TOPOISOMERASE I user 34 3 # 34 223 ARG O 114 ARG~? 4.95 CL CL O2036 265 HIS O 131 HIS.? 12.83 CL CL O2036 274 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo -15.18 55.46 8.55 -14.82 52.98 10.38 141.08 127.21 153.72 140.82 126.86 150.69 coo -14.48 45.59 11.18 -14.02 47.49 10.42 136.08 125.57 145.21 136.18 124.88 143.24 coo 0.94 52.26 9.16 1.95 54.78 9.91 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1a41_c01 TOPOISOMERASE I user 35 3 # 35 223 ARG P 114 ARG~? 18.57 O2 GOL P3034 265 HIS P 131 HIS.? 21.18 CL CL P2019 274 TYR P 75 TYR~? 10.23 CL CL P2019 coo -15.18 55.46 8.55 -14.82 52.98 10.38 193.59 185.96 211.51 194.17 188.98 211.79 coo -14.48 45.59 11.18 -14.02 47.49 10.42 199.94 193.83 213.04 200.54 195.72 213.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1a41_c01 TOPOISOMERASE I user 36 3 # 36 223 ARG P 114 ARG~? 18.57 O2 GOL P3034 265 HIS P 131 HIS.? 21.18 CL CL P2019 274 TYR P 143 TYR~? 15.20 CL CL P2019 coo -15.18 55.46 8.55 -14.82 52.98 10.38 193.59 185.96 211.51 194.17 188.98 211.79 coo -14.48 45.59 11.18 -14.02 47.49 10.42 199.94 193.83 213.04 200.54 195.72 213.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 202.86 183.43 199.65 203.11 184.67 202.14 1a41_c01 source 1a41 TOPOISOMERASE I : 36 hits 1a41_c01 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 150 TRP~? 9.40 O3 GOL A3037 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s 258 LYS A 142 LYS~? 20.36 CL CL A2020 coo 127.19 33.46 26.14 126.78 36.79 28.15 99.61 75.57 49.87 96.34 77.60 50.68 coo 126.95 41.66 23.38 128.48 40.72 24.51 90.44 78.16 48.76 91.65 76.94 50.06 coo 138.83 37.95 25.17 133.50 36.37 26.52 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 150 TRP~? 6.74 O3 GOL B3015 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s 258 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 127.19 33.46 26.14 126.78 36.79 28.15 14.34 60.39 20.70 17.67 58.57 19.72 coo 126.95 41.66 23.38 128.48 40.72 24.51 23.66 59.02 20.34 21.93 58.32 21.38 coo 138.83 37.95 25.17 133.50 36.37 26.52 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP C 150 TRP~? 6.00 O1 GOL C3036 223 ASP C 70 ASP~? 3.38 O1 GOL C3036s 258 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 127.19 33.46 26.14 126.78 36.79 28.15 92.29 22.45 66.79 88.93 21.17 65.17 coo 126.95 41.66 23.38 128.48 40.72 24.51 82.81 22.02 65.69 84.52 22.80 64.66 coo 138.83 37.95 25.17 133.50 36.37 26.52 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP D 150 TRP~? 10.12 O2 GOL D3020 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s 258 LYS D 142 LYS~? 18.65 CL CL D2012 coo 127.19 33.46 26.14 126.78 36.79 28.15 7.58 55.02 76.49 10.84 56.37 78.24 coo 126.95 41.66 23.38 128.48 40.72 24.51 16.94 54.59 79.01 15.65 55.42 77.54 coo 138.83 37.95 25.17 133.50 36.37 26.52 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP E 150 TRP~? 6.44 C3 GOL E3002 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 258 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 127.19 33.46 26.14 126.78 36.79 28.15 13.53 85.96 51.70 17.23 86.80 50.63 coo 126.95 41.66 23.38 128.48 40.72 24.51 23.07 86.29 52.35 21.57 85.17 51.32 coo 138.83 37.95 25.17 133.50 36.37 26.52 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP F 150 TRP~? 12.61 CL CL F2034 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s 258 LYS F 142 LYS~? 19.20 CL CL F2034 coo 127.19 33.46 26.14 126.78 36.79 28.15 98.06 40.24 31.68 95.06 41.77 29.63 coo 126.95 41.66 23.38 128.48 40.72 24.51 88.86 41.25 28.96 90.30 42.22 30.24 coo 138.83 37.95 25.17 133.50 36.37 26.52 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP G 150 TRP~? 4.79 O3 GOL G3001 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s 258 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 127.19 33.46 26.14 126.78 36.79 28.15 8.65 29.73 45.56 11.64 28.04 47.47 coo 126.95 41.66 23.38 128.48 40.72 24.51 17.70 27.34 47.09 16.19 28.71 47.73 coo 138.83 37.95 25.17 133.50 36.37 26.52 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 8 3 # 8 142 TRP H 150 TRP~? 9.03 C1 GOL H3016 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s 258 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 127.19 33.46 26.14 126.78 36.79 28.15 93.76 57.94 85.12 90.09 57.13 86.33 coo 126.95 41.66 23.38 128.48 40.72 24.51 84.24 58.93 85.48 85.73 57.59 84.66 coo 138.83 37.95 25.17 133.50 36.37 26.52 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 9 3 # 9 142 TRP I 150 TRP~? 8.45 O3 GOL I3032 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s 258 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 127.19 33.46 26.14 126.78 36.79 28.15 213.69 193.51 164.07 210.33 195.28 165.13 coo 126.95 41.66 23.38 128.48 40.72 24.51 204.37 195.46 163.61 205.75 194.30 164.79 coo 138.83 37.95 25.17 133.50 36.37 26.52 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 10 3 # 10 142 TRP J 150 TRP~? 9.82 O1 GOL J3033 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 258 LYS J 142 LYS~? 19.62 CL CL J2016 coo 127.19 33.46 26.14 126.78 36.79 28.15 127.85 175.49 138.51 131.22 173.81 137.27 coo 126.95 41.66 23.38 128.48 40.72 24.51 137.44 174.60 137.57 135.80 173.80 138.69 coo 138.83 37.95 25.17 133.50 36.37 26.52 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 11 3 # 11 142 TRP K 150 TRP~? 6.22 O2 GOL K3009 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s 258 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 127.19 33.46 26.14 126.78 36.79 28.15 209.66 139.23 178.83 206.28 137.79 177.39 coo 126.95 41.66 23.38 128.48 40.72 24.51 200.17 138.24 178.11 201.77 139.28 177.19 coo 138.83 37.95 25.17 133.50 36.37 26.52 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 12 3 # 12 142 TRP L 150 TRP~? 12.70 CL CL L2009 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s 258 LYS L 142 LYS~? 23.18 CL CL L2009 coo 127.19 33.46 26.14 126.78 36.79 28.15 124.03 167.33 194.23 127.41 168.49 195.83 coo 126.95 41.66 23.38 128.48 40.72 24.51 133.34 166.97 196.27 132.03 168.03 194.96 coo 138.83 37.95 25.17 133.50 36.37 26.52 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 13 3 # 13 142 TRP M 150 TRP~? 9.50 O3 GOL M3042 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s 258 LYS M 142 LYS~? 19.90 CL CL M2017 coo 127.19 33.46 26.14 126.78 36.79 28.15 127.35 199.32 170.42 130.91 200.46 169.17 coo 126.95 41.66 23.38 128.48 40.72 24.51 136.87 200.18 170.79 135.36 199.08 169.77 coo 138.83 37.95 25.17 133.50 36.37 26.52 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 14 3 # 14 142 TRP N 150 TRP~? 6.52 O2 GOL N3012 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s 258 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 127.19 33.46 26.14 126.78 36.79 28.15 212.92 158.88 144.19 209.70 160.35 142.44 coo 126.95 41.66 23.38 128.48 40.72 24.51 203.51 159.51 142.26 205.02 160.53 143.48 coo 138.83 37.95 25.17 133.50 36.37 26.52 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 15 3 # 15 142 TRP O 150 TRP~? 6.10 O1 GOL O3013 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s 258 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 127.19 33.46 26.14 126.78 36.79 28.15 124.79 143.29 162.05 128.01 141.74 163.72 coo 126.95 41.66 23.38 128.48 40.72 24.51 134.07 141.35 162.95 132.57 142.58 163.78 coo 138.83 37.95 25.17 133.50 36.37 26.52 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 16 3 # 16 142 TRP P 150 TRP~? 5.47 O2 GOL P3014 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 258 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 127.19 33.46 26.14 126.78 36.79 28.15 210.27 173.82 198.63 206.78 172.70 200.12 coo 126.95 41.66 23.38 128.48 40.72 24.51 200.75 174.15 199.66 202.28 173.10 198.62 coo 138.83 37.95 25.17 133.50 36.37 26.52 204.59 186.28 195.60 209.96 186.96 196.62 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 16 hits 1aam_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN B 31 ASN~? 16.07 O1 GOL B3003 63 ARG B 36 ARG~? 18.74 O2 GOL B3003 255 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 42.10 13.02 11.14 41.85 11.12 10.23 58.08 62.28 0.56 56.41 63.22 -0.34 coo 44.36 11.24 3.39 41.81 12.78 4.00 67.49 62.18 2.86 67.75 61.06 -0.01 coo 38.40 3.83 10.26 40.02 6.30 9.25 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN G 31 ASN~? 18.27 CL CL C2004 63 ARG G 36 ARG~? 19.13 CL CL C2004 255 ARG G 37 ARG~? 20.29 CL CL C2004 coo 42.10 13.02 11.14 41.85 11.12 10.23 47.68 0.09 44.37 45.83 -0.65 43.56 coo 44.36 11.24 3.39 41.81 12.78 4.00 57.05 1.30 44.33 57.17 -1.56 45.49 coo 38.40 3.83 10.26 40.02 6.30 9.25 52.62 7.45 38.03 50.95 9.97 37.63 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 2 hits 1aj0_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 79 HIS~? -3.92 CL CL A2020s A 262 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 29.33 36.13 69.70 30.07 34.20 70.11 103.72 86.36 44.76 104.87 88.01 44.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 98.48 94.83 47.66 98.07 96.39 49.01 coo 30.62 37.23 61.07 30.08 35.73 62.49 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 262 HIS A 79 HIS~? -3.92 CL CL A2020s A 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 29.33 36.13 69.70 30.07 34.20 70.11 98.48 94.83 47.66 98.07 96.39 49.01 coo 38.54 36.60 66.38 37.88 34.77 67.15 103.72 86.36 44.76 104.87 88.01 44.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS B 79 HIS~? 5.08 CL CL B2010 A 262 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 29.33 36.13 69.70 30.07 34.20 70.11 13.46 62.96 8.26 12.78 63.30 6.30 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.73 57.29 2.23 19.89 55.80 0.75 coo 30.62 37.23 61.07 30.08 35.73 62.49 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 262 HIS B 79 HIS~? 5.08 CL CL B2010 A 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 29.33 36.13 69.70 30.07 34.20 70.11 19.73 57.29 2.23 19.89 55.80 0.75 coo 38.54 36.60 66.38 37.88 34.77 67.15 13.46 62.96 8.26 12.78 63.30 6.30 coo 30.62 37.23 61.07 30.08 35.73 62.49 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS C 79 HIS~? -4.32 CL CL C2021s A 262 HIS C 125 HIS.? 6.65 CL CL C2011 A 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 29.33 36.13 69.70 30.07 34.20 70.11 92.85 10.89 71.99 93.43 9.18 73.06 coo 38.54 36.60 66.38 37.88 34.77 67.15 86.57 4.11 67.63 86.24 2.65 66.14 coo 30.62 37.23 61.07 30.08 35.73 62.49 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS C 125 HIS.? 6.65 CL CL C2011 A 262 HIS C 79 HIS~? -4.32 CL CL C2021s A 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 29.33 36.13 69.70 30.07 34.20 70.11 86.57 4.11 67.63 86.24 2.65 66.14 coo 38.54 36.60 66.38 37.88 34.77 67.15 92.85 10.89 71.99 93.43 9.18 73.06 coo 30.62 37.23 61.07 30.08 35.73 62.49 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS D 79 HIS~? -4.57 CL CL D2022s A 262 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 29.33 36.13 69.70 30.07 34.20 70.11 3.57 52.49 87.96 2.52 51.97 89.71 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.12 57.04 95.76 9.45 58.59 97.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 262 HIS D 79 HIS~? -4.57 CL CL D2022s A 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.12 57.04 95.76 9.45 58.59 97.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 3.57 52.49 87.96 2.52 51.97 89.71 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 9 3 # 9 A 223 HIS E 79 HIS~? -4.18 CL CL E2032s A 262 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 29.33 36.13 69.70 30.07 34.20 70.11 12.36 98.35 54.34 11.69 100.32 54.60 coo 38.54 36.60 66.38 37.88 34.77 67.15 19.41 104.46 50.06 20.14 105.76 48.58 coo 30.62 37.23 61.07 30.08 35.73 62.49 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 10 3 # 10 A 223 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 262 HIS E 79 HIS~? -4.18 CL CL E2032s A 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 29.33 36.13 69.70 30.07 34.20 70.11 19.41 104.46 50.06 20.14 105.76 48.58 coo 38.54 36.60 66.38 37.88 34.77 67.15 12.36 98.35 54.34 11.69 100.32 54.60 coo 30.62 37.23 61.07 30.08 35.73 62.49 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 11 3 # 11 A 223 HIS F 79 HIS~? -4.63 CL CL F2023s A 262 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 29.33 36.13 69.70 30.07 34.20 70.11 101.04 34.65 20.79 101.93 33.69 19.16 coo 38.54 36.60 66.38 37.88 34.77 67.15 96.50 38.92 12.23 96.44 40.22 10.57 coo 30.62 37.23 61.07 30.08 35.73 62.49 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 12 3 # 12 A 223 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 262 HIS F 79 HIS~? -4.63 CL CL F2023s A 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 29.33 36.13 69.70 30.07 34.20 70.11 96.50 38.92 12.23 96.44 40.22 10.57 coo 38.54 36.60 66.38 37.88 34.77 67.15 101.04 34.65 20.79 101.93 33.69 19.16 coo 30.62 37.23 61.07 30.08 35.73 62.49 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 13 3 # 13 A 223 HIS G 79 HIS~? -4.46 CL CL G2033s A 262 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 29.33 36.13 69.70 30.07 34.20 70.11 5.20 17.85 42.65 4.12 16.10 42.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 9.81 10.31 48.06 9.47 8.80 49.48 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 14 3 # 14 A 223 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 262 HIS G 79 HIS~? -4.46 CL CL G2033s A 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 29.33 36.13 69.70 30.07 34.20 70.11 9.81 10.31 48.06 9.47 8.80 49.48 coo 38.54 36.60 66.38 37.88 34.77 67.15 5.20 17.85 42.65 4.12 16.10 42.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 15 3 # 15 A 223 HIS H 79 HIS~? 4.82 CL CL H2024 A 262 HIS H 125 HIS.? 7.36 CL CL H2014 A 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 29.33 36.13 69.70 30.07 34.20 70.11 95.19 63.20 96.60 95.96 63.87 98.43 coo 38.54 36.60 66.38 37.88 34.77 67.15 88.12 60.23 103.63 87.33 59.09 105.21 coo 30.62 37.23 61.07 30.08 35.73 62.49 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 16 3 # 16 A 223 HIS H 125 HIS.? 7.36 CL CL H2014 A 262 HIS H 79 HIS~? 4.82 CL CL H2024 A 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 29.33 36.13 69.70 30.07 34.20 70.11 88.12 60.23 103.63 87.33 59.09 105.21 coo 38.54 36.60 66.38 37.88 34.77 67.15 95.19 63.20 96.60 95.96 63.87 98.43 coo 30.62 37.23 61.07 30.08 35.73 62.49 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 17 3 # 17 A 223 HIS I 79 HIS~? -4.56 CL CL I2025s A 262 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 29.33 36.13 69.70 30.07 34.20 70.11 216.99 204.94 159.50 218.07 206.60 158.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 211.42 212.80 162.96 211.20 214.50 164.16 coo 30.62 37.23 61.07 30.08 35.73 62.49 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 18 3 # 18 A 223 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 262 HIS I 79 HIS~? -4.56 CL CL I2025s A 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 29.33 36.13 69.70 30.07 34.20 70.11 211.42 212.80 162.96 211.20 214.50 164.16 coo 38.54 36.60 66.38 37.88 34.77 67.15 216.99 204.94 159.50 218.07 206.60 158.77 coo 30.62 37.23 61.07 30.08 35.73 62.49 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 19 3 # 19 A 223 HIS J 79 HIS~? -4.36 CL CL J2026s A 262 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 29.33 36.13 69.70 30.07 34.20 70.11 126.45 179.07 126.46 125.69 179.71 124.61 coo 38.54 36.60 66.38 37.88 34.77 67.15 132.43 173.86 119.73 132.77 172.30 118.36 coo 30.62 37.23 61.07 30.08 35.73 62.49 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 20 3 # 20 A 223 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 262 HIS J 79 HIS~? -4.36 CL CL J2026s A 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 29.33 36.13 69.70 30.07 34.20 70.11 132.43 173.86 119.73 132.77 172.30 118.36 coo 38.54 36.60 66.38 37.88 34.77 67.15 126.45 179.07 126.46 125.69 179.71 124.61 coo 30.62 37.23 61.07 30.08 35.73 62.49 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 21 3 # 21 A 223 HIS K 79 HIS~? -4.34 CL CL K2027s A 262 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 29.33 36.13 69.70 30.07 34.20 70.11 211.01 127.65 183.80 211.70 125.86 184.65 coo 38.54 36.60 66.38 37.88 34.77 67.15 204.92 120.38 179.37 204.44 118.90 177.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 22 3 # 22 A 223 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 262 HIS K 79 HIS~? -4.34 CL CL K2027s A 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 29.33 36.13 69.70 30.07 34.20 70.11 204.92 120.38 179.37 204.44 118.90 177.95 coo 38.54 36.60 66.38 37.88 34.77 67.15 211.01 127.65 183.80 211.70 125.86 184.65 coo 30.62 37.23 61.07 30.08 35.73 62.49 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 23 3 # 23 A 223 HIS L 79 HIS~? -4.09 CL CL L2028s A 262 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 29.33 36.13 69.70 30.07 34.20 70.11 120.65 164.52 206.19 119.64 164.06 207.98 coo 38.54 36.60 66.38 37.88 34.77 67.15 126.56 168.90 213.47 127.02 170.42 214.85 coo 30.62 37.23 61.07 30.08 35.73 62.49 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 24 3 # 24 A 223 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 262 HIS L 79 HIS~? -4.09 CL CL L2028s A 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 29.33 36.13 69.70 30.07 34.20 70.11 126.56 168.90 213.47 127.02 170.42 214.85 coo 38.54 36.60 66.38 37.88 34.77 67.15 120.65 164.52 206.19 119.64 164.06 207.98 coo 30.62 37.23 61.07 30.08 35.73 62.49 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 25 3 # 25 A 223 HIS M 79 HIS~? -4.31 CL CL M2029s A 262 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 29.33 36.13 69.70 30.07 34.20 70.11 125.50 211.59 173.52 124.72 213.49 173.99 coo 38.54 36.60 66.38 37.88 34.77 67.15 132.19 217.95 169.15 132.87 219.15 167.56 coo 30.62 37.23 61.07 30.08 35.73 62.49 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 26 3 # 26 A 223 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 262 HIS M 79 HIS~? -4.31 CL CL M2029s A 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 29.33 36.13 69.70 30.07 34.20 70.11 132.19 217.95 169.15 132.87 219.15 167.56 coo 38.54 36.60 66.38 37.88 34.77 67.15 125.50 211.59 173.52 124.72 213.49 173.99 coo 30.62 37.23 61.07 30.08 35.73 62.49 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 27 3 # 27 A 223 HIS N 79 HIS~? -4.33 CL CL N2030s A 262 HIS N 125 HIS.? 9.29 CL CL N2030 A 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 29.33 36.13 69.70 30.07 34.20 70.11 215.64 153.98 132.96 216.60 153.22 131.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 210.43 158.18 125.05 210.19 159.49 123.43 coo 30.62 37.23 61.07 30.08 35.73 62.49 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 28 3 # 28 A 223 HIS N 125 HIS.? 9.29 CL CL N2030 A 262 HIS N 79 HIS~? -4.33 CL CL N2030s A 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 29.33 36.13 69.70 30.07 34.20 70.11 210.43 158.18 125.05 210.19 159.49 123.43 coo 38.54 36.60 66.38 37.88 34.77 67.15 215.64 153.98 132.96 216.60 153.22 131.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 29 3 # 29 A 223 HIS O 79 HIS~? 5.21 CL CL O2018 A 262 HIS O 125 HIS.? 7.09 CL CL O2018 A 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 29.33 36.13 69.70 30.07 34.20 70.11 121.98 131.53 158.56 121.09 129.74 157.92 coo 38.54 36.60 66.38 37.88 34.77 67.15 126.97 124.39 163.68 126.90 122.97 165.24 coo 30.62 37.23 61.07 30.08 35.73 62.49 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 30 3 # 30 A 223 HIS O 125 HIS.? 7.09 CL CL O2018 A 262 HIS O 79 HIS~? 5.21 CL CL O2018 A 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 29.33 36.13 69.70 30.07 34.20 70.11 126.97 124.39 163.68 126.90 122.97 165.24 coo 38.54 36.60 66.38 37.88 34.77 67.15 121.98 131.53 158.56 121.09 129.74 157.92 coo 30.62 37.23 61.07 30.08 35.73 62.49 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 31 3 # 31 A 223 HIS P 79 HIS~? 5.38 CL CL P2019 A 262 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 29.33 36.13 69.70 30.07 34.20 70.11 212.25 178.47 210.26 213.09 179.27 212.01 coo 38.54 36.60 66.38 37.88 34.77 67.15 205.78 175.00 217.63 205.21 173.76 219.23 coo 30.62 37.23 61.07 30.08 35.73 62.49 207.19 183.81 214.61 207.22 185.89 215.11 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 32 3 # 32 A 223 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 262 HIS P 79 HIS~? 5.38 CL CL P2019 A 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 29.33 36.13 69.70 30.07 34.20 70.11 205.78 175.00 217.63 205.21 173.76 219.23 coo 38.54 36.60 66.38 37.88 34.77 67.15 212.25 178.47 210.26 213.09 179.27 212.01 coo 30.62 37.23 61.07 30.08 35.73 62.49 207.19 183.81 214.61 207.22 185.89 215.11 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 32 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 79 HIS~? -3.92 CL CL A2020s B 262 HIS A 125 HIS.? 6.10 O2 GOL A3040 B 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 23.86 29.50 91.20 24.12 31.58 91.00 103.72 86.36 44.76 104.87 88.01 44.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 98.48 94.83 47.66 98.07 96.39 49.01 coo 20.42 28.25 99.26 20.25 29.62 97.63 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 125 HIS.? 6.10 O2 GOL A3040 B 262 HIS A 79 HIS~? -3.92 CL CL A2020s B 312 ASP A 127 ASP.? 12.37 CL CL A2020 coo 23.86 29.50 91.20 24.12 31.58 91.00 98.48 94.83 47.66 98.07 96.39 49.01 coo 29.35 31.42 99.15 28.72 33.09 98.04 103.72 86.36 44.76 104.87 88.01 44.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS B 79 HIS~? 5.08 CL CL B2010 B 262 HIS B 125 HIS.? 5.37 C1 GOL B3023 B 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 23.86 29.50 91.20 24.12 31.58 91.00 13.46 62.96 8.26 12.78 63.30 6.30 coo 29.35 31.42 99.15 28.72 33.09 98.04 19.73 57.29 2.23 19.89 55.80 0.75 coo 20.42 28.25 99.26 20.25 29.62 97.63 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS B 125 HIS.? 5.37 C1 GOL B3023 B 262 HIS B 79 HIS~? 5.08 CL CL B2010 B 312 ASP B 127 ASP.? 11.35 CL CL B2010 coo 23.86 29.50 91.20 24.12 31.58 91.00 19.73 57.29 2.23 19.89 55.80 0.75 coo 29.35 31.42 99.15 28.72 33.09 98.04 13.46 62.96 8.26 12.78 63.30 6.30 coo 20.42 28.25 99.26 20.25 29.62 97.63 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS C 79 HIS~? -4.32 CL CL C2021s B 262 HIS C 125 HIS.? 6.65 CL CL C2011 B 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 23.86 29.50 91.20 24.12 31.58 91.00 92.85 10.89 71.99 93.43 9.18 73.06 coo 29.35 31.42 99.15 28.72 33.09 98.04 86.57 4.11 67.63 86.24 2.65 66.14 coo 20.42 28.25 99.26 20.25 29.62 97.63 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS C 125 HIS.? 6.65 CL CL C2011 B 262 HIS C 79 HIS~? -4.32 CL CL C2021s B 312 ASP C 127 ASP.? 10.87 CL CL C2011 coo 23.86 29.50 91.20 24.12 31.58 91.00 86.57 4.11 67.63 86.24 2.65 66.14 coo 29.35 31.42 99.15 28.72 33.09 98.04 92.85 10.89 71.99 93.43 9.18 73.06 coo 20.42 28.25 99.26 20.25 29.62 97.63 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS D 79 HIS~? -4.57 CL CL D2022s B 262 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 23.86 29.50 91.20 24.12 31.58 91.00 3.57 52.49 87.96 2.52 51.97 89.71 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.12 57.04 95.76 9.45 58.59 97.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 262 HIS D 79 HIS~? -4.57 CL CL D2022s B 312 ASP D 127 ASP.? 11.17 CL CL D2012 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.12 57.04 95.76 9.45 58.59 97.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 3.57 52.49 87.96 2.52 51.97 89.71 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 9 3 # 9 B 223 HIS E 79 HIS~? -4.18 CL CL E2032s B 262 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 23.86 29.50 91.20 24.12 31.58 91.00 12.36 98.35 54.34 11.69 100.32 54.60 coo 29.35 31.42 99.15 28.72 33.09 98.04 19.41 104.46 50.06 20.14 105.76 48.58 coo 20.42 28.25 99.26 20.25 29.62 97.63 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 10 3 # 10 B 223 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 262 HIS E 79 HIS~? -4.18 CL CL E2032s B 312 ASP E 127 ASP.? 11.39 CL CL E2013 coo 23.86 29.50 91.20 24.12 31.58 91.00 19.41 104.46 50.06 20.14 105.76 48.58 coo 29.35 31.42 99.15 28.72 33.09 98.04 12.36 98.35 54.34 11.69 100.32 54.60 coo 20.42 28.25 99.26 20.25 29.62 97.63 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 11 3 # 11 B 223 HIS F 79 HIS~? -4.63 CL CL F2023s B 262 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 23.86 29.50 91.20 24.12 31.58 91.00 101.04 34.65 20.79 101.93 33.69 19.16 coo 29.35 31.42 99.15 28.72 33.09 98.04 96.50 38.92 12.23 96.44 40.22 10.57 coo 20.42 28.25 99.26 20.25 29.62 97.63 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 12 3 # 12 B 223 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 262 HIS F 79 HIS~? -4.63 CL CL F2023s B 312 ASP F 127 ASP.? 10.85 CL CL F2034 coo 23.86 29.50 91.20 24.12 31.58 91.00 96.50 38.92 12.23 96.44 40.22 10.57 coo 29.35 31.42 99.15 28.72 33.09 98.04 101.04 34.65 20.79 101.93 33.69 19.16 coo 20.42 28.25 99.26 20.25 29.62 97.63 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 13 3 # 13 B 223 HIS G 79 HIS~? -4.46 CL CL G2033s B 262 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 23.86 29.50 91.20 24.12 31.58 91.00 5.20 17.85 42.65 4.12 16.10 42.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 9.81 10.31 48.06 9.47 8.80 49.48 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 14 3 # 14 B 223 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 262 HIS G 79 HIS~? -4.46 CL CL G2033s B 312 ASP G 127 ASP.? 12.80 CL CL G2033 coo 23.86 29.50 91.20 24.12 31.58 91.00 9.81 10.31 48.06 9.47 8.80 49.48 coo 29.35 31.42 99.15 28.72 33.09 98.04 5.20 17.85 42.65 4.12 16.10 42.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 15 3 # 15 B 223 HIS H 79 HIS~? 4.82 CL CL H2024 B 262 HIS H 125 HIS.? 7.36 CL CL H2014 B 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 23.86 29.50 91.20 24.12 31.58 91.00 95.19 63.20 96.60 95.96 63.87 98.43 coo 29.35 31.42 99.15 28.72 33.09 98.04 88.12 60.23 103.63 87.33 59.09 105.21 coo 20.42 28.25 99.26 20.25 29.62 97.63 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 16 3 # 16 B 223 HIS H 125 HIS.? 7.36 CL CL H2014 B 262 HIS H 79 HIS~? 4.82 CL CL H2024 B 312 ASP H 127 ASP.? 11.27 CL CL H2014 coo 23.86 29.50 91.20 24.12 31.58 91.00 88.12 60.23 103.63 87.33 59.09 105.21 coo 29.35 31.42 99.15 28.72 33.09 98.04 95.19 63.20 96.60 95.96 63.87 98.43 coo 20.42 28.25 99.26 20.25 29.62 97.63 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 17 3 # 17 B 223 HIS I 79 HIS~? -4.56 CL CL I2025s B 262 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 23.86 29.50 91.20 24.12 31.58 91.00 216.99 204.94 159.50 218.07 206.60 158.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 211.42 212.80 162.96 211.20 214.50 164.16 coo 20.42 28.25 99.26 20.25 29.62 97.63 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 18 3 # 18 B 223 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 262 HIS I 79 HIS~? -4.56 CL CL I2025s B 312 ASP I 127 ASP.? 10.93 CL CL I2015 coo 23.86 29.50 91.20 24.12 31.58 91.00 211.42 212.80 162.96 211.20 214.50 164.16 coo 29.35 31.42 99.15 28.72 33.09 98.04 216.99 204.94 159.50 218.07 206.60 158.77 coo 20.42 28.25 99.26 20.25 29.62 97.63 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 19 3 # 19 B 223 HIS J 79 HIS~? -4.36 CL CL J2026s B 262 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 23.86 29.50 91.20 24.12 31.58 91.00 126.45 179.07 126.46 125.69 179.71 124.61 coo 29.35 31.42 99.15 28.72 33.09 98.04 132.43 173.86 119.73 132.77 172.30 118.36 coo 20.42 28.25 99.26 20.25 29.62 97.63 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 20 3 # 20 B 223 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 262 HIS J 79 HIS~? -4.36 CL CL J2026s B 312 ASP J 127 ASP.? 11.08 CL CL J2016 coo 23.86 29.50 91.20 24.12 31.58 91.00 132.43 173.86 119.73 132.77 172.30 118.36 coo 29.35 31.42 99.15 28.72 33.09 98.04 126.45 179.07 126.46 125.69 179.71 124.61 coo 20.42 28.25 99.26 20.25 29.62 97.63 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 21 3 # 21 B 223 HIS K 79 HIS~? -4.34 CL CL K2027s B 262 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 23.86 29.50 91.20 24.12 31.58 91.00 211.01 127.65 183.80 211.70 125.86 184.65 coo 29.35 31.42 99.15 28.72 33.09 98.04 204.92 120.38 179.37 204.44 118.90 177.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 22 3 # 22 B 223 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 262 HIS K 79 HIS~? -4.34 CL CL K2027s B 312 ASP K 127 ASP.? 12.37 CL CL K2027 coo 23.86 29.50 91.20 24.12 31.58 91.00 204.92 120.38 179.37 204.44 118.90 177.95 coo 29.35 31.42 99.15 28.72 33.09 98.04 211.01 127.65 183.80 211.70 125.86 184.65 coo 20.42 28.25 99.26 20.25 29.62 97.63 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 23 3 # 23 B 223 HIS L 79 HIS~? -4.09 CL CL L2028s B 262 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 23.86 29.50 91.20 24.12 31.58 91.00 120.65 164.52 206.19 119.64 164.06 207.98 coo 29.35 31.42 99.15 28.72 33.09 98.04 126.56 168.90 213.47 127.02 170.42 214.85 coo 20.42 28.25 99.26 20.25 29.62 97.63 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 24 3 # 24 B 223 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 262 HIS L 79 HIS~? -4.09 CL CL L2028s B 312 ASP L 127 ASP.? 11.05 CL CL L2009 coo 23.86 29.50 91.20 24.12 31.58 91.00 126.56 168.90 213.47 127.02 170.42 214.85 coo 29.35 31.42 99.15 28.72 33.09 98.04 120.65 164.52 206.19 119.64 164.06 207.98 coo 20.42 28.25 99.26 20.25 29.62 97.63 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 25 3 # 25 B 223 HIS M 79 HIS~? -4.31 CL CL M2029s B 262 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 23.86 29.50 91.20 24.12 31.58 91.00 125.50 211.59 173.52 124.72 213.49 173.99 coo 29.35 31.42 99.15 28.72 33.09 98.04 132.19 217.95 169.15 132.87 219.15 167.56 coo 20.42 28.25 99.26 20.25 29.62 97.63 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 26 3 # 26 B 223 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 262 HIS M 79 HIS~? -4.31 CL CL M2029s B 312 ASP M 127 ASP.? 9.06 CL CL M2017 coo 23.86 29.50 91.20 24.12 31.58 91.00 132.19 217.95 169.15 132.87 219.15 167.56 coo 29.35 31.42 99.15 28.72 33.09 98.04 125.50 211.59 173.52 124.72 213.49 173.99 coo 20.42 28.25 99.26 20.25 29.62 97.63 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 27 3 # 27 B 223 HIS N 79 HIS~? -4.33 CL CL N2030s B 262 HIS N 125 HIS.? 9.29 CL CL N2030 B 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 23.86 29.50 91.20 24.12 31.58 91.00 215.64 153.98 132.96 216.60 153.22 131.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 210.43 158.18 125.05 210.19 159.49 123.43 coo 20.42 28.25 99.26 20.25 29.62 97.63 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 28 3 # 28 B 223 HIS N 125 HIS.? 9.29 CL CL N2030 B 262 HIS N 79 HIS~? -4.33 CL CL N2030s B 312 ASP N 127 ASP.? 12.60 CL CL N2030 coo 23.86 29.50 91.20 24.12 31.58 91.00 210.43 158.18 125.05 210.19 159.49 123.43 coo 29.35 31.42 99.15 28.72 33.09 98.04 215.64 153.98 132.96 216.60 153.22 131.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 29 3 # 29 B 223 HIS O 79 HIS~? 5.21 CL CL O2018 B 262 HIS O 125 HIS.? 7.09 CL CL O2018 B 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 23.86 29.50 91.20 24.12 31.58 91.00 121.98 131.53 158.56 121.09 129.74 157.92 coo 29.35 31.42 99.15 28.72 33.09 98.04 126.97 124.39 163.68 126.90 122.97 165.24 coo 20.42 28.25 99.26 20.25 29.62 97.63 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 30 3 # 30 B 223 HIS O 125 HIS.? 7.09 CL CL O2018 B 262 HIS O 79 HIS~? 5.21 CL CL O2018 B 312 ASP O 127 ASP.? 11.33 CL CL O2018 coo 23.86 29.50 91.20 24.12 31.58 91.00 126.97 124.39 163.68 126.90 122.97 165.24 coo 29.35 31.42 99.15 28.72 33.09 98.04 121.98 131.53 158.56 121.09 129.74 157.92 coo 20.42 28.25 99.26 20.25 29.62 97.63 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 31 3 # 31 B 223 HIS P 79 HIS~? 5.38 CL CL P2019 B 262 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 23.86 29.50 91.20 24.12 31.58 91.00 212.25 178.47 210.26 213.09 179.27 212.01 coo 29.35 31.42 99.15 28.72 33.09 98.04 205.78 175.00 217.63 205.21 173.76 219.23 coo 20.42 28.25 99.26 20.25 29.62 97.63 207.19 183.81 214.61 207.22 185.89 215.11 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 32 3 # 32 B 223 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 262 HIS P 79 HIS~? 5.38 CL CL P2019 B 312 ASP P 127 ASP.? 11.05 CL CL P2019 coo 23.86 29.50 91.20 24.12 31.58 91.00 205.78 175.00 217.63 205.21 173.76 219.23 coo 29.35 31.42 99.15 28.72 33.09 98.04 212.25 178.47 210.26 213.09 179.27 212.01 coo 20.42 28.25 99.26 20.25 29.62 97.63 207.19 183.81 214.61 207.22 185.89 215.11 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 32 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 79 HIS~? -3.92 CL CL A2020s 320 HIS A 125 HIS.? 6.10 O2 GOL A3040 375 ASP A 127 ASP.? 12.37 CL CL A2020 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 103.72 86.36 44.76 104.87 88.01 44.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 98.48 94.83 47.66 98.07 96.39 49.01 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 125 HIS.? 6.10 O2 GOL A3040 320 HIS A 79 HIS~? -3.92 CL CL A2020s 375 ASP A 127 ASP.? 12.37 CL CL A2020 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 98.48 94.83 47.66 98.07 96.39 49.01 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 103.72 86.36 44.76 104.87 88.01 44.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS B 79 HIS~? 5.08 CL CL B2010 320 HIS B 125 HIS.? 5.37 C1 GOL B3023 375 ASP B 127 ASP.? 11.35 CL CL B2010 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 13.46 62.96 8.26 12.78 63.30 6.30 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.73 57.29 2.23 19.89 55.80 0.75 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS B 125 HIS.? 5.37 C1 GOL B3023 320 HIS B 79 HIS~? 5.08 CL CL B2010 375 ASP B 127 ASP.? 11.35 CL CL B2010 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 19.73 57.29 2.23 19.89 55.80 0.75 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 13.46 62.96 8.26 12.78 63.30 6.30 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS C 79 HIS~? -4.32 CL CL C2021s 320 HIS C 125 HIS.? 6.65 CL CL C2011 375 ASP C 127 ASP.? 10.87 CL CL C2011 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 92.85 10.89 71.99 93.43 9.18 73.06 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 86.57 4.11 67.63 86.24 2.65 66.14 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS C 125 HIS.? 6.65 CL CL C2011 320 HIS C 79 HIS~? -4.32 CL CL C2021s 375 ASP C 127 ASP.? 10.87 CL CL C2011 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 86.57 4.11 67.63 86.24 2.65 66.14 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 92.85 10.89 71.99 93.43 9.18 73.06 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS D 79 HIS~? -4.57 CL CL D2022s 320 HIS D 125 HIS.? -3.96 O3 GOL D3018s 375 ASP D 127 ASP.? 11.17 CL CL D2012 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 3.57 52.49 87.96 2.52 51.97 89.71 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.12 57.04 95.76 9.45 58.59 97.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS D 125 HIS.? -3.96 O3 GOL D3018s 320 HIS D 79 HIS~? -4.57 CL CL D2022s 375 ASP D 127 ASP.? 11.17 CL CL D2012 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.12 57.04 95.76 9.45 58.59 97.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 3.57 52.49 87.96 2.52 51.97 89.71 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS E 79 HIS~? -4.18 CL CL E2032s 320 HIS E 125 HIS.? 5.41 C3 GOL E3022 375 ASP E 127 ASP.? 11.39 CL CL E2013 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 12.36 98.35 54.34 11.69 100.32 54.60 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 19.41 104.46 50.06 20.14 105.76 48.58 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1al6_c00 CITRATE SYNTHASE user 10 3 # 10 274 HIS E 125 HIS.? 5.41 C3 GOL E3022 320 HIS E 79 HIS~? -4.18 CL CL E2032s 375 ASP E 127 ASP.? 11.39 CL CL E2013 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 19.41 104.46 50.06 20.14 105.76 48.58 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 12.36 98.35 54.34 11.69 100.32 54.60 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1al6_c00 CITRATE SYNTHASE user 11 3 # 11 274 HIS F 79 HIS~? -4.63 CL CL F2023s 320 HIS F 125 HIS.? 6.27 C1 GOL F3039 375 ASP F 127 ASP.? 10.85 CL CL F2034 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 101.04 34.65 20.79 101.93 33.69 19.16 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 96.50 38.92 12.23 96.44 40.22 10.57 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1al6_c00 CITRATE SYNTHASE user 12 3 # 12 274 HIS F 125 HIS.? 6.27 C1 GOL F3039 320 HIS F 79 HIS~? -4.63 CL CL F2023s 375 ASP F 127 ASP.? 10.85 CL CL F2034 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 96.50 38.92 12.23 96.44 40.22 10.57 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 101.04 34.65 20.79 101.93 33.69 19.16 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1al6_c00 CITRATE SYNTHASE user 13 3 # 13 274 HIS G 79 HIS~? -4.46 CL CL G2033s 320 HIS G 125 HIS.? 6.66 C2 GOL G3038 375 ASP G 127 ASP.? 12.80 CL CL G2033 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 5.20 17.85 42.65 4.12 16.10 42.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 9.81 10.31 48.06 9.47 8.80 49.48 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1al6_c00 CITRATE SYNTHASE user 14 3 # 14 274 HIS G 125 HIS.? 6.66 C2 GOL G3038 320 HIS G 79 HIS~? -4.46 CL CL G2033s 375 ASP G 127 ASP.? 12.80 CL CL G2033 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 9.81 10.31 48.06 9.47 8.80 49.48 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 5.20 17.85 42.65 4.12 16.10 42.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1al6_c00 CITRATE SYNTHASE user 15 3 # 15 274 HIS H 79 HIS~? 4.82 CL CL H2024 320 HIS H 125 HIS.? 7.36 CL CL H2014 375 ASP H 127 ASP.? 11.27 CL CL H2014 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 95.19 63.20 96.60 95.96 63.87 98.43 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 88.12 60.23 103.63 87.33 59.09 105.21 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1al6_c00 CITRATE SYNTHASE user 16 3 # 16 274 HIS H 125 HIS.? 7.36 CL CL H2014 320 HIS H 79 HIS~? 4.82 CL CL H2024 375 ASP H 127 ASP.? 11.27 CL CL H2014 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 88.12 60.23 103.63 87.33 59.09 105.21 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 95.19 63.20 96.60 95.96 63.87 98.43 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1al6_c00 CITRATE SYNTHASE user 17 3 # 17 274 HIS I 79 HIS~? -4.56 CL CL I2025s 320 HIS I 125 HIS.? 6.50 O2 GOL I3031 375 ASP I 127 ASP.? 10.93 CL CL I2015 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 216.99 204.94 159.50 218.07 206.60 158.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 211.42 212.80 162.96 211.20 214.50 164.16 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1al6_c00 CITRATE SYNTHASE user 18 3 # 18 274 HIS I 125 HIS.? 6.50 O2 GOL I3031 320 HIS I 79 HIS~? -4.56 CL CL I2025s 375 ASP I 127 ASP.? 10.93 CL CL I2015 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 211.42 212.80 162.96 211.20 214.50 164.16 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 216.99 204.94 159.50 218.07 206.60 158.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1al6_c00 CITRATE SYNTHASE user 19 3 # 19 274 HIS J 79 HIS~? -4.36 CL CL J2026s 320 HIS J 125 HIS.? -4.00 O3 GOL J3030s 375 ASP J 127 ASP.? 11.08 CL CL J2016 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 126.45 179.07 126.46 125.69 179.71 124.61 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 132.43 173.86 119.73 132.77 172.30 118.36 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1al6_c00 CITRATE SYNTHASE user 20 3 # 20 274 HIS J 125 HIS.? -4.00 O3 GOL J3030s 320 HIS J 79 HIS~? -4.36 CL CL J2026s 375 ASP J 127 ASP.? 11.08 CL CL J2016 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 132.43 173.86 119.73 132.77 172.30 118.36 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.45 179.07 126.46 125.69 179.71 124.61 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1al6_c00 CITRATE SYNTHASE user 21 3 # 21 274 HIS K 79 HIS~? -4.34 CL CL K2027s 320 HIS K 125 HIS.? -4.02 O1 GOL K3041s 375 ASP K 127 ASP.? 12.37 CL CL K2027 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 211.01 127.65 183.80 211.70 125.86 184.65 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 204.92 120.38 179.37 204.44 118.90 177.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1al6_c00 CITRATE SYNTHASE user 22 3 # 22 274 HIS K 125 HIS.? -4.02 O1 GOL K3041s 320 HIS K 79 HIS~? -4.34 CL CL K2027s 375 ASP K 127 ASP.? 12.37 CL CL K2027 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 204.92 120.38 179.37 204.44 118.90 177.95 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 211.01 127.65 183.80 211.70 125.86 184.65 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1al6_c00 CITRATE SYNTHASE user 23 3 # 23 274 HIS L 79 HIS~? -4.09 CL CL L2028s 320 HIS L 125 HIS.? 5.88 O2 GOL L3027 375 ASP L 127 ASP.? 11.05 CL CL L2009 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 120.65 164.52 206.19 119.64 164.06 207.98 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.56 168.90 213.47 127.02 170.42 214.85 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1al6_c00 CITRATE SYNTHASE user 24 3 # 24 274 HIS L 125 HIS.? 5.88 O2 GOL L3027 320 HIS L 79 HIS~? -4.09 CL CL L2028s 375 ASP L 127 ASP.? 11.05 CL CL L2009 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 126.56 168.90 213.47 127.02 170.42 214.85 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 120.65 164.52 206.19 119.64 164.06 207.98 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1al6_c00 CITRATE SYNTHASE user 25 3 # 25 274 HIS M 79 HIS~? -4.31 CL CL M2029s 320 HIS M 125 HIS.? 4.98 C3 GOL M3043 375 ASP M 127 ASP.? 9.06 CL CL M2017 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 125.50 211.59 173.52 124.72 213.49 173.99 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 132.19 217.95 169.15 132.87 219.15 167.56 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1al6_c00 CITRATE SYNTHASE user 26 3 # 26 274 HIS M 125 HIS.? 4.98 C3 GOL M3043 320 HIS M 79 HIS~? -4.31 CL CL M2029s 375 ASP M 127 ASP.? 9.06 CL CL M2017 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 132.19 217.95 169.15 132.87 219.15 167.56 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 125.50 211.59 173.52 124.72 213.49 173.99 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1al6_c00 CITRATE SYNTHASE user 27 3 # 27 274 HIS N 79 HIS~? -4.33 CL CL N2030s 320 HIS N 125 HIS.? 9.29 CL CL N2030 375 ASP N 127 ASP.? 12.60 CL CL N2030 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 215.64 153.98 132.96 216.60 153.22 131.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 210.43 158.18 125.05 210.19 159.49 123.43 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1al6_c00 CITRATE SYNTHASE user 28 3 # 28 274 HIS N 125 HIS.? 9.29 CL CL N2030 320 HIS N 79 HIS~? -4.33 CL CL N2030s 375 ASP N 127 ASP.? 12.60 CL CL N2030 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 210.43 158.18 125.05 210.19 159.49 123.43 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 215.64 153.98 132.96 216.60 153.22 131.26 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1al6_c00 CITRATE SYNTHASE user 29 3 # 29 274 HIS O 79 HIS~? 5.21 CL CL O2018 320 HIS O 125 HIS.? 7.09 CL CL O2018 375 ASP O 127 ASP.? 11.33 CL CL O2018 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 121.98 131.53 158.56 121.09 129.74 157.92 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 126.97 124.39 163.68 126.90 122.97 165.24 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1al6_c00 CITRATE SYNTHASE user 30 3 # 30 274 HIS O 125 HIS.? 7.09 CL CL O2018 320 HIS O 79 HIS~? 5.21 CL CL O2018 375 ASP O 127 ASP.? 11.33 CL CL O2018 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 126.97 124.39 163.68 126.90 122.97 165.24 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 121.98 131.53 158.56 121.09 129.74 157.92 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1al6_c00 CITRATE SYNTHASE user 31 3 # 31 274 HIS P 79 HIS~? 5.38 CL CL P2019 320 HIS P 125 HIS.? 6.57 O3 GOL P3034 375 ASP P 127 ASP.? 11.05 CL CL P2019 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 212.25 178.47 210.26 213.09 179.27 212.01 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 205.78 175.00 217.63 205.21 173.76 219.23 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 207.19 183.81 214.61 207.22 185.89 215.11 ULMN 3 1al6_c00 CITRATE SYNTHASE user 32 3 # 32 274 HIS P 125 HIS.? 6.57 O3 GOL P3034 320 HIS P 79 HIS~? 5.38 CL CL P2019 375 ASP P 127 ASP.? 11.05 CL CL P2019 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 205.78 175.00 217.63 205.21 173.76 219.23 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 212.25 178.47 210.26 213.09 179.27 212.01 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 207.19 183.81 214.61 207.22 185.89 215.11 1al6_c00 source 1al6 CITRATE SYNTHASE : 32 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 70 ASP~? -9.95 O3 GOL A3037s 187 GLU A 62 GLU~? 17.89 O1 GOL A3040 229 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -52.57 56.60 47.75 -51.52 54.87 46.95 90.44 78.16 48.76 91.65 76.94 50.06 coo -45.08 48.37 46.81 -46.53 49.74 45.96 79.10 78.67 51.18 78.43 78.08 53.09 coo -47.40 44.36 48.48 -50.80 49.18 46.20 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 70 ASP~? -9.95 O3 GOL A3037s 187 GLU A 63 GLU~? 17.38 O3 GOL A3037 229 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -52.57 56.60 47.75 -51.52 54.87 46.95 90.44 78.16 48.76 91.65 76.94 50.06 coo -45.08 48.37 46.81 -46.53 49.74 45.96 80.85 73.88 49.67 82.12 74.36 51.37 coo -47.40 44.36 48.48 -50.80 49.18 46.20 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 102 ASP.? 25.18 C1 GOL A3040 187 GLU A 141 GLU~? 27.05 O1 GOL A3040 229 LYS A 142 LYS~? 20.36 CL CL A2020 coo -52.57 56.60 47.75 -51.52 54.87 46.95 88.23 80.63 30.72 87.92 80.82 28.67 coo -45.08 48.37 46.81 -46.53 49.74 45.96 89.05 70.31 35.51 89.11 68.84 33.95 coo -47.40 44.36 48.48 -50.80 49.18 46.20 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 70 ASP~? -3.24 O2 GOL B3024s 187 GLU B 62 GLU~? 6.16 O2 GOL B3017 229 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.66 59.02 20.34 21.93 58.32 21.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 34.07 54.53 23.00 34.19 52.69 24.02 coo -47.40 44.36 48.48 -50.80 49.18 46.20 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP B 70 ASP~? -3.24 O2 GOL B3024s 187 GLU B 63 GLU~? 5.73 C3 GOL B3024 229 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.66 59.02 20.34 21.93 58.32 21.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 31.78 57.54 26.90 30.14 56.11 26.75 coo -47.40 44.36 48.48 -50.80 49.18 46.20 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 102 ASP.? 20.31 O1 GOL B3024 187 GLU B 141 GLU~? 14.29 O1 GOL B3024 229 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -52.57 56.60 47.75 -51.52 54.87 46.95 30.49 75.29 14.98 31.30 77.16 14.42 coo -45.08 48.37 46.81 -46.53 49.74 45.96 26.68 73.50 25.50 26.49 75.15 26.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP C 70 ASP~? 3.38 O1 GOL C3036s 187 GLU C 62 GLU~? 6.84 O3 GOL C3021 229 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -52.57 56.60 47.75 -51.52 54.87 46.95 82.81 22.02 65.69 84.52 22.80 64.66 coo -45.08 48.37 46.81 -46.53 49.74 45.96 72.25 23.75 60.88 72.37 24.62 58.95 coo -47.40 44.36 48.48 -50.80 49.18 46.20 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP C 70 ASP~? 3.38 O1 GOL C3036s 187 GLU C 63 GLU~? 10.01 O3 GOL C3021 229 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -52.57 56.60 47.75 -51.52 54.87 46.95 82.81 22.02 65.69 84.52 22.80 64.66 coo -45.08 48.37 46.81 -46.53 49.74 45.96 74.66 28.22 62.99 76.28 27.57 61.69 coo -47.40 44.36 48.48 -50.80 49.18 46.20 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP C 102 ASP.? 24.57 CL CL C2011 187 GLU C 141 GLU~? 19.53 O2 GOL H3025 229 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -52.57 56.60 47.75 -51.52 54.87 46.95 76.25 20.52 82.74 75.40 20.56 84.65 coo -45.08 48.37 46.81 -46.53 49.74 45.96 80.37 30.30 78.61 80.09 31.65 80.29 coo -47.40 44.36 48.48 -50.80 49.18 46.20 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP D 70 ASP~? -11.51 O3 GOL D3019s 187 GLU D 62 GLU~? 6.84 O2 GOL D3019 229 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -52.57 56.60 47.75 -51.52 54.87 46.95 16.94 54.59 79.01 15.65 55.42 77.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 28.24 57.03 78.84 28.94 58.69 77.75 coo -47.40 44.36 48.48 -50.80 49.18 46.20 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP D 70 ASP~? -11.51 O3 GOL D3019s 187 GLU D 63 GLU~? 9.36 O3 GOL D3019 229 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -52.57 56.60 47.75 -51.52 54.87 46.95 16.94 54.59 79.01 15.65 55.42 77.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 26.38 54.52 74.49 25.00 56.17 74.76 coo -47.40 44.36 48.48 -50.80 49.18 46.20 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP D 102 ASP.? 24.32 CL CL D2012 187 GLU D 141 GLU~? 22.23 O1 GOL G3001 229 LYS D 142 LYS~? 18.65 CL CL D2012 coo -52.57 56.60 47.75 -51.52 54.87 46.95 18.96 37.41 85.00 19.42 35.40 85.42 coo -45.08 48.37 46.81 -46.53 49.74 45.96 17.13 41.08 72.88 18.91 42.32 72.55 coo -47.40 44.36 48.48 -50.80 49.18 46.20 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 13 3 # 13 33 ASP E 70 ASP~? 5.56 O3 GOL E3002 187 GLU E 62 GLU~? 6.69 C2 GOL E3035 229 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.07 86.29 52.35 21.57 85.17 51.32 coo -45.08 48.37 46.81 -46.53 49.74 45.96 34.02 83.69 49.99 34.45 82.62 48.22 coo -47.40 44.36 48.48 -50.80 49.18 46.20 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 14 3 # 14 33 ASP E 70 ASP~? 5.56 O3 GOL E3002 187 GLU E 63 GLU~? 9.77 O1 GOL E3035 229 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.07 86.29 52.35 21.57 85.17 51.32 coo -45.08 48.37 46.81 -46.53 49.74 45.96 31.45 79.77 52.47 30.08 79.96 50.79 coo -47.40 44.36 48.48 -50.80 49.18 46.20 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 15 3 # 15 33 ASP E 102 ASP.? 24.45 CL CL E2013 187 GLU E 141 GLU~? 19.75 O1 GOL D3019 229 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -52.57 56.60 47.75 -51.52 54.87 46.95 26.42 91.49 69.61 27.08 91.68 71.63 coo -45.08 48.37 46.81 -46.53 49.74 45.96 21.80 82.16 67.66 21.51 80.62 69.17 coo -47.40 44.36 48.48 -50.80 49.18 46.20 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 16 3 # 16 33 ASP F 70 ASP~? -11.57 O3 GOL F3039s 187 GLU F 62 GLU~? 11.61 CL CL F2035 229 LYS F 61 LYS~? -5.82 CL CL F2035s coo -52.57 56.60 47.75 -51.52 54.87 46.95 88.86 41.25 28.96 90.30 42.22 30.24 coo -45.08 48.37 46.81 -46.53 49.74 45.96 78.25 46.27 28.27 77.97 48.25 28.91 coo -47.40 44.36 48.48 -50.80 49.18 46.20 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 17 3 # 17 33 ASP F 70 ASP~? -11.57 O3 GOL F3039s 187 GLU F 63 GLU~? 10.86 CL CL F2035 229 LYS F 61 LYS~? -5.82 CL CL F2035s coo -52.57 56.60 47.75 -51.52 54.87 46.95 88.86 41.25 28.96 90.30 42.22 30.24 coo -45.08 48.37 46.81 -46.53 49.74 45.96 79.68 44.12 33.16 81.40 45.47 32.88 coo -47.40 44.36 48.48 -50.80 49.18 46.20 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 18 3 # 18 33 ASP F 102 ASP.? 16.73 CL CL F2035 187 GLU F 141 GLU~? 15.85 CL CL F2035 229 LYS F 142 LYS~? 19.20 CL CL F2034 coo -52.57 56.60 47.75 -51.52 54.87 46.95 82.74 24.28 26.35 81.91 22.30 26.35 coo -45.08 48.37 46.81 -46.53 49.74 45.96 84.56 28.39 36.54 84.29 26.85 38.03 coo -47.40 44.36 48.48 -50.80 49.18 46.20 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 19 3 # 19 33 ASP G 70 ASP~? -5.29 C3 GOL G3001s 187 GLU G 62 GLU~? 14.49 O2 GOL G3001 229 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -52.57 56.60 47.75 -51.52 54.87 46.95 17.70 27.34 47.09 16.19 28.71 47.73 coo -45.08 48.37 46.81 -46.53 49.74 45.96 28.36 27.46 51.94 28.55 28.64 53.65 coo -47.40 44.36 48.48 -50.80 49.18 46.20 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 20 3 # 20 33 ASP G 70 ASP~? -5.29 C3 GOL G3001s 187 GLU G 63 GLU~? 11.17 O2 GOL G3001 229 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -52.57 56.60 47.75 -51.52 54.87 46.95 17.70 27.34 47.09 16.19 28.71 47.73 coo -45.08 48.37 46.81 -46.53 49.74 45.96 27.02 31.92 48.98 25.38 31.91 50.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 21 3 # 21 33 ASP G 102 ASP.? 25.30 O3 GOL G3038 187 GLU G 141 GLU~? 19.33 O1 GOL B3017 229 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -52.57 56.60 47.75 -51.52 54.87 46.95 23.47 21.05 30.82 24.30 20.62 28.93 coo -45.08 48.37 46.81 -46.53 49.74 45.96 21.81 32.02 32.76 22.04 33.29 31.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 22 3 # 22 33 ASP H 70 ASP~? -4.05 C3 GOL H3016s 187 GLU H 62 GLU~? 6.87 C1 GOL H3025 229 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -52.57 56.60 47.75 -51.52 54.87 46.95 84.24 58.93 85.48 85.73 57.59 84.66 coo -45.08 48.37 46.81 -46.53 49.74 45.96 73.13 56.32 83.46 72.69 54.40 82.74 coo -47.40 44.36 48.48 -50.80 49.18 46.20 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 23 3 # 23 33 ASP H 70 ASP~? -4.05 C3 GOL H3016s 187 GLU H 63 GLU~? 5.58 O3 GOL H3016 229 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -52.57 56.60 47.75 -51.52 54.87 46.95 84.24 58.93 85.48 85.73 57.59 84.66 coo -45.08 48.37 46.81 -46.53 49.74 45.96 75.79 57.78 79.22 77.22 56.21 79.74 coo -47.40 44.36 48.48 -50.80 49.18 46.20 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 24 3 # 24 33 ASP H 102 ASP.? 20.45 O2 GOL H3016 187 GLU H 141 GLU~? 14.58 O1 GOL H3016 229 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -52.57 56.60 47.75 -51.52 54.87 46.95 81.36 76.99 86.94 80.90 79.01 86.89 coo -45.08 48.37 46.81 -46.53 49.74 45.96 84.42 72.24 77.39 84.86 73.57 75.76 coo -47.40 44.36 48.48 -50.80 49.18 46.20 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 25 3 # 25 33 ASP I 70 ASP~? -3.65 C2 GOL I3032s 187 GLU I 62 GLU~? 9.77 O2 GOL I3032 229 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -52.57 56.60 47.75 -51.52 54.87 46.95 204.37 195.46 163.61 205.75 194.30 164.79 coo -45.08 48.37 46.81 -46.53 49.74 45.96 193.02 195.43 166.68 192.61 194.52 168.53 coo -47.40 44.36 48.48 -50.80 49.18 46.20 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 26 3 # 26 33 ASP I 70 ASP~? -3.65 C2 GOL I3032s 187 GLU I 63 GLU~? 5.33 O2 GOL I3032 229 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -52.57 56.60 47.75 -51.52 54.87 46.95 204.37 195.46 163.61 205.75 194.30 164.79 coo -45.08 48.37 46.81 -46.53 49.74 45.96 195.05 190.75 164.81 196.51 190.81 166.36 coo -47.40 44.36 48.48 -50.80 49.18 46.20 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 27 3 # 27 33 ASP I 102 ASP.? 20.44 O1 GOL I3032 187 GLU I 141 GLU~? 15.06 O1 GOL I3032 229 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -52.57 56.60 47.75 -51.52 54.87 46.95 201.10 198.54 145.88 200.66 198.62 143.82 coo -45.08 48.37 46.81 -46.53 49.74 45.96 203.00 188.32 149.96 202.87 186.91 148.25 coo -47.40 44.36 48.48 -50.80 49.18 46.20 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 28 3 # 28 33 ASP J 70 ASP~? 11.68 O1 GOL J3033 187 GLU J 62 GLU~? 19.29 O1 GOL J3030 229 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -52.57 56.60 47.75 -51.52 54.87 46.95 137.44 174.60 137.57 135.80 173.80 138.69 coo -45.08 48.37 46.81 -46.53 49.74 45.96 148.05 170.40 139.46 148.28 168.51 140.38 coo -47.40 44.36 48.48 -50.80 49.18 46.20 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 29 3 # 29 33 ASP J 70 ASP~? 11.68 O1 GOL J3033 187 GLU J 63 GLU~? 19.53 O1 GOL J3033 229 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -52.57 56.60 47.75 -51.52 54.87 46.95 137.44 174.60 137.57 135.80 173.80 138.69 coo -45.08 48.37 46.81 -46.53 49.74 45.96 145.93 173.07 143.61 144.33 171.59 143.32 coo -47.40 44.36 48.48 -50.80 49.18 46.20 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 30 3 # 30 33 ASP J 102 ASP.? 24.08 CL CL J2016 187 GLU J 141 GLU~? 24.92 O2 GOL M3042 229 LYS J 142 LYS~? 19.62 CL CL J2016 coo -52.57 56.60 47.75 -51.52 54.87 46.95 143.25 191.36 132.98 143.80 193.32 132.63 coo -45.08 48.37 46.81 -46.53 49.74 45.96 139.93 188.85 143.36 139.82 190.60 144.63 coo -47.40 44.36 48.48 -50.80 49.18 46.20 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 31 3 # 31 33 ASP K 70 ASP~? -4.89 O3 GOL K3009s 187 GLU K 62 GLU~? 6.62 O2 GOL K3010 229 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -52.57 56.60 47.75 -51.52 54.87 46.95 200.17 138.24 178.11 201.77 139.28 177.19 coo -45.08 48.37 46.81 -46.53 49.74 45.96 189.61 139.57 173.68 189.43 140.41 171.76 coo -47.40 44.36 48.48 -50.80 49.18 46.20 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 32 3 # 32 33 ASP K 70 ASP~? -4.89 O3 GOL K3009s 187 GLU K 63 GLU~? 9.64 O2 GOL K3010 229 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -52.57 56.60 47.75 -51.52 54.87 46.95 200.17 138.24 178.11 201.77 139.28 177.19 coo -45.08 48.37 46.81 -46.53 49.74 45.96 191.78 144.13 175.87 193.39 143.52 174.53 coo -47.40 44.36 48.48 -50.80 49.18 46.20 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 33 3 # 33 33 ASP K 102 ASP.? 24.81 O1 GOL K3041 187 GLU K 141 GLU~? 22.10 C1 GOL P3014 229 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -52.57 56.60 47.75 -51.52 54.87 46.95 194.36 135.90 195.25 193.66 135.95 197.23 coo -45.08 48.37 46.81 -46.53 49.74 45.96 197.75 145.77 191.54 197.42 146.88 193.40 coo -47.40 44.36 48.48 -50.80 49.18 46.20 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 34 3 # 34 33 ASP L 70 ASP~? -12.27 O3 GOL L3028s 187 GLU L 62 GLU~? 6.90 C3 GOL L3028 229 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -52.57 56.60 47.75 -51.52 54.87 46.95 133.34 166.97 196.27 132.03 168.03 194.96 coo -45.08 48.37 46.81 -46.53 49.74 45.96 144.62 169.85 195.72 145.14 171.64 194.63 coo -47.40 44.36 48.48 -50.80 49.18 46.20 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 35 3 # 35 33 ASP L 70 ASP~? -12.27 O3 GOL L3028s 187 GLU L 63 GLU~? 9.87 O3 GOL L3028 229 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -52.57 56.60 47.75 -51.52 54.87 46.95 133.34 166.97 196.27 132.03 168.03 194.96 coo -45.08 48.37 46.81 -46.53 49.74 45.96 142.67 167.29 191.27 141.24 168.94 191.33 coo -47.40 44.36 48.48 -50.80 49.18 46.20 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 36 3 # 36 33 ASP L 102 ASP.? 24.59 CL CL L2009 187 GLU L 141 GLU~? 22.39 C3 GOL O3013 229 LYS L 142 LYS~? 23.18 CL CL L2009 coo -52.57 56.60 47.75 -51.52 54.87 46.95 136.52 149.82 201.33 136.95 147.73 201.53 coo -45.08 48.37 46.81 -46.53 49.74 45.96 132.89 153.36 189.75 130.85 152.81 189.78 coo -47.40 44.36 48.48 -50.80 49.18 46.20 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 37 3 # 37 33 ASP M 70 ASP~? -9.98 O3 GOL M3042s 187 GLU M 62 GLU~? 18.60 O3 GOL M3042 229 LYS M 61 LYS~? 24.74 CL CL I2007 coo -52.57 56.60 47.75 -51.52 54.87 46.95 136.87 200.18 170.79 135.36 199.08 169.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 148.09 198.35 167.82 148.51 197.28 166.06 coo -47.40 44.36 48.48 -50.80 49.18 46.20 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 38 3 # 38 33 ASP M 70 ASP~? -9.98 O3 GOL M3042s 187 GLU M 63 GLU~? 17.44 O3 GOL M3042 229 LYS M 61 LYS~? 24.74 CL CL I2007 coo -52.57 56.60 47.75 -51.52 54.87 46.95 136.87 200.18 170.79 135.36 199.08 169.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 145.53 194.15 170.27 144.03 194.27 168.71 coo -47.40 44.36 48.48 -50.80 49.18 46.20 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 39 3 # 39 33 ASP M 102 ASP.? 24.52 CL CL M2017 187 GLU M 141 GLU~? 19.50 O2 GOL L3028 229 LYS M 142 LYS~? 19.90 CL CL M2017 coo -52.57 56.60 47.75 -51.52 54.87 46.95 140.74 204.70 188.01 141.33 204.99 189.98 coo -45.08 48.37 46.81 -46.53 49.74 45.96 137.93 194.30 185.04 137.74 193.05 186.86 coo -47.40 44.36 48.48 -50.80 49.18 46.20 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 40 3 # 40 33 ASP N 70 ASP~? -3.26 O2 GOL N3029s 187 GLU N 62 GLU~? 6.38 C1 GOL N3044 229 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -52.57 56.60 47.75 -51.52 54.87 46.95 203.51 159.51 142.26 205.02 160.53 143.48 coo -45.08 48.37 46.81 -46.53 49.74 45.96 192.80 164.06 142.20 192.44 166.06 142.86 coo -47.40 44.36 48.48 -50.80 49.18 46.20 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 41 3 # 41 33 ASP N 70 ASP~? -3.26 O2 GOL N3029s 187 GLU N 63 GLU~? 5.47 O3 GOL N3029 229 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -52.57 56.60 47.75 -51.52 54.87 46.95 203.51 159.51 142.26 205.02 160.53 143.48 coo -45.08 48.37 46.81 -46.53 49.74 45.96 194.49 161.88 146.96 196.25 163.15 146.70 coo -47.40 44.36 48.48 -50.80 49.18 46.20 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 42 3 # 42 33 ASP N 102 ASP.? 20.60 O2 GOL N3029 187 GLU N 141 GLU~? 10.16 C1 GOL N3029 229 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -52.57 56.60 47.75 -51.52 54.87 46.95 197.96 142.41 139.19 197.06 140.46 139.09 coo -45.08 48.37 46.81 -46.53 49.74 45.96 199.85 147.19 149.72 199.65 149.31 150.43 coo -47.40 44.36 48.48 -50.80 49.18 46.20 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 43 3 # 43 33 ASP O 70 ASP~? 3.30 O1 GOL O3013s 187 GLU O 62 GLU~? 9.92 C1 GOL O3026 229 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -52.57 56.60 47.75 -51.52 54.87 46.95 134.07 141.35 162.95 132.57 142.58 163.78 coo -45.08 48.37 46.81 -46.53 49.74 45.96 144.85 142.00 167.10 145.13 142.93 168.92 coo -47.40 44.36 48.48 -50.80 49.18 46.20 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 44 3 # 44 33 ASP O 70 ASP~? 3.30 O1 GOL O3013s 187 GLU O 63 GLU~? 5.90 C1 GOL O3026 229 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -52.57 56.60 47.75 -51.52 54.87 46.95 134.07 141.35 162.95 132.57 142.58 163.78 coo -45.08 48.37 46.81 -46.53 49.74 45.96 143.37 146.22 164.56 141.71 146.26 165.94 coo -47.40 44.36 48.48 -50.80 49.18 46.20 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 45 3 # 45 33 ASP O 102 ASP.? 13.16 CL CL O2036 187 GLU O 141 GLU~? 15.58 O3 GOL O3026 229 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -52.57 56.60 47.75 -51.52 54.87 46.95 139.48 136.33 146.19 140.25 135.96 144.25 coo -45.08 48.37 46.81 -46.53 49.74 45.96 137.18 147.02 148.83 137.46 148.02 146.94 coo -47.40 44.36 48.48 -50.80 49.18 46.20 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 46 3 # 46 33 ASP P 70 ASP~? 4.30 O3 GOL P3014 187 GLU P 62 GLU~? 14.35 O3 GOL P3014 229 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -52.57 56.60 47.75 -51.52 54.87 46.95 200.75 174.15 199.66 202.28 173.10 198.62 coo -45.08 48.37 46.81 -46.53 49.74 45.96 189.60 171.13 198.21 189.20 169.27 197.38 coo -47.40 44.36 48.48 -50.80 49.18 46.20 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 47 3 # 47 33 ASP P 70 ASP~? 4.30 O3 GOL P3014 187 GLU P 63 GLU~? 10.86 O3 GOL P3014 229 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -52.57 56.60 47.75 -51.52 54.87 46.95 200.75 174.15 199.66 202.28 173.10 198.62 coo -45.08 48.37 46.81 -46.53 49.74 45.96 192.19 173.00 193.76 193.59 171.39 194.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 48 3 # 48 33 ASP P 102 ASP.? 24.26 CL CL P2019 187 GLU P 141 GLU~? 21.95 O3 GOL P3014 229 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -52.57 56.60 47.75 -51.52 54.87 46.95 197.01 191.93 202.05 196.73 194.01 202.05 coo -45.08 48.37 46.81 -46.53 49.74 45.96 200.04 187.90 192.14 200.20 189.50 190.73 coo -47.40 44.36 48.48 -50.80 49.18 46.20 204.59 186.28 195.60 209.96 186.96 196.62 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 48 hits 1ald_c00 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 36 ARG~? 20.86 C3 GOL E3035 B 342 ASP A 28 ASP~? 35.69 O2 GOL E3035 B 531 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 51.19 99.66 33.34 49.41 97.31 34.21 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 62.23 105.49 38.88 63.59 105.50 37.26 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 36 ARG~? 18.74 O2 GOL B3003 B 342 ASP B 28 ASP~? 19.20 C1 GOL B3003 B 531 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 67.49 62.18 2.86 67.75 61.06 -0.01 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG D 36 ARG~? 15.63 O1 GOL D3005 B 342 ASP D 28 ASP~? 15.80 CL CL H2005 B 531 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 55.93 43.64 102.74 57.91 43.73 100.41 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 45.36 50.43 107.49 43.88 48.98 107.89 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG E 36 ARG~? 16.00 C1 GOL E3004 B 342 ASP E 28 ASP~? 19.58 O1 GOL E3004 B 531 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 66.28 100.73 63.79 67.89 98.12 63.67 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 57.09 107.82 57.29 55.83 108.40 58.91 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG F 36 ARG~? 20.40 O1 GOL B3017 B 342 ASP F 28 ASP~? 32.62 CL CL F2035 B 531 ARG F 37 ARG~? -27.07 CL CL F2035s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 47.43 34.56 6.90 45.82 36.16 8.95 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 59.39 38.13 1.08 60.39 36.31 1.06 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG G 36 ARG~? 19.13 CL CL C2004 B 342 ASP G 28 ASP~? 15.85 CL CL C2004 B 531 ARG G 37 ARG~? 20.29 CL CL C2004 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 57.05 1.30 44.33 57.17 -1.56 45.49 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG H 36 ARG~? 15.68 C3 GOL H3006 B 342 ASP H 28 ASP~? 15.80 CL CL H2005 B 531 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 41.35 74.42 97.84 39.90 73.17 95.49 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 50.63 68.82 106.06 51.93 70.45 106.39 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG I 36 ARG~? 18.35 CL CL I2001 B 342 ASP I 28 ASP~? 15.71 CL CL I2001 B 531 ARG I 37 ARG~? 20.23 CL CL I2001 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 163.77 216.28 151.02 161.75 213.99 150.84 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 174.34 221.90 156.42 175.71 222.11 154.83 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG J 36 ARG~? 16.92 CL CL J2002 B 342 ASP J 28 ASP~? 15.67 CL CL J2002 B 531 ARG J 37 ARG~? 20.17 CL CL J2002 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 181.40 180.11 121.45 182.70 178.85 123.93 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 170.87 175.19 114.50 169.74 176.91 114.00 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG K 36 ARG~? 15.75 C1 GOL K3011 B 342 ASP K 28 ASP~? 19.61 O1 GOL K3011 B 531 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 156.15 122.83 185.77 154.85 125.10 184.29 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 166.96 115.59 181.42 167.86 115.34 183.30 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 11 3 # 11 B 325 ARG L 36 ARG~? 28.87 C1 GOL P3034 B 342 ASP L 28 ASP~? 34.50 O1 GOL L3028 B 531 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 174.06 157.20 217.38 176.23 157.17 215.21 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 163.49 162.78 223.08 162.21 161.15 223.46 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 12 3 # 12 B 325 ARG M 36 ARG~? 16.07 O1 GOL M3007 B 342 ASP M 28 ASP~? 15.52 CL CL I2001 B 531 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 179.97 216.30 180.98 181.48 213.82 180.04 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 170.27 223.20 174.57 168.89 223.83 176.08 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 13 3 # 13 B 325 ARG N 36 ARG~? 15.62 C3 GOL N3008 B 342 ASP N 28 ASP~? 15.68 CL CL J2002 B 531 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 161.60 152.07 121.93 160.06 153.41 124.19 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 173.04 156.37 115.74 174.12 154.54 115.64 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 14 3 # 14 B 325 ARG O 36 ARG~? 19.89 O1 GOL K3010 B 342 ASP O 28 ASP~? 23.95 CL CL O2036 B 531 ARG O 37 ARG~? 22.15 CL CL K2003 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 175.82 120.47 157.52 177.72 122.75 158.28 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 164.72 114.57 162.31 163.52 114.24 160.62 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 15 3 # 15 B 325 ARG P 36 ARG~? 18.56 O1 GOL L3028 B 342 ASP P 28 ASP~? 33.76 O1 GOL L3028 B 531 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 157.78 187.06 214.51 156.14 185.86 212.27 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 167.75 181.83 222.09 168.94 183.53 222.37 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 165.27 191.94 211.53 167.28 191.57 209.25 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 15 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG B 36 ARG~? 18.74 O2 GOL B3003 A 342 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 531 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 73.40 61.96 -24.99 72.46 63.92 -22.84 67.49 62.18 2.86 67.75 61.06 -0.01 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG G 36 ARG~? 19.13 CL CL C2004 A 342 ASP G 28 ASP~? 15.85 CL CL C2004 A 531 ARG G 37 ARG~? 20.29 CL CL C2004 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 57.05 1.30 44.33 57.17 -1.56 45.49 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 52.62 7.45 38.03 50.95 9.97 37.63 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c01 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 98 PHE.? 12.32 O1 GOL A3040 A 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 265 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 39.74 52.86 65.74 41.15 55.14 66.52 94.73 84.25 40.94 92.04 83.71 40.47 coo 30.70 47.50 67.53 29.83 49.47 67.39 90.44 78.16 48.76 91.65 76.94 50.06 coo 19.99 54.53 64.11 20.55 58.78 68.33 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE B 98 PHE.? 11.15 CL CL B2010 A 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 265 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 39.74 52.86 65.74 41.15 55.14 66.52 22.68 65.92 11.87 25.22 66.01 13.02 coo 30.70 47.50 67.53 29.83 49.47 67.39 23.66 59.02 20.34 21.93 58.32 21.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE C 98 PHE.? 11.39 CL CL C2011 A 223 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 265 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 39.74 52.86 65.74 41.15 55.14 66.52 83.86 15.19 74.07 81.38 16.44 74.03 coo 30.70 47.50 67.53 29.83 49.47 67.39 82.81 22.02 65.69 84.52 22.80 64.66 coo 19.99 54.53 64.11 20.55 58.78 68.33 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE D 98 PHE.? 11.07 CL CL D2012 A 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 265 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 39.74 52.86 65.74 41.15 55.14 66.52 12.59 48.19 86.72 15.29 47.64 86.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 16.94 54.59 79.01 15.65 55.42 77.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE E 98 PHE.? 11.20 CL CL E2013 A 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 265 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 39.74 52.86 65.74 41.15 55.14 66.52 20.72 94.66 58.85 23.24 93.53 59.37 coo 30.70 47.50 67.53 29.83 49.47 67.39 23.07 86.29 52.35 21.57 85.17 51.32 coo 19.99 54.53 64.11 20.55 58.78 68.33 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE F 98 PHE.? 11.09 CL CL F2034 A 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 265 LYS F 61 LYS~? -5.82 CL CL F2035s coo 39.74 52.86 65.74 41.15 55.14 66.52 91.41 32.84 22.80 88.70 32.93 23.40 coo 30.70 47.50 67.53 29.83 49.47 67.39 88.86 41.25 28.96 90.30 42.22 30.24 coo 19.99 54.53 64.11 20.55 58.78 68.33 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE G 98 PHE.? 12.40 C3 GOL G3038 A 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 265 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 39.74 52.86 65.74 41.15 55.14 66.52 15.02 19.56 40.09 17.78 20.04 40.01 coo 30.70 47.50 67.53 29.83 49.47 67.39 17.70 27.34 47.09 16.19 28.71 47.73 coo 19.99 54.53 64.11 20.55 58.78 68.33 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE H 98 PHE.? 11.23 CL CL H2014 A 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 265 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 39.74 52.86 65.74 41.15 55.14 66.52 86.83 66.96 92.26 84.37 67.28 91.08 coo 30.70 47.50 67.53 29.83 49.47 67.39 84.24 58.93 85.48 85.73 57.59 84.66 coo 19.99 54.53 64.11 20.55 58.78 68.33 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE I 98 PHE.? 11.14 CL CL I2015 A 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 265 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 39.74 52.86 65.74 41.15 55.14 66.52 207.94 202.24 155.85 205.25 201.61 155.56 coo 30.70 47.50 67.53 29.83 49.47 67.39 204.37 195.46 163.61 205.75 194.30 164.79 coo 19.99 54.53 64.11 20.55 58.78 68.33 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE J 98 PHE.? 11.05 CL CL J2016 A 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 265 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 39.74 52.86 65.74 41.15 55.14 66.52 135.63 181.85 129.67 138.24 181.95 130.69 coo 30.70 47.50 67.53 29.83 49.47 67.39 137.44 174.60 137.57 135.80 173.80 138.69 coo 19.99 54.53 64.11 20.55 58.78 68.33 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE K 98 PHE.? 11.99 O1 GOL K3041 A 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 265 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 39.74 52.86 65.74 41.15 55.14 66.52 201.94 131.33 186.30 199.31 132.28 186.27 coo 30.70 47.50 67.53 29.83 49.47 67.39 200.17 138.24 178.11 201.77 139.28 177.19 coo 19.99 54.53 64.11 20.55 58.78 68.33 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE L 98 PHE.? 11.24 CL CL L2009 A 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 265 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 39.74 52.86 65.74 41.15 55.14 66.52 129.72 160.22 203.93 132.34 159.70 203.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 133.34 166.97 196.27 132.03 168.03 194.96 coo 19.99 54.53 64.11 20.55 58.78 68.33 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE M 98 PHE.? 11.28 CL CL M2017 A 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 265 LYS M 61 LYS~? 24.74 CL CL I2007 coo 39.74 52.86 65.74 41.15 55.14 66.52 134.29 208.09 177.60 136.84 206.99 178.00 coo 30.70 47.50 67.53 29.83 49.47 67.39 136.87 200.18 170.79 135.36 199.08 169.77 coo 19.99 54.53 64.11 20.55 58.78 68.33 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE N 98 PHE.? 12.51 O2 GOL N3029 A 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 265 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 39.74 52.86 65.74 41.15 55.14 66.52 205.99 151.41 135.45 203.31 151.41 136.18 coo 30.70 47.50 67.53 29.83 49.47 67.39 203.51 159.51 142.26 205.02 160.53 143.48 coo 19.99 54.53 64.11 20.55 58.78 68.33 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE O 98 PHE.? 11.35 CL CL O2018 A 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 265 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 39.74 52.86 65.74 41.15 55.14 66.52 131.45 133.74 155.71 134.18 134.46 155.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 134.07 141.35 162.95 132.57 142.58 163.78 coo 19.99 54.53 64.11 20.55 58.78 68.33 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE P 98 PHE.? 11.01 CL CL P2019 A 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 265 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 39.74 52.86 65.74 41.15 55.14 66.52 203.50 182.03 206.67 200.90 182.30 205.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 200.75 174.15 199.66 202.28 173.10 198.62 coo 19.99 54.53 64.11 20.55 58.78 68.33 187.60 176.80 197.02 187.44 179.17 191.02 1ax4_c04 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 98 PHE.? 12.32 O1 GOL A3040 B 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 265 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 7.48 54.94 99.62 7.67 52.27 100.42 94.73 84.25 40.94 92.04 83.71 40.47 coo 10.43 61.66 91.81 9.80 60.04 90.61 90.44 78.16 48.76 91.65 76.94 50.06 coo 5.43 58.06 80.08 8.57 53.00 79.37 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE B 98 PHE.? 11.15 CL CL B2010 B 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 265 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 7.48 54.94 99.62 7.67 52.27 100.42 22.68 65.92 11.87 25.22 66.01 13.02 coo 10.43 61.66 91.81 9.80 60.04 90.61 23.66 59.02 20.34 21.93 58.32 21.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE C 98 PHE.? 11.39 CL CL C2011 B 223 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 265 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 7.48 54.94 99.62 7.67 52.27 100.42 83.86 15.19 74.07 81.38 16.44 74.03 coo 10.43 61.66 91.81 9.80 60.04 90.61 82.81 22.02 65.69 84.52 22.80 64.66 coo 5.43 58.06 80.08 8.57 53.00 79.37 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE D 98 PHE.? 11.07 CL CL D2012 B 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 265 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 7.48 54.94 99.62 7.67 52.27 100.42 12.59 48.19 86.72 15.29 47.64 86.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 16.94 54.59 79.01 15.65 55.42 77.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE E 98 PHE.? 11.20 CL CL E2013 B 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 265 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 7.48 54.94 99.62 7.67 52.27 100.42 20.72 94.66 58.85 23.24 93.53 59.37 coo 10.43 61.66 91.81 9.80 60.04 90.61 23.07 86.29 52.35 21.57 85.17 51.32 coo 5.43 58.06 80.08 8.57 53.00 79.37 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE F 98 PHE.? 11.09 CL CL F2034 B 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 265 LYS F 61 LYS~? -5.82 CL CL F2035s coo 7.48 54.94 99.62 7.67 52.27 100.42 91.41 32.84 22.80 88.70 32.93 23.40 coo 10.43 61.66 91.81 9.80 60.04 90.61 88.86 41.25 28.96 90.30 42.22 30.24 coo 5.43 58.06 80.08 8.57 53.00 79.37 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE G 98 PHE.? 12.40 C3 GOL G3038 B 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 265 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 7.48 54.94 99.62 7.67 52.27 100.42 15.02 19.56 40.09 17.78 20.04 40.01 coo 10.43 61.66 91.81 9.80 60.04 90.61 17.70 27.34 47.09 16.19 28.71 47.73 coo 5.43 58.06 80.08 8.57 53.00 79.37 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE H 98 PHE.? 11.23 CL CL H2014 B 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 265 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 7.48 54.94 99.62 7.67 52.27 100.42 86.83 66.96 92.26 84.37 67.28 91.08 coo 10.43 61.66 91.81 9.80 60.04 90.61 84.24 58.93 85.48 85.73 57.59 84.66 coo 5.43 58.06 80.08 8.57 53.00 79.37 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE I 98 PHE.? 11.14 CL CL I2015 B 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 265 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 7.48 54.94 99.62 7.67 52.27 100.42 207.94 202.24 155.85 205.25 201.61 155.56 coo 10.43 61.66 91.81 9.80 60.04 90.61 204.37 195.46 163.61 205.75 194.30 164.79 coo 5.43 58.06 80.08 8.57 53.00 79.37 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE J 98 PHE.? 11.05 CL CL J2016 B 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 265 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 7.48 54.94 99.62 7.67 52.27 100.42 135.63 181.85 129.67 138.24 181.95 130.69 coo 10.43 61.66 91.81 9.80 60.04 90.61 137.44 174.60 137.57 135.80 173.80 138.69 coo 5.43 58.06 80.08 8.57 53.00 79.37 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE K 98 PHE.? 11.99 O1 GOL K3041 B 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 265 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 7.48 54.94 99.62 7.67 52.27 100.42 201.94 131.33 186.30 199.31 132.28 186.27 coo 10.43 61.66 91.81 9.80 60.04 90.61 200.17 138.24 178.11 201.77 139.28 177.19 coo 5.43 58.06 80.08 8.57 53.00 79.37 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE L 98 PHE.? 11.24 CL CL L2009 B 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 265 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 7.48 54.94 99.62 7.67 52.27 100.42 129.72 160.22 203.93 132.34 159.70 203.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 133.34 166.97 196.27 132.03 168.03 194.96 coo 5.43 58.06 80.08 8.57 53.00 79.37 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE M 98 PHE.? 11.28 CL CL M2017 B 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 265 LYS M 61 LYS~? 24.74 CL CL I2007 coo 7.48 54.94 99.62 7.67 52.27 100.42 134.29 208.09 177.60 136.84 206.99 178.00 coo 10.43 61.66 91.81 9.80 60.04 90.61 136.87 200.18 170.79 135.36 199.08 169.77 coo 5.43 58.06 80.08 8.57 53.00 79.37 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE N 98 PHE.? 12.51 O2 GOL N3029 B 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 265 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 7.48 54.94 99.62 7.67 52.27 100.42 205.99 151.41 135.45 203.31 151.41 136.18 coo 10.43 61.66 91.81 9.80 60.04 90.61 203.51 159.51 142.26 205.02 160.53 143.48 coo 5.43 58.06 80.08 8.57 53.00 79.37 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE O 98 PHE.? 11.35 CL CL O2018 B 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 265 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 7.48 54.94 99.62 7.67 52.27 100.42 131.45 133.74 155.71 134.18 134.46 155.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 134.07 141.35 162.95 132.57 142.58 163.78 coo 5.43 58.06 80.08 8.57 53.00 79.37 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE P 98 PHE.? 11.01 CL CL P2019 B 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 265 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 7.48 54.94 99.62 7.67 52.27 100.42 203.50 182.03 206.67 200.90 182.30 205.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 200.75 174.15 199.66 202.28 173.10 198.62 coo 5.43 58.06 80.08 8.57 53.00 79.37 187.60 176.80 197.02 187.44 179.17 191.02 1ax4_c05 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 98 PHE.? 12.32 O1 GOL A3040 C 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 265 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -6.55 73.45 23.60 -6.77 71.48 21.66 94.73 84.25 40.94 92.04 83.71 40.47 coo -9.52 75.74 33.62 -8.85 73.74 33.93 90.44 78.16 48.76 91.65 76.94 50.06 coo -4.44 67.20 42.32 -7.50 62.41 40.49 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE B 98 PHE.? 11.15 CL CL B2010 C 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 265 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -6.55 73.45 23.60 -6.77 71.48 21.66 22.68 65.92 11.87 25.22 66.01 13.02 coo -9.52 75.74 33.62 -8.85 73.74 33.93 23.66 59.02 20.34 21.93 58.32 21.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE C 98 PHE.? 11.39 CL CL C2011 C 223 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 265 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -6.55 73.45 23.60 -6.77 71.48 21.66 83.86 15.19 74.07 81.38 16.44 74.03 coo -9.52 75.74 33.62 -8.85 73.74 33.93 82.81 22.02 65.69 84.52 22.80 64.66 coo -4.44 67.20 42.32 -7.50 62.41 40.49 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE D 98 PHE.? 11.07 CL CL D2012 C 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 265 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -6.55 73.45 23.60 -6.77 71.48 21.66 12.59 48.19 86.72 15.29 47.64 86.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 16.94 54.59 79.01 15.65 55.42 77.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE E 98 PHE.? 11.20 CL CL E2013 C 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 265 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -6.55 73.45 23.60 -6.77 71.48 21.66 20.72 94.66 58.85 23.24 93.53 59.37 coo -9.52 75.74 33.62 -8.85 73.74 33.93 23.07 86.29 52.35 21.57 85.17 51.32 coo -4.44 67.20 42.32 -7.50 62.41 40.49 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE F 98 PHE.? 11.09 CL CL F2034 C 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 265 LYS F 61 LYS~? -5.82 CL CL F2035s coo -6.55 73.45 23.60 -6.77 71.48 21.66 91.41 32.84 22.80 88.70 32.93 23.40 coo -9.52 75.74 33.62 -8.85 73.74 33.93 88.86 41.25 28.96 90.30 42.22 30.24 coo -4.44 67.20 42.32 -7.50 62.41 40.49 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE G 98 PHE.? 12.40 C3 GOL G3038 C 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 265 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -6.55 73.45 23.60 -6.77 71.48 21.66 15.02 19.56 40.09 17.78 20.04 40.01 coo -9.52 75.74 33.62 -8.85 73.74 33.93 17.70 27.34 47.09 16.19 28.71 47.73 coo -4.44 67.20 42.32 -7.50 62.41 40.49 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE H 98 PHE.? 11.23 CL CL H2014 C 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 265 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -6.55 73.45 23.60 -6.77 71.48 21.66 86.83 66.96 92.26 84.37 67.28 91.08 coo -9.52 75.74 33.62 -8.85 73.74 33.93 84.24 58.93 85.48 85.73 57.59 84.66 coo -4.44 67.20 42.32 -7.50 62.41 40.49 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE I 98 PHE.? 11.14 CL CL I2015 C 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 265 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -6.55 73.45 23.60 -6.77 71.48 21.66 207.94 202.24 155.85 205.25 201.61 155.56 coo -9.52 75.74 33.62 -8.85 73.74 33.93 204.37 195.46 163.61 205.75 194.30 164.79 coo -4.44 67.20 42.32 -7.50 62.41 40.49 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE J 98 PHE.? 11.05 CL CL J2016 C 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 265 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -6.55 73.45 23.60 -6.77 71.48 21.66 135.63 181.85 129.67 138.24 181.95 130.69 coo -9.52 75.74 33.62 -8.85 73.74 33.93 137.44 174.60 137.57 135.80 173.80 138.69 coo -4.44 67.20 42.32 -7.50 62.41 40.49 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE K 98 PHE.? 11.99 O1 GOL K3041 C 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 265 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -6.55 73.45 23.60 -6.77 71.48 21.66 201.94 131.33 186.30 199.31 132.28 186.27 coo -9.52 75.74 33.62 -8.85 73.74 33.93 200.17 138.24 178.11 201.77 139.28 177.19 coo -4.44 67.20 42.32 -7.50 62.41 40.49 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE L 98 PHE.? 11.24 CL CL L2009 C 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 265 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -6.55 73.45 23.60 -6.77 71.48 21.66 129.72 160.22 203.93 132.34 159.70 203.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 133.34 166.97 196.27 132.03 168.03 194.96 coo -4.44 67.20 42.32 -7.50 62.41 40.49 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE M 98 PHE.? 11.28 CL CL M2017 C 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 265 LYS M 61 LYS~? 24.74 CL CL I2007 coo -6.55 73.45 23.60 -6.77 71.48 21.66 134.29 208.09 177.60 136.84 206.99 178.00 coo -9.52 75.74 33.62 -8.85 73.74 33.93 136.87 200.18 170.79 135.36 199.08 169.77 coo -4.44 67.20 42.32 -7.50 62.41 40.49 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE N 98 PHE.? 12.51 O2 GOL N3029 C 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 265 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -6.55 73.45 23.60 -6.77 71.48 21.66 205.99 151.41 135.45 203.31 151.41 136.18 coo -9.52 75.74 33.62 -8.85 73.74 33.93 203.51 159.51 142.26 205.02 160.53 143.48 coo -4.44 67.20 42.32 -7.50 62.41 40.49 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE O 98 PHE.? 11.35 CL CL O2018 C 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 265 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -6.55 73.45 23.60 -6.77 71.48 21.66 131.45 133.74 155.71 134.18 134.46 155.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 134.07 141.35 162.95 132.57 142.58 163.78 coo -4.44 67.20 42.32 -7.50 62.41 40.49 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE P 98 PHE.? 11.01 CL CL P2019 C 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 265 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -6.55 73.45 23.60 -6.77 71.48 21.66 203.50 182.03 206.67 200.90 182.30 205.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 200.75 174.15 199.66 202.28 173.10 198.62 coo -4.44 67.20 42.32 -7.50 62.41 40.49 187.60 176.80 197.02 187.44 179.17 191.02 1ax4_c06 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 98 PHE.? 12.32 O1 GOL A3040 D 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 265 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -38.60 55.38 52.70 -40.06 57.72 53.04 94.73 84.25 40.94 92.04 83.71 40.47 coo -29.46 51.67 48.51 -28.63 53.31 49.56 90.44 78.16 48.76 91.65 76.94 50.06 coo -18.87 56.53 54.79 -19.47 62.22 53.03 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE B 98 PHE.? 11.15 CL CL B2010 D 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 265 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -38.60 55.38 52.70 -40.06 57.72 53.04 22.68 65.92 11.87 25.22 66.01 13.02 coo -29.46 51.67 48.51 -28.63 53.31 49.56 23.66 59.02 20.34 21.93 58.32 21.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE C 98 PHE.? 11.39 CL CL C2011 D 223 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 265 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -38.60 55.38 52.70 -40.06 57.72 53.04 83.86 15.19 74.07 81.38 16.44 74.03 coo -29.46 51.67 48.51 -28.63 53.31 49.56 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.87 56.53 54.79 -19.47 62.22 53.03 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE D 98 PHE.? 11.07 CL CL D2012 D 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 265 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -38.60 55.38 52.70 -40.06 57.72 53.04 12.59 48.19 86.72 15.29 47.64 86.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE E 98 PHE.? 11.20 CL CL E2013 D 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 265 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -38.60 55.38 52.70 -40.06 57.72 53.04 20.72 94.66 58.85 23.24 93.53 59.37 coo -29.46 51.67 48.51 -28.63 53.31 49.56 23.07 86.29 52.35 21.57 85.17 51.32 coo -18.87 56.53 54.79 -19.47 62.22 53.03 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE F 98 PHE.? 11.09 CL CL F2034 D 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 265 LYS F 61 LYS~? -5.82 CL CL F2035s coo -38.60 55.38 52.70 -40.06 57.72 53.04 91.41 32.84 22.80 88.70 32.93 23.40 coo -29.46 51.67 48.51 -28.63 53.31 49.56 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.87 56.53 54.79 -19.47 62.22 53.03 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE G 98 PHE.? 12.40 C3 GOL G3038 D 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 265 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -38.60 55.38 52.70 -40.06 57.72 53.04 15.02 19.56 40.09 17.78 20.04 40.01 coo -29.46 51.67 48.51 -28.63 53.31 49.56 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.87 56.53 54.79 -19.47 62.22 53.03 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE H 98 PHE.? 11.23 CL CL H2014 D 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 265 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -38.60 55.38 52.70 -40.06 57.72 53.04 86.83 66.96 92.26 84.37 67.28 91.08 coo -29.46 51.67 48.51 -28.63 53.31 49.56 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.87 56.53 54.79 -19.47 62.22 53.03 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE I 98 PHE.? 11.14 CL CL I2015 D 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 265 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -38.60 55.38 52.70 -40.06 57.72 53.04 207.94 202.24 155.85 205.25 201.61 155.56 coo -29.46 51.67 48.51 -28.63 53.31 49.56 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.87 56.53 54.79 -19.47 62.22 53.03 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE J 98 PHE.? 11.05 CL CL J2016 D 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 265 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -38.60 55.38 52.70 -40.06 57.72 53.04 135.63 181.85 129.67 138.24 181.95 130.69 coo -29.46 51.67 48.51 -28.63 53.31 49.56 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.87 56.53 54.79 -19.47 62.22 53.03 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE K 98 PHE.? 11.99 O1 GOL K3041 D 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 265 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -38.60 55.38 52.70 -40.06 57.72 53.04 201.94 131.33 186.30 199.31 132.28 186.27 coo -29.46 51.67 48.51 -28.63 53.31 49.56 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.87 56.53 54.79 -19.47 62.22 53.03 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE L 98 PHE.? 11.24 CL CL L2009 D 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 265 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -38.60 55.38 52.70 -40.06 57.72 53.04 129.72 160.22 203.93 132.34 159.70 203.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.87 56.53 54.79 -19.47 62.22 53.03 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE M 98 PHE.? 11.28 CL CL M2017 D 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 265 LYS M 61 LYS~? 24.74 CL CL I2007 coo -38.60 55.38 52.70 -40.06 57.72 53.04 134.29 208.09 177.60 136.84 206.99 178.00 coo -29.46 51.67 48.51 -28.63 53.31 49.56 136.87 200.18 170.79 135.36 199.08 169.77 coo -18.87 56.53 54.79 -19.47 62.22 53.03 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE N 98 PHE.? 12.51 O2 GOL N3029 D 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 265 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -38.60 55.38 52.70 -40.06 57.72 53.04 205.99 151.41 135.45 203.31 151.41 136.18 coo -29.46 51.67 48.51 -28.63 53.31 49.56 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.87 56.53 54.79 -19.47 62.22 53.03 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE O 98 PHE.? 11.35 CL CL O2018 D 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 265 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -38.60 55.38 52.70 -40.06 57.72 53.04 131.45 133.74 155.71 134.18 134.46 155.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.87 56.53 54.79 -19.47 62.22 53.03 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE P 98 PHE.? 11.01 CL CL P2019 D 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 265 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -38.60 55.38 52.70 -40.06 57.72 53.04 203.50 182.03 206.67 200.90 182.30 205.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.87 56.53 54.79 -19.47 62.22 53.03 187.60 176.80 197.02 187.44 179.17 191.02 1ax4_c07 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 150 TRP~? 9.40 O3 GOL A3037 A 222 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 258 LYS A 142 LYS~? 20.36 CL CL A2020 coo 89.83 15.40 0.01 90.61 18.86 1.71 99.61 75.57 49.87 96.34 77.60 50.68 coo 82.92 20.43 2.47 84.82 20.45 1.55 90.44 78.16 48.76 91.65 76.94 50.06 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP B 150 TRP~? 6.74 O3 GOL B3015 A 222 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 258 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 89.83 15.40 0.01 90.61 18.86 1.71 14.34 60.39 20.70 17.67 58.57 19.72 coo 82.92 20.43 2.47 84.82 20.45 1.55 23.66 59.02 20.34 21.93 58.32 21.38 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP C 150 TRP~? 6.00 O1 GOL C3036 A 222 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 258 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 89.83 15.40 0.01 90.61 18.86 1.71 92.29 22.45 66.79 88.93 21.17 65.17 coo 82.92 20.43 2.47 84.82 20.45 1.55 82.81 22.02 65.69 84.52 22.80 64.66 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP D 150 TRP~? 10.12 O2 GOL D3020 A 222 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 258 LYS D 142 LYS~? 18.65 CL CL D2012 coo 89.83 15.40 0.01 90.61 18.86 1.71 7.58 55.02 76.49 10.84 56.37 78.24 coo 82.92 20.43 2.47 84.82 20.45 1.55 16.94 54.59 79.01 15.65 55.42 77.54 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP E 150 TRP~? 6.44 C3 GOL E3002 A 222 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 258 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 89.83 15.40 0.01 90.61 18.86 1.71 13.53 85.96 51.70 17.23 86.80 50.63 coo 82.92 20.43 2.47 84.82 20.45 1.55 23.07 86.29 52.35 21.57 85.17 51.32 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP F 150 TRP~? 12.61 CL CL F2034 A 222 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 258 LYS F 142 LYS~? 19.20 CL CL F2034 coo 89.83 15.40 0.01 90.61 18.86 1.71 98.06 40.24 31.68 95.06 41.77 29.63 coo 82.92 20.43 2.47 84.82 20.45 1.55 88.86 41.25 28.96 90.30 42.22 30.24 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP G 150 TRP~? 4.79 O3 GOL G3001 A 222 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 258 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 89.83 15.40 0.01 90.61 18.86 1.71 8.65 29.73 45.56 11.64 28.04 47.47 coo 82.92 20.43 2.47 84.82 20.45 1.55 17.70 27.34 47.09 16.19 28.71 47.73 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 A 140 TRP H 150 TRP~? 9.03 C1 GOL H3016 A 222 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 258 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 89.83 15.40 0.01 90.61 18.86 1.71 93.76 57.94 85.12 90.09 57.13 86.33 coo 82.92 20.43 2.47 84.82 20.45 1.55 84.24 58.93 85.48 85.73 57.59 84.66 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 A 140 TRP I 150 TRP~? 8.45 O3 GOL I3032 A 222 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 258 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 89.83 15.40 0.01 90.61 18.86 1.71 213.69 193.51 164.07 210.33 195.28 165.13 coo 82.92 20.43 2.47 84.82 20.45 1.55 204.37 195.46 163.61 205.75 194.30 164.79 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 A 140 TRP J 150 TRP~? 9.82 O1 GOL J3033 A 222 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 258 LYS J 142 LYS~? 19.62 CL CL J2016 coo 89.83 15.40 0.01 90.61 18.86 1.71 127.85 175.49 138.51 131.22 173.81 137.27 coo 82.92 20.43 2.47 84.82 20.45 1.55 137.44 174.60 137.57 135.80 173.80 138.69 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 A 140 TRP K 150 TRP~? 6.22 O2 GOL K3009 A 222 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 258 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 89.83 15.40 0.01 90.61 18.86 1.71 209.66 139.23 178.83 206.28 137.79 177.39 coo 82.92 20.43 2.47 84.82 20.45 1.55 200.17 138.24 178.11 201.77 139.28 177.19 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 A 140 TRP L 150 TRP~? 12.70 CL CL L2009 A 222 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 258 LYS L 142 LYS~? 23.18 CL CL L2009 coo 89.83 15.40 0.01 90.61 18.86 1.71 124.03 167.33 194.23 127.41 168.49 195.83 coo 82.92 20.43 2.47 84.82 20.45 1.55 133.34 166.97 196.27 132.03 168.03 194.96 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 13 3 # 13 A 140 TRP M 150 TRP~? 9.50 O3 GOL M3042 A 222 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 258 LYS M 142 LYS~? 19.90 CL CL M2017 coo 89.83 15.40 0.01 90.61 18.86 1.71 127.35 199.32 170.42 130.91 200.46 169.17 coo 82.92 20.43 2.47 84.82 20.45 1.55 136.87 200.18 170.79 135.36 199.08 169.77 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 14 3 # 14 A 140 TRP N 150 TRP~? 6.52 O2 GOL N3012 A 222 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 258 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 89.83 15.40 0.01 90.61 18.86 1.71 212.92 158.88 144.19 209.70 160.35 142.44 coo 82.92 20.43 2.47 84.82 20.45 1.55 203.51 159.51 142.26 205.02 160.53 143.48 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 15 3 # 15 A 140 TRP O 150 TRP~? 6.10 O1 GOL O3013 A 222 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 258 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 89.83 15.40 0.01 90.61 18.86 1.71 124.79 143.29 162.05 128.01 141.74 163.72 coo 82.92 20.43 2.47 84.82 20.45 1.55 134.07 141.35 162.95 132.57 142.58 163.78 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 16 3 # 16 A 140 TRP P 150 TRP~? 5.47 O2 GOL P3014 A 222 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 258 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 89.83 15.40 0.01 90.61 18.86 1.71 210.27 173.82 198.63 206.78 172.70 200.12 coo 82.92 20.43 2.47 84.82 20.45 1.55 200.75 174.15 199.66 202.28 173.10 198.62 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 204.59 186.28 195.60 209.96 186.96 196.62 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 16 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 150 TRP~? 9.40 O3 GOL A3037 B 222 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 258 LYS A 142 LYS~? 20.36 CL CL A2020 coo 103.45 44.39 16.20 102.66 41.02 14.32 99.61 75.57 49.87 96.34 77.60 50.68 coo 110.10 38.66 15.58 108.40 39.41 14.53 90.44 78.16 48.76 91.65 76.94 50.06 coo 107.51 45.54 4.76 105.41 44.51 10.25 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP B 150 TRP~? 6.74 O3 GOL B3015 B 222 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 258 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 103.45 44.39 16.20 102.66 41.02 14.32 14.34 60.39 20.70 17.67 58.57 19.72 coo 110.10 38.66 15.58 108.40 39.41 14.53 23.66 59.02 20.34 21.93 58.32 21.38 coo 107.51 45.54 4.76 105.41 44.51 10.25 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP C 150 TRP~? 6.00 O1 GOL C3036 B 222 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 258 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 103.45 44.39 16.20 102.66 41.02 14.32 92.29 22.45 66.79 88.93 21.17 65.17 coo 110.10 38.66 15.58 108.40 39.41 14.53 82.81 22.02 65.69 84.52 22.80 64.66 coo 107.51 45.54 4.76 105.41 44.51 10.25 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP D 150 TRP~? 10.12 O2 GOL D3020 B 222 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 258 LYS D 142 LYS~? 18.65 CL CL D2012 coo 103.45 44.39 16.20 102.66 41.02 14.32 7.58 55.02 76.49 10.84 56.37 78.24 coo 110.10 38.66 15.58 108.40 39.41 14.53 16.94 54.59 79.01 15.65 55.42 77.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP E 150 TRP~? 6.44 C3 GOL E3002 B 222 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 258 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 103.45 44.39 16.20 102.66 41.02 14.32 13.53 85.96 51.70 17.23 86.80 50.63 coo 110.10 38.66 15.58 108.40 39.41 14.53 23.07 86.29 52.35 21.57 85.17 51.32 coo 107.51 45.54 4.76 105.41 44.51 10.25 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP F 150 TRP~? 12.61 CL CL F2034 B 222 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 258 LYS F 142 LYS~? 19.20 CL CL F2034 coo 103.45 44.39 16.20 102.66 41.02 14.32 98.06 40.24 31.68 95.06 41.77 29.63 coo 110.10 38.66 15.58 108.40 39.41 14.53 88.86 41.25 28.96 90.30 42.22 30.24 coo 107.51 45.54 4.76 105.41 44.51 10.25 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP G 150 TRP~? 4.79 O3 GOL G3001 B 222 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 258 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 103.45 44.39 16.20 102.66 41.02 14.32 8.65 29.73 45.56 11.64 28.04 47.47 coo 110.10 38.66 15.58 108.40 39.41 14.53 17.70 27.34 47.09 16.19 28.71 47.73 coo 107.51 45.54 4.76 105.41 44.51 10.25 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP H 150 TRP~? 9.03 C1 GOL H3016 B 222 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 258 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 103.45 44.39 16.20 102.66 41.02 14.32 93.76 57.94 85.12 90.09 57.13 86.33 coo 110.10 38.66 15.58 108.40 39.41 14.53 84.24 58.93 85.48 85.73 57.59 84.66 coo 107.51 45.54 4.76 105.41 44.51 10.25 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 B 140 TRP I 150 TRP~? 8.45 O3 GOL I3032 B 222 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 258 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 103.45 44.39 16.20 102.66 41.02 14.32 213.69 193.51 164.07 210.33 195.28 165.13 coo 110.10 38.66 15.58 108.40 39.41 14.53 204.37 195.46 163.61 205.75 194.30 164.79 coo 107.51 45.54 4.76 105.41 44.51 10.25 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 B 140 TRP J 150 TRP~? 9.82 O1 GOL J3033 B 222 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 258 LYS J 142 LYS~? 19.62 CL CL J2016 coo 103.45 44.39 16.20 102.66 41.02 14.32 127.85 175.49 138.51 131.22 173.81 137.27 coo 110.10 38.66 15.58 108.40 39.41 14.53 137.44 174.60 137.57 135.80 173.80 138.69 coo 107.51 45.54 4.76 105.41 44.51 10.25 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 B 140 TRP K 150 TRP~? 6.22 O2 GOL K3009 B 222 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 258 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 103.45 44.39 16.20 102.66 41.02 14.32 209.66 139.23 178.83 206.28 137.79 177.39 coo 110.10 38.66 15.58 108.40 39.41 14.53 200.17 138.24 178.11 201.77 139.28 177.19 coo 107.51 45.54 4.76 105.41 44.51 10.25 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 B 140 TRP L 150 TRP~? 12.70 CL CL L2009 B 222 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 258 LYS L 142 LYS~? 23.18 CL CL L2009 coo 103.45 44.39 16.20 102.66 41.02 14.32 124.03 167.33 194.23 127.41 168.49 195.83 coo 110.10 38.66 15.58 108.40 39.41 14.53 133.34 166.97 196.27 132.03 168.03 194.96 coo 107.51 45.54 4.76 105.41 44.51 10.25 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 13 3 # 13 B 140 TRP M 150 TRP~? 9.50 O3 GOL M3042 B 222 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 258 LYS M 142 LYS~? 19.90 CL CL M2017 coo 103.45 44.39 16.20 102.66 41.02 14.32 127.35 199.32 170.42 130.91 200.46 169.17 coo 110.10 38.66 15.58 108.40 39.41 14.53 136.87 200.18 170.79 135.36 199.08 169.77 coo 107.51 45.54 4.76 105.41 44.51 10.25 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 14 3 # 14 B 140 TRP N 150 TRP~? 6.52 O2 GOL N3012 B 222 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 258 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 103.45 44.39 16.20 102.66 41.02 14.32 212.92 158.88 144.19 209.70 160.35 142.44 coo 110.10 38.66 15.58 108.40 39.41 14.53 203.51 159.51 142.26 205.02 160.53 143.48 coo 107.51 45.54 4.76 105.41 44.51 10.25 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 15 3 # 15 B 140 TRP O 150 TRP~? 6.10 O1 GOL O3013 B 222 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 258 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 103.45 44.39 16.20 102.66 41.02 14.32 124.79 143.29 162.05 128.01 141.74 163.72 coo 110.10 38.66 15.58 108.40 39.41 14.53 134.07 141.35 162.95 132.57 142.58 163.78 coo 107.51 45.54 4.76 105.41 44.51 10.25 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 16 3 # 16 B 140 TRP P 150 TRP~? 5.47 O2 GOL P3014 B 222 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 258 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 103.45 44.39 16.20 102.66 41.02 14.32 210.27 173.82 198.63 206.78 172.70 200.12 coo 110.10 38.66 15.58 108.40 39.41 14.53 200.75 174.15 199.66 202.28 173.10 198.62 coo 107.51 45.54 4.76 105.41 44.51 10.25 204.59 186.28 195.60 209.96 186.96 196.62 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 16 hits 1ay4_c03 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 58 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 92 HIS A 151 HIS~? -11.70 O3 GOL A3037s coo 12.70 27.74 1.76 10.77 27.11 1.24 98.60 85.60 50.46 99.38 86.61 52.13 coo 11.38 23.30 3.20 9.27 23.34 3.13 94.58 81.89 51.70 95.31 83.75 52.44 coo 2.67 19.36 1.56 3.51 21.24 1.94 94.27 72.58 51.14 93.29 74.44 51.00 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 76 HIS~? 4.58 CL CL B2010s A 58 GLU B 73 GLU~? 6.38 O3 GOL B3023 A 92 HIS B 151 HIS~? -4.11 O3 GOL B3015s coo 12.70 27.74 1.76 10.77 27.11 1.24 17.08 57.14 11.39 16.06 55.49 10.59 coo 11.38 23.30 3.20 9.27 23.34 3.13 19.80 56.19 16.30 19.32 55.14 14.52 coo 2.67 19.36 1.56 3.51 21.24 1.94 18.48 59.01 25.15 19.77 58.54 23.56 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 A 40 HIS C 76 HIS~? -4.98 CL CL C2011s A 58 GLU C 73 GLU~? 6.99 O1 GOL C3036 A 92 HIS C 151 HIS~? -4.28 C2 GOL C3036s coo 12.70 27.74 1.76 10.77 27.11 1.24 89.28 12.80 65.47 90.23 11.67 63.98 coo 11.38 23.30 3.20 9.27 23.34 3.13 86.57 17.41 63.72 86.98 15.43 63.06 coo 2.67 19.36 1.56 3.51 21.24 1.94 88.24 26.50 64.44 86.75 25.04 64.52 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 A 40 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 58 GLU D 73 GLU~? 5.51 C2 GOL D3020 A 92 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 12.70 27.74 1.76 10.77 27.11 1.24 8.84 57.69 86.26 7.93 59.46 86.93 coo 11.38 23.30 3.20 9.27 23.34 3.13 12.99 58.17 82.26 12.31 59.24 83.94 coo 2.67 19.36 1.56 3.51 21.24 1.94 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 A 40 HIS E 76 HIS~? -4.87 CL CL E2013s A 58 GLU E 73 GLU~? -6.85 O1 GOL E3022s A 92 HIS E 151 HIS~? -4.12 O1 GOL E3002s coo 12.70 27.74 1.76 10.77 27.11 1.24 16.97 95.07 49.08 16.37 95.97 47.28 coo 11.38 23.30 3.20 9.27 23.34 3.13 19.82 90.31 48.74 19.50 92.07 47.58 coo 2.67 19.36 1.56 3.51 21.24 1.94 17.87 81.44 51.19 19.31 82.95 50.96 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 6 3 # 6 A 40 HIS F 76 HIS~? -4.65 CL CL F2034s A 58 GLU F 73 GLU~? 5.19 O3 GOL F3039 A 92 HIS F 151 HIS~? 14.76 O3 GOL F3039s coo 12.70 27.74 1.76 10.77 27.11 1.24 97.24 41.20 21.57 98.43 42.65 20.63 coo 11.38 23.30 3.20 9.27 23.34 3.13 93.55 43.24 25.35 94.46 43.89 23.55 coo 2.67 19.36 1.56 3.51 21.24 1.94 93.09 42.58 34.58 92.14 42.76 32.71 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 7 3 # 7 A 40 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 58 GLU G 73 GLU~? 5.63 O1 GOL G3038 A 92 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 12.70 27.74 1.76 10.77 27.11 1.24 9.26 20.10 48.62 8.05 19.49 50.22 coo 11.38 23.30 3.20 9.27 23.34 3.13 12.93 24.13 49.80 12.04 22.49 50.80 coo 2.67 19.36 1.56 3.51 21.24 1.94 13.55 33.19 47.26 14.46 31.35 47.64 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 8 3 # 8 A 40 HIS H 76 HIS~? 4.68 CL CL H2014s A 58 GLU H 73 GLU~? -8.72 CL CL H2014s A 92 HIS H 151 HIS~? 4.32 C1 GOL H3016s coo 12.70 27.74 1.76 10.77 27.11 1.24 90.35 57.57 94.69 91.06 55.99 95.89 coo 11.38 23.30 3.20 9.27 23.34 3.13 87.54 56.19 90.14 87.78 55.44 92.11 coo 2.67 19.36 1.56 3.51 21.24 1.94 89.33 56.65 80.95 87.93 56.76 82.51 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 9 3 # 9 A 40 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 58 GLU I 73 GLU~? -6.03 O3 GOL I3031s A 92 HIS I 151 HIS~? 3.98 O3 GOL I3032s coo 12.70 27.74 1.76 10.77 27.11 1.24 212.11 203.51 165.19 213.01 204.42 166.85 coo 11.38 23.30 3.20 9.27 23.34 3.13 208.30 199.46 166.53 209.06 201.27 167.27 coo 2.67 19.36 1.56 3.51 21.24 1.94 208.71 190.07 165.44 207.65 191.87 165.52 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 10 3 # 10 A 40 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 58 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 92 HIS J 151 HIS~? -12.73 O1 GOL J3033s coo 12.70 27.74 1.76 10.77 27.11 1.24 130.51 172.99 128.94 129.60 171.33 128.01 coo 11.38 23.30 3.20 9.27 23.34 3.13 133.49 171.70 133.63 132.81 170.83 131.84 coo 2.67 19.36 1.56 3.51 21.24 1.94 132.36 173.99 142.63 133.63 173.58 141.01 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 11 3 # 11 A 40 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 58 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 92 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 12.70 27.74 1.76 10.77 27.11 1.24 207.10 129.51 177.50 208.14 128.55 175.95 coo 11.38 23.30 3.20 9.27 23.34 3.13 204.07 133.93 175.85 204.65 132.02 175.03 coo 2.67 19.36 1.56 3.51 21.24 1.94 205.25 143.04 176.89 203.95 141.38 176.70 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 12 3 # 12 A 40 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 58 GLU L 73 GLU~? 5.94 O3 GOL L3027 A 92 HIS L 151 HIS~? -15.32 O3 GOL L3028s coo 12.70 27.74 1.76 10.77 27.11 1.24 125.69 169.77 203.98 124.79 171.51 204.73 coo 11.38 23.30 3.20 9.27 23.34 3.13 129.44 170.32 199.72 128.69 171.38 201.39 coo 2.67 19.36 1.56 3.51 21.24 1.94 129.06 168.07 190.57 130.17 168.32 192.34 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 13 3 # 13 A 40 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 58 GLU M 73 GLU~? -3.31 O3 GOL M3042s A 92 HIS M 151 HIS~? -11.81 O3 GOL M3042s coo 12.70 27.74 1.76 10.77 27.11 1.24 130.15 208.85 168.09 129.36 209.65 166.31 coo 11.38 23.30 3.20 9.27 23.34 3.13 133.35 204.22 167.43 132.84 205.99 166.43 coo 2.67 19.36 1.56 3.51 21.24 1.94 131.91 195.13 169.59 133.22 196.76 169.40 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 14 3 # 14 A 40 HIS N 76 HIS~? -6.89 CL CL N2030s A 58 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 92 HIS N 151 HIS~? 3.39 O2 GOL N3012s coo 12.70 27.74 1.76 10.77 27.11 1.24 211.54 160.16 134.29 212.67 161.69 133.40 coo 11.38 23.30 3.20 9.27 23.34 3.13 207.93 161.92 138.37 208.75 162.64 136.53 coo 2.67 19.36 1.56 3.51 21.24 1.94 207.96 160.84 147.59 206.93 161.03 145.77 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 15 3 # 15 A 40 HIS O 76 HIS~? 4.51 CL CL O2018s A 58 GLU O 73 GLU~? 6.85 O1 GOL O3013 A 92 HIS O 151 HIS~? 4.32 O2 GOL O3026s coo 12.70 27.74 1.76 10.77 27.11 1.24 126.10 133.61 164.62 125.01 132.87 166.26 coo 11.38 23.30 3.20 9.27 23.34 3.13 129.73 137.78 165.68 128.97 136.10 166.67 coo 2.67 19.36 1.56 3.51 21.24 1.94 129.65 146.92 163.60 130.73 145.15 163.91 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 16 3 # 16 A 40 HIS P 76 HIS~? 4.69 CL CL P2019s A 58 GLU P 73 GLU~? 5.04 O1 GOL P3034 A 92 HIS P 151 HIS~? -4.15 C3 GOL P3014s coo 12.70 27.74 1.76 10.77 27.11 1.24 207.59 172.73 208.38 208.33 171.09 209.49 coo 11.38 23.30 3.20 9.27 23.34 3.13 204.36 171.43 203.90 204.84 170.63 205.81 coo 2.67 19.36 1.56 3.51 21.24 1.94 205.70 172.52 194.71 204.41 172.45 196.35 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 16 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 76 HIS~? -4.53 C1 GOL A3037s B 58 GLU A 73 GLU~? -3.07 O3 GOL A3037s B 92 HIS A 151 HIS~? -11.70 O3 GOL A3037s coo 10.74 36.24 16.20 9.81 34.52 16.97 98.60 85.60 50.46 99.38 86.61 52.13 coo 5.02 36.40 17.74 5.55 34.41 17.37 94.58 81.89 51.70 95.31 83.75 52.44 coo 0.68 29.04 20.43 2.46 29.56 19.46 94.27 72.58 51.14 93.29 74.44 51.00 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS B 76 HIS~? 4.58 CL CL B2010s B 58 GLU B 73 GLU~? 6.38 O3 GOL B3023 B 92 HIS B 151 HIS~? -4.11 O3 GOL B3015s coo 10.74 36.24 16.20 9.81 34.52 16.97 17.08 57.14 11.39 16.06 55.49 10.59 coo 5.02 36.40 17.74 5.55 34.41 17.37 19.80 56.19 16.30 19.32 55.14 14.52 coo 0.68 29.04 20.43 2.46 29.56 19.46 18.48 59.01 25.15 19.77 58.54 23.56 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 B 40 HIS C 76 HIS~? -4.98 CL CL C2011s B 58 GLU C 73 GLU~? 6.99 O1 GOL C3036 B 92 HIS C 151 HIS~? -4.28 C2 GOL C3036s coo 10.74 36.24 16.20 9.81 34.52 16.97 89.28 12.80 65.47 90.23 11.67 63.98 coo 5.02 36.40 17.74 5.55 34.41 17.37 86.57 17.41 63.72 86.98 15.43 63.06 coo 0.68 29.04 20.43 2.46 29.56 19.46 88.24 26.50 64.44 86.75 25.04 64.52 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 B 40 HIS D 76 HIS~? 4.24 O2 GOL D3018s B 58 GLU D 73 GLU~? 5.51 C2 GOL D3020 B 92 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 10.74 36.24 16.20 9.81 34.52 16.97 8.84 57.69 86.26 7.93 59.46 86.93 coo 5.02 36.40 17.74 5.55 34.41 17.37 12.99 58.17 82.26 12.31 59.24 83.94 coo 0.68 29.04 20.43 2.46 29.56 19.46 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 B 40 HIS E 76 HIS~? -4.87 CL CL E2013s B 58 GLU E 73 GLU~? -6.85 O1 GOL E3022s B 92 HIS E 151 HIS~? -4.12 O1 GOL E3002s coo 10.74 36.24 16.20 9.81 34.52 16.97 16.97 95.07 49.08 16.37 95.97 47.28 coo 5.02 36.40 17.74 5.55 34.41 17.37 19.82 90.31 48.74 19.50 92.07 47.58 coo 0.68 29.04 20.43 2.46 29.56 19.46 17.87 81.44 51.19 19.31 82.95 50.96 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 6 3 # 6 B 40 HIS F 76 HIS~? -4.65 CL CL F2034s B 58 GLU F 73 GLU~? 5.19 O3 GOL F3039 B 92 HIS F 151 HIS~? 14.76 O3 GOL F3039s coo 10.74 36.24 16.20 9.81 34.52 16.97 97.24 41.20 21.57 98.43 42.65 20.63 coo 5.02 36.40 17.74 5.55 34.41 17.37 93.55 43.24 25.35 94.46 43.89 23.55 coo 0.68 29.04 20.43 2.46 29.56 19.46 93.09 42.58 34.58 92.14 42.76 32.71 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 7 3 # 7 B 40 HIS G 76 HIS~? -3.85 O1 GOL G3038s B 58 GLU G 73 GLU~? 5.63 O1 GOL G3038 B 92 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 10.74 36.24 16.20 9.81 34.52 16.97 9.26 20.10 48.62 8.05 19.49 50.22 coo 5.02 36.40 17.74 5.55 34.41 17.37 12.93 24.13 49.80 12.04 22.49 50.80 coo 0.68 29.04 20.43 2.46 29.56 19.46 13.55 33.19 47.26 14.46 31.35 47.64 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 8 3 # 8 B 40 HIS H 76 HIS~? 4.68 CL CL H2014s B 58 GLU H 73 GLU~? -8.72 CL CL H2014s B 92 HIS H 151 HIS~? 4.32 C1 GOL H3016s coo 10.74 36.24 16.20 9.81 34.52 16.97 90.35 57.57 94.69 91.06 55.99 95.89 coo 5.02 36.40 17.74 5.55 34.41 17.37 87.54 56.19 90.14 87.78 55.44 92.11 coo 0.68 29.04 20.43 2.46 29.56 19.46 89.33 56.65 80.95 87.93 56.76 82.51 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 9 3 # 9 B 40 HIS I 76 HIS~? 4.17 O3 GOL I3031s B 58 GLU I 73 GLU~? -6.03 O3 GOL I3031s B 92 HIS I 151 HIS~? 3.98 O3 GOL I3032s coo 10.74 36.24 16.20 9.81 34.52 16.97 212.11 203.51 165.19 213.01 204.42 166.85 coo 5.02 36.40 17.74 5.55 34.41 17.37 208.30 199.46 166.53 209.06 201.27 167.27 coo 0.68 29.04 20.43 2.46 29.56 19.46 208.71 190.07 165.44 207.65 191.87 165.52 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 10 3 # 10 B 40 HIS J 76 HIS~? 4.19 O2 GOL J3033s B 58 GLU J 73 GLU~? 5.06 O1 GOL J3033 B 92 HIS J 151 HIS~? -12.73 O1 GOL J3033s coo 10.74 36.24 16.20 9.81 34.52 16.97 130.51 172.99 128.94 129.60 171.33 128.01 coo 5.02 36.40 17.74 5.55 34.41 17.37 133.49 171.70 133.63 132.81 170.83 131.84 coo 0.68 29.04 20.43 2.46 29.56 19.46 132.36 173.99 142.63 133.63 173.58 141.01 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 11 3 # 11 B 40 HIS K 76 HIS~? -6.12 C3 GOL K3041s B 58 GLU K 73 GLU~? 7.36 C3 GOL K3041 B 92 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 10.74 36.24 16.20 9.81 34.52 16.97 207.10 129.51 177.50 208.14 128.55 175.95 coo 5.02 36.40 17.74 5.55 34.41 17.37 204.07 133.93 175.85 204.65 132.02 175.03 coo 0.68 29.04 20.43 2.46 29.56 19.46 205.25 143.04 176.89 203.95 141.38 176.70 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 12 3 # 12 B 40 HIS L 76 HIS~? 4.00 O3 GOL L3027s B 58 GLU L 73 GLU~? 5.94 O3 GOL L3027 B 92 HIS L 151 HIS~? -15.32 O3 GOL L3028s coo 10.74 36.24 16.20 9.81 34.52 16.97 125.69 169.77 203.98 124.79 171.51 204.73 coo 5.02 36.40 17.74 5.55 34.41 17.37 129.44 170.32 199.72 128.69 171.38 201.39 coo 0.68 29.04 20.43 2.46 29.56 19.46 129.06 168.07 190.57 130.17 168.32 192.34 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 13 3 # 13 B 40 HIS M 76 HIS~? 4.78 C1 GOL M3042s B 58 GLU M 73 GLU~? -3.31 O3 GOL M3042s B 92 HIS M 151 HIS~? -11.81 O3 GOL M3042s coo 10.74 36.24 16.20 9.81 34.52 16.97 130.15 208.85 168.09 129.36 209.65 166.31 coo 5.02 36.40 17.74 5.55 34.41 17.37 133.35 204.22 167.43 132.84 205.99 166.43 coo 0.68 29.04 20.43 2.46 29.56 19.46 131.91 195.13 169.59 133.22 196.76 169.40 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 14 3 # 14 B 40 HIS N 76 HIS~? -6.89 CL CL N2030s B 58 GLU N 73 GLU~? -8.02 O3 GOL N3012s B 92 HIS N 151 HIS~? 3.39 O2 GOL N3012s coo 10.74 36.24 16.20 9.81 34.52 16.97 211.54 160.16 134.29 212.67 161.69 133.40 coo 5.02 36.40 17.74 5.55 34.41 17.37 207.93 161.92 138.37 208.75 162.64 136.53 coo 0.68 29.04 20.43 2.46 29.56 19.46 207.96 160.84 147.59 206.93 161.03 145.77 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 15 3 # 15 B 40 HIS O 76 HIS~? 4.51 CL CL O2018s B 58 GLU O 73 GLU~? 6.85 O1 GOL O3013 B 92 HIS O 151 HIS~? 4.32 O2 GOL O3026s coo 10.74 36.24 16.20 9.81 34.52 16.97 126.10 133.61 164.62 125.01 132.87 166.26 coo 5.02 36.40 17.74 5.55 34.41 17.37 129.73 137.78 165.68 128.97 136.10 166.67 coo 0.68 29.04 20.43 2.46 29.56 19.46 129.65 146.92 163.60 130.73 145.15 163.91 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 16 3 # 16 B 40 HIS P 76 HIS~? 4.69 CL CL P2019s B 58 GLU P 73 GLU~? 5.04 O1 GOL P3034 B 92 HIS P 151 HIS~? -4.15 C3 GOL P3014s coo 10.74 36.24 16.20 9.81 34.52 16.97 207.59 172.73 208.38 208.33 171.09 209.49 coo 5.02 36.40 17.74 5.55 34.41 17.37 204.36 171.43 203.90 204.84 170.63 205.81 coo 0.68 29.04 20.43 2.46 29.56 19.46 205.70 172.52 194.71 204.41 172.45 196.35 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 16 hits 1b2m_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 63 GLU~? 17.38 O3 GOL A3037 B 88 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 89 HIS E 151 HIS~? -4.12 O1 GOL E3002s coo 44.53 38.98 5.35 43.53 40.60 6.22 80.85 73.88 49.67 82.12 74.36 51.37 coo 58.74 13.49 55.78 58.72 14.38 57.67 23.07 86.29 52.35 21.57 85.17 51.32 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.87 81.44 51.19 19.31 82.95 50.96 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 63 GLU~? 5.73 C3 GOL B3024 B 88 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 89 HIS F 151 HIS~? 14.76 O3 GOL F3039s coo 44.53 38.98 5.35 43.53 40.60 6.22 31.78 57.54 26.90 30.14 56.11 26.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 88.86 41.25 28.96 90.30 42.22 30.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 93.09 42.58 34.58 92.14 42.76 32.71 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU C 63 GLU~? 10.01 O3 GOL C3021 B 88 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 89 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 44.53 38.98 5.35 43.53 40.60 6.22 74.66 28.22 62.99 76.28 27.57 61.69 coo 58.74 13.49 55.78 58.72 14.38 57.67 17.70 27.34 47.09 16.19 28.71 47.73 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.55 33.19 47.26 14.46 31.35 47.64 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU D 63 GLU~? 9.36 O3 GOL D3019 B 88 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 89 HIS H 151 HIS~? 4.32 C1 GOL H3016s coo 44.53 38.98 5.35 43.53 40.60 6.22 26.38 54.52 74.49 25.00 56.17 74.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 84.24 58.93 85.48 85.73 57.59 84.66 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.33 56.65 80.95 87.93 56.76 82.51 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU E 63 GLU~? 9.77 O1 GOL E3035 B 88 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 89 HIS A 151 HIS~? -11.70 O3 GOL A3037s coo 44.53 38.98 5.35 43.53 40.60 6.22 31.45 79.77 52.47 30.08 79.96 50.79 coo 58.74 13.49 55.78 58.72 14.38 57.67 90.44 78.16 48.76 91.65 76.94 50.06 coo 60.89 12.20 60.42 60.43 13.81 61.68 94.27 72.58 51.14 93.29 74.44 51.00 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU F 63 GLU~? 10.86 CL CL F2035 B 88 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 89 HIS B 151 HIS~? -4.11 O3 GOL B3015s coo 44.53 38.98 5.35 43.53 40.60 6.22 79.68 44.12 33.16 81.40 45.47 32.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 23.66 59.02 20.34 21.93 58.32 21.38 coo 60.89 12.20 60.42 60.43 13.81 61.68 18.48 59.01 25.15 19.77 58.54 23.56 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU G 63 GLU~? 11.17 O2 GOL G3001 B 88 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 89 HIS C 151 HIS~? -4.28 C2 GOL C3036s coo 44.53 38.98 5.35 43.53 40.60 6.22 27.02 31.92 48.98 25.38 31.91 50.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 82.81 22.02 65.69 84.52 22.80 64.66 coo 60.89 12.20 60.42 60.43 13.81 61.68 88.24 26.50 64.44 86.75 25.04 64.52 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU H 63 GLU~? 5.58 O3 GOL H3016 B 88 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 89 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 44.53 38.98 5.35 43.53 40.60 6.22 75.79 57.78 79.22 77.22 56.21 79.74 coo 58.74 13.49 55.78 58.72 14.38 57.67 16.94 54.59 79.01 15.65 55.42 77.54 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU I 63 GLU~? 5.33 O2 GOL I3032 B 88 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 89 HIS M 151 HIS~? -11.81 O3 GOL M3042s coo 44.53 38.98 5.35 43.53 40.60 6.22 195.05 190.75 164.81 196.51 190.81 166.36 coo 58.74 13.49 55.78 58.72 14.38 57.67 136.87 200.18 170.79 135.36 199.08 169.77 coo 60.89 12.20 60.42 60.43 13.81 61.68 131.91 195.13 169.59 133.22 196.76 169.40 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU J 63 GLU~? 19.53 O1 GOL J3033 B 88 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 89 HIS N 151 HIS~? 3.39 O2 GOL N3012s coo 44.53 38.98 5.35 43.53 40.60 6.22 145.93 173.07 143.61 144.33 171.59 143.32 coo 58.74 13.49 55.78 58.72 14.38 57.67 203.51 159.51 142.26 205.02 160.53 143.48 coo 60.89 12.20 60.42 60.43 13.81 61.68 207.96 160.84 147.59 206.93 161.03 145.77 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU K 63 GLU~? 9.64 O2 GOL K3010 B 88 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 89 HIS O 151 HIS~? 4.32 O2 GOL O3026s coo 44.53 38.98 5.35 43.53 40.60 6.22 191.78 144.13 175.87 193.39 143.52 174.53 coo 58.74 13.49 55.78 58.72 14.38 57.67 134.07 141.35 162.95 132.57 142.58 163.78 coo 60.89 12.20 60.42 60.43 13.81 61.68 129.65 146.92 163.60 130.73 145.15 163.91 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU L 63 GLU~? 9.87 O3 GOL L3028 B 88 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 89 HIS P 151 HIS~? -4.15 C3 GOL P3014s coo 44.53 38.98 5.35 43.53 40.60 6.22 142.67 167.29 191.27 141.24 168.94 191.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 200.75 174.15 199.66 202.28 173.10 198.62 coo 60.89 12.20 60.42 60.43 13.81 61.68 205.70 172.52 194.71 204.41 172.45 196.35 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU M 63 GLU~? 17.44 O3 GOL M3042 B 88 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 89 HIS I 151 HIS~? 3.98 O3 GOL I3032s coo 44.53 38.98 5.35 43.53 40.60 6.22 145.53 194.15 170.27 144.03 194.27 168.71 coo 58.74 13.49 55.78 58.72 14.38 57.67 204.37 195.46 163.61 205.75 194.30 164.79 coo 60.89 12.20 60.42 60.43 13.81 61.68 208.71 190.07 165.44 207.65 191.87 165.52 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU N 63 GLU~? 5.47 O3 GOL N3029 B 88 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 89 HIS J 151 HIS~? -12.73 O1 GOL J3033s coo 44.53 38.98 5.35 43.53 40.60 6.22 194.49 161.88 146.96 196.25 163.15 146.70 coo 58.74 13.49 55.78 58.72 14.38 57.67 137.44 174.60 137.57 135.80 173.80 138.69 coo 60.89 12.20 60.42 60.43 13.81 61.68 132.36 173.99 142.63 133.63 173.58 141.01 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU O 63 GLU~? 5.90 C1 GOL O3026 B 88 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 89 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 44.53 38.98 5.35 43.53 40.60 6.22 143.37 146.22 164.56 141.71 146.26 165.94 coo 58.74 13.49 55.78 58.72 14.38 57.67 200.17 138.24 178.11 201.77 139.28 177.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 205.25 143.04 176.89 203.95 141.38 176.70 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU P 63 GLU~? 10.86 O3 GOL P3014 B 88 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 89 HIS L 151 HIS~? -15.32 O3 GOL L3028s coo 44.53 38.98 5.35 43.53 40.60 6.22 192.19 173.00 193.76 193.59 171.39 194.28 coo 58.74 13.49 55.78 58.72 14.38 57.67 133.34 166.97 196.27 132.03 168.03 194.96 coo 60.89 12.20 60.42 60.43 13.81 61.68 129.06 168.07 190.57 130.17 168.32 192.34 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 16 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 63 GLU~? 17.38 O3 GOL A3037 B 88 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 89 HIS E 151 HIS~? -4.12 O1 GOL E3002s coo 44.53 38.98 5.35 43.53 40.60 6.22 80.85 73.88 49.67 82.12 74.36 51.37 coo 58.74 13.49 55.78 58.72 14.38 57.67 23.07 86.29 52.35 21.57 85.17 51.32 coo 60.89 12.20 60.42 60.43 13.81 61.68 17.87 81.44 51.19 19.31 82.95 50.96 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU B 63 GLU~? 5.73 C3 GOL B3024 B 88 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 89 HIS F 151 HIS~? 14.76 O3 GOL F3039s coo 44.53 38.98 5.35 43.53 40.60 6.22 31.78 57.54 26.90 30.14 56.11 26.75 coo 58.74 13.49 55.78 58.72 14.38 57.67 88.86 41.25 28.96 90.30 42.22 30.24 coo 60.89 12.20 60.42 60.43 13.81 61.68 93.09 42.58 34.58 92.14 42.76 32.71 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU C 63 GLU~? 10.01 O3 GOL C3021 B 88 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 89 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 44.53 38.98 5.35 43.53 40.60 6.22 74.66 28.22 62.99 76.28 27.57 61.69 coo 58.74 13.49 55.78 58.72 14.38 57.67 17.70 27.34 47.09 16.19 28.71 47.73 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.55 33.19 47.26 14.46 31.35 47.64 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU D 63 GLU~? 9.36 O3 GOL D3019 B 88 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 89 HIS H 151 HIS~? 4.32 C1 GOL H3016s coo 44.53 38.98 5.35 43.53 40.60 6.22 26.38 54.52 74.49 25.00 56.17 74.76 coo 58.74 13.49 55.78 58.72 14.38 57.67 84.24 58.93 85.48 85.73 57.59 84.66 coo 60.89 12.20 60.42 60.43 13.81 61.68 89.33 56.65 80.95 87.93 56.76 82.51 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU E 63 GLU~? 9.77 O1 GOL E3035 B 88 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 89 HIS A 151 HIS~? -11.70 O3 GOL A3037s coo 44.53 38.98 5.35 43.53 40.60 6.22 31.45 79.77 52.47 30.08 79.96 50.79 coo 58.74 13.49 55.78 58.72 14.38 57.67 90.44 78.16 48.76 91.65 76.94 50.06 coo 60.89 12.20 60.42 60.43 13.81 61.68 94.27 72.58 51.14 93.29 74.44 51.00 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU F 63 GLU~? 10.86 CL CL F2035 B 88 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 89 HIS B 151 HIS~? -4.11 O3 GOL B3015s coo 44.53 38.98 5.35 43.53 40.60 6.22 79.68 44.12 33.16 81.40 45.47 32.88 coo 58.74 13.49 55.78 58.72 14.38 57.67 23.66 59.02 20.34 21.93 58.32 21.38 coo 60.89 12.20 60.42 60.43 13.81 61.68 18.48 59.01 25.15 19.77 58.54 23.56 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU G 63 GLU~? 11.17 O2 GOL G3001 B 88 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 89 HIS C 151 HIS~? -4.28 C2 GOL C3036s coo 44.53 38.98 5.35 43.53 40.60 6.22 27.02 31.92 48.98 25.38 31.91 50.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 82.81 22.02 65.69 84.52 22.80 64.66 coo 60.89 12.20 60.42 60.43 13.81 61.68 88.24 26.50 64.44 86.75 25.04 64.52 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 8 3 # 8 A 133 GLU H 63 GLU~? 5.58 O3 GOL H3016 B 88 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 89 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 44.53 38.98 5.35 43.53 40.60 6.22 75.79 57.78 79.22 77.22 56.21 79.74 coo 58.74 13.49 55.78 58.72 14.38 57.67 16.94 54.59 79.01 15.65 55.42 77.54 coo 60.89 12.20 60.42 60.43 13.81 61.68 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 9 3 # 9 A 133 GLU I 63 GLU~? 5.33 O2 GOL I3032 B 88 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 89 HIS M 151 HIS~? -11.81 O3 GOL M3042s coo 44.53 38.98 5.35 43.53 40.60 6.22 195.05 190.75 164.81 196.51 190.81 166.36 coo 58.74 13.49 55.78 58.72 14.38 57.67 136.87 200.18 170.79 135.36 199.08 169.77 coo 60.89 12.20 60.42 60.43 13.81 61.68 131.91 195.13 169.59 133.22 196.76 169.40 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 10 3 # 10 A 133 GLU J 63 GLU~? 19.53 O1 GOL J3033 B 88 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 89 HIS N 151 HIS~? 3.39 O2 GOL N3012s coo 44.53 38.98 5.35 43.53 40.60 6.22 145.93 173.07 143.61 144.33 171.59 143.32 coo 58.74 13.49 55.78 58.72 14.38 57.67 203.51 159.51 142.26 205.02 160.53 143.48 coo 60.89 12.20 60.42 60.43 13.81 61.68 207.96 160.84 147.59 206.93 161.03 145.77 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 11 3 # 11 A 133 GLU K 63 GLU~? 9.64 O2 GOL K3010 B 88 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 89 HIS O 151 HIS~? 4.32 O2 GOL O3026s coo 44.53 38.98 5.35 43.53 40.60 6.22 191.78 144.13 175.87 193.39 143.52 174.53 coo 58.74 13.49 55.78 58.72 14.38 57.67 134.07 141.35 162.95 132.57 142.58 163.78 coo 60.89 12.20 60.42 60.43 13.81 61.68 129.65 146.92 163.60 130.73 145.15 163.91 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 12 3 # 12 A 133 GLU L 63 GLU~? 9.87 O3 GOL L3028 B 88 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 89 HIS P 151 HIS~? -4.15 C3 GOL P3014s coo 44.53 38.98 5.35 43.53 40.60 6.22 142.67 167.29 191.27 141.24 168.94 191.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 200.75 174.15 199.66 202.28 173.10 198.62 coo 60.89 12.20 60.42 60.43 13.81 61.68 205.70 172.52 194.71 204.41 172.45 196.35 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 13 3 # 13 A 133 GLU M 63 GLU~? 17.44 O3 GOL M3042 B 88 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 89 HIS I 151 HIS~? 3.98 O3 GOL I3032s coo 44.53 38.98 5.35 43.53 40.60 6.22 145.53 194.15 170.27 144.03 194.27 168.71 coo 58.74 13.49 55.78 58.72 14.38 57.67 204.37 195.46 163.61 205.75 194.30 164.79 coo 60.89 12.20 60.42 60.43 13.81 61.68 208.71 190.07 165.44 207.65 191.87 165.52 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 14 3 # 14 A 133 GLU N 63 GLU~? 5.47 O3 GOL N3029 B 88 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 89 HIS J 151 HIS~? -12.73 O1 GOL J3033s coo 44.53 38.98 5.35 43.53 40.60 6.22 194.49 161.88 146.96 196.25 163.15 146.70 coo 58.74 13.49 55.78 58.72 14.38 57.67 137.44 174.60 137.57 135.80 173.80 138.69 coo 60.89 12.20 60.42 60.43 13.81 61.68 132.36 173.99 142.63 133.63 173.58 141.01 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 15 3 # 15 A 133 GLU O 63 GLU~? 5.90 C1 GOL O3026 B 88 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 89 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 44.53 38.98 5.35 43.53 40.60 6.22 143.37 146.22 164.56 141.71 146.26 165.94 coo 58.74 13.49 55.78 58.72 14.38 57.67 200.17 138.24 178.11 201.77 139.28 177.19 coo 60.89 12.20 60.42 60.43 13.81 61.68 205.25 143.04 176.89 203.95 141.38 176.70 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 16 3 # 16 A 133 GLU P 63 GLU~? 10.86 O3 GOL P3014 B 88 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 89 HIS L 151 HIS~? -15.32 O3 GOL L3028s coo 44.53 38.98 5.35 43.53 40.60 6.22 192.19 173.00 193.76 193.59 171.39 194.28 coo 58.74 13.49 55.78 58.72 14.38 57.67 133.34 166.97 196.27 132.03 168.03 194.96 coo 60.89 12.20 60.42 60.43 13.81 61.68 129.06 168.07 190.57 130.17 168.32 192.34 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 16 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 91 ARG D 155 ARG.? 13.82 O1 GOL D3020 B 129 SER D 160 SER~? 16.34 O1 GOL D3020 coo 18.19 17.03 40.71 18.55 17.18 38.64 0.86 62.48 80.06 1.83 63.91 81.27 coo 25.60 21.10 38.54 23.57 20.93 36.25 0.93 64.44 73.19 -0.93 62.13 72.64 coo 21.33 14.29 34.62 19.25 14.88 35.71 -2.72 55.63 75.90 -2.35 54.92 73.63 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 75 TYR~? 11.96 CL CL A2020 A 230 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 273 LYS A 142 LYS~? 20.36 CL CL A2020 coo 9.23 21.44 106.88 10.18 19.34 105.31 97.97 81.77 42.85 98.10 80.04 40.64 coo 1.45 22.80 104.16 2.58 21.02 104.01 90.44 78.16 48.76 91.65 76.94 50.06 coo 2.97 11.64 107.87 6.59 15.13 107.03 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 109 TYR~? 19.57 O1 GOL A3040 A 230 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 273 LYS A 142 LYS~? 20.36 CL CL A2020 coo 9.23 21.44 106.88 10.18 19.34 105.31 84.38 79.76 38.04 83.16 77.26 38.08 coo 1.45 22.80 104.16 2.58 21.02 104.01 88.23 80.63 30.72 87.92 80.82 28.67 coo 2.97 11.64 107.87 6.59 15.13 107.03 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR B 75 TYR~? 10.15 CL CL B2010 A 230 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.23 21.44 106.88 10.18 19.34 105.31 18.67 65.14 13.86 18.80 67.67 14.99 coo 1.45 22.80 104.16 2.58 21.02 104.01 23.66 59.02 20.34 21.93 58.32 21.38 coo 2.97 11.64 107.87 6.59 15.13 107.03 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR B 109 TYR~? 11.52 O1 GOL B3024 A 230 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.23 21.44 106.88 10.18 19.34 105.31 32.33 67.79 18.21 32.96 68.04 20.89 coo 1.45 22.80 104.16 2.58 21.02 104.01 30.49 75.29 14.98 31.30 77.16 14.42 coo 2.97 11.64 107.87 6.59 15.13 107.03 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR C 75 TYR~? 10.50 CL CL C2011 A 230 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.23 21.44 106.88 10.18 19.34 105.31 87.86 16.77 72.91 87.86 18.43 75.14 coo 1.45 22.80 104.16 2.58 21.02 104.01 82.81 22.02 65.69 84.52 22.80 64.66 coo 2.97 11.64 107.87 6.59 15.13 107.03 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 230 ASP C 102 ASP.? 24.57 CL CL C2011 A 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.23 21.44 106.88 10.18 19.34 105.31 74.32 21.96 74.78 73.58 24.65 74.54 coo 1.45 22.80 104.16 2.58 21.02 104.01 76.25 20.52 82.74 75.40 20.56 84.65 coo 2.97 11.64 107.87 6.59 15.13 107.03 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR D 75 TYR~? 10.03 CL CL D2012 A 230 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 273 LYS D 142 LYS~? 18.65 CL CL D2012 coo 9.23 21.44 106.88 10.18 19.34 105.31 9.41 49.60 83.94 9.22 47.13 82.70 coo 1.45 22.80 104.16 2.58 21.02 104.01 16.94 54.59 79.01 15.65 55.42 77.54 coo 2.97 11.64 107.87 6.59 15.13 107.03 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR D 109 TYR~? 18.34 O3 GOL D3019 A 230 ASP D 102 ASP.? 24.32 CL CL D2012 A 273 LYS D 142 LYS~? 18.65 CL CL D2012 coo 9.23 21.44 106.88 10.18 19.34 105.31 22.95 44.43 82.69 24.09 43.90 80.20 coo 1.45 22.80 104.16 2.58 21.02 104.01 18.96 37.41 85.00 19.42 35.40 85.42 coo 2.97 11.64 107.87 6.59 15.13 107.03 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR E 75 TYR~? 10.13 CL CL E2013 A 230 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.23 21.44 106.88 10.18 19.34 105.31 16.89 92.83 57.30 16.35 91.61 59.76 coo 1.45 22.80 104.16 2.58 21.02 104.01 23.07 86.29 52.35 21.57 85.17 51.32 coo 2.97 11.64 107.87 6.59 15.13 107.03 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR E 109 TYR~? 18.10 O1 GOL E3035 A 230 ASP E 102 ASP.? 24.45 CL CL E2013 A 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.23 21.44 106.88 10.18 19.34 105.31 29.73 88.43 62.54 30.41 85.74 63.01 coo 1.45 22.80 104.16 2.58 21.02 104.01 26.42 91.49 69.61 27.08 91.68 71.63 coo 2.97 11.64 107.87 6.59 15.13 107.03 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR F 75 TYR~? 9.99 CL CL F2034 A 230 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.23 21.44 106.88 10.18 19.34 105.31 95.01 33.97 25.26 94.64 31.83 27.03 coo 1.45 22.80 104.16 2.58 21.02 104.01 88.86 41.25 28.96 90.30 42.22 30.24 coo 2.97 11.64 107.87 6.59 15.13 107.03 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR F 109 TYR~? 6.98 CL CL F2035 A 230 ASP F 102 ASP.? 16.73 CL CL F2035 A 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.23 21.44 106.88 10.18 19.34 105.31 80.57 32.26 27.20 79.31 32.54 29.65 coo 1.45 22.80 104.16 2.58 21.02 104.01 82.74 24.28 26.35 81.91 22.30 26.35 coo 2.97 11.64 107.87 6.59 15.13 107.03 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 A 145 TYR G 75 TYR~? 12.69 CL CL G2033 A 230 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 273 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 9.23 21.44 106.88 10.18 19.34 105.31 11.49 22.21 40.76 11.82 23.42 38.24 coo 1.45 22.80 104.16 2.58 21.02 104.01 17.70 27.34 47.09 16.19 28.71 47.73 coo 2.97 11.64 107.87 6.59 15.13 107.03 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 A 145 TYR G 109 TYR~? 19.47 O2 GOL G3001 A 230 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 273 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 9.23 21.44 106.88 10.18 19.34 105.31 25.80 23.55 38.48 27.03 26.02 38.21 coo 1.45 22.80 104.16 2.58 21.02 104.01 23.47 21.05 30.82 24.30 20.62 28.93 coo 2.97 11.64 107.87 6.59 15.13 107.03 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 15 3 # 15 A 145 TYR H 75 TYR~? 10.27 CL CL H2014 A 230 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.23 21.44 106.88 10.18 19.34 105.31 90.64 65.09 90.65 91.11 67.21 88.98 coo 1.45 22.80 104.16 2.58 21.02 104.01 84.24 58.93 85.48 85.73 57.59 84.66 coo 2.97 11.64 107.87 6.59 15.13 107.03 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 16 3 # 16 A 145 TYR H 109 TYR~? 11.76 O2 GOL H3016 A 230 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.23 21.44 106.88 10.18 19.34 105.31 77.84 69.46 85.37 77.15 69.38 82.64 coo 1.45 22.80 104.16 2.58 21.02 104.01 81.36 76.99 86.94 80.90 79.01 86.89 coo 2.97 11.64 107.87 6.59 15.13 107.03 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 17 3 # 17 A 145 TYR I 75 TYR~? 10.32 CL CL I2015 A 230 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 273 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 9.23 21.44 106.88 10.18 19.34 105.31 211.34 199.93 157.52 211.50 198.33 155.24 coo 1.45 22.80 104.16 2.58 21.02 104.01 204.37 195.46 163.61 205.75 194.30 164.79 coo 2.97 11.64 107.87 6.59 15.13 107.03 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 18 3 # 18 A 145 TYR I 109 TYR~? 11.79 O1 GOL I3032 A 230 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 273 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 9.23 21.44 106.88 10.18 19.34 105.31 197.73 197.22 153.29 196.64 194.65 153.36 coo 1.45 22.80 104.16 2.58 21.02 104.01 201.10 198.54 145.88 200.66 198.62 143.82 coo 2.97 11.64 107.87 6.59 15.13 107.03 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 19 3 # 19 A 145 TYR J 75 TYR~? 10.17 CL CL J2016 A 230 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 273 LYS J 142 LYS~? 19.62 CL CL J2016 coo 9.23 21.44 106.88 10.18 19.34 105.31 131.82 180.89 131.78 131.82 183.34 133.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 137.44 174.60 137.57 135.80 173.80 138.69 coo 2.97 11.64 107.87 6.59 15.13 107.03 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 20 3 # 20 A 145 TYR J 109 TYR~? 19.91 O1 GOL J3030 A 230 ASP J 102 ASP.? 24.08 CL CL J2016 A 273 LYS J 142 LYS~? 19.62 CL CL J2016 coo 9.23 21.44 106.88 10.18 19.34 105.31 145.48 183.77 135.57 146.27 183.96 138.21 coo 1.45 22.80 104.16 2.58 21.02 104.01 143.25 191.36 132.98 143.80 193.32 132.63 coo 2.97 11.64 107.87 6.59 15.13 107.03 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 21 3 # 21 A 145 TYR K 75 TYR~? 12.36 CL CL K2027 A 230 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.23 21.44 106.88 10.18 19.34 105.31 205.79 133.16 185.06 205.81 134.80 187.34 coo 1.45 22.80 104.16 2.58 21.02 104.01 200.17 138.24 178.11 201.77 139.28 177.19 coo 2.97 11.64 107.87 6.59 15.13 107.03 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 22 3 # 22 A 145 TYR K 109 TYR~? 18.63 O3 GOL K3010 A 230 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.23 21.44 106.88 10.18 19.34 105.31 192.13 137.45 187.51 191.27 140.11 187.32 coo 1.45 22.80 104.16 2.58 21.02 104.01 194.36 135.90 195.25 193.66 135.95 197.23 coo 2.97 11.64 107.87 6.59 15.13 107.03 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 23 3 # 23 A 145 TYR L 75 TYR~? 10.07 CL CL L2009 A 230 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.23 21.44 106.88 10.18 19.34 105.31 126.23 161.73 201.55 126.10 159.32 200.24 coo 1.45 22.80 104.16 2.58 21.02 104.01 133.34 166.97 196.27 132.03 168.03 194.96 coo 2.97 11.64 107.87 6.59 15.13 107.03 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 24 3 # 24 A 145 TYR L 109 TYR~? 18.94 O3 GOL L3028 A 230 ASP L 102 ASP.? 24.59 CL CL L2009 A 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.23 21.44 106.88 10.18 19.34 105.31 139.89 156.88 199.30 141.02 156.55 196.75 coo 1.45 22.80 104.16 2.58 21.02 104.01 136.52 149.82 201.33 136.95 147.73 201.53 coo 2.97 11.64 107.87 6.59 15.13 107.03 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 25 3 # 25 A 145 TYR M 75 TYR~? 10.36 CL CL M2017 A 230 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.23 21.44 106.88 10.18 19.34 105.31 130.62 206.12 176.17 130.27 204.76 178.58 coo 1.45 22.80 104.16 2.58 21.02 104.01 136.87 200.18 170.79 135.36 199.08 169.77 coo 2.97 11.64 107.87 6.59 15.13 107.03 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 26 3 # 26 A 145 TYR M 109 TYR~? 20.13 O1 GOL M3043 A 230 ASP M 102 ASP.? 24.52 CL CL M2017 A 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.23 21.44 106.88 10.18 19.34 105.31 143.85 202.19 180.75 144.68 199.53 181.04 coo 1.45 22.80 104.16 2.58 21.02 104.01 140.74 204.70 188.01 141.33 204.99 189.98 coo 2.97 11.64 107.87 6.59 15.13 107.03 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 27 3 # 27 A 145 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 230 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.23 21.44 106.88 10.18 19.34 105.31 209.71 152.64 137.80 209.50 150.35 139.41 coo 1.45 22.80 104.16 2.58 21.02 104.01 203.51 159.51 142.26 205.02 160.53 143.48 coo 2.97 11.64 107.87 6.59 15.13 107.03 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 28 3 # 28 A 145 TYR N 109 TYR~? 12.25 C2 GOL N3029 A 230 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.23 21.44 106.88 10.18 19.34 105.31 195.52 150.33 140.44 194.35 150.45 143.01 coo 1.45 22.80 104.16 2.58 21.02 104.01 197.96 142.41 139.19 197.06 140.46 139.09 coo 2.97 11.64 107.87 6.59 15.13 107.03 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 29 3 # 29 A 145 TYR O 75 TYR~? 10.24 CL CL O2018 A 230 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.23 21.44 106.88 10.18 19.34 105.31 127.87 136.17 156.70 127.95 137.50 154.23 coo 1.45 22.80 104.16 2.58 21.02 104.01 134.07 141.35 162.95 132.57 142.58 163.78 coo 2.97 11.64 107.87 6.59 15.13 107.03 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 30 3 # 30 A 145 TYR O 109 TYR~? 12.46 CL CL O2036 A 230 ASP O 102 ASP.? 13.16 CL CL O2036 A 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.23 21.44 106.88 10.18 19.34 105.31 141.96 138.45 153.78 143.09 141.01 153.60 coo 1.45 22.80 104.16 2.58 21.02 104.01 139.48 136.33 146.19 140.25 135.96 144.25 coo 2.97 11.64 107.87 6.59 15.13 107.03 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 31 3 # 31 A 145 TYR P 75 TYR~? 10.23 CL CL P2019 A 230 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 273 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 9.23 21.44 106.88 10.18 19.34 105.31 207.22 180.36 204.70 207.43 182.65 203.13 coo 1.45 22.80 104.16 2.58 21.02 104.01 200.75 174.15 199.66 202.28 173.10 198.62 coo 2.97 11.64 107.87 6.59 15.13 107.03 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 32 3 # 32 A 145 TYR P 109 TYR~? 18.49 O3 GOL P3014 A 230 ASP P 102 ASP.? 24.26 CL CL P2019 A 273 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 9.23 21.44 106.88 10.18 19.34 105.31 193.88 184.51 200.52 193.11 184.53 197.85 coo 1.45 22.80 104.16 2.58 21.02 104.01 197.01 191.93 202.05 196.73 194.01 202.05 coo 2.97 11.64 107.87 6.59 15.13 107.03 204.59 186.28 195.60 209.96 186.96 196.62 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 32 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 75 TYR~? 11.96 CL CL A2020 B 230 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 273 LYS A 142 LYS~? 20.36 CL CL A2020 coo 11.81 13.41 73.03 10.00 13.03 75.12 97.97 81.77 42.85 98.10 80.04 40.64 coo 19.17 11.01 76.14 17.26 10.42 76.77 90.44 78.16 48.76 91.65 76.94 50.06 coo 11.10 2.31 76.60 10.24 7.24 75.62 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 109 TYR~? 19.57 O1 GOL A3040 B 230 ASP A 102 ASP.? 25.18 C1 GOL A3040 B 273 LYS A 142 LYS~? 20.36 CL CL A2020 coo 11.81 13.41 73.03 10.00 13.03 75.12 84.38 79.76 38.04 83.16 77.26 38.08 coo 19.17 11.01 76.14 17.26 10.42 76.77 88.23 80.63 30.72 87.92 80.82 28.67 coo 11.10 2.31 76.60 10.24 7.24 75.62 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR B 75 TYR~? 10.15 CL CL B2010 B 230 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 11.81 13.41 73.03 10.00 13.03 75.12 18.67 65.14 13.86 18.80 67.67 14.99 coo 19.17 11.01 76.14 17.26 10.42 76.77 23.66 59.02 20.34 21.93 58.32 21.38 coo 11.10 2.31 76.60 10.24 7.24 75.62 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 109 TYR~? 11.52 O1 GOL B3024 B 230 ASP B 102 ASP.? 20.31 O1 GOL B3024 B 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 11.81 13.41 73.03 10.00 13.03 75.12 32.33 67.79 18.21 32.96 68.04 20.89 coo 19.17 11.01 76.14 17.26 10.42 76.77 30.49 75.29 14.98 31.30 77.16 14.42 coo 11.10 2.31 76.60 10.24 7.24 75.62 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR C 75 TYR~? 10.50 CL CL C2011 B 230 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 11.81 13.41 73.03 10.00 13.03 75.12 87.86 16.77 72.91 87.86 18.43 75.14 coo 19.17 11.01 76.14 17.26 10.42 76.77 82.81 22.02 65.69 84.52 22.80 64.66 coo 11.10 2.31 76.60 10.24 7.24 75.62 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR C 109 TYR~? 17.83 O1 GOL C3036 B 230 ASP C 102 ASP.? 24.57 CL CL C2011 B 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 11.81 13.41 73.03 10.00 13.03 75.12 74.32 21.96 74.78 73.58 24.65 74.54 coo 19.17 11.01 76.14 17.26 10.42 76.77 76.25 20.52 82.74 75.40 20.56 84.65 coo 11.10 2.31 76.60 10.24 7.24 75.62 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR D 75 TYR~? 10.03 CL CL D2012 B 230 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 273 LYS D 142 LYS~? 18.65 CL CL D2012 coo 11.81 13.41 73.03 10.00 13.03 75.12 9.41 49.60 83.94 9.22 47.13 82.70 coo 19.17 11.01 76.14 17.26 10.42 76.77 16.94 54.59 79.01 15.65 55.42 77.54 coo 11.10 2.31 76.60 10.24 7.24 75.62 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR D 109 TYR~? 18.34 O3 GOL D3019 B 230 ASP D 102 ASP.? 24.32 CL CL D2012 B 273 LYS D 142 LYS~? 18.65 CL CL D2012 coo 11.81 13.41 73.03 10.00 13.03 75.12 22.95 44.43 82.69 24.09 43.90 80.20 coo 19.17 11.01 76.14 17.26 10.42 76.77 18.96 37.41 85.00 19.42 35.40 85.42 coo 11.10 2.31 76.60 10.24 7.24 75.62 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR E 75 TYR~? 10.13 CL CL E2013 B 230 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 11.81 13.41 73.03 10.00 13.03 75.12 16.89 92.83 57.30 16.35 91.61 59.76 coo 19.17 11.01 76.14 17.26 10.42 76.77 23.07 86.29 52.35 21.57 85.17 51.32 coo 11.10 2.31 76.60 10.24 7.24 75.62 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR E 109 TYR~? 18.10 O1 GOL E3035 B 230 ASP E 102 ASP.? 24.45 CL CL E2013 B 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 11.81 13.41 73.03 10.00 13.03 75.12 29.73 88.43 62.54 30.41 85.74 63.01 coo 19.17 11.01 76.14 17.26 10.42 76.77 26.42 91.49 69.61 27.08 91.68 71.63 coo 11.10 2.31 76.60 10.24 7.24 75.62 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR F 75 TYR~? 9.99 CL CL F2034 B 230 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 11.81 13.41 73.03 10.00 13.03 75.12 95.01 33.97 25.26 94.64 31.83 27.03 coo 19.17 11.01 76.14 17.26 10.42 76.77 88.86 41.25 28.96 90.30 42.22 30.24 coo 11.10 2.31 76.60 10.24 7.24 75.62 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR F 109 TYR~? 6.98 CL CL F2035 B 230 ASP F 102 ASP.? 16.73 CL CL F2035 B 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 11.81 13.41 73.03 10.00 13.03 75.12 80.57 32.26 27.20 79.31 32.54 29.65 coo 19.17 11.01 76.14 17.26 10.42 76.77 82.74 24.28 26.35 81.91 22.30 26.35 coo 11.10 2.31 76.60 10.24 7.24 75.62 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 13 3 # 13 B 145 TYR G 75 TYR~? 12.69 CL CL G2033 B 230 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 273 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 11.81 13.41 73.03 10.00 13.03 75.12 11.49 22.21 40.76 11.82 23.42 38.24 coo 19.17 11.01 76.14 17.26 10.42 76.77 17.70 27.34 47.09 16.19 28.71 47.73 coo 11.10 2.31 76.60 10.24 7.24 75.62 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 14 3 # 14 B 145 TYR G 109 TYR~? 19.47 O2 GOL G3001 B 230 ASP G 102 ASP.? 25.30 O3 GOL G3038 B 273 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 11.81 13.41 73.03 10.00 13.03 75.12 25.80 23.55 38.48 27.03 26.02 38.21 coo 19.17 11.01 76.14 17.26 10.42 76.77 23.47 21.05 30.82 24.30 20.62 28.93 coo 11.10 2.31 76.60 10.24 7.24 75.62 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 15 3 # 15 B 145 TYR H 75 TYR~? 10.27 CL CL H2014 B 230 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 11.81 13.41 73.03 10.00 13.03 75.12 90.64 65.09 90.65 91.11 67.21 88.98 coo 19.17 11.01 76.14 17.26 10.42 76.77 84.24 58.93 85.48 85.73 57.59 84.66 coo 11.10 2.31 76.60 10.24 7.24 75.62 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 16 3 # 16 B 145 TYR H 109 TYR~? 11.76 O2 GOL H3016 B 230 ASP H 102 ASP.? 20.45 O2 GOL H3016 B 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 11.81 13.41 73.03 10.00 13.03 75.12 77.84 69.46 85.37 77.15 69.38 82.64 coo 19.17 11.01 76.14 17.26 10.42 76.77 81.36 76.99 86.94 80.90 79.01 86.89 coo 11.10 2.31 76.60 10.24 7.24 75.62 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 17 3 # 17 B 145 TYR I 75 TYR~? 10.32 CL CL I2015 B 230 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 273 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 11.81 13.41 73.03 10.00 13.03 75.12 211.34 199.93 157.52 211.50 198.33 155.24 coo 19.17 11.01 76.14 17.26 10.42 76.77 204.37 195.46 163.61 205.75 194.30 164.79 coo 11.10 2.31 76.60 10.24 7.24 75.62 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 18 3 # 18 B 145 TYR I 109 TYR~? 11.79 O1 GOL I3032 B 230 ASP I 102 ASP.? 20.44 O1 GOL I3032 B 273 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 11.81 13.41 73.03 10.00 13.03 75.12 197.73 197.22 153.29 196.64 194.65 153.36 coo 19.17 11.01 76.14 17.26 10.42 76.77 201.10 198.54 145.88 200.66 198.62 143.82 coo 11.10 2.31 76.60 10.24 7.24 75.62 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 19 3 # 19 B 145 TYR J 75 TYR~? 10.17 CL CL J2016 B 230 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 273 LYS J 142 LYS~? 19.62 CL CL J2016 coo 11.81 13.41 73.03 10.00 13.03 75.12 131.82 180.89 131.78 131.82 183.34 133.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 137.44 174.60 137.57 135.80 173.80 138.69 coo 11.10 2.31 76.60 10.24 7.24 75.62 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 20 3 # 20 B 145 TYR J 109 TYR~? 19.91 O1 GOL J3030 B 230 ASP J 102 ASP.? 24.08 CL CL J2016 B 273 LYS J 142 LYS~? 19.62 CL CL J2016 coo 11.81 13.41 73.03 10.00 13.03 75.12 145.48 183.77 135.57 146.27 183.96 138.21 coo 19.17 11.01 76.14 17.26 10.42 76.77 143.25 191.36 132.98 143.80 193.32 132.63 coo 11.10 2.31 76.60 10.24 7.24 75.62 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 21 3 # 21 B 145 TYR K 75 TYR~? 12.36 CL CL K2027 B 230 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 11.81 13.41 73.03 10.00 13.03 75.12 205.79 133.16 185.06 205.81 134.80 187.34 coo 19.17 11.01 76.14 17.26 10.42 76.77 200.17 138.24 178.11 201.77 139.28 177.19 coo 11.10 2.31 76.60 10.24 7.24 75.62 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 22 3 # 22 B 145 TYR K 109 TYR~? 18.63 O3 GOL K3010 B 230 ASP K 102 ASP.? 24.81 O1 GOL K3041 B 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 11.81 13.41 73.03 10.00 13.03 75.12 192.13 137.45 187.51 191.27 140.11 187.32 coo 19.17 11.01 76.14 17.26 10.42 76.77 194.36 135.90 195.25 193.66 135.95 197.23 coo 11.10 2.31 76.60 10.24 7.24 75.62 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 23 3 # 23 B 145 TYR L 75 TYR~? 10.07 CL CL L2009 B 230 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 11.81 13.41 73.03 10.00 13.03 75.12 126.23 161.73 201.55 126.10 159.32 200.24 coo 19.17 11.01 76.14 17.26 10.42 76.77 133.34 166.97 196.27 132.03 168.03 194.96 coo 11.10 2.31 76.60 10.24 7.24 75.62 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 24 3 # 24 B 145 TYR L 109 TYR~? 18.94 O3 GOL L3028 B 230 ASP L 102 ASP.? 24.59 CL CL L2009 B 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 11.81 13.41 73.03 10.00 13.03 75.12 139.89 156.88 199.30 141.02 156.55 196.75 coo 19.17 11.01 76.14 17.26 10.42 76.77 136.52 149.82 201.33 136.95 147.73 201.53 coo 11.10 2.31 76.60 10.24 7.24 75.62 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 25 3 # 25 B 145 TYR M 75 TYR~? 10.36 CL CL M2017 B 230 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 11.81 13.41 73.03 10.00 13.03 75.12 130.62 206.12 176.17 130.27 204.76 178.58 coo 19.17 11.01 76.14 17.26 10.42 76.77 136.87 200.18 170.79 135.36 199.08 169.77 coo 11.10 2.31 76.60 10.24 7.24 75.62 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 26 3 # 26 B 145 TYR M 109 TYR~? 20.13 O1 GOL M3043 B 230 ASP M 102 ASP.? 24.52 CL CL M2017 B 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 11.81 13.41 73.03 10.00 13.03 75.12 143.85 202.19 180.75 144.68 199.53 181.04 coo 19.17 11.01 76.14 17.26 10.42 76.77 140.74 204.70 188.01 141.33 204.99 189.98 coo 11.10 2.31 76.60 10.24 7.24 75.62 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 27 3 # 27 B 145 TYR N 75 TYR~? 12.44 O2 GOL N3029 B 230 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 11.81 13.41 73.03 10.00 13.03 75.12 209.71 152.64 137.80 209.50 150.35 139.41 coo 19.17 11.01 76.14 17.26 10.42 76.77 203.51 159.51 142.26 205.02 160.53 143.48 coo 11.10 2.31 76.60 10.24 7.24 75.62 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 28 3 # 28 B 145 TYR N 109 TYR~? 12.25 C2 GOL N3029 B 230 ASP N 102 ASP.? 20.60 O2 GOL N3029 B 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 11.81 13.41 73.03 10.00 13.03 75.12 195.52 150.33 140.44 194.35 150.45 143.01 coo 19.17 11.01 76.14 17.26 10.42 76.77 197.96 142.41 139.19 197.06 140.46 139.09 coo 11.10 2.31 76.60 10.24 7.24 75.62 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 29 3 # 29 B 145 TYR O 75 TYR~? 10.24 CL CL O2018 B 230 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 11.81 13.41 73.03 10.00 13.03 75.12 127.87 136.17 156.70 127.95 137.50 154.23 coo 19.17 11.01 76.14 17.26 10.42 76.77 134.07 141.35 162.95 132.57 142.58 163.78 coo 11.10 2.31 76.60 10.24 7.24 75.62 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 30 3 # 30 B 145 TYR O 109 TYR~? 12.46 CL CL O2036 B 230 ASP O 102 ASP.? 13.16 CL CL O2036 B 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 11.81 13.41 73.03 10.00 13.03 75.12 141.96 138.45 153.78 143.09 141.01 153.60 coo 19.17 11.01 76.14 17.26 10.42 76.77 139.48 136.33 146.19 140.25 135.96 144.25 coo 11.10 2.31 76.60 10.24 7.24 75.62 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 31 3 # 31 B 145 TYR P 75 TYR~? 10.23 CL CL P2019 B 230 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 273 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 11.81 13.41 73.03 10.00 13.03 75.12 207.22 180.36 204.70 207.43 182.65 203.13 coo 19.17 11.01 76.14 17.26 10.42 76.77 200.75 174.15 199.66 202.28 173.10 198.62 coo 11.10 2.31 76.60 10.24 7.24 75.62 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 32 3 # 32 B 145 TYR P 109 TYR~? 18.49 O3 GOL P3014 B 230 ASP P 102 ASP.? 24.26 CL CL P2019 B 273 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 11.81 13.41 73.03 10.00 13.03 75.12 193.88 184.51 200.52 193.11 184.53 197.85 coo 19.17 11.01 76.14 17.26 10.42 76.77 197.01 191.93 202.05 196.73 194.01 202.05 coo 11.10 2.31 76.60 10.24 7.24 75.62 204.59 186.28 195.60 209.96 186.96 196.62 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 32 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 98 PHE.? 12.32 O1 GOL A3040 A 159 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 188 LYS A 142 LYS~? 20.36 CL CL A2020 coo 13.91 34.58 14.67 12.95 36.00 12.47 94.73 84.25 40.94 92.04 83.71 40.47 coo 20.97 28.40 16.26 20.19 30.15 15.34 90.44 78.16 48.76 91.65 76.94 50.06 coo 22.55 41.65 15.60 18.92 37.20 14.63 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 98 PHE.? 11.15 CL CL B2010 A 159 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 188 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 13.91 34.58 14.67 12.95 36.00 12.47 22.68 65.92 11.87 25.22 66.01 13.02 coo 20.97 28.40 16.26 20.19 30.15 15.34 23.66 59.02 20.34 21.93 58.32 21.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE C 98 PHE.? 11.39 CL CL C2011 A 159 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 188 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 13.91 34.58 14.67 12.95 36.00 12.47 83.86 15.19 74.07 81.38 16.44 74.03 coo 20.97 28.40 16.26 20.19 30.15 15.34 82.81 22.02 65.69 84.52 22.80 64.66 coo 22.55 41.65 15.60 18.92 37.20 14.63 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE D 98 PHE.? 11.07 CL CL D2012 A 159 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 188 LYS D 142 LYS~? 18.65 CL CL D2012 coo 13.91 34.58 14.67 12.95 36.00 12.47 12.59 48.19 86.72 15.29 47.64 86.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 16.94 54.59 79.01 15.65 55.42 77.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE E 98 PHE.? 11.20 CL CL E2013 A 159 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 188 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 13.91 34.58 14.67 12.95 36.00 12.47 20.72 94.66 58.85 23.24 93.53 59.37 coo 20.97 28.40 16.26 20.19 30.15 15.34 23.07 86.29 52.35 21.57 85.17 51.32 coo 22.55 41.65 15.60 18.92 37.20 14.63 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE F 98 PHE.? 11.09 CL CL F2034 A 159 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 188 LYS F 142 LYS~? 19.20 CL CL F2034 coo 13.91 34.58 14.67 12.95 36.00 12.47 91.41 32.84 22.80 88.70 32.93 23.40 coo 20.97 28.40 16.26 20.19 30.15 15.34 88.86 41.25 28.96 90.30 42.22 30.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE G 98 PHE.? 12.40 C3 GOL G3038 A 159 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 188 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 13.91 34.58 14.67 12.95 36.00 12.47 15.02 19.56 40.09 17.78 20.04 40.01 coo 20.97 28.40 16.26 20.19 30.15 15.34 17.70 27.34 47.09 16.19 28.71 47.73 coo 22.55 41.65 15.60 18.92 37.20 14.63 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE H 98 PHE.? 11.23 CL CL H2014 A 159 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 188 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 13.91 34.58 14.67 12.95 36.00 12.47 86.83 66.96 92.26 84.37 67.28 91.08 coo 20.97 28.40 16.26 20.19 30.15 15.34 84.24 58.93 85.48 85.73 57.59 84.66 coo 22.55 41.65 15.60 18.92 37.20 14.63 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE I 98 PHE.? 11.14 CL CL I2015 A 159 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 188 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 13.91 34.58 14.67 12.95 36.00 12.47 207.94 202.24 155.85 205.25 201.61 155.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 204.37 195.46 163.61 205.75 194.30 164.79 coo 22.55 41.65 15.60 18.92 37.20 14.63 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE J 98 PHE.? 11.05 CL CL J2016 A 159 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 188 LYS J 142 LYS~? 19.62 CL CL J2016 coo 13.91 34.58 14.67 12.95 36.00 12.47 135.63 181.85 129.67 138.24 181.95 130.69 coo 20.97 28.40 16.26 20.19 30.15 15.34 137.44 174.60 137.57 135.80 173.80 138.69 coo 22.55 41.65 15.60 18.92 37.20 14.63 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE K 98 PHE.? 11.99 O1 GOL K3041 A 159 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 188 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 13.91 34.58 14.67 12.95 36.00 12.47 201.94 131.33 186.30 199.31 132.28 186.27 coo 20.97 28.40 16.26 20.19 30.15 15.34 200.17 138.24 178.11 201.77 139.28 177.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE L 98 PHE.? 11.24 CL CL L2009 A 159 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 188 LYS L 142 LYS~? 23.18 CL CL L2009 coo 13.91 34.58 14.67 12.95 36.00 12.47 129.72 160.22 203.93 132.34 159.70 203.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 133.34 166.97 196.27 132.03 168.03 194.96 coo 22.55 41.65 15.60 18.92 37.20 14.63 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE M 98 PHE.? 11.28 CL CL M2017 A 159 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 188 LYS M 142 LYS~? 19.90 CL CL M2017 coo 13.91 34.58 14.67 12.95 36.00 12.47 134.29 208.09 177.60 136.84 206.99 178.00 coo 20.97 28.40 16.26 20.19 30.15 15.34 136.87 200.18 170.79 135.36 199.08 169.77 coo 22.55 41.65 15.60 18.92 37.20 14.63 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE N 98 PHE.? 12.51 O2 GOL N3029 A 159 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 188 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 13.91 34.58 14.67 12.95 36.00 12.47 205.99 151.41 135.45 203.31 151.41 136.18 coo 20.97 28.40 16.26 20.19 30.15 15.34 203.51 159.51 142.26 205.02 160.53 143.48 coo 22.55 41.65 15.60 18.92 37.20 14.63 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE O 98 PHE.? 11.35 CL CL O2018 A 159 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 188 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 13.91 34.58 14.67 12.95 36.00 12.47 131.45 133.74 155.71 134.18 134.46 155.64 coo 20.97 28.40 16.26 20.19 30.15 15.34 134.07 141.35 162.95 132.57 142.58 163.78 coo 22.55 41.65 15.60 18.92 37.20 14.63 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE P 98 PHE.? 11.01 CL CL P2019 A 159 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 188 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 13.91 34.58 14.67 12.95 36.00 12.47 203.50 182.03 206.67 200.90 182.30 205.78 coo 20.97 28.40 16.26 20.19 30.15 15.34 200.75 174.15 199.66 202.28 173.10 198.62 coo 22.55 41.65 15.60 18.92 37.20 14.63 204.59 186.28 195.60 209.96 186.96 196.62 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 16 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 A 141 THR A 64 THR~? 18.85 O1 GOL A3040 A 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo 6.21 93.81 36.58 4.58 96.33 37.17 77.54 80.61 37.36 78.31 77.83 38.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 82.36 77.26 44.89 81.47 76.71 42.95 coo 12.98 90.36 47.57 11.26 89.62 46.62 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 A 141 THR A 105 THR.? 26.87 O1 GOL A3040 A 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo 6.21 93.81 36.58 4.58 96.33 37.17 77.54 80.61 37.36 78.31 77.83 38.52 coo 6.80 92.87 28.33 4.91 92.74 27.40 83.67 79.06 29.76 85.17 77.94 28.71 coo 12.98 90.36 47.57 11.26 89.62 46.62 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 A 141 THR B 64 THR~? 8.71 O1 GOL B3024 A 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo 6.21 93.81 36.58 4.58 96.33 37.17 39.05 68.00 18.82 37.75 66.74 21.38 coo 6.80 92.87 28.33 4.91 92.74 27.40 32.17 61.57 22.45 33.36 63.36 22.67 coo 12.98 90.36 47.57 11.26 89.62 46.62 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 A 141 THR B 105 THR.? 19.41 O1 GOL B3024 A 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo 6.21 93.81 36.58 4.58 96.33 37.17 39.05 68.00 18.82 37.75 66.74 21.38 coo 6.80 92.87 28.33 4.91 92.74 27.40 34.49 75.75 17.47 33.13 77.30 18.07 coo 12.98 90.36 47.57 11.26 89.62 46.62 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 A 141 THR C 64 THR~? 15.20 O3 GOL C3021 A 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo 6.21 93.81 36.58 4.58 96.33 37.17 67.42 22.77 74.41 69.21 25.29 74.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 74.38 24.70 67.82 73.20 25.34 69.51 coo 12.98 90.36 47.57 11.26 89.62 46.62 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 A 141 THR C 105 THR.? 24.85 O2 GOL H3025 A 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo 6.21 93.81 36.58 4.58 96.33 37.17 67.42 22.77 74.41 69.21 25.29 74.04 coo 6.80 92.87 28.33 4.91 92.74 27.40 71.93 23.03 82.69 73.30 24.19 83.92 coo 12.98 90.36 47.57 11.26 89.62 46.62 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 A 141 THR D 64 THR~? 14.39 O3 GOL D3019 A 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo 6.21 93.81 36.58 4.58 96.33 37.17 29.84 43.62 83.53 28.05 43.26 81.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 25.01 50.48 78.85 25.86 48.54 78.75 coo 12.98 90.36 47.57 11.26 89.62 46.62 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 A 141 THR D 105 THR.? 26.78 CL CL D2012 A 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo 6.21 93.81 36.58 4.58 96.33 37.17 29.84 43.62 83.53 28.05 43.26 81.00 coo 6.80 92.87 28.33 4.91 92.74 27.40 23.59 36.21 83.60 22.17 35.02 82.50 coo 12.98 90.36 47.57 11.26 89.62 46.62 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 A 141 THR E 64 THR~? 14.21 O1 GOL E3035 A 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo 6.21 93.81 36.58 4.58 96.33 37.17 36.12 87.73 64.17 35.30 85.24 62.51 coo 6.80 92.87 28.33 4.91 92.74 27.40 30.87 84.28 56.42 31.61 84.06 58.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 A 141 THR E 105 THR.? 24.42 O1 GOL D3019 A 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo 6.21 93.81 36.58 4.58 96.33 37.17 36.12 87.73 64.17 35.30 85.24 62.51 coo 6.80 92.87 28.33 4.91 92.74 27.40 30.57 89.23 70.86 28.85 88.51 71.92 coo 12.98 90.36 47.57 11.26 89.62 46.62 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG F 108 ARG~? -3.40 CL CL F2035s A 141 THR F 64 THR~? -3.74 CL CL F2035s A 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo 6.21 93.81 36.58 4.58 96.33 37.17 74.01 31.91 26.65 74.85 33.96 28.84 coo 6.80 92.87 28.33 4.91 92.74 27.40 80.10 39.29 29.74 78.76 37.65 30.15 coo 12.98 90.36 47.57 11.26 89.62 46.62 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG F 108 ARG~? -3.40 CL CL F2035s A 141 THR F 105 THR.? 14.75 CL CL F2035 A 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo 6.21 93.81 36.58 4.58 96.33 37.17 74.01 31.91 26.65 74.85 33.96 28.84 coo 6.80 92.87 28.33 4.91 92.74 27.40 78.18 24.30 27.70 79.35 23.01 28.98 coo 12.98 90.36 47.57 11.26 89.62 46.62 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 A 141 THR G 64 THR~? 16.57 O2 GOL G3001 A 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo 6.21 93.81 36.58 4.58 96.33 37.17 32.32 22.84 38.36 31.62 25.53 39.73 coo 6.80 92.87 28.33 4.91 92.74 27.40 26.50 27.63 44.88 27.71 27.61 43.08 coo 12.98 90.36 47.57 11.26 89.62 46.62 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 A 141 THR G 105 THR.? 24.65 O1 GOL B3017 A 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo 6.21 93.81 36.58 4.58 96.33 37.17 32.32 22.84 38.36 31.62 25.53 39.73 coo 6.80 92.87 28.33 4.91 92.74 27.40 28.24 22.56 30.52 26.99 23.47 29.06 coo 12.98 90.36 47.57 11.26 89.62 46.62 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 A 141 THR H 64 THR~? 8.97 O2 GOL H3016 A 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo 6.21 93.81 36.58 4.58 96.33 37.17 71.22 70.92 84.57 72.18 68.95 82.36 coo 6.80 92.87 28.33 4.91 92.74 27.40 76.53 62.70 82.65 75.84 64.64 82.09 coo 12.98 90.36 47.57 11.26 89.62 46.62 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 A 141 THR H 105 THR.? 19.76 O2 GOL H3016 A 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo 6.21 93.81 36.58 4.58 96.33 37.17 71.22 70.92 84.57 72.18 68.95 82.36 coo 6.80 92.87 28.33 4.91 92.74 27.40 77.10 77.81 84.44 78.78 78.74 83.52 coo 12.98 90.36 47.57 11.26 89.62 46.62 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 A 141 THR I 64 THR~? 8.93 O1 GOL I3032 A 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo 6.21 93.81 36.58 4.58 96.33 37.17 191.22 197.47 152.14 191.76 195.04 153.98 coo 6.80 92.87 28.33 4.91 92.74 27.40 196.10 194.26 160.17 195.16 193.85 158.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 A 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 A 141 THR I 105 THR.? 19.75 O1 GOL I3032 A 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo 6.21 93.81 36.58 4.58 96.33 37.17 191.22 197.47 152.14 191.76 195.04 153.98 coo 6.80 92.87 28.33 4.91 92.74 27.40 196.67 196.85 145.06 198.08 195.68 144.00 coo 12.98 90.36 47.57 11.26 89.62 46.62 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 A 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 A 141 THR J 64 THR~? 19.68 O1 GOL J3030 A 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo 6.21 93.81 36.58 4.58 96.33 37.17 152.38 184.27 135.62 151.05 183.00 138.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 145.87 177.29 139.35 146.97 179.14 139.64 coo 12.98 90.36 47.57 11.26 89.62 46.62 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 A 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 A 141 THR J 105 THR.? 26.65 CL CL J2016 A 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo 6.21 93.81 36.58 4.58 96.33 37.17 152.38 184.27 135.62 151.05 183.00 138.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 147.52 191.90 135.01 146.15 193.36 135.77 coo 12.98 90.36 47.57 11.26 89.62 46.62 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 A 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 A 141 THR K 64 THR~? 14.85 O3 GOL K3010 A 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo 6.21 93.81 36.58 4.58 96.33 37.17 185.36 137.67 187.99 186.54 140.01 186.30 coo 6.80 92.87 28.33 4.91 92.74 27.40 191.77 140.44 180.59 190.64 140.95 182.34 coo 12.98 90.36 47.57 11.26 89.62 46.62 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 A 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 A 141 THR K 105 THR.? 26.54 O3 GOL K3011 A 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo 6.21 93.81 36.58 4.58 96.33 37.17 185.36 137.67 187.99 186.54 140.01 186.30 coo 6.80 92.87 28.33 4.91 92.74 27.40 189.99 137.92 195.49 191.30 139.02 196.78 coo 12.98 90.36 47.57 11.26 89.62 46.62 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 A 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 A 141 THR L 64 THR~? 14.87 O3 GOL L3028 A 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo 6.21 93.81 36.58 4.58 96.33 37.17 146.49 155.54 199.73 145.94 157.11 197.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 141.60 163.20 195.47 142.44 161.21 195.27 coo 12.98 90.36 47.57 11.26 89.62 46.62 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 A 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 A 141 THR L 105 THR.? 27.05 O1 GOL L3027 A 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo 6.21 93.81 36.58 4.58 96.33 37.17 146.49 155.54 199.73 145.94 157.11 197.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 141.08 148.74 199.62 139.85 147.56 198.24 coo 12.98 90.36 47.57 11.26 89.62 46.62 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 A 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 A 141 THR M 64 THR~? 19.60 O1 GOL M3043 A 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo 6.21 93.81 36.58 4.58 96.33 37.17 150.62 202.12 182.01 149.56 199.68 180.53 coo 6.80 92.87 28.33 4.91 92.74 27.40 144.87 198.36 174.46 145.82 198.07 176.32 coo 12.98 90.36 47.57 11.26 89.62 46.62 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 A 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 A 141 THR M 105 THR.? 24.57 C1 GOL L3028 A 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo 6.21 93.81 36.58 4.58 96.33 37.17 150.62 202.12 182.01 149.56 199.68 180.53 coo 6.80 92.87 28.33 4.91 92.74 27.40 145.11 202.54 189.01 143.57 201.62 190.19 coo 12.98 90.36 47.57 11.26 89.62 46.62 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 A 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 A 141 THR N 64 THR~? 9.33 C2 GOL N3029 A 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo 6.21 93.81 36.58 4.58 96.33 37.17 189.02 149.68 140.15 189.67 151.62 142.49 coo 6.80 92.87 28.33 4.91 92.74 27.40 194.93 157.15 143.34 193.70 155.46 143.76 coo 12.98 90.36 47.57 11.26 89.62 46.62 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 A 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 A 141 THR N 105 THR.? 20.04 C1 GOL N3029 A 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo 6.21 93.81 36.58 4.58 96.33 37.17 189.02 149.68 140.15 189.67 151.62 142.49 coo 6.80 92.87 28.33 4.91 92.74 27.40 193.42 142.19 140.79 194.84 140.97 141.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 A 137 ARG O 108 ARG~? 13.39 CL CL O2036 A 141 THR O 64 THR~? 9.90 C1 GOL O3026 A 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo 6.21 93.81 36.58 4.58 96.33 37.17 148.81 138.28 154.16 147.06 140.78 153.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 142.64 142.13 160.20 143.87 142.30 158.45 coo 12.98 90.36 47.57 11.26 89.62 46.62 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 A 137 ARG O 108 ARG~? 13.39 CL CL O2036 A 141 THR O 105 THR.? 14.69 CL CL O2036 A 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo 6.21 93.81 36.58 4.58 96.33 37.17 148.81 138.28 154.16 147.06 140.78 153.42 coo 6.80 92.87 28.33 4.91 92.74 27.40 144.01 137.98 145.72 142.72 139.07 144.35 coo 12.98 90.36 47.57 11.26 89.62 46.62 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 A 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 A 141 THR P 64 THR~? 15.75 O3 GOL P3014 A 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo 6.21 93.81 36.58 4.58 96.33 37.17 187.53 185.71 199.97 188.17 183.79 197.64 coo 6.80 92.87 28.33 4.91 92.74 27.40 192.75 177.71 197.46 191.86 179.57 196.92 coo 12.98 90.36 47.57 11.26 89.62 46.62 172.77 185.90 199.12 171.10 184.95 198.29 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 A 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 A 141 THR P 105 THR.? 26.53 O3 GOL P3014 A 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo 6.21 93.81 36.58 4.58 96.33 37.17 187.53 185.71 199.97 188.17 183.79 197.64 coo 6.80 92.87 28.33 4.91 92.74 27.40 192.76 192.82 199.88 194.36 193.92 198.88 coo 12.98 90.36 47.57 11.26 89.62 46.62 172.77 185.90 199.12 171.10 184.95 198.29 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 32 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 D 141 THR A 64 THR~? 18.85 O1 GOL A3040 D 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 77.54 80.61 37.36 78.31 77.83 38.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 82.36 77.26 44.89 81.47 76.71 42.95 coo -14.64 87.74 89.51 -12.89 87.43 90.65 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 D 141 THR A 105 THR.? 26.87 O1 GOL A3040 D 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 77.54 80.61 37.36 78.31 77.83 38.52 coo -9.24 93.49 108.77 -7.37 94.21 109.61 83.67 79.06 29.76 85.17 77.94 28.71 coo -14.64 87.74 89.51 -12.89 87.43 90.65 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 D 141 THR B 64 THR~? 8.71 O1 GOL B3024 D 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 39.05 68.00 18.82 37.75 66.74 21.38 coo -9.24 93.49 108.77 -7.37 94.21 109.61 32.17 61.57 22.45 33.36 63.36 22.67 coo -14.64 87.74 89.51 -12.89 87.43 90.65 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 D 141 THR B 105 THR.? 19.41 O1 GOL B3024 D 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 39.05 68.00 18.82 37.75 66.74 21.38 coo -9.24 93.49 108.77 -7.37 94.21 109.61 34.49 75.75 17.47 33.13 77.30 18.07 coo -14.64 87.74 89.51 -12.89 87.43 90.65 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 D 141 THR C 64 THR~? 15.20 O3 GOL C3021 D 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 67.42 22.77 74.41 69.21 25.29 74.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 74.38 24.70 67.82 73.20 25.34 69.51 coo -14.64 87.74 89.51 -12.89 87.43 90.65 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 D 141 THR C 105 THR.? 24.85 O2 GOL H3025 D 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 67.42 22.77 74.41 69.21 25.29 74.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 71.93 23.03 82.69 73.30 24.19 83.92 coo -14.64 87.74 89.51 -12.89 87.43 90.65 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 D 141 THR D 64 THR~? 14.39 O3 GOL D3019 D 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo -8.33 92.80 100.06 -7.71 95.33 98.44 29.84 43.62 83.53 28.05 43.26 81.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 25.01 50.48 78.85 25.86 48.54 78.75 coo -14.64 87.74 89.51 -12.89 87.43 90.65 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 D 141 THR D 105 THR.? 26.78 CL CL D2012 D 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo -8.33 92.80 100.06 -7.71 95.33 98.44 29.84 43.62 83.53 28.05 43.26 81.00 coo -9.24 93.49 108.77 -7.37 94.21 109.61 23.59 36.21 83.60 22.17 35.02 82.50 coo -14.64 87.74 89.51 -12.89 87.43 90.65 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 D 141 THR E 64 THR~? 14.21 O1 GOL E3035 D 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo -8.33 92.80 100.06 -7.71 95.33 98.44 36.12 87.73 64.17 35.30 85.24 62.51 coo -9.24 93.49 108.77 -7.37 94.21 109.61 30.87 84.28 56.42 31.61 84.06 58.39 coo -14.64 87.74 89.51 -12.89 87.43 90.65 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 D 141 THR E 105 THR.? 24.42 O1 GOL D3019 D 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo -8.33 92.80 100.06 -7.71 95.33 98.44 36.12 87.73 64.17 35.30 85.24 62.51 coo -9.24 93.49 108.77 -7.37 94.21 109.61 30.57 89.23 70.86 28.85 88.51 71.92 coo -14.64 87.74 89.51 -12.89 87.43 90.65 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG F 108 ARG~? -3.40 CL CL F2035s D 141 THR F 64 THR~? -3.74 CL CL F2035s D 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo -8.33 92.80 100.06 -7.71 95.33 98.44 74.01 31.91 26.65 74.85 33.96 28.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 80.10 39.29 29.74 78.76 37.65 30.15 coo -14.64 87.74 89.51 -12.89 87.43 90.65 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG F 108 ARG~? -3.40 CL CL F2035s D 141 THR F 105 THR.? 14.75 CL CL F2035 D 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo -8.33 92.80 100.06 -7.71 95.33 98.44 74.01 31.91 26.65 74.85 33.96 28.84 coo -9.24 93.49 108.77 -7.37 94.21 109.61 78.18 24.30 27.70 79.35 23.01 28.98 coo -14.64 87.74 89.51 -12.89 87.43 90.65 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 D 141 THR G 64 THR~? 16.57 O2 GOL G3001 D 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 32.32 22.84 38.36 31.62 25.53 39.73 coo -9.24 93.49 108.77 -7.37 94.21 109.61 26.50 27.63 44.88 27.71 27.61 43.08 coo -14.64 87.74 89.51 -12.89 87.43 90.65 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 D 141 THR G 105 THR.? 24.65 O1 GOL B3017 D 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 32.32 22.84 38.36 31.62 25.53 39.73 coo -9.24 93.49 108.77 -7.37 94.21 109.61 28.24 22.56 30.52 26.99 23.47 29.06 coo -14.64 87.74 89.51 -12.89 87.43 90.65 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 D 141 THR H 64 THR~? 8.97 O2 GOL H3016 D 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 71.22 70.92 84.57 72.18 68.95 82.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 76.53 62.70 82.65 75.84 64.64 82.09 coo -14.64 87.74 89.51 -12.89 87.43 90.65 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 D 141 THR H 105 THR.? 19.76 O2 GOL H3016 D 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo -8.33 92.80 100.06 -7.71 95.33 98.44 71.22 70.92 84.57 72.18 68.95 82.36 coo -9.24 93.49 108.77 -7.37 94.21 109.61 77.10 77.81 84.44 78.78 78.74 83.52 coo -14.64 87.74 89.51 -12.89 87.43 90.65 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 D 141 THR I 64 THR~? 8.93 O1 GOL I3032 D 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 191.22 197.47 152.14 191.76 195.04 153.98 coo -9.24 93.49 108.77 -7.37 94.21 109.61 196.10 194.26 160.17 195.16 193.85 158.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 D 141 THR I 105 THR.? 19.75 O1 GOL I3032 D 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 191.22 197.47 152.14 191.76 195.04 153.98 coo -9.24 93.49 108.77 -7.37 94.21 109.61 196.67 196.85 145.06 198.08 195.68 144.00 coo -14.64 87.74 89.51 -12.89 87.43 90.65 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 D 141 THR J 64 THR~? 19.68 O1 GOL J3030 D 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo -8.33 92.80 100.06 -7.71 95.33 98.44 152.38 184.27 135.62 151.05 183.00 138.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 145.87 177.29 139.35 146.97 179.14 139.64 coo -14.64 87.74 89.51 -12.89 87.43 90.65 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 D 141 THR J 105 THR.? 26.65 CL CL J2016 D 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo -8.33 92.80 100.06 -7.71 95.33 98.44 152.38 184.27 135.62 151.05 183.00 138.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 147.52 191.90 135.01 146.15 193.36 135.77 coo -14.64 87.74 89.51 -12.89 87.43 90.65 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 D 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 D 141 THR K 64 THR~? 14.85 O3 GOL K3010 D 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo -8.33 92.80 100.06 -7.71 95.33 98.44 185.36 137.67 187.99 186.54 140.01 186.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 191.77 140.44 180.59 190.64 140.95 182.34 coo -14.64 87.74 89.51 -12.89 87.43 90.65 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 D 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 D 141 THR K 105 THR.? 26.54 O3 GOL K3011 D 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo -8.33 92.80 100.06 -7.71 95.33 98.44 185.36 137.67 187.99 186.54 140.01 186.30 coo -9.24 93.49 108.77 -7.37 94.21 109.61 189.99 137.92 195.49 191.30 139.02 196.78 coo -14.64 87.74 89.51 -12.89 87.43 90.65 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 D 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 D 141 THR L 64 THR~? 14.87 O3 GOL L3028 D 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo -8.33 92.80 100.06 -7.71 95.33 98.44 146.49 155.54 199.73 145.94 157.11 197.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 141.60 163.20 195.47 142.44 161.21 195.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 D 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 D 141 THR L 105 THR.? 27.05 O1 GOL L3027 D 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo -8.33 92.80 100.06 -7.71 95.33 98.44 146.49 155.54 199.73 145.94 157.11 197.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 141.08 148.74 199.62 139.85 147.56 198.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 D 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 D 141 THR M 64 THR~? 19.60 O1 GOL M3043 D 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 150.62 202.12 182.01 149.56 199.68 180.53 coo -9.24 93.49 108.77 -7.37 94.21 109.61 144.87 198.36 174.46 145.82 198.07 176.32 coo -14.64 87.74 89.51 -12.89 87.43 90.65 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 D 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 D 141 THR M 105 THR.? 24.57 C1 GOL L3028 D 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 150.62 202.12 182.01 149.56 199.68 180.53 coo -9.24 93.49 108.77 -7.37 94.21 109.61 145.11 202.54 189.01 143.57 201.62 190.19 coo -14.64 87.74 89.51 -12.89 87.43 90.65 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 D 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 D 141 THR N 64 THR~? 9.33 C2 GOL N3029 D 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo -8.33 92.80 100.06 -7.71 95.33 98.44 189.02 149.68 140.15 189.67 151.62 142.49 coo -9.24 93.49 108.77 -7.37 94.21 109.61 194.93 157.15 143.34 193.70 155.46 143.76 coo -14.64 87.74 89.51 -12.89 87.43 90.65 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 D 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 D 141 THR N 105 THR.? 20.04 C1 GOL N3029 D 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo -8.33 92.80 100.06 -7.71 95.33 98.44 189.02 149.68 140.15 189.67 151.62 142.49 coo -9.24 93.49 108.77 -7.37 94.21 109.61 193.42 142.19 140.79 194.84 140.97 141.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 D 137 ARG O 108 ARG~? 13.39 CL CL O2036 D 141 THR O 64 THR~? 9.90 C1 GOL O3026 D 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 148.81 138.28 154.16 147.06 140.78 153.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 142.64 142.13 160.20 143.87 142.30 158.45 coo -14.64 87.74 89.51 -12.89 87.43 90.65 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 D 137 ARG O 108 ARG~? 13.39 CL CL O2036 D 141 THR O 105 THR.? 14.69 CL CL O2036 D 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo -8.33 92.80 100.06 -7.71 95.33 98.44 148.81 138.28 154.16 147.06 140.78 153.42 coo -9.24 93.49 108.77 -7.37 94.21 109.61 144.01 137.98 145.72 142.72 139.07 144.35 coo -14.64 87.74 89.51 -12.89 87.43 90.65 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 D 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 D 141 THR P 64 THR~? 15.75 O3 GOL P3014 D 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 187.53 185.71 199.97 188.17 183.79 197.64 coo -9.24 93.49 108.77 -7.37 94.21 109.61 192.75 177.71 197.46 191.86 179.57 196.92 coo -14.64 87.74 89.51 -12.89 87.43 90.65 172.77 185.90 199.12 171.10 184.95 198.29 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 D 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 D 141 THR P 105 THR.? 26.53 O3 GOL P3014 D 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo -8.33 92.80 100.06 -7.71 95.33 98.44 187.53 185.71 199.97 188.17 183.79 197.64 coo -9.24 93.49 108.77 -7.37 94.21 109.61 192.76 192.82 199.88 194.36 193.92 198.88 coo -14.64 87.74 89.51 -12.89 87.43 90.65 172.77 185.90 199.12 171.10 184.95 198.29 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 32 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 C 141 THR A 64 THR~? 18.85 O1 GOL A3040 C 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 77.54 80.61 37.36 78.31 77.83 38.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 82.36 77.26 44.89 81.47 76.71 42.95 coo -13.01 70.96 47.58 -11.44 71.65 46.34 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 C 141 THR A 105 THR.? 26.87 O1 GOL A3040 C 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 77.54 80.61 37.36 78.31 77.83 38.52 coo -6.81 68.31 28.28 -4.82 68.47 27.57 83.67 79.06 29.76 85.17 77.94 28.71 coo -13.01 70.96 47.58 -11.44 71.65 46.34 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 C 141 THR B 64 THR~? 8.71 O1 GOL B3024 C 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 39.05 68.00 18.82 37.75 66.74 21.38 coo -6.81 68.31 28.28 -4.82 68.47 27.57 32.17 61.57 22.45 33.36 63.36 22.67 coo -13.01 70.96 47.58 -11.44 71.65 46.34 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 C 141 THR B 105 THR.? 19.41 O1 GOL B3024 C 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 39.05 68.00 18.82 37.75 66.74 21.38 coo -6.81 68.31 28.28 -4.82 68.47 27.57 34.49 75.75 17.47 33.13 77.30 18.07 coo -13.01 70.96 47.58 -11.44 71.65 46.34 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 C 141 THR C 64 THR~? 15.20 O3 GOL C3021 C 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 67.42 22.77 74.41 69.21 25.29 74.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 74.38 24.70 67.82 73.20 25.34 69.51 coo -13.01 70.96 47.58 -11.44 71.65 46.34 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 C 141 THR C 105 THR.? 24.85 O2 GOL H3025 C 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 67.42 22.77 74.41 69.21 25.29 74.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 71.93 23.03 82.69 73.30 24.19 83.92 coo -13.01 70.96 47.58 -11.44 71.65 46.34 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 C 141 THR D 64 THR~? 14.39 O3 GOL D3019 C 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo -5.79 67.26 36.83 -4.57 64.58 37.74 29.84 43.62 83.53 28.05 43.26 81.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 25.01 50.48 78.85 25.86 48.54 78.75 coo -13.01 70.96 47.58 -11.44 71.65 46.34 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 C 141 THR D 105 THR.? 26.78 CL CL D2012 C 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo -5.79 67.26 36.83 -4.57 64.58 37.74 29.84 43.62 83.53 28.05 43.26 81.00 coo -6.81 68.31 28.28 -4.82 68.47 27.57 23.59 36.21 83.60 22.17 35.02 82.50 coo -13.01 70.96 47.58 -11.44 71.65 46.34 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 C 141 THR E 64 THR~? 14.21 O1 GOL E3035 C 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo -5.79 67.26 36.83 -4.57 64.58 37.74 36.12 87.73 64.17 35.30 85.24 62.51 coo -6.81 68.31 28.28 -4.82 68.47 27.57 30.87 84.28 56.42 31.61 84.06 58.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 C 141 THR E 105 THR.? 24.42 O1 GOL D3019 C 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo -5.79 67.26 36.83 -4.57 64.58 37.74 36.12 87.73 64.17 35.30 85.24 62.51 coo -6.81 68.31 28.28 -4.82 68.47 27.57 30.57 89.23 70.86 28.85 88.51 71.92 coo -13.01 70.96 47.58 -11.44 71.65 46.34 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG F 108 ARG~? -3.40 CL CL F2035s C 141 THR F 64 THR~? -3.74 CL CL F2035s C 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo -5.79 67.26 36.83 -4.57 64.58 37.74 74.01 31.91 26.65 74.85 33.96 28.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 80.10 39.29 29.74 78.76 37.65 30.15 coo -13.01 70.96 47.58 -11.44 71.65 46.34 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG F 108 ARG~? -3.40 CL CL F2035s C 141 THR F 105 THR.? 14.75 CL CL F2035 C 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo -5.79 67.26 36.83 -4.57 64.58 37.74 74.01 31.91 26.65 74.85 33.96 28.84 coo -6.81 68.31 28.28 -4.82 68.47 27.57 78.18 24.30 27.70 79.35 23.01 28.98 coo -13.01 70.96 47.58 -11.44 71.65 46.34 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 C 141 THR G 64 THR~? 16.57 O2 GOL G3001 C 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 32.32 22.84 38.36 31.62 25.53 39.73 coo -6.81 68.31 28.28 -4.82 68.47 27.57 26.50 27.63 44.88 27.71 27.61 43.08 coo -13.01 70.96 47.58 -11.44 71.65 46.34 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 C 141 THR G 105 THR.? 24.65 O1 GOL B3017 C 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 32.32 22.84 38.36 31.62 25.53 39.73 coo -6.81 68.31 28.28 -4.82 68.47 27.57 28.24 22.56 30.52 26.99 23.47 29.06 coo -13.01 70.96 47.58 -11.44 71.65 46.34 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 C 141 THR H 64 THR~? 8.97 O2 GOL H3016 C 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 71.22 70.92 84.57 72.18 68.95 82.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 76.53 62.70 82.65 75.84 64.64 82.09 coo -13.01 70.96 47.58 -11.44 71.65 46.34 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 C 141 THR H 105 THR.? 19.76 O2 GOL H3016 C 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo -5.79 67.26 36.83 -4.57 64.58 37.74 71.22 70.92 84.57 72.18 68.95 82.36 coo -6.81 68.31 28.28 -4.82 68.47 27.57 77.10 77.81 84.44 78.78 78.74 83.52 coo -13.01 70.96 47.58 -11.44 71.65 46.34 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 C 141 THR I 64 THR~? 8.93 O1 GOL I3032 C 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 191.22 197.47 152.14 191.76 195.04 153.98 coo -6.81 68.31 28.28 -4.82 68.47 27.57 196.10 194.26 160.17 195.16 193.85 158.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 C 141 THR I 105 THR.? 19.75 O1 GOL I3032 C 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 191.22 197.47 152.14 191.76 195.04 153.98 coo -6.81 68.31 28.28 -4.82 68.47 27.57 196.67 196.85 145.06 198.08 195.68 144.00 coo -13.01 70.96 47.58 -11.44 71.65 46.34 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 C 141 THR J 64 THR~? 19.68 O1 GOL J3030 C 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo -5.79 67.26 36.83 -4.57 64.58 37.74 152.38 184.27 135.62 151.05 183.00 138.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 145.87 177.29 139.35 146.97 179.14 139.64 coo -13.01 70.96 47.58 -11.44 71.65 46.34 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 C 141 THR J 105 THR.? 26.65 CL CL J2016 C 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo -5.79 67.26 36.83 -4.57 64.58 37.74 152.38 184.27 135.62 151.05 183.00 138.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 147.52 191.90 135.01 146.15 193.36 135.77 coo -13.01 70.96 47.58 -11.44 71.65 46.34 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 C 141 THR K 64 THR~? 14.85 O3 GOL K3010 C 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo -5.79 67.26 36.83 -4.57 64.58 37.74 185.36 137.67 187.99 186.54 140.01 186.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 191.77 140.44 180.59 190.64 140.95 182.34 coo -13.01 70.96 47.58 -11.44 71.65 46.34 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 C 141 THR K 105 THR.? 26.54 O3 GOL K3011 C 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo -5.79 67.26 36.83 -4.57 64.58 37.74 185.36 137.67 187.99 186.54 140.01 186.30 coo -6.81 68.31 28.28 -4.82 68.47 27.57 189.99 137.92 195.49 191.30 139.02 196.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 C 141 THR L 64 THR~? 14.87 O3 GOL L3028 C 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo -5.79 67.26 36.83 -4.57 64.58 37.74 146.49 155.54 199.73 145.94 157.11 197.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 141.60 163.20 195.47 142.44 161.21 195.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 C 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 C 141 THR L 105 THR.? 27.05 O1 GOL L3027 C 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo -5.79 67.26 36.83 -4.57 64.58 37.74 146.49 155.54 199.73 145.94 157.11 197.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 141.08 148.74 199.62 139.85 147.56 198.24 coo -13.01 70.96 47.58 -11.44 71.65 46.34 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 C 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 C 141 THR M 64 THR~? 19.60 O1 GOL M3043 C 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 150.62 202.12 182.01 149.56 199.68 180.53 coo -6.81 68.31 28.28 -4.82 68.47 27.57 144.87 198.36 174.46 145.82 198.07 176.32 coo -13.01 70.96 47.58 -11.44 71.65 46.34 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 C 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 C 141 THR M 105 THR.? 24.57 C1 GOL L3028 C 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 150.62 202.12 182.01 149.56 199.68 180.53 coo -6.81 68.31 28.28 -4.82 68.47 27.57 145.11 202.54 189.01 143.57 201.62 190.19 coo -13.01 70.96 47.58 -11.44 71.65 46.34 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 C 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 C 141 THR N 64 THR~? 9.33 C2 GOL N3029 C 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo -5.79 67.26 36.83 -4.57 64.58 37.74 189.02 149.68 140.15 189.67 151.62 142.49 coo -6.81 68.31 28.28 -4.82 68.47 27.57 194.93 157.15 143.34 193.70 155.46 143.76 coo -13.01 70.96 47.58 -11.44 71.65 46.34 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 C 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 C 141 THR N 105 THR.? 20.04 C1 GOL N3029 C 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo -5.79 67.26 36.83 -4.57 64.58 37.74 189.02 149.68 140.15 189.67 151.62 142.49 coo -6.81 68.31 28.28 -4.82 68.47 27.57 193.42 142.19 140.79 194.84 140.97 141.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 C 137 ARG O 108 ARG~? 13.39 CL CL O2036 C 141 THR O 64 THR~? 9.90 C1 GOL O3026 C 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 148.81 138.28 154.16 147.06 140.78 153.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 142.64 142.13 160.20 143.87 142.30 158.45 coo -13.01 70.96 47.58 -11.44 71.65 46.34 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 C 137 ARG O 108 ARG~? 13.39 CL CL O2036 C 141 THR O 105 THR.? 14.69 CL CL O2036 C 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo -5.79 67.26 36.83 -4.57 64.58 37.74 148.81 138.28 154.16 147.06 140.78 153.42 coo -6.81 68.31 28.28 -4.82 68.47 27.57 144.01 137.98 145.72 142.72 139.07 144.35 coo -13.01 70.96 47.58 -11.44 71.65 46.34 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 C 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 C 141 THR P 64 THR~? 15.75 O3 GOL P3014 C 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 187.53 185.71 199.97 188.17 183.79 197.64 coo -6.81 68.31 28.28 -4.82 68.47 27.57 192.75 177.71 197.46 191.86 179.57 196.92 coo -13.01 70.96 47.58 -11.44 71.65 46.34 172.77 185.90 199.12 171.10 184.95 198.29 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 C 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 C 141 THR P 105 THR.? 26.53 O3 GOL P3014 C 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo -5.79 67.26 36.83 -4.57 64.58 37.74 187.53 185.71 199.97 188.17 183.79 197.64 coo -6.81 68.31 28.28 -4.82 68.47 27.57 192.76 192.82 199.88 194.36 193.92 198.88 coo -13.01 70.96 47.58 -11.44 71.65 46.34 172.77 185.90 199.12 171.10 184.95 198.29 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 32 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 B 141 THR A 64 THR~? 18.85 O1 GOL A3040 B 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo 8.13 67.41 100.27 7.18 68.35 97.45 77.54 80.61 37.36 78.31 77.83 38.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 82.36 77.26 44.89 81.47 76.71 42.95 coo 14.55 73.52 89.47 12.81 73.95 90.56 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 108 ARG~? 22.68 O1 GOL A3040 B 141 THR A 105 THR.? 26.87 O1 GOL A3040 B 235 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo 8.13 67.41 100.27 7.18 68.35 97.45 77.54 80.61 37.36 78.31 77.83 38.52 coo 8.28 67.78 108.81 6.22 67.65 109.43 83.67 79.06 29.76 85.17 77.94 28.71 coo 14.55 73.52 89.47 12.81 73.95 90.56 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 B 141 THR B 64 THR~? 8.71 O1 GOL B3024 B 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo 8.13 67.41 100.27 7.18 68.35 97.45 39.05 68.00 18.82 37.75 66.74 21.38 coo 8.28 67.78 108.81 6.22 67.65 109.43 32.17 61.57 22.45 33.36 63.36 22.67 coo 14.55 73.52 89.47 12.81 73.95 90.56 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 108 ARG~? 14.18 O1 GOL B3024 B 141 THR B 105 THR.? 19.41 O1 GOL B3024 B 235 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo 8.13 67.41 100.27 7.18 68.35 97.45 39.05 68.00 18.82 37.75 66.74 21.38 coo 8.28 67.78 108.81 6.22 67.65 109.43 34.49 75.75 17.47 33.13 77.30 18.07 coo 14.55 73.52 89.47 12.81 73.95 90.56 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 B 141 THR C 64 THR~? 15.20 O3 GOL C3021 B 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo 8.13 67.41 100.27 7.18 68.35 97.45 67.42 22.77 74.41 69.21 25.29 74.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 74.38 24.70 67.82 73.20 25.34 69.51 coo 14.55 73.52 89.47 12.81 73.95 90.56 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG C 108 ARG~? 20.30 O3 GOL C3021 B 141 THR C 105 THR.? 24.85 O2 GOL H3025 B 235 ASP C 54 ASP~? 14.99 CL CL C2006 coo 8.13 67.41 100.27 7.18 68.35 97.45 67.42 22.77 74.41 69.21 25.29 74.04 coo 8.28 67.78 108.81 6.22 67.65 109.43 71.93 23.03 82.69 73.30 24.19 83.92 coo 14.55 73.52 89.47 12.81 73.95 90.56 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 B 141 THR D 64 THR~? 14.39 O3 GOL D3019 B 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo 8.13 67.41 100.27 7.18 68.35 97.45 29.84 43.62 83.53 28.05 43.26 81.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 25.01 50.48 78.85 25.86 48.54 78.75 coo 14.55 73.52 89.47 12.81 73.95 90.56 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG D 108 ARG~? 19.71 O3 GOL D3019 B 141 THR D 105 THR.? 26.78 CL CL D2012 B 235 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo 8.13 67.41 100.27 7.18 68.35 97.45 29.84 43.62 83.53 28.05 43.26 81.00 coo 8.28 67.78 108.81 6.22 67.65 109.43 23.59 36.21 83.60 22.17 35.02 82.50 coo 14.55 73.52 89.47 12.81 73.95 90.56 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 B 141 THR E 64 THR~? 14.21 O1 GOL E3035 B 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo 8.13 67.41 100.27 7.18 68.35 97.45 36.12 87.73 64.17 35.30 85.24 62.51 coo 8.28 67.78 108.81 6.22 67.65 109.43 30.87 84.28 56.42 31.61 84.06 58.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG E 108 ARG~? 18.65 O1 GOL E3035 B 141 THR E 105 THR.? 24.42 O1 GOL D3019 B 235 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo 8.13 67.41 100.27 7.18 68.35 97.45 36.12 87.73 64.17 35.30 85.24 62.51 coo 8.28 67.78 108.81 6.22 67.65 109.43 30.57 89.23 70.86 28.85 88.51 71.92 coo 14.55 73.52 89.47 12.81 73.95 90.56 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG F 108 ARG~? -3.40 CL CL F2035s B 141 THR F 64 THR~? -3.74 CL CL F2035s B 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo 8.13 67.41 100.27 7.18 68.35 97.45 74.01 31.91 26.65 74.85 33.96 28.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 80.10 39.29 29.74 78.76 37.65 30.15 coo 14.55 73.52 89.47 12.81 73.95 90.56 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG F 108 ARG~? -3.40 CL CL F2035s B 141 THR F 105 THR.? 14.75 CL CL F2035 B 235 ASP F 54 ASP~? 17.55 CL CL F2035 coo 8.13 67.41 100.27 7.18 68.35 97.45 74.01 31.91 26.65 74.85 33.96 28.84 coo 8.28 67.78 108.81 6.22 67.65 109.43 78.18 24.30 27.70 79.35 23.01 28.98 coo 14.55 73.52 89.47 12.81 73.95 90.56 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 B 141 THR G 64 THR~? 16.57 O2 GOL G3001 B 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo 8.13 67.41 100.27 7.18 68.35 97.45 32.32 22.84 38.36 31.62 25.53 39.73 coo 8.28 67.78 108.81 6.22 67.65 109.43 26.50 27.63 44.88 27.71 27.61 43.08 coo 14.55 73.52 89.47 12.81 73.95 90.56 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG G 108 ARG~? 22.05 O2 GOL G3001 B 141 THR G 105 THR.? 24.65 O1 GOL B3017 B 235 ASP G 54 ASP~? 15.07 CL CL C2006 coo 8.13 67.41 100.27 7.18 68.35 97.45 32.32 22.84 38.36 31.62 25.53 39.73 coo 8.28 67.78 108.81 6.22 67.65 109.43 28.24 22.56 30.52 26.99 23.47 29.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 B 141 THR H 64 THR~? 8.97 O2 GOL H3016 B 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo 8.13 67.41 100.27 7.18 68.35 97.45 71.22 70.92 84.57 72.18 68.95 82.36 coo 8.28 67.78 108.81 6.22 67.65 109.43 76.53 62.70 82.65 75.84 64.64 82.09 coo 14.55 73.52 89.47 12.81 73.95 90.56 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG H 108 ARG~? 14.48 O2 GOL H3016 B 141 THR H 105 THR.? 19.76 O2 GOL H3016 B 235 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo 8.13 67.41 100.27 7.18 68.35 97.45 71.22 70.92 84.57 72.18 68.95 82.36 coo 8.28 67.78 108.81 6.22 67.65 109.43 77.10 77.81 84.44 78.78 78.74 83.52 coo 14.55 73.52 89.47 12.81 73.95 90.56 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 B 141 THR I 64 THR~? 8.93 O1 GOL I3032 B 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo 8.13 67.41 100.27 7.18 68.35 97.45 191.22 197.47 152.14 191.76 195.04 153.98 coo 8.28 67.78 108.81 6.22 67.65 109.43 196.10 194.26 160.17 195.16 193.85 158.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG I 108 ARG~? 14.30 O1 GOL I3032 B 141 THR I 105 THR.? 19.75 O1 GOL I3032 B 235 ASP I 54 ASP~? 15.17 CL CL I2007 coo 8.13 67.41 100.27 7.18 68.35 97.45 191.22 197.47 152.14 191.76 195.04 153.98 coo 8.28 67.78 108.81 6.22 67.65 109.43 196.67 196.85 145.06 198.08 195.68 144.00 coo 14.55 73.52 89.47 12.81 73.95 90.56 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 B 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 B 141 THR J 64 THR~? 19.68 O1 GOL J3030 B 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo 8.13 67.41 100.27 7.18 68.35 97.45 152.38 184.27 135.62 151.05 183.00 138.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 145.87 177.29 139.35 146.97 179.14 139.64 coo 14.55 73.52 89.47 12.81 73.95 90.56 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 B 137 ARG J 108 ARG~? 23.02 O1 GOL J3030 B 141 THR J 105 THR.? 26.65 CL CL J2016 B 235 ASP J 54 ASP~? 19.87 CL CL J2002 coo 8.13 67.41 100.27 7.18 68.35 97.45 152.38 184.27 135.62 151.05 183.00 138.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 147.52 191.90 135.01 146.15 193.36 135.77 coo 14.55 73.52 89.47 12.81 73.95 90.56 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 B 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 B 141 THR K 64 THR~? 14.85 O3 GOL K3010 B 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo 8.13 67.41 100.27 7.18 68.35 97.45 185.36 137.67 187.99 186.54 140.01 186.30 coo 8.28 67.78 108.81 6.22 67.65 109.43 191.77 140.44 180.59 190.64 140.95 182.34 coo 14.55 73.52 89.47 12.81 73.95 90.56 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 B 137 ARG K 108 ARG~? 18.77 O3 GOL K3010 B 141 THR K 105 THR.? 26.54 O3 GOL K3011 B 235 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo 8.13 67.41 100.27 7.18 68.35 97.45 185.36 137.67 187.99 186.54 140.01 186.30 coo 8.28 67.78 108.81 6.22 67.65 109.43 189.99 137.92 195.49 191.30 139.02 196.78 coo 14.55 73.52 89.47 12.81 73.95 90.56 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 B 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 B 141 THR L 64 THR~? 14.87 O3 GOL L3028 B 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo 8.13 67.41 100.27 7.18 68.35 97.45 146.49 155.54 199.73 145.94 157.11 197.11 coo 8.28 67.78 108.81 6.22 67.65 109.43 141.60 163.20 195.47 142.44 161.21 195.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 B 137 ARG L 108 ARG~? 19.25 O3 GOL L3028 B 141 THR L 105 THR.? 27.05 O1 GOL L3027 B 235 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo 8.13 67.41 100.27 7.18 68.35 97.45 146.49 155.54 199.73 145.94 157.11 197.11 coo 8.28 67.78 108.81 6.22 67.65 109.43 141.08 148.74 199.62 139.85 147.56 198.24 coo 14.55 73.52 89.47 12.81 73.95 90.56 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 B 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 B 141 THR M 64 THR~? 19.60 O1 GOL M3043 B 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo 8.13 67.41 100.27 7.18 68.35 97.45 150.62 202.12 182.01 149.56 199.68 180.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 144.87 198.36 174.46 145.82 198.07 176.32 coo 14.55 73.52 89.47 12.81 73.95 90.56 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 B 137 ARG M 108 ARG~? 23.14 O1 GOL M3043 B 141 THR M 105 THR.? 24.57 C1 GOL L3028 B 235 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo 8.13 67.41 100.27 7.18 68.35 97.45 150.62 202.12 182.01 149.56 199.68 180.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 145.11 202.54 189.01 143.57 201.62 190.19 coo 14.55 73.52 89.47 12.81 73.95 90.56 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 27 3 # 27 B 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 B 141 THR N 64 THR~? 9.33 C2 GOL N3029 B 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo 8.13 67.41 100.27 7.18 68.35 97.45 189.02 149.68 140.15 189.67 151.62 142.49 coo 8.28 67.78 108.81 6.22 67.65 109.43 194.93 157.15 143.34 193.70 155.46 143.76 coo 14.55 73.52 89.47 12.81 73.95 90.56 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 28 3 # 28 B 137 ARG N 108 ARG~? 14.89 C2 GOL N3029 B 141 THR N 105 THR.? 20.04 C1 GOL N3029 B 235 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo 8.13 67.41 100.27 7.18 68.35 97.45 189.02 149.68 140.15 189.67 151.62 142.49 coo 8.28 67.78 108.81 6.22 67.65 109.43 193.42 142.19 140.79 194.84 140.97 141.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 29 3 # 29 B 137 ARG O 108 ARG~? 13.39 CL CL O2036 B 141 THR O 64 THR~? 9.90 C1 GOL O3026 B 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo 8.13 67.41 100.27 7.18 68.35 97.45 148.81 138.28 154.16 147.06 140.78 153.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 142.64 142.13 160.20 143.87 142.30 158.45 coo 14.55 73.52 89.47 12.81 73.95 90.56 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 30 3 # 30 B 137 ARG O 108 ARG~? 13.39 CL CL O2036 B 141 THR O 105 THR.? 14.69 CL CL O2036 B 235 ASP O 54 ASP~? 15.16 CL CL K2003 coo 8.13 67.41 100.27 7.18 68.35 97.45 148.81 138.28 154.16 147.06 140.78 153.42 coo 8.28 67.78 108.81 6.22 67.65 109.43 144.01 137.98 145.72 142.72 139.07 144.35 coo 14.55 73.52 89.47 12.81 73.95 90.56 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 31 3 # 31 B 137 ARG P 95 ARG~? 18.58 CL CL P2019 B 141 THR P 97 THR~? 9.06 CL CL P2019 B 235 ASP P 87 ASP.? 22.22 CL CL P2019 coo 8.13 67.41 100.27 7.18 68.35 97.45 215.71 187.54 202.72 215.66 187.33 199.63 coo 8.28 67.78 108.81 6.22 67.65 109.43 209.41 183.26 208.09 209.69 184.17 210.04 coo 14.55 73.52 89.47 12.81 73.95 90.56 228.00 178.08 205.41 229.30 179.67 204.97 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 32 3 # 32 B 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 B 141 THR P 64 THR~? 15.75 O3 GOL P3014 B 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo 8.13 67.41 100.27 7.18 68.35 97.45 187.53 185.71 199.97 188.17 183.79 197.64 coo 8.28 67.78 108.81 6.22 67.65 109.43 192.75 177.71 197.46 191.86 179.57 196.92 coo 14.55 73.52 89.47 12.81 73.95 90.56 172.77 185.90 199.12 171.10 184.95 198.29 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 33 3 # 33 B 137 ARG P 108 ARG~? 21.30 O3 GOL P3014 B 141 THR P 105 THR.? 26.53 O3 GOL P3014 B 235 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo 8.13 67.41 100.27 7.18 68.35 97.45 187.53 185.71 199.97 188.17 183.79 197.64 coo 8.28 67.78 108.81 6.22 67.65 109.43 192.76 192.82 199.88 194.36 193.92 198.88 coo 14.55 73.52 89.47 12.81 73.95 90.56 172.77 185.90 199.12 171.10 184.95 198.29 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 33 hits 1bd3_c03 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 503 TYR A 109 TYR~? 19.57 O1 GOL A3040 A 537 GLU A 106 GLU~? 21.37 O1 GOL A3040 coo 24.06 146.21 11.09 22.89 146.18 9.36 89.05 70.31 35.51 89.11 68.84 33.95 coo 15.91 140.69 8.32 15.71 143.39 9.13 84.38 79.76 38.04 83.16 77.26 38.08 coo 16.65 144.44 13.24 18.34 145.22 12.33 86.09 78.56 33.43 88.06 78.13 34.12 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 503 TYR B 109 TYR~? 11.52 O1 GOL B3024 A 537 GLU B 106 GLU~? 14.28 O1 GOL B3024 coo 24.06 146.21 11.09 22.89 146.18 9.36 26.68 73.50 25.50 26.49 75.15 26.91 coo 15.91 140.69 8.32 15.71 143.39 9.13 32.33 67.79 18.21 32.96 68.04 20.89 coo 16.65 144.44 13.24 18.34 145.22 12.33 31.31 72.93 17.86 29.23 72.75 18.06 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 503 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 537 GLU C 106 GLU~? 19.79 O1 GOL C3036 coo 24.06 146.21 11.09 22.89 146.18 9.36 80.37 30.30 78.61 80.09 31.65 80.29 coo 15.91 140.69 8.32 15.71 143.39 9.13 74.32 21.96 74.78 73.58 24.65 74.54 coo 16.65 144.44 13.24 18.34 145.22 12.33 75.34 22.76 79.72 77.40 22.80 79.51 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU E 141 GLU~? 19.75 O1 GOL D3019 A 503 TYR E 109 TYR~? 18.10 O1 GOL E3035 A 537 GLU E 106 GLU~? 21.05 O1 GOL E3022 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.80 82.16 67.66 21.51 80.62 69.17 coo 15.91 140.69 8.32 15.71 143.39 9.13 29.73 88.43 62.54 30.41 85.74 63.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 27.90 88.73 67.36 25.90 88.59 66.70 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU F 141 GLU~? 15.85 CL CL F2035 A 503 TYR F 109 TYR~? 6.98 CL CL F2035 A 537 GLU F 106 GLU~? 12.79 CL CL F2035 coo 24.06 146.21 11.09 22.89 146.18 9.36 84.56 28.39 36.54 84.29 26.85 38.03 coo 15.91 140.69 8.32 15.71 143.39 9.13 80.57 32.26 27.20 79.31 32.54 29.65 coo 16.65 144.44 13.24 18.34 145.22 12.33 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 6 3 # 6 A 461 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 503 TYR G 109 TYR~? 19.47 O2 GOL G3001 A 537 GLU G 106 GLU~? 21.38 C3 GOL G3001 coo 24.06 146.21 11.09 22.89 146.18 9.36 21.81 32.02 32.76 22.04 33.29 31.00 coo 15.91 140.69 8.32 15.71 143.39 9.13 25.80 23.55 38.48 27.03 26.02 38.21 coo 16.65 144.44 13.24 18.34 145.22 12.33 24.93 23.55 33.32 22.94 24.09 33.51 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 7 3 # 7 A 461 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 503 TYR H 109 TYR~? 11.76 O2 GOL H3016 A 537 GLU H 106 GLU~? 14.51 O2 GOL H3016 coo 24.06 146.21 11.09 22.89 146.18 9.36 84.42 72.24 77.39 84.86 73.57 75.76 coo 15.91 140.69 8.32 15.71 143.39 9.13 77.84 69.46 85.37 77.15 69.38 82.64 coo 16.65 144.44 13.24 18.34 145.22 12.33 79.71 74.06 84.56 81.75 73.57 84.59 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 8 3 # 8 A 461 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 503 TYR I 109 TYR~? 11.79 O1 GOL I3032 A 537 GLU I 106 GLU~? 14.47 O1 GOL I3032 coo 24.06 146.21 11.09 22.89 146.18 9.36 203.00 188.32 149.96 202.87 186.91 148.25 coo 15.91 140.69 8.32 15.71 143.39 9.13 197.73 197.22 153.29 196.64 194.65 153.36 coo 16.65 144.44 13.24 18.34 145.22 12.33 199.46 196.34 148.59 201.47 195.97 149.14 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 9 3 # 9 A 461 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 503 TYR J 109 TYR~? 19.91 O1 GOL J3030 A 537 GLU J 106 GLU~? 21.26 CL CL J2016 coo 24.06 146.21 11.09 22.89 146.18 9.36 139.93 188.85 143.36 139.82 190.60 144.63 coo 15.91 140.69 8.32 15.71 143.39 9.13 145.48 183.77 135.57 146.27 183.96 138.21 coo 16.65 144.44 13.24 18.34 145.22 12.33 144.43 188.69 135.80 142.30 188.60 135.89 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 10 3 # 10 A 461 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 503 TYR K 109 TYR~? 18.63 O3 GOL K3010 A 537 GLU K 106 GLU~? 21.15 O3 GOL K3009 coo 24.06 146.21 11.09 22.89 146.18 9.36 197.75 145.77 191.54 197.42 146.88 193.40 coo 15.91 140.69 8.32 15.71 143.39 9.13 192.13 137.45 187.51 191.27 140.11 187.32 coo 16.65 144.44 13.24 18.34 145.22 12.33 193.16 138.18 192.36 195.25 138.38 192.10 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 11 3 # 11 A 461 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 503 TYR M 109 TYR~? 20.13 O1 GOL M3043 A 537 GLU M 106 GLU~? 21.48 CL CL M2017 coo 24.06 146.21 11.09 22.89 146.18 9.36 137.93 194.30 185.04 137.74 193.05 186.86 coo 15.91 140.69 8.32 15.71 143.39 9.13 143.85 202.19 180.75 144.68 199.53 181.04 coo 16.65 144.44 13.24 18.34 145.22 12.33 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 12 3 # 12 A 461 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 503 TYR N 109 TYR~? 12.25 C2 GOL N3029 A 537 GLU N 106 GLU~? 14.62 O2 GOL N3029 coo 24.06 146.21 11.09 22.89 146.18 9.36 199.85 147.19 149.72 199.65 149.31 150.43 coo 15.91 140.69 8.32 15.71 143.39 9.13 195.52 150.33 140.44 194.35 150.45 143.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 196.48 145.55 141.46 198.54 145.70 141.81 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 13 3 # 13 A 461 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 503 TYR O 109 TYR~? 12.46 CL CL O2036 A 537 GLU O 106 GLU~? 13.74 CL CL O2036 coo 24.06 146.21 11.09 22.89 146.18 9.36 137.18 147.02 148.83 137.46 148.02 146.94 coo 15.91 140.69 8.32 15.71 143.39 9.13 141.96 138.45 153.78 143.09 141.01 153.60 coo 16.65 144.44 13.24 18.34 145.22 12.33 140.87 138.77 148.77 138.84 139.06 148.95 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 14 3 # 14 A 461 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 503 TYR P 109 TYR~? 18.49 O3 GOL P3014 A 537 GLU P 106 GLU~? 20.67 O3 GOL P3014 coo 24.06 146.21 11.09 22.89 146.18 9.36 200.04 187.90 192.14 200.20 189.50 190.73 coo 15.91 140.69 8.32 15.71 143.39 9.13 193.88 184.51 200.52 193.11 184.53 197.85 coo 16.65 144.44 13.24 18.34 145.22 12.33 195.52 189.19 199.68 197.57 188.76 199.63 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 14 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 504 TYR A 109 TYR~? 19.57 O1 GOL A3040 A 540 GLU A 106 GLU~? 21.37 O1 GOL A3040 coo 81.34 87.29 87.22 82.36 86.09 88.61 89.05 70.31 35.51 89.11 68.84 33.95 coo 80.85 81.34 94.77 81.70 80.16 92.41 84.38 79.76 38.04 83.16 77.26 38.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 86.09 78.56 33.43 88.06 78.13 34.12 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 504 TYR B 109 TYR~? 11.52 O1 GOL B3024 A 540 GLU B 106 GLU~? 14.28 O1 GOL B3024 coo 81.34 87.29 87.22 82.36 86.09 88.61 26.68 73.50 25.50 26.49 75.15 26.91 coo 80.85 81.34 94.77 81.70 80.16 92.41 32.33 67.79 18.21 32.96 68.04 20.89 coo 79.94 80.46 88.84 81.11 81.36 87.27 31.31 72.93 17.86 29.23 72.75 18.06 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 504 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 540 GLU C 106 GLU~? 19.79 O1 GOL C3036 coo 81.34 87.29 87.22 82.36 86.09 88.61 80.37 30.30 78.61 80.09 31.65 80.29 coo 80.85 81.34 94.77 81.70 80.16 92.41 74.32 21.96 74.78 73.58 24.65 74.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 75.34 22.76 79.72 77.40 22.80 79.51 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU E 141 GLU~? 19.75 O1 GOL D3019 A 504 TYR E 109 TYR~? 18.10 O1 GOL E3035 A 540 GLU E 106 GLU~? 21.05 O1 GOL E3022 coo 81.34 87.29 87.22 82.36 86.09 88.61 21.80 82.16 67.66 21.51 80.62 69.17 coo 80.85 81.34 94.77 81.70 80.16 92.41 29.73 88.43 62.54 30.41 85.74 63.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 27.90 88.73 67.36 25.90 88.59 66.70 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU F 141 GLU~? 15.85 CL CL F2035 A 504 TYR F 109 TYR~? 6.98 CL CL F2035 A 540 GLU F 106 GLU~? 12.79 CL CL F2035 coo 81.34 87.29 87.22 82.36 86.09 88.61 84.56 28.39 36.54 84.29 26.85 38.03 coo 80.85 81.34 94.77 81.70 80.16 92.41 80.57 32.26 27.20 79.31 32.54 29.65 coo 79.94 80.46 88.84 81.11 81.36 87.27 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 6 3 # 6 A 451 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 504 TYR G 109 TYR~? 19.47 O2 GOL G3001 A 540 GLU G 106 GLU~? 21.38 C3 GOL G3001 coo 81.34 87.29 87.22 82.36 86.09 88.61 21.81 32.02 32.76 22.04 33.29 31.00 coo 80.85 81.34 94.77 81.70 80.16 92.41 25.80 23.55 38.48 27.03 26.02 38.21 coo 79.94 80.46 88.84 81.11 81.36 87.27 24.93 23.55 33.32 22.94 24.09 33.51 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 7 3 # 7 A 451 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 504 TYR H 109 TYR~? 11.76 O2 GOL H3016 A 540 GLU H 106 GLU~? 14.51 O2 GOL H3016 coo 81.34 87.29 87.22 82.36 86.09 88.61 84.42 72.24 77.39 84.86 73.57 75.76 coo 80.85 81.34 94.77 81.70 80.16 92.41 77.84 69.46 85.37 77.15 69.38 82.64 coo 79.94 80.46 88.84 81.11 81.36 87.27 79.71 74.06 84.56 81.75 73.57 84.59 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 8 3 # 8 A 451 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 504 TYR I 109 TYR~? 11.79 O1 GOL I3032 A 540 GLU I 106 GLU~? 14.47 O1 GOL I3032 coo 81.34 87.29 87.22 82.36 86.09 88.61 203.00 188.32 149.96 202.87 186.91 148.25 coo 80.85 81.34 94.77 81.70 80.16 92.41 197.73 197.22 153.29 196.64 194.65 153.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 199.46 196.34 148.59 201.47 195.97 149.14 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 9 3 # 9 A 451 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 504 TYR J 109 TYR~? 19.91 O1 GOL J3030 A 540 GLU J 106 GLU~? 21.26 CL CL J2016 coo 81.34 87.29 87.22 82.36 86.09 88.61 139.93 188.85 143.36 139.82 190.60 144.63 coo 80.85 81.34 94.77 81.70 80.16 92.41 145.48 183.77 135.57 146.27 183.96 138.21 coo 79.94 80.46 88.84 81.11 81.36 87.27 144.43 188.69 135.80 142.30 188.60 135.89 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 10 3 # 10 A 451 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 504 TYR K 109 TYR~? 18.63 O3 GOL K3010 A 540 GLU K 106 GLU~? 21.15 O3 GOL K3009 coo 81.34 87.29 87.22 82.36 86.09 88.61 197.75 145.77 191.54 197.42 146.88 193.40 coo 80.85 81.34 94.77 81.70 80.16 92.41 192.13 137.45 187.51 191.27 140.11 187.32 coo 79.94 80.46 88.84 81.11 81.36 87.27 193.16 138.18 192.36 195.25 138.38 192.10 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 11 3 # 11 A 451 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 504 TYR M 109 TYR~? 20.13 O1 GOL M3043 A 540 GLU M 106 GLU~? 21.48 CL CL M2017 coo 81.34 87.29 87.22 82.36 86.09 88.61 137.93 194.30 185.04 137.74 193.05 186.86 coo 80.85 81.34 94.77 81.70 80.16 92.41 143.85 202.19 180.75 144.68 199.53 181.04 coo 79.94 80.46 88.84 81.11 81.36 87.27 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 12 3 # 12 A 451 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 504 TYR N 109 TYR~? 12.25 C2 GOL N3029 A 540 GLU N 106 GLU~? 14.62 O2 GOL N3029 coo 81.34 87.29 87.22 82.36 86.09 88.61 199.85 147.19 149.72 199.65 149.31 150.43 coo 80.85 81.34 94.77 81.70 80.16 92.41 195.52 150.33 140.44 194.35 150.45 143.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 196.48 145.55 141.46 198.54 145.70 141.81 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 13 3 # 13 A 451 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 504 TYR O 109 TYR~? 12.46 CL CL O2036 A 540 GLU O 106 GLU~? 13.74 CL CL O2036 coo 81.34 87.29 87.22 82.36 86.09 88.61 137.18 147.02 148.83 137.46 148.02 146.94 coo 80.85 81.34 94.77 81.70 80.16 92.41 141.96 138.45 153.78 143.09 141.01 153.60 coo 79.94 80.46 88.84 81.11 81.36 87.27 140.87 138.77 148.77 138.84 139.06 148.95 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 14 3 # 14 A 451 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 504 TYR P 109 TYR~? 18.49 O3 GOL P3014 A 540 GLU P 106 GLU~? 20.67 O3 GOL P3014 coo 81.34 87.29 87.22 82.36 86.09 88.61 200.04 187.90 192.14 200.20 189.50 190.73 coo 80.85 81.34 94.77 81.70 80.16 92.41 193.88 184.51 200.52 193.11 184.53 197.85 coo 79.94 80.46 88.84 81.11 81.36 87.27 195.52 189.19 199.68 197.57 188.76 199.63 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 14 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 55 ARG~? 19.31 O3 GOL B3003 A 451 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 540 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 79.04 80.20 80.81 79.58 81.40 83.63 66.98 80.93 31.90 64.74 79.05 32.90 coo 81.34 87.29 87.22 82.36 86.09 88.61 66.40 88.57 34.15 65.18 90.26 34.28 coo 79.94 80.46 88.84 81.11 81.36 87.27 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 55 ARG~? -14.24 O1 GOL B3003s A 451 GLU B 52 GLU~? -2.63 O3 GOL B3003s A 540 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo 79.04 80.20 80.81 79.58 81.40 83.63 50.06 69.68 20.36 47.07 69.49 19.37 coo 81.34 87.29 87.22 82.36 86.09 88.61 57.04 71.55 17.08 58.10 72.98 16.00 coo 79.94 80.46 88.84 81.11 81.36 87.27 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG C 55 ARG~? 19.41 CL CL C2006 A 451 GLU C 56 GLU~? 17.52 CL CL C2004 A 540 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 79.04 80.20 80.81 79.58 81.40 83.63 55.97 24.40 76.93 55.45 26.29 74.49 coo 81.34 87.29 87.22 82.36 86.09 88.61 54.66 16.88 74.36 53.19 15.44 73.98 coo 79.94 80.46 88.84 81.11 81.36 87.27 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG D 51 ARG~? -12.62 C3 GOL D3005s A 451 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 540 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 79.04 80.20 80.81 79.58 81.40 83.63 44.97 36.17 83.73 45.77 36.49 80.75 coo 81.34 87.29 87.22 82.36 86.09 88.61 40.62 42.19 92.06 41.92 42.65 93.65 coo 79.94 80.46 88.84 81.11 81.36 87.27 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG D 55 ARG~? 14.96 O1 GOL D3005 A 451 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 540 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 79.04 80.20 80.81 79.58 81.40 83.63 39.97 38.45 84.97 39.00 40.64 83.01 coo 81.34 87.29 87.22 82.36 86.09 88.61 40.62 42.19 92.06 41.92 42.65 93.65 coo 79.94 80.46 88.84 81.11 81.36 87.27 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG E 51 ARG~? 12.86 C3 GOL E3004 A 451 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 540 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 79.04 80.20 80.81 79.58 81.40 83.63 51.65 84.19 70.80 51.43 81.15 70.20 coo 81.34 87.29 87.22 82.36 86.09 88.61 49.08 93.57 65.06 50.69 94.83 64.79 coo 79.94 80.46 88.84 81.11 81.36 87.27 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG E 55 ARG~? 13.47 C3 GOL E3004 A 451 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 540 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 79.04 80.20 80.81 79.58 81.40 83.63 47.24 86.77 68.80 48.11 84.54 66.77 coo 81.34 87.29 87.22 82.36 86.09 88.61 49.08 93.57 65.06 50.69 94.83 64.79 coo 79.94 80.46 88.84 81.11 81.36 87.27 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG F 51 ARG~? 18.26 CL CL F2035 A 451 GLU F 56 GLU~? 19.98 CL CL F2035 A 540 GLU F 52 GLU~? -24.25 CL CL F2035s coo 79.04 80.20 80.81 79.58 81.40 83.63 56.56 29.17 27.33 58.39 29.67 29.78 coo 81.34 87.29 87.22 82.36 86.09 88.61 62.56 32.21 18.10 61.29 32.37 16.50 coo 79.94 80.46 88.84 81.11 81.36 87.27 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG F 55 ARG~? 14.19 CL CL F2035 A 451 GLU F 56 GLU~? 19.98 CL CL F2035 A 540 GLU F 52 GLU~? -24.25 CL CL F2035s coo 79.04 80.20 80.81 79.58 81.40 83.63 62.56 29.89 25.65 64.18 28.30 27.76 coo 81.34 87.29 87.22 82.36 86.09 88.61 62.56 32.21 18.10 61.29 32.37 16.50 coo 79.94 80.46 88.84 81.11 81.36 87.27 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 10 3 # 10 A 382 ARG H 55 ARG~? 13.48 O3 GOL H3006 A 451 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 540 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 79.04 80.20 80.81 79.58 81.40 83.63 60.33 75.55 82.58 59.37 73.14 80.81 coo 81.34 87.29 87.22 82.36 86.09 88.61 58.45 73.39 90.18 56.86 73.32 91.53 coo 79.94 80.46 88.84 81.11 81.36 87.27 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 11 3 # 11 A 382 ARG I 51 ARG~? 21.58 CL CL I2007 A 451 GLU I 56 GLU.? 17.30 CL CL I2001 A 540 GLU I 52 GLU~? -23.17 CL CL I2007s coo 79.04 80.20 80.81 79.58 81.40 83.63 174.23 196.17 146.19 174.71 193.30 147.29 coo 81.34 87.29 87.22 82.36 86.09 88.61 178.97 205.20 150.86 177.96 206.96 151.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 174.67 202.46 145.17 173.69 203.91 143.96 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 12 3 # 12 A 382 ARG J 55 ARG~? 24.05 CL CL J2002 A 451 GLU J 56 GLU.? 17.48 CL CL J2002 A 540 GLU J 52 GLU~? -23.89 CL CL J2002s coo 79.04 80.20 80.81 79.58 81.40 83.63 163.85 187.29 136.52 164.25 185.16 138.77 coo 81.34 87.29 87.22 82.36 86.09 88.61 164.69 183.53 129.34 166.31 182.92 128.17 coo 79.94 80.46 88.84 81.11 81.36 87.27 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 13 3 # 13 A 382 ARG K 55 ARG~? 13.86 O3 GOL K3011 A 451 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 540 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 79.04 80.20 80.81 79.58 81.40 83.63 173.95 138.80 190.43 173.34 140.90 188.20 coo 81.34 87.29 87.22 82.36 86.09 88.61 172.89 131.40 187.88 171.30 130.10 187.44 coo 79.94 80.46 88.84 81.11 81.36 87.27 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 14 3 # 14 A 382 ARG L 51 ARG~? 16.39 O3 GOL K3011 A 451 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 540 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 79.04 80.20 80.81 79.58 81.40 83.63 163.01 149.53 198.74 162.90 150.47 195.82 coo 81.34 87.29 87.22 82.36 86.09 88.61 158.53 155.21 207.26 159.92 155.54 208.73 coo 79.94 80.46 88.84 81.11 81.36 87.27 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 15 3 # 15 A 382 ARG L 55 ARG~? 21.00 O3 GOL K3011 A 451 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 540 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 79.04 80.20 80.81 79.58 81.40 83.63 158.05 151.49 200.24 157.97 153.99 198.35 coo 81.34 87.29 87.22 82.36 86.09 88.61 158.53 155.21 207.26 159.92 155.54 208.73 coo 79.94 80.46 88.84 81.11 81.36 87.27 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 16 3 # 16 A 382 ARG M 51 ARG~? -9.68 O2 GOL M3007s A 451 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 540 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 79.04 80.20 80.81 79.58 81.40 83.63 166.66 199.07 188.11 163.90 199.62 189.28 coo 81.34 87.29 87.22 82.36 86.09 88.61 163.29 208.10 182.55 164.69 209.62 182.16 coo 79.94 80.46 88.84 81.11 81.36 87.27 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 17 3 # 17 A 382 ARG N 55 ARG~? 13.92 O1 GOL N3008 A 451 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 540 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 79.04 80.20 80.81 79.58 81.40 83.63 177.28 147.38 139.71 179.40 146.33 141.72 coo 81.34 87.29 87.22 82.36 86.09 88.61 177.02 149.87 132.23 175.77 150.16 130.55 coo 79.94 80.46 88.84 81.11 81.36 87.27 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 18 3 # 18 A 382 ARG O 51 ARG~? 16.43 O1 GOL N3008 A 451 GLU O 56 GLU.? 16.78 CL CL O2036 A 540 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 79.04 80.20 80.81 79.58 81.40 83.63 165.78 138.84 148.96 164.30 141.49 149.44 coo 81.34 87.29 87.22 82.36 86.09 88.61 160.60 130.40 154.07 161.73 128.68 154.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 19 3 # 19 A 382 ARG O 55 ARG~? 19.37 CL CL K2003 A 451 GLU O 56 GLU.? 16.78 CL CL O2036 A 540 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 79.04 80.20 80.81 79.58 81.40 83.63 159.96 137.60 150.54 160.85 139.64 152.73 coo 81.34 87.29 87.22 82.36 86.09 88.61 160.60 130.40 154.07 161.73 128.68 154.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 20 3 # 20 A 382 ARG P 55 ARG~? 20.09 O3 GOL M3007 A 451 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 540 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 79.04 80.20 80.81 79.58 81.40 83.63 176.25 189.61 198.56 175.31 187.31 196.65 coo 81.34 87.29 87.22 82.36 86.09 88.61 174.58 187.04 206.13 173.17 186.75 207.60 coo 79.94 80.46 88.84 81.11 81.36 87.27 170.60 192.65 202.74 169.53 193.98 203.95 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 20 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 51 ARG~? 16.54 O3 GOL B3003 B 451 GLU A 56 GLU.? 25.60 O3 GOL B3003 B 540 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 82.21 41.07 119.14 83.95 40.66 116.59 61.69 79.67 29.64 62.00 76.91 30.99 coo 86.52 35.28 112.74 87.08 36.38 110.99 66.40 88.57 34.15 65.18 90.26 34.28 coo 83.38 41.19 112.55 85.47 40.59 112.72 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 55 ARG~? 19.31 O3 GOL B3003 B 451 GLU A 56 GLU.? 25.60 O3 GOL B3003 B 540 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 82.21 41.07 119.14 83.95 40.66 116.59 66.98 80.93 31.90 64.74 79.05 32.90 coo 86.52 35.28 112.74 87.08 36.38 110.99 66.40 88.57 34.15 65.18 90.26 34.28 coo 83.38 41.19 112.55 85.47 40.59 112.72 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 51 ARG~? 11.52 O3 GOL B3003 B 451 GLU B 56 GLU.? 9.23 C1 GOL B3003 B 540 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo 82.21 41.07 119.14 83.95 40.66 116.59 56.02 71.46 21.90 55.03 71.54 24.81 coo 86.52 35.28 112.74 87.08 36.38 110.99 52.16 66.04 13.94 53.39 65.68 12.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 55 ARG~? -14.24 O1 GOL B3003s B 451 GLU B 52 GLU~? -2.63 O3 GOL B3003s B 540 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo 82.21 41.07 119.14 83.95 40.66 116.59 50.06 69.68 20.36 47.07 69.49 19.37 coo 86.52 35.28 112.74 87.08 36.38 110.99 57.04 71.55 17.08 58.10 72.98 16.00 coo 83.38 41.19 112.55 85.47 40.59 112.72 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG B 55 ARG~? -14.24 O1 GOL B3003s B 451 GLU B 56 GLU.? 9.23 C1 GOL B3003 B 540 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo 82.21 41.07 119.14 83.95 40.66 116.59 50.06 69.68 20.36 47.07 69.49 19.37 coo 86.52 35.28 112.74 87.08 36.38 110.99 52.16 66.04 13.94 53.39 65.68 12.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG C 51 ARG~? 15.50 O3 GOL D3005 B 451 GLU C 56 GLU~? 17.52 CL CL C2004 B 540 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 82.21 41.07 119.14 83.95 40.66 116.59 50.80 26.41 78.15 53.63 27.50 78.75 coo 86.52 35.28 112.74 87.08 36.38 110.99 54.66 16.88 74.36 53.19 15.44 73.98 coo 83.38 41.19 112.55 85.47 40.59 112.72 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG C 55 ARG~? 19.41 CL CL C2006 B 451 GLU C 56 GLU~? 17.52 CL CL C2004 B 540 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 82.21 41.07 119.14 83.95 40.66 116.59 55.97 24.40 76.93 55.45 26.29 74.49 coo 86.52 35.28 112.74 87.08 36.38 110.99 54.66 16.88 74.36 53.19 15.44 73.98 coo 83.38 41.19 112.55 85.47 40.59 112.72 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG D 51 ARG~? -12.62 C3 GOL D3005s B 451 GLU D 56 GLU~? 9.22 O1 GOL D3005 B 540 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 82.21 41.07 119.14 83.95 40.66 116.59 44.97 36.17 83.73 45.77 36.49 80.75 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.62 42.19 92.06 41.92 42.65 93.65 coo 83.38 41.19 112.55 85.47 40.59 112.72 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 9 3 # 9 B 382 ARG D 55 ARG~? 14.96 O1 GOL D3005 B 451 GLU D 56 GLU~? 9.22 O1 GOL D3005 B 540 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 82.21 41.07 119.14 83.95 40.66 116.59 39.97 38.45 84.97 39.00 40.64 83.01 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.62 42.19 92.06 41.92 42.65 93.65 coo 83.38 41.19 112.55 85.47 40.59 112.72 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 10 3 # 10 B 382 ARG E 51 ARG~? 12.86 C3 GOL E3004 B 451 GLU E 56 GLU~? 9.34 O1 GOL E3004 B 540 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 82.21 41.07 119.14 83.95 40.66 116.59 51.65 84.19 70.80 51.43 81.15 70.20 coo 86.52 35.28 112.74 87.08 36.38 110.99 49.08 93.57 65.06 50.69 94.83 64.79 coo 83.38 41.19 112.55 85.47 40.59 112.72 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 11 3 # 11 B 382 ARG E 55 ARG~? 13.47 C3 GOL E3004 B 451 GLU E 56 GLU~? 9.34 O1 GOL E3004 B 540 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 82.21 41.07 119.14 83.95 40.66 116.59 47.24 86.77 68.80 48.11 84.54 66.77 coo 86.52 35.28 112.74 87.08 36.38 110.99 49.08 93.57 65.06 50.69 94.83 64.79 coo 83.38 41.19 112.55 85.47 40.59 112.72 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 12 3 # 12 B 382 ARG F 51 ARG~? 18.26 CL CL F2035 B 451 GLU F 56 GLU~? 19.98 CL CL F2035 B 540 GLU F 52 GLU~? -24.25 CL CL F2035s coo 82.21 41.07 119.14 83.95 40.66 116.59 56.56 29.17 27.33 58.39 29.67 29.78 coo 86.52 35.28 112.74 87.08 36.38 110.99 62.56 32.21 18.10 61.29 32.37 16.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 13 3 # 13 B 382 ARG F 55 ARG~? 14.19 CL CL F2035 B 451 GLU F 56 GLU~? 19.98 CL CL F2035 B 540 GLU F 52 GLU~? -24.25 CL CL F2035s coo 82.21 41.07 119.14 83.95 40.66 116.59 62.56 29.89 25.65 64.18 28.30 27.76 coo 86.52 35.28 112.74 87.08 36.38 110.99 62.56 32.21 18.10 61.29 32.37 16.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 14 3 # 14 B 382 ARG G 51 ARG~? 21.90 CL CL C2006 B 451 GLU G 56 GLU.? 17.83 CL CL C2004 B 540 GLU G 52 GLU~? -23.30 CL CL C2006s coo 82.21 41.07 119.14 83.95 40.66 116.59 49.60 22.70 34.88 49.12 25.71 35.34 coo 86.52 35.28 112.74 87.08 36.38 110.99 43.97 14.81 40.22 44.85 13.00 40.58 coo 83.38 41.19 112.55 85.47 40.59 112.72 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 15 3 # 15 B 382 ARG G 55 ARG~? 22.00 CL CL C2006 B 451 GLU G 56 GLU.? 17.83 CL CL C2004 B 540 GLU G 52 GLU~? -23.30 CL CL C2006s coo 82.21 41.07 119.14 83.95 40.66 116.59 44.23 21.19 35.75 42.00 23.24 36.25 coo 86.52 35.28 112.74 87.08 36.38 110.99 43.97 14.81 40.22 44.85 13.00 40.58 coo 83.38 41.19 112.55 85.47 40.59 112.72 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 16 3 # 16 B 382 ARG H 51 ARG~? -11.05 O1 GOL H3006s B 451 GLU H 56 GLU.? 8.74 O3 GOL H3006 B 540 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 82.21 41.07 119.14 83.95 40.66 116.59 55.75 78.18 80.83 58.67 78.05 79.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 58.45 73.39 90.18 56.86 73.32 91.53 coo 83.38 41.19 112.55 85.47 40.59 112.72 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 17 3 # 17 B 382 ARG H 55 ARG~? 13.48 O3 GOL H3006 B 451 GLU H 56 GLU.? 8.74 O3 GOL H3006 B 540 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 82.21 41.07 119.14 83.95 40.66 116.59 60.33 75.55 82.58 59.37 73.14 80.81 coo 86.52 35.28 112.74 87.08 36.38 110.99 58.45 73.39 90.18 56.86 73.32 91.53 coo 83.38 41.19 112.55 85.47 40.59 112.72 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 18 3 # 18 B 382 ARG I 51 ARG~? 21.58 CL CL I2007 B 451 GLU I 56 GLU.? 17.30 CL CL I2001 B 540 GLU I 52 GLU~? -23.17 CL CL I2007s coo 82.21 41.07 119.14 83.95 40.66 116.59 174.23 196.17 146.19 174.71 193.30 147.29 coo 86.52 35.28 112.74 87.08 36.38 110.99 178.97 205.20 150.86 177.96 206.96 151.01 coo 83.38 41.19 112.55 85.47 40.59 112.72 174.67 202.46 145.17 173.69 203.91 143.96 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 19 3 # 19 B 382 ARG I 55 ARG~? 19.02 CL CL I2007 B 451 GLU I 52 GLU~? -23.17 CL CL I2007s B 540 GLU I 56 GLU.? 17.30 CL CL I2001 coo 82.21 41.07 119.14 83.95 40.66 116.59 179.74 197.90 148.59 178.27 195.79 150.32 coo 86.52 35.28 112.74 87.08 36.38 110.99 174.67 202.46 145.17 173.69 203.91 143.96 coo 83.38 41.19 112.55 85.47 40.59 112.72 178.97 205.20 150.86 177.96 206.96 151.01 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 20 3 # 20 B 382 ARG I 55 ARG~? 19.02 CL CL I2007 B 451 GLU I 56 GLU.? 17.30 CL CL I2001 B 540 GLU I 52 GLU~? -23.17 CL CL I2007s coo 82.21 41.07 119.14 83.95 40.66 116.59 179.74 197.90 148.59 178.27 195.79 150.32 coo 86.52 35.28 112.74 87.08 36.38 110.99 178.97 205.20 150.86 177.96 206.96 151.01 coo 83.38 41.19 112.55 85.47 40.59 112.72 174.67 202.46 145.17 173.69 203.91 143.96 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 21 3 # 21 B 382 ARG J 51 ARG~? 27.44 CL CL J2002 B 451 GLU J 56 GLU.? 17.48 CL CL J2002 B 540 GLU J 52 GLU~? -23.89 CL CL J2002s coo 82.21 41.07 119.14 83.95 40.66 116.59 168.80 189.12 137.91 166.15 189.45 139.46 coo 86.52 35.28 112.74 87.08 36.38 110.99 164.69 183.53 129.34 166.31 182.92 128.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 22 3 # 22 B 382 ARG J 55 ARG~? 24.05 CL CL J2002 B 451 GLU J 56 GLU.? 17.48 CL CL J2002 B 540 GLU J 52 GLU~? -23.89 CL CL J2002s coo 82.21 41.07 119.14 83.95 40.66 116.59 163.85 187.29 136.52 164.25 185.16 138.77 coo 86.52 35.28 112.74 87.08 36.38 110.99 164.69 183.53 129.34 166.31 182.92 128.17 coo 83.38 41.19 112.55 85.47 40.59 112.72 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 23 3 # 23 B 382 ARG K 51 ARG~? -10.79 O3 GOL K3011s B 451 GLU K 56 GLU~? 9.32 O1 GOL K3011 B 540 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 82.21 41.07 119.14 83.95 40.66 116.59 168.73 140.32 192.51 171.31 141.97 192.79 coo 86.52 35.28 112.74 87.08 36.38 110.99 172.89 131.40 187.88 171.30 130.10 187.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 24 3 # 24 B 382 ARG K 55 ARG~? 13.86 O3 GOL K3011 B 451 GLU K 56 GLU~? 9.32 O1 GOL K3011 B 540 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 82.21 41.07 119.14 83.95 40.66 116.59 173.95 138.80 190.43 173.34 140.90 188.20 coo 86.52 35.28 112.74 87.08 36.38 110.99 172.89 131.40 187.88 171.30 130.10 187.44 coo 83.38 41.19 112.55 85.47 40.59 112.72 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 25 3 # 25 B 382 ARG L 51 ARG~? 16.39 O3 GOL K3011 B 451 GLU L 56 GLU.? 24.71 O3 GOL K3011 B 540 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 82.21 41.07 119.14 83.95 40.66 116.59 163.01 149.53 198.74 162.90 150.47 195.82 coo 86.52 35.28 112.74 87.08 36.38 110.99 158.53 155.21 207.26 159.92 155.54 208.73 coo 83.38 41.19 112.55 85.47 40.59 112.72 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 26 3 # 26 B 382 ARG L 55 ARG~? 21.00 O3 GOL K3011 B 451 GLU L 56 GLU.? 24.71 O3 GOL K3011 B 540 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 82.21 41.07 119.14 83.95 40.66 116.59 158.05 151.49 200.24 157.97 153.99 198.35 coo 86.52 35.28 112.74 87.08 36.38 110.99 158.53 155.21 207.26 159.92 155.54 208.73 coo 83.38 41.19 112.55 85.47 40.59 112.72 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 27 3 # 27 B 382 ARG M 51 ARG~? -9.68 O2 GOL M3007s B 451 GLU M 56 GLU~? 9.79 O1 GOL M3007 B 540 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 82.21 41.07 119.14 83.95 40.66 116.59 166.66 199.07 188.11 163.90 199.62 189.28 coo 86.52 35.28 112.74 87.08 36.38 110.99 163.29 208.10 182.55 164.69 209.62 182.16 coo 83.38 41.19 112.55 85.47 40.59 112.72 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 28 3 # 28 B 382 ARG M 55 ARG~? 12.49 O2 GOL M3007 B 451 GLU M 56 GLU~? 9.79 O1 GOL M3007 B 540 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 82.21 41.07 119.14 83.95 40.66 116.59 162.29 201.15 185.73 159.83 200.25 187.37 coo 86.52 35.28 112.74 87.08 36.38 110.99 163.29 208.10 182.55 164.69 209.62 182.16 coo 83.38 41.19 112.55 85.47 40.59 112.72 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 29 3 # 29 B 382 ARG N 51 ARG~? 10.93 O1 GOL N3008 B 451 GLU N 56 GLU.? 8.85 O3 GOL N3008 B 540 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 82.21 41.07 119.14 83.95 40.66 116.59 172.16 145.36 140.78 174.78 144.98 142.37 coo 86.52 35.28 112.74 87.08 36.38 110.99 177.02 149.87 132.23 175.77 150.16 130.55 coo 83.38 41.19 112.55 85.47 40.59 112.72 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 30 3 # 30 B 382 ARG N 55 ARG~? 13.92 O1 GOL N3008 B 451 GLU N 56 GLU.? 8.85 O3 GOL N3008 B 540 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 82.21 41.07 119.14 83.95 40.66 116.59 177.28 147.38 139.71 179.40 146.33 141.72 coo 86.52 35.28 112.74 87.08 36.38 110.99 177.02 149.87 132.23 175.77 150.16 130.55 coo 83.38 41.19 112.55 85.47 40.59 112.72 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 31 3 # 31 B 382 ARG O 51 ARG~? 16.43 O1 GOL N3008 B 451 GLU O 56 GLU.? 16.78 CL CL O2036 B 540 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 82.21 41.07 119.14 83.95 40.66 116.59 165.78 138.84 148.96 164.30 141.49 149.44 coo 86.52 35.28 112.74 87.08 36.38 110.99 160.60 130.40 154.07 161.73 128.68 154.54 coo 83.38 41.19 112.55 85.47 40.59 112.72 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 32 3 # 32 B 382 ARG O 55 ARG~? 19.37 CL CL K2003 B 451 GLU O 52 GLU~? 17.58 O1 GOL N3008s B 540 GLU O 56 GLU.? 16.78 CL CL O2036 coo 82.21 41.07 119.14 83.95 40.66 116.59 159.96 137.60 150.54 160.85 139.64 152.73 coo 86.52 35.28 112.74 87.08 36.38 110.99 165.51 132.62 148.90 166.63 131.12 147.92 coo 83.38 41.19 112.55 85.47 40.59 112.72 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 33 3 # 33 B 382 ARG O 55 ARG~? 19.37 CL CL K2003 B 451 GLU O 56 GLU.? 16.78 CL CL O2036 B 540 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 82.21 41.07 119.14 83.95 40.66 116.59 159.96 137.60 150.54 160.85 139.64 152.73 coo 86.52 35.28 112.74 87.08 36.38 110.99 160.60 130.40 154.07 161.73 128.68 154.54 coo 83.38 41.19 112.55 85.47 40.59 112.72 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 34 3 # 34 B 382 ARG P 51 ARG~? 14.75 O3 GOL M3007 B 451 GLU P 56 GLU.? 24.16 O3 GOL M3007 B 540 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 82.21 41.07 119.14 83.95 40.66 116.59 171.10 192.14 197.11 173.97 192.46 196.07 coo 86.52 35.28 112.74 87.08 36.38 110.99 174.58 187.04 206.13 173.17 186.75 207.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 170.60 192.65 202.74 169.53 193.98 203.95 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 35 3 # 35 B 382 ARG P 55 ARG~? 20.09 O3 GOL M3007 B 451 GLU P 52 GLU~? -15.89 O3 GOL M3007s B 540 GLU P 56 GLU.? 24.16 O3 GOL M3007 coo 82.21 41.07 119.14 83.95 40.66 116.59 176.25 189.61 198.56 175.31 187.31 196.65 coo 86.52 35.28 112.74 87.08 36.38 110.99 170.60 192.65 202.74 169.53 193.98 203.95 coo 83.38 41.19 112.55 85.47 40.59 112.72 174.58 187.04 206.13 173.17 186.75 207.60 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 36 3 # 36 B 382 ARG P 55 ARG~? 20.09 O3 GOL M3007 B 451 GLU P 56 GLU.? 24.16 O3 GOL M3007 B 540 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 82.21 41.07 119.14 83.95 40.66 116.59 176.25 189.61 198.56 175.31 187.31 196.65 coo 86.52 35.28 112.74 87.08 36.38 110.99 174.58 187.04 206.13 173.17 186.75 207.60 coo 83.38 41.19 112.55 85.47 40.59 112.72 170.60 192.65 202.74 169.53 193.98 203.95 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 36 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 95 ARG~? 18.23 CL CL A2020 183 LYS A 142 LYS~? 20.36 CL CL A2020 317 ARG A 114 ARG~? 18.99 O2 GOL A3040 coo 76.57 109.19 73.41 73.86 110.26 72.16 104.92 78.08 35.81 104.56 75.04 36.10 coo 82.09 117.51 66.37 80.60 114.32 71.44 94.05 73.09 37.15 99.40 72.43 37.04 coo 65.21 120.62 58.76 63.62 123.14 59.66 86.11 90.82 36.33 86.92 90.68 33.36 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 95 ARG~? 18.20 CL CL B2010 183 LYS B 142 LYS~? 15.72 O2 GOL B3024 317 ARG B 114 ARG~? 18.19 O1 GOL B3023 coo 76.57 109.19 73.41 73.86 110.26 72.16 12.73 74.04 13.96 12.10 74.25 16.98 coo 82.09 117.51 66.37 80.60 114.32 71.44 21.85 72.06 22.17 16.34 73.26 20.39 coo 65.21 120.62 58.76 63.62 123.14 59.66 33.27 67.19 7.11 33.19 70.17 6.41 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG C 95 ARG~? 15.71 CL CL C2031 183 LYS C 142 LYS~? 17.22 O1 GOL C3036 317 ARG C 114 ARG~? 19.78 CL CL C2011 coo 76.57 109.19 73.41 73.86 110.26 72.16 94.96 18.62 81.47 95.21 21.64 80.86 coo 82.09 117.51 66.37 80.60 114.32 71.44 84.87 26.44 78.04 89.10 24.68 78.66 coo 65.21 120.62 58.76 63.62 123.14 59.66 73.29 10.73 76.57 73.51 10.59 79.63 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG D 95 ARG~? 18.32 CL CL D2012 183 LYS D 142 LYS~? 18.65 CL CL D2012 317 ARG D 114 ARG~? 18.11 O3 GOL D3018 coo 76.57 109.19 73.41 73.86 110.26 72.16 1.08 42.29 81.69 1.93 41.79 78.81 coo 82.09 117.51 66.37 80.60 114.32 71.44 13.01 42.17 76.46 7.83 42.85 76.18 coo 65.21 120.62 58.76 63.62 123.14 59.66 21.28 44.89 93.84 20.52 41.96 94.27 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 5 3 # 5 118 ARG F 95 ARG~? 18.18 CL CL F2034 183 LYS F 142 LYS~? 19.20 CL CL F2034 317 ARG F 114 ARG~? 18.29 CL CL F2035 coo 76.57 109.19 73.41 73.86 110.26 72.16 101.23 25.44 29.03 100.92 26.10 32.03 coo 82.09 117.51 66.37 80.60 114.32 71.44 89.94 29.13 34.00 95.25 27.31 34.06 coo 65.21 120.62 58.76 63.62 123.14 59.66 81.94 30.32 15.98 81.85 27.28 16.31 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 6 3 # 6 118 ARG G 95 ARG~? 18.33 CL CL G2033 183 LYS G 142 LYS~? 22.79 C3 GOL G3001 317 ARG G 114 ARG~? 19.08 O3 GOL G3038 coo 76.57 109.19 73.41 73.86 110.26 72.16 5.43 23.41 31.57 5.00 26.51 31.76 coo 82.09 117.51 66.37 80.60 114.32 71.44 16.44 29.60 34.10 15.26 26.17 28.78 coo 65.21 120.62 58.76 63.62 123.14 59.66 24.45 12.48 38.95 24.54 11.96 35.94 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 7 3 # 7 118 ARG H 95 ARG~? 18.32 CL CL H2014 183 LYS H 142 LYS~? 14.79 O1 GOL H3016 317 ARG H 114 ARG~? 20.07 CL CL H2014 coo 76.57 109.19 73.41 73.86 110.26 72.16 99.22 72.04 88.85 99.19 71.48 85.82 coo 82.09 117.51 66.37 80.60 114.32 71.44 88.83 70.49 80.96 94.32 71.20 82.05 coo 65.21 120.62 58.76 63.62 123.14 59.66 76.88 71.50 96.54 77.56 74.47 96.38 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 8 3 # 8 118 ARG I 95 ARG~? 18.52 CL CL I2015 183 LYS I 142 LYS~? 14.36 O1 GOL I3032 317 ARG I 114 ARG~? 18.68 O1 GOL I3031 coo 76.57 109.19 73.41 73.86 110.26 72.16 219.42 197.06 150.20 219.02 193.99 150.58 coo 82.09 117.51 66.37 80.60 114.32 71.44 208.03 191.18 151.66 205.16 191.96 148.66 coo 65.21 120.62 58.76 63.62 123.14 59.66 198.65 208.42 151.97 199.12 208.35 148.94 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 9 3 # 9 118 ARG J 95 ARG~? 18.03 CL CL J2026 183 LYS J 142 LYS~? 19.62 CL CL J2016 317 ARG J 114 ARG~? 18.34 O3 GOL J3030 coo 76.57 109.19 73.41 73.86 110.26 72.16 124.49 189.48 132.73 124.81 189.21 135.78 coo 82.09 117.51 66.37 80.60 114.32 71.44 135.12 187.43 140.16 132.76 191.26 136.26 coo 65.21 120.62 58.76 63.62 123.14 59.66 145.85 183.80 124.31 145.72 186.84 123.92 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 10 3 # 10 118 ARG K 95 ARG~? 18.15 CL CL K2027 183 LYS K 142 LYS~? 19.15 C2 GOL K3009 317 ARG K 114 ARG~? 18.18 O1 GOL K3041 coo 76.57 109.19 73.41 73.86 110.26 72.16 211.85 134.99 193.85 212.13 138.00 193.03 coo 82.09 117.51 66.37 80.60 114.32 71.44 202.52 142.42 190.46 207.82 141.83 191.71 coo 65.21 120.62 58.76 63.62 123.14 59.66 191.56 126.17 188.91 191.90 126.17 191.97 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 11 3 # 11 118 ARG L 95 ARG~? 18.19 CL CL L2028 183 LYS L 142 LYS~? 23.18 CL CL L2009 317 ARG L 114 ARG~? 18.80 O1 GOL L3027 coo 76.57 109.19 73.41 73.86 110.26 72.16 118.02 154.26 199.66 118.36 154.13 196.59 coo 82.09 117.51 66.37 80.60 114.32 71.44 129.76 154.52 193.42 128.34 149.37 194.11 coo 65.21 120.62 58.76 63.62 123.14 59.66 138.87 157.00 210.52 138.32 154.00 210.96 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 12 3 # 12 118 ARG M 95 ARG~? 18.31 CL CL M2029 183 LYS M 142 LYS~? 19.90 CL CL M2017 317 ARG M 114 ARG~? 18.40 O3 GOL M3043 coo 76.57 109.19 73.41 73.86 110.26 72.16 122.27 205.29 183.68 122.29 202.20 183.61 coo 82.09 117.51 66.37 80.60 114.32 71.44 133.20 197.60 183.11 127.92 198.39 183.89 coo 65.21 120.62 58.76 63.62 123.14 59.66 144.35 213.37 180.84 143.79 213.88 183.80 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 13 3 # 13 118 ARG N 95 ARG~? 18.49 CL CL N2030 183 LYS N 142 LYS~? 14.74 O1 GOL N3029 317 ARG N 114 ARG~? 21.90 O2 GOL N3029 coo 76.57 109.19 73.41 73.86 110.26 72.16 215.46 144.14 140.72 215.90 144.66 143.75 coo 82.09 117.51 66.37 80.60 114.32 71.44 205.28 147.20 146.57 210.60 146.27 146.55 coo 65.21 120.62 58.76 63.62 123.14 59.66 196.45 148.76 129.28 196.55 145.72 129.25 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 14 3 # 14 118 ARG O 95 ARG~? 18.05 CL CL O2018 183 LYS O 142 LYS~? 15.43 O3 GOL O3026 317 ARG O 114 ARG~? 4.95 CL CL O2036 coo 76.57 109.19 73.41 73.86 110.26 72.16 121.75 137.79 148.01 121.99 140.87 148.18 coo 82.09 117.51 66.37 80.60 114.32 71.44 132.09 144.26 150.20 126.63 143.20 149.32 coo 65.21 120.62 58.76 63.62 123.14 59.66 141.08 127.21 153.72 140.82 126.86 150.69 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 14 hits 1bib_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 51 ARG~? 16.54 O3 GOL B3003 A 128 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 225 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 38.56 19.11 14.83 37.12 21.00 16.76 61.69 79.67 29.64 62.00 76.91 30.99 coo 36.48 24.43 22.02 36.86 26.34 21.13 66.40 88.57 34.15 65.18 90.26 34.28 coo 40.16 23.71 17.01 38.52 24.96 17.40 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 51 ARG~? 11.52 O3 GOL B3003 A 128 GLU B 56 GLU.? 9.23 C1 GOL B3003 A 225 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo 38.56 19.11 14.83 37.12 21.00 16.76 56.02 71.46 21.90 55.03 71.54 24.81 coo 36.48 24.43 22.02 36.86 26.34 21.13 52.16 66.04 13.94 53.39 65.68 12.39 coo 40.16 23.71 17.01 38.52 24.96 17.40 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG C 51 ARG~? 15.50 O3 GOL D3005 A 128 GLU C 56 GLU~? 17.52 CL CL C2004 A 225 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 38.56 19.11 14.83 37.12 21.00 16.76 50.80 26.41 78.15 53.63 27.50 78.75 coo 36.48 24.43 22.02 36.86 26.34 21.13 54.66 16.88 74.36 53.19 15.44 73.98 coo 40.16 23.71 17.01 38.52 24.96 17.40 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG D 51 ARG~? -12.62 C3 GOL D3005s A 128 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 225 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 38.56 19.11 14.83 37.12 21.00 16.76 44.97 36.17 83.73 45.77 36.49 80.75 coo 36.48 24.43 22.02 36.86 26.34 21.13 40.62 42.19 92.06 41.92 42.65 93.65 coo 40.16 23.71 17.01 38.52 24.96 17.40 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1bqc_c01 BETA-MANNANASE user 5 3 # 5 A 50 ARG E 55 ARG~? 13.47 C3 GOL E3004 A 128 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 225 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 38.56 19.11 14.83 37.12 21.00 16.76 47.24 86.77 68.80 48.11 84.54 66.77 coo 36.48 24.43 22.02 36.86 26.34 21.13 49.08 93.57 65.06 50.69 94.83 64.79 coo 40.16 23.71 17.01 38.52 24.96 17.40 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1bqc_c01 BETA-MANNANASE user 6 3 # 6 A 50 ARG G 51 ARG~? 21.90 CL CL C2006 A 128 GLU G 56 GLU.? 17.83 CL CL C2004 A 225 GLU G 52 GLU~? -23.30 CL CL C2006s coo 38.56 19.11 14.83 37.12 21.00 16.76 49.60 22.70 34.88 49.12 25.71 35.34 coo 36.48 24.43 22.02 36.86 26.34 21.13 43.97 14.81 40.22 44.85 13.00 40.58 coo 40.16 23.71 17.01 38.52 24.96 17.40 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1bqc_c01 BETA-MANNANASE user 7 3 # 7 A 50 ARG G 55 ARG~? 22.00 CL CL C2006 A 128 GLU G 56 GLU.? 17.83 CL CL C2004 A 225 GLU G 52 GLU~? -23.30 CL CL C2006s coo 38.56 19.11 14.83 37.12 21.00 16.76 44.23 21.19 35.75 42.00 23.24 36.25 coo 36.48 24.43 22.02 36.86 26.34 21.13 43.97 14.81 40.22 44.85 13.00 40.58 coo 40.16 23.71 17.01 38.52 24.96 17.40 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1bqc_c01 BETA-MANNANASE user 8 3 # 8 A 50 ARG H 51 ARG~? -11.05 O1 GOL H3006s A 128 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 225 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 38.56 19.11 14.83 37.12 21.00 16.76 55.75 78.18 80.83 58.67 78.05 79.79 coo 36.48 24.43 22.02 36.86 26.34 21.13 58.45 73.39 90.18 56.86 73.32 91.53 coo 40.16 23.71 17.01 38.52 24.96 17.40 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1bqc_c01 BETA-MANNANASE user 9 3 # 9 A 50 ARG J 51 ARG~? 27.44 CL CL J2002 A 128 GLU J 56 GLU.? 17.48 CL CL J2002 A 225 GLU J 52 GLU~? -23.89 CL CL J2002s coo 38.56 19.11 14.83 37.12 21.00 16.76 168.80 189.12 137.91 166.15 189.45 139.46 coo 36.48 24.43 22.02 36.86 26.34 21.13 164.69 183.53 129.34 166.31 182.92 128.17 coo 40.16 23.71 17.01 38.52 24.96 17.40 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1bqc_c01 BETA-MANNANASE user 10 3 # 10 A 50 ARG K 51 ARG~? -10.79 O3 GOL K3011s A 128 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 225 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 38.56 19.11 14.83 37.12 21.00 16.76 168.73 140.32 192.51 171.31 141.97 192.79 coo 36.48 24.43 22.02 36.86 26.34 21.13 172.89 131.40 187.88 171.30 130.10 187.44 coo 40.16 23.71 17.01 38.52 24.96 17.40 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1bqc_c01 BETA-MANNANASE user 11 3 # 11 A 50 ARG L 51 ARG~? 16.39 O3 GOL K3011 A 128 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 225 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 38.56 19.11 14.83 37.12 21.00 16.76 163.01 149.53 198.74 162.90 150.47 195.82 coo 36.48 24.43 22.02 36.86 26.34 21.13 158.53 155.21 207.26 159.92 155.54 208.73 coo 40.16 23.71 17.01 38.52 24.96 17.40 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bqc_c01 BETA-MANNANASE user 12 3 # 12 A 50 ARG L 55 ARG~? 21.00 O3 GOL K3011 A 128 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 225 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 38.56 19.11 14.83 37.12 21.00 16.76 158.05 151.49 200.24 157.97 153.99 198.35 coo 36.48 24.43 22.02 36.86 26.34 21.13 158.53 155.21 207.26 159.92 155.54 208.73 coo 40.16 23.71 17.01 38.52 24.96 17.40 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1bqc_c01 BETA-MANNANASE user 13 3 # 13 A 50 ARG M 51 ARG~? -9.68 O2 GOL M3007s A 128 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 225 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 38.56 19.11 14.83 37.12 21.00 16.76 166.66 199.07 188.11 163.90 199.62 189.28 coo 36.48 24.43 22.02 36.86 26.34 21.13 163.29 208.10 182.55 164.69 209.62 182.16 coo 40.16 23.71 17.01 38.52 24.96 17.40 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1bqc_c01 BETA-MANNANASE user 14 3 # 14 A 50 ARG M 55 ARG~? 12.49 O2 GOL M3007 A 128 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 225 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 38.56 19.11 14.83 37.12 21.00 16.76 162.29 201.15 185.73 159.83 200.25 187.37 coo 36.48 24.43 22.02 36.86 26.34 21.13 163.29 208.10 182.55 164.69 209.62 182.16 coo 40.16 23.71 17.01 38.52 24.96 17.40 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1bqc_c01 BETA-MANNANASE user 15 3 # 15 A 50 ARG N 51 ARG~? 10.93 O1 GOL N3008 A 128 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 225 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 38.56 19.11 14.83 37.12 21.00 16.76 172.16 145.36 140.78 174.78 144.98 142.37 coo 36.48 24.43 22.02 36.86 26.34 21.13 177.02 149.87 132.23 175.77 150.16 130.55 coo 40.16 23.71 17.01 38.52 24.96 17.40 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1bqc_c01 BETA-MANNANASE user 16 3 # 16 A 50 ARG O 51 ARG~? 16.43 O1 GOL N3008 A 128 GLU O 56 GLU.? 16.78 CL CL O2036 A 225 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 38.56 19.11 14.83 37.12 21.00 16.76 165.78 138.84 148.96 164.30 141.49 149.44 coo 36.48 24.43 22.02 36.86 26.34 21.13 160.60 130.40 154.07 161.73 128.68 154.54 coo 40.16 23.71 17.01 38.52 24.96 17.40 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1bqc_c01 BETA-MANNANASE user 17 3 # 17 A 50 ARG P 51 ARG~? 14.75 O3 GOL M3007 A 128 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 225 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 38.56 19.11 14.83 37.12 21.00 16.76 171.10 192.14 197.11 173.97 192.46 196.07 coo 36.48 24.43 22.02 36.86 26.34 21.13 174.58 187.04 206.13 173.17 186.75 207.60 coo 40.16 23.71 17.01 38.52 24.96 17.40 170.60 192.65 202.74 169.53 193.98 203.95 1bqc_c01 source 1bqc BETA-MANNANASE : 17 hits 1bqc_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 133 PHE.? 12.04 O2 GOL A3040 A 205 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 236 LYS A 142 LYS~? 20.36 CL CL A2020 coo 4.14 2.10 36.34 6.69 3.08 36.92 92.07 88.82 38.07 93.36 90.07 40.24 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 90.44 78.16 48.76 91.65 76.94 50.06 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 94.05 73.09 37.15 99.40 72.43 37.04 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 1 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN D 88 GLN.? 11.01 CL CL D2022 A 91 LEU D 85 LEU.? 11.70 CL CL D2022 A 133 GLU D 93 GLU~? 8.23 CL CL D2022 coo 43.58 43.67 66.73 42.32 42.78 68.15 -6.51 49.75 84.99 -6.00 51.28 86.45 coo 38.58 45.09 70.44 38.28 45.21 72.59 -5.44 54.10 82.44 -4.32 53.61 80.64 coo 44.05 36.87 70.65 43.15 38.64 69.97 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN E 89 GLN.? 11.91 CL CL E2032 A 91 LEU E 85 LEU.? 11.55 CL CL E2032 A 133 GLU E 93 GLU~? 8.42 CL CL E2032 coo 43.58 43.67 66.73 42.32 42.78 68.15 1.74 96.28 56.82 2.47 98.31 56.99 coo 38.58 45.09 70.44 38.28 45.21 72.59 2.28 95.28 52.42 2.76 93.21 52.90 coo 44.05 36.87 70.65 43.15 38.64 69.97 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN E 144 GLN~? 13.80 O3 GOL E3002 A 91 LEU E 147 LEU~? 9.23 C3 GOL E3002 A 133 GLU E 141 GLU~? 19.75 O1 GOL D3019 coo 43.58 43.67 66.73 42.32 42.78 68.15 22.86 81.65 61.34 23.71 82.87 59.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 19.19 83.00 56.15 20.63 84.47 55.58 coo 44.05 36.87 70.65 43.15 38.64 69.97 21.80 82.16 67.66 21.51 80.62 69.17 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN J 88 GLN.? 10.71 CL CL J2026 A 91 LEU J 85 LEU.? 11.46 CL CL J2026 A 133 GLU J 93 GLU~? 8.18 CL CL J2026 coo 43.58 43.67 66.73 42.32 42.78 68.15 116.12 182.84 127.15 117.48 182.26 125.60 coo 38.58 45.09 70.44 38.28 45.21 72.59 116.24 178.65 129.95 117.21 179.01 131.86 coo 44.05 36.87 70.65 43.15 38.64 69.97 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN O 88 GLN.? 13.36 CL CL O2018 A 91 LEU O 85 LEU.? 14.21 CL CL O2018 A 133 GLU O 93 GLU~? 9.72 CL CL O2018 coo 43.58 43.67 66.73 42.32 42.78 68.15 111.58 133.10 155.08 112.83 132.94 156.81 coo 38.58 45.09 70.44 38.28 45.21 72.59 112.49 136.21 158.93 113.28 138.18 158.58 coo 44.05 36.87 70.65 43.15 38.64 69.97 119.95 130.02 153.81 119.63 127.98 154.32 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN D 88 GLN.? 11.01 CL CL D2022 B 591 LEU D 85 LEU.? 11.70 CL CL D2022 B 633 GLU D 93 GLU~? 8.23 CL CL D2022 coo 88.06 44.34 57.19 89.06 45.53 55.74 -6.51 49.75 84.99 -6.00 51.28 86.45 coo 86.70 48.66 52.61 87.15 48.69 50.51 -5.44 54.10 82.44 -4.32 53.61 80.64 coo 95.42 44.52 54.43 93.46 45.31 54.70 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN E 89 GLN.? 11.91 CL CL E2032 B 591 LEU E 85 LEU.? 11.55 CL CL E2032 B 633 GLU E 93 GLU~? 8.42 CL CL E2032 coo 88.06 44.34 57.19 89.06 45.53 55.74 1.74 96.28 56.82 2.47 98.31 56.99 coo 86.70 48.66 52.61 87.15 48.69 50.51 2.28 95.28 52.42 2.76 93.21 52.90 coo 95.42 44.52 54.43 93.46 45.31 54.70 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN J 88 GLN.? 10.71 CL CL J2026 B 591 LEU J 85 LEU.? 11.46 CL CL J2026 B 633 GLU J 93 GLU~? 8.18 CL CL J2026 coo 88.06 44.34 57.19 89.06 45.53 55.74 116.12 182.84 127.15 117.48 182.26 125.60 coo 86.70 48.66 52.61 87.15 48.69 50.51 116.24 178.65 129.95 117.21 179.01 131.86 coo 95.42 44.52 54.43 93.46 45.31 54.70 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN O 88 GLN.? 13.36 CL CL O2018 B 591 LEU O 85 LEU.? 14.21 CL CL O2018 B 633 GLU O 93 GLU~? 9.72 CL CL O2018 coo 88.06 44.34 57.19 89.06 45.53 55.74 111.58 133.10 155.08 112.83 132.94 156.81 coo 86.70 48.66 52.61 87.15 48.69 50.51 112.49 136.21 158.93 113.28 138.18 158.58 coo 95.42 44.52 54.43 93.46 45.31 54.70 119.95 130.02 153.81 119.63 127.98 154.32 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN D 88 GLN.? 11.01 CL CL D2022 C1091 LEU D 85 LEU.? 11.70 CL CL D2022 C1133 GLU D 93 GLU~? 8.23 CL CL D2022 coo 68.29 34.44 43.03 66.67 34.74 44.37 -6.51 49.75 84.99 -6.00 51.28 86.45 coo 65.83 38.95 47.05 65.46 38.90 49.20 -5.44 54.10 82.44 -4.32 53.61 80.64 coo 63.14 29.39 46.25 63.84 31.31 45.74 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN E 89 GLN.? 11.91 CL CL E2032 C1091 LEU E 85 LEU.? 11.55 CL CL E2032 C1133 GLU E 93 GLU~? 8.42 CL CL E2032 coo 68.29 34.44 43.03 66.67 34.74 44.37 1.74 96.28 56.82 2.47 98.31 56.99 coo 65.83 38.95 47.05 65.46 38.90 49.20 2.28 95.28 52.42 2.76 93.21 52.90 coo 63.14 29.39 46.25 63.84 31.31 45.74 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN E 144 GLN~? 13.80 O3 GOL E3002 C1091 LEU E 147 LEU~? 9.23 C3 GOL E3002 C1133 GLU E 141 GLU~? 19.75 O1 GOL D3019 coo 68.29 34.44 43.03 66.67 34.74 44.37 22.86 81.65 61.34 23.71 82.87 59.78 coo 65.83 38.95 47.05 65.46 38.90 49.20 19.19 83.00 56.15 20.63 84.47 55.58 coo 63.14 29.39 46.25 63.84 31.31 45.74 21.80 82.16 67.66 21.51 80.62 69.17 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN J 88 GLN.? 10.71 CL CL J2026 C1091 LEU J 85 LEU.? 11.46 CL CL J2026 C1133 GLU J 93 GLU~? 8.18 CL CL J2026 coo 68.29 34.44 43.03 66.67 34.74 44.37 116.12 182.84 127.15 117.48 182.26 125.60 coo 65.83 38.95 47.05 65.46 38.90 49.20 116.24 178.65 129.95 117.21 179.01 131.86 coo 63.14 29.39 46.25 63.84 31.31 45.74 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN O 88 GLN.? 13.36 CL CL O2018 C1091 LEU O 85 LEU.? 14.21 CL CL O2018 C1133 GLU O 93 GLU~? 9.72 CL CL O2018 coo 68.29 34.44 43.03 66.67 34.74 44.37 111.58 133.10 155.08 112.83 132.94 156.81 coo 65.83 38.95 47.05 65.46 38.90 49.20 112.49 136.21 158.93 113.28 138.18 158.58 coo 63.14 29.39 46.25 63.84 31.31 45.74 119.95 130.02 153.81 119.63 127.98 154.32 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 156 GLN.? -9.57 O3 GOL A3037s A 91 LEU A 159 LEU.? 11.33 O1 GOL A3037 A 133 GLU A 73 GLU~? -3.07 O3 GOL A3037s coo 38.23 53.34 67.59 38.84 53.87 69.56 98.62 74.73 53.93 96.56 74.69 54.22 coo 35.40 53.22 73.30 35.37 54.87 74.74 105.70 76.86 50.52 103.64 76.30 50.58 coo 45.08 56.04 70.60 43.15 55.19 70.77 94.58 81.89 51.70 95.31 83.75 52.44 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 156 GLN.? -2.70 O3 GOL B3015s A 91 LEU B 159 LEU.? 11.27 O3 GOL B3015 A 133 GLU B 73 GLU~? 6.38 O3 GOL B3023 coo 38.23 53.34 67.59 38.84 53.87 69.56 14.10 56.69 22.58 16.03 56.11 23.16 coo 35.40 53.22 73.30 35.37 54.87 74.74 8.42 60.44 18.12 10.32 60.25 19.11 coo 45.08 56.04 70.60 43.15 55.19 70.77 19.80 56.19 16.30 19.32 55.14 14.52 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 156 GLN.? -2.71 C3 GOL C3036s A 91 LEU C 159 LEU.? 8.70 CL CL C2031 A 133 GLU C 73 GLU~? 6.99 O1 GOL C3036 coo 38.23 53.34 67.59 38.84 53.87 69.56 92.34 23.45 62.68 90.44 23.91 61.88 coo 35.40 53.22 73.30 35.37 54.87 74.74 98.02 19.71 67.34 96.17 20.81 66.94 coo 45.08 56.04 70.60 43.15 55.19 70.77 86.57 17.41 63.72 86.98 15.43 63.06 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN D 88 GLN.? 11.01 CL CL D2022 A 91 LEU D 85 LEU.? 11.70 CL CL D2022 A 133 GLU D 93 GLU~? 8.23 CL CL D2022 coo 38.23 53.34 67.59 38.84 53.87 69.56 -6.51 49.75 84.99 -6.00 51.28 86.45 coo 35.40 53.22 73.30 35.37 54.87 74.74 -5.44 54.10 82.44 -4.32 53.61 80.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN E 89 GLN.? 11.91 CL CL E2032 A 91 LEU E 85 LEU.? 11.55 CL CL E2032 A 133 GLU E 93 GLU~? 8.42 CL CL E2032 coo 38.23 53.34 67.59 38.84 53.87 69.56 1.74 96.28 56.82 2.47 98.31 56.99 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.28 95.28 52.42 2.76 93.21 52.90 coo 45.08 56.04 70.60 43.15 55.19 70.77 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN E 144 GLN~? 13.80 O3 GOL E3002 A 91 LEU E 147 LEU~? 9.23 C3 GOL E3002 A 133 GLU E 141 GLU~? 19.75 O1 GOL D3019 coo 38.23 53.34 67.59 38.84 53.87 69.56 22.86 81.65 61.34 23.71 82.87 59.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 19.19 83.00 56.15 20.63 84.47 55.58 coo 45.08 56.04 70.60 43.15 55.19 70.77 21.80 82.16 67.66 21.51 80.62 69.17 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN E 156 GLN.? -2.61 C3 GOL E3002s A 91 LEU E 159 LEU.? 11.49 O1 GOL E3002 A 133 GLU E 73 GLU~? -6.85 O1 GOL E3022s coo 38.23 53.34 67.59 38.84 53.87 69.56 14.23 83.94 47.81 16.25 83.38 47.77 coo 35.40 53.22 73.30 35.37 54.87 74.74 7.86 88.53 50.59 9.77 87.52 50.83 coo 45.08 56.04 70.60 43.15 55.19 70.77 19.82 90.31 48.74 19.50 92.07 47.58 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN F 156 GLN.? -14.31 O3 GOL F3039s A 91 LEU F 159 LEU.? 12.58 CL CL F2023 A 133 GLU F 73 GLU~? 5.19 O3 GOL F3039 coo 38.23 53.34 67.59 38.84 53.87 69.56 97.83 44.29 32.68 95.99 45.28 32.70 coo 35.40 53.22 73.30 35.37 54.87 74.74 104.21 39.59 30.34 102.19 39.92 30.93 coo 45.08 56.04 70.60 43.15 55.19 70.77 93.55 43.24 25.35 94.46 43.89 23.55 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN H 156 GLN.? -8.49 C1 GOL H3016s A 91 LEU H 159 LEU.? 12.60 CL CL H2024 A 133 GLU H 73 GLU~? -8.72 CL CL H2014s coo 38.23 53.34 67.59 38.84 53.87 69.56 93.11 53.95 84.03 91.11 53.67 83.58 coo 35.40 53.22 73.30 35.37 54.87 74.74 99.48 57.40 87.82 97.61 57.56 86.72 coo 45.08 56.04 70.60 43.15 55.19 70.77 87.54 56.19 90.14 87.78 55.44 92.11 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN J 88 GLN.? 10.71 CL CL J2026 A 91 LEU J 85 LEU.? 11.46 CL CL J2026 A 133 GLU J 93 GLU~? 8.18 CL CL J2026 coo 38.23 53.34 67.59 38.84 53.87 69.56 116.12 182.84 127.15 117.48 182.26 125.60 coo 35.40 53.22 73.30 35.37 54.87 74.74 116.24 178.65 129.95 117.21 179.01 131.86 coo 45.08 56.04 70.60 43.15 55.19 70.77 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN K 156 GLN.? -2.47 O2 GOL K3009s A 91 LEU K 159 LEU.? 11.20 O2 GOL K3009 A 133 GLU K 73 GLU~? 7.36 C3 GOL K3041 coo 38.23 53.34 67.59 38.84 53.87 69.56 209.60 140.38 174.58 207.54 140.72 174.28 coo 35.40 53.22 73.30 35.37 54.87 74.74 215.51 136.86 179.27 213.56 137.79 178.87 coo 45.08 56.04 70.60 43.15 55.19 70.77 204.07 133.93 175.85 204.65 132.02 175.03 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN M 156 GLN.? -9.47 O3 GOL M3042s A 91 LEU M 159 LEU.? 11.51 C2 GOL M3042 A 133 GLU M 73 GLU~? -3.31 O3 GOL M3042s coo 38.23 53.34 67.59 38.84 53.87 69.56 128.00 197.52 166.52 130.05 197.23 166.19 coo 35.40 53.22 73.30 35.37 54.87 74.74 121.55 201.64 169.75 123.57 200.68 169.84 coo 45.08 56.04 70.60 43.15 55.19 70.77 133.35 204.22 167.43 132.84 205.99 166.43 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN O 88 GLN.? 13.36 CL CL O2018 A 91 LEU O 85 LEU.? 14.21 CL CL O2018 A 133 GLU O 93 GLU~? 9.72 CL CL O2018 coo 38.23 53.34 67.59 38.84 53.87 69.56 111.58 133.10 155.08 112.83 132.94 156.81 coo 35.40 53.22 73.30 35.37 54.87 74.74 112.49 136.21 158.93 113.28 138.18 158.58 coo 45.08 56.04 70.60 43.15 55.19 70.77 119.95 130.02 153.81 119.63 127.98 154.32 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN O 156 GLN.? -2.63 O3 GOL O3013s A 91 LEU O 159 LEU.? 11.94 O3 GOL O3013 A 133 GLU O 73 GLU~? 6.85 O1 GOL O3013 coo 38.23 53.34 67.59 38.84 53.87 69.56 125.08 144.94 166.06 127.10 145.21 166.69 coo 35.40 53.22 73.30 35.37 54.87 74.74 118.64 141.59 162.03 120.68 142.42 162.11 coo 45.08 56.04 70.60 43.15 55.19 70.77 129.73 137.78 165.68 128.97 136.10 166.67 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 14 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 92 ASP~? 15.30 CL CL A2020 A 354 GLU A 93 GLU~? 8.07 CL CL A2020 A 421 ASP A 127 ASP.? 12.37 CL CL A2020 coo 31.05 49.37 64.51 31.97 51.11 63.85 108.94 81.51 35.78 108.70 83.14 34.47 coo 29.07 50.42 58.36 29.02 52.18 59.49 106.40 86.90 39.80 107.05 88.84 40.38 coo 30.82 59.76 58.47 31.12 59.02 60.40 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 92 ASP~? 16.05 CL CL B2010 A 354 GLU B 93 GLU~? 9.70 CL CL B2010 A 421 ASP B 127 ASP.? 11.35 CL CL B2010 coo 31.05 49.37 64.51 31.97 51.11 63.85 9.78 73.89 9.95 11.15 74.42 8.49 coo 29.07 50.42 58.36 29.02 52.18 59.49 11.87 67.96 6.38 12.21 67.44 4.38 coo 30.82 59.76 58.47 31.12 59.02 60.40 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP C 92 ASP~? 15.08 CL CL C2021 A 354 GLU C 93 GLU~? 8.05 CL CL C2021 A 421 ASP C 127 ASP.? 10.87 CL CL C2011 coo 31.05 49.37 64.51 31.97 51.11 63.85 96.74 14.44 81.93 95.51 12.97 82.84 coo 29.07 50.42 58.36 29.02 52.18 59.49 94.51 9.91 76.89 94.48 7.78 76.63 coo 30.82 59.76 58.47 31.12 59.02 60.40 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP D 92 ASP~? 15.62 CL CL D2022 A 354 GLU D 93 GLU~? 8.23 CL CL D2022 A 421 ASP D 127 ASP.? 11.17 CL CL D2012 coo 31.05 49.37 64.51 31.97 51.11 63.85 -1.67 42.91 85.09 -1.08 41.92 86.85 coo 29.07 50.42 58.36 29.02 52.18 59.49 0.77 48.16 89.31 0.23 49.10 91.12 coo 30.82 59.76 58.47 31.12 59.02 60.40 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP E 92 ASP~? 15.39 CL CL E2032 A 354 GLU E 93 GLU~? 8.42 CL CL E2032 A 421 ASP E 127 ASP.? 11.39 CL CL E2013 coo 31.05 49.37 64.51 31.97 51.11 63.85 6.40 96.69 64.15 7.81 98.00 64.97 coo 29.07 50.42 58.36 29.02 52.18 59.49 9.96 100.16 58.92 10.04 102.16 58.24 coo 30.82 59.76 58.47 31.12 59.02 60.40 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP F 92 ASP~? 15.33 CL CL F2023 A 354 GLU F 93 GLU~? 8.36 CL CL F2023 A 421 ASP F 127 ASP.? 10.85 CL CL F2034 coo 31.05 49.37 64.51 31.97 51.11 63.85 104.11 24.69 25.10 103.20 23.88 23.38 coo 29.07 50.42 58.36 29.02 52.18 59.49 102.94 29.85 20.29 103.30 29.96 18.20 coo 30.82 59.76 58.47 31.12 59.02 60.40 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP G 92 ASP~? 15.60 CL CL G2033 A 354 GLU G 93 GLU~? 8.63 CL CL G2033 A 421 ASP G 127 ASP.? 12.80 CL CL G2033 coo 31.05 49.37 64.51 31.97 51.11 63.85 2.22 20.23 31.66 3.30 18.41 31.31 coo 29.07 50.42 58.36 29.02 52.18 59.49 3.64 16.49 37.62 3.03 14.55 38.23 coo 30.82 59.76 58.47 31.12 59.02 60.40 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP H 92 ASP~? 15.85 CL CL H2024 A 354 GLU H 93 GLU~? 8.72 CL CL H2024 A 421 ASP H 127 ASP.? 11.27 CL CL H2014 coo 31.05 49.37 64.51 31.97 51.11 63.85 101.24 72.29 93.07 100.11 73.39 94.44 coo 29.07 50.42 58.36 29.02 52.18 59.49 97.56 68.07 97.57 97.65 67.50 99.59 coo 30.82 59.76 58.47 31.12 59.02 60.40 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP I 92 ASP~? 15.56 CL CL I2025 A 354 GLU I 93 GLU~? 8.40 CL CL I2025 A 421 ASP I 127 ASP.? 10.93 CL CL I2015 coo 31.05 49.37 64.51 31.97 51.11 63.85 222.01 200.70 150.15 220.98 202.18 149.11 coo 29.07 50.42 58.36 29.02 52.18 59.49 219.77 205.57 155.06 219.86 207.68 155.25 coo 30.82 59.76 58.47 31.12 59.02 60.40 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP J 92 ASP~? 15.35 CL CL J2026 A 354 GLU J 93 GLU~? 8.18 CL CL J2026 A 421 ASP J 127 ASP.? 11.08 CL CL J2016 coo 31.05 49.37 64.51 31.97 51.11 63.85 122.14 189.51 128.78 123.73 190.15 127.54 coo 29.07 50.42 58.36 29.02 52.18 59.49 124.50 183.71 125.04 124.44 183.21 122.99 coo 30.82 59.76 58.47 31.12 59.02 60.40 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP K 92 ASP~? 16.19 CL CL K2027 A 354 GLU K 93 GLU~? 8.22 CL CL K2027 A 421 ASP K 127 ASP.? 12.37 CL CL K2027 coo 31.05 49.37 64.51 31.97 51.11 63.85 214.98 131.64 193.77 214.74 130.33 195.35 coo 29.07 50.42 58.36 29.02 52.18 59.49 212.85 126.80 188.86 213.03 124.72 188.44 coo 30.82 59.76 58.47 31.12 59.02 60.40 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP L 92 ASP~? 15.46 CL CL L2028 A 354 GLU L 93 GLU~? 8.05 CL CL L2028 A 421 ASP L 127 ASP.? 11.05 CL CL L2009 coo 31.05 49.37 64.51 31.97 51.11 63.85 115.70 154.99 203.31 116.12 153.70 204.91 coo 29.07 50.42 58.36 29.02 52.18 59.49 118.11 159.89 208.04 117.71 160.95 209.86 coo 30.82 59.76 58.47 31.12 59.02 60.40 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 13 3 # 13 A 325 ASP M 92 ASP~? 15.40 CL CL M2029 A 354 GLU M 93 GLU~? 8.60 CL CL M2029 A 421 ASP M 127 ASP.? 9.06 CL CL M2017 coo 31.05 49.37 64.51 31.97 51.11 63.85 120.06 209.18 183.48 121.50 210.55 184.17 coo 29.07 50.42 58.36 29.02 52.18 59.49 123.31 213.00 178.36 123.21 215.02 177.75 coo 30.82 59.76 58.47 31.12 59.02 60.40 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 14 3 # 14 A 325 ASP N 92 ASP~? 15.48 CL CL N2030 A 354 GLU N 93 GLU~? 8.57 CL CL N2030 A 421 ASP N 127 ASP.? 12.60 CL CL N2030 coo 31.05 49.37 64.51 31.97 51.11 63.85 219.13 143.58 136.78 218.22 142.74 135.01 coo 29.07 50.42 58.36 29.02 52.18 59.49 217.47 148.79 132.22 217.76 148.97 130.14 coo 30.82 59.76 58.47 31.12 59.02 60.40 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 15 3 # 15 A 325 ASP O 92 ASP~? 15.96 CL CL O2018 A 354 GLU O 93 GLU~? 9.72 CL CL O2018 A 421 ASP O 127 ASP.? 11.33 CL CL O2018 coo 31.05 49.37 64.51 31.97 51.11 63.85 118.21 134.06 148.13 119.12 132.25 147.57 coo 29.07 50.42 58.36 29.02 52.18 59.49 119.95 130.02 153.81 119.63 127.98 154.32 coo 30.82 59.76 58.47 31.12 59.02 60.40 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 16 3 # 16 A 325 ASP P 92 ASP~? 16.23 CL CL P2019 A 354 GLU P 93 GLU~? 9.65 CL CL P2019 A 421 ASP P 127 ASP.? 11.05 CL CL P2019 coo 31.05 49.37 64.51 31.97 51.11 63.85 217.62 187.96 206.84 216.52 189.08 208.26 coo 29.07 50.42 58.36 29.02 52.18 59.49 214.54 183.14 211.27 214.54 182.92 213.36 coo 30.82 59.76 58.47 31.12 59.02 60.40 207.19 183.81 214.61 207.22 185.89 215.11 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 16 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP B 92 ASP~? 16.05 CL CL B2010 B 354 GLU B 93 GLU~? 9.70 CL CL B2010 B 421 ASP B 127 ASP.? 11.35 CL CL B2010 coo 25.90 8.19 53.87 25.36 6.97 52.29 9.78 73.89 9.95 11.15 74.42 8.49 coo 27.87 10.66 47.95 27.82 8.60 48.27 11.87 67.96 6.38 12.21 67.44 4.38 coo 26.02 1.87 43.38 25.90 1.97 45.49 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP D 92 ASP~? 15.62 CL CL D2022 B 354 GLU D 93 GLU~? 8.23 CL CL D2022 B 421 ASP D 127 ASP.? 11.17 CL CL D2012 coo 25.90 8.19 53.87 25.36 6.97 52.29 -1.67 42.91 85.09 -1.08 41.92 86.85 coo 27.87 10.66 47.95 27.82 8.60 48.27 0.77 48.16 89.31 0.23 49.10 91.12 coo 26.02 1.87 43.38 25.90 1.97 45.49 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP E 92 ASP~? 15.39 CL CL E2032 B 354 GLU E 93 GLU~? 8.42 CL CL E2032 B 421 ASP E 127 ASP.? 11.39 CL CL E2013 coo 25.90 8.19 53.87 25.36 6.97 52.29 6.40 96.69 64.15 7.81 98.00 64.97 coo 27.87 10.66 47.95 27.82 8.60 48.27 9.96 100.16 58.92 10.04 102.16 58.24 coo 26.02 1.87 43.38 25.90 1.97 45.49 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP I 92 ASP~? 15.56 CL CL I2025 B 354 GLU I 93 GLU~? 8.40 CL CL I2025 B 421 ASP I 127 ASP.? 10.93 CL CL I2015 coo 25.90 8.19 53.87 25.36 6.97 52.29 222.01 200.70 150.15 220.98 202.18 149.11 coo 27.87 10.66 47.95 27.82 8.60 48.27 219.77 205.57 155.06 219.86 207.68 155.25 coo 26.02 1.87 43.38 25.90 1.97 45.49 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP J 92 ASP~? 15.35 CL CL J2026 B 354 GLU J 93 GLU~? 8.18 CL CL J2026 B 421 ASP J 127 ASP.? 11.08 CL CL J2016 coo 25.90 8.19 53.87 25.36 6.97 52.29 122.14 189.51 128.78 123.73 190.15 127.54 coo 27.87 10.66 47.95 27.82 8.60 48.27 124.50 183.71 125.04 124.44 183.21 122.99 coo 26.02 1.87 43.38 25.90 1.97 45.49 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP M 92 ASP~? 15.40 CL CL M2029 B 354 GLU M 93 GLU~? 8.60 CL CL M2029 B 421 ASP M 127 ASP.? 9.06 CL CL M2017 coo 25.90 8.19 53.87 25.36 6.97 52.29 120.06 209.18 183.48 121.50 210.55 184.17 coo 27.87 10.66 47.95 27.82 8.60 48.27 123.31 213.00 178.36 123.21 215.02 177.75 coo 26.02 1.87 43.38 25.90 1.97 45.49 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP P 92 ASP~? 16.23 CL CL P2019 B 354 GLU P 93 GLU~? 9.65 CL CL P2019 B 421 ASP P 127 ASP.? 11.05 CL CL P2019 coo 25.90 8.19 53.87 25.36 6.97 52.29 217.62 187.96 206.84 216.52 189.08 208.26 coo 27.87 10.66 47.95 27.82 8.60 48.27 214.54 183.14 211.27 214.54 182.92 213.36 coo 26.02 1.87 43.38 25.90 1.97 45.49 207.19 183.81 214.61 207.22 185.89 215.11 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 7 hits 1bvz_c09 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 408 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 462 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 106.32 81.43 56.18 105.60 83.26 56.91 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 100.57 80.52 55.08 97.88 80.73 54.34 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS C 158 HIS.? 10.62 CL CL C2021 A 408 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 462 ARG C 155 ARG.? 9.50 CL CL C2031 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 98.99 15.14 61.83 98.04 13.53 60.88 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 93.23 17.43 61.74 90.40 17.73 61.84 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1c82_c01 HYALURONATE LYASE user 3 3 # 3 A 399 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 408 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 462 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 0.86 62.48 80.06 1.83 63.91 81.27 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.86 61.00 80.62 9.60 60.40 80.64 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1c82_c01 HYALURONATE LYASE user 4 3 # 4 A 399 HIS E 158 HIS.? 10.67 CL CL E2032 A 408 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 462 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 8.21 91.93 44.16 9.29 93.32 43.02 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 13.76 89.62 45.68 16.45 89.35 46.36 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1c82_c01 HYALURONATE LYASE user 5 3 # 5 A 399 HIS G 158 HIS.? 10.64 CL CL G2033 A 408 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 462 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 0.65 25.49 51.61 1.26 23.82 52.74 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.53 26.08 51.42 9.33 25.84 51.41 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1c82_c01 HYALURONATE LYASE user 6 3 # 6 A 399 HIS H 158 HIS.? 10.33 CL CL H2024 A 408 TYR H 157 TYR.? -11.04 CL CL H2014s A 462 ARG H 155 ARG.? 17.02 CL CL H2024 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 98.94 51.80 92.35 97.68 51.03 93.84 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 93.68 52.87 90.01 90.96 53.43 89.67 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1c82_c01 HYALURONATE LYASE user 7 3 # 7 A 399 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 408 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 462 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.18 169.23 132.79 122.06 167.98 131.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 126.93 169.72 134.52 129.73 169.94 134.63 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1c82_c01 HYALURONATE LYASE user 8 3 # 8 A 399 HIS L 158 HIS.? 11.11 CL CL L2028 A 408 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 462 ARG L 155 ARG.? 15.58 CL CL L2028 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 117.45 174.63 198.96 118.55 176.04 200.05 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 123.19 173.24 198.15 125.89 172.62 198.32 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1c82_c01 HYALURONATE LYASE user 9 3 # 9 A 399 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 408 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 462 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.40 205.18 163.43 122.55 206.46 162.23 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 127.03 203.34 164.58 129.75 203.18 165.07 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1c82_c01 HYALURONATE LYASE user 10 3 # 10 A 399 HIS N 158 HIS.? 10.50 CL CL N2030 A 408 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 462 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 220.32 164.11 138.58 219.66 165.01 136.80 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 214.45 164.07 139.74 211.68 163.84 139.51 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 219.49 166.94 144.14 219.55 170.01 143.56 1c82_c01 source 1c82 HYALURONATE LYASE : 10 hits 1c82_c01 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 79 HIS~? -3.92 CL CL A2020s A 408 TYR A 75 TYR~? 11.96 CL CL A2020 A 480 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 103.72 86.36 44.76 104.87 88.01 44.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 97.97 81.77 42.85 98.10 80.04 40.64 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS A 79 HIS~? -3.92 CL CL A2020s A 408 TYR A 75 TYR~? 11.96 CL CL A2020 A 480 ARG A 114 ARG~? 18.99 O2 GOL A3040 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 103.72 86.36 44.76 104.87 88.01 44.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 97.97 81.77 42.85 98.10 80.04 40.64 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 86.11 90.82 36.33 86.92 90.68 33.36 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS A 79 HIS~? -3.92 CL CL A2020s A 408 TYR A 75 TYR~? 11.96 CL CL A2020 A 480 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 103.72 86.36 44.76 104.87 88.01 44.15 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 97.97 81.77 42.85 98.10 80.04 40.64 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 408 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 480 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 106.32 81.43 56.18 105.60 83.26 56.91 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 100.57 80.52 55.08 97.88 80.73 54.34 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1c82_c02 HYALURONATE LYASE user 5 3 # 5 A 399 HIS B 158 HIS.? 12.55 CL CL B2010 A 408 TYR B 157 TYR.? 7.53 O1 GOL B3015 A 480 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 7.56 53.89 15.18 8.49 52.54 13.87 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 13.23 54.49 17.04 16.01 54.48 17.30 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1c82_c02 HYALURONATE LYASE user 6 3 # 6 A 399 HIS C 79 HIS~? -4.32 CL CL C2021s A 408 TYR C 75 TYR~? 10.50 CL CL C2011 A 480 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 92.85 10.89 71.99 93.43 9.18 73.06 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 87.86 16.77 72.91 87.86 18.43 75.14 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1c82_c02 HYALURONATE LYASE user 7 3 # 7 A 399 HIS C 79 HIS~? -4.32 CL CL C2021s A 408 TYR C 75 TYR~? 10.50 CL CL C2011 A 480 ARG C 114 ARG~? 19.78 CL CL C2011 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 92.85 10.89 71.99 93.43 9.18 73.06 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 87.86 16.77 72.91 87.86 18.43 75.14 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 73.29 10.73 76.57 73.51 10.59 79.63 ULMN 3 1c82_c02 HYALURONATE LYASE user 8 3 # 8 A 399 HIS C 79 HIS~? -4.32 CL CL C2021s A 408 TYR C 75 TYR~? 10.50 CL CL C2011 A 480 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 92.85 10.89 71.99 93.43 9.18 73.06 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 87.86 16.77 72.91 87.86 18.43 75.14 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1c82_c02 HYALURONATE LYASE user 9 3 # 9 A 399 HIS D 79 HIS~? -4.57 CL CL D2022s A 408 TYR D 75 TYR~? 10.03 CL CL D2012 A 480 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 3.57 52.49 87.96 2.52 51.97 89.71 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 9.41 49.60 83.94 9.22 47.13 82.70 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1c82_c02 HYALURONATE LYASE user 10 3 # 10 A 399 HIS D 79 HIS~? -4.57 CL CL D2022s A 408 TYR D 75 TYR~? 10.03 CL CL D2012 A 480 ARG D 114 ARG~? 18.11 O3 GOL D3018 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 3.57 52.49 87.96 2.52 51.97 89.71 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 9.41 49.60 83.94 9.22 47.13 82.70 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 21.28 44.89 93.84 20.52 41.96 94.27 ULMN 3 1c82_c02 HYALURONATE LYASE user 11 3 # 11 A 399 HIS D 79 HIS~? -4.57 CL CL D2022s A 408 TYR D 75 TYR~? 10.03 CL CL D2012 A 480 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 3.57 52.49 87.96 2.52 51.97 89.71 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 9.41 49.60 83.94 9.22 47.13 82.70 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1c82_c02 HYALURONATE LYASE user 12 3 # 12 A 399 HIS E 79 HIS~? -4.18 CL CL E2032s A 408 TYR E 75 TYR~? 10.13 CL CL E2013 A 480 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.36 98.35 54.34 11.69 100.32 54.60 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 16.89 92.83 57.30 16.35 91.61 59.76 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1c82_c02 HYALURONATE LYASE user 13 3 # 13 A 399 HIS E 79 HIS~? -4.18 CL CL E2032s A 408 TYR E 75 TYR~? 10.13 CL CL E2013 A 480 ARG E 114 ARG~? 18.39 O3 GOL E3022 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.36 98.35 54.34 11.69 100.32 54.60 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 16.89 92.83 57.30 16.35 91.61 59.76 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 31.03 99.62 62.12 30.45 100.18 65.09 ULMN 3 1c82_c02 HYALURONATE LYASE user 14 3 # 14 A 399 HIS E 79 HIS~? -4.18 CL CL E2032s A 408 TYR E 75 TYR~? 10.13 CL CL E2013 A 480 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 12.36 98.35 54.34 11.69 100.32 54.60 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 16.89 92.83 57.30 16.35 91.61 59.76 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1c82_c02 HYALURONATE LYASE user 15 3 # 15 A 399 HIS F 79 HIS~? -4.63 CL CL F2023s A 408 TYR F 75 TYR~? 9.99 CL CL F2034 A 480 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.04 34.65 20.79 101.93 33.69 19.16 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 95.01 33.97 25.26 94.64 31.83 27.03 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1c82_c02 HYALURONATE LYASE user 16 3 # 16 A 399 HIS F 79 HIS~? -4.63 CL CL F2023s A 408 TYR F 75 TYR~? 9.99 CL CL F2034 A 480 ARG F 114 ARG~? 18.29 CL CL F2035 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.04 34.65 20.79 101.93 33.69 19.16 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 95.01 33.97 25.26 94.64 31.83 27.03 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 81.94 30.32 15.98 81.85 27.28 16.31 ULMN 3 1c82_c02 HYALURONATE LYASE user 17 3 # 17 A 399 HIS F 79 HIS~? -4.63 CL CL F2023s A 408 TYR F 75 TYR~? 9.99 CL CL F2034 A 480 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 101.04 34.65 20.79 101.93 33.69 19.16 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 95.01 33.97 25.26 94.64 31.83 27.03 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1c82_c02 HYALURONATE LYASE user 18 3 # 18 A 399 HIS F 158 HIS.? -10.90 CL CL F2023s A 408 TYR F 157 TYR.? -10.36 O3 GOL F3039s A 480 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 105.92 45.34 26.29 105.13 46.33 24.62 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 100.15 45.18 26.97 97.32 45.17 26.68 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1c82_c02 HYALURONATE LYASE user 19 3 # 19 A 399 HIS G 79 HIS~? -4.46 CL CL G2033s A 408 TYR G 75 TYR~? 12.69 CL CL G2033 A 480 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 5.20 17.85 42.65 4.12 16.10 42.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 11.49 22.21 40.76 11.82 23.42 38.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1c82_c02 HYALURONATE LYASE user 20 3 # 20 A 399 HIS G 79 HIS~? -4.46 CL CL G2033s A 408 TYR G 75 TYR~? 12.69 CL CL G2033 A 480 ARG G 114 ARG~? 19.08 O3 GOL G3038 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 5.20 17.85 42.65 4.12 16.10 42.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 11.49 22.21 40.76 11.82 23.42 38.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.45 12.48 38.95 24.54 11.96 35.94 ULMN 3 1c82_c02 HYALURONATE LYASE user 21 3 # 21 A 399 HIS G 79 HIS~? -4.46 CL CL G2033s A 408 TYR G 75 TYR~? 12.69 CL CL G2033 A 480 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 5.20 17.85 42.65 4.12 16.10 42.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 11.49 22.21 40.76 11.82 23.42 38.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1c82_c02 HYALURONATE LYASE user 22 3 # 22 A 399 HIS G 158 HIS.? 10.64 CL CL G2033 A 408 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 480 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 0.65 25.49 51.61 1.26 23.82 52.74 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 6.53 26.08 51.42 9.33 25.84 51.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1c82_c02 HYALURONATE LYASE user 23 3 # 23 A 399 HIS H 79 HIS~? 4.82 CL CL H2024 A 408 TYR H 75 TYR~? 10.27 CL CL H2014 A 480 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 95.19 63.20 96.60 95.96 63.87 98.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 90.64 65.09 90.65 91.11 67.21 88.98 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1c82_c02 HYALURONATE LYASE user 24 3 # 24 A 399 HIS H 79 HIS~? 4.82 CL CL H2024 A 408 TYR H 75 TYR~? 10.27 CL CL H2014 A 480 ARG H 114 ARG~? 20.07 CL CL H2014 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 95.19 63.20 96.60 95.96 63.87 98.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 90.64 65.09 90.65 91.11 67.21 88.98 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 76.88 71.50 96.54 77.56 74.47 96.38 ULMN 3 1c82_c02 HYALURONATE LYASE user 25 3 # 25 A 399 HIS H 79 HIS~? 4.82 CL CL H2024 A 408 TYR H 75 TYR~? 10.27 CL CL H2014 A 480 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 95.19 63.20 96.60 95.96 63.87 98.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 90.64 65.09 90.65 91.11 67.21 88.98 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1c82_c02 HYALURONATE LYASE user 26 3 # 26 A 399 HIS H 158 HIS.? 10.33 CL CL H2024 A 408 TYR H 157 TYR.? -11.04 CL CL H2014s A 480 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 98.94 51.80 92.35 97.68 51.03 93.84 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 93.68 52.87 90.01 90.96 53.43 89.67 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1c82_c02 HYALURONATE LYASE user 27 3 # 27 A 399 HIS I 79 HIS~? -4.56 CL CL I2025s A 408 TYR I 75 TYR~? 10.32 CL CL I2015 A 480 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 216.99 204.94 159.50 218.07 206.60 158.77 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 211.34 199.93 157.52 211.50 198.33 155.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1c82_c02 HYALURONATE LYASE user 28 3 # 28 A 399 HIS I 79 HIS~? -4.56 CL CL I2025s A 408 TYR I 75 TYR~? 10.32 CL CL I2015 A 480 ARG I 114 ARG~? 18.68 O1 GOL I3031 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 216.99 204.94 159.50 218.07 206.60 158.77 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 211.34 199.93 157.52 211.50 198.33 155.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 198.65 208.42 151.97 199.12 208.35 148.94 ULMN 3 1c82_c02 HYALURONATE LYASE user 29 3 # 29 A 399 HIS I 79 HIS~? -4.56 CL CL I2025s A 408 TYR I 75 TYR~? 10.32 CL CL I2015 A 480 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 216.99 204.94 159.50 218.07 206.60 158.77 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 211.34 199.93 157.52 211.50 198.33 155.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1c82_c02 HYALURONATE LYASE user 30 3 # 30 A 399 HIS I 158 HIS.? 11.08 CL CL I2025 A 408 TYR I 157 TYR.? -10.00 O3 GOL I3031s A 480 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 220.34 199.03 170.60 219.44 200.67 171.57 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 214.62 198.06 169.41 211.87 198.21 168.94 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1c82_c02 HYALURONATE LYASE user 31 3 # 31 A 399 HIS J 79 HIS~? -4.36 CL CL J2026s A 408 TYR J 75 TYR~? 10.17 CL CL J2016 A 480 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 126.45 179.07 126.46 125.69 179.71 124.61 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 131.82 180.89 131.78 131.82 183.34 133.12 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1c82_c02 HYALURONATE LYASE user 32 3 # 32 A 399 HIS J 79 HIS~? -4.36 CL CL J2026s A 408 TYR J 75 TYR~? 10.17 CL CL J2016 A 480 ARG J 114 ARG~? 18.34 O3 GOL J3030 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 126.45 179.07 126.46 125.69 179.71 124.61 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 131.82 180.89 131.78 131.82 183.34 133.12 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 145.85 183.80 124.31 145.72 186.84 123.92 ULMN 3 1c82_c02 HYALURONATE LYASE user 33 3 # 33 A 399 HIS J 79 HIS~? -4.36 CL CL J2026s A 408 TYR J 75 TYR~? 10.17 CL CL J2016 A 480 ARG J 145 ARG~? 22.99 CL CL J2016 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 126.45 179.07 126.46 125.69 179.71 124.61 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 131.82 180.89 131.78 131.82 183.34 133.12 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1c82_c02 HYALURONATE LYASE user 34 3 # 34 A 399 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 408 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 480 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.18 169.23 132.79 122.06 167.98 131.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 126.93 169.72 134.52 129.73 169.94 134.63 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1c82_c02 HYALURONATE LYASE user 35 3 # 35 A 399 HIS K 79 HIS~? -4.34 CL CL K2027s A 408 TYR K 75 TYR~? 12.36 CL CL K2027 A 480 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 211.01 127.65 183.80 211.70 125.86 184.65 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 205.79 133.16 185.06 205.81 134.80 187.34 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1c82_c02 HYALURONATE LYASE user 36 3 # 36 A 399 HIS K 79 HIS~? -4.34 CL CL K2027s A 408 TYR K 75 TYR~? 12.36 CL CL K2027 A 480 ARG K 114 ARG~? 18.18 O1 GOL K3041 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 211.01 127.65 183.80 211.70 125.86 184.65 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 205.79 133.16 185.06 205.81 134.80 187.34 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 191.56 126.17 188.91 191.90 126.17 191.97 ULMN 3 1c82_c02 HYALURONATE LYASE user 37 3 # 37 A 399 HIS K 79 HIS~? -4.34 CL CL K2027s A 408 TYR K 75 TYR~? 12.36 CL CL K2027 A 480 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 211.01 127.65 183.80 211.70 125.86 184.65 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 205.79 133.16 185.06 205.81 134.80 187.34 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1c82_c02 HYALURONATE LYASE user 38 3 # 38 A 399 HIS L 79 HIS~? -4.09 CL CL L2028s A 408 TYR L 75 TYR~? 10.07 CL CL L2009 A 480 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 120.65 164.52 206.19 119.64 164.06 207.98 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 126.23 161.73 201.55 126.10 159.32 200.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1c82_c02 HYALURONATE LYASE user 39 3 # 39 A 399 HIS L 79 HIS~? -4.09 CL CL L2028s A 408 TYR L 75 TYR~? 10.07 CL CL L2009 A 480 ARG L 114 ARG~? 18.80 O1 GOL L3027 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 120.65 164.52 206.19 119.64 164.06 207.98 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 126.23 161.73 201.55 126.10 159.32 200.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 138.87 157.00 210.52 138.32 154.00 210.96 ULMN 3 1c82_c02 HYALURONATE LYASE user 40 3 # 40 A 399 HIS L 79 HIS~? -4.09 CL CL L2028s A 408 TYR L 75 TYR~? 10.07 CL CL L2009 A 480 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 120.65 164.52 206.19 119.64 164.06 207.98 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 126.23 161.73 201.55 126.10 159.32 200.24 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1c82_c02 HYALURONATE LYASE user 41 3 # 41 A 399 HIS L 158 HIS.? 11.11 CL CL L2028 A 408 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 480 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 117.45 174.63 198.96 118.55 176.04 200.05 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 123.19 173.24 198.15 125.89 172.62 198.32 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1c82_c02 HYALURONATE LYASE user 42 3 # 42 A 399 HIS N 79 HIS~? -4.33 CL CL N2030s A 408 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 480 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 215.64 153.98 132.96 216.60 153.22 131.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 209.71 152.64 137.80 209.50 150.35 139.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1c82_c02 HYALURONATE LYASE user 43 3 # 43 A 399 HIS N 79 HIS~? -4.33 CL CL N2030s A 408 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 480 ARG N 114 ARG~? 21.90 O2 GOL N3029 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 215.64 153.98 132.96 216.60 153.22 131.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 209.71 152.64 137.80 209.50 150.35 139.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 196.45 148.76 129.28 196.55 145.72 129.25 ULMN 3 1c82_c02 HYALURONATE LYASE user 44 3 # 44 A 399 HIS N 79 HIS~? -4.33 CL CL N2030s A 408 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 480 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 215.64 153.98 132.96 216.60 153.22 131.26 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 209.71 152.64 137.80 209.50 150.35 139.41 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1c82_c02 HYALURONATE LYASE user 45 3 # 45 A 399 HIS N 158 HIS.? 10.50 CL CL N2030 A 408 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 480 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 220.32 164.11 138.58 219.66 165.01 136.80 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 214.45 164.07 139.74 211.68 163.84 139.51 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1c82_c02 HYALURONATE LYASE user 46 3 # 46 A 399 HIS O 79 HIS~? 5.21 CL CL O2018 A 408 TYR O 75 TYR~? 10.24 CL CL O2018 A 480 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.98 131.53 158.56 121.09 129.74 157.92 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 127.87 136.17 156.70 127.95 137.50 154.23 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1c82_c02 HYALURONATE LYASE user 47 3 # 47 A 399 HIS O 79 HIS~? 5.21 CL CL O2018 A 408 TYR O 75 TYR~? 10.24 CL CL O2018 A 480 ARG O 114 ARG~? 4.95 CL CL O2036 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.98 131.53 158.56 121.09 129.74 157.92 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 127.87 136.17 156.70 127.95 137.50 154.23 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 141.08 127.21 153.72 140.82 126.86 150.69 ULMN 3 1c82_c02 HYALURONATE LYASE user 48 3 # 48 A 399 HIS O 79 HIS~? 5.21 CL CL O2018 A 408 TYR O 75 TYR~? 10.24 CL CL O2018 A 480 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 121.98 131.53 158.56 121.09 129.74 157.92 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 127.87 136.17 156.70 127.95 137.50 154.23 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1c82_c02 HYALURONATE LYASE user 49 3 # 49 A 399 HIS O 158 HIS.? 12.21 CL CL O2018 A 408 TYR O 157 TYR.? 6.41 O2 GOL O3013 A 480 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 117.44 138.41 168.51 118.31 136.96 169.75 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 123.23 139.38 167.80 126.05 139.22 167.65 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1c82_c02 HYALURONATE LYASE user 50 3 # 50 A 399 HIS P 79 HIS~? 5.38 CL CL P2019 A 408 TYR P 75 TYR~? 10.23 CL CL P2019 A 480 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 212.25 178.47 210.26 213.09 179.27 212.01 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 207.22 180.36 204.70 207.43 182.65 203.13 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 193.73 170.42 198.48 192.94 168.00 200.19 ULMN 3 1c82_c02 HYALURONATE LYASE user 51 3 # 51 A 399 HIS P 79 HIS~? 5.38 CL CL P2019 A 408 TYR P 75 TYR~? 10.23 CL CL P2019 A 480 ARG P 114 ARG~? 18.57 O2 GOL P3034 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 212.25 178.47 210.26 213.09 179.27 212.01 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 207.22 180.36 204.70 207.43 182.65 203.13 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 193.59 185.96 211.51 194.17 188.98 211.79 ULMN 3 1c82_c02 HYALURONATE LYASE user 52 3 # 52 A 399 HIS P 79 HIS~? 5.38 CL CL P2019 A 408 TYR P 75 TYR~? 10.23 CL CL P2019 A 480 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 212.25 178.47 210.26 213.09 179.27 212.01 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 207.22 180.36 204.70 207.43 182.65 203.13 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 206.30 185.90 191.05 208.78 186.92 189.45 1c82_c02 source 1c82 HYALURONATE LYASE : 52 hits 1c82_c02 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 234 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 288 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo 27.04 28.61 41.75 26.86 28.65 43.84 106.32 81.43 56.18 105.60 83.26 56.91 coo 21.80 30.48 43.67 23.70 29.06 45.12 100.57 80.52 55.08 97.88 80.73 54.34 coo 24.79 22.62 45.60 24.87 25.42 46.81 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS C 158 HIS.? 10.62 CL CL C2021 A 234 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 288 ARG C 155 ARG.? 9.50 CL CL C2031 coo 27.04 28.61 41.75 26.86 28.65 43.84 98.99 15.14 61.83 98.04 13.53 60.88 coo 21.80 30.48 43.67 23.70 29.06 45.12 93.23 17.43 61.74 90.40 17.73 61.84 coo 24.79 22.62 45.60 24.87 25.42 46.81 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1cb8_c01 CHONDROITINASE AC user 3 3 # 3 A 225 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 234 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 288 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 27.04 28.61 41.75 26.86 28.65 43.84 0.86 62.48 80.06 1.83 63.91 81.27 coo 21.80 30.48 43.67 23.70 29.06 45.12 6.86 61.00 80.62 9.60 60.40 80.64 coo 24.79 22.62 45.60 24.87 25.42 46.81 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1cb8_c01 CHONDROITINASE AC user 4 3 # 4 A 225 HIS E 158 HIS.? 10.67 CL CL E2032 A 234 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 288 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 27.04 28.61 41.75 26.86 28.65 43.84 8.21 91.93 44.16 9.29 93.32 43.02 coo 21.80 30.48 43.67 23.70 29.06 45.12 13.76 89.62 45.68 16.45 89.35 46.36 coo 24.79 22.62 45.60 24.87 25.42 46.81 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1cb8_c01 CHONDROITINASE AC user 5 3 # 5 A 225 HIS G 158 HIS.? 10.64 CL CL G2033 A 234 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 288 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo 27.04 28.61 41.75 26.86 28.65 43.84 0.65 25.49 51.61 1.26 23.82 52.74 coo 21.80 30.48 43.67 23.70 29.06 45.12 6.53 26.08 51.42 9.33 25.84 51.41 coo 24.79 22.62 45.60 24.87 25.42 46.81 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1cb8_c01 CHONDROITINASE AC user 6 3 # 6 A 225 HIS H 158 HIS.? 10.33 CL CL H2024 A 234 TYR H 157 TYR.? -11.04 CL CL H2014s A 288 ARG H 155 ARG.? 17.02 CL CL H2024 coo 27.04 28.61 41.75 26.86 28.65 43.84 98.94 51.80 92.35 97.68 51.03 93.84 coo 21.80 30.48 43.67 23.70 29.06 45.12 93.68 52.87 90.01 90.96 53.43 89.67 coo 24.79 22.62 45.60 24.87 25.42 46.81 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1cb8_c01 CHONDROITINASE AC user 7 3 # 7 A 225 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 234 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 288 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo 27.04 28.61 41.75 26.86 28.65 43.84 121.18 169.23 132.79 122.06 167.98 131.35 coo 21.80 30.48 43.67 23.70 29.06 45.12 126.93 169.72 134.52 129.73 169.94 134.63 coo 24.79 22.62 45.60 24.87 25.42 46.81 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1cb8_c01 CHONDROITINASE AC user 8 3 # 8 A 225 HIS L 158 HIS.? 11.11 CL CL L2028 A 234 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 288 ARG L 155 ARG.? 15.58 CL CL L2028 coo 27.04 28.61 41.75 26.86 28.65 43.84 117.45 174.63 198.96 118.55 176.04 200.05 coo 21.80 30.48 43.67 23.70 29.06 45.12 123.19 173.24 198.15 125.89 172.62 198.32 coo 24.79 22.62 45.60 24.87 25.42 46.81 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1cb8_c01 CHONDROITINASE AC user 9 3 # 9 A 225 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 234 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 288 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 27.04 28.61 41.75 26.86 28.65 43.84 121.40 205.18 163.43 122.55 206.46 162.23 coo 21.80 30.48 43.67 23.70 29.06 45.12 127.03 203.34 164.58 129.75 203.18 165.07 coo 24.79 22.62 45.60 24.87 25.42 46.81 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1cb8_c01 CHONDROITINASE AC user 10 3 # 10 A 225 HIS N 158 HIS.? 10.50 CL CL N2030 A 234 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 288 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 27.04 28.61 41.75 26.86 28.65 43.84 220.32 164.11 138.58 219.66 165.01 136.80 coo 21.80 30.48 43.67 23.70 29.06 45.12 214.45 164.07 139.74 211.68 163.84 139.51 coo 24.79 22.62 45.60 24.87 25.42 46.81 219.49 166.94 144.14 219.55 170.01 143.56 1cb8_c01 source 1cb8 CHONDROITINASE AC : 10 hits 1cb8_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 51 ARG~? 16.54 O3 GOL B3003 127 ARG A 55 ARG~? 19.31 O3 GOL B3003 270 GLU A 4 GLU.? 26.76 C3 GOL E3035 coo -0.83 25.63 1.57 0.97 28.05 0.90 61.69 79.67 29.64 62.00 76.91 30.99 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 66.98 80.93 31.90 64.74 79.05 32.90 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 59.22 77.78 43.29 58.16 77.76 45.17 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 55 ARG~? 19.31 O3 GOL B3003 127 ARG A 51 ARG~? 16.54 O3 GOL B3003 270 GLU A 4 GLU.? 26.76 C3 GOL E3035 coo -0.83 25.63 1.57 0.97 28.05 0.90 66.98 80.93 31.90 64.74 79.05 32.90 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 61.69 79.67 29.64 62.00 76.91 30.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 59.22 77.78 43.29 58.16 77.76 45.17 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 55 ARG~? 19.31 O3 GOL B3003 127 ARG A 51 ARG~? 16.54 O3 GOL B3003 270 GLU A 8 GLU~? 26.27 O3 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 66.98 80.93 31.90 64.74 79.05 32.90 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 61.69 79.67 29.64 62.00 76.91 30.99 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 55.94 76.65 40.48 57.46 75.24 40.93 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG B 34 ARG~? 11.02 O1 GOL B3003 127 ARG B 37 ARG~? -4.23 C1 GOL B3003s 270 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo -0.83 25.63 1.57 0.97 28.05 0.90 57.05 65.77 3.59 55.99 68.39 2.44 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 62.11 68.41 8.30 60.04 68.85 10.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG B 34 ARG~? 11.02 O1 GOL B3003 127 ARG B 37 ARG~? -4.23 C1 GOL B3003s 270 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 57.05 65.77 3.59 55.99 68.39 2.44 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 62.11 68.41 8.30 60.04 68.85 10.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 37 ARG~? -4.23 C1 GOL B3003s 127 ARG B 34 ARG~? 11.02 O1 GOL B3003 270 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 62.11 68.41 8.30 60.04 68.85 10.44 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 57.05 65.77 3.59 55.99 68.39 2.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 51 ARG~? 11.52 O3 GOL B3003 127 ARG B 55 ARG~? -14.24 O1 GOL B3003s 270 GLU B 4 GLU.? 22.11 C1 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 56.02 71.46 21.90 55.03 71.54 24.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 50.06 69.68 20.36 47.07 69.49 19.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 54.73 58.55 26.68 55.86 57.12 27.84 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 51 ARG~? 11.52 O3 GOL B3003 127 ARG B 55 ARG~? -14.24 O1 GOL B3003s 270 GLU B 8 GLU~? 20.28 O3 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 56.02 71.46 21.90 55.03 71.54 24.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 50.06 69.68 20.36 47.07 69.49 19.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 58.16 61.18 28.15 56.55 61.04 29.52 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG B 55 ARG~? -14.24 O1 GOL B3003s 127 ARG B 51 ARG~? 11.52 O3 GOL B3003 270 GLU B 4 GLU.? 22.11 C1 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 50.06 69.68 20.36 47.07 69.49 19.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 56.02 71.46 21.90 55.03 71.54 24.81 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 54.73 58.55 26.68 55.86 57.12 27.84 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG B 55 ARG~? -14.24 O1 GOL B3003s 127 ARG B 51 ARG~? 11.52 O3 GOL B3003 270 GLU B 8 GLU~? 20.28 O3 GOL B3003 coo -0.83 25.63 1.57 0.97 28.05 0.90 50.06 69.68 20.36 47.07 69.49 19.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 56.02 71.46 21.90 55.03 71.54 24.81 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 58.16 61.18 28.15 56.55 61.04 29.52 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 11 3 # 11 71 ARG C 51 ARG~? 15.50 O3 GOL D3005 127 ARG C 55 ARG~? 19.41 CL CL C2006 270 GLU C 4 GLU.? 9.47 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 50.80 26.41 78.15 53.63 27.50 78.75 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 55.97 24.40 76.93 55.45 26.29 74.49 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 51.62 28.50 64.04 50.84 28.75 62.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 12 3 # 12 71 ARG C 51 ARG~? 15.50 O3 GOL D3005 127 ARG C 55 ARG~? 19.41 CL CL C2006 270 GLU C 8 GLU~? 14.15 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 50.80 26.41 78.15 53.63 27.50 78.75 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 55.97 24.40 76.93 55.45 26.29 74.49 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 48.33 30.34 66.47 50.23 31.23 66.45 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 13 3 # 13 71 ARG C 55 ARG~? 19.41 CL CL C2006 127 ARG C 51 ARG~? 15.50 O3 GOL D3005 270 GLU C 4 GLU.? 9.47 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 55.97 24.40 76.93 55.45 26.29 74.49 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 50.80 26.41 78.15 53.63 27.50 78.75 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 51.62 28.50 64.04 50.84 28.75 62.00 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 14 3 # 14 71 ARG C 55 ARG~? 19.41 CL CL C2006 127 ARG C 51 ARG~? 15.50 O3 GOL D3005 270 GLU C 8 GLU~? 14.15 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 55.97 24.40 76.93 55.45 26.29 74.49 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 50.80 26.41 78.15 53.63 27.50 78.75 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 48.33 30.34 66.47 50.23 31.23 66.45 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 15 3 # 15 71 ARG D 51 ARG~? -12.62 C3 GOL D3005s 127 ARG D 55 ARG~? 14.96 O1 GOL D3005 270 GLU D 4 GLU.? 10.36 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 44.97 36.17 83.73 45.77 36.49 80.75 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 39.97 38.45 84.97 39.00 40.64 83.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 47.42 48.67 79.11 48.78 50.16 78.53 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 16 3 # 16 71 ARG D 51 ARG~? -12.62 C3 GOL D3005s 127 ARG D 55 ARG~? 14.96 O1 GOL D3005 270 GLU D 8 GLU~? 14.61 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 44.97 36.17 83.73 45.77 36.49 80.75 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 39.97 38.45 84.97 39.00 40.64 83.01 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 51.06 45.29 79.18 49.57 45.21 77.73 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 17 3 # 17 71 ARG D 55 ARG~? 14.96 O1 GOL D3005 127 ARG D 51 ARG~? -12.62 C3 GOL D3005s 270 GLU D 4 GLU.? 10.36 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 39.97 38.45 84.97 39.00 40.64 83.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 44.97 36.17 83.73 45.77 36.49 80.75 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 47.42 48.67 79.11 48.78 50.16 78.53 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 18 3 # 18 71 ARG D 55 ARG~? 14.96 O1 GOL D3005 127 ARG D 51 ARG~? -12.62 C3 GOL D3005s 270 GLU D 8 GLU~? 14.61 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 39.97 38.45 84.97 39.00 40.64 83.01 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 44.97 36.17 83.73 45.77 36.49 80.75 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 51.06 45.29 79.18 49.57 45.21 77.73 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 19 3 # 19 71 ARG E 34 ARG~? 12.13 O1 GOL E3004 127 ARG E 37 ARG~? -4.52 O1 GOL E3004s 270 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo -0.83 25.63 1.57 0.97 28.05 0.90 54.44 103.79 65.07 52.71 105.19 67.23 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 58.59 99.11 69.23 56.48 96.91 69.19 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 20 3 # 20 71 ARG E 37 ARG~? -4.52 O1 GOL E3004s 127 ARG E 34 ARG~? 12.13 O1 GOL E3004 270 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo -0.83 25.63 1.57 0.97 28.05 0.90 58.59 99.11 69.23 56.48 96.91 69.19 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 54.44 103.79 65.07 52.71 105.19 67.23 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 21 3 # 21 71 ARG E 51 ARG~? 12.86 C3 GOL E3004 127 ARG E 55 ARG~? 13.47 C3 GOL E3004 270 GLU E 8 GLU~? 20.37 C3 GOL E3004 coo -0.83 25.63 1.57 0.97 28.05 0.90 51.65 84.19 70.80 51.43 81.15 70.20 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 47.24 86.77 68.80 48.11 84.54 66.77 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 56.40 79.00 61.68 54.75 77.83 61.13 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 22 3 # 22 71 ARG E 55 ARG~? 13.47 C3 GOL E3004 127 ARG E 51 ARG~? 12.86 C3 GOL E3004 270 GLU E 4 GLU.? 23.16 O1 GOL E3004 coo -0.83 25.63 1.57 0.97 28.05 0.90 47.24 86.77 68.80 48.11 84.54 66.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 51.65 84.19 70.80 51.43 81.15 70.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 52.69 79.08 57.54 54.35 78.71 56.32 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 23 3 # 23 71 ARG E 55 ARG~? 13.47 C3 GOL E3004 127 ARG E 51 ARG~? 12.86 C3 GOL E3004 270 GLU E 8 GLU~? 20.37 C3 GOL E3004 coo -0.83 25.63 1.57 0.97 28.05 0.90 47.24 86.77 68.80 48.11 84.54 66.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 51.65 84.19 70.80 51.43 81.15 70.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 56.40 79.00 61.68 54.75 77.83 61.13 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 24 3 # 24 71 ARG F 34 ARG~? 28.76 CL CL F2035 127 ARG F 37 ARG~? -27.07 CL CL F2035s 270 GLU F 56 GLU~? 19.98 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 59.52 30.90 7.26 60.86 28.10 6.84 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 53.50 28.70 11.30 55.02 28.89 13.93 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 25 3 # 25 71 ARG F 37 ARG~? -27.07 CL CL F2035s 127 ARG F 34 ARG~? 28.76 CL CL F2035 270 GLU F 56 GLU~? 19.98 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 53.50 28.70 11.30 55.02 28.89 13.93 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 59.52 30.90 7.26 60.86 28.10 6.84 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 26 3 # 26 71 ARG F 51 ARG~? 18.26 CL CL F2035 127 ARG F 55 ARG~? 14.19 CL CL F2035 270 GLU F 4 GLU.? 20.54 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 56.56 29.17 27.33 58.39 29.67 29.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 62.56 29.89 25.65 64.18 28.30 27.76 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 56.74 42.66 28.58 56.05 44.66 28.52 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 27 3 # 27 71 ARG F 51 ARG~? 18.26 CL CL F2035 127 ARG F 55 ARG~? 14.19 CL CL F2035 270 GLU F 8 GLU~? 22.40 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 56.56 29.17 27.33 58.39 29.67 29.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 62.56 29.89 25.65 64.18 28.30 27.76 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 54.32 40.00 29.52 52.85 39.83 30.97 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 28 3 # 28 71 ARG F 55 ARG~? 14.19 CL CL F2035 127 ARG F 51 ARG~? 18.26 CL CL F2035 270 GLU F 4 GLU.? 20.54 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 62.56 29.89 25.65 64.18 28.30 27.76 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 56.56 29.17 27.33 58.39 29.67 29.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 56.74 42.66 28.58 56.05 44.66 28.52 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 29 3 # 29 71 ARG F 55 ARG~? 14.19 CL CL F2035 127 ARG F 51 ARG~? 18.26 CL CL F2035 270 GLU F 8 GLU~? 22.40 CL CL F2035 coo -0.83 25.63 1.57 0.97 28.05 0.90 62.56 29.89 25.65 64.18 28.30 27.76 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 56.56 29.17 27.33 58.39 29.67 29.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 54.32 40.00 29.52 52.85 39.83 30.97 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 30 3 # 30 71 ARG G 55 ARG~? 22.00 CL CL C2006 127 ARG G 51 ARG~? 21.90 CL CL C2006 270 GLU G 4 GLU.? 10.85 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 44.23 21.19 35.75 42.00 23.24 36.25 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 49.60 22.70 34.88 49.12 25.71 35.34 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 49.15 27.69 47.86 49.75 29.01 49.42 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 31 3 # 31 71 ARG G 55 ARG~? 22.00 CL CL C2006 127 ARG G 51 ARG~? 21.90 CL CL C2006 270 GLU G 8 GLU~? 13.62 CL CL C2006 coo -0.83 25.63 1.57 0.97 28.05 0.90 44.23 21.19 35.75 42.00 23.24 36.25 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 49.60 22.70 34.88 49.12 25.71 35.34 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 52.64 27.90 45.53 51.09 29.23 45.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 32 3 # 32 71 ARG H 51 ARG~? -11.05 O1 GOL H3006s 127 ARG H 55 ARG~? 13.48 O3 GOL H3006 270 GLU H 4 GLU.? 9.25 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 55.75 78.18 80.83 58.67 78.05 79.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 60.33 75.55 82.58 59.37 73.14 80.81 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 53.12 64.06 78.47 52.04 62.20 78.33 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 33 3 # 33 71 ARG H 51 ARG~? -11.05 O1 GOL H3006s 127 ARG H 55 ARG~? 13.48 O3 GOL H3006 270 GLU H 8 GLU~? 14.54 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 55.75 78.18 80.83 58.67 78.05 79.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 60.33 75.55 82.58 59.37 73.14 80.81 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 50.67 67.41 76.56 52.70 67.57 75.98 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 34 3 # 34 71 ARG H 55 ARG~? 13.48 O3 GOL H3006 127 ARG H 51 ARG~? -11.05 O1 GOL H3006s 270 GLU H 8 GLU~? 14.54 CL CL D2008 coo -0.83 25.63 1.57 0.97 28.05 0.90 60.33 75.55 82.58 59.37 73.14 80.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 55.75 78.18 80.83 58.67 78.05 79.79 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 50.67 67.41 76.56 52.70 67.57 75.98 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 35 3 # 35 71 ARG I 51 ARG~? 21.58 CL CL I2007 127 ARG I 55 ARG~? 19.02 CL CL I2007 270 GLU I 4 GLU.? 9.55 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 174.23 196.17 146.19 174.71 193.30 147.29 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 179.74 197.90 148.59 178.27 195.79 150.32 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 172.87 194.13 159.37 171.68 193.98 161.14 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 36 3 # 36 71 ARG I 51 ARG~? 21.58 CL CL I2007 127 ARG I 55 ARG~? 19.02 CL CL I2007 270 GLU I 8 GLU~? 13.89 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 174.23 196.17 146.19 174.71 193.30 147.29 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 179.74 197.90 148.59 178.27 195.79 150.32 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 170.22 193.07 156.46 171.58 191.67 157.15 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 37 3 # 37 71 ARG I 55 ARG~? 19.02 CL CL I2007 127 ARG I 51 ARG~? 21.58 CL CL I2007 270 GLU I 4 GLU.? 9.55 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 179.74 197.90 148.59 178.27 195.79 150.32 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 174.23 196.17 146.19 174.71 193.30 147.29 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 172.87 194.13 159.37 171.68 193.98 161.14 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 38 3 # 38 71 ARG I 55 ARG~? 19.02 CL CL I2007 127 ARG I 51 ARG~? 21.58 CL CL I2007 270 GLU I 8 GLU~? 13.89 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 179.74 197.90 148.59 178.27 195.79 150.32 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 174.23 196.17 146.19 174.71 193.30 147.29 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 170.22 193.07 156.46 171.58 191.67 157.15 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 39 3 # 39 71 ARG J 51 ARG~? 27.44 CL CL J2002 127 ARG J 55 ARG~? 24.05 CL CL J2002 270 GLU J 8 GLU~? 22.39 CL CL J2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 168.80 189.12 137.91 166.15 189.45 139.46 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 163.85 187.29 136.52 164.25 185.16 138.77 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 171.86 178.07 143.57 170.28 177.54 144.90 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 40 3 # 40 71 ARG J 55 ARG~? 24.05 CL CL J2002 127 ARG J 51 ARG~? 27.44 CL CL J2002 270 GLU J 8 GLU~? 22.39 CL CL J2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 163.85 187.29 136.52 164.25 185.16 138.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 168.80 189.12 137.91 166.15 189.45 139.46 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 171.86 178.07 143.57 170.28 177.54 144.90 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 41 3 # 41 71 ARG K 51 ARG~? -10.79 O3 GOL K3011s 127 ARG K 55 ARG~? 13.86 O3 GOL K3011 270 GLU K 4 GLU.? 10.47 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 168.73 140.32 192.51 171.31 141.97 192.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 173.95 138.80 190.43 173.34 140.90 188.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 168.96 143.52 178.36 168.13 144.65 176.72 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 42 3 # 42 71 ARG K 51 ARG~? -10.79 O3 GOL K3011s 127 ARG K 55 ARG~? 13.86 O3 GOL K3011 270 GLU K 8 GLU~? 14.31 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 168.73 140.32 192.51 171.31 141.97 192.79 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 173.95 138.80 190.43 173.34 140.90 188.20 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 166.29 144.34 181.01 165.98 146.34 180.71 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 43 3 # 43 71 ARG K 55 ARG~? 13.86 O3 GOL K3011 127 ARG K 51 ARG~? -10.79 O3 GOL K3011s 270 GLU K 8 GLU~? 14.31 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 173.95 138.80 190.43 173.34 140.90 188.20 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 168.73 140.32 192.51 171.31 141.97 192.79 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 166.29 144.34 181.01 165.98 146.34 180.71 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 44 3 # 44 71 ARG L 51 ARG~? 16.39 O3 GOL K3011 127 ARG L 55 ARG~? 21.00 O3 GOL K3011 270 GLU L 4 GLU.? 26.61 O1 GOL L3028 coo -0.83 25.63 1.57 0.97 28.05 0.90 163.01 149.53 198.74 162.90 150.47 195.82 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 158.05 151.49 200.24 157.97 153.99 198.35 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 164.36 162.97 195.39 165.70 164.44 194.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 45 3 # 45 71 ARG L 51 ARG~? 16.39 O3 GOL K3011 127 ARG L 55 ARG~? 21.00 O3 GOL K3011 270 GLU L 8 GLU~? 26.30 O3 GOL K3011 coo -0.83 25.63 1.57 0.97 28.05 0.90 163.01 149.53 198.74 162.90 150.47 195.82 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 158.05 151.49 200.24 157.97 153.99 198.35 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 167.69 159.47 194.26 167.52 160.00 192.23 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 46 3 # 46 71 ARG L 55 ARG~? 21.00 O3 GOL K3011 127 ARG L 51 ARG~? 16.39 O3 GOL K3011 270 GLU L 4 GLU.? 26.61 O1 GOL L3028 coo -0.83 25.63 1.57 0.97 28.05 0.90 158.05 151.49 200.24 157.97 153.99 198.35 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 163.01 149.53 198.74 162.90 150.47 195.82 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 164.36 162.97 195.39 165.70 164.44 194.50 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 47 3 # 47 71 ARG L 55 ARG~? 21.00 O3 GOL K3011 127 ARG L 51 ARG~? 16.39 O3 GOL K3011 270 GLU L 8 GLU~? 26.30 O3 GOL K3011 coo -0.83 25.63 1.57 0.97 28.05 0.90 158.05 151.49 200.24 157.97 153.99 198.35 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 163.01 149.53 198.74 162.90 150.47 195.82 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 167.69 159.47 194.26 167.52 160.00 192.23 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 48 3 # 48 71 ARG M 51 ARG~? -9.68 O2 GOL M3007s 127 ARG M 55 ARG~? 12.49 O2 GOL M3007 270 GLU M 4 GLU.? 9.58 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 166.66 199.07 188.11 163.90 199.62 189.28 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 162.29 201.15 185.73 159.83 200.25 187.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 168.05 195.36 174.90 169.23 194.67 173.26 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 49 3 # 49 71 ARG M 51 ARG~? -9.68 O2 GOL M3007s 127 ARG M 55 ARG~? 12.49 O2 GOL M3007 270 GLU M 8 GLU~? 14.09 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 166.66 199.07 188.11 163.90 199.62 189.28 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 162.29 201.15 185.73 159.83 200.25 187.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 170.87 194.05 178.21 169.19 192.83 177.76 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 50 3 # 50 71 ARG M 55 ARG~? 12.49 O2 GOL M3007 127 ARG M 51 ARG~? -9.68 O2 GOL M3007s 270 GLU M 4 GLU.? 9.58 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 162.29 201.15 185.73 159.83 200.25 187.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 166.66 199.07 188.11 163.90 199.62 189.28 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 168.05 195.36 174.90 169.23 194.67 173.26 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 51 3 # 51 71 ARG M 55 ARG~? 12.49 O2 GOL M3007 127 ARG M 51 ARG~? -9.68 O2 GOL M3007s 270 GLU M 8 GLU~? 14.09 CL CL I2007 coo -0.83 25.63 1.57 0.97 28.05 0.90 162.29 201.15 185.73 159.83 200.25 187.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 166.66 199.07 188.11 163.90 199.62 189.28 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 170.87 194.05 178.21 169.19 192.83 177.76 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 52 3 # 52 71 ARG N 51 ARG~? 10.93 O1 GOL N3008 127 ARG N 55 ARG~? 13.92 O1 GOL N3008 270 GLU N 4 GLU.? 18.86 CL CL J2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 172.16 145.36 140.78 174.78 144.98 142.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 177.28 147.38 139.71 179.40 146.33 141.72 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 171.67 159.43 143.17 170.71 161.26 143.65 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 53 3 # 53 71 ARG N 51 ARG~? 10.93 O1 GOL N3008 127 ARG N 55 ARG~? 13.92 O1 GOL N3008 270 GLU N 8 GLU~? 19.42 O1 GOL N3008 coo -0.83 25.63 1.57 0.97 28.05 0.90 172.16 145.36 140.78 174.78 144.98 142.37 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 177.28 147.38 139.71 179.40 146.33 141.72 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 168.83 156.63 144.46 167.27 156.30 145.82 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 54 3 # 54 71 ARG N 55 ARG~? 13.92 O1 GOL N3008 127 ARG N 51 ARG~? 10.93 O1 GOL N3008 270 GLU N 4 GLU.? 18.86 CL CL J2002 coo -0.83 25.63 1.57 0.97 28.05 0.90 177.28 147.38 139.71 179.40 146.33 141.72 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 172.16 145.36 140.78 174.78 144.98 142.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 171.67 159.43 143.17 170.71 161.26 143.65 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 55 3 # 55 71 ARG N 55 ARG~? 13.92 O1 GOL N3008 127 ARG N 51 ARG~? 10.93 O1 GOL N3008 270 GLU N 8 GLU~? 19.42 O1 GOL N3008 coo -0.83 25.63 1.57 0.97 28.05 0.90 177.28 147.38 139.71 179.40 146.33 141.72 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 172.16 145.36 140.78 174.78 144.98 142.37 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 168.83 156.63 144.46 167.27 156.30 145.82 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 56 3 # 56 71 ARG O 34 ARG~? 19.49 CL CL O2036 127 ARG O 37 ARG~? 22.15 CL CL K2003 270 GLU O 56 GLU.? 16.78 CL CL O2036 coo -0.83 25.63 1.57 0.97 28.05 0.90 163.83 119.56 154.44 162.36 118.67 151.85 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 169.49 123.46 151.21 167.81 125.99 151.08 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 57 3 # 57 71 ARG O 37 ARG~? 22.15 CL CL K2003 127 ARG O 34 ARG~? 19.49 CL CL O2036 270 GLU O 56 GLU.? 16.78 CL CL O2036 coo -0.83 25.63 1.57 0.97 28.05 0.90 169.49 123.46 151.21 167.81 125.99 151.08 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 163.83 119.56 154.44 162.36 118.67 151.85 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 58 3 # 58 71 ARG O 51 ARG~? 16.43 O1 GOL N3008 127 ARG O 55 ARG~? 19.37 CL CL K2003 270 GLU O 4 GLU.? 15.52 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 165.78 138.84 148.96 164.30 141.49 149.44 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 159.96 137.60 150.54 160.85 139.64 152.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 160.46 142.68 161.06 159.04 143.89 159.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 59 3 # 59 71 ARG O 51 ARG~? 16.43 O1 GOL N3008 127 ARG O 55 ARG~? 19.37 CL CL K2003 270 GLU O 8 GLU~? 14.62 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 165.78 138.84 148.96 164.30 141.49 149.44 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 159.96 137.60 150.54 160.85 139.64 152.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 169.51 143.54 159.40 167.68 144.45 158.79 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 60 3 # 60 71 ARG O 55 ARG~? 19.37 CL CL K2003 127 ARG O 51 ARG~? 16.43 O1 GOL N3008 270 GLU O 4 GLU.? 15.52 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 159.96 137.60 150.54 160.85 139.64 152.73 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 165.78 138.84 148.96 164.30 141.49 149.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 160.46 142.68 161.06 159.04 143.89 159.95 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 61 3 # 61 71 ARG O 55 ARG~? 19.37 CL CL K2003 127 ARG O 51 ARG~? 16.43 O1 GOL N3008 270 GLU O 8 GLU~? 14.62 CL CL K2003 coo -0.83 25.63 1.57 0.97 28.05 0.90 159.96 137.60 150.54 160.85 139.64 152.73 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 165.78 138.84 148.96 164.30 141.49 149.44 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 169.51 143.54 159.40 167.68 144.45 158.79 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 62 3 # 62 71 ARG P 51 ARG~? 14.75 O3 GOL M3007 127 ARG P 55 ARG~? 20.09 O3 GOL M3007 270 GLU P 4 GLU.? 25.05 O1 GOL L3028 coo -0.83 25.63 1.57 0.97 28.05 0.90 171.10 192.14 197.11 173.97 192.46 196.07 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 176.25 189.61 198.56 175.31 187.31 196.65 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 169.41 178.25 194.54 168.21 176.56 193.99 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 63 3 # 63 71 ARG P 51 ARG~? 14.75 O3 GOL M3007 127 ARG P 55 ARG~? 20.09 O3 GOL M3007 270 GLU P 8 GLU~? 25.06 O3 GOL M3007 coo -0.83 25.63 1.57 0.97 28.05 0.90 171.10 192.14 197.11 173.97 192.46 196.07 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 176.25 189.61 198.56 175.31 187.31 196.65 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 166.50 181.50 192.72 168.30 181.40 191.65 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 64 3 # 64 71 ARG P 55 ARG~? 20.09 O3 GOL M3007 127 ARG P 51 ARG~? 14.75 O3 GOL M3007 270 GLU P 4 GLU.? 25.05 O1 GOL L3028 coo -0.83 25.63 1.57 0.97 28.05 0.90 176.25 189.61 198.56 175.31 187.31 196.65 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 171.10 192.14 197.11 173.97 192.46 196.07 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 169.41 178.25 194.54 168.21 176.56 193.99 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 65 3 # 65 71 ARG P 55 ARG~? 20.09 O3 GOL M3007 127 ARG P 51 ARG~? 14.75 O3 GOL M3007 270 GLU P 8 GLU~? 25.06 O3 GOL M3007 coo -0.83 25.63 1.57 0.97 28.05 0.90 176.25 189.61 198.56 175.31 187.31 196.65 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 171.10 192.14 197.11 173.97 192.46 196.07 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 166.50 181.50 192.72 168.30 181.40 191.65 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 65 hits 1cbx_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 C 48 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 59.25 100.54 36.63 61.78 101.51 37.35 coo 24.35 4.55 25.11 25.94 3.23 25.53 62.23 105.49 38.88 63.59 105.50 37.26 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 C 48 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 59.25 100.54 36.63 61.78 101.51 37.35 coo 24.35 4.55 25.11 25.94 3.23 25.53 62.23 105.49 38.88 63.59 105.50 37.26 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 143 TYR~? 16.38 O1 GOL A3040 A 173 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 48 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 92.99 77.44 39.76 93.75 79.76 38.42 coo 24.35 4.55 25.11 25.94 3.23 25.53 90.44 78.16 48.76 91.65 76.94 50.06 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 35 TYR~? 15.50 C1 GOL B3003 A 173 ASP B 28 ASP~? 19.20 C1 GOL B3003 C 48 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 60.35 59.88 4.36 57.88 59.60 3.08 coo 24.35 4.55 25.11 25.94 3.23 25.53 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 143 TYR~? 10.77 O2 GOL B3024 A 173 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 48 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 23.25 68.41 18.58 23.33 69.19 15.92 coo 24.35 4.55 25.11 25.94 3.23 25.53 23.66 59.02 20.34 21.93 58.32 21.38 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR C 35 TYR~? 12.95 CL CL C2004 A 173 ASP C 28 ASP~? 15.70 CL CL C2004 C 48 ARG C 36 ARG~? 17.12 CL CL C2004 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 45.94 6.51 69.90 48.30 5.07 69.65 coo 24.35 4.55 25.11 25.94 3.23 25.53 48.49 0.93 68.23 49.38 0.74 70.13 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR C 35 TYR~? 12.95 CL CL C2004 A 173 ASP C 28 ASP~? 15.70 CL CL C2004 C 48 ARG C 37 ARG~? -20.33 CL CL C2004s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 45.94 6.51 69.90 48.30 5.07 69.65 coo 24.35 4.55 25.11 25.94 3.23 25.53 48.49 0.93 68.23 49.38 0.74 70.13 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR C 143 TYR~? 14.40 O1 GOL C3036 A 173 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 48 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 83.34 22.31 75.20 83.28 19.92 76.54 coo 24.35 4.55 25.11 25.94 3.23 25.53 82.81 22.02 65.69 84.52 22.80 64.66 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 101 TYR D 35 TYR~? 13.02 CL CL H2005 A 173 ASP D 28 ASP~? 15.80 CL CL H2005 C 48 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 48.27 47.24 102.95 45.77 48.18 103.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 45.36 50.43 107.49 43.88 48.98 107.89 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 101 TYR D 35 TYR~? 13.02 CL CL H2005 A 173 ASP D 28 ASP~? 15.80 CL CL H2005 C 48 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 48.27 47.24 102.95 45.77 48.18 103.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 45.36 50.43 107.49 43.88 48.98 107.89 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 101 TYR D 143 TYR~? 15.16 CL CL D2012 A 173 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 48 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 14.34 45.54 80.17 13.57 44.79 82.74 coo 24.35 4.55 25.11 25.94 3.23 25.53 16.94 54.59 79.01 15.65 55.42 77.54 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 A 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 C 48 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 58.94 102.78 60.36 56.69 104.19 59.52 coo 24.35 4.55 25.11 25.94 3.23 25.53 57.09 107.82 57.29 55.83 108.40 58.91 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 A 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 C 48 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 58.94 102.78 60.36 56.69 104.19 59.52 coo 24.35 4.55 25.11 25.94 3.23 25.53 57.09 107.82 57.29 55.83 108.40 58.91 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 101 TYR E 143 TYR~? 15.23 CL CL E2013 A 173 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 48 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 20.79 87.99 61.33 20.74 90.64 62.13 coo 24.35 4.55 25.11 25.94 3.23 25.53 23.07 86.29 52.35 21.57 85.17 51.32 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 101 TYR F 35 TYR~? 30.41 CL CL F2035 A 173 ASP F 28 ASP~? 32.62 CL CL F2035 C 48 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 55.89 36.47 6.05 58.49 36.69 5.11 coo 24.35 4.55 25.11 25.94 3.23 25.53 59.39 38.13 1.08 60.39 36.31 1.06 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 101 TYR F 35 TYR~? 30.41 CL CL F2035 A 173 ASP F 28 ASP~? 32.62 CL CL F2035 C 48 ARG F 37 ARG~? -27.07 CL CL F2035s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 55.89 36.47 6.05 58.49 36.69 5.11 coo 24.35 4.55 25.11 25.94 3.23 25.53 59.39 38.13 1.08 60.39 36.31 1.06 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 101 TYR F 143 TYR~? 15.09 CL CL F2034 A 173 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 48 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 89.42 31.84 29.55 89.79 30.44 27.17 coo 24.35 4.55 25.11 25.94 3.23 25.53 88.86 41.25 28.96 90.30 42.22 30.24 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 101 TYR G 35 TYR~? 13.11 CL CL C2004 A 173 ASP G 28 ASP~? 15.85 CL CL C2004 C 48 ARG G 37 ARG~? 20.29 CL CL C2004 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 50.35 3.70 46.66 47.74 2.77 47.00 coo 24.35 4.55 25.11 25.94 3.23 25.53 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 A 101 TYR G 143 TYR~? 15.53 C3 GOL G3001 A 173 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 48 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 16.97 25.90 37.77 16.51 23.33 36.84 coo 24.35 4.55 25.11 25.94 3.23 25.53 17.70 27.34 47.09 16.19 28.71 47.73 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 A 101 TYR H 35 TYR~? 13.05 CL CL H2005 A 173 ASP H 28 ASP~? 15.80 CL CL H2005 C 48 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 48.71 70.98 100.43 50.94 70.32 101.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 50.63 68.82 106.06 51.93 70.45 106.39 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 A 101 TYR H 35 TYR~? 13.05 CL CL H2005 A 173 ASP H 28 ASP~? 15.80 CL CL H2005 C 48 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 48.71 70.98 100.43 50.94 70.32 101.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 50.63 68.82 106.06 51.93 70.45 106.39 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 A 101 TYR H 143 TYR~? 11.30 O2 GOL H3016 A 173 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 48 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 86.77 67.99 85.16 86.88 69.36 87.57 coo 24.35 4.55 25.11 25.94 3.23 25.53 84.24 58.93 85.48 85.73 57.59 84.66 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 A 101 TYR I 35 TYR~? 13.03 CL CL I2001 A 173 ASP I 28 ASP~? 15.71 CL CL I2001 C 48 ARG I 36 ARG~? 18.35 CL CL I2001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 171.46 216.91 154.12 173.98 218.04 154.69 coo 24.35 4.55 25.11 25.94 3.23 25.53 174.34 221.90 156.42 175.71 222.11 154.83 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 A 101 TYR I 35 TYR~? 13.03 CL CL I2001 A 173 ASP I 28 ASP~? 15.71 CL CL I2001 C 48 ARG I 37 ARG~? 20.23 CL CL I2001 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 171.46 216.91 154.12 173.98 218.04 154.69 coo 24.35 4.55 25.11 25.94 3.23 25.53 174.34 221.90 156.42 175.71 222.11 154.83 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 A 101 TYR I 143 TYR~? 11.25 C1 GOL I3032 A 173 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 48 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 206.55 195.37 154.41 207.09 197.83 153.23 coo 24.35 4.55 25.11 25.94 3.23 25.53 204.37 195.46 163.61 205.75 194.30 164.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 A 101 TYR J 35 TYR~? 13.02 CL CL J2002 A 173 ASP J 28 ASP~? 15.67 CL CL J2002 C 48 ARG J 36 ARG~? 16.92 CL CL J2002 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 173.30 177.82 119.58 170.88 177.40 118.29 coo 24.35 4.55 25.11 25.94 3.23 25.53 170.87 175.19 114.50 169.74 176.91 114.00 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 A 101 TYR J 35 TYR~? 13.02 CL CL J2002 A 173 ASP J 28 ASP~? 15.67 CL CL J2002 C 48 ARG J 37 ARG~? 20.17 CL CL J2002 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 173.30 177.82 119.58 170.88 177.40 118.29 coo 24.35 4.55 25.11 25.94 3.23 25.53 170.87 175.19 114.50 169.74 176.91 114.00 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 A 101 TYR J 143 TYR~? 15.18 CL CL J2016 A 173 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 48 ARG J 145 ARG~? 22.99 CL CL J2016 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 136.50 183.91 136.49 136.50 184.93 133.88 coo 24.35 4.55 25.11 25.94 3.23 25.53 137.44 174.60 137.57 135.80 173.80 138.69 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 A 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 C 48 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 164.29 120.92 183.43 166.71 119.58 183.22 coo 24.35 4.55 25.11 25.94 3.23 25.53 166.96 115.59 181.42 167.86 115.34 183.30 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 A 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 C 48 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 164.29 120.92 183.43 166.71 119.58 183.22 coo 24.35 4.55 25.11 25.94 3.23 25.53 166.96 115.59 181.42 167.86 115.34 183.30 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 A 101 TYR K 143 TYR~? 15.99 O3 GOL K3009 A 173 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 48 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 201.16 138.32 187.50 201.22 135.84 188.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 200.17 138.24 178.11 201.77 139.28 177.19 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 A 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 A 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 C 48 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 166.36 159.94 218.26 163.88 160.60 219.34 coo 24.35 4.55 25.11 25.94 3.23 25.53 163.49 162.78 223.08 162.21 161.15 223.46 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 A 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 A 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 C 48 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 166.36 159.94 218.26 163.88 160.60 219.34 coo 24.35 4.55 25.11 25.94 3.23 25.53 163.49 162.78 223.08 162.21 161.15 223.46 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 A 101 TYR L 143 TYR~? 15.30 CL CL L2009 A 173 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 48 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 131.10 157.77 197.34 130.52 156.95 199.97 coo 24.35 4.55 25.11 25.94 3.23 25.53 133.34 166.97 196.27 132.03 168.03 194.96 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 A 101 TYR M 35 TYR~? 13.00 CL CL I2001 A 173 ASP M 28 ASP~? 15.52 CL CL I2001 C 48 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 172.26 218.21 177.69 169.95 219.60 176.96 coo 24.35 4.55 25.11 25.94 3.23 25.53 170.27 223.20 174.57 168.89 223.83 176.08 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 A 101 TYR M 35 TYR~? 13.00 CL CL I2001 A 173 ASP M 28 ASP~? 15.52 CL CL I2001 C 48 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 172.26 218.21 177.69 169.95 219.60 176.96 coo 24.35 4.55 25.11 25.94 3.23 25.53 170.27 223.20 174.57 168.89 223.83 176.08 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 A 101 TYR M 143 TYR~? 15.40 CL CL M2017 A 173 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 48 ARG M 145 ARG~? 23.51 CL CL M2017 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 134.88 201.35 179.85 134.66 203.97 180.76 coo 24.35 4.55 25.11 25.94 3.23 25.53 136.87 200.18 170.79 135.36 199.08 169.77 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 A 101 TYR N 35 TYR~? 13.09 CL CL J2002 A 173 ASP N 28 ASP~? 15.68 CL CL J2002 C 48 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 169.83 154.24 120.71 172.41 154.64 119.66 coo 24.35 4.55 25.11 25.94 3.23 25.53 173.04 156.37 115.74 174.12 154.54 115.64 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 A 101 TYR N 35 TYR~? 13.09 CL CL J2002 A 173 ASP N 28 ASP~? 15.68 CL CL J2002 C 48 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 169.83 154.24 120.71 172.41 154.64 119.66 coo 24.35 4.55 25.11 25.94 3.23 25.53 173.04 156.37 115.74 174.12 154.54 115.64 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 A 101 TYR N 143 TYR~? 10.73 O2 GOL N3029 A 173 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 48 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 204.41 150.24 142.39 204.78 148.95 139.97 coo 24.35 4.55 25.11 25.94 3.23 25.53 203.51 159.51 142.26 205.02 160.53 143.48 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 A 101 TYR O 35 TYR~? 20.32 CL CL K2003 A 173 ASP O 28 ASP~? 23.95 CL CL O2036 C 48 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 167.80 119.41 159.74 165.27 118.34 160.26 coo 24.35 4.55 25.11 25.94 3.23 25.53 164.72 114.57 162.31 163.52 114.24 160.62 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 A 101 TYR O 35 TYR~? 20.32 CL CL K2003 A 173 ASP O 28 ASP~? 23.95 CL CL O2036 C 48 ARG O 37 ARG~? 22.15 CL CL K2003 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 167.80 119.41 159.74 165.27 118.34 160.26 coo 24.35 4.55 25.11 25.94 3.23 25.53 164.72 114.57 162.31 163.52 114.24 160.62 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 A 101 TYR O 143 TYR~? 11.76 C3 GOL O3026 A 173 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 48 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 133.04 140.38 153.60 132.61 137.79 152.63 coo 24.35 4.55 25.11 25.94 3.23 25.53 134.07 141.35 162.95 132.57 142.58 163.78 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 A 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 A 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 C 48 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 165.51 183.94 216.71 167.90 183.49 218.05 coo 24.35 4.55 25.11 25.94 3.23 25.53 167.75 181.83 222.09 168.94 183.53 222.37 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 A 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 A 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 C 48 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 25.00 -3.03 25.68 27.14 -4.51 26.75 165.51 183.94 216.71 167.90 183.49 218.05 coo 24.35 4.55 25.11 25.94 3.23 25.53 167.75 181.83 222.09 168.94 183.53 222.37 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 A 101 TYR P 143 TYR~? 15.20 CL CL P2019 A 173 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 48 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 202.86 183.43 199.65 203.11 184.67 202.14 coo 24.35 4.55 25.11 25.94 3.23 25.53 200.75 174.15 199.66 202.28 173.10 198.62 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 206.30 185.90 191.05 208.78 186.92 189.45 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 36 ARG~? 20.86 C3 GOL E3035 C 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 C 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 32.27 5.62 48.15 31.93 6.48 51.06 51.19 99.66 33.34 49.41 97.31 34.21 coo 29.64 3.64 57.39 31.22 5.14 55.65 59.25 100.54 36.63 61.78 101.51 37.35 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 37 ARG~? 23.00 O3 GOL B3003 C 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 C 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 32.27 5.62 48.15 31.93 6.48 51.06 58.38 95.12 28.70 59.87 92.50 29.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 59.25 100.54 36.63 61.78 101.51 37.35 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG A 145 ARG~? 24.46 O3 GOL A3037 C 101 TYR A 143 TYR~? 16.38 O1 GOL A3040 C 173 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 32.27 5.62 48.15 31.93 6.48 51.06 94.33 67.29 39.79 97.00 65.79 39.32 coo 29.64 3.64 57.39 31.22 5.14 55.65 92.99 77.44 39.76 93.75 79.76 38.42 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 37 ARG~? -4.23 C1 GOL B3003s C 101 TYR B 35 TYR~? 15.50 C1 GOL B3003 C 173 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 32.27 5.62 48.15 31.93 6.48 51.06 62.11 68.41 8.30 60.04 68.85 10.44 coo 29.64 3.64 57.39 31.22 5.14 55.65 60.35 59.88 4.36 57.88 59.60 3.08 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 36 ARG~? 17.12 CL CL C2004 C 101 TYR C 35 TYR~? 12.95 CL CL C2004 C 173 ASP C 28 ASP~? 15.70 CL CL C2004 coo 32.27 5.62 48.15 31.93 6.48 51.06 37.77 8.89 71.79 36.83 11.19 70.06 coo 29.64 3.64 57.39 31.22 5.14 55.65 45.94 6.51 69.90 48.30 5.07 69.65 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 37 ARG~? -20.33 CL CL C2004s C 101 TYR C 35 TYR~? 12.95 CL CL C2004 C 173 ASP C 28 ASP~? 15.70 CL CL C2004 coo 32.27 5.62 48.15 31.93 6.48 51.06 44.35 12.06 77.77 46.44 14.26 77.62 coo 29.64 3.64 57.39 31.22 5.14 55.65 45.94 6.51 69.90 48.30 5.07 69.65 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG D 36 ARG~? 15.63 O1 GOL D3005 C 101 TYR D 35 TYR~? 13.02 CL CL H2005 C 173 ASP D 28 ASP~? 15.80 CL CL H2005 coo 32.27 5.62 48.15 31.93 6.48 51.06 55.93 43.64 102.74 57.91 43.73 100.41 coo 29.64 3.64 57.39 31.22 5.14 55.65 48.27 47.24 102.95 45.77 48.18 103.82 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG D 37 ARG~? -4.25 O1 GOL D3005s C 101 TYR D 35 TYR~? 13.02 CL CL H2005 C 173 ASP D 28 ASP~? 15.80 CL CL H2005 coo 32.27 5.62 48.15 31.93 6.48 51.06 48.82 38.28 99.42 47.22 38.23 96.82 coo 29.64 3.64 57.39 31.22 5.14 55.65 48.27 47.24 102.95 45.77 48.18 103.82 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 48 ARG D 145 ARG~? 21.40 O1 GOL G3001 C 101 TYR D 143 TYR~? 15.16 CL CL D2012 C 173 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 32.27 5.62 48.15 31.93 6.48 51.06 12.08 41.78 71.45 11.86 39.69 73.74 coo 29.64 3.64 57.39 31.22 5.14 55.65 14.34 45.54 80.17 13.57 44.79 82.74 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 48 ARG E 36 ARG~? 16.00 C1 GOL E3004 C 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 C 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 32.27 5.62 48.15 31.93 6.48 51.06 66.28 100.73 63.79 67.89 98.12 63.67 coo 29.64 3.64 57.39 31.22 5.14 55.65 58.94 102.78 60.36 56.69 104.19 59.52 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 48 ARG E 37 ARG~? -4.52 O1 GOL E3004s C 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 C 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 32.27 5.62 48.15 31.93 6.48 51.06 58.59 99.11 69.23 56.48 96.91 69.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 58.94 102.78 60.36 56.69 104.19 59.52 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 48 ARG E 145 ARG~? 19.70 O1 GOL E3002 C 101 TYR E 143 TYR~? 15.23 CL CL E2013 C 173 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 32.27 5.62 48.15 31.93 6.48 51.06 16.30 80.38 65.14 17.26 82.53 67.17 coo 29.64 3.64 57.39 31.22 5.14 55.65 20.79 87.99 61.33 20.74 90.64 62.13 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 48 ARG F 36 ARG~? 20.40 O1 GOL B3017 C 101 TYR F 35 TYR~? 30.41 CL CL F2035 C 173 ASP F 28 ASP~? 32.62 CL CL F2035 coo 32.27 5.62 48.15 31.93 6.48 51.06 47.43 34.56 6.90 45.82 36.16 8.95 coo 29.64 3.64 57.39 31.22 5.14 55.65 55.89 36.47 6.05 58.49 36.69 5.11 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 48 ARG F 37 ARG~? -27.07 CL CL F2035s C 101 TYR F 35 TYR~? 30.41 CL CL F2035 C 173 ASP F 28 ASP~? 32.62 CL CL F2035 coo 32.27 5.62 48.15 31.93 6.48 51.06 53.50 28.70 11.30 55.02 28.89 13.93 coo 29.64 3.64 57.39 31.22 5.14 55.65 55.89 36.47 6.05 58.49 36.69 5.11 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 48 ARG F 145 ARG~? 19.97 O3 GOL C3036 C 101 TYR F 143 TYR~? 15.09 CL CL F2034 C 173 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 32.27 5.62 48.15 31.93 6.48 51.06 91.49 29.42 38.83 93.62 28.28 40.76 coo 29.64 3.64 57.39 31.22 5.14 55.65 89.42 31.84 29.55 89.79 30.44 27.17 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 48 ARG G 37 ARG~? 20.29 CL CL C2004 C 101 TYR G 35 TYR~? 13.11 CL CL C2004 C 173 ASP G 28 ASP~? 15.85 CL CL C2004 coo 32.27 5.62 48.15 31.93 6.48 51.06 52.62 7.45 38.03 50.95 9.97 37.63 coo 29.64 3.64 57.39 31.22 5.14 55.65 50.35 3.70 46.66 47.74 2.77 47.00 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 48 ARG G 145 ARG~? 20.03 C3 GOL G3001 C 101 TYR G 143 TYR~? 15.53 C3 GOL G3001 C 173 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 32.27 5.62 48.15 31.93 6.48 51.06 15.17 34.68 33.42 15.78 32.53 31.28 coo 29.64 3.64 57.39 31.22 5.14 55.65 16.97 25.90 37.77 16.51 23.33 36.84 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 48 ARG H 36 ARG~? 15.68 C3 GOL H3006 C 101 TYR H 35 TYR~? 13.05 CL CL H2005 C 173 ASP H 28 ASP~? 15.80 CL CL H2005 coo 32.27 5.62 48.15 31.93 6.48 51.06 41.35 74.42 97.84 39.90 73.17 95.49 coo 29.64 3.64 57.39 31.22 5.14 55.65 48.71 70.98 100.43 50.94 70.32 101.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 A 48 ARG H 37 ARG~? -4.44 O3 GOL H3006s C 101 TYR H 35 TYR~? 13.05 CL CL H2005 C 173 ASP H 28 ASP~? 15.80 CL CL H2005 coo 32.27 5.62 48.15 31.93 6.48 51.06 49.12 78.88 94.88 51.18 78.27 92.74 coo 29.64 3.64 57.39 31.22 5.14 55.65 48.71 70.98 100.43 50.94 70.32 101.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 A 48 ARG H 145 ARG~? 14.63 O1 GOL H3016 C 101 TYR H 143 TYR~? 11.30 O2 GOL H3016 C 173 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 32.27 5.62 48.15 31.93 6.48 51.06 91.20 69.90 76.54 91.87 72.67 77.80 coo 29.64 3.64 57.39 31.22 5.14 55.65 86.77 67.99 85.16 86.88 69.36 87.57 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 A 48 ARG I 36 ARG~? 18.35 CL CL I2001 C 101 TYR I 35 TYR~? 13.03 CL CL I2001 C 173 ASP I 28 ASP~? 15.71 CL CL I2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 163.77 216.28 151.02 161.75 213.99 150.84 coo 29.64 3.64 57.39 31.22 5.14 55.65 171.46 216.91 154.12 173.98 218.04 154.69 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 A 48 ARG I 37 ARG~? 20.23 CL CL I2001 C 101 TYR I 35 TYR~? 13.03 CL CL I2001 C 173 ASP I 28 ASP~? 15.71 CL CL I2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 170.53 211.87 145.98 172.22 209.35 146.21 coo 29.64 3.64 57.39 31.22 5.14 55.65 171.46 216.91 154.12 173.98 218.04 154.69 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 A 48 ARG I 145 ARG~? 15.37 O1 GOL I3032 C 101 TYR I 143 TYR~? 11.25 C1 GOL I3032 C 173 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 32.27 5.62 48.15 31.93 6.48 51.06 209.45 186.59 151.83 209.12 188.26 149.20 coo 29.64 3.64 57.39 31.22 5.14 55.65 206.55 195.37 154.41 207.09 197.83 153.23 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 A 48 ARG J 36 ARG~? 16.92 CL CL J2002 C 101 TYR J 35 TYR~? 13.02 CL CL J2002 C 173 ASP J 28 ASP~? 15.67 CL CL J2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 181.40 180.11 121.45 182.70 178.85 123.93 coo 29.64 3.64 57.39 31.22 5.14 55.65 173.30 177.82 119.58 170.88 177.40 118.29 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 A 48 ARG J 37 ARG~? 20.17 CL CL J2002 C 101 TYR J 35 TYR~? 13.02 CL CL J2002 C 173 ASP J 28 ASP~? 15.67 CL CL J2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 174.71 186.35 123.78 172.76 186.51 126.11 coo 29.64 3.64 57.39 31.22 5.14 55.65 173.30 177.82 119.58 170.88 177.40 118.29 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 A 48 ARG J 145 ARG~? 22.99 CL CL J2016 C 101 TYR J 143 TYR~? 15.18 CL CL J2016 C 173 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 32.27 5.62 48.15 31.93 6.48 51.06 132.84 187.86 144.62 133.71 189.96 142.45 coo 29.64 3.64 57.39 31.22 5.14 55.65 136.50 183.91 136.49 136.50 184.93 133.88 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 A 48 ARG K 36 ARG~? 15.75 C1 GOL K3011 C 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 C 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 32.27 5.62 48.15 31.93 6.48 51.06 156.15 122.83 185.77 154.85 125.10 184.29 coo 29.64 3.64 57.39 31.22 5.14 55.65 164.29 120.92 183.43 166.71 119.58 183.22 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 A 48 ARG K 37 ARG~? -4.30 O1 GOL K3011s C 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 C 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 32.27 5.62 48.15 31.93 6.48 51.06 162.88 126.06 191.42 164.87 128.39 191.36 coo 29.64 3.64 57.39 31.22 5.14 55.65 164.29 120.92 183.43 166.71 119.58 183.22 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 A 48 ARG K 145 ARG~? 19.97 C2 GOL K3009 C 101 TYR K 143 TYR~? 15.99 O3 GOL K3009 C 173 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 32.27 5.62 48.15 31.93 6.48 51.06 204.60 147.17 190.28 202.10 146.29 191.85 coo 29.64 3.64 57.39 31.22 5.14 55.65 201.16 138.32 187.50 201.22 135.84 188.82 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 A 48 ARG L 36 ARG~? 28.87 C1 GOL P3034 C 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 C 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 32.27 5.62 48.15 31.93 6.48 51.06 174.06 157.20 217.38 176.23 157.17 215.21 coo 29.64 3.64 57.39 31.22 5.14 55.65 166.36 159.94 218.26 163.88 160.60 219.34 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 A 48 ARG L 37 ARG~? 22.34 O3 GOL K3011 C 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 C 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 32.27 5.62 48.15 31.93 6.48 51.06 167.17 151.29 214.24 165.45 151.32 211.73 coo 29.64 3.64 57.39 31.22 5.14 55.65 166.36 159.94 218.26 163.88 160.60 219.34 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 A 48 ARG M 36 ARG~? 16.07 O1 GOL M3007 C 101 TYR M 35 TYR~? 13.00 CL CL I2001 C 173 ASP M 28 ASP~? 15.52 CL CL I2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 179.97 216.30 180.98 181.48 213.82 180.04 coo 29.64 3.64 57.39 31.22 5.14 55.65 172.26 218.21 177.69 169.95 219.60 176.96 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 A 48 ARG M 37 ARG~? -4.64 O1 GOL M3007s C 101 TYR M 35 TYR~? 13.00 CL CL I2001 C 173 ASP M 28 ASP~? 15.52 CL CL I2001 coo 32.27 5.62 48.15 31.93 6.48 51.06 172.69 214.03 186.60 170.63 211.79 186.52 coo 29.64 3.64 57.39 31.22 5.14 55.65 172.26 218.21 177.69 169.95 219.60 176.96 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 A 48 ARG M 145 ARG~? 23.51 CL CL M2017 C 101 TYR M 143 TYR~? 15.40 CL CL M2017 C 173 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 32.27 5.62 48.15 31.93 6.48 51.06 131.12 192.72 183.38 131.87 195.02 185.33 coo 29.64 3.64 57.39 31.22 5.14 55.65 134.88 201.35 179.85 134.66 203.97 180.76 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 A 48 ARG N 36 ARG~? 15.62 C3 GOL N3008 C 101 TYR N 35 TYR~? 13.09 CL CL J2002 C 173 ASP N 28 ASP~? 15.68 CL CL J2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 161.60 152.07 121.93 160.06 153.41 124.19 coo 29.64 3.64 57.39 31.22 5.14 55.65 169.83 154.24 120.71 172.41 154.64 119.66 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 A 48 ARG N 37 ARG~? -4.21 O3 GOL N3008s C 101 TYR N 35 TYR~? 13.09 CL CL J2002 C 173 ASP N 28 ASP~? 15.68 CL CL J2002 coo 32.27 5.62 48.15 31.93 6.48 51.06 167.97 146.21 125.72 169.64 146.36 128.31 coo 29.64 3.64 57.39 31.22 5.14 55.65 169.83 154.24 120.71 172.41 154.64 119.66 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 A 48 ARG N 145 ARG~? 14.05 C1 GOL N3029 C 101 TYR N 143 TYR~? 10.73 O2 GOL N3029 C 173 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 32.27 5.62 48.15 31.93 6.48 51.06 206.36 147.54 151.55 205.74 145.29 149.50 coo 29.64 3.64 57.39 31.22 5.14 55.65 204.41 150.24 142.39 204.78 148.95 139.97 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 A 48 ARG O 36 ARG~? 19.89 O1 GOL K3010 C 101 TYR O 35 TYR~? 20.32 CL CL K2003 C 173 ASP O 28 ASP~? 23.95 CL CL O2036 coo 32.27 5.62 48.15 31.93 6.48 51.06 175.82 120.47 157.52 177.72 122.75 158.28 coo 29.64 3.64 57.39 31.22 5.14 55.65 167.80 119.41 159.74 165.27 118.34 160.26 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 A 48 ARG O 37 ARG~? 22.15 CL CL K2003 C 101 TYR O 35 TYR~? 20.32 CL CL K2003 C 173 ASP O 28 ASP~? 23.95 CL CL O2036 coo 32.27 5.62 48.15 31.93 6.48 51.06 169.49 123.46 151.21 167.81 125.99 151.08 coo 29.64 3.64 57.39 31.22 5.14 55.65 167.80 119.41 159.74 165.27 118.34 160.26 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 A 48 ARG O 145 ARG~? 14.75 O3 GOL O3026 C 101 TYR O 143 TYR~? 11.76 C3 GOL O3026 C 173 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 32.27 5.62 48.15 31.93 6.48 51.06 130.60 149.22 149.86 131.12 146.92 147.82 coo 29.64 3.64 57.39 31.22 5.14 55.65 133.04 140.38 153.60 132.61 137.79 152.63 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 A 48 ARG P 36 ARG~? 18.56 O1 GOL L3028 C 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 C 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 32.27 5.62 48.15 31.93 6.48 51.06 157.78 187.06 214.51 156.14 185.86 212.27 coo 29.64 3.64 57.39 31.22 5.14 55.65 165.51 183.94 216.71 167.90 183.49 218.05 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 167.75 181.83 222.09 168.94 183.53 222.37 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 A 48 ARG P 37 ARG~? -21.37 O3 GOL M3007s C 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 C 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 32.27 5.62 48.15 31.93 6.48 51.06 165.27 191.94 211.53 167.28 191.57 209.25 coo 29.64 3.64 57.39 31.22 5.14 55.65 165.51 183.94 216.71 167.90 183.49 218.05 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 167.75 181.83 222.09 168.94 183.53 222.37 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 42 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 36 ARG~? 20.86 C3 GOL E3035 D 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 D 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 69.08 8.58 32.60 69.70 10.81 30.58 51.19 99.66 33.34 49.41 97.31 34.21 coo 71.77 11.86 24.26 70.23 12.22 26.56 59.25 100.54 36.63 61.78 101.51 37.35 coo 71.60 6.14 19.25 70.26 6.87 20.69 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 37 ARG~? 23.00 O3 GOL B3003 D 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 D 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 69.08 8.58 32.60 69.70 10.81 30.58 58.38 95.12 28.70 59.87 92.50 29.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 59.25 100.54 36.63 61.78 101.51 37.35 coo 71.60 6.14 19.25 70.26 6.87 20.69 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG A 114 ARG~? 18.99 O2 GOL A3040 D 101 TYR A 109 TYR~? 19.57 O1 GOL A3040 D 173 ASP A 102 ASP.? 25.18 C1 GOL A3040 coo 69.08 8.58 32.60 69.70 10.81 30.58 86.11 90.82 36.33 86.92 90.68 33.36 coo 71.77 11.86 24.26 70.23 12.22 26.56 84.38 79.76 38.04 83.16 77.26 38.08 coo 71.60 6.14 19.25 70.26 6.87 20.69 88.23 80.63 30.72 87.92 80.82 28.67 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG A 145 ARG~? 24.46 O3 GOL A3037 D 101 TYR A 143 TYR~? 16.38 O1 GOL A3040 D 173 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 69.08 8.58 32.60 69.70 10.81 30.58 94.33 67.29 39.79 97.00 65.79 39.32 coo 71.77 11.86 24.26 70.23 12.22 26.56 92.99 77.44 39.76 93.75 79.76 38.42 coo 71.60 6.14 19.25 70.26 6.87 20.69 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 37 ARG~? -4.23 C1 GOL B3003s D 101 TYR B 35 TYR~? 15.50 C1 GOL B3003 D 173 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 69.08 8.58 32.60 69.70 10.81 30.58 62.11 68.41 8.30 60.04 68.85 10.44 coo 71.77 11.86 24.26 70.23 12.22 26.56 60.35 59.88 4.36 57.88 59.60 3.08 coo 71.60 6.14 19.25 70.26 6.87 20.69 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG B 145 ARG~? 9.64 O1 GOL B3024 D 101 TYR B 143 TYR~? 10.77 O2 GOL B3024 D 173 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 69.08 8.58 32.60 69.70 10.81 30.58 19.64 71.23 27.64 22.06 69.48 28.42 coo 71.77 11.86 24.26 70.23 12.22 26.56 23.25 68.41 18.58 23.33 69.19 15.92 coo 71.60 6.14 19.25 70.26 6.87 20.69 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG C 36 ARG~? 17.12 CL CL C2004 D 101 TYR C 35 TYR~? 12.95 CL CL C2004 D 173 ASP C 28 ASP~? 15.70 CL CL C2004 coo 69.08 8.58 32.60 69.70 10.81 30.58 37.77 8.89 71.79 36.83 11.19 70.06 coo 71.77 11.86 24.26 70.23 12.22 26.56 45.94 6.51 69.90 48.30 5.07 69.65 coo 71.60 6.14 19.25 70.26 6.87 20.69 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG C 37 ARG~? -20.33 CL CL C2004s D 101 TYR C 35 TYR~? 12.95 CL CL C2004 D 173 ASP C 28 ASP~? 15.70 CL CL C2004 coo 69.08 8.58 32.60 69.70 10.81 30.58 44.35 12.06 77.77 46.44 14.26 77.62 coo 71.77 11.86 24.26 70.23 12.22 26.56 45.94 6.51 69.90 48.30 5.07 69.65 coo 71.60 6.14 19.25 70.26 6.87 20.69 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 48 ARG C 145 ARG~? 15.99 O1 GOL C3036 D 101 TYR C 143 TYR~? 14.40 O1 GOL C3036 D 173 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 69.08 8.58 32.60 69.70 10.81 30.58 85.99 31.07 76.22 83.80 32.01 74.28 coo 71.77 11.86 24.26 70.23 12.22 26.56 83.34 22.31 75.20 83.28 19.92 76.54 coo 71.60 6.14 19.25 70.26 6.87 20.69 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 48 ARG D 36 ARG~? 15.63 O1 GOL D3005 D 101 TYR D 35 TYR~? 13.02 CL CL H2005 D 173 ASP D 28 ASP~? 15.80 CL CL H2005 coo 69.08 8.58 32.60 69.70 10.81 30.58 55.93 43.64 102.74 57.91 43.73 100.41 coo 71.77 11.86 24.26 70.23 12.22 26.56 48.27 47.24 102.95 45.77 48.18 103.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 48 ARG D 37 ARG~? -4.25 O1 GOL D3005s D 101 TYR D 35 TYR~? 13.02 CL CL H2005 D 173 ASP D 28 ASP~? 15.80 CL CL H2005 coo 69.08 8.58 32.60 69.70 10.81 30.58 48.82 38.28 99.42 47.22 38.23 96.82 coo 71.77 11.86 24.26 70.23 12.22 26.56 48.27 47.24 102.95 45.77 48.18 103.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 48 ARG D 114 ARG~? 18.11 O3 GOL D3018 D 101 TYR D 109 TYR~? 18.34 O3 GOL D3019 D 173 ASP D 102 ASP.? 24.32 CL CL D2012 coo 69.08 8.58 32.60 69.70 10.81 30.58 21.28 44.89 93.84 20.52 41.96 94.27 coo 71.77 11.86 24.26 70.23 12.22 26.56 22.95 44.43 82.69 24.09 43.90 80.20 coo 71.60 6.14 19.25 70.26 6.87 20.69 18.96 37.41 85.00 19.42 35.40 85.42 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 48 ARG D 145 ARG~? 21.40 O1 GOL G3001 D 101 TYR D 143 TYR~? 15.16 CL CL D2012 D 173 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 69.08 8.58 32.60 69.70 10.81 30.58 12.08 41.78 71.45 11.86 39.69 73.74 coo 71.77 11.86 24.26 70.23 12.22 26.56 14.34 45.54 80.17 13.57 44.79 82.74 coo 71.60 6.14 19.25 70.26 6.87 20.69 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 48 ARG E 36 ARG~? 16.00 C1 GOL E3004 D 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 D 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 69.08 8.58 32.60 69.70 10.81 30.58 66.28 100.73 63.79 67.89 98.12 63.67 coo 71.77 11.86 24.26 70.23 12.22 26.56 58.94 102.78 60.36 56.69 104.19 59.52 coo 71.60 6.14 19.25 70.26 6.87 20.69 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 48 ARG E 37 ARG~? -4.52 O1 GOL E3004s D 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 D 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 69.08 8.58 32.60 69.70 10.81 30.58 58.59 99.11 69.23 56.48 96.91 69.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 58.94 102.78 60.36 56.69 104.19 59.52 coo 71.60 6.14 19.25 70.26 6.87 20.69 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 48 ARG E 114 ARG~? 18.39 O3 GOL E3022 D 101 TYR E 109 TYR~? 18.10 O1 GOL E3035 D 173 ASP E 102 ASP.? 24.45 CL CL E2013 coo 69.08 8.58 32.60 69.70 10.81 30.58 31.03 99.62 62.12 30.45 100.18 65.09 coo 71.77 11.86 24.26 70.23 12.22 26.56 29.73 88.43 62.54 30.41 85.74 63.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 26.42 91.49 69.61 27.08 91.68 71.63 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 48 ARG E 145 ARG~? 19.70 O1 GOL E3002 D 101 TYR E 143 TYR~? 15.23 CL CL E2013 D 173 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 69.08 8.58 32.60 69.70 10.81 30.58 16.30 80.38 65.14 17.26 82.53 67.17 coo 71.77 11.86 24.26 70.23 12.22 26.56 20.79 87.99 61.33 20.74 90.64 62.13 coo 71.60 6.14 19.25 70.26 6.87 20.69 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 48 ARG F 36 ARG~? 20.40 O1 GOL B3017 D 101 TYR F 35 TYR~? 30.41 CL CL F2035 D 173 ASP F 28 ASP~? 32.62 CL CL F2035 coo 69.08 8.58 32.60 69.70 10.81 30.58 47.43 34.56 6.90 45.82 36.16 8.95 coo 71.77 11.86 24.26 70.23 12.22 26.56 55.89 36.47 6.05 58.49 36.69 5.11 coo 71.60 6.14 19.25 70.26 6.87 20.69 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 B 48 ARG F 37 ARG~? -27.07 CL CL F2035s D 101 TYR F 35 TYR~? 30.41 CL CL F2035 D 173 ASP F 28 ASP~? 32.62 CL CL F2035 coo 69.08 8.58 32.60 69.70 10.81 30.58 53.50 28.70 11.30 55.02 28.89 13.93 coo 71.77 11.86 24.26 70.23 12.22 26.56 55.89 36.47 6.05 58.49 36.69 5.11 coo 71.60 6.14 19.25 70.26 6.87 20.69 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 B 48 ARG F 145 ARG~? 19.97 O3 GOL C3036 D 101 TYR F 143 TYR~? 15.09 CL CL F2034 D 173 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 69.08 8.58 32.60 69.70 10.81 30.58 91.49 29.42 38.83 93.62 28.28 40.76 coo 71.77 11.86 24.26 70.23 12.22 26.56 89.42 31.84 29.55 89.79 30.44 27.17 coo 71.60 6.14 19.25 70.26 6.87 20.69 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 B 48 ARG G 37 ARG~? 20.29 CL CL C2004 D 101 TYR G 35 TYR~? 13.11 CL CL C2004 D 173 ASP G 28 ASP~? 15.85 CL CL C2004 coo 69.08 8.58 32.60 69.70 10.81 30.58 52.62 7.45 38.03 50.95 9.97 37.63 coo 71.77 11.86 24.26 70.23 12.22 26.56 50.35 3.70 46.66 47.74 2.77 47.00 coo 71.60 6.14 19.25 70.26 6.87 20.69 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 B 48 ARG G 114 ARG~? 19.08 O3 GOL G3038 D 101 TYR G 109 TYR~? 19.47 O2 GOL G3001 D 173 ASP G 102 ASP.? 25.30 O3 GOL G3038 coo 69.08 8.58 32.60 69.70 10.81 30.58 24.45 12.48 38.95 24.54 11.96 35.94 coo 71.77 11.86 24.26 70.23 12.22 26.56 25.80 23.55 38.48 27.03 26.02 38.21 coo 71.60 6.14 19.25 70.26 6.87 20.69 23.47 21.05 30.82 24.30 20.62 28.93 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 B 48 ARG G 145 ARG~? 20.03 C3 GOL G3001 D 101 TYR G 143 TYR~? 15.53 C3 GOL G3001 D 173 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 69.08 8.58 32.60 69.70 10.81 30.58 15.17 34.68 33.42 15.78 32.53 31.28 coo 71.77 11.86 24.26 70.23 12.22 26.56 16.97 25.90 37.77 16.51 23.33 36.84 coo 71.60 6.14 19.25 70.26 6.87 20.69 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 B 48 ARG H 36 ARG~? 15.68 C3 GOL H3006 D 101 TYR H 35 TYR~? 13.05 CL CL H2005 D 173 ASP H 28 ASP~? 15.80 CL CL H2005 coo 69.08 8.58 32.60 69.70 10.81 30.58 41.35 74.42 97.84 39.90 73.17 95.49 coo 71.77 11.86 24.26 70.23 12.22 26.56 48.71 70.98 100.43 50.94 70.32 101.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 B 48 ARG H 37 ARG~? -4.44 O3 GOL H3006s D 101 TYR H 35 TYR~? 13.05 CL CL H2005 D 173 ASP H 28 ASP~? 15.80 CL CL H2005 coo 69.08 8.58 32.60 69.70 10.81 30.58 49.12 78.88 94.88 51.18 78.27 92.74 coo 71.77 11.86 24.26 70.23 12.22 26.56 48.71 70.98 100.43 50.94 70.32 101.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 B 48 ARG H 114 ARG~? 20.07 CL CL H2014 D 101 TYR H 109 TYR~? 11.76 O2 GOL H3016 D 173 ASP H 102 ASP.? 20.45 O2 GOL H3016 coo 69.08 8.58 32.60 69.70 10.81 30.58 76.88 71.50 96.54 77.56 74.47 96.38 coo 71.77 11.86 24.26 70.23 12.22 26.56 77.84 69.46 85.37 77.15 69.38 82.64 coo 71.60 6.14 19.25 70.26 6.87 20.69 81.36 76.99 86.94 80.90 79.01 86.89 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 B 48 ARG H 145 ARG~? 14.63 O1 GOL H3016 D 101 TYR H 143 TYR~? 11.30 O2 GOL H3016 D 173 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 69.08 8.58 32.60 69.70 10.81 30.58 91.20 69.90 76.54 91.87 72.67 77.80 coo 71.77 11.86 24.26 70.23 12.22 26.56 86.77 67.99 85.16 86.88 69.36 87.57 coo 71.60 6.14 19.25 70.26 6.87 20.69 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 B 48 ARG I 36 ARG~? 18.35 CL CL I2001 D 101 TYR I 35 TYR~? 13.03 CL CL I2001 D 173 ASP I 28 ASP~? 15.71 CL CL I2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 163.77 216.28 151.02 161.75 213.99 150.84 coo 71.77 11.86 24.26 70.23 12.22 26.56 171.46 216.91 154.12 173.98 218.04 154.69 coo 71.60 6.14 19.25 70.26 6.87 20.69 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 B 48 ARG I 37 ARG~? 20.23 CL CL I2001 D 101 TYR I 35 TYR~? 13.03 CL CL I2001 D 173 ASP I 28 ASP~? 15.71 CL CL I2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 170.53 211.87 145.98 172.22 209.35 146.21 coo 71.77 11.86 24.26 70.23 12.22 26.56 171.46 216.91 154.12 173.98 218.04 154.69 coo 71.60 6.14 19.25 70.26 6.87 20.69 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 B 48 ARG I 114 ARG~? 18.68 O1 GOL I3031 D 101 TYR I 109 TYR~? 11.79 O1 GOL I3032 D 173 ASP I 102 ASP.? 20.44 O1 GOL I3032 coo 69.08 8.58 32.60 69.70 10.81 30.58 198.65 208.42 151.97 199.12 208.35 148.94 coo 71.77 11.86 24.26 70.23 12.22 26.56 197.73 197.22 153.29 196.64 194.65 153.36 coo 71.60 6.14 19.25 70.26 6.87 20.69 201.10 198.54 145.88 200.66 198.62 143.82 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 B 48 ARG I 145 ARG~? 15.37 O1 GOL I3032 D 101 TYR I 143 TYR~? 11.25 C1 GOL I3032 D 173 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 69.08 8.58 32.60 69.70 10.81 30.58 209.45 186.59 151.83 209.12 188.26 149.20 coo 71.77 11.86 24.26 70.23 12.22 26.56 206.55 195.37 154.41 207.09 197.83 153.23 coo 71.60 6.14 19.25 70.26 6.87 20.69 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 B 48 ARG J 36 ARG~? 16.92 CL CL J2002 D 101 TYR J 35 TYR~? 13.02 CL CL J2002 D 173 ASP J 28 ASP~? 15.67 CL CL J2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 181.40 180.11 121.45 182.70 178.85 123.93 coo 71.77 11.86 24.26 70.23 12.22 26.56 173.30 177.82 119.58 170.88 177.40 118.29 coo 71.60 6.14 19.25 70.26 6.87 20.69 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 B 48 ARG J 37 ARG~? 20.17 CL CL J2002 D 101 TYR J 35 TYR~? 13.02 CL CL J2002 D 173 ASP J 28 ASP~? 15.67 CL CL J2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 174.71 186.35 123.78 172.76 186.51 126.11 coo 71.77 11.86 24.26 70.23 12.22 26.56 173.30 177.82 119.58 170.88 177.40 118.29 coo 71.60 6.14 19.25 70.26 6.87 20.69 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 B 48 ARG J 145 ARG~? 22.99 CL CL J2016 D 101 TYR J 143 TYR~? 15.18 CL CL J2016 D 173 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 69.08 8.58 32.60 69.70 10.81 30.58 132.84 187.86 144.62 133.71 189.96 142.45 coo 71.77 11.86 24.26 70.23 12.22 26.56 136.50 183.91 136.49 136.50 184.93 133.88 coo 71.60 6.14 19.25 70.26 6.87 20.69 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 B 48 ARG K 36 ARG~? 15.75 C1 GOL K3011 D 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 D 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 69.08 8.58 32.60 69.70 10.81 30.58 156.15 122.83 185.77 154.85 125.10 184.29 coo 71.77 11.86 24.26 70.23 12.22 26.56 164.29 120.92 183.43 166.71 119.58 183.22 coo 71.60 6.14 19.25 70.26 6.87 20.69 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 B 48 ARG K 37 ARG~? -4.30 O1 GOL K3011s D 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 D 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 69.08 8.58 32.60 69.70 10.81 30.58 162.88 126.06 191.42 164.87 128.39 191.36 coo 71.77 11.86 24.26 70.23 12.22 26.56 164.29 120.92 183.43 166.71 119.58 183.22 coo 71.60 6.14 19.25 70.26 6.87 20.69 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 B 48 ARG K 114 ARG~? 18.18 O1 GOL K3041 D 101 TYR K 109 TYR~? 18.63 O3 GOL K3010 D 173 ASP K 102 ASP.? 24.81 O1 GOL K3041 coo 69.08 8.58 32.60 69.70 10.81 30.58 191.56 126.17 188.91 191.90 126.17 191.97 coo 71.77 11.86 24.26 70.23 12.22 26.56 192.13 137.45 187.51 191.27 140.11 187.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 194.36 135.90 195.25 193.66 135.95 197.23 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 B 48 ARG K 145 ARG~? 19.97 C2 GOL K3009 D 101 TYR K 143 TYR~? 15.99 O3 GOL K3009 D 173 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 69.08 8.58 32.60 69.70 10.81 30.58 204.60 147.17 190.28 202.10 146.29 191.85 coo 71.77 11.86 24.26 70.23 12.22 26.56 201.16 138.32 187.50 201.22 135.84 188.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 B 48 ARG L 36 ARG~? 28.87 C1 GOL P3034 D 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 D 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 69.08 8.58 32.60 69.70 10.81 30.58 174.06 157.20 217.38 176.23 157.17 215.21 coo 71.77 11.86 24.26 70.23 12.22 26.56 166.36 159.94 218.26 163.88 160.60 219.34 coo 71.60 6.14 19.25 70.26 6.87 20.69 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 B 48 ARG L 37 ARG~? 22.34 O3 GOL K3011 D 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 D 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 69.08 8.58 32.60 69.70 10.81 30.58 167.17 151.29 214.24 165.45 151.32 211.73 coo 71.77 11.86 24.26 70.23 12.22 26.56 166.36 159.94 218.26 163.88 160.60 219.34 coo 71.60 6.14 19.25 70.26 6.87 20.69 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 B 48 ARG L 114 ARG~? 18.80 O1 GOL L3027 D 101 TYR L 109 TYR~? 18.94 O3 GOL L3028 D 173 ASP L 102 ASP.? 24.59 CL CL L2009 coo 69.08 8.58 32.60 69.70 10.81 30.58 138.87 157.00 210.52 138.32 154.00 210.96 coo 71.77 11.86 24.26 70.23 12.22 26.56 139.89 156.88 199.30 141.02 156.55 196.75 coo 71.60 6.14 19.25 70.26 6.87 20.69 136.52 149.82 201.33 136.95 147.73 201.53 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 B 48 ARG L 145 ARG~? 21.94 C3 GOL O3013 D 101 TYR L 143 TYR~? 15.30 CL CL L2009 D 173 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 69.08 8.58 32.60 69.70 10.81 30.58 129.45 155.66 188.12 131.98 157.11 187.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 131.10 157.77 197.34 130.52 156.95 199.97 coo 71.60 6.14 19.25 70.26 6.87 20.69 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 B 48 ARG M 36 ARG~? 16.07 O1 GOL M3007 D 101 TYR M 35 TYR~? 13.00 CL CL I2001 D 173 ASP M 28 ASP~? 15.52 CL CL I2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 179.97 216.30 180.98 181.48 213.82 180.04 coo 71.77 11.86 24.26 70.23 12.22 26.56 172.26 218.21 177.69 169.95 219.60 176.96 coo 71.60 6.14 19.25 70.26 6.87 20.69 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 B 48 ARG M 37 ARG~? -4.64 O1 GOL M3007s D 101 TYR M 35 TYR~? 13.00 CL CL I2001 D 173 ASP M 28 ASP~? 15.52 CL CL I2001 coo 69.08 8.58 32.60 69.70 10.81 30.58 172.69 214.03 186.60 170.63 211.79 186.52 coo 71.77 11.86 24.26 70.23 12.22 26.56 172.26 218.21 177.69 169.95 219.60 176.96 coo 71.60 6.14 19.25 70.26 6.87 20.69 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 B 48 ARG M 114 ARG~? 18.40 O3 GOL M3043 D 101 TYR M 109 TYR~? 20.13 O1 GOL M3043 D 173 ASP M 102 ASP.? 24.52 CL CL M2017 coo 69.08 8.58 32.60 69.70 10.81 30.58 144.35 213.37 180.84 143.79 213.88 183.80 coo 71.77 11.86 24.26 70.23 12.22 26.56 143.85 202.19 180.75 144.68 199.53 181.04 coo 71.60 6.14 19.25 70.26 6.87 20.69 140.74 204.70 188.01 141.33 204.99 189.98 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 B 48 ARG M 145 ARG~? 23.51 CL CL M2017 D 101 TYR M 143 TYR~? 15.40 CL CL M2017 D 173 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 69.08 8.58 32.60 69.70 10.81 30.58 131.12 192.72 183.38 131.87 195.02 185.33 coo 71.77 11.86 24.26 70.23 12.22 26.56 134.88 201.35 179.85 134.66 203.97 180.76 coo 71.60 6.14 19.25 70.26 6.87 20.69 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 47 3 # 47 B 48 ARG N 36 ARG~? 15.62 C3 GOL N3008 D 101 TYR N 35 TYR~? 13.09 CL CL J2002 D 173 ASP N 28 ASP~? 15.68 CL CL J2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 161.60 152.07 121.93 160.06 153.41 124.19 coo 71.77 11.86 24.26 70.23 12.22 26.56 169.83 154.24 120.71 172.41 154.64 119.66 coo 71.60 6.14 19.25 70.26 6.87 20.69 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 48 3 # 48 B 48 ARG N 37 ARG~? -4.21 O3 GOL N3008s D 101 TYR N 35 TYR~? 13.09 CL CL J2002 D 173 ASP N 28 ASP~? 15.68 CL CL J2002 coo 69.08 8.58 32.60 69.70 10.81 30.58 167.97 146.21 125.72 169.64 146.36 128.31 coo 71.77 11.86 24.26 70.23 12.22 26.56 169.83 154.24 120.71 172.41 154.64 119.66 coo 71.60 6.14 19.25 70.26 6.87 20.69 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 49 3 # 49 B 48 ARG N 114 ARG~? 21.90 O2 GOL N3029 D 101 TYR N 109 TYR~? 12.25 C2 GOL N3029 D 173 ASP N 102 ASP.? 20.60 O2 GOL N3029 coo 69.08 8.58 32.60 69.70 10.81 30.58 196.45 148.76 129.28 196.55 145.72 129.25 coo 71.77 11.86 24.26 70.23 12.22 26.56 195.52 150.33 140.44 194.35 150.45 143.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 197.96 142.41 139.19 197.06 140.46 139.09 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 50 3 # 50 B 48 ARG N 145 ARG~? 14.05 C1 GOL N3029 D 101 TYR N 143 TYR~? 10.73 O2 GOL N3029 D 173 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 69.08 8.58 32.60 69.70 10.81 30.58 206.36 147.54 151.55 205.74 145.29 149.50 coo 71.77 11.86 24.26 70.23 12.22 26.56 204.41 150.24 142.39 204.78 148.95 139.97 coo 71.60 6.14 19.25 70.26 6.87 20.69 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 51 3 # 51 B 48 ARG O 36 ARG~? 19.89 O1 GOL K3010 D 101 TYR O 35 TYR~? 20.32 CL CL K2003 D 173 ASP O 28 ASP~? 23.95 CL CL O2036 coo 69.08 8.58 32.60 69.70 10.81 30.58 175.82 120.47 157.52 177.72 122.75 158.28 coo 71.77 11.86 24.26 70.23 12.22 26.56 167.80 119.41 159.74 165.27 118.34 160.26 coo 71.60 6.14 19.25 70.26 6.87 20.69 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 52 3 # 52 B 48 ARG O 37 ARG~? 22.15 CL CL K2003 D 101 TYR O 35 TYR~? 20.32 CL CL K2003 D 173 ASP O 28 ASP~? 23.95 CL CL O2036 coo 69.08 8.58 32.60 69.70 10.81 30.58 169.49 123.46 151.21 167.81 125.99 151.08 coo 71.77 11.86 24.26 70.23 12.22 26.56 167.80 119.41 159.74 165.27 118.34 160.26 coo 71.60 6.14 19.25 70.26 6.87 20.69 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 53 3 # 53 B 48 ARG O 114 ARG~? 4.95 CL CL O2036 D 101 TYR O 109 TYR~? 12.46 CL CL O2036 D 173 ASP O 102 ASP.? 13.16 CL CL O2036 coo 69.08 8.58 32.60 69.70 10.81 30.58 141.08 127.21 153.72 140.82 126.86 150.69 coo 71.77 11.86 24.26 70.23 12.22 26.56 141.96 138.45 153.78 143.09 141.01 153.60 coo 71.60 6.14 19.25 70.26 6.87 20.69 139.48 136.33 146.19 140.25 135.96 144.25 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 54 3 # 54 B 48 ARG O 145 ARG~? 14.75 O3 GOL O3026 D 101 TYR O 143 TYR~? 11.76 C3 GOL O3026 D 173 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 69.08 8.58 32.60 69.70 10.81 30.58 130.60 149.22 149.86 131.12 146.92 147.82 coo 71.77 11.86 24.26 70.23 12.22 26.56 133.04 140.38 153.60 132.61 137.79 152.63 coo 71.60 6.14 19.25 70.26 6.87 20.69 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 55 3 # 55 B 48 ARG P 36 ARG~? 18.56 O1 GOL L3028 D 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 D 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 69.08 8.58 32.60 69.70 10.81 30.58 157.78 187.06 214.51 156.14 185.86 212.27 coo 71.77 11.86 24.26 70.23 12.22 26.56 165.51 183.94 216.71 167.90 183.49 218.05 coo 71.60 6.14 19.25 70.26 6.87 20.69 167.75 181.83 222.09 168.94 183.53 222.37 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 56 3 # 56 B 48 ARG P 37 ARG~? -21.37 O3 GOL M3007s D 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 D 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 69.08 8.58 32.60 69.70 10.81 30.58 165.27 191.94 211.53 167.28 191.57 209.25 coo 71.77 11.86 24.26 70.23 12.22 26.56 165.51 183.94 216.71 167.90 183.49 218.05 coo 71.60 6.14 19.25 70.26 6.87 20.69 167.75 181.83 222.09 168.94 183.53 222.37 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 57 3 # 57 B 48 ARG P 145 ARG~? 19.93 O1 GOL P3014 D 101 TYR P 143 TYR~? 15.20 CL CL P2019 D 173 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 69.08 8.58 32.60 69.70 10.81 30.58 206.30 185.90 191.05 208.78 186.92 189.45 coo 71.77 11.86 24.26 70.23 12.22 26.56 202.86 183.43 199.65 203.11 184.67 202.14 coo 71.60 6.14 19.25 70.26 6.87 20.69 200.75 174.15 199.66 202.28 173.10 198.62 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 57 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 B 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 D 48 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 59.25 100.54 36.63 61.78 101.51 37.35 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 62.23 105.49 38.88 63.59 105.50 37.26 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 35 TYR~? 31.11 O2 GOL E3035 B 173 ASP A 28 ASP~? 35.69 O2 GOL E3035 D 48 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 59.25 100.54 36.63 61.78 101.51 37.35 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 62.23 105.49 38.88 63.59 105.50 37.26 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 143 TYR~? 16.38 O1 GOL A3040 B 173 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 48 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 92.99 77.44 39.76 93.75 79.76 38.42 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 90.44 78.16 48.76 91.65 76.94 50.06 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 35 TYR~? 15.50 C1 GOL B3003 B 173 ASP B 28 ASP~? 19.20 C1 GOL B3003 D 48 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 60.35 59.88 4.36 57.88 59.60 3.08 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 143 TYR~? 10.77 O2 GOL B3024 B 173 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 48 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 23.25 68.41 18.58 23.33 69.19 15.92 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 23.66 59.02 20.34 21.93 58.32 21.38 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR C 35 TYR~? 12.95 CL CL C2004 B 173 ASP C 28 ASP~? 15.70 CL CL C2004 D 48 ARG C 36 ARG~? 17.12 CL CL C2004 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 45.94 6.51 69.90 48.30 5.07 69.65 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 48.49 0.93 68.23 49.38 0.74 70.13 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR C 35 TYR~? 12.95 CL CL C2004 B 173 ASP C 28 ASP~? 15.70 CL CL C2004 D 48 ARG C 37 ARG~? -20.33 CL CL C2004s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 45.94 6.51 69.90 48.30 5.07 69.65 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 48.49 0.93 68.23 49.38 0.74 70.13 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR C 143 TYR~? 14.40 O1 GOL C3036 B 173 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 48 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 83.34 22.31 75.20 83.28 19.92 76.54 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 82.81 22.02 65.69 84.52 22.80 64.66 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR D 35 TYR~? 13.02 CL CL H2005 B 173 ASP D 28 ASP~? 15.80 CL CL H2005 D 48 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 48.27 47.24 102.95 45.77 48.18 103.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 45.36 50.43 107.49 43.88 48.98 107.89 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 101 TYR D 35 TYR~? 13.02 CL CL H2005 B 173 ASP D 28 ASP~? 15.80 CL CL H2005 D 48 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 48.27 47.24 102.95 45.77 48.18 103.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 45.36 50.43 107.49 43.88 48.98 107.89 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 101 TYR D 143 TYR~? 15.16 CL CL D2012 B 173 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 48 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 14.34 45.54 80.17 13.57 44.79 82.74 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 16.94 54.59 79.01 15.65 55.42 77.54 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 B 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 D 48 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 58.94 102.78 60.36 56.69 104.19 59.52 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 57.09 107.82 57.29 55.83 108.40 58.91 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 101 TYR E 35 TYR~? 15.88 O1 GOL E3004 B 173 ASP E 28 ASP~? 19.58 O1 GOL E3004 D 48 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 58.94 102.78 60.36 56.69 104.19 59.52 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 57.09 107.82 57.29 55.83 108.40 58.91 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 101 TYR E 143 TYR~? 15.23 CL CL E2013 B 173 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 48 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 20.79 87.99 61.33 20.74 90.64 62.13 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 23.07 86.29 52.35 21.57 85.17 51.32 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 101 TYR F 35 TYR~? 30.41 CL CL F2035 B 173 ASP F 28 ASP~? 32.62 CL CL F2035 D 48 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 55.89 36.47 6.05 58.49 36.69 5.11 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 59.39 38.13 1.08 60.39 36.31 1.06 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 101 TYR F 35 TYR~? 30.41 CL CL F2035 B 173 ASP F 28 ASP~? 32.62 CL CL F2035 D 48 ARG F 37 ARG~? -27.07 CL CL F2035s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 55.89 36.47 6.05 58.49 36.69 5.11 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 59.39 38.13 1.08 60.39 36.31 1.06 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 101 TYR F 143 TYR~? 15.09 CL CL F2034 B 173 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 48 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 89.42 31.84 29.55 89.79 30.44 27.17 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 88.86 41.25 28.96 90.30 42.22 30.24 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 101 TYR G 35 TYR~? 13.11 CL CL C2004 B 173 ASP G 28 ASP~? 15.85 CL CL C2004 D 48 ARG G 37 ARG~? 20.29 CL CL C2004 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 50.35 3.70 46.66 47.74 2.77 47.00 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 B 101 TYR G 143 TYR~? 15.53 C3 GOL G3001 B 173 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 48 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 16.97 25.90 37.77 16.51 23.33 36.84 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 17.70 27.34 47.09 16.19 28.71 47.73 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 B 101 TYR H 35 TYR~? 13.05 CL CL H2005 B 173 ASP H 28 ASP~? 15.80 CL CL H2005 D 48 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 48.71 70.98 100.43 50.94 70.32 101.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 50.63 68.82 106.06 51.93 70.45 106.39 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 B 101 TYR H 35 TYR~? 13.05 CL CL H2005 B 173 ASP H 28 ASP~? 15.80 CL CL H2005 D 48 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 48.71 70.98 100.43 50.94 70.32 101.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 50.63 68.82 106.06 51.93 70.45 106.39 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 B 101 TYR H 143 TYR~? 11.30 O2 GOL H3016 B 173 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 48 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 86.77 67.99 85.16 86.88 69.36 87.57 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 84.24 58.93 85.48 85.73 57.59 84.66 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 B 101 TYR I 35 TYR~? 13.03 CL CL I2001 B 173 ASP I 28 ASP~? 15.71 CL CL I2001 D 48 ARG I 36 ARG~? 18.35 CL CL I2001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 171.46 216.91 154.12 173.98 218.04 154.69 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 174.34 221.90 156.42 175.71 222.11 154.83 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 B 101 TYR I 35 TYR~? 13.03 CL CL I2001 B 173 ASP I 28 ASP~? 15.71 CL CL I2001 D 48 ARG I 37 ARG~? 20.23 CL CL I2001 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 171.46 216.91 154.12 173.98 218.04 154.69 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 174.34 221.90 156.42 175.71 222.11 154.83 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 B 101 TYR I 143 TYR~? 11.25 C1 GOL I3032 B 173 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 48 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 206.55 195.37 154.41 207.09 197.83 153.23 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 204.37 195.46 163.61 205.75 194.30 164.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 B 101 TYR J 35 TYR~? 13.02 CL CL J2002 B 173 ASP J 28 ASP~? 15.67 CL CL J2002 D 48 ARG J 36 ARG~? 16.92 CL CL J2002 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 173.30 177.82 119.58 170.88 177.40 118.29 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 170.87 175.19 114.50 169.74 176.91 114.00 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 B 101 TYR J 35 TYR~? 13.02 CL CL J2002 B 173 ASP J 28 ASP~? 15.67 CL CL J2002 D 48 ARG J 37 ARG~? 20.17 CL CL J2002 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 173.30 177.82 119.58 170.88 177.40 118.29 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 170.87 175.19 114.50 169.74 176.91 114.00 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 B 101 TYR J 143 TYR~? 15.18 CL CL J2016 B 173 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 48 ARG J 145 ARG~? 22.99 CL CL J2016 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 136.50 183.91 136.49 136.50 184.93 133.88 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 137.44 174.60 137.57 135.80 173.80 138.69 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 B 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 B 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 D 48 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 164.29 120.92 183.43 166.71 119.58 183.22 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 166.96 115.59 181.42 167.86 115.34 183.30 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 B 101 TYR K 35 TYR~? 15.70 O1 GOL K3011 B 173 ASP K 28 ASP~? 19.61 O1 GOL K3011 D 48 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 164.29 120.92 183.43 166.71 119.58 183.22 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 166.96 115.59 181.42 167.86 115.34 183.30 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 B 101 TYR K 143 TYR~? 15.99 O3 GOL K3009 B 173 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 48 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 201.16 138.32 187.50 201.22 135.84 188.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 200.17 138.24 178.11 201.77 139.28 177.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 B 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 B 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 D 48 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 166.36 159.94 218.26 163.88 160.60 219.34 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 163.49 162.78 223.08 162.21 161.15 223.46 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 B 101 TYR L 35 TYR~? 33.75 O3 GOL K3011 B 173 ASP L 28 ASP~? 34.50 O1 GOL L3028 D 48 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 166.36 159.94 218.26 163.88 160.60 219.34 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 163.49 162.78 223.08 162.21 161.15 223.46 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 B 101 TYR L 143 TYR~? 15.30 CL CL L2009 B 173 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 48 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 131.10 157.77 197.34 130.52 156.95 199.97 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 133.34 166.97 196.27 132.03 168.03 194.96 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 B 101 TYR M 35 TYR~? 13.00 CL CL I2001 B 173 ASP M 28 ASP~? 15.52 CL CL I2001 D 48 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 172.26 218.21 177.69 169.95 219.60 176.96 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 170.27 223.20 174.57 168.89 223.83 176.08 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 B 101 TYR M 35 TYR~? 13.00 CL CL I2001 B 173 ASP M 28 ASP~? 15.52 CL CL I2001 D 48 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 172.26 218.21 177.69 169.95 219.60 176.96 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 170.27 223.20 174.57 168.89 223.83 176.08 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 B 101 TYR M 143 TYR~? 15.40 CL CL M2017 B 173 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 48 ARG M 145 ARG~? 23.51 CL CL M2017 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 134.88 201.35 179.85 134.66 203.97 180.76 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 136.87 200.18 170.79 135.36 199.08 169.77 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 B 101 TYR N 35 TYR~? 13.09 CL CL J2002 B 173 ASP N 28 ASP~? 15.68 CL CL J2002 D 48 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 169.83 154.24 120.71 172.41 154.64 119.66 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 173.04 156.37 115.74 174.12 154.54 115.64 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 B 101 TYR N 35 TYR~? 13.09 CL CL J2002 B 173 ASP N 28 ASP~? 15.68 CL CL J2002 D 48 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 169.83 154.24 120.71 172.41 154.64 119.66 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 173.04 156.37 115.74 174.12 154.54 115.64 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 B 101 TYR N 143 TYR~? 10.73 O2 GOL N3029 B 173 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 48 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 204.41 150.24 142.39 204.78 148.95 139.97 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 203.51 159.51 142.26 205.02 160.53 143.48 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 B 101 TYR O 35 TYR~? 20.32 CL CL K2003 B 173 ASP O 28 ASP~? 23.95 CL CL O2036 D 48 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 167.80 119.41 159.74 165.27 118.34 160.26 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 164.72 114.57 162.31 163.52 114.24 160.62 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 B 101 TYR O 35 TYR~? 20.32 CL CL K2003 B 173 ASP O 28 ASP~? 23.95 CL CL O2036 D 48 ARG O 37 ARG~? 22.15 CL CL K2003 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 167.80 119.41 159.74 165.27 118.34 160.26 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 164.72 114.57 162.31 163.52 114.24 160.62 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 B 101 TYR O 143 TYR~? 11.76 C3 GOL O3026 B 173 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 48 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 133.04 140.38 153.60 132.61 137.79 152.63 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 134.07 141.35 162.95 132.57 142.58 163.78 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 B 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 B 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 D 48 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 165.51 183.94 216.71 167.90 183.49 218.05 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 167.75 181.83 222.09 168.94 183.53 222.37 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 B 101 TYR P 35 TYR~? 28.94 O1 GOL L3028 B 173 ASP P 28 ASP~? 33.76 O1 GOL L3028 D 48 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 74.59 -12.57 45.75 72.37 -12.96 44.12 165.51 183.94 216.71 167.90 183.49 218.05 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 167.75 181.83 222.09 168.94 183.53 222.37 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 B 101 TYR P 143 TYR~? 15.20 CL CL P2019 B 173 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 48 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 202.86 183.43 199.65 203.11 184.67 202.14 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 200.75 174.15 199.66 202.28 173.10 198.62 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 206.30 185.90 191.05 208.78 186.92 189.45 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 135 ALA.? 20.01 CL CL A2020 A 74 ASN A 134 ASN.? 22.60 O2 GOL A3040 A 75 GLY A 132 GLY.? 16.45 O2 GOL A3040 coo -1.80 62.71 122.76 -1.88 63.70 123.92 92.96 83.99 31.70 93.11 82.79 32.66 coo 1.20 66.40 122.20 2.03 64.53 121.46 89.85 87.69 31.14 89.29 86.47 29.46 coo 4.68 65.84 125.52 4.11 65.60 126.05 91.45 91.87 34.64 91.64 91.15 34.23 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 135 ALA.? 17.88 O2 GOL B3024 A 74 ASN B 134 ASN.? 21.61 CL CL B2010 A 75 GLY B 132 GLY.? 15.54 O1 GOL B3023 coo -1.80 62.71 122.76 -1.88 63.70 123.92 26.30 74.37 10.83 25.77 73.85 12.21 coo 1.20 66.40 122.20 2.03 64.53 121.46 30.08 73.64 8.08 31.06 75.15 9.33 coo 4.68 65.84 125.52 4.11 65.60 126.05 28.89 69.23 4.26 28.61 69.82 4.74 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA C 135 ALA.? 18.18 CL CL C2011 A 74 ASN C 134 ASN.? 21.68 CL CL C2011 A 75 GLY C 132 GLY.? 16.13 CL CL C2011 coo -1.80 62.71 122.76 -1.88 63.70 123.92 80.29 16.27 82.51 80.76 17.49 81.72 coo 1.20 66.40 122.20 2.03 64.53 121.46 76.46 13.23 82.50 75.64 14.68 83.88 coo 4.68 65.84 125.52 4.11 65.60 126.05 77.75 8.57 79.24 77.97 9.20 79.71 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA D 135 ALA.? 17.96 CL CL D2012 A 74 ASN D 134 ASN.? 21.42 O3 GOL D3018 A 75 GLY D 132 GLY.? 15.06 O3 GOL D3018 coo -1.80 62.71 122.76 -1.88 63.70 123.92 14.36 39.19 88.01 14.38 39.77 86.62 coo 1.20 66.40 122.20 2.03 64.53 121.46 17.21 39.17 91.82 18.06 37.43 90.85 coo 4.68 65.84 125.52 4.11 65.60 126.05 16.18 43.51 95.35 15.93 42.99 94.76 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 5 3 # 5 A 1 ALA E 135 ALA.? 17.76 CL CL E2013 A 74 ASN E 134 ASN.? 21.44 CL CL E2013 A 75 GLY E 132 GLY.? 15.84 O3 GOL E3022 coo -1.80 62.71 122.76 -1.88 63.70 123.92 22.68 95.82 67.83 22.19 94.52 67.17 coo 1.20 66.40 122.20 2.03 64.53 121.46 26.64 98.55 67.66 26.91 97.58 69.55 coo 4.68 65.84 125.52 4.11 65.60 126.05 26.22 102.29 63.56 25.89 101.75 64.09 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 6 3 # 6 A 1 ALA F 135 ALA.? 17.61 CL CL F2034 A 74 ASN F 134 ASN.? 19.08 CL CL F2035 A 75 GLY F 132 GLY.? 16.08 O2 GOL F3039 coo -1.80 62.71 122.76 -1.88 63.70 123.92 87.72 24.37 22.89 88.08 25.22 24.08 coo 1.20 66.40 122.20 2.03 64.53 121.46 84.48 24.50 19.28 83.57 23.00 20.51 coo 4.68 65.84 125.52 4.11 65.60 126.05 86.82 27.58 14.96 86.95 27.14 15.66 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 7 3 # 7 A 1 ALA G 135 ALA.? 19.98 C3 GOL G3038 A 74 ASN G 134 ASN.? 22.43 C3 GOL G3038 A 75 GLY G 132 GLY.? 16.31 C3 GOL G3038 coo -1.80 62.71 122.76 -1.88 63.70 123.92 18.49 17.87 31.65 18.29 19.28 32.20 coo 1.20 66.40 122.20 2.03 64.53 121.46 21.73 14.27 32.50 22.54 15.11 30.68 coo 4.68 65.84 125.52 4.11 65.60 126.05 19.28 10.80 36.53 19.22 11.38 35.96 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 8 3 # 8 A 1 ALA H 135 ALA.? 17.80 CL CL H2014 A 74 ASN H 134 ASN.? 21.68 CL CL H2014 A 75 GLY H 132 GLY.? 16.30 CL CL H2014 coo -1.80 62.71 122.76 -1.88 63.70 123.92 85.12 76.02 91.45 85.59 75.06 90.35 coo 1.20 66.40 122.20 2.03 64.53 121.46 81.15 76.65 94.15 80.84 78.27 92.76 coo 4.68 65.84 125.52 4.11 65.60 126.05 81.84 73.30 98.81 82.16 73.70 98.17 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 9 3 # 9 A 1 ALA I 135 ALA.? 17.77 CL CL I2015 A 74 ASN I 134 ASN.? 21.46 CL CL I2015 A 75 GLY I 132 GLY.? 16.04 CL CL I2015 coo -1.80 62.71 122.76 -1.88 63.70 123.92 205.79 202.14 146.97 205.93 200.92 147.82 coo 1.20 66.40 122.20 2.03 64.53 121.46 202.50 205.66 146.54 201.90 204.42 144.84 coo 4.68 65.84 125.52 4.11 65.60 126.05 203.89 209.98 150.21 204.10 209.32 149.73 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 10 3 # 10 A 1 ALA J 135 ALA.? 17.65 CL CL J2016 A 74 ASN J 134 ASN.? 21.36 CL CL J2016 A 75 GLY J 132 GLY.? 15.02 O3 GOL J3030 coo -1.80 62.71 122.76 -1.88 63.70 123.92 138.91 190.36 128.97 138.50 189.71 130.36 coo 1.20 66.40 122.20 2.03 64.53 121.46 142.59 189.93 125.86 143.30 191.66 127.03 coo 4.68 65.84 125.52 4.11 65.60 126.05 141.22 185.96 121.93 140.95 186.49 122.53 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 11 3 # 11 A 1 ALA K 135 ALA.? 19.10 O1 GOL K3041 A 74 ASN K 134 ASN.? 21.40 O1 GOL K3041 A 75 GLY K 132 GLY.? 14.94 O1 GOL K3041 coo -1.80 62.71 122.76 -1.88 63.70 123.92 198.59 131.76 194.84 198.93 133.01 194.07 coo 1.20 66.40 122.20 2.03 64.53 121.46 194.99 128.59 194.84 194.18 129.99 196.32 coo 4.68 65.84 125.52 4.11 65.60 126.05 196.31 124.21 191.29 196.56 124.84 191.79 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 12 3 # 12 A 1 ALA L 135 ALA.? 17.56 CL CL L2009 A 74 ASN L 134 ASN.? 21.61 CL CL L2009 A 75 GLY L 132 GLY.? 16.20 CL CL L2009 coo -1.80 62.71 122.76 -1.88 63.70 123.92 131.31 151.62 205.34 131.24 152.15 203.93 coo 1.20 66.40 122.20 2.03 64.53 121.46 134.78 151.23 208.60 135.91 149.70 207.44 coo 4.68 65.84 125.52 4.11 65.60 126.05 133.68 155.67 212.39 133.37 155.15 211.84 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 13 3 # 13 A 1 ALA M 135 ALA.? 17.94 CL CL M2017 A 74 ASN M 134 ASN.? 21.64 CL CL M2017 A 75 GLY M 132 GLY.? 15.75 O3 GOL M3043 coo -1.80 62.71 122.76 -1.88 63.70 123.92 136.61 208.69 186.51 136.19 207.38 185.80 coo 1.20 66.40 122.20 2.03 64.53 121.46 140.32 211.77 186.52 140.85 210.60 188.28 coo 4.68 65.84 125.52 4.11 65.60 126.05 139.37 215.92 182.33 139.07 215.36 182.86 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 14 3 # 14 A 1 ALA N 135 ALA.? 17.79 O2 GOL N3029 A 74 ASN N 134 ASN.? 22.01 O2 GOL N3029 A 75 GLY N 132 GLY.? 19.66 CL CL N2030 coo -1.80 62.71 122.76 -1.88 63.70 123.92 202.74 142.87 135.54 203.09 143.71 136.74 coo 1.20 66.40 122.20 2.03 64.53 121.46 199.33 142.96 132.06 198.55 141.35 133.25 coo 4.68 65.84 125.52 4.11 65.60 126.05 201.21 146.17 127.81 201.38 145.71 128.51 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 15 3 # 15 A 1 ALA O 135 ALA.? 13.72 CL CL O2036 A 74 ASN O 134 ASN.? 10.04 CL CL O2036 A 75 GLY O 132 GLY.? 9.54 CL CL O2036 coo -1.80 62.71 122.76 -1.88 63.70 123.92 134.59 132.69 147.05 134.19 133.97 147.77 coo 1.20 66.40 122.20 2.03 64.53 121.46 138.05 129.32 147.60 138.80 130.30 145.81 coo 4.68 65.84 125.52 4.11 65.60 126.05 135.90 125.45 151.48 135.82 126.02 150.88 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 16 3 # 16 A 1 ALA P 135 ALA.? 17.74 CL CL P2019 A 74 ASN P 134 ASN.? 21.42 CL CL P2019 A 75 GLY P 132 GLY.? 16.20 O2 GOL P3034 coo -1.80 62.71 122.76 -1.88 63.70 123.92 201.29 191.04 206.34 201.72 190.19 205.13 coo 1.20 66.40 122.20 2.03 64.53 121.46 197.55 191.31 209.34 197.08 192.94 207.98 coo 4.68 65.84 125.52 4.11 65.60 126.05 198.36 187.78 213.79 198.73 188.18 213.14 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 16 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 135 ALA.? 20.01 CL CL A2020 B 74 ASN A 134 ASN.? 22.60 O2 GOL A3040 B 75 GLY A 132 GLY.? 16.45 O2 GOL A3040 coo 39.21 14.97 27.55 40.19 16.01 27.08 92.96 83.99 31.70 93.11 82.79 32.66 coo 43.06 12.94 25.74 42.26 11.81 27.44 89.85 87.69 31.14 89.29 86.47 29.46 coo 46.38 13.54 29.18 46.14 14.29 29.26 91.45 91.87 34.64 91.64 91.15 34.23 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 135 ALA.? 17.88 O2 GOL B3024 B 74 ASN B 134 ASN.? 21.61 CL CL B2010 B 75 GLY B 132 GLY.? 15.54 O1 GOL B3023 coo 39.21 14.97 27.55 40.19 16.01 27.08 26.30 74.37 10.83 25.77 73.85 12.21 coo 43.06 12.94 25.74 42.26 11.81 27.44 30.08 73.64 8.08 31.06 75.15 9.33 coo 46.38 13.54 29.18 46.14 14.29 29.26 28.89 69.23 4.26 28.61 69.82 4.74 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA C 135 ALA.? 18.18 CL CL C2011 B 74 ASN C 134 ASN.? 21.68 CL CL C2011 B 75 GLY C 132 GLY.? 16.13 CL CL C2011 coo 39.21 14.97 27.55 40.19 16.01 27.08 80.29 16.27 82.51 80.76 17.49 81.72 coo 43.06 12.94 25.74 42.26 11.81 27.44 76.46 13.23 82.50 75.64 14.68 83.88 coo 46.38 13.54 29.18 46.14 14.29 29.26 77.75 8.57 79.24 77.97 9.20 79.71 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA D 135 ALA.? 17.96 CL CL D2012 B 74 ASN D 134 ASN.? 21.42 O3 GOL D3018 B 75 GLY D 132 GLY.? 15.06 O3 GOL D3018 coo 39.21 14.97 27.55 40.19 16.01 27.08 14.36 39.19 88.01 14.38 39.77 86.62 coo 43.06 12.94 25.74 42.26 11.81 27.44 17.21 39.17 91.82 18.06 37.43 90.85 coo 46.38 13.54 29.18 46.14 14.29 29.26 16.18 43.51 95.35 15.93 42.99 94.76 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 5 3 # 5 B 1 ALA E 135 ALA.? 17.76 CL CL E2013 B 74 ASN E 134 ASN.? 21.44 CL CL E2013 B 75 GLY E 132 GLY.? 15.84 O3 GOL E3022 coo 39.21 14.97 27.55 40.19 16.01 27.08 22.68 95.82 67.83 22.19 94.52 67.17 coo 43.06 12.94 25.74 42.26 11.81 27.44 26.64 98.55 67.66 26.91 97.58 69.55 coo 46.38 13.54 29.18 46.14 14.29 29.26 26.22 102.29 63.56 25.89 101.75 64.09 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 6 3 # 6 B 1 ALA F 135 ALA.? 17.61 CL CL F2034 B 74 ASN F 134 ASN.? 19.08 CL CL F2035 B 75 GLY F 132 GLY.? 16.08 O2 GOL F3039 coo 39.21 14.97 27.55 40.19 16.01 27.08 87.72 24.37 22.89 88.08 25.22 24.08 coo 43.06 12.94 25.74 42.26 11.81 27.44 84.48 24.50 19.28 83.57 23.00 20.51 coo 46.38 13.54 29.18 46.14 14.29 29.26 86.82 27.58 14.96 86.95 27.14 15.66 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 7 3 # 7 B 1 ALA G 135 ALA.? 19.98 C3 GOL G3038 B 74 ASN G 134 ASN.? 22.43 C3 GOL G3038 B 75 GLY G 132 GLY.? 16.31 C3 GOL G3038 coo 39.21 14.97 27.55 40.19 16.01 27.08 18.49 17.87 31.65 18.29 19.28 32.20 coo 43.06 12.94 25.74 42.26 11.81 27.44 21.73 14.27 32.50 22.54 15.11 30.68 coo 46.38 13.54 29.18 46.14 14.29 29.26 19.28 10.80 36.53 19.22 11.38 35.96 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 8 3 # 8 B 1 ALA H 135 ALA.? 17.80 CL CL H2014 B 74 ASN H 134 ASN.? 21.68 CL CL H2014 B 75 GLY H 132 GLY.? 16.30 CL CL H2014 coo 39.21 14.97 27.55 40.19 16.01 27.08 85.12 76.02 91.45 85.59 75.06 90.35 coo 43.06 12.94 25.74 42.26 11.81 27.44 81.15 76.65 94.15 80.84 78.27 92.76 coo 46.38 13.54 29.18 46.14 14.29 29.26 81.84 73.30 98.81 82.16 73.70 98.17 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 9 3 # 9 B 1 ALA I 135 ALA.? 17.77 CL CL I2015 B 74 ASN I 134 ASN.? 21.46 CL CL I2015 B 75 GLY I 132 GLY.? 16.04 CL CL I2015 coo 39.21 14.97 27.55 40.19 16.01 27.08 205.79 202.14 146.97 205.93 200.92 147.82 coo 43.06 12.94 25.74 42.26 11.81 27.44 202.50 205.66 146.54 201.90 204.42 144.84 coo 46.38 13.54 29.18 46.14 14.29 29.26 203.89 209.98 150.21 204.10 209.32 149.73 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 10 3 # 10 B 1 ALA J 135 ALA.? 17.65 CL CL J2016 B 74 ASN J 134 ASN.? 21.36 CL CL J2016 B 75 GLY J 132 GLY.? 15.02 O3 GOL J3030 coo 39.21 14.97 27.55 40.19 16.01 27.08 138.91 190.36 128.97 138.50 189.71 130.36 coo 43.06 12.94 25.74 42.26 11.81 27.44 142.59 189.93 125.86 143.30 191.66 127.03 coo 46.38 13.54 29.18 46.14 14.29 29.26 141.22 185.96 121.93 140.95 186.49 122.53 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 11 3 # 11 B 1 ALA K 135 ALA.? 19.10 O1 GOL K3041 B 74 ASN K 134 ASN.? 21.40 O1 GOL K3041 B 75 GLY K 132 GLY.? 14.94 O1 GOL K3041 coo 39.21 14.97 27.55 40.19 16.01 27.08 198.59 131.76 194.84 198.93 133.01 194.07 coo 43.06 12.94 25.74 42.26 11.81 27.44 194.99 128.59 194.84 194.18 129.99 196.32 coo 46.38 13.54 29.18 46.14 14.29 29.26 196.31 124.21 191.29 196.56 124.84 191.79 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 12 3 # 12 B 1 ALA L 135 ALA.? 17.56 CL CL L2009 B 74 ASN L 134 ASN.? 21.61 CL CL L2009 B 75 GLY L 132 GLY.? 16.20 CL CL L2009 coo 39.21 14.97 27.55 40.19 16.01 27.08 131.31 151.62 205.34 131.24 152.15 203.93 coo 43.06 12.94 25.74 42.26 11.81 27.44 134.78 151.23 208.60 135.91 149.70 207.44 coo 46.38 13.54 29.18 46.14 14.29 29.26 133.68 155.67 212.39 133.37 155.15 211.84 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 13 3 # 13 B 1 ALA M 135 ALA.? 17.94 CL CL M2017 B 74 ASN M 134 ASN.? 21.64 CL CL M2017 B 75 GLY M 132 GLY.? 15.75 O3 GOL M3043 coo 39.21 14.97 27.55 40.19 16.01 27.08 136.61 208.69 186.51 136.19 207.38 185.80 coo 43.06 12.94 25.74 42.26 11.81 27.44 140.32 211.77 186.52 140.85 210.60 188.28 coo 46.38 13.54 29.18 46.14 14.29 29.26 139.37 215.92 182.33 139.07 215.36 182.86 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 14 3 # 14 B 1 ALA N 135 ALA.? 17.79 O2 GOL N3029 B 74 ASN N 134 ASN.? 22.01 O2 GOL N3029 B 75 GLY N 132 GLY.? 19.66 CL CL N2030 coo 39.21 14.97 27.55 40.19 16.01 27.08 202.74 142.87 135.54 203.09 143.71 136.74 coo 43.06 12.94 25.74 42.26 11.81 27.44 199.33 142.96 132.06 198.55 141.35 133.25 coo 46.38 13.54 29.18 46.14 14.29 29.26 201.21 146.17 127.81 201.38 145.71 128.51 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 15 3 # 15 B 1 ALA O 135 ALA.? 13.72 CL CL O2036 B 74 ASN O 134 ASN.? 10.04 CL CL O2036 B 75 GLY O 132 GLY.? 9.54 CL CL O2036 coo 39.21 14.97 27.55 40.19 16.01 27.08 134.59 132.69 147.05 134.19 133.97 147.77 coo 43.06 12.94 25.74 42.26 11.81 27.44 138.05 129.32 147.60 138.80 130.30 145.81 coo 46.38 13.54 29.18 46.14 14.29 29.26 135.90 125.45 151.48 135.82 126.02 150.88 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 16 3 # 16 B 1 ALA P 135 ALA.? 17.74 CL CL P2019 B 74 ASN P 134 ASN.? 21.42 CL CL P2019 B 75 GLY P 132 GLY.? 16.20 O2 GOL P3034 coo 39.21 14.97 27.55 40.19 16.01 27.08 201.29 191.04 206.34 201.72 190.19 205.13 coo 43.06 12.94 25.74 42.26 11.81 27.44 197.55 191.31 209.34 197.08 192.94 207.98 coo 46.38 13.54 29.18 46.14 14.29 29.26 198.36 187.78 213.79 198.73 188.18 213.14 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 16 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 135 ALA.? 20.01 CL CL A2020 C 74 ASN A 134 ASN.? 22.60 O2 GOL A3040 C 75 GLY A 132 GLY.? 16.45 O2 GOL A3040 coo 16.14 15.08 36.63 15.28 14.65 37.81 92.96 83.99 31.70 93.11 82.79 32.66 coo 11.60 16.13 36.70 12.80 17.74 35.96 89.85 87.69 31.14 89.29 86.47 29.46 coo 10.99 19.23 40.32 11.50 18.77 40.74 91.45 91.87 34.64 91.64 91.15 34.23 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 135 ALA.? 17.88 O2 GOL B3024 C 74 ASN B 134 ASN.? 21.61 CL CL B2010 C 75 GLY B 132 GLY.? 15.54 O1 GOL B3023 coo 16.14 15.08 36.63 15.28 14.65 37.81 26.30 74.37 10.83 25.77 73.85 12.21 coo 11.60 16.13 36.70 12.80 17.74 35.96 30.08 73.64 8.08 31.06 75.15 9.33 coo 10.99 19.23 40.32 11.50 18.77 40.74 28.89 69.23 4.26 28.61 69.82 4.74 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA C 135 ALA.? 18.18 CL CL C2011 C 74 ASN C 134 ASN.? 21.68 CL CL C2011 C 75 GLY C 132 GLY.? 16.13 CL CL C2011 coo 16.14 15.08 36.63 15.28 14.65 37.81 80.29 16.27 82.51 80.76 17.49 81.72 coo 11.60 16.13 36.70 12.80 17.74 35.96 76.46 13.23 82.50 75.64 14.68 83.88 coo 10.99 19.23 40.32 11.50 18.77 40.74 77.75 8.57 79.24 77.97 9.20 79.71 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA D 135 ALA.? 17.96 CL CL D2012 C 74 ASN D 134 ASN.? 21.42 O3 GOL D3018 C 75 GLY D 132 GLY.? 15.06 O3 GOL D3018 coo 16.14 15.08 36.63 15.28 14.65 37.81 14.36 39.19 88.01 14.38 39.77 86.62 coo 11.60 16.13 36.70 12.80 17.74 35.96 17.21 39.17 91.82 18.06 37.43 90.85 coo 10.99 19.23 40.32 11.50 18.77 40.74 16.18 43.51 95.35 15.93 42.99 94.76 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 5 3 # 5 C 1 ALA E 135 ALA.? 17.76 CL CL E2013 C 74 ASN E 134 ASN.? 21.44 CL CL E2013 C 75 GLY E 132 GLY.? 15.84 O3 GOL E3022 coo 16.14 15.08 36.63 15.28 14.65 37.81 22.68 95.82 67.83 22.19 94.52 67.17 coo 11.60 16.13 36.70 12.80 17.74 35.96 26.64 98.55 67.66 26.91 97.58 69.55 coo 10.99 19.23 40.32 11.50 18.77 40.74 26.22 102.29 63.56 25.89 101.75 64.09 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 6 3 # 6 C 1 ALA F 135 ALA.? 17.61 CL CL F2034 C 74 ASN F 134 ASN.? 19.08 CL CL F2035 C 75 GLY F 132 GLY.? 16.08 O2 GOL F3039 coo 16.14 15.08 36.63 15.28 14.65 37.81 87.72 24.37 22.89 88.08 25.22 24.08 coo 11.60 16.13 36.70 12.80 17.74 35.96 84.48 24.50 19.28 83.57 23.00 20.51 coo 10.99 19.23 40.32 11.50 18.77 40.74 86.82 27.58 14.96 86.95 27.14 15.66 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 7 3 # 7 C 1 ALA G 135 ALA.? 19.98 C3 GOL G3038 C 74 ASN G 134 ASN.? 22.43 C3 GOL G3038 C 75 GLY G 132 GLY.? 16.31 C3 GOL G3038 coo 16.14 15.08 36.63 15.28 14.65 37.81 18.49 17.87 31.65 18.29 19.28 32.20 coo 11.60 16.13 36.70 12.80 17.74 35.96 21.73 14.27 32.50 22.54 15.11 30.68 coo 10.99 19.23 40.32 11.50 18.77 40.74 19.28 10.80 36.53 19.22 11.38 35.96 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 8 3 # 8 C 1 ALA H 135 ALA.? 17.80 CL CL H2014 C 74 ASN H 134 ASN.? 21.68 CL CL H2014 C 75 GLY H 132 GLY.? 16.30 CL CL H2014 coo 16.14 15.08 36.63 15.28 14.65 37.81 85.12 76.02 91.45 85.59 75.06 90.35 coo 11.60 16.13 36.70 12.80 17.74 35.96 81.15 76.65 94.15 80.84 78.27 92.76 coo 10.99 19.23 40.32 11.50 18.77 40.74 81.84 73.30 98.81 82.16 73.70 98.17 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 9 3 # 9 C 1 ALA I 135 ALA.? 17.77 CL CL I2015 C 74 ASN I 134 ASN.? 21.46 CL CL I2015 C 75 GLY I 132 GLY.? 16.04 CL CL I2015 coo 16.14 15.08 36.63 15.28 14.65 37.81 205.79 202.14 146.97 205.93 200.92 147.82 coo 11.60 16.13 36.70 12.80 17.74 35.96 202.50 205.66 146.54 201.90 204.42 144.84 coo 10.99 19.23 40.32 11.50 18.77 40.74 203.89 209.98 150.21 204.10 209.32 149.73 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 10 3 # 10 C 1 ALA J 135 ALA.? 17.65 CL CL J2016 C 74 ASN J 134 ASN.? 21.36 CL CL J2016 C 75 GLY J 132 GLY.? 15.02 O3 GOL J3030 coo 16.14 15.08 36.63 15.28 14.65 37.81 138.91 190.36 128.97 138.50 189.71 130.36 coo 11.60 16.13 36.70 12.80 17.74 35.96 142.59 189.93 125.86 143.30 191.66 127.03 coo 10.99 19.23 40.32 11.50 18.77 40.74 141.22 185.96 121.93 140.95 186.49 122.53 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 11 3 # 11 C 1 ALA K 135 ALA.? 19.10 O1 GOL K3041 C 74 ASN K 134 ASN.? 21.40 O1 GOL K3041 C 75 GLY K 132 GLY.? 14.94 O1 GOL K3041 coo 16.14 15.08 36.63 15.28 14.65 37.81 198.59 131.76 194.84 198.93 133.01 194.07 coo 11.60 16.13 36.70 12.80 17.74 35.96 194.99 128.59 194.84 194.18 129.99 196.32 coo 10.99 19.23 40.32 11.50 18.77 40.74 196.31 124.21 191.29 196.56 124.84 191.79 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 12 3 # 12 C 1 ALA L 135 ALA.? 17.56 CL CL L2009 C 74 ASN L 134 ASN.? 21.61 CL CL L2009 C 75 GLY L 132 GLY.? 16.20 CL CL L2009 coo 16.14 15.08 36.63 15.28 14.65 37.81 131.31 151.62 205.34 131.24 152.15 203.93 coo 11.60 16.13 36.70 12.80 17.74 35.96 134.78 151.23 208.60 135.91 149.70 207.44 coo 10.99 19.23 40.32 11.50 18.77 40.74 133.68 155.67 212.39 133.37 155.15 211.84 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 13 3 # 13 C 1 ALA M 135 ALA.? 17.94 CL CL M2017 C 74 ASN M 134 ASN.? 21.64 CL CL M2017 C 75 GLY M 132 GLY.? 15.75 O3 GOL M3043 coo 16.14 15.08 36.63 15.28 14.65 37.81 136.61 208.69 186.51 136.19 207.38 185.80 coo 11.60 16.13 36.70 12.80 17.74 35.96 140.32 211.77 186.52 140.85 210.60 188.28 coo 10.99 19.23 40.32 11.50 18.77 40.74 139.37 215.92 182.33 139.07 215.36 182.86 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 14 3 # 14 C 1 ALA N 135 ALA.? 17.79 O2 GOL N3029 C 74 ASN N 134 ASN.? 22.01 O2 GOL N3029 C 75 GLY N 132 GLY.? 19.66 CL CL N2030 coo 16.14 15.08 36.63 15.28 14.65 37.81 202.74 142.87 135.54 203.09 143.71 136.74 coo 11.60 16.13 36.70 12.80 17.74 35.96 199.33 142.96 132.06 198.55 141.35 133.25 coo 10.99 19.23 40.32 11.50 18.77 40.74 201.21 146.17 127.81 201.38 145.71 128.51 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 15 3 # 15 C 1 ALA O 135 ALA.? 13.72 CL CL O2036 C 74 ASN O 134 ASN.? 10.04 CL CL O2036 C 75 GLY O 132 GLY.? 9.54 CL CL O2036 coo 16.14 15.08 36.63 15.28 14.65 37.81 134.59 132.69 147.05 134.19 133.97 147.77 coo 11.60 16.13 36.70 12.80 17.74 35.96 138.05 129.32 147.60 138.80 130.30 145.81 coo 10.99 19.23 40.32 11.50 18.77 40.74 135.90 125.45 151.48 135.82 126.02 150.88 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 16 3 # 16 C 1 ALA P 135 ALA.? 17.74 CL CL P2019 C 74 ASN P 134 ASN.? 21.42 CL CL P2019 C 75 GLY P 132 GLY.? 16.20 O2 GOL P3034 coo 16.14 15.08 36.63 15.28 14.65 37.81 201.29 191.04 206.34 201.72 190.19 205.13 coo 11.60 16.13 36.70 12.80 17.74 35.96 197.55 191.31 209.34 197.08 192.94 207.98 coo 10.99 19.23 40.32 11.50 18.77 40.74 198.36 187.78 213.79 198.73 188.18 213.14 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 16 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 135 ALA.? 20.01 CL CL A2020 D 74 ASN A 134 ASN.? 22.60 O2 GOL A3040 D 75 GLY A 132 GLY.? 16.45 O2 GOL A3040 coo -13.31 41.90 116.45 -13.05 40.39 116.25 92.96 83.99 31.70 93.11 82.79 32.66 coo -16.85 39.36 115.26 -17.55 40.58 116.90 89.85 87.69 31.14 89.29 86.47 29.46 coo -17.65 36.37 119.00 -16.85 36.22 119.00 91.45 91.87 34.64 91.64 91.15 34.23 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 135 ALA.? 17.88 O2 GOL B3024 D 74 ASN B 134 ASN.? 21.61 CL CL B2010 D 75 GLY B 132 GLY.? 15.54 O1 GOL B3023 coo -13.31 41.90 116.45 -13.05 40.39 116.25 26.30 74.37 10.83 25.77 73.85 12.21 coo -16.85 39.36 115.26 -17.55 40.58 116.90 30.08 73.64 8.08 31.06 75.15 9.33 coo -17.65 36.37 119.00 -16.85 36.22 119.00 28.89 69.23 4.26 28.61 69.82 4.74 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA C 135 ALA.? 18.18 CL CL C2011 D 74 ASN C 134 ASN.? 21.68 CL CL C2011 D 75 GLY C 132 GLY.? 16.13 CL CL C2011 coo -13.31 41.90 116.45 -13.05 40.39 116.25 80.29 16.27 82.51 80.76 17.49 81.72 coo -16.85 39.36 115.26 -17.55 40.58 116.90 76.46 13.23 82.50 75.64 14.68 83.88 coo -17.65 36.37 119.00 -16.85 36.22 119.00 77.75 8.57 79.24 77.97 9.20 79.71 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA D 135 ALA.? 17.96 CL CL D2012 D 74 ASN D 134 ASN.? 21.42 O3 GOL D3018 D 75 GLY D 132 GLY.? 15.06 O3 GOL D3018 coo -13.31 41.90 116.45 -13.05 40.39 116.25 14.36 39.19 88.01 14.38 39.77 86.62 coo -16.85 39.36 115.26 -17.55 40.58 116.90 17.21 39.17 91.82 18.06 37.43 90.85 coo -17.65 36.37 119.00 -16.85 36.22 119.00 16.18 43.51 95.35 15.93 42.99 94.76 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 5 3 # 5 D 1 ALA E 135 ALA.? 17.76 CL CL E2013 D 74 ASN E 134 ASN.? 21.44 CL CL E2013 D 75 GLY E 132 GLY.? 15.84 O3 GOL E3022 coo -13.31 41.90 116.45 -13.05 40.39 116.25 22.68 95.82 67.83 22.19 94.52 67.17 coo -16.85 39.36 115.26 -17.55 40.58 116.90 26.64 98.55 67.66 26.91 97.58 69.55 coo -17.65 36.37 119.00 -16.85 36.22 119.00 26.22 102.29 63.56 25.89 101.75 64.09 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 6 3 # 6 D 1 ALA F 135 ALA.? 17.61 CL CL F2034 D 74 ASN F 134 ASN.? 19.08 CL CL F2035 D 75 GLY F 132 GLY.? 16.08 O2 GOL F3039 coo -13.31 41.90 116.45 -13.05 40.39 116.25 87.72 24.37 22.89 88.08 25.22 24.08 coo -16.85 39.36 115.26 -17.55 40.58 116.90 84.48 24.50 19.28 83.57 23.00 20.51 coo -17.65 36.37 119.00 -16.85 36.22 119.00 86.82 27.58 14.96 86.95 27.14 15.66 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 7 3 # 7 D 1 ALA G 135 ALA.? 19.98 C3 GOL G3038 D 74 ASN G 134 ASN.? 22.43 C3 GOL G3038 D 75 GLY G 132 GLY.? 16.31 C3 GOL G3038 coo -13.31 41.90 116.45 -13.05 40.39 116.25 18.49 17.87 31.65 18.29 19.28 32.20 coo -16.85 39.36 115.26 -17.55 40.58 116.90 21.73 14.27 32.50 22.54 15.11 30.68 coo -17.65 36.37 119.00 -16.85 36.22 119.00 19.28 10.80 36.53 19.22 11.38 35.96 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 8 3 # 8 D 1 ALA H 135 ALA.? 17.80 CL CL H2014 D 74 ASN H 134 ASN.? 21.68 CL CL H2014 D 75 GLY H 132 GLY.? 16.30 CL CL H2014 coo -13.31 41.90 116.45 -13.05 40.39 116.25 85.12 76.02 91.45 85.59 75.06 90.35 coo -16.85 39.36 115.26 -17.55 40.58 116.90 81.15 76.65 94.15 80.84 78.27 92.76 coo -17.65 36.37 119.00 -16.85 36.22 119.00 81.84 73.30 98.81 82.16 73.70 98.17 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 9 3 # 9 D 1 ALA I 135 ALA.? 17.77 CL CL I2015 D 74 ASN I 134 ASN.? 21.46 CL CL I2015 D 75 GLY I 132 GLY.? 16.04 CL CL I2015 coo -13.31 41.90 116.45 -13.05 40.39 116.25 205.79 202.14 146.97 205.93 200.92 147.82 coo -16.85 39.36 115.26 -17.55 40.58 116.90 202.50 205.66 146.54 201.90 204.42 144.84 coo -17.65 36.37 119.00 -16.85 36.22 119.00 203.89 209.98 150.21 204.10 209.32 149.73 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 10 3 # 10 D 1 ALA J 135 ALA.? 17.65 CL CL J2016 D 74 ASN J 134 ASN.? 21.36 CL CL J2016 D 75 GLY J 132 GLY.? 15.02 O3 GOL J3030 coo -13.31 41.90 116.45 -13.05 40.39 116.25 138.91 190.36 128.97 138.50 189.71 130.36 coo -16.85 39.36 115.26 -17.55 40.58 116.90 142.59 189.93 125.86 143.30 191.66 127.03 coo -17.65 36.37 119.00 -16.85 36.22 119.00 141.22 185.96 121.93 140.95 186.49 122.53 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 11 3 # 11 D 1 ALA K 135 ALA.? 19.10 O1 GOL K3041 D 74 ASN K 134 ASN.? 21.40 O1 GOL K3041 D 75 GLY K 132 GLY.? 14.94 O1 GOL K3041 coo -13.31 41.90 116.45 -13.05 40.39 116.25 198.59 131.76 194.84 198.93 133.01 194.07 coo -16.85 39.36 115.26 -17.55 40.58 116.90 194.99 128.59 194.84 194.18 129.99 196.32 coo -17.65 36.37 119.00 -16.85 36.22 119.00 196.31 124.21 191.29 196.56 124.84 191.79 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 12 3 # 12 D 1 ALA L 135 ALA.? 17.56 CL CL L2009 D 74 ASN L 134 ASN.? 21.61 CL CL L2009 D 75 GLY L 132 GLY.? 16.20 CL CL L2009 coo -13.31 41.90 116.45 -13.05 40.39 116.25 131.31 151.62 205.34 131.24 152.15 203.93 coo -16.85 39.36 115.26 -17.55 40.58 116.90 134.78 151.23 208.60 135.91 149.70 207.44 coo -17.65 36.37 119.00 -16.85 36.22 119.00 133.68 155.67 212.39 133.37 155.15 211.84 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 13 3 # 13 D 1 ALA M 135 ALA.? 17.94 CL CL M2017 D 74 ASN M 134 ASN.? 21.64 CL CL M2017 D 75 GLY M 132 GLY.? 15.75 O3 GOL M3043 coo -13.31 41.90 116.45 -13.05 40.39 116.25 136.61 208.69 186.51 136.19 207.38 185.80 coo -16.85 39.36 115.26 -17.55 40.58 116.90 140.32 211.77 186.52 140.85 210.60 188.28 coo -17.65 36.37 119.00 -16.85 36.22 119.00 139.37 215.92 182.33 139.07 215.36 182.86 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 14 3 # 14 D 1 ALA N 135 ALA.? 17.79 O2 GOL N3029 D 74 ASN N 134 ASN.? 22.01 O2 GOL N3029 D 75 GLY N 132 GLY.? 19.66 CL CL N2030 coo -13.31 41.90 116.45 -13.05 40.39 116.25 202.74 142.87 135.54 203.09 143.71 136.74 coo -16.85 39.36 115.26 -17.55 40.58 116.90 199.33 142.96 132.06 198.55 141.35 133.25 coo -17.65 36.37 119.00 -16.85 36.22 119.00 201.21 146.17 127.81 201.38 145.71 128.51 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 15 3 # 15 D 1 ALA O 135 ALA.? 13.72 CL CL O2036 D 74 ASN O 134 ASN.? 10.04 CL CL O2036 D 75 GLY O 132 GLY.? 9.54 CL CL O2036 coo -13.31 41.90 116.45 -13.05 40.39 116.25 134.59 132.69 147.05 134.19 133.97 147.77 coo -16.85 39.36 115.26 -17.55 40.58 116.90 138.05 129.32 147.60 138.80 130.30 145.81 coo -17.65 36.37 119.00 -16.85 36.22 119.00 135.90 125.45 151.48 135.82 126.02 150.88 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 16 3 # 16 D 1 ALA P 135 ALA.? 17.74 CL CL P2019 D 74 ASN P 134 ASN.? 21.42 CL CL P2019 D 75 GLY P 132 GLY.? 16.20 O2 GOL P3034 coo -13.31 41.90 116.45 -13.05 40.39 116.25 201.29 191.04 206.34 201.72 190.19 205.13 coo -16.85 39.36 115.26 -17.55 40.58 116.90 197.55 191.31 209.34 197.08 192.94 207.98 coo -17.65 36.37 119.00 -16.85 36.22 119.00 198.36 187.78 213.79 198.73 188.18 213.14 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 16 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 70 ASP~? -9.95 O3 GOL A3037s 315 GLU A 73 GLU~? -3.07 O3 GOL A3037s 390 TYR A 75 TYR~? 11.96 CL CL A2020 coo 32.46 99.13 19.34 30.94 100.38 20.07 90.44 78.16 48.76 91.65 76.94 50.06 coo 32.04 94.22 18.23 30.57 94.75 16.88 94.58 81.89 51.70 95.31 83.75 52.44 coo 21.10 94.74 18.36 23.09 96.71 18.59 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 102 ASP.? 25.18 C1 GOL A3040 315 GLU A 106 GLU~? 21.37 O1 GOL A3040 390 TYR A 143 TYR~? 16.38 O1 GOL A3040 coo 32.46 99.13 19.34 30.94 100.38 20.07 88.23 80.63 30.72 87.92 80.82 28.67 coo 32.04 94.22 18.23 30.57 94.75 16.88 86.09 78.56 33.43 88.06 78.13 34.12 coo 21.10 94.74 18.36 23.09 96.71 18.59 92.99 77.44 39.76 93.75 79.76 38.42 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 70 ASP~? -3.24 O2 GOL B3024s 315 GLU B 73 GLU~? 6.38 O3 GOL B3023 390 TYR B 75 TYR~? 10.15 CL CL B2010 coo 32.46 99.13 19.34 30.94 100.38 20.07 23.66 59.02 20.34 21.93 58.32 21.38 coo 32.04 94.22 18.23 30.57 94.75 16.88 19.80 56.19 16.30 19.32 55.14 14.52 coo 21.10 94.74 18.36 23.09 96.71 18.59 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 102 ASP.? 20.31 O1 GOL B3024 315 GLU B 106 GLU~? 14.28 O1 GOL B3024 390 TYR B 143 TYR~? 10.77 O2 GOL B3024 coo 32.46 99.13 19.34 30.94 100.38 20.07 30.49 75.29 14.98 31.30 77.16 14.42 coo 32.04 94.22 18.23 30.57 94.75 16.88 31.31 72.93 17.86 29.23 72.75 18.06 coo 21.10 94.74 18.36 23.09 96.71 18.59 23.25 68.41 18.58 23.33 69.19 15.92 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 3 # 5 313 ASP C 70 ASP~? 3.38 O1 GOL C3036s 315 GLU C 73 GLU~? 6.99 O1 GOL C3036 390 TYR C 75 TYR~? 10.50 CL CL C2011 coo 32.46 99.13 19.34 30.94 100.38 20.07 82.81 22.02 65.69 84.52 22.80 64.66 coo 32.04 94.22 18.23 30.57 94.75 16.88 86.57 17.41 63.72 86.98 15.43 63.06 coo 21.10 94.74 18.36 23.09 96.71 18.59 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 3 # 6 313 ASP C 102 ASP.? 24.57 CL CL C2011 315 GLU C 106 GLU~? 19.79 O1 GOL C3036 390 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo 32.46 99.13 19.34 30.94 100.38 20.07 76.25 20.52 82.74 75.40 20.56 84.65 coo 32.04 94.22 18.23 30.57 94.75 16.88 75.34 22.76 79.72 77.40 22.80 79.51 coo 21.10 94.74 18.36 23.09 96.71 18.59 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 3 # 7 313 ASP D 70 ASP~? -11.51 O3 GOL D3019s 315 GLU D 73 GLU~? 5.51 C2 GOL D3020 390 TYR D 75 TYR~? 10.03 CL CL D2012 coo 32.46 99.13 19.34 30.94 100.38 20.07 16.94 54.59 79.01 15.65 55.42 77.54 coo 32.04 94.22 18.23 30.57 94.75 16.88 12.99 58.17 82.26 12.31 59.24 83.94 coo 21.10 94.74 18.36 23.09 96.71 18.59 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 8 3 # 8 313 ASP D 102 ASP.? 24.32 CL CL D2012 315 GLU D 106 GLU~? 21.38 CL CL D2012 390 TYR D 143 TYR~? 15.16 CL CL D2012 coo 32.46 99.13 19.34 30.94 100.38 20.07 18.96 37.41 85.00 19.42 35.40 85.42 coo 32.04 94.22 18.23 30.57 94.75 16.88 21.11 39.74 82.39 19.19 40.22 81.74 coo 21.10 94.74 18.36 23.09 96.71 18.59 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 9 3 # 9 313 ASP E 70 ASP~? 5.56 O3 GOL E3002 315 GLU E 73 GLU~? -6.85 O1 GOL E3022s 390 TYR E 75 TYR~? 10.13 CL CL E2013 coo 32.46 99.13 19.34 30.94 100.38 20.07 23.07 86.29 52.35 21.57 85.17 51.32 coo 32.04 94.22 18.23 30.57 94.75 16.88 19.82 90.31 48.74 19.50 92.07 47.58 coo 21.10 94.74 18.36 23.09 96.71 18.59 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 10 3 # 10 313 ASP E 102 ASP.? 24.45 CL CL E2013 315 GLU E 106 GLU~? 21.05 O1 GOL E3022 390 TYR E 143 TYR~? 15.23 CL CL E2013 coo 32.46 99.13 19.34 30.94 100.38 20.07 26.42 91.49 69.61 27.08 91.68 71.63 coo 32.04 94.22 18.23 30.57 94.75 16.88 27.90 88.73 67.36 25.90 88.59 66.70 coo 21.10 94.74 18.36 23.09 96.71 18.59 20.79 87.99 61.33 20.74 90.64 62.13 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 11 3 # 11 313 ASP F 70 ASP~? -11.57 O3 GOL F3039s 315 GLU F 73 GLU~? 5.19 O3 GOL F3039 390 TYR F 75 TYR~? 9.99 CL CL F2034 coo 32.46 99.13 19.34 30.94 100.38 20.07 88.86 41.25 28.96 90.30 42.22 30.24 coo 32.04 94.22 18.23 30.57 94.75 16.88 93.55 43.24 25.35 94.46 43.89 23.55 coo 21.10 94.74 18.36 23.09 96.71 18.59 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 12 3 # 12 313 ASP F 102 ASP.? 16.73 CL CL F2035 315 GLU F 106 GLU~? 12.79 CL CL F2035 390 TYR F 143 TYR~? 15.09 CL CL F2034 coo 32.46 99.13 19.34 30.94 100.38 20.07 82.74 24.28 26.35 81.91 22.30 26.35 coo 32.04 94.22 18.23 30.57 94.75 16.88 81.39 27.31 28.31 83.45 27.54 28.69 coo 21.10 94.74 18.36 23.09 96.71 18.59 89.42 31.84 29.55 89.79 30.44 27.17 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 13 3 # 13 313 ASP G 70 ASP~? -5.29 C3 GOL G3001s 315 GLU G 73 GLU~? 5.63 O1 GOL G3038 390 TYR G 75 TYR~? 12.69 CL CL G2033 coo 32.46 99.13 19.34 30.94 100.38 20.07 17.70 27.34 47.09 16.19 28.71 47.73 coo 32.04 94.22 18.23 30.57 94.75 16.88 12.93 24.13 49.80 12.04 22.49 50.80 coo 21.10 94.74 18.36 23.09 96.71 18.59 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 14 3 # 14 313 ASP G 102 ASP.? 25.30 O3 GOL G3038 315 GLU G 106 GLU~? 21.38 C3 GOL G3001 390 TYR G 143 TYR~? 15.53 C3 GOL G3001 coo 32.46 99.13 19.34 30.94 100.38 20.07 23.47 21.05 30.82 24.30 20.62 28.93 coo 32.04 94.22 18.23 30.57 94.75 16.88 24.93 23.55 33.32 22.94 24.09 33.51 coo 21.10 94.74 18.36 23.09 96.71 18.59 16.97 25.90 37.77 16.51 23.33 36.84 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 15 3 # 15 313 ASP H 70 ASP~? -4.05 C3 GOL H3016s 315 GLU H 73 GLU~? -8.72 CL CL H2014s 390 TYR H 75 TYR~? 10.27 CL CL H2014 coo 32.46 99.13 19.34 30.94 100.38 20.07 84.24 58.93 85.48 85.73 57.59 84.66 coo 32.04 94.22 18.23 30.57 94.75 16.88 87.54 56.19 90.14 87.78 55.44 92.11 coo 21.10 94.74 18.36 23.09 96.71 18.59 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 16 3 # 16 313 ASP H 102 ASP.? 20.45 O2 GOL H3016 315 GLU H 106 GLU~? 14.51 O2 GOL H3016 390 TYR H 143 TYR~? 11.30 O2 GOL H3016 coo 32.46 99.13 19.34 30.94 100.38 20.07 81.36 76.99 86.94 80.90 79.01 86.89 coo 32.04 94.22 18.23 30.57 94.75 16.88 79.71 74.06 84.56 81.75 73.57 84.59 coo 21.10 94.74 18.36 23.09 96.71 18.59 86.77 67.99 85.16 86.88 69.36 87.57 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 17 3 # 17 313 ASP I 70 ASP~? -3.65 C2 GOL I3032s 315 GLU I 73 GLU~? -6.03 O3 GOL I3031s 390 TYR I 75 TYR~? 10.32 CL CL I2015 coo 32.46 99.13 19.34 30.94 100.38 20.07 204.37 195.46 163.61 205.75 194.30 164.79 coo 32.04 94.22 18.23 30.57 94.75 16.88 208.30 199.46 166.53 209.06 201.27 167.27 coo 21.10 94.74 18.36 23.09 96.71 18.59 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 18 3 # 18 313 ASP I 102 ASP.? 20.44 O1 GOL I3032 315 GLU I 106 GLU~? 14.47 O1 GOL I3032 390 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo 32.46 99.13 19.34 30.94 100.38 20.07 201.10 198.54 145.88 200.66 198.62 143.82 coo 32.04 94.22 18.23 30.57 94.75 16.88 199.46 196.34 148.59 201.47 195.97 149.14 coo 21.10 94.74 18.36 23.09 96.71 18.59 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 19 3 # 19 313 ASP J 70 ASP~? 11.68 O1 GOL J3033 315 GLU J 73 GLU~? 5.06 O1 GOL J3033 390 TYR J 75 TYR~? 10.17 CL CL J2016 coo 32.46 99.13 19.34 30.94 100.38 20.07 137.44 174.60 137.57 135.80 173.80 138.69 coo 32.04 94.22 18.23 30.57 94.75 16.88 133.49 171.70 133.63 132.81 170.83 131.84 coo 21.10 94.74 18.36 23.09 96.71 18.59 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 20 3 # 20 313 ASP J 102 ASP.? 24.08 CL CL J2016 315 GLU J 106 GLU~? 21.26 CL CL J2016 390 TYR J 143 TYR~? 15.18 CL CL J2016 coo 32.46 99.13 19.34 30.94 100.38 20.07 143.25 191.36 132.98 143.80 193.32 132.63 coo 32.04 94.22 18.23 30.57 94.75 16.88 144.43 188.69 135.80 142.30 188.60 135.89 coo 21.10 94.74 18.36 23.09 96.71 18.59 136.50 183.91 136.49 136.50 184.93 133.88 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 21 3 # 21 313 ASP K 70 ASP~? -4.89 O3 GOL K3009s 315 GLU K 73 GLU~? 7.36 C3 GOL K3041 390 TYR K 75 TYR~? 12.36 CL CL K2027 coo 32.46 99.13 19.34 30.94 100.38 20.07 200.17 138.24 178.11 201.77 139.28 177.19 coo 32.04 94.22 18.23 30.57 94.75 16.88 204.07 133.93 175.85 204.65 132.02 175.03 coo 21.10 94.74 18.36 23.09 96.71 18.59 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 22 3 # 22 313 ASP K 102 ASP.? 24.81 O1 GOL K3041 315 GLU K 106 GLU~? 21.15 O3 GOL K3009 390 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo 32.46 99.13 19.34 30.94 100.38 20.07 194.36 135.90 195.25 193.66 135.95 197.23 coo 32.04 94.22 18.23 30.57 94.75 16.88 193.16 138.18 192.36 195.25 138.38 192.10 coo 21.10 94.74 18.36 23.09 96.71 18.59 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 23 3 # 23 313 ASP L 70 ASP~? -12.27 O3 GOL L3028s 315 GLU L 73 GLU~? 5.94 O3 GOL L3027 390 TYR L 75 TYR~? 10.07 CL CL L2009 coo 32.46 99.13 19.34 30.94 100.38 20.07 133.34 166.97 196.27 132.03 168.03 194.96 coo 32.04 94.22 18.23 30.57 94.75 16.88 129.44 170.32 199.72 128.69 171.38 201.39 coo 21.10 94.74 18.36 23.09 96.71 18.59 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 24 3 # 24 313 ASP L 102 ASP.? 24.59 CL CL L2009 315 GLU L 106 GLU~? 21.37 CL CL L2009 390 TYR L 143 TYR~? 15.30 CL CL L2009 coo 32.46 99.13 19.34 30.94 100.38 20.07 136.52 149.82 201.33 136.95 147.73 201.53 coo 32.04 94.22 18.23 30.57 94.75 16.88 138.12 152.20 198.93 136.10 152.63 198.56 coo 21.10 94.74 18.36 23.09 96.71 18.59 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 25 3 # 25 313 ASP M 102 ASP.? 24.52 CL CL M2017 315 GLU M 106 GLU~? 21.48 CL CL M2017 390 TYR M 143 TYR~? 15.40 CL CL M2017 coo 32.46 99.13 19.34 30.94 100.38 20.07 140.74 204.70 188.01 141.33 204.99 189.98 coo 32.04 94.22 18.23 30.57 94.75 16.88 142.15 202.05 185.59 140.16 201.82 184.97 coo 21.10 94.74 18.36 23.09 96.71 18.59 134.88 201.35 179.85 134.66 203.97 180.76 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 26 3 # 26 313 ASP N 70 ASP~? -3.26 O2 GOL N3029s 315 GLU N 73 GLU~? -8.02 O3 GOL N3012s 390 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 32.46 99.13 19.34 30.94 100.38 20.07 203.51 159.51 142.26 205.02 160.53 143.48 coo 32.04 94.22 18.23 30.57 94.75 16.88 207.93 161.92 138.37 208.75 162.64 136.53 coo 21.10 94.74 18.36 23.09 96.71 18.59 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 27 3 # 27 313 ASP N 102 ASP.? 20.60 O2 GOL N3029 315 GLU N 106 GLU~? 14.62 O2 GOL N3029 390 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo 32.46 99.13 19.34 30.94 100.38 20.07 197.96 142.41 139.19 197.06 140.46 139.09 coo 32.04 94.22 18.23 30.57 94.75 16.88 196.48 145.55 141.46 198.54 145.70 141.81 coo 21.10 94.74 18.36 23.09 96.71 18.59 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 28 3 # 28 313 ASP O 70 ASP~? 3.30 O1 GOL O3013s 315 GLU O 73 GLU~? 6.85 O1 GOL O3013 390 TYR O 75 TYR~? 10.24 CL CL O2018 coo 32.46 99.13 19.34 30.94 100.38 20.07 134.07 141.35 162.95 132.57 142.58 163.78 coo 32.04 94.22 18.23 30.57 94.75 16.88 129.73 137.78 165.68 128.97 136.10 166.67 coo 21.10 94.74 18.36 23.09 96.71 18.59 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 29 3 # 29 313 ASP O 102 ASP.? 13.16 CL CL O2036 315 GLU O 106 GLU~? 13.74 CL CL O2036 390 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo 32.46 99.13 19.34 30.94 100.38 20.07 139.48 136.33 146.19 140.25 135.96 144.25 coo 32.04 94.22 18.23 30.57 94.75 16.88 140.87 138.77 148.77 138.84 139.06 148.95 coo 21.10 94.74 18.36 23.09 96.71 18.59 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 30 3 # 30 313 ASP P 70 ASP~? 4.30 O3 GOL P3014 315 GLU P 73 GLU~? 5.04 O1 GOL P3034 390 TYR P 75 TYR~? 10.23 CL CL P2019 coo 32.46 99.13 19.34 30.94 100.38 20.07 200.75 174.15 199.66 202.28 173.10 198.62 coo 32.04 94.22 18.23 30.57 94.75 16.88 204.36 171.43 203.90 204.84 170.63 205.81 coo 21.10 94.74 18.36 23.09 96.71 18.59 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 31 3 # 31 313 ASP P 102 ASP.? 24.26 CL CL P2019 315 GLU P 106 GLU~? 20.67 O3 GOL P3014 390 TYR P 143 TYR~? 15.20 CL CL P2019 coo 32.46 99.13 19.34 30.94 100.38 20.07 197.01 191.93 202.05 196.73 194.01 202.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 195.52 189.19 199.68 197.57 188.76 199.63 coo 21.10 94.74 18.36 23.09 96.71 18.59 202.86 183.43 199.65 203.11 184.67 202.14 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 31 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP C 102 ASP.? 24.57 CL CL C2011 A 56 ILE C 71 ILE~? 10.34 O1 GOL C3036 A 82 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 76.25 20.52 82.74 75.40 20.56 84.65 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 82.90 20.56 70.88 82.49 21.25 71.98 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP D 102 ASP.? 24.32 CL CL D2012 A 56 ILE D 71 ILE~? 13.51 O2 GOL D3018 A 82 TYR D 143 TYR~? 15.16 CL CL D2012 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 18.96 37.41 85.00 19.42 35.40 85.42 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 15.34 49.97 81.39 15.63 48.68 81.04 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 56 ILE I 71 ILE~? 7.55 C1 GOL I3032 A 82 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 201.10 198.54 145.88 200.66 198.62 143.82 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 205.58 197.07 158.62 205.25 196.44 157.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 56 ILE K 71 ILE~? 12.02 O3 GOL K3009 A 82 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 194.36 135.90 195.25 193.66 135.95 197.23 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 200.58 136.57 183.29 200.11 137.14 184.34 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP L 102 ASP.? 24.59 CL CL L2009 A 56 ILE L 71 ILE~? 13.91 O1 GOL L3027 A 82 TYR L 143 TYR~? 15.30 CL CL L2009 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 136.52 149.82 201.33 136.95 147.73 201.53 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 132.03 162.16 198.44 132.36 160.93 197.95 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP M 102 ASP.? 24.52 CL CL M2017 A 56 ILE M 71 ILE~? 13.86 O1 GOL M3043 A 82 TYR M 143 TYR~? 15.40 CL CL M2017 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 140.74 204.70 188.01 141.33 204.99 189.98 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 135.90 202.44 175.52 136.21 201.89 176.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 134.88 201.35 179.85 134.66 203.97 180.76 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 56 ILE N 71 ILE~? 7.06 O2 GOL N3029 A 82 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 197.96 142.41 139.19 197.06 140.46 139.09 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 204.02 154.49 140.54 203.54 153.36 141.23 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP P 102 ASP.? 24.26 CL CL P2019 A 56 ILE P 71 ILE~? 11.42 O3 GOL P3014 A 82 TYR P 143 TYR~? 15.20 CL CL P2019 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 197.01 191.93 202.05 196.73 194.01 202.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 201.74 179.28 201.32 201.38 180.45 200.73 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 202.86 183.43 199.65 203.11 184.67 202.14 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 8 hits 1d6o_c00 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 96 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 137 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 1.83 2.95 4.76 1.26 0.98 4.81 207.10 129.51 177.50 208.14 128.55 175.95 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 204.07 133.93 175.85 204.65 132.02 175.03 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 205.25 143.04 176.89 203.95 141.38 176.70 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 1 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 200 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 229 LYS A 142 LYS~? 20.36 CL CL A2020 coo 1.13 77.49 40.64 0.62 75.57 39.98 106.32 81.43 56.18 105.60 83.26 56.91 coo 0.84 91.24 49.01 2.91 91.61 49.23 90.44 78.16 48.76 91.65 76.94 50.06 coo 10.53 97.56 43.71 9.33 93.71 47.17 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 158 HIS.? 12.55 CL CL B2010 A 200 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 229 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 1.13 77.49 40.64 0.62 75.57 39.98 7.56 53.89 15.18 8.49 52.54 13.87 coo 0.84 91.24 49.01 2.91 91.61 49.23 23.66 59.02 20.34 21.93 58.32 21.38 coo 10.53 97.56 43.71 9.33 93.71 47.17 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS C 158 HIS.? 10.62 CL CL C2021 A 200 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 229 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 1.13 77.49 40.64 0.62 75.57 39.98 98.99 15.14 61.83 98.04 13.53 60.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 82.81 22.02 65.69 84.52 22.80 64.66 coo 10.53 97.56 43.71 9.33 93.71 47.17 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 200 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 229 LYS D 142 LYS~? 18.65 CL CL D2012 coo 1.13 77.49 40.64 0.62 75.57 39.98 0.86 62.48 80.06 1.83 63.91 81.27 coo 0.84 91.24 49.01 2.91 91.61 49.23 16.94 54.59 79.01 15.65 55.42 77.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS E 158 HIS.? 10.67 CL CL E2032 A 200 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 229 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 1.13 77.49 40.64 0.62 75.57 39.98 8.21 91.93 44.16 9.29 93.32 43.02 coo 0.84 91.24 49.01 2.91 91.61 49.23 23.07 86.29 52.35 21.57 85.17 51.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS F 158 HIS.? -10.90 CL CL F2023s A 200 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 229 LYS F 142 LYS~? 19.20 CL CL F2034 coo 1.13 77.49 40.64 0.62 75.57 39.98 105.92 45.34 26.29 105.13 46.33 24.62 coo 0.84 91.24 49.01 2.91 91.61 49.23 88.86 41.25 28.96 90.30 42.22 30.24 coo 10.53 97.56 43.71 9.33 93.71 47.17 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS G 158 HIS.? 10.64 CL CL G2033 A 200 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 229 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 1.13 77.49 40.64 0.62 75.57 39.98 0.65 25.49 51.61 1.26 23.82 52.74 coo 0.84 91.24 49.01 2.91 91.61 49.23 17.70 27.34 47.09 16.19 28.71 47.73 coo 10.53 97.56 43.71 9.33 93.71 47.17 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS H 158 HIS.? 10.33 CL CL H2024 A 200 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 229 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 1.13 77.49 40.64 0.62 75.57 39.98 98.94 51.80 92.35 97.68 51.03 93.84 coo 0.84 91.24 49.01 2.91 91.61 49.23 84.24 58.93 85.48 85.73 57.59 84.66 coo 10.53 97.56 43.71 9.33 93.71 47.17 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS I 158 HIS.? 11.08 CL CL I2025 A 200 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 229 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 1.13 77.49 40.64 0.62 75.57 39.98 220.34 199.03 170.60 219.44 200.67 171.57 coo 0.84 91.24 49.01 2.91 91.61 49.23 204.37 195.46 163.61 205.75 194.30 164.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 200 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 229 LYS J 142 LYS~? 19.62 CL CL J2016 coo 1.13 77.49 40.64 0.62 75.57 39.98 121.18 169.23 132.79 122.06 167.98 131.35 coo 0.84 91.24 49.01 2.91 91.61 49.23 137.44 174.60 137.57 135.80 173.80 138.69 coo 10.53 97.56 43.71 9.33 93.71 47.17 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS K 158 HIS.? 10.92 CL CL K2027 A 200 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 229 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 1.13 77.49 40.64 0.62 75.57 39.98 216.60 132.79 173.33 215.77 131.08 172.42 coo 0.84 91.24 49.01 2.91 91.61 49.23 200.17 138.24 178.11 201.77 139.28 177.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS L 158 HIS.? 11.11 CL CL L2028 A 200 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 229 LYS L 142 LYS~? 23.18 CL CL L2009 coo 1.13 77.49 40.64 0.62 75.57 39.98 117.45 174.63 198.96 118.55 176.04 200.05 coo 0.84 91.24 49.01 2.91 91.61 49.23 133.34 166.97 196.27 132.03 168.03 194.96 coo 10.53 97.56 43.71 9.33 93.71 47.17 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 200 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 229 LYS M 142 LYS~? 19.90 CL CL M2017 coo 1.13 77.49 40.64 0.62 75.57 39.98 121.40 205.18 163.43 122.55 206.46 162.23 coo 0.84 91.24 49.01 2.91 91.61 49.23 136.87 200.18 170.79 135.36 199.08 169.77 coo 10.53 97.56 43.71 9.33 93.71 47.17 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS N 158 HIS.? 10.50 CL CL N2030 A 200 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 229 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 1.13 77.49 40.64 0.62 75.57 39.98 220.32 164.11 138.58 219.66 165.01 136.80 coo 0.84 91.24 49.01 2.91 91.61 49.23 203.51 159.51 142.26 205.02 160.53 143.48 coo 10.53 97.56 43.71 9.33 93.71 47.17 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS O 158 HIS.? 12.21 CL CL O2018 A 200 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 229 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 1.13 77.49 40.64 0.62 75.57 39.98 117.44 138.41 168.51 118.31 136.96 169.75 coo 0.84 91.24 49.01 2.91 91.61 49.23 134.07 141.35 162.95 132.57 142.58 163.78 coo 10.53 97.56 43.71 9.33 93.71 47.17 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS P 158 HIS.? 12.33 O2 GOL P3014 A 200 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 229 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 1.13 77.49 40.64 0.62 75.57 39.98 216.29 167.50 205.15 215.20 166.66 206.73 coo 0.84 91.24 49.01 2.91 91.61 49.23 200.75 174.15 199.66 202.28 173.10 198.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 204.59 186.28 195.60 209.96 186.96 196.62 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 158 HIS.? 6.53 O1 GOL A3037 B 200 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 229 LYS A 142 LYS~? 20.36 CL CL A2020 coo 9.24 94.26 88.22 8.02 94.07 89.92 106.32 81.43 56.18 105.60 83.26 56.91 coo 17.54 90.31 75.01 17.17 92.01 73.80 90.44 78.16 48.76 91.65 76.94 50.06 coo 22.32 101.61 71.64 17.89 98.63 71.55 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 158 HIS.? 12.55 CL CL B2010 B 200 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 229 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.24 94.26 88.22 8.02 94.07 89.92 7.56 53.89 15.18 8.49 52.54 13.87 coo 17.54 90.31 75.01 17.17 92.01 73.80 23.66 59.02 20.34 21.93 58.32 21.38 coo 22.32 101.61 71.64 17.89 98.63 71.55 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS C 158 HIS.? 10.62 CL CL C2021 B 200 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 229 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.24 94.26 88.22 8.02 94.07 89.92 98.99 15.14 61.83 98.04 13.53 60.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 82.81 22.02 65.69 84.52 22.80 64.66 coo 22.32 101.61 71.64 17.89 98.63 71.55 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 200 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 229 LYS D 142 LYS~? 18.65 CL CL D2012 coo 9.24 94.26 88.22 8.02 94.07 89.92 0.86 62.48 80.06 1.83 63.91 81.27 coo 17.54 90.31 75.01 17.17 92.01 73.80 16.94 54.59 79.01 15.65 55.42 77.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS E 158 HIS.? 10.67 CL CL E2032 B 200 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 229 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.24 94.26 88.22 8.02 94.07 89.92 8.21 91.93 44.16 9.29 93.32 43.02 coo 17.54 90.31 75.01 17.17 92.01 73.80 23.07 86.29 52.35 21.57 85.17 51.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS F 158 HIS.? -10.90 CL CL F2023s B 200 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 229 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.24 94.26 88.22 8.02 94.07 89.92 105.92 45.34 26.29 105.13 46.33 24.62 coo 17.54 90.31 75.01 17.17 92.01 73.80 88.86 41.25 28.96 90.30 42.22 30.24 coo 22.32 101.61 71.64 17.89 98.63 71.55 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS G 158 HIS.? 10.64 CL CL G2033 B 200 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 229 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 9.24 94.26 88.22 8.02 94.07 89.92 0.65 25.49 51.61 1.26 23.82 52.74 coo 17.54 90.31 75.01 17.17 92.01 73.80 17.70 27.34 47.09 16.19 28.71 47.73 coo 22.32 101.61 71.64 17.89 98.63 71.55 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS H 158 HIS.? 10.33 CL CL H2024 B 200 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 229 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.24 94.26 88.22 8.02 94.07 89.92 98.94 51.80 92.35 97.68 51.03 93.84 coo 17.54 90.31 75.01 17.17 92.01 73.80 84.24 58.93 85.48 85.73 57.59 84.66 coo 22.32 101.61 71.64 17.89 98.63 71.55 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS I 158 HIS.? 11.08 CL CL I2025 B 200 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 229 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 9.24 94.26 88.22 8.02 94.07 89.92 220.34 199.03 170.60 219.44 200.67 171.57 coo 17.54 90.31 75.01 17.17 92.01 73.80 204.37 195.46 163.61 205.75 194.30 164.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS J 158 HIS.? 7.50 O2 GOL J3033 B 200 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 229 LYS J 142 LYS~? 19.62 CL CL J2016 coo 9.24 94.26 88.22 8.02 94.07 89.92 121.18 169.23 132.79 122.06 167.98 131.35 coo 17.54 90.31 75.01 17.17 92.01 73.80 137.44 174.60 137.57 135.80 173.80 138.69 coo 22.32 101.61 71.64 17.89 98.63 71.55 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS K 158 HIS.? 10.92 CL CL K2027 B 200 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 229 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.24 94.26 88.22 8.02 94.07 89.92 216.60 132.79 173.33 215.77 131.08 172.42 coo 17.54 90.31 75.01 17.17 92.01 73.80 200.17 138.24 178.11 201.77 139.28 177.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS L 158 HIS.? 11.11 CL CL L2028 B 200 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 229 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.24 94.26 88.22 8.02 94.07 89.92 117.45 174.63 198.96 118.55 176.04 200.05 coo 17.54 90.31 75.01 17.17 92.01 73.80 133.34 166.97 196.27 132.03 168.03 194.96 coo 22.32 101.61 71.64 17.89 98.63 71.55 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS M 158 HIS.? 6.42 O1 GOL M3042 B 200 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 229 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.24 94.26 88.22 8.02 94.07 89.92 121.40 205.18 163.43 122.55 206.46 162.23 coo 17.54 90.31 75.01 17.17 92.01 73.80 136.87 200.18 170.79 135.36 199.08 169.77 coo 22.32 101.61 71.64 17.89 98.63 71.55 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS N 158 HIS.? 10.50 CL CL N2030 B 200 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 229 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.24 94.26 88.22 8.02 94.07 89.92 220.32 164.11 138.58 219.66 165.01 136.80 coo 17.54 90.31 75.01 17.17 92.01 73.80 203.51 159.51 142.26 205.02 160.53 143.48 coo 22.32 101.61 71.64 17.89 98.63 71.55 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS O 158 HIS.? 12.21 CL CL O2018 B 200 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 229 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.24 94.26 88.22 8.02 94.07 89.92 117.44 138.41 168.51 118.31 136.96 169.75 coo 17.54 90.31 75.01 17.17 92.01 73.80 134.07 141.35 162.95 132.57 142.58 163.78 coo 22.32 101.61 71.64 17.89 98.63 71.55 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS P 158 HIS.? 12.33 O2 GOL P3014 B 200 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 229 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 9.24 94.26 88.22 8.02 94.07 89.92 216.29 167.50 205.15 215.20 166.66 206.73 coo 17.54 90.31 75.01 17.17 92.01 73.80 200.75 174.15 199.66 202.28 173.10 198.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 204.59 186.28 195.60 209.96 186.96 196.62 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 158 HIS.? 6.53 O1 GOL A3037 C 200 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 229 LYS A 142 LYS~? 20.36 CL CL A2020 coo 26.77 65.84 83.49 27.06 67.76 84.27 106.32 81.43 56.18 105.60 83.26 56.91 coo 19.52 52.01 79.59 20.28 51.65 77.65 90.44 78.16 48.76 91.65 76.94 50.06 coo 28.90 45.91 73.55 25.22 49.72 72.97 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 158 HIS.? 12.55 CL CL B2010 C 200 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 229 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 26.77 65.84 83.49 27.06 67.76 84.27 7.56 53.89 15.18 8.49 52.54 13.87 coo 19.52 52.01 79.59 20.28 51.65 77.65 23.66 59.02 20.34 21.93 58.32 21.38 coo 28.90 45.91 73.55 25.22 49.72 72.97 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS C 158 HIS.? 10.62 CL CL C2021 C 200 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 229 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 26.77 65.84 83.49 27.06 67.76 84.27 98.99 15.14 61.83 98.04 13.53 60.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 82.81 22.02 65.69 84.52 22.80 64.66 coo 28.90 45.91 73.55 25.22 49.72 72.97 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS D 158 HIS.? 6.33 O1 GOL D3020 C 200 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 229 LYS D 142 LYS~? 18.65 CL CL D2012 coo 26.77 65.84 83.49 27.06 67.76 84.27 0.86 62.48 80.06 1.83 63.91 81.27 coo 19.52 52.01 79.59 20.28 51.65 77.65 16.94 54.59 79.01 15.65 55.42 77.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS E 158 HIS.? 10.67 CL CL E2032 C 200 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 229 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 26.77 65.84 83.49 27.06 67.76 84.27 8.21 91.93 44.16 9.29 93.32 43.02 coo 19.52 52.01 79.59 20.28 51.65 77.65 23.07 86.29 52.35 21.57 85.17 51.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS F 158 HIS.? -10.90 CL CL F2023s C 200 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 229 LYS F 142 LYS~? 19.20 CL CL F2034 coo 26.77 65.84 83.49 27.06 67.76 84.27 105.92 45.34 26.29 105.13 46.33 24.62 coo 19.52 52.01 79.59 20.28 51.65 77.65 88.86 41.25 28.96 90.30 42.22 30.24 coo 28.90 45.91 73.55 25.22 49.72 72.97 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS G 158 HIS.? 10.64 CL CL G2033 C 200 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 229 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 26.77 65.84 83.49 27.06 67.76 84.27 0.65 25.49 51.61 1.26 23.82 52.74 coo 19.52 52.01 79.59 20.28 51.65 77.65 17.70 27.34 47.09 16.19 28.71 47.73 coo 28.90 45.91 73.55 25.22 49.72 72.97 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS H 158 HIS.? 10.33 CL CL H2024 C 200 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 229 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 26.77 65.84 83.49 27.06 67.76 84.27 98.94 51.80 92.35 97.68 51.03 93.84 coo 19.52 52.01 79.59 20.28 51.65 77.65 84.24 58.93 85.48 85.73 57.59 84.66 coo 28.90 45.91 73.55 25.22 49.72 72.97 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS I 158 HIS.? 11.08 CL CL I2025 C 200 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 229 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 26.77 65.84 83.49 27.06 67.76 84.27 220.34 199.03 170.60 219.44 200.67 171.57 coo 19.52 52.01 79.59 20.28 51.65 77.65 204.37 195.46 163.61 205.75 194.30 164.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS J 158 HIS.? 7.50 O2 GOL J3033 C 200 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 229 LYS J 142 LYS~? 19.62 CL CL J2016 coo 26.77 65.84 83.49 27.06 67.76 84.27 121.18 169.23 132.79 122.06 167.98 131.35 coo 19.52 52.01 79.59 20.28 51.65 77.65 137.44 174.60 137.57 135.80 173.80 138.69 coo 28.90 45.91 73.55 25.22 49.72 72.97 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS K 158 HIS.? 10.92 CL CL K2027 C 200 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 229 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 26.77 65.84 83.49 27.06 67.76 84.27 216.60 132.79 173.33 215.77 131.08 172.42 coo 19.52 52.01 79.59 20.28 51.65 77.65 200.17 138.24 178.11 201.77 139.28 177.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS L 158 HIS.? 11.11 CL CL L2028 C 200 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 229 LYS L 142 LYS~? 23.18 CL CL L2009 coo 26.77 65.84 83.49 27.06 67.76 84.27 117.45 174.63 198.96 118.55 176.04 200.05 coo 19.52 52.01 79.59 20.28 51.65 77.65 133.34 166.97 196.27 132.03 168.03 194.96 coo 28.90 45.91 73.55 25.22 49.72 72.97 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS M 158 HIS.? 6.42 O1 GOL M3042 C 200 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 229 LYS M 142 LYS~? 19.90 CL CL M2017 coo 26.77 65.84 83.49 27.06 67.76 84.27 121.40 205.18 163.43 122.55 206.46 162.23 coo 19.52 52.01 79.59 20.28 51.65 77.65 136.87 200.18 170.79 135.36 199.08 169.77 coo 28.90 45.91 73.55 25.22 49.72 72.97 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS N 158 HIS.? 10.50 CL CL N2030 C 200 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 229 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 26.77 65.84 83.49 27.06 67.76 84.27 220.32 164.11 138.58 219.66 165.01 136.80 coo 19.52 52.01 79.59 20.28 51.65 77.65 203.51 159.51 142.26 205.02 160.53 143.48 coo 28.90 45.91 73.55 25.22 49.72 72.97 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS O 158 HIS.? 12.21 CL CL O2018 C 200 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 229 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 26.77 65.84 83.49 27.06 67.76 84.27 117.44 138.41 168.51 118.31 136.96 169.75 coo 19.52 52.01 79.59 20.28 51.65 77.65 134.07 141.35 162.95 132.57 142.58 163.78 coo 28.90 45.91 73.55 25.22 49.72 72.97 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS P 158 HIS.? 12.33 O2 GOL P3014 C 200 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 229 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 26.77 65.84 83.49 27.06 67.76 84.27 216.29 167.50 205.15 215.20 166.66 206.73 coo 19.52 52.01 79.59 20.28 51.65 77.65 200.75 174.15 199.66 202.28 173.10 198.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 204.59 186.28 195.60 209.96 186.96 196.62 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 158 HIS.? 6.53 O1 GOL A3037 D 200 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 229 LYS A 142 LYS~? 20.36 CL CL A2020 coo -10.90 48.74 53.41 -12.98 48.90 53.67 106.32 81.43 56.18 105.60 83.26 56.91 coo 4.60 52.95 52.50 5.57 51.29 53.40 90.44 78.16 48.76 91.65 76.94 50.06 coo 10.05 41.79 49.80 7.94 44.71 53.76 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 158 HIS.? 12.55 CL CL B2010 D 200 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 229 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -10.90 48.74 53.41 -12.98 48.90 53.67 7.56 53.89 15.18 8.49 52.54 13.87 coo 4.60 52.95 52.50 5.57 51.29 53.40 23.66 59.02 20.34 21.93 58.32 21.38 coo 10.05 41.79 49.80 7.94 44.71 53.76 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS C 158 HIS.? 10.62 CL CL C2021 D 200 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 229 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -10.90 48.74 53.41 -12.98 48.90 53.67 98.99 15.14 61.83 98.04 13.53 60.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 82.81 22.02 65.69 84.52 22.80 64.66 coo 10.05 41.79 49.80 7.94 44.71 53.76 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS D 158 HIS.? 6.33 O1 GOL D3020 D 200 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 229 LYS D 142 LYS~? 18.65 CL CL D2012 coo -10.90 48.74 53.41 -12.98 48.90 53.67 0.86 62.48 80.06 1.83 63.91 81.27 coo 4.60 52.95 52.50 5.57 51.29 53.40 16.94 54.59 79.01 15.65 55.42 77.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS E 158 HIS.? 10.67 CL CL E2032 D 200 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 229 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -10.90 48.74 53.41 -12.98 48.90 53.67 8.21 91.93 44.16 9.29 93.32 43.02 coo 4.60 52.95 52.50 5.57 51.29 53.40 23.07 86.29 52.35 21.57 85.17 51.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS F 158 HIS.? -10.90 CL CL F2023s D 200 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 229 LYS F 142 LYS~? 19.20 CL CL F2034 coo -10.90 48.74 53.41 -12.98 48.90 53.67 105.92 45.34 26.29 105.13 46.33 24.62 coo 4.60 52.95 52.50 5.57 51.29 53.40 88.86 41.25 28.96 90.30 42.22 30.24 coo 10.05 41.79 49.80 7.94 44.71 53.76 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS G 158 HIS.? 10.64 CL CL G2033 D 200 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 229 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -10.90 48.74 53.41 -12.98 48.90 53.67 0.65 25.49 51.61 1.26 23.82 52.74 coo 4.60 52.95 52.50 5.57 51.29 53.40 17.70 27.34 47.09 16.19 28.71 47.73 coo 10.05 41.79 49.80 7.94 44.71 53.76 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS H 158 HIS.? 10.33 CL CL H2024 D 200 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 229 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -10.90 48.74 53.41 -12.98 48.90 53.67 98.94 51.80 92.35 97.68 51.03 93.84 coo 4.60 52.95 52.50 5.57 51.29 53.40 84.24 58.93 85.48 85.73 57.59 84.66 coo 10.05 41.79 49.80 7.94 44.71 53.76 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS I 158 HIS.? 11.08 CL CL I2025 D 200 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 229 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -10.90 48.74 53.41 -12.98 48.90 53.67 220.34 199.03 170.60 219.44 200.67 171.57 coo 4.60 52.95 52.50 5.57 51.29 53.40 204.37 195.46 163.61 205.75 194.30 164.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS J 158 HIS.? 7.50 O2 GOL J3033 D 200 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 229 LYS J 142 LYS~? 19.62 CL CL J2016 coo -10.90 48.74 53.41 -12.98 48.90 53.67 121.18 169.23 132.79 122.06 167.98 131.35 coo 4.60 52.95 52.50 5.57 51.29 53.40 137.44 174.60 137.57 135.80 173.80 138.69 coo 10.05 41.79 49.80 7.94 44.71 53.76 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS K 158 HIS.? 10.92 CL CL K2027 D 200 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 229 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -10.90 48.74 53.41 -12.98 48.90 53.67 216.60 132.79 173.33 215.77 131.08 172.42 coo 4.60 52.95 52.50 5.57 51.29 53.40 200.17 138.24 178.11 201.77 139.28 177.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS L 158 HIS.? 11.11 CL CL L2028 D 200 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 229 LYS L 142 LYS~? 23.18 CL CL L2009 coo -10.90 48.74 53.41 -12.98 48.90 53.67 117.45 174.63 198.96 118.55 176.04 200.05 coo 4.60 52.95 52.50 5.57 51.29 53.40 133.34 166.97 196.27 132.03 168.03 194.96 coo 10.05 41.79 49.80 7.94 44.71 53.76 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS M 158 HIS.? 6.42 O1 GOL M3042 D 200 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 229 LYS M 142 LYS~? 19.90 CL CL M2017 coo -10.90 48.74 53.41 -12.98 48.90 53.67 121.40 205.18 163.43 122.55 206.46 162.23 coo 4.60 52.95 52.50 5.57 51.29 53.40 136.87 200.18 170.79 135.36 199.08 169.77 coo 10.05 41.79 49.80 7.94 44.71 53.76 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS N 158 HIS.? 10.50 CL CL N2030 D 200 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 229 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -10.90 48.74 53.41 -12.98 48.90 53.67 220.32 164.11 138.58 219.66 165.01 136.80 coo 4.60 52.95 52.50 5.57 51.29 53.40 203.51 159.51 142.26 205.02 160.53 143.48 coo 10.05 41.79 49.80 7.94 44.71 53.76 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS O 158 HIS.? 12.21 CL CL O2018 D 200 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 229 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -10.90 48.74 53.41 -12.98 48.90 53.67 117.44 138.41 168.51 118.31 136.96 169.75 coo 4.60 52.95 52.50 5.57 51.29 53.40 134.07 141.35 162.95 132.57 142.58 163.78 coo 10.05 41.79 49.80 7.94 44.71 53.76 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS P 158 HIS.? 12.33 O2 GOL P3014 D 200 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 229 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -10.90 48.74 53.41 -12.98 48.90 53.67 216.29 167.50 205.15 215.20 166.66 206.73 coo 4.60 52.95 52.50 5.57 51.29 53.40 200.75 174.15 199.66 202.28 173.10 198.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 204.59 186.28 195.60 209.96 186.96 196.62 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 16 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 21 TYR~? 26.32 C3 GOL E3035 A 138 ARG A 34 ARG~? 29.77 O3 GOL B3003 A 161 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 29.03 88.95 86.80 28.09 90.57 84.75 56.96 96.11 38.73 58.94 94.19 38.55 coo 23.31 93.18 82.88 23.00 93.71 79.86 63.78 99.32 32.06 65.50 99.77 29.57 coo 33.83 91.15 88.62 31.07 91.06 83.02 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 138 ARG A 34 ARG~? 29.77 O3 GOL B3003 A 161 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 29.03 88.95 86.80 28.09 90.57 84.75 59.25 100.54 36.63 61.78 101.51 37.35 coo 23.31 93.18 82.88 23.00 93.71 79.86 63.78 99.32 32.06 65.50 99.77 29.57 coo 33.83 91.15 88.62 31.07 91.06 83.02 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR B 21 TYR~? 13.85 C1 GOL B3003 A 138 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 29.03 88.95 86.80 28.09 90.57 84.75 61.46 58.47 9.41 59.23 59.36 10.88 coo 23.31 93.18 82.88 23.00 93.71 79.86 62.11 68.41 8.30 60.04 68.85 10.44 coo 33.83 91.15 88.62 31.07 91.06 83.02 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR B 35 TYR~? 15.50 C1 GOL B3003 A 138 ARG B 34 ARG~? 11.02 O1 GOL B3003 A 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 29.03 88.95 86.80 28.09 90.57 84.75 60.35 59.88 4.36 57.88 59.60 3.08 coo 23.31 93.18 82.88 23.00 93.71 79.86 57.05 65.77 3.59 55.99 68.39 2.44 coo 33.83 91.15 88.62 31.07 91.06 83.02 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 133 TYR B 35 TYR~? 15.50 C1 GOL B3003 A 138 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 29.03 88.95 86.80 28.09 90.57 84.75 60.35 59.88 4.36 57.88 59.60 3.08 coo 23.31 93.18 82.88 23.00 93.71 79.86 62.11 68.41 8.30 60.04 68.85 10.44 coo 33.83 91.15 88.62 31.07 91.06 83.02 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 133 TYR C 21 TYR~? 10.49 CL CL C2004 A 138 ARG C 34 ARG~? 20.14 CL CL C2004 A 161 LYS C 22 LYS~? 13.40 CL CL C2004 coo 29.03 88.95 86.80 28.09 90.57 84.75 45.13 11.15 67.52 47.31 12.70 68.21 coo 23.31 93.18 82.88 23.00 93.71 79.86 49.42 6.75 74.39 49.90 6.28 77.46 coo 33.83 91.15 88.62 31.07 91.06 83.02 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 133 TYR D 21 TYR~? 10.58 CL CL H2005 A 138 ARG D 34 ARG~? 12.13 O1 GOL D3005 A 161 LYS D 22 LYS~? 13.25 CL CL H2005 coo 29.03 88.95 86.80 28.09 90.57 84.75 50.45 48.27 98.24 48.40 47.71 96.43 coo 23.31 93.18 82.88 23.00 93.71 79.86 43.70 43.25 103.08 42.03 40.72 103.99 coo 33.83 91.15 88.62 31.07 91.06 83.02 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 133 TYR E 35 TYR~? 15.88 O1 GOL E3004 A 138 ARG E 34 ARG~? 12.13 O1 GOL E3004 A 161 LYS E 22 LYS~? 21.81 O1 GOL E3004 coo 29.03 88.95 86.80 28.09 90.57 84.75 58.94 102.78 60.36 56.69 104.19 59.52 coo 23.31 93.18 82.88 23.00 93.71 79.86 54.44 103.79 65.07 52.71 105.19 67.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 64.37 100.86 56.32 69.54 97.12 56.69 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 133 TYR F 35 TYR~? 30.41 CL CL F2035 A 138 ARG F 34 ARG~? 28.76 CL CL F2035 A 161 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 29.03 88.95 86.80 28.09 90.57 84.75 55.89 36.47 6.05 58.49 36.69 5.11 coo 23.31 93.18 82.88 23.00 93.71 79.86 59.52 30.90 7.26 60.86 28.10 6.84 coo 33.83 91.15 88.62 31.07 91.06 83.02 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 133 TYR G 21 TYR~? 10.57 CL CL C2004 A 138 ARG G 34 ARG~? 20.84 CL CL C2004 A 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 29.03 88.95 86.80 28.09 90.57 84.75 52.17 8.74 48.00 50.23 10.55 47.07 coo 23.31 93.18 82.88 23.00 93.71 79.86 46.76 3.66 41.28 45.52 3.22 38.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 A 133 TYR G 21 TYR~? 10.57 CL CL C2004 A 138 ARG G 37 ARG~? 20.29 CL CL C2004 A 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 29.03 88.95 86.80 28.09 90.57 84.75 52.17 8.74 48.00 50.23 10.55 47.07 coo 23.31 93.18 82.88 23.00 93.71 79.86 52.62 7.45 38.03 50.95 9.97 37.63 coo 33.83 91.15 88.62 31.07 91.06 83.02 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 A 133 TYR G 35 TYR~? 13.11 CL CL C2004 A 138 ARG G 34 ARG~? 20.84 CL CL C2004 A 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 29.03 88.95 86.80 28.09 90.57 84.75 50.35 3.70 46.66 47.74 2.77 47.00 coo 23.31 93.18 82.88 23.00 93.71 79.86 46.76 3.66 41.28 45.52 3.22 38.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 A 133 TYR G 35 TYR~? 13.11 CL CL C2004 A 138 ARG G 37 ARG~? 20.29 CL CL C2004 A 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 29.03 88.95 86.80 28.09 90.57 84.75 50.35 3.70 46.66 47.74 2.77 47.00 coo 23.31 93.18 82.88 23.00 93.71 79.86 52.62 7.45 38.03 50.95 9.97 37.63 coo 33.83 91.15 88.62 31.07 91.06 83.02 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 A 133 TYR H 21 TYR~? 10.50 CL CL H2005 A 138 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 161 LYS H 22 LYS~? 13.32 CL CL H2005 coo 29.03 88.95 86.80 28.09 90.57 84.75 47.46 68.84 95.61 49.74 68.96 94.05 coo 23.31 93.18 82.88 23.00 93.71 79.86 53.27 74.94 100.30 54.87 77.69 100.34 coo 33.83 91.15 88.62 31.07 91.06 83.02 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 A 133 TYR I 21 TYR~? 10.49 CL CL I2001 A 138 ARG I 34 ARG~? 20.72 CL CL I2001 A 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 29.03 88.95 86.80 28.09 90.57 84.75 169.47 212.28 156.01 171.53 210.49 155.65 coo 23.31 93.18 82.88 23.00 93.71 79.86 175.86 216.47 149.42 177.66 216.28 146.86 coo 33.83 91.15 88.62 31.07 91.06 83.02 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 A 133 TYR I 21 TYR~? 10.49 CL CL I2001 A 138 ARG I 37 ARG~? 20.23 CL CL I2001 A 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 29.03 88.95 86.80 28.09 90.57 84.75 169.47 212.28 156.01 171.53 210.49 155.65 coo 23.31 93.18 82.88 23.00 93.71 79.86 170.53 211.87 145.98 172.22 209.35 146.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 A 133 TYR I 35 TYR~? 13.03 CL CL I2001 A 138 ARG I 34 ARG~? 20.72 CL CL I2001 A 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 29.03 88.95 86.80 28.09 90.57 84.75 171.46 216.91 154.12 173.98 218.04 154.69 coo 23.31 93.18 82.88 23.00 93.71 79.86 175.86 216.47 149.42 177.66 216.28 146.86 coo 33.83 91.15 88.62 31.07 91.06 83.02 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 A 133 TYR I 35 TYR~? 13.03 CL CL I2001 A 138 ARG I 37 ARG~? 20.23 CL CL I2001 A 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 29.03 88.95 86.80 28.09 90.57 84.75 171.46 216.91 154.12 173.98 218.04 154.69 coo 23.31 93.18 82.88 23.00 93.71 79.86 170.53 211.87 145.98 172.22 209.35 146.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 A 133 TYR J 35 TYR~? 13.02 CL CL J2002 A 138 ARG J 34 ARG~? 20.21 CL CL J2002 A 161 LYS J 22 LYS~? 13.36 CL CL J2002 coo 29.03 88.95 86.80 28.09 90.57 84.75 173.30 177.82 119.58 170.88 177.40 118.29 coo 23.31 93.18 82.88 23.00 93.71 79.86 169.79 183.14 118.82 167.66 185.29 119.35 coo 33.83 91.15 88.62 31.07 91.06 83.02 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 A 133 TYR J 35 TYR~? 13.02 CL CL J2002 A 138 ARG J 37 ARG~? 20.17 CL CL J2002 A 161 LYS J 22 LYS~? 13.36 CL CL J2002 coo 29.03 88.95 86.80 28.09 90.57 84.75 173.30 177.82 119.58 170.88 177.40 118.29 coo 23.31 93.18 82.88 23.00 93.71 79.86 174.71 186.35 123.78 172.76 186.51 126.11 coo 33.83 91.15 88.62 31.07 91.06 83.02 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 A 133 TYR K 21 TYR~? 13.85 O1 GOL K3011 A 138 ARG K 34 ARG~? 11.32 O1 GOL K3011 A 161 LYS K 22 LYS~? 17.74 CL CL K2003 coo 29.03 88.95 86.80 28.09 90.57 84.75 163.15 125.72 181.32 165.33 127.37 181.87 coo 23.31 93.18 82.88 23.00 93.71 79.86 167.98 121.31 187.60 169.63 121.60 190.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 A 133 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 138 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 161 LYS K 22 LYS~? 17.74 CL CL K2003 coo 29.03 88.95 86.80 28.09 90.57 84.75 164.29 120.92 183.43 166.71 119.58 183.22 coo 23.31 93.18 82.88 23.00 93.71 79.86 162.88 126.06 191.42 164.87 128.39 191.36 coo 33.83 91.15 88.62 31.07 91.06 83.02 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 A 133 TYR L 21 TYR~? 30.92 O3 GOL K3011 A 138 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 161 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 29.03 88.95 86.80 28.09 90.57 84.75 168.26 161.38 213.44 166.20 160.80 211.67 coo 23.31 93.18 82.88 23.00 93.71 79.86 162.35 156.38 218.07 160.56 153.83 217.87 coo 33.83 91.15 88.62 31.07 91.06 83.02 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 24 3 # 24 A 133 TYR M 35 TYR~? 13.00 CL CL I2001 A 138 ARG M 34 ARG~? 12.31 O1 GOL M3007 A 161 LYS M 22 LYS~? 13.38 CL CL I2001 coo 29.03 88.95 86.80 28.09 90.57 84.75 172.26 218.21 177.69 169.95 219.60 176.96 coo 23.31 93.18 82.88 23.00 93.71 79.86 167.85 218.77 182.40 165.86 219.39 184.74 coo 33.83 91.15 88.62 31.07 91.06 83.02 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 25 3 # 25 A 133 TYR N 21 TYR~? 10.52 CL CL J2002 A 138 ARG N 34 ARG~? 11.02 O3 GOL N3008 A 161 LYS N 22 LYS~? 13.40 CL CL J2002 coo 29.03 88.95 86.80 28.09 90.57 84.75 168.15 156.47 125.36 170.14 155.81 127.21 coo 23.31 93.18 82.88 23.00 93.71 79.86 173.47 149.90 121.53 175.07 147.29 121.87 coo 33.83 91.15 88.62 31.07 91.06 83.02 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 26 3 # 26 A 133 TYR O 21 TYR~? 14.79 CL CL K2003 A 138 ARG O 34 ARG~? 19.49 CL CL O2036 A 161 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 29.03 88.95 86.80 28.09 90.57 84.75 169.50 124.29 161.32 167.44 126.02 160.55 coo 23.31 93.18 82.88 23.00 93.71 79.86 163.83 119.56 154.44 162.36 118.67 151.85 coo 33.83 91.15 88.62 31.07 91.06 83.02 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 27 3 # 27 A 133 TYR O 35 TYR~? 20.32 CL CL K2003 A 138 ARG O 34 ARG~? 19.49 CL CL O2036 A 161 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 29.03 88.95 86.80 28.09 90.57 84.75 167.80 119.41 159.74 165.27 118.34 160.26 coo 23.31 93.18 82.88 23.00 93.71 79.86 163.83 119.56 154.44 162.36 118.67 151.85 coo 33.83 91.15 88.62 31.07 91.06 83.02 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 28 3 # 28 A 133 TYR P 21 TYR~? 24.07 O1 GOL L3028 A 138 ARG P 34 ARG~? 27.86 O3 GOL M3007 A 161 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 29.03 88.95 86.80 28.09 90.57 84.75 164.13 181.87 211.82 166.34 182.20 210.17 coo 23.31 93.18 82.88 23.00 93.71 79.86 169.45 187.34 216.38 171.34 189.81 216.30 coo 33.83 91.15 88.62 31.07 91.06 83.02 160.29 179.27 215.80 155.06 178.69 212.33 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 28 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 21 TYR~? 26.32 C3 GOL E3035 B 138 ARG A 34 ARG~? 29.77 O3 GOL B3003 B 161 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 4.62 122.69 99.88 5.46 122.82 97.24 56.96 96.11 38.73 58.94 94.19 38.55 coo 10.44 122.27 94.08 11.02 123.87 91.53 63.78 99.32 32.06 65.50 99.77 29.57 coo -0.17 119.75 99.65 2.51 123.83 95.70 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR A 35 TYR~? 31.11 O2 GOL E3035 B 138 ARG A 34 ARG~? 29.77 O3 GOL B3003 B 161 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 4.62 122.69 99.88 5.46 122.82 97.24 59.25 100.54 36.63 61.78 101.51 37.35 coo 10.44 122.27 94.08 11.02 123.87 91.53 63.78 99.32 32.06 65.50 99.77 29.57 coo -0.17 119.75 99.65 2.51 123.83 95.70 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR B 21 TYR~? 13.85 C1 GOL B3003 B 138 ARG B 37 ARG~? -4.23 C1 GOL B3003s B 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 4.62 122.69 99.88 5.46 122.82 97.24 61.46 58.47 9.41 59.23 59.36 10.88 coo 10.44 122.27 94.08 11.02 123.87 91.53 62.11 68.41 8.30 60.04 68.85 10.44 coo -0.17 119.75 99.65 2.51 123.83 95.70 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR B 35 TYR~? 15.50 C1 GOL B3003 B 138 ARG B 34 ARG~? 11.02 O1 GOL B3003 B 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 4.62 122.69 99.88 5.46 122.82 97.24 60.35 59.88 4.36 57.88 59.60 3.08 coo 10.44 122.27 94.08 11.02 123.87 91.53 57.05 65.77 3.59 55.99 68.39 2.44 coo -0.17 119.75 99.65 2.51 123.83 95.70 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 133 TYR B 35 TYR~? 15.50 C1 GOL B3003 B 138 ARG B 37 ARG~? -4.23 C1 GOL B3003s B 161 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 4.62 122.69 99.88 5.46 122.82 97.24 60.35 59.88 4.36 57.88 59.60 3.08 coo 10.44 122.27 94.08 11.02 123.87 91.53 62.11 68.41 8.30 60.04 68.85 10.44 coo -0.17 119.75 99.65 2.51 123.83 95.70 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 133 TYR C 21 TYR~? 10.49 CL CL C2004 B 138 ARG C 34 ARG~? 20.14 CL CL C2004 B 161 LYS C 22 LYS~? 13.40 CL CL C2004 coo 4.62 122.69 99.88 5.46 122.82 97.24 45.13 11.15 67.52 47.31 12.70 68.21 coo 10.44 122.27 94.08 11.02 123.87 91.53 49.42 6.75 74.39 49.90 6.28 77.46 coo -0.17 119.75 99.65 2.51 123.83 95.70 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 133 TYR D 21 TYR~? 10.58 CL CL H2005 B 138 ARG D 34 ARG~? 12.13 O1 GOL D3005 B 161 LYS D 22 LYS~? 13.25 CL CL H2005 coo 4.62 122.69 99.88 5.46 122.82 97.24 50.45 48.27 98.24 48.40 47.71 96.43 coo 10.44 122.27 94.08 11.02 123.87 91.53 43.70 43.25 103.08 42.03 40.72 103.99 coo -0.17 119.75 99.65 2.51 123.83 95.70 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 133 TYR E 35 TYR~? 15.88 O1 GOL E3004 B 138 ARG E 34 ARG~? 12.13 O1 GOL E3004 B 161 LYS E 22 LYS~? 21.81 O1 GOL E3004 coo 4.62 122.69 99.88 5.46 122.82 97.24 58.94 102.78 60.36 56.69 104.19 59.52 coo 10.44 122.27 94.08 11.02 123.87 91.53 54.44 103.79 65.07 52.71 105.19 67.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 64.37 100.86 56.32 69.54 97.12 56.69 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 133 TYR F 21 TYR~? 26.08 O1 GOL B3017 B 138 ARG F 34 ARG~? 28.76 CL CL F2035 B 161 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 4.62 122.69 99.88 5.46 122.82 97.24 54.13 38.92 10.51 56.02 38.27 12.47 coo 10.44 122.27 94.08 11.02 123.87 91.53 59.52 30.90 7.26 60.86 28.10 6.84 coo -0.17 119.75 99.65 2.51 123.83 95.70 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 133 TYR F 35 TYR~? 30.41 CL CL F2035 B 138 ARG F 34 ARG~? 28.76 CL CL F2035 B 161 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 4.62 122.69 99.88 5.46 122.82 97.24 55.89 36.47 6.05 58.49 36.69 5.11 coo 10.44 122.27 94.08 11.02 123.87 91.53 59.52 30.90 7.26 60.86 28.10 6.84 coo -0.17 119.75 99.65 2.51 123.83 95.70 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 B 133 TYR G 21 TYR~? 10.57 CL CL C2004 B 138 ARG G 34 ARG~? 20.84 CL CL C2004 B 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 4.62 122.69 99.88 5.46 122.82 97.24 52.17 8.74 48.00 50.23 10.55 47.07 coo 10.44 122.27 94.08 11.02 123.87 91.53 46.76 3.66 41.28 45.52 3.22 38.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 B 133 TYR G 21 TYR~? 10.57 CL CL C2004 B 138 ARG G 37 ARG~? 20.29 CL CL C2004 B 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 4.62 122.69 99.88 5.46 122.82 97.24 52.17 8.74 48.00 50.23 10.55 47.07 coo 10.44 122.27 94.08 11.02 123.87 91.53 52.62 7.45 38.03 50.95 9.97 37.63 coo -0.17 119.75 99.65 2.51 123.83 95.70 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 B 133 TYR G 35 TYR~? 13.11 CL CL C2004 B 138 ARG G 34 ARG~? 20.84 CL CL C2004 B 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 4.62 122.69 99.88 5.46 122.82 97.24 50.35 3.70 46.66 47.74 2.77 47.00 coo 10.44 122.27 94.08 11.02 123.87 91.53 46.76 3.66 41.28 45.52 3.22 38.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 B 133 TYR G 35 TYR~? 13.11 CL CL C2004 B 138 ARG G 37 ARG~? 20.29 CL CL C2004 B 161 LYS G 22 LYS~? 13.25 CL CL C2004 coo 4.62 122.69 99.88 5.46 122.82 97.24 50.35 3.70 46.66 47.74 2.77 47.00 coo 10.44 122.27 94.08 11.02 123.87 91.53 52.62 7.45 38.03 50.95 9.97 37.63 coo -0.17 119.75 99.65 2.51 123.83 95.70 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 B 133 TYR H 21 TYR~? 10.50 CL CL H2005 B 138 ARG H 34 ARG~? 11.22 O3 GOL H3006 B 161 LYS H 22 LYS~? 13.32 CL CL H2005 coo 4.62 122.69 99.88 5.46 122.82 97.24 47.46 68.84 95.61 49.74 68.96 94.05 coo 10.44 122.27 94.08 11.02 123.87 91.53 53.27 74.94 100.30 54.87 77.69 100.34 coo -0.17 119.75 99.65 2.51 123.83 95.70 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 B 133 TYR I 21 TYR~? 10.49 CL CL I2001 B 138 ARG I 34 ARG~? 20.72 CL CL I2001 B 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 169.47 212.28 156.01 171.53 210.49 155.65 coo 10.44 122.27 94.08 11.02 123.87 91.53 175.86 216.47 149.42 177.66 216.28 146.86 coo -0.17 119.75 99.65 2.51 123.83 95.70 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 B 133 TYR I 21 TYR~? 10.49 CL CL I2001 B 138 ARG I 37 ARG~? 20.23 CL CL I2001 B 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 169.47 212.28 156.01 171.53 210.49 155.65 coo 10.44 122.27 94.08 11.02 123.87 91.53 170.53 211.87 145.98 172.22 209.35 146.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 B 133 TYR I 35 TYR~? 13.03 CL CL I2001 B 138 ARG I 34 ARG~? 20.72 CL CL I2001 B 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 171.46 216.91 154.12 173.98 218.04 154.69 coo 10.44 122.27 94.08 11.02 123.87 91.53 175.86 216.47 149.42 177.66 216.28 146.86 coo -0.17 119.75 99.65 2.51 123.83 95.70 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 B 133 TYR I 35 TYR~? 13.03 CL CL I2001 B 138 ARG I 37 ARG~? 20.23 CL CL I2001 B 161 LYS I 22 LYS~? 13.37 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 171.46 216.91 154.12 173.98 218.04 154.69 coo 10.44 122.27 94.08 11.02 123.87 91.53 170.53 211.87 145.98 172.22 209.35 146.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 B 133 TYR J 21 TYR~? 10.46 CL CL J2002 B 138 ARG J 37 ARG~? 20.17 CL CL J2002 B 161 LYS J 22 LYS~? 13.36 CL CL J2002 coo 4.62 122.69 99.88 5.46 122.82 97.24 174.52 176.28 124.74 172.25 177.04 126.20 coo 10.44 122.27 94.08 11.02 123.87 91.53 174.71 186.35 123.78 172.76 186.51 126.11 coo -0.17 119.75 99.65 2.51 123.83 95.70 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 B 133 TYR J 35 TYR~? 13.02 CL CL J2002 B 138 ARG J 34 ARG~? 20.21 CL CL J2002 B 161 LYS J 22 LYS~? 13.36 CL CL J2002 coo 4.62 122.69 99.88 5.46 122.82 97.24 173.30 177.82 119.58 170.88 177.40 118.29 coo 10.44 122.27 94.08 11.02 123.87 91.53 169.79 183.14 118.82 167.66 185.29 119.35 coo -0.17 119.75 99.65 2.51 123.83 95.70 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 B 133 TYR J 35 TYR~? 13.02 CL CL J2002 B 138 ARG J 37 ARG~? 20.17 CL CL J2002 B 161 LYS J 22 LYS~? 13.36 CL CL J2002 coo 4.62 122.69 99.88 5.46 122.82 97.24 173.30 177.82 119.58 170.88 177.40 118.29 coo 10.44 122.27 94.08 11.02 123.87 91.53 174.71 186.35 123.78 172.76 186.51 126.11 coo -0.17 119.75 99.65 2.51 123.83 95.70 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 B 133 TYR K 21 TYR~? 13.85 O1 GOL K3011 B 138 ARG K 34 ARG~? 11.32 O1 GOL K3011 B 161 LYS K 22 LYS~? 17.74 CL CL K2003 coo 4.62 122.69 99.88 5.46 122.82 97.24 163.15 125.72 181.32 165.33 127.37 181.87 coo 10.44 122.27 94.08 11.02 123.87 91.53 167.98 121.31 187.60 169.63 121.60 190.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 24 3 # 24 B 133 TYR K 21 TYR~? 13.85 O1 GOL K3011 B 138 ARG K 37 ARG~? -4.30 O1 GOL K3011s B 161 LYS K 22 LYS~? 17.74 CL CL K2003 coo 4.62 122.69 99.88 5.46 122.82 97.24 163.15 125.72 181.32 165.33 127.37 181.87 coo 10.44 122.27 94.08 11.02 123.87 91.53 162.88 126.06 191.42 164.87 128.39 191.36 coo -0.17 119.75 99.65 2.51 123.83 95.70 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 25 3 # 25 B 133 TYR K 35 TYR~? 15.70 O1 GOL K3011 B 138 ARG K 37 ARG~? -4.30 O1 GOL K3011s B 161 LYS K 22 LYS~? 17.74 CL CL K2003 coo 4.62 122.69 99.88 5.46 122.82 97.24 164.29 120.92 183.43 166.71 119.58 183.22 coo 10.44 122.27 94.08 11.02 123.87 91.53 162.88 126.06 191.42 164.87 128.39 191.36 coo -0.17 119.75 99.65 2.51 123.83 95.70 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 26 3 # 26 B 133 TYR L 21 TYR~? 30.92 O3 GOL K3011 B 138 ARG L 34 ARG~? 28.77 O3 GOL K3011 B 161 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 4.62 122.69 99.88 5.46 122.82 97.24 168.26 161.38 213.44 166.20 160.80 211.67 coo 10.44 122.27 94.08 11.02 123.87 91.53 162.35 156.38 218.07 160.56 153.83 217.87 coo -0.17 119.75 99.65 2.51 123.83 95.70 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 27 3 # 27 B 133 TYR M 21 TYR~? 10.54 CL CL I2001 B 138 ARG M 34 ARG~? 12.31 O1 GOL M3007 B 161 LYS M 22 LYS~? 13.38 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 173.68 213.02 176.47 171.32 211.57 177.01 coo 10.44 122.27 94.08 11.02 123.87 91.53 167.85 218.77 182.40 165.86 219.39 184.74 coo -0.17 119.75 99.65 2.51 123.83 95.70 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 28 3 # 28 B 133 TYR M 35 TYR~? 13.00 CL CL I2001 B 138 ARG M 34 ARG~? 12.31 O1 GOL M3007 B 161 LYS M 22 LYS~? 13.38 CL CL I2001 coo 4.62 122.69 99.88 5.46 122.82 97.24 172.26 218.21 177.69 169.95 219.60 176.96 coo 10.44 122.27 94.08 11.02 123.87 91.53 167.85 218.77 182.40 165.86 219.39 184.74 coo -0.17 119.75 99.65 2.51 123.83 95.70 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 29 3 # 29 B 133 TYR N 21 TYR~? 10.52 CL CL J2002 B 138 ARG N 34 ARG~? 11.02 O3 GOL N3008 B 161 LYS N 22 LYS~? 13.40 CL CL J2002 coo 4.62 122.69 99.88 5.46 122.82 97.24 168.15 156.47 125.36 170.14 155.81 127.21 coo 10.44 122.27 94.08 11.02 123.87 91.53 173.47 149.90 121.53 175.07 147.29 121.87 coo -0.17 119.75 99.65 2.51 123.83 95.70 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 30 3 # 30 B 133 TYR O 21 TYR~? 14.79 CL CL K2003 B 138 ARG O 34 ARG~? 19.49 CL CL O2036 B 161 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 4.62 122.69 99.88 5.46 122.82 97.24 169.50 124.29 161.32 167.44 126.02 160.55 coo 10.44 122.27 94.08 11.02 123.87 91.53 163.83 119.56 154.44 162.36 118.67 151.85 coo -0.17 119.75 99.65 2.51 123.83 95.70 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 31 3 # 31 B 133 TYR O 35 TYR~? 20.32 CL CL K2003 B 138 ARG O 34 ARG~? 19.49 CL CL O2036 B 161 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 4.62 122.69 99.88 5.46 122.82 97.24 167.80 119.41 159.74 165.27 118.34 160.26 coo 10.44 122.27 94.08 11.02 123.87 91.53 163.83 119.56 154.44 162.36 118.67 151.85 coo -0.17 119.75 99.65 2.51 123.83 95.70 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 32 3 # 32 B 133 TYR P 21 TYR~? 24.07 O1 GOL L3028 B 138 ARG P 34 ARG~? 27.86 O3 GOL M3007 B 161 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 4.62 122.69 99.88 5.46 122.82 97.24 164.13 181.87 211.82 166.34 182.20 210.17 coo 10.44 122.27 94.08 11.02 123.87 91.53 169.45 187.34 216.38 171.34 189.81 216.30 coo -0.17 119.75 99.65 2.51 123.83 95.70 160.29 179.27 215.80 155.06 178.69 212.33 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 32 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 67 THR~? -15.67 O1 GOL A3040s A 45 THR A 64 THR~? 18.85 O1 GOL A3040 A 161 LYS A 142 LYS~? 20.36 CL CL A2020 coo 26.16 88.25 79.16 25.22 89.47 80.71 87.07 77.47 46.60 86.90 75.54 45.71 coo 27.73 89.90 76.08 29.24 91.46 75.95 82.36 77.26 44.89 81.47 76.71 42.95 coo 33.83 91.15 88.62 31.07 91.06 83.02 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR B 67 THR~? -3.12 O1 GOL B3024s A 45 THR B 64 THR~? 8.71 O1 GOL B3024 A 161 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 26.16 88.25 79.16 25.22 89.47 80.71 27.39 60.76 21.45 27.39 62.11 23.11 coo 27.73 89.90 76.08 29.24 91.46 75.95 32.17 61.57 22.45 33.36 63.36 22.67 coo 33.83 91.15 88.62 31.07 91.06 83.02 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR C 67 THR~? -9.97 O1 GOL C3036s A 45 THR C 64 THR~? 15.20 O3 GOL C3021 A 161 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 26.16 88.25 79.16 25.22 89.47 80.71 79.21 23.47 67.21 79.25 25.46 68.14 coo 27.73 89.90 76.08 29.24 91.46 75.95 74.38 24.70 67.82 73.20 25.34 69.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR D 67 THR~? -12.87 O3 GOL D3019s A 45 THR D 64 THR~? 14.39 O3 GOL D3019 A 161 LYS D 142 LYS~? 18.65 CL CL D2012 coo 26.16 88.25 79.16 25.22 89.47 80.71 20.32 52.20 78.84 20.42 50.85 77.22 coo 27.73 89.90 76.08 29.24 91.46 75.95 25.01 50.48 78.85 25.86 48.54 78.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR E 67 THR~? 11.29 O3 GOL E3002 A 45 THR E 64 THR~? 14.21 O1 GOL E3035 A 161 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 26.16 88.25 79.16 25.22 89.47 80.71 26.25 85.32 54.72 25.97 83.60 56.04 coo 27.73 89.90 76.08 29.24 91.46 75.95 30.87 84.28 56.42 31.61 84.06 58.39 coo 33.83 91.15 88.62 31.07 91.06 83.02 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR F 67 THR~? -9.79 CL CL F2035s A 45 THR F 64 THR~? -3.74 CL CL F2035s A 161 LYS F 142 LYS~? 19.20 CL CL F2034 coo 26.16 88.25 79.16 25.22 89.47 80.71 85.04 39.90 29.55 84.60 38.93 31.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 80.10 39.29 29.74 78.76 37.65 30.15 coo 33.83 91.15 88.62 31.07 91.06 83.02 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR G 67 THR~? -11.16 O2 GOL G3001s A 45 THR G 64 THR~? 16.57 O2 GOL G3001 A 161 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 26.16 88.25 79.16 25.22 89.47 80.71 21.46 27.56 45.47 21.91 29.27 44.22 coo 27.73 89.90 76.08 29.24 91.46 75.95 26.50 27.63 44.88 27.71 27.61 43.08 coo 33.83 91.15 88.62 31.07 91.06 83.02 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR H 67 THR~? -3.39 O2 GOL H3016s A 45 THR H 64 THR~? 8.97 O2 GOL H3016 A 161 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 26.16 88.25 79.16 25.22 89.47 80.71 81.07 61.13 84.03 81.35 62.09 82.15 coo 27.73 89.90 76.08 29.24 91.46 75.95 76.53 62.70 82.65 75.84 64.64 82.09 coo 33.83 91.15 88.62 31.07 91.06 83.02 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR I 67 THR~? -3.29 O1 GOL I3032s A 45 THR I 64 THR~? 8.93 O1 GOL I3032 A 161 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 26.16 88.25 79.16 25.22 89.47 80.71 200.92 194.71 161.46 200.82 192.87 160.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 196.10 194.26 160.17 195.16 193.85 158.25 coo 33.83 91.15 88.62 31.07 91.06 83.02 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 44 THR J 67 THR~? 17.03 O1 GOL J3030 A 45 THR J 64 THR~? 19.68 O1 GOL J3030 A 161 LYS J 142 LYS~? 19.62 CL CL J2016 coo 26.16 88.25 79.16 25.22 89.47 80.71 140.95 176.39 138.48 140.95 177.60 140.30 coo 27.73 89.90 76.08 29.24 91.46 75.95 145.87 177.29 139.35 146.97 179.14 139.64 coo 33.83 91.15 88.62 31.07 91.06 83.02 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 A 44 THR K 67 THR~? -10.70 O3 GOL K3009s A 45 THR K 64 THR~? 14.85 O3 GOL K3010 A 161 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 26.16 88.25 79.16 25.22 89.47 80.71 196.56 139.40 179.79 196.53 141.28 180.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 191.77 140.44 180.59 190.64 140.95 182.34 coo 33.83 91.15 88.62 31.07 91.06 83.02 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 A 44 THR L 67 THR~? -13.61 O3 GOL L3028s A 45 THR L 64 THR~? 14.87 O3 GOL L3028 A 161 LYS L 142 LYS~? 23.18 CL CL L2009 coo 26.16 88.25 79.16 25.22 89.47 80.71 136.82 164.69 195.74 136.92 163.47 194.00 coo 27.73 89.90 76.08 29.24 91.46 75.95 141.60 163.20 195.47 142.44 161.21 195.27 coo 33.83 91.15 88.62 31.07 91.06 83.02 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 A 44 THR M 67 THR~? -15.94 O3 GOL M3042s A 45 THR M 64 THR~? 19.60 O1 GOL M3043 A 161 LYS M 142 LYS~? 19.90 CL CL M2017 coo 26.16 88.25 79.16 25.22 89.47 80.71 140.30 199.27 172.95 140.11 197.51 174.22 coo 27.73 89.90 76.08 29.24 91.46 75.95 144.87 198.36 174.46 145.82 198.07 176.32 coo 33.83 91.15 88.62 31.07 91.06 83.02 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 A 44 THR N 67 THR~? -3.68 C2 GOL N3029s A 45 THR N 64 THR~? 9.33 C2 GOL N3029 A 161 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 26.16 88.25 79.16 25.22 89.47 80.71 199.85 157.94 142.85 199.59 156.93 144.76 coo 27.73 89.90 76.08 29.24 91.46 75.95 194.93 157.15 143.34 193.70 155.46 143.76 coo 33.83 91.15 88.62 31.07 91.06 83.02 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 A 44 THR O 67 THR~? 4.30 C3 GOL O3026 A 45 THR O 64 THR~? 9.90 C1 GOL O3026 A 161 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 26.16 88.25 79.16 25.22 89.47 80.71 137.76 141.84 161.16 138.02 143.59 159.91 coo 27.73 89.90 76.08 29.24 91.46 75.95 142.64 142.13 160.20 143.87 142.30 158.45 coo 33.83 91.15 88.62 31.07 91.06 83.02 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 A 44 THR P 67 THR~? 10.43 O3 GOL P3014 A 45 THR P 64 THR~? 15.75 O3 GOL P3014 A 161 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 26.16 88.25 79.16 25.22 89.47 80.71 197.48 176.33 198.45 197.56 177.49 196.62 coo 27.73 89.90 76.08 29.24 91.46 75.95 192.75 177.71 197.46 191.86 179.57 196.92 coo 33.83 91.15 88.62 31.07 91.06 83.02 204.59 186.28 195.60 209.96 186.96 196.62 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 16 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 67 THR~? -15.67 O1 GOL A3040s B 45 THR A 64 THR~? 18.85 O1 GOL A3040 B 161 LYS A 142 LYS~? 20.36 CL CL A2020 coo 7.39 128.28 94.56 8.34 126.36 94.79 87.07 77.47 46.60 86.90 75.54 45.71 coo 5.75 129.25 91.25 4.29 128.16 90.07 82.36 77.26 44.89 81.47 76.71 42.95 coo -0.17 119.75 99.65 2.51 123.83 95.70 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR B 67 THR~? -3.12 O1 GOL B3024s B 45 THR B 64 THR~? 8.71 O1 GOL B3024 B 161 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 7.39 128.28 94.56 8.34 126.36 94.79 27.39 60.76 21.45 27.39 62.11 23.11 coo 5.75 129.25 91.25 4.29 128.16 90.07 32.17 61.57 22.45 33.36 63.36 22.67 coo -0.17 119.75 99.65 2.51 123.83 95.70 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR C 67 THR~? -9.97 O1 GOL C3036s B 45 THR C 64 THR~? 15.20 O3 GOL C3021 B 161 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 7.39 128.28 94.56 8.34 126.36 94.79 79.21 23.47 67.21 79.25 25.46 68.14 coo 5.75 129.25 91.25 4.29 128.16 90.07 74.38 24.70 67.82 73.20 25.34 69.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR D 67 THR~? -12.87 O3 GOL D3019s B 45 THR D 64 THR~? 14.39 O3 GOL D3019 B 161 LYS D 142 LYS~? 18.65 CL CL D2012 coo 7.39 128.28 94.56 8.34 126.36 94.79 20.32 52.20 78.84 20.42 50.85 77.22 coo 5.75 129.25 91.25 4.29 128.16 90.07 25.01 50.48 78.85 25.86 48.54 78.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR E 67 THR~? 11.29 O3 GOL E3002 B 45 THR E 64 THR~? 14.21 O1 GOL E3035 B 161 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 7.39 128.28 94.56 8.34 126.36 94.79 26.25 85.32 54.72 25.97 83.60 56.04 coo 5.75 129.25 91.25 4.29 128.16 90.07 30.87 84.28 56.42 31.61 84.06 58.39 coo -0.17 119.75 99.65 2.51 123.83 95.70 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR F 67 THR~? -9.79 CL CL F2035s B 45 THR F 64 THR~? -3.74 CL CL F2035s B 161 LYS F 142 LYS~? 19.20 CL CL F2034 coo 7.39 128.28 94.56 8.34 126.36 94.79 85.04 39.90 29.55 84.60 38.93 31.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 80.10 39.29 29.74 78.76 37.65 30.15 coo -0.17 119.75 99.65 2.51 123.83 95.70 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR G 67 THR~? -11.16 O2 GOL G3001s B 45 THR G 64 THR~? 16.57 O2 GOL G3001 B 161 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 7.39 128.28 94.56 8.34 126.36 94.79 21.46 27.56 45.47 21.91 29.27 44.22 coo 5.75 129.25 91.25 4.29 128.16 90.07 26.50 27.63 44.88 27.71 27.61 43.08 coo -0.17 119.75 99.65 2.51 123.83 95.70 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR H 67 THR~? -3.39 O2 GOL H3016s B 45 THR H 64 THR~? 8.97 O2 GOL H3016 B 161 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 7.39 128.28 94.56 8.34 126.36 94.79 81.07 61.13 84.03 81.35 62.09 82.15 coo 5.75 129.25 91.25 4.29 128.16 90.07 76.53 62.70 82.65 75.84 64.64 82.09 coo -0.17 119.75 99.65 2.51 123.83 95.70 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR I 67 THR~? -3.29 O1 GOL I3032s B 45 THR I 64 THR~? 8.93 O1 GOL I3032 B 161 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 7.39 128.28 94.56 8.34 126.36 94.79 200.92 194.71 161.46 200.82 192.87 160.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 196.10 194.26 160.17 195.16 193.85 158.25 coo -0.17 119.75 99.65 2.51 123.83 95.70 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 44 THR J 67 THR~? 17.03 O1 GOL J3030 B 45 THR J 64 THR~? 19.68 O1 GOL J3030 B 161 LYS J 142 LYS~? 19.62 CL CL J2016 coo 7.39 128.28 94.56 8.34 126.36 94.79 140.95 176.39 138.48 140.95 177.60 140.30 coo 5.75 129.25 91.25 4.29 128.16 90.07 145.87 177.29 139.35 146.97 179.14 139.64 coo -0.17 119.75 99.65 2.51 123.83 95.70 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 B 44 THR K 67 THR~? -10.70 O3 GOL K3009s B 45 THR K 64 THR~? 14.85 O3 GOL K3010 B 161 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 7.39 128.28 94.56 8.34 126.36 94.79 196.56 139.40 179.79 196.53 141.28 180.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 191.77 140.44 180.59 190.64 140.95 182.34 coo -0.17 119.75 99.65 2.51 123.83 95.70 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 B 44 THR L 67 THR~? -13.61 O3 GOL L3028s B 45 THR L 64 THR~? 14.87 O3 GOL L3028 B 161 LYS L 142 LYS~? 23.18 CL CL L2009 coo 7.39 128.28 94.56 8.34 126.36 94.79 136.82 164.69 195.74 136.92 163.47 194.00 coo 5.75 129.25 91.25 4.29 128.16 90.07 141.60 163.20 195.47 142.44 161.21 195.27 coo -0.17 119.75 99.65 2.51 123.83 95.70 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 B 44 THR M 67 THR~? -15.94 O3 GOL M3042s B 45 THR M 64 THR~? 19.60 O1 GOL M3043 B 161 LYS M 142 LYS~? 19.90 CL CL M2017 coo 7.39 128.28 94.56 8.34 126.36 94.79 140.30 199.27 172.95 140.11 197.51 174.22 coo 5.75 129.25 91.25 4.29 128.16 90.07 144.87 198.36 174.46 145.82 198.07 176.32 coo -0.17 119.75 99.65 2.51 123.83 95.70 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 B 44 THR N 67 THR~? -3.68 C2 GOL N3029s B 45 THR N 64 THR~? 9.33 C2 GOL N3029 B 161 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 7.39 128.28 94.56 8.34 126.36 94.79 199.85 157.94 142.85 199.59 156.93 144.76 coo 5.75 129.25 91.25 4.29 128.16 90.07 194.93 157.15 143.34 193.70 155.46 143.76 coo -0.17 119.75 99.65 2.51 123.83 95.70 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 B 44 THR O 67 THR~? 4.30 C3 GOL O3026 B 45 THR O 64 THR~? 9.90 C1 GOL O3026 B 161 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 7.39 128.28 94.56 8.34 126.36 94.79 137.76 141.84 161.16 138.02 143.59 159.91 coo 5.75 129.25 91.25 4.29 128.16 90.07 142.64 142.13 160.20 143.87 142.30 158.45 coo -0.17 119.75 99.65 2.51 123.83 95.70 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 B 44 THR P 67 THR~? 10.43 O3 GOL P3014 B 45 THR P 64 THR~? 15.75 O3 GOL P3014 B 161 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 7.39 128.28 94.56 8.34 126.36 94.79 197.48 176.33 198.45 197.56 177.49 196.62 coo 5.75 129.25 91.25 4.29 128.16 90.07 192.75 177.71 197.46 191.86 179.57 196.92 coo -0.17 119.75 99.65 2.51 123.83 95.70 204.59 186.28 195.60 209.96 186.96 196.62 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 16 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 21 TYR~? 26.32 C3 GOL E3035 150 LYS A 22 LYS~? 17.94 O2 GOL E3035 186 ASN A 11 ASN~? 13.90 C3 GOL E3035 coo 32.88 50.55 24.33 31.89 51.78 26.65 56.96 96.11 38.73 58.94 94.19 38.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 53.67 100.75 40.87 47.74 98.27 41.17 coo 36.98 50.30 37.29 35.85 50.29 35.50 47.69 85.14 44.28 46.82 84.21 42.52 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 143 TYR~? 16.38 O1 GOL A3040 150 LYS A 142 LYS~? 20.36 CL CL A2020 186 ASN A 134 ASN.? 22.60 O2 GOL A3040 coo 32.88 50.55 24.33 31.89 51.78 26.65 92.99 77.44 39.76 93.75 79.76 38.42 coo 27.04 52.42 22.30 26.88 49.99 27.00 94.05 73.09 37.15 99.40 72.43 37.04 coo 36.98 50.30 37.29 35.85 50.29 35.50 89.85 87.69 31.14 89.29 86.47 29.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 21 TYR~? 13.85 C1 GOL B3003 150 LYS B 22 LYS~? 21.36 O2 GOL B3003 186 ASN B 11 ASN~? 20.64 CL CL F2035 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.46 58.47 9.41 59.23 59.36 10.88 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.01 54.92 6.02 70.07 53.87 9.73 coo 36.98 50.30 37.29 35.85 50.29 35.50 67.09 53.72 23.05 68.24 55.42 23.61 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 143 TYR~? 10.77 O2 GOL B3024 150 LYS B 142 LYS~? 15.72 O2 GOL B3024 186 ASN B 134 ASN.? 21.61 CL CL B2010 coo 32.88 50.55 24.33 31.89 51.78 26.65 23.25 68.41 18.58 23.33 69.19 15.92 coo 27.04 52.42 22.30 26.88 49.99 27.00 21.85 72.06 22.17 16.34 73.26 20.39 coo 36.98 50.30 37.29 35.85 50.29 35.50 30.08 73.64 8.08 31.06 75.15 9.33 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR C 21 TYR~? 10.49 CL CL C2004 150 LYS C 22 LYS~? 13.40 CL CL C2004 186 ASN C 11 ASN~? 13.02 CL CL C2006 coo 32.88 50.55 24.33 31.89 51.78 26.65 45.13 11.15 67.52 47.31 12.70 68.21 coo 27.04 52.42 22.30 26.88 49.99 27.00 41.54 7.20 64.53 36.41 10.79 63.02 coo 36.98 50.30 37.29 35.85 50.29 35.50 39.48 23.73 60.48 38.53 24.80 62.04 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR C 143 TYR~? 14.40 O1 GOL C3036 150 LYS C 142 LYS~? 17.22 O1 GOL C3036 186 ASN C 134 ASN.? 21.68 CL CL C2011 coo 32.88 50.55 24.33 31.89 51.78 26.65 83.34 22.31 75.20 83.28 19.92 76.54 coo 27.04 52.42 22.30 26.88 49.99 27.00 84.87 26.44 78.04 89.10 24.68 78.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 76.46 13.23 82.50 75.64 14.68 83.88 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR D 21 TYR~? 10.58 CL CL H2005 150 LYS D 22 LYS~? 13.25 CL CL H2005 186 ASN D 11 ASN~? 12.70 O3 GOL H3025 coo 32.88 50.55 24.33 31.89 51.78 26.65 50.45 48.27 98.24 48.40 47.71 96.43 coo 27.04 52.42 22.30 26.88 49.99 27.00 53.93 51.31 102.22 59.63 51.16 99.48 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.63 51.24 86.13 60.38 49.29 85.64 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR D 143 TYR~? 15.16 CL CL D2012 150 LYS D 142 LYS~? 18.65 CL CL D2012 186 ASN D 134 ASN.? 21.42 O3 GOL D3018 coo 32.88 50.55 24.33 31.89 51.78 26.65 14.34 45.54 80.17 13.57 44.79 82.74 coo 27.04 52.42 22.30 26.88 49.99 27.00 13.01 42.17 76.46 7.83 42.85 76.18 coo 36.98 50.30 37.29 35.85 50.29 35.50 17.21 39.17 91.82 18.06 37.43 90.85 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR E 21 TYR~? 14.13 O1 GOL E3004 150 LYS E 22 LYS~? 21.81 O1 GOL E3004 186 ASN E 11 ASN~? 21.92 C1 GOL E3004 coo 32.88 50.55 24.33 31.89 51.78 26.65 60.20 97.64 59.27 57.81 96.28 59.79 coo 27.04 52.42 22.30 26.88 49.99 27.00 64.37 100.86 56.32 69.54 97.12 56.69 coo 36.98 50.30 37.29 35.85 50.29 35.50 66.56 84.05 56.14 67.19 83.33 58.06 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR E 143 TYR~? 15.23 CL CL E2013 150 LYS E 142 LYS~? 18.17 O1 GOL E3002 186 ASN E 134 ASN.? 21.44 CL CL E2013 coo 32.88 50.55 24.33 31.89 51.78 26.65 20.79 87.99 61.33 20.74 90.64 62.13 coo 27.04 52.42 22.30 26.88 49.99 27.00 18.76 84.43 64.64 13.52 85.68 64.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 26.64 98.55 67.66 26.91 97.58 69.55 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR F 21 TYR~? 26.08 O1 GOL B3017 150 LYS F 22 LYS~? 18.36 O1 GOL B3017 186 ASN F 11 ASN~? 13.91 O1 GOL B3017 coo 32.88 50.55 24.33 31.89 51.78 26.65 54.13 38.92 10.51 56.02 38.27 12.47 coo 27.04 52.42 22.30 26.88 49.99 27.00 51.36 41.84 5.91 45.78 43.39 8.51 coo 36.98 50.30 37.29 35.85 50.29 35.50 46.13 46.06 21.64 44.92 44.52 22.55 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 12 3 # 12 146 TYR F 143 TYR~? 15.09 CL CL F2034 150 LYS F 142 LYS~? 19.20 CL CL F2034 186 ASN F 134 ASN.? 19.08 CL CL F2035 coo 32.88 50.55 24.33 31.89 51.78 26.65 89.42 31.84 29.55 89.79 30.44 27.17 coo 27.04 52.42 22.30 26.88 49.99 27.00 89.94 29.13 34.00 95.25 27.31 34.06 coo 36.98 50.30 37.29 35.85 50.29 35.50 84.48 24.50 19.28 83.57 23.00 20.51 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 13 3 # 13 146 TYR G 21 TYR~? 10.57 CL CL C2004 150 LYS G 22 LYS~? 13.25 CL CL C2004 186 ASN G 11 ASN~? 12.45 O1 GOL C3021 coo 32.88 50.55 24.33 31.89 51.78 26.65 52.17 8.74 48.00 50.23 10.55 47.07 coo 27.04 52.42 22.30 26.88 49.99 27.00 55.06 4.83 51.67 60.67 7.73 52.68 coo 36.98 50.30 37.29 35.85 50.29 35.50 60.32 20.98 52.71 61.40 21.45 50.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 14 3 # 14 146 TYR G 143 TYR~? 15.53 C3 GOL G3001 150 LYS G 142 LYS~? 22.79 C3 GOL G3001 186 ASN G 134 ASN.? 22.43 C3 GOL G3038 coo 32.88 50.55 24.33 31.89 51.78 26.65 16.97 25.90 37.77 16.51 23.33 36.84 coo 27.04 52.42 22.30 26.88 49.99 27.00 16.44 29.60 34.10 15.26 26.17 28.78 coo 36.98 50.30 37.29 35.85 50.29 35.50 21.73 14.27 32.50 22.54 15.11 30.68 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 15 3 # 15 146 TYR H 21 TYR~? 10.50 CL CL H2005 150 LYS H 22 LYS~? 13.32 CL CL H2005 186 ASN H 11 ASN~? 13.03 CL CL D2008 coo 32.88 50.55 24.33 31.89 51.78 26.65 47.46 68.84 95.61 49.74 68.96 94.05 coo 27.04 52.42 22.30 26.88 49.99 27.00 43.36 66.64 99.44 38.17 66.18 95.68 coo 36.98 50.30 37.29 35.85 50.29 35.50 40.80 62.96 83.01 40.13 64.68 81.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 16 3 # 16 146 TYR H 143 TYR~? 11.30 O2 GOL H3016 150 LYS H 142 LYS~? 14.79 O1 GOL H3016 186 ASN H 134 ASN.? 21.68 CL CL H2014 coo 32.88 50.55 24.33 31.89 51.78 26.65 86.77 67.99 85.16 86.88 69.36 87.57 coo 27.04 52.42 22.30 26.88 49.99 27.00 88.83 70.49 80.96 94.32 71.20 82.05 coo 36.98 50.30 37.29 35.85 50.29 35.50 81.15 76.65 94.15 80.84 78.27 92.76 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 17 3 # 17 146 TYR I 21 TYR~? 10.49 CL CL I2001 150 LYS I 22 LYS~? 13.37 CL CL I2001 186 ASN I 11 ASN~? 13.03 CL CL I2007 coo 32.88 50.55 24.33 31.89 51.78 26.65 169.47 212.28 156.01 171.53 210.49 155.65 coo 27.04 52.42 22.30 26.88 49.99 27.00 166.16 216.63 158.59 160.45 213.84 159.02 coo 36.98 50.30 37.29 35.85 50.29 35.50 161.01 200.49 161.41 160.17 199.75 159.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 18 3 # 18 146 TYR I 143 TYR~? 11.25 C1 GOL I3032 150 LYS I 142 LYS~? 14.36 O1 GOL I3032 186 ASN I 134 ASN.? 21.46 CL CL I2015 coo 32.88 50.55 24.33 31.89 51.78 26.65 206.55 195.37 154.41 207.09 197.83 153.23 coo 27.04 52.42 22.30 26.88 49.99 27.00 208.03 191.18 151.66 205.16 191.96 148.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 202.50 205.66 146.54 201.90 204.42 144.84 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 19 3 # 19 146 TYR J 21 TYR~? 10.46 CL CL J2002 150 LYS J 22 LYS~? 13.36 CL CL J2002 186 ASN J 11 ASN~? 12.94 O2 GOL N3044 coo 32.88 50.55 24.33 31.89 51.78 26.65 174.52 176.28 124.74 172.25 177.04 126.20 coo 27.04 52.42 22.30 26.88 49.99 27.00 178.14 172.91 121.18 183.42 172.10 124.71 coo 36.98 50.30 37.29 35.85 50.29 35.50 180.98 171.30 137.88 181.93 173.10 138.53 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 20 3 # 20 146 TYR J 143 TYR~? 15.18 CL CL J2016 150 LYS J 142 LYS~? 19.62 CL CL J2016 186 ASN J 134 ASN.? 21.36 CL CL J2016 coo 32.88 50.55 24.33 31.89 51.78 26.65 136.50 183.91 136.49 136.50 184.93 133.88 coo 27.04 52.42 22.30 26.88 49.99 27.00 135.12 187.43 140.16 132.76 191.26 136.26 coo 36.98 50.30 37.29 35.85 50.29 35.50 142.59 189.93 125.86 143.30 191.66 127.03 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 21 3 # 21 146 TYR K 21 TYR~? 13.85 O1 GOL K3011 150 LYS K 22 LYS~? 17.74 CL CL K2003 186 ASN K 11 ASN~? 12.99 CL CL K2003 coo 32.88 50.55 24.33 31.89 51.78 26.65 163.15 125.72 181.32 165.33 127.37 181.87 coo 27.04 52.42 22.30 26.88 49.99 27.00 159.62 121.79 178.29 154.49 125.24 177.13 coo 36.98 50.30 37.29 35.85 50.29 35.50 156.74 138.31 174.91 155.83 139.22 176.64 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 22 3 # 22 146 TYR K 143 TYR~? 15.99 O3 GOL K3009 150 LYS K 142 LYS~? 19.15 C2 GOL K3009 186 ASN K 134 ASN.? 21.40 O1 GOL K3041 coo 32.88 50.55 24.33 31.89 51.78 26.65 201.16 138.32 187.50 201.22 135.84 188.82 coo 27.04 52.42 22.30 26.88 49.99 27.00 202.52 142.42 190.46 207.82 141.83 191.71 coo 36.98 50.30 37.29 35.85 50.29 35.50 194.99 128.59 194.84 194.18 129.99 196.32 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 23 3 # 23 146 TYR L 21 TYR~? 30.92 O3 GOL K3011 150 LYS L 22 LYS~? 25.13 O2 GOL P3034 186 ASN L 11 ASN~? 26.76 O3 GOL P3014 coo 32.88 50.55 24.33 31.89 51.78 26.65 168.26 161.38 213.44 166.20 160.80 211.67 coo 27.04 52.42 22.30 26.88 49.99 27.00 171.60 164.44 217.42 177.37 164.59 214.60 coo 36.98 50.30 37.29 35.85 50.29 35.50 176.63 165.37 201.14 177.48 163.54 200.51 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 24 3 # 24 146 TYR L 143 TYR~? 15.30 CL CL L2009 150 LYS L 142 LYS~? 23.18 CL CL L2009 186 ASN L 134 ASN.? 21.61 CL CL L2009 coo 32.88 50.55 24.33 31.89 51.78 26.65 131.10 157.77 197.34 130.52 156.95 199.97 coo 27.04 52.42 22.30 26.88 49.99 27.00 129.76 154.52 193.42 128.34 149.37 194.11 coo 36.98 50.30 37.29 35.85 50.29 35.50 134.78 151.23 208.60 135.91 149.70 207.44 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 25 3 # 25 146 TYR M 21 TYR~? 10.54 CL CL I2001 150 LYS M 22 LYS~? 13.38 CL CL I2001 186 ASN M 11 ASN~? 13.05 CL CL I2007 coo 32.88 50.55 24.33 31.89 51.78 26.65 173.68 213.02 176.47 171.32 211.57 177.01 coo 27.04 52.42 22.30 26.88 49.99 27.00 177.61 216.43 173.42 182.96 212.88 173.24 coo 36.98 50.30 37.29 35.85 50.29 35.50 180.57 199.77 172.35 181.29 199.01 174.20 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 26 3 # 26 146 TYR M 143 TYR~? 15.40 CL CL M2017 150 LYS M 142 LYS~? 19.90 CL CL M2017 186 ASN M 134 ASN.? 21.64 CL CL M2017 coo 32.88 50.55 24.33 31.89 51.78 26.65 134.88 201.35 179.85 134.66 203.97 180.76 coo 27.04 52.42 22.30 26.88 49.99 27.00 133.20 197.60 183.11 127.92 198.39 183.89 coo 36.98 50.30 37.29 35.85 50.29 35.50 140.32 211.77 186.52 140.85 210.60 188.28 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 27 3 # 27 146 TYR N 21 TYR~? 10.52 CL CL J2002 150 LYS N 22 LYS~? 13.40 CL CL J2002 186 ASN N 11 ASN~? 18.16 CL CL J2002 coo 32.88 50.55 24.33 31.89 51.78 26.65 168.15 156.47 125.36 170.14 155.81 127.21 coo 27.04 52.42 22.30 26.88 49.99 27.00 165.10 159.41 121.05 159.46 160.48 123.77 coo 36.98 50.30 37.29 35.85 50.29 35.50 160.32 162.66 137.06 159.27 161.03 137.96 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 28 3 # 28 146 TYR N 143 TYR~? 10.73 O2 GOL N3029 150 LYS N 142 LYS~? 14.74 O1 GOL N3029 186 ASN N 134 ASN.? 22.01 O2 GOL N3029 coo 32.88 50.55 24.33 31.89 51.78 26.65 204.41 150.24 142.39 204.78 148.95 139.97 coo 27.04 52.42 22.30 26.88 49.99 27.00 205.28 147.20 146.57 210.60 146.27 146.55 coo 36.98 50.30 37.29 35.85 50.29 35.50 199.33 142.96 132.06 198.55 141.35 133.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 29 3 # 29 146 TYR O 21 TYR~? 14.79 CL CL K2003 150 LYS O 22 LYS~? 17.69 O3 GOL K3010 186 ASN O 11 ASN~? 13.05 CL CL K2003 coo 32.88 50.55 24.33 31.89 51.78 26.65 169.50 124.29 161.32 167.44 126.02 160.55 coo 27.04 52.42 22.30 26.88 49.99 27.00 172.63 120.27 164.76 178.18 123.25 165.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 177.30 136.62 166.28 178.38 137.16 164.50 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 30 3 # 30 146 TYR O 143 TYR~? 11.76 C3 GOL O3026 150 LYS O 142 LYS~? 15.43 O3 GOL O3026 186 ASN O 134 ASN.? 10.04 CL CL O2036 coo 32.88 50.55 24.33 31.89 51.78 26.65 133.04 140.38 153.60 132.61 137.79 152.63 coo 27.04 52.42 22.30 26.88 49.99 27.00 132.09 144.26 150.20 126.63 143.20 149.32 coo 36.98 50.30 37.29 35.85 50.29 35.50 138.05 129.32 147.60 138.80 130.30 145.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 31 3 # 31 146 TYR P 21 TYR~? 24.07 O1 GOL L3028 150 LYS P 22 LYS~? 16.49 O1 GOL L3028 186 ASN P 11 ASN~? 12.58 O1 GOL L3028 coo 32.88 50.55 24.33 31.89 51.78 26.65 164.13 181.87 211.82 166.34 182.20 210.17 coo 27.04 52.42 22.30 26.88 49.99 27.00 160.29 179.27 215.80 155.06 178.69 212.33 coo 36.98 50.30 37.29 35.85 50.29 35.50 157.20 176.23 199.28 156.46 178.04 198.37 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 32 3 # 32 146 TYR P 143 TYR~? 15.20 CL CL P2019 150 LYS P 142 LYS~? 18.94 O2 GOL P3014 186 ASN P 134 ASN.? 21.42 CL CL P2019 coo 32.88 50.55 24.33 31.89 51.78 26.65 202.86 183.43 199.65 203.11 184.67 202.14 coo 27.04 52.42 22.30 26.88 49.99 27.00 204.59 186.28 195.60 209.96 186.96 196.62 coo 36.98 50.30 37.29 35.85 50.29 35.50 197.55 191.31 209.34 197.08 192.94 207.98 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 32 hits 1dhr_c00 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 77 ALA~? 7.34 O2 GOL A3037 A 52 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 191 TRP A 82 TRP~? 8.67 CL CL A2020 coo 0.32 19.13 2.10 -0.45 20.12 1.22 100.75 81.76 50.18 100.07 80.47 50.63 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 98.60 85.60 50.46 99.38 86.61 52.13 coo -12.27 21.19 4.26 -8.94 21.66 2.22 109.14 82.09 43.02 109.21 85.94 42.13 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA F 77 ALA~? 8.70 CL CL F2034 A 52 HIS F 76 HIS~? -4.65 CL CL F2034s A 191 TRP F 82 TRP~? 9.00 CL CL F2023 coo 0.32 19.13 2.10 -0.45 20.12 1.22 99.32 40.41 25.48 98.76 40.99 26.78 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 97.24 41.20 21.57 98.43 42.65 20.63 coo -12.27 21.19 4.26 -8.94 21.66 2.22 106.15 31.91 24.85 106.17 31.15 20.99 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA J 77 ALA~? 7.22 O2 GOL J3033 A 52 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 191 TRP J 82 TRP~? 8.74 CL CL J2026 coo 0.32 19.13 2.10 -0.45 20.12 1.22 127.70 174.36 132.33 128.03 174.02 133.80 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 130.51 172.99 128.94 129.60 171.33 128.01 coo -12.27 21.19 4.26 -8.94 21.66 2.22 120.81 182.25 129.28 121.40 182.19 125.39 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 4 3 # 4 A 48 ALA L 77 ALA~? 8.83 CL CL L2009 A 52 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 191 TRP L 82 TRP~? 8.52 CL CL L2028 coo 0.32 19.13 2.10 -0.45 20.12 1.22 123.16 168.73 200.29 123.66 168.91 198.87 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 125.69 169.77 203.98 124.79 171.51 204.73 coo -12.27 21.19 4.26 -8.94 21.66 2.22 114.77 162.30 202.99 115.21 162.18 206.89 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 5 3 # 5 A 48 ALA P 77 ALA~? 8.06 O2 GOL P3014 A 52 HIS P 76 HIS~? 4.69 CL CL P2019s A 191 TRP P 82 TRP~? 11.18 CL CL P2019 coo 0.32 19.13 2.10 -0.45 20.12 1.22 210.48 173.29 204.91 210.13 172.95 203.48 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 207.59 172.73 208.38 208.33 171.09 209.49 coo -12.27 21.19 4.26 -8.94 21.66 2.22 218.35 180.63 207.32 217.67 181.08 211.18 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 5 hits 1dj1_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 21 TYR~? 26.32 C3 GOL E3035 A 183 LYS A 22 LYS~? 17.94 O2 GOL E3035 A 278 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 19.43 18.53 42.32 17.66 18.80 40.15 56.96 96.11 38.73 58.94 94.19 38.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 53.67 100.75 40.87 47.74 98.27 41.17 coo 15.46 19.03 31.40 15.01 18.25 33.31 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 21 TYR~? 13.85 C1 GOL B3003 A 183 LYS B 22 LYS~? 21.36 O2 GOL B3003 A 278 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 19.43 18.53 42.32 17.66 18.80 40.15 61.46 58.47 9.41 59.23 59.36 10.88 coo 21.92 15.80 36.19 17.64 19.44 36.35 65.01 54.92 6.02 70.07 53.87 9.73 coo 15.46 19.03 31.40 15.01 18.25 33.31 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR C 21 TYR~? 10.49 CL CL C2004 A 183 LYS C 22 LYS~? 13.40 CL CL C2004 A 278 ASP C 28 ASP~? 15.70 CL CL C2004 coo 19.43 18.53 42.32 17.66 18.80 40.15 45.13 11.15 67.52 47.31 12.70 68.21 coo 21.92 15.80 36.19 17.64 19.44 36.35 41.54 7.20 64.53 36.41 10.79 63.02 coo 15.46 19.03 31.40 15.01 18.25 33.31 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR D 21 TYR~? 10.58 CL CL H2005 A 183 LYS D 22 LYS~? 13.25 CL CL H2005 A 278 ASP D 28 ASP~? 15.80 CL CL H2005 coo 19.43 18.53 42.32 17.66 18.80 40.15 50.45 48.27 98.24 48.40 47.71 96.43 coo 21.92 15.80 36.19 17.64 19.44 36.35 53.93 51.31 102.22 59.63 51.16 99.48 coo 15.46 19.03 31.40 15.01 18.25 33.31 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR E 21 TYR~? 14.13 O1 GOL E3004 A 183 LYS E 22 LYS~? 21.81 O1 GOL E3004 A 278 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 19.43 18.53 42.32 17.66 18.80 40.15 60.20 97.64 59.27 57.81 96.28 59.79 coo 21.92 15.80 36.19 17.64 19.44 36.35 64.37 100.86 56.32 69.54 97.12 56.69 coo 15.46 19.03 31.40 15.01 18.25 33.31 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR F 21 TYR~? 26.08 O1 GOL B3017 A 183 LYS F 22 LYS~? 18.36 O1 GOL B3017 A 278 ASP F 28 ASP~? 32.62 CL CL F2035 coo 19.43 18.53 42.32 17.66 18.80 40.15 54.13 38.92 10.51 56.02 38.27 12.47 coo 21.92 15.80 36.19 17.64 19.44 36.35 51.36 41.84 5.91 45.78 43.39 8.51 coo 15.46 19.03 31.40 15.01 18.25 33.31 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR G 21 TYR~? 10.57 CL CL C2004 A 183 LYS G 22 LYS~? 13.25 CL CL C2004 A 278 ASP G 28 ASP~? 15.85 CL CL C2004 coo 19.43 18.53 42.32 17.66 18.80 40.15 52.17 8.74 48.00 50.23 10.55 47.07 coo 21.92 15.80 36.19 17.64 19.44 36.35 55.06 4.83 51.67 60.67 7.73 52.68 coo 15.46 19.03 31.40 15.01 18.25 33.31 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR H 21 TYR~? 10.50 CL CL H2005 A 183 LYS H 22 LYS~? 13.32 CL CL H2005 A 278 ASP H 28 ASP~? 15.80 CL CL H2005 coo 19.43 18.53 42.32 17.66 18.80 40.15 47.46 68.84 95.61 49.74 68.96 94.05 coo 21.92 15.80 36.19 17.64 19.44 36.35 43.36 66.64 99.44 38.17 66.18 95.68 coo 15.46 19.03 31.40 15.01 18.25 33.31 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1do8_c00 MALIC ENZYME user 9 3 # 9 A 112 TYR I 21 TYR~? 10.49 CL CL I2001 A 183 LYS I 22 LYS~? 13.37 CL CL I2001 A 278 ASP I 28 ASP~? 15.71 CL CL I2001 coo 19.43 18.53 42.32 17.66 18.80 40.15 169.47 212.28 156.01 171.53 210.49 155.65 coo 21.92 15.80 36.19 17.64 19.44 36.35 166.16 216.63 158.59 160.45 213.84 159.02 coo 15.46 19.03 31.40 15.01 18.25 33.31 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1do8_c00 MALIC ENZYME user 10 3 # 10 A 112 TYR J 21 TYR~? 10.46 CL CL J2002 A 183 LYS J 22 LYS~? 13.36 CL CL J2002 A 278 ASP J 28 ASP~? 15.67 CL CL J2002 coo 19.43 18.53 42.32 17.66 18.80 40.15 174.52 176.28 124.74 172.25 177.04 126.20 coo 21.92 15.80 36.19 17.64 19.44 36.35 178.14 172.91 121.18 183.42 172.10 124.71 coo 15.46 19.03 31.40 15.01 18.25 33.31 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1do8_c00 MALIC ENZYME user 11 3 # 11 A 112 TYR K 21 TYR~? 13.85 O1 GOL K3011 A 183 LYS K 22 LYS~? 17.74 CL CL K2003 A 278 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 19.43 18.53 42.32 17.66 18.80 40.15 163.15 125.72 181.32 165.33 127.37 181.87 coo 21.92 15.80 36.19 17.64 19.44 36.35 159.62 121.79 178.29 154.49 125.24 177.13 coo 15.46 19.03 31.40 15.01 18.25 33.31 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1do8_c00 MALIC ENZYME user 12 3 # 12 A 112 TYR L 21 TYR~? 30.92 O3 GOL K3011 A 183 LYS L 22 LYS~? 25.13 O2 GOL P3034 A 278 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 19.43 18.53 42.32 17.66 18.80 40.15 168.26 161.38 213.44 166.20 160.80 211.67 coo 21.92 15.80 36.19 17.64 19.44 36.35 171.60 164.44 217.42 177.37 164.59 214.60 coo 15.46 19.03 31.40 15.01 18.25 33.31 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1do8_c00 MALIC ENZYME user 13 3 # 13 A 112 TYR M 21 TYR~? 10.54 CL CL I2001 A 183 LYS M 22 LYS~? 13.38 CL CL I2001 A 278 ASP M 28 ASP~? 15.52 CL CL I2001 coo 19.43 18.53 42.32 17.66 18.80 40.15 173.68 213.02 176.47 171.32 211.57 177.01 coo 21.92 15.80 36.19 17.64 19.44 36.35 177.61 216.43 173.42 182.96 212.88 173.24 coo 15.46 19.03 31.40 15.01 18.25 33.31 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1do8_c00 MALIC ENZYME user 14 3 # 14 A 112 TYR N 21 TYR~? 10.52 CL CL J2002 A 183 LYS N 22 LYS~? 13.40 CL CL J2002 A 278 ASP N 28 ASP~? 15.68 CL CL J2002 coo 19.43 18.53 42.32 17.66 18.80 40.15 168.15 156.47 125.36 170.14 155.81 127.21 coo 21.92 15.80 36.19 17.64 19.44 36.35 165.10 159.41 121.05 159.46 160.48 123.77 coo 15.46 19.03 31.40 15.01 18.25 33.31 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1do8_c00 MALIC ENZYME user 15 3 # 15 A 112 TYR O 21 TYR~? 14.79 CL CL K2003 A 183 LYS O 22 LYS~? 17.69 O3 GOL K3010 A 278 ASP O 28 ASP~? 23.95 CL CL O2036 coo 19.43 18.53 42.32 17.66 18.80 40.15 169.50 124.29 161.32 167.44 126.02 160.55 coo 21.92 15.80 36.19 17.64 19.44 36.35 172.63 120.27 164.76 178.18 123.25 165.65 coo 15.46 19.03 31.40 15.01 18.25 33.31 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1do8_c00 MALIC ENZYME user 16 3 # 16 A 112 TYR P 21 TYR~? 24.07 O1 GOL L3028 A 183 LYS P 22 LYS~? 16.49 O1 GOL L3028 A 278 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 19.43 18.53 42.32 17.66 18.80 40.15 164.13 181.87 211.82 166.34 182.20 210.17 coo 21.92 15.80 36.19 17.64 19.44 36.35 160.29 179.27 215.80 155.06 178.69 212.33 coo 15.46 19.03 31.40 15.01 18.25 33.31 167.75 181.83 222.09 168.94 183.53 222.37 1do8_c00 source 1do8 MALIC ENZYME : 16 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 21 TYR~? 26.32 C3 GOL E3035 B 183 LYS A 22 LYS~? 17.94 O2 GOL E3035 B 278 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 58.62 15.99 58.34 60.98 14.60 58.93 56.96 96.11 38.73 58.94 94.19 38.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 53.67 100.75 40.87 47.74 98.27 41.17 coo 66.50 7.32 58.45 66.26 9.42 58.23 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 21 TYR~? 13.85 C1 GOL B3003 B 183 LYS B 22 LYS~? 21.36 O2 GOL B3003 B 278 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 58.62 15.99 58.34 60.98 14.60 58.93 61.46 58.47 9.41 59.23 59.36 10.88 coo 60.11 10.60 53.63 62.59 10.74 58.67 65.01 54.92 6.02 70.07 53.87 9.73 coo 66.50 7.32 58.45 66.26 9.42 58.23 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR C 21 TYR~? 10.49 CL CL C2004 B 183 LYS C 22 LYS~? 13.40 CL CL C2004 B 278 ASP C 28 ASP~? 15.70 CL CL C2004 coo 58.62 15.99 58.34 60.98 14.60 58.93 45.13 11.15 67.52 47.31 12.70 68.21 coo 60.11 10.60 53.63 62.59 10.74 58.67 41.54 7.20 64.53 36.41 10.79 63.02 coo 66.50 7.32 58.45 66.26 9.42 58.23 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR D 21 TYR~? 10.58 CL CL H2005 B 183 LYS D 22 LYS~? 13.25 CL CL H2005 B 278 ASP D 28 ASP~? 15.80 CL CL H2005 coo 58.62 15.99 58.34 60.98 14.60 58.93 50.45 48.27 98.24 48.40 47.71 96.43 coo 60.11 10.60 53.63 62.59 10.74 58.67 53.93 51.31 102.22 59.63 51.16 99.48 coo 66.50 7.32 58.45 66.26 9.42 58.23 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR E 21 TYR~? 14.13 O1 GOL E3004 B 183 LYS E 22 LYS~? 21.81 O1 GOL E3004 B 278 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 58.62 15.99 58.34 60.98 14.60 58.93 60.20 97.64 59.27 57.81 96.28 59.79 coo 60.11 10.60 53.63 62.59 10.74 58.67 64.37 100.86 56.32 69.54 97.12 56.69 coo 66.50 7.32 58.45 66.26 9.42 58.23 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR F 21 TYR~? 26.08 O1 GOL B3017 B 183 LYS F 22 LYS~? 18.36 O1 GOL B3017 B 278 ASP F 28 ASP~? 32.62 CL CL F2035 coo 58.62 15.99 58.34 60.98 14.60 58.93 54.13 38.92 10.51 56.02 38.27 12.47 coo 60.11 10.60 53.63 62.59 10.74 58.67 51.36 41.84 5.91 45.78 43.39 8.51 coo 66.50 7.32 58.45 66.26 9.42 58.23 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR G 21 TYR~? 10.57 CL CL C2004 B 183 LYS G 22 LYS~? 13.25 CL CL C2004 B 278 ASP G 28 ASP~? 15.85 CL CL C2004 coo 58.62 15.99 58.34 60.98 14.60 58.93 52.17 8.74 48.00 50.23 10.55 47.07 coo 60.11 10.60 53.63 62.59 10.74 58.67 55.06 4.83 51.67 60.67 7.73 52.68 coo 66.50 7.32 58.45 66.26 9.42 58.23 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1do8_c01 MALIC ENZYME user 8 3 # 8 B 112 TYR H 21 TYR~? 10.50 CL CL H2005 B 183 LYS H 22 LYS~? 13.32 CL CL H2005 B 278 ASP H 28 ASP~? 15.80 CL CL H2005 coo 58.62 15.99 58.34 60.98 14.60 58.93 47.46 68.84 95.61 49.74 68.96 94.05 coo 60.11 10.60 53.63 62.59 10.74 58.67 43.36 66.64 99.44 38.17 66.18 95.68 coo 66.50 7.32 58.45 66.26 9.42 58.23 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1do8_c01 MALIC ENZYME user 9 3 # 9 B 112 TYR I 21 TYR~? 10.49 CL CL I2001 B 183 LYS I 22 LYS~? 13.37 CL CL I2001 B 278 ASP I 28 ASP~? 15.71 CL CL I2001 coo 58.62 15.99 58.34 60.98 14.60 58.93 169.47 212.28 156.01 171.53 210.49 155.65 coo 60.11 10.60 53.63 62.59 10.74 58.67 166.16 216.63 158.59 160.45 213.84 159.02 coo 66.50 7.32 58.45 66.26 9.42 58.23 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1do8_c01 MALIC ENZYME user 10 3 # 10 B 112 TYR J 21 TYR~? 10.46 CL CL J2002 B 183 LYS J 22 LYS~? 13.36 CL CL J2002 B 278 ASP J 28 ASP~? 15.67 CL CL J2002 coo 58.62 15.99 58.34 60.98 14.60 58.93 174.52 176.28 124.74 172.25 177.04 126.20 coo 60.11 10.60 53.63 62.59 10.74 58.67 178.14 172.91 121.18 183.42 172.10 124.71 coo 66.50 7.32 58.45 66.26 9.42 58.23 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1do8_c01 MALIC ENZYME user 11 3 # 11 B 112 TYR K 21 TYR~? 13.85 O1 GOL K3011 B 183 LYS K 22 LYS~? 17.74 CL CL K2003 B 278 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 58.62 15.99 58.34 60.98 14.60 58.93 163.15 125.72 181.32 165.33 127.37 181.87 coo 60.11 10.60 53.63 62.59 10.74 58.67 159.62 121.79 178.29 154.49 125.24 177.13 coo 66.50 7.32 58.45 66.26 9.42 58.23 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1do8_c01 MALIC ENZYME user 12 3 # 12 B 112 TYR L 21 TYR~? 30.92 O3 GOL K3011 B 183 LYS L 22 LYS~? 25.13 O2 GOL P3034 B 278 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 58.62 15.99 58.34 60.98 14.60 58.93 168.26 161.38 213.44 166.20 160.80 211.67 coo 60.11 10.60 53.63 62.59 10.74 58.67 171.60 164.44 217.42 177.37 164.59 214.60 coo 66.50 7.32 58.45 66.26 9.42 58.23 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1do8_c01 MALIC ENZYME user 13 3 # 13 B 112 TYR M 21 TYR~? 10.54 CL CL I2001 B 183 LYS M 22 LYS~? 13.38 CL CL I2001 B 278 ASP M 28 ASP~? 15.52 CL CL I2001 coo 58.62 15.99 58.34 60.98 14.60 58.93 173.68 213.02 176.47 171.32 211.57 177.01 coo 60.11 10.60 53.63 62.59 10.74 58.67 177.61 216.43 173.42 182.96 212.88 173.24 coo 66.50 7.32 58.45 66.26 9.42 58.23 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1do8_c01 MALIC ENZYME user 14 3 # 14 B 112 TYR N 21 TYR~? 10.52 CL CL J2002 B 183 LYS N 22 LYS~? 13.40 CL CL J2002 B 278 ASP N 28 ASP~? 15.68 CL CL J2002 coo 58.62 15.99 58.34 60.98 14.60 58.93 168.15 156.47 125.36 170.14 155.81 127.21 coo 60.11 10.60 53.63 62.59 10.74 58.67 165.10 159.41 121.05 159.46 160.48 123.77 coo 66.50 7.32 58.45 66.26 9.42 58.23 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1do8_c01 MALIC ENZYME user 15 3 # 15 B 112 TYR O 21 TYR~? 14.79 CL CL K2003 B 183 LYS O 22 LYS~? 17.69 O3 GOL K3010 B 278 ASP O 28 ASP~? 23.95 CL CL O2036 coo 58.62 15.99 58.34 60.98 14.60 58.93 169.50 124.29 161.32 167.44 126.02 160.55 coo 60.11 10.60 53.63 62.59 10.74 58.67 172.63 120.27 164.76 178.18 123.25 165.65 coo 66.50 7.32 58.45 66.26 9.42 58.23 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1do8_c01 MALIC ENZYME user 16 3 # 16 B 112 TYR P 21 TYR~? 24.07 O1 GOL L3028 B 183 LYS P 22 LYS~? 16.49 O1 GOL L3028 B 278 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 58.62 15.99 58.34 60.98 14.60 58.93 164.13 181.87 211.82 166.34 182.20 210.17 coo 60.11 10.60 53.63 62.59 10.74 58.67 160.29 179.27 215.80 155.06 178.69 212.33 coo 66.50 7.32 58.45 66.26 9.42 58.23 167.75 181.83 222.09 168.94 183.53 222.37 1do8_c01 source 1do8 MALIC ENZYME : 16 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 21 TYR~? 26.32 C3 GOL E3035 C 183 LYS A 22 LYS~? 17.94 O2 GOL E3035 C 278 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 56.96 96.11 38.73 58.94 94.19 38.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 53.67 100.75 40.87 47.74 98.27 41.17 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 21 TYR~? 13.85 C1 GOL B3003 C 183 LYS B 22 LYS~? 21.36 O2 GOL B3003 C 278 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 61.46 58.47 9.41 59.23 59.36 10.88 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 65.01 54.92 6.02 70.07 53.87 9.73 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR C 21 TYR~? 10.49 CL CL C2004 C 183 LYS C 22 LYS~? 13.40 CL CL C2004 C 278 ASP C 28 ASP~? 15.70 CL CL C2004 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 45.13 11.15 67.52 47.31 12.70 68.21 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 41.54 7.20 64.53 36.41 10.79 63.02 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR D 21 TYR~? 10.58 CL CL H2005 C 183 LYS D 22 LYS~? 13.25 CL CL H2005 C 278 ASP D 28 ASP~? 15.80 CL CL H2005 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 50.45 48.27 98.24 48.40 47.71 96.43 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 53.93 51.31 102.22 59.63 51.16 99.48 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR E 21 TYR~? 14.13 O1 GOL E3004 C 183 LYS E 22 LYS~? 21.81 O1 GOL E3004 C 278 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 60.20 97.64 59.27 57.81 96.28 59.79 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 64.37 100.86 56.32 69.54 97.12 56.69 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR F 21 TYR~? 26.08 O1 GOL B3017 C 183 LYS F 22 LYS~? 18.36 O1 GOL B3017 C 278 ASP F 28 ASP~? 32.62 CL CL F2035 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 54.13 38.92 10.51 56.02 38.27 12.47 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 51.36 41.84 5.91 45.78 43.39 8.51 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR G 21 TYR~? 10.57 CL CL C2004 C 183 LYS G 22 LYS~? 13.25 CL CL C2004 C 278 ASP G 28 ASP~? 15.85 CL CL C2004 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 52.17 8.74 48.00 50.23 10.55 47.07 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 55.06 4.83 51.67 60.67 7.73 52.68 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR H 21 TYR~? 10.50 CL CL H2005 C 183 LYS H 22 LYS~? 13.32 CL CL H2005 C 278 ASP H 28 ASP~? 15.80 CL CL H2005 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 47.46 68.84 95.61 49.74 68.96 94.05 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 43.36 66.64 99.44 38.17 66.18 95.68 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1do8_c02 MALIC ENZYME user 9 3 # 9 C 112 TYR I 21 TYR~? 10.49 CL CL I2001 C 183 LYS I 22 LYS~? 13.37 CL CL I2001 C 278 ASP I 28 ASP~? 15.71 CL CL I2001 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 169.47 212.28 156.01 171.53 210.49 155.65 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 166.16 216.63 158.59 160.45 213.84 159.02 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1do8_c02 MALIC ENZYME user 10 3 # 10 C 112 TYR J 21 TYR~? 10.46 CL CL J2002 C 183 LYS J 22 LYS~? 13.36 CL CL J2002 C 278 ASP J 28 ASP~? 15.67 CL CL J2002 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 174.52 176.28 124.74 172.25 177.04 126.20 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 178.14 172.91 121.18 183.42 172.10 124.71 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1do8_c02 MALIC ENZYME user 11 3 # 11 C 112 TYR K 21 TYR~? 13.85 O1 GOL K3011 C 183 LYS K 22 LYS~? 17.74 CL CL K2003 C 278 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 163.15 125.72 181.32 165.33 127.37 181.87 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 159.62 121.79 178.29 154.49 125.24 177.13 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1do8_c02 MALIC ENZYME user 12 3 # 12 C 112 TYR L 21 TYR~? 30.92 O3 GOL K3011 C 183 LYS L 22 LYS~? 25.13 O2 GOL P3034 C 278 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 168.26 161.38 213.44 166.20 160.80 211.67 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 171.60 164.44 217.42 177.37 164.59 214.60 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1do8_c02 MALIC ENZYME user 13 3 # 13 C 112 TYR M 21 TYR~? 10.54 CL CL I2001 C 183 LYS M 22 LYS~? 13.38 CL CL I2001 C 278 ASP M 28 ASP~? 15.52 CL CL I2001 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 173.68 213.02 176.47 171.32 211.57 177.01 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 177.61 216.43 173.42 182.96 212.88 173.24 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1do8_c02 MALIC ENZYME user 14 3 # 14 C 112 TYR N 21 TYR~? 10.52 CL CL J2002 C 183 LYS N 22 LYS~? 13.40 CL CL J2002 C 278 ASP N 28 ASP~? 15.68 CL CL J2002 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 168.15 156.47 125.36 170.14 155.81 127.21 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 165.10 159.41 121.05 159.46 160.48 123.77 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1do8_c02 MALIC ENZYME user 15 3 # 15 C 112 TYR O 21 TYR~? 14.79 CL CL K2003 C 183 LYS O 22 LYS~? 17.69 O3 GOL K3010 C 278 ASP O 28 ASP~? 23.95 CL CL O2036 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 169.50 124.29 161.32 167.44 126.02 160.55 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 172.63 120.27 164.76 178.18 123.25 165.65 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1do8_c02 MALIC ENZYME user 16 3 # 16 C 112 TYR P 21 TYR~? 24.07 O1 GOL L3028 C 183 LYS P 22 LYS~? 16.49 O1 GOL L3028 C 278 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 164.13 181.87 211.82 166.34 182.20 210.17 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 160.29 179.27 215.80 155.06 178.69 212.33 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 167.75 181.83 222.09 168.94 183.53 222.37 1do8_c02 source 1do8 MALIC ENZYME : 16 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 21 TYR~? 26.32 C3 GOL E3035 D 183 LYS A 22 LYS~? 17.94 O2 GOL E3035 D 278 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 56.96 96.11 38.73 58.94 94.19 38.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 53.67 100.75 40.87 47.74 98.27 41.17 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 21 TYR~? 13.85 C1 GOL B3003 D 183 LYS B 22 LYS~? 21.36 O2 GOL B3003 D 278 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 61.46 58.47 9.41 59.23 59.36 10.88 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 65.01 54.92 6.02 70.07 53.87 9.73 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR C 21 TYR~? 10.49 CL CL C2004 D 183 LYS C 22 LYS~? 13.40 CL CL C2004 D 278 ASP C 28 ASP~? 15.70 CL CL C2004 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 45.13 11.15 67.52 47.31 12.70 68.21 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 41.54 7.20 64.53 36.41 10.79 63.02 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR D 21 TYR~? 10.58 CL CL H2005 D 183 LYS D 22 LYS~? 13.25 CL CL H2005 D 278 ASP D 28 ASP~? 15.80 CL CL H2005 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 50.45 48.27 98.24 48.40 47.71 96.43 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 53.93 51.31 102.22 59.63 51.16 99.48 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR E 21 TYR~? 14.13 O1 GOL E3004 D 183 LYS E 22 LYS~? 21.81 O1 GOL E3004 D 278 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 60.20 97.64 59.27 57.81 96.28 59.79 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 64.37 100.86 56.32 69.54 97.12 56.69 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR F 21 TYR~? 26.08 O1 GOL B3017 D 183 LYS F 22 LYS~? 18.36 O1 GOL B3017 D 278 ASP F 28 ASP~? 32.62 CL CL F2035 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 54.13 38.92 10.51 56.02 38.27 12.47 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 51.36 41.84 5.91 45.78 43.39 8.51 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR G 21 TYR~? 10.57 CL CL C2004 D 183 LYS G 22 LYS~? 13.25 CL CL C2004 D 278 ASP G 28 ASP~? 15.85 CL CL C2004 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 52.17 8.74 48.00 50.23 10.55 47.07 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 55.06 4.83 51.67 60.67 7.73 52.68 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR H 21 TYR~? 10.50 CL CL H2005 D 183 LYS H 22 LYS~? 13.32 CL CL H2005 D 278 ASP H 28 ASP~? 15.80 CL CL H2005 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 47.46 68.84 95.61 49.74 68.96 94.05 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 43.36 66.64 99.44 38.17 66.18 95.68 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1do8_c03 MALIC ENZYME user 9 3 # 9 D 112 TYR I 21 TYR~? 10.49 CL CL I2001 D 183 LYS I 22 LYS~? 13.37 CL CL I2001 D 278 ASP I 28 ASP~? 15.71 CL CL I2001 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 169.47 212.28 156.01 171.53 210.49 155.65 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 166.16 216.63 158.59 160.45 213.84 159.02 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1do8_c03 MALIC ENZYME user 10 3 # 10 D 112 TYR J 21 TYR~? 10.46 CL CL J2002 D 183 LYS J 22 LYS~? 13.36 CL CL J2002 D 278 ASP J 28 ASP~? 15.67 CL CL J2002 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 174.52 176.28 124.74 172.25 177.04 126.20 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 178.14 172.91 121.18 183.42 172.10 124.71 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1do8_c03 MALIC ENZYME user 11 3 # 11 D 112 TYR K 21 TYR~? 13.85 O1 GOL K3011 D 183 LYS K 22 LYS~? 17.74 CL CL K2003 D 278 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 163.15 125.72 181.32 165.33 127.37 181.87 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 159.62 121.79 178.29 154.49 125.24 177.13 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1do8_c03 MALIC ENZYME user 12 3 # 12 D 112 TYR L 21 TYR~? 30.92 O3 GOL K3011 D 183 LYS L 22 LYS~? 25.13 O2 GOL P3034 D 278 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 168.26 161.38 213.44 166.20 160.80 211.67 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 171.60 164.44 217.42 177.37 164.59 214.60 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1do8_c03 MALIC ENZYME user 13 3 # 13 D 112 TYR M 21 TYR~? 10.54 CL CL I2001 D 183 LYS M 22 LYS~? 13.38 CL CL I2001 D 278 ASP M 28 ASP~? 15.52 CL CL I2001 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 173.68 213.02 176.47 171.32 211.57 177.01 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 177.61 216.43 173.42 182.96 212.88 173.24 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1do8_c03 MALIC ENZYME user 14 3 # 14 D 112 TYR N 21 TYR~? 10.52 CL CL J2002 D 183 LYS N 22 LYS~? 13.40 CL CL J2002 D 278 ASP N 28 ASP~? 15.68 CL CL J2002 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 168.15 156.47 125.36 170.14 155.81 127.21 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 165.10 159.41 121.05 159.46 160.48 123.77 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1do8_c03 MALIC ENZYME user 15 3 # 15 D 112 TYR O 21 TYR~? 14.79 CL CL K2003 D 183 LYS O 22 LYS~? 17.69 O3 GOL K3010 D 278 ASP O 28 ASP~? 23.95 CL CL O2036 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 169.50 124.29 161.32 167.44 126.02 160.55 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 172.63 120.27 164.76 178.18 123.25 165.65 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1do8_c03 MALIC ENZYME user 16 3 # 16 D 112 TYR P 21 TYR~? 24.07 O1 GOL L3028 D 183 LYS P 22 LYS~? 16.49 O1 GOL L3028 D 278 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 164.13 181.87 211.82 166.34 182.20 210.17 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 160.29 179.27 215.80 155.06 178.69 212.33 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 167.75 181.83 222.09 168.94 183.53 222.37 1do8_c03 source 1do8 MALIC ENZYME : 16 hits 1do8_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 32 ALA~? 30.70 O2 GOL E3035 A 136 TYR A 21 TYR~? 26.32 C3 GOL E3035 A 140 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 55.90 7.49 23.83 56.71 8.23 22.76 57.58 103.94 33.75 56.64 105.03 33.68 coo 59.38 10.02 17.51 59.95 9.89 20.21 56.96 96.11 38.73 58.94 94.19 38.55 coo 59.52 3.69 18.67 62.31 6.19 22.58 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 32 ALA~? 17.30 C1 GOL B3003 A 136 TYR B 21 TYR~? 13.85 C1 GOL B3003 A 140 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 55.90 7.49 23.83 56.71 8.23 22.76 62.97 61.73 1.02 64.08 61.35 0.06 coo 59.38 10.02 17.51 59.95 9.89 20.21 61.46 58.47 9.41 59.23 59.36 10.88 coo 59.52 3.69 18.67 62.31 6.19 22.58 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA C 32 ALA~? 17.73 CL CL C2004 A 136 TYR C 21 TYR~? 10.49 CL CL C2004 A 140 LYS C 22 LYS~? 13.40 CL CL C2004 coo 55.90 7.49 23.83 56.71 8.23 22.76 42.95 3.42 72.24 41.78 2.52 72.04 coo 59.38 10.02 17.51 59.95 9.89 20.21 45.13 11.15 67.52 47.31 12.70 68.21 coo 59.52 3.69 18.67 62.31 6.19 22.58 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 4 3 # 4 A 107 ALA D 32 ALA~? 17.55 O1 GOL D3005 A 136 TYR D 21 TYR~? 10.58 CL CL H2005 A 140 LYS D 22 LYS~? 13.25 CL CL H2005 coo 55.90 7.49 23.83 56.71 8.23 22.76 49.88 45.02 106.85 50.83 45.18 107.92 coo 59.38 10.02 17.51 59.95 9.89 20.21 50.45 48.27 98.24 48.40 47.71 96.43 coo 59.52 3.69 18.67 62.31 6.19 22.58 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 5 3 # 5 A 107 ALA E 32 ALA~? 17.67 O1 GOL E3004 A 136 TYR E 21 TYR~? 14.13 O1 GOL E3004 A 140 LYS E 22 LYS~? 21.81 O1 GOL E3004 coo 55.90 7.49 23.83 56.71 8.23 22.76 61.40 106.11 62.60 62.61 106.96 62.51 coo 59.38 10.02 17.51 59.95 9.89 20.21 60.20 97.64 59.27 57.81 96.28 59.79 coo 59.52 3.69 18.67 62.31 6.19 22.58 64.37 100.86 56.32 69.54 97.12 56.69 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 6 3 # 6 A 107 ALA F 32 ALA~? 30.31 O1 GOL B3017 A 136 TYR F 21 TYR~? 26.08 O1 GOL B3017 A 140 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 55.90 7.49 23.83 56.71 8.23 22.76 53.72 34.03 2.68 52.74 34.16 1.55 coo 59.38 10.02 17.51 59.95 9.89 20.21 54.13 38.92 10.51 56.02 38.27 12.47 coo 59.52 3.69 18.67 62.31 6.19 22.58 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 7 3 # 7 A 107 ALA G 32 ALA~? 17.75 CL CL C2004 A 136 TYR G 21 TYR~? 10.57 CL CL C2004 A 140 LYS G 22 LYS~? 13.25 CL CL C2004 coo 55.90 7.49 23.83 56.71 8.23 22.76 52.53 -0.04 44.80 53.52 -1.08 45.14 coo 59.38 10.02 17.51 59.95 9.89 20.21 52.17 8.74 48.00 50.23 10.55 47.07 coo 59.52 3.69 18.67 62.31 6.19 22.58 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 8 3 # 8 A 107 ALA H 32 ALA~? 17.62 C3 GOL H3006 A 136 TYR H 21 TYR~? 10.50 CL CL H2005 A 140 LYS H 22 LYS~? 13.32 CL CL H2005 coo 55.90 7.49 23.83 56.71 8.23 22.76 46.31 73.93 103.35 45.12 74.04 104.17 coo 59.38 10.02 17.51 59.95 9.89 20.21 47.46 68.84 95.61 49.74 68.96 94.05 coo 59.52 3.69 18.67 62.31 6.19 22.58 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 9 3 # 9 A 107 ALA I 32 ALA~? 17.74 CL CL I2001 A 136 TYR I 21 TYR~? 10.49 CL CL I2001 A 140 LYS I 22 LYS~? 13.37 CL CL I2001 coo 55.90 7.49 23.83 56.71 8.23 22.76 169.46 220.32 151.45 168.41 221.36 151.42 coo 59.38 10.02 17.51 59.95 9.89 20.21 169.47 212.28 156.01 171.53 210.49 155.65 coo 59.52 3.69 18.67 62.31 6.19 22.58 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 10 3 # 10 A 107 ALA J 32 ALA~? 17.36 CL CL J2002 A 136 TYR J 21 TYR~? 10.46 CL CL J2002 A 140 LYS J 22 LYS~? 13.36 CL CL J2002 coo 55.90 7.49 23.83 56.71 8.23 22.76 175.83 179.83 116.42 176.99 179.45 115.55 coo 59.38 10.02 17.51 59.95 9.89 20.21 174.52 176.28 124.74 172.25 177.04 126.20 coo 59.52 3.69 18.67 62.31 6.19 22.58 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 11 3 # 11 A 107 ALA K 32 ALA~? 17.75 O1 GOL K3011 A 136 TYR K 21 TYR~? 13.85 O1 GOL K3011 A 140 LYS K 22 LYS~? 17.74 CL CL K2003 coo 55.90 7.49 23.83 56.71 8.23 22.76 161.45 117.68 185.72 160.27 116.73 185.65 coo 59.38 10.02 17.51 59.95 9.89 20.21 163.15 125.72 181.32 165.33 127.37 181.87 coo 59.52 3.69 18.67 62.31 6.19 22.58 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 12 3 # 12 A 107 ALA L 32 ALA~? 35.22 O3 GOL K3011 A 136 TYR L 21 TYR~? 30.92 O3 GOL K3011 A 140 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 55.90 7.49 23.83 56.71 8.23 22.76 168.55 157.71 222.06 169.65 157.86 223.06 coo 59.38 10.02 17.51 59.95 9.89 20.21 168.26 161.38 213.44 166.20 160.80 211.67 coo 59.52 3.69 18.67 62.31 6.19 22.58 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 13 3 # 13 A 107 ALA M 32 ALA~? 17.60 CL CL I2001 A 136 TYR M 21 TYR~? 10.54 CL CL I2001 A 140 LYS M 22 LYS~? 13.38 CL CL I2001 coo 55.90 7.49 23.83 56.71 8.23 22.76 174.72 221.62 179.85 175.89 222.50 179.79 coo 59.38 10.02 17.51 59.95 9.89 20.21 173.68 213.02 176.47 171.32 211.57 177.01 coo 59.52 3.69 18.67 62.31 6.19 22.58 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 14 3 # 14 A 107 ALA N 32 ALA~? 17.62 O3 GOL N3008 A 136 TYR N 21 TYR~? 10.52 CL CL J2002 A 140 LYS N 22 LYS~? 13.40 CL CL J2002 coo 55.90 7.49 23.83 56.71 8.23 22.76 167.51 151.87 117.28 166.48 151.92 116.17 coo 59.38 10.02 17.51 59.95 9.89 20.21 168.15 156.47 125.36 170.14 155.81 127.21 coo 59.52 3.69 18.67 62.31 6.19 22.58 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 15 3 # 15 A 107 ALA O 32 ALA~? 25.34 CL CL K2003 A 136 TYR O 21 TYR~? 14.79 CL CL K2003 A 140 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 55.90 7.49 23.83 56.71 8.23 22.76 170.01 115.77 157.68 171.02 114.70 157.81 coo 59.38 10.02 17.51 59.95 9.89 20.21 169.50 124.29 161.32 167.44 126.02 160.55 coo 59.52 3.69 18.67 62.31 6.19 22.58 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 16 3 # 16 A 107 ALA P 32 ALA~? 28.28 O1 GOL L3028 A 136 TYR P 21 TYR~? 24.07 O1 GOL L3028 A 140 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 55.90 7.49 23.83 56.71 8.23 22.76 162.95 186.57 219.86 161.75 186.59 220.72 coo 59.38 10.02 17.51 59.95 9.89 20.21 164.13 181.87 211.82 166.34 182.20 210.17 coo 59.52 3.69 18.67 62.31 6.19 22.58 160.29 179.27 215.80 155.06 178.69 212.33 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 16 hits 1e7q_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 177 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 203 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 8.74 45.76 47.19 9.33 46.93 45.56 18.48 59.01 25.15 19.77 58.54 23.56 coo 11.68 42.31 52.96 12.05 43.92 51.65 23.66 59.02 20.34 21.93 58.32 21.38 coo 18.07 52.81 49.62 14.17 49.99 48.07 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 177 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 203 LYS D 142 LYS~? 18.65 CL CL D2012 coo 8.74 45.76 47.19 9.33 46.93 45.56 13.06 55.69 73.24 14.03 55.94 75.08 coo 11.68 42.31 52.96 12.05 43.92 51.65 16.94 54.59 79.01 15.65 55.42 77.54 coo 18.07 52.81 49.62 14.17 49.99 48.07 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 177 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 203 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 8.74 45.76 47.19 9.33 46.93 45.56 17.87 81.44 51.19 19.31 82.95 50.96 coo 11.68 42.31 52.96 12.05 43.92 51.65 23.07 86.29 52.35 21.57 85.17 51.32 coo 18.07 52.81 49.62 14.17 49.99 48.07 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 177 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 203 LYS F 142 LYS~? 19.20 CL CL F2034 coo 8.74 45.76 47.19 9.33 46.93 45.56 93.09 42.58 34.58 92.14 42.76 32.71 coo 11.68 42.31 52.96 12.05 43.92 51.65 88.86 41.25 28.96 90.30 42.22 30.24 coo 18.07 52.81 49.62 14.17 49.99 48.07 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 177 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 203 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 8.74 45.76 47.19 9.33 46.93 45.56 89.33 56.65 80.95 87.93 56.76 82.51 coo 11.68 42.31 52.96 12.05 43.92 51.65 84.24 58.93 85.48 85.73 57.59 84.66 coo 18.07 52.81 49.62 14.17 49.99 48.07 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 177 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 203 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 8.74 45.76 47.19 9.33 46.93 45.56 208.71 190.07 165.44 207.65 191.87 165.52 coo 11.68 42.31 52.96 12.05 43.92 51.65 204.37 195.46 163.61 205.75 194.30 164.79 coo 18.07 52.81 49.62 14.17 49.99 48.07 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 177 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 203 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 8.74 45.76 47.19 9.33 46.93 45.56 205.25 143.04 176.89 203.95 141.38 176.70 coo 11.68 42.31 52.96 12.05 43.92 51.65 200.17 138.24 178.11 201.77 139.28 177.19 coo 18.07 52.81 49.62 14.17 49.99 48.07 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 8 3 # 8 A 99 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 177 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 203 LYS L 142 LYS~? 23.18 CL CL L2009 coo 8.74 45.76 47.19 9.33 46.93 45.56 129.06 168.07 190.57 130.17 168.32 192.34 coo 11.68 42.31 52.96 12.05 43.92 51.65 133.34 166.97 196.27 132.03 168.03 194.96 coo 18.07 52.81 49.62 14.17 49.99 48.07 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 9 3 # 9 A 99 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 177 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 203 LYS M 142 LYS~? 19.90 CL CL M2017 coo 8.74 45.76 47.19 9.33 46.93 45.56 131.91 195.13 169.59 133.22 196.76 169.40 coo 11.68 42.31 52.96 12.05 43.92 51.65 136.87 200.18 170.79 135.36 199.08 169.77 coo 18.07 52.81 49.62 14.17 49.99 48.07 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 10 3 # 10 A 99 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 177 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 203 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 8.74 45.76 47.19 9.33 46.93 45.56 129.65 146.92 163.60 130.73 145.15 163.91 coo 11.68 42.31 52.96 12.05 43.92 51.65 134.07 141.35 162.95 132.57 142.58 163.78 coo 18.07 52.81 49.62 14.17 49.99 48.07 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 11 3 # 11 A 99 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 177 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 203 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 8.74 45.76 47.19 9.33 46.93 45.56 205.70 172.52 194.71 204.41 172.45 196.35 coo 11.68 42.31 52.96 12.05 43.92 51.65 200.75 174.15 199.66 202.28 173.10 198.62 coo 18.07 52.81 49.62 14.17 49.99 48.07 204.59 186.28 195.60 209.96 186.96 196.62 1ecx_c02 source 1ecx AMINOTRANSFERASE : 11 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS B 151 HIS~? -4.11 O3 GOL B3015s B 177 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 203 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 14.87 88.04 21.51 13.64 87.90 19.81 18.48 59.01 25.15 19.77 58.54 23.56 coo 15.87 92.46 27.37 14.46 91.76 25.94 23.66 59.02 20.34 21.93 58.32 21.38 coo 3.60 91.42 23.52 8.20 89.55 22.63 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS D 151 HIS~? -13.00 O2 GOL D3020s B 177 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 203 LYS D 142 LYS~? 18.65 CL CL D2012 coo 14.87 88.04 21.51 13.64 87.90 19.81 13.06 55.69 73.24 14.03 55.94 75.08 coo 15.87 92.46 27.37 14.46 91.76 25.94 16.94 54.59 79.01 15.65 55.42 77.54 coo 3.60 91.42 23.52 8.20 89.55 22.63 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS E 151 HIS~? -4.12 O1 GOL E3002s B 177 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 203 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 14.87 88.04 21.51 13.64 87.90 19.81 17.87 81.44 51.19 19.31 82.95 50.96 coo 15.87 92.46 27.37 14.46 91.76 25.94 23.07 86.29 52.35 21.57 85.17 51.32 coo 3.60 91.42 23.52 8.20 89.55 22.63 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS F 151 HIS~? 14.76 O3 GOL F3039s B 177 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 203 LYS F 142 LYS~? 19.20 CL CL F2034 coo 14.87 88.04 21.51 13.64 87.90 19.81 93.09 42.58 34.58 92.14 42.76 32.71 coo 15.87 92.46 27.37 14.46 91.76 25.94 88.86 41.25 28.96 90.30 42.22 30.24 coo 3.60 91.42 23.52 8.20 89.55 22.63 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS H 151 HIS~? 4.32 C1 GOL H3016s B 177 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 203 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 14.87 88.04 21.51 13.64 87.90 19.81 89.33 56.65 80.95 87.93 56.76 82.51 coo 15.87 92.46 27.37 14.46 91.76 25.94 84.24 58.93 85.48 85.73 57.59 84.66 coo 3.60 91.42 23.52 8.20 89.55 22.63 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS I 151 HIS~? 3.98 O3 GOL I3032s B 177 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 203 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 14.87 88.04 21.51 13.64 87.90 19.81 208.71 190.07 165.44 207.65 191.87 165.52 coo 15.87 92.46 27.37 14.46 91.76 25.94 204.37 195.46 163.61 205.75 194.30 164.79 coo 3.60 91.42 23.52 8.20 89.55 22.63 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS K 151 HIS~? -4.18 C2 GOL K3009s B 177 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 203 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 14.87 88.04 21.51 13.64 87.90 19.81 205.25 143.04 176.89 203.95 141.38 176.70 coo 15.87 92.46 27.37 14.46 91.76 25.94 200.17 138.24 178.11 201.77 139.28 177.19 coo 3.60 91.42 23.52 8.20 89.55 22.63 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS L 151 HIS~? -15.32 O3 GOL L3028s B 177 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 203 LYS L 142 LYS~? 23.18 CL CL L2009 coo 14.87 88.04 21.51 13.64 87.90 19.81 129.06 168.07 190.57 130.17 168.32 192.34 coo 15.87 92.46 27.37 14.46 91.76 25.94 133.34 166.97 196.27 132.03 168.03 194.96 coo 3.60 91.42 23.52 8.20 89.55 22.63 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS M 151 HIS~? -11.81 O3 GOL M3042s B 177 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 203 LYS M 142 LYS~? 19.90 CL CL M2017 coo 14.87 88.04 21.51 13.64 87.90 19.81 131.91 195.13 169.59 133.22 196.76 169.40 coo 15.87 92.46 27.37 14.46 91.76 25.94 136.87 200.18 170.79 135.36 199.08 169.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS O 151 HIS~? 4.32 O2 GOL O3026s B 177 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 203 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 14.87 88.04 21.51 13.64 87.90 19.81 129.65 146.92 163.60 130.73 145.15 163.91 coo 15.87 92.46 27.37 14.46 91.76 25.94 134.07 141.35 162.95 132.57 142.58 163.78 coo 3.60 91.42 23.52 8.20 89.55 22.63 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 11 3 # 11 B 99 HIS P 151 HIS~? -4.15 C3 GOL P3014s B 177 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 203 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 14.87 88.04 21.51 13.64 87.90 19.81 205.70 172.52 194.71 204.41 172.45 196.35 coo 15.87 92.46 27.37 14.46 91.76 25.94 200.75 174.15 199.66 202.28 173.10 198.62 coo 3.60 91.42 23.52 8.20 89.55 22.63 204.59 186.28 195.60 209.96 186.96 196.62 1ecx_c03 source 1ecx AMINOTRANSFERASE : 11 hits 1ecx_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 151 HIS~? -11.70 O3 GOL A3037s A 197 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 223 LYS A 142 LYS~? 20.36 CL CL A2020 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 94.27 72.58 51.14 93.29 74.44 51.00 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 90.44 78.16 48.76 91.65 76.94 50.06 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 197 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 223 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 18.48 59.01 25.15 19.77 58.54 23.56 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 23.66 59.02 20.34 21.93 58.32 21.38 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS C 151 HIS~? -4.28 C2 GOL C3036s A 197 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 223 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 88.24 26.50 64.44 86.75 25.04 64.52 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 82.81 22.02 65.69 84.52 22.80 64.66 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 197 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 223 LYS D 142 LYS~? 18.65 CL CL D2012 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 13.06 55.69 73.24 14.03 55.94 75.08 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 16.94 54.59 79.01 15.65 55.42 77.54 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 197 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 223 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 17.87 81.44 51.19 19.31 82.95 50.96 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 23.07 86.29 52.35 21.57 85.17 51.32 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 197 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 223 LYS F 142 LYS~? 19.20 CL CL F2034 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 93.09 42.58 34.58 92.14 42.76 32.71 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 88.86 41.25 28.96 90.30 42.22 30.24 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 197 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 223 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 13.55 33.19 47.26 14.46 31.35 47.64 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 17.70 27.34 47.09 16.19 28.71 47.73 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 197 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 223 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 89.33 56.65 80.95 87.93 56.76 82.51 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 84.24 58.93 85.48 85.73 57.59 84.66 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 197 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 223 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 208.71 190.07 165.44 207.65 191.87 165.52 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 204.37 195.46 163.61 205.75 194.30 164.79 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 197 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 223 LYS J 142 LYS~? 19.62 CL CL J2016 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 132.36 173.99 142.63 133.63 173.58 141.01 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 137.44 174.60 137.57 135.80 173.80 138.69 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 197 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 223 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 205.25 143.04 176.89 203.95 141.38 176.70 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 200.17 138.24 178.11 201.77 139.28 177.19 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 197 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 223 LYS L 142 LYS~? 23.18 CL CL L2009 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 129.06 168.07 190.57 130.17 168.32 192.34 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 133.34 166.97 196.27 132.03 168.03 194.96 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 197 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 223 LYS M 142 LYS~? 19.90 CL CL M2017 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 131.91 195.13 169.59 133.22 196.76 169.40 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 136.87 200.18 170.79 135.36 199.08 169.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 A 114 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 197 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 223 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 207.96 160.84 147.59 206.93 161.03 145.77 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 203.51 159.51 142.26 205.02 160.53 143.48 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 A 114 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 197 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 223 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 129.65 146.92 163.60 130.73 145.15 163.91 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 134.07 141.35 162.95 132.57 142.58 163.78 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 A 114 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 197 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 223 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 205.70 172.52 194.71 204.41 172.45 196.35 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 200.75 174.15 199.66 202.28 173.10 198.62 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 204.59 186.28 195.60 209.96 186.96 196.62 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 16 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 151 HIS~? -11.70 O3 GOL A3037s B 197 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 223 LYS A 142 LYS~? 20.36 CL CL A2020 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 94.27 72.58 51.14 93.29 74.44 51.00 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 90.44 78.16 48.76 91.65 76.94 50.06 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 151 HIS~? -4.11 O3 GOL B3015s B 197 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 223 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 18.48 59.01 25.15 19.77 58.54 23.56 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 23.66 59.02 20.34 21.93 58.32 21.38 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS C 151 HIS~? -4.28 C2 GOL C3036s B 197 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 223 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 88.24 26.50 64.44 86.75 25.04 64.52 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 82.81 22.02 65.69 84.52 22.80 64.66 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS D 151 HIS~? -13.00 O2 GOL D3020s B 197 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 223 LYS D 142 LYS~? 18.65 CL CL D2012 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 13.06 55.69 73.24 14.03 55.94 75.08 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 16.94 54.59 79.01 15.65 55.42 77.54 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS E 151 HIS~? -4.12 O1 GOL E3002s B 197 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 223 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 17.87 81.44 51.19 19.31 82.95 50.96 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 23.07 86.29 52.35 21.57 85.17 51.32 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS F 151 HIS~? 14.76 O3 GOL F3039s B 197 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 223 LYS F 142 LYS~? 19.20 CL CL F2034 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 93.09 42.58 34.58 92.14 42.76 32.71 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 88.86 41.25 28.96 90.30 42.22 30.24 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS G 151 HIS~? -4.14 C3 GOL G3001s B 197 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 223 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 13.55 33.19 47.26 14.46 31.35 47.64 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 17.70 27.34 47.09 16.19 28.71 47.73 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS H 151 HIS~? 4.32 C1 GOL H3016s B 197 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 223 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 89.33 56.65 80.95 87.93 56.76 82.51 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 84.24 58.93 85.48 85.73 57.59 84.66 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS I 151 HIS~? 3.98 O3 GOL I3032s B 197 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 223 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 208.71 190.07 165.44 207.65 191.87 165.52 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 204.37 195.46 163.61 205.75 194.30 164.79 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS J 151 HIS~? -12.73 O1 GOL J3033s B 197 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 223 LYS J 142 LYS~? 19.62 CL CL J2016 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 132.36 173.99 142.63 133.63 173.58 141.01 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 137.44 174.60 137.57 135.80 173.80 138.69 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS K 151 HIS~? -4.18 C2 GOL K3009s B 197 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 223 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 205.25 143.04 176.89 203.95 141.38 176.70 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 200.17 138.24 178.11 201.77 139.28 177.19 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS L 151 HIS~? -15.32 O3 GOL L3028s B 197 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 223 LYS L 142 LYS~? 23.18 CL CL L2009 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 129.06 168.07 190.57 130.17 168.32 192.34 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 133.34 166.97 196.27 132.03 168.03 194.96 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS M 151 HIS~? -11.81 O3 GOL M3042s B 197 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 223 LYS M 142 LYS~? 19.90 CL CL M2017 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 131.91 195.13 169.59 133.22 196.76 169.40 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 136.87 200.18 170.79 135.36 199.08 169.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS N 151 HIS~? 3.39 O2 GOL N3012s B 197 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 223 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 207.96 160.84 147.59 206.93 161.03 145.77 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 203.51 159.51 142.26 205.02 160.53 143.48 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 B 114 HIS O 151 HIS~? 4.32 O2 GOL O3026s B 197 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 223 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 129.65 146.92 163.60 130.73 145.15 163.91 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 134.07 141.35 162.95 132.57 142.58 163.78 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 B 114 HIS P 151 HIS~? -4.15 C3 GOL P3014s B 197 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 223 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 205.70 172.52 194.71 204.41 172.45 196.35 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 200.75 174.15 199.66 202.28 173.10 198.62 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 204.59 186.28 195.60 209.96 186.96 196.62 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 16 hits 1elq_c03 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 102 ASP.? 25.18 C1 GOL A3040 260 GLU A 141 GLU~? 27.05 O1 GOL A3040 370 TYR A 143 TYR~? 16.38 O1 GOL A3040 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 88.23 80.63 30.72 87.92 80.82 28.67 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 89.05 70.31 35.51 89.11 68.84 33.95 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 92.99 77.44 39.76 93.75 79.76 38.42 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 102 ASP.? 20.31 O1 GOL B3024 260 GLU B 141 GLU~? 14.29 O1 GOL B3024 370 TYR B 143 TYR~? 10.77 O2 GOL B3024 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 30.49 75.29 14.98 31.30 77.16 14.42 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 26.68 73.50 25.50 26.49 75.15 26.91 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 23.25 68.41 18.58 23.33 69.19 15.92 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 102 ASP.? 24.57 CL CL C2011 260 GLU C 141 GLU~? 19.53 O2 GOL H3025 370 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 76.25 20.52 82.74 75.40 20.56 84.65 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 80.37 30.30 78.61 80.09 31.65 80.29 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP D 102 ASP.? 24.32 CL CL D2012 260 GLU D 141 GLU~? 22.23 O1 GOL G3001 370 TYR D 143 TYR~? 15.16 CL CL D2012 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 18.96 37.41 85.00 19.42 35.40 85.42 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 17.13 41.08 72.88 18.91 42.32 72.55 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP E 102 ASP.? 24.45 CL CL E2013 260 GLU E 141 GLU~? 19.75 O1 GOL D3019 370 TYR E 143 TYR~? 15.23 CL CL E2013 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 26.42 91.49 69.61 27.08 91.68 71.63 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 21.80 82.16 67.66 21.51 80.62 69.17 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 20.79 87.99 61.33 20.74 90.64 62.13 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP F 102 ASP.? 16.73 CL CL F2035 260 GLU F 141 GLU~? 15.85 CL CL F2035 370 TYR F 143 TYR~? 15.09 CL CL F2034 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 82.74 24.28 26.35 81.91 22.30 26.35 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 84.56 28.39 36.54 84.29 26.85 38.03 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 89.42 31.84 29.55 89.79 30.44 27.17 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP G 102 ASP.? 25.30 O3 GOL G3038 260 GLU G 141 GLU~? 19.33 O1 GOL B3017 370 TYR G 143 TYR~? 15.53 C3 GOL G3001 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 23.47 21.05 30.82 24.30 20.62 28.93 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 21.81 32.02 32.76 22.04 33.29 31.00 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 16.97 25.90 37.77 16.51 23.33 36.84 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP H 102 ASP.? 20.45 O2 GOL H3016 260 GLU H 141 GLU~? 14.58 O1 GOL H3016 370 TYR H 143 TYR~? 11.30 O2 GOL H3016 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 81.36 76.99 86.94 80.90 79.01 86.89 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 84.42 72.24 77.39 84.86 73.57 75.76 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 86.77 67.99 85.16 86.88 69.36 87.57 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP I 102 ASP.? 20.44 O1 GOL I3032 260 GLU I 141 GLU~? 15.06 O1 GOL I3032 370 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 201.10 198.54 145.88 200.66 198.62 143.82 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 203.00 188.32 149.96 202.87 186.91 148.25 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP J 102 ASP.? 24.08 CL CL J2016 260 GLU J 141 GLU~? 24.92 O2 GOL M3042 370 TYR J 143 TYR~? 15.18 CL CL J2016 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 143.25 191.36 132.98 143.80 193.32 132.63 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 139.93 188.85 143.36 139.82 190.60 144.63 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 136.50 183.91 136.49 136.50 184.93 133.88 ULMN 3 1euu_c00 SIALIDASE user 11 3 # 11 92 ASP K 102 ASP.? 24.81 O1 GOL K3041 260 GLU K 141 GLU~? 22.10 C1 GOL P3014 370 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 194.36 135.90 195.25 193.66 135.95 197.23 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 197.75 145.77 191.54 197.42 146.88 193.40 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1euu_c00 SIALIDASE user 12 3 # 12 92 ASP L 102 ASP.? 24.59 CL CL L2009 260 GLU L 141 GLU~? 22.39 C3 GOL O3013 370 TYR L 143 TYR~? 15.30 CL CL L2009 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 136.52 149.82 201.33 136.95 147.73 201.53 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 132.89 153.36 189.75 130.85 152.81 189.78 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1euu_c00 SIALIDASE user 13 3 # 13 92 ASP M 102 ASP.? 24.52 CL CL M2017 260 GLU M 141 GLU~? 19.50 O2 GOL L3028 370 TYR M 143 TYR~? 15.40 CL CL M2017 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 140.74 204.70 188.01 141.33 204.99 189.98 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 137.93 194.30 185.04 137.74 193.05 186.86 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 134.88 201.35 179.85 134.66 203.97 180.76 ULMN 3 1euu_c00 SIALIDASE user 14 3 # 14 92 ASP N 102 ASP.? 20.60 O2 GOL N3029 260 GLU N 141 GLU~? 10.16 C1 GOL N3029 370 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 197.96 142.41 139.19 197.06 140.46 139.09 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 199.85 147.19 149.72 199.65 149.31 150.43 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1euu_c00 SIALIDASE user 15 3 # 15 92 ASP O 102 ASP.? 13.16 CL CL O2036 260 GLU O 141 GLU~? 15.58 O3 GOL O3026 370 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 139.48 136.33 146.19 140.25 135.96 144.25 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 137.18 147.02 148.83 137.46 148.02 146.94 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1euu_c00 SIALIDASE user 16 3 # 16 92 ASP P 102 ASP.? 24.26 CL CL P2019 260 GLU P 141 GLU~? 21.95 O3 GOL P3014 370 TYR P 143 TYR~? 15.20 CL CL P2019 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 197.01 191.93 202.05 196.73 194.01 202.05 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 200.04 187.90 192.14 200.20 189.50 190.73 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 202.86 183.43 199.65 203.11 184.67 202.14 1euu_c00 source 1euu SIALIDASE : 16 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU C 43 GLU~? 15.46 CL CL C2004 A 260 ARG C 34 ARG~? 20.14 CL CL C2004 A 270 LYS C 22 LYS~? 13.40 CL CL C2004 coo 50.99 29.43 12.86 52.11 29.45 14.65 38.06 16.03 67.09 37.03 14.19 67.14 coo 39.80 27.50 22.98 42.20 26.56 21.34 49.42 6.75 74.39 49.90 6.28 77.46 coo 48.83 21.70 19.50 47.44 24.99 15.25 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU D 43 GLU~? 15.38 CL CL H2005 A 260 ARG D 34 ARG~? 12.13 O1 GOL D3005 A 270 LYS D 22 LYS~? 13.25 CL CL H2005 coo 50.99 29.43 12.86 52.11 29.45 14.65 58.07 46.43 95.03 58.79 46.64 97.07 coo 39.80 27.50 22.98 42.20 26.56 21.34 43.70 43.25 103.08 42.03 40.72 103.99 coo 48.83 21.70 19.50 47.44 24.99 15.25 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU H 43 GLU~? 15.40 CL CL H2005 A 260 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 270 LYS H 22 LYS~? 13.32 CL CL H2005 coo 50.99 29.43 12.86 52.11 29.45 14.65 40.68 69.93 90.74 39.73 70.17 92.61 coo 39.80 27.50 22.98 42.20 26.56 21.34 53.27 74.94 100.30 54.87 77.69 100.34 coo 48.83 21.70 19.50 47.44 24.99 15.25 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU K 43 GLU~? 16.84 C1 GOL K3011 A 260 ARG K 34 ARG~? 11.32 O1 GOL K3011 A 270 LYS K 22 LYS~? 17.74 CL CL K2003 coo 50.99 29.43 12.86 52.11 29.45 14.65 155.84 130.25 181.35 154.86 128.33 181.37 coo 39.80 27.50 22.98 42.20 26.56 21.34 167.98 121.31 187.60 169.63 121.60 190.28 coo 48.83 21.70 19.50 47.44 24.99 15.25 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU L 43 GLU~? 27.03 C1 GOL P3034 A 260 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 270 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 50.99 29.43 12.86 52.11 29.45 14.65 175.92 159.97 209.77 176.60 160.07 211.76 coo 39.80 27.50 22.98 42.20 26.56 21.34 162.35 156.38 218.07 160.56 153.83 217.87 coo 48.83 21.70 19.50 47.44 24.99 15.25 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU N 43 GLU~? 15.48 CL CL J2002 A 260 ARG N 34 ARG~? 11.02 O3 GOL N3008 A 270 LYS N 22 LYS~? 13.40 CL CL J2002 coo 50.99 29.43 12.86 52.11 29.45 14.65 160.49 156.26 129.04 159.76 156.26 127.05 coo 39.80 27.50 22.98 42.20 26.56 21.34 173.47 149.90 121.53 175.07 147.29 121.87 coo 48.83 21.70 19.50 47.44 24.99 15.25 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU P 43 GLU~? 15.67 O1 GOL L3028 A 260 ARG P 34 ARG~? 27.86 O3 GOL M3007 A 270 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 50.99 29.43 12.86 52.11 29.45 14.65 157.04 182.77 207.26 156.16 182.81 209.15 coo 39.80 27.50 22.98 42.20 26.56 21.34 169.45 187.34 216.38 171.34 189.81 216.30 coo 48.83 21.70 19.50 47.44 24.99 15.25 160.29 179.27 215.80 155.06 178.69 212.33 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 7 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 151 HIS~? -11.70 O3 GOL A3037s C 62 LYS A 142 LYS~? 20.36 CL CL A2020 F 35 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 15.40 22.79 16.66 13.93 24.10 15.98 94.27 72.58 51.14 93.29 74.44 51.00 coo 19.95 18.98 4.81 18.82 20.94 10.49 94.05 73.09 37.15 99.40 72.43 37.04 coo 16.32 15.30 17.19 17.71 14.73 18.69 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 151 HIS~? -4.11 O3 GOL B3015s C 62 LYS B 142 LYS~? 15.72 O2 GOL B3024 F 35 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 15.40 22.79 16.66 13.93 24.10 15.98 18.48 59.01 25.15 19.77 58.54 23.56 coo 19.95 18.98 4.81 18.82 20.94 10.49 21.85 72.06 22.17 16.34 73.26 20.39 coo 16.32 15.30 17.19 17.71 14.73 18.69 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS C 151 HIS~? -4.28 C2 GOL C3036s C 62 LYS C 142 LYS~? 17.22 O1 GOL C3036 F 35 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 15.40 22.79 16.66 13.93 24.10 15.98 88.24 26.50 64.44 86.75 25.04 64.52 coo 19.95 18.98 4.81 18.82 20.94 10.49 84.87 26.44 78.04 89.10 24.68 78.66 coo 16.32 15.30 17.19 17.71 14.73 18.69 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS D 151 HIS~? -13.00 O2 GOL D3020s C 62 LYS D 142 LYS~? 18.65 CL CL D2012 F 35 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 15.40 22.79 16.66 13.93 24.10 15.98 13.06 55.69 73.24 14.03 55.94 75.08 coo 19.95 18.98 4.81 18.82 20.94 10.49 13.01 42.17 76.46 7.83 42.85 76.18 coo 16.32 15.30 17.19 17.71 14.73 18.69 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS E 151 HIS~? -4.12 O1 GOL E3002s C 62 LYS E 142 LYS~? 18.17 O1 GOL E3002 F 35 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 15.40 22.79 16.66 13.93 24.10 15.98 17.87 81.44 51.19 19.31 82.95 50.96 coo 19.95 18.98 4.81 18.82 20.94 10.49 18.76 84.43 64.64 13.52 85.68 64.66 coo 16.32 15.30 17.19 17.71 14.73 18.69 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS F 151 HIS~? 14.76 O3 GOL F3039s C 62 LYS F 142 LYS~? 19.20 CL CL F2034 F 35 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 15.40 22.79 16.66 13.93 24.10 15.98 93.09 42.58 34.58 92.14 42.76 32.71 coo 19.95 18.98 4.81 18.82 20.94 10.49 89.94 29.13 34.00 95.25 27.31 34.06 coo 16.32 15.30 17.19 17.71 14.73 18.69 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS G 151 HIS~? -4.14 C3 GOL G3001s C 62 LYS G 142 LYS~? 22.79 C3 GOL G3001 F 35 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 15.40 22.79 16.66 13.93 24.10 15.98 13.55 33.19 47.26 14.46 31.35 47.64 coo 19.95 18.98 4.81 18.82 20.94 10.49 16.44 29.60 34.10 15.26 26.17 28.78 coo 16.32 15.30 17.19 17.71 14.73 18.69 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS H 151 HIS~? 4.32 C1 GOL H3016s C 62 LYS H 142 LYS~? 14.79 O1 GOL H3016 F 35 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 15.40 22.79 16.66 13.93 24.10 15.98 89.33 56.65 80.95 87.93 56.76 82.51 coo 19.95 18.98 4.81 18.82 20.94 10.49 88.83 70.49 80.96 94.32 71.20 82.05 coo 16.32 15.30 17.19 17.71 14.73 18.69 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS I 151 HIS~? 3.98 O3 GOL I3032s C 62 LYS I 142 LYS~? 14.36 O1 GOL I3032 F 35 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 15.40 22.79 16.66 13.93 24.10 15.98 208.71 190.07 165.44 207.65 191.87 165.52 coo 19.95 18.98 4.81 18.82 20.94 10.49 208.03 191.18 151.66 205.16 191.96 148.66 coo 16.32 15.30 17.19 17.71 14.73 18.69 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS J 151 HIS~? -12.73 O1 GOL J3033s C 62 LYS J 142 LYS~? 19.62 CL CL J2016 F 35 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 15.40 22.79 16.66 13.93 24.10 15.98 132.36 173.99 142.63 133.63 173.58 141.01 coo 19.95 18.98 4.81 18.82 20.94 10.49 135.12 187.43 140.16 132.76 191.26 136.26 coo 16.32 15.30 17.19 17.71 14.73 18.69 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS K 151 HIS~? -4.18 C2 GOL K3009s C 62 LYS K 142 LYS~? 19.15 C2 GOL K3009 F 35 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 15.40 22.79 16.66 13.93 24.10 15.98 205.25 143.04 176.89 203.95 141.38 176.70 coo 19.95 18.98 4.81 18.82 20.94 10.49 202.52 142.42 190.46 207.82 141.83 191.71 coo 16.32 15.30 17.19 17.71 14.73 18.69 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS L 151 HIS~? -15.32 O3 GOL L3028s C 62 LYS L 142 LYS~? 23.18 CL CL L2009 F 35 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 15.40 22.79 16.66 13.93 24.10 15.98 129.06 168.07 190.57 130.17 168.32 192.34 coo 19.95 18.98 4.81 18.82 20.94 10.49 129.76 154.52 193.42 128.34 149.37 194.11 coo 16.32 15.30 17.19 17.71 14.73 18.69 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS M 151 HIS~? -11.81 O3 GOL M3042s C 62 LYS M 142 LYS~? 19.90 CL CL M2017 F 35 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 15.40 22.79 16.66 13.93 24.10 15.98 131.91 195.13 169.59 133.22 196.76 169.40 coo 19.95 18.98 4.81 18.82 20.94 10.49 133.20 197.60 183.11 127.92 198.39 183.89 coo 16.32 15.30 17.19 17.71 14.73 18.69 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 14 3 # 14 A 105 HIS N 151 HIS~? 3.39 O2 GOL N3012s C 62 LYS N 142 LYS~? 14.74 O1 GOL N3029 F 35 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 15.40 22.79 16.66 13.93 24.10 15.98 207.96 160.84 147.59 206.93 161.03 145.77 coo 19.95 18.98 4.81 18.82 20.94 10.49 205.28 147.20 146.57 210.60 146.27 146.55 coo 16.32 15.30 17.19 17.71 14.73 18.69 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 15 3 # 15 A 105 HIS O 151 HIS~? 4.32 O2 GOL O3026s C 62 LYS O 142 LYS~? 15.43 O3 GOL O3026 F 35 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 15.40 22.79 16.66 13.93 24.10 15.98 129.65 146.92 163.60 130.73 145.15 163.91 coo 19.95 18.98 4.81 18.82 20.94 10.49 132.09 144.26 150.20 126.63 143.20 149.32 coo 16.32 15.30 17.19 17.71 14.73 18.69 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 16 3 # 16 A 105 HIS P 151 HIS~? -4.15 C3 GOL P3014s C 62 LYS P 142 LYS~? 18.94 O2 GOL P3014 F 35 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 15.40 22.79 16.66 13.93 24.10 15.98 205.70 172.52 194.71 204.41 172.45 196.35 coo 19.95 18.98 4.81 18.82 20.94 10.49 204.59 186.28 195.60 209.96 186.96 196.62 coo 16.32 15.30 17.19 17.71 14.73 18.69 200.75 174.15 199.66 202.28 173.10 198.62 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 16 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 142 LYS~? 20.36 CL CL A2020 C 105 HIS A 151 HIS~? -11.70 O3 GOL A3037s D 35 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 38.76 28.25 7.87 36.33 26.41 13.58 94.05 73.09 37.15 99.40 72.43 37.04 coo 34.93 19.72 17.37 34.72 18.17 15.98 94.27 72.58 51.14 93.29 74.44 51.00 coo 41.01 23.02 20.83 40.65 24.26 22.55 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 142 LYS~? 15.72 O2 GOL B3024 C 105 HIS B 151 HIS~? -4.11 O3 GOL B3015s D 35 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 38.76 28.25 7.87 36.33 26.41 13.58 21.85 72.06 22.17 16.34 73.26 20.39 coo 34.93 19.72 17.37 34.72 18.17 15.98 18.48 59.01 25.15 19.77 58.54 23.56 coo 41.01 23.02 20.83 40.65 24.26 22.55 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS C 142 LYS~? 17.22 O1 GOL C3036 C 105 HIS C 151 HIS~? -4.28 C2 GOL C3036s D 35 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 38.76 28.25 7.87 36.33 26.41 13.58 84.87 26.44 78.04 89.10 24.68 78.66 coo 34.93 19.72 17.37 34.72 18.17 15.98 88.24 26.50 64.44 86.75 25.04 64.52 coo 41.01 23.02 20.83 40.65 24.26 22.55 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS D 142 LYS~? 18.65 CL CL D2012 C 105 HIS D 151 HIS~? -13.00 O2 GOL D3020s D 35 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 38.76 28.25 7.87 36.33 26.41 13.58 13.01 42.17 76.46 7.83 42.85 76.18 coo 34.93 19.72 17.37 34.72 18.17 15.98 13.06 55.69 73.24 14.03 55.94 75.08 coo 41.01 23.02 20.83 40.65 24.26 22.55 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS E 142 LYS~? 18.17 O1 GOL E3002 C 105 HIS E 151 HIS~? -4.12 O1 GOL E3002s D 35 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 38.76 28.25 7.87 36.33 26.41 13.58 18.76 84.43 64.64 13.52 85.68 64.66 coo 34.93 19.72 17.37 34.72 18.17 15.98 17.87 81.44 51.19 19.31 82.95 50.96 coo 41.01 23.02 20.83 40.65 24.26 22.55 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS F 142 LYS~? 19.20 CL CL F2034 C 105 HIS F 151 HIS~? 14.76 O3 GOL F3039s D 35 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 38.76 28.25 7.87 36.33 26.41 13.58 89.94 29.13 34.00 95.25 27.31 34.06 coo 34.93 19.72 17.37 34.72 18.17 15.98 93.09 42.58 34.58 92.14 42.76 32.71 coo 41.01 23.02 20.83 40.65 24.26 22.55 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS G 142 LYS~? 22.79 C3 GOL G3001 C 105 HIS G 151 HIS~? -4.14 C3 GOL G3001s D 35 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 38.76 28.25 7.87 36.33 26.41 13.58 16.44 29.60 34.10 15.26 26.17 28.78 coo 34.93 19.72 17.37 34.72 18.17 15.98 13.55 33.19 47.26 14.46 31.35 47.64 coo 41.01 23.02 20.83 40.65 24.26 22.55 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS H 142 LYS~? 14.79 O1 GOL H3016 C 105 HIS H 151 HIS~? 4.32 C1 GOL H3016s D 35 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 38.76 28.25 7.87 36.33 26.41 13.58 88.83 70.49 80.96 94.32 71.20 82.05 coo 34.93 19.72 17.37 34.72 18.17 15.98 89.33 56.65 80.95 87.93 56.76 82.51 coo 41.01 23.02 20.83 40.65 24.26 22.55 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS I 142 LYS~? 14.36 O1 GOL I3032 C 105 HIS I 151 HIS~? 3.98 O3 GOL I3032s D 35 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 38.76 28.25 7.87 36.33 26.41 13.58 208.03 191.18 151.66 205.16 191.96 148.66 coo 34.93 19.72 17.37 34.72 18.17 15.98 208.71 190.07 165.44 207.65 191.87 165.52 coo 41.01 23.02 20.83 40.65 24.26 22.55 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS J 142 LYS~? 19.62 CL CL J2016 C 105 HIS J 151 HIS~? -12.73 O1 GOL J3033s D 35 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 38.76 28.25 7.87 36.33 26.41 13.58 135.12 187.43 140.16 132.76 191.26 136.26 coo 34.93 19.72 17.37 34.72 18.17 15.98 132.36 173.99 142.63 133.63 173.58 141.01 coo 41.01 23.02 20.83 40.65 24.26 22.55 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS K 142 LYS~? 19.15 C2 GOL K3009 C 105 HIS K 151 HIS~? -4.18 C2 GOL K3009s D 35 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 38.76 28.25 7.87 36.33 26.41 13.58 202.52 142.42 190.46 207.82 141.83 191.71 coo 34.93 19.72 17.37 34.72 18.17 15.98 205.25 143.04 176.89 203.95 141.38 176.70 coo 41.01 23.02 20.83 40.65 24.26 22.55 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS L 142 LYS~? 23.18 CL CL L2009 C 105 HIS L 151 HIS~? -15.32 O3 GOL L3028s D 35 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 38.76 28.25 7.87 36.33 26.41 13.58 129.76 154.52 193.42 128.34 149.37 194.11 coo 34.93 19.72 17.37 34.72 18.17 15.98 129.06 168.07 190.57 130.17 168.32 192.34 coo 41.01 23.02 20.83 40.65 24.26 22.55 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS M 142 LYS~? 19.90 CL CL M2017 C 105 HIS M 151 HIS~? -11.81 O3 GOL M3042s D 35 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 38.76 28.25 7.87 36.33 26.41 13.58 133.20 197.60 183.11 127.92 198.39 183.89 coo 34.93 19.72 17.37 34.72 18.17 15.98 131.91 195.13 169.59 133.22 196.76 169.40 coo 41.01 23.02 20.83 40.65 24.26 22.55 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 14 3 # 14 B 62 LYS N 142 LYS~? 14.74 O1 GOL N3029 C 105 HIS N 151 HIS~? 3.39 O2 GOL N3012s D 35 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 38.76 28.25 7.87 36.33 26.41 13.58 205.28 147.20 146.57 210.60 146.27 146.55 coo 34.93 19.72 17.37 34.72 18.17 15.98 207.96 160.84 147.59 206.93 161.03 145.77 coo 41.01 23.02 20.83 40.65 24.26 22.55 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 15 3 # 15 B 62 LYS O 142 LYS~? 15.43 O3 GOL O3026 C 105 HIS O 151 HIS~? 4.32 O2 GOL O3026s D 35 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 38.76 28.25 7.87 36.33 26.41 13.58 132.09 144.26 150.20 126.63 143.20 149.32 coo 34.93 19.72 17.37 34.72 18.17 15.98 129.65 146.92 163.60 130.73 145.15 163.91 coo 41.01 23.02 20.83 40.65 24.26 22.55 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 16 3 # 16 B 62 LYS P 142 LYS~? 18.94 O2 GOL P3014 C 105 HIS P 151 HIS~? -4.15 C3 GOL P3014s D 35 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 38.76 28.25 7.87 36.33 26.41 13.58 204.59 186.28 195.60 209.96 186.96 196.62 coo 34.93 19.72 17.37 34.72 18.17 15.98 205.70 172.52 194.71 204.41 172.45 196.35 coo 41.01 23.02 20.83 40.65 24.26 22.55 200.75 174.15 199.66 202.28 173.10 198.62 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 16 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 142 LYS~? 20.36 CL CL A2020 B 105 HIS A 151 HIS~? -11.70 O3 GOL A3037s E 35 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 20.51 39.76 8.83 21.23 37.38 14.18 94.05 73.09 37.15 99.40 72.43 37.04 coo 27.18 37.56 20.68 29.07 38.28 20.13 94.27 72.58 51.14 93.29 74.44 51.00 coo 19.97 40.39 22.03 18.53 39.30 23.18 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 142 LYS~? 15.72 O2 GOL B3024 B 105 HIS B 151 HIS~? -4.11 O3 GOL B3015s E 35 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 20.51 39.76 8.83 21.23 37.38 14.18 21.85 72.06 22.17 16.34 73.26 20.39 coo 27.18 37.56 20.68 29.07 38.28 20.13 18.48 59.01 25.15 19.77 58.54 23.56 coo 19.97 40.39 22.03 18.53 39.30 23.18 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 142 LYS~? 17.22 O1 GOL C3036 B 105 HIS C 151 HIS~? -4.28 C2 GOL C3036s E 35 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 20.51 39.76 8.83 21.23 37.38 14.18 84.87 26.44 78.04 89.10 24.68 78.66 coo 27.18 37.56 20.68 29.07 38.28 20.13 88.24 26.50 64.44 86.75 25.04 64.52 coo 19.97 40.39 22.03 18.53 39.30 23.18 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS D 142 LYS~? 18.65 CL CL D2012 B 105 HIS D 151 HIS~? -13.00 O2 GOL D3020s E 35 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 20.51 39.76 8.83 21.23 37.38 14.18 13.01 42.17 76.46 7.83 42.85 76.18 coo 27.18 37.56 20.68 29.07 38.28 20.13 13.06 55.69 73.24 14.03 55.94 75.08 coo 19.97 40.39 22.03 18.53 39.30 23.18 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS E 142 LYS~? 18.17 O1 GOL E3002 B 105 HIS E 151 HIS~? -4.12 O1 GOL E3002s E 35 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 20.51 39.76 8.83 21.23 37.38 14.18 18.76 84.43 64.64 13.52 85.68 64.66 coo 27.18 37.56 20.68 29.07 38.28 20.13 17.87 81.44 51.19 19.31 82.95 50.96 coo 19.97 40.39 22.03 18.53 39.30 23.18 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS F 142 LYS~? 19.20 CL CL F2034 B 105 HIS F 151 HIS~? 14.76 O3 GOL F3039s E 35 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 20.51 39.76 8.83 21.23 37.38 14.18 89.94 29.13 34.00 95.25 27.31 34.06 coo 27.18 37.56 20.68 29.07 38.28 20.13 93.09 42.58 34.58 92.14 42.76 32.71 coo 19.97 40.39 22.03 18.53 39.30 23.18 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS G 142 LYS~? 22.79 C3 GOL G3001 B 105 HIS G 151 HIS~? -4.14 C3 GOL G3001s E 35 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 20.51 39.76 8.83 21.23 37.38 14.18 16.44 29.60 34.10 15.26 26.17 28.78 coo 27.18 37.56 20.68 29.07 38.28 20.13 13.55 33.19 47.26 14.46 31.35 47.64 coo 19.97 40.39 22.03 18.53 39.30 23.18 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS H 142 LYS~? 14.79 O1 GOL H3016 B 105 HIS H 151 HIS~? 4.32 C1 GOL H3016s E 35 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 20.51 39.76 8.83 21.23 37.38 14.18 88.83 70.49 80.96 94.32 71.20 82.05 coo 27.18 37.56 20.68 29.07 38.28 20.13 89.33 56.65 80.95 87.93 56.76 82.51 coo 19.97 40.39 22.03 18.53 39.30 23.18 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS I 142 LYS~? 14.36 O1 GOL I3032 B 105 HIS I 151 HIS~? 3.98 O3 GOL I3032s E 35 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 20.51 39.76 8.83 21.23 37.38 14.18 208.03 191.18 151.66 205.16 191.96 148.66 coo 27.18 37.56 20.68 29.07 38.28 20.13 208.71 190.07 165.44 207.65 191.87 165.52 coo 19.97 40.39 22.03 18.53 39.30 23.18 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS J 142 LYS~? 19.62 CL CL J2016 B 105 HIS J 151 HIS~? -12.73 O1 GOL J3033s E 35 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 20.51 39.76 8.83 21.23 37.38 14.18 135.12 187.43 140.16 132.76 191.26 136.26 coo 27.18 37.56 20.68 29.07 38.28 20.13 132.36 173.99 142.63 133.63 173.58 141.01 coo 19.97 40.39 22.03 18.53 39.30 23.18 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS K 142 LYS~? 19.15 C2 GOL K3009 B 105 HIS K 151 HIS~? -4.18 C2 GOL K3009s E 35 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 20.51 39.76 8.83 21.23 37.38 14.18 202.52 142.42 190.46 207.82 141.83 191.71 coo 27.18 37.56 20.68 29.07 38.28 20.13 205.25 143.04 176.89 203.95 141.38 176.70 coo 19.97 40.39 22.03 18.53 39.30 23.18 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 12 3 # 12 A 62 LYS L 142 LYS~? 23.18 CL CL L2009 B 105 HIS L 151 HIS~? -15.32 O3 GOL L3028s E 35 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 20.51 39.76 8.83 21.23 37.38 14.18 129.76 154.52 193.42 128.34 149.37 194.11 coo 27.18 37.56 20.68 29.07 38.28 20.13 129.06 168.07 190.57 130.17 168.32 192.34 coo 19.97 40.39 22.03 18.53 39.30 23.18 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 13 3 # 13 A 62 LYS M 142 LYS~? 19.90 CL CL M2017 B 105 HIS M 151 HIS~? -11.81 O3 GOL M3042s E 35 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 20.51 39.76 8.83 21.23 37.38 14.18 133.20 197.60 183.11 127.92 198.39 183.89 coo 27.18 37.56 20.68 29.07 38.28 20.13 131.91 195.13 169.59 133.22 196.76 169.40 coo 19.97 40.39 22.03 18.53 39.30 23.18 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 14 3 # 14 A 62 LYS N 142 LYS~? 14.74 O1 GOL N3029 B 105 HIS N 151 HIS~? 3.39 O2 GOL N3012s E 35 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 20.51 39.76 8.83 21.23 37.38 14.18 205.28 147.20 146.57 210.60 146.27 146.55 coo 27.18 37.56 20.68 29.07 38.28 20.13 207.96 160.84 147.59 206.93 161.03 145.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 15 3 # 15 A 62 LYS O 142 LYS~? 15.43 O3 GOL O3026 B 105 HIS O 151 HIS~? 4.32 O2 GOL O3026s E 35 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 20.51 39.76 8.83 21.23 37.38 14.18 132.09 144.26 150.20 126.63 143.20 149.32 coo 27.18 37.56 20.68 29.07 38.28 20.13 129.65 146.92 163.60 130.73 145.15 163.91 coo 19.97 40.39 22.03 18.53 39.30 23.18 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 16 3 # 16 A 62 LYS P 142 LYS~? 18.94 O2 GOL P3014 B 105 HIS P 151 HIS~? -4.15 C3 GOL P3014s E 35 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 20.51 39.76 8.83 21.23 37.38 14.18 204.59 186.28 195.60 209.96 186.96 196.62 coo 27.18 37.56 20.68 29.07 38.28 20.13 205.70 172.52 194.71 204.41 172.45 196.35 coo 19.97 40.39 22.03 18.53 39.30 23.18 200.75 174.15 199.66 202.28 173.10 198.62 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 16 hits 1f80_c05 naa= 3 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 1 3 # 1 A 180 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 191 CYH A 153 CYH.? 14.43 O2 GOL A3037 A 228 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo 26.35 46.39 51.64 24.52 45.66 52.39 106.32 81.43 56.18 105.60 83.26 56.91 coo 16.62 40.80 48.93 16.46 38.74 50.82 101.61 70.42 52.87 102.62 71.46 50.52 coo 24.60 42.24 47.99 21.60 41.75 48.44 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 2 3 # 2 A 180 HIS B 158 HIS.? 12.55 CL CL B2010 A 191 CYH B 153 CYH~? 8.68 O3 GOL B3015 A 228 ARG B 155 ARG.? 12.69 O3 GOL B3015 coo 26.35 46.39 51.64 24.52 45.66 52.39 7.56 53.89 15.18 8.49 52.54 13.87 coo 16.62 40.80 48.93 16.46 38.74 50.82 10.51 59.26 25.83 10.35 61.25 24.02 coo 24.60 42.24 47.99 21.60 41.75 48.44 7.18 53.45 20.49 4.91 55.44 21.24 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 3 3 # 3 A 180 HIS C 158 HIS.? 10.62 CL CL C2021 A 191 CYH C 153 CYH.? 7.56 CL CL C2031 A 228 ARG C 155 ARG.? 9.50 CL CL C2031 coo 26.35 46.39 51.64 24.52 45.66 52.39 98.99 15.14 61.83 98.04 13.53 60.88 coo 16.62 40.80 48.93 16.46 38.74 50.82 96.07 27.08 64.55 96.20 25.81 66.95 coo 24.60 42.24 47.99 21.60 41.75 48.44 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 4 3 # 4 A 180 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 191 CYH D 153 CYH.? 14.75 O1 GOL D3020 A 228 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 26.35 46.39 51.64 24.52 45.66 52.39 0.86 62.48 80.06 1.83 63.91 81.27 coo 16.62 40.80 48.93 16.46 38.74 50.82 5.67 57.11 70.86 4.62 54.95 72.38 coo 24.60 42.24 47.99 21.60 41.75 48.44 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 5 3 # 5 A 180 HIS E 158 HIS.? 10.67 CL CL E2032 A 191 CYH E 153 CYH~? 8.85 O1 GOL E3002 A 228 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 26.35 46.39 51.64 24.52 45.66 52.39 8.21 91.93 44.16 9.29 93.32 43.02 coo 16.62 40.80 48.93 16.46 38.74 50.82 10.10 80.75 49.90 9.59 82.62 51.85 coo 24.60 42.24 47.99 21.60 41.75 48.44 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 6 3 # 6 A 180 HIS F 158 HIS.? -10.90 CL CL F2023s A 191 CYH F 153 CYH~? 17.48 CL CL F2034 A 228 ARG F 155 ARG.? 16.94 CL CL F2023 coo 26.35 46.39 51.64 24.52 45.66 52.39 105.92 45.34 26.29 105.13 46.33 24.62 coo 16.62 40.80 48.93 16.46 38.74 50.82 100.56 42.65 36.94 101.15 40.25 35.75 coo 24.60 42.24 47.99 21.60 41.75 48.44 105.33 46.75 31.26 107.63 45.25 32.77 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 7 3 # 7 A 180 HIS G 158 HIS.? 10.64 CL CL G2033 A 191 CYH G 153 CYH~? 9.03 O3 GOL G3001 A 228 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo 26.35 46.39 51.64 24.52 45.66 52.39 0.65 25.49 51.61 1.26 23.82 52.74 coo 16.62 40.80 48.93 16.46 38.74 50.82 6.06 35.44 46.92 5.44 33.82 44.74 coo 24.60 42.24 47.99 21.60 41.75 48.44 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 8 3 # 8 A 180 HIS H 158 HIS.? 10.33 CL CL H2024 A 191 CYH H 153 CYH.? 12.27 O1 GOL H3016 A 228 ARG H 155 ARG.? 17.02 CL CL H2024 coo 26.35 46.39 51.64 24.52 45.66 52.39 98.94 51.80 92.35 97.68 51.03 93.84 coo 16.62 40.80 48.93 16.46 38.74 50.82 97.03 55.04 80.47 97.67 57.42 81.76 coo 24.60 42.24 47.99 21.60 41.75 48.44 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 9 3 # 9 A 180 HIS I 158 HIS.? 11.08 CL CL I2025 A 191 CYH I 153 CYH~? 13.03 O3 GOL I3032 A 228 ARG I 155 ARG.? 16.75 CL CL I2025 coo 26.35 46.39 51.64 24.52 45.66 52.39 220.34 199.03 170.60 219.44 200.67 171.57 coo 16.62 40.80 48.93 16.46 38.74 50.82 216.28 188.21 166.60 217.09 189.60 164.27 coo 24.60 42.24 47.99 21.60 41.75 48.44 219.78 193.99 171.61 222.12 192.73 169.97 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 10 3 # 10 A 180 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 191 CYH J 153 CYH.? 14.69 O1 GOL J3033 A 228 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo 26.35 46.39 51.64 24.52 45.66 52.39 121.18 169.23 132.79 122.06 167.98 131.35 coo 16.62 40.80 48.93 16.46 38.74 50.82 124.53 173.82 143.70 124.14 176.01 142.05 coo 24.60 42.24 47.99 21.60 41.75 48.44 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 11 3 # 11 A 180 HIS K 158 HIS.? 10.92 CL CL K2027 A 191 CYH K 153 CYH.? 10.08 C1 GOL K3009 A 228 ARG K 155 ARG.? 13.03 O2 GOL K3009 coo 26.35 46.39 51.64 24.52 45.66 52.39 216.60 132.79 173.33 215.77 131.08 172.42 coo 16.62 40.80 48.93 16.46 38.74 50.82 213.02 144.07 176.61 213.41 142.76 178.95 coo 24.60 42.24 47.99 21.60 41.75 48.44 216.54 137.96 172.21 218.86 139.31 173.84 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 12 3 # 12 A 180 HIS L 158 HIS.? 11.11 CL CL L2028 A 191 CYH L 153 CYH.? 17.58 CL CL L2028 A 228 ARG L 155 ARG.? 15.58 CL CL L2028 coo 26.35 46.39 51.64 24.52 45.66 52.39 117.45 174.63 198.96 118.55 176.04 200.05 coo 16.62 40.80 48.93 16.46 38.74 50.82 121.51 169.13 188.69 120.63 167.06 190.29 coo 24.60 42.24 47.99 21.60 41.75 48.44 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 13 3 # 13 A 180 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 191 CYH M 153 CYH~? 14.73 C2 GOL M3042 A 228 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 26.35 46.39 51.64 24.52 45.66 52.39 121.40 205.18 163.43 122.55 206.46 162.23 coo 16.62 40.80 48.93 16.46 38.74 50.82 124.18 194.08 168.46 123.60 195.77 170.58 coo 24.60 42.24 47.99 21.60 41.75 48.44 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 14 3 # 14 A 180 HIS N 158 HIS.? 10.50 CL CL N2030 A 191 CYH N 153 CYH.? 9.71 O1 GOL N3012 A 228 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 26.35 46.39 51.64 24.52 45.66 52.39 220.32 164.11 138.58 219.66 165.01 136.80 coo 16.62 40.80 48.93 16.46 38.74 50.82 215.62 161.14 149.48 216.18 158.76 148.20 coo 24.60 42.24 47.99 21.60 41.75 48.44 219.49 166.94 144.14 219.55 170.01 143.56 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 15 3 # 15 A 180 HIS O 158 HIS.? 12.21 CL CL O2018 A 191 CYH O 153 CYH.? 10.07 O3 GOL O3013 A 228 ARG O 155 ARG.? 13.45 O3 GOL O3013 coo 26.35 46.39 51.64 24.52 45.66 52.39 117.44 138.41 168.51 118.31 136.96 169.75 coo 16.62 40.80 48.93 16.46 38.74 50.82 121.90 148.90 163.71 121.42 147.29 161.55 coo 24.60 42.24 47.99 21.60 41.75 48.44 117.87 143.72 169.20 115.63 144.83 167.33 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 16 3 # 16 A 180 HIS P 158 HIS.? 12.33 O2 GOL P3014 A 191 CYH P 153 CYH.? 9.50 O2 GOL P3014 A 228 ARG P 155 ARG.? 12.61 O2 GOL P3014 coo 26.35 46.39 51.64 24.52 45.66 52.39 216.29 167.50 205.15 215.20 166.66 206.73 coo 16.62 40.80 48.93 16.46 38.74 50.82 213.41 171.20 193.92 214.01 173.48 195.24 coo 24.60 42.24 47.99 21.60 41.75 48.44 216.42 165.88 200.05 218.98 167.31 198.98 1f8m_c00 source 1f8m ISOCITRATE LYASE : 16 hits 1f8m_c00 naa= 3 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 1 3 # 1 B 180 HIS A 158 HIS.? 6.53 O1 GOL A3037 B 191 CYH A 153 CYH.? 14.43 O2 GOL A3037 B 228 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo -1.29 58.02 79.43 0.64 57.19 79.31 106.32 81.43 56.18 105.60 83.26 56.91 coo 8.78 59.01 84.54 9.56 56.29 85.16 101.61 70.42 52.87 102.62 71.46 50.52 coo 0.68 59.10 84.66 3.77 58.91 84.59 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 2 3 # 2 B 180 HIS B 158 HIS.? 12.55 CL CL B2010 B 191 CYH B 153 CYH~? 8.68 O3 GOL B3015 B 228 ARG B 155 ARG.? 12.69 O3 GOL B3015 coo -1.29 58.02 79.43 0.64 57.19 79.31 7.56 53.89 15.18 8.49 52.54 13.87 coo 8.78 59.01 84.54 9.56 56.29 85.16 10.51 59.26 25.83 10.35 61.25 24.02 coo 0.68 59.10 84.66 3.77 58.91 84.59 7.18 53.45 20.49 4.91 55.44 21.24 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 3 3 # 3 B 180 HIS C 158 HIS.? 10.62 CL CL C2021 B 191 CYH C 153 CYH.? 7.56 CL CL C2031 B 228 ARG C 155 ARG.? 9.50 CL CL C2031 coo -1.29 58.02 79.43 0.64 57.19 79.31 98.99 15.14 61.83 98.04 13.53 60.88 coo 8.78 59.01 84.54 9.56 56.29 85.16 96.07 27.08 64.55 96.20 25.81 66.95 coo 0.68 59.10 84.66 3.77 58.91 84.59 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 4 3 # 4 B 180 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 191 CYH D 153 CYH.? 14.75 O1 GOL D3020 B 228 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo -1.29 58.02 79.43 0.64 57.19 79.31 0.86 62.48 80.06 1.83 63.91 81.27 coo 8.78 59.01 84.54 9.56 56.29 85.16 5.67 57.11 70.86 4.62 54.95 72.38 coo 0.68 59.10 84.66 3.77 58.91 84.59 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 5 3 # 5 B 180 HIS E 158 HIS.? 10.67 CL CL E2032 B 191 CYH E 153 CYH~? 8.85 O1 GOL E3002 B 228 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo -1.29 58.02 79.43 0.64 57.19 79.31 8.21 91.93 44.16 9.29 93.32 43.02 coo 8.78 59.01 84.54 9.56 56.29 85.16 10.10 80.75 49.90 9.59 82.62 51.85 coo 0.68 59.10 84.66 3.77 58.91 84.59 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 6 3 # 6 B 180 HIS F 158 HIS.? -10.90 CL CL F2023s B 191 CYH F 153 CYH~? 17.48 CL CL F2034 B 228 ARG F 155 ARG.? 16.94 CL CL F2023 coo -1.29 58.02 79.43 0.64 57.19 79.31 105.92 45.34 26.29 105.13 46.33 24.62 coo 8.78 59.01 84.54 9.56 56.29 85.16 100.56 42.65 36.94 101.15 40.25 35.75 coo 0.68 59.10 84.66 3.77 58.91 84.59 105.33 46.75 31.26 107.63 45.25 32.77 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 7 3 # 7 B 180 HIS G 158 HIS.? 10.64 CL CL G2033 B 191 CYH G 153 CYH~? 9.03 O3 GOL G3001 B 228 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo -1.29 58.02 79.43 0.64 57.19 79.31 0.65 25.49 51.61 1.26 23.82 52.74 coo 8.78 59.01 84.54 9.56 56.29 85.16 6.06 35.44 46.92 5.44 33.82 44.74 coo 0.68 59.10 84.66 3.77 58.91 84.59 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 8 3 # 8 B 180 HIS H 158 HIS.? 10.33 CL CL H2024 B 191 CYH H 153 CYH.? 12.27 O1 GOL H3016 B 228 ARG H 155 ARG.? 17.02 CL CL H2024 coo -1.29 58.02 79.43 0.64 57.19 79.31 98.94 51.80 92.35 97.68 51.03 93.84 coo 8.78 59.01 84.54 9.56 56.29 85.16 97.03 55.04 80.47 97.67 57.42 81.76 coo 0.68 59.10 84.66 3.77 58.91 84.59 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 9 3 # 9 B 180 HIS I 158 HIS.? 11.08 CL CL I2025 B 191 CYH I 153 CYH~? 13.03 O3 GOL I3032 B 228 ARG I 155 ARG.? 16.75 CL CL I2025 coo -1.29 58.02 79.43 0.64 57.19 79.31 220.34 199.03 170.60 219.44 200.67 171.57 coo 8.78 59.01 84.54 9.56 56.29 85.16 216.28 188.21 166.60 217.09 189.60 164.27 coo 0.68 59.10 84.66 3.77 58.91 84.59 219.78 193.99 171.61 222.12 192.73 169.97 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 10 3 # 10 B 180 HIS J 158 HIS.? 7.50 O2 GOL J3033 B 191 CYH J 153 CYH.? 14.69 O1 GOL J3033 B 228 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo -1.29 58.02 79.43 0.64 57.19 79.31 121.18 169.23 132.79 122.06 167.98 131.35 coo 8.78 59.01 84.54 9.56 56.29 85.16 124.53 173.82 143.70 124.14 176.01 142.05 coo 0.68 59.10 84.66 3.77 58.91 84.59 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 11 3 # 11 B 180 HIS K 158 HIS.? 10.92 CL CL K2027 B 191 CYH K 153 CYH.? 10.08 C1 GOL K3009 B 228 ARG K 155 ARG.? 13.03 O2 GOL K3009 coo -1.29 58.02 79.43 0.64 57.19 79.31 216.60 132.79 173.33 215.77 131.08 172.42 coo 8.78 59.01 84.54 9.56 56.29 85.16 213.02 144.07 176.61 213.41 142.76 178.95 coo 0.68 59.10 84.66 3.77 58.91 84.59 216.54 137.96 172.21 218.86 139.31 173.84 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 12 3 # 12 B 180 HIS L 158 HIS.? 11.11 CL CL L2028 B 191 CYH L 153 CYH.? 17.58 CL CL L2028 B 228 ARG L 155 ARG.? 15.58 CL CL L2028 coo -1.29 58.02 79.43 0.64 57.19 79.31 117.45 174.63 198.96 118.55 176.04 200.05 coo 8.78 59.01 84.54 9.56 56.29 85.16 121.51 169.13 188.69 120.63 167.06 190.29 coo 0.68 59.10 84.66 3.77 58.91 84.59 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 13 3 # 13 B 180 HIS M 158 HIS.? 6.42 O1 GOL M3042 B 191 CYH M 153 CYH~? 14.73 C2 GOL M3042 B 228 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo -1.29 58.02 79.43 0.64 57.19 79.31 121.40 205.18 163.43 122.55 206.46 162.23 coo 8.78 59.01 84.54 9.56 56.29 85.16 124.18 194.08 168.46 123.60 195.77 170.58 coo 0.68 59.10 84.66 3.77 58.91 84.59 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 14 3 # 14 B 180 HIS N 158 HIS.? 10.50 CL CL N2030 B 191 CYH N 153 CYH.? 9.71 O1 GOL N3012 B 228 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo -1.29 58.02 79.43 0.64 57.19 79.31 220.32 164.11 138.58 219.66 165.01 136.80 coo 8.78 59.01 84.54 9.56 56.29 85.16 215.62 161.14 149.48 216.18 158.76 148.20 coo 0.68 59.10 84.66 3.77 58.91 84.59 219.49 166.94 144.14 219.55 170.01 143.56 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 15 3 # 15 B 180 HIS O 158 HIS.? 12.21 CL CL O2018 B 191 CYH O 153 CYH.? 10.07 O3 GOL O3013 B 228 ARG O 155 ARG.? 13.45 O3 GOL O3013 coo -1.29 58.02 79.43 0.64 57.19 79.31 117.44 138.41 168.51 118.31 136.96 169.75 coo 8.78 59.01 84.54 9.56 56.29 85.16 121.90 148.90 163.71 121.42 147.29 161.55 coo 0.68 59.10 84.66 3.77 58.91 84.59 117.87 143.72 169.20 115.63 144.83 167.33 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 16 3 # 16 B 180 HIS P 158 HIS.? 12.33 O2 GOL P3014 B 191 CYH P 153 CYH.? 9.50 O2 GOL P3014 B 228 ARG P 155 ARG.? 12.61 O2 GOL P3014 coo -1.29 58.02 79.43 0.64 57.19 79.31 216.29 167.50 205.15 215.20 166.66 206.73 coo 8.78 59.01 84.54 9.56 56.29 85.16 213.41 171.20 193.92 214.01 173.48 195.24 coo 0.68 59.10 84.66 3.77 58.91 84.59 216.42 165.88 200.05 218.98 167.31 198.98 1f8m_c01 source 1f8m ISOCITRATE LYASE : 16 hits 1f8m_c01 naa= 3 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 1 3 # 1 C 180 HIS A 158 HIS.? 6.53 O1 GOL A3037 C 191 CYH A 153 CYH.? 14.43 O2 GOL A3037 C 228 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo 2.43 65.34 36.80 3.92 66.76 37.21 106.32 81.43 56.18 105.60 83.26 56.91 coo 13.01 68.26 34.18 13.01 71.04 33.71 101.61 70.42 52.87 102.62 71.46 50.52 coo 5.82 65.41 32.29 8.60 66.57 33.01 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 2 3 # 2 C 180 HIS B 158 HIS.? 12.55 CL CL B2010 C 191 CYH B 153 CYH~? 8.68 O3 GOL B3015 C 228 ARG B 155 ARG.? 12.69 O3 GOL B3015 coo 2.43 65.34 36.80 3.92 66.76 37.21 7.56 53.89 15.18 8.49 52.54 13.87 coo 13.01 68.26 34.18 13.01 71.04 33.71 10.51 59.26 25.83 10.35 61.25 24.02 coo 5.82 65.41 32.29 8.60 66.57 33.01 7.18 53.45 20.49 4.91 55.44 21.24 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 3 3 # 3 C 180 HIS C 158 HIS.? 10.62 CL CL C2021 C 191 CYH C 153 CYH.? 7.56 CL CL C2031 C 228 ARG C 155 ARG.? 9.50 CL CL C2031 coo 2.43 65.34 36.80 3.92 66.76 37.21 98.99 15.14 61.83 98.04 13.53 60.88 coo 13.01 68.26 34.18 13.01 71.04 33.71 96.07 27.08 64.55 96.20 25.81 66.95 coo 5.82 65.41 32.29 8.60 66.57 33.01 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 4 3 # 4 C 180 HIS D 158 HIS.? 6.33 O1 GOL D3020 C 191 CYH D 153 CYH.? 14.75 O1 GOL D3020 C 228 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 2.43 65.34 36.80 3.92 66.76 37.21 0.86 62.48 80.06 1.83 63.91 81.27 coo 13.01 68.26 34.18 13.01 71.04 33.71 5.67 57.11 70.86 4.62 54.95 72.38 coo 5.82 65.41 32.29 8.60 66.57 33.01 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 5 3 # 5 C 180 HIS E 158 HIS.? 10.67 CL CL E2032 C 191 CYH E 153 CYH~? 8.85 O1 GOL E3002 C 228 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 2.43 65.34 36.80 3.92 66.76 37.21 8.21 91.93 44.16 9.29 93.32 43.02 coo 13.01 68.26 34.18 13.01 71.04 33.71 10.10 80.75 49.90 9.59 82.62 51.85 coo 5.82 65.41 32.29 8.60 66.57 33.01 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 6 3 # 6 C 180 HIS F 158 HIS.? -10.90 CL CL F2023s C 191 CYH F 153 CYH~? 17.48 CL CL F2034 C 228 ARG F 155 ARG.? 16.94 CL CL F2023 coo 2.43 65.34 36.80 3.92 66.76 37.21 105.92 45.34 26.29 105.13 46.33 24.62 coo 13.01 68.26 34.18 13.01 71.04 33.71 100.56 42.65 36.94 101.15 40.25 35.75 coo 5.82 65.41 32.29 8.60 66.57 33.01 105.33 46.75 31.26 107.63 45.25 32.77 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 7 3 # 7 C 180 HIS G 158 HIS.? 10.64 CL CL G2033 C 191 CYH G 153 CYH~? 9.03 O3 GOL G3001 C 228 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo 2.43 65.34 36.80 3.92 66.76 37.21 0.65 25.49 51.61 1.26 23.82 52.74 coo 13.01 68.26 34.18 13.01 71.04 33.71 6.06 35.44 46.92 5.44 33.82 44.74 coo 5.82 65.41 32.29 8.60 66.57 33.01 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 8 3 # 8 C 180 HIS H 158 HIS.? 10.33 CL CL H2024 C 191 CYH H 153 CYH.? 12.27 O1 GOL H3016 C 228 ARG H 155 ARG.? 17.02 CL CL H2024 coo 2.43 65.34 36.80 3.92 66.76 37.21 98.94 51.80 92.35 97.68 51.03 93.84 coo 13.01 68.26 34.18 13.01 71.04 33.71 97.03 55.04 80.47 97.67 57.42 81.76 coo 5.82 65.41 32.29 8.60 66.57 33.01 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 9 3 # 9 C 180 HIS I 158 HIS.? 11.08 CL CL I2025 C 191 CYH I 153 CYH~? 13.03 O3 GOL I3032 C 228 ARG I 155 ARG.? 16.75 CL CL I2025 coo 2.43 65.34 36.80 3.92 66.76 37.21 220.34 199.03 170.60 219.44 200.67 171.57 coo 13.01 68.26 34.18 13.01 71.04 33.71 216.28 188.21 166.60 217.09 189.60 164.27 coo 5.82 65.41 32.29 8.60 66.57 33.01 219.78 193.99 171.61 222.12 192.73 169.97 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 10 3 # 10 C 180 HIS J 158 HIS.? 7.50 O2 GOL J3033 C 191 CYH J 153 CYH.? 14.69 O1 GOL J3033 C 228 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo 2.43 65.34 36.80 3.92 66.76 37.21 121.18 169.23 132.79 122.06 167.98 131.35 coo 13.01 68.26 34.18 13.01 71.04 33.71 124.53 173.82 143.70 124.14 176.01 142.05 coo 5.82 65.41 32.29 8.60 66.57 33.01 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 11 3 # 11 C 180 HIS K 158 HIS.? 10.92 CL CL K2027 C 191 CYH K 153 CYH.? 10.08 C1 GOL K3009 C 228 ARG K 155 ARG.? 13.03 O2 GOL K3009 coo 2.43 65.34 36.80 3.92 66.76 37.21 216.60 132.79 173.33 215.77 131.08 172.42 coo 13.01 68.26 34.18 13.01 71.04 33.71 213.02 144.07 176.61 213.41 142.76 178.95 coo 5.82 65.41 32.29 8.60 66.57 33.01 216.54 137.96 172.21 218.86 139.31 173.84 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 12 3 # 12 C 180 HIS L 158 HIS.? 11.11 CL CL L2028 C 191 CYH L 153 CYH.? 17.58 CL CL L2028 C 228 ARG L 155 ARG.? 15.58 CL CL L2028 coo 2.43 65.34 36.80 3.92 66.76 37.21 117.45 174.63 198.96 118.55 176.04 200.05 coo 13.01 68.26 34.18 13.01 71.04 33.71 121.51 169.13 188.69 120.63 167.06 190.29 coo 5.82 65.41 32.29 8.60 66.57 33.01 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 13 3 # 13 C 180 HIS M 158 HIS.? 6.42 O1 GOL M3042 C 191 CYH M 153 CYH~? 14.73 C2 GOL M3042 C 228 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 2.43 65.34 36.80 3.92 66.76 37.21 121.40 205.18 163.43 122.55 206.46 162.23 coo 13.01 68.26 34.18 13.01 71.04 33.71 124.18 194.08 168.46 123.60 195.77 170.58 coo 5.82 65.41 32.29 8.60 66.57 33.01 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 14 3 # 14 C 180 HIS N 158 HIS.? 10.50 CL CL N2030 C 191 CYH N 153 CYH.? 9.71 O1 GOL N3012 C 228 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 2.43 65.34 36.80 3.92 66.76 37.21 220.32 164.11 138.58 219.66 165.01 136.80 coo 13.01 68.26 34.18 13.01 71.04 33.71 215.62 161.14 149.48 216.18 158.76 148.20 coo 5.82 65.41 32.29 8.60 66.57 33.01 219.49 166.94 144.14 219.55 170.01 143.56 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 15 3 # 15 C 180 HIS O 158 HIS.? 12.21 CL CL O2018 C 191 CYH O 153 CYH.? 10.07 O3 GOL O3013 C 228 ARG O 155 ARG.? 13.45 O3 GOL O3013 coo 2.43 65.34 36.80 3.92 66.76 37.21 117.44 138.41 168.51 118.31 136.96 169.75 coo 13.01 68.26 34.18 13.01 71.04 33.71 121.90 148.90 163.71 121.42 147.29 161.55 coo 5.82 65.41 32.29 8.60 66.57 33.01 117.87 143.72 169.20 115.63 144.83 167.33 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 16 3 # 16 C 180 HIS P 158 HIS.? 12.33 O2 GOL P3014 C 191 CYH P 153 CYH.? 9.50 O2 GOL P3014 C 228 ARG P 155 ARG.? 12.61 O2 GOL P3014 coo 2.43 65.34 36.80 3.92 66.76 37.21 216.29 167.50 205.15 215.20 166.66 206.73 coo 13.01 68.26 34.18 13.01 71.04 33.71 213.41 171.20 193.92 214.01 173.48 195.24 coo 5.82 65.41 32.29 8.60 66.57 33.01 216.42 165.88 200.05 218.98 167.31 198.98 1f8m_c02 source 1f8m ISOCITRATE LYASE : 16 hits 1f8m_c02 naa= 3 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 1 3 # 1 D 180 HIS A 158 HIS.? 6.53 O1 GOL A3037 D 191 CYH A 153 CYH.? 14.43 O2 GOL A3037 D 228 ARG A 155 ARG.? 9.00 O2 GOL A3037 coo 17.18 84.74 69.76 15.58 84.83 68.40 106.32 81.43 56.18 105.60 83.26 56.91 coo 5.89 86.47 69.92 5.21 88.39 67.91 101.61 70.42 52.87 102.62 71.46 50.52 coo 13.48 87.80 72.67 10.60 87.44 71.57 105.02 75.56 59.01 104.52 78.07 60.78 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 2 3 # 2 D 180 HIS B 158 HIS.? 12.55 CL CL B2010 D 191 CYH B 153 CYH~? 8.68 O3 GOL B3015 D 228 ARG B 155 ARG.? 12.69 O3 GOL B3015 coo 17.18 84.74 69.76 15.58 84.83 68.40 7.56 53.89 15.18 8.49 52.54 13.87 coo 5.89 86.47 69.92 5.21 88.39 67.91 10.51 59.26 25.83 10.35 61.25 24.02 coo 13.48 87.80 72.67 10.60 87.44 71.57 7.18 53.45 20.49 4.91 55.44 21.24 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 3 3 # 3 D 180 HIS C 158 HIS.? 10.62 CL CL C2021 D 191 CYH C 153 CYH.? 7.56 CL CL C2031 D 228 ARG C 155 ARG.? 9.50 CL CL C2031 coo 17.18 84.74 69.76 15.58 84.83 68.40 98.99 15.14 61.83 98.04 13.53 60.88 coo 5.89 86.47 69.92 5.21 88.39 67.91 96.07 27.08 64.55 96.20 25.81 66.95 coo 13.48 87.80 72.67 10.60 87.44 71.57 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 4 3 # 4 D 180 HIS D 158 HIS.? 6.33 O1 GOL D3020 D 191 CYH D 153 CYH.? 14.75 O1 GOL D3020 D 228 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 17.18 84.74 69.76 15.58 84.83 68.40 0.86 62.48 80.06 1.83 63.91 81.27 coo 5.89 86.47 69.92 5.21 88.39 67.91 5.67 57.11 70.86 4.62 54.95 72.38 coo 13.48 87.80 72.67 10.60 87.44 71.57 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 5 3 # 5 D 180 HIS E 158 HIS.? 10.67 CL CL E2032 D 191 CYH E 153 CYH~? 8.85 O1 GOL E3002 D 228 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 17.18 84.74 69.76 15.58 84.83 68.40 8.21 91.93 44.16 9.29 93.32 43.02 coo 5.89 86.47 69.92 5.21 88.39 67.91 10.10 80.75 49.90 9.59 82.62 51.85 coo 13.48 87.80 72.67 10.60 87.44 71.57 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 6 3 # 6 D 180 HIS F 158 HIS.? -10.90 CL CL F2023s D 191 CYH F 153 CYH~? 17.48 CL CL F2034 D 228 ARG F 155 ARG.? 16.94 CL CL F2023 coo 17.18 84.74 69.76 15.58 84.83 68.40 105.92 45.34 26.29 105.13 46.33 24.62 coo 5.89 86.47 69.92 5.21 88.39 67.91 100.56 42.65 36.94 101.15 40.25 35.75 coo 13.48 87.80 72.67 10.60 87.44 71.57 105.33 46.75 31.26 107.63 45.25 32.77 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 7 3 # 7 D 180 HIS G 158 HIS.? 10.64 CL CL G2033 D 191 CYH G 153 CYH~? 9.03 O3 GOL G3001 D 228 ARG G 155 ARG.? 12.01 O3 GOL G3001 coo 17.18 84.74 69.76 15.58 84.83 68.40 0.65 25.49 51.61 1.26 23.82 52.74 coo 5.89 86.47 69.92 5.21 88.39 67.91 6.06 35.44 46.92 5.44 33.82 44.74 coo 13.48 87.80 72.67 10.60 87.44 71.57 1.41 31.05 53.14 0.04 33.40 54.68 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 8 3 # 8 D 180 HIS H 158 HIS.? 10.33 CL CL H2024 D 191 CYH H 153 CYH.? 12.27 O1 GOL H3016 D 228 ARG H 155 ARG.? 17.02 CL CL H2024 coo 17.18 84.74 69.76 15.58 84.83 68.40 98.94 51.80 92.35 97.68 51.03 93.84 coo 5.89 86.47 69.92 5.21 88.39 67.91 97.03 55.04 80.47 97.67 57.42 81.76 coo 13.48 87.80 72.67 10.60 87.44 71.57 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 9 3 # 9 D 180 HIS I 158 HIS.? 11.08 CL CL I2025 D 191 CYH I 153 CYH~? 13.03 O3 GOL I3032 D 228 ARG I 155 ARG.? 16.75 CL CL I2025 coo 17.18 84.74 69.76 15.58 84.83 68.40 220.34 199.03 170.60 219.44 200.67 171.57 coo 5.89 86.47 69.92 5.21 88.39 67.91 216.28 188.21 166.60 217.09 189.60 164.27 coo 13.48 87.80 72.67 10.60 87.44 71.57 219.78 193.99 171.61 222.12 192.73 169.97 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 10 3 # 10 D 180 HIS J 158 HIS.? 7.50 O2 GOL J3033 D 191 CYH J 153 CYH.? 14.69 O1 GOL J3033 D 228 ARG J 155 ARG.? 11.80 O1 GOL J3033 coo 17.18 84.74 69.76 15.58 84.83 68.40 121.18 169.23 132.79 122.06 167.98 131.35 coo 5.89 86.47 69.92 5.21 88.39 67.91 124.53 173.82 143.70 124.14 176.01 142.05 coo 13.48 87.80 72.67 10.60 87.44 71.57 121.13 167.88 138.18 121.17 165.29 139.87 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 11 3 # 11 D 180 HIS K 158 HIS.? 10.92 CL CL K2027 D 191 CYH K 153 CYH.? 10.08 C1 GOL K3009 D 228 ARG K 155 ARG.? 13.03 O2 GOL K3009 coo 17.18 84.74 69.76 15.58 84.83 68.40 216.60 132.79 173.33 215.77 131.08 172.42 coo 5.89 86.47 69.92 5.21 88.39 67.91 213.02 144.07 176.61 213.41 142.76 178.95 coo 13.48 87.80 72.67 10.60 87.44 71.57 216.54 137.96 172.21 218.86 139.31 173.84 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 12 3 # 12 D 180 HIS L 158 HIS.? 11.11 CL CL L2028 D 191 CYH L 153 CYH.? 17.58 CL CL L2028 D 228 ARG L 155 ARG.? 15.58 CL CL L2028 coo 17.18 84.74 69.76 15.58 84.83 68.40 117.45 174.63 198.96 118.55 176.04 200.05 coo 5.89 86.47 69.92 5.21 88.39 67.91 121.51 169.13 188.69 120.63 167.06 190.29 coo 13.48 87.80 72.67 10.60 87.44 71.57 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 13 3 # 13 D 180 HIS M 158 HIS.? 6.42 O1 GOL M3042 D 191 CYH M 153 CYH~? 14.73 C2 GOL M3042 D 228 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 17.18 84.74 69.76 15.58 84.83 68.40 121.40 205.18 163.43 122.55 206.46 162.23 coo 5.89 86.47 69.92 5.21 88.39 67.91 124.18 194.08 168.46 123.60 195.77 170.58 coo 13.48 87.80 72.67 10.60 87.44 71.57 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 14 3 # 14 D 180 HIS N 158 HIS.? 10.50 CL CL N2030 D 191 CYH N 153 CYH.? 9.71 O1 GOL N3012 D 228 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 17.18 84.74 69.76 15.58 84.83 68.40 220.32 164.11 138.58 219.66 165.01 136.80 coo 5.89 86.47 69.92 5.21 88.39 67.91 215.62 161.14 149.48 216.18 158.76 148.20 coo 13.48 87.80 72.67 10.60 87.44 71.57 219.49 166.94 144.14 219.55 170.01 143.56 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 15 3 # 15 D 180 HIS O 158 HIS.? 12.21 CL CL O2018 D 191 CYH O 153 CYH.? 10.07 O3 GOL O3013 D 228 ARG O 155 ARG.? 13.45 O3 GOL O3013 coo 17.18 84.74 69.76 15.58 84.83 68.40 117.44 138.41 168.51 118.31 136.96 169.75 coo 5.89 86.47 69.92 5.21 88.39 67.91 121.90 148.90 163.71 121.42 147.29 161.55 coo 13.48 87.80 72.67 10.60 87.44 71.57 117.87 143.72 169.20 115.63 144.83 167.33 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 16 3 # 16 D 180 HIS P 158 HIS.? 12.33 O2 GOL P3014 D 191 CYH P 153 CYH.? 9.50 O2 GOL P3014 D 228 ARG P 155 ARG.? 12.61 O2 GOL P3014 coo 17.18 84.74 69.76 15.58 84.83 68.40 216.29 167.50 205.15 215.20 166.66 206.73 coo 5.89 86.47 69.92 5.21 88.39 67.91 213.41 171.20 193.92 214.01 173.48 195.24 coo 13.48 87.80 72.67 10.60 87.44 71.57 216.42 165.88 200.05 218.98 167.31 198.98 1f8m_c03 source 1f8m ISOCITRATE LYASE : 16 hits 1f8m_c03 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 98 PHE.? 12.32 O1 GOL A3040 A 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 244 LYS A 142 LYS~? 20.36 CL CL A2020 coo 9.23 46.77 25.11 11.48 48.39 24.76 94.73 84.25 40.94 92.04 83.71 40.47 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.44 78.16 48.76 91.65 76.94 50.06 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 101 PHE.? 16.29 O1 GOL A3040 A 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 244 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 9.23 46.77 25.11 11.48 48.39 24.76 88.47 81.56 37.13 88.90 80.34 39.61 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.44 78.16 48.76 91.65 76.94 50.06 coo -1.20 42.34 17.67 3.19 45.13 19.06 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE B 98 PHE.? 11.15 CL CL B2010 A 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 244 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.23 46.77 25.11 11.48 48.39 24.76 22.68 65.92 11.87 25.22 66.01 13.02 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.66 59.02 20.34 21.93 58.32 21.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 101 PHE.? 11.70 O2 GOL B3024 A 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 244 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 9.23 46.77 25.11 11.48 48.39 24.76 28.89 69.07 15.24 27.85 67.09 16.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.66 59.02 20.34 21.93 58.32 21.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE C 98 PHE.? 11.39 CL CL C2011 A 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 244 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.23 46.77 25.11 11.48 48.39 24.76 83.86 15.19 74.07 81.38 16.44 74.03 coo 10.51 37.86 19.71 9.07 39.38 20.04 82.81 22.02 65.69 84.52 22.80 64.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE C 101 PHE.? 16.02 O1 GOL C3036 A 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 244 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 9.23 46.77 25.11 11.48 48.39 24.76 77.63 19.27 76.58 78.76 20.45 74.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 82.81 22.02 65.69 84.52 22.80 64.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE D 98 PHE.? 11.07 CL CL D2012 A 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 244 LYS D 142 LYS~? 18.65 CL CL D2012 coo 9.23 46.77 25.11 11.48 48.39 24.76 12.59 48.19 86.72 15.29 47.64 86.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.94 54.59 79.01 15.65 55.42 77.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE D 101 PHE.? 16.52 O1 GOL D3018 A 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 244 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 9.23 46.77 25.11 11.48 48.39 24.76 18.72 43.85 84.71 18.50 46.02 82.98 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.94 54.59 79.01 15.65 55.42 77.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE E 98 PHE.? 11.20 CL CL E2013 A 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 244 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.23 46.77 25.11 11.48 48.39 24.76 20.72 94.66 58.85 23.24 93.53 59.37 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.07 86.29 52.35 21.57 85.17 51.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE E 101 PHE.? 16.02 O1 GOL E3022 A 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 244 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 9.23 46.77 25.11 11.48 48.39 24.76 26.26 91.40 63.08 25.56 89.78 60.94 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.07 86.29 52.35 21.57 85.17 51.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE F 98 PHE.? 11.09 CL CL F2034 A 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 244 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.23 46.77 25.11 11.48 48.39 24.76 91.41 32.84 22.80 88.70 32.93 23.40 coo 10.51 37.86 19.71 9.07 39.38 20.04 88.86 41.25 28.96 90.30 42.22 30.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE F 101 PHE.? 12.00 CL CL F2035 A 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 244 LYS F 61 LYS~? -5.82 CL CL F2035s coo 9.23 46.77 25.11 11.48 48.39 24.76 84.48 30.46 25.35 85.33 32.81 26.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 88.86 41.25 28.96 90.30 42.22 30.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE G 98 PHE.? 12.40 C3 GOL G3038 A 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 244 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 9.23 46.77 25.11 11.48 48.39 24.76 15.02 19.56 40.09 17.78 20.04 40.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.70 27.34 47.09 16.19 28.71 47.73 coo -1.20 42.34 17.67 3.19 45.13 19.06 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE G 101 PHE.? 16.70 O3 GOL G3038 A 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 244 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 9.23 46.77 25.11 11.48 48.39 24.76 21.93 21.41 37.11 21.15 23.14 39.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.70 27.34 47.09 16.19 28.71 47.73 coo -1.20 42.34 17.67 3.19 45.13 19.06 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE H 98 PHE.? 11.23 CL CL H2014 A 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 244 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.23 46.77 25.11 11.48 48.39 24.76 86.83 66.96 92.26 84.37 67.28 91.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.24 58.93 85.48 85.73 57.59 84.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE H 101 PHE.? 12.01 O2 GOL H3016 A 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 244 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 9.23 46.77 25.11 11.48 48.39 24.76 81.37 70.59 88.12 82.00 68.03 87.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.24 58.93 85.48 85.73 57.59 84.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE I 98 PHE.? 11.14 CL CL I2015 A 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 244 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 9.23 46.77 25.11 11.48 48.39 24.76 207.94 202.24 155.85 205.25 201.61 155.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 204.37 195.46 163.61 205.75 194.30 164.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE I 101 PHE.? 11.99 O1 GOL I3032 A 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 244 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 9.23 46.77 25.11 11.48 48.39 24.76 201.72 199.29 152.26 202.23 197.96 154.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 204.37 195.46 163.61 205.75 194.30 164.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE J 98 PHE.? 11.05 CL CL J2016 A 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 244 LYS J 142 LYS~? 19.62 CL CL J2016 coo 9.23 46.77 25.11 11.48 48.39 24.76 135.63 181.85 129.67 138.24 181.95 130.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 137.44 174.60 137.57 135.80 173.80 138.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE J 101 PHE.? 16.46 O1 GOL J3030 A 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 244 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 9.23 46.77 25.11 11.48 48.39 24.76 141.95 185.09 132.92 141.02 182.89 134.35 coo 10.51 37.86 19.71 9.07 39.38 20.04 137.44 174.60 137.57 135.80 173.80 138.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 112 PHE K 98 PHE.? 11.99 O1 GOL K3041 A 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 244 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.23 46.77 25.11 11.48 48.39 24.76 201.94 131.33 186.30 199.31 132.28 186.27 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.17 138.24 178.11 201.77 139.28 177.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 112 PHE K 101 PHE.? 16.66 O2 GOL K3041 A 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 244 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 9.23 46.77 25.11 11.48 48.39 24.76 195.66 134.79 189.08 196.68 136.09 186.76 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.17 138.24 178.11 201.77 139.28 177.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 112 PHE L 98 PHE.? 11.24 CL CL L2009 A 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 244 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.23 46.77 25.11 11.48 48.39 24.76 129.72 160.22 203.93 132.34 159.70 203.19 coo 10.51 37.86 19.71 9.07 39.38 20.04 133.34 166.97 196.27 132.03 168.03 194.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 112 PHE L 101 PHE.? 16.46 O1 GOL L3027 A 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 244 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 9.23 46.77 25.11 11.48 48.39 24.76 135.84 156.17 201.54 135.43 158.30 199.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 133.34 166.97 196.27 132.03 168.03 194.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 112 PHE M 98 PHE.? 11.28 CL CL M2017 A 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 244 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.23 46.77 25.11 11.48 48.39 24.76 134.29 208.09 177.60 136.84 206.99 178.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 136.87 200.18 170.79 135.36 199.08 169.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 112 PHE M 101 PHE.? 16.71 C1 GOL M3043 A 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 244 LYS M 61 LYS~? 24.74 CL CL I2007 coo 9.23 46.77 25.11 11.48 48.39 24.76 140.23 204.88 181.56 139.51 203.37 179.33 coo 10.51 37.86 19.71 9.07 39.38 20.04 136.87 200.18 170.79 135.36 199.08 169.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 A 112 PHE N 98 PHE.? 12.51 O2 GOL N3029 A 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 244 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.23 46.77 25.11 11.48 48.39 24.76 205.99 151.41 135.45 203.31 151.41 136.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 203.51 159.51 142.26 205.02 160.53 143.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 A 112 PHE N 101 PHE.? 11.69 O2 GOL N3029 A 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 244 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 9.23 46.77 25.11 11.48 48.39 24.76 199.31 148.71 138.37 200.16 151.05 139.65 coo 10.51 37.86 19.71 9.07 39.38 20.04 203.51 159.51 142.26 205.02 160.53 143.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 A 112 PHE O 98 PHE.? 11.35 CL CL O2018 A 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 244 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.23 46.77 25.11 11.48 48.39 24.76 131.45 133.74 155.71 134.18 134.46 155.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 134.07 141.35 162.95 132.57 142.58 163.78 coo -1.20 42.34 17.67 3.19 45.13 19.06 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 A 112 PHE O 101 PHE.? 12.02 CL CL O2036 A 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 244 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 9.23 46.77 25.11 11.48 48.39 24.76 138.04 136.16 152.49 137.26 137.85 154.61 coo 10.51 37.86 19.71 9.07 39.38 20.04 134.07 141.35 162.95 132.57 142.58 163.78 coo -1.20 42.34 17.67 3.19 45.13 19.06 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 A 112 PHE P 98 PHE.? 11.01 CL CL P2019 A 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 244 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 9.23 46.77 25.11 11.48 48.39 24.76 203.50 182.03 206.67 200.90 182.30 205.78 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.75 174.15 199.66 202.28 173.10 198.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 A 112 PHE P 101 PHE.? 16.12 O1 GOL P3034 A 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 244 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 9.23 46.77 25.11 11.48 48.39 24.76 197.59 185.62 203.03 198.21 183.20 201.89 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.75 174.15 199.66 202.28 173.10 198.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 187.60 176.80 197.02 187.44 179.17 191.02 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 32 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 98 PHE.? 12.32 O1 GOL A3040 B 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 244 LYS A 142 LYS~? 20.36 CL CL A2020 coo 8.76 47.85 34.91 11.08 46.36 35.41 94.73 84.25 40.94 92.04 83.71 40.47 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.44 78.16 48.76 91.65 76.94 50.06 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 101 PHE.? 16.29 O1 GOL A3040 B 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 244 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 8.76 47.85 34.91 11.08 46.36 35.41 88.47 81.56 37.13 88.90 80.34 39.61 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.44 78.16 48.76 91.65 76.94 50.06 coo -2.38 51.82 41.62 2.07 49.19 40.42 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE B 98 PHE.? 11.15 CL CL B2010 B 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 244 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 8.76 47.85 34.91 11.08 46.36 35.41 22.68 65.92 11.87 25.22 66.01 13.02 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.66 59.02 20.34 21.93 58.32 21.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 101 PHE.? 11.70 O2 GOL B3024 B 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 244 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 8.76 47.85 34.91 11.08 46.36 35.41 28.89 69.07 15.24 27.85 67.09 16.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.66 59.02 20.34 21.93 58.32 21.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE C 98 PHE.? 11.39 CL CL C2011 B 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 244 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 8.76 47.85 34.91 11.08 46.36 35.41 83.86 15.19 74.07 81.38 16.44 74.03 coo 9.06 56.85 40.30 7.71 55.27 39.90 82.81 22.02 65.69 84.52 22.80 64.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE C 101 PHE.? 16.02 O1 GOL C3036 B 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 244 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 8.76 47.85 34.91 11.08 46.36 35.41 77.63 19.27 76.58 78.76 20.45 74.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 82.81 22.02 65.69 84.52 22.80 64.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE D 98 PHE.? 11.07 CL CL D2012 B 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 244 LYS D 142 LYS~? 18.65 CL CL D2012 coo 8.76 47.85 34.91 11.08 46.36 35.41 12.59 48.19 86.72 15.29 47.64 86.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.94 54.59 79.01 15.65 55.42 77.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE D 101 PHE.? 16.52 O1 GOL D3018 B 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 244 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 8.76 47.85 34.91 11.08 46.36 35.41 18.72 43.85 84.71 18.50 46.02 82.98 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.94 54.59 79.01 15.65 55.42 77.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE E 98 PHE.? 11.20 CL CL E2013 B 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 244 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 8.76 47.85 34.91 11.08 46.36 35.41 20.72 94.66 58.85 23.24 93.53 59.37 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.07 86.29 52.35 21.57 85.17 51.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE E 101 PHE.? 16.02 O1 GOL E3022 B 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 244 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 8.76 47.85 34.91 11.08 46.36 35.41 26.26 91.40 63.08 25.56 89.78 60.94 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.07 86.29 52.35 21.57 85.17 51.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE F 98 PHE.? 11.09 CL CL F2034 B 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 244 LYS F 142 LYS~? 19.20 CL CL F2034 coo 8.76 47.85 34.91 11.08 46.36 35.41 91.41 32.84 22.80 88.70 32.93 23.40 coo 9.06 56.85 40.30 7.71 55.27 39.90 88.86 41.25 28.96 90.30 42.22 30.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE F 101 PHE.? 12.00 CL CL F2035 B 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 244 LYS F 61 LYS~? -5.82 CL CL F2035s coo 8.76 47.85 34.91 11.08 46.36 35.41 84.48 30.46 25.35 85.33 32.81 26.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 88.86 41.25 28.96 90.30 42.22 30.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE G 98 PHE.? 12.40 C3 GOL G3038 B 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 244 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 8.76 47.85 34.91 11.08 46.36 35.41 15.02 19.56 40.09 17.78 20.04 40.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 17.70 27.34 47.09 16.19 28.71 47.73 coo -2.38 51.82 41.62 2.07 49.19 40.42 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE G 101 PHE.? 16.70 O3 GOL G3038 B 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 244 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 8.76 47.85 34.91 11.08 46.36 35.41 21.93 21.41 37.11 21.15 23.14 39.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 17.70 27.34 47.09 16.19 28.71 47.73 coo -2.38 51.82 41.62 2.07 49.19 40.42 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE H 98 PHE.? 11.23 CL CL H2014 B 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 244 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 8.76 47.85 34.91 11.08 46.36 35.41 86.83 66.96 92.26 84.37 67.28 91.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.24 58.93 85.48 85.73 57.59 84.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE H 101 PHE.? 12.01 O2 GOL H3016 B 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 244 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 8.76 47.85 34.91 11.08 46.36 35.41 81.37 70.59 88.12 82.00 68.03 87.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.24 58.93 85.48 85.73 57.59 84.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE I 98 PHE.? 11.14 CL CL I2015 B 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 244 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 8.76 47.85 34.91 11.08 46.36 35.41 207.94 202.24 155.85 205.25 201.61 155.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 204.37 195.46 163.61 205.75 194.30 164.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE I 101 PHE.? 11.99 O1 GOL I3032 B 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 244 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 8.76 47.85 34.91 11.08 46.36 35.41 201.72 199.29 152.26 202.23 197.96 154.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 204.37 195.46 163.61 205.75 194.30 164.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE J 98 PHE.? 11.05 CL CL J2016 B 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 244 LYS J 142 LYS~? 19.62 CL CL J2016 coo 8.76 47.85 34.91 11.08 46.36 35.41 135.63 181.85 129.67 138.24 181.95 130.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 137.44 174.60 137.57 135.80 173.80 138.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE J 101 PHE.? 16.46 O1 GOL J3030 B 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 244 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 8.76 47.85 34.91 11.08 46.36 35.41 141.95 185.09 132.92 141.02 182.89 134.35 coo 9.06 56.85 40.30 7.71 55.27 39.90 137.44 174.60 137.57 135.80 173.80 138.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 112 PHE K 98 PHE.? 11.99 O1 GOL K3041 B 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 244 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 8.76 47.85 34.91 11.08 46.36 35.41 201.94 131.33 186.30 199.31 132.28 186.27 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.17 138.24 178.11 201.77 139.28 177.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 112 PHE K 101 PHE.? 16.66 O2 GOL K3041 B 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 244 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 8.76 47.85 34.91 11.08 46.36 35.41 195.66 134.79 189.08 196.68 136.09 186.76 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.17 138.24 178.11 201.77 139.28 177.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 112 PHE L 98 PHE.? 11.24 CL CL L2009 B 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 244 LYS L 142 LYS~? 23.18 CL CL L2009 coo 8.76 47.85 34.91 11.08 46.36 35.41 129.72 160.22 203.93 132.34 159.70 203.19 coo 9.06 56.85 40.30 7.71 55.27 39.90 133.34 166.97 196.27 132.03 168.03 194.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 112 PHE L 101 PHE.? 16.46 O1 GOL L3027 B 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 244 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 8.76 47.85 34.91 11.08 46.36 35.41 135.84 156.17 201.54 135.43 158.30 199.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 133.34 166.97 196.27 132.03 168.03 194.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 112 PHE M 98 PHE.? 11.28 CL CL M2017 B 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 244 LYS M 142 LYS~? 19.90 CL CL M2017 coo 8.76 47.85 34.91 11.08 46.36 35.41 134.29 208.09 177.60 136.84 206.99 178.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 136.87 200.18 170.79 135.36 199.08 169.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 112 PHE M 101 PHE.? 16.71 C1 GOL M3043 B 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 244 LYS M 61 LYS~? 24.74 CL CL I2007 coo 8.76 47.85 34.91 11.08 46.36 35.41 140.23 204.88 181.56 139.51 203.37 179.33 coo 9.06 56.85 40.30 7.71 55.27 39.90 136.87 200.18 170.79 135.36 199.08 169.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 B 112 PHE N 98 PHE.? 12.51 O2 GOL N3029 B 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 244 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 8.76 47.85 34.91 11.08 46.36 35.41 205.99 151.41 135.45 203.31 151.41 136.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 203.51 159.51 142.26 205.02 160.53 143.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 B 112 PHE N 101 PHE.? 11.69 O2 GOL N3029 B 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 244 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 8.76 47.85 34.91 11.08 46.36 35.41 199.31 148.71 138.37 200.16 151.05 139.65 coo 9.06 56.85 40.30 7.71 55.27 39.90 203.51 159.51 142.26 205.02 160.53 143.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 29 3 # 29 B 112 PHE O 98 PHE.? 11.35 CL CL O2018 B 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 244 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 8.76 47.85 34.91 11.08 46.36 35.41 131.45 133.74 155.71 134.18 134.46 155.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 134.07 141.35 162.95 132.57 142.58 163.78 coo -2.38 51.82 41.62 2.07 49.19 40.42 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 30 3 # 30 B 112 PHE O 101 PHE.? 12.02 CL CL O2036 B 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 244 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 8.76 47.85 34.91 11.08 46.36 35.41 138.04 136.16 152.49 137.26 137.85 154.61 coo 9.06 56.85 40.30 7.71 55.27 39.90 134.07 141.35 162.95 132.57 142.58 163.78 coo -2.38 51.82 41.62 2.07 49.19 40.42 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 31 3 # 31 B 112 PHE P 98 PHE.? 11.01 CL CL P2019 B 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 244 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 8.76 47.85 34.91 11.08 46.36 35.41 203.50 182.03 206.67 200.90 182.30 205.78 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.75 174.15 199.66 202.28 173.10 198.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 32 3 # 32 B 112 PHE P 101 PHE.? 16.12 O1 GOL P3034 B 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 244 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 8.76 47.85 34.91 11.08 46.36 35.41 197.59 185.62 203.03 198.21 183.20 201.89 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.75 174.15 199.66 202.28 173.10 198.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 187.60 176.80 197.02 187.44 179.17 191.02 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 32 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 151 HIS~? -11.70 O3 GOL A3037s A 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 244 LYS A 142 LYS~? 20.36 CL CL A2020 coo 11.28 44.53 18.60 9.91 46.00 19.20 94.27 72.58 51.14 93.29 74.44 51.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 90.44 78.16 48.76 91.65 76.94 50.06 coo -1.20 42.34 17.67 3.19 45.13 19.06 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 244 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 11.28 44.53 18.60 9.91 46.00 19.20 18.48 59.01 25.15 19.77 58.54 23.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.66 59.02 20.34 21.93 58.32 21.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS C 151 HIS~? -4.28 C2 GOL C3036s A 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 244 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 11.28 44.53 18.60 9.91 46.00 19.20 88.24 26.50 64.44 86.75 25.04 64.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 82.81 22.02 65.69 84.52 22.80 64.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 244 LYS D 142 LYS~? 18.65 CL CL D2012 coo 11.28 44.53 18.60 9.91 46.00 19.20 13.06 55.69 73.24 14.03 55.94 75.08 coo 10.51 37.86 19.71 9.07 39.38 20.04 16.94 54.59 79.01 15.65 55.42 77.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 244 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 11.28 44.53 18.60 9.91 46.00 19.20 17.87 81.44 51.19 19.31 82.95 50.96 coo 10.51 37.86 19.71 9.07 39.38 20.04 23.07 86.29 52.35 21.57 85.17 51.32 coo -1.20 42.34 17.67 3.19 45.13 19.06 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 244 LYS F 142 LYS~? 19.20 CL CL F2034 coo 11.28 44.53 18.60 9.91 46.00 19.20 93.09 42.58 34.58 92.14 42.76 32.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 88.86 41.25 28.96 90.30 42.22 30.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 244 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 11.28 44.53 18.60 9.91 46.00 19.20 13.55 33.19 47.26 14.46 31.35 47.64 coo 10.51 37.86 19.71 9.07 39.38 20.04 17.70 27.34 47.09 16.19 28.71 47.73 coo -1.20 42.34 17.67 3.19 45.13 19.06 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 244 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 11.28 44.53 18.60 9.91 46.00 19.20 89.33 56.65 80.95 87.93 56.76 82.51 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.24 58.93 85.48 85.73 57.59 84.66 coo -1.20 42.34 17.67 3.19 45.13 19.06 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 244 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 11.28 44.53 18.60 9.91 46.00 19.20 208.71 190.07 165.44 207.65 191.87 165.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 204.37 195.46 163.61 205.75 194.30 164.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 244 LYS J 142 LYS~? 19.62 CL CL J2016 coo 11.28 44.53 18.60 9.91 46.00 19.20 132.36 173.99 142.63 133.63 173.58 141.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 137.44 174.60 137.57 135.80 173.80 138.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 244 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 11.28 44.53 18.60 9.91 46.00 19.20 205.25 143.04 176.89 203.95 141.38 176.70 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.17 138.24 178.11 201.77 139.28 177.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 244 LYS L 142 LYS~? 23.18 CL CL L2009 coo 11.28 44.53 18.60 9.91 46.00 19.20 129.06 168.07 190.57 130.17 168.32 192.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 133.34 166.97 196.27 132.03 168.03 194.96 coo -1.20 42.34 17.67 3.19 45.13 19.06 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 136 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 244 LYS M 142 LYS~? 19.90 CL CL M2017 coo 11.28 44.53 18.60 9.91 46.00 19.20 131.91 195.13 169.59 133.22 196.76 169.40 coo 10.51 37.86 19.71 9.07 39.38 20.04 136.87 200.18 170.79 135.36 199.08 169.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 136 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 244 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 11.28 44.53 18.60 9.91 46.00 19.20 207.96 160.84 147.59 206.93 161.03 145.77 coo 10.51 37.86 19.71 9.07 39.38 20.04 203.51 159.51 142.26 205.02 160.53 143.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 136 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 244 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 11.28 44.53 18.60 9.91 46.00 19.20 129.65 146.92 163.60 130.73 145.15 163.91 coo 10.51 37.86 19.71 9.07 39.38 20.04 134.07 141.35 162.95 132.57 142.58 163.78 coo -1.20 42.34 17.67 3.19 45.13 19.06 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 136 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 244 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 11.28 44.53 18.60 9.91 46.00 19.20 205.70 172.52 194.71 204.41 172.45 196.35 coo 10.51 37.86 19.71 9.07 39.38 20.04 200.75 174.15 199.66 202.28 173.10 198.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 204.59 186.28 195.60 209.96 186.96 196.62 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 16 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 151 HIS~? -11.70 O3 GOL A3037s B 210 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 244 LYS A 142 LYS~? 20.36 CL CL A2020 coo 10.08 50.18 41.78 8.91 48.61 41.04 94.27 72.58 51.14 93.29 74.44 51.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 90.44 78.16 48.76 91.65 76.94 50.06 coo -2.38 51.82 41.62 2.07 49.19 40.42 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS B 151 HIS~? -4.11 O3 GOL B3015s B 210 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 244 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 10.08 50.18 41.78 8.91 48.61 41.04 18.48 59.01 25.15 19.77 58.54 23.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.66 59.02 20.34 21.93 58.32 21.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS C 151 HIS~? -4.28 C2 GOL C3036s B 210 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 244 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 10.08 50.18 41.78 8.91 48.61 41.04 88.24 26.50 64.44 86.75 25.04 64.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 82.81 22.02 65.69 84.52 22.80 64.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS D 151 HIS~? -13.00 O2 GOL D3020s B 210 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 244 LYS D 142 LYS~? 18.65 CL CL D2012 coo 10.08 50.18 41.78 8.91 48.61 41.04 13.06 55.69 73.24 14.03 55.94 75.08 coo 9.06 56.85 40.30 7.71 55.27 39.90 16.94 54.59 79.01 15.65 55.42 77.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS E 151 HIS~? -4.12 O1 GOL E3002s B 210 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 244 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 10.08 50.18 41.78 8.91 48.61 41.04 17.87 81.44 51.19 19.31 82.95 50.96 coo 9.06 56.85 40.30 7.71 55.27 39.90 23.07 86.29 52.35 21.57 85.17 51.32 coo -2.38 51.82 41.62 2.07 49.19 40.42 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS F 151 HIS~? 14.76 O3 GOL F3039s B 210 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 244 LYS F 142 LYS~? 19.20 CL CL F2034 coo 10.08 50.18 41.78 8.91 48.61 41.04 93.09 42.58 34.58 92.14 42.76 32.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 88.86 41.25 28.96 90.30 42.22 30.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS G 151 HIS~? -4.14 C3 GOL G3001s B 210 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 244 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 10.08 50.18 41.78 8.91 48.61 41.04 13.55 33.19 47.26 14.46 31.35 47.64 coo 9.06 56.85 40.30 7.71 55.27 39.90 17.70 27.34 47.09 16.19 28.71 47.73 coo -2.38 51.82 41.62 2.07 49.19 40.42 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS H 151 HIS~? 4.32 C1 GOL H3016s B 210 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 244 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 10.08 50.18 41.78 8.91 48.61 41.04 89.33 56.65 80.95 87.93 56.76 82.51 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.24 58.93 85.48 85.73 57.59 84.66 coo -2.38 51.82 41.62 2.07 49.19 40.42 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS I 151 HIS~? 3.98 O3 GOL I3032s B 210 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 244 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 10.08 50.18 41.78 8.91 48.61 41.04 208.71 190.07 165.44 207.65 191.87 165.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 204.37 195.46 163.61 205.75 194.30 164.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS J 151 HIS~? -12.73 O1 GOL J3033s B 210 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 244 LYS J 142 LYS~? 19.62 CL CL J2016 coo 10.08 50.18 41.78 8.91 48.61 41.04 132.36 173.99 142.63 133.63 173.58 141.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 137.44 174.60 137.57 135.80 173.80 138.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS K 151 HIS~? -4.18 C2 GOL K3009s B 210 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 244 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 10.08 50.18 41.78 8.91 48.61 41.04 205.25 143.04 176.89 203.95 141.38 176.70 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.17 138.24 178.11 201.77 139.28 177.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 136 HIS L 151 HIS~? -15.32 O3 GOL L3028s B 210 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 244 LYS L 142 LYS~? 23.18 CL CL L2009 coo 10.08 50.18 41.78 8.91 48.61 41.04 129.06 168.07 190.57 130.17 168.32 192.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 133.34 166.97 196.27 132.03 168.03 194.96 coo -2.38 51.82 41.62 2.07 49.19 40.42 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 136 HIS M 151 HIS~? -11.81 O3 GOL M3042s B 210 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 244 LYS M 142 LYS~? 19.90 CL CL M2017 coo 10.08 50.18 41.78 8.91 48.61 41.04 131.91 195.13 169.59 133.22 196.76 169.40 coo 9.06 56.85 40.30 7.71 55.27 39.90 136.87 200.18 170.79 135.36 199.08 169.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 136 HIS N 151 HIS~? 3.39 O2 GOL N3012s B 210 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 244 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 10.08 50.18 41.78 8.91 48.61 41.04 207.96 160.84 147.59 206.93 161.03 145.77 coo 9.06 56.85 40.30 7.71 55.27 39.90 203.51 159.51 142.26 205.02 160.53 143.48 coo -2.38 51.82 41.62 2.07 49.19 40.42 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 136 HIS O 151 HIS~? 4.32 O2 GOL O3026s B 210 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 244 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 10.08 50.18 41.78 8.91 48.61 41.04 129.65 146.92 163.60 130.73 145.15 163.91 coo 9.06 56.85 40.30 7.71 55.27 39.90 134.07 141.35 162.95 132.57 142.58 163.78 coo -2.38 51.82 41.62 2.07 49.19 40.42 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 136 HIS P 151 HIS~? -4.15 C3 GOL P3014s B 210 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 244 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 10.08 50.18 41.78 8.91 48.61 41.04 205.70 172.52 194.71 204.41 172.45 196.35 coo 9.06 56.85 40.30 7.71 55.27 39.90 200.75 174.15 199.66 202.28 173.10 198.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 204.59 186.28 195.60 209.96 186.96 196.62 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 16 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 143 TYR~? 16.38 O1 GOL A3040 A 142 LEU A 99 LEU.? 15.49 CL CL A2020 A 165 LYS A 142 LYS~? 20.36 CL CL A2020 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 92.99 77.44 39.76 93.75 79.76 38.42 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 96.68 83.55 35.29 98.87 83.52 34.86 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 143 TYR~? 10.77 O2 GOL B3024 A 142 LEU B 99 LEU.? 13.87 CL CL B2010 A 165 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 23.25 68.41 18.58 23.33 69.19 15.92 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 21.93 71.67 10.80 20.15 72.56 9.78 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR C 143 TYR~? 14.40 O1 GOL C3036 A 142 LEU C 99 LEU.? 14.27 CL CL C2011 A 165 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 83.34 22.31 75.20 83.28 19.92 76.54 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 84.64 15.71 79.79 86.53 15.48 80.91 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR D 143 TYR~? 15.16 CL CL D2012 A 142 LEU D 99 LEU.? 13.98 CL CL D2012 A 165 LYS D 142 LYS~? 18.65 CL CL D2012 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 14.34 45.54 80.17 13.57 44.79 82.74 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 10.70 42.57 87.13 8.63 41.98 87.46 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR E 143 TYR~? 15.23 CL CL E2013 A 142 LEU E 99 LEU.? 14.23 CL CL E2013 A 165 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 20.79 87.99 61.33 20.74 90.64 62.13 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 18.95 95.36 64.50 17.03 96.10 65.27 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR F 143 TYR~? 15.09 CL CL F2034 A 142 LEU F 99 LEU.? 13.96 CL CL F2034 A 165 LYS F 142 LYS~? 19.20 CL CL F2034 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 89.42 31.84 29.55 89.79 30.44 27.17 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 92.01 27.08 23.54 93.77 25.78 23.40 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR G 143 TYR~? 15.53 C3 GOL G3001 A 142 LEU G 99 LEU.? 16.17 CL CL G2033 A 165 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 16.97 25.90 37.77 16.51 23.33 36.84 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 14.23 19.01 34.29 12.19 18.63 33.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR H 143 TYR~? 11.30 O2 GOL H3016 A 142 LEU H 99 LEU.? 14.24 CL CL H2014 A 165 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 86.77 67.99 85.16 86.88 69.36 87.57 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 88.74 72.63 91.84 90.81 73.32 92.17 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR I 143 TYR~? 11.25 C1 GOL I3032 A 142 LEU I 99 LEU.? 14.05 CL CL I2015 A 165 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 206.55 195.37 154.41 207.09 197.83 153.23 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 209.53 201.81 150.19 211.63 201.97 149.59 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR J 143 TYR~? 15.18 CL CL J2016 A 142 LEU J 99 LEU.? 13.96 CL CL J2016 A 165 LYS J 142 LYS~? 19.62 CL CL J2016 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 136.50 183.91 136.49 136.50 184.93 133.88 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 134.68 187.63 129.42 132.80 188.60 128.96 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR K 143 TYR~? 15.99 O3 GOL K3009 A 142 LEU K 99 LEU.? 15.90 CL CL K2027 A 165 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 201.16 138.32 187.50 201.22 135.84 188.82 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 202.94 131.53 192.10 204.93 130.90 192.94 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR L 143 TYR~? 15.30 CL CL L2009 A 142 LEU L 99 LEU.? 13.85 CL CL L2009 A 165 LYS L 142 LYS~? 23.18 CL CL L2009 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 131.10 157.77 197.34 130.52 156.95 199.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 127.71 154.64 204.45 125.47 154.23 204.74 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR M 143 TYR~? 15.40 CL CL M2017 A 142 LEU M 99 LEU.? 13.91 CL CL M2017 A 165 LYS M 142 LYS~? 19.90 CL CL M2017 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 134.88 201.35 179.85 134.66 203.97 180.76 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 132.61 208.78 183.22 130.76 209.95 183.74 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR N 143 TYR~? 10.73 O2 GOL N3029 A 142 LEU N 99 LEU.? 16.24 CL CL N2030 A 165 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 204.41 150.24 142.39 204.78 148.95 139.97 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 206.93 145.59 136.00 209.00 144.75 135.80 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR O 143 TYR~? 11.76 C3 GOL O3026 A 142 LEU O 99 LEU.? 14.37 CL CL O2018 A 165 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 133.04 140.38 153.60 132.61 137.79 152.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 130.52 133.57 149.85 128.56 133.58 148.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR P 143 TYR~? 15.20 CL CL P2019 A 142 LEU P 99 LEU.? 13.98 CL CL P2019 A 165 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 202.86 183.43 199.65 203.11 184.67 202.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 205.13 187.68 206.38 207.13 188.38 206.85 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 204.59 186.28 195.60 209.96 186.96 196.62 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 16 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR B 143 TYR~? 10.77 O2 GOL B3024 B 142 LEU B 99 LEU.? 13.87 CL CL B2010 B 165 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 23.25 68.41 18.58 23.33 69.19 15.92 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 21.93 71.67 10.80 20.15 72.56 9.78 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR H 143 TYR~? 11.30 O2 GOL H3016 B 142 LEU H 99 LEU.? 14.24 CL CL H2014 B 165 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 86.77 67.99 85.16 86.88 69.36 87.57 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 88.74 72.63 91.84 90.81 73.32 92.17 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR K 143 TYR~? 15.99 O3 GOL K3009 B 142 LEU K 99 LEU.? 15.90 CL CL K2027 B 165 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 201.16 138.32 187.50 201.22 135.84 188.82 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 202.94 131.53 192.10 204.93 130.90 192.94 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR L 143 TYR~? 15.30 CL CL L2009 B 142 LEU L 99 LEU.? 13.85 CL CL L2009 B 165 LYS L 142 LYS~? 23.18 CL CL L2009 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 131.10 157.77 197.34 130.52 156.95 199.97 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 127.71 154.64 204.45 125.47 154.23 204.74 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR M 143 TYR~? 15.40 CL CL M2017 B 142 LEU M 99 LEU.? 13.91 CL CL M2017 B 165 LYS M 142 LYS~? 19.90 CL CL M2017 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 134.88 201.35 179.85 134.66 203.97 180.76 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 132.61 208.78 183.22 130.76 209.95 183.74 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 133.20 197.60 183.11 127.92 198.39 183.89 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR B 143 TYR~? 10.77 O2 GOL B3024 C 142 LEU B 99 LEU.? 13.87 CL CL B2010 C 165 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 23.25 68.41 18.58 23.33 69.19 15.92 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 21.93 71.67 10.80 20.15 72.56 9.78 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR L 143 TYR~? 15.30 CL CL L2009 C 142 LEU L 99 LEU.? 13.85 CL CL L2009 C 165 LYS L 142 LYS~? 23.18 CL CL L2009 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 131.10 157.77 197.34 130.52 156.95 199.97 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 127.71 154.64 204.45 125.47 154.23 204.74 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR M 143 TYR~? 15.40 CL CL M2017 C 142 LEU M 99 LEU.? 13.91 CL CL M2017 C 165 LYS M 142 LYS~? 19.90 CL CL M2017 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 134.88 201.35 179.85 134.66 203.97 180.76 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 132.61 208.78 183.22 130.76 209.95 183.74 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 133.20 197.60 183.11 127.92 198.39 183.89 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR B 143 TYR~? 10.77 O2 GOL B3024 D 142 LEU B 99 LEU.? 13.87 CL CL B2010 D 165 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 23.25 68.41 18.58 23.33 69.19 15.92 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 21.93 71.67 10.80 20.15 72.56 9.78 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR H 143 TYR~? 11.30 O2 GOL H3016 D 142 LEU H 99 LEU.? 14.24 CL CL H2014 D 165 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 86.77 67.99 85.16 86.88 69.36 87.57 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 88.74 72.63 91.84 90.81 73.32 92.17 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR K 143 TYR~? 15.99 O3 GOL K3009 D 142 LEU K 99 LEU.? 15.90 CL CL K2027 D 165 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 201.16 138.32 187.50 201.22 135.84 188.82 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 202.94 131.53 192.10 204.93 130.90 192.94 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR L 143 TYR~? 15.30 CL CL L2009 D 142 LEU L 99 LEU.? 13.85 CL CL L2009 D 165 LYS L 142 LYS~? 23.18 CL CL L2009 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 131.10 157.77 197.34 130.52 156.95 199.97 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 127.71 154.64 204.45 125.47 154.23 204.74 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR M 143 TYR~? 15.40 CL CL M2017 D 142 LEU M 99 LEU.? 13.91 CL CL M2017 D 165 LYS M 142 LYS~? 19.90 CL CL M2017 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 134.88 201.35 179.85 134.66 203.97 180.76 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 132.61 208.78 183.22 130.76 209.95 183.74 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 133.20 197.60 183.11 127.92 198.39 183.89 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 51 ARG~? 16.54 O3 GOL B3003 A 136 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 246 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 13.48 30.30 107.06 11.75 30.99 109.44 61.69 79.67 29.64 62.00 76.91 30.99 coo 9.46 32.37 115.82 8.50 34.20 115.47 66.40 88.57 34.15 65.18 90.26 34.28 coo 11.99 34.33 109.92 10.08 34.19 110.77 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 51 ARG~? 11.52 O3 GOL B3003 A 136 GLU B 56 GLU.? 9.23 C1 GOL B3003 A 246 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo 13.48 30.30 107.06 11.75 30.99 109.44 56.02 71.46 21.90 55.03 71.54 24.81 coo 9.46 32.37 115.82 8.50 34.20 115.47 52.16 66.04 13.94 53.39 65.68 12.39 coo 11.99 34.33 109.92 10.08 34.19 110.77 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 51 ARG~? 15.50 O3 GOL D3005 A 136 GLU C 56 GLU~? 17.52 CL CL C2004 A 246 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 13.48 30.30 107.06 11.75 30.99 109.44 50.80 26.41 78.15 53.63 27.50 78.75 coo 9.46 32.37 115.82 8.50 34.20 115.47 54.66 16.88 74.36 53.19 15.44 73.98 coo 11.99 34.33 109.92 10.08 34.19 110.77 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 51 ARG~? -12.62 C3 GOL D3005s A 136 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 246 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 13.48 30.30 107.06 11.75 30.99 109.44 44.97 36.17 83.73 45.77 36.49 80.75 coo 9.46 32.37 115.82 8.50 34.20 115.47 40.62 42.19 92.06 41.92 42.65 93.65 coo 11.99 34.33 109.92 10.08 34.19 110.77 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG E 51 ARG~? 12.86 C3 GOL E3004 A 136 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 246 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 13.48 30.30 107.06 11.75 30.99 109.44 51.65 84.19 70.80 51.43 81.15 70.20 coo 9.46 32.37 115.82 8.50 34.20 115.47 49.08 93.57 65.06 50.69 94.83 64.79 coo 11.99 34.33 109.92 10.08 34.19 110.77 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG F 51 ARG~? 18.26 CL CL F2035 A 136 GLU F 56 GLU~? 19.98 CL CL F2035 A 246 GLU F 52 GLU~? -24.25 CL CL F2035s coo 13.48 30.30 107.06 11.75 30.99 109.44 56.56 29.17 27.33 58.39 29.67 29.78 coo 9.46 32.37 115.82 8.50 34.20 115.47 62.56 32.21 18.10 61.29 32.37 16.50 coo 11.99 34.33 109.92 10.08 34.19 110.77 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG G 51 ARG~? 21.90 CL CL C2006 A 136 GLU G 56 GLU.? 17.83 CL CL C2004 A 246 GLU G 52 GLU~? -23.30 CL CL C2006s coo 13.48 30.30 107.06 11.75 30.99 109.44 49.60 22.70 34.88 49.12 25.71 35.34 coo 9.46 32.37 115.82 8.50 34.20 115.47 43.97 14.81 40.22 44.85 13.00 40.58 coo 11.99 34.33 109.92 10.08 34.19 110.77 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG H 51 ARG~? -11.05 O1 GOL H3006s A 136 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 246 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 13.48 30.30 107.06 11.75 30.99 109.44 55.75 78.18 80.83 58.67 78.05 79.79 coo 9.46 32.37 115.82 8.50 34.20 115.47 58.45 73.39 90.18 56.86 73.32 91.53 coo 11.99 34.33 109.92 10.08 34.19 110.77 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG I 51 ARG~? 21.58 CL CL I2007 A 136 GLU I 56 GLU.? 17.30 CL CL I2001 A 246 GLU I 52 GLU~? -23.17 CL CL I2007s coo 13.48 30.30 107.06 11.75 30.99 109.44 174.23 196.17 146.19 174.71 193.30 147.29 coo 9.46 32.37 115.82 8.50 34.20 115.47 178.97 205.20 150.86 177.96 206.96 151.01 coo 11.99 34.33 109.92 10.08 34.19 110.77 174.67 202.46 145.17 173.69 203.91 143.96 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 10 3 # 10 A 45 ARG J 51 ARG~? 27.44 CL CL J2002 A 136 GLU J 56 GLU.? 17.48 CL CL J2002 A 246 GLU J 52 GLU~? -23.89 CL CL J2002s coo 13.48 30.30 107.06 11.75 30.99 109.44 168.80 189.12 137.91 166.15 189.45 139.46 coo 9.46 32.37 115.82 8.50 34.20 115.47 164.69 183.53 129.34 166.31 182.92 128.17 coo 11.99 34.33 109.92 10.08 34.19 110.77 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 11 3 # 11 A 45 ARG K 51 ARG~? -10.79 O3 GOL K3011s A 136 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 246 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 13.48 30.30 107.06 11.75 30.99 109.44 168.73 140.32 192.51 171.31 141.97 192.79 coo 9.46 32.37 115.82 8.50 34.20 115.47 172.89 131.40 187.88 171.30 130.10 187.44 coo 11.99 34.33 109.92 10.08 34.19 110.77 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 12 3 # 12 A 45 ARG L 51 ARG~? 16.39 O3 GOL K3011 A 136 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 246 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 13.48 30.30 107.06 11.75 30.99 109.44 163.01 149.53 198.74 162.90 150.47 195.82 coo 9.46 32.37 115.82 8.50 34.20 115.47 158.53 155.21 207.26 159.92 155.54 208.73 coo 11.99 34.33 109.92 10.08 34.19 110.77 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 13 3 # 13 A 45 ARG L 55 ARG~? 21.00 O3 GOL K3011 A 136 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 246 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 13.48 30.30 107.06 11.75 30.99 109.44 158.05 151.49 200.24 157.97 153.99 198.35 coo 9.46 32.37 115.82 8.50 34.20 115.47 158.53 155.21 207.26 159.92 155.54 208.73 coo 11.99 34.33 109.92 10.08 34.19 110.77 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 14 3 # 14 A 45 ARG M 51 ARG~? -9.68 O2 GOL M3007s A 136 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 246 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 13.48 30.30 107.06 11.75 30.99 109.44 166.66 199.07 188.11 163.90 199.62 189.28 coo 9.46 32.37 115.82 8.50 34.20 115.47 163.29 208.10 182.55 164.69 209.62 182.16 coo 11.99 34.33 109.92 10.08 34.19 110.77 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 15 3 # 15 A 45 ARG N 51 ARG~? 10.93 O1 GOL N3008 A 136 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 246 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 13.48 30.30 107.06 11.75 30.99 109.44 172.16 145.36 140.78 174.78 144.98 142.37 coo 9.46 32.37 115.82 8.50 34.20 115.47 177.02 149.87 132.23 175.77 150.16 130.55 coo 11.99 34.33 109.92 10.08 34.19 110.77 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 16 3 # 16 A 45 ARG O 51 ARG~? 16.43 O1 GOL N3008 A 136 GLU O 56 GLU.? 16.78 CL CL O2036 A 246 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 13.48 30.30 107.06 11.75 30.99 109.44 165.78 138.84 148.96 164.30 141.49 149.44 coo 9.46 32.37 115.82 8.50 34.20 115.47 160.60 130.40 154.07 161.73 128.68 154.54 coo 11.99 34.33 109.92 10.08 34.19 110.77 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 17 3 # 17 A 45 ARG P 51 ARG~? 14.75 O3 GOL M3007 A 136 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 246 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 13.48 30.30 107.06 11.75 30.99 109.44 171.10 192.14 197.11 173.97 192.46 196.07 coo 9.46 32.37 115.82 8.50 34.20 115.47 174.58 187.04 206.13 173.17 186.75 207.60 coo 11.99 34.33 109.92 10.08 34.19 110.77 170.60 192.65 202.74 169.53 193.98 203.95 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 17 hits 1fhl_c00 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER P 160 SER~? 15.55 O2 GOL P3014 272 CYH P 153 CYH.? 9.50 O2 GOL P3014 312 GLU P 163 GLU~? 11.95 O2 GOL P3014 coo 27.57 5.78 14.13 25.30 6.31 13.99 220.63 173.93 200.59 220.88 174.20 198.17 coo 18.48 7.50 15.98 21.17 6.92 15.38 213.41 171.20 193.92 214.01 173.48 195.24 coo 22.30 10.15 12.52 24.07 9.52 13.47 218.06 173.97 196.16 217.79 171.96 196.61 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 1 hits 1fnb_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 51 ARG~? 16.54 O3 GOL B3003 A 136 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 246 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo 13.94 29.84 106.80 11.67 30.40 108.79 61.69 79.67 29.64 62.00 76.91 30.99 coo 9.52 31.97 115.23 8.45 33.74 114.72 66.40 88.57 34.15 65.18 90.26 34.28 coo 11.92 33.82 109.35 10.10 33.50 110.39 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 51 ARG~? 11.52 O3 GOL B3003 A 136 GLU B 56 GLU.? 9.23 C1 GOL B3003 A 246 GLU B 52 GLU~? -2.63 O3 GOL B3003s coo 13.94 29.84 106.80 11.67 30.40 108.79 56.02 71.46 21.90 55.03 71.54 24.81 coo 9.52 31.97 115.23 8.45 33.74 114.72 52.16 66.04 13.94 53.39 65.68 12.39 coo 11.92 33.82 109.35 10.10 33.50 110.39 57.04 71.55 17.08 58.10 72.98 16.00 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG C 51 ARG~? 15.50 O3 GOL D3005 A 136 GLU C 56 GLU~? 17.52 CL CL C2004 A 246 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 13.94 29.84 106.80 11.67 30.40 108.79 50.80 26.41 78.15 53.63 27.50 78.75 coo 9.52 31.97 115.23 8.45 33.74 114.72 54.66 16.88 74.36 53.19 15.44 73.98 coo 11.92 33.82 109.35 10.10 33.50 110.39 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG D 51 ARG~? -12.62 C3 GOL D3005s A 136 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 246 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 13.94 29.84 106.80 11.67 30.40 108.79 44.97 36.17 83.73 45.77 36.49 80.75 coo 9.52 31.97 115.23 8.45 33.74 114.72 40.62 42.19 92.06 41.92 42.65 93.65 coo 11.92 33.82 109.35 10.10 33.50 110.39 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG E 51 ARG~? 12.86 C3 GOL E3004 A 136 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 246 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo 13.94 29.84 106.80 11.67 30.40 108.79 51.65 84.19 70.80 51.43 81.15 70.20 coo 9.52 31.97 115.23 8.45 33.74 114.72 49.08 93.57 65.06 50.69 94.83 64.79 coo 11.92 33.82 109.35 10.10 33.50 110.39 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG F 51 ARG~? 18.26 CL CL F2035 A 136 GLU F 56 GLU~? 19.98 CL CL F2035 A 246 GLU F 52 GLU~? -24.25 CL CL F2035s coo 13.94 29.84 106.80 11.67 30.40 108.79 56.56 29.17 27.33 58.39 29.67 29.78 coo 9.52 31.97 115.23 8.45 33.74 114.72 62.56 32.21 18.10 61.29 32.37 16.50 coo 11.92 33.82 109.35 10.10 33.50 110.39 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG G 51 ARG~? 21.90 CL CL C2006 A 136 GLU G 56 GLU.? 17.83 CL CL C2004 A 246 GLU G 52 GLU~? -23.30 CL CL C2006s coo 13.94 29.84 106.80 11.67 30.40 108.79 49.60 22.70 34.88 49.12 25.71 35.34 coo 9.52 31.97 115.23 8.45 33.74 114.72 43.97 14.81 40.22 44.85 13.00 40.58 coo 11.92 33.82 109.35 10.10 33.50 110.39 49.29 16.65 35.00 50.30 14.93 34.20 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG H 51 ARG~? -11.05 O1 GOL H3006s A 136 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 246 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 13.94 29.84 106.80 11.67 30.40 108.79 55.75 78.18 80.83 58.67 78.05 79.79 coo 9.52 31.97 115.23 8.45 33.74 114.72 58.45 73.39 90.18 56.86 73.32 91.53 coo 11.92 33.82 109.35 10.10 33.50 110.39 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 9 3 # 9 A 45 ARG I 51 ARG~? 21.58 CL CL I2007 A 136 GLU I 56 GLU.? 17.30 CL CL I2001 A 246 GLU I 52 GLU~? -23.17 CL CL I2007s coo 13.94 29.84 106.80 11.67 30.40 108.79 174.23 196.17 146.19 174.71 193.30 147.29 coo 9.52 31.97 115.23 8.45 33.74 114.72 178.97 205.20 150.86 177.96 206.96 151.01 coo 11.92 33.82 109.35 10.10 33.50 110.39 174.67 202.46 145.17 173.69 203.91 143.96 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 10 3 # 10 A 45 ARG J 51 ARG~? 27.44 CL CL J2002 A 136 GLU J 56 GLU.? 17.48 CL CL J2002 A 246 GLU J 52 GLU~? -23.89 CL CL J2002s coo 13.94 29.84 106.80 11.67 30.40 108.79 168.80 189.12 137.91 166.15 189.45 139.46 coo 9.52 31.97 115.23 8.45 33.74 114.72 164.69 183.53 129.34 166.31 182.92 128.17 coo 11.92 33.82 109.35 10.10 33.50 110.39 169.71 188.73 132.35 170.94 189.67 130.91 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 11 3 # 11 A 45 ARG K 51 ARG~? -10.79 O3 GOL K3011s A 136 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 246 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 13.94 29.84 106.80 11.67 30.40 108.79 168.73 140.32 192.51 171.31 141.97 192.79 coo 9.52 31.97 115.23 8.45 33.74 114.72 172.89 131.40 187.88 171.30 130.10 187.44 coo 11.92 33.82 109.35 10.10 33.50 110.39 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 12 3 # 12 A 45 ARG L 51 ARG~? 16.39 O3 GOL K3011 A 136 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 246 GLU L 52 GLU~? -16.81 O3 GOL K3011s coo 13.94 29.84 106.80 11.67 30.40 108.79 163.01 149.53 198.74 162.90 150.47 195.82 coo 9.52 31.97 115.23 8.45 33.74 114.72 158.53 155.21 207.26 159.92 155.54 208.73 coo 11.92 33.82 109.35 10.10 33.50 110.39 163.03 149.29 204.90 163.96 148.28 206.51 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 13 3 # 13 A 45 ARG M 51 ARG~? -9.68 O2 GOL M3007s A 136 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 246 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 13.94 29.84 106.80 11.67 30.40 108.79 166.66 199.07 188.11 163.90 199.62 189.28 coo 9.52 31.97 115.23 8.45 33.74 114.72 163.29 208.10 182.55 164.69 209.62 182.16 coo 11.92 33.82 109.35 10.10 33.50 110.39 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 14 3 # 14 A 45 ARG N 51 ARG~? 10.93 O1 GOL N3008 A 136 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 246 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 13.94 29.84 106.80 11.67 30.40 108.79 172.16 145.36 140.78 174.78 144.98 142.37 coo 9.52 31.97 115.23 8.45 33.74 114.72 177.02 149.87 132.23 175.77 150.16 130.55 coo 11.92 33.82 109.35 10.10 33.50 110.39 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 15 3 # 15 A 45 ARG O 51 ARG~? 16.43 O1 GOL N3008 A 136 GLU O 56 GLU.? 16.78 CL CL O2036 A 246 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 13.94 29.84 106.80 11.67 30.40 108.79 165.78 138.84 148.96 164.30 141.49 149.44 coo 9.52 31.97 115.23 8.45 33.74 114.72 160.60 130.40 154.07 161.73 128.68 154.54 coo 11.92 33.82 109.35 10.10 33.50 110.39 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 16 3 # 16 A 45 ARG P 51 ARG~? 14.75 O3 GOL M3007 A 136 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 246 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 13.94 29.84 106.80 11.67 30.40 108.79 171.10 192.14 197.11 173.97 192.46 196.07 coo 9.52 31.97 115.23 8.45 33.74 114.72 174.58 187.04 206.13 173.17 186.75 207.60 coo 11.92 33.82 109.35 10.10 33.50 110.39 170.60 192.65 202.74 169.53 193.98 203.95 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 16 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 319 ASP A 54 ASP~? 22.76 O3 GOL B3003 A 359 ARG A 51 ARG~? 16.54 O3 GOL B3003 coo 14.41 12.40 16.42 12.92 13.74 15.71 66.40 88.57 34.15 65.18 90.26 34.28 coo 12.25 13.04 23.85 11.56 15.02 23.93 63.60 81.91 35.55 61.73 81.46 36.38 coo 10.89 14.95 28.28 12.39 12.53 29.31 61.69 79.67 29.64 62.00 76.91 30.99 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 4 GLU.? 22.11 C1 GOL B3003 A 319 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 359 ARG B 51 ARG~? 11.52 O3 GOL B3003 coo 14.41 12.40 16.42 12.92 13.74 15.71 54.73 58.55 26.68 55.86 57.12 27.84 coo 12.25 13.04 23.85 11.56 15.02 23.93 53.08 65.82 20.87 54.46 64.71 21.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 56.02 71.46 21.90 55.03 71.54 24.81 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 4 GLU.? 22.11 C1 GOL B3003 A 319 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 359 ARG B 55 ARG~? -14.24 O1 GOL B3003s coo 14.41 12.40 16.42 12.92 13.74 15.71 54.73 58.55 26.68 55.86 57.12 27.84 coo 12.25 13.04 23.85 11.56 15.02 23.93 53.08 65.82 20.87 54.46 64.71 21.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 50.06 69.68 20.36 47.07 69.49 19.37 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 A 317 GLU C 4 GLU.? 9.47 CL CL C2006 A 319 ASP C 54 ASP~? 14.99 CL CL C2006 A 359 ARG C 51 ARG~? 15.50 O3 GOL D3005 coo 14.41 12.40 16.42 12.92 13.74 15.71 51.62 28.50 64.04 50.84 28.75 62.00 coo 12.25 13.04 23.85 11.56 15.02 23.93 53.32 23.86 72.39 51.93 24.66 71.07 coo 10.89 14.95 28.28 12.39 12.53 29.31 50.80 26.41 78.15 53.63 27.50 78.75 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 A 317 GLU C 4 GLU.? 9.47 CL CL C2006 A 319 ASP C 54 ASP~? 14.99 CL CL C2006 A 359 ARG C 55 ARG~? 19.41 CL CL C2006 coo 14.41 12.40 16.42 12.92 13.74 15.71 51.62 28.50 64.04 50.84 28.75 62.00 coo 12.25 13.04 23.85 11.56 15.02 23.93 53.32 23.86 72.39 51.93 24.66 71.07 coo 10.89 14.95 28.28 12.39 12.53 29.31 55.97 24.40 76.93 55.45 26.29 74.49 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 A 317 GLU C 56 GLU~? 17.52 CL CL C2004 A 319 ASP C 54 ASP~? 14.99 CL CL C2006 A 359 ARG C 51 ARG~? 15.50 O3 GOL D3005 coo 14.41 12.40 16.42 12.92 13.74 15.71 54.66 16.88 74.36 53.19 15.44 73.98 coo 12.25 13.04 23.85 11.56 15.02 23.93 53.32 23.86 72.39 51.93 24.66 71.07 coo 10.89 14.95 28.28 12.39 12.53 29.31 50.80 26.41 78.15 53.63 27.50 78.75 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 A 317 GLU D 4 GLU.? 10.36 CL CL D2008 A 319 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 359 ARG D 51 ARG~? -12.62 C3 GOL D3005s coo 14.41 12.40 16.42 12.92 13.74 15.71 47.42 48.67 79.11 48.78 50.16 78.53 coo 12.25 13.04 23.85 11.56 15.02 23.93 43.67 42.20 85.12 45.49 43.03 84.45 coo 10.89 14.95 28.28 12.39 12.53 29.31 44.97 36.17 83.73 45.77 36.49 80.75 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 A 317 GLU D 4 GLU.? 10.36 CL CL D2008 A 319 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 359 ARG D 55 ARG~? 14.96 O1 GOL D3005 coo 14.41 12.40 16.42 12.92 13.74 15.71 47.42 48.67 79.11 48.78 50.16 78.53 coo 12.25 13.04 23.85 11.56 15.02 23.93 43.67 42.20 85.12 45.49 43.03 84.45 coo 10.89 14.95 28.28 12.39 12.53 29.31 39.97 38.45 84.97 39.00 40.64 83.01 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 A 317 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 319 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 359 ARG D 51 ARG~? -12.62 C3 GOL D3005s coo 14.41 12.40 16.42 12.92 13.74 15.71 40.62 42.19 92.06 41.92 42.65 93.65 coo 12.25 13.04 23.85 11.56 15.02 23.93 43.67 42.20 85.12 45.49 43.03 84.45 coo 10.89 14.95 28.28 12.39 12.53 29.31 44.97 36.17 83.73 45.77 36.49 80.75 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 A 317 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 319 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 359 ARG E 51 ARG~? 12.86 C3 GOL E3004 coo 14.41 12.40 16.42 12.92 13.74 15.71 49.08 93.57 65.06 50.69 94.83 64.79 coo 12.25 13.04 23.85 11.56 15.02 23.93 50.61 86.23 65.01 52.31 85.22 64.30 coo 10.89 14.95 28.28 12.39 12.53 29.31 51.65 84.19 70.80 51.43 81.15 70.20 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 11 3 # 11 A 317 GLU F 8 GLU~? 22.40 CL CL F2035 A 319 ASP F 54 ASP~? 17.55 CL CL F2035 A 359 ARG F 51 ARG~? 18.26 CL CL F2035 coo 14.41 12.40 16.42 12.92 13.74 15.71 54.32 40.00 29.52 52.85 39.83 30.97 coo 12.25 13.04 23.85 11.56 15.02 23.93 59.85 34.12 24.67 58.32 35.47 25.18 coo 10.89 14.95 28.28 12.39 12.53 29.31 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 12 3 # 12 A 317 GLU F 8 GLU~? 22.40 CL CL F2035 A 319 ASP F 54 ASP~? 17.55 CL CL F2035 A 359 ARG F 55 ARG~? 14.19 CL CL F2035 coo 14.41 12.40 16.42 12.92 13.74 15.71 54.32 40.00 29.52 52.85 39.83 30.97 coo 12.25 13.04 23.85 11.56 15.02 23.93 59.85 34.12 24.67 58.32 35.47 25.18 coo 10.89 14.95 28.28 12.39 12.53 29.31 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 13 3 # 13 A 317 GLU F 56 GLU~? 19.98 CL CL F2035 A 319 ASP F 54 ASP~? 17.55 CL CL F2035 A 359 ARG F 51 ARG~? 18.26 CL CL F2035 coo 14.41 12.40 16.42 12.92 13.74 15.71 62.56 32.21 18.10 61.29 32.37 16.50 coo 12.25 13.04 23.85 11.56 15.02 23.93 59.85 34.12 24.67 58.32 35.47 25.18 coo 10.89 14.95 28.28 12.39 12.53 29.31 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 14 3 # 14 A 317 GLU G 56 GLU.? 17.83 CL CL C2004 A 319 ASP G 54 ASP~? 15.07 CL CL C2006 A 359 ARG G 51 ARG~? 21.90 CL CL C2006 coo 14.41 12.40 16.42 12.92 13.74 15.71 43.97 14.81 40.22 44.85 13.00 40.58 coo 12.25 13.04 23.85 11.56 15.02 23.93 46.65 21.52 40.60 48.29 22.27 41.77 coo 10.89 14.95 28.28 12.39 12.53 29.31 49.60 22.70 34.88 49.12 25.71 35.34 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 15 3 # 15 A 317 GLU H 4 GLU.? 9.25 CL CL D2008 A 319 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 359 ARG H 51 ARG~? -11.05 O1 GOL H3006s coo 14.41 12.40 16.42 12.92 13.74 15.71 53.12 64.06 78.47 52.04 62.20 78.33 coo 12.25 13.04 23.85 11.56 15.02 23.93 56.87 71.80 83.08 55.07 70.98 82.33 coo 10.89 14.95 28.28 12.39 12.53 29.31 55.75 78.18 80.83 58.67 78.05 79.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 16 3 # 16 A 317 GLU H 4 GLU.? 9.25 CL CL D2008 A 319 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 359 ARG H 55 ARG~? 13.48 O3 GOL H3006 coo 14.41 12.40 16.42 12.92 13.74 15.71 53.12 64.06 78.47 52.04 62.20 78.33 coo 12.25 13.04 23.85 11.56 15.02 23.93 56.87 71.80 83.08 55.07 70.98 82.33 coo 10.89 14.95 28.28 12.39 12.53 29.31 60.33 75.55 82.58 59.37 73.14 80.81 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 17 3 # 17 A 317 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 319 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 359 ARG H 51 ARG~? -11.05 O1 GOL H3006s coo 14.41 12.40 16.42 12.92 13.74 15.71 58.45 73.39 90.18 56.86 73.32 91.53 coo 12.25 13.04 23.85 11.56 15.02 23.93 56.87 71.80 83.08 55.07 70.98 82.33 coo 10.89 14.95 28.28 12.39 12.53 29.31 55.75 78.18 80.83 58.67 78.05 79.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 18 3 # 18 A 317 GLU I 4 GLU.? 9.55 CL CL I2007 A 319 ASP I 54 ASP~? 15.17 CL CL I2007 A 359 ARG I 51 ARG~? 21.58 CL CL I2007 coo 14.41 12.40 16.42 12.92 13.74 15.71 172.87 194.13 159.37 171.68 193.98 161.14 coo 12.25 13.04 23.85 11.56 15.02 23.93 176.64 198.53 151.72 174.93 197.89 152.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 19 3 # 19 A 317 GLU I 4 GLU.? 9.55 CL CL I2007 A 319 ASP I 54 ASP~? 15.17 CL CL I2007 A 359 ARG I 55 ARG~? 19.02 CL CL I2007 coo 14.41 12.40 16.42 12.92 13.74 15.71 172.87 194.13 159.37 171.68 193.98 161.14 coo 12.25 13.04 23.85 11.56 15.02 23.93 176.64 198.53 151.72 174.93 197.89 152.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 179.74 197.90 148.59 178.27 195.79 150.32 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 20 3 # 20 A 317 GLU I 8 GLU~? 13.89 CL CL I2007 A 319 ASP I 54 ASP~? 15.17 CL CL I2007 A 359 ARG I 51 ARG~? 21.58 CL CL I2007 coo 14.41 12.40 16.42 12.92 13.74 15.71 170.22 193.07 156.46 171.58 191.67 157.15 coo 12.25 13.04 23.85 11.56 15.02 23.93 176.64 198.53 151.72 174.93 197.89 152.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 21 3 # 21 A 317 GLU I 8 GLU~? 13.89 CL CL I2007 A 319 ASP I 54 ASP~? 15.17 CL CL I2007 A 359 ARG I 55 ARG~? 19.02 CL CL I2007 coo 14.41 12.40 16.42 12.92 13.74 15.71 170.22 193.07 156.46 171.58 191.67 157.15 coo 12.25 13.04 23.85 11.56 15.02 23.93 176.64 198.53 151.72 174.93 197.89 152.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 179.74 197.90 148.59 178.27 195.79 150.32 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 22 3 # 22 A 317 GLU I 56 GLU.? 17.30 CL CL I2001 A 319 ASP I 54 ASP~? 15.17 CL CL I2007 A 359 ARG I 51 ARG~? 21.58 CL CL I2007 coo 14.41 12.40 16.42 12.92 13.74 15.71 178.97 205.20 150.86 177.96 206.96 151.01 coo 12.25 13.04 23.85 11.56 15.02 23.93 176.64 198.53 151.72 174.93 197.89 152.71 coo 10.89 14.95 28.28 12.39 12.53 29.31 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 23 3 # 23 A 317 GLU J 56 GLU.? 17.48 CL CL J2002 A 319 ASP J 54 ASP~? 19.87 CL CL J2002 A 359 ARG J 51 ARG~? 27.44 CL CL J2002 coo 14.41 12.40 16.42 12.92 13.74 15.71 164.69 183.53 129.34 166.31 182.92 128.17 coo 12.25 13.04 23.85 11.56 15.02 23.93 166.52 182.87 136.75 168.05 181.78 137.64 coo 10.89 14.95 28.28 12.39 12.53 29.31 168.80 189.12 137.91 166.15 189.45 139.46 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 24 3 # 24 A 317 GLU K 4 GLU.? 10.47 CL CL K2003 A 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 359 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 14.41 12.40 16.42 12.92 13.74 15.71 168.96 143.52 178.36 168.13 144.65 176.72 coo 12.25 13.04 23.85 11.56 15.02 23.93 171.09 138.55 186.41 169.55 139.29 185.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 25 3 # 25 A 317 GLU K 4 GLU.? 10.47 CL CL K2003 A 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 359 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 168.96 143.52 178.36 168.13 144.65 176.72 coo 12.25 13.04 23.85 11.56 15.02 23.93 171.09 138.55 186.41 169.55 139.29 185.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 26 3 # 26 A 317 GLU K 8 GLU~? 14.31 CL CL K2003 A 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 359 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 14.41 12.40 16.42 12.92 13.74 15.71 166.29 144.34 181.01 165.98 146.34 180.71 coo 12.25 13.04 23.85 11.56 15.02 23.93 171.09 138.55 186.41 169.55 139.29 185.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 27 3 # 27 A 317 GLU K 8 GLU~? 14.31 CL CL K2003 A 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 359 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 166.29 144.34 181.01 165.98 146.34 180.71 coo 12.25 13.04 23.85 11.56 15.02 23.93 171.09 138.55 186.41 169.55 139.29 185.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 28 3 # 28 A 317 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 359 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 14.41 12.40 16.42 12.92 13.74 15.71 172.89 131.40 187.88 171.30 130.10 187.44 coo 12.25 13.04 23.85 11.56 15.02 23.93 171.09 138.55 186.41 169.55 139.29 185.16 coo 10.89 14.95 28.28 12.39 12.53 29.31 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 29 3 # 29 A 317 GLU L 4 GLU.? 26.61 O1 GOL L3028 A 319 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 359 ARG L 51 ARG~? 16.39 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 164.36 162.97 195.39 165.70 164.44 194.50 coo 12.25 13.04 23.85 11.56 15.02 23.93 161.13 155.54 200.38 162.83 156.50 199.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 163.01 149.53 198.74 162.90 150.47 195.82 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 30 3 # 30 A 317 GLU L 4 GLU.? 26.61 O1 GOL L3028 A 319 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 359 ARG L 55 ARG~? 21.00 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 164.36 162.97 195.39 165.70 164.44 194.50 coo 12.25 13.04 23.85 11.56 15.02 23.93 161.13 155.54 200.38 162.83 156.50 199.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 158.05 151.49 200.24 157.97 153.99 198.35 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 31 3 # 31 A 317 GLU L 8 GLU~? 26.30 O3 GOL K3011 A 319 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 359 ARG L 51 ARG~? 16.39 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 167.69 159.47 194.26 167.52 160.00 192.23 coo 12.25 13.04 23.85 11.56 15.02 23.93 161.13 155.54 200.38 162.83 156.50 199.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 163.01 149.53 198.74 162.90 150.47 195.82 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 32 3 # 32 A 317 GLU L 8 GLU~? 26.30 O3 GOL K3011 A 319 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 359 ARG L 55 ARG~? 21.00 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 167.69 159.47 194.26 167.52 160.00 192.23 coo 12.25 13.04 23.85 11.56 15.02 23.93 161.13 155.54 200.38 162.83 156.50 199.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 158.05 151.49 200.24 157.97 153.99 198.35 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 33 3 # 33 A 317 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 319 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 359 ARG L 51 ARG~? 16.39 O3 GOL K3011 coo 14.41 12.40 16.42 12.92 13.74 15.71 158.53 155.21 207.26 159.92 155.54 208.73 coo 12.25 13.04 23.85 11.56 15.02 23.93 161.13 155.54 200.38 162.83 156.50 199.58 coo 10.89 14.95 28.28 12.39 12.53 29.31 163.01 149.53 198.74 162.90 150.47 195.82 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 34 3 # 34 A 317 GLU M 4 GLU.? 9.58 CL CL I2007 A 319 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 359 ARG M 51 ARG~? -9.68 O2 GOL M3007s coo 14.41 12.40 16.42 12.92 13.74 15.71 168.05 195.36 174.90 169.23 194.67 173.26 coo 12.25 13.04 23.85 11.56 15.02 23.93 164.95 201.02 181.99 166.71 200.19 181.24 coo 10.89 14.95 28.28 12.39 12.53 29.31 166.66 199.07 188.11 163.90 199.62 189.28 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 35 3 # 35 A 317 GLU M 4 GLU.? 9.58 CL CL I2007 A 319 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 359 ARG M 55 ARG~? 12.49 O2 GOL M3007 coo 14.41 12.40 16.42 12.92 13.74 15.71 168.05 195.36 174.90 169.23 194.67 173.26 coo 12.25 13.04 23.85 11.56 15.02 23.93 164.95 201.02 181.99 166.71 200.19 181.24 coo 10.89 14.95 28.28 12.39 12.53 29.31 162.29 201.15 185.73 159.83 200.25 187.37 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 36 3 # 36 A 317 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 319 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 359 ARG M 51 ARG~? -9.68 O2 GOL M3007s coo 14.41 12.40 16.42 12.92 13.74 15.71 163.29 208.10 182.55 164.69 209.62 182.16 coo 12.25 13.04 23.85 11.56 15.02 23.93 164.95 201.02 181.99 166.71 200.19 181.24 coo 10.89 14.95 28.28 12.39 12.53 29.31 166.66 199.07 188.11 163.90 199.62 189.28 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 37 3 # 37 A 317 GLU N 4 GLU.? 18.86 CL CL J2002 A 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 359 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 171.67 159.43 143.17 170.71 161.26 143.65 coo 12.25 13.04 23.85 11.56 15.02 23.93 174.60 151.44 139.08 172.92 152.56 139.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 38 3 # 38 A 317 GLU N 4 GLU.? 18.86 CL CL J2002 A 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 359 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 171.67 159.43 143.17 170.71 161.26 143.65 coo 12.25 13.04 23.85 11.56 15.02 23.93 174.60 151.44 139.08 172.92 152.56 139.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 39 3 # 39 A 317 GLU N 8 GLU~? 19.42 O1 GOL N3008 A 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 359 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 168.83 156.63 144.46 167.27 156.30 145.82 coo 12.25 13.04 23.85 11.56 15.02 23.93 174.60 151.44 139.08 172.92 152.56 139.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 40 3 # 40 A 317 GLU N 8 GLU~? 19.42 O1 GOL N3008 A 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 359 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 168.83 156.63 144.46 167.27 156.30 145.82 coo 12.25 13.04 23.85 11.56 15.02 23.93 174.60 151.44 139.08 172.92 152.56 139.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 41 3 # 41 A 317 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 359 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 177.02 149.87 132.23 175.77 150.16 130.55 coo 12.25 13.04 23.85 11.56 15.02 23.93 174.60 151.44 139.08 172.92 152.56 139.62 coo 10.89 14.95 28.28 12.39 12.53 29.31 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 42 3 # 42 A 317 GLU O 4 GLU.? 15.52 CL CL K2003 A 319 ASP O 54 ASP~? 15.16 CL CL K2003 A 359 ARG O 51 ARG~? 16.43 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 160.46 142.68 161.06 159.04 143.89 159.95 coo 12.25 13.04 23.85 11.56 15.02 23.93 162.95 137.35 154.91 164.67 137.97 155.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 165.78 138.84 148.96 164.30 141.49 149.44 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 43 3 # 43 A 317 GLU O 4 GLU.? 15.52 CL CL K2003 A 319 ASP O 54 ASP~? 15.16 CL CL K2003 A 359 ARG O 55 ARG~? 19.37 CL CL K2003 coo 14.41 12.40 16.42 12.92 13.74 15.71 160.46 142.68 161.06 159.04 143.89 159.95 coo 12.25 13.04 23.85 11.56 15.02 23.93 162.95 137.35 154.91 164.67 137.97 155.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 159.96 137.60 150.54 160.85 139.64 152.73 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 44 3 # 44 A 317 GLU O 56 GLU.? 16.78 CL CL O2036 A 319 ASP O 54 ASP~? 15.16 CL CL K2003 A 359 ARG O 51 ARG~? 16.43 O1 GOL N3008 coo 14.41 12.40 16.42 12.92 13.74 15.71 160.60 130.40 154.07 161.73 128.68 154.54 coo 12.25 13.04 23.85 11.56 15.02 23.93 162.95 137.35 154.91 164.67 137.97 155.90 coo 10.89 14.95 28.28 12.39 12.53 29.31 165.78 138.84 148.96 164.30 141.49 149.44 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 45 3 # 45 A 317 GLU P 4 GLU.? 25.05 O1 GOL L3028 A 319 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 359 ARG P 51 ARG~? 14.75 O3 GOL M3007 coo 14.41 12.40 16.42 12.92 13.74 15.71 169.41 178.25 194.54 168.21 176.56 193.99 coo 12.25 13.04 23.85 11.56 15.02 23.93 172.77 185.90 199.12 171.10 184.95 198.29 coo 10.89 14.95 28.28 12.39 12.53 29.31 171.10 192.14 197.11 173.97 192.46 196.07 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 46 3 # 46 A 317 GLU P 4 GLU.? 25.05 O1 GOL L3028 A 319 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 359 ARG P 55 ARG~? 20.09 O3 GOL M3007 coo 14.41 12.40 16.42 12.92 13.74 15.71 169.41 178.25 194.54 168.21 176.56 193.99 coo 12.25 13.04 23.85 11.56 15.02 23.93 172.77 185.90 199.12 171.10 184.95 198.29 coo 10.89 14.95 28.28 12.39 12.53 29.31 176.25 189.61 198.56 175.31 187.31 196.65 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 47 3 # 47 A 317 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 319 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 359 ARG P 51 ARG~? 14.75 O3 GOL M3007 coo 14.41 12.40 16.42 12.92 13.74 15.71 174.58 187.04 206.13 173.17 186.75 207.60 coo 12.25 13.04 23.85 11.56 15.02 23.93 172.77 185.90 199.12 171.10 184.95 198.29 coo 10.89 14.95 28.28 12.39 12.53 29.31 171.10 192.14 197.11 173.97 192.46 196.07 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 47 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 73 GLU~? -3.07 O3 GOL A3037s B 319 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 359 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 10.77 13.13 40.94 11.03 14.73 39.51 94.58 81.89 51.70 95.31 83.75 52.44 coo 3.77 12.64 38.21 3.35 14.53 37.39 90.44 78.16 48.76 91.65 76.94 50.06 coo -1.16 15.32 35.60 -3.32 13.56 36.98 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 4 GLU.? 22.11 C1 GOL B3003 B 319 ASP B 54 ASP~? 13.29 O3 GOL B3003 B 359 ARG B 51 ARG~? 11.52 O3 GOL B3003 coo 10.77 13.13 40.94 11.03 14.73 39.51 54.73 58.55 26.68 55.86 57.12 27.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 53.08 65.82 20.87 54.46 64.71 21.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 56.02 71.46 21.90 55.03 71.54 24.81 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU B 4 GLU.? 22.11 C1 GOL B3003 B 319 ASP B 54 ASP~? 13.29 O3 GOL B3003 B 359 ARG B 55 ARG~? -14.24 O1 GOL B3003s coo 10.77 13.13 40.94 11.03 14.73 39.51 54.73 58.55 26.68 55.86 57.12 27.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 53.08 65.82 20.87 54.46 64.71 21.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 50.06 69.68 20.36 47.07 69.49 19.37 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 73 GLU~? 6.38 O3 GOL B3023 B 319 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 359 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 10.77 13.13 40.94 11.03 14.73 39.51 19.80 56.19 16.30 19.32 55.14 14.52 coo 3.77 12.64 38.21 3.35 14.53 37.39 23.66 59.02 20.34 21.93 58.32 21.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU C 73 GLU~? 6.99 O1 GOL C3036 B 319 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 359 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 10.77 13.13 40.94 11.03 14.73 39.51 86.57 17.41 63.72 86.98 15.43 63.06 coo 3.77 12.64 38.21 3.35 14.53 37.39 82.81 22.02 65.69 84.52 22.80 64.66 coo -1.16 15.32 35.60 -3.32 13.56 36.98 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU D 73 GLU~? 5.51 C2 GOL D3020 B 319 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 359 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 10.77 13.13 40.94 11.03 14.73 39.51 12.99 58.17 82.26 12.31 59.24 83.94 coo 3.77 12.64 38.21 3.35 14.53 37.39 16.94 54.59 79.01 15.65 55.42 77.54 coo -1.16 15.32 35.60 -3.32 13.56 36.98 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU E 73 GLU~? -6.85 O1 GOL E3022s B 319 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 359 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 10.77 13.13 40.94 11.03 14.73 39.51 19.82 90.31 48.74 19.50 92.07 47.58 coo 3.77 12.64 38.21 3.35 14.53 37.39 23.07 86.29 52.35 21.57 85.17 51.32 coo -1.16 15.32 35.60 -3.32 13.56 36.98 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU F 8 GLU~? 22.40 CL CL F2035 B 319 ASP F 54 ASP~? 17.55 CL CL F2035 B 359 ARG F 55 ARG~? 14.19 CL CL F2035 coo 10.77 13.13 40.94 11.03 14.73 39.51 54.32 40.00 29.52 52.85 39.83 30.97 coo 3.77 12.64 38.21 3.35 14.53 37.39 59.85 34.12 24.67 58.32 35.47 25.18 coo -1.16 15.32 35.60 -3.32 13.56 36.98 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 9 3 # 9 B 317 GLU F 56 GLU~? 19.98 CL CL F2035 B 319 ASP F 54 ASP~? 17.55 CL CL F2035 B 359 ARG F 51 ARG~? 18.26 CL CL F2035 coo 10.77 13.13 40.94 11.03 14.73 39.51 62.56 32.21 18.10 61.29 32.37 16.50 coo 3.77 12.64 38.21 3.35 14.53 37.39 59.85 34.12 24.67 58.32 35.47 25.18 coo -1.16 15.32 35.60 -3.32 13.56 36.98 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 10 3 # 10 B 317 GLU F 73 GLU~? 5.19 O3 GOL F3039 B 319 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 359 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 10.77 13.13 40.94 11.03 14.73 39.51 93.55 43.24 25.35 94.46 43.89 23.55 coo 3.77 12.64 38.21 3.35 14.53 37.39 88.86 41.25 28.96 90.30 42.22 30.24 coo -1.16 15.32 35.60 -3.32 13.56 36.98 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 11 3 # 11 B 317 GLU G 73 GLU~? 5.63 O1 GOL G3038 B 319 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 359 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 10.77 13.13 40.94 11.03 14.73 39.51 12.93 24.13 49.80 12.04 22.49 50.80 coo 3.77 12.64 38.21 3.35 14.53 37.39 17.70 27.34 47.09 16.19 28.71 47.73 coo -1.16 15.32 35.60 -3.32 13.56 36.98 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 12 3 # 12 B 317 GLU H 73 GLU~? -8.72 CL CL H2014s B 319 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 359 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 10.77 13.13 40.94 11.03 14.73 39.51 87.54 56.19 90.14 87.78 55.44 92.11 coo 3.77 12.64 38.21 3.35 14.53 37.39 84.24 58.93 85.48 85.73 57.59 84.66 coo -1.16 15.32 35.60 -3.32 13.56 36.98 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 13 3 # 13 B 317 GLU I 73 GLU~? -6.03 O3 GOL I3031s B 319 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 359 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 10.77 13.13 40.94 11.03 14.73 39.51 208.30 199.46 166.53 209.06 201.27 167.27 coo 3.77 12.64 38.21 3.35 14.53 37.39 204.37 195.46 163.61 205.75 194.30 164.79 coo -1.16 15.32 35.60 -3.32 13.56 36.98 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 14 3 # 14 B 317 GLU J 73 GLU~? 5.06 O1 GOL J3033 B 319 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 359 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 10.77 13.13 40.94 11.03 14.73 39.51 133.49 171.70 133.63 132.81 170.83 131.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 137.44 174.60 137.57 135.80 173.80 138.69 coo -1.16 15.32 35.60 -3.32 13.56 36.98 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 15 3 # 15 B 317 GLU K 8 GLU~? 14.31 CL CL K2003 B 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 B 359 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 10.77 13.13 40.94 11.03 14.73 39.51 166.29 144.34 181.01 165.98 146.34 180.71 coo 3.77 12.64 38.21 3.35 14.53 37.39 171.09 138.55 186.41 169.55 139.29 185.16 coo -1.16 15.32 35.60 -3.32 13.56 36.98 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 16 3 # 16 B 317 GLU K 8 GLU~? 14.31 CL CL K2003 B 319 ASP K 54 ASP~? 13.11 O1 GOL K3011 B 359 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 10.77 13.13 40.94 11.03 14.73 39.51 166.29 144.34 181.01 165.98 146.34 180.71 coo 3.77 12.64 38.21 3.35 14.53 37.39 171.09 138.55 186.41 169.55 139.29 185.16 coo -1.16 15.32 35.60 -3.32 13.56 36.98 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 17 3 # 17 B 317 GLU K 73 GLU~? 7.36 C3 GOL K3041 B 319 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 359 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 10.77 13.13 40.94 11.03 14.73 39.51 204.07 133.93 175.85 204.65 132.02 175.03 coo 3.77 12.64 38.21 3.35 14.53 37.39 200.17 138.24 178.11 201.77 139.28 177.19 coo -1.16 15.32 35.60 -3.32 13.56 36.98 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 18 3 # 18 B 317 GLU L 73 GLU~? 5.94 O3 GOL L3027 B 319 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 359 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 10.77 13.13 40.94 11.03 14.73 39.51 129.44 170.32 199.72 128.69 171.38 201.39 coo 3.77 12.64 38.21 3.35 14.53 37.39 133.34 166.97 196.27 132.03 168.03 194.96 coo -1.16 15.32 35.60 -3.32 13.56 36.98 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 19 3 # 19 B 317 GLU M 73 GLU~? -3.31 O3 GOL M3042s B 319 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 359 ARG M 66 ARG~? -13.90 O3 GOL M3042s coo 10.77 13.13 40.94 11.03 14.73 39.51 133.35 204.22 167.43 132.84 205.99 166.43 coo 3.77 12.64 38.21 3.35 14.53 37.39 136.87 200.18 170.79 135.36 199.08 169.77 coo -1.16 15.32 35.60 -3.32 13.56 36.98 143.89 198.49 167.11 144.75 199.90 164.48 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 20 3 # 20 B 317 GLU N 4 GLU.? 18.86 CL CL J2002 B 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 B 359 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 10.77 13.13 40.94 11.03 14.73 39.51 171.67 159.43 143.17 170.71 161.26 143.65 coo 3.77 12.64 38.21 3.35 14.53 37.39 174.60 151.44 139.08 172.92 152.56 139.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 21 3 # 21 B 317 GLU N 4 GLU.? 18.86 CL CL J2002 B 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 B 359 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 10.77 13.13 40.94 11.03 14.73 39.51 171.67 159.43 143.17 170.71 161.26 143.65 coo 3.77 12.64 38.21 3.35 14.53 37.39 174.60 151.44 139.08 172.92 152.56 139.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 22 3 # 22 B 317 GLU N 8 GLU~? 19.42 O1 GOL N3008 B 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 B 359 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 10.77 13.13 40.94 11.03 14.73 39.51 168.83 156.63 144.46 167.27 156.30 145.82 coo 3.77 12.64 38.21 3.35 14.53 37.39 174.60 151.44 139.08 172.92 152.56 139.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 23 3 # 23 B 317 GLU N 8 GLU~? 19.42 O1 GOL N3008 B 319 ASP N 54 ASP~? 13.04 O3 GOL N3008 B 359 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 10.77 13.13 40.94 11.03 14.73 39.51 168.83 156.63 144.46 167.27 156.30 145.82 coo 3.77 12.64 38.21 3.35 14.53 37.39 174.60 151.44 139.08 172.92 152.56 139.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 24 3 # 24 B 317 GLU N 73 GLU~? -8.02 O3 GOL N3012s B 319 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 359 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 10.77 13.13 40.94 11.03 14.73 39.51 207.93 161.92 138.37 208.75 162.64 136.53 coo 3.77 12.64 38.21 3.35 14.53 37.39 203.51 159.51 142.26 205.02 160.53 143.48 coo -1.16 15.32 35.60 -3.32 13.56 36.98 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 25 3 # 25 B 317 GLU O 4 GLU.? 15.52 CL CL K2003 B 319 ASP O 54 ASP~? 15.16 CL CL K2003 B 359 ARG O 51 ARG~? 16.43 O1 GOL N3008 coo 10.77 13.13 40.94 11.03 14.73 39.51 160.46 142.68 161.06 159.04 143.89 159.95 coo 3.77 12.64 38.21 3.35 14.53 37.39 162.95 137.35 154.91 164.67 137.97 155.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 165.78 138.84 148.96 164.30 141.49 149.44 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 26 3 # 26 B 317 GLU O 4 GLU.? 15.52 CL CL K2003 B 319 ASP O 54 ASP~? 15.16 CL CL K2003 B 359 ARG O 55 ARG~? 19.37 CL CL K2003 coo 10.77 13.13 40.94 11.03 14.73 39.51 160.46 142.68 161.06 159.04 143.89 159.95 coo 3.77 12.64 38.21 3.35 14.53 37.39 162.95 137.35 154.91 164.67 137.97 155.90 coo -1.16 15.32 35.60 -3.32 13.56 36.98 159.96 137.60 150.54 160.85 139.64 152.73 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 27 3 # 27 B 317 GLU O 73 GLU~? 6.85 O1 GOL O3013 B 319 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 359 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 10.77 13.13 40.94 11.03 14.73 39.51 129.73 137.78 165.68 128.97 136.10 166.67 coo 3.77 12.64 38.21 3.35 14.53 37.39 134.07 141.35 162.95 132.57 142.58 163.78 coo -1.16 15.32 35.60 -3.32 13.56 36.98 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 28 3 # 28 B 317 GLU P 73 GLU~? 5.04 O1 GOL P3034 B 319 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 359 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 10.77 13.13 40.94 11.03 14.73 39.51 204.36 171.43 203.90 204.84 170.63 205.81 coo 3.77 12.64 38.21 3.35 14.53 37.39 200.75 174.15 199.66 202.28 173.10 198.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 193.73 170.42 198.48 192.94 168.00 200.19 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 28 hits 1fr8_c01 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 140 TRP~? 19.71 O1 GOL A3040 A 317 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 365 ARG A 108 ARG~? 22.68 O1 GOL A3040 coo 79.91 26.87 38.77 78.95 23.18 37.81 86.86 73.43 38.30 85.96 75.78 41.27 coo 85.55 26.30 41.25 85.59 24.97 39.65 89.05 70.31 35.51 89.11 68.84 33.95 coo 83.47 25.30 27.10 83.44 27.82 25.29 77.54 80.61 37.36 78.31 77.83 38.52 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 140 TRP~? 8.05 O1 GOL B3024 A 317 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 365 ARG B 108 ARG~? 14.18 O1 GOL B3024 coo 79.91 26.87 38.77 78.95 23.18 37.81 28.64 69.61 23.75 29.26 66.08 22.13 coo 85.55 26.30 41.25 85.59 24.97 39.65 26.68 73.50 25.50 26.49 75.15 26.91 coo 83.47 25.30 27.10 83.44 27.82 25.29 39.05 68.00 18.82 37.75 66.74 21.38 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP C 140 TRP~? 15.28 O1 GOL C3036 A 317 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 365 ARG C 108 ARG~? 20.30 O3 GOL C3021 coo 79.91 26.87 38.77 78.95 23.18 37.81 78.11 27.78 75.21 77.27 25.39 72.20 coo 85.55 26.30 41.25 85.59 24.97 39.65 80.37 30.30 78.61 80.09 31.65 80.29 coo 83.47 25.30 27.10 83.44 27.82 25.29 67.42 22.77 74.41 69.21 25.29 74.04 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP E 140 TRP~? 16.70 O3 GOL E3002 A 317 GLU E 141 GLU~? 19.75 O1 GOL D3019 A 365 ARG E 108 ARG~? 18.65 O1 GOL E3035 coo 79.91 26.87 38.77 78.95 23.18 37.81 25.76 82.84 63.51 27.17 84.46 60.23 coo 85.55 26.30 41.25 85.59 24.97 39.65 21.80 82.16 67.66 21.51 80.62 69.17 coo 83.47 25.30 27.10 83.44 27.82 25.29 36.12 87.73 64.17 35.30 85.24 62.51 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP F 140 TRP~? 8.92 CL CL F2035 A 317 GLU F 141 GLU~? 15.85 CL CL F2035 A 365 ARG F 108 ARG~? -3.40 CL CL F2035s coo 79.91 26.87 38.77 78.95 23.18 37.81 83.02 31.96 33.59 82.83 34.93 31.09 coo 85.55 26.30 41.25 85.59 24.97 39.65 84.56 28.39 36.54 84.29 26.85 38.03 coo 83.47 25.30 27.10 83.44 27.82 25.29 74.01 31.91 26.65 74.85 33.96 28.84 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 6 3 # 6 A 314 TRP G 140 TRP~? 16.58 O2 GOL G3001 A 317 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 365 ARG G 108 ARG~? 22.05 O2 GOL G3001 coo 79.91 26.87 38.77 78.95 23.18 37.81 23.50 29.78 36.87 23.65 28.03 40.35 coo 85.55 26.30 41.25 85.59 24.97 39.65 21.81 32.02 32.76 22.04 33.29 31.00 coo 83.47 25.30 27.10 83.44 27.82 25.29 32.32 22.84 38.36 31.62 25.53 39.73 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 7 3 # 7 A 314 TRP H 140 TRP~? 8.50 O2 GOL H3016 A 317 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 365 ARG H 108 ARG~? 14.48 O2 GOL H3016 coo 79.91 26.87 38.77 78.95 23.18 37.81 81.64 69.31 79.75 80.29 66.46 82.07 coo 85.55 26.30 41.25 85.59 24.97 39.65 84.42 72.24 77.39 84.86 73.57 75.76 coo 83.47 25.30 27.10 83.44 27.82 25.29 71.22 70.92 84.57 72.18 68.95 82.36 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 8 3 # 8 A 314 TRP I 140 TRP~? 8.49 O1 GOL I3032 A 317 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 365 ARG I 108 ARG~? 14.30 O1 GOL I3032 coo 79.91 26.87 38.77 78.95 23.18 37.81 200.60 190.99 153.07 199.64 193.20 156.12 coo 85.55 26.30 41.25 85.59 24.97 39.65 203.00 188.32 149.96 202.87 186.91 148.25 coo 83.47 25.30 27.10 83.44 27.82 25.29 191.22 197.47 152.14 191.76 195.04 153.98 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 9 3 # 9 A 314 TRP J 140 TRP~? 20.55 O1 GOL J3030 A 317 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 365 ARG J 108 ARG~? 23.02 O1 GOL J3030 coo 79.91 26.87 38.77 78.95 23.18 37.81 142.14 185.05 141.31 142.82 181.62 139.53 coo 85.55 26.30 41.25 85.59 24.97 39.65 139.93 188.85 143.36 139.82 190.60 144.63 coo 83.47 25.30 27.10 83.44 27.82 25.29 152.38 184.27 135.62 151.05 183.00 138.10 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 10 3 # 10 A 314 TRP K 140 TRP~? 16.16 O3 GOL K3009 A 317 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 365 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 79.91 26.87 38.77 78.95 23.18 37.81 195.63 143.37 188.00 194.83 141.14 184.89 coo 85.55 26.30 41.25 85.59 24.97 39.65 197.75 145.77 191.54 197.42 146.88 193.40 coo 83.47 25.30 27.10 83.44 27.82 25.29 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 11 3 # 11 A 314 TRP M 140 TRP~? 20.58 O1 GOL M3043 A 317 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 365 ARG M 108 ARG~? 23.14 O1 GOL M3043 coo 79.91 26.87 38.77 78.95 23.18 37.81 140.33 196.32 181.61 141.36 198.32 178.41 coo 85.55 26.30 41.25 85.59 24.97 39.65 137.93 194.30 185.04 137.74 193.05 186.86 coo 83.47 25.30 27.10 83.44 27.82 25.29 150.62 202.12 182.01 149.56 199.68 180.53 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 12 3 # 12 A 314 TRP N 140 TRP~? 8.69 C1 GOL N3029 A 317 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 365 ARG N 108 ARG~? 14.89 C2 GOL N3029 coo 79.91 26.87 38.77 78.95 23.18 37.81 198.25 149.79 146.79 197.78 152.90 144.45 coo 85.55 26.30 41.25 85.59 24.97 39.65 199.85 147.19 149.72 199.65 149.31 150.43 coo 83.47 25.30 27.10 83.44 27.82 25.29 189.02 149.68 140.15 189.67 151.62 142.49 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 13 3 # 13 A 314 TRP O 140 TRP~? 9.56 C3 GOL O3026 A 317 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 365 ARG O 108 ARG~? 13.39 CL CL O2036 coo 79.91 26.87 38.77 78.95 23.18 37.81 139.12 144.67 152.54 139.71 142.75 155.91 coo 85.55 26.30 41.25 85.59 24.97 39.65 137.18 147.02 148.83 137.46 148.02 146.94 coo 83.47 25.30 27.10 83.44 27.82 25.29 148.81 138.28 154.16 147.06 140.78 153.42 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 14 3 # 14 A 314 TRP P 140 TRP~? 15.82 O3 GOL P3014 A 317 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 365 ARG P 108 ARG~? 21.30 O3 GOL P3014 coo 79.91 26.87 38.77 78.95 23.18 37.81 197.38 184.75 194.70 196.33 181.69 196.87 coo 85.55 26.30 41.25 85.59 24.97 39.65 200.04 187.90 192.14 200.20 189.50 190.73 coo 83.47 25.30 27.10 83.44 27.82 25.29 187.53 185.71 199.97 188.17 183.79 197.64 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 14 hits 1g8o_c01 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 70 ASP~? -9.95 O3 GOL A3037s 41 HIS A 151 HIS~? -11.70 O3 GOL A3037s 224 GLN A 144 GLN~? 18.34 O3 GOL A3037 coo -3.80 50.71 49.48 -5.59 51.85 49.27 90.44 78.16 48.76 91.65 76.94 50.06 coo -6.45 47.32 41.99 -8.32 46.87 42.83 94.27 72.58 51.14 93.29 74.44 51.00 coo -12.35 49.13 49.89 -13.38 48.89 48.03 89.55 71.95 40.89 88.93 73.36 42.34 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP B 70 ASP~? -3.24 O2 GOL B3024s 41 HIS B 151 HIS~? -4.11 O3 GOL B3015s 224 GLN B 144 GLN~? 5.36 O1 GOL B3024 coo -3.80 50.71 49.48 -5.59 51.85 49.27 23.66 59.02 20.34 21.93 58.32 21.38 coo -6.45 47.32 41.99 -8.32 46.87 42.83 18.48 59.01 25.15 19.77 58.54 23.56 coo -12.35 49.13 49.89 -13.38 48.89 48.03 25.23 67.97 25.00 25.82 66.20 23.96 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 3 3 # 3 13 ASP C 70 ASP~? 3.38 O1 GOL C3036s 41 HIS C 151 HIS~? -4.28 C2 GOL C3036s 224 GLN C 144 GLN~? 12.42 O1 GOL C3036 coo -3.80 50.71 49.48 -5.59 51.85 49.27 82.81 22.02 65.69 84.52 22.80 64.66 coo -6.45 47.32 41.99 -8.32 46.87 42.83 88.24 26.50 64.44 86.75 25.04 64.52 coo -12.35 49.13 49.89 -13.38 48.89 48.03 81.50 28.39 73.43 80.87 26.87 72.03 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 4 3 # 4 13 ASP D 70 ASP~? -11.51 O3 GOL D3019s 41 HIS D 151 HIS~? -13.00 O2 GOL D3020s 224 GLN D 144 GLN~? 17.30 O3 GOL D3019 coo -3.80 50.71 49.48 -5.59 51.85 49.27 16.94 54.59 79.01 15.65 55.42 77.54 coo -6.45 47.32 41.99 -8.32 46.87 42.83 13.06 55.69 73.24 14.03 55.94 75.08 coo -12.35 49.13 49.89 -13.38 48.89 48.03 17.88 45.80 74.24 18.72 47.75 74.07 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 5 3 # 5 13 ASP E 70 ASP~? 5.56 O3 GOL E3002 41 HIS E 151 HIS~? -4.12 O1 GOL E3002s 224 GLN E 144 GLN~? 13.80 O3 GOL E3002 coo -3.80 50.71 49.48 -5.59 51.85 49.27 23.07 86.29 52.35 21.57 85.17 51.32 coo -6.45 47.32 41.99 -8.32 46.87 42.83 17.87 81.44 51.19 19.31 82.95 50.96 coo -12.35 49.13 49.89 -13.38 48.89 48.03 22.86 81.65 61.34 23.71 82.87 59.78 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 6 3 # 6 13 ASP F 70 ASP~? -11.57 O3 GOL F3039s 41 HIS F 151 HIS~? 14.76 O3 GOL F3039s 224 GLN F 144 GLN~? 11.49 CL CL F2035 coo -3.80 50.71 49.48 -5.59 51.85 49.27 88.86 41.25 28.96 90.30 42.22 30.24 coo -6.45 47.32 41.99 -8.32 46.87 42.83 93.09 42.58 34.58 92.14 42.76 32.71 coo -12.35 49.13 49.89 -13.38 48.89 48.03 86.06 33.92 35.15 85.92 35.17 33.44 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 7 3 # 7 13 ASP G 70 ASP~? -5.29 C3 GOL G3001s 41 HIS G 151 HIS~? -4.14 C3 GOL G3001s 224 GLN G 144 GLN~? 13.62 C3 GOL G3001 coo -3.80 50.71 49.48 -5.59 51.85 49.27 17.70 27.34 47.09 16.19 28.71 47.73 coo -6.45 47.32 41.99 -8.32 46.87 42.83 13.55 33.19 47.26 14.46 31.35 47.64 coo -12.35 49.13 49.89 -13.38 48.89 48.03 20.40 31.78 38.43 20.75 30.54 40.14 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 8 3 # 8 13 ASP H 70 ASP~? -4.05 C3 GOL H3016s 41 HIS H 151 HIS~? 4.32 C1 GOL H3016s 224 GLN H 144 GLN~? 5.80 O2 GOL H3016 coo -3.80 50.71 49.48 -5.59 51.85 49.27 84.24 58.93 85.48 85.73 57.59 84.66 coo -6.45 47.32 41.99 -8.32 46.87 42.83 89.33 56.65 80.95 87.93 56.76 82.51 coo -12.35 49.13 49.89 -13.38 48.89 48.03 84.54 66.68 78.81 83.66 65.46 80.38 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 9 3 # 9 13 ASP I 70 ASP~? -3.65 C2 GOL I3032s 41 HIS I 151 HIS~? 3.98 O3 GOL I3032s 224 GLN I 144 GLN~? 5.83 O1 GOL I3032 coo -3.80 50.71 49.48 -5.59 51.85 49.27 204.37 195.46 163.61 205.75 194.30 164.79 coo -6.45 47.32 41.99 -8.32 46.87 42.83 208.71 190.07 165.44 207.65 191.87 165.52 coo -12.35 49.13 49.89 -13.38 48.89 48.03 203.35 189.41 155.57 202.68 190.98 156.90 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 10 3 # 10 13 ASP J 70 ASP~? 11.68 O1 GOL J3033 41 HIS J 151 HIS~? -12.73 O1 GOL J3033s 224 GLN J 144 GLN~? 19.62 O1 GOL J3030 coo -3.80 50.71 49.48 -5.59 51.85 49.27 137.44 174.60 137.57 135.80 173.80 138.69 coo -6.45 47.32 41.99 -8.32 46.87 42.83 132.36 173.99 142.63 133.63 173.58 141.01 coo -12.35 49.13 49.89 -13.38 48.89 48.03 138.83 183.31 142.69 139.42 181.74 141.36 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 11 3 # 11 13 ASP K 70 ASP~? -4.89 O3 GOL K3009s 41 HIS K 151 HIS~? -4.18 C2 GOL K3009s 224 GLN K 144 GLN~? 13.25 O3 GOL K3009 coo -3.80 50.71 49.48 -5.59 51.85 49.27 200.17 138.24 178.11 201.77 139.28 177.19 coo -6.45 47.32 41.99 -8.32 46.87 42.83 205.25 143.04 176.89 203.95 141.38 176.70 coo -12.35 49.13 49.89 -13.38 48.89 48.03 198.77 144.45 186.07 198.16 143.26 184.38 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 12 3 # 12 13 ASP L 70 ASP~? -12.27 O3 GOL L3028s 41 HIS L 151 HIS~? -15.32 O3 GOL L3028s 224 GLN L 144 GLN~? 18.25 O3 GOL L3028 coo -3.80 50.71 49.48 -5.59 51.85 49.27 133.34 166.97 196.27 132.03 168.03 194.96 coo -6.45 47.32 41.99 -8.32 46.87 42.83 129.06 168.07 190.57 130.17 168.32 192.34 coo -12.35 49.13 49.89 -13.38 48.89 48.03 134.07 157.87 191.59 134.72 159.48 192.82 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 13 3 # 13 13 ASP M 70 ASP~? -9.98 O3 GOL M3042s 41 HIS M 151 HIS~? -11.81 O3 GOL M3042s 224 GLN M 144 GLN~? 18.53 O3 GOL M3042 coo -3.80 50.71 49.48 -5.59 51.85 49.27 136.87 200.18 170.79 135.36 199.08 169.77 coo -6.45 47.32 41.99 -8.32 46.87 42.83 131.91 195.13 169.59 133.22 196.76 169.40 coo -12.35 49.13 49.89 -13.38 48.89 48.03 137.26 195.03 179.49 137.97 196.37 178.00 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 14 3 # 14 13 ASP N 70 ASP~? -3.26 O2 GOL N3029s 41 HIS N 151 HIS~? 3.39 O2 GOL N3012s 224 GLN N 144 GLN~? 5.76 C1 GOL N3029 coo -3.80 50.71 49.48 -5.59 51.85 49.27 203.51 159.51 142.26 205.02 160.53 143.48 coo -6.45 47.32 41.99 -8.32 46.87 42.83 207.96 160.84 147.59 206.93 161.03 145.77 coo -12.35 49.13 49.89 -13.38 48.89 48.03 201.39 151.74 148.20 201.01 153.17 146.62 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 15 3 # 15 13 ASP O 70 ASP~? 3.30 O1 GOL O3013s 41 HIS O 151 HIS~? 4.32 O2 GOL O3026s 224 GLN O 144 GLN~? 6.42 O3 GOL O3026 coo -3.80 50.71 49.48 -5.59 51.85 49.27 134.07 141.35 162.95 132.57 142.58 163.78 coo -6.45 47.32 41.99 -8.32 46.87 42.83 129.65 146.92 163.60 130.73 145.15 163.91 coo -12.35 49.13 49.89 -13.38 48.89 48.03 136.08 146.43 154.31 136.54 145.45 156.17 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 16 3 # 16 13 ASP P 70 ASP~? 4.30 O3 GOL P3014 41 HIS P 151 HIS~? -4.15 C3 GOL P3014s 224 GLN P 144 GLN~? 12.96 O3 GOL P3014 coo -3.80 50.71 49.48 -5.59 51.85 49.27 200.75 174.15 199.66 202.28 173.10 198.62 coo -6.45 47.32 41.99 -8.32 46.87 42.83 205.70 172.52 194.71 204.41 172.45 196.35 coo -12.35 49.13 49.89 -13.38 48.89 48.03 200.41 182.40 193.61 199.53 181.01 194.99 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 16 hits 1gim_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 98 PHE.? 12.32 O1 GOL A3040 A 298 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 329 LYS A 142 LYS~? 20.36 CL CL A2020 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 94.73 84.25 40.94 92.04 83.71 40.47 coo 2.59 0.29 25.55 4.65 0.18 25.07 90.44 78.16 48.76 91.65 76.94 50.06 coo 12.42 6.10 23.27 9.95 1.57 20.16 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 98 PHE.? 11.15 CL CL B2010 A 298 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 329 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 22.68 65.92 11.87 25.22 66.01 13.02 coo 2.59 0.29 25.55 4.65 0.18 25.07 23.66 59.02 20.34 21.93 58.32 21.38 coo 12.42 6.10 23.27 9.95 1.57 20.16 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE C 98 PHE.? 11.39 CL CL C2011 A 298 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 329 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 83.86 15.19 74.07 81.38 16.44 74.03 coo 2.59 0.29 25.55 4.65 0.18 25.07 82.81 22.02 65.69 84.52 22.80 64.66 coo 12.42 6.10 23.27 9.95 1.57 20.16 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE D 98 PHE.? 11.07 CL CL D2012 A 298 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 329 LYS D 142 LYS~? 18.65 CL CL D2012 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 12.59 48.19 86.72 15.29 47.64 86.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 16.94 54.59 79.01 15.65 55.42 77.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE E 98 PHE.? 11.20 CL CL E2013 A 298 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 329 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 20.72 94.66 58.85 23.24 93.53 59.37 coo 2.59 0.29 25.55 4.65 0.18 25.07 23.07 86.29 52.35 21.57 85.17 51.32 coo 12.42 6.10 23.27 9.95 1.57 20.16 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE F 98 PHE.? 11.09 CL CL F2034 A 298 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 329 LYS F 142 LYS~? 19.20 CL CL F2034 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 91.41 32.84 22.80 88.70 32.93 23.40 coo 2.59 0.29 25.55 4.65 0.18 25.07 88.86 41.25 28.96 90.30 42.22 30.24 coo 12.42 6.10 23.27 9.95 1.57 20.16 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE G 98 PHE.? 12.40 C3 GOL G3038 A 298 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 329 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 15.02 19.56 40.09 17.78 20.04 40.01 coo 2.59 0.29 25.55 4.65 0.18 25.07 17.70 27.34 47.09 16.19 28.71 47.73 coo 12.42 6.10 23.27 9.95 1.57 20.16 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE H 98 PHE.? 11.23 CL CL H2014 A 298 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 329 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 86.83 66.96 92.26 84.37 67.28 91.08 coo 2.59 0.29 25.55 4.65 0.18 25.07 84.24 58.93 85.48 85.73 57.59 84.66 coo 12.42 6.10 23.27 9.95 1.57 20.16 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE I 98 PHE.? 11.14 CL CL I2015 A 298 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 329 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 207.94 202.24 155.85 205.25 201.61 155.56 coo 2.59 0.29 25.55 4.65 0.18 25.07 204.37 195.46 163.61 205.75 194.30 164.79 coo 12.42 6.10 23.27 9.95 1.57 20.16 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE J 98 PHE.? 11.05 CL CL J2016 A 298 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 329 LYS J 142 LYS~? 19.62 CL CL J2016 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 135.63 181.85 129.67 138.24 181.95 130.69 coo 2.59 0.29 25.55 4.65 0.18 25.07 137.44 174.60 137.57 135.80 173.80 138.69 coo 12.42 6.10 23.27 9.95 1.57 20.16 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE K 98 PHE.? 11.99 O1 GOL K3041 A 298 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 329 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 201.94 131.33 186.30 199.31 132.28 186.27 coo 2.59 0.29 25.55 4.65 0.18 25.07 200.17 138.24 178.11 201.77 139.28 177.19 coo 12.42 6.10 23.27 9.95 1.57 20.16 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE L 98 PHE.? 11.24 CL CL L2009 A 298 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 329 LYS L 142 LYS~? 23.18 CL CL L2009 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 129.72 160.22 203.93 132.34 159.70 203.19 coo 2.59 0.29 25.55 4.65 0.18 25.07 133.34 166.97 196.27 132.03 168.03 194.96 coo 12.42 6.10 23.27 9.95 1.57 20.16 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE M 98 PHE.? 11.28 CL CL M2017 A 298 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 329 LYS M 142 LYS~? 19.90 CL CL M2017 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 134.29 208.09 177.60 136.84 206.99 178.00 coo 2.59 0.29 25.55 4.65 0.18 25.07 136.87 200.18 170.79 135.36 199.08 169.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 A 189 PHE N 98 PHE.? 12.51 O2 GOL N3029 A 298 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 329 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 205.99 151.41 135.45 203.31 151.41 136.18 coo 2.59 0.29 25.55 4.65 0.18 25.07 203.51 159.51 142.26 205.02 160.53 143.48 coo 12.42 6.10 23.27 9.95 1.57 20.16 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 A 189 PHE O 98 PHE.? 11.35 CL CL O2018 A 298 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 329 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 131.45 133.74 155.71 134.18 134.46 155.64 coo 2.59 0.29 25.55 4.65 0.18 25.07 134.07 141.35 162.95 132.57 142.58 163.78 coo 12.42 6.10 23.27 9.95 1.57 20.16 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 A 189 PHE P 98 PHE.? 11.01 CL CL P2019 A 298 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 329 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 203.50 182.03 206.67 200.90 182.30 205.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 200.75 174.15 199.66 202.28 173.10 198.62 coo 12.42 6.10 23.27 9.95 1.57 20.16 204.59 186.28 195.60 209.96 186.96 196.62 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 98 PHE.? 12.32 O1 GOL A3040 B 298 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 329 LYS A 142 LYS~? 20.36 CL CL A2020 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 94.73 84.25 40.94 92.04 83.71 40.47 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 90.44 78.16 48.76 91.65 76.94 50.06 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 98 PHE.? 11.15 CL CL B2010 B 298 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 329 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 22.68 65.92 11.87 25.22 66.01 13.02 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 23.66 59.02 20.34 21.93 58.32 21.38 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE C 98 PHE.? 11.39 CL CL C2011 B 298 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 329 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 83.86 15.19 74.07 81.38 16.44 74.03 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 82.81 22.02 65.69 84.52 22.80 64.66 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE D 98 PHE.? 11.07 CL CL D2012 B 298 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 329 LYS D 142 LYS~? 18.65 CL CL D2012 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 12.59 48.19 86.72 15.29 47.64 86.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 16.94 54.59 79.01 15.65 55.42 77.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE E 98 PHE.? 11.20 CL CL E2013 B 298 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 329 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 20.72 94.66 58.85 23.24 93.53 59.37 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 23.07 86.29 52.35 21.57 85.17 51.32 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE F 98 PHE.? 11.09 CL CL F2034 B 298 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 329 LYS F 142 LYS~? 19.20 CL CL F2034 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 91.41 32.84 22.80 88.70 32.93 23.40 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 88.86 41.25 28.96 90.30 42.22 30.24 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE G 98 PHE.? 12.40 C3 GOL G3038 B 298 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 329 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 15.02 19.56 40.09 17.78 20.04 40.01 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 17.70 27.34 47.09 16.19 28.71 47.73 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE H 98 PHE.? 11.23 CL CL H2014 B 298 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 329 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 86.83 66.96 92.26 84.37 67.28 91.08 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 84.24 58.93 85.48 85.73 57.59 84.66 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE I 98 PHE.? 11.14 CL CL I2015 B 298 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 329 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 207.94 202.24 155.85 205.25 201.61 155.56 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 204.37 195.46 163.61 205.75 194.30 164.79 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE J 98 PHE.? 11.05 CL CL J2016 B 298 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 329 LYS J 142 LYS~? 19.62 CL CL J2016 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 135.63 181.85 129.67 138.24 181.95 130.69 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 137.44 174.60 137.57 135.80 173.80 138.69 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE K 98 PHE.? 11.99 O1 GOL K3041 B 298 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 329 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 201.94 131.33 186.30 199.31 132.28 186.27 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE L 98 PHE.? 11.24 CL CL L2009 B 298 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 329 LYS L 142 LYS~? 23.18 CL CL L2009 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 129.72 160.22 203.93 132.34 159.70 203.19 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 133.34 166.97 196.27 132.03 168.03 194.96 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE M 98 PHE.? 11.28 CL CL M2017 B 298 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 329 LYS M 142 LYS~? 19.90 CL CL M2017 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 134.29 208.09 177.60 136.84 206.99 178.00 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 136.87 200.18 170.79 135.36 199.08 169.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 B 189 PHE N 98 PHE.? 12.51 O2 GOL N3029 B 298 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 329 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 205.99 151.41 135.45 203.31 151.41 136.18 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 203.51 159.51 142.26 205.02 160.53 143.48 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 B 189 PHE O 98 PHE.? 11.35 CL CL O2018 B 298 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 329 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 131.45 133.74 155.71 134.18 134.46 155.64 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 134.07 141.35 162.95 132.57 142.58 163.78 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 B 189 PHE P 98 PHE.? 11.01 CL CL P2019 B 298 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 329 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 203.50 182.03 206.67 200.90 182.30 205.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 200.75 174.15 199.66 202.28 173.10 198.62 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 204.59 186.28 195.60 209.96 186.96 196.62 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 98 PHE.? 12.32 O1 GOL A3040 C 298 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 329 LYS A 142 LYS~? 20.36 CL CL A2020 coo 17.41 60.57 64.39 18.40 58.12 65.34 94.73 84.25 40.94 92.04 83.71 40.47 coo 24.10 66.43 63.33 24.18 64.30 63.40 90.44 78.16 48.76 91.65 76.94 50.06 coo 27.64 56.61 58.17 22.18 57.92 60.36 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 98 PHE.? 11.15 CL CL B2010 C 298 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 329 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 17.41 60.57 64.39 18.40 58.12 65.34 22.68 65.92 11.87 25.22 66.01 13.02 coo 24.10 66.43 63.33 24.18 64.30 63.40 23.66 59.02 20.34 21.93 58.32 21.38 coo 27.64 56.61 58.17 22.18 57.92 60.36 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE C 98 PHE.? 11.39 CL CL C2011 C 298 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 329 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 17.41 60.57 64.39 18.40 58.12 65.34 83.86 15.19 74.07 81.38 16.44 74.03 coo 24.10 66.43 63.33 24.18 64.30 63.40 82.81 22.02 65.69 84.52 22.80 64.66 coo 27.64 56.61 58.17 22.18 57.92 60.36 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE D 98 PHE.? 11.07 CL CL D2012 C 298 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 329 LYS D 142 LYS~? 18.65 CL CL D2012 coo 17.41 60.57 64.39 18.40 58.12 65.34 12.59 48.19 86.72 15.29 47.64 86.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 16.94 54.59 79.01 15.65 55.42 77.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE E 98 PHE.? 11.20 CL CL E2013 C 298 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 329 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 17.41 60.57 64.39 18.40 58.12 65.34 20.72 94.66 58.85 23.24 93.53 59.37 coo 24.10 66.43 63.33 24.18 64.30 63.40 23.07 86.29 52.35 21.57 85.17 51.32 coo 27.64 56.61 58.17 22.18 57.92 60.36 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE F 98 PHE.? 11.09 CL CL F2034 C 298 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 329 LYS F 142 LYS~? 19.20 CL CL F2034 coo 17.41 60.57 64.39 18.40 58.12 65.34 91.41 32.84 22.80 88.70 32.93 23.40 coo 24.10 66.43 63.33 24.18 64.30 63.40 88.86 41.25 28.96 90.30 42.22 30.24 coo 27.64 56.61 58.17 22.18 57.92 60.36 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE G 98 PHE.? 12.40 C3 GOL G3038 C 298 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 329 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 17.41 60.57 64.39 18.40 58.12 65.34 15.02 19.56 40.09 17.78 20.04 40.01 coo 24.10 66.43 63.33 24.18 64.30 63.40 17.70 27.34 47.09 16.19 28.71 47.73 coo 27.64 56.61 58.17 22.18 57.92 60.36 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE H 98 PHE.? 11.23 CL CL H2014 C 298 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 329 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 17.41 60.57 64.39 18.40 58.12 65.34 86.83 66.96 92.26 84.37 67.28 91.08 coo 24.10 66.43 63.33 24.18 64.30 63.40 84.24 58.93 85.48 85.73 57.59 84.66 coo 27.64 56.61 58.17 22.18 57.92 60.36 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE I 98 PHE.? 11.14 CL CL I2015 C 298 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 329 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 17.41 60.57 64.39 18.40 58.12 65.34 207.94 202.24 155.85 205.25 201.61 155.56 coo 24.10 66.43 63.33 24.18 64.30 63.40 204.37 195.46 163.61 205.75 194.30 164.79 coo 27.64 56.61 58.17 22.18 57.92 60.36 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE J 98 PHE.? 11.05 CL CL J2016 C 298 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 329 LYS J 142 LYS~? 19.62 CL CL J2016 coo 17.41 60.57 64.39 18.40 58.12 65.34 135.63 181.85 129.67 138.24 181.95 130.69 coo 24.10 66.43 63.33 24.18 64.30 63.40 137.44 174.60 137.57 135.80 173.80 138.69 coo 27.64 56.61 58.17 22.18 57.92 60.36 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE K 98 PHE.? 11.99 O1 GOL K3041 C 298 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 329 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 17.41 60.57 64.39 18.40 58.12 65.34 201.94 131.33 186.30 199.31 132.28 186.27 coo 24.10 66.43 63.33 24.18 64.30 63.40 200.17 138.24 178.11 201.77 139.28 177.19 coo 27.64 56.61 58.17 22.18 57.92 60.36 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE L 98 PHE.? 11.24 CL CL L2009 C 298 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 329 LYS L 142 LYS~? 23.18 CL CL L2009 coo 17.41 60.57 64.39 18.40 58.12 65.34 129.72 160.22 203.93 132.34 159.70 203.19 coo 24.10 66.43 63.33 24.18 64.30 63.40 133.34 166.97 196.27 132.03 168.03 194.96 coo 27.64 56.61 58.17 22.18 57.92 60.36 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE M 98 PHE.? 11.28 CL CL M2017 C 298 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 329 LYS M 142 LYS~? 19.90 CL CL M2017 coo 17.41 60.57 64.39 18.40 58.12 65.34 134.29 208.09 177.60 136.84 206.99 178.00 coo 24.10 66.43 63.33 24.18 64.30 63.40 136.87 200.18 170.79 135.36 199.08 169.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 C 189 PHE N 98 PHE.? 12.51 O2 GOL N3029 C 298 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 329 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 17.41 60.57 64.39 18.40 58.12 65.34 205.99 151.41 135.45 203.31 151.41 136.18 coo 24.10 66.43 63.33 24.18 64.30 63.40 203.51 159.51 142.26 205.02 160.53 143.48 coo 27.64 56.61 58.17 22.18 57.92 60.36 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 C 189 PHE O 98 PHE.? 11.35 CL CL O2018 C 298 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 329 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 17.41 60.57 64.39 18.40 58.12 65.34 131.45 133.74 155.71 134.18 134.46 155.64 coo 24.10 66.43 63.33 24.18 64.30 63.40 134.07 141.35 162.95 132.57 142.58 163.78 coo 27.64 56.61 58.17 22.18 57.92 60.36 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 C 189 PHE P 98 PHE.? 11.01 CL CL P2019 C 298 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 329 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 17.41 60.57 64.39 18.40 58.12 65.34 203.50 182.03 206.67 200.90 182.30 205.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 200.75 174.15 199.66 202.28 173.10 198.62 coo 27.64 56.61 58.17 22.18 57.92 60.36 204.59 186.28 195.60 209.96 186.96 196.62 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 98 PHE.? 12.32 O1 GOL A3040 D 298 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 329 LYS A 142 LYS~? 20.36 CL CL A2020 coo 35.44 53.35 83.81 35.65 54.53 81.28 94.73 84.25 40.94 92.04 83.71 40.47 coo 29.72 46.46 83.60 30.79 47.36 81.99 90.44 78.16 48.76 91.65 76.94 50.06 coo 36.89 44.91 74.55 37.33 48.94 79.01 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 98 PHE.? 11.15 CL CL B2010 D 298 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 329 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 35.44 53.35 83.81 35.65 54.53 81.28 22.68 65.92 11.87 25.22 66.01 13.02 coo 29.72 46.46 83.60 30.79 47.36 81.99 23.66 59.02 20.34 21.93 58.32 21.38 coo 36.89 44.91 74.55 37.33 48.94 79.01 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE C 98 PHE.? 11.39 CL CL C2011 D 298 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 329 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 35.44 53.35 83.81 35.65 54.53 81.28 83.86 15.19 74.07 81.38 16.44 74.03 coo 29.72 46.46 83.60 30.79 47.36 81.99 82.81 22.02 65.69 84.52 22.80 64.66 coo 36.89 44.91 74.55 37.33 48.94 79.01 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE D 98 PHE.? 11.07 CL CL D2012 D 298 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 329 LYS D 142 LYS~? 18.65 CL CL D2012 coo 35.44 53.35 83.81 35.65 54.53 81.28 12.59 48.19 86.72 15.29 47.64 86.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 16.94 54.59 79.01 15.65 55.42 77.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE E 98 PHE.? 11.20 CL CL E2013 D 298 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 329 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 35.44 53.35 83.81 35.65 54.53 81.28 20.72 94.66 58.85 23.24 93.53 59.37 coo 29.72 46.46 83.60 30.79 47.36 81.99 23.07 86.29 52.35 21.57 85.17 51.32 coo 36.89 44.91 74.55 37.33 48.94 79.01 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE F 98 PHE.? 11.09 CL CL F2034 D 298 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 329 LYS F 142 LYS~? 19.20 CL CL F2034 coo 35.44 53.35 83.81 35.65 54.53 81.28 91.41 32.84 22.80 88.70 32.93 23.40 coo 29.72 46.46 83.60 30.79 47.36 81.99 88.86 41.25 28.96 90.30 42.22 30.24 coo 36.89 44.91 74.55 37.33 48.94 79.01 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE G 98 PHE.? 12.40 C3 GOL G3038 D 298 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 329 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 35.44 53.35 83.81 35.65 54.53 81.28 15.02 19.56 40.09 17.78 20.04 40.01 coo 29.72 46.46 83.60 30.79 47.36 81.99 17.70 27.34 47.09 16.19 28.71 47.73 coo 36.89 44.91 74.55 37.33 48.94 79.01 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE H 98 PHE.? 11.23 CL CL H2014 D 298 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 329 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 35.44 53.35 83.81 35.65 54.53 81.28 86.83 66.96 92.26 84.37 67.28 91.08 coo 29.72 46.46 83.60 30.79 47.36 81.99 84.24 58.93 85.48 85.73 57.59 84.66 coo 36.89 44.91 74.55 37.33 48.94 79.01 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE I 98 PHE.? 11.14 CL CL I2015 D 298 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 329 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 35.44 53.35 83.81 35.65 54.53 81.28 207.94 202.24 155.85 205.25 201.61 155.56 coo 29.72 46.46 83.60 30.79 47.36 81.99 204.37 195.46 163.61 205.75 194.30 164.79 coo 36.89 44.91 74.55 37.33 48.94 79.01 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE J 98 PHE.? 11.05 CL CL J2016 D 298 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 329 LYS J 142 LYS~? 19.62 CL CL J2016 coo 35.44 53.35 83.81 35.65 54.53 81.28 135.63 181.85 129.67 138.24 181.95 130.69 coo 29.72 46.46 83.60 30.79 47.36 81.99 137.44 174.60 137.57 135.80 173.80 138.69 coo 36.89 44.91 74.55 37.33 48.94 79.01 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE K 98 PHE.? 11.99 O1 GOL K3041 D 298 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 329 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 35.44 53.35 83.81 35.65 54.53 81.28 201.94 131.33 186.30 199.31 132.28 186.27 coo 29.72 46.46 83.60 30.79 47.36 81.99 200.17 138.24 178.11 201.77 139.28 177.19 coo 36.89 44.91 74.55 37.33 48.94 79.01 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE L 98 PHE.? 11.24 CL CL L2009 D 298 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 329 LYS L 142 LYS~? 23.18 CL CL L2009 coo 35.44 53.35 83.81 35.65 54.53 81.28 129.72 160.22 203.93 132.34 159.70 203.19 coo 29.72 46.46 83.60 30.79 47.36 81.99 133.34 166.97 196.27 132.03 168.03 194.96 coo 36.89 44.91 74.55 37.33 48.94 79.01 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE M 98 PHE.? 11.28 CL CL M2017 D 298 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 329 LYS M 142 LYS~? 19.90 CL CL M2017 coo 35.44 53.35 83.81 35.65 54.53 81.28 134.29 208.09 177.60 136.84 206.99 178.00 coo 29.72 46.46 83.60 30.79 47.36 81.99 136.87 200.18 170.79 135.36 199.08 169.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 D 189 PHE N 98 PHE.? 12.51 O2 GOL N3029 D 298 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 329 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 35.44 53.35 83.81 35.65 54.53 81.28 205.99 151.41 135.45 203.31 151.41 136.18 coo 29.72 46.46 83.60 30.79 47.36 81.99 203.51 159.51 142.26 205.02 160.53 143.48 coo 36.89 44.91 74.55 37.33 48.94 79.01 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 D 189 PHE O 98 PHE.? 11.35 CL CL O2018 D 298 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 329 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 35.44 53.35 83.81 35.65 54.53 81.28 131.45 133.74 155.71 134.18 134.46 155.64 coo 29.72 46.46 83.60 30.79 47.36 81.99 134.07 141.35 162.95 132.57 142.58 163.78 coo 36.89 44.91 74.55 37.33 48.94 79.01 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 D 189 PHE P 98 PHE.? 11.01 CL CL P2019 D 298 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 329 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 35.44 53.35 83.81 35.65 54.53 81.28 203.50 182.03 206.67 200.90 182.30 205.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 200.75 174.15 199.66 202.28 173.10 198.62 coo 36.89 44.91 74.55 37.33 48.94 79.01 204.59 186.28 195.60 209.96 186.96 196.62 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 156 GLN.? -9.57 O3 GOL A3037s A 296 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 383 TYR A 75 TYR~? 11.96 CL CL A2020 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 98.62 74.73 53.93 96.56 74.69 54.22 coo 40.93 4.45 2.36 38.91 3.75 2.26 94.58 81.89 51.70 95.31 83.75 52.44 coo 30.54 7.22 6.23 31.38 5.79 3.97 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN B 144 GLN~? 5.36 O1 GOL B3024 A 296 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 383 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 25.23 67.97 25.00 25.82 66.20 23.96 coo 40.93 4.45 2.36 38.91 3.75 2.26 26.68 73.50 25.50 26.49 75.15 26.91 coo 30.54 7.22 6.23 31.38 5.79 3.97 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN D 144 GLN~? 17.30 O3 GOL D3019 A 296 GLU D 141 GLU~? 22.23 O1 GOL G3001 A 383 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 17.88 45.80 74.24 18.72 47.75 74.07 coo 40.93 4.45 2.36 38.91 3.75 2.26 17.13 41.08 72.88 18.91 42.32 72.55 coo 30.54 7.22 6.23 31.38 5.79 3.97 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN F 144 GLN~? 11.49 CL CL F2035 A 296 GLU F 141 GLU~? 15.85 CL CL F2035 A 383 TYR F 109 TYR~? 6.98 CL CL F2035 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 86.06 33.92 35.15 85.92 35.17 33.44 coo 40.93 4.45 2.36 38.91 3.75 2.26 84.56 28.39 36.54 84.29 26.85 38.03 coo 30.54 7.22 6.23 31.38 5.79 3.97 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN G 144 GLN~? 13.62 C3 GOL G3001 A 296 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 383 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 20.40 31.78 38.43 20.75 30.54 40.14 coo 40.93 4.45 2.36 38.91 3.75 2.26 21.81 32.02 32.76 22.04 33.29 31.00 coo 30.54 7.22 6.23 31.38 5.79 3.97 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN H 156 GLN.? -8.49 C1 GOL H3016s A 296 GLU H 73 GLU~? -8.72 CL CL H2014s A 383 TYR H 75 TYR~? 10.27 CL CL H2014 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 93.11 53.95 84.03 91.11 53.67 83.58 coo 40.93 4.45 2.36 38.91 3.75 2.26 87.54 56.19 90.14 87.78 55.44 92.11 coo 30.54 7.22 6.23 31.38 5.79 3.97 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN I 144 GLN~? 5.83 O1 GOL I3032 A 296 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 383 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 203.35 189.41 155.57 202.68 190.98 156.90 coo 40.93 4.45 2.36 38.91 3.75 2.26 203.00 188.32 149.96 202.87 186.91 148.25 coo 30.54 7.22 6.23 31.38 5.79 3.97 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN J 156 GLN.? -9.65 O1 GOL J3033s A 296 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 383 TYR J 75 TYR~? 10.17 CL CL J2016 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 128.06 171.27 140.20 130.09 170.91 140.43 coo 40.93 4.45 2.36 38.91 3.75 2.26 133.49 171.70 133.63 132.81 170.83 131.84 coo 30.54 7.22 6.23 31.38 5.79 3.97 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN K 156 GLN.? -2.47 O2 GOL K3009s A 296 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 383 TYR K 75 TYR~? 12.36 CL CL K2027 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 209.60 140.38 174.58 207.54 140.72 174.28 coo 40.93 4.45 2.36 38.91 3.75 2.26 204.07 133.93 175.85 204.65 132.02 175.03 coo 30.54 7.22 6.23 31.38 5.79 3.97 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 10 3 # 10 A 271 GLN M 144 GLN~? 18.53 O3 GOL M3042 A 296 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 383 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 137.26 195.03 179.49 137.97 196.37 178.00 coo 40.93 4.45 2.36 38.91 3.75 2.26 137.93 194.30 185.04 137.74 193.05 186.86 coo 30.54 7.22 6.23 31.38 5.79 3.97 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 11 3 # 11 A 271 GLN N 144 GLN~? 5.76 C1 GOL N3029 A 296 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 383 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 201.39 151.74 148.20 201.01 153.17 146.62 coo 40.93 4.45 2.36 38.91 3.75 2.26 199.85 147.19 149.72 199.65 149.31 150.43 coo 30.54 7.22 6.23 31.38 5.79 3.97 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 12 3 # 12 A 271 GLN N 156 GLN.? -2.65 O1 GOL N3012s A 296 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 383 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 212.49 162.95 145.52 210.46 163.61 145.52 coo 40.93 4.45 2.36 38.91 3.75 2.26 207.93 161.92 138.37 208.75 162.64 136.53 coo 30.54 7.22 6.23 31.38 5.79 3.97 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 13 3 # 13 A 271 GLN O 144 GLN~? 6.42 O3 GOL O3026 A 296 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 383 TYR O 109 TYR~? 12.46 CL CL O2036 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 136.08 146.43 154.31 136.54 145.45 156.17 coo 40.93 4.45 2.36 38.91 3.75 2.26 137.18 147.02 148.83 137.46 148.02 146.94 coo 30.54 7.22 6.23 31.38 5.79 3.97 141.96 138.45 153.78 143.09 141.01 153.60 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 13 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 28 ASP~? 35.69 O2 GOL E3035 A 327 GLU A 93 GLU~? 8.07 CL CL A2020 A 339 ARG A 94 ARG~? 16.48 CL CL A2020 coo 85.81 57.99 116.01 86.03 55.86 115.89 62.23 105.49 38.88 63.59 105.50 37.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 106.40 86.90 39.80 107.05 88.84 40.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 103.08 84.27 32.66 100.64 86.13 32.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 54 ASP~? 22.76 O3 GOL B3003 A 327 GLU F 73 GLU~? 5.19 O3 GOL F3039 A 339 ARG F 122 ARG.? -4.08 O3 GOL F3039s coo 85.81 57.99 116.01 86.03 55.86 115.89 63.60 81.91 35.55 61.73 81.46 36.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 93.55 43.24 25.35 94.46 43.89 23.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 88.42 43.62 18.77 88.84 45.09 21.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 54 ASP~? 22.76 O3 GOL B3003 A 327 GLU F 120 GLU.? -11.16 O2 GOL F3039s A 339 ARG F 122 ARG.? -4.08 O3 GOL F3039s coo 85.81 57.99 116.01 86.03 55.86 115.89 63.60 81.91 35.55 61.73 81.46 36.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 82.16 42.76 15.61 80.62 43.81 14.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 88.42 43.62 18.77 88.84 45.09 21.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 327 GLU E 56 GLU~? 9.34 O1 GOL E3004 A 339 ARG E 55 ARG~? 13.47 C3 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.44 78.16 48.76 91.65 76.94 50.06 coo 75.11 41.01 160.30 76.65 40.06 161.41 49.08 93.57 65.06 50.69 94.83 64.79 coo 82.23 40.35 159.87 85.09 40.67 161.01 47.24 86.77 68.80 48.11 84.54 66.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 327 GLU F 120 GLU.? -11.16 O2 GOL F3039s A 339 ARG F 122 ARG.? -4.08 O3 GOL F3039s coo 85.81 57.99 116.01 86.03 55.86 115.89 90.44 78.16 48.76 91.65 76.94 50.06 coo 75.11 41.01 160.30 76.65 40.06 161.41 82.16 42.76 15.61 80.62 43.81 14.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 88.42 43.62 18.77 88.84 45.09 21.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 92 ASP~? 15.30 CL CL A2020 A 327 GLU A 52 GLU~? -17.57 O3 GOL B3003s A 339 ARG A 51 ARG~? 16.54 O3 GOL B3003 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.94 81.51 35.78 108.70 83.14 34.47 coo 75.11 41.01 160.30 76.65 40.06 161.41 62.12 85.51 28.52 61.28 86.90 27.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 61.69 79.67 29.64 62.00 76.91 30.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 92 ASP~? 15.30 CL CL A2020 A 327 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 339 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 85.81 57.99 116.01 86.03 55.86 115.89 108.94 81.51 35.78 108.70 83.14 34.47 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.42 72.24 77.39 84.86 73.57 75.76 coo 82.23 40.35 159.87 85.09 40.67 161.01 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 327 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 339 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 85.81 57.99 116.01 86.03 55.86 115.89 88.23 80.63 30.72 87.92 80.82 28.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.42 72.24 77.39 84.86 73.57 75.76 coo 82.23 40.35 159.87 85.09 40.67 161.01 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 327 GLU A 59 GLU.? 24.46 O1 GOL A3040 A 339 ARG A 108 ARG~? 22.68 O1 GOL A3040 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.55 78.44 42.57 74.34 76.74 41.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.54 80.61 37.36 78.31 77.83 38.52 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 327 GLU B 93 GLU~? 9.70 CL CL B2010 A 339 ARG B 94 ARG~? 16.70 CL CL B2010 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 11.87 67.96 6.38 12.21 67.44 4.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.95 75.41 8.08 19.04 75.79 8.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 327 GLU B 163 GLU~? 11.65 O3 GOL B3015 A 339 ARG B 155 ARG.? 12.69 O3 GOL B3015 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.08 65.82 20.87 54.46 64.71 21.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.39 62.04 22.34 6.51 59.97 22.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.18 53.45 20.49 4.91 55.44 21.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 327 GLU E 43 GLU~? 17.32 C1 GOL E3004 A 339 ARG E 14 ARG~? 16.26 C1 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.08 65.82 20.87 54.46 64.71 21.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 66.77 92.95 61.24 67.88 94.70 61.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 63.05 87.03 60.24 64.56 85.62 62.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 327 GLU E 73 GLU~? -6.85 O1 GOL E3022s A 339 ARG E 122 ARG.? -5.69 O1 GOL E3022s coo 85.81 57.99 116.01 86.03 55.86 115.89 53.08 65.82 20.87 54.46 64.71 21.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 19.82 90.31 48.74 19.50 92.07 47.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.42 95.37 48.46 25.62 92.61 47.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP B 54 ASP~? 13.29 O3 GOL B3003 A 327 GLU E 120 GLU.? -9.65 O2 GOL E3035s A 339 ARG E 122 ARG.? -5.69 O1 GOL E3022s coo 85.81 57.99 116.01 86.03 55.86 115.89 53.08 65.82 20.87 54.46 64.71 21.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.01 97.18 49.59 34.45 97.37 48.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.42 95.37 48.46 25.62 92.61 47.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 327 GLU E 120 GLU.? -9.65 O2 GOL E3035s A 339 ARG E 122 ARG.? -5.69 O1 GOL E3022s coo 85.81 57.99 116.01 86.03 55.86 115.89 23.66 59.02 20.34 21.93 58.32 21.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.01 97.18 49.59 34.45 97.37 48.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.42 95.37 48.46 25.62 92.61 47.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 327 GLU F 56 GLU~? 19.98 CL CL F2035 A 339 ARG F 55 ARG~? 14.19 CL CL F2035 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.66 59.02 20.34 21.93 58.32 21.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 62.56 32.21 18.10 61.29 32.37 16.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP B 92 ASP~? 16.05 CL CL B2010 A 327 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 339 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 9.78 73.89 9.95 11.15 74.42 8.49 coo 75.11 41.01 160.30 76.65 40.06 161.41 21.81 32.02 32.76 22.04 33.29 31.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 327 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 339 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 30.49 75.29 14.98 31.30 77.16 14.42 coo 75.11 41.01 160.30 76.65 40.06 161.41 21.81 32.02 32.76 22.04 33.29 31.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP C 28 ASP~? 15.70 CL CL C2004 A 327 GLU C 93 GLU~? 8.05 CL CL C2021 A 339 ARG C 94 ARG~? 17.54 CL CL C2011 coo 85.81 57.99 116.01 86.03 55.86 115.89 48.49 0.93 68.23 49.38 0.74 70.13 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.51 9.91 76.89 94.48 7.78 76.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 90.04 13.41 83.93 87.43 14.95 84.75 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP C 54 ASP~? 14.99 CL CL C2006 A 327 GLU C 163 GLU~? 4.89 CL CL C2031 A 339 ARG C 155 ARG.? 9.50 CL CL C2031 coo 85.81 57.99 116.01 86.03 55.86 115.89 53.32 23.86 72.39 51.93 24.66 71.07 coo 75.11 41.01 160.30 76.65 40.06 161.41 100.18 24.25 67.88 99.96 23.77 65.85 coo 82.23 40.35 159.87 85.09 40.67 161.01 100.04 20.62 60.58 101.89 22.90 59.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP C 54 ASP~? 14.99 CL CL C2006 A 327 GLU H 73 GLU~? -8.72 CL CL H2014s A 339 ARG H 122 ARG.? -8.72 O1 GOL H3025s coo 85.81 57.99 116.01 86.03 55.86 115.89 53.32 23.86 72.39 51.93 24.66 71.07 coo 75.11 41.01 160.30 76.65 40.06 161.41 87.54 56.19 90.14 87.78 55.44 92.11 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.95 57.12 95.14 81.70 55.44 92.71 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP C 54 ASP~? 14.99 CL CL C2006 A 327 GLU H 120 GLU.? -11.59 C3 GOL H3025s A 339 ARG H 122 ARG.? -8.72 O1 GOL H3025s coo 85.81 57.99 116.01 86.03 55.86 115.89 53.32 23.86 72.39 51.93 24.66 71.07 coo 75.11 41.01 160.30 76.65 40.06 161.41 74.48 59.31 96.72 72.63 58.20 97.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.95 57.12 95.14 81.70 55.44 92.71 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 327 GLU F 93 GLU~? 8.36 CL CL F2023 A 339 ARG F 94 ARG~? 17.00 CL CL F2034 coo 85.81 57.99 116.01 86.03 55.86 115.89 82.81 22.02 65.69 84.52 22.80 64.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 102.94 29.85 20.29 103.30 29.96 18.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 98.12 23.01 22.37 95.90 22.43 24.48 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 327 GLU G 56 GLU.? 17.83 CL CL C2004 A 339 ARG G 55 ARG~? 22.00 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 82.81 22.02 65.69 84.52 22.80 64.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 43.97 14.81 40.22 44.85 13.00 40.58 coo 82.23 40.35 159.87 85.09 40.67 161.01 44.23 21.19 35.75 42.00 23.24 36.25 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 327 GLU H 120 GLU.? -11.59 C3 GOL H3025s A 339 ARG H 122 ARG.? -8.72 O1 GOL H3025s coo 85.81 57.99 116.01 86.03 55.86 115.89 82.81 22.02 65.69 84.52 22.80 64.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 74.48 59.31 96.72 72.63 58.20 97.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.95 57.12 95.14 81.70 55.44 92.71 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP C 92 ASP~? 15.08 CL CL C2021 A 327 GLU C 52 GLU~? -16.46 O3 GOL D3005s A 339 ARG C 51 ARG~? 15.50 O3 GOL D3005 coo 85.81 57.99 116.01 86.03 55.86 115.89 96.74 14.44 81.93 95.51 12.97 82.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 49.96 20.70 78.97 48.54 19.65 80.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 50.80 26.41 78.15 53.63 27.50 78.75 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP C 92 ASP~? 15.08 CL CL C2021 A 327 GLU F 141 GLU~? 15.85 CL CL F2035 A 339 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 85.81 57.99 116.01 86.03 55.86 115.89 96.74 14.44 81.93 95.51 12.97 82.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.56 28.39 36.54 84.29 26.85 38.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP C 92 ASP~? 15.08 CL CL C2021 A 327 GLU H 63 GLU~? 5.58 O3 GOL H3016 A 339 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 85.81 57.99 116.01 86.03 55.86 115.89 96.74 14.44 81.93 95.51 12.97 82.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 75.79 57.78 79.22 77.22 56.21 79.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 29 3 # 29 A 50 ASP C 102 ASP.? 24.57 CL CL C2011 A 327 GLU F 141 GLU~? 15.85 CL CL F2035 A 339 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 85.81 57.99 116.01 86.03 55.86 115.89 76.25 20.52 82.74 75.40 20.56 84.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 84.56 28.39 36.54 84.29 26.85 38.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 30 3 # 30 A 50 ASP C 127 ASP.? 10.87 CL CL C2011 A 327 GLU C 43 GLU~? 15.46 CL CL C2004 A 339 ARG C 14 ARG~? 14.47 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 86.95 7.50 76.71 86.89 6.71 78.70 coo 75.11 41.01 160.30 76.65 40.06 161.41 38.06 16.03 67.09 37.03 14.19 67.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 42.37 22.00 65.55 40.14 23.31 67.25 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 31 3 # 31 A 50 ASP D 28 ASP~? 15.80 CL CL H2005 A 327 GLU D 93 GLU~? 8.23 CL CL D2022 A 339 ARG D 94 ARG~? 15.71 CL CL D2012 coo 85.81 57.99 116.01 86.03 55.86 115.89 45.36 50.43 107.49 43.88 48.98 107.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 0.77 48.16 89.31 0.23 49.10 91.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 3.39 42.85 90.39 4.96 40.19 90.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 32 3 # 32 A 50 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 327 GLU G 73 GLU~? 5.63 O1 GOL G3038 A 339 ARG G 122 ARG.? -6.12 O3 GOL G3038s coo 85.81 57.99 116.01 86.03 55.86 115.89 43.67 42.20 85.12 45.49 43.03 84.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 12.93 24.13 49.80 12.04 22.49 50.80 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.11 17.77 51.41 17.63 20.64 52.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 33 3 # 33 A 50 ASP D 54 ASP~? 13.05 O1 GOL D3005 A 327 GLU G 120 GLU.? -11.42 O3 GOL G3038s A 339 ARG G 122 ARG.? -6.12 O3 GOL G3038s coo 85.81 57.99 116.01 86.03 55.86 115.89 43.67 42.20 85.12 45.49 43.03 84.45 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.27 14.49 51.28 25.51 14.14 52.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.11 17.77 51.41 17.63 20.64 52.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 34 3 # 34 A 50 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 327 GLU C 52 GLU~? -16.46 O3 GOL D3005s A 339 ARG C 55 ARG~? 19.41 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.94 54.59 79.01 15.65 55.42 77.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 49.96 20.70 78.97 48.54 19.65 80.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.97 24.40 76.93 55.45 26.29 74.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 35 3 # 35 A 50 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 327 GLU E 93 GLU~? 8.42 CL CL E2032 A 339 ARG E 94 ARG~? 16.65 CL CL E2013 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.94 54.59 79.01 15.65 55.42 77.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 9.96 100.16 58.92 10.04 102.16 58.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.62 99.03 66.62 15.44 98.70 67.89 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 36 3 # 36 A 50 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 327 GLU G 120 GLU.? -11.42 O3 GOL G3038s A 339 ARG G 122 ARG.? -6.12 O3 GOL G3038s coo 85.81 57.99 116.01 86.03 55.86 115.89 16.94 54.59 79.01 15.65 55.42 77.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.27 14.49 51.28 25.51 14.14 52.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.11 17.77 51.41 17.63 20.64 52.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 37 3 # 37 A 50 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 327 GLU H 56 GLU.? 8.74 O3 GOL H3006 A 339 ARG H 55 ARG~? 13.48 O3 GOL H3006 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.94 54.59 79.01 15.65 55.42 77.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 58.45 73.39 90.18 56.86 73.32 91.53 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.33 75.55 82.58 59.37 73.14 80.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 38 3 # 38 A 50 ASP D 92 ASP~? 15.62 CL CL D2022 A 327 GLU D 52 GLU~? 2.84 O1 GOL D3005s A 339 ARG D 51 ARG~? -12.62 C3 GOL D3005s coo 85.81 57.99 116.01 86.03 55.86 115.89 -1.67 42.91 85.09 -1.08 41.92 86.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 44.94 36.04 90.12 45.74 34.99 91.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 44.97 36.17 83.73 45.77 36.49 80.75 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 39 3 # 39 A 50 ASP D 92 ASP~? 15.62 CL CL D2022 A 327 GLU E 141 GLU~? 19.75 O1 GOL D3019 A 339 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 85.81 57.99 116.01 86.03 55.86 115.89 -1.67 42.91 85.09 -1.08 41.92 86.85 coo 75.11 41.01 160.30 76.65 40.06 161.41 21.80 82.16 67.66 21.51 80.62 69.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 40 3 # 40 A 50 ASP D 102 ASP.? 24.32 CL CL D2012 A 327 GLU E 141 GLU~? 19.75 O1 GOL D3019 A 339 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 85.81 57.99 116.01 86.03 55.86 115.89 18.96 37.41 85.00 19.42 35.40 85.42 coo 75.11 41.01 160.30 76.65 40.06 161.41 21.80 82.16 67.66 21.51 80.62 69.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 41 3 # 41 A 50 ASP D 127 ASP.? 11.17 CL CL D2012 A 327 GLU D 43 GLU~? 15.38 CL CL H2005 A 339 ARG D 14 ARG~? 14.52 CL CL D2008 coo 85.81 57.99 116.01 86.03 55.86 115.89 7.65 47.79 93.97 7.18 46.10 95.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 58.07 46.43 95.03 58.79 46.64 97.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.60 47.14 88.58 57.38 44.84 87.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 42 3 # 42 A 50 ASP D 127 ASP.? 11.17 CL CL D2012 A 327 GLU D 43 GLU~? 15.38 CL CL H2005 A 339 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 85.81 57.99 116.01 86.03 55.86 115.89 7.65 47.79 93.97 7.18 46.10 95.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 58.07 46.43 95.03 58.79 46.64 97.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 43 3 # 43 A 50 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 327 GLU E 93 GLU~? 8.42 CL CL E2032 A 339 ARG E 94 ARG~? 16.65 CL CL E2013 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.09 107.82 57.29 55.83 108.40 58.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 9.96 100.16 58.92 10.04 102.16 58.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.62 99.03 66.62 15.44 98.70 67.89 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 44 3 # 44 A 50 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 327 GLU H 59 GLU.? 16.22 O2 GOL H3016 A 339 ARG H 108 ARG~? 14.48 O2 GOL H3016 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.09 107.82 57.29 55.83 108.40 58.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 68.06 65.41 81.65 68.51 66.61 79.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 71.22 70.92 84.57 72.18 68.95 82.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 45 3 # 45 A 50 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 327 GLU H 106 GLU~? 14.51 O2 GOL H3016 A 339 ARG H 108 ARG~? 14.48 O2 GOL H3016 coo 85.81 57.99 116.01 86.03 55.86 115.89 57.09 107.82 57.29 55.83 108.40 58.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 79.71 74.06 84.56 81.75 73.57 84.59 coo 82.23 40.35 159.87 85.09 40.67 161.01 71.22 70.92 84.57 72.18 68.95 82.36 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 46 3 # 46 A 50 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 327 GLU B 52 GLU~? -2.63 O3 GOL B3003s A 339 ARG B 55 ARG~? -14.24 O1 GOL B3003s coo 85.81 57.99 116.01 86.03 55.86 115.89 50.61 86.23 65.01 52.31 85.22 64.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.04 71.55 17.08 58.10 72.98 16.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 50.06 69.68 20.36 47.07 69.49 19.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 47 3 # 47 A 50 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 327 GLU D 43 GLU~? 15.38 CL CL H2005 A 339 ARG D 14 ARG~? 14.52 CL CL D2008 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.61 86.23 65.01 52.31 85.22 64.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 58.07 46.43 95.03 58.79 46.64 97.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.60 47.14 88.58 57.38 44.84 87.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 48 3 # 48 A 50 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 327 GLU D 73 GLU~? 5.51 C2 GOL D3020 A 339 ARG D 122 ARG.? -6.47 O1 GOL D3018s coo 85.81 57.99 116.01 86.03 55.86 115.89 50.61 86.23 65.01 52.31 85.22 64.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 12.99 58.17 82.26 12.31 59.24 83.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.06 58.51 88.62 17.90 59.58 85.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 49 3 # 49 A 50 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 327 GLU D 120 GLU.? -10.99 O2 GOL D3019s A 339 ARG D 122 ARG.? -6.47 O1 GOL D3018s coo 85.81 57.99 116.01 86.03 55.86 115.89 50.61 86.23 65.01 52.31 85.22 64.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 23.97 57.13 91.99 25.36 58.66 92.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.06 58.51 88.62 17.90 59.58 85.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 50 3 # 50 A 50 ASP E 54 ASP~? 13.23 O1 GOL E3004 A 327 GLU E 163 GLU~? 11.74 O1 GOL E3002 A 339 ARG E 155 ARG.? 13.04 O1 GOL E3002 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.61 86.23 65.01 52.31 85.22 64.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 5.75 84.10 51.71 6.08 84.26 49.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.91 86.02 43.52 5.22 85.54 45.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 51 3 # 51 A 50 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 327 GLU A 56 GLU.? 25.60 O3 GOL B3003 A 339 ARG A 55 ARG~? 19.31 O3 GOL B3003 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.07 86.29 52.35 21.57 85.17 51.32 coo 75.11 41.01 160.30 76.65 40.06 161.41 66.40 88.57 34.15 65.18 90.26 34.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 66.98 80.93 31.90 64.74 79.05 32.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 52 3 # 52 A 50 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 327 GLU D 120 GLU.? -10.99 O2 GOL D3019s A 339 ARG D 122 ARG.? -6.47 O1 GOL D3018s coo 85.81 57.99 116.01 86.03 55.86 115.89 23.07 86.29 52.35 21.57 85.17 51.32 coo 75.11 41.01 160.30 76.65 40.06 161.41 23.97 57.13 91.99 25.36 58.66 92.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 18.06 58.51 88.62 17.90 59.58 85.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 53 3 # 53 A 50 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 327 GLU H 52 GLU~? -2.46 O3 GOL H3006s A 339 ARG H 55 ARG~? 13.48 O3 GOL H3006 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.07 86.29 52.35 21.57 85.17 51.32 coo 75.11 41.01 160.30 76.65 40.06 161.41 54.90 78.91 86.42 53.66 80.21 87.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 60.33 75.55 82.58 59.37 73.14 80.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 54 3 # 54 A 50 ASP E 92 ASP~? 15.39 CL CL E2032 A 327 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 339 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.40 96.69 64.15 7.81 98.00 64.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 26.68 73.50 25.50 26.49 75.15 26.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 55 3 # 55 A 50 ASP E 92 ASP~? 15.39 CL CL E2032 A 327 GLU E 52 GLU~? -2.93 O1 GOL E3004s A 339 ARG E 51 ARG~? 12.86 C3 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 6.40 96.69 64.15 7.81 98.00 64.97 coo 75.11 41.01 160.30 76.65 40.06 161.41 52.85 90.79 71.14 54.01 92.22 72.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 51.65 84.19 70.80 51.43 81.15 70.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 56 3 # 56 A 50 ASP E 102 ASP.? 24.45 CL CL E2013 A 327 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 339 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 85.81 57.99 116.01 86.03 55.86 115.89 26.42 91.49 69.61 27.08 91.68 71.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 26.68 73.50 25.50 26.49 75.15 26.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 57 3 # 57 A 50 ASP E 127 ASP.? 11.39 CL CL E2013 A 327 GLU E 43 GLU~? 17.32 C1 GOL E3004 A 339 ARG E 14 ARG~? 16.26 C1 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.80 103.20 59.40 17.93 103.89 61.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 66.77 92.95 61.24 67.88 94.70 61.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 63.05 87.03 60.24 64.56 85.62 62.59 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 58 3 # 58 A 50 ASP E 127 ASP.? 11.39 CL CL E2013 A 327 GLU E 43 GLU~? 17.32 C1 GOL E3004 A 339 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.80 103.20 59.40 17.93 103.89 61.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 66.77 92.95 61.24 67.88 94.70 61.00 coo 82.23 40.35 159.87 85.09 40.67 161.01 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 59 3 # 59 A 50 ASP F 28 ASP~? 32.62 CL CL F2035 A 327 GLU F 93 GLU~? 8.36 CL CL F2023 A 339 ARG F 94 ARG~? 17.00 CL CL F2034 coo 85.81 57.99 116.01 86.03 55.86 115.89 59.39 38.13 1.08 60.39 36.31 1.06 coo 75.11 41.01 160.30 76.65 40.06 161.41 102.94 29.85 20.29 103.30 29.96 18.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 98.12 23.01 22.37 95.90 22.43 24.48 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 60 3 # 60 A 50 ASP F 28 ASP~? 32.62 CL CL F2035 A 327 GLU G 59 GLU.? 19.70 CL CL C2006 A 339 ARG G 108 ARG~? 22.05 O2 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 59.39 38.13 1.08 60.39 36.31 1.06 coo 75.11 41.01 160.30 76.65 40.06 161.41 36.26 26.21 43.47 36.13 28.17 44.46 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.32 22.84 38.36 31.62 25.53 39.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 61 3 # 61 A 50 ASP F 28 ASP~? 32.62 CL CL F2035 A 327 GLU G 106 GLU~? 21.38 C3 GOL G3001 A 339 ARG G 108 ARG~? 22.05 O2 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 59.39 38.13 1.08 60.39 36.31 1.06 coo 75.11 41.01 160.30 76.65 40.06 161.41 24.93 23.55 33.32 22.94 24.09 33.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 32.32 22.84 38.36 31.62 25.53 39.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 62 3 # 62 A 50 ASP F 54 ASP~? 17.55 CL CL F2035 A 327 GLU C 73 GLU~? 6.99 O1 GOL C3036 A 339 ARG C 122 ARG.? -9.05 O1 GOL C3036s coo 85.81 57.99 116.01 86.03 55.86 115.89 59.85 34.12 24.67 58.32 35.47 25.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 86.57 17.41 63.72 86.98 15.43 63.06 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.03 12.35 63.23 81.23 14.78 61.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 63 3 # 63 A 50 ASP F 54 ASP~? 17.55 CL CL F2035 A 327 GLU C 120 GLU.? -12.41 C3 GOL C3021s A 339 ARG C 122 ARG.? -9.05 O1 GOL C3036s coo 85.81 57.99 116.01 86.03 55.86 115.89 59.85 34.12 24.67 58.32 35.47 25.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.42 10.71 63.99 71.68 10.30 62.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.03 12.35 63.23 81.23 14.78 61.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 64 3 # 64 A 50 ASP F 54 ASP~? 17.55 CL CL F2035 A 327 GLU F 163 GLU~? 16.81 CL CL F2023 A 339 ARG F 155 ARG.? 16.94 CL CL F2023 coo 85.81 57.99 116.01 86.03 55.86 115.89 59.85 34.12 24.67 58.32 35.47 25.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 105.09 39.28 35.27 105.30 41.23 34.49 coo 82.23 40.35 159.87 85.09 40.67 161.01 105.33 46.75 31.26 107.63 45.25 32.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 65 3 # 65 A 50 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 327 GLU A 93 GLU~? 8.07 CL CL A2020 A 339 ARG A 94 ARG~? 16.48 CL CL A2020 coo 85.81 57.99 116.01 86.03 55.86 115.89 88.86 41.25 28.96 90.30 42.22 30.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 106.40 86.90 39.80 107.05 88.84 40.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 103.08 84.27 32.66 100.64 86.13 32.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 66 3 # 66 A 50 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 327 GLU B 56 GLU.? 9.23 C1 GOL B3003 A 339 ARG B 55 ARG~? -14.24 O1 GOL B3003s coo 85.81 57.99 116.01 86.03 55.86 115.89 88.86 41.25 28.96 90.30 42.22 30.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 52.16 66.04 13.94 53.39 65.68 12.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 50.06 69.68 20.36 47.07 69.49 19.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 67 3 # 67 A 50 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 327 GLU C 120 GLU.? -12.41 C3 GOL C3021s A 339 ARG C 122 ARG.? -9.05 O1 GOL C3036s coo 85.81 57.99 116.01 86.03 55.86 115.89 88.86 41.25 28.96 90.30 42.22 30.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 73.42 10.71 63.99 71.68 10.30 62.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 80.03 12.35 63.23 81.23 14.78 61.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 68 3 # 68 A 50 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 327 GLU G 52 GLU~? -23.30 CL CL C2006s A 339 ARG G 55 ARG~? 22.00 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 88.86 41.25 28.96 90.30 42.22 30.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 49.29 16.65 35.00 50.30 14.93 34.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 44.23 21.19 35.75 42.00 23.24 36.25 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 69 3 # 69 A 50 ASP F 92 ASP~? 15.33 CL CL F2023 A 327 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 339 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 85.81 57.99 116.01 86.03 55.86 115.89 104.11 24.69 25.10 103.20 23.88 23.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 89.05 70.31 35.51 89.11 68.84 33.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 70 3 # 70 A 50 ASP F 92 ASP~? 15.33 CL CL F2023 A 327 GLU F 52 GLU~? -24.25 CL CL F2035s A 339 ARG F 51 ARG~? 18.26 CL CL F2035 coo 85.81 57.99 116.01 86.03 55.86 115.89 104.11 24.69 25.10 103.20 23.88 23.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 57.13 27.62 20.93 55.96 26.54 19.60 coo 82.23 40.35 159.87 85.09 40.67 161.01 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 71 3 # 71 A 50 ASP F 102 ASP.? 16.73 CL CL F2035 A 327 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 339 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 85.81 57.99 116.01 86.03 55.86 115.89 82.74 24.28 26.35 81.91 22.30 26.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 89.05 70.31 35.51 89.11 68.84 33.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 72 3 # 72 A 50 ASP G 28 ASP~? 15.85 CL CL C2004 A 327 GLU F 59 GLU.? -3.47 CL CL F2035s A 339 ARG F 108 ARG~? -3.40 CL CL F2035s coo 85.81 57.99 116.01 86.03 55.86 115.89 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 70.01 37.30 28.39 71.62 37.24 29.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 74.01 31.91 26.65 74.85 33.96 28.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 73 3 # 73 A 50 ASP G 28 ASP~? 15.85 CL CL C2004 A 327 GLU F 106 GLU~? 12.79 CL CL F2035 A 339 ARG F 108 ARG~? -3.40 CL CL F2035s coo 85.81 57.99 116.01 86.03 55.86 115.89 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 81.39 27.31 28.31 83.45 27.54 28.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 74.01 31.91 26.65 74.85 33.96 28.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 74 3 # 74 A 50 ASP G 28 ASP~? 15.85 CL CL C2004 A 327 GLU G 93 GLU~? 8.63 CL CL G2033 A 339 ARG G 94 ARG~? 18.02 CL CL G2033 coo 85.81 57.99 116.01 86.03 55.86 115.89 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 3.64 16.49 37.62 3.03 14.55 38.23 coo 82.23 40.35 159.87 85.09 40.67 161.01 8.15 17.84 30.29 11.01 16.64 30.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 75 3 # 75 A 50 ASP G 54 ASP~? 15.07 CL CL C2006 A 327 GLU B 73 GLU~? 6.38 O3 GOL B3023 A 339 ARG B 122 ARG.? -6.42 O2 GOL B3023s coo 85.81 57.99 116.01 86.03 55.86 115.89 46.65 21.52 40.60 48.29 22.27 41.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 19.80 56.19 16.30 19.32 55.14 14.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.34 54.66 11.25 25.32 53.82 13.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 76 3 # 76 A 50 ASP G 54 ASP~? 15.07 CL CL C2006 A 327 GLU B 120 GLU.? -11.49 O3 GOL B3017s A 339 ARG B 122 ARG.? -6.42 O2 GOL B3023s coo 85.81 57.99 116.01 86.03 55.86 115.89 46.65 21.52 40.60 48.29 22.27 41.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.11 55.06 9.52 34.74 53.67 9.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.34 54.66 11.25 25.32 53.82 13.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 77 3 # 77 A 50 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 327 GLU B 120 GLU.? -11.49 O3 GOL B3017s A 339 ARG B 122 ARG.? -6.42 O2 GOL B3023s coo 85.81 57.99 116.01 86.03 55.86 115.89 17.70 27.34 47.09 16.19 28.71 47.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 33.11 55.06 9.52 34.74 53.67 9.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 26.34 54.66 11.25 25.32 53.82 13.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 78 3 # 78 A 50 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 327 GLU C 56 GLU~? 17.52 CL CL C2004 A 339 ARG C 55 ARG~? 19.41 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.70 27.34 47.09 16.19 28.71 47.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 54.66 16.88 74.36 53.19 15.44 73.98 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.97 24.40 76.93 55.45 26.29 74.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 79 3 # 79 A 50 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 327 GLU D 93 GLU~? 8.23 CL CL D2022 A 339 ARG D 94 ARG~? 15.71 CL CL D2012 coo 85.81 57.99 116.01 86.03 55.86 115.89 17.70 27.34 47.09 16.19 28.71 47.73 coo 75.11 41.01 160.30 76.65 40.06 161.41 0.77 48.16 89.31 0.23 49.10 91.12 coo 82.23 40.35 159.87 85.09 40.67 161.01 3.39 42.85 90.39 4.96 40.19 90.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 80 3 # 80 A 50 ASP G 92 ASP~? 15.60 CL CL G2033 A 327 GLU D 141 GLU~? 22.23 O1 GOL G3001 A 339 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 2.22 20.23 31.66 3.30 18.41 31.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 17.13 41.08 72.88 18.91 42.32 72.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 81 3 # 81 A 50 ASP G 92 ASP~? 15.60 CL CL G2033 A 327 GLU G 52 GLU~? -23.30 CL CL C2006s A 339 ARG G 51 ARG~? 21.90 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 2.22 20.23 31.66 3.30 18.41 31.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 49.29 16.65 35.00 50.30 14.93 34.20 coo 82.23 40.35 159.87 85.09 40.67 161.01 49.60 22.70 34.88 49.12 25.71 35.34 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 82 3 # 82 A 50 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 327 GLU D 141 GLU~? 22.23 O1 GOL G3001 A 339 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 85.81 57.99 116.01 86.03 55.86 115.89 23.47 21.05 30.82 24.30 20.62 28.93 coo 75.11 41.01 160.30 76.65 40.06 161.41 17.13 41.08 72.88 18.91 42.32 72.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 83 3 # 83 A 50 ASP G 127 ASP.? 12.80 CL CL G2033 A 327 GLU G 43 GLU~? 15.32 CL CL C2004 A 339 ARG G 14 ARG~? 14.57 CL CL C2006 coo 85.81 57.99 116.01 86.03 55.86 115.89 10.22 12.11 38.73 10.33 11.10 36.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 59.87 11.86 47.66 60.57 9.92 48.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 57.32 18.45 47.88 59.70 19.45 46.16 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 84 3 # 84 A 50 ASP H 28 ASP~? 15.80 CL CL H2005 A 327 GLU E 59 GLU.? 18.54 O2 GOL E3035 A 339 ARG E 108 ARG~? 18.65 O1 GOL E3035 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.63 68.82 106.06 51.93 70.45 106.39 coo 75.11 41.01 160.30 76.65 40.06 161.41 39.30 83.55 59.19 38.26 82.82 60.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 36.12 87.73 64.17 35.30 85.24 62.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 85 3 # 85 A 50 ASP H 28 ASP~? 15.80 CL CL H2005 A 327 GLU E 106 GLU~? 21.05 O1 GOL E3022 A 339 ARG E 108 ARG~? 18.65 O1 GOL E3035 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.63 68.82 106.06 51.93 70.45 106.39 coo 75.11 41.01 160.30 76.65 40.06 161.41 27.90 88.73 67.36 25.90 88.59 66.70 coo 82.23 40.35 159.87 85.09 40.67 161.01 36.12 87.73 64.17 35.30 85.24 62.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 86 3 # 86 A 50 ASP H 28 ASP~? 15.80 CL CL H2005 A 327 GLU H 93 GLU~? 8.72 CL CL H2024 A 339 ARG H 94 ARG~? 16.71 CL CL H2014 coo 85.81 57.99 116.01 86.03 55.86 115.89 50.63 68.82 106.06 51.93 70.45 106.39 coo 75.11 41.01 160.30 76.65 40.06 161.41 97.56 68.07 97.57 97.65 67.50 99.59 coo 82.23 40.35 159.87 85.09 40.67 161.01 95.40 74.55 93.00 92.97 76.33 93.68 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 87 3 # 87 A 50 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 327 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 339 ARG A 122 ARG.? -4.29 O1 GOL A3040s coo 85.81 57.99 116.01 86.03 55.86 115.89 56.87 71.80 83.08 55.07 70.98 82.33 coo 75.11 41.01 160.30 76.65 40.06 161.41 94.58 81.89 51.70 95.31 83.75 52.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.32 88.48 50.81 89.57 85.85 52.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 88 3 # 88 A 50 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 327 GLU A 120 GLU.? -11.73 C1 GOL A3040s A 339 ARG A 122 ARG.? -4.29 O1 GOL A3040s coo 85.81 57.99 116.01 86.03 55.86 115.89 56.87 71.80 83.08 55.07 70.98 82.33 coo 75.11 41.01 160.30 76.65 40.06 161.41 83.52 91.40 48.59 81.73 92.29 49.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.32 88.48 50.81 89.57 85.85 52.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 89 3 # 89 A 50 ASP H 54 ASP~? 12.64 O3 GOL H3006 A 327 GLU H 163 GLU~? 16.69 O1 GOL H3016 A 339 ARG H 155 ARG.? 17.02 CL CL H2024 coo 85.81 57.99 116.01 86.03 55.86 115.89 56.87 71.80 83.08 55.07 70.98 82.33 coo 75.11 41.01 160.30 76.65 40.06 161.41 101.55 57.39 83.25 101.29 55.39 84.02 coo 82.23 40.35 159.87 85.09 40.67 161.01 99.48 50.13 87.00 102.10 51.31 85.80 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 90 3 # 90 A 50 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 327 GLU A 120 GLU.? -11.73 C1 GOL A3040s A 339 ARG A 122 ARG.? -4.29 O1 GOL A3040s coo 85.81 57.99 116.01 86.03 55.86 115.89 84.24 58.93 85.48 85.73 57.59 84.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 83.52 91.40 48.59 81.73 92.29 49.38 coo 82.23 40.35 159.87 85.09 40.67 161.01 89.32 88.48 50.81 89.57 85.85 52.38 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 91 3 # 91 A 50 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 327 GLU D 56 GLU~? 9.22 O1 GOL D3005 A 339 ARG D 55 ARG~? 14.96 O1 GOL D3005 coo 85.81 57.99 116.01 86.03 55.86 115.89 84.24 58.93 85.48 85.73 57.59 84.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 40.62 42.19 92.06 41.92 42.65 93.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 39.97 38.45 84.97 39.00 40.64 83.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 92 3 # 92 A 50 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 327 GLU E 52 GLU~? -2.93 O1 GOL E3004s A 339 ARG E 55 ARG~? 13.47 C3 GOL E3004 coo 85.81 57.99 116.01 86.03 55.86 115.89 84.24 58.93 85.48 85.73 57.59 84.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 52.85 90.79 71.14 54.01 92.22 72.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 47.24 86.77 68.80 48.11 84.54 66.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 93 3 # 93 A 50 ASP H 92 ASP~? 15.85 CL CL H2024 A 327 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 339 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 85.81 57.99 116.01 86.03 55.86 115.89 101.24 72.29 93.07 100.11 73.39 94.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 80.37 30.30 78.61 80.09 31.65 80.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 94 3 # 94 A 50 ASP H 92 ASP~? 15.85 CL CL H2024 A 327 GLU H 52 GLU~? -2.46 O3 GOL H3006s A 339 ARG H 51 ARG~? -11.05 O1 GOL H3006s coo 85.81 57.99 116.01 86.03 55.86 115.89 101.24 72.29 93.07 100.11 73.39 94.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 54.90 78.91 86.42 53.66 80.21 87.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 55.75 78.18 80.83 58.67 78.05 79.79 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 95 3 # 95 A 50 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 327 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 339 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 85.81 57.99 116.01 86.03 55.86 115.89 81.36 76.99 86.94 80.90 79.01 86.89 coo 75.11 41.01 160.30 76.65 40.06 161.41 80.37 30.30 78.61 80.09 31.65 80.29 coo 82.23 40.35 159.87 85.09 40.67 161.01 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 96 3 # 96 A 50 ASP H 127 ASP.? 11.27 CL CL H2014 A 327 GLU H 43 GLU~? 15.40 CL CL H2005 A 339 ARG H 14 ARG~? 14.44 CL CL D2008 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.18 69.09 100.25 90.25 71.19 100.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 40.68 69.93 90.74 39.73 70.17 92.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 44.51 67.63 85.23 43.02 69.63 83.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 97 3 # 97 A 50 ASP H 127 ASP.? 11.27 CL CL H2014 A 327 GLU H 43 GLU~? 15.40 CL CL H2005 A 339 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 85.81 57.99 116.01 86.03 55.86 115.89 90.18 69.09 100.25 90.25 71.19 100.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 40.68 69.93 90.74 39.73 70.17 92.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 98 3 # 98 A 50 ASP I 28 ASP~? 15.71 CL CL I2001 A 327 GLU I 93 GLU~? 8.40 CL CL I2025 A 339 ARG I 94 ARG~? 17.03 CL CL I2015 coo 85.81 57.99 116.01 86.03 55.86 115.89 174.34 221.90 156.42 175.71 222.11 154.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 219.77 205.57 155.06 219.86 207.68 155.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 216.21 203.80 147.44 213.68 202.45 146.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 99 3 # 99 A 50 ASP I 28 ASP~? 15.71 CL CL I2001 A 327 GLU J 106 GLU~? 21.26 CL CL J2016 A 339 ARG J 108 ARG~? 23.02 O1 GOL J3030 coo 85.81 57.99 116.01 86.03 55.86 115.89 174.34 221.90 156.42 175.71 222.11 154.83 coo 75.11 41.01 160.30 76.65 40.06 161.41 144.43 188.69 135.80 142.30 188.60 135.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 152.38 184.27 135.62 151.05 183.00 138.10 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 100 3 # 100 A 50 ASP I 54 ASP~? 15.17 CL CL I2007 A 327 GLU I 163 GLU~? 16.56 O3 GOL I3032 A 339 ARG I 155 ARG.? 16.75 CL CL I2025 coo 85.81 57.99 116.01 86.03 55.86 115.89 176.64 198.53 151.72 174.93 197.89 152.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 221.15 190.35 164.07 220.95 190.90 166.06 coo 82.23 40.35 159.87 85.09 40.67 161.01 219.78 193.99 171.61 222.12 192.73 169.97 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 101 3 # 101 A 50 ASP I 54 ASP~? 15.17 CL CL I2007 A 327 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 339 ARG N 122 ARG.? -8.98 O1 GOL N3044s coo 85.81 57.99 116.01 86.03 55.86 115.89 176.64 198.53 151.72 174.93 197.89 152.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 207.93 161.92 138.37 208.75 162.64 136.53 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.43 162.21 132.12 202.95 163.61 134.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 102 3 # 102 A 50 ASP I 54 ASP~? 15.17 CL CL I2007 A 327 GLU N 120 GLU.? -11.11 O2 GOL N3044s A 339 ARG N 122 ARG.? -8.98 O1 GOL N3044s coo 85.81 57.99 116.01 86.03 55.86 115.89 176.64 198.53 151.72 174.93 197.89 152.71 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.16 161.38 129.21 195.01 163.08 128.79 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.43 162.21 132.12 202.95 163.61 134.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 103 3 # 103 A 50 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 327 GLU M 56 GLU~? 9.79 O1 GOL M3007 A 339 ARG M 55 ARG~? 12.49 O2 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 204.37 195.46 163.61 205.75 194.30 164.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 163.29 208.10 182.55 164.69 209.62 182.16 coo 82.23 40.35 159.87 85.09 40.67 161.01 162.29 201.15 185.73 159.83 200.25 187.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 104 3 # 104 A 50 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 327 GLU N 120 GLU.? -11.11 O2 GOL N3044s A 339 ARG N 122 ARG.? -8.98 O1 GOL N3044s coo 85.81 57.99 116.01 86.03 55.86 115.89 204.37 195.46 163.61 205.75 194.30 164.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.16 161.38 129.21 195.01 163.08 128.79 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.43 162.21 132.12 202.95 163.61 134.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 105 3 # 105 A 50 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 327 GLU P 93 GLU~? 9.65 CL CL P2019 A 339 ARG P 94 ARG~? 16.84 CL CL P2019 coo 85.81 57.99 116.01 86.03 55.86 115.89 204.37 195.46 163.61 205.75 194.30 164.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 214.54 183.14 211.27 214.54 182.92 213.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 211.03 190.17 208.71 208.47 191.85 208.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 106 3 # 106 A 50 ASP I 92 ASP~? 15.56 CL CL I2025 A 327 GLU I 52 GLU~? -23.17 CL CL I2007s A 339 ARG I 51 ARG~? 21.58 CL CL I2007 coo 85.81 57.99 116.01 86.03 55.86 115.89 222.01 200.70 150.15 220.98 202.18 149.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 174.67 202.46 145.17 173.69 203.91 143.96 coo 82.23 40.35 159.87 85.09 40.67 161.01 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 107 3 # 107 A 50 ASP I 92 ASP~? 15.56 CL CL I2025 A 327 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 339 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 85.81 57.99 116.01 86.03 55.86 115.89 222.01 200.70 150.15 220.98 202.18 149.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 200.04 187.90 192.14 200.20 189.50 190.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 206.30 185.90 191.05 208.78 186.92 189.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 108 3 # 108 A 50 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 327 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 339 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 85.81 57.99 116.01 86.03 55.86 115.89 201.10 198.54 145.88 200.66 198.62 143.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 200.04 187.90 192.14 200.20 189.50 190.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 206.30 185.90 191.05 208.78 186.92 189.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 109 3 # 109 A 50 ASP I 127 ASP.? 10.93 CL CL I2015 A 327 GLU I 43 GLU~? 15.44 CL CL I2001 A 339 ARG I 14 ARG~? 14.48 CL CL I2007 coo 85.81 57.99 116.01 86.03 55.86 115.89 212.49 209.49 154.15 212.74 210.27 152.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 161.95 208.67 154.98 161.14 210.63 154.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 165.05 201.86 156.79 162.79 201.13 154.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 110 3 # 110 A 50 ASP I 127 ASP.? 10.93 CL CL I2015 A 327 GLU I 43 GLU~? 15.44 CL CL I2001 A 339 ARG I 36 ARG~? 18.35 CL CL I2001 coo 85.81 57.99 116.01 86.03 55.86 115.89 212.49 209.49 154.15 212.74 210.27 152.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 161.95 208.67 154.98 161.14 210.63 154.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 111 3 # 111 A 50 ASP J 28 ASP~? 15.67 CL CL J2002 A 327 GLU I 106 GLU~? 14.47 O1 GOL I3032 A 339 ARG I 108 ARG~? 14.30 O1 GOL I3032 coo 85.81 57.99 116.01 86.03 55.86 115.89 170.87 175.19 114.50 169.74 176.91 114.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 199.46 196.34 148.59 201.47 195.97 149.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 191.22 197.47 152.14 191.76 195.04 153.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 112 3 # 112 A 50 ASP J 28 ASP~? 15.67 CL CL J2002 A 327 GLU J 93 GLU~? 8.18 CL CL J2026 A 339 ARG J 94 ARG~? 16.81 CL CL J2016 coo 85.81 57.99 116.01 86.03 55.86 115.89 170.87 175.19 114.50 169.74 176.91 114.00 coo 75.11 41.01 160.30 76.65 40.06 161.41 124.50 183.71 125.04 124.44 183.21 122.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 128.91 190.77 127.30 131.74 191.98 127.17 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 113 3 # 113 A 50 ASP J 54 ASP~? 19.87 CL CL J2002 A 327 GLU M 73 GLU~? -3.31 O3 GOL M3042s A 339 ARG M 122 ARG.? -5.48 O1 GOL M3043s coo 85.81 57.99 116.01 86.03 55.86 115.89 166.52 182.87 136.75 168.05 181.78 137.64 coo 75.11 41.01 160.30 76.65 40.06 161.41 133.35 204.22 167.43 132.84 205.99 166.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.60 209.60 166.99 138.90 206.81 165.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 114 3 # 114 A 50 ASP J 54 ASP~? 19.87 CL CL J2002 A 327 GLU M 120 GLU.? -11.44 O3 GOL M3043s A 339 ARG M 122 ARG.? -5.48 O1 GOL M3043s coo 85.81 57.99 116.01 86.03 55.86 115.89 166.52 182.87 136.75 168.05 181.78 137.64 coo 75.11 41.01 160.30 76.65 40.06 161.41 146.06 211.81 168.53 147.94 211.97 167.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.60 209.60 166.99 138.90 206.81 165.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 115 3 # 115 A 50 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 327 GLU M 120 GLU.? -11.44 O3 GOL M3043s A 339 ARG M 122 ARG.? -5.48 O1 GOL M3043s coo 85.81 57.99 116.01 86.03 55.86 115.89 137.44 174.60 137.57 135.80 173.80 138.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 146.06 211.81 168.53 147.94 211.97 167.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.60 209.60 166.99 138.90 206.81 165.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 116 3 # 116 A 50 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 327 GLU N 56 GLU.? 8.85 O3 GOL N3008 A 339 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 85.81 57.99 116.01 86.03 55.86 115.89 137.44 174.60 137.57 135.80 173.80 138.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 177.02 149.87 132.23 175.77 150.16 130.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 117 3 # 117 A 50 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 327 GLU O 93 GLU~? 9.72 CL CL O2018 A 339 ARG O 94 ARG~? 17.23 CL CL O2018 coo 85.81 57.99 116.01 86.03 55.86 115.89 137.44 174.60 137.57 135.80 173.80 138.69 coo 75.11 41.01 160.30 76.65 40.06 161.41 119.95 130.02 153.81 119.63 127.98 154.32 coo 82.23 40.35 159.87 85.09 40.67 161.01 124.05 130.93 146.77 126.63 131.98 145.39 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 118 3 # 118 A 50 ASP J 92 ASP~? 15.35 CL CL J2026 A 327 GLU J 52 GLU~? -23.89 CL CL J2002s A 339 ARG J 51 ARG~? 27.44 CL CL J2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 122.14 189.51 128.78 123.73 190.15 127.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 169.71 188.73 132.35 170.94 189.67 130.91 coo 82.23 40.35 159.87 85.09 40.67 161.01 168.80 189.12 137.91 166.15 189.45 139.46 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 119 3 # 119 A 50 ASP J 92 ASP~? 15.35 CL CL J2026 A 327 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 339 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 85.81 57.99 116.01 86.03 55.86 115.89 122.14 189.51 128.78 123.73 190.15 127.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 137.18 147.02 148.83 137.46 148.02 146.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 120 3 # 120 A 50 ASP J 102 ASP.? 24.08 CL CL J2016 A 327 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 339 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 85.81 57.99 116.01 86.03 55.86 115.89 143.25 191.36 132.98 143.80 193.32 132.63 coo 75.11 41.01 160.30 76.65 40.06 161.41 137.18 147.02 148.83 137.46 148.02 146.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 121 3 # 121 A 50 ASP K 28 ASP~? 19.61 O1 GOL K3011 A 327 GLU K 93 GLU~? 8.22 CL CL K2027 A 339 ARG K 94 ARG~? 18.44 CL CL K2027 coo 85.81 57.99 116.01 86.03 55.86 115.89 166.96 115.59 181.42 167.86 115.34 183.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 212.85 126.80 188.86 213.03 124.72 188.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 208.90 129.35 195.92 206.24 130.62 196.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 122 3 # 122 A 50 ASP K 28 ASP~? 19.61 O1 GOL K3011 A 327 GLU L 106 GLU~? 21.37 CL CL L2009 A 339 ARG L 108 ARG~? 19.25 O3 GOL L3028 coo 85.81 57.99 116.01 86.03 55.86 115.89 166.96 115.59 181.42 167.86 115.34 183.30 coo 75.11 41.01 160.30 76.65 40.06 161.41 138.12 152.20 198.93 136.10 152.63 198.56 coo 82.23 40.35 159.87 85.09 40.67 161.01 146.49 155.54 199.73 145.94 157.11 197.11 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 123 3 # 123 A 50 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 327 GLU K 163 GLU~? 12.51 O2 GOL K3009 A 339 ARG K 155 ARG.? 13.03 O2 GOL K3009 coo 85.81 57.99 116.01 86.03 55.86 115.89 171.09 138.55 186.41 169.55 139.29 185.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 217.27 141.62 179.80 217.24 141.01 177.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 216.54 137.96 172.21 218.86 139.31 173.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 124 3 # 124 A 50 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 327 GLU P 73 GLU~? 5.04 O1 GOL P3034 A 339 ARG P 122 ARG.? -4.11 O1 GOL P3034s coo 85.81 57.99 116.01 86.03 55.86 115.89 171.09 138.55 186.41 169.55 139.29 185.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 204.36 171.43 203.90 204.84 170.63 205.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 198.11 171.86 209.38 198.78 170.26 206.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 125 3 # 125 A 50 ASP K 54 ASP~? 13.11 O1 GOL K3011 A 327 GLU P 120 GLU.? -11.18 O2 GOL P3034s A 339 ARG P 122 ARG.? -4.11 O1 GOL P3034s coo 85.81 57.99 116.01 86.03 55.86 115.89 171.09 138.55 186.41 169.55 139.29 185.16 coo 75.11 41.01 160.30 76.65 40.06 161.41 191.64 173.40 211.51 190.22 171.88 211.85 coo 82.23 40.35 159.87 85.09 40.67 161.01 198.11 171.86 209.38 198.78 170.26 206.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 126 3 # 126 A 50 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 327 GLU K 33 GLU~? 15.23 O1 GOL K3011 A 339 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 159.57 118.25 190.56 157.88 119.02 189.34 coo 82.23 40.35 159.87 85.09 40.67 161.01 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 127 3 # 127 A 50 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 327 GLU L 52 GLU~? -16.81 O3 GOL K3011s A 339 ARG L 55 ARG~? 21.00 O3 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 163.03 149.29 204.90 163.96 148.28 206.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 158.05 151.49 200.24 157.97 153.99 198.35 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 128 3 # 128 A 50 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 327 GLU N 93 GLU~? 8.57 CL CL N2030 A 339 ARG N 94 ARG~? 18.33 CL CL N2030 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 217.47 148.79 132.22 217.76 148.97 130.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 212.83 142.20 134.40 210.04 140.93 133.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 129 3 # 129 A 50 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 327 GLU O 56 GLU.? 16.78 CL CL O2036 A 339 ARG O 55 ARG~? 19.37 CL CL K2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 160.60 130.40 154.07 161.73 128.68 154.54 coo 82.23 40.35 159.87 85.09 40.67 161.01 159.96 137.60 150.54 160.85 139.64 152.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 130 3 # 130 A 50 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 327 GLU P 120 GLU.? -11.18 O2 GOL P3034s A 339 ARG P 122 ARG.? -4.11 O1 GOL P3034s coo 85.81 57.99 116.01 86.03 55.86 115.89 200.17 138.24 178.11 201.77 139.28 177.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 191.64 173.40 211.51 190.22 171.88 211.85 coo 82.23 40.35 159.87 85.09 40.67 161.01 198.11 171.86 209.38 198.78 170.26 206.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 131 3 # 131 A 50 ASP K 92 ASP~? 16.19 CL CL K2027 A 327 GLU K 52 GLU~? -2.85 O1 GOL K3011s A 339 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 85.81 57.99 116.01 86.03 55.86 115.89 214.98 131.64 193.77 214.74 130.33 195.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 168.06 134.81 192.85 166.74 133.62 193.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 132 3 # 132 A 50 ASP K 92 ASP~? 16.19 CL CL K2027 A 327 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 339 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 85.81 57.99 116.01 86.03 55.86 115.89 214.98 131.64 193.77 214.74 130.33 195.35 coo 75.11 41.01 160.30 76.65 40.06 161.41 199.85 147.19 149.72 199.65 149.31 150.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 133 3 # 133 A 50 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 327 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 339 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 85.81 57.99 116.01 86.03 55.86 115.89 194.36 135.90 195.25 193.66 135.95 197.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 199.85 147.19 149.72 199.65 149.31 150.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 134 3 # 134 A 50 ASP K 127 ASP.? 12.37 CL CL K2027 A 327 GLU K 43 GLU~? 16.84 C1 GOL K3011 A 339 ARG K 14 ARG~? 14.49 CL CL K2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 205.42 123.70 188.60 205.51 122.74 190.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 155.84 130.25 181.35 154.86 128.33 181.37 coo 82.23 40.35 159.87 85.09 40.67 161.01 159.72 136.15 179.98 157.68 137.80 181.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 135 3 # 135 A 50 ASP K 127 ASP.? 12.37 CL CL K2027 A 327 GLU K 43 GLU~? 16.84 C1 GOL K3011 A 339 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 205.42 123.70 188.60 205.51 122.74 190.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 155.84 130.25 181.35 154.86 128.33 181.37 coo 82.23 40.35 159.87 85.09 40.67 161.01 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 136 3 # 136 A 50 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 327 GLU K 59 GLU.? 18.15 O3 GOL K3010 A 339 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 85.81 57.99 116.01 86.03 55.86 115.89 163.49 162.78 223.08 162.21 161.15 223.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 181.67 140.70 183.14 183.47 141.86 183.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 137 3 # 137 A 50 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 327 GLU K 106 GLU~? 21.15 O3 GOL K3009 A 339 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 85.81 57.99 116.01 86.03 55.86 115.89 163.49 162.78 223.08 162.21 161.15 223.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 193.16 138.18 192.36 195.25 138.38 192.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 138 3 # 138 A 50 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 327 GLU L 93 GLU~? 8.05 CL CL L2028 A 339 ARG L 94 ARG~? 15.79 CL CL L2009 coo 85.81 57.99 116.01 86.03 55.86 115.89 163.49 162.78 223.08 162.21 161.15 223.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 118.11 159.89 208.04 117.71 160.95 209.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 121.28 153.19 204.82 123.22 151.93 206.95 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 139 3 # 139 A 50 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 327 GLU L 163 GLU~? 16.77 CL CL L2028 A 339 ARG L 155 ARG.? 15.58 CL CL L2028 coo 85.81 57.99 116.01 86.03 55.86 115.89 161.13 155.54 200.38 162.83 156.50 199.58 coo 75.11 41.01 160.30 76.65 40.06 161.41 116.58 166.98 191.20 116.69 169.04 191.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 117.81 174.80 193.27 115.12 175.12 194.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 140 3 # 140 A 50 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 327 GLU O 73 GLU~? 6.85 O1 GOL O3013 A 339 ARG O 122 ARG.? -8.86 O1 GOL O3013s coo 85.81 57.99 116.01 86.03 55.86 115.89 161.13 155.54 200.38 162.83 156.50 199.58 coo 75.11 41.01 160.30 76.65 40.06 161.41 129.73 137.78 165.68 128.97 136.10 166.67 coo 82.23 40.35 159.87 85.09 40.67 161.01 135.19 131.73 166.81 134.71 134.57 167.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 141 3 # 141 A 50 ASP L 54 ASP~? 22.45 O3 GOL K3011 A 327 GLU O 120 GLU.? -14.26 CL CL O2036s A 339 ARG O 122 ARG.? -8.86 O1 GOL O3013s coo 85.81 57.99 116.01 86.03 55.86 115.89 161.13 155.54 200.38 162.83 156.50 199.58 coo 75.11 41.01 160.30 76.65 40.06 161.41 141.54 128.80 166.07 143.30 128.41 167.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 135.19 131.73 166.81 134.71 134.57 167.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 142 3 # 142 A 50 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 327 GLU M 93 GLU~? 8.60 CL CL M2029 A 339 ARG M 94 ARG~? 15.98 CL CL M2017 coo 85.81 57.99 116.01 86.03 55.86 115.89 133.34 166.97 196.27 132.03 168.03 194.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 123.31 213.00 178.36 123.21 215.02 177.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 126.25 211.46 185.79 129.25 212.02 186.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 143 3 # 143 A 50 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 327 GLU O 120 GLU.? -14.26 CL CL O2036s A 339 ARG O 122 ARG.? -8.86 O1 GOL O3013s coo 85.81 57.99 116.01 86.03 55.86 115.89 133.34 166.97 196.27 132.03 168.03 194.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 141.54 128.80 166.07 143.30 128.41 167.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 135.19 131.73 166.81 134.71 134.57 167.84 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 144 3 # 144 A 50 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 327 GLU P 56 GLU.? 24.16 O3 GOL M3007 A 339 ARG P 55 ARG~? 20.09 O3 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 133.34 166.97 196.27 132.03 168.03 194.96 coo 75.11 41.01 160.30 76.65 40.06 161.41 174.58 187.04 206.13 173.17 186.75 207.60 coo 82.23 40.35 159.87 85.09 40.67 161.01 176.25 189.61 198.56 175.31 187.31 196.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 145 3 # 145 A 50 ASP L 92 ASP~? 15.46 CL CL L2028 A 327 GLU L 52 GLU~? -16.81 O3 GOL K3011s A 339 ARG L 51 ARG~? 16.39 O3 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 115.70 154.99 203.31 116.12 153.70 204.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 163.03 149.29 204.90 163.96 148.28 206.51 coo 82.23 40.35 159.87 85.09 40.67 161.01 163.01 149.53 198.74 162.90 150.47 195.82 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 146 3 # 146 A 50 ASP L 92 ASP~? 15.46 CL CL L2028 A 327 GLU O 63 GLU~? 5.90 C1 GOL O3026 A 339 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 85.81 57.99 116.01 86.03 55.86 115.89 115.70 154.99 203.31 116.12 153.70 204.91 coo 75.11 41.01 160.30 76.65 40.06 161.41 143.37 146.22 164.56 141.71 146.26 165.94 coo 82.23 40.35 159.87 85.09 40.67 161.01 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 147 3 # 147 A 50 ASP L 102 ASP.? 24.59 CL CL L2009 A 327 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 339 ARG M 145 ARG~? 23.51 CL CL M2017 coo 85.81 57.99 116.01 86.03 55.86 115.89 136.52 149.82 201.33 136.95 147.73 201.53 coo 75.11 41.01 160.30 76.65 40.06 161.41 137.93 194.30 185.04 137.74 193.05 186.86 coo 82.23 40.35 159.87 85.09 40.67 161.01 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 148 3 # 148 A 50 ASP M 28 ASP~? 15.52 CL CL I2001 A 327 GLU M 93 GLU~? 8.60 CL CL M2029 A 339 ARG M 94 ARG~? 15.98 CL CL M2017 coo 85.81 57.99 116.01 86.03 55.86 115.89 170.27 223.20 174.57 168.89 223.83 176.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 123.31 213.00 178.36 123.21 215.02 177.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 126.25 211.46 185.79 129.25 212.02 186.24 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 149 3 # 149 A 50 ASP M 28 ASP~? 15.52 CL CL I2001 A 327 GLU P 59 GLU.? 23.07 O3 GOL P3014 A 339 ARG P 108 ARG~? 21.30 O3 GOL P3014 coo 85.81 57.99 116.01 86.03 55.86 115.89 170.27 223.20 174.57 168.89 223.83 176.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 183.91 180.18 196.89 184.59 182.10 196.19 coo 82.23 40.35 159.87 85.09 40.67 161.01 187.53 185.71 199.97 188.17 183.79 197.64 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 150 3 # 150 A 50 ASP M 28 ASP~? 15.52 CL CL I2001 A 327 GLU P 106 GLU~? 20.67 O3 GOL P3014 A 339 ARG P 108 ARG~? 21.30 O3 GOL P3014 coo 85.81 57.99 116.01 86.03 55.86 115.89 170.27 223.20 174.57 168.89 223.83 176.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 195.52 189.19 199.68 197.57 188.76 199.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 187.53 185.71 199.97 188.17 183.79 197.64 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 151 3 # 151 A 50 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 327 GLU L 73 GLU~? 5.94 O3 GOL L3027 A 339 ARG L 122 ARG.? -6.18 O1 GOL L3027s coo 85.81 57.99 116.01 86.03 55.86 115.89 164.95 201.02 181.99 166.71 200.19 181.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 129.44 170.32 199.72 128.69 171.38 201.39 coo 82.23 40.35 159.87 85.09 40.67 161.01 134.93 170.64 205.87 134.58 171.85 203.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 152 3 # 152 A 50 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 327 GLU L 120 GLU.? -11.39 O1 GOL L3027s A 339 ARG L 122 ARG.? -6.18 O1 GOL L3027s coo 85.81 57.99 116.01 86.03 55.86 115.89 164.95 201.02 181.99 166.71 200.19 181.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 141.12 169.24 208.86 142.52 170.84 209.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 134.93 170.64 205.87 134.58 171.85 203.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 153 3 # 153 A 50 ASP M 54 ASP~? 13.03 O2 GOL M3007 A 327 GLU M 163 GLU~? 14.80 C2 GOL M3042 A 339 ARG M 155 ARG.? 12.99 O1 GOL M3042 coo 85.81 57.99 116.01 86.03 55.86 115.89 164.95 201.02 181.99 166.71 200.19 181.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 119.51 197.10 170.73 120.12 197.15 168.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 121.45 199.58 162.40 118.88 198.67 163.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 154 3 # 154 A 50 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 327 GLU I 56 GLU.? 17.30 CL CL I2001 A 339 ARG I 55 ARG~? 19.02 CL CL I2007 coo 85.81 57.99 116.01 86.03 55.86 115.89 136.87 200.18 170.79 135.36 199.08 169.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 178.97 205.20 150.86 177.96 206.96 151.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 179.74 197.90 148.59 178.27 195.79 150.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 155 3 # 155 A 50 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 327 GLU L 120 GLU.? -11.39 O1 GOL L3027s A 339 ARG L 122 ARG.? -6.18 O1 GOL L3027s coo 85.81 57.99 116.01 86.03 55.86 115.89 136.87 200.18 170.79 135.36 199.08 169.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 141.12 169.24 208.86 142.52 170.84 209.07 coo 82.23 40.35 159.87 85.09 40.67 161.01 134.93 170.64 205.87 134.58 171.85 203.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 156 3 # 156 A 50 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 327 GLU P 52 GLU~? -15.89 O3 GOL M3007s A 339 ARG P 55 ARG~? 20.09 O3 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 136.87 200.18 170.79 135.36 199.08 169.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 170.60 192.65 202.74 169.53 193.98 203.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 176.25 189.61 198.56 175.31 187.31 196.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 157 3 # 157 A 50 ASP M 92 ASP~? 15.40 CL CL M2029 A 327 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 339 ARG J 145 ARG~? 22.99 CL CL J2016 coo 85.81 57.99 116.01 86.03 55.86 115.89 120.06 209.18 183.48 121.50 210.55 184.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 139.93 188.85 143.36 139.82 190.60 144.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 158 3 # 158 A 50 ASP M 92 ASP~? 15.40 CL CL M2029 A 327 GLU M 52 GLU~? 2.53 O2 GOL M3007s A 339 ARG M 51 ARG~? -9.68 O2 GOL M3007s coo 85.81 57.99 116.01 86.03 55.86 115.89 120.06 209.18 183.48 121.50 210.55 184.17 coo 75.11 41.01 160.30 76.65 40.06 161.41 167.24 205.49 188.41 168.46 206.85 189.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 166.66 199.07 188.11 163.90 199.62 189.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 159 3 # 159 A 50 ASP M 102 ASP.? 24.52 CL CL M2017 A 327 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 339 ARG J 145 ARG~? 22.99 CL CL J2016 coo 85.81 57.99 116.01 86.03 55.86 115.89 140.74 204.70 188.01 141.33 204.99 189.98 coo 75.11 41.01 160.30 76.65 40.06 161.41 139.93 188.85 143.36 139.82 190.60 144.63 coo 82.23 40.35 159.87 85.09 40.67 161.01 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 160 3 # 160 A 50 ASP M 127 ASP.? 9.06 CL CL M2017 A 327 GLU M 43 GLU~? 15.49 CL CL I2001 A 339 ARG M 14 ARG~? 14.61 CL CL I2007 coo 85.81 57.99 116.01 86.03 55.86 115.89 130.79 216.32 178.32 129.76 218.07 177.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 180.74 208.70 177.96 181.77 210.50 177.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 177.02 202.54 176.79 178.85 201.28 179.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 161 3 # 161 A 50 ASP M 127 ASP.? 9.06 CL CL M2017 A 327 GLU M 43 GLU~? 15.49 CL CL I2001 A 339 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 130.79 216.32 178.32 129.76 218.07 177.66 coo 75.11 41.01 160.30 76.65 40.06 161.41 180.74 208.70 177.96 181.77 210.50 177.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 162 3 # 162 A 50 ASP N 28 ASP~? 15.68 CL CL J2002 A 327 GLU N 93 GLU~? 8.57 CL CL N2030 A 339 ARG N 94 ARG~? 18.33 CL CL N2030 coo 85.81 57.99 116.01 86.03 55.86 115.89 173.04 156.37 115.74 174.12 154.54 115.64 coo 75.11 41.01 160.30 76.65 40.06 161.41 217.47 148.79 132.22 217.76 148.97 130.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 212.83 142.20 134.40 210.04 140.93 133.99 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 163 3 # 163 A 50 ASP N 28 ASP~? 15.68 CL CL J2002 A 327 GLU O 59 GLU.? 16.38 CL CL O2036 A 339 ARG O 108 ARG~? 13.39 CL CL O2036 coo 85.81 57.99 116.01 86.03 55.86 115.89 173.04 156.37 115.74 174.12 154.54 115.64 coo 75.11 41.01 160.30 76.65 40.06 161.41 151.76 141.44 158.93 151.52 142.12 156.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 148.81 138.28 154.16 147.06 140.78 153.42 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 164 3 # 164 A 50 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 327 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 339 ARG K 122 ARG.? -6.46 O2 GOL K3041s coo 85.81 57.99 116.01 86.03 55.86 115.89 174.60 151.44 139.08 172.92 152.56 139.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 204.07 133.93 175.85 204.65 132.02 175.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 197.94 128.45 175.54 198.81 130.96 174.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 165 3 # 165 A 50 ASP N 54 ASP~? 13.04 O3 GOL N3008 A 327 GLU K 120 GLU.? 9.38 O3 GOL K3010 A 339 ARG K 122 ARG.? -6.46 O2 GOL K3041s coo 85.81 57.99 116.01 86.03 55.86 115.89 174.60 151.44 139.08 172.92 152.56 139.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 191.40 126.33 176.24 190.06 126.00 174.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 197.94 128.45 175.54 198.81 130.96 174.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 166 3 # 166 A 50 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 327 GLU I 93 GLU~? 8.40 CL CL I2025 A 339 ARG I 94 ARG~? 17.03 CL CL I2015 coo 85.81 57.99 116.01 86.03 55.86 115.89 203.51 159.51 142.26 205.02 160.53 143.48 coo 75.11 41.01 160.30 76.65 40.06 161.41 219.77 205.57 155.06 219.86 207.68 155.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 216.21 203.80 147.44 213.68 202.45 146.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 167 3 # 167 A 50 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 327 GLU J 56 GLU.? 17.48 CL CL J2002 A 339 ARG J 55 ARG~? 24.05 CL CL J2002 coo 85.81 57.99 116.01 86.03 55.86 115.89 203.51 159.51 142.26 205.02 160.53 143.48 coo 75.11 41.01 160.30 76.65 40.06 161.41 164.69 183.53 129.34 166.31 182.92 128.17 coo 82.23 40.35 159.87 85.09 40.67 161.01 163.85 187.29 136.52 164.25 185.16 138.77 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 168 3 # 168 A 50 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 327 GLU K 120 GLU.? 9.38 O3 GOL K3010 A 339 ARG K 122 ARG.? -6.46 O2 GOL K3041s coo 85.81 57.99 116.01 86.03 55.86 115.89 203.51 159.51 142.26 205.02 160.53 143.48 coo 75.11 41.01 160.30 76.65 40.06 161.41 191.40 126.33 176.24 190.06 126.00 174.65 coo 82.23 40.35 159.87 85.09 40.67 161.01 197.94 128.45 175.54 198.81 130.96 174.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 169 3 # 169 A 50 ASP N 92 ASP~? 15.48 CL CL N2030 A 327 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 339 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 85.81 57.99 116.01 86.03 55.86 115.89 219.13 143.58 136.78 218.22 142.74 135.01 coo 75.11 41.01 160.30 76.65 40.06 161.41 203.00 188.32 149.96 202.87 186.91 148.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 170 3 # 170 A 50 ASP N 92 ASP~? 15.48 CL CL N2030 A 327 GLU N 52 GLU~? -2.84 O3 GOL N3008s A 339 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 85.81 57.99 116.01 86.03 55.86 115.89 219.13 143.58 136.78 218.22 142.74 135.01 coo 75.11 41.01 160.30 76.65 40.06 161.41 171.98 144.88 135.10 170.87 143.79 133.67 coo 82.23 40.35 159.87 85.09 40.67 161.01 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 171 3 # 171 A 50 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 327 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 339 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 85.81 57.99 116.01 86.03 55.86 115.89 197.96 142.41 139.19 197.06 140.46 139.09 coo 75.11 41.01 160.30 76.65 40.06 161.41 203.00 188.32 149.96 202.87 186.91 148.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 172 3 # 172 A 50 ASP N 127 ASP.? 12.60 CL CL N2030 A 327 GLU N 43 GLU~? 15.48 CL CL J2002 A 339 ARG N 14 ARG~? 15.89 C3 GOL N3008 coo 85.81 57.99 116.01 86.03 55.86 115.89 210.39 149.08 128.41 210.51 147.14 127.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 160.49 156.26 129.04 159.76 156.26 127.05 coo 82.23 40.35 159.87 85.09 40.67 161.01 163.48 157.63 135.35 161.30 155.86 136.73 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 173 3 # 173 A 50 ASP N 127 ASP.? 12.60 CL CL N2030 A 327 GLU N 43 GLU~? 15.48 CL CL J2002 A 339 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 85.81 57.99 116.01 86.03 55.86 115.89 210.39 149.08 128.41 210.51 147.14 127.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 160.49 156.26 129.04 159.76 156.26 127.05 coo 82.23 40.35 159.87 85.09 40.67 161.01 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 174 3 # 174 A 50 ASP O 28 ASP~? 23.95 CL CL O2036 A 327 GLU N 106 GLU~? 14.62 O2 GOL N3029 A 339 ARG N 108 ARG~? 14.89 C2 GOL N3029 coo 85.81 57.99 116.01 86.03 55.86 115.89 164.72 114.57 162.31 163.52 114.24 160.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.48 145.55 141.46 198.54 145.70 141.81 coo 82.23 40.35 159.87 85.09 40.67 161.01 189.02 149.68 140.15 189.67 151.62 142.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 175 3 # 175 A 50 ASP O 28 ASP~? 23.95 CL CL O2036 A 327 GLU O 93 GLU~? 9.72 CL CL O2018 A 339 ARG O 94 ARG~? 17.23 CL CL O2018 coo 85.81 57.99 116.01 86.03 55.86 115.89 164.72 114.57 162.31 163.52 114.24 160.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 119.95 130.02 153.81 119.63 127.98 154.32 coo 82.23 40.35 159.87 85.09 40.67 161.01 124.05 130.93 146.77 126.63 131.98 145.39 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 176 3 # 176 A 50 ASP O 54 ASP~? 15.16 CL CL K2003 A 327 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 339 ARG J 122 ARG.? -6.11 O1 GOL J3030s coo 85.81 57.99 116.01 86.03 55.86 115.89 162.95 137.35 154.91 164.67 137.97 155.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 133.49 171.70 133.63 132.81 170.83 131.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.69 170.93 128.19 138.90 169.62 130.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 177 3 # 177 A 50 ASP O 54 ASP~? 15.16 CL CL K2003 A 327 GLU J 120 GLU.? -11.66 O1 GOL J3030s A 339 ARG J 122 ARG.? -6.11 O1 GOL J3030s coo 85.81 57.99 116.01 86.03 55.86 115.89 162.95 137.35 154.91 164.67 137.97 155.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 146.22 171.46 125.96 147.90 170.17 125.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.69 170.93 128.19 138.90 169.62 130.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 178 3 # 178 A 50 ASP O 54 ASP~? 15.16 CL CL K2003 A 327 GLU O 163 GLU~? 12.66 O3 GOL O3013 A 339 ARG O 155 ARG.? 13.45 O3 GOL O3013 coo 85.81 57.99 116.01 86.03 55.86 115.89 162.95 137.35 154.91 164.67 137.97 155.90 coo 75.11 41.01 160.30 76.65 40.06 161.41 117.45 146.43 160.85 117.44 146.23 162.92 coo 82.23 40.35 159.87 85.09 40.67 161.01 117.87 143.72 169.20 115.63 144.83 167.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 179 3 # 179 A 50 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 327 GLU J 120 GLU.? -11.66 O1 GOL J3030s A 339 ARG J 122 ARG.? -6.11 O1 GOL J3030s coo 85.81 57.99 116.01 86.03 55.86 115.89 134.07 141.35 162.95 132.57 142.58 163.78 coo 75.11 41.01 160.30 76.65 40.06 161.41 146.22 171.46 125.96 147.90 170.17 125.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 139.69 170.93 128.19 138.90 169.62 130.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 180 3 # 180 A 50 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 327 GLU K 56 GLU~? 9.32 O1 GOL K3011 A 339 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 134.07 141.35 162.95 132.57 142.58 163.78 coo 75.11 41.01 160.30 76.65 40.06 161.41 172.89 131.40 187.88 171.30 130.10 187.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 181 3 # 181 A 50 ASP O 92 ASP~? 15.96 CL CL O2018 A 327 GLU O 52 GLU~? 17.58 O1 GOL N3008s A 339 ARG O 51 ARG~? 16.43 O1 GOL N3008 coo 85.81 57.99 116.01 86.03 55.86 115.89 118.21 134.06 148.13 119.12 132.25 147.57 coo 75.11 41.01 160.30 76.65 40.06 161.41 165.51 132.62 148.90 166.63 131.12 147.92 coo 82.23 40.35 159.87 85.09 40.67 161.01 165.78 138.84 148.96 164.30 141.49 149.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 182 3 # 182 A 50 ASP O 127 ASP.? 11.33 CL CL O2018 A 327 GLU O 43 GLU~? 17.17 O1 GOL K3010 A 339 ARG O 14 ARG~? 14.59 CL CL K2003 coo 85.81 57.99 116.01 86.03 55.86 115.89 127.12 126.29 154.29 127.00 125.34 152.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 177.14 127.85 160.77 177.95 125.93 161.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 174.25 134.10 161.46 176.22 135.49 159.49 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 183 3 # 183 A 50 ASP O 127 ASP.? 11.33 CL CL O2018 A 327 GLU O 43 GLU~? 17.17 O1 GOL K3010 A 339 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 85.81 57.99 116.01 86.03 55.86 115.89 127.12 126.29 154.29 127.00 125.34 152.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 177.14 127.85 160.77 177.95 125.93 161.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 184 3 # 184 A 50 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 327 GLU M 59 GLU.? 20.39 CL CL I2007 A 339 ARG M 108 ARG~? 23.14 O1 GOL M3043 coo 85.81 57.99 116.01 86.03 55.86 115.89 167.75 181.83 222.09 168.94 183.53 222.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 154.66 198.25 177.60 153.49 196.88 176.48 coo 82.23 40.35 159.87 85.09 40.67 161.01 150.62 202.12 182.01 149.56 199.68 180.53 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 185 3 # 185 A 50 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 327 GLU M 106 GLU~? 21.48 CL CL M2017 A 339 ARG M 108 ARG~? 23.14 O1 GOL M3043 coo 85.81 57.99 116.01 86.03 55.86 115.89 167.75 181.83 222.09 168.94 183.53 222.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 142.15 202.05 185.59 140.16 201.82 184.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 150.62 202.12 182.01 149.56 199.68 180.53 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 186 3 # 186 A 50 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 327 GLU P 93 GLU~? 9.65 CL CL P2019 A 339 ARG P 94 ARG~? 16.84 CL CL P2019 coo 85.81 57.99 116.01 86.03 55.86 115.89 167.75 181.83 222.09 168.94 183.53 222.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 214.54 183.14 211.27 214.54 182.92 213.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 211.03 190.17 208.71 208.47 191.85 208.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 187 3 # 187 A 50 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 327 GLU I 73 GLU~? -6.03 O3 GOL I3031s A 339 ARG I 122 ARG.? -5.95 O1 GOL I3031s coo 85.81 57.99 116.01 86.03 55.86 115.89 172.77 185.90 199.12 171.10 184.95 198.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 208.30 199.46 166.53 209.06 201.27 167.27 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.92 205.52 166.02 203.30 202.90 167.57 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 188 3 # 188 A 50 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 327 GLU I 120 GLU.? -11.94 O1 GOL I3031s A 339 ARG I 122 ARG.? -5.95 O1 GOL I3031s coo 85.81 57.99 116.01 86.03 55.86 115.89 172.77 185.90 199.12 171.10 184.95 198.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.64 208.29 164.24 194.84 208.90 165.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.92 205.52 166.02 203.30 202.90 167.57 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 189 3 # 189 A 50 ASP P 54 ASP~? 21.88 O3 GOL M3007 A 327 GLU P 163 GLU~? 11.95 O2 GOL P3014 A 339 ARG P 155 ARG.? 12.61 O2 GOL P3014 coo 85.81 57.99 116.01 86.03 55.86 115.89 172.77 185.90 199.12 171.10 184.95 198.29 coo 75.11 41.01 160.30 76.65 40.06 161.41 218.06 173.97 196.16 217.79 171.96 196.61 coo 82.23 40.35 159.87 85.09 40.67 161.01 216.42 165.88 200.05 218.98 167.31 198.98 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 190 3 # 190 A 50 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 327 GLU I 120 GLU.? -11.94 O1 GOL I3031s A 339 ARG I 122 ARG.? -5.95 O1 GOL I3031s coo 85.81 57.99 116.01 86.03 55.86 115.89 200.75 174.15 199.66 202.28 173.10 198.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.64 208.29 164.24 194.84 208.90 165.25 coo 82.23 40.35 159.87 85.09 40.67 161.01 202.92 205.52 166.02 203.30 202.90 167.57 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 191 3 # 191 A 50 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 327 GLU K 93 GLU~? 8.22 CL CL K2027 A 339 ARG K 94 ARG~? 18.44 CL CL K2027 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.75 174.15 199.66 202.28 173.10 198.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 212.85 126.80 188.86 213.03 124.72 188.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 208.90 129.35 195.92 206.24 130.62 196.90 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 192 3 # 192 A 50 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 327 GLU L 56 GLU.? 24.71 O3 GOL K3011 A 339 ARG L 55 ARG~? 21.00 O3 GOL K3011 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.75 174.15 199.66 202.28 173.10 198.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 158.53 155.21 207.26 159.92 155.54 208.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 158.05 151.49 200.24 157.97 153.99 198.35 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 193 3 # 193 A 50 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 327 GLU M 52 GLU~? 2.53 O2 GOL M3007s A 339 ARG M 55 ARG~? 12.49 O2 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 200.75 174.15 199.66 202.28 173.10 198.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 167.24 205.49 188.41 168.46 206.85 189.44 coo 82.23 40.35 159.87 85.09 40.67 161.01 162.29 201.15 185.73 159.83 200.25 187.37 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 194 3 # 194 A 50 ASP P 92 ASP~? 16.23 CL CL P2019 A 327 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 339 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 85.81 57.99 116.01 86.03 55.86 115.89 217.62 187.96 206.84 216.52 189.08 208.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 197.75 145.77 191.54 197.42 146.88 193.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 195 3 # 195 A 50 ASP P 92 ASP~? 16.23 CL CL P2019 A 327 GLU P 52 GLU~? -15.89 O3 GOL M3007s A 339 ARG P 51 ARG~? 14.75 O3 GOL M3007 coo 85.81 57.99 116.01 86.03 55.86 115.89 217.62 187.96 206.84 216.52 189.08 208.26 coo 75.11 41.01 160.30 76.65 40.06 161.41 170.60 192.65 202.74 169.53 193.98 203.95 coo 82.23 40.35 159.87 85.09 40.67 161.01 171.10 192.14 197.11 173.97 192.46 196.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 196 3 # 196 A 50 ASP P 102 ASP.? 24.26 CL CL P2019 A 327 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 339 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 85.81 57.99 116.01 86.03 55.86 115.89 197.01 191.93 202.05 196.73 194.01 202.05 coo 75.11 41.01 160.30 76.65 40.06 161.41 197.75 145.77 191.54 197.42 146.88 193.40 coo 82.23 40.35 159.87 85.09 40.67 161.01 204.60 147.17 190.28 202.10 146.29 191.85 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 196 hits 1hto_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 62 GLU~? 17.89 O1 GOL A3040 A 475 GLU A 63 GLU~? 17.38 O3 GOL A3037 A 477 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 13.27 46.15 59.96 13.96 44.19 59.76 79.10 78.67 51.18 78.43 78.08 53.09 coo 9.69 44.01 59.12 10.58 42.11 58.89 80.85 73.88 49.67 82.12 74.36 51.37 coo 13.49 45.17 55.56 13.84 42.22 54.75 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 2 3 # 2 A 311 GLU A 63 GLU~? 17.38 O3 GOL A3037 A 475 GLU A 62 GLU~? 17.89 O1 GOL A3040 A 477 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 13.27 46.15 59.96 13.96 44.19 59.76 80.85 73.88 49.67 82.12 74.36 51.37 coo 9.69 44.01 59.12 10.58 42.11 58.89 79.10 78.67 51.18 78.43 78.08 53.09 coo 13.49 45.17 55.56 13.84 42.22 54.75 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 3 3 # 3 A 311 GLU B 62 GLU~? 6.16 O2 GOL B3017 A 475 GLU B 63 GLU~? 5.73 C3 GOL B3024 A 477 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 13.27 46.15 59.96 13.96 44.19 59.76 34.07 54.53 23.00 34.19 52.69 24.02 coo 9.69 44.01 59.12 10.58 42.11 58.89 31.78 57.54 26.90 30.14 56.11 26.75 coo 13.49 45.17 55.56 13.84 42.22 54.75 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 4 3 # 4 A 311 GLU B 63 GLU~? 5.73 C3 GOL B3024 A 475 GLU B 62 GLU~? 6.16 O2 GOL B3017 A 477 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 13.27 46.15 59.96 13.96 44.19 59.76 31.78 57.54 26.90 30.14 56.11 26.75 coo 9.69 44.01 59.12 10.58 42.11 58.89 34.07 54.53 23.00 34.19 52.69 24.02 coo 13.49 45.17 55.56 13.84 42.22 54.75 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 5 3 # 5 A 311 GLU C 62 GLU~? 6.84 O3 GOL C3021 A 475 GLU C 63 GLU~? 10.01 O3 GOL C3021 A 477 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 13.27 46.15 59.96 13.96 44.19 59.76 72.25 23.75 60.88 72.37 24.62 58.95 coo 9.69 44.01 59.12 10.58 42.11 58.89 74.66 28.22 62.99 76.28 27.57 61.69 coo 13.49 45.17 55.56 13.84 42.22 54.75 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 6 3 # 6 A 311 GLU C 63 GLU~? 10.01 O3 GOL C3021 A 475 GLU C 62 GLU~? 6.84 O3 GOL C3021 A 477 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 13.27 46.15 59.96 13.96 44.19 59.76 74.66 28.22 62.99 76.28 27.57 61.69 coo 9.69 44.01 59.12 10.58 42.11 58.89 72.25 23.75 60.88 72.37 24.62 58.95 coo 13.49 45.17 55.56 13.84 42.22 54.75 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 7 3 # 7 A 311 GLU D 62 GLU~? 6.84 O2 GOL D3019 A 475 GLU D 63 GLU~? 9.36 O3 GOL D3019 A 477 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 13.27 46.15 59.96 13.96 44.19 59.76 28.24 57.03 78.84 28.94 58.69 77.75 coo 9.69 44.01 59.12 10.58 42.11 58.89 26.38 54.52 74.49 25.00 56.17 74.76 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 8 3 # 8 A 311 GLU D 63 GLU~? 9.36 O3 GOL D3019 A 475 GLU D 62 GLU~? 6.84 O2 GOL D3019 A 477 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 13.27 46.15 59.96 13.96 44.19 59.76 26.38 54.52 74.49 25.00 56.17 74.76 coo 9.69 44.01 59.12 10.58 42.11 58.89 28.24 57.03 78.84 28.94 58.69 77.75 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 9 3 # 9 A 311 GLU E 62 GLU~? 6.69 C2 GOL E3035 A 475 GLU E 63 GLU~? 9.77 O1 GOL E3035 A 477 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 13.27 46.15 59.96 13.96 44.19 59.76 34.02 83.69 49.99 34.45 82.62 48.22 coo 9.69 44.01 59.12 10.58 42.11 58.89 31.45 79.77 52.47 30.08 79.96 50.79 coo 13.49 45.17 55.56 13.84 42.22 54.75 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 10 3 # 10 A 311 GLU E 63 GLU~? 9.77 O1 GOL E3035 A 475 GLU E 62 GLU~? 6.69 C2 GOL E3035 A 477 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 13.27 46.15 59.96 13.96 44.19 59.76 31.45 79.77 52.47 30.08 79.96 50.79 coo 9.69 44.01 59.12 10.58 42.11 58.89 34.02 83.69 49.99 34.45 82.62 48.22 coo 13.49 45.17 55.56 13.84 42.22 54.75 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 11 3 # 11 A 311 GLU F 62 GLU~? 11.61 CL CL F2035 A 475 GLU F 63 GLU~? 10.86 CL CL F2035 A 477 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 13.27 46.15 59.96 13.96 44.19 59.76 78.25 46.27 28.27 77.97 48.25 28.91 coo 9.69 44.01 59.12 10.58 42.11 58.89 79.68 44.12 33.16 81.40 45.47 32.88 coo 13.49 45.17 55.56 13.84 42.22 54.75 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 12 3 # 12 A 311 GLU F 63 GLU~? 10.86 CL CL F2035 A 475 GLU F 62 GLU~? 11.61 CL CL F2035 A 477 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 13.27 46.15 59.96 13.96 44.19 59.76 79.68 44.12 33.16 81.40 45.47 32.88 coo 9.69 44.01 59.12 10.58 42.11 58.89 78.25 46.27 28.27 77.97 48.25 28.91 coo 13.49 45.17 55.56 13.84 42.22 54.75 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 13 3 # 13 A 311 GLU G 62 GLU~? 14.49 O2 GOL G3001 A 475 GLU G 63 GLU~? 11.17 O2 GOL G3001 A 477 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 13.27 46.15 59.96 13.96 44.19 59.76 28.36 27.46 51.94 28.55 28.64 53.65 coo 9.69 44.01 59.12 10.58 42.11 58.89 27.02 31.92 48.98 25.38 31.91 50.33 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 14 3 # 14 A 311 GLU G 63 GLU~? 11.17 O2 GOL G3001 A 475 GLU G 62 GLU~? 14.49 O2 GOL G3001 A 477 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 13.27 46.15 59.96 13.96 44.19 59.76 27.02 31.92 48.98 25.38 31.91 50.33 coo 9.69 44.01 59.12 10.58 42.11 58.89 28.36 27.46 51.94 28.55 28.64 53.65 coo 13.49 45.17 55.56 13.84 42.22 54.75 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 15 3 # 15 A 311 GLU H 62 GLU~? 6.87 C1 GOL H3025 A 475 GLU H 63 GLU~? 5.58 O3 GOL H3016 A 477 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 13.27 46.15 59.96 13.96 44.19 59.76 73.13 56.32 83.46 72.69 54.40 82.74 coo 9.69 44.01 59.12 10.58 42.11 58.89 75.79 57.78 79.22 77.22 56.21 79.74 coo 13.49 45.17 55.56 13.84 42.22 54.75 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 16 3 # 16 A 311 GLU H 63 GLU~? 5.58 O3 GOL H3016 A 475 GLU H 62 GLU~? 6.87 C1 GOL H3025 A 477 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 13.27 46.15 59.96 13.96 44.19 59.76 75.79 57.78 79.22 77.22 56.21 79.74 coo 9.69 44.01 59.12 10.58 42.11 58.89 73.13 56.32 83.46 72.69 54.40 82.74 coo 13.49 45.17 55.56 13.84 42.22 54.75 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 17 3 # 17 A 311 GLU I 62 GLU~? 9.77 O2 GOL I3032 A 475 GLU I 63 GLU~? 5.33 O2 GOL I3032 A 477 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 13.27 46.15 59.96 13.96 44.19 59.76 193.02 195.43 166.68 192.61 194.52 168.53 coo 9.69 44.01 59.12 10.58 42.11 58.89 195.05 190.75 164.81 196.51 190.81 166.36 coo 13.49 45.17 55.56 13.84 42.22 54.75 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 18 3 # 18 A 311 GLU I 63 GLU~? 5.33 O2 GOL I3032 A 475 GLU I 62 GLU~? 9.77 O2 GOL I3032 A 477 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 13.27 46.15 59.96 13.96 44.19 59.76 195.05 190.75 164.81 196.51 190.81 166.36 coo 9.69 44.01 59.12 10.58 42.11 58.89 193.02 195.43 166.68 192.61 194.52 168.53 coo 13.49 45.17 55.56 13.84 42.22 54.75 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 19 3 # 19 A 311 GLU J 62 GLU~? 19.29 O1 GOL J3030 A 475 GLU J 63 GLU~? 19.53 O1 GOL J3033 A 477 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 13.27 46.15 59.96 13.96 44.19 59.76 148.05 170.40 139.46 148.28 168.51 140.38 coo 9.69 44.01 59.12 10.58 42.11 58.89 145.93 173.07 143.61 144.33 171.59 143.32 coo 13.49 45.17 55.56 13.84 42.22 54.75 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 20 3 # 20 A 311 GLU J 63 GLU~? 19.53 O1 GOL J3033 A 475 GLU J 62 GLU~? 19.29 O1 GOL J3030 A 477 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 13.27 46.15 59.96 13.96 44.19 59.76 145.93 173.07 143.61 144.33 171.59 143.32 coo 9.69 44.01 59.12 10.58 42.11 58.89 148.05 170.40 139.46 148.28 168.51 140.38 coo 13.49 45.17 55.56 13.84 42.22 54.75 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 21 3 # 21 A 311 GLU K 62 GLU~? 6.62 O2 GOL K3010 A 475 GLU K 63 GLU~? 9.64 O2 GOL K3010 A 477 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 13.27 46.15 59.96 13.96 44.19 59.76 189.61 139.57 173.68 189.43 140.41 171.76 coo 9.69 44.01 59.12 10.58 42.11 58.89 191.78 144.13 175.87 193.39 143.52 174.53 coo 13.49 45.17 55.56 13.84 42.22 54.75 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 22 3 # 22 A 311 GLU K 63 GLU~? 9.64 O2 GOL K3010 A 475 GLU K 62 GLU~? 6.62 O2 GOL K3010 A 477 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 13.27 46.15 59.96 13.96 44.19 59.76 191.78 144.13 175.87 193.39 143.52 174.53 coo 9.69 44.01 59.12 10.58 42.11 58.89 189.61 139.57 173.68 189.43 140.41 171.76 coo 13.49 45.17 55.56 13.84 42.22 54.75 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 23 3 # 23 A 311 GLU L 62 GLU~? 6.90 C3 GOL L3028 A 475 GLU L 63 GLU~? 9.87 O3 GOL L3028 A 477 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 13.27 46.15 59.96 13.96 44.19 59.76 144.62 169.85 195.72 145.14 171.64 194.63 coo 9.69 44.01 59.12 10.58 42.11 58.89 142.67 167.29 191.27 141.24 168.94 191.33 coo 13.49 45.17 55.56 13.84 42.22 54.75 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 24 3 # 24 A 311 GLU L 63 GLU~? 9.87 O3 GOL L3028 A 475 GLU L 62 GLU~? 6.90 C3 GOL L3028 A 477 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 13.27 46.15 59.96 13.96 44.19 59.76 142.67 167.29 191.27 141.24 168.94 191.33 coo 9.69 44.01 59.12 10.58 42.11 58.89 144.62 169.85 195.72 145.14 171.64 194.63 coo 13.49 45.17 55.56 13.84 42.22 54.75 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 25 3 # 25 A 311 GLU M 62 GLU~? 18.60 O3 GOL M3042 A 475 GLU M 63 GLU~? 17.44 O3 GOL M3042 A 477 ARG M 66 ARG~? -13.90 O3 GOL M3042s coo 13.27 46.15 59.96 13.96 44.19 59.76 148.09 198.35 167.82 148.51 197.28 166.06 coo 9.69 44.01 59.12 10.58 42.11 58.89 145.53 194.15 170.27 144.03 194.27 168.71 coo 13.49 45.17 55.56 13.84 42.22 54.75 143.89 198.49 167.11 144.75 199.90 164.48 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 26 3 # 26 A 311 GLU M 63 GLU~? 17.44 O3 GOL M3042 A 475 GLU M 62 GLU~? 18.60 O3 GOL M3042 A 477 ARG M 66 ARG~? -13.90 O3 GOL M3042s coo 13.27 46.15 59.96 13.96 44.19 59.76 145.53 194.15 170.27 144.03 194.27 168.71 coo 9.69 44.01 59.12 10.58 42.11 58.89 148.09 198.35 167.82 148.51 197.28 166.06 coo 13.49 45.17 55.56 13.84 42.22 54.75 143.89 198.49 167.11 144.75 199.90 164.48 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 27 3 # 27 A 311 GLU N 62 GLU~? 6.38 C1 GOL N3044 A 475 GLU N 63 GLU~? 5.47 O3 GOL N3029 A 477 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 13.27 46.15 59.96 13.96 44.19 59.76 192.80 164.06 142.20 192.44 166.06 142.86 coo 9.69 44.01 59.12 10.58 42.11 58.89 194.49 161.88 146.96 196.25 163.15 146.70 coo 13.49 45.17 55.56 13.84 42.22 54.75 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 28 3 # 28 A 311 GLU N 63 GLU~? 5.47 O3 GOL N3029 A 475 GLU N 62 GLU~? 6.38 C1 GOL N3044 A 477 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 13.27 46.15 59.96 13.96 44.19 59.76 194.49 161.88 146.96 196.25 163.15 146.70 coo 9.69 44.01 59.12 10.58 42.11 58.89 192.80 164.06 142.20 192.44 166.06 142.86 coo 13.49 45.17 55.56 13.84 42.22 54.75 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 29 3 # 29 A 311 GLU O 62 GLU~? 9.92 C1 GOL O3026 A 475 GLU O 63 GLU~? 5.90 C1 GOL O3026 A 477 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 13.27 46.15 59.96 13.96 44.19 59.76 144.85 142.00 167.10 145.13 142.93 168.92 coo 9.69 44.01 59.12 10.58 42.11 58.89 143.37 146.22 164.56 141.71 146.26 165.94 coo 13.49 45.17 55.56 13.84 42.22 54.75 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 30 3 # 30 A 311 GLU O 63 GLU~? 5.90 C1 GOL O3026 A 475 GLU O 62 GLU~? 9.92 C1 GOL O3026 A 477 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 13.27 46.15 59.96 13.96 44.19 59.76 143.37 146.22 164.56 141.71 146.26 165.94 coo 9.69 44.01 59.12 10.58 42.11 58.89 144.85 142.00 167.10 145.13 142.93 168.92 coo 13.49 45.17 55.56 13.84 42.22 54.75 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 31 3 # 31 A 311 GLU P 62 GLU~? 14.35 O3 GOL P3014 A 475 GLU P 63 GLU~? 10.86 O3 GOL P3014 A 477 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 13.27 46.15 59.96 13.96 44.19 59.76 189.60 171.13 198.21 189.20 169.27 197.38 coo 9.69 44.01 59.12 10.58 42.11 58.89 192.19 173.00 193.76 193.59 171.39 194.28 coo 13.49 45.17 55.56 13.84 42.22 54.75 193.73 170.42 198.48 192.94 168.00 200.19 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 32 3 # 32 A 311 GLU P 63 GLU~? 10.86 O3 GOL P3014 A 475 GLU P 62 GLU~? 14.35 O3 GOL P3014 A 477 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 13.27 46.15 59.96 13.96 44.19 59.76 192.19 173.00 193.76 193.59 171.39 194.28 coo 9.69 44.01 59.12 10.58 42.11 58.89 189.60 171.13 198.21 189.20 169.27 197.38 coo 13.49 45.17 55.56 13.84 42.22 54.75 193.73 170.42 198.48 192.94 168.00 200.19 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 32 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU A 62 GLU~? 17.89 O1 GOL A3040 B 475 GLU A 63 GLU~? 17.38 O3 GOL A3037 B 477 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 42.69 29.93 84.57 42.00 28.96 82.83 79.10 78.67 51.18 78.43 78.08 53.09 coo 46.14 28.45 82.89 45.10 27.86 81.15 80.85 73.88 49.67 82.12 74.36 51.37 coo 42.47 25.53 85.29 42.25 23.66 82.85 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 2 3 # 2 B 311 GLU A 63 GLU~? 17.38 O3 GOL A3037 B 475 GLU A 62 GLU~? 17.89 O1 GOL A3040 B 477 ARG A 66 ARG~? -13.60 O1 GOL A3040s coo 42.69 29.93 84.57 42.00 28.96 82.83 80.85 73.88 49.67 82.12 74.36 51.37 coo 46.14 28.45 82.89 45.10 27.86 81.15 79.10 78.67 51.18 78.43 78.08 53.09 coo 42.47 25.53 85.29 42.25 23.66 82.85 83.22 78.39 52.24 82.40 80.24 54.60 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 3 3 # 3 B 311 GLU B 62 GLU~? 6.16 O2 GOL B3017 B 475 GLU B 63 GLU~? 5.73 C3 GOL B3024 B 477 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 42.69 29.93 84.57 42.00 28.96 82.83 34.07 54.53 23.00 34.19 52.69 24.02 coo 46.14 28.45 82.89 45.10 27.86 81.15 31.78 57.54 26.90 30.14 56.11 26.75 coo 42.47 25.53 85.29 42.25 23.66 82.85 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 4 3 # 4 B 311 GLU B 63 GLU~? 5.73 C3 GOL B3024 B 475 GLU B 62 GLU~? 6.16 O2 GOL B3017 B 477 ARG B 66 ARG~? -3.22 C3 GOL B3017s coo 42.69 29.93 84.57 42.00 28.96 82.83 31.78 57.54 26.90 30.14 56.11 26.75 coo 46.14 28.45 82.89 45.10 27.86 81.15 34.07 54.53 23.00 34.19 52.69 24.02 coo 42.47 25.53 85.29 42.25 23.66 82.85 29.84 54.47 22.57 30.43 51.70 21.39 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 5 3 # 5 B 311 GLU C 62 GLU~? 6.84 O3 GOL C3021 B 475 GLU C 63 GLU~? 10.01 O3 GOL C3021 B 477 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 42.69 29.93 84.57 42.00 28.96 82.83 72.25 23.75 60.88 72.37 24.62 58.95 coo 46.14 28.45 82.89 45.10 27.86 81.15 74.66 28.22 62.99 76.28 27.57 61.69 coo 42.47 25.53 85.29 42.25 23.66 82.85 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 6 3 # 6 B 311 GLU C 63 GLU~? 10.01 O3 GOL C3021 B 475 GLU C 62 GLU~? 6.84 O3 GOL C3021 B 477 ARG C 66 ARG~? 3.32 O3 GOL C3021s coo 42.69 29.93 84.57 42.00 28.96 82.83 74.66 28.22 62.99 76.28 27.57 61.69 coo 46.14 28.45 82.89 45.10 27.86 81.15 72.25 23.75 60.88 72.37 24.62 58.95 coo 42.47 25.53 85.29 42.25 23.66 82.85 76.71 23.22 60.80 75.90 21.54 58.34 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 7 3 # 7 B 311 GLU D 62 GLU~? 6.84 O2 GOL D3019 B 475 GLU D 63 GLU~? 9.36 O3 GOL D3019 B 477 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 42.69 29.93 84.57 42.00 28.96 82.83 28.24 57.03 78.84 28.94 58.69 77.75 coo 46.14 28.45 82.89 45.10 27.86 81.15 26.38 54.52 74.49 25.00 56.17 74.76 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 8 3 # 8 B 311 GLU D 63 GLU~? 9.36 O3 GOL D3019 B 475 GLU D 62 GLU~? 6.84 O2 GOL D3019 B 477 ARG D 66 ARG~? -2.85 O3 GOL D3019s coo 42.69 29.93 84.57 42.00 28.96 82.83 26.38 54.52 74.49 25.00 56.17 74.76 coo 46.14 28.45 82.89 45.10 27.86 81.15 28.24 57.03 78.84 28.94 58.69 77.75 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.11 57.93 78.36 24.91 60.51 79.85 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 9 3 # 9 B 311 GLU E 62 GLU~? 6.69 C2 GOL E3035 B 475 GLU E 63 GLU~? 9.77 O1 GOL E3035 B 477 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 42.69 29.93 84.57 42.00 28.96 82.83 34.02 83.69 49.99 34.45 82.62 48.22 coo 46.14 28.45 82.89 45.10 27.86 81.15 31.45 79.77 52.47 30.08 79.96 50.79 coo 42.47 25.53 85.29 42.25 23.66 82.85 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 10 3 # 10 B 311 GLU E 63 GLU~? 9.77 O1 GOL E3035 B 475 GLU E 62 GLU~? 6.69 C2 GOL E3035 B 477 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 42.69 29.93 84.57 42.00 28.96 82.83 31.45 79.77 52.47 30.08 79.96 50.79 coo 46.14 28.45 82.89 45.10 27.86 81.15 34.02 83.69 49.99 34.45 82.62 48.22 coo 42.47 25.53 85.29 42.25 23.66 82.85 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 11 3 # 11 B 311 GLU F 62 GLU~? 11.61 CL CL F2035 B 475 GLU F 63 GLU~? 10.86 CL CL F2035 B 477 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 42.69 29.93 84.57 42.00 28.96 82.83 78.25 46.27 28.27 77.97 48.25 28.91 coo 46.14 28.45 82.89 45.10 27.86 81.15 79.68 44.12 33.16 81.40 45.47 32.88 coo 42.47 25.53 85.29 42.25 23.66 82.85 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 12 3 # 12 B 311 GLU F 63 GLU~? 10.86 CL CL F2035 B 475 GLU F 62 GLU~? 11.61 CL CL F2035 B 477 ARG F 66 ARG~? 13.15 O3 GOL F3039 coo 42.69 29.93 84.57 42.00 28.96 82.83 79.68 44.12 33.16 81.40 45.47 32.88 coo 46.14 28.45 82.89 45.10 27.86 81.15 78.25 46.27 28.27 77.97 48.25 28.91 coo 42.47 25.53 85.29 42.25 23.66 82.85 82.56 46.21 28.69 82.42 48.67 26.84 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 13 3 # 13 B 311 GLU G 62 GLU~? 14.49 O2 GOL G3001 B 475 GLU G 63 GLU~? 11.17 O2 GOL G3001 B 477 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 42.69 29.93 84.57 42.00 28.96 82.83 28.36 27.46 51.94 28.55 28.64 53.65 coo 46.14 28.45 82.89 45.10 27.86 81.15 27.02 31.92 48.98 25.38 31.91 50.33 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 14 3 # 14 B 311 GLU G 63 GLU~? 11.17 O2 GOL G3001 B 475 GLU G 62 GLU~? 14.49 O2 GOL G3001 B 477 ARG G 66 ARG~? 11.24 O2 GOL G3001s coo 42.69 29.93 84.57 42.00 28.96 82.83 27.02 31.92 48.98 25.38 31.91 50.33 coo 46.14 28.45 82.89 45.10 27.86 81.15 28.36 27.46 51.94 28.55 28.64 53.65 coo 42.47 25.53 85.29 42.25 23.66 82.85 24.09 28.03 51.86 24.32 26.69 54.64 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 15 3 # 15 B 311 GLU H 62 GLU~? 6.87 C1 GOL H3025 B 475 GLU H 63 GLU~? 5.58 O3 GOL H3016 B 477 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 42.69 29.93 84.57 42.00 28.96 82.83 73.13 56.32 83.46 72.69 54.40 82.74 coo 46.14 28.45 82.89 45.10 27.86 81.15 75.79 57.78 79.22 77.22 56.21 79.74 coo 42.47 25.53 85.29 42.25 23.66 82.85 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 16 3 # 16 B 311 GLU H 63 GLU~? 5.58 O3 GOL H3016 B 475 GLU H 62 GLU~? 6.87 C1 GOL H3025 B 477 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 42.69 29.93 84.57 42.00 28.96 82.83 75.79 57.78 79.22 77.22 56.21 79.74 coo 46.14 28.45 82.89 45.10 27.86 81.15 73.13 56.32 83.46 72.69 54.40 82.74 coo 42.47 25.53 85.29 42.25 23.66 82.85 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 17 3 # 17 B 311 GLU I 62 GLU~? 9.77 O2 GOL I3032 B 475 GLU I 63 GLU~? 5.33 O2 GOL I3032 B 477 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 42.69 29.93 84.57 42.00 28.96 82.83 193.02 195.43 166.68 192.61 194.52 168.53 coo 46.14 28.45 82.89 45.10 27.86 81.15 195.05 190.75 164.81 196.51 190.81 166.36 coo 42.47 25.53 85.29 42.25 23.66 82.85 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 18 3 # 18 B 311 GLU I 63 GLU~? 5.33 O2 GOL I3032 B 475 GLU I 62 GLU~? 9.77 O2 GOL I3032 B 477 ARG I 66 ARG~? 8.20 O2 GOL I3032 coo 42.69 29.93 84.57 42.00 28.96 82.83 195.05 190.75 164.81 196.51 190.81 166.36 coo 46.14 28.45 82.89 45.10 27.86 81.15 193.02 195.43 166.68 192.61 194.52 168.53 coo 42.47 25.53 85.29 42.25 23.66 82.85 197.40 195.23 167.36 196.57 196.87 169.82 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 19 3 # 19 B 311 GLU J 62 GLU~? 19.29 O1 GOL J3030 B 475 GLU J 63 GLU~? 19.53 O1 GOL J3033 B 477 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 42.69 29.93 84.57 42.00 28.96 82.83 148.05 170.40 139.46 148.28 168.51 140.38 coo 46.14 28.45 82.89 45.10 27.86 81.15 145.93 173.07 143.61 144.33 171.59 143.32 coo 42.47 25.53 85.29 42.25 23.66 82.85 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 20 3 # 20 B 311 GLU J 63 GLU~? 19.53 O1 GOL J3033 B 475 GLU J 62 GLU~? 19.29 O1 GOL J3030 B 477 ARG J 66 ARG~? -15.15 O1 GOL J3030s coo 42.69 29.93 84.57 42.00 28.96 82.83 145.93 173.07 143.61 144.33 171.59 143.32 coo 46.14 28.45 82.89 45.10 27.86 81.15 148.05 170.40 139.46 148.28 168.51 140.38 coo 42.47 25.53 85.29 42.25 23.66 82.85 143.81 170.22 139.23 144.43 167.54 137.80 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 21 3 # 21 B 311 GLU K 62 GLU~? 6.62 O2 GOL K3010 B 475 GLU K 63 GLU~? 9.64 O2 GOL K3010 B 477 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 42.69 29.93 84.57 42.00 28.96 82.83 189.61 139.57 173.68 189.43 140.41 171.76 coo 46.14 28.45 82.89 45.10 27.86 81.15 191.78 144.13 175.87 193.39 143.52 174.53 coo 42.47 25.53 85.29 42.25 23.66 82.85 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 22 3 # 22 B 311 GLU K 63 GLU~? 9.64 O2 GOL K3010 B 475 GLU K 62 GLU~? 6.62 O2 GOL K3010 B 477 ARG K 66 ARG~? -3.30 O2 GOL K3010s coo 42.69 29.93 84.57 42.00 28.96 82.83 191.78 144.13 175.87 193.39 143.52 174.53 coo 46.14 28.45 82.89 45.10 27.86 81.15 189.61 139.57 173.68 189.43 140.41 171.76 coo 42.47 25.53 85.29 42.25 23.66 82.85 193.71 139.32 173.56 193.18 137.60 171.05 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 23 3 # 23 B 311 GLU L 62 GLU~? 6.90 C3 GOL L3028 B 475 GLU L 63 GLU~? 9.87 O3 GOL L3028 B 477 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 42.69 29.93 84.57 42.00 28.96 82.83 144.62 169.85 195.72 145.14 171.64 194.63 coo 46.14 28.45 82.89 45.10 27.86 81.15 142.67 167.29 191.27 141.24 168.94 191.33 coo 42.47 25.53 85.29 42.25 23.66 82.85 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 24 3 # 24 B 311 GLU L 63 GLU~? 9.87 O3 GOL L3028 B 475 GLU L 62 GLU~? 6.90 C3 GOL L3028 B 477 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 42.69 29.93 84.57 42.00 28.96 82.83 142.67 167.29 191.27 141.24 168.94 191.33 coo 46.14 28.45 82.89 45.10 27.86 81.15 144.62 169.85 195.72 145.14 171.64 194.63 coo 42.47 25.53 85.29 42.25 23.66 82.85 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 25 3 # 25 B 311 GLU M 62 GLU~? 18.60 O3 GOL M3042 B 475 GLU M 63 GLU~? 17.44 O3 GOL M3042 B 477 ARG M 66 ARG~? -13.90 O3 GOL M3042s coo 42.69 29.93 84.57 42.00 28.96 82.83 148.09 198.35 167.82 148.51 197.28 166.06 coo 46.14 28.45 82.89 45.10 27.86 81.15 145.53 194.15 170.27 144.03 194.27 168.71 coo 42.47 25.53 85.29 42.25 23.66 82.85 143.89 198.49 167.11 144.75 199.90 164.48 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 26 3 # 26 B 311 GLU M 63 GLU~? 17.44 O3 GOL M3042 B 475 GLU M 62 GLU~? 18.60 O3 GOL M3042 B 477 ARG M 66 ARG~? -13.90 O3 GOL M3042s coo 42.69 29.93 84.57 42.00 28.96 82.83 145.53 194.15 170.27 144.03 194.27 168.71 coo 46.14 28.45 82.89 45.10 27.86 81.15 148.09 198.35 167.82 148.51 197.28 166.06 coo 42.47 25.53 85.29 42.25 23.66 82.85 143.89 198.49 167.11 144.75 199.90 164.48 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 27 3 # 27 B 311 GLU N 62 GLU~? 6.38 C1 GOL N3044 B 475 GLU N 63 GLU~? 5.47 O3 GOL N3029 B 477 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 42.69 29.93 84.57 42.00 28.96 82.83 192.80 164.06 142.20 192.44 166.06 142.86 coo 46.14 28.45 82.89 45.10 27.86 81.15 194.49 161.88 146.96 196.25 163.15 146.70 coo 42.47 25.53 85.29 42.25 23.66 82.85 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 28 3 # 28 B 311 GLU N 63 GLU~? 5.47 O3 GOL N3029 B 475 GLU N 62 GLU~? 6.38 C1 GOL N3044 B 477 ARG N 66 ARG~? -3.13 O1 GOL N3044s coo 42.69 29.93 84.57 42.00 28.96 82.83 194.49 161.88 146.96 196.25 163.15 146.70 coo 46.14 28.45 82.89 45.10 27.86 81.15 192.80 164.06 142.20 192.44 166.06 142.86 coo 42.47 25.53 85.29 42.25 23.66 82.85 197.02 164.21 142.49 196.52 166.74 140.76 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 29 3 # 29 B 311 GLU O 62 GLU~? 9.92 C1 GOL O3026 B 475 GLU O 63 GLU~? 5.90 C1 GOL O3026 B 477 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 42.69 29.93 84.57 42.00 28.96 82.83 144.85 142.00 167.10 145.13 142.93 168.92 coo 46.14 28.45 82.89 45.10 27.86 81.15 143.37 146.22 164.56 141.71 146.26 165.94 coo 42.47 25.53 85.29 42.25 23.66 82.85 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 30 3 # 30 B 311 GLU O 63 GLU~? 5.90 C1 GOL O3026 B 475 GLU O 62 GLU~? 9.92 C1 GOL O3026 B 477 ARG O 66 ARG~? 7.61 O1 GOL O3026 coo 42.69 29.93 84.57 42.00 28.96 82.83 143.37 146.22 164.56 141.71 146.26 165.94 coo 46.14 28.45 82.89 45.10 27.86 81.15 144.85 142.00 167.10 145.13 142.93 168.92 coo 42.47 25.53 85.29 42.25 23.66 82.85 140.63 142.20 167.36 141.15 140.73 170.05 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 31 3 # 31 B 311 GLU P 62 GLU~? 14.35 O3 GOL P3014 B 475 GLU P 63 GLU~? 10.86 O3 GOL P3014 B 477 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 42.69 29.93 84.57 42.00 28.96 82.83 189.60 171.13 198.21 189.20 169.27 197.38 coo 46.14 28.45 82.89 45.10 27.86 81.15 192.19 173.00 193.76 193.59 171.39 194.28 coo 42.47 25.53 85.29 42.25 23.66 82.85 193.73 170.42 198.48 192.94 168.00 200.19 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 32 3 # 32 B 311 GLU P 63 GLU~? 10.86 O3 GOL P3014 B 475 GLU P 62 GLU~? 14.35 O3 GOL P3014 B 477 ARG P 66 ARG~? -10.88 O3 GOL P3014s coo 42.69 29.93 84.57 42.00 28.96 82.83 192.19 173.00 193.76 193.59 171.39 194.28 coo 46.14 28.45 82.89 45.10 27.86 81.15 189.60 171.13 198.21 189.20 169.27 197.38 coo 42.47 25.53 85.29 42.25 23.66 82.85 193.73 170.42 198.48 192.94 168.00 200.19 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 32 hits 1i19_c01 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU A 106 GLU~? 21.37 O1 GOL A3040 A 369 ARG A 108 ARG~? 22.68 O1 GOL A3040 A 372 TYR A 109 TYR~? 19.57 O1 GOL A3040 coo 16.47 7.99 31.03 17.36 6.90 32.63 86.09 78.56 33.43 88.06 78.13 34.12 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 77.54 80.61 37.36 78.31 77.83 38.52 coo 16.01 4.58 27.39 13.82 5.38 28.94 84.38 79.76 38.04 83.16 77.26 38.08 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 2 3 # 2 A 267 GLU B 106 GLU~? 14.28 O1 GOL B3024 A 369 ARG B 108 ARG~? 14.18 O1 GOL B3024 A 372 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo 16.47 7.99 31.03 17.36 6.90 32.63 31.31 72.93 17.86 29.23 72.75 18.06 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 39.05 68.00 18.82 37.75 66.74 21.38 coo 16.01 4.58 27.39 13.82 5.38 28.94 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 3 3 # 3 A 267 GLU C 106 GLU~? 19.79 O1 GOL C3036 A 369 ARG C 108 ARG~? 20.30 O3 GOL C3021 A 372 TYR C 109 TYR~? 17.83 O1 GOL C3036 coo 16.47 7.99 31.03 17.36 6.90 32.63 75.34 22.76 79.72 77.40 22.80 79.51 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 67.42 22.77 74.41 69.21 25.29 74.04 coo 16.01 4.58 27.39 13.82 5.38 28.94 74.32 21.96 74.78 73.58 24.65 74.54 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 4 3 # 4 A 267 GLU D 106 GLU~? 21.38 CL CL D2012 A 369 ARG D 108 ARG~? 19.71 O3 GOL D3019 A 372 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo 16.47 7.99 31.03 17.36 6.90 32.63 21.11 39.74 82.39 19.19 40.22 81.74 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 29.84 43.62 83.53 28.05 43.26 81.00 coo 16.01 4.58 27.39 13.82 5.38 28.94 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 5 3 # 5 A 267 GLU E 106 GLU~? 21.05 O1 GOL E3022 A 369 ARG E 108 ARG~? 18.65 O1 GOL E3035 A 372 TYR E 109 TYR~? 18.10 O1 GOL E3035 coo 16.47 7.99 31.03 17.36 6.90 32.63 27.90 88.73 67.36 25.90 88.59 66.70 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 36.12 87.73 64.17 35.30 85.24 62.51 coo 16.01 4.58 27.39 13.82 5.38 28.94 29.73 88.43 62.54 30.41 85.74 63.01 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 6 3 # 6 A 267 GLU F 106 GLU~? 12.79 CL CL F2035 A 369 ARG F 108 ARG~? -3.40 CL CL F2035s A 372 TYR F 109 TYR~? 6.98 CL CL F2035 coo 16.47 7.99 31.03 17.36 6.90 32.63 81.39 27.31 28.31 83.45 27.54 28.69 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 74.01 31.91 26.65 74.85 33.96 28.84 coo 16.01 4.58 27.39 13.82 5.38 28.94 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 7 3 # 7 A 267 GLU G 106 GLU~? 21.38 C3 GOL G3001 A 369 ARG G 108 ARG~? 22.05 O2 GOL G3001 A 372 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo 16.47 7.99 31.03 17.36 6.90 32.63 24.93 23.55 33.32 22.94 24.09 33.51 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 32.32 22.84 38.36 31.62 25.53 39.73 coo 16.01 4.58 27.39 13.82 5.38 28.94 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 8 3 # 8 A 267 GLU H 106 GLU~? 14.51 O2 GOL H3016 A 369 ARG H 108 ARG~? 14.48 O2 GOL H3016 A 372 TYR H 109 TYR~? 11.76 O2 GOL H3016 coo 16.47 7.99 31.03 17.36 6.90 32.63 79.71 74.06 84.56 81.75 73.57 84.59 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 71.22 70.92 84.57 72.18 68.95 82.36 coo 16.01 4.58 27.39 13.82 5.38 28.94 77.84 69.46 85.37 77.15 69.38 82.64 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 9 3 # 9 A 267 GLU I 106 GLU~? 14.47 O1 GOL I3032 A 369 ARG I 108 ARG~? 14.30 O1 GOL I3032 A 372 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo 16.47 7.99 31.03 17.36 6.90 32.63 199.46 196.34 148.59 201.47 195.97 149.14 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 191.22 197.47 152.14 191.76 195.04 153.98 coo 16.01 4.58 27.39 13.82 5.38 28.94 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 10 3 # 10 A 267 GLU J 106 GLU~? 21.26 CL CL J2016 A 369 ARG J 108 ARG~? 23.02 O1 GOL J3030 A 372 TYR J 109 TYR~? 19.91 O1 GOL J3030 coo 16.47 7.99 31.03 17.36 6.90 32.63 144.43 188.69 135.80 142.30 188.60 135.89 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 152.38 184.27 135.62 151.05 183.00 138.10 coo 16.01 4.58 27.39 13.82 5.38 28.94 145.48 183.77 135.57 146.27 183.96 138.21 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 11 3 # 11 A 267 GLU K 106 GLU~? 21.15 O3 GOL K3009 A 369 ARG K 108 ARG~? 18.77 O3 GOL K3010 A 372 TYR K 109 TYR~? 18.63 O3 GOL K3010 coo 16.47 7.99 31.03 17.36 6.90 32.63 193.16 138.18 192.36 195.25 138.38 192.10 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 185.36 137.67 187.99 186.54 140.01 186.30 coo 16.01 4.58 27.39 13.82 5.38 28.94 192.13 137.45 187.51 191.27 140.11 187.32 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 12 3 # 12 A 267 GLU L 106 GLU~? 21.37 CL CL L2009 A 369 ARG L 108 ARG~? 19.25 O3 GOL L3028 A 372 TYR L 109 TYR~? 18.94 O3 GOL L3028 coo 16.47 7.99 31.03 17.36 6.90 32.63 138.12 152.20 198.93 136.10 152.63 198.56 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 146.49 155.54 199.73 145.94 157.11 197.11 coo 16.01 4.58 27.39 13.82 5.38 28.94 139.89 156.88 199.30 141.02 156.55 196.75 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 13 3 # 13 A 267 GLU M 106 GLU~? 21.48 CL CL M2017 A 369 ARG M 108 ARG~? 23.14 O1 GOL M3043 A 372 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo 16.47 7.99 31.03 17.36 6.90 32.63 142.15 202.05 185.59 140.16 201.82 184.97 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 150.62 202.12 182.01 149.56 199.68 180.53 coo 16.01 4.58 27.39 13.82 5.38 28.94 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 14 3 # 14 A 267 GLU N 106 GLU~? 14.62 O2 GOL N3029 A 369 ARG N 108 ARG~? 14.89 C2 GOL N3029 A 372 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo 16.47 7.99 31.03 17.36 6.90 32.63 196.48 145.55 141.46 198.54 145.70 141.81 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 189.02 149.68 140.15 189.67 151.62 142.49 coo 16.01 4.58 27.39 13.82 5.38 28.94 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 15 3 # 15 A 267 GLU O 106 GLU~? 13.74 CL CL O2036 A 369 ARG O 108 ARG~? 13.39 CL CL O2036 A 372 TYR O 109 TYR~? 12.46 CL CL O2036 coo 16.47 7.99 31.03 17.36 6.90 32.63 140.87 138.77 148.77 138.84 139.06 148.95 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 148.81 138.28 154.16 147.06 140.78 153.42 coo 16.01 4.58 27.39 13.82 5.38 28.94 141.96 138.45 153.78 143.09 141.01 153.60 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 16 3 # 16 A 267 GLU P 106 GLU~? 20.67 O3 GOL P3014 A 369 ARG P 108 ARG~? 21.30 O3 GOL P3014 A 372 TYR P 109 TYR~? 18.49 O3 GOL P3014 coo 16.47 7.99 31.03 17.36 6.90 32.63 195.52 189.19 199.68 197.57 188.76 199.63 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 187.53 185.71 199.97 188.17 183.79 197.64 coo 16.01 4.58 27.39 13.82 5.38 28.94 193.88 184.51 200.52 193.11 184.53 197.85 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 16 hits 1i1e_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 151 HIS~? -11.70 O3 GOL A3037s A 200 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 226 LYS A 142 LYS~? 20.36 CL CL A2020 coo 23.24 46.58 4.39 24.43 46.59 2.66 94.27 72.58 51.14 93.29 74.44 51.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 90.44 78.16 48.76 91.65 76.94 50.06 coo 34.47 51.09 7.19 28.58 51.18 7.53 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 200 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 226 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 23.24 46.58 4.39 24.43 46.59 2.66 18.48 59.01 25.15 19.77 58.54 23.56 coo 24.51 43.28 11.18 25.17 44.50 9.58 23.66 59.02 20.34 21.93 58.32 21.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS C 151 HIS~? -4.28 C2 GOL C3036s A 200 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 226 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 23.24 46.58 4.39 24.43 46.59 2.66 88.24 26.50 64.44 86.75 25.04 64.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 82.81 22.02 65.69 84.52 22.80 64.66 coo 34.47 51.09 7.19 28.58 51.18 7.53 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 200 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 226 LYS D 142 LYS~? 18.65 CL CL D2012 coo 23.24 46.58 4.39 24.43 46.59 2.66 13.06 55.69 73.24 14.03 55.94 75.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 16.94 54.59 79.01 15.65 55.42 77.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 200 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 226 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 23.24 46.58 4.39 24.43 46.59 2.66 17.87 81.44 51.19 19.31 82.95 50.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 23.07 86.29 52.35 21.57 85.17 51.32 coo 34.47 51.09 7.19 28.58 51.18 7.53 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 200 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 226 LYS F 142 LYS~? 19.20 CL CL F2034 coo 23.24 46.58 4.39 24.43 46.59 2.66 93.09 42.58 34.58 92.14 42.76 32.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 88.86 41.25 28.96 90.30 42.22 30.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 200 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 226 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 23.24 46.58 4.39 24.43 46.59 2.66 13.55 33.19 47.26 14.46 31.35 47.64 coo 24.51 43.28 11.18 25.17 44.50 9.58 17.70 27.34 47.09 16.19 28.71 47.73 coo 34.47 51.09 7.19 28.58 51.18 7.53 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 200 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 226 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 23.24 46.58 4.39 24.43 46.59 2.66 89.33 56.65 80.95 87.93 56.76 82.51 coo 24.51 43.28 11.18 25.17 44.50 9.58 84.24 58.93 85.48 85.73 57.59 84.66 coo 34.47 51.09 7.19 28.58 51.18 7.53 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 200 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 226 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 23.24 46.58 4.39 24.43 46.59 2.66 208.71 190.07 165.44 207.65 191.87 165.52 coo 24.51 43.28 11.18 25.17 44.50 9.58 204.37 195.46 163.61 205.75 194.30 164.79 coo 34.47 51.09 7.19 28.58 51.18 7.53 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1i29_c01 CSDB user 10 3 # 10 A 123 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 200 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 226 LYS J 142 LYS~? 19.62 CL CL J2016 coo 23.24 46.58 4.39 24.43 46.59 2.66 132.36 173.99 142.63 133.63 173.58 141.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 137.44 174.60 137.57 135.80 173.80 138.69 coo 34.47 51.09 7.19 28.58 51.18 7.53 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1i29_c01 CSDB user 11 3 # 11 A 123 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 200 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 226 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 23.24 46.58 4.39 24.43 46.59 2.66 205.25 143.04 176.89 203.95 141.38 176.70 coo 24.51 43.28 11.18 25.17 44.50 9.58 200.17 138.24 178.11 201.77 139.28 177.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1i29_c01 CSDB user 12 3 # 12 A 123 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 200 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 226 LYS L 142 LYS~? 23.18 CL CL L2009 coo 23.24 46.58 4.39 24.43 46.59 2.66 129.06 168.07 190.57 130.17 168.32 192.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 133.34 166.97 196.27 132.03 168.03 194.96 coo 34.47 51.09 7.19 28.58 51.18 7.53 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1i29_c01 CSDB user 13 3 # 13 A 123 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 200 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 226 LYS M 142 LYS~? 19.90 CL CL M2017 coo 23.24 46.58 4.39 24.43 46.59 2.66 131.91 195.13 169.59 133.22 196.76 169.40 coo 24.51 43.28 11.18 25.17 44.50 9.58 136.87 200.18 170.79 135.36 199.08 169.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1i29_c01 CSDB user 14 3 # 14 A 123 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 200 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 226 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 23.24 46.58 4.39 24.43 46.59 2.66 207.96 160.84 147.59 206.93 161.03 145.77 coo 24.51 43.28 11.18 25.17 44.50 9.58 203.51 159.51 142.26 205.02 160.53 143.48 coo 34.47 51.09 7.19 28.58 51.18 7.53 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1i29_c01 CSDB user 15 3 # 15 A 123 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 200 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 226 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 23.24 46.58 4.39 24.43 46.59 2.66 129.65 146.92 163.60 130.73 145.15 163.91 coo 24.51 43.28 11.18 25.17 44.50 9.58 134.07 141.35 162.95 132.57 142.58 163.78 coo 34.47 51.09 7.19 28.58 51.18 7.53 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1i29_c01 CSDB user 16 3 # 16 A 123 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 200 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 226 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 23.24 46.58 4.39 24.43 46.59 2.66 205.70 172.52 194.71 204.41 172.45 196.35 coo 24.51 43.28 11.18 25.17 44.50 9.58 200.75 174.15 199.66 202.28 173.10 198.62 coo 34.47 51.09 7.19 28.58 51.18 7.53 204.59 186.28 195.60 209.96 186.96 196.62 1i29_c01 source 1i29 CSDB : 16 hits 1i29_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER D 90 SER.? 19.08 CL CL D2022 A 173 ARG D 94 ARG~? 15.71 CL CL D2012 A 211 ASP D 87 ASP.? 13.27 CL CL D2022 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -7.58 45.67 82.56 -9.65 44.31 82.61 coo 18.77 77.82 11.69 20.55 80.22 10.73 3.39 42.85 90.39 4.96 40.19 90.49 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -10.63 52.08 85.92 -9.45 52.62 87.62 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER K 90 SER.? 15.98 CL CL K2027 A 173 ARG K 95 ARG~? 18.15 CL CL K2027 A 211 ASP K 87 ASP.? 18.29 CL CL K2027 coo 22.72 76.24 0.23 24.60 76.86 -1.25 221.55 131.48 191.08 222.77 129.44 191.28 coo 18.77 77.82 11.69 20.55 80.22 10.73 211.85 134.99 193.85 212.13 138.00 193.03 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 226.46 132.41 185.48 226.78 133.13 187.48 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER N 90 SER.? 19.47 CL CL N2030 A 173 ARG N 95 ARG~? 18.49 CL CL N2030 A 211 ASP N 87 ASP.? 18.39 CL CL N2030 coo 22.72 76.24 0.23 24.60 76.86 -1.25 225.68 145.48 139.18 227.68 144.31 140.08 coo 18.77 77.82 11.69 20.55 80.22 10.73 215.46 144.14 140.72 215.90 144.66 143.75 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 230.54 151.79 139.42 230.64 149.76 140.17 1ig8_c00 source 1ig8 HEXOKINASE PII : 3 hits 1ig8_c00 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 28 ASP~? 35.69 O2 GOL E3035 A1134 ALA A 30 ALA.? 37.44 O2 GOL E3035 A1137 ASN A 31 ASN~? 35.25 O3 GOL B3003 coo -27.05 34.58 17.12 -25.81 32.84 17.16 62.23 105.49 38.88 63.59 105.50 37.26 coo -20.53 36.39 15.81 -20.80 35.01 16.40 61.40 108.08 33.56 62.86 108.52 33.72 coo -23.72 34.69 12.49 -24.32 32.83 13.34 62.40 103.46 34.22 64.32 104.05 33.59 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 28 ASP~? 35.69 O2 GOL E3035 A1134 ALA A 32 ALA~? 30.70 O2 GOL E3035 A1137 ASN A 31 ASN~? 35.25 O3 GOL B3003 coo -27.05 34.58 17.12 -25.81 32.84 17.16 62.23 105.49 38.88 63.59 105.50 37.26 coo -20.53 36.39 15.81 -20.80 35.01 16.40 57.58 103.94 33.75 56.64 105.03 33.68 coo -23.72 34.69 12.49 -24.32 32.83 13.34 62.40 103.46 34.22 64.32 104.05 33.59 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP A 102 ASP.? 25.18 C1 GOL A3040 A1134 ALA A 135 ALA.? 20.01 CL CL A2020 A1137 ASN A 134 ASN.? 22.60 O2 GOL A3040 coo -27.05 34.58 17.12 -25.81 32.84 17.16 88.23 80.63 30.72 87.92 80.82 28.67 coo -20.53 36.39 15.81 -20.80 35.01 16.40 92.96 83.99 31.70 93.11 82.79 32.66 coo -23.72 34.69 12.49 -24.32 32.83 13.34 89.85 87.69 31.14 89.29 86.47 29.46 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP B 28 ASP~? 19.20 C1 GOL B3003 A1134 ALA B 30 ALA.? 19.97 O1 GOL B3003 A1137 ASN B 31 ASN~? 16.07 O1 GOL B3003 coo -27.05 34.58 17.12 -25.81 32.84 17.16 57.70 57.51 -0.61 56.74 59.29 -1.16 coo -20.53 36.39 15.81 -20.80 35.01 16.40 59.83 62.01 -3.84 58.48 62.03 -4.51 coo -23.72 34.69 12.49 -24.32 32.83 13.34 58.08 62.28 0.56 56.41 63.22 -0.34 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP B 28 ASP~? 19.20 C1 GOL B3003 A1134 ALA B 32 ALA~? 17.30 C1 GOL B3003 A1137 ASN B 31 ASN~? 16.07 O1 GOL B3003 coo -27.05 34.58 17.12 -25.81 32.84 17.16 57.70 57.51 -0.61 56.74 59.29 -1.16 coo -20.53 36.39 15.81 -20.80 35.01 16.40 62.97 61.73 1.02 64.08 61.35 0.06 coo -23.72 34.69 12.49 -24.32 32.83 13.34 58.08 62.28 0.56 56.41 63.22 -0.34 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP B 102 ASP.? 20.31 O1 GOL B3024 A1134 ALA B 135 ALA.? 17.88 O2 GOL B3024 A1137 ASN B 134 ASN.? 21.61 CL CL B2010 coo -27.05 34.58 17.12 -25.81 32.84 17.16 30.49 75.29 14.98 31.30 77.16 14.42 coo -20.53 36.39 15.81 -20.80 35.01 16.40 26.30 74.37 10.83 25.77 73.85 12.21 coo -23.72 34.69 12.49 -24.32 32.83 13.34 30.08 73.64 8.08 31.06 75.15 9.33 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 7 3 # 7 A1132 ASP C 28 ASP~? 15.70 CL CL C2004 A1134 ALA C 30 ALA.? 19.98 CL CL C2004 A1137 ASN C 31 ASN~? 18.06 CL CL C2004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 48.49 0.93 68.23 49.38 0.74 70.13 coo -20.53 36.39 15.81 -20.80 35.01 16.40 45.81 -1.40 73.04 47.12 -2.15 73.23 coo -23.72 34.69 12.49 -24.32 32.83 13.34 47.83 2.95 72.82 49.52 2.14 73.82 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 8 3 # 8 A1132 ASP C 28 ASP~? 15.70 CL CL C2004 A1134 ALA C 32 ALA~? 17.73 CL CL C2004 A1137 ASN C 31 ASN~? 18.06 CL CL C2004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 48.49 0.93 68.23 49.38 0.74 70.13 coo -20.53 36.39 15.81 -20.80 35.01 16.40 42.95 3.42 72.24 41.78 2.52 72.04 coo -23.72 34.69 12.49 -24.32 32.83 13.34 47.83 2.95 72.82 49.52 2.14 73.82 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 9 3 # 9 A1132 ASP C 102 ASP.? 24.57 CL CL C2011 A1134 ALA C 135 ALA.? 18.18 CL CL C2011 A1137 ASN C 134 ASN.? 21.68 CL CL C2011 coo -27.05 34.58 17.12 -25.81 32.84 17.16 76.25 20.52 82.74 75.40 20.56 84.65 coo -20.53 36.39 15.81 -20.80 35.01 16.40 80.29 16.27 82.51 80.76 17.49 81.72 coo -23.72 34.69 12.49 -24.32 32.83 13.34 76.46 13.23 82.50 75.64 14.68 83.88 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 10 3 # 10 A1132 ASP D 28 ASP~? 15.80 CL CL H2005 A1134 ALA D 30 ALA.? 20.09 CL CL H2005 A1137 ASN D 31 ASN~? 16.80 O1 GOL D3005 coo -27.05 34.58 17.12 -25.81 32.84 17.16 45.36 50.43 107.49 43.88 48.98 107.89 coo -20.53 36.39 15.81 -20.80 35.01 16.40 46.21 45.78 111.11 44.79 46.03 111.57 coo -23.72 34.69 12.49 -24.32 32.83 13.34 45.01 45.50 106.50 43.03 45.09 107.22 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 11 3 # 11 A1132 ASP D 28 ASP~? 15.80 CL CL H2005 A1134 ALA D 32 ALA~? 17.55 O1 GOL D3005 A1137 ASN D 31 ASN~? 16.80 O1 GOL D3005 coo -27.05 34.58 17.12 -25.81 32.84 17.16 45.36 50.43 107.49 43.88 48.98 107.89 coo -20.53 36.39 15.81 -20.80 35.01 16.40 49.88 45.02 106.85 50.83 45.18 107.92 coo -23.72 34.69 12.49 -24.32 32.83 13.34 45.01 45.50 106.50 43.03 45.09 107.22 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 12 3 # 12 A1132 ASP D 102 ASP.? 24.32 CL CL D2012 A1134 ALA D 135 ALA.? 17.96 CL CL D2012 A1137 ASN D 134 ASN.? 21.42 O3 GOL D3018 coo -27.05 34.58 17.12 -25.81 32.84 17.16 18.96 37.41 85.00 19.42 35.40 85.42 coo -20.53 36.39 15.81 -20.80 35.01 16.40 14.36 39.19 88.01 14.38 39.77 86.62 coo -23.72 34.69 12.49 -24.32 32.83 13.34 17.21 39.17 91.82 18.06 37.43 90.85 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 13 3 # 13 A1132 ASP E 28 ASP~? 19.58 O1 GOL E3004 A1134 ALA E 30 ALA.? 20.54 O1 GOL E3004 A1137 ASN E 31 ASN~? 16.68 O1 GOL E3004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 57.09 107.82 57.29 55.83 108.40 58.91 coo -20.53 36.39 15.81 -20.80 35.01 16.40 58.65 111.08 61.98 57.40 111.87 61.76 coo -23.72 34.69 12.49 -24.32 32.83 13.34 56.53 106.82 62.15 54.79 107.93 62.69 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 14 3 # 14 A1132 ASP E 28 ASP~? 19.58 O1 GOL E3004 A1134 ALA E 32 ALA~? 17.67 O1 GOL E3004 A1137 ASN E 31 ASN~? 16.68 O1 GOL E3004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 57.09 107.82 57.29 55.83 108.40 58.91 coo -20.53 36.39 15.81 -20.80 35.01 16.40 61.40 106.11 62.60 62.61 106.96 62.51 coo -23.72 34.69 12.49 -24.32 32.83 13.34 56.53 106.82 62.15 54.79 107.93 62.69 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 15 3 # 15 A1132 ASP E 102 ASP.? 24.45 CL CL E2013 A1134 ALA E 135 ALA.? 17.76 CL CL E2013 A1137 ASN E 134 ASN.? 21.44 CL CL E2013 coo -27.05 34.58 17.12 -25.81 32.84 17.16 26.42 91.49 69.61 27.08 91.68 71.63 coo -20.53 36.39 15.81 -20.80 35.01 16.40 22.68 95.82 67.83 22.19 94.52 67.17 coo -23.72 34.69 12.49 -24.32 32.83 13.34 26.64 98.55 67.66 26.91 97.58 69.55 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 16 3 # 16 A1132 ASP F 28 ASP~? 32.62 CL CL F2035 A1134 ALA F 30 ALA.? 36.20 CL CL F2035 A1137 ASN F 31 ASN~? 31.62 CL CL F2035 coo -27.05 34.58 17.12 -25.81 32.84 17.16 59.39 38.13 1.08 60.39 36.31 1.06 coo -20.53 36.39 15.81 -20.80 35.01 16.40 57.51 33.10 -1.55 58.97 32.95 -1.98 coo -23.72 34.69 12.49 -24.32 32.83 13.34 58.51 33.50 3.06 60.38 32.61 2.54 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 17 3 # 17 A1132 ASP F 28 ASP~? 32.62 CL CL F2035 A1134 ALA F 32 ALA~? 30.31 O1 GOL B3017 A1137 ASN F 31 ASN~? 31.62 CL CL F2035 coo -27.05 34.58 17.12 -25.81 32.84 17.16 59.39 38.13 1.08 60.39 36.31 1.06 coo -20.53 36.39 15.81 -20.80 35.01 16.40 53.72 34.03 2.68 52.74 34.16 1.55 coo -23.72 34.69 12.49 -24.32 32.83 13.34 58.51 33.50 3.06 60.38 32.61 2.54 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 18 3 # 18 A1132 ASP F 102 ASP.? 16.73 CL CL F2035 A1134 ALA F 135 ALA.? 17.61 CL CL F2034 A1137 ASN F 134 ASN.? 19.08 CL CL F2035 coo -27.05 34.58 17.12 -25.81 32.84 17.16 82.74 24.28 26.35 81.91 22.30 26.35 coo -20.53 36.39 15.81 -20.80 35.01 16.40 87.72 24.37 22.89 88.08 25.22 24.08 coo -23.72 34.69 12.49 -24.32 32.83 13.34 84.48 24.50 19.28 83.57 23.00 20.51 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 19 3 # 19 A1132 ASP G 28 ASP~? 15.85 CL CL C2004 A1134 ALA G 30 ALA.? 19.83 CL CL C2004 A1137 ASN G 31 ASN~? 18.27 CL CL C2004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 47.14 -0.91 49.29 46.12 -1.37 47.54 coo -20.53 36.39 15.81 -20.80 35.01 16.40 48.76 -4.41 44.96 47.26 -4.74 45.11 coo -23.72 34.69 12.49 -24.32 32.83 13.34 47.68 0.09 44.37 45.83 -0.65 43.56 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 20 3 # 20 A1132 ASP G 28 ASP~? 15.85 CL CL C2004 A1134 ALA G 32 ALA~? 17.75 CL CL C2004 A1137 ASN G 31 ASN~? 18.27 CL CL C2004 coo -27.05 34.58 17.12 -25.81 32.84 17.16 47.14 -0.91 49.29 46.12 -1.37 47.54 coo -20.53 36.39 15.81 -20.80 35.01 16.40 52.53 -0.04 44.80 53.52 -1.08 45.14 coo -23.72 34.69 12.49 -24.32 32.83 13.34 47.68 0.09 44.37 45.83 -0.65 43.56 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 21 3 # 21 A1132 ASP G 102 ASP.? 25.30 O3 GOL G3038 A1134 ALA G 135 ALA.? 19.98 C3 GOL G3038 A1137 ASN G 134 ASN.? 22.43 C3 GOL G3038 coo -27.05 34.58 17.12 -25.81 32.84 17.16 23.47 21.05 30.82 24.30 20.62 28.93 coo -20.53 36.39 15.81 -20.80 35.01 16.40 18.49 17.87 31.65 18.29 19.28 32.20 coo -23.72 34.69 12.49 -24.32 32.83 13.34 21.73 14.27 32.50 22.54 15.11 30.68 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 22 3 # 22 A1132 ASP H 28 ASP~? 15.80 CL CL H2005 A1134 ALA H 30 ALA.? 20.07 CL CL H2005 A1137 ASN H 31 ASN~? 16.72 O3 GOL H3006 coo -27.05 34.58 17.12 -25.81 32.84 17.16 50.63 68.82 106.06 51.93 70.45 106.39 coo -20.53 36.39 15.81 -20.80 35.01 16.40 49.06 74.15 108.36 50.40 74.01 109.11 coo -23.72 34.69 12.49 -24.32 32.83 13.34 51.10 73.51 104.06 52.89 74.15 105.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 23 3 # 23 A1132 ASP H 28 ASP~? 15.80 CL CL H2005 A1134 ALA H 32 ALA~? 17.62 C3 GOL H3006 A1137 ASN H 31 ASN~? 16.72 O3 GOL H3006 coo -27.05 34.58 17.12 -25.81 32.84 17.16 50.63 68.82 106.06 51.93 70.45 106.39 coo -20.53 36.39 15.81 -20.80 35.01 16.40 46.31 73.93 103.35 45.12 74.04 104.17 coo -23.72 34.69 12.49 -24.32 32.83 13.34 51.10 73.51 104.06 52.89 74.15 105.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 24 3 # 24 A1132 ASP H 102 ASP.? 20.45 O2 GOL H3016 A1134 ALA H 135 ALA.? 17.80 CL CL H2014 A1137 ASN H 134 ASN.? 21.68 CL CL H2014 coo -27.05 34.58 17.12 -25.81 32.84 17.16 81.36 76.99 86.94 80.90 79.01 86.89 coo -20.53 36.39 15.81 -20.80 35.01 16.40 85.12 76.02 91.45 85.59 75.06 90.35 coo -23.72 34.69 12.49 -24.32 32.83 13.34 81.15 76.65 94.15 80.84 78.27 92.76 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 25 3 # 25 A1132 ASP I 28 ASP~? 15.71 CL CL I2001 A1134 ALA I 30 ALA.? 19.94 CL CL I2001 A1137 ASN I 31 ASN~? 18.18 CL CL I2001 coo -27.05 34.58 17.12 -25.81 32.84 17.16 174.34 221.90 156.42 175.71 222.11 154.83 coo -20.53 36.39 15.81 -20.80 35.01 16.40 173.09 224.80 151.36 174.53 225.24 151.50 coo -23.72 34.69 12.49 -24.32 32.83 13.34 174.31 220.26 151.67 176.20 220.84 150.96 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 26 3 # 26 A1132 ASP I 28 ASP~? 15.71 CL CL I2001 A1134 ALA I 32 ALA~? 17.74 CL CL I2001 A1137 ASN I 31 ASN~? 18.18 CL CL I2001 coo -27.05 34.58 17.12 -25.81 32.84 17.16 174.34 221.90 156.42 175.71 222.11 154.83 coo -20.53 36.39 15.81 -20.80 35.01 16.40 169.46 220.32 151.45 168.41 221.36 151.42 coo -23.72 34.69 12.49 -24.32 32.83 13.34 174.31 220.26 151.67 176.20 220.84 150.96 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 27 3 # 27 A1132 ASP I 102 ASP.? 20.44 O1 GOL I3032 A1134 ALA I 135 ALA.? 17.77 CL CL I2015 A1137 ASN I 134 ASN.? 21.46 CL CL I2015 coo -27.05 34.58 17.12 -25.81 32.84 17.16 201.10 198.54 145.88 200.66 198.62 143.82 coo -20.53 36.39 15.81 -20.80 35.01 16.40 205.79 202.14 146.97 205.93 200.92 147.82 coo -23.72 34.69 12.49 -24.32 32.83 13.34 202.50 205.66 146.54 201.90 204.42 144.84 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 28 3 # 28 A1132 ASP J 28 ASP~? 15.67 CL CL J2002 A1134 ALA J 30 ALA.? 19.97 CL CL J2002 A1137 ASN J 31 ASN~? 18.09 CL CL J2002 coo -27.05 34.58 17.12 -25.81 32.84 17.16 170.87 175.19 114.50 169.74 176.91 114.00 coo -20.53 36.39 15.81 -20.80 35.01 16.40 172.85 179.89 111.46 171.54 179.85 110.75 coo -23.72 34.69 12.49 -24.32 32.83 13.34 171.02 180.04 115.82 169.37 180.80 114.74 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 29 3 # 29 A1132 ASP J 28 ASP~? 15.67 CL CL J2002 A1134 ALA J 32 ALA~? 17.36 CL CL J2002 A1137 ASN J 31 ASN~? 18.09 CL CL J2002 coo -27.05 34.58 17.12 -25.81 32.84 17.16 170.87 175.19 114.50 169.74 176.91 114.00 coo -20.53 36.39 15.81 -20.80 35.01 16.40 175.83 179.83 116.42 176.99 179.45 115.55 coo -23.72 34.69 12.49 -24.32 32.83 13.34 171.02 180.04 115.82 169.37 180.80 114.74 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 30 3 # 30 A1132 ASP J 102 ASP.? 24.08 CL CL J2016 A1134 ALA J 135 ALA.? 17.65 CL CL J2016 A1137 ASN J 134 ASN.? 21.36 CL CL J2016 coo -27.05 34.58 17.12 -25.81 32.84 17.16 143.25 191.36 132.98 143.80 193.32 132.63 coo -20.53 36.39 15.81 -20.80 35.01 16.40 138.91 190.36 128.97 138.50 189.71 130.36 coo -23.72 34.69 12.49 -24.32 32.83 13.34 142.59 189.93 125.86 143.30 191.66 127.03 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 31 3 # 31 A1132 ASP K 28 ASP~? 19.61 O1 GOL K3011 A1134 ALA K 30 ALA.? 20.83 O1 GOL K3011 A1137 ASN K 31 ASN~? 16.74 O1 GOL K3011 coo -27.05 34.58 17.12 -25.81 32.84 17.16 166.96 115.59 181.42 167.86 115.34 183.30 coo -20.53 36.39 15.81 -20.80 35.01 16.40 164.44 112.89 186.14 165.69 112.04 186.36 coo -23.72 34.69 12.49 -24.32 32.83 13.34 166.35 117.31 186.12 168.04 116.44 187.09 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 32 3 # 32 A1132 ASP K 28 ASP~? 19.61 O1 GOL K3011 A1134 ALA K 32 ALA~? 17.75 O1 GOL K3011 A1137 ASN K 31 ASN~? 16.74 O1 GOL K3011 coo -27.05 34.58 17.12 -25.81 32.84 17.16 166.96 115.59 181.42 167.86 115.34 183.30 coo -20.53 36.39 15.81 -20.80 35.01 16.40 161.45 117.68 185.72 160.27 116.73 185.65 coo -23.72 34.69 12.49 -24.32 32.83 13.34 166.35 117.31 186.12 168.04 116.44 187.09 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 33 3 # 33 A1132 ASP K 102 ASP.? 24.81 O1 GOL K3041 A1134 ALA K 135 ALA.? 19.10 O1 GOL K3041 A1137 ASN K 134 ASN.? 21.40 O1 GOL K3041 coo -27.05 34.58 17.12 -25.81 32.84 17.16 194.36 135.90 195.25 193.66 135.95 197.23 coo -20.53 36.39 15.81 -20.80 35.01 16.40 198.59 131.76 194.84 198.93 133.01 194.07 coo -23.72 34.69 12.49 -24.32 32.83 13.34 194.99 128.59 194.84 194.18 129.99 196.32 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 34 3 # 34 A1132 ASP L 28 ASP~? 34.50 O1 GOL L3028 A1134 ALA L 30 ALA.? 38.41 O3 GOL K3011 A1137 ASN L 31 ASN~? 34.54 O3 GOL K3011 coo -27.05 34.58 17.12 -25.81 32.84 17.16 163.49 162.78 223.08 162.21 161.15 223.46 coo -20.53 36.39 15.81 -20.80 35.01 16.40 165.18 158.14 226.58 163.90 158.18 227.31 coo -23.72 34.69 12.49 -24.32 32.83 13.34 163.63 157.90 222.01 161.73 157.29 222.80 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 35 3 # 35 A1132 ASP L 28 ASP~? 34.50 O1 GOL L3028 A1134 ALA L 32 ALA~? 35.22 O3 GOL K3011 A1137 ASN L 31 ASN~? 34.54 O3 GOL K3011 coo -27.05 34.58 17.12 -25.81 32.84 17.16 163.49 162.78 223.08 162.21 161.15 223.46 coo -20.53 36.39 15.81 -20.80 35.01 16.40 168.55 157.71 222.06 169.65 157.86 223.06 coo -23.72 34.69 12.49 -24.32 32.83 13.34 163.63 157.90 222.01 161.73 157.29 222.80 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 36 3 # 36 A1132 ASP L 102 ASP.? 24.59 CL CL L2009 A1134 ALA L 135 ALA.? 17.56 CL CL L2009 A1137 ASN L 134 ASN.? 21.61 CL CL L2009 coo -27.05 34.58 17.12 -25.81 32.84 17.16 136.52 149.82 201.33 136.95 147.73 201.53 coo -20.53 36.39 15.81 -20.80 35.01 16.40 131.31 151.62 205.34 131.24 152.15 203.93 coo -23.72 34.69 12.49 -24.32 32.83 13.34 134.78 151.23 208.60 135.91 149.70 207.44 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 37 3 # 37 A1132 ASP M 28 ASP~? 15.52 CL CL I2001 A1134 ALA M 30 ALA.? 19.68 CL CL I2001 A1137 ASN M 31 ASN~? 17.43 O1 GOL M3007 coo -27.05 34.58 17.12 -25.81 32.84 17.16 170.27 223.20 174.57 168.89 223.83 176.08 coo -20.53 36.39 15.81 -20.80 35.01 16.40 171.56 226.40 179.34 170.20 227.02 179.04 coo -23.72 34.69 12.49 -24.32 32.83 13.34 169.82 222.03 179.48 168.08 223.12 179.98 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 38 3 # 38 A1132 ASP M 28 ASP~? 15.52 CL CL I2001 A1134 ALA M 32 ALA~? 17.60 CL CL I2001 A1137 ASN M 31 ASN~? 17.43 O1 GOL M3007 coo -27.05 34.58 17.12 -25.81 32.84 17.16 170.27 223.20 174.57 168.89 223.83 176.08 coo -20.53 36.39 15.81 -20.80 35.01 16.40 174.72 221.62 179.85 175.89 222.50 179.79 coo -23.72 34.69 12.49 -24.32 32.83 13.34 169.82 222.03 179.48 168.08 223.12 179.98 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 39 3 # 39 A1132 ASP M 102 ASP.? 24.52 CL CL M2017 A1134 ALA M 135 ALA.? 17.94 CL CL M2017 A1137 ASN M 134 ASN.? 21.64 CL CL M2017 coo -27.05 34.58 17.12 -25.81 32.84 17.16 140.74 204.70 188.01 141.33 204.99 189.98 coo -20.53 36.39 15.81 -20.80 35.01 16.40 136.61 208.69 186.51 136.19 207.38 185.80 coo -23.72 34.69 12.49 -24.32 32.83 13.34 140.32 211.77 186.52 140.85 210.60 188.28 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 40 3 # 40 A1132 ASP N 28 ASP~? 15.68 CL CL J2002 A1134 ALA N 30 ALA.? 20.00 CL CL J2002 A1137 ASN N 31 ASN~? 16.42 O3 GOL N3008 coo -27.05 34.58 17.12 -25.81 32.84 17.16 173.04 156.37 115.74 174.12 154.54 115.64 coo -20.53 36.39 15.81 -20.80 35.01 16.40 171.22 151.36 112.97 172.69 151.33 112.42 coo -23.72 34.69 12.49 -24.32 32.83 13.34 172.40 151.59 117.56 174.20 150.72 116.88 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 41 3 # 41 A1132 ASP N 28 ASP~? 15.68 CL CL J2002 A1134 ALA N 32 ALA~? 17.62 O3 GOL N3008 A1137 ASN N 31 ASN~? 16.42 O3 GOL N3008 coo -27.05 34.58 17.12 -25.81 32.84 17.16 173.04 156.37 115.74 174.12 154.54 115.64 coo -20.53 36.39 15.81 -20.80 35.01 16.40 167.51 151.87 117.28 166.48 151.92 116.17 coo -23.72 34.69 12.49 -24.32 32.83 13.34 172.40 151.59 117.56 174.20 150.72 116.88 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 42 3 # 42 A1132 ASP N 102 ASP.? 20.60 O2 GOL N3029 A1134 ALA N 135 ALA.? 17.79 O2 GOL N3029 A1137 ASN N 134 ASN.? 22.01 O2 GOL N3029 coo -27.05 34.58 17.12 -25.81 32.84 17.16 197.96 142.41 139.19 197.06 140.46 139.09 coo -20.53 36.39 15.81 -20.80 35.01 16.40 202.74 142.87 135.54 203.09 143.71 136.74 coo -23.72 34.69 12.49 -24.32 32.83 13.34 199.33 142.96 132.06 198.55 141.35 133.25 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 43 3 # 43 A1132 ASP O 28 ASP~? 23.95 CL CL O2036 A1134 ALA O 30 ALA.? 26.51 CL CL O2036 A1137 ASN O 31 ASN~? 22.31 CL CL O2036 coo -27.05 34.58 17.12 -25.81 32.84 17.16 164.72 114.57 162.31 163.52 114.24 160.62 coo -20.53 36.39 15.81 -20.80 35.01 16.40 166.52 111.32 157.68 165.10 110.81 157.73 coo -23.72 34.69 12.49 -24.32 32.83 13.34 165.12 115.88 157.47 163.27 115.16 156.70 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 44 3 # 44 A1132 ASP O 28 ASP~? 23.95 CL CL O2036 A1134 ALA O 32 ALA~? 25.34 CL CL K2003 A1137 ASN O 31 ASN~? 22.31 CL CL O2036 coo -27.05 34.58 17.12 -25.81 32.84 17.16 164.72 114.57 162.31 163.52 114.24 160.62 coo -20.53 36.39 15.81 -20.80 35.01 16.40 170.01 115.77 157.68 171.02 114.70 157.81 coo -23.72 34.69 12.49 -24.32 32.83 13.34 165.12 115.88 157.47 163.27 115.16 156.70 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 45 3 # 45 A1132 ASP O 102 ASP.? 13.16 CL CL O2036 A1134 ALA O 135 ALA.? 13.72 CL CL O2036 A1137 ASN O 134 ASN.? 10.04 CL CL O2036 coo -27.05 34.58 17.12 -25.81 32.84 17.16 139.48 136.33 146.19 140.25 135.96 144.25 coo -20.53 36.39 15.81 -20.80 35.01 16.40 134.59 132.69 147.05 134.19 133.97 147.77 coo -23.72 34.69 12.49 -24.32 32.83 13.34 138.05 129.32 147.60 138.80 130.30 145.81 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 46 3 # 46 A1132 ASP P 28 ASP~? 33.76 O1 GOL L3028 A1134 ALA P 30 ALA.? 35.16 O1 GOL L3028 A1137 ASN P 31 ASN~? 33.36 O3 GOL M3007 coo -27.05 34.58 17.12 -25.81 32.84 17.16 167.75 181.83 222.09 168.94 183.53 222.37 coo -20.53 36.39 15.81 -20.80 35.01 16.40 165.78 186.84 224.71 167.10 186.81 225.38 coo -23.72 34.69 12.49 -24.32 32.83 13.34 167.75 186.44 220.46 169.52 187.23 221.29 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 47 3 # 47 A1132 ASP P 28 ASP~? 33.76 O1 GOL L3028 A1134 ALA P 32 ALA~? 28.28 O1 GOL L3028 A1137 ASN P 31 ASN~? 33.36 O3 GOL M3007 coo -27.05 34.58 17.12 -25.81 32.84 17.16 167.75 181.83 222.09 168.94 183.53 222.37 coo -20.53 36.39 15.81 -20.80 35.01 16.40 162.95 186.57 219.86 161.75 186.59 220.72 coo -23.72 34.69 12.49 -24.32 32.83 13.34 167.75 186.44 220.46 169.52 187.23 221.29 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 48 3 # 48 A1132 ASP P 102 ASP.? 24.26 CL CL P2019 A1134 ALA P 135 ALA.? 17.74 CL CL P2019 A1137 ASN P 134 ASN.? 21.42 CL CL P2019 coo -27.05 34.58 17.12 -25.81 32.84 17.16 197.01 191.93 202.05 196.73 194.01 202.05 coo -20.53 36.39 15.81 -20.80 35.01 16.40 201.29 191.04 206.34 201.72 190.19 205.13 coo -23.72 34.69 12.49 -24.32 32.83 13.34 197.55 191.31 209.34 197.08 192.94 207.98 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 48 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 204 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 279 TYR A 75 TYR~? 11.96 CL CL A2020 coo 5.85 5.60 30.32 5.00 7.49 29.88 90.44 78.16 48.76 91.65 76.94 50.06 coo 7.79 1.83 27.81 9.08 3.25 26.92 94.58 81.89 51.70 95.31 83.75 52.44 coo 8.22 7.77 18.64 7.58 8.47 21.28 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 204 GLU A 106 GLU~? 21.37 O1 GOL A3040 A 279 TYR A 143 TYR~? 16.38 O1 GOL A3040 coo 5.85 5.60 30.32 5.00 7.49 29.88 88.23 80.63 30.72 87.92 80.82 28.67 coo 7.79 1.83 27.81 9.08 3.25 26.92 86.09 78.56 33.43 88.06 78.13 34.12 coo 8.22 7.77 18.64 7.58 8.47 21.28 92.99 77.44 39.76 93.75 79.76 38.42 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 204 GLU B 73 GLU~? 6.38 O3 GOL B3023 A 279 TYR B 75 TYR~? 10.15 CL CL B2010 coo 5.85 5.60 30.32 5.00 7.49 29.88 23.66 59.02 20.34 21.93 58.32 21.38 coo 7.79 1.83 27.81 9.08 3.25 26.92 19.80 56.19 16.30 19.32 55.14 14.52 coo 8.22 7.77 18.64 7.58 8.47 21.28 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 204 GLU B 106 GLU~? 14.28 O1 GOL B3024 A 279 TYR B 143 TYR~? 10.77 O2 GOL B3024 coo 5.85 5.60 30.32 5.00 7.49 29.88 30.49 75.29 14.98 31.30 77.16 14.42 coo 7.79 1.83 27.81 9.08 3.25 26.92 31.31 72.93 17.86 29.23 72.75 18.06 coo 8.22 7.77 18.64 7.58 8.47 21.28 23.25 68.41 18.58 23.33 69.19 15.92 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 5 3 # 5 A 202 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 204 GLU C 73 GLU~? 6.99 O1 GOL C3036 A 279 TYR C 75 TYR~? 10.50 CL CL C2011 coo 5.85 5.60 30.32 5.00 7.49 29.88 82.81 22.02 65.69 84.52 22.80 64.66 coo 7.79 1.83 27.81 9.08 3.25 26.92 86.57 17.41 63.72 86.98 15.43 63.06 coo 8.22 7.77 18.64 7.58 8.47 21.28 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 6 3 # 6 A 202 ASP C 102 ASP.? 24.57 CL CL C2011 A 204 GLU C 106 GLU~? 19.79 O1 GOL C3036 A 279 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo 5.85 5.60 30.32 5.00 7.49 29.88 76.25 20.52 82.74 75.40 20.56 84.65 coo 7.79 1.83 27.81 9.08 3.25 26.92 75.34 22.76 79.72 77.40 22.80 79.51 coo 8.22 7.77 18.64 7.58 8.47 21.28 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 7 3 # 7 A 202 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 204 GLU D 73 GLU~? 5.51 C2 GOL D3020 A 279 TYR D 75 TYR~? 10.03 CL CL D2012 coo 5.85 5.60 30.32 5.00 7.49 29.88 16.94 54.59 79.01 15.65 55.42 77.54 coo 7.79 1.83 27.81 9.08 3.25 26.92 12.99 58.17 82.26 12.31 59.24 83.94 coo 8.22 7.77 18.64 7.58 8.47 21.28 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 8 3 # 8 A 202 ASP D 102 ASP.? 24.32 CL CL D2012 A 204 GLU D 106 GLU~? 21.38 CL CL D2012 A 279 TYR D 143 TYR~? 15.16 CL CL D2012 coo 5.85 5.60 30.32 5.00 7.49 29.88 18.96 37.41 85.00 19.42 35.40 85.42 coo 7.79 1.83 27.81 9.08 3.25 26.92 21.11 39.74 82.39 19.19 40.22 81.74 coo 8.22 7.77 18.64 7.58 8.47 21.28 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 9 3 # 9 A 202 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 204 GLU E 73 GLU~? -6.85 O1 GOL E3022s A 279 TYR E 75 TYR~? 10.13 CL CL E2013 coo 5.85 5.60 30.32 5.00 7.49 29.88 23.07 86.29 52.35 21.57 85.17 51.32 coo 7.79 1.83 27.81 9.08 3.25 26.92 19.82 90.31 48.74 19.50 92.07 47.58 coo 8.22 7.77 18.64 7.58 8.47 21.28 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 10 3 # 10 A 202 ASP E 102 ASP.? 24.45 CL CL E2013 A 204 GLU E 106 GLU~? 21.05 O1 GOL E3022 A 279 TYR E 143 TYR~? 15.23 CL CL E2013 coo 5.85 5.60 30.32 5.00 7.49 29.88 26.42 91.49 69.61 27.08 91.68 71.63 coo 7.79 1.83 27.81 9.08 3.25 26.92 27.90 88.73 67.36 25.90 88.59 66.70 coo 8.22 7.77 18.64 7.58 8.47 21.28 20.79 87.99 61.33 20.74 90.64 62.13 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 11 3 # 11 A 202 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 204 GLU F 73 GLU~? 5.19 O3 GOL F3039 A 279 TYR F 75 TYR~? 9.99 CL CL F2034 coo 5.85 5.60 30.32 5.00 7.49 29.88 88.86 41.25 28.96 90.30 42.22 30.24 coo 7.79 1.83 27.81 9.08 3.25 26.92 93.55 43.24 25.35 94.46 43.89 23.55 coo 8.22 7.77 18.64 7.58 8.47 21.28 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 12 3 # 12 A 202 ASP F 102 ASP.? 16.73 CL CL F2035 A 204 GLU F 106 GLU~? 12.79 CL CL F2035 A 279 TYR F 143 TYR~? 15.09 CL CL F2034 coo 5.85 5.60 30.32 5.00 7.49 29.88 82.74 24.28 26.35 81.91 22.30 26.35 coo 7.79 1.83 27.81 9.08 3.25 26.92 81.39 27.31 28.31 83.45 27.54 28.69 coo 8.22 7.77 18.64 7.58 8.47 21.28 89.42 31.84 29.55 89.79 30.44 27.17 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 13 3 # 13 A 202 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 204 GLU G 73 GLU~? 5.63 O1 GOL G3038 A 279 TYR G 75 TYR~? 12.69 CL CL G2033 coo 5.85 5.60 30.32 5.00 7.49 29.88 17.70 27.34 47.09 16.19 28.71 47.73 coo 7.79 1.83 27.81 9.08 3.25 26.92 12.93 24.13 49.80 12.04 22.49 50.80 coo 8.22 7.77 18.64 7.58 8.47 21.28 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 14 3 # 14 A 202 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 204 GLU G 106 GLU~? 21.38 C3 GOL G3001 A 279 TYR G 143 TYR~? 15.53 C3 GOL G3001 coo 5.85 5.60 30.32 5.00 7.49 29.88 23.47 21.05 30.82 24.30 20.62 28.93 coo 7.79 1.83 27.81 9.08 3.25 26.92 24.93 23.55 33.32 22.94 24.09 33.51 coo 8.22 7.77 18.64 7.58 8.47 21.28 16.97 25.90 37.77 16.51 23.33 36.84 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 15 3 # 15 A 202 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 204 GLU H 73 GLU~? -8.72 CL CL H2014s A 279 TYR H 75 TYR~? 10.27 CL CL H2014 coo 5.85 5.60 30.32 5.00 7.49 29.88 84.24 58.93 85.48 85.73 57.59 84.66 coo 7.79 1.83 27.81 9.08 3.25 26.92 87.54 56.19 90.14 87.78 55.44 92.11 coo 8.22 7.77 18.64 7.58 8.47 21.28 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 16 3 # 16 A 202 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 204 GLU H 106 GLU~? 14.51 O2 GOL H3016 A 279 TYR H 143 TYR~? 11.30 O2 GOL H3016 coo 5.85 5.60 30.32 5.00 7.49 29.88 81.36 76.99 86.94 80.90 79.01 86.89 coo 7.79 1.83 27.81 9.08 3.25 26.92 79.71 74.06 84.56 81.75 73.57 84.59 coo 8.22 7.77 18.64 7.58 8.47 21.28 86.77 67.99 85.16 86.88 69.36 87.57 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 17 3 # 17 A 202 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 204 GLU I 73 GLU~? -6.03 O3 GOL I3031s A 279 TYR I 75 TYR~? 10.32 CL CL I2015 coo 5.85 5.60 30.32 5.00 7.49 29.88 204.37 195.46 163.61 205.75 194.30 164.79 coo 7.79 1.83 27.81 9.08 3.25 26.92 208.30 199.46 166.53 209.06 201.27 167.27 coo 8.22 7.77 18.64 7.58 8.47 21.28 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 18 3 # 18 A 202 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 204 GLU I 106 GLU~? 14.47 O1 GOL I3032 A 279 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo 5.85 5.60 30.32 5.00 7.49 29.88 201.10 198.54 145.88 200.66 198.62 143.82 coo 7.79 1.83 27.81 9.08 3.25 26.92 199.46 196.34 148.59 201.47 195.97 149.14 coo 8.22 7.77 18.64 7.58 8.47 21.28 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 19 3 # 19 A 202 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 204 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 279 TYR J 75 TYR~? 10.17 CL CL J2016 coo 5.85 5.60 30.32 5.00 7.49 29.88 137.44 174.60 137.57 135.80 173.80 138.69 coo 7.79 1.83 27.81 9.08 3.25 26.92 133.49 171.70 133.63 132.81 170.83 131.84 coo 8.22 7.77 18.64 7.58 8.47 21.28 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 20 3 # 20 A 202 ASP J 102 ASP.? 24.08 CL CL J2016 A 204 GLU J 106 GLU~? 21.26 CL CL J2016 A 279 TYR J 143 TYR~? 15.18 CL CL J2016 coo 5.85 5.60 30.32 5.00 7.49 29.88 143.25 191.36 132.98 143.80 193.32 132.63 coo 7.79 1.83 27.81 9.08 3.25 26.92 144.43 188.69 135.80 142.30 188.60 135.89 coo 8.22 7.77 18.64 7.58 8.47 21.28 136.50 183.91 136.49 136.50 184.93 133.88 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 21 3 # 21 A 202 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 204 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 279 TYR K 75 TYR~? 12.36 CL CL K2027 coo 5.85 5.60 30.32 5.00 7.49 29.88 200.17 138.24 178.11 201.77 139.28 177.19 coo 7.79 1.83 27.81 9.08 3.25 26.92 204.07 133.93 175.85 204.65 132.02 175.03 coo 8.22 7.77 18.64 7.58 8.47 21.28 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 22 3 # 22 A 202 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 204 GLU K 106 GLU~? 21.15 O3 GOL K3009 A 279 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo 5.85 5.60 30.32 5.00 7.49 29.88 194.36 135.90 195.25 193.66 135.95 197.23 coo 7.79 1.83 27.81 9.08 3.25 26.92 193.16 138.18 192.36 195.25 138.38 192.10 coo 8.22 7.77 18.64 7.58 8.47 21.28 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 23 3 # 23 A 202 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 204 GLU L 73 GLU~? 5.94 O3 GOL L3027 A 279 TYR L 75 TYR~? 10.07 CL CL L2009 coo 5.85 5.60 30.32 5.00 7.49 29.88 133.34 166.97 196.27 132.03 168.03 194.96 coo 7.79 1.83 27.81 9.08 3.25 26.92 129.44 170.32 199.72 128.69 171.38 201.39 coo 8.22 7.77 18.64 7.58 8.47 21.28 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 24 3 # 24 A 202 ASP L 102 ASP.? 24.59 CL CL L2009 A 204 GLU L 106 GLU~? 21.37 CL CL L2009 A 279 TYR L 143 TYR~? 15.30 CL CL L2009 coo 5.85 5.60 30.32 5.00 7.49 29.88 136.52 149.82 201.33 136.95 147.73 201.53 coo 7.79 1.83 27.81 9.08 3.25 26.92 138.12 152.20 198.93 136.10 152.63 198.56 coo 8.22 7.77 18.64 7.58 8.47 21.28 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 25 3 # 25 A 202 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 204 GLU M 73 GLU~? -3.31 O3 GOL M3042s A 279 TYR M 75 TYR~? 10.36 CL CL M2017 coo 5.85 5.60 30.32 5.00 7.49 29.88 136.87 200.18 170.79 135.36 199.08 169.77 coo 7.79 1.83 27.81 9.08 3.25 26.92 133.35 204.22 167.43 132.84 205.99 166.43 coo 8.22 7.77 18.64 7.58 8.47 21.28 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 26 3 # 26 A 202 ASP M 102 ASP.? 24.52 CL CL M2017 A 204 GLU M 106 GLU~? 21.48 CL CL M2017 A 279 TYR M 143 TYR~? 15.40 CL CL M2017 coo 5.85 5.60 30.32 5.00 7.49 29.88 140.74 204.70 188.01 141.33 204.99 189.98 coo 7.79 1.83 27.81 9.08 3.25 26.92 142.15 202.05 185.59 140.16 201.82 184.97 coo 8.22 7.77 18.64 7.58 8.47 21.28 134.88 201.35 179.85 134.66 203.97 180.76 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 27 3 # 27 A 202 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 204 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 279 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 5.85 5.60 30.32 5.00 7.49 29.88 203.51 159.51 142.26 205.02 160.53 143.48 coo 7.79 1.83 27.81 9.08 3.25 26.92 207.93 161.92 138.37 208.75 162.64 136.53 coo 8.22 7.77 18.64 7.58 8.47 21.28 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 28 3 # 28 A 202 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 204 GLU N 106 GLU~? 14.62 O2 GOL N3029 A 279 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo 5.85 5.60 30.32 5.00 7.49 29.88 197.96 142.41 139.19 197.06 140.46 139.09 coo 7.79 1.83 27.81 9.08 3.25 26.92 196.48 145.55 141.46 198.54 145.70 141.81 coo 8.22 7.77 18.64 7.58 8.47 21.28 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 29 3 # 29 A 202 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 204 GLU O 73 GLU~? 6.85 O1 GOL O3013 A 279 TYR O 75 TYR~? 10.24 CL CL O2018 coo 5.85 5.60 30.32 5.00 7.49 29.88 134.07 141.35 162.95 132.57 142.58 163.78 coo 7.79 1.83 27.81 9.08 3.25 26.92 129.73 137.78 165.68 128.97 136.10 166.67 coo 8.22 7.77 18.64 7.58 8.47 21.28 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 30 3 # 30 A 202 ASP O 102 ASP.? 13.16 CL CL O2036 A 204 GLU O 106 GLU~? 13.74 CL CL O2036 A 279 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo 5.85 5.60 30.32 5.00 7.49 29.88 139.48 136.33 146.19 140.25 135.96 144.25 coo 7.79 1.83 27.81 9.08 3.25 26.92 140.87 138.77 148.77 138.84 139.06 148.95 coo 8.22 7.77 18.64 7.58 8.47 21.28 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 31 3 # 31 A 202 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 204 GLU P 73 GLU~? 5.04 O1 GOL P3034 A 279 TYR P 75 TYR~? 10.23 CL CL P2019 coo 5.85 5.60 30.32 5.00 7.49 29.88 200.75 174.15 199.66 202.28 173.10 198.62 coo 7.79 1.83 27.81 9.08 3.25 26.92 204.36 171.43 203.90 204.84 170.63 205.81 coo 8.22 7.77 18.64 7.58 8.47 21.28 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 32 3 # 32 A 202 ASP P 102 ASP.? 24.26 CL CL P2019 A 204 GLU P 106 GLU~? 20.67 O3 GOL P3014 A 279 TYR P 143 TYR~? 15.20 CL CL P2019 coo 5.85 5.60 30.32 5.00 7.49 29.88 197.01 191.93 202.05 196.73 194.01 202.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 195.52 189.19 199.68 197.57 188.76 199.63 coo 8.22 7.77 18.64 7.58 8.47 21.28 202.86 183.43 199.65 203.11 184.67 202.14 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 32 hits 1itx_c00 naa= 3 ULMN 3 1joa_c00 NADH PEROXIDASE user 1 3 # 1 10 HIS N 158 HIS.? 10.50 CL CL N2030 41 SER N 160 SER~? 16.10 O1 GOL N3012 303 ARG N 155 ARG.? 11.80 C1 GOL N3012 coo 62.94 54.74 73.45 64.13 56.17 74.27 220.32 164.11 138.58 219.66 165.01 136.80 coo 65.67 62.51 70.93 64.56 61.94 68.74 223.14 157.57 143.87 222.99 157.22 146.29 coo 63.38 52.38 77.01 66.48 52.75 76.49 219.49 166.94 144.14 219.55 170.01 143.56 1joa_c00 source 1joa NADH PEROXIDASE : 1 hits 1joa_c00 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 581 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 713 ARG A 44 ARG~? 20.37 O3 GOL E3035 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 51.19 99.66 33.34 49.41 97.31 34.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 58.38 95.12 28.70 59.87 92.50 29.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 47.85 90.78 30.63 47.19 93.18 28.89 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 581 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 713 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 51.19 99.66 33.34 49.41 97.31 34.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 47.85 90.78 30.63 47.19 93.18 28.89 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 581 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 713 ARG A 44 ARG~? 20.37 O3 GOL E3035 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 58.38 95.12 28.70 59.87 92.50 29.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 51.19 99.66 33.34 49.41 97.31 34.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 47.85 90.78 30.63 47.19 93.18 28.89 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 581 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 713 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 58.38 95.12 28.70 59.87 92.50 29.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 47.85 90.78 30.63 47.19 93.18 28.89 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 581 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 713 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 47.85 90.78 30.63 47.19 93.18 28.89 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 51.19 99.66 33.34 49.41 97.31 34.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 581 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 713 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 47.85 90.78 30.63 47.19 93.18 28.89 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 58.38 95.12 28.70 59.87 92.50 29.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG C 36 ARG~? 17.12 CL CL C2004 A 581 ARG C 37 ARG~? -20.33 CL CL C2004s A 713 ARG C 44 ARG~? 23.41 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 37.77 8.89 71.79 36.83 11.19 70.06 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 44.35 12.06 77.77 46.44 14.26 77.62 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 35.63 18.34 73.64 34.17 16.13 75.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG C 36 ARG~? 17.12 CL CL C2004 A 581 ARG C 44 ARG~? 23.41 CL CL C2004 A 713 ARG C 37 ARG~? -20.33 CL CL C2004s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 37.77 8.89 71.79 36.83 11.19 70.06 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 35.63 18.34 73.64 34.17 16.13 75.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 34 ARG~? 20.14 CL CL C2004 A 713 ARG C 36 ARG~? 17.12 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 44.35 12.06 77.77 46.44 14.26 77.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 49.42 6.75 74.39 49.90 6.28 77.46 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 36 ARG~? 17.12 CL CL C2004 A 713 ARG C 34 ARG~? 20.14 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 44.35 12.06 77.77 46.44 14.26 77.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 37.77 8.89 71.79 36.83 11.19 70.06 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 49.42 6.75 74.39 49.90 6.28 77.46 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 36 ARG~? 17.12 CL CL C2004 A 713 ARG C 44 ARG~? 23.41 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 44.35 12.06 77.77 46.44 14.26 77.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 37.77 8.89 71.79 36.83 11.19 70.06 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 35.63 18.34 73.64 34.17 16.13 75.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 44 ARG~? 23.41 CL CL C2004 A 713 ARG C 36 ARG~? 17.12 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 44.35 12.06 77.77 46.44 14.26 77.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 35.63 18.34 73.64 34.17 16.13 75.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG C 44 ARG~? 23.41 CL CL C2004 A 581 ARG C 36 ARG~? 17.12 CL CL C2004 A 713 ARG C 37 ARG~? -20.33 CL CL C2004s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 35.63 18.34 73.64 34.17 16.13 75.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 37.77 8.89 71.79 36.83 11.19 70.06 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG C 44 ARG~? 23.41 CL CL C2004 A 581 ARG C 37 ARG~? -20.33 CL CL C2004s A 713 ARG C 36 ARG~? 17.12 CL CL C2004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 35.63 18.34 73.64 34.17 16.13 75.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 44.35 12.06 77.77 46.44 14.26 77.62 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 581 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 713 ARG D 44 ARG~? 13.53 C1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 55.93 43.64 102.74 57.91 43.73 100.41 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 48.82 38.28 99.42 47.22 38.23 96.82 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 59.28 39.14 94.57 59.93 38.01 97.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 581 ARG D 44 ARG~? 13.53 C1 GOL D3005 A 713 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 55.93 43.64 102.74 57.91 43.73 100.41 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 59.28 39.14 94.57 59.93 38.01 97.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 34 ARG~? 12.13 O1 GOL D3005 A 713 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 48.82 38.28 99.42 47.22 38.23 96.82 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 43.70 43.25 103.08 42.03 40.72 103.99 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 713 ARG D 34 ARG~? 12.13 O1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 48.82 38.28 99.42 47.22 38.23 96.82 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 55.93 43.64 102.74 57.91 43.73 100.41 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 43.70 43.25 103.08 42.03 40.72 103.99 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 713 ARG D 44 ARG~? 13.53 C1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 48.82 38.28 99.42 47.22 38.23 96.82 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 55.93 43.64 102.74 57.91 43.73 100.41 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 59.28 39.14 94.57 59.93 38.01 97.32 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 44 ARG~? 13.53 C1 GOL D3005 A 713 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 48.82 38.28 99.42 47.22 38.23 96.82 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 59.28 39.14 94.57 59.93 38.01 97.32 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG D 44 ARG~? 13.53 C1 GOL D3005 A 581 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 713 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 59.28 39.14 94.57 59.93 38.01 97.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 55.93 43.64 102.74 57.91 43.73 100.41 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG D 44 ARG~? 13.53 C1 GOL D3005 A 581 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 713 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 59.28 39.14 94.57 59.93 38.01 97.32 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 48.82 38.28 99.42 47.22 38.23 96.82 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 581 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 713 ARG E 44 ARG~? 13.68 C1 GOL E3004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 66.28 100.73 63.79 67.89 98.12 63.67 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 58.59 99.11 69.23 56.48 96.91 69.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 67.85 92.14 68.56 69.19 94.64 69.74 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 581 ARG E 44 ARG~? 13.68 C1 GOL E3004 A 713 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 66.28 100.73 63.79 67.89 98.12 63.67 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 67.85 92.14 68.56 69.19 94.64 69.74 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 25 3 # 25 A 396 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 581 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 713 ARG E 44 ARG~? 13.68 C1 GOL E3004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 58.59 99.11 69.23 56.48 96.91 69.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 66.28 100.73 63.79 67.89 98.12 63.67 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 67.85 92.14 68.56 69.19 94.64 69.74 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 26 3 # 26 A 396 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 581 ARG E 44 ARG~? 13.68 C1 GOL E3004 A 713 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 58.59 99.11 69.23 56.48 96.91 69.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 67.85 92.14 68.56 69.19 94.64 69.74 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 27 3 # 27 A 396 ARG E 44 ARG~? 13.68 C1 GOL E3004 A 581 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 713 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 67.85 92.14 68.56 69.19 94.64 69.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 66.28 100.73 63.79 67.89 98.12 63.67 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 28 3 # 28 A 396 ARG E 44 ARG~? 13.68 C1 GOL E3004 A 581 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 713 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 67.85 92.14 68.56 69.19 94.64 69.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 58.59 99.11 69.23 56.48 96.91 69.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 29 3 # 29 A 396 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 581 ARG F 37 ARG~? -27.07 CL CL F2035s A 713 ARG F 44 ARG~? 19.46 O1 GOL B3017 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 47.43 34.56 6.90 45.82 36.16 8.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 53.50 28.70 11.30 55.02 28.89 13.93 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 43.53 32.70 15.75 42.58 31.25 13.24 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 30 3 # 30 A 396 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 581 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 713 ARG F 37 ARG~? -27.07 CL CL F2035s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 47.43 34.56 6.90 45.82 36.16 8.95 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 43.53 32.70 15.75 42.58 31.25 13.24 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 31 3 # 31 A 396 ARG F 37 ARG~? -27.07 CL CL F2035s A 581 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 713 ARG F 44 ARG~? 19.46 O1 GOL B3017 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 53.50 28.70 11.30 55.02 28.89 13.93 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 47.43 34.56 6.90 45.82 36.16 8.95 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 43.53 32.70 15.75 42.58 31.25 13.24 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 32 3 # 32 A 396 ARG F 37 ARG~? -27.07 CL CL F2035s A 581 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 713 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 53.50 28.70 11.30 55.02 28.89 13.93 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 43.53 32.70 15.75 42.58 31.25 13.24 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 33 3 # 33 A 396 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 581 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 713 ARG F 37 ARG~? -27.07 CL CL F2035s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 43.53 32.70 15.75 42.58 31.25 13.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 47.43 34.56 6.90 45.82 36.16 8.95 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 34 3 # 34 A 396 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 581 ARG F 37 ARG~? -27.07 CL CL F2035s A 713 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 43.53 32.70 15.75 42.58 31.25 13.24 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 53.50 28.70 11.30 55.02 28.89 13.93 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 35 3 # 35 A 396 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 581 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 713 ARG H 44 ARG~? 13.32 O2 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 41.35 74.42 97.84 39.90 73.17 95.49 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 49.12 78.88 94.88 51.18 78.27 92.74 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 39.82 76.81 88.50 38.54 78.60 90.61 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 36 3 # 36 A 396 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 581 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 713 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 41.35 74.42 97.84 39.90 73.17 95.49 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 39.82 76.81 88.50 38.54 78.60 90.61 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 37 3 # 37 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 713 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 49.12 78.88 94.88 51.18 78.27 92.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 53.27 74.94 100.30 54.87 77.69 100.34 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 38 3 # 38 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 713 ARG H 34 ARG~? 11.22 O3 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 49.12 78.88 94.88 51.18 78.27 92.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 41.35 74.42 97.84 39.90 73.17 95.49 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 53.27 74.94 100.30 54.87 77.69 100.34 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 39 3 # 39 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 713 ARG H 44 ARG~? 13.32 O2 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 49.12 78.88 94.88 51.18 78.27 92.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 41.35 74.42 97.84 39.90 73.17 95.49 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 39.82 76.81 88.50 38.54 78.60 90.61 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 40 3 # 40 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 713 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 49.12 78.88 94.88 51.18 78.27 92.74 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 39.82 76.81 88.50 38.54 78.60 90.61 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 41 3 # 41 A 396 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 581 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 713 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 39.82 76.81 88.50 38.54 78.60 90.61 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 41.35 74.42 97.84 39.90 73.17 95.49 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 42 3 # 42 A 396 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 581 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 713 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 39.82 76.81 88.50 38.54 78.60 90.61 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 49.12 78.88 94.88 51.18 78.27 92.74 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 43 3 # 43 A 396 ARG I 36 ARG~? 18.35 CL CL I2001 A 581 ARG I 37 ARG~? 20.23 CL CL I2001 A 713 ARG I 44 ARG~? 23.41 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 163.77 216.28 151.02 161.75 213.99 150.84 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 170.53 211.87 145.98 172.22 209.35 146.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 160.24 207.09 148.05 159.51 209.54 146.34 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 44 3 # 44 A 396 ARG I 36 ARG~? 18.35 CL CL I2001 A 581 ARG I 44 ARG~? 23.41 CL CL I2001 A 713 ARG I 37 ARG~? 20.23 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 163.77 216.28 151.02 161.75 213.99 150.84 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 160.24 207.09 148.05 159.51 209.54 146.34 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 45 3 # 45 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 34 ARG~? 20.72 CL CL I2001 A 713 ARG I 36 ARG~? 18.35 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 170.53 211.87 145.98 172.22 209.35 146.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 175.86 216.47 149.42 177.66 216.28 146.86 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 46 3 # 46 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 36 ARG~? 18.35 CL CL I2001 A 713 ARG I 34 ARG~? 20.72 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 170.53 211.87 145.98 172.22 209.35 146.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 163.77 216.28 151.02 161.75 213.99 150.84 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 175.86 216.47 149.42 177.66 216.28 146.86 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 47 3 # 47 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 36 ARG~? 18.35 CL CL I2001 A 713 ARG I 44 ARG~? 23.41 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 170.53 211.87 145.98 172.22 209.35 146.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 163.77 216.28 151.02 161.75 213.99 150.84 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 160.24 207.09 148.05 159.51 209.54 146.34 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 48 3 # 48 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 44 ARG~? 23.41 CL CL I2001 A 713 ARG I 36 ARG~? 18.35 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 170.53 211.87 145.98 172.22 209.35 146.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 160.24 207.09 148.05 159.51 209.54 146.34 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 49 3 # 49 A 396 ARG I 44 ARG~? 23.41 CL CL I2001 A 581 ARG I 36 ARG~? 18.35 CL CL I2001 A 713 ARG I 37 ARG~? 20.23 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 160.24 207.09 148.05 159.51 209.54 146.34 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 163.77 216.28 151.02 161.75 213.99 150.84 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 50 3 # 50 A 396 ARG I 44 ARG~? 23.41 CL CL I2001 A 581 ARG I 37 ARG~? 20.23 CL CL I2001 A 713 ARG I 36 ARG~? 18.35 CL CL I2001 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 160.24 207.09 148.05 159.51 209.54 146.34 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 170.53 211.87 145.98 172.22 209.35 146.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 51 3 # 51 A 396 ARG J 36 ARG~? 16.92 CL CL J2002 A 581 ARG J 37 ARG~? 20.17 CL CL J2002 A 713 ARG J 44 ARG~? 18.91 O3 GOL N3044 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 181.40 180.11 121.45 182.70 178.85 123.93 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 174.71 186.35 123.78 172.76 186.51 126.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 183.90 183.73 130.13 185.30 184.88 127.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 52 3 # 52 A 396 ARG J 36 ARG~? 16.92 CL CL J2002 A 581 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 713 ARG J 37 ARG~? 20.17 CL CL J2002 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 181.40 180.11 121.45 182.70 178.85 123.93 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 183.90 183.73 130.13 185.30 184.88 127.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 53 3 # 53 A 396 ARG J 37 ARG~? 20.17 CL CL J2002 A 581 ARG J 36 ARG~? 16.92 CL CL J2002 A 713 ARG J 44 ARG~? 18.91 O3 GOL N3044 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 174.71 186.35 123.78 172.76 186.51 126.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 181.40 180.11 121.45 182.70 178.85 123.93 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 183.90 183.73 130.13 185.30 184.88 127.66 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 54 3 # 54 A 396 ARG J 37 ARG~? 20.17 CL CL J2002 A 581 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 713 ARG J 36 ARG~? 16.92 CL CL J2002 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 174.71 186.35 123.78 172.76 186.51 126.11 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 183.90 183.73 130.13 185.30 184.88 127.66 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 55 3 # 55 A 396 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 581 ARG J 36 ARG~? 16.92 CL CL J2002 A 713 ARG J 37 ARG~? 20.17 CL CL J2002 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 183.90 183.73 130.13 185.30 184.88 127.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 181.40 180.11 121.45 182.70 178.85 123.93 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 56 3 # 56 A 396 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 581 ARG J 37 ARG~? 20.17 CL CL J2002 A 713 ARG J 36 ARG~? 16.92 CL CL J2002 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 183.90 183.73 130.13 185.30 184.88 127.66 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 174.71 186.35 123.78 172.76 186.51 126.11 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 57 3 # 57 A 396 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 581 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 713 ARG K 44 ARG~? 13.27 C1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 156.15 122.83 185.77 154.85 125.10 184.29 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 162.88 126.06 191.42 164.87 128.39 191.36 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 153.63 132.28 188.00 152.37 129.86 189.45 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 58 3 # 58 A 396 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 581 ARG K 44 ARG~? 13.27 C1 GOL K3011 A 713 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 156.15 122.83 185.77 154.85 125.10 184.29 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 153.63 132.28 188.00 152.37 129.86 189.45 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 59 3 # 59 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 34 ARG~? 11.32 O1 GOL K3011 A 713 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 162.88 126.06 191.42 164.87 128.39 191.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.98 121.31 187.60 169.63 121.60 190.28 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 60 3 # 60 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 713 ARG K 34 ARG~? 11.32 O1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 162.88 126.06 191.42 164.87 128.39 191.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 156.15 122.83 185.77 154.85 125.10 184.29 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 167.98 121.31 187.60 169.63 121.60 190.28 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 61 3 # 61 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 713 ARG K 44 ARG~? 13.27 C1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 162.88 126.06 191.42 164.87 128.39 191.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 156.15 122.83 185.77 154.85 125.10 184.29 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 153.63 132.28 188.00 152.37 129.86 189.45 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 62 3 # 62 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 44 ARG~? 13.27 C1 GOL K3011 A 713 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 162.88 126.06 191.42 164.87 128.39 191.36 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 153.63 132.28 188.00 152.37 129.86 189.45 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 63 3 # 63 A 396 ARG K 44 ARG~? 13.27 C1 GOL K3011 A 581 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 713 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 153.63 132.28 188.00 152.37 129.86 189.45 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 156.15 122.83 185.77 154.85 125.10 184.29 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 64 3 # 64 A 396 ARG K 44 ARG~? 13.27 C1 GOL K3011 A 581 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 713 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 153.63 132.28 188.00 152.37 129.86 189.45 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 162.88 126.06 191.42 164.87 128.39 191.36 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 65 3 # 65 A 396 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 581 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 162.35 156.38 218.07 160.56 153.83 217.87 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.17 151.29 214.24 165.45 151.32 211.73 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 66 3 # 66 A 396 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 581 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 713 ARG L 44 ARG~? 26.02 O3 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 174.06 157.20 217.38 176.23 157.17 215.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.17 151.29 214.24 165.45 151.32 211.73 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 177.39 152.73 209.01 178.24 151.54 211.72 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 67 3 # 67 A 396 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 581 ARG L 44 ARG~? 26.02 O3 GOL K3011 A 713 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 174.06 157.20 217.38 176.23 157.17 215.21 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 177.39 152.73 209.01 178.24 151.54 211.72 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 68 3 # 68 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.17 151.29 214.24 165.45 151.32 211.73 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 162.35 156.38 218.07 160.56 153.83 217.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 69 3 # 69 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 713 ARG L 34 ARG~? 28.77 O3 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.17 151.29 214.24 165.45 151.32 211.73 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 174.06 157.20 217.38 176.23 157.17 215.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 162.35 156.38 218.07 160.56 153.83 217.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 70 3 # 70 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 713 ARG L 44 ARG~? 26.02 O3 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.17 151.29 214.24 165.45 151.32 211.73 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 174.06 157.20 217.38 176.23 157.17 215.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 177.39 152.73 209.01 178.24 151.54 211.72 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 71 3 # 71 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 44 ARG~? 26.02 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.17 151.29 214.24 165.45 151.32 211.73 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 177.39 152.73 209.01 178.24 151.54 211.72 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 72 3 # 72 A 396 ARG L 44 ARG~? 26.02 O3 GOL K3011 A 581 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 713 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 177.39 152.73 209.01 178.24 151.54 211.72 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 174.06 157.20 217.38 176.23 157.17 215.21 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 73 3 # 73 A 396 ARG L 44 ARG~? 26.02 O3 GOL K3011 A 581 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 177.39 152.73 209.01 178.24 151.54 211.72 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.17 151.29 214.24 165.45 151.32 211.73 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 74 3 # 74 A 396 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 581 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 713 ARG M 44 ARG~? 13.46 C1 GOL M3007 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 179.97 216.30 180.98 181.48 213.82 180.04 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 172.69 214.03 186.60 170.63 211.79 186.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 182.09 207.66 185.06 183.17 210.24 186.35 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 75 3 # 75 A 396 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 581 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 713 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 179.97 216.30 180.98 181.48 213.82 180.04 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 182.09 207.66 185.06 183.17 210.24 186.35 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 76 3 # 76 A 396 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 581 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 713 ARG M 44 ARG~? 13.46 C1 GOL M3007 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 172.69 214.03 186.60 170.63 211.79 186.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 179.97 216.30 180.98 181.48 213.82 180.04 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 182.09 207.66 185.06 183.17 210.24 186.35 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 77 3 # 77 A 396 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 581 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 713 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 172.69 214.03 186.60 170.63 211.79 186.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 182.09 207.66 185.06 183.17 210.24 186.35 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 78 3 # 78 A 396 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 581 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 713 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 182.09 207.66 185.06 183.17 210.24 186.35 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 179.97 216.30 180.98 181.48 213.82 180.04 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 79 3 # 79 A 396 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 581 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 713 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 182.09 207.66 185.06 183.17 210.24 186.35 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 172.69 214.03 186.60 170.63 211.79 186.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 80 3 # 80 A 396 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 581 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 713 ARG N 44 ARG~? 12.62 O2 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 161.60 152.07 121.93 160.06 153.41 124.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.97 146.21 125.72 169.64 146.36 128.31 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 157.97 149.49 130.76 157.12 148.00 128.25 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 81 3 # 81 A 396 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 581 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 713 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 161.60 152.07 121.93 160.06 153.41 124.19 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 157.97 149.49 130.76 157.12 148.00 128.25 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 82 3 # 82 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 34 ARG~? 11.02 O3 GOL N3008 A 713 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.97 146.21 125.72 169.64 146.36 128.31 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 173.47 149.90 121.53 175.07 147.29 121.87 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 83 3 # 83 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 713 ARG N 34 ARG~? 11.02 O3 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.97 146.21 125.72 169.64 146.36 128.31 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 161.60 152.07 121.93 160.06 153.41 124.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 173.47 149.90 121.53 175.07 147.29 121.87 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 84 3 # 84 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 713 ARG N 44 ARG~? 12.62 O2 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.97 146.21 125.72 169.64 146.36 128.31 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 161.60 152.07 121.93 160.06 153.41 124.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 157.97 149.49 130.76 157.12 148.00 128.25 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 85 3 # 85 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 713 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 167.97 146.21 125.72 169.64 146.36 128.31 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 157.97 149.49 130.76 157.12 148.00 128.25 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 86 3 # 86 A 396 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 581 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 713 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 157.97 149.49 130.76 157.12 148.00 128.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 161.60 152.07 121.93 160.06 153.41 124.19 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 87 3 # 87 A 396 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 581 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 713 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 157.97 149.49 130.76 157.12 148.00 128.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 167.97 146.21 125.72 169.64 146.36 128.31 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 88 3 # 88 A 396 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 581 ARG O 37 ARG~? 22.15 CL CL K2003 A 713 ARG O 44 ARG~? 19.56 O1 GOL K3010 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 175.82 120.47 157.52 177.72 122.75 158.28 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 169.49 123.46 151.21 167.81 125.99 151.08 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 179.51 128.71 153.87 180.36 126.03 152.63 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 89 3 # 89 A 396 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 581 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 713 ARG O 37 ARG~? 22.15 CL CL K2003 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 175.82 120.47 157.52 177.72 122.75 158.28 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 179.51 128.71 153.87 180.36 126.03 152.63 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 90 3 # 90 A 396 ARG O 37 ARG~? 22.15 CL CL K2003 A 581 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 713 ARG O 44 ARG~? 19.56 O1 GOL K3010 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 169.49 123.46 151.21 167.81 125.99 151.08 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 175.82 120.47 157.52 177.72 122.75 158.28 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 179.51 128.71 153.87 180.36 126.03 152.63 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 91 3 # 91 A 396 ARG O 37 ARG~? 22.15 CL CL K2003 A 581 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 713 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 169.49 123.46 151.21 167.81 125.99 151.08 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 179.51 128.71 153.87 180.36 126.03 152.63 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 92 3 # 92 A 396 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 581 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 713 ARG O 37 ARG~? 22.15 CL CL K2003 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 179.51 128.71 153.87 180.36 126.03 152.63 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 175.82 120.47 157.52 177.72 122.75 158.28 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 93 3 # 93 A 396 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 581 ARG O 37 ARG~? 22.15 CL CL K2003 A 713 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 179.51 128.71 153.87 180.36 126.03 152.63 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 169.49 123.46 151.21 167.81 125.99 151.08 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 94 3 # 94 A 396 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 581 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 713 ARG P 44 ARG~? 18.01 O1 GOL L3028 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 157.78 187.06 214.51 156.14 185.86 212.27 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 165.27 191.94 211.53 167.28 191.57 209.25 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 155.73 189.76 205.27 154.58 191.34 207.62 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 95 3 # 95 A 396 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 581 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 713 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 157.78 187.06 214.51 156.14 185.86 212.27 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 155.73 189.76 205.27 154.58 191.34 207.62 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 96 3 # 96 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 34 ARG~? 27.86 O3 GOL M3007 A 713 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 165.27 191.94 211.53 167.28 191.57 209.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 169.45 187.34 216.38 171.34 189.81 216.30 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 97 3 # 97 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 713 ARG P 34 ARG~? 27.86 O3 GOL M3007 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 165.27 191.94 211.53 167.28 191.57 209.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 157.78 187.06 214.51 156.14 185.86 212.27 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 169.45 187.34 216.38 171.34 189.81 216.30 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 98 3 # 98 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 713 ARG P 44 ARG~? 18.01 O1 GOL L3028 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 165.27 191.94 211.53 167.28 191.57 209.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 157.78 187.06 214.51 156.14 185.86 212.27 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 155.73 189.76 205.27 154.58 191.34 207.62 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 99 3 # 99 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 713 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 165.27 191.94 211.53 167.28 191.57 209.25 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 155.73 189.76 205.27 154.58 191.34 207.62 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 100 3 # 100 A 396 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 581 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 713 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 23.87 26.44 -10.48 23.95 28.93 -12.26 155.73 189.76 205.27 154.58 191.34 207.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 157.78 187.06 214.51 156.14 185.86 212.27 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 101 3 # 101 A 396 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 581 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 713 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 155.73 189.76 205.27 154.58 191.34 207.62 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 165.27 191.94 211.53 167.28 191.57 209.25 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 157.78 187.06 214.51 156.14 185.86 212.27 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 101 hits 1jqn_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU F 59 GLU.? -3.47 CL CL F2035s A 56 LYS F 61 LYS~? -5.82 CL CL F2035s A 258 ARG F 55 ARG~? 14.19 CL CL F2035 coo 42.33 1.56 26.99 42.38 2.91 28.66 70.01 37.30 28.39 71.62 37.24 29.74 coo 38.45 -0.44 19.89 37.36 0.90 25.90 75.18 41.05 29.20 73.13 39.59 35.06 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU G 43 GLU~? 15.32 CL CL C2004 A 56 LYS G 22 LYS~? 13.25 CL CL C2004 A 258 ARG G 37 ARG~? 20.29 CL CL C2004 coo 42.33 1.56 26.99 42.38 2.91 28.66 59.87 11.86 47.66 60.57 9.92 48.07 coo 38.45 -0.44 19.89 37.36 0.90 25.90 55.06 4.83 51.67 60.67 7.73 52.68 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU I 43 GLU~? 15.44 CL CL I2001 A 56 LYS I 22 LYS~? 13.37 CL CL I2001 A 258 ARG I 37 ARG~? 20.23 CL CL I2001 coo 42.33 1.56 26.99 42.38 2.91 28.66 161.95 208.67 154.98 161.14 210.63 154.95 coo 38.45 -0.44 19.89 37.36 0.90 25.90 166.16 216.63 158.59 160.45 213.84 159.02 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU K 59 GLU.? 18.15 O3 GOL K3010 A 56 LYS K 61 LYS~? 17.02 C3 GOL K3010 A 258 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 42.33 1.56 26.99 42.38 2.91 28.66 181.67 140.70 183.14 183.47 141.86 183.25 coo 38.45 -0.44 19.89 37.36 0.90 25.90 186.73 140.78 179.08 183.84 145.13 179.62 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 173.95 138.80 190.43 173.34 140.90 188.20 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 43 GLU~? 17.96 C3 GOL E3035 B 56 LYS A 22 LYS~? 17.94 O2 GOL E3035 B 258 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 49.19 92.81 37.46 48.57 94.78 37.27 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 53.67 100.75 40.87 47.74 98.27 41.17 coo 2.64 1.83 34.81 1.56 1.13 32.02 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 43 GLU~? 16.83 O2 GOL B3003 B 56 LYS B 22 LYS~? 21.36 O2 GOL B3003 B 258 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 68.56 58.79 14.03 69.54 58.38 12.22 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 65.01 54.92 6.02 70.07 53.87 9.73 coo 2.64 1.83 34.81 1.56 1.13 32.02 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU E 43 GLU~? 17.32 C1 GOL E3004 B 56 LYS E 22 LYS~? 21.81 O1 GOL E3004 B 258 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 66.77 92.95 61.24 67.88 94.70 61.00 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 64.37 100.86 56.32 69.54 97.12 56.69 coo 2.64 1.83 34.81 1.56 1.13 32.02 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU F 43 GLU~? 17.56 O1 GOL B3017 B 56 LYS F 22 LYS~? 18.36 O1 GOL B3017 B 258 ARG F 37 ARG~? -27.07 CL CL F2035s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 46.38 39.16 13.84 45.66 39.18 11.88 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 51.36 41.84 5.91 45.78 43.39 8.51 coo 2.64 1.83 34.81 1.56 1.13 32.02 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU F 59 GLU.? -3.47 CL CL F2035s B 56 LYS F 61 LYS~? -5.82 CL CL F2035s B 258 ARG F 55 ARG~? 14.19 CL CL F2035 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 70.01 37.30 28.39 71.62 37.24 29.74 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 75.18 41.05 29.20 73.13 39.59 35.06 coo 2.64 1.83 34.81 1.56 1.13 32.02 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU G 43 GLU~? 15.32 CL CL C2004 B 56 LYS G 22 LYS~? 13.25 CL CL C2004 B 258 ARG G 37 ARG~? 20.29 CL CL C2004 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 59.87 11.86 47.66 60.57 9.92 48.07 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 55.06 4.83 51.67 60.67 7.73 52.68 coo 2.64 1.83 34.81 1.56 1.13 32.02 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU H 43 GLU~? 15.40 CL CL H2005 B 56 LYS H 22 LYS~? 13.32 CL CL H2005 B 258 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 40.68 69.93 90.74 39.73 70.17 92.61 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 43.36 66.64 99.44 38.17 66.18 95.68 coo 2.64 1.83 34.81 1.56 1.13 32.02 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU I 43 GLU~? 15.44 CL CL I2001 B 56 LYS I 22 LYS~? 13.37 CL CL I2001 B 258 ARG I 37 ARG~? 20.23 CL CL I2001 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 161.95 208.67 154.98 161.14 210.63 154.95 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 166.16 216.63 158.59 160.45 213.84 159.02 coo 2.64 1.83 34.81 1.56 1.13 32.02 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU J 43 GLU~? 15.36 CL CL J2002 B 56 LYS J 22 LYS~? 13.36 CL CL J2002 B 258 ARG J 37 ARG~? 20.17 CL CL J2002 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 181.82 176.83 128.99 182.77 176.54 127.14 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 178.14 172.91 121.18 183.42 172.10 124.71 coo 2.64 1.83 34.81 1.56 1.13 32.02 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU K 43 GLU~? 16.84 C1 GOL K3011 B 56 LYS K 22 LYS~? 17.74 CL CL K2003 B 258 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 155.84 130.25 181.35 154.86 128.33 181.37 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 159.62 121.79 178.29 154.49 125.24 177.13 coo 2.64 1.83 34.81 1.56 1.13 32.02 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU K 59 GLU.? 18.15 O3 GOL K3010 B 56 LYS K 61 LYS~? 17.02 C3 GOL K3010 B 258 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 181.67 140.70 183.14 183.47 141.86 183.25 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 186.73 140.78 179.08 183.84 145.13 179.62 coo 2.64 1.83 34.81 1.56 1.13 32.02 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU M 43 GLU~? 15.49 CL CL I2001 B 56 LYS M 22 LYS~? 13.38 CL CL I2001 B 258 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 180.74 208.70 177.96 181.77 210.50 177.78 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 177.61 216.43 173.42 182.96 212.88 173.24 coo 2.64 1.83 34.81 1.56 1.13 32.02 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU N 43 GLU~? 15.48 CL CL J2002 B 56 LYS N 22 LYS~? 13.40 CL CL J2002 B 258 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 160.49 156.26 129.04 159.76 156.26 127.05 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 165.10 159.41 121.05 159.46 160.48 123.77 coo 2.64 1.83 34.81 1.56 1.13 32.02 167.97 146.21 125.72 169.64 146.36 128.31 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 13 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 43 GLU~? 17.96 C3 GOL E3035 C 56 LYS A 22 LYS~? 17.94 O2 GOL E3035 C 258 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 49.19 92.81 37.46 48.57 94.78 37.27 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 53.67 100.75 40.87 47.74 98.27 41.17 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 43 GLU~? 16.83 O2 GOL B3003 C 56 LYS B 22 LYS~? 21.36 O2 GOL B3003 C 258 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 68.56 58.79 14.03 69.54 58.38 12.22 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 65.01 54.92 6.02 70.07 53.87 9.73 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU E 43 GLU~? 17.32 C1 GOL E3004 C 56 LYS E 22 LYS~? 21.81 O1 GOL E3004 C 258 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 66.77 92.95 61.24 67.88 94.70 61.00 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 64.37 100.86 56.32 69.54 97.12 56.69 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU F 43 GLU~? 17.56 O1 GOL B3017 C 56 LYS F 22 LYS~? 18.36 O1 GOL B3017 C 258 ARG F 37 ARG~? -27.07 CL CL F2035s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 46.38 39.16 13.84 45.66 39.18 11.88 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 51.36 41.84 5.91 45.78 43.39 8.51 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU F 59 GLU.? -3.47 CL CL F2035s C 56 LYS F 61 LYS~? -5.82 CL CL F2035s C 258 ARG F 55 ARG~? 14.19 CL CL F2035 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 70.01 37.30 28.39 71.62 37.24 29.74 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 75.18 41.05 29.20 73.13 39.59 35.06 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU G 43 GLU~? 15.32 CL CL C2004 C 56 LYS G 22 LYS~? 13.25 CL CL C2004 C 258 ARG G 37 ARG~? 20.29 CL CL C2004 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 59.87 11.86 47.66 60.57 9.92 48.07 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 55.06 4.83 51.67 60.67 7.73 52.68 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU H 43 GLU~? 15.40 CL CL H2005 C 56 LYS H 22 LYS~? 13.32 CL CL H2005 C 258 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 40.68 69.93 90.74 39.73 70.17 92.61 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 43.36 66.64 99.44 38.17 66.18 95.68 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU I 43 GLU~? 15.44 CL CL I2001 C 56 LYS I 22 LYS~? 13.37 CL CL I2001 C 258 ARG I 37 ARG~? 20.23 CL CL I2001 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 161.95 208.67 154.98 161.14 210.63 154.95 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 166.16 216.63 158.59 160.45 213.84 159.02 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU J 43 GLU~? 15.36 CL CL J2002 C 56 LYS J 22 LYS~? 13.36 CL CL J2002 C 258 ARG J 37 ARG~? 20.17 CL CL J2002 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 181.82 176.83 128.99 182.77 176.54 127.14 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 178.14 172.91 121.18 183.42 172.10 124.71 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU K 43 GLU~? 16.84 C1 GOL K3011 C 56 LYS K 22 LYS~? 17.74 CL CL K2003 C 258 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 155.84 130.25 181.35 154.86 128.33 181.37 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 159.62 121.79 178.29 154.49 125.24 177.13 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU K 59 GLU.? 18.15 O3 GOL K3010 C 56 LYS K 61 LYS~? 17.02 C3 GOL K3010 C 258 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 181.67 140.70 183.14 183.47 141.86 183.25 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 186.73 140.78 179.08 183.84 145.13 179.62 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU M 43 GLU~? 15.49 CL CL I2001 C 56 LYS M 22 LYS~? 13.38 CL CL I2001 C 258 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 180.74 208.70 177.96 181.77 210.50 177.78 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 177.61 216.43 173.42 182.96 212.88 173.24 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU N 43 GLU~? 15.48 CL CL J2002 C 56 LYS N 22 LYS~? 13.40 CL CL J2002 C 258 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 160.49 156.26 129.04 159.76 156.26 127.05 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 165.10 159.41 121.05 159.46 160.48 123.77 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 167.97 146.21 125.72 169.64 146.36 128.31 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 13 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 43 GLU~? 17.96 C3 GOL E3035 D 56 LYS A 22 LYS~? 17.94 O2 GOL E3035 D 258 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 49.19 92.81 37.46 48.57 94.78 37.27 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 53.67 100.75 40.87 47.74 98.27 41.17 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 43 GLU~? 16.83 O2 GOL B3003 D 56 LYS B 22 LYS~? 21.36 O2 GOL B3003 D 258 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 68.56 58.79 14.03 69.54 58.38 12.22 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 65.01 54.92 6.02 70.07 53.87 9.73 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU E 43 GLU~? 17.32 C1 GOL E3004 D 56 LYS E 22 LYS~? 21.81 O1 GOL E3004 D 258 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 66.77 92.95 61.24 67.88 94.70 61.00 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 64.37 100.86 56.32 69.54 97.12 56.69 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU F 43 GLU~? 17.56 O1 GOL B3017 D 56 LYS F 22 LYS~? 18.36 O1 GOL B3017 D 258 ARG F 37 ARG~? -27.07 CL CL F2035s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 46.38 39.16 13.84 45.66 39.18 11.88 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 51.36 41.84 5.91 45.78 43.39 8.51 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU F 59 GLU.? -3.47 CL CL F2035s D 56 LYS F 61 LYS~? -5.82 CL CL F2035s D 258 ARG F 55 ARG~? 14.19 CL CL F2035 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 70.01 37.30 28.39 71.62 37.24 29.74 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 75.18 41.05 29.20 73.13 39.59 35.06 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU G 43 GLU~? 15.32 CL CL C2004 D 56 LYS G 22 LYS~? 13.25 CL CL C2004 D 258 ARG G 37 ARG~? 20.29 CL CL C2004 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 59.87 11.86 47.66 60.57 9.92 48.07 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 55.06 4.83 51.67 60.67 7.73 52.68 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU H 43 GLU~? 15.40 CL CL H2005 D 56 LYS H 22 LYS~? 13.32 CL CL H2005 D 258 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 40.68 69.93 90.74 39.73 70.17 92.61 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 43.36 66.64 99.44 38.17 66.18 95.68 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU I 43 GLU~? 15.44 CL CL I2001 D 56 LYS I 22 LYS~? 13.37 CL CL I2001 D 258 ARG I 37 ARG~? 20.23 CL CL I2001 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 161.95 208.67 154.98 161.14 210.63 154.95 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 166.16 216.63 158.59 160.45 213.84 159.02 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU J 43 GLU~? 15.36 CL CL J2002 D 56 LYS J 22 LYS~? 13.36 CL CL J2002 D 258 ARG J 37 ARG~? 20.17 CL CL J2002 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 181.82 176.83 128.99 182.77 176.54 127.14 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 178.14 172.91 121.18 183.42 172.10 124.71 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU K 43 GLU~? 16.84 C1 GOL K3011 D 56 LYS K 22 LYS~? 17.74 CL CL K2003 D 258 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 155.84 130.25 181.35 154.86 128.33 181.37 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 159.62 121.79 178.29 154.49 125.24 177.13 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU K 59 GLU.? 18.15 O3 GOL K3010 D 56 LYS K 61 LYS~? 17.02 C3 GOL K3010 D 258 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 181.67 140.70 183.14 183.47 141.86 183.25 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 186.73 140.78 179.08 183.84 145.13 179.62 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU M 43 GLU~? 15.49 CL CL I2001 D 56 LYS M 22 LYS~? 13.38 CL CL I2001 D 258 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 180.74 208.70 177.96 181.77 210.50 177.78 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 177.61 216.43 173.42 182.96 212.88 173.24 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU N 43 GLU~? 15.48 CL CL J2002 D 56 LYS N 22 LYS~? 13.40 CL CL J2002 D 258 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 160.49 156.26 129.04 159.76 156.26 127.05 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 165.10 159.41 121.05 159.46 160.48 123.77 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 167.97 146.21 125.72 169.64 146.36 128.31 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 13 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 33 GLU~? 29.96 O3 GOL B3003 A 163 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 222 ARG A 34 ARG~? 29.77 O3 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 58.19 101.47 27.98 58.76 102.32 26.06 coo 48.06 78.22 50.94 48.51 78.27 53.98 58.38 95.12 28.70 59.87 92.50 29.19 coo 54.85 84.16 52.60 54.26 81.23 53.34 63.78 99.32 32.06 65.50 99.77 29.57 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 43 GLU~? 17.96 C3 GOL E3035 A 163 ARG A 14 ARG~? 17.33 C3 GOL E3035 A 222 ARG A 44 ARG~? 20.37 O3 GOL E3035 coo 51.27 81.34 48.31 51.67 80.79 50.28 49.19 92.81 37.46 48.57 94.78 37.27 coo 48.06 78.22 50.94 48.51 78.27 53.98 51.58 86.56 39.71 49.78 85.03 37.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 47.85 90.78 30.63 47.19 93.18 28.89 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 34 ARG~? 11.02 O1 GOL B3003 A 222 ARG B 36 ARG~? 18.74 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 57.05 65.77 3.59 55.99 68.39 2.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 67.49 62.18 2.86 67.75 61.06 -0.01 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 34 ARG~? 11.02 O1 GOL B3003 A 222 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 57.05 65.77 3.59 55.99 68.39 2.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 36 ARG~? 18.74 O2 GOL B3003 A 222 ARG B 34 ARG~? 11.02 O1 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 67.49 62.18 2.86 67.75 61.06 -0.01 coo 54.85 84.16 52.60 54.26 81.23 53.34 57.05 65.77 3.59 55.99 68.39 2.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 36 ARG~? 18.74 O2 GOL B3003 A 222 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 67.49 62.18 2.86 67.75 61.06 -0.01 coo 54.85 84.16 52.60 54.26 81.23 53.34 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 222 ARG B 34 ARG~? 11.02 O1 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 62.11 68.41 8.30 60.04 68.85 10.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 57.05 65.77 3.59 55.99 68.39 2.44 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU B 33 GLU~? 13.27 C1 GOL B3003 A 163 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 222 ARG B 36 ARG~? 18.74 O2 GOL B3003 coo 51.27 81.34 48.31 51.67 80.79 50.28 63.47 67.77 1.76 63.37 69.16 0.19 coo 48.06 78.22 50.94 48.51 78.27 53.98 62.11 68.41 8.30 60.04 68.85 10.44 coo 54.85 84.16 52.60 54.26 81.23 53.34 67.49 62.18 2.86 67.75 61.06 -0.01 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU C 33 GLU~? 23.49 CL CL C2004 A 163 ARG C 37 ARG~? -20.33 CL CL C2004s A 222 ARG C 34 ARG~? 20.14 CL CL C2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 42.54 5.71 78.02 42.76 4.46 79.70 coo 48.06 78.22 50.94 48.51 78.27 53.98 44.35 12.06 77.77 46.44 14.26 77.62 coo 54.85 84.16 52.60 54.26 81.23 53.34 49.42 6.75 74.39 49.90 6.28 77.46 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU D 43 GLU~? 15.38 CL CL H2005 A 163 ARG D 14 ARG~? 14.52 CL CL D2008 A 222 ARG D 44 ARG~? 13.53 C1 GOL D3005 coo 51.27 81.34 48.31 51.67 80.79 50.28 58.07 46.43 95.03 58.79 46.64 97.07 coo 48.06 78.22 50.94 48.51 78.27 53.98 55.60 47.14 88.58 57.38 44.84 87.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 59.28 39.14 94.57 59.93 38.01 97.32 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU E 43 GLU~? 17.32 C1 GOL E3004 A 163 ARG E 14 ARG~? 16.26 C1 GOL E3004 A 222 ARG E 44 ARG~? 13.68 C1 GOL E3004 coo 51.27 81.34 48.31 51.67 80.79 50.28 66.77 92.95 61.24 67.88 94.70 61.00 coo 48.06 78.22 50.94 48.51 78.27 53.98 63.05 87.03 60.24 64.56 85.62 62.59 coo 54.85 84.16 52.60 54.26 81.23 53.34 67.85 92.14 68.56 69.19 94.64 69.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU F 33 GLU~? 33.28 O1 GOL B3017 A 163 ARG F 37 ARG~? -27.07 CL CL F2035s A 222 ARG F 34 ARG~? 28.76 CL CL F2035 coo 51.27 81.34 48.31 51.67 80.79 50.28 52.99 28.23 5.09 53.65 26.29 4.47 coo 48.06 78.22 50.94 48.51 78.27 53.98 53.50 28.70 11.30 55.02 28.89 13.93 coo 54.85 84.16 52.60 54.26 81.23 53.34 59.52 30.90 7.26 60.86 28.10 6.84 ULMN 3 1kim_c00 THYMIDINE KINASE user 13 3 # 13 A 83 GLU F 43 GLU~? 17.56 O1 GOL B3017 A 163 ARG F 14 ARG~? 16.88 O1 GOL B3017 A 222 ARG F 44 ARG~? 19.46 O1 GOL B3017 coo 51.27 81.34 48.31 51.67 80.79 50.28 46.38 39.16 13.84 45.66 39.18 11.88 coo 48.06 78.22 50.94 48.51 78.27 53.98 49.17 40.62 20.09 46.79 39.22 21.58 coo 54.85 84.16 52.60 54.26 81.23 53.34 43.53 32.70 15.75 42.58 31.25 13.24 ULMN 3 1kim_c00 THYMIDINE KINASE user 14 3 # 14 A 83 GLU G 33 GLU~? 23.63 CL CL C2004 A 163 ARG G 36 ARG~? 19.13 CL CL C2004 A 222 ARG G 34 ARG~? 20.84 CL CL C2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 52.99 1.16 38.63 52.43 0.05 36.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 57.05 1.30 44.33 57.17 -1.56 45.49 coo 54.85 84.16 52.60 54.26 81.23 53.34 46.76 3.66 41.28 45.52 3.22 38.51 ULMN 3 1kim_c00 THYMIDINE KINASE user 15 3 # 15 A 83 GLU G 33 GLU~? 23.63 CL CL C2004 A 163 ARG G 36 ARG~? 19.13 CL CL C2004 A 222 ARG G 37 ARG~? 20.29 CL CL C2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 52.99 1.16 38.63 52.43 0.05 36.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 57.05 1.30 44.33 57.17 -1.56 45.49 coo 54.85 84.16 52.60 54.26 81.23 53.34 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1kim_c00 THYMIDINE KINASE user 16 3 # 16 A 83 GLU G 33 GLU~? 23.63 CL CL C2004 A 163 ARG G 37 ARG~? 20.29 CL CL C2004 A 222 ARG G 34 ARG~? 20.84 CL CL C2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 52.99 1.16 38.63 52.43 0.05 36.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 52.62 7.45 38.03 50.95 9.97 37.63 coo 54.85 84.16 52.60 54.26 81.23 53.34 46.76 3.66 41.28 45.52 3.22 38.51 ULMN 3 1kim_c00 THYMIDINE KINASE user 17 3 # 17 A 83 GLU G 33 GLU~? 23.63 CL CL C2004 A 163 ARG G 37 ARG~? 20.29 CL CL C2004 A 222 ARG G 36 ARG~? 19.13 CL CL C2004 coo 51.27 81.34 48.31 51.67 80.79 50.28 52.99 1.16 38.63 52.43 0.05 36.89 coo 48.06 78.22 50.94 48.51 78.27 53.98 52.62 7.45 38.03 50.95 9.97 37.63 coo 54.85 84.16 52.60 54.26 81.23 53.34 57.05 1.30 44.33 57.17 -1.56 45.49 ULMN 3 1kim_c00 THYMIDINE KINASE user 18 3 # 18 A 83 GLU G 43 GLU~? 15.32 CL CL C2004 A 163 ARG G 14 ARG~? 14.57 CL CL C2006 A 222 ARG G 44 ARG~? 17.70 O1 GOL C3021 coo 51.27 81.34 48.31 51.67 80.79 50.28 59.87 11.86 47.66 60.57 9.92 48.07 coo 48.06 78.22 50.94 48.51 78.27 53.98 57.32 18.45 47.88 59.70 19.45 46.16 coo 54.85 84.16 52.60 54.26 81.23 53.34 62.74 12.21 40.97 63.67 9.49 39.89 ULMN 3 1kim_c00 THYMIDINE KINASE user 19 3 # 19 A 83 GLU H 33 GLU~? 12.50 C3 GOL H3006 A 163 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 222 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 51.27 81.34 48.31 51.67 80.79 50.28 48.05 79.48 100.95 48.41 81.47 101.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 53.27 74.94 100.30 54.87 77.69 100.34 coo 54.85 84.16 52.60 54.26 81.23 53.34 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 20 3 # 20 A 83 GLU H 33 GLU~? 12.50 C3 GOL H3006 A 163 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 222 ARG H 34 ARG~? 11.22 O3 GOL H3006 coo 51.27 81.34 48.31 51.67 80.79 50.28 48.05 79.48 100.95 48.41 81.47 101.74 coo 48.06 78.22 50.94 48.51 78.27 53.98 49.12 78.88 94.88 51.18 78.27 92.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 53.27 74.94 100.30 54.87 77.69 100.34 ULMN 3 1kim_c00 THYMIDINE KINASE user 21 3 # 21 A 83 GLU H 43 GLU~? 15.40 CL CL H2005 A 163 ARG H 14 ARG~? 14.44 CL CL D2008 A 222 ARG H 44 ARG~? 13.32 O2 GOL H3006 coo 51.27 81.34 48.31 51.67 80.79 50.28 40.68 69.93 90.74 39.73 70.17 92.61 coo 48.06 78.22 50.94 48.51 78.27 53.98 44.51 67.63 85.23 43.02 69.63 83.32 coo 54.85 84.16 52.60 54.26 81.23 53.34 39.82 76.81 88.50 38.54 78.60 90.61 ULMN 3 1kim_c00 THYMIDINE KINASE user 22 3 # 22 A 83 GLU I 33 GLU~? 23.50 CL CL I2001 A 163 ARG I 37 ARG~? 20.23 CL CL I2001 A 222 ARG I 34 ARG~? 20.72 CL CL I2001 coo 51.27 81.34 48.31 51.67 80.79 50.28 169.93 218.13 145.49 171.04 218.83 143.72 coo 48.06 78.22 50.94 48.51 78.27 53.98 170.53 211.87 145.98 172.22 209.35 146.21 coo 54.85 84.16 52.60 54.26 81.23 53.34 175.86 216.47 149.42 177.66 216.28 146.86 ULMN 3 1kim_c00 THYMIDINE KINASE user 23 3 # 23 A 83 GLU J 33 GLU~? 23.63 CL CL J2002 A 163 ARG J 37 ARG~? 20.17 CL CL J2002 A 222 ARG J 34 ARG~? 20.21 CL CL J2002 coo 51.27 81.34 48.31 51.67 80.79 50.28 176.38 185.90 117.21 176.25 187.26 115.55 coo 48.06 78.22 50.94 48.51 78.27 53.98 174.71 186.35 123.78 172.76 186.51 126.11 coo 54.85 84.16 52.60 54.26 81.23 53.34 169.79 183.14 118.82 167.66 185.29 119.35 ULMN 3 1kim_c00 THYMIDINE KINASE user 24 3 # 24 A 83 GLU K 43 GLU~? 16.84 C1 GOL K3011 A 163 ARG K 14 ARG~? 14.49 CL CL K2003 A 222 ARG K 44 ARG~? 13.27 C1 GOL K3011 coo 51.27 81.34 48.31 51.67 80.79 50.28 155.84 130.25 181.35 154.86 128.33 181.37 coo 48.06 78.22 50.94 48.51 78.27 53.98 159.72 136.15 179.98 157.68 137.80 181.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 153.63 132.28 188.00 152.37 129.86 189.45 ULMN 3 1kim_c00 THYMIDINE KINASE user 25 3 # 25 A 83 GLU L 33 GLU~? 30.18 O3 GOL K3011 A 163 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 222 ARG L 34 ARG~? 28.77 O3 GOL K3011 coo 51.27 81.34 48.31 51.67 80.79 50.28 168.48 151.57 220.91 168.49 150.30 222.63 coo 48.06 78.22 50.94 48.51 78.27 53.98 167.17 151.29 214.24 165.45 151.32 211.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 162.35 156.38 218.07 160.56 153.83 217.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 26 3 # 26 A 83 GLU L 43 GLU~? 27.03 C1 GOL P3034 A 163 ARG L 14 ARG~? 26.83 O3 GOL K3011 A 222 ARG L 44 ARG~? 26.02 O3 GOL K3011 coo 51.27 81.34 48.31 51.67 80.79 50.28 175.92 159.97 209.77 176.60 160.07 211.76 coo 48.06 78.22 50.94 48.51 78.27 53.98 172.85 160.87 203.42 174.90 158.78 202.32 coo 54.85 84.16 52.60 54.26 81.23 53.34 177.39 152.73 209.01 178.24 151.54 211.72 ULMN 3 1kim_c00 THYMIDINE KINASE user 27 3 # 27 A 83 GLU M 33 GLU~? 12.64 O1 GOL M3007 A 163 ARG M 34 ARG~? 12.31 O1 GOL M3007 A 222 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 51.27 81.34 48.31 51.67 80.79 50.28 173.63 220.13 185.95 172.97 221.25 187.66 coo 48.06 78.22 50.94 48.51 78.27 53.98 167.85 218.77 182.40 165.86 219.39 184.74 coo 54.85 84.16 52.60 54.26 81.23 53.34 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1kim_c00 THYMIDINE KINASE user 28 3 # 28 A 83 GLU M 33 GLU~? 12.64 O1 GOL M3007 A 163 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 222 ARG M 34 ARG~? 12.31 O1 GOL M3007 coo 51.27 81.34 48.31 51.67 80.79 50.28 173.63 220.13 185.95 172.97 221.25 187.66 coo 48.06 78.22 50.94 48.51 78.27 53.98 172.69 214.03 186.60 170.63 211.79 186.52 coo 54.85 84.16 52.60 54.26 81.23 53.34 167.85 218.77 182.40 165.86 219.39 184.74 ULMN 3 1kim_c00 THYMIDINE KINASE user 29 3 # 29 A 83 GLU N 33 GLU~? 12.42 O3 GOL N3008 A 163 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 222 ARG N 34 ARG~? 11.02 O3 GOL N3008 coo 51.27 81.34 48.31 51.67 80.79 50.28 167.24 145.98 119.57 168.05 144.16 118.79 coo 48.06 78.22 50.94 48.51 78.27 53.98 167.97 146.21 125.72 169.64 146.36 128.31 coo 54.85 84.16 52.60 54.26 81.23 53.34 173.47 149.90 121.53 175.07 147.29 121.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 30 3 # 30 A 83 GLU N 43 GLU~? 15.48 CL CL J2002 A 163 ARG N 14 ARG~? 15.89 C3 GOL N3008 A 222 ARG N 44 ARG~? 12.62 O2 GOL N3008 coo 51.27 81.34 48.31 51.67 80.79 50.28 160.49 156.26 129.04 159.76 156.26 127.05 coo 48.06 78.22 50.94 48.51 78.27 53.98 163.48 157.63 135.35 161.30 155.86 136.73 coo 54.85 84.16 52.60 54.26 81.23 53.34 157.97 149.49 130.76 157.12 148.00 128.25 ULMN 3 1kim_c00 THYMIDINE KINASE user 31 3 # 31 A 83 GLU O 33 GLU~? 27.49 CL CL O2036 A 163 ARG O 37 ARG~? 22.15 CL CL K2003 A 222 ARG O 34 ARG~? 19.49 CL CL O2036 coo 51.27 81.34 48.31 51.67 80.79 50.28 170.20 117.15 151.62 169.74 115.90 149.90 coo 48.06 78.22 50.94 48.51 78.27 53.98 169.49 123.46 151.21 167.81 125.99 151.08 coo 54.85 84.16 52.60 54.26 81.23 53.34 163.83 119.56 154.44 162.36 118.67 151.85 ULMN 3 1kim_c00 THYMIDINE KINASE user 32 3 # 32 A 83 GLU O 43 GLU~? 17.17 O1 GOL K3010 A 163 ARG O 14 ARG~? 14.59 CL CL K2003 A 222 ARG O 44 ARG~? 19.56 O1 GOL K3010 coo 51.27 81.34 48.31 51.67 80.79 50.28 177.14 127.85 160.77 177.95 125.93 161.03 coo 48.06 78.22 50.94 48.51 78.27 53.98 174.25 134.10 161.46 176.22 135.49 159.49 coo 54.85 84.16 52.60 54.26 81.23 53.34 179.51 128.71 153.87 180.36 126.03 152.63 ULMN 3 1kim_c00 THYMIDINE KINASE user 33 3 # 33 A 83 GLU P 33 GLU~? 27.79 O3 GOL M3007 A 163 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 222 ARG P 34 ARG~? 27.86 O3 GOL M3007 coo 51.27 81.34 48.31 51.67 80.79 50.28 163.74 192.47 217.62 164.80 194.16 218.49 coo 48.06 78.22 50.94 48.51 78.27 53.98 165.27 191.94 211.53 167.28 191.57 209.25 coo 54.85 84.16 52.60 54.26 81.23 53.34 169.45 187.34 216.38 171.34 189.81 216.30 ULMN 3 1kim_c00 THYMIDINE KINASE user 34 3 # 34 A 83 GLU P 43 GLU~? 15.67 O1 GOL L3028 A 163 ARG P 14 ARG~? 15.62 O1 GOL L3028 A 222 ARG P 44 ARG~? 18.01 O1 GOL L3028 coo 51.27 81.34 48.31 51.67 80.79 50.28 157.04 182.77 207.26 156.16 182.81 209.15 coo 48.06 78.22 50.94 48.51 78.27 53.98 160.23 180.86 201.41 159.06 183.03 199.69 coo 54.85 84.16 52.60 54.26 81.23 53.34 155.73 189.76 205.27 154.58 191.34 207.62 1kim_c00 source 1kim THYMIDINE KINASE : 34 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG B 155 ARG.? 12.69 O3 GOL B3015 A 351 HIS B 158 HIS.? 12.55 CL CL B2010 A 386 LEU B 159 LEU.? 11.27 O3 GOL B3015 coo 57.36 53.34 128.83 58.45 50.56 128.34 7.18 53.45 20.49 4.91 55.44 21.24 coo 60.60 50.64 133.59 60.63 48.82 132.56 7.56 53.89 15.18 8.49 52.54 13.87 coo 63.28 54.23 126.45 63.53 52.07 126.70 8.42 60.44 18.12 10.32 60.25 19.11 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG C 155 ARG.? 9.50 CL CL C2031 A 351 HIS C 158 HIS.? 10.62 CL CL C2021 A 386 LEU C 159 LEU.? 8.70 CL CL C2031 coo 57.36 53.34 128.83 58.45 50.56 128.34 100.04 20.62 60.58 101.89 22.90 59.46 coo 60.60 50.64 133.59 60.63 48.82 132.56 98.99 15.14 61.83 98.04 13.53 60.88 coo 63.28 54.23 126.45 63.53 52.07 126.70 98.02 19.71 67.34 96.17 20.81 66.94 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG E 155 ARG.? 13.04 O1 GOL E3002 A 351 HIS E 158 HIS.? 10.67 CL CL E2032 A 386 LEU E 159 LEU.? 11.49 O1 GOL E3002 coo 57.36 53.34 128.83 58.45 50.56 128.34 7.91 86.02 43.52 5.22 85.54 45.07 coo 60.60 50.64 133.59 60.63 48.82 132.56 8.21 91.93 44.16 9.29 93.32 43.02 coo 63.28 54.23 126.45 63.53 52.07 126.70 7.86 88.53 50.59 9.77 87.52 50.83 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG F 155 ARG.? 16.94 CL CL F2023 A 351 HIS F 158 HIS.? -10.90 CL CL F2023s A 386 LEU F 159 LEU.? 12.58 CL CL F2023 coo 57.36 53.34 128.83 58.45 50.56 128.34 105.33 46.75 31.26 107.63 45.25 32.77 coo 60.60 50.64 133.59 60.63 48.82 132.56 105.92 45.34 26.29 105.13 46.33 24.62 coo 63.28 54.23 126.45 63.53 52.07 126.70 104.21 39.59 30.34 102.19 39.92 30.93 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 5 3 # 5 A 290 ARG H 155 ARG.? 17.02 CL CL H2024 A 351 HIS H 158 HIS.? 10.33 CL CL H2024 A 386 LEU H 159 LEU.? 12.60 CL CL H2024 coo 57.36 53.34 128.83 58.45 50.56 128.34 99.48 50.13 87.00 102.10 51.31 85.80 coo 60.60 50.64 133.59 60.63 48.82 132.56 98.94 51.80 92.35 97.68 51.03 93.84 coo 63.28 54.23 126.45 63.53 52.07 126.70 99.48 57.40 87.82 97.61 57.56 86.72 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 6 3 # 6 A 290 ARG I 155 ARG.? 16.75 CL CL I2025 A 351 HIS I 158 HIS.? 11.08 CL CL I2025 A 386 LEU I 159 LEU.? 12.71 CL CL I2025 coo 57.36 53.34 128.83 58.45 50.56 128.34 219.78 193.99 171.61 222.12 192.73 169.97 coo 60.60 50.64 133.59 60.63 48.82 132.56 220.34 199.03 170.60 219.44 200.67 171.57 coo 63.28 54.23 126.45 63.53 52.07 126.70 219.80 195.23 164.43 217.77 194.50 164.47 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 7 3 # 7 A 290 ARG J 155 ARG.? 11.80 O1 GOL J3033 A 351 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 386 LEU J 159 LEU.? 11.64 O2 GOL J3033 coo 57.36 53.34 128.83 58.45 50.56 128.34 121.13 167.88 138.18 121.17 165.29 139.87 coo 60.60 50.64 133.59 60.63 48.82 132.56 121.18 169.23 132.79 122.06 167.98 131.35 coo 63.28 54.23 126.45 63.53 52.07 126.70 121.99 175.54 136.35 124.04 175.41 137.02 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 8 3 # 8 A 290 ARG K 155 ARG.? 13.03 O2 GOL K3009 A 351 HIS K 158 HIS.? 10.92 CL CL K2027 A 386 LEU K 159 LEU.? 11.20 O2 GOL K3009 coo 57.36 53.34 128.83 58.45 50.56 128.34 216.54 137.96 172.21 218.86 139.31 173.84 coo 60.60 50.64 133.59 60.63 48.82 132.56 216.60 132.79 173.33 215.77 131.08 172.42 coo 63.28 54.23 126.45 63.53 52.07 126.70 215.51 136.86 179.27 213.56 137.79 178.87 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 9 3 # 9 A 290 ARG L 155 ARG.? 15.58 CL CL L2028 A 351 HIS L 158 HIS.? 11.11 CL CL L2028 A 386 LEU L 159 LEU.? 12.41 CL CL L2028 coo 57.36 53.34 128.83 58.45 50.56 128.34 117.81 174.80 193.27 115.12 175.12 194.77 coo 60.60 50.64 133.59 60.63 48.82 132.56 117.45 174.63 198.96 118.55 176.04 200.05 coo 63.28 54.23 126.45 63.53 52.07 126.70 117.85 168.14 195.82 119.91 168.00 195.16 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 10 3 # 10 A 290 ARG M 155 ARG.? 12.99 O1 GOL M3042 A 351 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 386 LEU M 159 LEU.? 11.51 C2 GOL M3042 coo 57.36 53.34 128.83 58.45 50.56 128.34 121.45 199.58 162.40 118.88 198.67 163.91 coo 60.60 50.64 133.59 60.63 48.82 132.56 121.40 205.18 163.43 122.55 206.46 162.23 coo 63.28 54.23 126.45 63.53 52.07 126.70 121.55 201.64 169.75 123.57 200.68 169.84 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 11 3 # 11 A 290 ARG O 155 ARG.? 13.45 O3 GOL O3013 A 351 HIS O 158 HIS.? 12.21 CL CL O2018 A 386 LEU O 159 LEU.? 11.94 O3 GOL O3013 coo 57.36 53.34 128.83 58.45 50.56 128.34 117.87 143.72 169.20 115.63 144.83 167.33 coo 60.60 50.64 133.59 60.63 48.82 132.56 117.44 138.41 168.51 118.31 136.96 169.75 coo 63.28 54.23 126.45 63.53 52.07 126.70 118.64 141.59 162.03 120.68 142.42 162.11 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 12 3 # 12 A 290 ARG P 155 ARG.? 12.61 O2 GOL P3014 A 351 HIS P 158 HIS.? 12.33 O2 GOL P3014 A 386 LEU P 159 LEU.? 10.45 O2 GOL P3014 coo 57.36 53.34 128.83 58.45 50.56 128.34 216.42 165.88 200.05 218.98 167.31 198.98 coo 60.60 50.64 133.59 60.63 48.82 132.56 216.29 167.50 205.15 215.20 166.66 206.73 coo 63.28 54.23 126.45 63.53 52.07 126.70 216.28 173.40 200.98 214.29 173.26 200.18 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 12 hits 1knp_c00 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP E 28 ASP~? 19.58 O1 GOL E3004 262 LYS E 22 LYS~? 21.81 O1 GOL E3004 336 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 61.88 50.78 12.96 63.84 50.60 13.71 57.09 107.82 57.29 55.83 108.40 58.91 coo 63.59 44.40 18.32 63.20 49.74 17.95 64.37 100.86 56.32 69.54 97.12 56.69 coo 72.60 57.42 15.86 71.61 56.68 18.70 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP P 28 ASP~? 33.76 O1 GOL L3028 262 LYS P 22 LYS~? 16.49 O1 GOL L3028 336 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 61.88 50.78 12.96 63.84 50.60 13.71 167.75 181.83 222.09 168.94 183.53 222.37 coo 63.59 44.40 18.32 63.20 49.74 17.95 160.29 179.27 215.80 155.06 178.69 212.33 coo 72.60 57.42 15.86 71.61 56.68 18.70 165.27 191.94 211.53 167.28 191.57 209.25 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 2 hits 1lam_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 128 ALA.? 13.36 O2 GOL A3040 A 317 GLY A 129 GLY.? 16.08 CL CL A2020 A 318 ASP A 127 ASP.? 12.37 CL CL A2020 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 95.27 91.54 37.35 94.22 92.64 37.53 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 96.95 90.98 33.96 96.57 91.66 34.21 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 128 ALA.? 12.65 CL CL B2010 A 317 GLY B 129 GLY.? 14.26 CL CL B2010 A 318 ASP B 127 ASP.? 11.35 CL CL B2010 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 24.45 67.55 4.22 25.71 67.00 3.59 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 23.38 70.92 2.96 23.93 70.32 2.60 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 128 ALA.? 12.39 CL CL C2011 A 317 GLY C 129 GLY.? 14.69 CL CL C2011 A 318 ASP C 127 ASP.? 10.87 CL CL C2011 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 82.17 7.76 77.14 80.94 6.87 76.93 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 81.78 8.76 80.79 81.72 8.03 80.50 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 128 ALA.? 11.58 O3 GOL D3018 A 317 GLY D 129 GLY.? 14.02 CL CL D2012 A 318 ASP D 127 ASP.? 11.17 CL CL D2012 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 12.19 46.30 94.61 13.15 46.51 95.73 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 10.05 43.17 94.83 10.56 43.50 95.44 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1lij_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA E 128 ALA.? 12.84 CL CL E2013 A 317 GLY E 129 GLY.? 14.25 CL CL E2013 A 318 ASP E 127 ASP.? 11.39 CL CL E2013 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 22.28 102.43 60.93 23.57 103.26 60.70 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 20.44 102.98 64.21 20.96 103.48 63.67 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1lij_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA F 128 ALA.? 12.59 CL CL F2034 A 317 GLY F 129 GLY.? 14.09 CL CL F2034 A 318 ASP F 127 ASP.? 10.85 CL CL F2034 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 91.36 29.40 15.50 90.29 29.73 14.45 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 92.60 25.79 15.59 92.12 26.16 15.04 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1lij_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA G 128 ALA.? 13.29 C3 GOL G3038 A 317 GLY G 129 GLY.? 16.82 C3 GOL G3038 A 318 ASP G 127 ASP.? 12.80 CL CL G2033 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 14.98 11.60 38.42 15.98 10.56 38.85 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 15.32 11.77 34.67 15.32 11.08 35.12 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1lij_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA H 128 ALA.? 12.60 CL CL H2014 A 317 GLY H 129 GLY.? 14.25 CL CL H2014 A 318 ASP H 127 ASP.? 11.27 CL CL H2014 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 85.67 70.52 99.37 84.40 70.42 100.15 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 87.45 73.88 99.29 86.89 73.62 99.80 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1lij_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA I 128 ALA.? 12.51 CL CL I2015 A 317 GLY I 129 GLY.? 13.91 CL CL I2015 A 318 ASP I 127 ASP.? 10.93 CL CL I2015 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 207.93 209.75 152.71 206.86 210.81 152.79 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 209.85 209.51 149.43 209.30 210.08 149.73 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1lij_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA J 128 ALA.? 11.61 O3 GOL J3030 A 317 GLY J 129 GLY.? 13.90 CL CL J2016 A 318 ASP J 127 ASP.? 11.08 CL CL J2016 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 136.84 183.95 121.83 137.97 183.60 120.89 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 135.43 187.49 121.46 135.94 187.11 120.95 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1lij_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA K 128 ALA.? 11.56 O1 GOL K3041 A 317 GLY K 129 GLY.? 14.73 O1 GOL K3041 A 318 ASP K 127 ASP.? 12.37 CL CL K2027 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 200.65 123.83 189.34 199.48 122.89 189.03 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 202.21 123.63 192.85 201.55 123.47 192.72 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1lij_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA L 128 ALA.? 12.59 CL CL L2009 A 317 GLY L 129 GLY.? 13.94 CL CL L2009 A 318 ASP L 127 ASP.? 11.05 CL CL L2009 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 129.58 158.29 211.87 130.69 158.48 212.90 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 127.66 155.03 212.10 128.14 155.43 212.70 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1lij_c01 ADENOSINE KINASE user 13 3 # 13 A 316 ALA M 128 ALA.? 12.66 CL CL M2017 A 317 GLY M 129 GLY.? 14.05 CL CL M2017 A 318 ASP M 127 ASP.? 9.06 CL CL M2017 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 135.37 215.97 179.88 136.60 216.85 179.62 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 133.41 216.38 183.16 134.04 216.71 183.09 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1lij_c01 ADENOSINE KINASE user 14 3 # 14 A 316 ALA N 128 ALA.? 15.61 CL CL N2030 A 317 GLY N 129 GLY.? 16.53 CL CL N2030 A 318 ASP N 127 ASP.? 12.60 CL CL N2030 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 205.73 148.25 128.07 204.65 148.66 127.07 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 206.92 144.66 128.10 206.47 145.04 127.54 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1lij_c01 ADENOSINE KINASE user 15 3 # 15 A 316 ALA O 128 ALA.? 12.41 CL CL O2036 A 317 GLY O 129 GLY.? 14.42 CL CL O2018 A 318 ASP O 127 ASP.? 11.33 CL CL O2018 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 131.83 126.01 153.49 132.92 125.04 153.92 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 130.49 125.78 149.93 130.89 125.19 150.35 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1lij_c01 ADENOSINE KINASE user 16 3 # 16 A 316 ALA P 128 ALA.? 12.43 CL CL P2019 A 317 GLY P 129 GLY.? 13.95 CL CL P2019 A 318 ASP P 127 ASP.? 11.05 CL CL P2019 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 202.58 185.14 214.18 201.42 184.99 215.13 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 204.46 188.51 214.20 203.84 188.48 214.51 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 207.19 183.81 214.61 207.22 185.89 215.11 1lij_c01 source 1lij ADENOSINE KINASE : 16 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 128 ALA.? 13.36 O2 GOL A3040 A 317 GLY A 129 GLY.? 16.08 CL CL A2020 A 318 ASP A 127 ASP.? 12.37 CL CL A2020 coo 27.04 23.54 41.85 25.72 24.19 42.18 95.27 91.54 37.35 94.22 92.64 37.53 coo 27.87 23.16 38.17 28.43 22.97 38.87 96.95 90.98 33.96 96.57 91.66 34.21 coo 32.11 22.71 40.58 33.42 24.22 39.78 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 128 ALA.? 12.65 CL CL B2010 A 317 GLY B 129 GLY.? 14.26 CL CL B2010 A 318 ASP B 127 ASP.? 11.35 CL CL B2010 coo 27.04 23.54 41.85 25.72 24.19 42.18 24.45 67.55 4.22 25.71 67.00 3.59 coo 27.87 23.16 38.17 28.43 22.97 38.87 23.38 70.92 2.96 23.93 70.32 2.60 coo 32.11 22.71 40.58 33.42 24.22 39.78 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA C 128 ALA.? 12.39 CL CL C2011 A 317 GLY C 129 GLY.? 14.69 CL CL C2011 A 318 ASP C 127 ASP.? 10.87 CL CL C2011 coo 27.04 23.54 41.85 25.72 24.19 42.18 82.17 7.76 77.14 80.94 6.87 76.93 coo 27.87 23.16 38.17 28.43 22.97 38.87 81.78 8.76 80.79 81.72 8.03 80.50 coo 32.11 22.71 40.58 33.42 24.22 39.78 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA D 128 ALA.? 11.58 O3 GOL D3018 A 317 GLY D 129 GLY.? 14.02 CL CL D2012 A 318 ASP D 127 ASP.? 11.17 CL CL D2012 coo 27.04 23.54 41.85 25.72 24.19 42.18 12.19 46.30 94.61 13.15 46.51 95.73 coo 27.87 23.16 38.17 28.43 22.97 38.87 10.05 43.17 94.83 10.56 43.50 95.44 coo 32.11 22.71 40.58 33.42 24.22 39.78 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1lio_c01 ADENOSINE KINASE user 5 3 # 5 A 316 ALA E 128 ALA.? 12.84 CL CL E2013 A 317 GLY E 129 GLY.? 14.25 CL CL E2013 A 318 ASP E 127 ASP.? 11.39 CL CL E2013 coo 27.04 23.54 41.85 25.72 24.19 42.18 22.28 102.43 60.93 23.57 103.26 60.70 coo 27.87 23.16 38.17 28.43 22.97 38.87 20.44 102.98 64.21 20.96 103.48 63.67 coo 32.11 22.71 40.58 33.42 24.22 39.78 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1lio_c01 ADENOSINE KINASE user 6 3 # 6 A 316 ALA F 128 ALA.? 12.59 CL CL F2034 A 317 GLY F 129 GLY.? 14.09 CL CL F2034 A 318 ASP F 127 ASP.? 10.85 CL CL F2034 coo 27.04 23.54 41.85 25.72 24.19 42.18 91.36 29.40 15.50 90.29 29.73 14.45 coo 27.87 23.16 38.17 28.43 22.97 38.87 92.60 25.79 15.59 92.12 26.16 15.04 coo 32.11 22.71 40.58 33.42 24.22 39.78 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1lio_c01 ADENOSINE KINASE user 7 3 # 7 A 316 ALA G 128 ALA.? 13.29 C3 GOL G3038 A 317 GLY G 129 GLY.? 16.82 C3 GOL G3038 A 318 ASP G 127 ASP.? 12.80 CL CL G2033 coo 27.04 23.54 41.85 25.72 24.19 42.18 14.98 11.60 38.42 15.98 10.56 38.85 coo 27.87 23.16 38.17 28.43 22.97 38.87 15.32 11.77 34.67 15.32 11.08 35.12 coo 32.11 22.71 40.58 33.42 24.22 39.78 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1lio_c01 ADENOSINE KINASE user 8 3 # 8 A 316 ALA H 128 ALA.? 12.60 CL CL H2014 A 317 GLY H 129 GLY.? 14.25 CL CL H2014 A 318 ASP H 127 ASP.? 11.27 CL CL H2014 coo 27.04 23.54 41.85 25.72 24.19 42.18 85.67 70.52 99.37 84.40 70.42 100.15 coo 27.87 23.16 38.17 28.43 22.97 38.87 87.45 73.88 99.29 86.89 73.62 99.80 coo 32.11 22.71 40.58 33.42 24.22 39.78 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1lio_c01 ADENOSINE KINASE user 9 3 # 9 A 316 ALA I 128 ALA.? 12.51 CL CL I2015 A 317 GLY I 129 GLY.? 13.91 CL CL I2015 A 318 ASP I 127 ASP.? 10.93 CL CL I2015 coo 27.04 23.54 41.85 25.72 24.19 42.18 207.93 209.75 152.71 206.86 210.81 152.79 coo 27.87 23.16 38.17 28.43 22.97 38.87 209.85 209.51 149.43 209.30 210.08 149.73 coo 32.11 22.71 40.58 33.42 24.22 39.78 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1lio_c01 ADENOSINE KINASE user 10 3 # 10 A 316 ALA J 128 ALA.? 11.61 O3 GOL J3030 A 317 GLY J 129 GLY.? 13.90 CL CL J2016 A 318 ASP J 127 ASP.? 11.08 CL CL J2016 coo 27.04 23.54 41.85 25.72 24.19 42.18 136.84 183.95 121.83 137.97 183.60 120.89 coo 27.87 23.16 38.17 28.43 22.97 38.87 135.43 187.49 121.46 135.94 187.11 120.95 coo 32.11 22.71 40.58 33.42 24.22 39.78 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1lio_c01 ADENOSINE KINASE user 11 3 # 11 A 316 ALA K 128 ALA.? 11.56 O1 GOL K3041 A 317 GLY K 129 GLY.? 14.73 O1 GOL K3041 A 318 ASP K 127 ASP.? 12.37 CL CL K2027 coo 27.04 23.54 41.85 25.72 24.19 42.18 200.65 123.83 189.34 199.48 122.89 189.03 coo 27.87 23.16 38.17 28.43 22.97 38.87 202.21 123.63 192.85 201.55 123.47 192.72 coo 32.11 22.71 40.58 33.42 24.22 39.78 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1lio_c01 ADENOSINE KINASE user 12 3 # 12 A 316 ALA L 128 ALA.? 12.59 CL CL L2009 A 317 GLY L 129 GLY.? 13.94 CL CL L2009 A 318 ASP L 127 ASP.? 11.05 CL CL L2009 coo 27.04 23.54 41.85 25.72 24.19 42.18 129.58 158.29 211.87 130.69 158.48 212.90 coo 27.87 23.16 38.17 28.43 22.97 38.87 127.66 155.03 212.10 128.14 155.43 212.70 coo 32.11 22.71 40.58 33.42 24.22 39.78 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1lio_c01 ADENOSINE KINASE user 13 3 # 13 A 316 ALA M 128 ALA.? 12.66 CL CL M2017 A 317 GLY M 129 GLY.? 14.05 CL CL M2017 A 318 ASP M 127 ASP.? 9.06 CL CL M2017 coo 27.04 23.54 41.85 25.72 24.19 42.18 135.37 215.97 179.88 136.60 216.85 179.62 coo 27.87 23.16 38.17 28.43 22.97 38.87 133.41 216.38 183.16 134.04 216.71 183.09 coo 32.11 22.71 40.58 33.42 24.22 39.78 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1lio_c01 ADENOSINE KINASE user 14 3 # 14 A 316 ALA N 128 ALA.? 15.61 CL CL N2030 A 317 GLY N 129 GLY.? 16.53 CL CL N2030 A 318 ASP N 127 ASP.? 12.60 CL CL N2030 coo 27.04 23.54 41.85 25.72 24.19 42.18 205.73 148.25 128.07 204.65 148.66 127.07 coo 27.87 23.16 38.17 28.43 22.97 38.87 206.92 144.66 128.10 206.47 145.04 127.54 coo 32.11 22.71 40.58 33.42 24.22 39.78 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1lio_c01 ADENOSINE KINASE user 15 3 # 15 A 316 ALA O 128 ALA.? 12.41 CL CL O2036 A 317 GLY O 129 GLY.? 14.42 CL CL O2018 A 318 ASP O 127 ASP.? 11.33 CL CL O2018 coo 27.04 23.54 41.85 25.72 24.19 42.18 131.83 126.01 153.49 132.92 125.04 153.92 coo 27.87 23.16 38.17 28.43 22.97 38.87 130.49 125.78 149.93 130.89 125.19 150.35 coo 32.11 22.71 40.58 33.42 24.22 39.78 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1lio_c01 ADENOSINE KINASE user 16 3 # 16 A 316 ALA P 128 ALA.? 12.43 CL CL P2019 A 317 GLY P 129 GLY.? 13.95 CL CL P2019 A 318 ASP P 127 ASP.? 11.05 CL CL P2019 coo 27.04 23.54 41.85 25.72 24.19 42.18 202.58 185.14 214.18 201.42 184.99 215.13 coo 27.87 23.16 38.17 28.43 22.97 38.87 204.46 188.51 214.20 203.84 188.48 214.51 coo 32.11 22.71 40.58 33.42 24.22 39.78 207.19 183.81 214.61 207.22 185.89 215.11 1lio_c01 source 1lio ADENOSINE KINASE : 16 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 45 HIS A 79 HIS~? -3.92 CL CL A2020s A 261 PHE A 133 PHE.? 12.04 O2 GOL A3040 coo 49.89 1.93 30.83 50.54 1.43 32.81 98.60 85.60 50.46 99.38 86.61 52.13 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 103.72 86.36 44.76 104.87 88.01 44.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 92.07 88.82 38.07 93.36 90.07 40.24 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS C 76 HIS~? -4.98 CL CL C2011s A 45 HIS C 79 HIS~? -4.32 CL CL C2021s A 261 PHE C 133 PHE.? 11.67 CL CL C2011 coo 49.89 1.93 30.83 50.54 1.43 32.81 89.28 12.80 65.47 90.23 11.67 63.98 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 92.85 10.89 71.99 93.43 9.18 73.06 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 79.64 11.37 76.08 81.06 9.81 74.24 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 45 HIS D 79 HIS~? -4.57 CL CL D2022s A 261 PHE D 133 PHE.? 10.72 O3 GOL D3018 coo 49.89 1.93 30.83 50.54 1.43 32.81 8.84 57.69 86.26 7.93 59.46 86.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.57 52.49 87.96 2.52 51.97 89.71 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 15.39 46.38 91.74 14.15 48.70 92.64 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS E 76 HIS~? -4.87 CL CL E2013s A 45 HIS E 79 HIS~? -4.18 CL CL E2032s A 261 PHE E 133 PHE.? 11.73 CL CL E2013 coo 49.89 1.93 30.83 50.54 1.43 32.81 16.97 95.07 49.08 16.37 95.97 47.28 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 12.36 98.35 54.34 11.69 100.32 54.60 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 24.68 99.06 60.63 23.71 100.37 58.35 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS F 76 HIS~? -4.65 CL CL F2034s A 45 HIS F 79 HIS~? -4.63 CL CL F2023s A 261 PHE F 133 PHE.? 11.60 CL CL F2034 coo 49.89 1.93 30.83 50.54 1.43 32.81 97.24 41.20 21.57 98.43 42.65 20.63 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 101.04 34.65 20.79 101.93 33.69 19.16 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 88.20 30.77 18.11 90.12 32.49 17.02 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 45 HIS G 79 HIS~? -4.46 CL CL G2033s A 261 PHE G 133 PHE.? 11.92 C3 GOL G3038 coo 49.89 1.93 30.83 50.54 1.43 32.81 9.26 20.10 48.62 8.05 19.49 50.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 5.20 17.85 42.65 4.12 16.10 42.26 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 18.18 14.54 38.93 16.36 13.72 40.86 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS H 76 HIS~? 4.68 CL CL H2014s A 45 HIS H 79 HIS~? 4.82 CL CL H2024 A 261 PHE H 133 PHE.? 11.75 CL CL H2014 coo 49.89 1.93 30.83 50.54 1.43 32.81 90.35 57.57 94.69 91.06 55.99 95.89 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 95.19 63.20 96.60 95.96 63.87 98.43 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 83.17 69.82 96.05 84.11 67.74 97.67 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 45 HIS I 79 HIS~? -4.56 CL CL I2025s A 261 PHE I 133 PHE.? 11.49 CL CL I2015 coo 49.89 1.93 30.83 50.54 1.43 32.81 212.11 203.51 165.19 213.01 204.42 166.85 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 216.99 204.94 159.50 218.07 206.60 158.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 204.83 206.82 153.45 206.25 207.95 155.53 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 9 3 # 9 A 44 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 45 HIS J 79 HIS~? -4.36 CL CL J2026s A 261 PHE J 133 PHE.? 10.68 O3 GOL J3030 coo 49.89 1.93 30.83 50.54 1.43 32.81 130.51 172.99 128.94 129.60 171.33 128.01 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 126.45 179.07 126.46 125.69 179.71 124.61 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 139.53 183.24 125.26 138.18 181.13 124.04 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 10 3 # 10 A 44 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 45 HIS K 79 HIS~? -4.34 CL CL K2027s A 261 PHE K 133 PHE.? 10.58 O1 GOL K3041 coo 49.89 1.93 30.83 50.54 1.43 32.81 207.10 129.51 177.50 208.14 128.55 175.95 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 211.01 127.65 183.80 211.70 125.86 184.65 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 198.09 127.04 188.19 199.51 125.58 186.31 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 11 3 # 11 A 44 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 45 HIS L 79 HIS~? -4.09 CL CL L2028s A 261 PHE L 133 PHE.? 11.68 CL CL L2009 coo 49.89 1.93 30.83 50.54 1.43 32.81 125.69 169.77 203.98 124.79 171.51 204.73 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 120.65 164.52 206.19 119.64 164.06 207.98 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 132.81 158.45 208.85 131.53 160.71 209.89 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 12 3 # 12 A 44 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 45 HIS M 79 HIS~? -4.31 CL CL M2029s A 261 PHE M 133 PHE.? 11.73 CL CL M2017 coo 49.89 1.93 30.83 50.54 1.43 32.81 130.15 208.85 168.09 129.36 209.65 166.31 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 125.50 211.59 173.52 124.72 213.49 173.99 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 138.05 212.57 179.55 136.90 213.80 177.31 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 13 3 # 13 A 44 HIS N 76 HIS~? -6.89 CL CL N2030s A 45 HIS N 79 HIS~? -4.33 CL CL N2030s A 261 PHE N 133 PHE.? 15.44 CL CL N2030 coo 49.89 1.93 30.83 50.54 1.43 32.81 211.54 160.16 134.29 212.67 161.69 133.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 215.64 153.98 132.96 216.60 153.22 131.26 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 202.63 149.38 130.89 204.14 151.27 129.54 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 14 3 # 14 A 44 HIS O 76 HIS~? 4.51 CL CL O2018s A 45 HIS O 79 HIS~? 5.21 CL CL O2018 A 261 PHE O 133 PHE.? 11.09 CL CL O2036 coo 49.89 1.93 30.83 50.54 1.43 32.81 126.10 133.61 164.62 125.01 132.87 166.26 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 121.98 131.53 158.56 121.09 129.74 157.92 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 134.85 128.95 154.15 133.51 127.75 156.23 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 15 3 # 15 A 44 HIS P 76 HIS~? 4.69 CL CL P2019s A 45 HIS P 79 HIS~? 5.38 CL CL P2019 A 261 PHE P 133 PHE.? 11.52 CL CL P2019 coo 49.89 1.93 30.83 50.54 1.43 32.81 207.59 172.73 208.38 208.33 171.09 209.49 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 212.25 178.47 210.26 213.09 179.27 212.01 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 199.80 184.45 210.90 201.07 182.43 212.28 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 15 hits 1luc_c00 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP D 87 ASP.? 13.27 CL CL D2022 A 168 ASN D 84 ASN~? 7.04 CL CL D2022 A 241 HIS D 79 HIS~? -4.57 CL CL D2022s coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -10.63 52.08 85.92 -9.45 52.62 87.62 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -3.16 59.10 84.71 -2.15 60.07 86.28 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP H 87 ASP.? 16.75 CL CL H2024 A 168 ASN H 84 ASN~? 6.41 CL CL H2024 A 241 HIS H 79 HIS~? 4.82 CL CL H2024 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 108.61 60.74 92.20 109.31 60.57 90.21 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 102.16 56.25 96.45 100.56 55.72 97.69 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 95.19 63.20 96.60 95.96 63.87 98.43 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP H 87 ASP.? 16.75 CL CL H2024 B 168 ASN H 84 ASN~? 6.41 CL CL H2024 B 241 HIS H 79 HIS~? 4.82 CL CL H2024 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 108.61 60.74 92.20 109.31 60.57 90.21 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 102.16 56.25 96.45 100.56 55.72 97.69 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 95.19 63.20 96.60 95.96 63.87 98.43 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c01 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 79 HIS~? -3.92 CL CL A2020s A 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 255 TYR A 123 TYR.? -4.01 O1 GOL A3040s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 103.72 86.36 44.76 104.87 88.01 44.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 98.60 85.60 50.46 99.38 86.61 52.13 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 92.97 88.22 47.49 92.65 86.11 49.28 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS A 79 HIS~? -3.92 CL CL A2020s A 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 255 TYR A 157 TYR.? -3.90 O2 GOL A3037s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 103.72 86.36 44.76 104.87 88.01 44.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 98.60 85.60 50.46 99.38 86.61 52.13 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 100.57 80.52 55.08 97.88 80.73 54.34 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS A 79 HIS~? -3.92 CL CL A2020s A 246 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 255 TYR A 123 TYR.? -4.01 O1 GOL A3040s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 103.72 86.36 44.76 104.87 88.01 44.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 98.48 94.83 47.66 98.07 96.39 49.01 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 92.97 88.22 47.49 92.65 86.11 49.28 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 98.48 94.83 47.66 98.07 96.39 49.01 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 98.60 85.60 50.46 99.38 86.61 52.13 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 A 246 HIS A 79 HIS~? -3.92 CL CL A2020s A 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 98.48 94.83 47.66 98.07 96.39 49.01 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 103.72 86.36 44.76 104.87 88.01 44.15 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS B 79 HIS~? 5.08 CL CL B2010 A 246 HIS B 76 HIS~? 4.58 CL CL B2010s A 255 TYR B 123 TYR.? -4.36 O2 GOL B3023s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 13.46 62.96 8.26 12.78 63.30 6.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 17.08 57.14 11.39 16.06 55.49 10.59 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 23.54 58.32 9.82 22.98 57.14 12.28 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 A 199 HIS B 79 HIS~? 5.08 CL CL B2010 A 246 HIS B 76 HIS~? 4.58 CL CL B2010s A 255 TYR B 157 TYR.? 7.53 O1 GOL B3015 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 13.46 62.96 8.26 12.78 63.30 6.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 17.08 57.14 11.39 16.06 55.49 10.59 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 13.23 54.49 17.04 16.01 54.48 17.30 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 A 199 HIS B 79 HIS~? 5.08 CL CL B2010 A 246 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 255 TYR B 123 TYR.? -4.36 O2 GOL B3023s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 13.46 62.96 8.26 12.78 63.30 6.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 19.73 57.29 2.23 19.89 55.80 0.75 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 23.54 58.32 9.82 22.98 57.14 12.28 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 9 3 # 9 A 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 246 HIS B 76 HIS~? 4.58 CL CL B2010s A 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 19.73 57.29 2.23 19.89 55.80 0.75 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 17.08 57.14 11.39 16.06 55.49 10.59 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 10 3 # 10 A 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 A 246 HIS B 79 HIS~? 5.08 CL CL B2010 A 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 19.73 57.29 2.23 19.89 55.80 0.75 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 13.46 62.96 8.26 12.78 63.30 6.30 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 11 3 # 11 A 199 HIS C 79 HIS~? -4.32 CL CL C2021s A 246 HIS C 76 HIS~? -4.98 CL CL C2011s A 255 TYR C 123 TYR.? -8.00 CL CL C2011s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 92.85 10.89 71.99 93.43 9.18 73.06 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 89.28 12.80 65.47 90.23 11.67 63.98 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 82.73 11.63 67.15 83.32 13.82 65.52 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 12 3 # 12 A 199 HIS C 79 HIS~? -4.32 CL CL C2021s A 246 HIS C 76 HIS~? -4.98 CL CL C2011s A 255 TYR C 157 TYR.? 7.25 O1 GOL C3036 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 92.85 10.89 71.99 93.43 9.18 73.06 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 89.28 12.80 65.47 90.23 11.67 63.98 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 93.23 17.43 61.74 90.40 17.73 61.84 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 13 3 # 13 A 199 HIS C 79 HIS~? -4.32 CL CL C2021s A 246 HIS C 125 HIS.? 6.65 CL CL C2011 A 255 TYR C 123 TYR.? -8.00 CL CL C2011s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 92.85 10.89 71.99 93.43 9.18 73.06 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 86.57 4.11 67.63 86.24 2.65 66.14 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 82.73 11.63 67.15 83.32 13.82 65.52 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 14 3 # 14 A 199 HIS C 125 HIS.? 6.65 CL CL C2011 A 246 HIS C 76 HIS~? -4.98 CL CL C2011s A 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 86.57 4.11 67.63 86.24 2.65 66.14 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 89.28 12.80 65.47 90.23 11.67 63.98 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 15 3 # 15 A 199 HIS C 125 HIS.? 6.65 CL CL C2011 A 246 HIS C 79 HIS~? -4.32 CL CL C2021s A 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 86.57 4.11 67.63 86.24 2.65 66.14 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 92.85 10.89 71.99 93.43 9.18 73.06 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 16 3 # 16 A 199 HIS D 79 HIS~? -4.57 CL CL D2022s A 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 255 TYR D 123 TYR.? -4.29 O1 GOL D3018s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 3.57 52.49 87.96 2.52 51.97 89.71 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 8.84 57.69 86.26 7.93 59.46 86.93 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 14.40 55.37 89.22 14.73 56.67 86.77 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 17 3 # 17 A 199 HIS D 79 HIS~? -4.57 CL CL D2022s A 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 255 TYR D 157 TYR.? 4.28 O2 GOL D3020 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 3.57 52.49 87.96 2.52 51.97 89.71 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 8.84 57.69 86.26 7.93 59.46 86.93 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 6.86 61.00 80.62 9.60 60.40 80.64 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 18 3 # 18 A 199 HIS D 79 HIS~? -4.57 CL CL D2022s A 246 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 255 TYR D 123 TYR.? -4.29 O1 GOL D3018s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 3.57 52.49 87.96 2.52 51.97 89.71 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 9.12 57.04 95.76 9.45 58.59 97.15 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 14.40 55.37 89.22 14.73 56.67 86.77 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 19 3 # 19 A 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 9.12 57.04 95.76 9.45 58.59 97.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 8.84 57.69 86.26 7.93 59.46 86.93 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 20 3 # 20 A 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 246 HIS D 79 HIS~? -4.57 CL CL D2022s A 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 9.12 57.04 95.76 9.45 58.59 97.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.57 52.49 87.96 2.52 51.97 89.71 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 21 3 # 21 A 199 HIS E 79 HIS~? -4.18 CL CL E2032s A 246 HIS E 76 HIS~? -4.87 CL CL E2013s A 255 TYR E 123 TYR.? -3.70 O1 GOL E3022s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 12.36 98.35 54.34 11.69 100.32 54.60 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 16.97 95.07 49.08 16.37 95.97 47.28 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 23.00 96.79 51.50 22.74 94.30 50.21 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 22 3 # 22 A 199 HIS E 79 HIS~? -4.18 CL CL E2032s A 246 HIS E 76 HIS~? -4.87 CL CL E2013s A 255 TYR E 157 TYR.? -7.44 C3 GOL E3002s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 12.36 98.35 54.34 11.69 100.32 54.60 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 16.97 95.07 49.08 16.37 95.97 47.28 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 13.76 89.62 45.68 16.45 89.35 46.36 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 23 3 # 23 A 199 HIS E 79 HIS~? -4.18 CL CL E2032s A 246 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 255 TYR E 123 TYR.? -3.70 O1 GOL E3022s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 12.36 98.35 54.34 11.69 100.32 54.60 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 19.41 104.46 50.06 20.14 105.76 48.58 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 23.00 96.79 51.50 22.74 94.30 50.21 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 24 3 # 24 A 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 246 HIS E 76 HIS~? -4.87 CL CL E2013s A 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 19.41 104.46 50.06 20.14 105.76 48.58 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 16.97 95.07 49.08 16.37 95.97 47.28 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 25 3 # 25 A 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 246 HIS E 79 HIS~? -4.18 CL CL E2032s A 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 19.41 104.46 50.06 20.14 105.76 48.58 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 12.36 98.35 54.34 11.69 100.32 54.60 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 26 3 # 26 A 199 HIS F 79 HIS~? -4.63 CL CL F2023s A 246 HIS F 76 HIS~? -4.65 CL CL F2034s A 255 TYR F 123 TYR.? -3.90 O3 GOL F3039s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 101.04 34.65 20.79 101.93 33.69 19.16 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 97.24 41.20 21.57 98.43 42.65 20.63 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 91.29 39.67 18.85 91.31 41.46 21.04 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 27 3 # 27 A 199 HIS F 79 HIS~? -4.63 CL CL F2023s A 246 HIS F 76 HIS~? -4.65 CL CL F2034s A 255 TYR F 157 TYR.? -10.36 O3 GOL F3039s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 101.04 34.65 20.79 101.93 33.69 19.16 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 97.24 41.20 21.57 98.43 42.65 20.63 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 100.15 45.18 26.97 97.32 45.17 26.68 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 28 3 # 28 A 199 HIS F 79 HIS~? -4.63 CL CL F2023s A 246 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 255 TYR F 123 TYR.? -3.90 O3 GOL F3039s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 101.04 34.65 20.79 101.93 33.69 19.16 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 96.50 38.92 12.23 96.44 40.22 10.57 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 91.29 39.67 18.85 91.31 41.46 21.04 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 29 3 # 29 A 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 246 HIS F 76 HIS~? -4.65 CL CL F2034s A 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 96.50 38.92 12.23 96.44 40.22 10.57 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 97.24 41.20 21.57 98.43 42.65 20.63 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 30 3 # 30 A 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 246 HIS F 79 HIS~? -4.63 CL CL F2023s A 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 96.50 38.92 12.23 96.44 40.22 10.57 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 101.04 34.65 20.79 101.93 33.69 19.16 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 31 3 # 31 A 199 HIS G 79 HIS~? -4.46 CL CL G2033s A 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 255 TYR G 123 TYR.? -4.47 O3 GOL G3038s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 5.20 17.85 42.65 4.12 16.10 42.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 9.26 20.10 48.62 8.05 19.49 50.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 15.30 16.99 47.49 15.28 19.49 48.80 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 32 3 # 32 A 199 HIS G 79 HIS~? -4.46 CL CL G2033s A 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 255 TYR G 157 TYR.? 5.49 O3 GOL G3001 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 5.20 17.85 42.65 4.12 16.10 42.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 9.26 20.10 48.62 8.05 19.49 50.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 6.53 26.08 51.42 9.33 25.84 51.41 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 33 3 # 33 A 199 HIS G 79 HIS~? -4.46 CL CL G2033s A 246 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 255 TYR G 123 TYR.? -4.47 O3 GOL G3038s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 5.20 17.85 42.65 4.12 16.10 42.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 9.81 10.31 48.06 9.47 8.80 49.48 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 15.30 16.99 47.49 15.28 19.49 48.80 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 34 3 # 34 A 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 9.81 10.31 48.06 9.47 8.80 49.48 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 9.26 20.10 48.62 8.05 19.49 50.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 35 3 # 35 A 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 246 HIS G 79 HIS~? -4.46 CL CL G2033s A 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 9.81 10.31 48.06 9.47 8.80 49.48 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 5.20 17.85 42.65 4.12 16.10 42.26 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 36 3 # 36 A 199 HIS H 79 HIS~? 4.82 CL CL H2024 A 246 HIS H 76 HIS~? 4.68 CL CL H2014s A 255 TYR H 123 TYR.? -7.93 CL CL H2014s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 95.19 63.20 96.60 95.96 63.87 98.43 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 90.35 57.57 94.69 91.06 55.99 95.89 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 84.40 60.41 95.89 84.67 58.62 93.77 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 37 3 # 37 A 199 HIS H 79 HIS~? 4.82 CL CL H2024 A 246 HIS H 76 HIS~? 4.68 CL CL H2014s A 255 TYR H 157 TYR.? -11.04 CL CL H2014s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 95.19 63.20 96.60 95.96 63.87 98.43 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 90.35 57.57 94.69 91.06 55.99 95.89 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 93.68 52.87 90.01 90.96 53.43 89.67 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 38 3 # 38 A 199 HIS H 79 HIS~? 4.82 CL CL H2024 A 246 HIS H 125 HIS.? 7.36 CL CL H2014 A 255 TYR H 123 TYR.? -7.93 CL CL H2014s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 95.19 63.20 96.60 95.96 63.87 98.43 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 88.12 60.23 103.63 87.33 59.09 105.21 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 84.40 60.41 95.89 84.67 58.62 93.77 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 39 3 # 39 A 199 HIS H 125 HIS.? 7.36 CL CL H2014 A 246 HIS H 76 HIS~? 4.68 CL CL H2014s A 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 88.12 60.23 103.63 87.33 59.09 105.21 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 90.35 57.57 94.69 91.06 55.99 95.89 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 40 3 # 40 A 199 HIS H 125 HIS.? 7.36 CL CL H2014 A 246 HIS H 79 HIS~? 4.82 CL CL H2024 A 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 88.12 60.23 103.63 87.33 59.09 105.21 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 95.19 63.20 96.60 95.96 63.87 98.43 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 41 3 # 41 A 199 HIS I 79 HIS~? -4.56 CL CL I2025s A 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 255 TYR I 123 TYR.? -3.81 O1 GOL I3031s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 216.99 204.94 159.50 218.07 206.60 158.77 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 212.11 203.51 165.19 213.01 204.42 166.85 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 206.34 205.79 162.64 206.20 203.62 164.36 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 42 3 # 42 A 199 HIS I 79 HIS~? -4.56 CL CL I2025s A 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 255 TYR I 157 TYR.? -10.00 O3 GOL I3031s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 216.99 204.94 159.50 218.07 206.60 158.77 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 212.11 203.51 165.19 213.01 204.42 166.85 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 214.62 198.06 169.41 211.87 198.21 168.94 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 43 3 # 43 A 199 HIS I 79 HIS~? -4.56 CL CL I2025s A 246 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 255 TYR I 123 TYR.? -3.81 O1 GOL I3031s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 216.99 204.94 159.50 218.07 206.60 158.77 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 211.42 212.80 162.96 211.20 214.50 164.16 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 206.34 205.79 162.64 206.20 203.62 164.36 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 44 3 # 44 A 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 211.42 212.80 162.96 211.20 214.50 164.16 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 212.11 203.51 165.19 213.01 204.42 166.85 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 45 3 # 45 A 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 246 HIS I 79 HIS~? -4.56 CL CL I2025s A 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 211.42 212.80 162.96 211.20 214.50 164.16 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 216.99 204.94 159.50 218.07 206.60 158.77 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 46 3 # 46 A 199 HIS J 79 HIS~? -4.36 CL CL J2026s A 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 255 TYR J 123 TYR.? -4.20 O1 GOL J3030s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.45 179.07 126.46 125.69 179.71 124.61 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.51 172.99 128.94 129.60 171.33 128.01 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 136.67 174.46 127.10 136.30 173.08 129.51 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 47 3 # 47 A 199 HIS J 79 HIS~? -4.36 CL CL J2026s A 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 255 TYR J 157 TYR.? 4.16 O1 GOL J3033 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.45 179.07 126.46 125.69 179.71 124.61 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.51 172.99 128.94 129.60 171.33 128.01 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 126.93 169.72 134.52 129.73 169.94 134.63 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 48 3 # 48 A 199 HIS J 79 HIS~? -4.36 CL CL J2026s A 246 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 255 TYR J 123 TYR.? -4.20 O1 GOL J3030s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.45 179.07 126.46 125.69 179.71 124.61 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 132.43 173.86 119.73 132.77 172.30 118.36 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 136.67 174.46 127.10 136.30 173.08 129.51 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 49 3 # 49 A 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 132.43 173.86 119.73 132.77 172.30 118.36 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.51 172.99 128.94 129.60 171.33 128.01 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 50 3 # 50 A 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 246 HIS J 79 HIS~? -4.36 CL CL J2026s A 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 132.43 173.86 119.73 132.77 172.30 118.36 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.45 179.07 126.46 125.69 179.71 124.61 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 51 3 # 51 A 199 HIS K 79 HIS~? -4.34 CL CL K2027s A 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 255 TYR K 123 TYR.? -4.42 O2 GOL K3041s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 211.01 127.65 183.80 211.70 125.86 184.65 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.10 129.51 177.50 208.14 128.55 175.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 200.86 127.71 179.28 201.20 129.91 177.64 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 52 3 # 52 A 199 HIS K 79 HIS~? -4.34 CL CL K2027s A 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 255 TYR K 157 TYR.? 6.79 O2 GOL K3009 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 211.01 127.65 183.80 211.70 125.86 184.65 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.10 129.51 177.50 208.14 128.55 175.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 210.77 134.37 173.74 207.96 134.59 173.91 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 53 3 # 53 A 199 HIS K 79 HIS~? -4.34 CL CL K2027s A 246 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 255 TYR K 123 TYR.? -4.42 O2 GOL K3041s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 211.01 127.65 183.80 211.70 125.86 184.65 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 204.92 120.38 179.37 204.44 118.90 177.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 200.86 127.71 179.28 201.20 129.91 177.64 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 54 3 # 54 A 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 204.92 120.38 179.37 204.44 118.90 177.95 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.10 129.51 177.50 208.14 128.55 175.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 55 3 # 55 A 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s A 246 HIS K 79 HIS~? -4.34 CL CL K2027s A 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 204.92 120.38 179.37 204.44 118.90 177.95 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 211.01 127.65 183.80 211.70 125.86 184.65 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 56 3 # 56 A 199 HIS L 79 HIS~? -4.09 CL CL L2028s A 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 255 TYR L 123 TYR.? -4.18 O1 GOL L3027s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 120.65 164.52 206.19 119.64 164.06 207.98 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 125.69 169.77 203.98 124.79 171.51 204.73 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 131.49 167.37 206.62 131.53 168.77 204.19 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 57 3 # 57 A 199 HIS L 79 HIS~? -4.09 CL CL L2028s A 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 255 TYR L 157 TYR.? 9.71 O3 GOL L3027 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 120.65 164.52 206.19 119.64 164.06 207.98 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 125.69 169.77 203.98 124.79 171.51 204.73 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 123.19 173.24 198.15 125.89 172.62 198.32 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 58 3 # 58 A 199 HIS L 79 HIS~? -4.09 CL CL L2028s A 246 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 255 TYR L 123 TYR.? -4.18 O1 GOL L3027s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 120.65 164.52 206.19 119.64 164.06 207.98 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.56 168.90 213.47 127.02 170.42 214.85 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 131.49 167.37 206.62 131.53 168.77 204.19 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 59 3 # 59 A 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.56 168.90 213.47 127.02 170.42 214.85 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 125.69 169.77 203.98 124.79 171.51 204.73 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 60 3 # 60 A 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 246 HIS L 79 HIS~? -4.09 CL CL L2028s A 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.56 168.90 213.47 127.02 170.42 214.85 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 120.65 164.52 206.19 119.64 164.06 207.98 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 61 3 # 61 A 199 HIS M 79 HIS~? -4.31 CL CL M2029s A 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 255 TYR M 123 TYR.? -4.30 O1 GOL M3043s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 125.50 211.59 173.52 124.72 213.49 173.99 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.15 208.85 168.09 129.36 209.65 166.31 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 136.30 210.69 170.36 136.06 208.30 168.99 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 62 3 # 62 A 199 HIS M 79 HIS~? -4.31 CL CL M2029s A 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 255 TYR M 157 TYR.? -4.16 C2 GOL M3042s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 125.50 211.59 173.52 124.72 213.49 173.99 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.15 208.85 168.09 129.36 209.65 166.31 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 127.03 203.34 164.58 129.75 203.18 165.07 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 63 3 # 63 A 199 HIS M 79 HIS~? -4.31 CL CL M2029s A 246 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 255 TYR M 123 TYR.? -4.30 O1 GOL M3043s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 125.50 211.59 173.52 124.72 213.49 173.99 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 132.19 217.95 169.15 132.87 219.15 167.56 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 136.30 210.69 170.36 136.06 208.30 168.99 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 64 3 # 64 A 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 132.19 217.95 169.15 132.87 219.15 167.56 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 130.15 208.85 168.09 129.36 209.65 166.31 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 65 3 # 65 A 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 246 HIS M 79 HIS~? -4.31 CL CL M2029s A 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 132.19 217.95 169.15 132.87 219.15 167.56 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 125.50 211.59 173.52 124.72 213.49 173.99 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 66 3 # 66 A 199 HIS N 79 HIS~? -4.33 CL CL N2030s A 246 HIS N 76 HIS~? -6.89 CL CL N2030s A 255 TYR N 123 TYR.? -12.00 CL CL N2030s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 215.64 153.98 132.96 216.60 153.22 131.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 211.54 160.16 134.29 212.67 161.69 133.40 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 205.39 158.43 131.87 205.49 160.09 134.09 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 67 3 # 67 A 199 HIS N 79 HIS~? -4.33 CL CL N2030s A 246 HIS N 76 HIS~? -6.89 CL CL N2030s A 255 TYR N 157 TYR.? 7.89 C1 GOL N3012 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 215.64 153.98 132.96 216.60 153.22 131.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 211.54 160.16 134.29 212.67 161.69 133.40 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 214.45 164.07 139.74 211.68 163.84 139.51 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 68 3 # 68 A 199 HIS N 79 HIS~? -4.33 CL CL N2030s A 246 HIS N 125 HIS.? 9.29 CL CL N2030 A 255 TYR N 123 TYR.? -12.00 CL CL N2030s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 215.64 153.98 132.96 216.60 153.22 131.26 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 210.43 158.18 125.05 210.19 159.49 123.43 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 205.39 158.43 131.87 205.49 160.09 134.09 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 69 3 # 69 A 199 HIS N 125 HIS.? 9.29 CL CL N2030 A 246 HIS N 76 HIS~? -6.89 CL CL N2030s A 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 210.43 158.18 125.05 210.19 159.49 123.43 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 211.54 160.16 134.29 212.67 161.69 133.40 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 70 3 # 70 A 199 HIS N 125 HIS.? 9.29 CL CL N2030 A 246 HIS N 79 HIS~? -4.33 CL CL N2030s A 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 210.43 158.18 125.05 210.19 159.49 123.43 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 215.64 153.98 132.96 216.60 153.22 131.26 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 71 3 # 71 A 199 HIS O 79 HIS~? 5.21 CL CL O2018 A 246 HIS O 76 HIS~? 4.51 CL CL O2018s A 255 TYR O 123 TYR.? -7.90 CL CL O2018s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 121.98 131.53 158.56 121.09 129.74 157.92 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.10 133.61 164.62 125.01 132.87 166.26 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 132.12 130.96 163.05 132.10 133.32 164.44 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 72 3 # 72 A 199 HIS O 79 HIS~? 5.21 CL CL O2018 A 246 HIS O 76 HIS~? 4.51 CL CL O2018s A 255 TYR O 157 TYR.? 6.41 O2 GOL O3013 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 121.98 131.53 158.56 121.09 129.74 157.92 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.10 133.61 164.62 125.01 132.87 166.26 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 123.23 139.38 167.80 126.05 139.22 167.65 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 73 3 # 73 A 199 HIS O 79 HIS~? 5.21 CL CL O2018 A 246 HIS O 125 HIS.? 7.09 CL CL O2018 A 255 TYR O 123 TYR.? -7.90 CL CL O2018s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 121.98 131.53 158.56 121.09 129.74 157.92 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.97 124.39 163.68 126.90 122.97 165.24 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 132.12 130.96 163.05 132.10 133.32 164.44 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 74 3 # 74 A 199 HIS O 125 HIS.? 7.09 CL CL O2018 A 246 HIS O 76 HIS~? 4.51 CL CL O2018s A 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.97 124.39 163.68 126.90 122.97 165.24 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 126.10 133.61 164.62 125.01 132.87 166.26 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 75 3 # 75 A 199 HIS O 125 HIS.? 7.09 CL CL O2018 A 246 HIS O 79 HIS~? 5.21 CL CL O2018 A 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 126.97 124.39 163.68 126.90 122.97 165.24 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 121.98 131.53 158.56 121.09 129.74 157.92 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 76 3 # 76 A 199 HIS P 79 HIS~? 5.38 CL CL P2019 A 246 HIS P 76 HIS~? 4.69 CL CL P2019s A 255 TYR P 123 TYR.? -3.93 O1 GOL P3034s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 212.25 178.47 210.26 213.09 179.27 212.01 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.59 172.73 208.38 208.33 171.09 209.49 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 201.57 175.22 210.06 201.77 173.54 207.86 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 77 3 # 77 A 199 HIS P 79 HIS~? 5.38 CL CL P2019 A 246 HIS P 76 HIS~? 4.69 CL CL P2019s A 255 TYR P 157 TYR.? 6.12 O2 GOL P3014 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 212.25 178.47 210.26 213.09 179.27 212.01 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.59 172.73 208.38 208.33 171.09 209.49 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 210.70 168.63 203.45 207.96 169.02 203.20 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 78 3 # 78 A 199 HIS P 79 HIS~? 5.38 CL CL P2019 A 246 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 255 TYR P 123 TYR.? -3.93 O1 GOL P3034s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 212.25 178.47 210.26 213.09 179.27 212.01 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 205.78 175.00 217.63 205.21 173.76 219.23 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 201.57 175.22 210.06 201.77 173.54 207.86 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 79 3 # 79 A 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 246 HIS P 76 HIS~? 4.69 CL CL P2019s A 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 205.78 175.00 217.63 205.21 173.76 219.23 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 207.59 172.73 208.38 208.33 171.09 209.49 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 80 3 # 80 A 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 246 HIS P 79 HIS~? 5.38 CL CL P2019 A 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 205.78 175.00 217.63 205.21 173.76 219.23 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 212.25 178.47 210.26 213.09 179.27 212.01 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 207.22 180.36 204.70 207.43 182.65 203.13 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 80 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 79 HIS~? -3.92 CL CL A2020s B 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s B 255 TYR A 157 TYR.? -3.90 O2 GOL A3037s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 103.72 86.36 44.76 104.87 88.01 44.15 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 98.60 85.60 50.46 99.38 86.61 52.13 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 100.57 80.52 55.08 97.88 80.73 54.34 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 B 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s B 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 98.48 94.83 47.66 98.07 96.39 49.01 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 98.60 85.60 50.46 99.38 86.61 52.13 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 B 246 HIS A 79 HIS~? -3.92 CL CL A2020s B 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 98.48 94.83 47.66 98.07 96.39 49.01 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 103.72 86.36 44.76 104.87 88.01 44.15 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS B 79 HIS~? 5.08 CL CL B2010 B 246 HIS B 76 HIS~? 4.58 CL CL B2010s B 255 TYR B 157 TYR.? 7.53 O1 GOL B3015 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 13.46 62.96 8.26 12.78 63.30 6.30 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 17.08 57.14 11.39 16.06 55.49 10.59 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 13.23 54.49 17.04 16.01 54.48 17.30 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 B 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 B 246 HIS B 76 HIS~? 4.58 CL CL B2010s B 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 19.73 57.29 2.23 19.89 55.80 0.75 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 17.08 57.14 11.39 16.06 55.49 10.59 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 B 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 B 246 HIS B 79 HIS~? 5.08 CL CL B2010 B 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 19.73 57.29 2.23 19.89 55.80 0.75 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 13.46 62.96 8.26 12.78 63.30 6.30 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 B 199 HIS C 79 HIS~? -4.32 CL CL C2021s B 246 HIS C 76 HIS~? -4.98 CL CL C2011s B 255 TYR C 157 TYR.? 7.25 O1 GOL C3036 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 92.85 10.89 71.99 93.43 9.18 73.06 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 89.28 12.80 65.47 90.23 11.67 63.98 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 93.23 17.43 61.74 90.40 17.73 61.84 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 B 199 HIS C 125 HIS.? 6.65 CL CL C2011 B 246 HIS C 76 HIS~? -4.98 CL CL C2011s B 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 86.57 4.11 67.63 86.24 2.65 66.14 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 89.28 12.80 65.47 90.23 11.67 63.98 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 9 3 # 9 B 199 HIS C 125 HIS.? 6.65 CL CL C2011 B 246 HIS C 79 HIS~? -4.32 CL CL C2021s B 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 86.57 4.11 67.63 86.24 2.65 66.14 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 92.85 10.89 71.99 93.43 9.18 73.06 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 10 3 # 10 B 199 HIS D 79 HIS~? -4.57 CL CL D2022s B 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s B 255 TYR D 157 TYR.? 4.28 O2 GOL D3020 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 3.57 52.49 87.96 2.52 51.97 89.71 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 8.84 57.69 86.26 7.93 59.46 86.93 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 6.86 61.00 80.62 9.60 60.40 80.64 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 11 3 # 11 B 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s B 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 9.12 57.04 95.76 9.45 58.59 97.15 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 8.84 57.69 86.26 7.93 59.46 86.93 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 12 3 # 12 B 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 246 HIS D 79 HIS~? -4.57 CL CL D2022s B 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 9.12 57.04 95.76 9.45 58.59 97.15 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 3.57 52.49 87.96 2.52 51.97 89.71 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 13 3 # 13 B 199 HIS E 79 HIS~? -4.18 CL CL E2032s B 246 HIS E 76 HIS~? -4.87 CL CL E2013s B 255 TYR E 157 TYR.? -7.44 C3 GOL E3002s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 12.36 98.35 54.34 11.69 100.32 54.60 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 16.97 95.07 49.08 16.37 95.97 47.28 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 13.76 89.62 45.68 16.45 89.35 46.36 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 14 3 # 14 B 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 246 HIS E 76 HIS~? -4.87 CL CL E2013s B 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 19.41 104.46 50.06 20.14 105.76 48.58 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 16.97 95.07 49.08 16.37 95.97 47.28 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 15 3 # 15 B 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 246 HIS E 79 HIS~? -4.18 CL CL E2032s B 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 19.41 104.46 50.06 20.14 105.76 48.58 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 12.36 98.35 54.34 11.69 100.32 54.60 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 16 3 # 16 B 199 HIS F 79 HIS~? -4.63 CL CL F2023s B 246 HIS F 76 HIS~? -4.65 CL CL F2034s B 255 TYR F 157 TYR.? -10.36 O3 GOL F3039s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 101.04 34.65 20.79 101.93 33.69 19.16 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 97.24 41.20 21.57 98.43 42.65 20.63 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 100.15 45.18 26.97 97.32 45.17 26.68 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 17 3 # 17 B 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 246 HIS F 76 HIS~? -4.65 CL CL F2034s B 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 96.50 38.92 12.23 96.44 40.22 10.57 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 97.24 41.20 21.57 98.43 42.65 20.63 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 18 3 # 18 B 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 246 HIS F 79 HIS~? -4.63 CL CL F2023s B 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 96.50 38.92 12.23 96.44 40.22 10.57 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 101.04 34.65 20.79 101.93 33.69 19.16 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 19 3 # 19 B 199 HIS G 79 HIS~? -4.46 CL CL G2033s B 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s B 255 TYR G 157 TYR.? 5.49 O3 GOL G3001 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 5.20 17.85 42.65 4.12 16.10 42.26 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 9.26 20.10 48.62 8.05 19.49 50.22 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 6.53 26.08 51.42 9.33 25.84 51.41 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 20 3 # 20 B 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s B 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 9.81 10.31 48.06 9.47 8.80 49.48 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 9.26 20.10 48.62 8.05 19.49 50.22 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 21 3 # 21 B 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 246 HIS G 79 HIS~? -4.46 CL CL G2033s B 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 9.81 10.31 48.06 9.47 8.80 49.48 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 5.20 17.85 42.65 4.12 16.10 42.26 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 22 3 # 22 B 199 HIS H 79 HIS~? 4.82 CL CL H2024 B 246 HIS H 76 HIS~? 4.68 CL CL H2014s B 255 TYR H 157 TYR.? -11.04 CL CL H2014s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 95.19 63.20 96.60 95.96 63.87 98.43 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 90.35 57.57 94.69 91.06 55.99 95.89 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 93.68 52.87 90.01 90.96 53.43 89.67 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 23 3 # 23 B 199 HIS H 125 HIS.? 7.36 CL CL H2014 B 246 HIS H 76 HIS~? 4.68 CL CL H2014s B 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 88.12 60.23 103.63 87.33 59.09 105.21 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 90.35 57.57 94.69 91.06 55.99 95.89 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 24 3 # 24 B 199 HIS H 125 HIS.? 7.36 CL CL H2014 B 246 HIS H 79 HIS~? 4.82 CL CL H2024 B 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 88.12 60.23 103.63 87.33 59.09 105.21 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 95.19 63.20 96.60 95.96 63.87 98.43 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 25 3 # 25 B 199 HIS I 79 HIS~? -4.56 CL CL I2025s B 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s B 255 TYR I 157 TYR.? -10.00 O3 GOL I3031s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 216.99 204.94 159.50 218.07 206.60 158.77 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 212.11 203.51 165.19 213.01 204.42 166.85 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 214.62 198.06 169.41 211.87 198.21 168.94 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 26 3 # 26 B 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s B 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 211.42 212.80 162.96 211.20 214.50 164.16 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 212.11 203.51 165.19 213.01 204.42 166.85 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 27 3 # 27 B 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 246 HIS I 79 HIS~? -4.56 CL CL I2025s B 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 211.42 212.80 162.96 211.20 214.50 164.16 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 216.99 204.94 159.50 218.07 206.60 158.77 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 28 3 # 28 B 199 HIS J 79 HIS~? -4.36 CL CL J2026s B 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s B 255 TYR J 157 TYR.? 4.16 O1 GOL J3033 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 126.45 179.07 126.46 125.69 179.71 124.61 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 130.51 172.99 128.94 129.60 171.33 128.01 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 126.93 169.72 134.52 129.73 169.94 134.63 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 29 3 # 29 B 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s B 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 132.43 173.86 119.73 132.77 172.30 118.36 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 130.51 172.99 128.94 129.60 171.33 128.01 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 30 3 # 30 B 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 246 HIS J 79 HIS~? -4.36 CL CL J2026s B 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 132.43 173.86 119.73 132.77 172.30 118.36 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 126.45 179.07 126.46 125.69 179.71 124.61 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 31 3 # 31 B 199 HIS K 79 HIS~? -4.34 CL CL K2027s B 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s B 255 TYR K 157 TYR.? 6.79 O2 GOL K3009 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 211.01 127.65 183.80 211.70 125.86 184.65 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 207.10 129.51 177.50 208.14 128.55 175.95 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 210.77 134.37 173.74 207.96 134.59 173.91 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 32 3 # 32 B 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s B 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 204.92 120.38 179.37 204.44 118.90 177.95 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 207.10 129.51 177.50 208.14 128.55 175.95 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 33 3 # 33 B 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s B 246 HIS K 79 HIS~? -4.34 CL CL K2027s B 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 204.92 120.38 179.37 204.44 118.90 177.95 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 211.01 127.65 183.80 211.70 125.86 184.65 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 34 3 # 34 B 199 HIS L 79 HIS~? -4.09 CL CL L2028s B 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s B 255 TYR L 157 TYR.? 9.71 O3 GOL L3027 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 120.65 164.52 206.19 119.64 164.06 207.98 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 125.69 169.77 203.98 124.79 171.51 204.73 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 123.19 173.24 198.15 125.89 172.62 198.32 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 35 3 # 35 B 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s B 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 126.56 168.90 213.47 127.02 170.42 214.85 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 125.69 169.77 203.98 124.79 171.51 204.73 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 36 3 # 36 B 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 246 HIS L 79 HIS~? -4.09 CL CL L2028s B 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 126.56 168.90 213.47 127.02 170.42 214.85 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 120.65 164.52 206.19 119.64 164.06 207.98 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 37 3 # 37 B 199 HIS M 79 HIS~? -4.31 CL CL M2029s B 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s B 255 TYR M 157 TYR.? -4.16 C2 GOL M3042s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 125.50 211.59 173.52 124.72 213.49 173.99 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 130.15 208.85 168.09 129.36 209.65 166.31 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 127.03 203.34 164.58 129.75 203.18 165.07 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 38 3 # 38 B 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s B 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 132.19 217.95 169.15 132.87 219.15 167.56 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 130.15 208.85 168.09 129.36 209.65 166.31 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 39 3 # 39 B 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 246 HIS M 79 HIS~? -4.31 CL CL M2029s B 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 132.19 217.95 169.15 132.87 219.15 167.56 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 125.50 211.59 173.52 124.72 213.49 173.99 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 40 3 # 40 B 199 HIS N 79 HIS~? -4.33 CL CL N2030s B 246 HIS N 76 HIS~? -6.89 CL CL N2030s B 255 TYR N 157 TYR.? 7.89 C1 GOL N3012 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 215.64 153.98 132.96 216.60 153.22 131.26 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 211.54 160.16 134.29 212.67 161.69 133.40 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 214.45 164.07 139.74 211.68 163.84 139.51 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 41 3 # 41 B 199 HIS N 125 HIS.? 9.29 CL CL N2030 B 246 HIS N 76 HIS~? -6.89 CL CL N2030s B 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 210.43 158.18 125.05 210.19 159.49 123.43 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 211.54 160.16 134.29 212.67 161.69 133.40 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 42 3 # 42 B 199 HIS N 125 HIS.? 9.29 CL CL N2030 B 246 HIS N 79 HIS~? -4.33 CL CL N2030s B 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 210.43 158.18 125.05 210.19 159.49 123.43 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 215.64 153.98 132.96 216.60 153.22 131.26 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 43 3 # 43 B 199 HIS O 79 HIS~? 5.21 CL CL O2018 B 246 HIS O 76 HIS~? 4.51 CL CL O2018s B 255 TYR O 157 TYR.? 6.41 O2 GOL O3013 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 121.98 131.53 158.56 121.09 129.74 157.92 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 126.10 133.61 164.62 125.01 132.87 166.26 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 123.23 139.38 167.80 126.05 139.22 167.65 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 44 3 # 44 B 199 HIS O 125 HIS.? 7.09 CL CL O2018 B 246 HIS O 76 HIS~? 4.51 CL CL O2018s B 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 126.97 124.39 163.68 126.90 122.97 165.24 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 126.10 133.61 164.62 125.01 132.87 166.26 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 45 3 # 45 B 199 HIS O 125 HIS.? 7.09 CL CL O2018 B 246 HIS O 79 HIS~? 5.21 CL CL O2018 B 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 126.97 124.39 163.68 126.90 122.97 165.24 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 121.98 131.53 158.56 121.09 129.74 157.92 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 46 3 # 46 B 199 HIS P 79 HIS~? 5.38 CL CL P2019 B 246 HIS P 76 HIS~? 4.69 CL CL P2019s B 255 TYR P 157 TYR.? 6.12 O2 GOL P3014 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 212.25 178.47 210.26 213.09 179.27 212.01 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 207.59 172.73 208.38 208.33 171.09 209.49 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 210.70 168.63 203.45 207.96 169.02 203.20 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 47 3 # 47 B 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 246 HIS P 76 HIS~? 4.69 CL CL P2019s B 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 205.78 175.00 217.63 205.21 173.76 219.23 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 207.59 172.73 208.38 208.33 171.09 209.49 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 48 3 # 48 B 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 246 HIS P 79 HIS~? 5.38 CL CL P2019 B 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 205.78 175.00 217.63 205.21 173.76 219.23 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 212.25 178.47 210.26 213.09 179.27 212.01 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 207.22 180.36 204.70 207.43 182.65 203.13 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 48 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 79 HIS~? -3.92 CL CL A2020s C 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s C 255 TYR A 123 TYR.? -4.01 O1 GOL A3040s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 103.72 86.36 44.76 104.87 88.01 44.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 98.60 85.60 50.46 99.38 86.61 52.13 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 92.97 88.22 47.49 92.65 86.11 49.28 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS A 79 HIS~? -3.92 CL CL A2020s C 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s C 255 TYR A 157 TYR.? -3.90 O2 GOL A3037s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 103.72 86.36 44.76 104.87 88.01 44.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 98.60 85.60 50.46 99.38 86.61 52.13 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 100.57 80.52 55.08 97.88 80.73 54.34 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS A 79 HIS~? -3.92 CL CL A2020s C 246 HIS A 125 HIS.? 6.10 O2 GOL A3040 C 255 TYR A 123 TYR.? -4.01 O1 GOL A3040s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 103.72 86.36 44.76 104.87 88.01 44.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 98.48 94.83 47.66 98.07 96.39 49.01 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 92.97 88.22 47.49 92.65 86.11 49.28 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 C 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s C 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 98.48 94.83 47.66 98.07 96.39 49.01 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 98.60 85.60 50.46 99.38 86.61 52.13 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 C 246 HIS A 79 HIS~? -3.92 CL CL A2020s C 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 98.48 94.83 47.66 98.07 96.39 49.01 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 103.72 86.36 44.76 104.87 88.01 44.15 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 C 199 HIS B 79 HIS~? 5.08 CL CL B2010 C 246 HIS B 76 HIS~? 4.58 CL CL B2010s C 255 TYR B 123 TYR.? -4.36 O2 GOL B3023s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 13.46 62.96 8.26 12.78 63.30 6.30 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 17.08 57.14 11.39 16.06 55.49 10.59 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 23.54 58.32 9.82 22.98 57.14 12.28 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 C 199 HIS B 79 HIS~? 5.08 CL CL B2010 C 246 HIS B 76 HIS~? 4.58 CL CL B2010s C 255 TYR B 157 TYR.? 7.53 O1 GOL B3015 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 13.46 62.96 8.26 12.78 63.30 6.30 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 17.08 57.14 11.39 16.06 55.49 10.59 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 13.23 54.49 17.04 16.01 54.48 17.30 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 C 199 HIS B 79 HIS~? 5.08 CL CL B2010 C 246 HIS B 125 HIS.? 5.37 C1 GOL B3023 C 255 TYR B 123 TYR.? -4.36 O2 GOL B3023s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 13.46 62.96 8.26 12.78 63.30 6.30 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 19.73 57.29 2.23 19.89 55.80 0.75 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 23.54 58.32 9.82 22.98 57.14 12.28 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 9 3 # 9 C 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 C 246 HIS B 76 HIS~? 4.58 CL CL B2010s C 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 19.73 57.29 2.23 19.89 55.80 0.75 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 17.08 57.14 11.39 16.06 55.49 10.59 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 10 3 # 10 C 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 C 246 HIS B 79 HIS~? 5.08 CL CL B2010 C 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 19.73 57.29 2.23 19.89 55.80 0.75 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 13.46 62.96 8.26 12.78 63.30 6.30 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 11 3 # 11 C 199 HIS C 79 HIS~? -4.32 CL CL C2021s C 246 HIS C 76 HIS~? -4.98 CL CL C2011s C 255 TYR C 123 TYR.? -8.00 CL CL C2011s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 92.85 10.89 71.99 93.43 9.18 73.06 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 89.28 12.80 65.47 90.23 11.67 63.98 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 82.73 11.63 67.15 83.32 13.82 65.52 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 12 3 # 12 C 199 HIS C 79 HIS~? -4.32 CL CL C2021s C 246 HIS C 76 HIS~? -4.98 CL CL C2011s C 255 TYR C 157 TYR.? 7.25 O1 GOL C3036 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 92.85 10.89 71.99 93.43 9.18 73.06 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 89.28 12.80 65.47 90.23 11.67 63.98 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 93.23 17.43 61.74 90.40 17.73 61.84 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 13 3 # 13 C 199 HIS C 79 HIS~? -4.32 CL CL C2021s C 246 HIS C 125 HIS.? 6.65 CL CL C2011 C 255 TYR C 123 TYR.? -8.00 CL CL C2011s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 92.85 10.89 71.99 93.43 9.18 73.06 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 86.57 4.11 67.63 86.24 2.65 66.14 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 82.73 11.63 67.15 83.32 13.82 65.52 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 14 3 # 14 C 199 HIS C 125 HIS.? 6.65 CL CL C2011 C 246 HIS C 76 HIS~? -4.98 CL CL C2011s C 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 86.57 4.11 67.63 86.24 2.65 66.14 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 89.28 12.80 65.47 90.23 11.67 63.98 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 15 3 # 15 C 199 HIS C 125 HIS.? 6.65 CL CL C2011 C 246 HIS C 79 HIS~? -4.32 CL CL C2021s C 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 86.57 4.11 67.63 86.24 2.65 66.14 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 92.85 10.89 71.99 93.43 9.18 73.06 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 16 3 # 16 C 199 HIS D 79 HIS~? -4.57 CL CL D2022s C 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s C 255 TYR D 123 TYR.? -4.29 O1 GOL D3018s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 3.57 52.49 87.96 2.52 51.97 89.71 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 8.84 57.69 86.26 7.93 59.46 86.93 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 14.40 55.37 89.22 14.73 56.67 86.77 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 17 3 # 17 C 199 HIS D 79 HIS~? -4.57 CL CL D2022s C 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s C 255 TYR D 157 TYR.? 4.28 O2 GOL D3020 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 3.57 52.49 87.96 2.52 51.97 89.71 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 8.84 57.69 86.26 7.93 59.46 86.93 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 6.86 61.00 80.62 9.60 60.40 80.64 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 18 3 # 18 C 199 HIS D 79 HIS~? -4.57 CL CL D2022s C 246 HIS D 125 HIS.? -3.96 O3 GOL D3018s C 255 TYR D 123 TYR.? -4.29 O1 GOL D3018s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 3.57 52.49 87.96 2.52 51.97 89.71 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 9.12 57.04 95.76 9.45 58.59 97.15 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 14.40 55.37 89.22 14.73 56.67 86.77 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 19 3 # 19 C 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s C 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s C 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 9.12 57.04 95.76 9.45 58.59 97.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 8.84 57.69 86.26 7.93 59.46 86.93 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 20 3 # 20 C 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s C 246 HIS D 79 HIS~? -4.57 CL CL D2022s C 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 9.12 57.04 95.76 9.45 58.59 97.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 3.57 52.49 87.96 2.52 51.97 89.71 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 21 3 # 21 C 199 HIS E 79 HIS~? -4.18 CL CL E2032s C 246 HIS E 76 HIS~? -4.87 CL CL E2013s C 255 TYR E 157 TYR.? -7.44 C3 GOL E3002s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 12.36 98.35 54.34 11.69 100.32 54.60 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 16.97 95.07 49.08 16.37 95.97 47.28 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 13.76 89.62 45.68 16.45 89.35 46.36 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 22 3 # 22 C 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 C 246 HIS E 76 HIS~? -4.87 CL CL E2013s C 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 19.41 104.46 50.06 20.14 105.76 48.58 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 16.97 95.07 49.08 16.37 95.97 47.28 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 23 3 # 23 C 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 C 246 HIS E 79 HIS~? -4.18 CL CL E2032s C 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 19.41 104.46 50.06 20.14 105.76 48.58 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 12.36 98.35 54.34 11.69 100.32 54.60 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 24 3 # 24 C 199 HIS F 79 HIS~? -4.63 CL CL F2023s C 246 HIS F 76 HIS~? -4.65 CL CL F2034s C 255 TYR F 157 TYR.? -10.36 O3 GOL F3039s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 101.04 34.65 20.79 101.93 33.69 19.16 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 97.24 41.20 21.57 98.43 42.65 20.63 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 100.15 45.18 26.97 97.32 45.17 26.68 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 25 3 # 25 C 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 C 246 HIS F 76 HIS~? -4.65 CL CL F2034s C 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 96.50 38.92 12.23 96.44 40.22 10.57 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 97.24 41.20 21.57 98.43 42.65 20.63 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 26 3 # 26 C 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 C 246 HIS F 79 HIS~? -4.63 CL CL F2023s C 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 96.50 38.92 12.23 96.44 40.22 10.57 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 101.04 34.65 20.79 101.93 33.69 19.16 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 27 3 # 27 C 199 HIS G 79 HIS~? -4.46 CL CL G2033s C 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s C 255 TYR G 123 TYR.? -4.47 O3 GOL G3038s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 5.20 17.85 42.65 4.12 16.10 42.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 9.26 20.10 48.62 8.05 19.49 50.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 15.30 16.99 47.49 15.28 19.49 48.80 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 28 3 # 28 C 199 HIS G 79 HIS~? -4.46 CL CL G2033s C 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s C 255 TYR G 157 TYR.? 5.49 O3 GOL G3001 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 5.20 17.85 42.65 4.12 16.10 42.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 9.26 20.10 48.62 8.05 19.49 50.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 6.53 26.08 51.42 9.33 25.84 51.41 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 29 3 # 29 C 199 HIS G 79 HIS~? -4.46 CL CL G2033s C 246 HIS G 125 HIS.? 6.66 C2 GOL G3038 C 255 TYR G 123 TYR.? -4.47 O3 GOL G3038s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 5.20 17.85 42.65 4.12 16.10 42.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 9.81 10.31 48.06 9.47 8.80 49.48 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 15.30 16.99 47.49 15.28 19.49 48.80 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 30 3 # 30 C 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 C 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s C 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 9.81 10.31 48.06 9.47 8.80 49.48 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 9.26 20.10 48.62 8.05 19.49 50.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 31 3 # 31 C 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 C 246 HIS G 79 HIS~? -4.46 CL CL G2033s C 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 9.81 10.31 48.06 9.47 8.80 49.48 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 5.20 17.85 42.65 4.12 16.10 42.26 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 32 3 # 32 C 199 HIS H 79 HIS~? 4.82 CL CL H2024 C 246 HIS H 76 HIS~? 4.68 CL CL H2014s C 255 TYR H 157 TYR.? -11.04 CL CL H2014s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 95.19 63.20 96.60 95.96 63.87 98.43 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 90.35 57.57 94.69 91.06 55.99 95.89 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 93.68 52.87 90.01 90.96 53.43 89.67 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 33 3 # 33 C 199 HIS H 125 HIS.? 7.36 CL CL H2014 C 246 HIS H 76 HIS~? 4.68 CL CL H2014s C 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 88.12 60.23 103.63 87.33 59.09 105.21 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 90.35 57.57 94.69 91.06 55.99 95.89 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 34 3 # 34 C 199 HIS H 125 HIS.? 7.36 CL CL H2014 C 246 HIS H 79 HIS~? 4.82 CL CL H2024 C 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 88.12 60.23 103.63 87.33 59.09 105.21 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 95.19 63.20 96.60 95.96 63.87 98.43 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 35 3 # 35 C 199 HIS I 79 HIS~? -4.56 CL CL I2025s C 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s C 255 TYR I 157 TYR.? -10.00 O3 GOL I3031s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 216.99 204.94 159.50 218.07 206.60 158.77 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 212.11 203.51 165.19 213.01 204.42 166.85 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 214.62 198.06 169.41 211.87 198.21 168.94 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 36 3 # 36 C 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 C 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s C 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 211.42 212.80 162.96 211.20 214.50 164.16 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 212.11 203.51 165.19 213.01 204.42 166.85 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 37 3 # 37 C 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 C 246 HIS I 79 HIS~? -4.56 CL CL I2025s C 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 211.42 212.80 162.96 211.20 214.50 164.16 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 216.99 204.94 159.50 218.07 206.60 158.77 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 38 3 # 38 C 199 HIS J 79 HIS~? -4.36 CL CL J2026s C 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s C 255 TYR J 123 TYR.? -4.20 O1 GOL J3030s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.45 179.07 126.46 125.69 179.71 124.61 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.51 172.99 128.94 129.60 171.33 128.01 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 136.67 174.46 127.10 136.30 173.08 129.51 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 39 3 # 39 C 199 HIS J 79 HIS~? -4.36 CL CL J2026s C 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s C 255 TYR J 157 TYR.? 4.16 O1 GOL J3033 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.45 179.07 126.46 125.69 179.71 124.61 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.51 172.99 128.94 129.60 171.33 128.01 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 126.93 169.72 134.52 129.73 169.94 134.63 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 40 3 # 40 C 199 HIS J 79 HIS~? -4.36 CL CL J2026s C 246 HIS J 125 HIS.? -4.00 O3 GOL J3030s C 255 TYR J 123 TYR.? -4.20 O1 GOL J3030s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.45 179.07 126.46 125.69 179.71 124.61 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 132.43 173.86 119.73 132.77 172.30 118.36 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 136.67 174.46 127.10 136.30 173.08 129.51 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 41 3 # 41 C 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s C 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s C 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 132.43 173.86 119.73 132.77 172.30 118.36 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.51 172.99 128.94 129.60 171.33 128.01 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 42 3 # 42 C 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s C 246 HIS J 79 HIS~? -4.36 CL CL J2026s C 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 132.43 173.86 119.73 132.77 172.30 118.36 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 126.45 179.07 126.46 125.69 179.71 124.61 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 43 3 # 43 C 199 HIS K 79 HIS~? -4.34 CL CL K2027s C 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s C 255 TYR K 157 TYR.? 6.79 O2 GOL K3009 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 211.01 127.65 183.80 211.70 125.86 184.65 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 207.10 129.51 177.50 208.14 128.55 175.95 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 210.77 134.37 173.74 207.96 134.59 173.91 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 44 3 # 44 C 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s C 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s C 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 204.92 120.38 179.37 204.44 118.90 177.95 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 207.10 129.51 177.50 208.14 128.55 175.95 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 45 3 # 45 C 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s C 246 HIS K 79 HIS~? -4.34 CL CL K2027s C 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 204.92 120.38 179.37 204.44 118.90 177.95 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 211.01 127.65 183.80 211.70 125.86 184.65 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 46 3 # 46 C 199 HIS L 79 HIS~? -4.09 CL CL L2028s C 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s C 255 TYR L 123 TYR.? -4.18 O1 GOL L3027s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 120.65 164.52 206.19 119.64 164.06 207.98 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 125.69 169.77 203.98 124.79 171.51 204.73 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 131.49 167.37 206.62 131.53 168.77 204.19 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 47 3 # 47 C 199 HIS L 79 HIS~? -4.09 CL CL L2028s C 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s C 255 TYR L 157 TYR.? 9.71 O3 GOL L3027 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 120.65 164.52 206.19 119.64 164.06 207.98 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 125.69 169.77 203.98 124.79 171.51 204.73 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 123.19 173.24 198.15 125.89 172.62 198.32 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 48 3 # 48 C 199 HIS L 79 HIS~? -4.09 CL CL L2028s C 246 HIS L 125 HIS.? 5.88 O2 GOL L3027 C 255 TYR L 123 TYR.? -4.18 O1 GOL L3027s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 120.65 164.52 206.19 119.64 164.06 207.98 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 126.56 168.90 213.47 127.02 170.42 214.85 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 131.49 167.37 206.62 131.53 168.77 204.19 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 49 3 # 49 C 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 C 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s C 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.56 168.90 213.47 127.02 170.42 214.85 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 125.69 169.77 203.98 124.79 171.51 204.73 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 50 3 # 50 C 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 C 246 HIS L 79 HIS~? -4.09 CL CL L2028s C 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.56 168.90 213.47 127.02 170.42 214.85 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 120.65 164.52 206.19 119.64 164.06 207.98 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 51 3 # 51 C 199 HIS M 79 HIS~? -4.31 CL CL M2029s C 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s C 255 TYR M 123 TYR.? -4.30 O1 GOL M3043s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 125.50 211.59 173.52 124.72 213.49 173.99 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.15 208.85 168.09 129.36 209.65 166.31 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 136.30 210.69 170.36 136.06 208.30 168.99 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 52 3 # 52 C 199 HIS M 79 HIS~? -4.31 CL CL M2029s C 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s C 255 TYR M 157 TYR.? -4.16 C2 GOL M3042s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 125.50 211.59 173.52 124.72 213.49 173.99 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.15 208.85 168.09 129.36 209.65 166.31 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 127.03 203.34 164.58 129.75 203.18 165.07 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 53 3 # 53 C 199 HIS M 79 HIS~? -4.31 CL CL M2029s C 246 HIS M 125 HIS.? 4.98 C3 GOL M3043 C 255 TYR M 123 TYR.? -4.30 O1 GOL M3043s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 125.50 211.59 173.52 124.72 213.49 173.99 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 132.19 217.95 169.15 132.87 219.15 167.56 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 136.30 210.69 170.36 136.06 208.30 168.99 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 54 3 # 54 C 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 C 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s C 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 132.19 217.95 169.15 132.87 219.15 167.56 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 130.15 208.85 168.09 129.36 209.65 166.31 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 55 3 # 55 C 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 C 246 HIS M 79 HIS~? -4.31 CL CL M2029s C 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 132.19 217.95 169.15 132.87 219.15 167.56 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 125.50 211.59 173.52 124.72 213.49 173.99 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 56 3 # 56 C 199 HIS N 79 HIS~? -4.33 CL CL N2030s C 246 HIS N 76 HIS~? -6.89 CL CL N2030s C 255 TYR N 123 TYR.? -12.00 CL CL N2030s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 215.64 153.98 132.96 216.60 153.22 131.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 211.54 160.16 134.29 212.67 161.69 133.40 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 205.39 158.43 131.87 205.49 160.09 134.09 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 57 3 # 57 C 199 HIS N 79 HIS~? -4.33 CL CL N2030s C 246 HIS N 76 HIS~? -6.89 CL CL N2030s C 255 TYR N 157 TYR.? 7.89 C1 GOL N3012 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 215.64 153.98 132.96 216.60 153.22 131.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 211.54 160.16 134.29 212.67 161.69 133.40 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 214.45 164.07 139.74 211.68 163.84 139.51 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 58 3 # 58 C 199 HIS N 79 HIS~? -4.33 CL CL N2030s C 246 HIS N 125 HIS.? 9.29 CL CL N2030 C 255 TYR N 123 TYR.? -12.00 CL CL N2030s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 215.64 153.98 132.96 216.60 153.22 131.26 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 210.43 158.18 125.05 210.19 159.49 123.43 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 205.39 158.43 131.87 205.49 160.09 134.09 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 59 3 # 59 C 199 HIS N 125 HIS.? 9.29 CL CL N2030 C 246 HIS N 76 HIS~? -6.89 CL CL N2030s C 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 210.43 158.18 125.05 210.19 159.49 123.43 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 211.54 160.16 134.29 212.67 161.69 133.40 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 60 3 # 60 C 199 HIS N 125 HIS.? 9.29 CL CL N2030 C 246 HIS N 79 HIS~? -4.33 CL CL N2030s C 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 210.43 158.18 125.05 210.19 159.49 123.43 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 215.64 153.98 132.96 216.60 153.22 131.26 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 61 3 # 61 C 199 HIS O 79 HIS~? 5.21 CL CL O2018 C 246 HIS O 76 HIS~? 4.51 CL CL O2018s C 255 TYR O 157 TYR.? 6.41 O2 GOL O3013 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 121.98 131.53 158.56 121.09 129.74 157.92 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 126.10 133.61 164.62 125.01 132.87 166.26 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 123.23 139.38 167.80 126.05 139.22 167.65 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 62 3 # 62 C 199 HIS O 125 HIS.? 7.09 CL CL O2018 C 246 HIS O 76 HIS~? 4.51 CL CL O2018s C 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.97 124.39 163.68 126.90 122.97 165.24 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 126.10 133.61 164.62 125.01 132.87 166.26 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 63 3 # 63 C 199 HIS O 125 HIS.? 7.09 CL CL O2018 C 246 HIS O 79 HIS~? 5.21 CL CL O2018 C 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 126.97 124.39 163.68 126.90 122.97 165.24 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 121.98 131.53 158.56 121.09 129.74 157.92 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 64 3 # 64 C 199 HIS P 79 HIS~? 5.38 CL CL P2019 C 246 HIS P 76 HIS~? 4.69 CL CL P2019s C 255 TYR P 157 TYR.? 6.12 O2 GOL P3014 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 212.25 178.47 210.26 213.09 179.27 212.01 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 207.59 172.73 208.38 208.33 171.09 209.49 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 210.70 168.63 203.45 207.96 169.02 203.20 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 65 3 # 65 C 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 C 246 HIS P 76 HIS~? 4.69 CL CL P2019s C 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 205.78 175.00 217.63 205.21 173.76 219.23 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 207.59 172.73 208.38 208.33 171.09 209.49 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 66 3 # 66 C 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 C 246 HIS P 79 HIS~? 5.38 CL CL P2019 C 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 205.78 175.00 217.63 205.21 173.76 219.23 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 212.25 178.47 210.26 213.09 179.27 212.01 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 207.22 180.36 204.70 207.43 182.65 203.13 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 66 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 79 HIS~? -3.92 CL CL A2020s D 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s D 255 TYR A 157 TYR.? -3.90 O2 GOL A3037s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 103.72 86.36 44.76 104.87 88.01 44.15 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 98.60 85.60 50.46 99.38 86.61 52.13 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 100.57 80.52 55.08 97.88 80.73 54.34 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 D 246 HIS A 76 HIS~? -4.53 C1 GOL A3037s D 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 98.48 94.83 47.66 98.07 96.39 49.01 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 98.60 85.60 50.46 99.38 86.61 52.13 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS A 125 HIS.? 6.10 O2 GOL A3040 D 246 HIS A 79 HIS~? -3.92 CL CL A2020s D 255 TYR A 75 TYR~? 11.96 CL CL A2020 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 98.48 94.83 47.66 98.07 96.39 49.01 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 103.72 86.36 44.76 104.87 88.01 44.15 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 97.97 81.77 42.85 98.10 80.04 40.64 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 D 246 HIS B 76 HIS~? 4.58 CL CL B2010s D 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 19.73 57.29 2.23 19.89 55.80 0.75 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 17.08 57.14 11.39 16.06 55.49 10.59 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS B 125 HIS.? 5.37 C1 GOL B3023 D 246 HIS B 79 HIS~? 5.08 CL CL B2010 D 255 TYR B 75 TYR~? 10.15 CL CL B2010 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 19.73 57.29 2.23 19.89 55.80 0.75 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 13.46 62.96 8.26 12.78 63.30 6.30 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 18.67 65.14 13.86 18.80 67.67 14.99 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 D 199 HIS C 79 HIS~? -4.32 CL CL C2021s D 246 HIS C 76 HIS~? -4.98 CL CL C2011s D 255 TYR C 157 TYR.? 7.25 O1 GOL C3036 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 92.85 10.89 71.99 93.43 9.18 73.06 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 89.28 12.80 65.47 90.23 11.67 63.98 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 93.23 17.43 61.74 90.40 17.73 61.84 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 D 199 HIS C 125 HIS.? 6.65 CL CL C2011 D 246 HIS C 76 HIS~? -4.98 CL CL C2011s D 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 86.57 4.11 67.63 86.24 2.65 66.14 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 89.28 12.80 65.47 90.23 11.67 63.98 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 D 199 HIS C 125 HIS.? 6.65 CL CL C2011 D 246 HIS C 79 HIS~? -4.32 CL CL C2021s D 255 TYR C 75 TYR~? 10.50 CL CL C2011 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 86.57 4.11 67.63 86.24 2.65 66.14 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 92.85 10.89 71.99 93.43 9.18 73.06 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 87.86 16.77 72.91 87.86 18.43 75.14 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 9 3 # 9 D 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s D 246 HIS D 76 HIS~? 4.24 O2 GOL D3018s D 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 9.12 57.04 95.76 9.45 58.59 97.15 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 8.84 57.69 86.26 7.93 59.46 86.93 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 10 3 # 10 D 199 HIS D 125 HIS.? -3.96 O3 GOL D3018s D 246 HIS D 79 HIS~? -4.57 CL CL D2022s D 255 TYR D 75 TYR~? 10.03 CL CL D2012 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 9.12 57.04 95.76 9.45 58.59 97.15 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 3.57 52.49 87.96 2.52 51.97 89.71 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 9.41 49.60 83.94 9.22 47.13 82.70 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 11 3 # 11 D 199 HIS E 79 HIS~? -4.18 CL CL E2032s D 246 HIS E 76 HIS~? -4.87 CL CL E2013s D 255 TYR E 157 TYR.? -7.44 C3 GOL E3002s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 12.36 98.35 54.34 11.69 100.32 54.60 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 16.97 95.07 49.08 16.37 95.97 47.28 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 13.76 89.62 45.68 16.45 89.35 46.36 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 12 3 # 12 D 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 D 246 HIS E 76 HIS~? -4.87 CL CL E2013s D 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 19.41 104.46 50.06 20.14 105.76 48.58 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 16.97 95.07 49.08 16.37 95.97 47.28 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 13 3 # 13 D 199 HIS E 125 HIS.? 5.41 C3 GOL E3022 D 246 HIS E 79 HIS~? -4.18 CL CL E2032s D 255 TYR E 75 TYR~? 10.13 CL CL E2013 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 19.41 104.46 50.06 20.14 105.76 48.58 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 12.36 98.35 54.34 11.69 100.32 54.60 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 16.89 92.83 57.30 16.35 91.61 59.76 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 14 3 # 14 D 199 HIS F 79 HIS~? -4.63 CL CL F2023s D 246 HIS F 76 HIS~? -4.65 CL CL F2034s D 255 TYR F 157 TYR.? -10.36 O3 GOL F3039s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 101.04 34.65 20.79 101.93 33.69 19.16 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 97.24 41.20 21.57 98.43 42.65 20.63 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 100.15 45.18 26.97 97.32 45.17 26.68 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 15 3 # 15 D 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 D 246 HIS F 76 HIS~? -4.65 CL CL F2034s D 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 96.50 38.92 12.23 96.44 40.22 10.57 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 97.24 41.20 21.57 98.43 42.65 20.63 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 16 3 # 16 D 199 HIS F 125 HIS.? 6.27 C1 GOL F3039 D 246 HIS F 79 HIS~? -4.63 CL CL F2023s D 255 TYR F 75 TYR~? 9.99 CL CL F2034 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 96.50 38.92 12.23 96.44 40.22 10.57 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 101.04 34.65 20.79 101.93 33.69 19.16 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 95.01 33.97 25.26 94.64 31.83 27.03 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 17 3 # 17 D 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 D 246 HIS G 76 HIS~? -3.85 O1 GOL G3038s D 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 9.81 10.31 48.06 9.47 8.80 49.48 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 9.26 20.10 48.62 8.05 19.49 50.22 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 18 3 # 18 D 199 HIS G 125 HIS.? 6.66 C2 GOL G3038 D 246 HIS G 79 HIS~? -4.46 CL CL G2033s D 255 TYR G 75 TYR~? 12.69 CL CL G2033 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 9.81 10.31 48.06 9.47 8.80 49.48 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 5.20 17.85 42.65 4.12 16.10 42.26 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 11.49 22.21 40.76 11.82 23.42 38.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 19 3 # 19 D 199 HIS H 79 HIS~? 4.82 CL CL H2024 D 246 HIS H 76 HIS~? 4.68 CL CL H2014s D 255 TYR H 157 TYR.? -11.04 CL CL H2014s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 95.19 63.20 96.60 95.96 63.87 98.43 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 90.35 57.57 94.69 91.06 55.99 95.89 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 93.68 52.87 90.01 90.96 53.43 89.67 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 20 3 # 20 D 199 HIS H 125 HIS.? 7.36 CL CL H2014 D 246 HIS H 76 HIS~? 4.68 CL CL H2014s D 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 88.12 60.23 103.63 87.33 59.09 105.21 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 90.35 57.57 94.69 91.06 55.99 95.89 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 21 3 # 21 D 199 HIS H 125 HIS.? 7.36 CL CL H2014 D 246 HIS H 79 HIS~? 4.82 CL CL H2024 D 255 TYR H 75 TYR~? 10.27 CL CL H2014 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 88.12 60.23 103.63 87.33 59.09 105.21 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 95.19 63.20 96.60 95.96 63.87 98.43 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 90.64 65.09 90.65 91.11 67.21 88.98 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 22 3 # 22 D 199 HIS I 79 HIS~? -4.56 CL CL I2025s D 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s D 255 TYR I 157 TYR.? -10.00 O3 GOL I3031s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 216.99 204.94 159.50 218.07 206.60 158.77 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 212.11 203.51 165.19 213.01 204.42 166.85 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 214.62 198.06 169.41 211.87 198.21 168.94 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 23 3 # 23 D 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 D 246 HIS I 76 HIS~? 4.17 O3 GOL I3031s D 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 211.42 212.80 162.96 211.20 214.50 164.16 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 212.11 203.51 165.19 213.01 204.42 166.85 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 24 3 # 24 D 199 HIS I 125 HIS.? 6.50 O2 GOL I3031 D 246 HIS I 79 HIS~? -4.56 CL CL I2025s D 255 TYR I 75 TYR~? 10.32 CL CL I2015 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 211.42 212.80 162.96 211.20 214.50 164.16 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 216.99 204.94 159.50 218.07 206.60 158.77 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 211.34 199.93 157.52 211.50 198.33 155.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 25 3 # 25 D 199 HIS J 79 HIS~? -4.36 CL CL J2026s D 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s D 255 TYR J 157 TYR.? 4.16 O1 GOL J3033 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 126.45 179.07 126.46 125.69 179.71 124.61 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 130.51 172.99 128.94 129.60 171.33 128.01 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 126.93 169.72 134.52 129.73 169.94 134.63 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 26 3 # 26 D 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s D 246 HIS J 76 HIS~? 4.19 O2 GOL J3033s D 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 132.43 173.86 119.73 132.77 172.30 118.36 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 130.51 172.99 128.94 129.60 171.33 128.01 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 27 3 # 27 D 199 HIS J 125 HIS.? -4.00 O3 GOL J3030s D 246 HIS J 79 HIS~? -4.36 CL CL J2026s D 255 TYR J 75 TYR~? 10.17 CL CL J2016 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 132.43 173.86 119.73 132.77 172.30 118.36 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 126.45 179.07 126.46 125.69 179.71 124.61 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 131.82 180.89 131.78 131.82 183.34 133.12 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 28 3 # 28 D 199 HIS K 79 HIS~? -4.34 CL CL K2027s D 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s D 255 TYR K 157 TYR.? 6.79 O2 GOL K3009 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 211.01 127.65 183.80 211.70 125.86 184.65 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 207.10 129.51 177.50 208.14 128.55 175.95 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 210.77 134.37 173.74 207.96 134.59 173.91 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 29 3 # 29 D 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s D 246 HIS K 76 HIS~? -6.12 C3 GOL K3041s D 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 204.92 120.38 179.37 204.44 118.90 177.95 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 207.10 129.51 177.50 208.14 128.55 175.95 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 30 3 # 30 D 199 HIS K 125 HIS.? -4.02 O1 GOL K3041s D 246 HIS K 79 HIS~? -4.34 CL CL K2027s D 255 TYR K 75 TYR~? 12.36 CL CL K2027 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 204.92 120.38 179.37 204.44 118.90 177.95 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 211.01 127.65 183.80 211.70 125.86 184.65 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 205.79 133.16 185.06 205.81 134.80 187.34 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 31 3 # 31 D 199 HIS L 79 HIS~? -4.09 CL CL L2028s D 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s D 255 TYR L 157 TYR.? 9.71 O3 GOL L3027 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 120.65 164.52 206.19 119.64 164.06 207.98 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 125.69 169.77 203.98 124.79 171.51 204.73 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 123.19 173.24 198.15 125.89 172.62 198.32 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 32 3 # 32 D 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 D 246 HIS L 76 HIS~? 4.00 O3 GOL L3027s D 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 126.56 168.90 213.47 127.02 170.42 214.85 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 125.69 169.77 203.98 124.79 171.51 204.73 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 33 3 # 33 D 199 HIS L 125 HIS.? 5.88 O2 GOL L3027 D 246 HIS L 79 HIS~? -4.09 CL CL L2028s D 255 TYR L 75 TYR~? 10.07 CL CL L2009 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 126.56 168.90 213.47 127.02 170.42 214.85 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 120.65 164.52 206.19 119.64 164.06 207.98 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 34 3 # 34 D 199 HIS M 79 HIS~? -4.31 CL CL M2029s D 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s D 255 TYR M 157 TYR.? -4.16 C2 GOL M3042s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 125.50 211.59 173.52 124.72 213.49 173.99 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 130.15 208.85 168.09 129.36 209.65 166.31 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 127.03 203.34 164.58 129.75 203.18 165.07 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 35 3 # 35 D 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 D 246 HIS M 76 HIS~? 4.78 C1 GOL M3042s D 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 132.19 217.95 169.15 132.87 219.15 167.56 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 130.15 208.85 168.09 129.36 209.65 166.31 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 36 3 # 36 D 199 HIS M 125 HIS.? 4.98 C3 GOL M3043 D 246 HIS M 79 HIS~? -4.31 CL CL M2029s D 255 TYR M 75 TYR~? 10.36 CL CL M2017 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 132.19 217.95 169.15 132.87 219.15 167.56 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 125.50 211.59 173.52 124.72 213.49 173.99 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 130.62 206.12 176.17 130.27 204.76 178.58 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 37 3 # 37 D 199 HIS N 125 HIS.? 9.29 CL CL N2030 D 246 HIS N 76 HIS~? -6.89 CL CL N2030s D 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 210.43 158.18 125.05 210.19 159.49 123.43 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 211.54 160.16 134.29 212.67 161.69 133.40 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 38 3 # 38 D 199 HIS N 125 HIS.? 9.29 CL CL N2030 D 246 HIS N 79 HIS~? -4.33 CL CL N2030s D 255 TYR N 75 TYR~? 12.44 O2 GOL N3029 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 210.43 158.18 125.05 210.19 159.49 123.43 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 215.64 153.98 132.96 216.60 153.22 131.26 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 209.71 152.64 137.80 209.50 150.35 139.41 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 39 3 # 39 D 199 HIS O 79 HIS~? 5.21 CL CL O2018 D 246 HIS O 76 HIS~? 4.51 CL CL O2018s D 255 TYR O 157 TYR.? 6.41 O2 GOL O3013 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 121.98 131.53 158.56 121.09 129.74 157.92 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 126.10 133.61 164.62 125.01 132.87 166.26 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 123.23 139.38 167.80 126.05 139.22 167.65 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 40 3 # 40 D 199 HIS O 125 HIS.? 7.09 CL CL O2018 D 246 HIS O 76 HIS~? 4.51 CL CL O2018s D 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 126.97 124.39 163.68 126.90 122.97 165.24 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 126.10 133.61 164.62 125.01 132.87 166.26 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 41 3 # 41 D 199 HIS O 125 HIS.? 7.09 CL CL O2018 D 246 HIS O 79 HIS~? 5.21 CL CL O2018 D 255 TYR O 75 TYR~? 10.24 CL CL O2018 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 126.97 124.39 163.68 126.90 122.97 165.24 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 121.98 131.53 158.56 121.09 129.74 157.92 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 127.87 136.17 156.70 127.95 137.50 154.23 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 42 3 # 42 D 199 HIS P 79 HIS~? 5.38 CL CL P2019 D 246 HIS P 76 HIS~? 4.69 CL CL P2019s D 255 TYR P 157 TYR.? 6.12 O2 GOL P3014 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 212.25 178.47 210.26 213.09 179.27 212.01 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 207.59 172.73 208.38 208.33 171.09 209.49 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 210.70 168.63 203.45 207.96 169.02 203.20 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 43 3 # 43 D 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 D 246 HIS P 76 HIS~? 4.69 CL CL P2019s D 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 205.78 175.00 217.63 205.21 173.76 219.23 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 207.59 172.73 208.38 208.33 171.09 209.49 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 207.22 180.36 204.70 207.43 182.65 203.13 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 44 3 # 44 D 199 HIS P 125 HIS.? 6.57 O3 GOL P3034 D 246 HIS P 79 HIS~? 5.38 CL CL P2019 D 255 TYR P 75 TYR~? 10.23 CL CL P2019 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 205.78 175.00 217.63 205.21 173.76 219.23 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 212.25 178.47 210.26 213.09 179.27 212.01 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 207.22 180.36 204.70 207.43 182.65 203.13 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 44 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 58 GLY.? 25.44 O1 GOL A3040 A 501 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 367 TYR E 21 TYR~? 14.13 O1 GOL E3004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 72.01 82.97 38.85 71.63 83.18 39.53 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 90.44 78.16 48.76 91.65 76.94 50.06 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 60.20 97.64 59.27 57.81 96.28 59.79 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 58 GLY.? 18.09 O1 GOL B3003 A 501 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 367 TYR F 21 TYR~? 26.08 O1 GOL B3017 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 44.56 63.99 18.46 44.83 63.17 18.52 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 23.66 59.02 20.34 21.93 58.32 21.38 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 54.13 38.92 10.51 56.02 38.27 12.47 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY C 58 GLY.? 18.89 CL CL C2006 A 501 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 367 TYR G 21 TYR~? 10.57 CL CL C2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 61.95 21.22 71.14 61.69 21.11 70.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 82.81 22.02 65.69 84.52 22.80 64.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 52.17 8.74 48.00 50.23 10.55 47.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY D 58 GLY.? 18.13 O1 GOL D3005 A 501 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 367 TYR H 21 TYR~? 10.50 CL CL H2005 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 35.29 45.78 85.57 35.70 46.47 85.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 16.94 54.59 79.01 15.65 55.42 77.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 47.46 68.84 95.61 49.74 68.96 94.05 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY E 58 GLY.? 18.36 O1 GOL E3004 A 501 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 367 TYR A 21 TYR~? 26.32 C3 GOL E3035 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 42.49 88.38 61.38 42.87 88.40 60.61 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 23.07 86.29 52.35 21.57 85.17 51.32 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 56.96 96.11 38.73 58.94 94.19 38.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY F 58 GLY.? 9.01 CL CL F2035 A 501 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 367 TYR B 21 TYR~? 13.85 C1 GOL B3003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 68.80 35.71 23.84 68.57 36.47 23.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 88.86 41.25 28.96 90.30 42.22 30.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 61.46 58.47 9.41 59.23 59.36 10.88 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY G 58 GLY.? 18.83 CL CL C2006 A 501 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 367 TYR C 21 TYR~? 10.49 CL CL C2004 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 37.54 20.92 42.39 37.85 20.95 43.17 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 17.70 27.34 47.09 16.19 28.71 47.73 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 45.13 11.15 67.52 47.31 12.70 68.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY H 58 GLY.? 17.64 O3 GOL H3006 A 501 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 367 TYR D 21 TYR~? 10.58 CL CL H2005 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 65.05 68.68 85.82 64.63 67.97 85.93 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 84.24 58.93 85.48 85.73 57.59 84.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 50.45 48.27 98.24 48.40 47.71 96.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY I 58 GLY.? 18.81 CL CL I2007 A 501 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 367 TYR M 21 TYR~? 10.54 CL CL I2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 185.16 199.62 154.81 184.82 199.83 155.56 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 204.37 195.46 163.61 205.75 194.30 164.79 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 173.68 213.02 176.47 171.32 211.57 177.01 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY J 58 GLY.? 21.75 CL CL J2002 A 501 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 367 TYR N 21 TYR~? 10.52 CL CL J2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 157.87 180.66 134.88 158.15 179.86 134.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 137.44 174.60 137.57 135.80 173.80 138.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.15 156.47 125.36 170.14 155.81 127.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY K 58 GLY.? 18.35 O1 GOL K3011 A 501 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 367 TYR O 21 TYR~? 14.79 CL CL K2003 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 179.79 136.37 184.44 179.50 136.20 183.68 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 200.17 138.24 178.11 201.77 139.28 177.19 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 169.50 124.29 161.32 167.44 126.02 160.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY L 58 GLY.? 20.77 O3 GOL L3028 A 501 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 367 TYR P 21 TYR~? 24.07 O1 GOL L3028 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 152.51 158.63 201.46 152.89 159.37 201.52 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 133.34 166.97 196.27 132.03 168.03 194.96 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 164.13 181.87 211.82 166.34 182.20 210.17 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY M 58 GLY.? 18.41 O2 GOL M3007 A 501 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 367 TYR I 21 TYR~? 10.49 CL CL I2001 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 156.56 202.96 179.07 156.91 202.98 178.30 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 136.87 200.18 170.79 135.36 199.08 169.77 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 169.47 212.28 156.01 171.53 210.49 155.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY N 58 GLY.? 17.87 O3 GOL N3008 A 501 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 367 TYR J 21 TYR~? 10.46 CL CL J2002 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 183.43 153.24 137.84 183.14 154.05 137.70 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.51 159.51 142.26 205.02 160.53 143.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 174.52 176.28 124.74 172.25 177.04 126.20 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY O 58 GLY.? 13.15 CL CL O2036 A 501 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 367 TYR K 21 TYR~? 13.85 O1 GOL K3011 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 154.09 136.29 157.02 154.38 136.21 157.78 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 134.07 141.35 162.95 132.57 142.58 163.78 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 163.15 125.72 181.32 165.33 127.37 181.87 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY P 58 GLY.? 25.31 O1 GOL P3034 A 501 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 367 TYR L 21 TYR~? 30.92 O3 GOL K3011 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 181.27 182.97 201.43 180.87 182.24 201.54 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 200.75 174.15 199.66 202.28 173.10 198.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.26 161.38 213.44 166.20 160.80 211.67 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 16 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 58 GLY.? 25.44 O1 GOL A3040 D 501 ASP A 70 ASP~? -9.95 O3 GOL A3037s E 367 TYR E 21 TYR~? 14.13 O1 GOL E3004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 72.01 82.97 38.85 71.63 83.18 39.53 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 90.44 78.16 48.76 91.65 76.94 50.06 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 60.20 97.64 59.27 57.81 96.28 59.79 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 58 GLY.? 18.09 O1 GOL B3003 D 501 ASP B 70 ASP~? -3.24 O2 GOL B3024s E 367 TYR F 21 TYR~? 26.08 O1 GOL B3017 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 44.56 63.99 18.46 44.83 63.17 18.52 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 23.66 59.02 20.34 21.93 58.32 21.38 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 54.13 38.92 10.51 56.02 38.27 12.47 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY C 58 GLY.? 18.89 CL CL C2006 D 501 ASP C 70 ASP~? 3.38 O1 GOL C3036s E 367 TYR G 21 TYR~? 10.57 CL CL C2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 61.95 21.22 71.14 61.69 21.11 70.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 82.81 22.02 65.69 84.52 22.80 64.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 52.17 8.74 48.00 50.23 10.55 47.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY D 58 GLY.? 18.13 O1 GOL D3005 D 501 ASP D 70 ASP~? -11.51 O3 GOL D3019s E 367 TYR H 21 TYR~? 10.50 CL CL H2005 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 35.29 45.78 85.57 35.70 46.47 85.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 16.94 54.59 79.01 15.65 55.42 77.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 47.46 68.84 95.61 49.74 68.96 94.05 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY E 58 GLY.? 18.36 O1 GOL E3004 D 501 ASP E 70 ASP~? 5.56 O3 GOL E3002 E 367 TYR A 21 TYR~? 26.32 C3 GOL E3035 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 42.49 88.38 61.38 42.87 88.40 60.61 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 23.07 86.29 52.35 21.57 85.17 51.32 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 56.96 96.11 38.73 58.94 94.19 38.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY F 58 GLY.? 9.01 CL CL F2035 D 501 ASP F 70 ASP~? -11.57 O3 GOL F3039s E 367 TYR B 21 TYR~? 13.85 C1 GOL B3003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 68.80 35.71 23.84 68.57 36.47 23.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 88.86 41.25 28.96 90.30 42.22 30.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 61.46 58.47 9.41 59.23 59.36 10.88 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY G 58 GLY.? 18.83 CL CL C2006 D 501 ASP G 70 ASP~? -5.29 C3 GOL G3001s E 367 TYR C 21 TYR~? 10.49 CL CL C2004 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 37.54 20.92 42.39 37.85 20.95 43.17 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 17.70 27.34 47.09 16.19 28.71 47.73 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 45.13 11.15 67.52 47.31 12.70 68.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY H 58 GLY.? 17.64 O3 GOL H3006 D 501 ASP H 70 ASP~? -4.05 C3 GOL H3016s E 367 TYR D 21 TYR~? 10.58 CL CL H2005 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 65.05 68.68 85.82 64.63 67.97 85.93 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 84.24 58.93 85.48 85.73 57.59 84.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 50.45 48.27 98.24 48.40 47.71 96.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY I 58 GLY.? 18.81 CL CL I2007 D 501 ASP I 70 ASP~? -3.65 C2 GOL I3032s E 367 TYR M 21 TYR~? 10.54 CL CL I2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 185.16 199.62 154.81 184.82 199.83 155.56 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 204.37 195.46 163.61 205.75 194.30 164.79 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 173.68 213.02 176.47 171.32 211.57 177.01 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY J 58 GLY.? 21.75 CL CL J2002 D 501 ASP J 70 ASP~? 11.68 O1 GOL J3033 E 367 TYR N 21 TYR~? 10.52 CL CL J2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 157.87 180.66 134.88 158.15 179.86 134.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 137.44 174.60 137.57 135.80 173.80 138.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.15 156.47 125.36 170.14 155.81 127.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY K 58 GLY.? 18.35 O1 GOL K3011 D 501 ASP K 70 ASP~? -4.89 O3 GOL K3009s E 367 TYR O 21 TYR~? 14.79 CL CL K2003 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 179.79 136.37 184.44 179.50 136.20 183.68 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 200.17 138.24 178.11 201.77 139.28 177.19 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 169.50 124.29 161.32 167.44 126.02 160.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY L 58 GLY.? 20.77 O3 GOL L3028 D 501 ASP L 70 ASP~? -12.27 O3 GOL L3028s E 367 TYR P 21 TYR~? 24.07 O1 GOL L3028 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 152.51 158.63 201.46 152.89 159.37 201.52 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 133.34 166.97 196.27 132.03 168.03 194.96 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 164.13 181.87 211.82 166.34 182.20 210.17 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY M 58 GLY.? 18.41 O2 GOL M3007 D 501 ASP M 70 ASP~? -9.98 O3 GOL M3042s E 367 TYR I 21 TYR~? 10.49 CL CL I2001 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 156.56 202.96 179.07 156.91 202.98 178.30 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 136.87 200.18 170.79 135.36 199.08 169.77 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 169.47 212.28 156.01 171.53 210.49 155.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY N 58 GLY.? 17.87 O3 GOL N3008 D 501 ASP N 70 ASP~? -3.26 O2 GOL N3029s E 367 TYR J 21 TYR~? 10.46 CL CL J2002 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 183.43 153.24 137.84 183.14 154.05 137.70 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.51 159.51 142.26 205.02 160.53 143.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 174.52 176.28 124.74 172.25 177.04 126.20 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY O 58 GLY.? 13.15 CL CL O2036 D 501 ASP O 70 ASP~? 3.30 O1 GOL O3013s E 367 TYR K 21 TYR~? 13.85 O1 GOL K3011 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 154.09 136.29 157.02 154.38 136.21 157.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 134.07 141.35 162.95 132.57 142.58 163.78 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 163.15 125.72 181.32 165.33 127.37 181.87 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY P 58 GLY.? 25.31 O1 GOL P3034 D 501 ASP P 70 ASP~? 4.30 O3 GOL P3014 E 367 TYR L 21 TYR~? 30.92 O3 GOL K3011 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 181.27 182.97 201.43 180.87 182.24 201.54 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 200.75 174.15 199.66 202.28 173.10 198.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.26 161.38 213.44 166.20 160.80 211.67 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 16 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 28 ASP~? 35.69 O2 GOL E3035 A 55 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 84 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 11.09 42.89 24.44 11.32 42.06 22.49 62.23 105.49 38.88 63.59 105.50 37.26 coo 4.60 40.33 20.42 7.25 39.50 20.05 59.25 100.54 36.63 61.78 101.51 37.35 coo 9.71 44.83 15.47 10.13 41.43 19.93 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 55 TYR B 35 TYR~? 15.50 C1 GOL B3003 A 84 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 11.09 42.89 24.44 11.32 42.06 22.49 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 4.60 40.33 20.42 7.25 39.50 20.05 60.35 59.88 4.36 57.88 59.60 3.08 coo 9.71 44.83 15.47 10.13 41.43 19.93 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP C 28 ASP~? 15.70 CL CL C2004 A 55 TYR C 35 TYR~? 12.95 CL CL C2004 A 84 LYS C 22 LYS~? 13.40 CL CL C2004 coo 11.09 42.89 24.44 11.32 42.06 22.49 48.49 0.93 68.23 49.38 0.74 70.13 coo 4.60 40.33 20.42 7.25 39.50 20.05 45.94 6.51 69.90 48.30 5.07 69.65 coo 9.71 44.83 15.47 10.13 41.43 19.93 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP D 28 ASP~? 15.80 CL CL H2005 A 55 TYR D 35 TYR~? 13.02 CL CL H2005 A 84 LYS D 22 LYS~? 13.25 CL CL H2005 coo 11.09 42.89 24.44 11.32 42.06 22.49 45.36 50.43 107.49 43.88 48.98 107.89 coo 4.60 40.33 20.42 7.25 39.50 20.05 48.27 47.24 102.95 45.77 48.18 103.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 55 TYR E 35 TYR~? 15.88 O1 GOL E3004 A 84 LYS E 22 LYS~? 21.81 O1 GOL E3004 coo 11.09 42.89 24.44 11.32 42.06 22.49 57.09 107.82 57.29 55.83 108.40 58.91 coo 4.60 40.33 20.42 7.25 39.50 20.05 58.94 102.78 60.36 56.69 104.19 59.52 coo 9.71 44.83 15.47 10.13 41.43 19.93 64.37 100.86 56.32 69.54 97.12 56.69 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP F 28 ASP~? 32.62 CL CL F2035 A 55 TYR F 35 TYR~? 30.41 CL CL F2035 A 84 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 11.09 42.89 24.44 11.32 42.06 22.49 59.39 38.13 1.08 60.39 36.31 1.06 coo 4.60 40.33 20.42 7.25 39.50 20.05 55.89 36.47 6.05 58.49 36.69 5.11 coo 9.71 44.83 15.47 10.13 41.43 19.93 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP G 28 ASP~? 15.85 CL CL C2004 A 55 TYR G 35 TYR~? 13.11 CL CL C2004 A 84 LYS G 22 LYS~? 13.25 CL CL C2004 coo 11.09 42.89 24.44 11.32 42.06 22.49 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 4.60 40.33 20.42 7.25 39.50 20.05 50.35 3.70 46.66 47.74 2.77 47.00 coo 9.71 44.83 15.47 10.13 41.43 19.93 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP H 28 ASP~? 15.80 CL CL H2005 A 55 TYR H 35 TYR~? 13.05 CL CL H2005 A 84 LYS H 22 LYS~? 13.32 CL CL H2005 coo 11.09 42.89 24.44 11.32 42.06 22.49 50.63 68.82 106.06 51.93 70.45 106.39 coo 4.60 40.33 20.42 7.25 39.50 20.05 48.71 70.98 100.43 50.94 70.32 101.95 coo 9.71 44.83 15.47 10.13 41.43 19.93 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP I 28 ASP~? 15.71 CL CL I2001 A 55 TYR I 35 TYR~? 13.03 CL CL I2001 A 84 LYS I 22 LYS~? 13.37 CL CL I2001 coo 11.09 42.89 24.44 11.32 42.06 22.49 174.34 221.90 156.42 175.71 222.11 154.83 coo 4.60 40.33 20.42 7.25 39.50 20.05 171.46 216.91 154.12 173.98 218.04 154.69 coo 9.71 44.83 15.47 10.13 41.43 19.93 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 10 3 # 10 A 50 ASP J 28 ASP~? 15.67 CL CL J2002 A 55 TYR J 35 TYR~? 13.02 CL CL J2002 A 84 LYS J 22 LYS~? 13.36 CL CL J2002 coo 11.09 42.89 24.44 11.32 42.06 22.49 170.87 175.19 114.50 169.74 176.91 114.00 coo 4.60 40.33 20.42 7.25 39.50 20.05 173.30 177.82 119.58 170.88 177.40 118.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 11 3 # 11 A 50 ASP K 28 ASP~? 19.61 O1 GOL K3011 A 55 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 84 LYS K 22 LYS~? 17.74 CL CL K2003 coo 11.09 42.89 24.44 11.32 42.06 22.49 166.96 115.59 181.42 167.86 115.34 183.30 coo 4.60 40.33 20.42 7.25 39.50 20.05 164.29 120.92 183.43 166.71 119.58 183.22 coo 9.71 44.83 15.47 10.13 41.43 19.93 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 12 3 # 12 A 50 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 55 TYR L 35 TYR~? 33.75 O3 GOL K3011 A 84 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 11.09 42.89 24.44 11.32 42.06 22.49 163.49 162.78 223.08 162.21 161.15 223.46 coo 4.60 40.33 20.42 7.25 39.50 20.05 166.36 159.94 218.26 163.88 160.60 219.34 coo 9.71 44.83 15.47 10.13 41.43 19.93 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 13 3 # 13 A 50 ASP M 28 ASP~? 15.52 CL CL I2001 A 55 TYR M 35 TYR~? 13.00 CL CL I2001 A 84 LYS M 22 LYS~? 13.38 CL CL I2001 coo 11.09 42.89 24.44 11.32 42.06 22.49 170.27 223.20 174.57 168.89 223.83 176.08 coo 4.60 40.33 20.42 7.25 39.50 20.05 172.26 218.21 177.69 169.95 219.60 176.96 coo 9.71 44.83 15.47 10.13 41.43 19.93 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 14 3 # 14 A 50 ASP N 28 ASP~? 15.68 CL CL J2002 A 55 TYR N 35 TYR~? 13.09 CL CL J2002 A 84 LYS N 22 LYS~? 13.40 CL CL J2002 coo 11.09 42.89 24.44 11.32 42.06 22.49 173.04 156.37 115.74 174.12 154.54 115.64 coo 4.60 40.33 20.42 7.25 39.50 20.05 169.83 154.24 120.71 172.41 154.64 119.66 coo 9.71 44.83 15.47 10.13 41.43 19.93 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 15 3 # 15 A 50 ASP O 28 ASP~? 23.95 CL CL O2036 A 55 TYR O 35 TYR~? 20.32 CL CL K2003 A 84 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 11.09 42.89 24.44 11.32 42.06 22.49 164.72 114.57 162.31 163.52 114.24 160.62 coo 4.60 40.33 20.42 7.25 39.50 20.05 167.80 119.41 159.74 165.27 118.34 160.26 coo 9.71 44.83 15.47 10.13 41.43 19.93 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 16 3 # 16 A 50 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 55 TYR P 35 TYR~? 28.94 O1 GOL L3028 A 84 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 11.09 42.89 24.44 11.32 42.06 22.49 167.75 181.83 222.09 168.94 183.53 222.37 coo 4.60 40.33 20.42 7.25 39.50 20.05 165.51 183.94 216.71 167.90 183.49 218.05 coo 9.71 44.83 15.47 10.13 41.43 19.93 160.29 179.27 215.80 155.06 178.69 212.33 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 16 hits 1mrq_c02 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 166 GLN~? 20.22 O2 GOL A3037 328 ASN A 162 ASN~? 20.80 CL CL A2020 409 GLU A 163 GLU~? 14.44 O2 GOL A3037 coo 45.09 114.33 52.30 45.59 116.18 51.29 106.23 68.64 45.05 106.26 67.90 47.02 coo 41.10 116.46 52.80 42.09 116.00 54.64 110.86 71.03 47.42 111.08 69.19 46.38 coo 42.69 118.64 56.27 44.58 118.34 55.45 106.73 71.90 50.38 106.39 72.49 52.36 ULMN 3 1myr_c00 MYROSINASE user 2 3 # 2 187 GLN B 166 GLN~? 13.97 O3 GOL B3015 328 ASN B 162 ASN~? 18.91 O3 GOL B3015 409 GLU B 163 GLU~? 11.65 O3 GOL B3015 coo 45.09 114.33 52.30 45.59 116.18 51.29 7.49 67.50 24.43 7.04 65.69 25.53 coo 41.10 116.46 52.80 42.09 116.00 54.64 3.18 65.96 21.79 2.54 67.75 22.68 coo 42.69 118.64 56.27 44.58 118.34 55.45 6.39 62.04 22.34 6.51 59.97 22.27 ULMN 3 1myr_c00 MYROSINASE user 3 3 # 3 187 GLN C 166 GLN~? 4.34 CL CL C2031 328 ASN C 162 ASN~? -4.56 CL CL C2031s 409 GLU C 163 GLU~? 4.89 CL CL C2031 coo 45.09 114.33 52.30 45.59 116.18 51.29 99.43 27.39 72.68 100.38 27.44 70.70 coo 41.10 116.46 52.80 42.09 116.00 54.64 103.70 24.43 71.40 105.80 24.17 71.94 coo 42.69 118.64 56.27 44.58 118.34 55.45 100.18 24.25 67.88 99.96 23.77 65.85 ULMN 3 1myr_c00 MYROSINASE user 4 3 # 4 187 GLN E 166 GLN~? 14.31 O1 GOL E3002 328 ASN E 162 ASN~? 18.79 O1 GOL E3002 409 GLU E 163 GLU~? 11.74 O1 GOL E3002 coo 45.09 114.33 52.30 45.59 116.18 51.29 5.52 81.96 57.48 5.30 80.80 55.69 coo 41.10 116.46 52.80 42.09 116.00 54.64 1.60 84.75 54.79 0.68 83.54 56.28 coo 42.69 118.64 56.27 44.58 118.34 55.45 5.75 84.10 51.71 6.08 84.26 49.61 ULMN 3 1myr_c00 MYROSINASE user 5 3 # 5 187 GLN F 166 GLN~? 21.12 CL CL F2023 328 ASN F 162 ASN~? 20.44 CL CL F2023 409 GLU F 163 GLU~? 16.81 CL CL F2023 coo 45.09 114.33 52.30 45.59 116.18 51.29 103.62 34.05 38.32 104.43 35.87 39.06 coo 41.10 116.46 52.80 42.09 116.00 54.64 108.49 35.42 36.44 110.53 34.82 36.67 coo 42.69 118.64 56.27 44.58 118.34 55.45 105.09 39.28 35.27 105.30 41.23 34.49 ULMN 3 1myr_c00 MYROSINASE user 6 3 # 6 187 GLN G 166 GLN~? 15.15 O3 GOL G3001 328 ASN G 162 ASN~? 17.59 O3 GOL G3001 409 GLU G 163 GLU~? 11.22 O3 GOL G3001 coo 45.09 114.33 52.30 45.59 116.18 51.29 2.96 35.06 38.24 2.53 36.35 39.90 coo 41.10 116.46 52.80 42.09 116.00 54.64 -1.80 33.61 39.96 -0.92 35.33 39.04 coo 42.69 118.64 56.27 44.58 118.34 55.45 1.42 33.23 43.78 1.39 32.97 45.86 ULMN 3 1myr_c00 MYROSINASE user 7 3 # 7 187 GLN H 166 GLN~? 16.27 O1 GOL H3016 328 ASN H 162 ASN~? 19.79 CL CL H2024 409 GLU H 163 GLU~? 16.69 O1 GOL H3016 coo 45.09 114.33 52.30 45.59 116.18 51.29 101.81 62.69 80.18 102.06 60.81 79.30 coo 41.10 116.46 52.80 42.09 116.00 54.64 105.86 60.31 83.22 107.86 60.06 84.05 coo 42.69 118.64 56.27 44.58 118.34 55.45 101.55 57.39 83.25 101.29 55.39 84.02 ULMN 3 1myr_c00 MYROSINASE user 8 3 # 8 187 GLN I 166 GLN~? 17.50 O3 GOL I3032 328 ASN I 162 ASN~? 21.04 CL CL I2025 409 GLU I 163 GLU~? 16.56 O3 GOL I3032 coo 45.09 114.33 52.30 45.59 116.18 51.29 220.47 187.37 158.82 220.07 186.40 160.66 coo 41.10 116.46 52.80 42.09 116.00 54.64 225.18 189.96 161.14 225.82 188.37 160.00 coo 42.69 118.64 56.27 44.58 118.34 55.45 221.15 190.35 164.07 220.95 190.90 166.06 ULMN 3 1myr_c00 MYROSINASE user 9 3 # 9 187 GLN J 166 GLN~? 20.11 O1 GOL J3033 328 ASN J 162 ASN~? 20.00 CL CL J2026 409 GLU J 163 GLU~? 14.80 O1 GOL J3033 coo 45.09 114.33 52.30 45.59 116.18 51.29 121.19 182.02 143.22 120.95 180.21 144.33 coo 41.10 116.46 52.80 42.09 116.00 54.64 116.58 180.36 140.72 114.44 180.36 140.30 coo 42.69 118.64 56.27 44.58 118.34 55.45 120.24 176.69 140.95 120.35 174.56 140.67 ULMN 3 1myr_c00 MYROSINASE user 10 3 # 10 187 GLN K 166 GLN~? 15.82 C1 GOL K3009 328 ASN K 162 ASN~? 20.55 CL CL K2027 409 GLU K 163 GLU~? 12.51 O2 GOL K3009 coo 45.09 114.33 52.30 45.59 116.18 51.29 216.30 144.78 185.12 216.83 145.57 183.22 coo 41.10 116.46 52.80 42.09 116.00 54.64 220.99 141.86 183.52 222.93 141.99 184.43 coo 42.69 118.64 56.27 44.58 118.34 55.45 217.27 141.62 179.80 217.24 141.01 177.77 ULMN 3 1myr_c00 MYROSINASE user 11 3 # 11 187 GLN L 166 GLN~? 20.21 CL CL L2028 328 ASN L 162 ASN~? 19.26 CL CL L2028 409 GLU L 163 GLU~? 16.77 CL CL L2028 coo 45.09 114.33 52.30 45.59 116.18 51.29 116.52 161.43 189.18 115.71 163.43 188.74 coo 41.10 116.46 52.80 42.09 116.00 54.64 112.25 163.92 191.15 110.27 164.53 191.77 coo 42.69 118.64 56.27 44.58 118.34 55.45 116.58 166.98 191.20 116.69 169.04 191.44 ULMN 3 1myr_c00 MYROSINASE user 12 3 # 12 187 GLN M 166 GLN~? 21.00 C2 GOL M3042 328 ASN M 162 ASN~? 21.06 CL CL M2029 409 GLU M 163 GLU~? 14.80 C2 GOL M3042 coo 45.09 114.33 52.30 45.59 116.18 51.29 119.90 194.72 176.46 120.18 192.88 175.40 coo 41.10 116.46 52.80 42.09 116.00 54.64 115.58 197.49 173.95 115.83 195.56 174.88 coo 42.69 118.64 56.27 44.58 118.34 55.45 119.51 197.10 170.73 120.12 197.15 168.74 ULMN 3 1myr_c00 MYROSINASE user 13 3 # 13 187 GLN N 166 GLN~? 15.48 O1 GOL N3012 328 ASN N 162 ASN~? 20.47 O1 GOL N3012 409 GLU N 163 GLU~? 12.29 O1 GOL N3012 coo 45.09 114.33 52.30 45.59 116.18 51.29 218.83 152.49 150.52 219.21 154.40 151.36 coo 41.10 116.46 52.80 42.09 116.00 54.64 223.57 153.98 148.46 225.62 153.32 148.64 coo 42.69 118.64 56.27 44.58 118.34 55.45 220.21 157.81 147.58 220.09 159.81 146.98 ULMN 3 1myr_c00 MYROSINASE user 14 3 # 14 187 GLN O 166 GLN~? 15.76 O3 GOL O3013 328 ASN O 162 ASN~? 20.65 O3 GOL O3013 409 GLU O 163 GLU~? 12.66 O3 GOL O3013 coo 45.09 114.33 52.30 45.59 116.18 51.29 118.57 148.69 155.27 118.42 149.92 157.00 coo 41.10 116.46 52.80 42.09 116.00 54.64 113.68 146.60 157.20 111.65 146.01 156.91 coo 42.69 118.64 56.27 44.58 118.34 55.45 117.45 146.43 160.85 117.44 146.23 162.92 ULMN 3 1myr_c00 MYROSINASE user 15 3 # 15 187 GLN P 166 GLN~? 15.12 O1 GOL P3014 328 ASN P 162 ASN~? 19.02 O2 GOL P3014 409 GLU P 163 GLU~? 11.95 O2 GOL P3014 coo 45.09 114.33 52.30 45.59 116.18 51.29 217.71 179.11 193.44 217.65 177.49 192.12 coo 41.10 116.46 52.80 42.09 116.00 54.64 222.14 176.71 196.35 222.77 177.56 194.52 coo 42.69 118.64 56.27 44.58 118.34 55.45 218.06 173.97 196.16 217.79 171.96 196.61 1myr_c00 source 1myr MYROSINASE : 15 hits 1myr_c00 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS D 125 HIS.? -3.96 O3 GOL D3018s A 197 ASP D 127 ASP.? 11.17 CL CL D2012 A 223 ALA D 77 ALA~? 7.20 C1 GOL D3020 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 9.12 57.04 95.76 9.45 58.59 97.15 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 7.65 47.79 93.97 7.18 46.10 95.19 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 6.55 56.57 82.37 7.24 56.79 81.03 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS E 125 HIS.? 5.41 C3 GOL E3022 A 197 ASP E 127 ASP.? 11.39 CL CL E2013 A 223 ALA E 77 ALA~? 8.91 CL CL E2013 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 19.41 104.46 50.06 20.14 105.76 48.58 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 17.80 103.20 59.40 17.93 103.89 61.44 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 13.89 92.05 50.21 14.20 90.55 50.08 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS F 125 HIS.? 6.27 C1 GOL F3039 A 197 ASP F 127 ASP.? 10.85 CL CL F2034 A 223 ALA F 77 ALA~? 8.70 CL CL F2034 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 96.50 38.92 12.23 96.44 40.22 10.57 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 96.13 30.12 15.93 96.25 28.10 15.23 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 99.32 40.41 25.48 98.76 40.99 26.78 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS G 125 HIS.? 6.66 C2 GOL G3038 A 197 ASP G 127 ASP.? 12.80 CL CL G2033 A 223 ALA G 77 ALA~? 7.25 O3 GOL G3001 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 9.81 10.31 48.06 9.47 8.80 49.48 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 10.22 12.11 38.73 10.33 11.10 36.86 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 7.15 23.73 47.01 7.71 25.14 47.31 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS I 125 HIS.? 6.50 O2 GOL I3031 A 197 ASP I 127 ASP.? 10.93 CL CL I2015 A 223 ALA I 77 ALA~? 9.03 CL CL I2015 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 211.42 212.80 162.96 211.20 214.50 164.16 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 212.49 209.49 154.15 212.74 210.27 152.16 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 214.62 199.75 164.52 214.07 198.37 164.98 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS J 125 HIS.? -4.00 O3 GOL J3030s A 197 ASP J 127 ASP.? 11.08 CL CL J2016 A 223 ALA J 77 ALA~? 7.22 O2 GOL J3033 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 132.43 173.86 119.73 132.77 172.30 118.36 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 132.13 183.26 121.62 132.41 185.18 120.66 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 127.70 174.36 132.33 128.03 174.02 133.80 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS L 125 HIS.? 5.88 O2 GOL L3027 A 197 ASP L 127 ASP.? 11.05 CL CL L2009 A 223 ALA L 77 ALA~? 8.83 CL CL L2009 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 126.56 168.90 213.47 127.02 170.42 214.85 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 124.97 159.68 211.55 124.68 157.87 212.62 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 123.16 168.73 200.29 123.66 168.91 198.87 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS M 125 HIS.? 4.98 C3 GOL M3043 A 197 ASP M 127 ASP.? 9.06 CL CL M2017 A 223 ALA M 77 ALA~? 6.98 C2 GOL M3042 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 132.19 217.95 169.15 132.87 219.15 167.56 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 130.79 216.32 178.32 129.76 218.07 177.66 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 127.30 205.48 169.06 127.68 204.04 168.84 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS O 125 HIS.? 7.09 CL CL O2018 A 197 ASP O 127 ASP.? 11.33 CL CL O2018 A 223 ALA O 77 ALA~? 8.55 O1 GOL O3013 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 126.97 124.39 163.68 126.90 122.97 165.24 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 127.12 126.29 154.29 127.00 125.34 152.37 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 123.76 137.25 163.23 124.22 138.65 163.60 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS P 125 HIS.? 6.57 O3 GOL P3034 A 197 ASP P 127 ASP.? 11.05 CL CL P2019 A 223 ALA P 77 ALA~? 8.06 O2 GOL P3014 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 205.78 175.00 217.63 205.21 173.76 219.23 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 207.19 183.81 214.61 207.22 185.89 215.11 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 210.48 173.29 204.91 210.13 172.95 203.48 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 10 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS D 125 HIS.? -3.96 O3 GOL D3018s B 197 ASP D 127 ASP.? 11.17 CL CL D2012 B 223 ALA D 77 ALA~? 7.20 C1 GOL D3020 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 9.12 57.04 95.76 9.45 58.59 97.15 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 7.65 47.79 93.97 7.18 46.10 95.19 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 6.55 56.57 82.37 7.24 56.79 81.03 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS E 125 HIS.? 5.41 C3 GOL E3022 B 197 ASP E 127 ASP.? 11.39 CL CL E2013 B 223 ALA E 77 ALA~? 8.91 CL CL E2013 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 19.41 104.46 50.06 20.14 105.76 48.58 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 17.80 103.20 59.40 17.93 103.89 61.44 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 13.89 92.05 50.21 14.20 90.55 50.08 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS F 125 HIS.? 6.27 C1 GOL F3039 B 197 ASP F 127 ASP.? 10.85 CL CL F2034 B 223 ALA F 77 ALA~? 8.70 CL CL F2034 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 96.50 38.92 12.23 96.44 40.22 10.57 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 96.13 30.12 15.93 96.25 28.10 15.23 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 99.32 40.41 25.48 98.76 40.99 26.78 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS G 125 HIS.? 6.66 C2 GOL G3038 B 197 ASP G 127 ASP.? 12.80 CL CL G2033 B 223 ALA G 77 ALA~? 7.25 O3 GOL G3001 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 9.81 10.31 48.06 9.47 8.80 49.48 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 10.22 12.11 38.73 10.33 11.10 36.86 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 7.15 23.73 47.01 7.71 25.14 47.31 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS I 125 HIS.? 6.50 O2 GOL I3031 B 197 ASP I 127 ASP.? 10.93 CL CL I2015 B 223 ALA I 77 ALA~? 9.03 CL CL I2015 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 211.42 212.80 162.96 211.20 214.50 164.16 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 212.49 209.49 154.15 212.74 210.27 152.16 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 214.62 199.75 164.52 214.07 198.37 164.98 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS J 125 HIS.? -4.00 O3 GOL J3030s B 197 ASP J 127 ASP.? 11.08 CL CL J2016 B 223 ALA J 77 ALA~? 7.22 O2 GOL J3033 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 132.43 173.86 119.73 132.77 172.30 118.36 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 132.13 183.26 121.62 132.41 185.18 120.66 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 127.70 174.36 132.33 128.03 174.02 133.80 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS L 125 HIS.? 5.88 O2 GOL L3027 B 197 ASP L 127 ASP.? 11.05 CL CL L2009 B 223 ALA L 77 ALA~? 8.83 CL CL L2009 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 126.56 168.90 213.47 127.02 170.42 214.85 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 124.97 159.68 211.55 124.68 157.87 212.62 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 123.16 168.73 200.29 123.66 168.91 198.87 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS M 125 HIS.? 4.98 C3 GOL M3043 B 197 ASP M 127 ASP.? 9.06 CL CL M2017 B 223 ALA M 77 ALA~? 6.98 C2 GOL M3042 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 132.19 217.95 169.15 132.87 219.15 167.56 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 130.79 216.32 178.32 129.76 218.07 177.66 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 127.30 205.48 169.06 127.68 204.04 168.84 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS O 125 HIS.? 7.09 CL CL O2018 B 197 ASP O 127 ASP.? 11.33 CL CL O2018 B 223 ALA O 77 ALA~? 8.55 O1 GOL O3013 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 126.97 124.39 163.68 126.90 122.97 165.24 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 127.12 126.29 154.29 127.00 125.34 152.37 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 123.76 137.25 163.23 124.22 138.65 163.60 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS P 125 HIS.? 6.57 O3 GOL P3034 B 197 ASP P 127 ASP.? 11.05 CL CL P2019 B 223 ALA P 77 ALA~? 8.06 O2 GOL P3014 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 205.78 175.00 217.63 205.21 173.76 219.23 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 207.19 183.81 214.61 207.22 185.89 215.11 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 210.48 173.29 204.91 210.13 172.95 203.48 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 10 hits 1n2t_c03 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 93 GLU~? 8.07 CL CL A2020 B 128 HIS A 76 HIS~? -4.53 C1 GOL A3037s C 263 HIS A 158 HIS.? 6.53 O1 GOL A3037 coo 6.12 5.94 82.00 7.16 6.32 83.81 106.40 86.90 39.80 107.05 88.84 40.38 coo 12.51 16.35 80.99 13.16 14.90 82.37 98.60 85.60 50.46 99.38 86.61 52.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 106.32 81.43 56.18 105.60 83.26 56.91 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 B 128 HIS A 151 HIS~? -11.70 O3 GOL A3037s C 263 HIS A 76 HIS~? -4.53 C1 GOL A3037s coo 6.12 5.94 82.00 7.16 6.32 83.81 106.73 71.90 50.38 106.39 72.49 52.36 coo 12.51 16.35 80.99 13.16 14.90 82.37 94.27 72.58 51.14 93.29 74.44 51.00 coo 11.58 14.94 93.26 12.25 14.03 91.50 98.60 85.60 50.46 99.38 86.61 52.13 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 B 128 HIS A 158 HIS.? 6.53 O1 GOL A3037 C 263 HIS A 76 HIS~? -4.53 C1 GOL A3037s coo 6.12 5.94 82.00 7.16 6.32 83.81 106.73 71.90 50.38 106.39 72.49 52.36 coo 12.51 16.35 80.99 13.16 14.90 82.37 106.32 81.43 56.18 105.60 83.26 56.91 coo 11.58 14.94 93.26 12.25 14.03 91.50 98.60 85.60 50.46 99.38 86.61 52.13 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 B 128 HIS A 158 HIS.? 6.53 O1 GOL A3037 C 263 HIS A 79 HIS~? -3.92 CL CL A2020s coo 6.12 5.94 82.00 7.16 6.32 83.81 106.73 71.90 50.38 106.39 72.49 52.36 coo 12.51 16.35 80.99 13.16 14.90 82.37 106.32 81.43 56.18 105.60 83.26 56.91 coo 11.58 14.94 93.26 12.25 14.03 91.50 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 93 GLU~? 9.70 CL CL B2010 B 128 HIS B 76 HIS~? 4.58 CL CL B2010s C 263 HIS B 158 HIS.? 12.55 CL CL B2010 coo 6.12 5.94 82.00 7.16 6.32 83.81 11.87 67.96 6.38 12.21 67.44 4.38 coo 12.51 16.35 80.99 13.16 14.90 82.37 17.08 57.14 11.39 16.06 55.49 10.59 coo 11.58 14.94 93.26 12.25 14.03 91.50 7.56 53.89 15.18 8.49 52.54 13.87 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 B 128 HIS B 151 HIS~? -4.11 O3 GOL B3015s C 263 HIS B 76 HIS~? 4.58 CL CL B2010s coo 6.12 5.94 82.00 7.16 6.32 83.81 6.39 62.04 22.34 6.51 59.97 22.27 coo 12.51 16.35 80.99 13.16 14.90 82.37 18.48 59.01 25.15 19.77 58.54 23.56 coo 11.58 14.94 93.26 12.25 14.03 91.50 17.08 57.14 11.39 16.06 55.49 10.59 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 B 128 HIS B 158 HIS.? 12.55 CL CL B2010 C 263 HIS B 76 HIS~? 4.58 CL CL B2010s coo 6.12 5.94 82.00 7.16 6.32 83.81 6.39 62.04 22.34 6.51 59.97 22.27 coo 12.51 16.35 80.99 13.16 14.90 82.37 7.56 53.89 15.18 8.49 52.54 13.87 coo 11.58 14.94 93.26 12.25 14.03 91.50 17.08 57.14 11.39 16.06 55.49 10.59 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 B 128 HIS B 158 HIS.? 12.55 CL CL B2010 C 263 HIS B 79 HIS~? 5.08 CL CL B2010 coo 6.12 5.94 82.00 7.16 6.32 83.81 6.39 62.04 22.34 6.51 59.97 22.27 coo 12.51 16.35 80.99 13.16 14.90 82.37 7.56 53.89 15.18 8.49 52.54 13.87 coo 11.58 14.94 93.26 12.25 14.03 91.50 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 B 59 GLU C 93 GLU~? 8.05 CL CL C2021 B 128 HIS C 76 HIS~? -4.98 CL CL C2011s C 263 HIS C 158 HIS.? 10.62 CL CL C2021 coo 6.12 5.94 82.00 7.16 6.32 83.81 94.51 9.91 76.89 94.48 7.78 76.63 coo 12.51 16.35 80.99 13.16 14.90 82.37 89.28 12.80 65.47 90.23 11.67 63.98 coo 11.58 14.94 93.26 12.25 14.03 91.50 98.99 15.14 61.83 98.04 13.53 60.88 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 B 59 GLU C 163 GLU~? 4.89 CL CL C2031 B 128 HIS C 151 HIS~? -4.28 C2 GOL C3036s C 263 HIS C 76 HIS~? -4.98 CL CL C2011s coo 6.12 5.94 82.00 7.16 6.32 83.81 100.18 24.25 67.88 99.96 23.77 65.85 coo 12.51 16.35 80.99 13.16 14.90 82.37 88.24 26.50 64.44 86.75 25.04 64.52 coo 11.58 14.94 93.26 12.25 14.03 91.50 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 11 3 # 11 B 59 GLU C 163 GLU~? 4.89 CL CL C2031 B 128 HIS C 158 HIS.? 10.62 CL CL C2021 C 263 HIS C 76 HIS~? -4.98 CL CL C2011s coo 6.12 5.94 82.00 7.16 6.32 83.81 100.18 24.25 67.88 99.96 23.77 65.85 coo 12.51 16.35 80.99 13.16 14.90 82.37 98.99 15.14 61.83 98.04 13.53 60.88 coo 11.58 14.94 93.26 12.25 14.03 91.50 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 12 3 # 12 B 59 GLU C 163 GLU~? 4.89 CL CL C2031 B 128 HIS C 158 HIS.? 10.62 CL CL C2021 C 263 HIS C 79 HIS~? -4.32 CL CL C2021s coo 6.12 5.94 82.00 7.16 6.32 83.81 100.18 24.25 67.88 99.96 23.77 65.85 coo 12.51 16.35 80.99 13.16 14.90 82.37 98.99 15.14 61.83 98.04 13.53 60.88 coo 11.58 14.94 93.26 12.25 14.03 91.50 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 13 3 # 13 B 59 GLU D 73 GLU~? 5.51 C2 GOL D3020 B 128 HIS D 79 HIS~? -4.57 CL CL D2022s C 263 HIS D 125 HIS.? -3.96 O3 GOL D3018s coo 6.12 5.94 82.00 7.16 6.32 83.81 12.99 58.17 82.26 12.31 59.24 83.94 coo 12.51 16.35 80.99 13.16 14.90 82.37 3.57 52.49 87.96 2.52 51.97 89.71 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.12 57.04 95.76 9.45 58.59 97.15 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 14 3 # 14 B 59 GLU D 93 GLU~? 8.23 CL CL D2022 B 128 HIS D 76 HIS~? 4.24 O2 GOL D3018s C 263 HIS D 158 HIS.? 6.33 O1 GOL D3020 coo 6.12 5.94 82.00 7.16 6.32 83.81 0.77 48.16 89.31 0.23 49.10 91.12 coo 12.51 16.35 80.99 13.16 14.90 82.37 8.84 57.69 86.26 7.93 59.46 86.93 coo 11.58 14.94 93.26 12.25 14.03 91.50 0.86 62.48 80.06 1.83 63.91 81.27 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 15 3 # 15 B 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 B 128 HIS D 151 HIS~? -13.00 O2 GOL D3020s C 263 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo 6.12 5.94 82.00 7.16 6.32 83.81 0.62 54.76 72.61 1.16 56.78 72.68 coo 12.51 16.35 80.99 13.16 14.90 82.37 13.06 55.69 73.24 14.03 55.94 75.08 coo 11.58 14.94 93.26 12.25 14.03 91.50 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 16 3 # 16 B 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 B 128 HIS D 158 HIS.? 6.33 O1 GOL D3020 C 263 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo 6.12 5.94 82.00 7.16 6.32 83.81 0.62 54.76 72.61 1.16 56.78 72.68 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.86 62.48 80.06 1.83 63.91 81.27 coo 11.58 14.94 93.26 12.25 14.03 91.50 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 17 3 # 17 B 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 B 128 HIS D 158 HIS.? 6.33 O1 GOL D3020 C 263 HIS D 79 HIS~? -4.57 CL CL D2022s coo 6.12 5.94 82.00 7.16 6.32 83.81 0.62 54.76 72.61 1.16 56.78 72.68 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.86 62.48 80.06 1.83 63.91 81.27 coo 11.58 14.94 93.26 12.25 14.03 91.50 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 18 3 # 18 B 59 GLU E 93 GLU~? 8.42 CL CL E2032 B 128 HIS E 76 HIS~? -4.87 CL CL E2013s C 263 HIS E 158 HIS.? 10.67 CL CL E2032 coo 6.12 5.94 82.00 7.16 6.32 83.81 9.96 100.16 58.92 10.04 102.16 58.24 coo 12.51 16.35 80.99 13.16 14.90 82.37 16.97 95.07 49.08 16.37 95.97 47.28 coo 11.58 14.94 93.26 12.25 14.03 91.50 8.21 91.93 44.16 9.29 93.32 43.02 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 19 3 # 19 B 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 B 128 HIS E 151 HIS~? -4.12 O1 GOL E3002s C 263 HIS E 76 HIS~? -4.87 CL CL E2013s coo 6.12 5.94 82.00 7.16 6.32 83.81 5.75 84.10 51.71 6.08 84.26 49.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 17.87 81.44 51.19 19.31 82.95 50.96 coo 11.58 14.94 93.26 12.25 14.03 91.50 16.97 95.07 49.08 16.37 95.97 47.28 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 20 3 # 20 B 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 B 128 HIS E 158 HIS.? 10.67 CL CL E2032 C 263 HIS E 76 HIS~? -4.87 CL CL E2013s coo 6.12 5.94 82.00 7.16 6.32 83.81 5.75 84.10 51.71 6.08 84.26 49.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 8.21 91.93 44.16 9.29 93.32 43.02 coo 11.58 14.94 93.26 12.25 14.03 91.50 16.97 95.07 49.08 16.37 95.97 47.28 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 21 3 # 21 B 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 B 128 HIS E 158 HIS.? 10.67 CL CL E2032 C 263 HIS E 79 HIS~? -4.18 CL CL E2032s coo 6.12 5.94 82.00 7.16 6.32 83.81 5.75 84.10 51.71 6.08 84.26 49.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 8.21 91.93 44.16 9.29 93.32 43.02 coo 11.58 14.94 93.26 12.25 14.03 91.50 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 22 3 # 22 B 59 GLU F 73 GLU~? 5.19 O3 GOL F3039 B 128 HIS F 79 HIS~? -4.63 CL CL F2023s C 263 HIS F 125 HIS.? 6.27 C1 GOL F3039 coo 6.12 5.94 82.00 7.16 6.32 83.81 93.55 43.24 25.35 94.46 43.89 23.55 coo 12.51 16.35 80.99 13.16 14.90 82.37 101.04 34.65 20.79 101.93 33.69 19.16 coo 11.58 14.94 93.26 12.25 14.03 91.50 96.50 38.92 12.23 96.44 40.22 10.57 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 23 3 # 23 B 59 GLU F 93 GLU~? 8.36 CL CL F2023 B 128 HIS F 76 HIS~? -4.65 CL CL F2034s C 263 HIS F 158 HIS.? -10.90 CL CL F2023s coo 6.12 5.94 82.00 7.16 6.32 83.81 102.94 29.85 20.29 103.30 29.96 18.20 coo 12.51 16.35 80.99 13.16 14.90 82.37 97.24 41.20 21.57 98.43 42.65 20.63 coo 11.58 14.94 93.26 12.25 14.03 91.50 105.92 45.34 26.29 105.13 46.33 24.62 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 24 3 # 24 B 59 GLU F 163 GLU~? 16.81 CL CL F2023 B 128 HIS F 151 HIS~? 14.76 O3 GOL F3039s C 263 HIS F 76 HIS~? -4.65 CL CL F2034s coo 6.12 5.94 82.00 7.16 6.32 83.81 105.09 39.28 35.27 105.30 41.23 34.49 coo 12.51 16.35 80.99 13.16 14.90 82.37 93.09 42.58 34.58 92.14 42.76 32.71 coo 11.58 14.94 93.26 12.25 14.03 91.50 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 25 3 # 25 B 59 GLU F 163 GLU~? 16.81 CL CL F2023 B 128 HIS F 158 HIS.? -10.90 CL CL F2023s C 263 HIS F 76 HIS~? -4.65 CL CL F2034s coo 6.12 5.94 82.00 7.16 6.32 83.81 105.09 39.28 35.27 105.30 41.23 34.49 coo 12.51 16.35 80.99 13.16 14.90 82.37 105.92 45.34 26.29 105.13 46.33 24.62 coo 11.58 14.94 93.26 12.25 14.03 91.50 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 26 3 # 26 B 59 GLU F 163 GLU~? 16.81 CL CL F2023 B 128 HIS F 158 HIS.? -10.90 CL CL F2023s C 263 HIS F 79 HIS~? -4.63 CL CL F2023s coo 6.12 5.94 82.00 7.16 6.32 83.81 105.09 39.28 35.27 105.30 41.23 34.49 coo 12.51 16.35 80.99 13.16 14.90 82.37 105.92 45.34 26.29 105.13 46.33 24.62 coo 11.58 14.94 93.26 12.25 14.03 91.50 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 27 3 # 27 B 59 GLU G 93 GLU~? 8.63 CL CL G2033 B 128 HIS G 76 HIS~? -3.85 O1 GOL G3038s C 263 HIS G 158 HIS.? 10.64 CL CL G2033 coo 6.12 5.94 82.00 7.16 6.32 83.81 3.64 16.49 37.62 3.03 14.55 38.23 coo 12.51 16.35 80.99 13.16 14.90 82.37 9.26 20.10 48.62 8.05 19.49 50.22 coo 11.58 14.94 93.26 12.25 14.03 91.50 0.65 25.49 51.61 1.26 23.82 52.74 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 28 3 # 28 B 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 B 128 HIS G 151 HIS~? -4.14 C3 GOL G3001s C 263 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo 6.12 5.94 82.00 7.16 6.32 83.81 1.42 33.23 43.78 1.39 32.97 45.86 coo 12.51 16.35 80.99 13.16 14.90 82.37 13.55 33.19 47.26 14.46 31.35 47.64 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 29 3 # 29 B 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 B 128 HIS G 158 HIS.? 10.64 CL CL G2033 C 263 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo 6.12 5.94 82.00 7.16 6.32 83.81 1.42 33.23 43.78 1.39 32.97 45.86 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.65 25.49 51.61 1.26 23.82 52.74 coo 11.58 14.94 93.26 12.25 14.03 91.50 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 30 3 # 30 B 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 B 128 HIS G 158 HIS.? 10.64 CL CL G2033 C 263 HIS G 79 HIS~? -4.46 CL CL G2033s coo 6.12 5.94 82.00 7.16 6.32 83.81 1.42 33.23 43.78 1.39 32.97 45.86 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.65 25.49 51.61 1.26 23.82 52.74 coo 11.58 14.94 93.26 12.25 14.03 91.50 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 31 3 # 31 B 59 GLU H 73 GLU~? -8.72 CL CL H2014s B 128 HIS H 79 HIS~? 4.82 CL CL H2024 C 263 HIS H 125 HIS.? 7.36 CL CL H2014 coo 6.12 5.94 82.00 7.16 6.32 83.81 87.54 56.19 90.14 87.78 55.44 92.11 coo 12.51 16.35 80.99 13.16 14.90 82.37 95.19 63.20 96.60 95.96 63.87 98.43 coo 11.58 14.94 93.26 12.25 14.03 91.50 88.12 60.23 103.63 87.33 59.09 105.21 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 32 3 # 32 B 59 GLU H 93 GLU~? 8.72 CL CL H2024 B 128 HIS H 76 HIS~? 4.68 CL CL H2014s C 263 HIS H 158 HIS.? 10.33 CL CL H2024 coo 6.12 5.94 82.00 7.16 6.32 83.81 97.56 68.07 97.57 97.65 67.50 99.59 coo 12.51 16.35 80.99 13.16 14.90 82.37 90.35 57.57 94.69 91.06 55.99 95.89 coo 11.58 14.94 93.26 12.25 14.03 91.50 98.94 51.80 92.35 97.68 51.03 93.84 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 33 3 # 33 B 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 B 128 HIS H 151 HIS~? 4.32 C1 GOL H3016s C 263 HIS H 76 HIS~? 4.68 CL CL H2014s coo 6.12 5.94 82.00 7.16 6.32 83.81 101.55 57.39 83.25 101.29 55.39 84.02 coo 12.51 16.35 80.99 13.16 14.90 82.37 89.33 56.65 80.95 87.93 56.76 82.51 coo 11.58 14.94 93.26 12.25 14.03 91.50 90.35 57.57 94.69 91.06 55.99 95.89 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 34 3 # 34 B 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 B 128 HIS H 158 HIS.? 10.33 CL CL H2024 C 263 HIS H 76 HIS~? 4.68 CL CL H2014s coo 6.12 5.94 82.00 7.16 6.32 83.81 101.55 57.39 83.25 101.29 55.39 84.02 coo 12.51 16.35 80.99 13.16 14.90 82.37 98.94 51.80 92.35 97.68 51.03 93.84 coo 11.58 14.94 93.26 12.25 14.03 91.50 90.35 57.57 94.69 91.06 55.99 95.89 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 35 3 # 35 B 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 B 128 HIS H 158 HIS.? 10.33 CL CL H2024 C 263 HIS H 79 HIS~? 4.82 CL CL H2024 coo 6.12 5.94 82.00 7.16 6.32 83.81 101.55 57.39 83.25 101.29 55.39 84.02 coo 12.51 16.35 80.99 13.16 14.90 82.37 98.94 51.80 92.35 97.68 51.03 93.84 coo 11.58 14.94 93.26 12.25 14.03 91.50 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 36 3 # 36 B 59 GLU I 93 GLU~? 8.40 CL CL I2025 B 128 HIS I 76 HIS~? 4.17 O3 GOL I3031s C 263 HIS I 158 HIS.? 11.08 CL CL I2025 coo 6.12 5.94 82.00 7.16 6.32 83.81 219.77 205.57 155.06 219.86 207.68 155.25 coo 12.51 16.35 80.99 13.16 14.90 82.37 212.11 203.51 165.19 213.01 204.42 166.85 coo 11.58 14.94 93.26 12.25 14.03 91.50 220.34 199.03 170.60 219.44 200.67 171.57 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 37 3 # 37 B 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 B 128 HIS I 151 HIS~? 3.98 O3 GOL I3032s C 263 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo 6.12 5.94 82.00 7.16 6.32 83.81 221.15 190.35 164.07 220.95 190.90 166.06 coo 12.51 16.35 80.99 13.16 14.90 82.37 208.71 190.07 165.44 207.65 191.87 165.52 coo 11.58 14.94 93.26 12.25 14.03 91.50 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 38 3 # 38 B 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 B 128 HIS I 158 HIS.? 11.08 CL CL I2025 C 263 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo 6.12 5.94 82.00 7.16 6.32 83.81 221.15 190.35 164.07 220.95 190.90 166.06 coo 12.51 16.35 80.99 13.16 14.90 82.37 220.34 199.03 170.60 219.44 200.67 171.57 coo 11.58 14.94 93.26 12.25 14.03 91.50 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 39 3 # 39 B 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 B 128 HIS I 158 HIS.? 11.08 CL CL I2025 C 263 HIS I 79 HIS~? -4.56 CL CL I2025s coo 6.12 5.94 82.00 7.16 6.32 83.81 221.15 190.35 164.07 220.95 190.90 166.06 coo 12.51 16.35 80.99 13.16 14.90 82.37 220.34 199.03 170.60 219.44 200.67 171.57 coo 11.58 14.94 93.26 12.25 14.03 91.50 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 40 3 # 40 B 59 GLU J 73 GLU~? 5.06 O1 GOL J3033 B 128 HIS J 79 HIS~? -4.36 CL CL J2026s C 263 HIS J 125 HIS.? -4.00 O3 GOL J3030s coo 6.12 5.94 82.00 7.16 6.32 83.81 133.49 171.70 133.63 132.81 170.83 131.84 coo 12.51 16.35 80.99 13.16 14.90 82.37 126.45 179.07 126.46 125.69 179.71 124.61 coo 11.58 14.94 93.26 12.25 14.03 91.50 132.43 173.86 119.73 132.77 172.30 118.36 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 41 3 # 41 B 59 GLU J 93 GLU~? 8.18 CL CL J2026 B 128 HIS J 76 HIS~? 4.19 O2 GOL J3033s C 263 HIS J 158 HIS.? 7.50 O2 GOL J3033 coo 6.12 5.94 82.00 7.16 6.32 83.81 124.50 183.71 125.04 124.44 183.21 122.99 coo 12.51 16.35 80.99 13.16 14.90 82.37 130.51 172.99 128.94 129.60 171.33 128.01 coo 11.58 14.94 93.26 12.25 14.03 91.50 121.18 169.23 132.79 122.06 167.98 131.35 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 42 3 # 42 B 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 B 128 HIS J 151 HIS~? -12.73 O1 GOL J3033s C 263 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo 6.12 5.94 82.00 7.16 6.32 83.81 120.24 176.69 140.95 120.35 174.56 140.67 coo 12.51 16.35 80.99 13.16 14.90 82.37 132.36 173.99 142.63 133.63 173.58 141.01 coo 11.58 14.94 93.26 12.25 14.03 91.50 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 43 3 # 43 B 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 B 128 HIS J 158 HIS.? 7.50 O2 GOL J3033 C 263 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo 6.12 5.94 82.00 7.16 6.32 83.81 120.24 176.69 140.95 120.35 174.56 140.67 coo 12.51 16.35 80.99 13.16 14.90 82.37 121.18 169.23 132.79 122.06 167.98 131.35 coo 11.58 14.94 93.26 12.25 14.03 91.50 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 44 3 # 44 B 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 B 128 HIS J 158 HIS.? 7.50 O2 GOL J3033 C 263 HIS J 79 HIS~? -4.36 CL CL J2026s coo 6.12 5.94 82.00 7.16 6.32 83.81 120.24 176.69 140.95 120.35 174.56 140.67 coo 12.51 16.35 80.99 13.16 14.90 82.37 121.18 169.23 132.79 122.06 167.98 131.35 coo 11.58 14.94 93.26 12.25 14.03 91.50 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 45 3 # 45 B 59 GLU K 73 GLU~? 7.36 C3 GOL K3041 B 128 HIS K 79 HIS~? -4.34 CL CL K2027s C 263 HIS K 125 HIS.? -4.02 O1 GOL K3041s coo 6.12 5.94 82.00 7.16 6.32 83.81 204.07 133.93 175.85 204.65 132.02 175.03 coo 12.51 16.35 80.99 13.16 14.90 82.37 211.01 127.65 183.80 211.70 125.86 184.65 coo 11.58 14.94 93.26 12.25 14.03 91.50 204.92 120.38 179.37 204.44 118.90 177.95 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 46 3 # 46 B 59 GLU K 93 GLU~? 8.22 CL CL K2027 B 128 HIS K 76 HIS~? -6.12 C3 GOL K3041s C 263 HIS K 158 HIS.? 10.92 CL CL K2027 coo 6.12 5.94 82.00 7.16 6.32 83.81 212.85 126.80 188.86 213.03 124.72 188.44 coo 12.51 16.35 80.99 13.16 14.90 82.37 207.10 129.51 177.50 208.14 128.55 175.95 coo 11.58 14.94 93.26 12.25 14.03 91.50 216.60 132.79 173.33 215.77 131.08 172.42 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 47 3 # 47 B 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 B 128 HIS K 151 HIS~? -4.18 C2 GOL K3009s C 263 HIS K 76 HIS~? -6.12 C3 GOL K3041s coo 6.12 5.94 82.00 7.16 6.32 83.81 217.27 141.62 179.80 217.24 141.01 177.77 coo 12.51 16.35 80.99 13.16 14.90 82.37 205.25 143.04 176.89 203.95 141.38 176.70 coo 11.58 14.94 93.26 12.25 14.03 91.50 207.10 129.51 177.50 208.14 128.55 175.95 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 48 3 # 48 B 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 B 128 HIS K 158 HIS.? 10.92 CL CL K2027 C 263 HIS K 76 HIS~? -6.12 C3 GOL K3041s coo 6.12 5.94 82.00 7.16 6.32 83.81 217.27 141.62 179.80 217.24 141.01 177.77 coo 12.51 16.35 80.99 13.16 14.90 82.37 216.60 132.79 173.33 215.77 131.08 172.42 coo 11.58 14.94 93.26 12.25 14.03 91.50 207.10 129.51 177.50 208.14 128.55 175.95 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 49 3 # 49 B 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 B 128 HIS K 158 HIS.? 10.92 CL CL K2027 C 263 HIS K 79 HIS~? -4.34 CL CL K2027s coo 6.12 5.94 82.00 7.16 6.32 83.81 217.27 141.62 179.80 217.24 141.01 177.77 coo 12.51 16.35 80.99 13.16 14.90 82.37 216.60 132.79 173.33 215.77 131.08 172.42 coo 11.58 14.94 93.26 12.25 14.03 91.50 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 50 3 # 50 B 59 GLU L 93 GLU~? 8.05 CL CL L2028 B 128 HIS L 76 HIS~? 4.00 O3 GOL L3027s C 263 HIS L 158 HIS.? 11.11 CL CL L2028 coo 6.12 5.94 82.00 7.16 6.32 83.81 118.11 159.89 208.04 117.71 160.95 209.86 coo 12.51 16.35 80.99 13.16 14.90 82.37 125.69 169.77 203.98 124.79 171.51 204.73 coo 11.58 14.94 93.26 12.25 14.03 91.50 117.45 174.63 198.96 118.55 176.04 200.05 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 51 3 # 51 B 59 GLU L 163 GLU~? 16.77 CL CL L2028 B 128 HIS L 151 HIS~? -15.32 O3 GOL L3028s C 263 HIS L 76 HIS~? 4.00 O3 GOL L3027s coo 6.12 5.94 82.00 7.16 6.32 83.81 116.58 166.98 191.20 116.69 169.04 191.44 coo 12.51 16.35 80.99 13.16 14.90 82.37 129.06 168.07 190.57 130.17 168.32 192.34 coo 11.58 14.94 93.26 12.25 14.03 91.50 125.69 169.77 203.98 124.79 171.51 204.73 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 52 3 # 52 B 59 GLU L 163 GLU~? 16.77 CL CL L2028 B 128 HIS L 158 HIS.? 11.11 CL CL L2028 C 263 HIS L 76 HIS~? 4.00 O3 GOL L3027s coo 6.12 5.94 82.00 7.16 6.32 83.81 116.58 166.98 191.20 116.69 169.04 191.44 coo 12.51 16.35 80.99 13.16 14.90 82.37 117.45 174.63 198.96 118.55 176.04 200.05 coo 11.58 14.94 93.26 12.25 14.03 91.50 125.69 169.77 203.98 124.79 171.51 204.73 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 53 3 # 53 B 59 GLU L 163 GLU~? 16.77 CL CL L2028 B 128 HIS L 158 HIS.? 11.11 CL CL L2028 C 263 HIS L 79 HIS~? -4.09 CL CL L2028s coo 6.12 5.94 82.00 7.16 6.32 83.81 116.58 166.98 191.20 116.69 169.04 191.44 coo 12.51 16.35 80.99 13.16 14.90 82.37 117.45 174.63 198.96 118.55 176.04 200.05 coo 11.58 14.94 93.26 12.25 14.03 91.50 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 54 3 # 54 B 59 GLU M 93 GLU~? 8.60 CL CL M2029 B 128 HIS M 76 HIS~? 4.78 C1 GOL M3042s C 263 HIS M 158 HIS.? 6.42 O1 GOL M3042 coo 6.12 5.94 82.00 7.16 6.32 83.81 123.31 213.00 178.36 123.21 215.02 177.75 coo 12.51 16.35 80.99 13.16 14.90 82.37 130.15 208.85 168.09 129.36 209.65 166.31 coo 11.58 14.94 93.26 12.25 14.03 91.50 121.40 205.18 163.43 122.55 206.46 162.23 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 55 3 # 55 B 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 B 128 HIS M 151 HIS~? -11.81 O3 GOL M3042s C 263 HIS M 76 HIS~? 4.78 C1 GOL M3042s coo 6.12 5.94 82.00 7.16 6.32 83.81 119.51 197.10 170.73 120.12 197.15 168.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 131.91 195.13 169.59 133.22 196.76 169.40 coo 11.58 14.94 93.26 12.25 14.03 91.50 130.15 208.85 168.09 129.36 209.65 166.31 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 56 3 # 56 B 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 B 128 HIS M 158 HIS.? 6.42 O1 GOL M3042 C 263 HIS M 76 HIS~? 4.78 C1 GOL M3042s coo 6.12 5.94 82.00 7.16 6.32 83.81 119.51 197.10 170.73 120.12 197.15 168.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 121.40 205.18 163.43 122.55 206.46 162.23 coo 11.58 14.94 93.26 12.25 14.03 91.50 130.15 208.85 168.09 129.36 209.65 166.31 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 57 3 # 57 B 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 B 128 HIS M 158 HIS.? 6.42 O1 GOL M3042 C 263 HIS M 79 HIS~? -4.31 CL CL M2029s coo 6.12 5.94 82.00 7.16 6.32 83.81 119.51 197.10 170.73 120.12 197.15 168.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 121.40 205.18 163.43 122.55 206.46 162.23 coo 11.58 14.94 93.26 12.25 14.03 91.50 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 58 3 # 58 B 59 GLU N 93 GLU~? 8.57 CL CL N2030 B 128 HIS N 76 HIS~? -6.89 CL CL N2030s C 263 HIS N 158 HIS.? 10.50 CL CL N2030 coo 6.12 5.94 82.00 7.16 6.32 83.81 217.47 148.79 132.22 217.76 148.97 130.14 coo 12.51 16.35 80.99 13.16 14.90 82.37 211.54 160.16 134.29 212.67 161.69 133.40 coo 11.58 14.94 93.26 12.25 14.03 91.50 220.32 164.11 138.58 219.66 165.01 136.80 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 59 3 # 59 B 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 B 128 HIS N 151 HIS~? 3.39 O2 GOL N3012s C 263 HIS N 76 HIS~? -6.89 CL CL N2030s coo 6.12 5.94 82.00 7.16 6.32 83.81 220.21 157.81 147.58 220.09 159.81 146.98 coo 12.51 16.35 80.99 13.16 14.90 82.37 207.96 160.84 147.59 206.93 161.03 145.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 211.54 160.16 134.29 212.67 161.69 133.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 60 3 # 60 B 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 B 128 HIS N 158 HIS.? 10.50 CL CL N2030 C 263 HIS N 76 HIS~? -6.89 CL CL N2030s coo 6.12 5.94 82.00 7.16 6.32 83.81 220.21 157.81 147.58 220.09 159.81 146.98 coo 12.51 16.35 80.99 13.16 14.90 82.37 220.32 164.11 138.58 219.66 165.01 136.80 coo 11.58 14.94 93.26 12.25 14.03 91.50 211.54 160.16 134.29 212.67 161.69 133.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 61 3 # 61 B 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 B 128 HIS N 158 HIS.? 10.50 CL CL N2030 C 263 HIS N 79 HIS~? -4.33 CL CL N2030s coo 6.12 5.94 82.00 7.16 6.32 83.81 220.21 157.81 147.58 220.09 159.81 146.98 coo 12.51 16.35 80.99 13.16 14.90 82.37 220.32 164.11 138.58 219.66 165.01 136.80 coo 11.58 14.94 93.26 12.25 14.03 91.50 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 62 3 # 62 B 59 GLU O 93 GLU~? 9.72 CL CL O2018 B 128 HIS O 76 HIS~? 4.51 CL CL O2018s C 263 HIS O 158 HIS.? 12.21 CL CL O2018 coo 6.12 5.94 82.00 7.16 6.32 83.81 119.95 130.02 153.81 119.63 127.98 154.32 coo 12.51 16.35 80.99 13.16 14.90 82.37 126.10 133.61 164.62 125.01 132.87 166.26 coo 11.58 14.94 93.26 12.25 14.03 91.50 117.44 138.41 168.51 118.31 136.96 169.75 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 63 3 # 63 B 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 B 128 HIS O 151 HIS~? 4.32 O2 GOL O3026s C 263 HIS O 76 HIS~? 4.51 CL CL O2018s coo 6.12 5.94 82.00 7.16 6.32 83.81 117.45 146.43 160.85 117.44 146.23 162.92 coo 12.51 16.35 80.99 13.16 14.90 82.37 129.65 146.92 163.60 130.73 145.15 163.91 coo 11.58 14.94 93.26 12.25 14.03 91.50 126.10 133.61 164.62 125.01 132.87 166.26 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 64 3 # 64 B 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 B 128 HIS O 158 HIS.? 12.21 CL CL O2018 C 263 HIS O 76 HIS~? 4.51 CL CL O2018s coo 6.12 5.94 82.00 7.16 6.32 83.81 117.45 146.43 160.85 117.44 146.23 162.92 coo 12.51 16.35 80.99 13.16 14.90 82.37 117.44 138.41 168.51 118.31 136.96 169.75 coo 11.58 14.94 93.26 12.25 14.03 91.50 126.10 133.61 164.62 125.01 132.87 166.26 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 65 3 # 65 B 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 B 128 HIS O 158 HIS.? 12.21 CL CL O2018 C 263 HIS O 79 HIS~? 5.21 CL CL O2018 coo 6.12 5.94 82.00 7.16 6.32 83.81 117.45 146.43 160.85 117.44 146.23 162.92 coo 12.51 16.35 80.99 13.16 14.90 82.37 117.44 138.41 168.51 118.31 136.96 169.75 coo 11.58 14.94 93.26 12.25 14.03 91.50 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 66 3 # 66 B 59 GLU P 73 GLU~? 5.04 O1 GOL P3034 B 128 HIS P 79 HIS~? 5.38 CL CL P2019 C 263 HIS P 125 HIS.? 6.57 O3 GOL P3034 coo 6.12 5.94 82.00 7.16 6.32 83.81 204.36 171.43 203.90 204.84 170.63 205.81 coo 12.51 16.35 80.99 13.16 14.90 82.37 212.25 178.47 210.26 213.09 179.27 212.01 coo 11.58 14.94 93.26 12.25 14.03 91.50 205.78 175.00 217.63 205.21 173.76 219.23 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 67 3 # 67 B 59 GLU P 93 GLU~? 9.65 CL CL P2019 B 128 HIS P 76 HIS~? 4.69 CL CL P2019s C 263 HIS P 158 HIS.? 12.33 O2 GOL P3014 coo 6.12 5.94 82.00 7.16 6.32 83.81 214.54 183.14 211.27 214.54 182.92 213.36 coo 12.51 16.35 80.99 13.16 14.90 82.37 207.59 172.73 208.38 208.33 171.09 209.49 coo 11.58 14.94 93.26 12.25 14.03 91.50 216.29 167.50 205.15 215.20 166.66 206.73 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 68 3 # 68 B 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 B 128 HIS P 151 HIS~? -4.15 C3 GOL P3014s C 263 HIS P 76 HIS~? 4.69 CL CL P2019s coo 6.12 5.94 82.00 7.16 6.32 83.81 218.06 173.97 196.16 217.79 171.96 196.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 205.70 172.52 194.71 204.41 172.45 196.35 coo 11.58 14.94 93.26 12.25 14.03 91.50 207.59 172.73 208.38 208.33 171.09 209.49 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 69 3 # 69 B 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 B 128 HIS P 158 HIS.? 12.33 O2 GOL P3014 C 263 HIS P 76 HIS~? 4.69 CL CL P2019s coo 6.12 5.94 82.00 7.16 6.32 83.81 218.06 173.97 196.16 217.79 171.96 196.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 216.29 167.50 205.15 215.20 166.66 206.73 coo 11.58 14.94 93.26 12.25 14.03 91.50 207.59 172.73 208.38 208.33 171.09 209.49 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 70 3 # 70 B 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 B 128 HIS P 158 HIS.? 12.33 O2 GOL P3014 C 263 HIS P 79 HIS~? 5.38 CL CL P2019 coo 6.12 5.94 82.00 7.16 6.32 83.81 218.06 173.97 196.16 217.79 171.96 196.61 coo 12.51 16.35 80.99 13.16 14.90 82.37 216.29 167.50 205.15 215.20 166.66 206.73 coo 11.58 14.94 93.26 12.25 14.03 91.50 212.25 178.47 210.26 213.09 179.27 212.01 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 70 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 76 HIS~? -4.53 C1 GOL A3037s D 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 D 128 HIS A 151 HIS~? -11.70 O3 GOL A3037s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 98.60 85.60 50.46 99.38 86.61 52.13 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 106.73 71.90 50.38 106.39 72.49 52.36 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 94.27 72.58 51.14 93.29 74.44 51.00 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 76 HIS~? -4.53 C1 GOL A3037s D 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 D 128 HIS A 158 HIS.? 6.53 O1 GOL A3037 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 98.60 85.60 50.46 99.38 86.61 52.13 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 106.73 71.90 50.38 106.39 72.49 52.36 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 106.32 81.43 56.18 105.60 83.26 56.91 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS A 79 HIS~? -3.92 CL CL A2020s D 59 GLU A 163 GLU~? 14.44 O2 GOL A3037 D 128 HIS A 158 HIS.? 6.53 O1 GOL A3037 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 103.72 86.36 44.76 104.87 88.01 44.15 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 106.73 71.90 50.38 106.39 72.49 52.36 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 106.32 81.43 56.18 105.60 83.26 56.91 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS A 125 HIS.? 6.10 O2 GOL A3040 D 59 GLU A 73 GLU~? -3.07 O3 GOL A3037s D 128 HIS A 79 HIS~? -3.92 CL CL A2020s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 98.48 94.83 47.66 98.07 96.39 49.01 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 94.58 81.89 51.70 95.31 83.75 52.44 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS B 76 HIS~? 4.58 CL CL B2010s D 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 D 128 HIS B 151 HIS~? -4.11 O3 GOL B3015s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 17.08 57.14 11.39 16.06 55.49 10.59 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 6.39 62.04 22.34 6.51 59.97 22.27 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 18.48 59.01 25.15 19.77 58.54 23.56 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS B 76 HIS~? 4.58 CL CL B2010s D 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 D 128 HIS B 158 HIS.? 12.55 CL CL B2010 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 17.08 57.14 11.39 16.06 55.49 10.59 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 6.39 62.04 22.34 6.51 59.97 22.27 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 7.56 53.89 15.18 8.49 52.54 13.87 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS B 79 HIS~? 5.08 CL CL B2010 D 59 GLU B 163 GLU~? 11.65 O3 GOL B3015 D 128 HIS B 158 HIS.? 12.55 CL CL B2010 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 13.46 62.96 8.26 12.78 63.30 6.30 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 6.39 62.04 22.34 6.51 59.97 22.27 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 7.56 53.89 15.18 8.49 52.54 13.87 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS B 125 HIS.? 5.37 C1 GOL B3023 D 59 GLU B 73 GLU~? 6.38 O3 GOL B3023 D 128 HIS B 79 HIS~? 5.08 CL CL B2010 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 19.73 57.29 2.23 19.89 55.80 0.75 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 19.80 56.19 16.30 19.32 55.14 14.52 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 A 263 HIS B 158 HIS.? 12.55 CL CL B2010 D 59 GLU B 93 GLU~? 9.70 CL CL B2010 D 128 HIS B 76 HIS~? 4.58 CL CL B2010s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 7.56 53.89 15.18 8.49 52.54 13.87 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 11.87 67.96 6.38 12.21 67.44 4.38 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 17.08 57.14 11.39 16.06 55.49 10.59 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 10 3 # 10 A 263 HIS C 76 HIS~? -4.98 CL CL C2011s D 59 GLU C 163 GLU~? 4.89 CL CL C2031 D 128 HIS C 151 HIS~? -4.28 C2 GOL C3036s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 89.28 12.80 65.47 90.23 11.67 63.98 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 100.18 24.25 67.88 99.96 23.77 65.85 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 88.24 26.50 64.44 86.75 25.04 64.52 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 11 3 # 11 A 263 HIS C 76 HIS~? -4.98 CL CL C2011s D 59 GLU C 163 GLU~? 4.89 CL CL C2031 D 128 HIS C 158 HIS.? 10.62 CL CL C2021 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 89.28 12.80 65.47 90.23 11.67 63.98 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 100.18 24.25 67.88 99.96 23.77 65.85 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 98.99 15.14 61.83 98.04 13.53 60.88 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 12 3 # 12 A 263 HIS C 79 HIS~? -4.32 CL CL C2021s D 59 GLU C 163 GLU~? 4.89 CL CL C2031 D 128 HIS C 158 HIS.? 10.62 CL CL C2021 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 92.85 10.89 71.99 93.43 9.18 73.06 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 100.18 24.25 67.88 99.96 23.77 65.85 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 98.99 15.14 61.83 98.04 13.53 60.88 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 13 3 # 13 A 263 HIS C 125 HIS.? 6.65 CL CL C2011 D 59 GLU C 73 GLU~? 6.99 O1 GOL C3036 D 128 HIS C 79 HIS~? -4.32 CL CL C2021s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 86.57 4.11 67.63 86.24 2.65 66.14 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 86.57 17.41 63.72 86.98 15.43 63.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 14 3 # 14 A 263 HIS C 158 HIS.? 10.62 CL CL C2021 D 59 GLU C 93 GLU~? 8.05 CL CL C2021 D 128 HIS C 76 HIS~? -4.98 CL CL C2011s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 98.99 15.14 61.83 98.04 13.53 60.88 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 94.51 9.91 76.89 94.48 7.78 76.63 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 15 3 # 15 A 263 HIS D 76 HIS~? 4.24 O2 GOL D3018s D 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 D 128 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 8.84 57.69 86.26 7.93 59.46 86.93 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.62 54.76 72.61 1.16 56.78 72.68 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 16 3 # 16 A 263 HIS D 76 HIS~? 4.24 O2 GOL D3018s D 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 D 128 HIS D 158 HIS.? 6.33 O1 GOL D3020 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 8.84 57.69 86.26 7.93 59.46 86.93 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.62 54.76 72.61 1.16 56.78 72.68 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.86 62.48 80.06 1.83 63.91 81.27 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 17 3 # 17 A 263 HIS D 79 HIS~? -4.57 CL CL D2022s D 59 GLU D 163 GLU~? 14.42 O1 GOL D3020 D 128 HIS D 158 HIS.? 6.33 O1 GOL D3020 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 3.57 52.49 87.96 2.52 51.97 89.71 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.62 54.76 72.61 1.16 56.78 72.68 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.86 62.48 80.06 1.83 63.91 81.27 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 18 3 # 18 A 263 HIS D 125 HIS.? -3.96 O3 GOL D3018s D 59 GLU D 73 GLU~? 5.51 C2 GOL D3020 D 128 HIS D 79 HIS~? -4.57 CL CL D2022s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.12 57.04 95.76 9.45 58.59 97.15 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 12.99 58.17 82.26 12.31 59.24 83.94 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 19 3 # 19 A 263 HIS D 158 HIS.? 6.33 O1 GOL D3020 D 59 GLU D 93 GLU~? 8.23 CL CL D2022 D 128 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 0.86 62.48 80.06 1.83 63.91 81.27 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.77 48.16 89.31 0.23 49.10 91.12 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 20 3 # 20 A 263 HIS E 76 HIS~? -4.87 CL CL E2013s D 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 D 128 HIS E 151 HIS~? -4.12 O1 GOL E3002s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 16.97 95.07 49.08 16.37 95.97 47.28 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 5.75 84.10 51.71 6.08 84.26 49.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 17.87 81.44 51.19 19.31 82.95 50.96 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 21 3 # 21 A 263 HIS E 76 HIS~? -4.87 CL CL E2013s D 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 D 128 HIS E 158 HIS.? 10.67 CL CL E2032 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 16.97 95.07 49.08 16.37 95.97 47.28 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 5.75 84.10 51.71 6.08 84.26 49.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 8.21 91.93 44.16 9.29 93.32 43.02 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 22 3 # 22 A 263 HIS E 79 HIS~? -4.18 CL CL E2032s D 59 GLU E 163 GLU~? 11.74 O1 GOL E3002 D 128 HIS E 158 HIS.? 10.67 CL CL E2032 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 12.36 98.35 54.34 11.69 100.32 54.60 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 5.75 84.10 51.71 6.08 84.26 49.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 8.21 91.93 44.16 9.29 93.32 43.02 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 23 3 # 23 A 263 HIS E 125 HIS.? 5.41 C3 GOL E3022 D 59 GLU E 73 GLU~? -6.85 O1 GOL E3022s D 128 HIS E 79 HIS~? -4.18 CL CL E2032s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 19.41 104.46 50.06 20.14 105.76 48.58 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 19.82 90.31 48.74 19.50 92.07 47.58 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 24 3 # 24 A 263 HIS E 158 HIS.? 10.67 CL CL E2032 D 59 GLU E 93 GLU~? 8.42 CL CL E2032 D 128 HIS E 76 HIS~? -4.87 CL CL E2013s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 8.21 91.93 44.16 9.29 93.32 43.02 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 9.96 100.16 58.92 10.04 102.16 58.24 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 16.97 95.07 49.08 16.37 95.97 47.28 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 25 3 # 25 A 263 HIS F 76 HIS~? -4.65 CL CL F2034s D 59 GLU F 163 GLU~? 16.81 CL CL F2023 D 128 HIS F 151 HIS~? 14.76 O3 GOL F3039s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 97.24 41.20 21.57 98.43 42.65 20.63 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 105.09 39.28 35.27 105.30 41.23 34.49 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 93.09 42.58 34.58 92.14 42.76 32.71 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 26 3 # 26 A 263 HIS F 76 HIS~? -4.65 CL CL F2034s D 59 GLU F 163 GLU~? 16.81 CL CL F2023 D 128 HIS F 158 HIS.? -10.90 CL CL F2023s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 97.24 41.20 21.57 98.43 42.65 20.63 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 105.09 39.28 35.27 105.30 41.23 34.49 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 105.92 45.34 26.29 105.13 46.33 24.62 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 27 3 # 27 A 263 HIS F 79 HIS~? -4.63 CL CL F2023s D 59 GLU F 163 GLU~? 16.81 CL CL F2023 D 128 HIS F 158 HIS.? -10.90 CL CL F2023s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 101.04 34.65 20.79 101.93 33.69 19.16 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 105.09 39.28 35.27 105.30 41.23 34.49 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 105.92 45.34 26.29 105.13 46.33 24.62 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 28 3 # 28 A 263 HIS F 125 HIS.? 6.27 C1 GOL F3039 D 59 GLU F 73 GLU~? 5.19 O3 GOL F3039 D 128 HIS F 79 HIS~? -4.63 CL CL F2023s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 96.50 38.92 12.23 96.44 40.22 10.57 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 93.55 43.24 25.35 94.46 43.89 23.55 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 29 3 # 29 A 263 HIS F 158 HIS.? -10.90 CL CL F2023s D 59 GLU F 93 GLU~? 8.36 CL CL F2023 D 128 HIS F 76 HIS~? -4.65 CL CL F2034s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 105.92 45.34 26.29 105.13 46.33 24.62 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 102.94 29.85 20.29 103.30 29.96 18.20 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 30 3 # 30 A 263 HIS G 76 HIS~? -3.85 O1 GOL G3038s D 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 D 128 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.26 20.10 48.62 8.05 19.49 50.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 1.42 33.23 43.78 1.39 32.97 45.86 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 13.55 33.19 47.26 14.46 31.35 47.64 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 31 3 # 31 A 263 HIS G 76 HIS~? -3.85 O1 GOL G3038s D 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 D 128 HIS G 158 HIS.? 10.64 CL CL G2033 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.26 20.10 48.62 8.05 19.49 50.22 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 1.42 33.23 43.78 1.39 32.97 45.86 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.65 25.49 51.61 1.26 23.82 52.74 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 32 3 # 32 A 263 HIS G 79 HIS~? -4.46 CL CL G2033s D 59 GLU G 163 GLU~? 11.22 O3 GOL G3001 D 128 HIS G 158 HIS.? 10.64 CL CL G2033 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 5.20 17.85 42.65 4.12 16.10 42.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 1.42 33.23 43.78 1.39 32.97 45.86 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.65 25.49 51.61 1.26 23.82 52.74 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 33 3 # 33 A 263 HIS G 125 HIS.? 6.66 C2 GOL G3038 D 59 GLU G 73 GLU~? 5.63 O1 GOL G3038 D 128 HIS G 79 HIS~? -4.46 CL CL G2033s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 9.81 10.31 48.06 9.47 8.80 49.48 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 12.93 24.13 49.80 12.04 22.49 50.80 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 34 3 # 34 A 263 HIS G 158 HIS.? 10.64 CL CL G2033 D 59 GLU G 93 GLU~? 8.63 CL CL G2033 D 128 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 0.65 25.49 51.61 1.26 23.82 52.74 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 3.64 16.49 37.62 3.03 14.55 38.23 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 35 3 # 35 A 263 HIS H 76 HIS~? 4.68 CL CL H2014s D 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 D 128 HIS H 151 HIS~? 4.32 C1 GOL H3016s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 90.35 57.57 94.69 91.06 55.99 95.89 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 101.55 57.39 83.25 101.29 55.39 84.02 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 89.33 56.65 80.95 87.93 56.76 82.51 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 36 3 # 36 A 263 HIS H 76 HIS~? 4.68 CL CL H2014s D 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 D 128 HIS H 158 HIS.? 10.33 CL CL H2024 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 90.35 57.57 94.69 91.06 55.99 95.89 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 101.55 57.39 83.25 101.29 55.39 84.02 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 98.94 51.80 92.35 97.68 51.03 93.84 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 37 3 # 37 A 263 HIS H 79 HIS~? 4.82 CL CL H2024 D 59 GLU H 163 GLU~? 16.69 O1 GOL H3016 D 128 HIS H 158 HIS.? 10.33 CL CL H2024 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 95.19 63.20 96.60 95.96 63.87 98.43 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 101.55 57.39 83.25 101.29 55.39 84.02 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 98.94 51.80 92.35 97.68 51.03 93.84 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 38 3 # 38 A 263 HIS H 125 HIS.? 7.36 CL CL H2014 D 59 GLU H 73 GLU~? -8.72 CL CL H2014s D 128 HIS H 79 HIS~? 4.82 CL CL H2024 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 88.12 60.23 103.63 87.33 59.09 105.21 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 87.54 56.19 90.14 87.78 55.44 92.11 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 39 3 # 39 A 263 HIS H 158 HIS.? 10.33 CL CL H2024 D 59 GLU H 93 GLU~? 8.72 CL CL H2024 D 128 HIS H 76 HIS~? 4.68 CL CL H2014s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 98.94 51.80 92.35 97.68 51.03 93.84 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 97.56 68.07 97.57 97.65 67.50 99.59 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 90.35 57.57 94.69 91.06 55.99 95.89 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 40 3 # 40 A 263 HIS I 76 HIS~? 4.17 O3 GOL I3031s D 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 D 128 HIS I 151 HIS~? 3.98 O3 GOL I3032s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 212.11 203.51 165.19 213.01 204.42 166.85 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 221.15 190.35 164.07 220.95 190.90 166.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 208.71 190.07 165.44 207.65 191.87 165.52 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 41 3 # 41 A 263 HIS I 76 HIS~? 4.17 O3 GOL I3031s D 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 D 128 HIS I 158 HIS.? 11.08 CL CL I2025 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 212.11 203.51 165.19 213.01 204.42 166.85 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 221.15 190.35 164.07 220.95 190.90 166.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 220.34 199.03 170.60 219.44 200.67 171.57 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 42 3 # 42 A 263 HIS I 79 HIS~? -4.56 CL CL I2025s D 59 GLU I 163 GLU~? 16.56 O3 GOL I3032 D 128 HIS I 158 HIS.? 11.08 CL CL I2025 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 216.99 204.94 159.50 218.07 206.60 158.77 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 221.15 190.35 164.07 220.95 190.90 166.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 220.34 199.03 170.60 219.44 200.67 171.57 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 43 3 # 43 A 263 HIS I 125 HIS.? 6.50 O2 GOL I3031 D 59 GLU I 73 GLU~? -6.03 O3 GOL I3031s D 128 HIS I 79 HIS~? -4.56 CL CL I2025s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 211.42 212.80 162.96 211.20 214.50 164.16 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 208.30 199.46 166.53 209.06 201.27 167.27 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 44 3 # 44 A 263 HIS I 158 HIS.? 11.08 CL CL I2025 D 59 GLU I 93 GLU~? 8.40 CL CL I2025 D 128 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 220.34 199.03 170.60 219.44 200.67 171.57 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 219.77 205.57 155.06 219.86 207.68 155.25 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 45 3 # 45 A 263 HIS J 76 HIS~? 4.19 O2 GOL J3033s D 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 D 128 HIS J 151 HIS~? -12.73 O1 GOL J3033s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 130.51 172.99 128.94 129.60 171.33 128.01 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 120.24 176.69 140.95 120.35 174.56 140.67 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 132.36 173.99 142.63 133.63 173.58 141.01 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 46 3 # 46 A 263 HIS J 76 HIS~? 4.19 O2 GOL J3033s D 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 D 128 HIS J 158 HIS.? 7.50 O2 GOL J3033 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 130.51 172.99 128.94 129.60 171.33 128.01 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 120.24 176.69 140.95 120.35 174.56 140.67 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 121.18 169.23 132.79 122.06 167.98 131.35 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 47 3 # 47 A 263 HIS J 79 HIS~? -4.36 CL CL J2026s D 59 GLU J 163 GLU~? 14.80 O1 GOL J3033 D 128 HIS J 158 HIS.? 7.50 O2 GOL J3033 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 126.45 179.07 126.46 125.69 179.71 124.61 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 120.24 176.69 140.95 120.35 174.56 140.67 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 121.18 169.23 132.79 122.06 167.98 131.35 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 48 3 # 48 A 263 HIS J 125 HIS.? -4.00 O3 GOL J3030s D 59 GLU J 73 GLU~? 5.06 O1 GOL J3033 D 128 HIS J 79 HIS~? -4.36 CL CL J2026s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 132.43 173.86 119.73 132.77 172.30 118.36 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 133.49 171.70 133.63 132.81 170.83 131.84 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 49 3 # 49 A 263 HIS J 158 HIS.? 7.50 O2 GOL J3033 D 59 GLU J 93 GLU~? 8.18 CL CL J2026 D 128 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 121.18 169.23 132.79 122.06 167.98 131.35 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 124.50 183.71 125.04 124.44 183.21 122.99 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 50 3 # 50 A 263 HIS K 76 HIS~? -6.12 C3 GOL K3041s D 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 D 128 HIS K 151 HIS~? -4.18 C2 GOL K3009s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 207.10 129.51 177.50 208.14 128.55 175.95 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 217.27 141.62 179.80 217.24 141.01 177.77 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 205.25 143.04 176.89 203.95 141.38 176.70 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 51 3 # 51 A 263 HIS K 76 HIS~? -6.12 C3 GOL K3041s D 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 D 128 HIS K 158 HIS.? 10.92 CL CL K2027 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 207.10 129.51 177.50 208.14 128.55 175.95 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 217.27 141.62 179.80 217.24 141.01 177.77 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 216.60 132.79 173.33 215.77 131.08 172.42 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 52 3 # 52 A 263 HIS K 79 HIS~? -4.34 CL CL K2027s D 59 GLU K 163 GLU~? 12.51 O2 GOL K3009 D 128 HIS K 158 HIS.? 10.92 CL CL K2027 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 211.01 127.65 183.80 211.70 125.86 184.65 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 217.27 141.62 179.80 217.24 141.01 177.77 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 216.60 132.79 173.33 215.77 131.08 172.42 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 53 3 # 53 A 263 HIS K 125 HIS.? -4.02 O1 GOL K3041s D 59 GLU K 73 GLU~? 7.36 C3 GOL K3041 D 128 HIS K 79 HIS~? -4.34 CL CL K2027s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 204.92 120.38 179.37 204.44 118.90 177.95 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 204.07 133.93 175.85 204.65 132.02 175.03 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 54 3 # 54 A 263 HIS K 158 HIS.? 10.92 CL CL K2027 D 59 GLU K 93 GLU~? 8.22 CL CL K2027 D 128 HIS K 76 HIS~? -6.12 C3 GOL K3041s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 216.60 132.79 173.33 215.77 131.08 172.42 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 212.85 126.80 188.86 213.03 124.72 188.44 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 207.10 129.51 177.50 208.14 128.55 175.95 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 55 3 # 55 A 263 HIS L 76 HIS~? 4.00 O3 GOL L3027s D 59 GLU L 163 GLU~? 16.77 CL CL L2028 D 128 HIS L 151 HIS~? -15.32 O3 GOL L3028s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 125.69 169.77 203.98 124.79 171.51 204.73 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 116.58 166.98 191.20 116.69 169.04 191.44 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 129.06 168.07 190.57 130.17 168.32 192.34 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 56 3 # 56 A 263 HIS L 76 HIS~? 4.00 O3 GOL L3027s D 59 GLU L 163 GLU~? 16.77 CL CL L2028 D 128 HIS L 158 HIS.? 11.11 CL CL L2028 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 125.69 169.77 203.98 124.79 171.51 204.73 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 116.58 166.98 191.20 116.69 169.04 191.44 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 117.45 174.63 198.96 118.55 176.04 200.05 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 57 3 # 57 A 263 HIS L 79 HIS~? -4.09 CL CL L2028s D 59 GLU L 163 GLU~? 16.77 CL CL L2028 D 128 HIS L 158 HIS.? 11.11 CL CL L2028 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 120.65 164.52 206.19 119.64 164.06 207.98 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 116.58 166.98 191.20 116.69 169.04 191.44 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 117.45 174.63 198.96 118.55 176.04 200.05 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 58 3 # 58 A 263 HIS L 125 HIS.? 5.88 O2 GOL L3027 D 59 GLU L 73 GLU~? 5.94 O3 GOL L3027 D 128 HIS L 79 HIS~? -4.09 CL CL L2028s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 126.56 168.90 213.47 127.02 170.42 214.85 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 129.44 170.32 199.72 128.69 171.38 201.39 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 59 3 # 59 A 263 HIS M 76 HIS~? 4.78 C1 GOL M3042s D 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 D 128 HIS M 151 HIS~? -11.81 O3 GOL M3042s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 130.15 208.85 168.09 129.36 209.65 166.31 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 119.51 197.10 170.73 120.12 197.15 168.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 131.91 195.13 169.59 133.22 196.76 169.40 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 60 3 # 60 A 263 HIS M 76 HIS~? 4.78 C1 GOL M3042s D 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 D 128 HIS M 158 HIS.? 6.42 O1 GOL M3042 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 130.15 208.85 168.09 129.36 209.65 166.31 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 119.51 197.10 170.73 120.12 197.15 168.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 121.40 205.18 163.43 122.55 206.46 162.23 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 61 3 # 61 A 263 HIS M 79 HIS~? -4.31 CL CL M2029s D 59 GLU M 163 GLU~? 14.80 C2 GOL M3042 D 128 HIS M 158 HIS.? 6.42 O1 GOL M3042 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 125.50 211.59 173.52 124.72 213.49 173.99 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 119.51 197.10 170.73 120.12 197.15 168.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 121.40 205.18 163.43 122.55 206.46 162.23 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 62 3 # 62 A 263 HIS M 125 HIS.? 4.98 C3 GOL M3043 D 59 GLU M 73 GLU~? -3.31 O3 GOL M3042s D 128 HIS M 79 HIS~? -4.31 CL CL M2029s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 132.19 217.95 169.15 132.87 219.15 167.56 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 133.35 204.22 167.43 132.84 205.99 166.43 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 63 3 # 63 A 263 HIS M 158 HIS.? 6.42 O1 GOL M3042 D 59 GLU M 93 GLU~? 8.60 CL CL M2029 D 128 HIS M 76 HIS~? 4.78 C1 GOL M3042s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 121.40 205.18 163.43 122.55 206.46 162.23 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 123.31 213.00 178.36 123.21 215.02 177.75 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 130.15 208.85 168.09 129.36 209.65 166.31 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 64 3 # 64 A 263 HIS N 76 HIS~? -6.89 CL CL N2030s D 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 D 128 HIS N 151 HIS~? 3.39 O2 GOL N3012s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 211.54 160.16 134.29 212.67 161.69 133.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 220.21 157.81 147.58 220.09 159.81 146.98 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 207.96 160.84 147.59 206.93 161.03 145.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 65 3 # 65 A 263 HIS N 76 HIS~? -6.89 CL CL N2030s D 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 D 128 HIS N 158 HIS.? 10.50 CL CL N2030 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 211.54 160.16 134.29 212.67 161.69 133.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 220.21 157.81 147.58 220.09 159.81 146.98 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 220.32 164.11 138.58 219.66 165.01 136.80 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 66 3 # 66 A 263 HIS N 79 HIS~? -4.33 CL CL N2030s D 59 GLU N 163 GLU~? 12.29 O1 GOL N3012 D 128 HIS N 158 HIS.? 10.50 CL CL N2030 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 215.64 153.98 132.96 216.60 153.22 131.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 220.21 157.81 147.58 220.09 159.81 146.98 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 220.32 164.11 138.58 219.66 165.01 136.80 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 67 3 # 67 A 263 HIS N 125 HIS.? 9.29 CL CL N2030 D 59 GLU N 73 GLU~? -8.02 O3 GOL N3012s D 128 HIS N 79 HIS~? -4.33 CL CL N2030s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 210.43 158.18 125.05 210.19 159.49 123.43 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 207.93 161.92 138.37 208.75 162.64 136.53 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 68 3 # 68 A 263 HIS N 158 HIS.? 10.50 CL CL N2030 D 59 GLU N 93 GLU~? 8.57 CL CL N2030 D 128 HIS N 76 HIS~? -6.89 CL CL N2030s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 220.32 164.11 138.58 219.66 165.01 136.80 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 217.47 148.79 132.22 217.76 148.97 130.14 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 211.54 160.16 134.29 212.67 161.69 133.40 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 69 3 # 69 A 263 HIS O 76 HIS~? 4.51 CL CL O2018s D 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 D 128 HIS O 151 HIS~? 4.32 O2 GOL O3026s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 126.10 133.61 164.62 125.01 132.87 166.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 117.45 146.43 160.85 117.44 146.23 162.92 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 129.65 146.92 163.60 130.73 145.15 163.91 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 70 3 # 70 A 263 HIS O 76 HIS~? 4.51 CL CL O2018s D 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 D 128 HIS O 158 HIS.? 12.21 CL CL O2018 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 126.10 133.61 164.62 125.01 132.87 166.26 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 117.45 146.43 160.85 117.44 146.23 162.92 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 117.44 138.41 168.51 118.31 136.96 169.75 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 71 3 # 71 A 263 HIS O 79 HIS~? 5.21 CL CL O2018 D 59 GLU O 163 GLU~? 12.66 O3 GOL O3013 D 128 HIS O 158 HIS.? 12.21 CL CL O2018 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 121.98 131.53 158.56 121.09 129.74 157.92 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 117.45 146.43 160.85 117.44 146.23 162.92 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 117.44 138.41 168.51 118.31 136.96 169.75 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 72 3 # 72 A 263 HIS O 158 HIS.? 12.21 CL CL O2018 D 59 GLU O 93 GLU~? 9.72 CL CL O2018 D 128 HIS O 76 HIS~? 4.51 CL CL O2018s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 117.44 138.41 168.51 118.31 136.96 169.75 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 119.95 130.02 153.81 119.63 127.98 154.32 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 126.10 133.61 164.62 125.01 132.87 166.26 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 73 3 # 73 A 263 HIS P 76 HIS~? 4.69 CL CL P2019s D 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 D 128 HIS P 151 HIS~? -4.15 C3 GOL P3014s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 207.59 172.73 208.38 208.33 171.09 209.49 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 218.06 173.97 196.16 217.79 171.96 196.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 205.70 172.52 194.71 204.41 172.45 196.35 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 74 3 # 74 A 263 HIS P 76 HIS~? 4.69 CL CL P2019s D 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 D 128 HIS P 158 HIS.? 12.33 O2 GOL P3014 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 207.59 172.73 208.38 208.33 171.09 209.49 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 218.06 173.97 196.16 217.79 171.96 196.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 216.29 167.50 205.15 215.20 166.66 206.73 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 75 3 # 75 A 263 HIS P 79 HIS~? 5.38 CL CL P2019 D 59 GLU P 163 GLU~? 11.95 O2 GOL P3014 D 128 HIS P 158 HIS.? 12.33 O2 GOL P3014 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 212.25 178.47 210.26 213.09 179.27 212.01 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 218.06 173.97 196.16 217.79 171.96 196.61 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 216.29 167.50 205.15 215.20 166.66 206.73 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 76 3 # 76 A 263 HIS P 125 HIS.? 6.57 O3 GOL P3034 D 59 GLU P 73 GLU~? 5.04 O1 GOL P3034 D 128 HIS P 79 HIS~? 5.38 CL CL P2019 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 205.78 175.00 217.63 205.21 173.76 219.23 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 204.36 171.43 203.90 204.84 170.63 205.81 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 77 3 # 77 A 263 HIS P 158 HIS.? 12.33 O2 GOL P3014 D 59 GLU P 93 GLU~? 9.65 CL CL P2019 D 128 HIS P 76 HIS~? 4.69 CL CL P2019s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 216.29 167.50 205.15 215.20 166.66 206.73 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 214.54 183.14 211.27 214.54 182.92 213.36 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 207.59 172.73 208.38 208.33 171.09 209.49 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 77 hits 1ni4_c01 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 A 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -3.50 124.89 25.05 -2.25 124.77 23.26 90.44 78.16 48.76 91.65 76.94 50.06 coo 1.87 119.38 16.45 1.41 122.11 16.84 82.86 85.03 43.55 82.36 85.03 46.30 coo -2.59 124.07 12.67 -0.91 126.17 18.42 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 A 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -3.50 124.89 25.05 -2.25 124.77 23.26 23.66 59.02 20.34 21.93 58.32 21.38 coo 1.87 119.38 16.45 1.41 122.11 16.84 33.54 61.27 14.83 33.38 58.57 15.48 coo -2.59 124.07 12.67 -0.91 126.17 18.42 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 A 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -3.50 124.89 25.05 -2.25 124.77 23.26 82.81 22.02 65.69 84.52 22.80 64.66 coo 1.87 119.38 16.45 1.41 122.11 16.84 72.92 17.11 69.08 73.05 17.20 66.28 coo -2.59 124.07 12.67 -0.91 126.17 18.42 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 A 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -3.50 124.89 25.05 -2.25 124.77 23.26 16.94 54.59 79.01 15.65 55.42 77.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 24.56 50.70 86.69 25.05 53.37 86.07 coo -2.59 124.07 12.67 -0.91 126.17 18.42 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 A 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -3.50 124.89 25.05 -2.25 124.77 23.26 23.07 86.29 52.35 21.57 85.17 51.32 coo 1.87 119.38 16.45 1.41 122.11 16.84 32.26 92.00 56.29 32.65 91.34 53.61 coo -2.59 124.07 12.67 -0.91 126.17 18.42 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 146 TYR F 112 TYR~? 9.99 CL CL F2035 A 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -3.50 124.89 25.05 -2.25 124.77 23.26 88.86 41.25 28.96 90.30 42.22 30.24 coo 1.87 119.38 16.45 1.41 122.11 16.84 80.32 37.88 21.99 80.47 40.63 22.04 coo -2.59 124.07 12.67 -0.91 126.17 18.42 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 A 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -3.50 124.89 25.05 -2.25 124.77 23.26 17.70 27.34 47.09 16.19 28.71 47.73 coo 1.87 119.38 16.45 1.41 122.11 16.84 26.10 19.68 45.15 26.07 20.41 47.86 coo -2.59 124.07 12.67 -0.91 126.17 18.42 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 A 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -3.50 124.89 25.05 -2.25 124.77 23.26 84.24 58.93 85.48 85.73 57.59 84.66 coo 1.87 119.38 16.45 1.41 122.11 16.84 75.20 64.22 90.27 74.79 61.48 90.12 coo -2.59 124.07 12.67 -0.91 126.17 18.42 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 A 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -3.50 124.89 25.05 -2.25 124.77 23.26 204.37 195.46 163.61 205.75 194.30 164.79 coo 1.87 119.38 16.45 1.41 122.11 16.84 196.16 202.11 159.00 195.80 201.93 161.71 coo -2.59 124.07 12.67 -0.91 126.17 18.42 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 A 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -3.50 124.89 25.05 -2.25 124.77 23.26 137.44 174.60 137.57 135.80 173.80 138.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 146.80 177.39 131.57 146.79 174.66 132.11 coo -2.59 124.07 12.67 -0.91 126.17 18.42 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 A 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 A 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -3.50 124.89 25.05 -2.25 124.77 23.26 200.17 138.24 178.11 201.77 139.28 177.19 coo 1.87 119.38 16.45 1.41 122.11 16.84 190.77 132.67 181.60 190.81 132.90 178.83 coo -2.59 124.07 12.67 -0.91 126.17 18.42 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 A 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 A 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -3.50 124.89 25.05 -2.25 124.77 23.26 133.34 166.97 196.27 132.03 168.03 194.96 coo 1.87 119.38 16.45 1.41 122.11 16.84 141.53 163.06 203.38 141.93 165.73 202.75 coo -2.59 124.07 12.67 -0.91 126.17 18.42 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 A 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 A 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -3.50 124.89 25.05 -2.25 124.77 23.26 136.87 200.18 170.79 135.36 199.08 169.77 coo 1.87 119.38 16.45 1.41 122.11 16.84 145.86 206.20 174.56 146.17 205.67 171.86 coo -2.59 124.07 12.67 -0.91 126.17 18.42 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 A 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 A 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -3.50 124.89 25.05 -2.25 124.77 23.26 203.51 159.51 142.26 205.02 160.53 143.48 coo 1.87 119.38 16.45 1.41 122.11 16.84 194.78 156.07 135.52 194.77 158.81 135.67 coo -2.59 124.07 12.67 -0.91 126.17 18.42 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 A 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 146 TYR O 112 TYR~? 11.14 CL CL O2036 A 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -3.50 124.89 25.05 -2.25 124.77 23.26 134.07 141.35 162.95 132.57 142.58 163.78 coo 1.87 119.38 16.45 1.41 122.11 16.84 142.72 134.33 160.12 142.81 134.85 162.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 A 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 A 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -3.50 124.89 25.05 -2.25 124.77 23.26 200.75 174.15 199.66 202.28 173.10 198.62 coo 1.87 119.38 16.45 1.41 122.11 16.84 191.84 178.79 205.19 191.53 176.04 204.95 coo -2.59 124.07 12.67 -0.91 126.17 18.42 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 B 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -7.43 109.06 51.23 -5.84 110.54 50.86 90.44 78.16 48.76 91.65 76.94 50.06 coo 0.22 114.56 44.62 -0.76 115.18 47.18 82.86 85.03 43.55 82.36 85.03 46.30 coo -4.18 120.17 46.85 -4.02 115.31 51.00 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 B 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -7.43 109.06 51.23 -5.84 110.54 50.86 23.66 59.02 20.34 21.93 58.32 21.38 coo 0.22 114.56 44.62 -0.76 115.18 47.18 33.54 61.27 14.83 33.38 58.57 15.48 coo -4.18 120.17 46.85 -4.02 115.31 51.00 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 B 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -7.43 109.06 51.23 -5.84 110.54 50.86 82.81 22.02 65.69 84.52 22.80 64.66 coo 0.22 114.56 44.62 -0.76 115.18 47.18 72.92 17.11 69.08 73.05 17.20 66.28 coo -4.18 120.17 46.85 -4.02 115.31 51.00 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 B 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -7.43 109.06 51.23 -5.84 110.54 50.86 16.94 54.59 79.01 15.65 55.42 77.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 24.56 50.70 86.69 25.05 53.37 86.07 coo -4.18 120.17 46.85 -4.02 115.31 51.00 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 B 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -7.43 109.06 51.23 -5.84 110.54 50.86 23.07 86.29 52.35 21.57 85.17 51.32 coo 0.22 114.56 44.62 -0.76 115.18 47.18 32.26 92.00 56.29 32.65 91.34 53.61 coo -4.18 120.17 46.85 -4.02 115.31 51.00 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 146 TYR F 112 TYR~? 9.99 CL CL F2035 B 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -7.43 109.06 51.23 -5.84 110.54 50.86 88.86 41.25 28.96 90.30 42.22 30.24 coo 0.22 114.56 44.62 -0.76 115.18 47.18 80.32 37.88 21.99 80.47 40.63 22.04 coo -4.18 120.17 46.85 -4.02 115.31 51.00 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 B 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -7.43 109.06 51.23 -5.84 110.54 50.86 17.70 27.34 47.09 16.19 28.71 47.73 coo 0.22 114.56 44.62 -0.76 115.18 47.18 26.10 19.68 45.15 26.07 20.41 47.86 coo -4.18 120.17 46.85 -4.02 115.31 51.00 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 B 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -7.43 109.06 51.23 -5.84 110.54 50.86 84.24 58.93 85.48 85.73 57.59 84.66 coo 0.22 114.56 44.62 -0.76 115.18 47.18 75.20 64.22 90.27 74.79 61.48 90.12 coo -4.18 120.17 46.85 -4.02 115.31 51.00 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 B 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -7.43 109.06 51.23 -5.84 110.54 50.86 204.37 195.46 163.61 205.75 194.30 164.79 coo 0.22 114.56 44.62 -0.76 115.18 47.18 196.16 202.11 159.00 195.80 201.93 161.71 coo -4.18 120.17 46.85 -4.02 115.31 51.00 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 B 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -7.43 109.06 51.23 -5.84 110.54 50.86 137.44 174.60 137.57 135.80 173.80 138.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 146.80 177.39 131.57 146.79 174.66 132.11 coo -4.18 120.17 46.85 -4.02 115.31 51.00 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 B 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 B 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -7.43 109.06 51.23 -5.84 110.54 50.86 200.17 138.24 178.11 201.77 139.28 177.19 coo 0.22 114.56 44.62 -0.76 115.18 47.18 190.77 132.67 181.60 190.81 132.90 178.83 coo -4.18 120.17 46.85 -4.02 115.31 51.00 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 B 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 B 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -7.43 109.06 51.23 -5.84 110.54 50.86 133.34 166.97 196.27 132.03 168.03 194.96 coo 0.22 114.56 44.62 -0.76 115.18 47.18 141.53 163.06 203.38 141.93 165.73 202.75 coo -4.18 120.17 46.85 -4.02 115.31 51.00 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 B 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 B 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -7.43 109.06 51.23 -5.84 110.54 50.86 136.87 200.18 170.79 135.36 199.08 169.77 coo 0.22 114.56 44.62 -0.76 115.18 47.18 145.86 206.20 174.56 146.17 205.67 171.86 coo -4.18 120.17 46.85 -4.02 115.31 51.00 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 B 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 B 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -7.43 109.06 51.23 -5.84 110.54 50.86 203.51 159.51 142.26 205.02 160.53 143.48 coo 0.22 114.56 44.62 -0.76 115.18 47.18 194.78 156.07 135.52 194.77 158.81 135.67 coo -4.18 120.17 46.85 -4.02 115.31 51.00 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 B 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 146 TYR O 112 TYR~? 11.14 CL CL O2036 B 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -7.43 109.06 51.23 -5.84 110.54 50.86 134.07 141.35 162.95 132.57 142.58 163.78 coo 0.22 114.56 44.62 -0.76 115.18 47.18 142.72 134.33 160.12 142.81 134.85 162.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 B 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 B 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -7.43 109.06 51.23 -5.84 110.54 50.86 200.75 174.15 199.66 202.28 173.10 198.62 coo 0.22 114.56 44.62 -0.76 115.18 47.18 191.84 178.79 205.19 191.53 176.04 204.95 coo -4.18 120.17 46.85 -4.02 115.31 51.00 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 C 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -13.49 79.65 43.90 -12.13 80.29 45.45 90.44 78.16 48.76 91.65 76.94 50.06 coo -5.65 86.78 48.49 -7.16 84.72 49.65 82.86 85.03 43.55 82.36 85.03 46.30 coo -11.22 87.18 53.49 -10.94 81.64 50.31 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 C 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -13.49 79.65 43.90 -12.13 80.29 45.45 23.66 59.02 20.34 21.93 58.32 21.38 coo -5.65 86.78 48.49 -7.16 84.72 49.65 33.54 61.27 14.83 33.38 58.57 15.48 coo -11.22 87.18 53.49 -10.94 81.64 50.31 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 C 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -13.49 79.65 43.90 -12.13 80.29 45.45 82.81 22.02 65.69 84.52 22.80 64.66 coo -5.65 86.78 48.49 -7.16 84.72 49.65 72.92 17.11 69.08 73.05 17.20 66.28 coo -11.22 87.18 53.49 -10.94 81.64 50.31 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 C 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -13.49 79.65 43.90 -12.13 80.29 45.45 16.94 54.59 79.01 15.65 55.42 77.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 24.56 50.70 86.69 25.05 53.37 86.07 coo -11.22 87.18 53.49 -10.94 81.64 50.31 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 C 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -13.49 79.65 43.90 -12.13 80.29 45.45 23.07 86.29 52.35 21.57 85.17 51.32 coo -5.65 86.78 48.49 -7.16 84.72 49.65 32.26 92.00 56.29 32.65 91.34 53.61 coo -11.22 87.18 53.49 -10.94 81.64 50.31 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 146 TYR F 112 TYR~? 9.99 CL CL F2035 C 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -13.49 79.65 43.90 -12.13 80.29 45.45 88.86 41.25 28.96 90.30 42.22 30.24 coo -5.65 86.78 48.49 -7.16 84.72 49.65 80.32 37.88 21.99 80.47 40.63 22.04 coo -11.22 87.18 53.49 -10.94 81.64 50.31 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 C 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -13.49 79.65 43.90 -12.13 80.29 45.45 17.70 27.34 47.09 16.19 28.71 47.73 coo -5.65 86.78 48.49 -7.16 84.72 49.65 26.10 19.68 45.15 26.07 20.41 47.86 coo -11.22 87.18 53.49 -10.94 81.64 50.31 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 C 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -13.49 79.65 43.90 -12.13 80.29 45.45 84.24 58.93 85.48 85.73 57.59 84.66 coo -5.65 86.78 48.49 -7.16 84.72 49.65 75.20 64.22 90.27 74.79 61.48 90.12 coo -11.22 87.18 53.49 -10.94 81.64 50.31 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 C 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -13.49 79.65 43.90 -12.13 80.29 45.45 204.37 195.46 163.61 205.75 194.30 164.79 coo -5.65 86.78 48.49 -7.16 84.72 49.65 196.16 202.11 159.00 195.80 201.93 161.71 coo -11.22 87.18 53.49 -10.94 81.64 50.31 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 C 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -13.49 79.65 43.90 -12.13 80.29 45.45 137.44 174.60 137.57 135.80 173.80 138.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 146.80 177.39 131.57 146.79 174.66 132.11 coo -11.22 87.18 53.49 -10.94 81.64 50.31 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 C 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 C 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -13.49 79.65 43.90 -12.13 80.29 45.45 200.17 138.24 178.11 201.77 139.28 177.19 coo -5.65 86.78 48.49 -7.16 84.72 49.65 190.77 132.67 181.60 190.81 132.90 178.83 coo -11.22 87.18 53.49 -10.94 81.64 50.31 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 C 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 C 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -13.49 79.65 43.90 -12.13 80.29 45.45 133.34 166.97 196.27 132.03 168.03 194.96 coo -5.65 86.78 48.49 -7.16 84.72 49.65 141.53 163.06 203.38 141.93 165.73 202.75 coo -11.22 87.18 53.49 -10.94 81.64 50.31 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 C 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 C 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -13.49 79.65 43.90 -12.13 80.29 45.45 136.87 200.18 170.79 135.36 199.08 169.77 coo -5.65 86.78 48.49 -7.16 84.72 49.65 145.86 206.20 174.56 146.17 205.67 171.86 coo -11.22 87.18 53.49 -10.94 81.64 50.31 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 C 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 C 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -13.49 79.65 43.90 -12.13 80.29 45.45 203.51 159.51 142.26 205.02 160.53 143.48 coo -5.65 86.78 48.49 -7.16 84.72 49.65 194.78 156.07 135.52 194.77 158.81 135.67 coo -11.22 87.18 53.49 -10.94 81.64 50.31 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 C 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 146 TYR O 112 TYR~? 11.14 CL CL O2036 C 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -13.49 79.65 43.90 -12.13 80.29 45.45 134.07 141.35 162.95 132.57 142.58 163.78 coo -5.65 86.78 48.49 -7.16 84.72 49.65 142.72 134.33 160.12 142.81 134.85 162.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 C 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 C 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -13.49 79.65 43.90 -12.13 80.29 45.45 200.75 174.15 199.66 202.28 173.10 198.62 coo -5.65 86.78 48.49 -7.16 84.72 49.65 191.84 178.79 205.19 191.53 176.04 204.95 coo -11.22 87.18 53.49 -10.94 81.64 50.31 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 D 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -13.44 77.36 13.12 -12.53 75.97 14.48 90.44 78.16 48.76 91.65 76.94 50.06 coo -7.85 74.44 22.75 -9.22 72.86 20.89 82.86 85.03 43.55 82.36 85.03 46.30 coo -14.24 70.61 23.48 -12.55 71.73 17.42 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 D 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -13.44 77.36 13.12 -12.53 75.97 14.48 23.66 59.02 20.34 21.93 58.32 21.38 coo -7.85 74.44 22.75 -9.22 72.86 20.89 33.54 61.27 14.83 33.38 58.57 15.48 coo -14.24 70.61 23.48 -12.55 71.73 17.42 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 D 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -13.44 77.36 13.12 -12.53 75.97 14.48 82.81 22.02 65.69 84.52 22.80 64.66 coo -7.85 74.44 22.75 -9.22 72.86 20.89 72.92 17.11 69.08 73.05 17.20 66.28 coo -14.24 70.61 23.48 -12.55 71.73 17.42 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 D 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -13.44 77.36 13.12 -12.53 75.97 14.48 16.94 54.59 79.01 15.65 55.42 77.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 24.56 50.70 86.69 25.05 53.37 86.07 coo -14.24 70.61 23.48 -12.55 71.73 17.42 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 D 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -13.44 77.36 13.12 -12.53 75.97 14.48 23.07 86.29 52.35 21.57 85.17 51.32 coo -7.85 74.44 22.75 -9.22 72.86 20.89 32.26 92.00 56.29 32.65 91.34 53.61 coo -14.24 70.61 23.48 -12.55 71.73 17.42 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 146 TYR F 112 TYR~? 9.99 CL CL F2035 D 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -13.44 77.36 13.12 -12.53 75.97 14.48 88.86 41.25 28.96 90.30 42.22 30.24 coo -7.85 74.44 22.75 -9.22 72.86 20.89 80.32 37.88 21.99 80.47 40.63 22.04 coo -14.24 70.61 23.48 -12.55 71.73 17.42 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 D 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -13.44 77.36 13.12 -12.53 75.97 14.48 17.70 27.34 47.09 16.19 28.71 47.73 coo -7.85 74.44 22.75 -9.22 72.86 20.89 26.10 19.68 45.15 26.07 20.41 47.86 coo -14.24 70.61 23.48 -12.55 71.73 17.42 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 D 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -13.44 77.36 13.12 -12.53 75.97 14.48 84.24 58.93 85.48 85.73 57.59 84.66 coo -7.85 74.44 22.75 -9.22 72.86 20.89 75.20 64.22 90.27 74.79 61.48 90.12 coo -14.24 70.61 23.48 -12.55 71.73 17.42 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 D 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -13.44 77.36 13.12 -12.53 75.97 14.48 204.37 195.46 163.61 205.75 194.30 164.79 coo -7.85 74.44 22.75 -9.22 72.86 20.89 196.16 202.11 159.00 195.80 201.93 161.71 coo -14.24 70.61 23.48 -12.55 71.73 17.42 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 D 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -13.44 77.36 13.12 -12.53 75.97 14.48 137.44 174.60 137.57 135.80 173.80 138.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 146.80 177.39 131.57 146.79 174.66 132.11 coo -14.24 70.61 23.48 -12.55 71.73 17.42 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 D 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 D 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -13.44 77.36 13.12 -12.53 75.97 14.48 200.17 138.24 178.11 201.77 139.28 177.19 coo -7.85 74.44 22.75 -9.22 72.86 20.89 190.77 132.67 181.60 190.81 132.90 178.83 coo -14.24 70.61 23.48 -12.55 71.73 17.42 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 D 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 D 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -13.44 77.36 13.12 -12.53 75.97 14.48 133.34 166.97 196.27 132.03 168.03 194.96 coo -7.85 74.44 22.75 -9.22 72.86 20.89 141.53 163.06 203.38 141.93 165.73 202.75 coo -14.24 70.61 23.48 -12.55 71.73 17.42 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 D 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 D 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -13.44 77.36 13.12 -12.53 75.97 14.48 136.87 200.18 170.79 135.36 199.08 169.77 coo -7.85 74.44 22.75 -9.22 72.86 20.89 145.86 206.20 174.56 146.17 205.67 171.86 coo -14.24 70.61 23.48 -12.55 71.73 17.42 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 D 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 D 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -13.44 77.36 13.12 -12.53 75.97 14.48 203.51 159.51 142.26 205.02 160.53 143.48 coo -7.85 74.44 22.75 -9.22 72.86 20.89 194.78 156.07 135.52 194.77 158.81 135.67 coo -14.24 70.61 23.48 -12.55 71.73 17.42 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 D 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 146 TYR O 112 TYR~? 11.14 CL CL O2036 D 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -13.44 77.36 13.12 -12.53 75.97 14.48 134.07 141.35 162.95 132.57 142.58 163.78 coo -7.85 74.44 22.75 -9.22 72.86 20.89 142.72 134.33 160.12 142.81 134.85 162.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 D 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 D 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -13.44 77.36 13.12 -12.53 75.97 14.48 200.75 174.15 199.66 202.28 173.10 198.62 coo -7.85 74.44 22.75 -9.22 72.86 20.89 191.84 178.79 205.19 191.53 176.04 204.95 coo -14.24 70.61 23.48 -12.55 71.73 17.42 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s E 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 E 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -7.12 105.25 1.43 -6.30 103.34 0.77 90.44 78.16 48.76 91.65 76.94 50.06 coo -3.11 94.55 3.01 -3.83 95.92 0.66 82.86 85.03 43.55 82.36 85.03 46.30 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s E 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 E 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -7.12 105.25 1.43 -6.30 103.34 0.77 23.66 59.02 20.34 21.93 58.32 21.38 coo -3.11 94.55 3.01 -3.83 95.92 0.66 33.54 61.27 14.83 33.38 58.57 15.48 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s E 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 E 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -7.12 105.25 1.43 -6.30 103.34 0.77 82.81 22.02 65.69 84.52 22.80 64.66 coo -3.11 94.55 3.01 -3.83 95.92 0.66 72.92 17.11 69.08 73.05 17.20 66.28 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s E 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 E 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -7.12 105.25 1.43 -6.30 103.34 0.77 16.94 54.59 79.01 15.65 55.42 77.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 24.56 50.70 86.69 25.05 53.37 86.07 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 E 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 E 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -7.12 105.25 1.43 -6.30 103.34 0.77 23.07 86.29 52.35 21.57 85.17 51.32 coo -3.11 94.55 3.01 -3.83 95.92 0.66 32.26 92.00 56.29 32.65 91.34 53.61 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s E 146 TYR F 112 TYR~? 9.99 CL CL F2035 E 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -7.12 105.25 1.43 -6.30 103.34 0.77 88.86 41.25 28.96 90.30 42.22 30.24 coo -3.11 94.55 3.01 -3.83 95.92 0.66 80.32 37.88 21.99 80.47 40.63 22.04 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s E 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 E 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -7.12 105.25 1.43 -6.30 103.34 0.77 17.70 27.34 47.09 16.19 28.71 47.73 coo -3.11 94.55 3.01 -3.83 95.92 0.66 26.10 19.68 45.15 26.07 20.41 47.86 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s E 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 E 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -7.12 105.25 1.43 -6.30 103.34 0.77 84.24 58.93 85.48 85.73 57.59 84.66 coo -3.11 94.55 3.01 -3.83 95.92 0.66 75.20 64.22 90.27 74.79 61.48 90.12 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s E 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 E 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -7.12 105.25 1.43 -6.30 103.34 0.77 204.37 195.46 163.61 205.75 194.30 164.79 coo -3.11 94.55 3.01 -3.83 95.92 0.66 196.16 202.11 159.00 195.80 201.93 161.71 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 E 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 E 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -7.12 105.25 1.43 -6.30 103.34 0.77 137.44 174.60 137.57 135.80 173.80 138.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 146.80 177.39 131.57 146.79 174.66 132.11 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 E 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s E 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 E 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -7.12 105.25 1.43 -6.30 103.34 0.77 200.17 138.24 178.11 201.77 139.28 177.19 coo -3.11 94.55 3.01 -3.83 95.92 0.66 190.77 132.67 181.60 190.81 132.90 178.83 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 E 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s E 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 E 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -7.12 105.25 1.43 -6.30 103.34 0.77 133.34 166.97 196.27 132.03 168.03 194.96 coo -3.11 94.55 3.01 -3.83 95.92 0.66 141.53 163.06 203.38 141.93 165.73 202.75 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 E 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s E 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 E 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -7.12 105.25 1.43 -6.30 103.34 0.77 136.87 200.18 170.79 135.36 199.08 169.77 coo -3.11 94.55 3.01 -3.83 95.92 0.66 145.86 206.20 174.56 146.17 205.67 171.86 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 E 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s E 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 E 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -7.12 105.25 1.43 -6.30 103.34 0.77 203.51 159.51 142.26 205.02 160.53 143.48 coo -3.11 94.55 3.01 -3.83 95.92 0.66 194.78 156.07 135.52 194.77 158.81 135.67 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 E 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s E 146 TYR O 112 TYR~? 11.14 CL CL O2036 E 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -7.12 105.25 1.43 -6.30 103.34 0.77 134.07 141.35 162.95 132.57 142.58 163.78 coo -3.11 94.55 3.01 -3.83 95.92 0.66 142.72 134.33 160.12 142.81 134.85 162.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 E 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 E 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 E 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -7.12 105.25 1.43 -6.30 103.34 0.77 200.75 174.15 199.66 202.28 173.10 198.62 coo -3.11 94.55 3.01 -3.83 95.92 0.66 191.84 178.79 205.19 191.53 176.04 204.95 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s F 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 F 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -44.75 128.15 10.28 -45.68 129.67 11.55 90.44 78.16 48.76 91.65 76.94 50.06 coo -50.43 131.90 19.60 -49.04 133.31 17.60 82.86 85.03 43.55 82.36 85.03 46.30 coo -44.10 135.86 19.99 -45.67 134.21 14.07 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s F 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 F 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -44.75 128.15 10.28 -45.68 129.67 11.55 23.66 59.02 20.34 21.93 58.32 21.38 coo -50.43 131.90 19.60 -49.04 133.31 17.60 33.54 61.27 14.83 33.38 58.57 15.48 coo -44.10 135.86 19.99 -45.67 134.21 14.07 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s F 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 F 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -44.75 128.15 10.28 -45.68 129.67 11.55 82.81 22.02 65.69 84.52 22.80 64.66 coo -50.43 131.90 19.60 -49.04 133.31 17.60 72.92 17.11 69.08 73.05 17.20 66.28 coo -44.10 135.86 19.99 -45.67 134.21 14.07 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s F 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 F 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -44.75 128.15 10.28 -45.68 129.67 11.55 16.94 54.59 79.01 15.65 55.42 77.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 24.56 50.70 86.69 25.05 53.37 86.07 coo -44.10 135.86 19.99 -45.67 134.21 14.07 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 F 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 F 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -44.75 128.15 10.28 -45.68 129.67 11.55 23.07 86.29 52.35 21.57 85.17 51.32 coo -50.43 131.90 19.60 -49.04 133.31 17.60 32.26 92.00 56.29 32.65 91.34 53.61 coo -44.10 135.86 19.99 -45.67 134.21 14.07 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s F 146 TYR F 112 TYR~? 9.99 CL CL F2035 F 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -44.75 128.15 10.28 -45.68 129.67 11.55 88.86 41.25 28.96 90.30 42.22 30.24 coo -50.43 131.90 19.60 -49.04 133.31 17.60 80.32 37.88 21.99 80.47 40.63 22.04 coo -44.10 135.86 19.99 -45.67 134.21 14.07 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s F 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 F 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -44.75 128.15 10.28 -45.68 129.67 11.55 17.70 27.34 47.09 16.19 28.71 47.73 coo -50.43 131.90 19.60 -49.04 133.31 17.60 26.10 19.68 45.15 26.07 20.41 47.86 coo -44.10 135.86 19.99 -45.67 134.21 14.07 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s F 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 F 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -44.75 128.15 10.28 -45.68 129.67 11.55 84.24 58.93 85.48 85.73 57.59 84.66 coo -50.43 131.90 19.60 -49.04 133.31 17.60 75.20 64.22 90.27 74.79 61.48 90.12 coo -44.10 135.86 19.99 -45.67 134.21 14.07 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s F 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 F 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -44.75 128.15 10.28 -45.68 129.67 11.55 204.37 195.46 163.61 205.75 194.30 164.79 coo -50.43 131.90 19.60 -49.04 133.31 17.60 196.16 202.11 159.00 195.80 201.93 161.71 coo -44.10 135.86 19.99 -45.67 134.21 14.07 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 F 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 F 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -44.75 128.15 10.28 -45.68 129.67 11.55 137.44 174.60 137.57 135.80 173.80 138.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 146.80 177.39 131.57 146.79 174.66 132.11 coo -44.10 135.86 19.99 -45.67 134.21 14.07 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 F 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s F 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 F 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -44.75 128.15 10.28 -45.68 129.67 11.55 200.17 138.24 178.11 201.77 139.28 177.19 coo -50.43 131.90 19.60 -49.04 133.31 17.60 190.77 132.67 181.60 190.81 132.90 178.83 coo -44.10 135.86 19.99 -45.67 134.21 14.07 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 F 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s F 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 F 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -44.75 128.15 10.28 -45.68 129.67 11.55 133.34 166.97 196.27 132.03 168.03 194.96 coo -50.43 131.90 19.60 -49.04 133.31 17.60 141.53 163.06 203.38 141.93 165.73 202.75 coo -44.10 135.86 19.99 -45.67 134.21 14.07 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 F 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s F 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 F 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -44.75 128.15 10.28 -45.68 129.67 11.55 136.87 200.18 170.79 135.36 199.08 169.77 coo -50.43 131.90 19.60 -49.04 133.31 17.60 145.86 206.20 174.56 146.17 205.67 171.86 coo -44.10 135.86 19.99 -45.67 134.21 14.07 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 F 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s F 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 F 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -44.75 128.15 10.28 -45.68 129.67 11.55 203.51 159.51 142.26 205.02 160.53 143.48 coo -50.43 131.90 19.60 -49.04 133.31 17.60 194.78 156.07 135.52 194.77 158.81 135.67 coo -44.10 135.86 19.99 -45.67 134.21 14.07 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 F 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s F 146 TYR O 112 TYR~? 11.14 CL CL O2036 F 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -44.75 128.15 10.28 -45.68 129.67 11.55 134.07 141.35 162.95 132.57 142.58 163.78 coo -50.43 131.90 19.60 -49.04 133.31 17.60 142.72 134.33 160.12 142.81 134.85 162.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 F 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 F 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 F 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -44.75 128.15 10.28 -45.68 129.67 11.55 200.75 174.15 199.66 202.28 173.10 198.62 coo -50.43 131.90 19.60 -49.04 133.31 17.60 191.84 178.79 205.19 191.53 176.04 204.95 coo -44.10 135.86 19.99 -45.67 134.21 14.07 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s G 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 G 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -44.97 128.78 41.20 -46.32 128.26 42.83 90.44 78.16 48.76 91.65 76.94 50.06 coo -52.83 122.13 46.42 -51.31 124.30 47.39 82.86 85.03 43.55 82.36 85.03 46.30 coo -47.30 122.24 51.49 -47.46 127.44 47.81 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s G 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 G 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -44.97 128.78 41.20 -46.32 128.26 42.83 23.66 59.02 20.34 21.93 58.32 21.38 coo -52.83 122.13 46.42 -51.31 124.30 47.39 33.54 61.27 14.83 33.38 58.57 15.48 coo -47.30 122.24 51.49 -47.46 127.44 47.81 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s G 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 G 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -44.97 128.78 41.20 -46.32 128.26 42.83 82.81 22.02 65.69 84.52 22.80 64.66 coo -52.83 122.13 46.42 -51.31 124.30 47.39 72.92 17.11 69.08 73.05 17.20 66.28 coo -47.30 122.24 51.49 -47.46 127.44 47.81 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s G 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 G 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -44.97 128.78 41.20 -46.32 128.26 42.83 16.94 54.59 79.01 15.65 55.42 77.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 24.56 50.70 86.69 25.05 53.37 86.07 coo -47.30 122.24 51.49 -47.46 127.44 47.81 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 G 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 G 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -44.97 128.78 41.20 -46.32 128.26 42.83 23.07 86.29 52.35 21.57 85.17 51.32 coo -52.83 122.13 46.42 -51.31 124.30 47.39 32.26 92.00 56.29 32.65 91.34 53.61 coo -47.30 122.24 51.49 -47.46 127.44 47.81 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s G 146 TYR F 112 TYR~? 9.99 CL CL F2035 G 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -44.97 128.78 41.20 -46.32 128.26 42.83 88.86 41.25 28.96 90.30 42.22 30.24 coo -52.83 122.13 46.42 -51.31 124.30 47.39 80.32 37.88 21.99 80.47 40.63 22.04 coo -47.30 122.24 51.49 -47.46 127.44 47.81 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s G 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 G 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -44.97 128.78 41.20 -46.32 128.26 42.83 17.70 27.34 47.09 16.19 28.71 47.73 coo -52.83 122.13 46.42 -51.31 124.30 47.39 26.10 19.68 45.15 26.07 20.41 47.86 coo -47.30 122.24 51.49 -47.46 127.44 47.81 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s G 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 G 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -44.97 128.78 41.20 -46.32 128.26 42.83 84.24 58.93 85.48 85.73 57.59 84.66 coo -52.83 122.13 46.42 -51.31 124.30 47.39 75.20 64.22 90.27 74.79 61.48 90.12 coo -47.30 122.24 51.49 -47.46 127.44 47.81 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s G 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 G 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -44.97 128.78 41.20 -46.32 128.26 42.83 204.37 195.46 163.61 205.75 194.30 164.79 coo -52.83 122.13 46.42 -51.31 124.30 47.39 196.16 202.11 159.00 195.80 201.93 161.71 coo -47.30 122.24 51.49 -47.46 127.44 47.81 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 G 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 G 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -44.97 128.78 41.20 -46.32 128.26 42.83 137.44 174.60 137.57 135.80 173.80 138.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 146.80 177.39 131.57 146.79 174.66 132.11 coo -47.30 122.24 51.49 -47.46 127.44 47.81 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 G 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s G 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 G 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -44.97 128.78 41.20 -46.32 128.26 42.83 200.17 138.24 178.11 201.77 139.28 177.19 coo -52.83 122.13 46.42 -51.31 124.30 47.39 190.77 132.67 181.60 190.81 132.90 178.83 coo -47.30 122.24 51.49 -47.46 127.44 47.81 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 G 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s G 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 G 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -44.97 128.78 41.20 -46.32 128.26 42.83 133.34 166.97 196.27 132.03 168.03 194.96 coo -52.83 122.13 46.42 -51.31 124.30 47.39 141.53 163.06 203.38 141.93 165.73 202.75 coo -47.30 122.24 51.49 -47.46 127.44 47.81 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 G 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s G 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 G 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -44.97 128.78 41.20 -46.32 128.26 42.83 136.87 200.18 170.79 135.36 199.08 169.77 coo -52.83 122.13 46.42 -51.31 124.30 47.39 145.86 206.20 174.56 146.17 205.67 171.86 coo -47.30 122.24 51.49 -47.46 127.44 47.81 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 G 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s G 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 G 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -44.97 128.78 41.20 -46.32 128.26 42.83 203.51 159.51 142.26 205.02 160.53 143.48 coo -52.83 122.13 46.42 -51.31 124.30 47.39 194.78 156.07 135.52 194.77 158.81 135.67 coo -47.30 122.24 51.49 -47.46 127.44 47.81 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 G 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s G 146 TYR O 112 TYR~? 11.14 CL CL O2036 G 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -44.97 128.78 41.20 -46.32 128.26 42.83 134.07 141.35 162.95 132.57 142.58 163.78 coo -52.83 122.13 46.42 -51.31 124.30 47.39 142.72 134.33 160.12 142.81 134.85 162.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 G 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 G 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 G 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -44.97 128.78 41.20 -46.32 128.26 42.83 200.75 174.15 199.66 202.28 173.10 198.62 coo -52.83 122.13 46.42 -51.31 124.30 47.39 191.84 178.79 205.19 191.53 176.04 204.95 coo -47.30 122.24 51.49 -47.46 127.44 47.81 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s H 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 H 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -51.11 100.30 51.41 -52.67 98.82 51.12 90.44 78.16 48.76 91.65 76.94 50.06 coo -58.70 94.17 45.32 -57.76 93.82 47.92 82.86 85.03 43.55 82.36 85.03 46.30 coo -54.32 88.79 48.13 -54.61 94.04 51.74 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s H 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 H 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -51.11 100.30 51.41 -52.67 98.82 51.12 23.66 59.02 20.34 21.93 58.32 21.38 coo -58.70 94.17 45.32 -57.76 93.82 47.92 33.54 61.27 14.83 33.38 58.57 15.48 coo -54.32 88.79 48.13 -54.61 94.04 51.74 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s H 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 H 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -51.11 100.30 51.41 -52.67 98.82 51.12 82.81 22.02 65.69 84.52 22.80 64.66 coo -58.70 94.17 45.32 -57.76 93.82 47.92 72.92 17.11 69.08 73.05 17.20 66.28 coo -54.32 88.79 48.13 -54.61 94.04 51.74 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s H 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 H 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -51.11 100.30 51.41 -52.67 98.82 51.12 16.94 54.59 79.01 15.65 55.42 77.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 24.56 50.70 86.69 25.05 53.37 86.07 coo -54.32 88.79 48.13 -54.61 94.04 51.74 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 H 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 H 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -51.11 100.30 51.41 -52.67 98.82 51.12 23.07 86.29 52.35 21.57 85.17 51.32 coo -58.70 94.17 45.32 -57.76 93.82 47.92 32.26 92.00 56.29 32.65 91.34 53.61 coo -54.32 88.79 48.13 -54.61 94.04 51.74 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s H 146 TYR F 112 TYR~? 9.99 CL CL F2035 H 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -51.11 100.30 51.41 -52.67 98.82 51.12 88.86 41.25 28.96 90.30 42.22 30.24 coo -58.70 94.17 45.32 -57.76 93.82 47.92 80.32 37.88 21.99 80.47 40.63 22.04 coo -54.32 88.79 48.13 -54.61 94.04 51.74 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s H 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 H 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -51.11 100.30 51.41 -52.67 98.82 51.12 17.70 27.34 47.09 16.19 28.71 47.73 coo -58.70 94.17 45.32 -57.76 93.82 47.92 26.10 19.68 45.15 26.07 20.41 47.86 coo -54.32 88.79 48.13 -54.61 94.04 51.74 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s H 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 H 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -51.11 100.30 51.41 -52.67 98.82 51.12 84.24 58.93 85.48 85.73 57.59 84.66 coo -58.70 94.17 45.32 -57.76 93.82 47.92 75.20 64.22 90.27 74.79 61.48 90.12 coo -54.32 88.79 48.13 -54.61 94.04 51.74 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s H 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 H 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -51.11 100.30 51.41 -52.67 98.82 51.12 204.37 195.46 163.61 205.75 194.30 164.79 coo -58.70 94.17 45.32 -57.76 93.82 47.92 196.16 202.11 159.00 195.80 201.93 161.71 coo -54.32 88.79 48.13 -54.61 94.04 51.74 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 H 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 H 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -51.11 100.30 51.41 -52.67 98.82 51.12 137.44 174.60 137.57 135.80 173.80 138.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 146.80 177.39 131.57 146.79 174.66 132.11 coo -54.32 88.79 48.13 -54.61 94.04 51.74 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 H 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s H 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 H 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -51.11 100.30 51.41 -52.67 98.82 51.12 200.17 138.24 178.11 201.77 139.28 177.19 coo -58.70 94.17 45.32 -57.76 93.82 47.92 190.77 132.67 181.60 190.81 132.90 178.83 coo -54.32 88.79 48.13 -54.61 94.04 51.74 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 H 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s H 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 H 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -51.11 100.30 51.41 -52.67 98.82 51.12 133.34 166.97 196.27 132.03 168.03 194.96 coo -58.70 94.17 45.32 -57.76 93.82 47.92 141.53 163.06 203.38 141.93 165.73 202.75 coo -54.32 88.79 48.13 -54.61 94.04 51.74 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 H 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s H 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 H 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -51.11 100.30 51.41 -52.67 98.82 51.12 136.87 200.18 170.79 135.36 199.08 169.77 coo -58.70 94.17 45.32 -57.76 93.82 47.92 145.86 206.20 174.56 146.17 205.67 171.86 coo -54.32 88.79 48.13 -54.61 94.04 51.74 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 H 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s H 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 H 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -51.11 100.30 51.41 -52.67 98.82 51.12 203.51 159.51 142.26 205.02 160.53 143.48 coo -58.70 94.17 45.32 -57.76 93.82 47.92 194.78 156.07 135.52 194.77 158.81 135.67 coo -54.32 88.79 48.13 -54.61 94.04 51.74 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 H 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s H 146 TYR O 112 TYR~? 11.14 CL CL O2036 H 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -51.11 100.30 51.41 -52.67 98.82 51.12 134.07 141.35 162.95 132.57 142.58 163.78 coo -58.70 94.17 45.32 -57.76 93.82 47.92 142.72 134.33 160.12 142.81 134.85 162.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 H 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 H 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 H 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -51.11 100.30 51.41 -52.67 98.82 51.12 200.75 174.15 199.66 202.28 173.10 198.62 coo -58.70 94.17 45.32 -57.76 93.82 47.92 191.84 178.79 205.19 191.53 176.04 204.95 coo -54.32 88.79 48.13 -54.61 94.04 51.74 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s I 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 I 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -54.65 81.97 26.87 -55.88 81.89 25.07 90.44 78.16 48.76 91.65 76.94 50.06 coo -59.92 86.62 17.74 -59.42 83.94 18.40 82.86 85.03 43.55 82.36 85.03 46.30 coo -55.38 81.61 14.50 -57.11 80.05 20.41 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s I 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 I 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -54.65 81.97 26.87 -55.88 81.89 25.07 23.66 59.02 20.34 21.93 58.32 21.38 coo -59.92 86.62 17.74 -59.42 83.94 18.40 33.54 61.27 14.83 33.38 58.57 15.48 coo -55.38 81.61 14.50 -57.11 80.05 20.41 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s I 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 I 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -54.65 81.97 26.87 -55.88 81.89 25.07 82.81 22.02 65.69 84.52 22.80 64.66 coo -59.92 86.62 17.74 -59.42 83.94 18.40 72.92 17.11 69.08 73.05 17.20 66.28 coo -55.38 81.61 14.50 -57.11 80.05 20.41 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s I 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 I 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -54.65 81.97 26.87 -55.88 81.89 25.07 16.94 54.59 79.01 15.65 55.42 77.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 24.56 50.70 86.69 25.05 53.37 86.07 coo -55.38 81.61 14.50 -57.11 80.05 20.41 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 I 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 I 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -54.65 81.97 26.87 -55.88 81.89 25.07 23.07 86.29 52.35 21.57 85.17 51.32 coo -59.92 86.62 17.74 -59.42 83.94 18.40 32.26 92.00 56.29 32.65 91.34 53.61 coo -55.38 81.61 14.50 -57.11 80.05 20.41 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s I 146 TYR F 112 TYR~? 9.99 CL CL F2035 I 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -54.65 81.97 26.87 -55.88 81.89 25.07 88.86 41.25 28.96 90.30 42.22 30.24 coo -59.92 86.62 17.74 -59.42 83.94 18.40 80.32 37.88 21.99 80.47 40.63 22.04 coo -55.38 81.61 14.50 -57.11 80.05 20.41 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s I 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 I 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -54.65 81.97 26.87 -55.88 81.89 25.07 17.70 27.34 47.09 16.19 28.71 47.73 coo -59.92 86.62 17.74 -59.42 83.94 18.40 26.10 19.68 45.15 26.07 20.41 47.86 coo -55.38 81.61 14.50 -57.11 80.05 20.41 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s I 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 I 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -54.65 81.97 26.87 -55.88 81.89 25.07 84.24 58.93 85.48 85.73 57.59 84.66 coo -59.92 86.62 17.74 -59.42 83.94 18.40 75.20 64.22 90.27 74.79 61.48 90.12 coo -55.38 81.61 14.50 -57.11 80.05 20.41 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s I 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 I 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -54.65 81.97 26.87 -55.88 81.89 25.07 204.37 195.46 163.61 205.75 194.30 164.79 coo -59.92 86.62 17.74 -59.42 83.94 18.40 196.16 202.11 159.00 195.80 201.93 161.71 coo -55.38 81.61 14.50 -57.11 80.05 20.41 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 I 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 I 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -54.65 81.97 26.87 -55.88 81.89 25.07 137.44 174.60 137.57 135.80 173.80 138.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 146.80 177.39 131.57 146.79 174.66 132.11 coo -55.38 81.61 14.50 -57.11 80.05 20.41 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 I 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s I 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 I 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -54.65 81.97 26.87 -55.88 81.89 25.07 200.17 138.24 178.11 201.77 139.28 177.19 coo -59.92 86.62 17.74 -59.42 83.94 18.40 190.77 132.67 181.60 190.81 132.90 178.83 coo -55.38 81.61 14.50 -57.11 80.05 20.41 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 I 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s I 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 I 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -54.65 81.97 26.87 -55.88 81.89 25.07 133.34 166.97 196.27 132.03 168.03 194.96 coo -59.92 86.62 17.74 -59.42 83.94 18.40 141.53 163.06 203.38 141.93 165.73 202.75 coo -55.38 81.61 14.50 -57.11 80.05 20.41 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 I 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s I 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 I 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -54.65 81.97 26.87 -55.88 81.89 25.07 136.87 200.18 170.79 135.36 199.08 169.77 coo -59.92 86.62 17.74 -59.42 83.94 18.40 145.86 206.20 174.56 146.17 205.67 171.86 coo -55.38 81.61 14.50 -57.11 80.05 20.41 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 I 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s I 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 I 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -54.65 81.97 26.87 -55.88 81.89 25.07 203.51 159.51 142.26 205.02 160.53 143.48 coo -59.92 86.62 17.74 -59.42 83.94 18.40 194.78 156.07 135.52 194.77 158.81 135.67 coo -55.38 81.61 14.50 -57.11 80.05 20.41 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 I 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s I 146 TYR O 112 TYR~? 11.14 CL CL O2036 I 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -54.65 81.97 26.87 -55.88 81.89 25.07 134.07 141.35 162.95 132.57 142.58 163.78 coo -59.92 86.62 17.74 -59.42 83.94 18.40 142.72 134.33 160.12 142.81 134.85 162.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 I 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 I 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 I 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -54.65 81.97 26.87 -55.88 81.89 25.07 200.75 174.15 199.66 202.28 173.10 198.62 coo -59.92 86.62 17.74 -59.42 83.94 18.40 191.84 178.79 205.19 191.53 176.04 204.95 coo -55.38 81.61 14.50 -57.11 80.05 20.41 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 70 ASP~? -9.95 O3 GOL A3037s J 146 TYR A 112 TYR~? 13.10 O1 GOL A3040 J 177 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -50.64 99.08 1.52 -51.52 100.83 0.67 90.44 78.16 48.76 91.65 76.94 50.06 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 82.86 85.03 43.55 82.36 85.03 46.30 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 70 ASP~? -3.24 O2 GOL B3024s J 146 TYR B 112 TYR~? 11.41 O3 GOL B3017 J 177 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -50.64 99.08 1.52 -51.52 100.83 0.67 23.66 59.02 20.34 21.93 58.32 21.38 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 33.54 61.27 14.83 33.38 58.57 15.48 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP C 70 ASP~? 3.38 O1 GOL C3036s J 146 TYR C 112 TYR~? 12.57 O3 GOL C3021 J 177 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -50.64 99.08 1.52 -51.52 100.83 0.67 82.81 22.02 65.69 84.52 22.80 64.66 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 72.92 17.11 69.08 73.05 17.20 66.28 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP D 70 ASP~? -11.51 O3 GOL D3019s J 146 TYR D 112 TYR~? 11.57 O3 GOL D3019 J 177 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -50.64 99.08 1.52 -51.52 100.83 0.67 16.94 54.59 79.01 15.65 55.42 77.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 24.56 50.70 86.69 25.05 53.37 86.07 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP E 70 ASP~? 5.56 O3 GOL E3002 J 146 TYR E 112 TYR~? 11.16 O2 GOL E3035 J 177 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -50.64 99.08 1.52 -51.52 100.83 0.67 23.07 86.29 52.35 21.57 85.17 51.32 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 32.26 92.00 56.29 32.65 91.34 53.61 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP F 70 ASP~? -11.57 O3 GOL F3039s J 146 TYR F 112 TYR~? 9.99 CL CL F2035 J 177 LYS F 61 LYS~? -5.82 CL CL F2035s coo -50.64 99.08 1.52 -51.52 100.83 0.67 88.86 41.25 28.96 90.30 42.22 30.24 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 80.32 37.88 21.99 80.47 40.63 22.04 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP G 70 ASP~? -5.29 C3 GOL G3001s J 146 TYR G 112 TYR~? 13.62 O3 GOL G3038 J 177 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -50.64 99.08 1.52 -51.52 100.83 0.67 17.70 27.34 47.09 16.19 28.71 47.73 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 26.10 19.68 45.15 26.07 20.41 47.86 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP H 70 ASP~? -4.05 C3 GOL H3016s J 146 TYR H 112 TYR~? 11.95 O3 GOL H3016 J 177 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -50.64 99.08 1.52 -51.52 100.83 0.67 84.24 58.93 85.48 85.73 57.59 84.66 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 75.20 64.22 90.27 74.79 61.48 90.12 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP I 70 ASP~? -3.65 C2 GOL I3032s J 146 TYR I 112 TYR~? 12.20 O2 GOL I3032 J 177 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -50.64 99.08 1.52 -51.52 100.83 0.67 204.37 195.46 163.61 205.75 194.30 164.79 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 196.16 202.11 159.00 195.80 201.93 161.71 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP J 70 ASP~? 11.68 O1 GOL J3033 J 146 TYR J 112 TYR~? 13.43 O1 GOL J3030 J 177 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -50.64 99.08 1.52 -51.52 100.83 0.67 137.44 174.60 137.57 135.80 173.80 138.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 146.80 177.39 131.57 146.79 174.66 132.11 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 J 24 ASP K 70 ASP~? -4.89 O3 GOL K3009s J 146 TYR K 112 TYR~? 10.80 O3 GOL K3010 J 177 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -50.64 99.08 1.52 -51.52 100.83 0.67 200.17 138.24 178.11 201.77 139.28 177.19 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 190.77 132.67 181.60 190.81 132.90 178.83 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 J 24 ASP L 70 ASP~? -12.27 O3 GOL L3028s J 146 TYR L 112 TYR~? 12.13 O3 GOL L3028 J 177 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -50.64 99.08 1.52 -51.52 100.83 0.67 133.34 166.97 196.27 132.03 168.03 194.96 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 141.53 163.06 203.38 141.93 165.73 202.75 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 J 24 ASP M 70 ASP~? -9.98 O3 GOL M3042s J 146 TYR M 112 TYR~? 13.51 O1 GOL M3043 J 177 LYS M 61 LYS~? 24.74 CL CL I2007 coo -50.64 99.08 1.52 -51.52 100.83 0.67 136.87 200.18 170.79 135.36 199.08 169.77 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 145.86 206.20 174.56 146.17 205.67 171.86 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 J 24 ASP N 70 ASP~? -3.26 O2 GOL N3029s J 146 TYR N 112 TYR~? 12.42 O1 GOL N3044 J 177 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -50.64 99.08 1.52 -51.52 100.83 0.67 203.51 159.51 142.26 205.02 160.53 143.48 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 194.78 156.07 135.52 194.77 158.81 135.67 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 J 24 ASP O 70 ASP~? 3.30 O1 GOL O3013s J 146 TYR O 112 TYR~? 11.14 CL CL O2036 J 177 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -50.64 99.08 1.52 -51.52 100.83 0.67 134.07 141.35 162.95 132.57 142.58 163.78 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 142.72 134.33 160.12 142.81 134.85 162.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 16 3 # 16 J 24 ASP P 70 ASP~? 4.30 O3 GOL P3014 J 146 TYR P 112 TYR~? 13.01 O1 GOL P3034 J 177 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -50.64 99.08 1.52 -51.52 100.83 0.67 200.75 174.15 199.66 202.28 173.10 198.62 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 191.84 178.79 205.19 191.53 176.04 204.95 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 187.60 176.80 197.02 187.44 179.17 191.02 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 16 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 96 GLU A 62 GLU~? 17.89 O1 GOL A3040 A 132 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 31.23 12.29 16.44 30.82 11.56 18.39 90.44 78.16 48.76 91.65 76.94 50.06 coo 26.82 3.20 24.36 27.99 4.86 24.98 79.10 78.67 51.18 78.43 78.08 53.09 coo 29.99 0.62 22.18 30.38 6.69 20.81 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 96 GLU A 141 GLU~? 27.05 O1 GOL A3040 A 132 LYS A 142 LYS~? 20.36 CL CL A2020 coo 31.23 12.29 16.44 30.82 11.56 18.39 88.23 80.63 30.72 87.92 80.82 28.67 coo 26.82 3.20 24.36 27.99 4.86 24.98 89.05 70.31 35.51 89.11 68.84 33.95 coo 29.99 0.62 22.18 30.38 6.69 20.81 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 96 GLU B 62 GLU~? 6.16 O2 GOL B3017 A 132 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 31.23 12.29 16.44 30.82 11.56 18.39 23.66 59.02 20.34 21.93 58.32 21.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 34.07 54.53 23.00 34.19 52.69 24.02 coo 29.99 0.62 22.18 30.38 6.69 20.81 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 96 GLU B 141 GLU~? 14.29 O1 GOL B3024 A 132 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 31.23 12.29 16.44 30.82 11.56 18.39 30.49 75.29 14.98 31.30 77.16 14.42 coo 26.82 3.20 24.36 27.99 4.86 24.98 26.68 73.50 25.50 26.49 75.15 26.91 coo 29.99 0.62 22.18 30.38 6.69 20.81 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 96 GLU C 62 GLU~? 6.84 O3 GOL C3021 A 132 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 31.23 12.29 16.44 30.82 11.56 18.39 82.81 22.02 65.69 84.52 22.80 64.66 coo 26.82 3.20 24.36 27.99 4.86 24.98 72.25 23.75 60.88 72.37 24.62 58.95 coo 29.99 0.62 22.18 30.38 6.69 20.81 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 102 ASP.? 24.57 CL CL C2011 A 96 GLU C 141 GLU~? 19.53 O2 GOL H3025 A 132 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 31.23 12.29 16.44 30.82 11.56 18.39 76.25 20.52 82.74 75.40 20.56 84.65 coo 26.82 3.20 24.36 27.99 4.86 24.98 80.37 30.30 78.61 80.09 31.65 80.29 coo 29.99 0.62 22.18 30.38 6.69 20.81 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 96 GLU D 62 GLU~? 6.84 O2 GOL D3019 A 132 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 31.23 12.29 16.44 30.82 11.56 18.39 16.94 54.59 79.01 15.65 55.42 77.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 28.24 57.03 78.84 28.94 58.69 77.75 coo 29.99 0.62 22.18 30.38 6.69 20.81 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP D 102 ASP.? 24.32 CL CL D2012 A 96 GLU D 141 GLU~? 22.23 O1 GOL G3001 A 132 LYS D 142 LYS~? 18.65 CL CL D2012 coo 31.23 12.29 16.44 30.82 11.56 18.39 18.96 37.41 85.00 19.42 35.40 85.42 coo 26.82 3.20 24.36 27.99 4.86 24.98 17.13 41.08 72.88 18.91 42.32 72.55 coo 29.99 0.62 22.18 30.38 6.69 20.81 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 96 GLU E 62 GLU~? 6.69 C2 GOL E3035 A 132 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 31.23 12.29 16.44 30.82 11.56 18.39 23.07 86.29 52.35 21.57 85.17 51.32 coo 26.82 3.20 24.36 27.99 4.86 24.98 34.02 83.69 49.99 34.45 82.62 48.22 coo 29.99 0.62 22.18 30.38 6.69 20.81 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 96 GLU F 62 GLU~? 11.61 CL CL F2035 A 132 LYS F 61 LYS~? -5.82 CL CL F2035s coo 31.23 12.29 16.44 30.82 11.56 18.39 88.86 41.25 28.96 90.30 42.22 30.24 coo 26.82 3.20 24.36 27.99 4.86 24.98 78.25 46.27 28.27 77.97 48.25 28.91 coo 29.99 0.62 22.18 30.38 6.69 20.81 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP F 102 ASP.? 16.73 CL CL F2035 A 96 GLU F 141 GLU~? 15.85 CL CL F2035 A 132 LYS F 142 LYS~? 19.20 CL CL F2034 coo 31.23 12.29 16.44 30.82 11.56 18.39 82.74 24.28 26.35 81.91 22.30 26.35 coo 26.82 3.20 24.36 27.99 4.86 24.98 84.56 28.39 36.54 84.29 26.85 38.03 coo 29.99 0.62 22.18 30.38 6.69 20.81 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1onr_c00 TRANSALDOLASE B user 12 3 # 12 A 17 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 96 GLU G 62 GLU~? 14.49 O2 GOL G3001 A 132 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 31.23 12.29 16.44 30.82 11.56 18.39 17.70 27.34 47.09 16.19 28.71 47.73 coo 26.82 3.20 24.36 27.99 4.86 24.98 28.36 27.46 51.94 28.55 28.64 53.65 coo 29.99 0.62 22.18 30.38 6.69 20.81 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1onr_c00 TRANSALDOLASE B user 13 3 # 13 A 17 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 96 GLU G 141 GLU~? 19.33 O1 GOL B3017 A 132 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 31.23 12.29 16.44 30.82 11.56 18.39 23.47 21.05 30.82 24.30 20.62 28.93 coo 26.82 3.20 24.36 27.99 4.86 24.98 21.81 32.02 32.76 22.04 33.29 31.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1onr_c00 TRANSALDOLASE B user 14 3 # 14 A 17 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 96 GLU H 62 GLU~? 6.87 C1 GOL H3025 A 132 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 31.23 12.29 16.44 30.82 11.56 18.39 84.24 58.93 85.48 85.73 57.59 84.66 coo 26.82 3.20 24.36 27.99 4.86 24.98 73.13 56.32 83.46 72.69 54.40 82.74 coo 29.99 0.62 22.18 30.38 6.69 20.81 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1onr_c00 TRANSALDOLASE B user 15 3 # 15 A 17 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 96 GLU H 141 GLU~? 14.58 O1 GOL H3016 A 132 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 31.23 12.29 16.44 30.82 11.56 18.39 81.36 76.99 86.94 80.90 79.01 86.89 coo 26.82 3.20 24.36 27.99 4.86 24.98 84.42 72.24 77.39 84.86 73.57 75.76 coo 29.99 0.62 22.18 30.38 6.69 20.81 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1onr_c00 TRANSALDOLASE B user 16 3 # 16 A 17 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 96 GLU I 62 GLU~? 9.77 O2 GOL I3032 A 132 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 31.23 12.29 16.44 30.82 11.56 18.39 204.37 195.46 163.61 205.75 194.30 164.79 coo 26.82 3.20 24.36 27.99 4.86 24.98 193.02 195.43 166.68 192.61 194.52 168.53 coo 29.99 0.62 22.18 30.38 6.69 20.81 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1onr_c00 TRANSALDOLASE B user 17 3 # 17 A 17 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 96 GLU I 141 GLU~? 15.06 O1 GOL I3032 A 132 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 31.23 12.29 16.44 30.82 11.56 18.39 201.10 198.54 145.88 200.66 198.62 143.82 coo 26.82 3.20 24.36 27.99 4.86 24.98 203.00 188.32 149.96 202.87 186.91 148.25 coo 29.99 0.62 22.18 30.38 6.69 20.81 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1onr_c00 TRANSALDOLASE B user 18 3 # 18 A 17 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 96 GLU J 62 GLU~? 19.29 O1 GOL J3030 A 132 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 31.23 12.29 16.44 30.82 11.56 18.39 137.44 174.60 137.57 135.80 173.80 138.69 coo 26.82 3.20 24.36 27.99 4.86 24.98 148.05 170.40 139.46 148.28 168.51 140.38 coo 29.99 0.62 22.18 30.38 6.69 20.81 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1onr_c00 TRANSALDOLASE B user 19 3 # 19 A 17 ASP J 102 ASP.? 24.08 CL CL J2016 A 96 GLU J 141 GLU~? 24.92 O2 GOL M3042 A 132 LYS J 142 LYS~? 19.62 CL CL J2016 coo 31.23 12.29 16.44 30.82 11.56 18.39 143.25 191.36 132.98 143.80 193.32 132.63 coo 26.82 3.20 24.36 27.99 4.86 24.98 139.93 188.85 143.36 139.82 190.60 144.63 coo 29.99 0.62 22.18 30.38 6.69 20.81 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1onr_c00 TRANSALDOLASE B user 20 3 # 20 A 17 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 96 GLU K 62 GLU~? 6.62 O2 GOL K3010 A 132 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 31.23 12.29 16.44 30.82 11.56 18.39 200.17 138.24 178.11 201.77 139.28 177.19 coo 26.82 3.20 24.36 27.99 4.86 24.98 189.61 139.57 173.68 189.43 140.41 171.76 coo 29.99 0.62 22.18 30.38 6.69 20.81 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1onr_c00 TRANSALDOLASE B user 21 3 # 21 A 17 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 96 GLU K 141 GLU~? 22.10 C1 GOL P3014 A 132 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 31.23 12.29 16.44 30.82 11.56 18.39 194.36 135.90 195.25 193.66 135.95 197.23 coo 26.82 3.20 24.36 27.99 4.86 24.98 197.75 145.77 191.54 197.42 146.88 193.40 coo 29.99 0.62 22.18 30.38 6.69 20.81 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1onr_c00 TRANSALDOLASE B user 22 3 # 22 A 17 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 96 GLU L 62 GLU~? 6.90 C3 GOL L3028 A 132 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 31.23 12.29 16.44 30.82 11.56 18.39 133.34 166.97 196.27 132.03 168.03 194.96 coo 26.82 3.20 24.36 27.99 4.86 24.98 144.62 169.85 195.72 145.14 171.64 194.63 coo 29.99 0.62 22.18 30.38 6.69 20.81 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1onr_c00 TRANSALDOLASE B user 23 3 # 23 A 17 ASP L 102 ASP.? 24.59 CL CL L2009 A 96 GLU L 141 GLU~? 22.39 C3 GOL O3013 A 132 LYS L 142 LYS~? 23.18 CL CL L2009 coo 31.23 12.29 16.44 30.82 11.56 18.39 136.52 149.82 201.33 136.95 147.73 201.53 coo 26.82 3.20 24.36 27.99 4.86 24.98 132.89 153.36 189.75 130.85 152.81 189.78 coo 29.99 0.62 22.18 30.38 6.69 20.81 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1onr_c00 TRANSALDOLASE B user 24 3 # 24 A 17 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 96 GLU M 62 GLU~? 18.60 O3 GOL M3042 A 132 LYS M 61 LYS~? 24.74 CL CL I2007 coo 31.23 12.29 16.44 30.82 11.56 18.39 136.87 200.18 170.79 135.36 199.08 169.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 148.09 198.35 167.82 148.51 197.28 166.06 coo 29.99 0.62 22.18 30.38 6.69 20.81 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1onr_c00 TRANSALDOLASE B user 25 3 # 25 A 17 ASP M 102 ASP.? 24.52 CL CL M2017 A 96 GLU M 141 GLU~? 19.50 O2 GOL L3028 A 132 LYS M 142 LYS~? 19.90 CL CL M2017 coo 31.23 12.29 16.44 30.82 11.56 18.39 140.74 204.70 188.01 141.33 204.99 189.98 coo 26.82 3.20 24.36 27.99 4.86 24.98 137.93 194.30 185.04 137.74 193.05 186.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1onr_c00 TRANSALDOLASE B user 26 3 # 26 A 17 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 96 GLU N 62 GLU~? 6.38 C1 GOL N3044 A 132 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 31.23 12.29 16.44 30.82 11.56 18.39 203.51 159.51 142.26 205.02 160.53 143.48 coo 26.82 3.20 24.36 27.99 4.86 24.98 192.80 164.06 142.20 192.44 166.06 142.86 coo 29.99 0.62 22.18 30.38 6.69 20.81 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1onr_c00 TRANSALDOLASE B user 27 3 # 27 A 17 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 96 GLU N 141 GLU~? 10.16 C1 GOL N3029 A 132 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 31.23 12.29 16.44 30.82 11.56 18.39 197.96 142.41 139.19 197.06 140.46 139.09 coo 26.82 3.20 24.36 27.99 4.86 24.98 199.85 147.19 149.72 199.65 149.31 150.43 coo 29.99 0.62 22.18 30.38 6.69 20.81 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1onr_c00 TRANSALDOLASE B user 28 3 # 28 A 17 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 96 GLU O 62 GLU~? 9.92 C1 GOL O3026 A 132 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 31.23 12.29 16.44 30.82 11.56 18.39 134.07 141.35 162.95 132.57 142.58 163.78 coo 26.82 3.20 24.36 27.99 4.86 24.98 144.85 142.00 167.10 145.13 142.93 168.92 coo 29.99 0.62 22.18 30.38 6.69 20.81 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1onr_c00 TRANSALDOLASE B user 29 3 # 29 A 17 ASP O 102 ASP.? 13.16 CL CL O2036 A 96 GLU O 141 GLU~? 15.58 O3 GOL O3026 A 132 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 31.23 12.29 16.44 30.82 11.56 18.39 139.48 136.33 146.19 140.25 135.96 144.25 coo 26.82 3.20 24.36 27.99 4.86 24.98 137.18 147.02 148.83 137.46 148.02 146.94 coo 29.99 0.62 22.18 30.38 6.69 20.81 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1onr_c00 TRANSALDOLASE B user 30 3 # 30 A 17 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 96 GLU P 62 GLU~? 14.35 O3 GOL P3014 A 132 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 31.23 12.29 16.44 30.82 11.56 18.39 200.75 174.15 199.66 202.28 173.10 198.62 coo 26.82 3.20 24.36 27.99 4.86 24.98 189.60 171.13 198.21 189.20 169.27 197.38 coo 29.99 0.62 22.18 30.38 6.69 20.81 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 1onr_c00 TRANSALDOLASE B user 31 3 # 31 A 17 ASP P 102 ASP.? 24.26 CL CL P2019 A 96 GLU P 141 GLU~? 21.95 O3 GOL P3014 A 132 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 31.23 12.29 16.44 30.82 11.56 18.39 197.01 191.93 202.05 196.73 194.01 202.05 coo 26.82 3.20 24.36 27.99 4.86 24.98 200.04 187.90 192.14 200.20 189.50 190.73 coo 29.99 0.62 22.18 30.38 6.69 20.81 204.59 186.28 195.60 209.96 186.96 196.62 1onr_c00 source 1onr TRANSALDOLASE B : 31 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 96 GLU A 62 GLU~? 17.89 O1 GOL A3040 B 132 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 31.16 57.31 -0.94 30.73 56.64 1.01 90.44 78.16 48.76 91.65 76.94 50.06 coo 26.69 48.45 7.18 27.85 50.13 7.74 79.10 78.67 51.18 78.43 78.08 53.09 coo 29.82 45.80 5.07 30.26 51.81 3.56 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 102 ASP.? 25.18 C1 GOL A3040 B 96 GLU A 141 GLU~? 27.05 O1 GOL A3040 B 132 LYS A 142 LYS~? 20.36 CL CL A2020 coo 31.16 57.31 -0.94 30.73 56.64 1.01 88.23 80.63 30.72 87.92 80.82 28.67 coo 26.69 48.45 7.18 27.85 50.13 7.74 89.05 70.31 35.51 89.11 68.84 33.95 coo 29.82 45.80 5.07 30.26 51.81 3.56 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 96 GLU B 62 GLU~? 6.16 O2 GOL B3017 B 132 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.66 59.02 20.34 21.93 58.32 21.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 34.07 54.53 23.00 34.19 52.69 24.02 coo 29.82 45.80 5.07 30.26 51.81 3.56 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 102 ASP.? 20.31 O1 GOL B3024 B 96 GLU B 141 GLU~? 14.29 O1 GOL B3024 B 132 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 31.16 57.31 -0.94 30.73 56.64 1.01 30.49 75.29 14.98 31.30 77.16 14.42 coo 26.69 48.45 7.18 27.85 50.13 7.74 26.68 73.50 25.50 26.49 75.15 26.91 coo 29.82 45.80 5.07 30.26 51.81 3.56 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 96 GLU C 62 GLU~? 6.84 O3 GOL C3021 B 132 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 31.16 57.31 -0.94 30.73 56.64 1.01 82.81 22.02 65.69 84.52 22.80 64.66 coo 26.69 48.45 7.18 27.85 50.13 7.74 72.25 23.75 60.88 72.37 24.62 58.95 coo 29.82 45.80 5.07 30.26 51.81 3.56 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 102 ASP.? 24.57 CL CL C2011 B 96 GLU C 141 GLU~? 19.53 O2 GOL H3025 B 132 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 31.16 57.31 -0.94 30.73 56.64 1.01 76.25 20.52 82.74 75.40 20.56 84.65 coo 26.69 48.45 7.18 27.85 50.13 7.74 80.37 30.30 78.61 80.09 31.65 80.29 coo 29.82 45.80 5.07 30.26 51.81 3.56 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 96 GLU D 62 GLU~? 6.84 O2 GOL D3019 B 132 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 31.16 57.31 -0.94 30.73 56.64 1.01 16.94 54.59 79.01 15.65 55.42 77.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 28.24 57.03 78.84 28.94 58.69 77.75 coo 29.82 45.80 5.07 30.26 51.81 3.56 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP D 102 ASP.? 24.32 CL CL D2012 B 96 GLU D 141 GLU~? 22.23 O1 GOL G3001 B 132 LYS D 142 LYS~? 18.65 CL CL D2012 coo 31.16 57.31 -0.94 30.73 56.64 1.01 18.96 37.41 85.00 19.42 35.40 85.42 coo 26.69 48.45 7.18 27.85 50.13 7.74 17.13 41.08 72.88 18.91 42.32 72.55 coo 29.82 45.80 5.07 30.26 51.81 3.56 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 96 GLU E 62 GLU~? 6.69 C2 GOL E3035 B 132 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.07 86.29 52.35 21.57 85.17 51.32 coo 26.69 48.45 7.18 27.85 50.13 7.74 34.02 83.69 49.99 34.45 82.62 48.22 coo 29.82 45.80 5.07 30.26 51.81 3.56 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 96 GLU F 62 GLU~? 11.61 CL CL F2035 B 132 LYS F 61 LYS~? -5.82 CL CL F2035s coo 31.16 57.31 -0.94 30.73 56.64 1.01 88.86 41.25 28.96 90.30 42.22 30.24 coo 26.69 48.45 7.18 27.85 50.13 7.74 78.25 46.27 28.27 77.97 48.25 28.91 coo 29.82 45.80 5.07 30.26 51.81 3.56 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP F 102 ASP.? 16.73 CL CL F2035 B 96 GLU F 141 GLU~? 15.85 CL CL F2035 B 132 LYS F 142 LYS~? 19.20 CL CL F2034 coo 31.16 57.31 -0.94 30.73 56.64 1.01 82.74 24.28 26.35 81.91 22.30 26.35 coo 26.69 48.45 7.18 27.85 50.13 7.74 84.56 28.39 36.54 84.29 26.85 38.03 coo 29.82 45.80 5.07 30.26 51.81 3.56 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1onr_c01 TRANSALDOLASE B user 12 3 # 12 B 17 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 96 GLU G 62 GLU~? 14.49 O2 GOL G3001 B 132 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 31.16 57.31 -0.94 30.73 56.64 1.01 17.70 27.34 47.09 16.19 28.71 47.73 coo 26.69 48.45 7.18 27.85 50.13 7.74 28.36 27.46 51.94 28.55 28.64 53.65 coo 29.82 45.80 5.07 30.26 51.81 3.56 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1onr_c01 TRANSALDOLASE B user 13 3 # 13 B 17 ASP G 102 ASP.? 25.30 O3 GOL G3038 B 96 GLU G 141 GLU~? 19.33 O1 GOL B3017 B 132 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 31.16 57.31 -0.94 30.73 56.64 1.01 23.47 21.05 30.82 24.30 20.62 28.93 coo 26.69 48.45 7.18 27.85 50.13 7.74 21.81 32.02 32.76 22.04 33.29 31.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1onr_c01 TRANSALDOLASE B user 14 3 # 14 B 17 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 96 GLU H 62 GLU~? 6.87 C1 GOL H3025 B 132 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 31.16 57.31 -0.94 30.73 56.64 1.01 84.24 58.93 85.48 85.73 57.59 84.66 coo 26.69 48.45 7.18 27.85 50.13 7.74 73.13 56.32 83.46 72.69 54.40 82.74 coo 29.82 45.80 5.07 30.26 51.81 3.56 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1onr_c01 TRANSALDOLASE B user 15 3 # 15 B 17 ASP H 102 ASP.? 20.45 O2 GOL H3016 B 96 GLU H 141 GLU~? 14.58 O1 GOL H3016 B 132 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 31.16 57.31 -0.94 30.73 56.64 1.01 81.36 76.99 86.94 80.90 79.01 86.89 coo 26.69 48.45 7.18 27.85 50.13 7.74 84.42 72.24 77.39 84.86 73.57 75.76 coo 29.82 45.80 5.07 30.26 51.81 3.56 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1onr_c01 TRANSALDOLASE B user 16 3 # 16 B 17 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 96 GLU I 62 GLU~? 9.77 O2 GOL I3032 B 132 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 31.16 57.31 -0.94 30.73 56.64 1.01 204.37 195.46 163.61 205.75 194.30 164.79 coo 26.69 48.45 7.18 27.85 50.13 7.74 193.02 195.43 166.68 192.61 194.52 168.53 coo 29.82 45.80 5.07 30.26 51.81 3.56 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1onr_c01 TRANSALDOLASE B user 17 3 # 17 B 17 ASP I 102 ASP.? 20.44 O1 GOL I3032 B 96 GLU I 141 GLU~? 15.06 O1 GOL I3032 B 132 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 31.16 57.31 -0.94 30.73 56.64 1.01 201.10 198.54 145.88 200.66 198.62 143.82 coo 26.69 48.45 7.18 27.85 50.13 7.74 203.00 188.32 149.96 202.87 186.91 148.25 coo 29.82 45.80 5.07 30.26 51.81 3.56 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1onr_c01 TRANSALDOLASE B user 18 3 # 18 B 17 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 96 GLU J 62 GLU~? 19.29 O1 GOL J3030 B 132 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 31.16 57.31 -0.94 30.73 56.64 1.01 137.44 174.60 137.57 135.80 173.80 138.69 coo 26.69 48.45 7.18 27.85 50.13 7.74 148.05 170.40 139.46 148.28 168.51 140.38 coo 29.82 45.80 5.07 30.26 51.81 3.56 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1onr_c01 TRANSALDOLASE B user 19 3 # 19 B 17 ASP J 102 ASP.? 24.08 CL CL J2016 B 96 GLU J 141 GLU~? 24.92 O2 GOL M3042 B 132 LYS J 142 LYS~? 19.62 CL CL J2016 coo 31.16 57.31 -0.94 30.73 56.64 1.01 143.25 191.36 132.98 143.80 193.32 132.63 coo 26.69 48.45 7.18 27.85 50.13 7.74 139.93 188.85 143.36 139.82 190.60 144.63 coo 29.82 45.80 5.07 30.26 51.81 3.56 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1onr_c01 TRANSALDOLASE B user 20 3 # 20 B 17 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 96 GLU K 62 GLU~? 6.62 O2 GOL K3010 B 132 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 31.16 57.31 -0.94 30.73 56.64 1.01 200.17 138.24 178.11 201.77 139.28 177.19 coo 26.69 48.45 7.18 27.85 50.13 7.74 189.61 139.57 173.68 189.43 140.41 171.76 coo 29.82 45.80 5.07 30.26 51.81 3.56 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1onr_c01 TRANSALDOLASE B user 21 3 # 21 B 17 ASP K 102 ASP.? 24.81 O1 GOL K3041 B 96 GLU K 141 GLU~? 22.10 C1 GOL P3014 B 132 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 31.16 57.31 -0.94 30.73 56.64 1.01 194.36 135.90 195.25 193.66 135.95 197.23 coo 26.69 48.45 7.18 27.85 50.13 7.74 197.75 145.77 191.54 197.42 146.88 193.40 coo 29.82 45.80 5.07 30.26 51.81 3.56 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1onr_c01 TRANSALDOLASE B user 22 3 # 22 B 17 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 96 GLU L 62 GLU~? 6.90 C3 GOL L3028 B 132 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 31.16 57.31 -0.94 30.73 56.64 1.01 133.34 166.97 196.27 132.03 168.03 194.96 coo 26.69 48.45 7.18 27.85 50.13 7.74 144.62 169.85 195.72 145.14 171.64 194.63 coo 29.82 45.80 5.07 30.26 51.81 3.56 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1onr_c01 TRANSALDOLASE B user 23 3 # 23 B 17 ASP L 102 ASP.? 24.59 CL CL L2009 B 96 GLU L 141 GLU~? 22.39 C3 GOL O3013 B 132 LYS L 142 LYS~? 23.18 CL CL L2009 coo 31.16 57.31 -0.94 30.73 56.64 1.01 136.52 149.82 201.33 136.95 147.73 201.53 coo 26.69 48.45 7.18 27.85 50.13 7.74 132.89 153.36 189.75 130.85 152.81 189.78 coo 29.82 45.80 5.07 30.26 51.81 3.56 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1onr_c01 TRANSALDOLASE B user 24 3 # 24 B 17 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 96 GLU M 62 GLU~? 18.60 O3 GOL M3042 B 132 LYS M 61 LYS~? 24.74 CL CL I2007 coo 31.16 57.31 -0.94 30.73 56.64 1.01 136.87 200.18 170.79 135.36 199.08 169.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 148.09 198.35 167.82 148.51 197.28 166.06 coo 29.82 45.80 5.07 30.26 51.81 3.56 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1onr_c01 TRANSALDOLASE B user 25 3 # 25 B 17 ASP M 102 ASP.? 24.52 CL CL M2017 B 96 GLU M 141 GLU~? 19.50 O2 GOL L3028 B 132 LYS M 142 LYS~? 19.90 CL CL M2017 coo 31.16 57.31 -0.94 30.73 56.64 1.01 140.74 204.70 188.01 141.33 204.99 189.98 coo 26.69 48.45 7.18 27.85 50.13 7.74 137.93 194.30 185.04 137.74 193.05 186.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1onr_c01 TRANSALDOLASE B user 26 3 # 26 B 17 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 96 GLU N 62 GLU~? 6.38 C1 GOL N3044 B 132 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 31.16 57.31 -0.94 30.73 56.64 1.01 203.51 159.51 142.26 205.02 160.53 143.48 coo 26.69 48.45 7.18 27.85 50.13 7.74 192.80 164.06 142.20 192.44 166.06 142.86 coo 29.82 45.80 5.07 30.26 51.81 3.56 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1onr_c01 TRANSALDOLASE B user 27 3 # 27 B 17 ASP N 102 ASP.? 20.60 O2 GOL N3029 B 96 GLU N 141 GLU~? 10.16 C1 GOL N3029 B 132 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 31.16 57.31 -0.94 30.73 56.64 1.01 197.96 142.41 139.19 197.06 140.46 139.09 coo 26.69 48.45 7.18 27.85 50.13 7.74 199.85 147.19 149.72 199.65 149.31 150.43 coo 29.82 45.80 5.07 30.26 51.81 3.56 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1onr_c01 TRANSALDOLASE B user 28 3 # 28 B 17 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 96 GLU O 62 GLU~? 9.92 C1 GOL O3026 B 132 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 31.16 57.31 -0.94 30.73 56.64 1.01 134.07 141.35 162.95 132.57 142.58 163.78 coo 26.69 48.45 7.18 27.85 50.13 7.74 144.85 142.00 167.10 145.13 142.93 168.92 coo 29.82 45.80 5.07 30.26 51.81 3.56 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1onr_c01 TRANSALDOLASE B user 29 3 # 29 B 17 ASP O 102 ASP.? 13.16 CL CL O2036 B 96 GLU O 141 GLU~? 15.58 O3 GOL O3026 B 132 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 31.16 57.31 -0.94 30.73 56.64 1.01 139.48 136.33 146.19 140.25 135.96 144.25 coo 26.69 48.45 7.18 27.85 50.13 7.74 137.18 147.02 148.83 137.46 148.02 146.94 coo 29.82 45.80 5.07 30.26 51.81 3.56 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1onr_c01 TRANSALDOLASE B user 30 3 # 30 B 17 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 96 GLU P 62 GLU~? 14.35 O3 GOL P3014 B 132 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 31.16 57.31 -0.94 30.73 56.64 1.01 200.75 174.15 199.66 202.28 173.10 198.62 coo 26.69 48.45 7.18 27.85 50.13 7.74 189.60 171.13 198.21 189.20 169.27 197.38 coo 29.82 45.80 5.07 30.26 51.81 3.56 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 1onr_c01 TRANSALDOLASE B user 31 3 # 31 B 17 ASP P 102 ASP.? 24.26 CL CL P2019 B 96 GLU P 141 GLU~? 21.95 O3 GOL P3014 B 132 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 31.16 57.31 -0.94 30.73 56.64 1.01 197.01 191.93 202.05 196.73 194.01 202.05 coo 26.69 48.45 7.18 27.85 50.13 7.74 200.04 187.90 192.14 200.20 189.50 190.73 coo 29.82 45.80 5.07 30.26 51.81 3.56 204.59 186.28 195.60 209.96 186.96 196.62 1onr_c01 source 1onr TRANSALDOLASE B : 31 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER B 83 SER~? 7.75 CL CL B2010 A 239 VAL B 80 VAL~? 5.84 CL CL B2010 A 413 ASN B 84 ASN~? 10.19 CL CL B2010 coo 80.14 40.76 52.28 77.73 40.59 51.94 7.70 61.77 7.67 8.73 59.61 7.20 coo 75.67 35.37 52.30 76.00 35.96 50.23 11.18 58.98 10.24 11.78 56.84 10.20 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.47 57.99 9.65 6.63 56.79 8.31 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER C 83 SER~? 3.84 CL CL C2021 A 239 VAL C 80 VAL~? 4.09 CL CL C2021 A 413 ASN C 84 ASN~? 7.25 CL CL C2021 coo 80.14 40.76 52.28 77.73 40.59 51.94 99.03 9.95 70.83 97.44 9.06 69.22 coo 75.67 35.37 52.30 76.00 35.96 50.23 95.17 11.84 67.49 94.46 11.27 65.48 coo 81.75 35.21 52.13 80.92 37.12 51.69 100.78 11.44 66.55 99.89 10.02 65.23 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER D 83 SER~? 4.15 CL CL D2022 A 239 VAL D 80 VAL~? -3.98 CL CL D2022s A 413 ASN D 84 ASN~? 7.04 CL CL D2022 coo 80.14 40.76 52.28 77.73 40.59 51.94 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 75.67 35.37 52.30 76.00 35.96 50.23 2.32 56.98 85.67 3.21 58.91 86.18 coo 81.75 35.21 52.13 80.92 37.12 51.69 -3.16 59.10 84.71 -2.15 60.07 86.28 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER E 83 SER~? 3.98 CL CL E2032 A 239 VAL E 80 VAL~? 4.03 CL CL E2032 A 413 ASN E 84 ASN~? 6.86 CL CL E2032 coo 80.14 40.76 52.28 77.73 40.59 51.94 6.89 98.81 51.94 8.26 99.71 50.10 coo 75.67 35.37 52.30 76.00 35.96 50.23 10.81 96.40 49.90 11.82 96.49 47.93 coo 81.75 35.21 52.13 80.92 37.12 51.69 5.48 96.99 47.72 6.68 98.41 46.68 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER F 83 SER~? 4.14 CL CL F2023 A 239 VAL F 80 VAL~? -3.94 CL CL F2023s A 413 ASN F 84 ASN.? 7.11 CL CL F2023 coo 80.14 40.76 52.28 77.73 40.59 51.94 107.41 36.26 21.11 106.31 38.05 19.96 coo 75.67 35.37 52.30 76.00 35.96 50.23 103.23 39.13 21.93 102.76 41.19 21.29 coo 81.75 35.21 52.13 80.92 37.12 51.69 109.54 40.13 22.81 108.36 41.04 21.28 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER G 83 SER~? 4.16 CL CL G2033 A 239 VAL G 80 VAL~? 4.22 CL CL G2033 A 413 ASN G 84 ASN~? 7.24 CL CL G2033 coo 80.14 40.76 52.28 77.73 40.59 51.94 -0.88 18.73 43.69 0.20 17.85 45.68 coo 75.67 35.37 52.30 76.00 35.96 50.23 3.15 20.19 46.53 3.54 19.95 48.68 coo 81.75 35.21 52.13 80.92 37.12 51.69 -2.25 21.18 47.67 -1.73 19.89 49.31 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER H 83 SER~? 4.17 CL CL H2024 A 239 VAL H 80 VAL~? -3.72 CL CL H2024s A 413 ASN H 84 ASN~? 6.41 CL CL H2024 coo 80.14 40.76 52.28 77.73 40.59 51.94 100.86 60.76 97.52 99.44 59.04 98.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 96.53 58.45 95.73 95.40 56.64 96.32 coo 81.75 35.21 52.13 80.92 37.12 51.69 102.16 56.25 96.45 100.56 55.72 97.69 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER I 83 SER~? 4.12 CL CL I2025 A 239 VAL I 80 VAL~? 4.00 CL CL I2025 A 413 ASN I 84 ASN~? 7.02 CL CL I2025 coo 80.14 40.76 52.28 77.73 40.59 51.94 222.83 204.85 161.89 221.39 205.66 163.52 coo 75.67 35.37 52.30 76.00 35.96 50.23 218.34 203.57 164.17 217.45 204.22 166.05 coo 81.75 35.21 52.13 80.92 37.12 51.69 223.75 203.10 166.30 222.73 204.63 167.34 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 9 3 # 9 A 170 SER J 83 SER~? 3.90 CL CL J2026 A 239 VAL J 80 VAL~? 3.94 CL CL J2026 A 413 ASN J 84 ASN~? 7.23 CL CL J2026 coo 80.14 40.76 52.28 77.73 40.59 51.94 120.35 177.35 126.19 121.76 175.49 125.60 coo 75.67 35.37 52.30 76.00 35.96 50.23 124.29 174.79 128.10 124.92 172.71 127.83 coo 81.75 35.21 52.13 80.92 37.12 51.69 118.44 173.52 128.48 119.65 172.15 127.42 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 10 3 # 10 A 170 SER L 83 SER~? 3.95 CL CL L2028 A 239 VAL L 80 VAL~? -3.76 CL CL L2028s A 413 ASN L 84 ASN~? 6.99 CL CL L2028 coo 80.14 40.76 52.28 77.73 40.59 51.94 115.00 167.12 206.00 116.47 168.85 206.74 coo 75.67 35.37 52.30 76.00 35.96 50.23 119.43 168.99 204.21 120.36 170.93 204.70 coo 81.75 35.21 52.13 80.92 37.12 51.69 114.19 171.29 203.61 115.33 172.43 205.02 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 11 3 # 11 A 170 SER M 83 SER~? 4.48 CL CL M2029 A 239 VAL M 80 VAL~? 4.21 CL CL M2029 A 413 ASN M 84 ASN~? 7.69 CL CL M2029 coo 80.14 40.76 52.28 77.73 40.59 51.94 119.79 211.86 171.05 121.18 212.22 169.09 coo 75.67 35.37 52.30 76.00 35.96 50.23 124.02 209.65 168.96 125.03 209.83 167.05 coo 81.75 35.21 52.13 80.92 37.12 51.69 118.35 209.44 167.10 119.51 210.52 165.71 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 12 3 # 12 A 170 SER N 83 SER~? 3.82 CL CL N2030 A 239 VAL N 80 VAL~? 4.00 CL CL N2030 A 413 ASN N 84 ASN~? 6.35 CL CL N2030 coo 80.14 40.76 52.28 77.73 40.59 51.94 221.50 155.10 133.13 220.51 157.01 132.05 coo 75.67 35.37 52.30 76.00 35.96 50.23 217.56 158.35 134.37 216.87 160.29 133.72 coo 81.75 35.21 52.13 80.92 37.12 51.69 223.39 159.28 134.52 222.37 160.07 132.83 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 13 3 # 13 A 170 SER O 83 SER~? 7.53 CL CL O2018 A 239 VAL O 80 VAL~? 5.47 CL CL O2018 A 413 ASN O 84 ASN.? 10.27 CL CL O2018 coo 80.14 40.76 52.28 77.73 40.59 51.94 115.90 131.94 160.39 117.13 130.87 162.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 120.06 133.48 162.85 120.79 133.02 164.86 coo 81.75 35.21 52.13 80.92 37.12 51.69 113.86 134.05 164.18 115.11 132.69 165.22 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 14 3 # 14 A 170 SER P 83 SER~? 8.38 CL CL P2019 A 239 VAL P 80 VAL~? 6.02 CL CL P2019 A 413 ASN P 84 ASN~? 10.96 CL CL P2019 coo 80.14 40.76 52.28 77.73 40.59 51.94 218.12 176.21 210.92 216.94 174.20 211.47 coo 75.67 35.37 52.30 76.00 35.96 50.23 213.81 173.77 209.07 212.90 171.82 209.48 coo 81.75 35.21 52.13 80.92 37.12 51.69 219.43 171.97 209.05 218.45 170.73 210.43 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 14 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER B 83 SER~? 7.75 CL CL B2010 B 239 VAL B 80 VAL~? 5.84 CL CL B2010 B 413 ASN B 84 ASN~? 10.19 CL CL B2010 coo 25.22 6.41 2.90 27.67 6.33 3.11 7.70 61.77 7.67 8.73 59.61 7.20 coo 29.71 1.00 2.66 29.43 1.57 4.74 11.18 58.98 10.24 11.78 56.84 10.20 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.47 57.99 9.65 6.63 56.79 8.31 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER C 83 SER~? 3.84 CL CL C2021 B 239 VAL C 80 VAL~? 4.09 CL CL C2021 B 413 ASN C 84 ASN~? 7.25 CL CL C2021 coo 25.22 6.41 2.90 27.67 6.33 3.11 99.03 9.95 70.83 97.44 9.06 69.22 coo 29.71 1.00 2.66 29.43 1.57 4.74 95.17 11.84 67.49 94.46 11.27 65.48 coo 23.72 0.88 2.95 24.56 2.79 3.34 100.78 11.44 66.55 99.89 10.02 65.23 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER D 83 SER~? 4.15 CL CL D2022 B 239 VAL D 80 VAL~? -3.98 CL CL D2022s B 413 ASN D 84 ASN~? 7.04 CL CL D2022 coo 25.22 6.41 2.90 27.67 6.33 3.11 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 29.71 1.00 2.66 29.43 1.57 4.74 2.32 56.98 85.67 3.21 58.91 86.18 coo 23.72 0.88 2.95 24.56 2.79 3.34 -3.16 59.10 84.71 -2.15 60.07 86.28 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER E 83 SER~? 3.98 CL CL E2032 B 239 VAL E 80 VAL~? 4.03 CL CL E2032 B 413 ASN E 84 ASN~? 6.86 CL CL E2032 coo 25.22 6.41 2.90 27.67 6.33 3.11 6.89 98.81 51.94 8.26 99.71 50.10 coo 29.71 1.00 2.66 29.43 1.57 4.74 10.81 96.40 49.90 11.82 96.49 47.93 coo 23.72 0.88 2.95 24.56 2.79 3.34 5.48 96.99 47.72 6.68 98.41 46.68 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER F 83 SER~? 4.14 CL CL F2023 B 239 VAL F 80 VAL~? -3.94 CL CL F2023s B 413 ASN F 84 ASN.? 7.11 CL CL F2023 coo 25.22 6.41 2.90 27.67 6.33 3.11 107.41 36.26 21.11 106.31 38.05 19.96 coo 29.71 1.00 2.66 29.43 1.57 4.74 103.23 39.13 21.93 102.76 41.19 21.29 coo 23.72 0.88 2.95 24.56 2.79 3.34 109.54 40.13 22.81 108.36 41.04 21.28 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER G 83 SER~? 4.16 CL CL G2033 B 239 VAL G 80 VAL~? 4.22 CL CL G2033 B 413 ASN G 84 ASN~? 7.24 CL CL G2033 coo 25.22 6.41 2.90 27.67 6.33 3.11 -0.88 18.73 43.69 0.20 17.85 45.68 coo 29.71 1.00 2.66 29.43 1.57 4.74 3.15 20.19 46.53 3.54 19.95 48.68 coo 23.72 0.88 2.95 24.56 2.79 3.34 -2.25 21.18 47.67 -1.73 19.89 49.31 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER H 83 SER~? 4.17 CL CL H2024 B 239 VAL H 80 VAL~? -3.72 CL CL H2024s B 413 ASN H 84 ASN~? 6.41 CL CL H2024 coo 25.22 6.41 2.90 27.67 6.33 3.11 100.86 60.76 97.52 99.44 59.04 98.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 96.53 58.45 95.73 95.40 56.64 96.32 coo 23.72 0.88 2.95 24.56 2.79 3.34 102.16 56.25 96.45 100.56 55.72 97.69 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER I 83 SER~? 4.12 CL CL I2025 B 239 VAL I 80 VAL~? 4.00 CL CL I2025 B 413 ASN I 84 ASN~? 7.02 CL CL I2025 coo 25.22 6.41 2.90 27.67 6.33 3.11 222.83 204.85 161.89 221.39 205.66 163.52 coo 29.71 1.00 2.66 29.43 1.57 4.74 218.34 203.57 164.17 217.45 204.22 166.05 coo 23.72 0.88 2.95 24.56 2.79 3.34 223.75 203.10 166.30 222.73 204.63 167.34 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 9 3 # 9 B 170 SER J 83 SER~? 3.90 CL CL J2026 B 239 VAL J 80 VAL~? 3.94 CL CL J2026 B 413 ASN J 84 ASN~? 7.23 CL CL J2026 coo 25.22 6.41 2.90 27.67 6.33 3.11 120.35 177.35 126.19 121.76 175.49 125.60 coo 29.71 1.00 2.66 29.43 1.57 4.74 124.29 174.79 128.10 124.92 172.71 127.83 coo 23.72 0.88 2.95 24.56 2.79 3.34 118.44 173.52 128.48 119.65 172.15 127.42 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 10 3 # 10 B 170 SER L 83 SER~? 3.95 CL CL L2028 B 239 VAL L 80 VAL~? -3.76 CL CL L2028s B 413 ASN L 84 ASN~? 6.99 CL CL L2028 coo 25.22 6.41 2.90 27.67 6.33 3.11 115.00 167.12 206.00 116.47 168.85 206.74 coo 29.71 1.00 2.66 29.43 1.57 4.74 119.43 168.99 204.21 120.36 170.93 204.70 coo 23.72 0.88 2.95 24.56 2.79 3.34 114.19 171.29 203.61 115.33 172.43 205.02 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 11 3 # 11 B 170 SER M 83 SER~? 4.48 CL CL M2029 B 239 VAL M 80 VAL~? 4.21 CL CL M2029 B 413 ASN M 84 ASN~? 7.69 CL CL M2029 coo 25.22 6.41 2.90 27.67 6.33 3.11 119.79 211.86 171.05 121.18 212.22 169.09 coo 29.71 1.00 2.66 29.43 1.57 4.74 124.02 209.65 168.96 125.03 209.83 167.05 coo 23.72 0.88 2.95 24.56 2.79 3.34 118.35 209.44 167.10 119.51 210.52 165.71 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 12 3 # 12 B 170 SER N 83 SER~? 3.82 CL CL N2030 B 239 VAL N 80 VAL~? 4.00 CL CL N2030 B 413 ASN N 84 ASN~? 6.35 CL CL N2030 coo 25.22 6.41 2.90 27.67 6.33 3.11 221.50 155.10 133.13 220.51 157.01 132.05 coo 29.71 1.00 2.66 29.43 1.57 4.74 217.56 158.35 134.37 216.87 160.29 133.72 coo 23.72 0.88 2.95 24.56 2.79 3.34 223.39 159.28 134.52 222.37 160.07 132.83 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 13 3 # 13 B 170 SER O 83 SER~? 7.53 CL CL O2018 B 239 VAL O 80 VAL~? 5.47 CL CL O2018 B 413 ASN O 84 ASN.? 10.27 CL CL O2018 coo 25.22 6.41 2.90 27.67 6.33 3.11 115.90 131.94 160.39 117.13 130.87 162.21 coo 29.71 1.00 2.66 29.43 1.57 4.74 120.06 133.48 162.85 120.79 133.02 164.86 coo 23.72 0.88 2.95 24.56 2.79 3.34 113.86 134.05 164.18 115.11 132.69 165.22 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 14 3 # 14 B 170 SER P 83 SER~? 8.38 CL CL P2019 B 239 VAL P 80 VAL~? 6.02 CL CL P2019 B 413 ASN P 84 ASN~? 10.96 CL CL P2019 coo 25.22 6.41 2.90 27.67 6.33 3.11 218.12 176.21 210.92 216.94 174.20 211.47 coo 29.71 1.00 2.66 29.43 1.57 4.74 213.81 173.77 209.07 212.90 171.82 209.48 coo 23.72 0.88 2.95 24.56 2.79 3.34 219.43 171.97 209.05 218.45 170.73 210.43 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 14 hits 1oqz_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 38 GLU A 163 GLU~? 14.44 O2 GOL A3037 A 46 TRP A 150 TRP~? 9.40 O3 GOL A3037 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 100.57 80.52 55.08 97.88 80.73 54.34 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 106.73 71.90 50.38 106.39 72.49 52.36 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 99.61 75.57 49.87 96.34 77.60 50.68 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 2 3 # 2 A 16 TYR B 157 TYR.? 7.53 O1 GOL B3015 A 38 GLU B 163 GLU~? 11.65 O3 GOL B3015 A 46 TRP B 150 TRP~? 6.74 O3 GOL B3015 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 13.23 54.49 17.04 16.01 54.48 17.30 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 6.39 62.04 22.34 6.51 59.97 22.27 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 14.34 60.39 20.70 17.67 58.57 19.72 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 3 3 # 3 A 16 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 38 GLU C 163 GLU~? 4.89 CL CL C2031 A 46 TRP C 150 TRP~? 6.00 O1 GOL C3036 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 93.23 17.43 61.74 90.40 17.73 61.84 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 100.18 24.25 67.88 99.96 23.77 65.85 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 92.29 22.45 66.79 88.93 21.17 65.17 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 4 3 # 4 A 16 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 38 GLU D 163 GLU~? 14.42 O1 GOL D3020 A 46 TRP D 150 TRP~? 10.12 O2 GOL D3020 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 6.86 61.00 80.62 9.60 60.40 80.64 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 0.62 54.76 72.61 1.16 56.78 72.68 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 7.58 55.02 76.49 10.84 56.37 78.24 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 5 3 # 5 A 16 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 38 GLU E 163 GLU~? 11.74 O1 GOL E3002 A 46 TRP E 150 TRP~? 6.44 C3 GOL E3002 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 13.76 89.62 45.68 16.45 89.35 46.36 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 5.75 84.10 51.71 6.08 84.26 49.61 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 13.53 85.96 51.70 17.23 86.80 50.63 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 6 3 # 6 A 16 TYR F 157 TYR.? -10.36 O3 GOL F3039s A 38 GLU F 163 GLU~? 16.81 CL CL F2023 A 46 TRP F 150 TRP~? 12.61 CL CL F2034 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 100.15 45.18 26.97 97.32 45.17 26.68 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 105.09 39.28 35.27 105.30 41.23 34.49 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 98.06 40.24 31.68 95.06 41.77 29.63 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 7 3 # 7 A 16 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 38 GLU G 163 GLU~? 11.22 O3 GOL G3001 A 46 TRP G 150 TRP~? 4.79 O3 GOL G3001 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 6.53 26.08 51.42 9.33 25.84 51.41 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 1.42 33.23 43.78 1.39 32.97 45.86 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 8.65 29.73 45.56 11.64 28.04 47.47 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 8 3 # 8 A 16 TYR H 157 TYR.? -11.04 CL CL H2014s A 38 GLU H 163 GLU~? 16.69 O1 GOL H3016 A 46 TRP H 150 TRP~? 9.03 C1 GOL H3016 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 93.68 52.87 90.01 90.96 53.43 89.67 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 101.55 57.39 83.25 101.29 55.39 84.02 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 93.76 57.94 85.12 90.09 57.13 86.33 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 9 3 # 9 A 16 TYR I 157 TYR.? -10.00 O3 GOL I3031s A 38 GLU I 163 GLU~? 16.56 O3 GOL I3032 A 46 TRP I 150 TRP~? 8.45 O3 GOL I3032 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 214.62 198.06 169.41 211.87 198.21 168.94 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 221.15 190.35 164.07 220.95 190.90 166.06 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 213.69 193.51 164.07 210.33 195.28 165.13 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 10 3 # 10 A 16 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 38 GLU J 163 GLU~? 14.80 O1 GOL J3033 A 46 TRP J 150 TRP~? 9.82 O1 GOL J3033 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 126.93 169.72 134.52 129.73 169.94 134.63 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 120.24 176.69 140.95 120.35 174.56 140.67 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 127.85 175.49 138.51 131.22 173.81 137.27 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 11 3 # 11 A 16 TYR K 157 TYR.? 6.79 O2 GOL K3009 A 38 GLU K 163 GLU~? 12.51 O2 GOL K3009 A 46 TRP K 150 TRP~? 6.22 O2 GOL K3009 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 210.77 134.37 173.74 207.96 134.59 173.91 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 217.27 141.62 179.80 217.24 141.01 177.77 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 209.66 139.23 178.83 206.28 137.79 177.39 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 12 3 # 12 A 16 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 38 GLU L 163 GLU~? 16.77 CL CL L2028 A 46 TRP L 150 TRP~? 12.70 CL CL L2009 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 123.19 173.24 198.15 125.89 172.62 198.32 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 116.58 166.98 191.20 116.69 169.04 191.44 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 124.03 167.33 194.23 127.41 168.49 195.83 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 13 3 # 13 A 16 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 38 GLU M 163 GLU~? 14.80 C2 GOL M3042 A 46 TRP M 150 TRP~? 9.50 O3 GOL M3042 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 127.03 203.34 164.58 129.75 203.18 165.07 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 119.51 197.10 170.73 120.12 197.15 168.74 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 127.35 199.32 170.42 130.91 200.46 169.17 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 14 3 # 14 A 16 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 38 GLU N 163 GLU~? 12.29 O1 GOL N3012 A 46 TRP N 150 TRP~? 6.52 O2 GOL N3012 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 214.45 164.07 139.74 211.68 163.84 139.51 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 220.21 157.81 147.58 220.09 159.81 146.98 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 212.92 158.88 144.19 209.70 160.35 142.44 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 15 3 # 15 A 16 TYR O 157 TYR.? 6.41 O2 GOL O3013 A 38 GLU O 163 GLU~? 12.66 O3 GOL O3013 A 46 TRP O 150 TRP~? 6.10 O1 GOL O3013 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 123.23 139.38 167.80 126.05 139.22 167.65 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 117.45 146.43 160.85 117.44 146.23 162.92 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 124.79 143.29 162.05 128.01 141.74 163.72 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 16 3 # 16 A 16 TYR P 157 TYR.? 6.12 O2 GOL P3014 A 38 GLU P 163 GLU~? 11.95 O2 GOL P3014 A 46 TRP P 150 TRP~? 5.47 O2 GOL P3014 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 210.70 168.63 203.45 207.96 169.02 203.20 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 218.06 173.97 196.16 217.79 171.96 196.61 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 210.27 173.82 198.63 206.78 172.70 200.12 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 16 hits 1p7m_c00 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 83 SER~? 4.31 CL CL A2020 A 709 ASP A 127 ASP.? 12.37 CL CL A2020 A 740 HIS A 79 HIS~? -3.92 CL CL A2020s coo -7.09 7.44 6.22 -7.53 5.14 5.59 109.33 86.01 47.44 108.27 87.28 49.22 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 99.76 91.11 38.83 100.13 91.74 36.79 coo -8.70 2.86 9.96 -8.03 3.92 8.29 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 83 SER~? 7.75 CL CL B2010 A 709 ASP B 127 ASP.? 11.35 CL CL B2010 A 740 HIS B 79 HIS~? 5.08 CL CL B2010 coo -7.09 7.44 6.22 -7.53 5.14 5.59 7.70 61.77 7.67 8.73 59.61 7.20 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 19.74 66.97 3.53 20.01 68.79 2.38 coo -8.70 2.86 9.96 -8.03 3.92 8.29 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 83 SER~? 3.84 CL CL C2021 A 709 ASP C 127 ASP.? 10.87 CL CL C2011 A 740 HIS C 79 HIS~? -4.32 CL CL C2021s coo -7.09 7.44 6.22 -7.53 5.14 5.59 99.03 9.95 70.83 97.44 9.06 69.22 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 86.95 7.50 76.71 86.89 6.71 78.70 coo -8.70 2.86 9.96 -8.03 3.92 8.29 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER D 83 SER~? 4.15 CL CL D2022 A 709 ASP D 127 ASP.? 11.17 CL CL D2012 A 740 HIS D 79 HIS~? -4.57 CL CL D2022s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -2.16 54.95 86.89 -0.79 56.60 88.02 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 7.65 47.79 93.97 7.18 46.10 95.19 coo -8.70 2.86 9.96 -8.03 3.92 8.29 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER E 83 SER~? 3.98 CL CL E2032 A 709 ASP E 127 ASP.? 11.39 CL CL E2013 A 740 HIS E 79 HIS~? -4.18 CL CL E2032s coo -7.09 7.44 6.22 -7.53 5.14 5.59 6.89 98.81 51.94 8.26 99.71 50.10 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 17.80 103.20 59.40 17.93 103.89 61.44 coo -8.70 2.86 9.96 -8.03 3.92 8.29 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER F 83 SER~? 4.14 CL CL F2023 A 709 ASP F 127 ASP.? 10.85 CL CL F2034 A 740 HIS F 79 HIS~? -4.63 CL CL F2023s coo -7.09 7.44 6.22 -7.53 5.14 5.59 107.41 36.26 21.11 106.31 38.05 19.96 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 96.13 30.12 15.93 96.25 28.10 15.23 coo -8.70 2.86 9.96 -8.03 3.92 8.29 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 A 630 SER G 83 SER~? 4.16 CL CL G2033 A 709 ASP G 127 ASP.? 12.80 CL CL G2033 A 740 HIS G 79 HIS~? -4.46 CL CL G2033s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -0.88 18.73 43.69 0.20 17.85 45.68 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 10.22 12.11 38.73 10.33 11.10 36.86 coo -8.70 2.86 9.96 -8.03 3.92 8.29 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 A 630 SER H 83 SER~? 4.17 CL CL H2024 A 709 ASP H 127 ASP.? 11.27 CL CL H2014 A 740 HIS H 79 HIS~? 4.82 CL CL H2024 coo -7.09 7.44 6.22 -7.53 5.14 5.59 100.86 60.76 97.52 99.44 59.04 98.47 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 90.18 69.09 100.25 90.25 71.19 100.79 coo -8.70 2.86 9.96 -8.03 3.92 8.29 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 9 3 # 9 A 630 SER I 83 SER~? 4.12 CL CL I2025 A 709 ASP I 127 ASP.? 10.93 CL CL I2015 A 740 HIS I 79 HIS~? -4.56 CL CL I2025s coo -7.09 7.44 6.22 -7.53 5.14 5.59 222.83 204.85 161.89 221.39 205.66 163.52 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 212.49 209.49 154.15 212.74 210.27 152.16 coo -8.70 2.86 9.96 -8.03 3.92 8.29 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 10 3 # 10 A 630 SER J 83 SER~? 3.90 CL CL J2026 A 709 ASP J 127 ASP.? 11.08 CL CL J2016 A 740 HIS J 79 HIS~? -4.36 CL CL J2026s coo -7.09 7.44 6.22 -7.53 5.14 5.59 120.35 177.35 126.19 121.76 175.49 125.60 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 132.13 183.26 121.62 132.41 185.18 120.66 coo -8.70 2.86 9.96 -8.03 3.92 8.29 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 11 3 # 11 A 630 SER K 83 SER~? 3.98 CL CL K2027 A 709 ASP K 127 ASP.? 12.37 CL CL K2027 A 740 HIS K 79 HIS~? -4.34 CL CL K2027s coo -7.09 7.44 6.22 -7.53 5.14 5.59 216.96 127.03 182.22 215.88 126.06 180.30 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 205.42 123.70 188.60 205.51 122.74 190.54 coo -8.70 2.86 9.96 -8.03 3.92 8.29 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 12 3 # 12 A 630 SER L 83 SER~? 3.95 CL CL L2028 A 709 ASP L 127 ASP.? 11.05 CL CL L2009 A 740 HIS L 79 HIS~? -4.09 CL CL L2028s coo -7.09 7.44 6.22 -7.53 5.14 5.59 115.00 167.12 206.00 116.47 168.85 206.74 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 124.97 159.68 211.55 124.68 157.87 212.62 coo -8.70 2.86 9.96 -8.03 3.92 8.29 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 13 3 # 13 A 630 SER M 83 SER~? 4.48 CL CL M2029 A 709 ASP M 127 ASP.? 9.06 CL CL M2017 A 740 HIS M 79 HIS~? -4.31 CL CL M2029s coo -7.09 7.44 6.22 -7.53 5.14 5.59 119.79 211.86 171.05 121.18 212.22 169.09 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 130.79 216.32 178.32 129.76 218.07 177.66 coo -8.70 2.86 9.96 -8.03 3.92 8.29 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 14 3 # 14 A 630 SER N 83 SER~? 3.82 CL CL N2030 A 709 ASP N 127 ASP.? 12.60 CL CL N2030 A 740 HIS N 79 HIS~? -4.33 CL CL N2030s coo -7.09 7.44 6.22 -7.53 5.14 5.59 221.50 155.10 133.13 220.51 157.01 132.05 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 210.39 149.08 128.41 210.51 147.14 127.55 coo -8.70 2.86 9.96 -8.03 3.92 8.29 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 15 3 # 15 A 630 SER O 83 SER~? 7.53 CL CL O2018 A 709 ASP O 127 ASP.? 11.33 CL CL O2018 A 740 HIS O 79 HIS~? 5.21 CL CL O2018 coo -7.09 7.44 6.22 -7.53 5.14 5.59 115.90 131.94 160.39 117.13 130.87 162.21 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 127.12 126.29 154.29 127.00 125.34 152.37 coo -8.70 2.86 9.96 -8.03 3.92 8.29 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 16 3 # 16 A 630 SER P 83 SER~? 8.38 CL CL P2019 A 709 ASP P 127 ASP.? 11.05 CL CL P2019 A 740 HIS P 79 HIS~? 5.38 CL CL P2019 coo -7.09 7.44 6.22 -7.53 5.14 5.59 218.12 176.21 210.92 216.94 174.20 211.47 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 207.19 183.81 214.61 207.22 185.89 215.11 coo -8.70 2.86 9.96 -8.03 3.92 8.29 212.25 178.47 210.26 213.09 179.27 212.01 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 16 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 83 SER~? 4.31 CL CL A2020 B 709 ASP A 127 ASP.? 12.37 CL CL A2020 B 740 HIS A 79 HIS~? -3.92 CL CL A2020s coo 4.44 13.29 37.64 6.01 11.66 38.49 109.33 86.01 47.44 108.27 87.28 49.22 coo 10.26 2.81 31.69 11.64 4.30 32.43 99.76 91.11 38.83 100.13 91.74 36.79 coo 8.57 10.09 34.47 7.10 10.73 35.82 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 83 SER~? 7.75 CL CL B2010 B 709 ASP B 127 ASP.? 11.35 CL CL B2010 B 740 HIS B 79 HIS~? 5.08 CL CL B2010 coo 4.44 13.29 37.64 6.01 11.66 38.49 7.70 61.77 7.67 8.73 59.61 7.20 coo 10.26 2.81 31.69 11.64 4.30 32.43 19.74 66.97 3.53 20.01 68.79 2.38 coo 8.57 10.09 34.47 7.10 10.73 35.82 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER C 83 SER~? 3.84 CL CL C2021 B 709 ASP C 127 ASP.? 10.87 CL CL C2011 B 740 HIS C 79 HIS~? -4.32 CL CL C2021s coo 4.44 13.29 37.64 6.01 11.66 38.49 99.03 9.95 70.83 97.44 9.06 69.22 coo 10.26 2.81 31.69 11.64 4.30 32.43 86.95 7.50 76.71 86.89 6.71 78.70 coo 8.57 10.09 34.47 7.10 10.73 35.82 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER D 83 SER~? 4.15 CL CL D2022 B 709 ASP D 127 ASP.? 11.17 CL CL D2012 B 740 HIS D 79 HIS~? -4.57 CL CL D2022s coo 4.44 13.29 37.64 6.01 11.66 38.49 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 10.26 2.81 31.69 11.64 4.30 32.43 7.65 47.79 93.97 7.18 46.10 95.19 coo 8.57 10.09 34.47 7.10 10.73 35.82 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER E 83 SER~? 3.98 CL CL E2032 B 709 ASP E 127 ASP.? 11.39 CL CL E2013 B 740 HIS E 79 HIS~? -4.18 CL CL E2032s coo 4.44 13.29 37.64 6.01 11.66 38.49 6.89 98.81 51.94 8.26 99.71 50.10 coo 10.26 2.81 31.69 11.64 4.30 32.43 17.80 103.20 59.40 17.93 103.89 61.44 coo 8.57 10.09 34.47 7.10 10.73 35.82 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER F 83 SER~? 4.14 CL CL F2023 B 709 ASP F 127 ASP.? 10.85 CL CL F2034 B 740 HIS F 79 HIS~? -4.63 CL CL F2023s coo 4.44 13.29 37.64 6.01 11.66 38.49 107.41 36.26 21.11 106.31 38.05 19.96 coo 10.26 2.81 31.69 11.64 4.30 32.43 96.13 30.12 15.93 96.25 28.10 15.23 coo 8.57 10.09 34.47 7.10 10.73 35.82 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER G 83 SER~? 4.16 CL CL G2033 B 709 ASP G 127 ASP.? 12.80 CL CL G2033 B 740 HIS G 79 HIS~? -4.46 CL CL G2033s coo 4.44 13.29 37.64 6.01 11.66 38.49 -0.88 18.73 43.69 0.20 17.85 45.68 coo 10.26 2.81 31.69 11.64 4.30 32.43 10.22 12.11 38.73 10.33 11.10 36.86 coo 8.57 10.09 34.47 7.10 10.73 35.82 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER H 83 SER~? 4.17 CL CL H2024 B 709 ASP H 127 ASP.? 11.27 CL CL H2014 B 740 HIS H 79 HIS~? 4.82 CL CL H2024 coo 4.44 13.29 37.64 6.01 11.66 38.49 100.86 60.76 97.52 99.44 59.04 98.47 coo 10.26 2.81 31.69 11.64 4.30 32.43 90.18 69.09 100.25 90.25 71.19 100.79 coo 8.57 10.09 34.47 7.10 10.73 35.82 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 9 3 # 9 B 630 SER I 83 SER~? 4.12 CL CL I2025 B 709 ASP I 127 ASP.? 10.93 CL CL I2015 B 740 HIS I 79 HIS~? -4.56 CL CL I2025s coo 4.44 13.29 37.64 6.01 11.66 38.49 222.83 204.85 161.89 221.39 205.66 163.52 coo 10.26 2.81 31.69 11.64 4.30 32.43 212.49 209.49 154.15 212.74 210.27 152.16 coo 8.57 10.09 34.47 7.10 10.73 35.82 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 10 3 # 10 B 630 SER J 83 SER~? 3.90 CL CL J2026 B 709 ASP J 127 ASP.? 11.08 CL CL J2016 B 740 HIS J 79 HIS~? -4.36 CL CL J2026s coo 4.44 13.29 37.64 6.01 11.66 38.49 120.35 177.35 126.19 121.76 175.49 125.60 coo 10.26 2.81 31.69 11.64 4.30 32.43 132.13 183.26 121.62 132.41 185.18 120.66 coo 8.57 10.09 34.47 7.10 10.73 35.82 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 11 3 # 11 B 630 SER K 83 SER~? 3.98 CL CL K2027 B 709 ASP K 127 ASP.? 12.37 CL CL K2027 B 740 HIS K 79 HIS~? -4.34 CL CL K2027s coo 4.44 13.29 37.64 6.01 11.66 38.49 216.96 127.03 182.22 215.88 126.06 180.30 coo 10.26 2.81 31.69 11.64 4.30 32.43 205.42 123.70 188.60 205.51 122.74 190.54 coo 8.57 10.09 34.47 7.10 10.73 35.82 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 12 3 # 12 B 630 SER L 83 SER~? 3.95 CL CL L2028 B 709 ASP L 127 ASP.? 11.05 CL CL L2009 B 740 HIS L 79 HIS~? -4.09 CL CL L2028s coo 4.44 13.29 37.64 6.01 11.66 38.49 115.00 167.12 206.00 116.47 168.85 206.74 coo 10.26 2.81 31.69 11.64 4.30 32.43 124.97 159.68 211.55 124.68 157.87 212.62 coo 8.57 10.09 34.47 7.10 10.73 35.82 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 13 3 # 13 B 630 SER M 83 SER~? 4.48 CL CL M2029 B 709 ASP M 127 ASP.? 9.06 CL CL M2017 B 740 HIS M 79 HIS~? -4.31 CL CL M2029s coo 4.44 13.29 37.64 6.01 11.66 38.49 119.79 211.86 171.05 121.18 212.22 169.09 coo 10.26 2.81 31.69 11.64 4.30 32.43 130.79 216.32 178.32 129.76 218.07 177.66 coo 8.57 10.09 34.47 7.10 10.73 35.82 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 14 3 # 14 B 630 SER N 83 SER~? 3.82 CL CL N2030 B 709 ASP N 127 ASP.? 12.60 CL CL N2030 B 740 HIS N 79 HIS~? -4.33 CL CL N2030s coo 4.44 13.29 37.64 6.01 11.66 38.49 221.50 155.10 133.13 220.51 157.01 132.05 coo 10.26 2.81 31.69 11.64 4.30 32.43 210.39 149.08 128.41 210.51 147.14 127.55 coo 8.57 10.09 34.47 7.10 10.73 35.82 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 15 3 # 15 B 630 SER O 83 SER~? 7.53 CL CL O2018 B 709 ASP O 127 ASP.? 11.33 CL CL O2018 B 740 HIS O 79 HIS~? 5.21 CL CL O2018 coo 4.44 13.29 37.64 6.01 11.66 38.49 115.90 131.94 160.39 117.13 130.87 162.21 coo 10.26 2.81 31.69 11.64 4.30 32.43 127.12 126.29 154.29 127.00 125.34 152.37 coo 8.57 10.09 34.47 7.10 10.73 35.82 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 16 3 # 16 B 630 SER P 83 SER~? 8.38 CL CL P2019 B 709 ASP P 127 ASP.? 11.05 CL CL P2019 B 740 HIS P 79 HIS~? 5.38 CL CL P2019 coo 4.44 13.29 37.64 6.01 11.66 38.49 218.12 176.21 210.92 216.94 174.20 211.47 coo 10.26 2.81 31.69 11.64 4.30 32.43 207.19 183.81 214.61 207.22 185.89 215.11 coo 8.57 10.09 34.47 7.10 10.73 35.82 212.25 178.47 210.26 213.09 179.27 212.01 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 16 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 259 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 552 ASP A 54 ASP~? 22.76 O3 GOL B3003 coo 11.34 95.90 25.54 12.13 96.42 23.67 98.60 85.60 50.46 99.38 86.61 52.13 coo 14.91 97.39 18.63 13.39 95.60 20.20 100.57 80.52 55.08 97.88 80.73 54.34 coo 46.37 82.54 38.83 45.97 84.66 38.77 63.60 81.91 35.55 61.73 81.46 36.38 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 259 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 552 ASP H 92 ASP~? 15.85 CL CL H2024 coo 11.34 95.90 25.54 12.13 96.42 23.67 106.32 81.43 56.18 105.60 83.26 56.91 coo 14.91 97.39 18.63 13.39 95.60 20.20 100.57 80.52 55.08 97.88 80.73 54.34 coo 46.37 82.54 38.83 45.97 84.66 38.77 101.24 72.29 93.07 100.11 73.39 94.44 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 76 HIS~? 4.58 CL CL B2010s A 259 TYR B 157 TYR.? 7.53 O1 GOL B3015 A 552 ASP B 54 ASP~? 13.29 O3 GOL B3003 coo 11.34 95.90 25.54 12.13 96.42 23.67 17.08 57.14 11.39 16.06 55.49 10.59 coo 14.91 97.39 18.63 13.39 95.60 20.20 13.23 54.49 17.04 16.01 54.48 17.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 53.08 65.82 20.87 54.46 64.71 21.90 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 158 HIS.? 12.55 CL CL B2010 A 259 TYR B 157 TYR.? 7.53 O1 GOL B3015 A 552 ASP G 92 ASP~? 15.60 CL CL G2033 coo 11.34 95.90 25.54 12.13 96.42 23.67 7.56 53.89 15.18 8.49 52.54 13.87 coo 14.91 97.39 18.63 13.39 95.60 20.20 13.23 54.49 17.04 16.01 54.48 17.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 2.22 20.23 31.66 3.30 18.41 31.31 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS C 76 HIS~? -4.98 CL CL C2011s A 259 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 552 ASP C 54 ASP~? 14.99 CL CL C2006 coo 11.34 95.90 25.54 12.13 96.42 23.67 89.28 12.80 65.47 90.23 11.67 63.98 coo 14.91 97.39 18.63 13.39 95.60 20.20 93.23 17.43 61.74 90.40 17.73 61.84 coo 46.37 82.54 38.83 45.97 84.66 38.77 53.32 23.86 72.39 51.93 24.66 71.07 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS C 158 HIS.? 10.62 CL CL C2021 A 259 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 552 ASP F 92 ASP~? 15.33 CL CL F2023 coo 11.34 95.90 25.54 12.13 96.42 23.67 98.99 15.14 61.83 98.04 13.53 60.88 coo 14.91 97.39 18.63 13.39 95.60 20.20 93.23 17.43 61.74 90.40 17.73 61.84 coo 46.37 82.54 38.83 45.97 84.66 38.77 104.11 24.69 25.10 103.20 23.88 23.38 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 259 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 552 ASP D 54 ASP~? 13.05 O1 GOL D3005 coo 11.34 95.90 25.54 12.13 96.42 23.67 8.84 57.69 86.26 7.93 59.46 86.93 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.86 61.00 80.62 9.60 60.40 80.64 coo 46.37 82.54 38.83 45.97 84.66 38.77 43.67 42.20 85.12 45.49 43.03 84.45 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 259 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 552 ASP E 92 ASP~? 15.39 CL CL E2032 coo 11.34 95.90 25.54 12.13 96.42 23.67 0.86 62.48 80.06 1.83 63.91 81.27 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.86 61.00 80.62 9.60 60.40 80.64 coo 46.37 82.54 38.83 45.97 84.66 38.77 6.40 96.69 64.15 7.81 98.00 64.97 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS E 76 HIS~? -4.87 CL CL E2013s A 259 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 552 ASP E 54 ASP~? 13.23 O1 GOL E3004 coo 11.34 95.90 25.54 12.13 96.42 23.67 16.97 95.07 49.08 16.37 95.97 47.28 coo 14.91 97.39 18.63 13.39 95.60 20.20 13.76 89.62 45.68 16.45 89.35 46.36 coo 46.37 82.54 38.83 45.97 84.66 38.77 50.61 86.23 65.01 52.31 85.22 64.30 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS E 158 HIS.? 10.67 CL CL E2032 A 259 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 552 ASP B 92 ASP~? 16.05 CL CL B2010 coo 11.34 95.90 25.54 12.13 96.42 23.67 8.21 91.93 44.16 9.29 93.32 43.02 coo 14.91 97.39 18.63 13.39 95.60 20.20 13.76 89.62 45.68 16.45 89.35 46.36 coo 46.37 82.54 38.83 45.97 84.66 38.77 9.78 73.89 9.95 11.15 74.42 8.49 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS F 76 HIS~? -4.65 CL CL F2034s A 259 TYR F 157 TYR.? -10.36 O3 GOL F3039s A 552 ASP F 54 ASP~? 17.55 CL CL F2035 coo 11.34 95.90 25.54 12.13 96.42 23.67 97.24 41.20 21.57 98.43 42.65 20.63 coo 14.91 97.39 18.63 13.39 95.60 20.20 100.15 45.18 26.97 97.32 45.17 26.68 coo 46.37 82.54 38.83 45.97 84.66 38.77 59.85 34.12 24.67 58.32 35.47 25.18 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 259 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 552 ASP G 54 ASP~? 15.07 CL CL C2006 coo 11.34 95.90 25.54 12.13 96.42 23.67 9.26 20.10 48.62 8.05 19.49 50.22 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.53 26.08 51.42 9.33 25.84 51.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 46.65 21.52 40.60 48.29 22.27 41.77 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS G 158 HIS.? 10.64 CL CL G2033 A 259 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 552 ASP D 92 ASP~? 15.62 CL CL D2022 coo 11.34 95.90 25.54 12.13 96.42 23.67 0.65 25.49 51.61 1.26 23.82 52.74 coo 14.91 97.39 18.63 13.39 95.60 20.20 6.53 26.08 51.42 9.33 25.84 51.41 coo 46.37 82.54 38.83 45.97 84.66 38.77 -1.67 42.91 85.09 -1.08 41.92 86.85 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 14 3 # 14 A 225 HIS H 76 HIS~? 4.68 CL CL H2014s A 259 TYR H 157 TYR.? -11.04 CL CL H2014s A 552 ASP H 54 ASP~? 12.64 O3 GOL H3006 coo 11.34 95.90 25.54 12.13 96.42 23.67 90.35 57.57 94.69 91.06 55.99 95.89 coo 14.91 97.39 18.63 13.39 95.60 20.20 93.68 52.87 90.01 90.96 53.43 89.67 coo 46.37 82.54 38.83 45.97 84.66 38.77 56.87 71.80 83.08 55.07 70.98 82.33 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 15 3 # 15 A 225 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 259 TYR I 157 TYR.? -10.00 O3 GOL I3031s A 552 ASP I 54 ASP~? 15.17 CL CL I2007 coo 11.34 95.90 25.54 12.13 96.42 23.67 212.11 203.51 165.19 213.01 204.42 166.85 coo 14.91 97.39 18.63 13.39 95.60 20.20 214.62 198.06 169.41 211.87 198.21 168.94 coo 46.37 82.54 38.83 45.97 84.66 38.77 176.64 198.53 151.72 174.93 197.89 152.71 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 16 3 # 16 A 225 HIS I 158 HIS.? 11.08 CL CL I2025 A 259 TYR I 157 TYR.? -10.00 O3 GOL I3031s A 552 ASP P 92 ASP~? 16.23 CL CL P2019 coo 11.34 95.90 25.54 12.13 96.42 23.67 220.34 199.03 170.60 219.44 200.67 171.57 coo 14.91 97.39 18.63 13.39 95.60 20.20 214.62 198.06 169.41 211.87 198.21 168.94 coo 46.37 82.54 38.83 45.97 84.66 38.77 217.62 187.96 206.84 216.52 189.08 208.26 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 17 3 # 17 A 225 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 259 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 552 ASP J 54 ASP~? 19.87 CL CL J2002 coo 11.34 95.90 25.54 12.13 96.42 23.67 130.51 172.99 128.94 129.60 171.33 128.01 coo 14.91 97.39 18.63 13.39 95.60 20.20 126.93 169.72 134.52 129.73 169.94 134.63 coo 46.37 82.54 38.83 45.97 84.66 38.77 166.52 182.87 136.75 168.05 181.78 137.64 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 18 3 # 18 A 225 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 259 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 552 ASP O 92 ASP~? 15.96 CL CL O2018 coo 11.34 95.90 25.54 12.13 96.42 23.67 121.18 169.23 132.79 122.06 167.98 131.35 coo 14.91 97.39 18.63 13.39 95.60 20.20 126.93 169.72 134.52 129.73 169.94 134.63 coo 46.37 82.54 38.83 45.97 84.66 38.77 118.21 134.06 148.13 119.12 132.25 147.57 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 19 3 # 19 A 225 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 259 TYR K 157 TYR.? 6.79 O2 GOL K3009 A 552 ASP K 54 ASP~? 13.11 O1 GOL K3011 coo 11.34 95.90 25.54 12.13 96.42 23.67 207.10 129.51 177.50 208.14 128.55 175.95 coo 14.91 97.39 18.63 13.39 95.60 20.20 210.77 134.37 173.74 207.96 134.59 173.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 171.09 138.55 186.41 169.55 139.29 185.16 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 20 3 # 20 A 225 HIS K 158 HIS.? 10.92 CL CL K2027 A 259 TYR K 157 TYR.? 6.79 O2 GOL K3009 A 552 ASP N 92 ASP~? 15.48 CL CL N2030 coo 11.34 95.90 25.54 12.13 96.42 23.67 216.60 132.79 173.33 215.77 131.08 172.42 coo 14.91 97.39 18.63 13.39 95.60 20.20 210.77 134.37 173.74 207.96 134.59 173.91 coo 46.37 82.54 38.83 45.97 84.66 38.77 219.13 143.58 136.78 218.22 142.74 135.01 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 21 3 # 21 A 225 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 259 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 552 ASP L 54 ASP~? 22.45 O3 GOL K3011 coo 11.34 95.90 25.54 12.13 96.42 23.67 125.69 169.77 203.98 124.79 171.51 204.73 coo 14.91 97.39 18.63 13.39 95.60 20.20 123.19 173.24 198.15 125.89 172.62 198.32 coo 46.37 82.54 38.83 45.97 84.66 38.77 161.13 155.54 200.38 162.83 156.50 199.58 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 22 3 # 22 A 225 HIS L 158 HIS.? 11.11 CL CL L2028 A 259 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 552 ASP M 92 ASP~? 15.40 CL CL M2029 coo 11.34 95.90 25.54 12.13 96.42 23.67 117.45 174.63 198.96 118.55 176.04 200.05 coo 14.91 97.39 18.63 13.39 95.60 20.20 123.19 173.24 198.15 125.89 172.62 198.32 coo 46.37 82.54 38.83 45.97 84.66 38.77 120.06 209.18 183.48 121.50 210.55 184.17 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 23 3 # 23 A 225 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 259 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 552 ASP M 54 ASP~? 13.03 O2 GOL M3007 coo 11.34 95.90 25.54 12.13 96.42 23.67 130.15 208.85 168.09 129.36 209.65 166.31 coo 14.91 97.39 18.63 13.39 95.60 20.20 127.03 203.34 164.58 129.75 203.18 165.07 coo 46.37 82.54 38.83 45.97 84.66 38.77 164.95 201.02 181.99 166.71 200.19 181.24 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 24 3 # 24 A 225 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 259 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 552 ASP J 92 ASP~? 15.35 CL CL J2026 coo 11.34 95.90 25.54 12.13 96.42 23.67 121.40 205.18 163.43 122.55 206.46 162.23 coo 14.91 97.39 18.63 13.39 95.60 20.20 127.03 203.34 164.58 129.75 203.18 165.07 coo 46.37 82.54 38.83 45.97 84.66 38.77 122.14 189.51 128.78 123.73 190.15 127.54 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 25 3 # 25 A 225 HIS N 76 HIS~? -6.89 CL CL N2030s A 259 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 552 ASP N 54 ASP~? 13.04 O3 GOL N3008 coo 11.34 95.90 25.54 12.13 96.42 23.67 211.54 160.16 134.29 212.67 161.69 133.40 coo 14.91 97.39 18.63 13.39 95.60 20.20 214.45 164.07 139.74 211.68 163.84 139.51 coo 46.37 82.54 38.83 45.97 84.66 38.77 174.60 151.44 139.08 172.92 152.56 139.62 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 26 3 # 26 A 225 HIS N 158 HIS.? 10.50 CL CL N2030 A 259 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 552 ASP I 92 ASP~? 15.56 CL CL I2025 coo 11.34 95.90 25.54 12.13 96.42 23.67 220.32 164.11 138.58 219.66 165.01 136.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 214.45 164.07 139.74 211.68 163.84 139.51 coo 46.37 82.54 38.83 45.97 84.66 38.77 222.01 200.70 150.15 220.98 202.18 149.11 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 27 3 # 27 A 225 HIS O 76 HIS~? 4.51 CL CL O2018s A 259 TYR O 157 TYR.? 6.41 O2 GOL O3013 A 552 ASP O 54 ASP~? 15.16 CL CL K2003 coo 11.34 95.90 25.54 12.13 96.42 23.67 126.10 133.61 164.62 125.01 132.87 166.26 coo 14.91 97.39 18.63 13.39 95.60 20.20 123.23 139.38 167.80 126.05 139.22 167.65 coo 46.37 82.54 38.83 45.97 84.66 38.77 162.95 137.35 154.91 164.67 137.97 155.90 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 28 3 # 28 A 225 HIS O 158 HIS.? 12.21 CL CL O2018 A 259 TYR O 157 TYR.? 6.41 O2 GOL O3013 A 552 ASP L 92 ASP~? 15.46 CL CL L2028 coo 11.34 95.90 25.54 12.13 96.42 23.67 117.44 138.41 168.51 118.31 136.96 169.75 coo 14.91 97.39 18.63 13.39 95.60 20.20 123.23 139.38 167.80 126.05 139.22 167.65 coo 46.37 82.54 38.83 45.97 84.66 38.77 115.70 154.99 203.31 116.12 153.70 204.91 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 29 3 # 29 A 225 HIS P 76 HIS~? 4.69 CL CL P2019s A 259 TYR P 157 TYR.? 6.12 O2 GOL P3014 A 552 ASP P 54 ASP~? 21.88 O3 GOL M3007 coo 11.34 95.90 25.54 12.13 96.42 23.67 207.59 172.73 208.38 208.33 171.09 209.49 coo 14.91 97.39 18.63 13.39 95.60 20.20 210.70 168.63 203.45 207.96 169.02 203.20 coo 46.37 82.54 38.83 45.97 84.66 38.77 172.77 185.90 199.12 171.10 184.95 198.29 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 29 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 77 ALA~? 7.34 O2 GOL A3037 A 126 LEU A 159 LEU.? 11.33 O1 GOL A3037 A 158 GLU A 163 GLU~? 14.44 O2 GOL A3037 coo -2.29 37.66 144.73 -1.46 37.12 145.87 100.75 81.76 50.18 100.07 80.47 50.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 105.70 76.86 50.52 103.64 76.30 50.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 106.73 71.90 50.38 106.39 72.49 52.36 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 77 ALA~? 8.79 CL CL B2010 A 126 LEU B 159 LEU.? 11.27 O3 GOL B3015 A 158 GLU B 163 GLU~? 11.65 O3 GOL B3015 coo -2.29 37.66 144.73 -1.46 37.12 145.87 14.35 58.87 14.63 14.64 58.71 16.11 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.42 60.44 18.12 10.32 60.25 19.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.39 62.04 22.34 6.51 59.97 22.27 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA C 77 ALA~? 8.49 O1 GOL C3036 A 126 LEU C 159 LEU.? 8.70 CL CL C2031 A 158 GLU C 163 GLU~? 4.89 CL CL C2031 coo -2.29 37.66 144.73 -1.46 37.12 145.87 92.17 16.11 66.53 91.99 17.53 65.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 98.02 19.71 67.34 96.17 20.81 66.94 coo -0.83 29.57 149.77 -0.39 31.47 148.95 100.18 24.25 67.88 99.96 23.77 65.85 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA C 135 ALA.? 18.18 CL CL C2011 A 126 LEU C 110 LEU~? 19.25 CL CL C2011 A 158 GLU C 106 GLU~? 19.79 O1 GOL C3036 coo -2.29 37.66 144.73 -1.46 37.12 145.87 80.29 16.27 82.51 80.76 17.49 81.72 coo -4.62 32.83 147.14 -5.50 32.85 149.12 74.12 15.92 77.70 74.61 14.19 78.82 coo -0.83 29.57 149.77 -0.39 31.47 148.95 75.34 22.76 79.72 77.40 22.80 79.51 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA D 77 ALA~? 7.20 C1 GOL D3020 A 126 LEU D 159 LEU.? 11.20 O1 GOL D3020 A 158 GLU D 163 GLU~? 14.42 O1 GOL D3020 coo -2.29 37.66 144.73 -1.46 37.12 145.87 6.55 56.57 82.37 7.24 56.79 81.03 coo -4.62 32.83 147.14 -5.50 32.85 149.12 1.60 55.77 77.50 3.74 55.70 77.05 coo -0.83 29.57 149.77 -0.39 31.47 148.95 0.62 54.76 72.61 1.16 56.78 72.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA E 77 ALA~? 8.91 CL CL E2013 A 126 LEU E 159 LEU.? 11.49 O1 GOL E3002 A 158 GLU E 163 GLU~? 11.74 O1 GOL E3002 coo -2.29 37.66 144.73 -1.46 37.12 145.87 13.89 92.05 50.21 14.20 90.55 50.08 coo -4.62 32.83 147.14 -5.50 32.85 149.12 7.86 88.53 50.59 9.77 87.52 50.83 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.75 84.10 51.71 6.08 84.26 49.61 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA F 77 ALA~? 8.70 CL CL F2034 A 126 LEU F 159 LEU.? 12.58 CL CL F2023 A 158 GLU F 163 GLU~? 16.81 CL CL F2023 coo -2.29 37.66 144.73 -1.46 37.12 145.87 99.32 40.41 25.48 98.76 40.99 26.78 coo -4.62 32.83 147.14 -5.50 32.85 149.12 104.21 39.59 30.34 102.19 39.92 30.93 coo -0.83 29.57 149.77 -0.39 31.47 148.95 105.09 39.28 35.27 105.30 41.23 34.49 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA G 77 ALA~? 7.25 O3 GOL G3001 A 126 LEU G 159 LEU.? 9.64 O3 GOL G3001 A 158 GLU G 163 GLU~? 11.22 O3 GOL G3001 coo -2.29 37.66 144.73 -1.46 37.12 145.87 7.15 23.73 47.01 7.71 25.14 47.31 coo -4.62 32.83 147.14 -5.50 32.85 149.12 2.35 28.46 45.20 4.40 29.00 45.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 1.42 33.23 43.78 1.39 32.97 45.86 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA H 77 ALA~? 8.84 CL CL H2014 A 126 LEU H 159 LEU.? 12.60 CL CL H2024 A 158 GLU H 163 GLU~? 16.69 O1 GOL H3016 coo -2.29 37.66 144.73 -1.46 37.12 145.87 93.56 57.80 91.48 93.28 57.22 90.10 coo -4.62 32.83 147.14 -5.50 32.85 149.12 99.48 57.40 87.82 97.61 57.56 86.72 coo -0.83 29.57 149.77 -0.39 31.47 148.95 101.55 57.39 83.25 101.29 55.39 84.02 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA I 77 ALA~? 9.03 CL CL I2015 A 126 LEU I 159 LEU.? 12.71 CL CL I2025 A 158 GLU I 163 GLU~? 16.56 O3 GOL I3032 coo -2.29 37.66 144.73 -1.46 37.12 145.87 214.62 199.75 164.52 214.07 198.37 164.98 coo -4.62 32.83 147.14 -5.50 32.85 149.12 219.80 195.23 164.43 217.77 194.50 164.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 221.15 190.35 164.07 220.95 190.90 166.06 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA K 77 ALA~? 8.79 O2 GOL K3009 A 126 LEU K 159 LEU.? 11.20 O2 GOL K3009 A 158 GLU K 163 GLU~? 12.51 O2 GOL K3009 coo -2.29 37.66 144.73 -1.46 37.12 145.87 209.89 132.99 178.48 209.55 134.39 178.02 coo -4.62 32.83 147.14 -5.50 32.85 149.12 215.51 136.86 179.27 213.56 137.79 178.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 217.27 141.62 179.80 217.24 141.01 177.77 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA L 77 ALA~? 8.83 CL CL L2009 A 126 LEU L 159 LEU.? 12.41 CL CL L2028 A 158 GLU L 163 GLU~? 16.77 CL CL L2028 coo -2.29 37.66 144.73 -1.46 37.12 145.87 123.16 168.73 200.29 123.66 168.91 198.87 coo -4.62 32.83 147.14 -5.50 32.85 149.12 117.85 168.14 195.82 119.91 168.00 195.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 116.58 166.98 191.20 116.69 169.04 191.44 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 A 70 ALA M 77 ALA~? 6.98 C2 GOL M3042 A 126 LEU M 159 LEU.? 11.51 C2 GOL M3042 A 158 GLU M 163 GLU~? 14.80 C2 GOL M3042 coo -2.29 37.66 144.73 -1.46 37.12 145.87 127.30 205.48 169.06 127.68 204.04 168.84 coo -4.62 32.83 147.14 -5.50 32.85 149.12 121.55 201.64 169.75 123.57 200.68 169.84 coo -0.83 29.57 149.77 -0.39 31.47 148.95 119.51 197.10 170.73 120.12 197.15 168.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 A 70 ALA M 135 ALA.? 17.94 CL CL M2017 A 126 LEU M 110 LEU~? 18.24 C1 GOL M3043 A 158 GLU M 106 GLU~? 21.48 CL CL M2017 coo -2.29 37.66 144.73 -1.46 37.12 145.87 136.61 208.69 186.51 136.19 207.38 185.80 coo -4.62 32.83 147.14 -5.50 32.85 149.12 143.49 208.34 182.71 142.65 210.11 183.53 coo -0.83 29.57 149.77 -0.39 31.47 148.95 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 A 70 ALA N 77 ALA~? 9.77 O2 GOL N3012 A 126 LEU N 159 LEU.? 11.76 O1 GOL N3012 A 158 GLU N 163 GLU~? 12.29 O1 GOL N3012 coo -2.29 37.66 144.73 -1.46 37.12 145.87 213.79 159.16 138.04 213.32 159.76 139.40 coo -4.62 32.83 147.14 -5.50 32.85 149.12 218.98 158.41 142.85 216.91 158.82 143.43 coo -0.83 29.57 149.77 -0.39 31.47 148.95 220.21 157.81 147.58 220.09 159.81 146.98 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 A 70 ALA O 77 ALA~? 8.55 O1 GOL O3013 A 126 LEU O 159 LEU.? 11.94 O3 GOL O3013 A 158 GLU O 163 GLU~? 12.66 O3 GOL O3013 coo -2.29 37.66 144.73 -1.46 37.12 145.87 123.76 137.25 163.23 124.22 138.65 163.60 coo -4.62 32.83 147.14 -5.50 32.85 149.12 118.64 141.59 162.03 120.68 142.42 162.11 coo -0.83 29.57 149.77 -0.39 31.47 148.95 117.45 146.43 160.85 117.44 146.23 162.92 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 A 70 ALA P 77 ALA~? 8.06 O2 GOL P3014 A 126 LEU P 159 LEU.? 10.45 O2 GOL P3014 A 158 GLU P 163 GLU~? 11.95 O2 GOL P3014 coo -2.29 37.66 144.73 -1.46 37.12 145.87 210.48 173.29 204.91 210.13 172.95 203.48 coo -4.62 32.83 147.14 -5.50 32.85 149.12 216.28 173.40 200.98 214.29 173.26 200.18 coo -0.83 29.57 149.77 -0.39 31.47 148.95 218.06 173.97 196.16 217.79 171.96 196.61 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 17 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 77 ALA~? 7.34 O2 GOL A3037 B 126 LEU A 159 LEU.? 11.33 O1 GOL A3037 B 158 GLU A 163 GLU~? 14.44 O2 GOL A3037 coo -39.79 4.61 147.27 -39.61 5.56 148.47 100.75 81.76 50.18 100.07 80.47 50.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 105.70 76.86 50.52 103.64 76.30 50.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 106.73 71.90 50.38 106.39 72.49 52.36 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 77 ALA~? 8.79 CL CL B2010 B 126 LEU B 159 LEU.? 11.27 O3 GOL B3015 B 158 GLU B 163 GLU~? 11.65 O3 GOL B3015 coo -39.79 4.61 147.27 -39.61 5.56 148.47 14.35 58.87 14.63 14.64 58.71 16.11 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.42 60.44 18.12 10.32 60.25 19.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.39 62.04 22.34 6.51 59.97 22.27 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA C 77 ALA~? 8.49 O1 GOL C3036 B 126 LEU C 159 LEU.? 8.70 CL CL C2031 B 158 GLU C 163 GLU~? 4.89 CL CL C2031 coo -39.79 4.61 147.27 -39.61 5.56 148.47 92.17 16.11 66.53 91.99 17.53 65.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 98.02 19.71 67.34 96.17 20.81 66.94 coo -33.03 9.93 151.71 -34.98 9.38 151.11 100.18 24.25 67.88 99.96 23.77 65.85 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA C 135 ALA.? 18.18 CL CL C2011 B 126 LEU C 110 LEU~? 19.25 CL CL C2011 B 158 GLU C 106 GLU~? 19.79 O1 GOL C3036 coo -39.79 4.61 147.27 -39.61 5.56 148.47 80.29 16.27 82.51 80.76 17.49 81.72 coo -34.22 5.06 149.25 -33.65 4.24 151.15 74.12 15.92 77.70 74.61 14.19 78.82 coo -33.03 9.93 151.71 -34.98 9.38 151.11 75.34 22.76 79.72 77.40 22.80 79.51 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA D 77 ALA~? 7.20 C1 GOL D3020 B 126 LEU D 159 LEU.? 11.20 O1 GOL D3020 B 158 GLU D 163 GLU~? 14.42 O1 GOL D3020 coo -39.79 4.61 147.27 -39.61 5.56 148.47 6.55 56.57 82.37 7.24 56.79 81.03 coo -34.22 5.06 149.25 -33.65 4.24 151.15 1.60 55.77 77.50 3.74 55.70 77.05 coo -33.03 9.93 151.71 -34.98 9.38 151.11 0.62 54.76 72.61 1.16 56.78 72.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA E 77 ALA~? 8.91 CL CL E2013 B 126 LEU E 159 LEU.? 11.49 O1 GOL E3002 B 158 GLU E 163 GLU~? 11.74 O1 GOL E3002 coo -39.79 4.61 147.27 -39.61 5.56 148.47 13.89 92.05 50.21 14.20 90.55 50.08 coo -34.22 5.06 149.25 -33.65 4.24 151.15 7.86 88.53 50.59 9.77 87.52 50.83 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.75 84.10 51.71 6.08 84.26 49.61 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA F 77 ALA~? 8.70 CL CL F2034 B 126 LEU F 159 LEU.? 12.58 CL CL F2023 B 158 GLU F 163 GLU~? 16.81 CL CL F2023 coo -39.79 4.61 147.27 -39.61 5.56 148.47 99.32 40.41 25.48 98.76 40.99 26.78 coo -34.22 5.06 149.25 -33.65 4.24 151.15 104.21 39.59 30.34 102.19 39.92 30.93 coo -33.03 9.93 151.71 -34.98 9.38 151.11 105.09 39.28 35.27 105.30 41.23 34.49 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA G 77 ALA~? 7.25 O3 GOL G3001 B 126 LEU G 159 LEU.? 9.64 O3 GOL G3001 B 158 GLU G 163 GLU~? 11.22 O3 GOL G3001 coo -39.79 4.61 147.27 -39.61 5.56 148.47 7.15 23.73 47.01 7.71 25.14 47.31 coo -34.22 5.06 149.25 -33.65 4.24 151.15 2.35 28.46 45.20 4.40 29.00 45.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 1.42 33.23 43.78 1.39 32.97 45.86 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA H 77 ALA~? 8.84 CL CL H2014 B 126 LEU H 159 LEU.? 12.60 CL CL H2024 B 158 GLU H 163 GLU~? 16.69 O1 GOL H3016 coo -39.79 4.61 147.27 -39.61 5.56 148.47 93.56 57.80 91.48 93.28 57.22 90.10 coo -34.22 5.06 149.25 -33.65 4.24 151.15 99.48 57.40 87.82 97.61 57.56 86.72 coo -33.03 9.93 151.71 -34.98 9.38 151.11 101.55 57.39 83.25 101.29 55.39 84.02 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA I 77 ALA~? 9.03 CL CL I2015 B 126 LEU I 159 LEU.? 12.71 CL CL I2025 B 158 GLU I 163 GLU~? 16.56 O3 GOL I3032 coo -39.79 4.61 147.27 -39.61 5.56 148.47 214.62 199.75 164.52 214.07 198.37 164.98 coo -34.22 5.06 149.25 -33.65 4.24 151.15 219.80 195.23 164.43 217.77 194.50 164.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 221.15 190.35 164.07 220.95 190.90 166.06 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA J 77 ALA~? 7.22 O2 GOL J3033 B 126 LEU J 159 LEU.? 11.64 O2 GOL J3033 B 158 GLU J 163 GLU~? 14.80 O1 GOL J3033 coo -39.79 4.61 147.27 -39.61 5.56 148.47 127.70 174.36 132.33 128.03 174.02 133.80 coo -34.22 5.06 149.25 -33.65 4.24 151.15 121.99 175.54 136.35 124.04 175.41 137.02 coo -33.03 9.93 151.71 -34.98 9.38 151.11 120.24 176.69 140.95 120.35 174.56 140.67 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA K 77 ALA~? 8.79 O2 GOL K3009 B 126 LEU K 159 LEU.? 11.20 O2 GOL K3009 B 158 GLU K 163 GLU~? 12.51 O2 GOL K3009 coo -39.79 4.61 147.27 -39.61 5.56 148.47 209.89 132.99 178.48 209.55 134.39 178.02 coo -34.22 5.06 149.25 -33.65 4.24 151.15 215.51 136.86 179.27 213.56 137.79 178.87 coo -33.03 9.93 151.71 -34.98 9.38 151.11 217.27 141.62 179.80 217.24 141.01 177.77 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA L 77 ALA~? 8.83 CL CL L2009 B 126 LEU L 159 LEU.? 12.41 CL CL L2028 B 158 GLU L 163 GLU~? 16.77 CL CL L2028 coo -39.79 4.61 147.27 -39.61 5.56 148.47 123.16 168.73 200.29 123.66 168.91 198.87 coo -34.22 5.06 149.25 -33.65 4.24 151.15 117.85 168.14 195.82 119.91 168.00 195.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 116.58 166.98 191.20 116.69 169.04 191.44 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 B 70 ALA M 77 ALA~? 6.98 C2 GOL M3042 B 126 LEU M 159 LEU.? 11.51 C2 GOL M3042 B 158 GLU M 163 GLU~? 14.80 C2 GOL M3042 coo -39.79 4.61 147.27 -39.61 5.56 148.47 127.30 205.48 169.06 127.68 204.04 168.84 coo -34.22 5.06 149.25 -33.65 4.24 151.15 121.55 201.64 169.75 123.57 200.68 169.84 coo -33.03 9.93 151.71 -34.98 9.38 151.11 119.51 197.10 170.73 120.12 197.15 168.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 B 70 ALA M 135 ALA.? 17.94 CL CL M2017 B 126 LEU M 110 LEU~? 18.24 C1 GOL M3043 B 158 GLU M 106 GLU~? 21.48 CL CL M2017 coo -39.79 4.61 147.27 -39.61 5.56 148.47 136.61 208.69 186.51 136.19 207.38 185.80 coo -34.22 5.06 149.25 -33.65 4.24 151.15 143.49 208.34 182.71 142.65 210.11 183.53 coo -33.03 9.93 151.71 -34.98 9.38 151.11 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 16 3 # 16 B 70 ALA N 77 ALA~? 9.77 O2 GOL N3012 B 126 LEU N 159 LEU.? 11.76 O1 GOL N3012 B 158 GLU N 163 GLU~? 12.29 O1 GOL N3012 coo -39.79 4.61 147.27 -39.61 5.56 148.47 213.79 159.16 138.04 213.32 159.76 139.40 coo -34.22 5.06 149.25 -33.65 4.24 151.15 218.98 158.41 142.85 216.91 158.82 143.43 coo -33.03 9.93 151.71 -34.98 9.38 151.11 220.21 157.81 147.58 220.09 159.81 146.98 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 17 3 # 17 B 70 ALA O 77 ALA~? 8.55 O1 GOL O3013 B 126 LEU O 159 LEU.? 11.94 O3 GOL O3013 B 158 GLU O 163 GLU~? 12.66 O3 GOL O3013 coo -39.79 4.61 147.27 -39.61 5.56 148.47 123.76 137.25 163.23 124.22 138.65 163.60 coo -34.22 5.06 149.25 -33.65 4.24 151.15 118.64 141.59 162.03 120.68 142.42 162.11 coo -33.03 9.93 151.71 -34.98 9.38 151.11 117.45 146.43 160.85 117.44 146.23 162.92 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 18 3 # 18 B 70 ALA P 77 ALA~? 8.06 O2 GOL P3014 B 126 LEU P 159 LEU.? 10.45 O2 GOL P3014 B 158 GLU P 163 GLU~? 11.95 O2 GOL P3014 coo -39.79 4.61 147.27 -39.61 5.56 148.47 210.48 173.29 204.91 210.13 172.95 203.48 coo -34.22 5.06 149.25 -33.65 4.24 151.15 216.28 173.40 200.98 214.29 173.26 200.18 coo -33.03 9.93 151.71 -34.98 9.38 151.11 218.06 173.97 196.16 217.79 171.96 196.61 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 18 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 77 ALA~? 7.34 O2 GOL A3037 C 126 LEU A 159 LEU.? 11.33 O1 GOL A3037 C 158 GLU A 163 GLU~? 14.44 O2 GOL A3037 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 100.75 81.76 50.18 100.07 80.47 50.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 105.70 76.86 50.52 103.64 76.30 50.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 106.73 71.90 50.38 106.39 72.49 52.36 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 77 ALA~? 8.79 CL CL B2010 C 126 LEU B 159 LEU.? 11.27 O3 GOL B3015 C 158 GLU B 163 GLU~? 11.65 O3 GOL B3015 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 14.35 58.87 14.63 14.64 58.71 16.11 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.42 60.44 18.12 10.32 60.25 19.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.39 62.04 22.34 6.51 59.97 22.27 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA C 77 ALA~? 8.49 O1 GOL C3036 C 126 LEU C 159 LEU.? 8.70 CL CL C2031 C 158 GLU C 163 GLU~? 4.89 CL CL C2031 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 92.17 16.11 66.53 91.99 17.53 65.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 98.02 19.71 67.34 96.17 20.81 66.94 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 100.18 24.25 67.88 99.96 23.77 65.85 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA D 77 ALA~? 7.20 C1 GOL D3020 C 126 LEU D 159 LEU.? 11.20 O1 GOL D3020 C 158 GLU D 163 GLU~? 14.42 O1 GOL D3020 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 6.55 56.57 82.37 7.24 56.79 81.03 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 1.60 55.77 77.50 3.74 55.70 77.05 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 0.62 54.76 72.61 1.16 56.78 72.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA E 77 ALA~? 8.91 CL CL E2013 C 126 LEU E 159 LEU.? 11.49 O1 GOL E3002 C 158 GLU E 163 GLU~? 11.74 O1 GOL E3002 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 13.89 92.05 50.21 14.20 90.55 50.08 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 7.86 88.53 50.59 9.77 87.52 50.83 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.75 84.10 51.71 6.08 84.26 49.61 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA F 77 ALA~? 8.70 CL CL F2034 C 126 LEU F 159 LEU.? 12.58 CL CL F2023 C 158 GLU F 163 GLU~? 16.81 CL CL F2023 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 99.32 40.41 25.48 98.76 40.99 26.78 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 104.21 39.59 30.34 102.19 39.92 30.93 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 105.09 39.28 35.27 105.30 41.23 34.49 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA G 77 ALA~? 7.25 O3 GOL G3001 C 126 LEU G 159 LEU.? 9.64 O3 GOL G3001 C 158 GLU G 163 GLU~? 11.22 O3 GOL G3001 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 7.15 23.73 47.01 7.71 25.14 47.31 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 2.35 28.46 45.20 4.40 29.00 45.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 1.42 33.23 43.78 1.39 32.97 45.86 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA H 77 ALA~? 8.84 CL CL H2014 C 126 LEU H 159 LEU.? 12.60 CL CL H2024 C 158 GLU H 163 GLU~? 16.69 O1 GOL H3016 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 93.56 57.80 91.48 93.28 57.22 90.10 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 99.48 57.40 87.82 97.61 57.56 86.72 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 101.55 57.39 83.25 101.29 55.39 84.02 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA I 77 ALA~? 9.03 CL CL I2015 C 126 LEU I 159 LEU.? 12.71 CL CL I2025 C 158 GLU I 163 GLU~? 16.56 O3 GOL I3032 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 214.62 199.75 164.52 214.07 198.37 164.98 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 219.80 195.23 164.43 217.77 194.50 164.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 221.15 190.35 164.07 220.95 190.90 166.06 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA K 77 ALA~? 8.79 O2 GOL K3009 C 126 LEU K 159 LEU.? 11.20 O2 GOL K3009 C 158 GLU K 163 GLU~? 12.51 O2 GOL K3009 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 209.89 132.99 178.48 209.55 134.39 178.02 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 215.51 136.86 179.27 213.56 137.79 178.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 217.27 141.62 179.80 217.24 141.01 177.77 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA L 77 ALA~? 8.83 CL CL L2009 C 126 LEU L 159 LEU.? 12.41 CL CL L2028 C 158 GLU L 163 GLU~? 16.77 CL CL L2028 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 123.16 168.73 200.29 123.66 168.91 198.87 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 117.85 168.14 195.82 119.91 168.00 195.16 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 116.58 166.98 191.20 116.69 169.04 191.44 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA M 77 ALA~? 6.98 C2 GOL M3042 C 126 LEU M 159 LEU.? 11.51 C2 GOL M3042 C 158 GLU M 163 GLU~? 14.80 C2 GOL M3042 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 127.30 205.48 169.06 127.68 204.04 168.84 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 121.55 201.64 169.75 123.57 200.68 169.84 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 119.51 197.10 170.73 120.12 197.15 168.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 C 70 ALA N 77 ALA~? 9.77 O2 GOL N3012 C 126 LEU N 159 LEU.? 11.76 O1 GOL N3012 C 158 GLU N 163 GLU~? 12.29 O1 GOL N3012 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 213.79 159.16 138.04 213.32 159.76 139.40 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 218.98 158.41 142.85 216.91 158.82 143.43 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 220.21 157.81 147.58 220.09 159.81 146.98 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 14 3 # 14 C 70 ALA O 77 ALA~? 8.55 O1 GOL O3013 C 126 LEU O 159 LEU.? 11.94 O3 GOL O3013 C 158 GLU O 163 GLU~? 12.66 O3 GOL O3013 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 123.76 137.25 163.23 124.22 138.65 163.60 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 118.64 141.59 162.03 120.68 142.42 162.11 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 117.45 146.43 160.85 117.44 146.23 162.92 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 15 3 # 15 C 70 ALA P 77 ALA~? 8.06 O2 GOL P3014 C 126 LEU P 159 LEU.? 10.45 O2 GOL P3014 C 158 GLU P 163 GLU~? 11.95 O2 GOL P3014 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 210.48 173.29 204.91 210.13 172.95 203.48 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 216.28 173.40 200.98 214.29 173.26 200.18 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 218.06 173.97 196.16 217.79 171.96 196.61 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 15 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 28 ASP~? 35.69 O2 GOL E3035 A 270 LYS A 22 LYS~? 17.94 O2 GOL E3035 A 382 MET E 23 MET~? 24.83 O1 GOL E3004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 62.23 105.49 38.88 63.59 105.50 37.26 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.67 100.75 40.87 47.74 98.27 41.17 coo -23.75 127.89 58.42 -26.02 128.79 55.12 62.43 102.35 53.43 62.16 100.38 49.79 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 28 ASP~? 35.69 O2 GOL E3035 A 270 LYS A 22 LYS~? 17.94 O2 GOL E3035 A 382 MET E 26 MET~? 25.25 O1 GOL E3004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 62.23 105.49 38.88 63.59 105.50 37.26 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.67 100.75 40.87 47.74 98.27 41.17 coo -23.75 127.89 58.42 -26.02 128.79 55.12 63.26 107.20 54.65 65.58 104.80 52.23 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 270 LYS B 22 LYS~? 21.36 O2 GOL B3003 A 382 MET F 23 MET~? 26.06 C1 GOL B3003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 57.70 57.51 -0.61 56.74 59.29 -1.16 coo -32.20 115.91 49.56 -31.37 121.03 53.12 65.01 54.92 6.02 70.07 53.87 9.73 coo -23.75 127.89 58.42 -26.02 128.79 55.12 54.19 43.96 4.53 54.80 47.79 5.88 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 28 ASP~? 19.20 C1 GOL B3003 A 270 LYS B 22 LYS~? 21.36 O2 GOL B3003 A 382 MET F 26 MET~? 27.46 O1 GOL B3017 coo -27.63 121.99 45.48 -26.66 123.86 45.68 57.70 57.51 -0.61 56.74 59.29 -1.16 coo -32.20 115.91 49.56 -31.37 121.03 53.12 65.01 54.92 6.02 70.07 53.87 9.73 coo -23.75 127.89 58.42 -26.02 128.79 55.12 53.86 41.93 -0.01 51.83 45.24 1.32 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP C 28 ASP~? 15.70 CL CL C2004 A 270 LYS C 22 LYS~? 13.40 CL CL C2004 A 382 MET G 23 MET~? 5.36 CL CL C2004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 48.49 0.93 68.23 49.38 0.74 70.13 coo -32.20 115.91 49.56 -31.37 121.03 53.12 41.54 7.20 64.53 36.41 10.79 63.02 coo -23.75 127.89 58.42 -26.02 128.79 55.12 52.31 3.79 54.11 51.63 5.92 57.54 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP C 28 ASP~? 15.70 CL CL C2004 A 270 LYS C 22 LYS~? 13.40 CL CL C2004 A 382 MET G 26 MET~? 11.41 CL CL C2004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 48.49 0.93 68.23 49.38 0.74 70.13 coo -32.20 115.91 49.56 -31.37 121.03 53.12 41.54 7.20 64.53 36.41 10.79 63.02 coo -23.75 127.89 58.42 -26.02 128.79 55.12 52.68 -1.12 53.01 54.90 1.04 55.74 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP D 28 ASP~? 15.80 CL CL H2005 A 270 LYS D 22 LYS~? 13.25 CL CL H2005 A 382 MET H 23 MET~? 5.42 CL CL H2005 coo -27.63 121.99 45.48 -26.66 123.86 45.68 45.36 50.43 107.49 43.88 48.98 107.89 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.93 51.31 102.22 59.63 51.16 99.48 coo -23.75 127.89 58.42 -26.02 128.79 55.12 45.29 64.04 101.47 45.50 60.09 100.20 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP D 28 ASP~? 15.80 CL CL H2005 A 270 LYS D 22 LYS~? 13.25 CL CL H2005 A 382 MET H 26 MET~? 11.26 CL CL H2005 coo -27.63 121.99 45.48 -26.66 123.86 45.68 45.36 50.43 107.49 43.88 48.98 107.89 coo -32.20 115.91 49.56 -31.37 121.03 53.12 53.93 51.31 102.22 59.63 51.16 99.48 coo -23.75 127.89 58.42 -26.02 128.79 55.12 44.42 66.19 105.84 42.10 63.34 103.86 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 270 LYS E 22 LYS~? 21.81 O1 GOL E3004 A 382 MET A 23 MET~? 26.24 O1 GOL E3004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 57.09 107.82 57.29 55.83 108.40 58.91 coo -32.20 115.91 49.56 -31.37 121.03 53.12 64.37 100.86 56.32 69.54 97.12 56.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 55.97 102.18 43.55 55.94 100.85 47.44 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 10 3 # 10 A 248 ASP E 28 ASP~? 19.58 O1 GOL E3004 A 270 LYS E 22 LYS~? 21.81 O1 GOL E3004 A 382 MET A 26 MET~? 26.45 O2 GOL E3035 coo -27.63 121.99 45.48 -26.66 123.86 45.68 57.09 107.82 57.29 55.83 108.40 58.91 coo -32.20 115.91 49.56 -31.37 121.03 53.12 64.37 100.86 56.32 69.54 97.12 56.69 coo -23.75 127.89 58.42 -26.02 128.79 55.12 56.14 106.69 41.38 53.44 105.32 44.23 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 11 3 # 11 A 248 ASP F 28 ASP~? 32.62 CL CL F2035 A 270 LYS F 22 LYS~? 18.36 O1 GOL B3017 A 382 MET B 23 MET~? 24.45 C1 GOL B3003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 59.39 38.13 1.08 60.39 36.31 1.06 coo -32.20 115.91 49.56 -31.37 121.03 53.12 51.36 41.84 5.91 45.78 43.39 8.51 coo -23.75 127.89 58.42 -26.02 128.79 55.12 62.51 52.49 4.49 61.53 48.93 6.43 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 12 3 # 12 A 248 ASP F 28 ASP~? 32.62 CL CL F2035 A 270 LYS F 22 LYS~? 18.36 O1 GOL B3017 A 382 MET B 26 MET~? 24.79 C1 GOL B3003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 59.39 38.13 1.08 60.39 36.31 1.06 coo -32.20 115.91 49.56 -31.37 121.03 53.12 51.36 41.84 5.91 45.78 43.39 8.51 coo -23.75 127.89 58.42 -26.02 128.79 55.12 63.33 53.81 -0.36 65.34 50.92 1.80 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 13 3 # 13 A 248 ASP G 28 ASP~? 15.85 CL CL C2004 A 270 LYS G 22 LYS~? 13.25 CL CL C2004 A 382 MET C 23 MET~? 5.32 CL CL C2004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.14 -0.91 49.29 46.12 -1.37 47.54 coo -32.20 115.91 49.56 -31.37 121.03 53.12 55.06 4.83 51.67 60.67 7.73 52.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 44.03 5.30 62.37 45.21 6.54 58.59 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 14 3 # 14 A 248 ASP G 28 ASP~? 15.85 CL CL C2004 A 270 LYS G 22 LYS~? 13.25 CL CL C2004 A 382 MET C 26 MET~? 11.35 CL CL C2004 coo -27.63 121.99 45.48 -26.66 123.86 45.68 47.14 -0.91 49.29 46.12 -1.37 47.54 coo -32.20 115.91 49.56 -31.37 121.03 53.12 55.06 4.83 51.67 60.67 7.73 52.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 42.95 0.90 64.33 41.11 2.70 61.08 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 15 3 # 15 A 248 ASP H 28 ASP~? 15.80 CL CL H2005 A 270 LYS H 22 LYS~? 13.32 CL CL H2005 A 382 MET D 23 MET~? 5.39 CL CL H2005 coo -27.63 121.99 45.48 -26.66 123.86 45.68 50.63 68.82 106.06 51.93 70.45 106.39 coo -32.20 115.91 49.56 -31.37 121.03 53.12 43.36 66.64 99.44 38.17 66.18 95.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 51.64 54.25 103.18 51.79 57.75 101.00 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 16 3 # 16 A 248 ASP H 28 ASP~? 15.80 CL CL H2005 A 270 LYS H 22 LYS~? 13.32 CL CL H2005 A 382 MET D 26 MET~? 11.47 CL CL H2005 coo -27.63 121.99 45.48 -26.66 123.86 45.68 50.63 68.82 106.06 51.93 70.45 106.39 coo -32.20 115.91 49.56 -31.37 121.03 53.12 43.36 66.64 99.44 38.17 66.18 95.68 coo -23.75 127.89 58.42 -26.02 128.79 55.12 51.58 53.07 108.07 54.31 55.40 106.13 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 17 3 # 17 A 248 ASP I 28 ASP~? 15.71 CL CL I2001 A 270 LYS I 22 LYS~? 13.37 CL CL I2001 A 382 MET M 23 MET~? 5.22 CL CL I2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 174.34 221.90 156.42 175.71 222.11 154.83 coo -32.20 115.91 49.56 -31.37 121.03 53.12 166.16 216.63 158.59 160.45 213.84 159.02 coo -23.75 127.89 58.42 -26.02 128.79 55.12 175.52 217.83 170.56 175.11 215.89 167.00 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 18 3 # 18 A 248 ASP I 28 ASP~? 15.71 CL CL I2001 A 270 LYS I 22 LYS~? 13.37 CL CL I2001 A 382 MET M 26 MET~? 11.18 CL CL I2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 174.34 221.90 156.42 175.71 222.11 154.83 coo -32.20 115.91 49.56 -31.37 121.03 53.12 166.16 216.63 158.59 160.45 213.84 159.02 coo -23.75 127.89 58.42 -26.02 128.79 55.12 176.45 222.50 171.85 178.69 220.21 169.25 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 19 3 # 19 A 248 ASP J 28 ASP~? 15.67 CL CL J2002 A 270 LYS J 22 LYS~? 13.36 CL CL J2002 A 382 MET N 23 MET~? 5.43 CL CL J2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 170.87 175.19 114.50 169.74 176.91 114.00 coo -32.20 115.91 49.56 -31.37 121.03 53.12 178.14 172.91 121.18 183.42 172.10 124.71 coo -23.75 127.89 58.42 -26.02 128.79 55.12 167.73 161.76 119.52 168.39 165.50 121.05 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 20 3 # 20 A 248 ASP J 28 ASP~? 15.67 CL CL J2002 A 270 LYS J 22 LYS~? 13.36 CL CL J2002 A 382 MET N 26 MET~? 11.36 CL CL J2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 170.87 175.19 114.50 169.74 176.91 114.00 coo -32.20 115.91 49.56 -31.37 121.03 53.12 178.14 172.91 121.18 183.42 172.10 124.71 coo -23.75 127.89 58.42 -26.02 128.79 55.12 167.34 159.88 114.96 165.24 163.05 116.54 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 21 3 # 21 A 248 ASP K 28 ASP~? 19.61 O1 GOL K3011 A 270 LYS K 22 LYS~? 17.74 CL CL K2003 A 382 MET O 23 MET~? 15.11 CL CL K2003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 166.96 115.59 181.42 167.86 115.34 183.30 coo -32.20 115.91 49.56 -31.37 121.03 53.12 159.62 121.79 178.29 154.49 125.24 177.13 coo -23.75 127.89 58.42 -26.02 128.79 55.12 169.98 119.14 167.26 169.46 121.20 170.81 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 22 3 # 22 A 248 ASP K 28 ASP~? 19.61 O1 GOL K3011 A 270 LYS K 22 LYS~? 17.74 CL CL K2003 A 382 MET O 26 MET~? 20.64 CL CL K2003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 166.96 115.59 181.42 167.86 115.34 183.30 coo -32.20 115.91 49.56 -31.37 121.03 53.12 159.62 121.79 178.29 154.49 125.24 177.13 coo -23.75 127.89 58.42 -26.02 128.79 55.12 170.43 114.33 165.89 172.57 116.33 168.83 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 23 3 # 23 A 248 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 270 LYS L 22 LYS~? 25.13 O2 GOL P3034 A 382 MET P 23 MET~? 25.42 O1 GOL L3028 coo -27.63 121.99 45.48 -26.66 123.86 45.68 163.49 162.78 223.08 162.21 161.15 223.46 coo -32.20 115.91 49.56 -31.37 121.03 53.12 171.60 164.44 217.42 177.37 164.59 214.60 coo -23.75 127.89 58.42 -26.02 128.79 55.12 162.53 176.78 217.61 162.78 172.89 216.17 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 24 3 # 24 A 248 ASP L 28 ASP~? 34.50 O1 GOL L3028 A 270 LYS L 22 LYS~? 25.13 O2 GOL P3034 A 382 MET P 26 MET~? 25.60 O1 GOL L3028 coo -27.63 121.99 45.48 -26.66 123.86 45.68 163.49 162.78 223.08 162.21 161.15 223.46 coo -32.20 115.91 49.56 -31.37 121.03 53.12 171.60 164.44 217.42 177.37 164.59 214.60 coo -23.75 127.89 58.42 -26.02 128.79 55.12 161.71 178.77 222.07 159.53 175.77 220.21 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 25 3 # 25 A 248 ASP M 28 ASP~? 15.52 CL CL I2001 A 270 LYS M 22 LYS~? 13.38 CL CL I2001 A 382 MET I 23 MET~? 5.34 CL CL I2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 170.27 223.20 174.57 168.89 223.83 176.08 coo -32.20 115.91 49.56 -31.37 121.03 53.12 177.61 216.43 173.42 182.96 212.88 173.24 coo -23.75 127.89 58.42 -26.02 128.79 55.12 168.54 218.05 161.26 168.72 216.49 165.05 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 26 3 # 26 A 248 ASP M 28 ASP~? 15.52 CL CL I2001 A 270 LYS M 22 LYS~? 13.38 CL CL I2001 A 382 MET I 24 MET~? 8.38 CL CL I2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 170.27 223.20 174.57 168.89 223.83 176.08 coo -32.20 115.91 49.56 -31.37 121.03 53.12 177.61 216.43 173.42 182.96 212.88 173.24 coo -23.75 127.89 58.42 -26.02 128.79 55.12 171.41 218.26 158.77 173.17 214.52 158.36 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 27 3 # 27 A 248 ASP M 28 ASP~? 15.52 CL CL I2001 A 270 LYS M 22 LYS~? 13.38 CL CL I2001 A 382 MET I 26 MET~? 11.40 CL CL I2001 coo -27.63 121.99 45.48 -26.66 123.86 45.68 170.27 223.20 174.57 168.89 223.83 176.08 coo -32.20 115.91 49.56 -31.37 121.03 53.12 177.61 216.43 173.42 182.96 212.88 173.24 coo -23.75 127.89 58.42 -26.02 128.79 55.12 168.31 222.67 159.35 165.73 221.05 162.19 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 28 3 # 28 A 248 ASP N 28 ASP~? 15.68 CL CL J2002 A 270 LYS N 22 LYS~? 13.40 CL CL J2002 A 382 MET J 23 MET~? 5.30 CL CL J2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 173.04 156.37 115.74 174.12 154.54 115.64 coo -32.20 115.91 49.56 -31.37 121.03 53.12 165.10 159.41 121.05 159.46 160.48 123.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 175.69 170.41 119.66 174.89 166.85 121.58 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 29 3 # 29 A 248 ASP N 28 ASP~? 15.68 CL CL J2002 A 270 LYS N 22 LYS~? 13.40 CL CL J2002 A 382 MET J 26 MET~? 11.18 CL CL J2002 coo -27.63 121.99 45.48 -26.66 123.86 45.68 173.04 156.37 115.74 174.12 154.54 115.64 coo -32.20 115.91 49.56 -31.37 121.03 53.12 165.10 159.41 121.05 159.46 160.48 123.77 coo -23.75 127.89 58.42 -26.02 128.79 55.12 176.68 171.74 115.04 178.54 168.76 117.27 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 30 3 # 30 A 248 ASP O 28 ASP~? 23.95 CL CL O2036 A 270 LYS O 22 LYS~? 17.69 O3 GOL K3010 A 382 MET K 23 MET~? 15.25 CL CL K2003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 164.72 114.57 162.31 163.52 114.24 160.62 coo -32.20 115.91 49.56 -31.37 121.03 53.12 172.63 120.27 164.76 178.18 123.25 165.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 162.15 120.06 176.02 162.86 121.49 172.15 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 31 3 # 31 A 248 ASP O 28 ASP~? 23.95 CL CL O2036 A 270 LYS O 22 LYS~? 17.69 O3 GOL K3010 A 382 MET K 26 MET~? 20.55 CL CL K2003 coo -27.63 121.99 45.48 -26.66 123.86 45.68 164.72 114.57 162.31 163.52 114.24 160.62 coo -32.20 115.91 49.56 -31.37 121.03 53.12 172.63 120.27 164.76 178.18 123.25 165.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 161.22 115.50 177.81 159.33 117.44 174.68 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 32 3 # 32 A 248 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 270 LYS P 22 LYS~? 16.49 O1 GOL L3028 A 382 MET L 23 MET~? 31.08 O1 GOL L3028 coo -27.63 121.99 45.48 -26.66 123.86 45.68 167.75 181.83 222.09 168.94 183.53 222.37 coo -32.20 115.91 49.56 -31.37 121.03 53.12 160.29 179.27 215.80 155.06 178.69 212.33 coo -23.75 127.89 58.42 -26.02 128.79 55.12 169.24 167.21 218.56 169.15 170.83 216.53 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 33 3 # 33 A 248 ASP P 28 ASP~? 33.76 O1 GOL L3028 A 270 LYS P 22 LYS~? 16.49 O1 GOL L3028 A 382 MET L 26 MET~? 30.87 O2 GOL P3034 coo -27.63 121.99 45.48 -26.66 123.86 45.68 167.75 181.83 222.09 168.94 183.53 222.37 coo -32.20 115.91 49.56 -31.37 121.03 53.12 160.29 179.27 215.80 155.06 178.69 212.33 coo -23.75 127.89 58.42 -26.02 128.79 55.12 169.49 165.91 223.32 171.82 168.60 221.24 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 33 hits 1pjq_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 144 GLN~? 18.34 O3 GOL A3037 294 GLU A 106 GLU~? 21.37 O1 GOL A3040 304 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 15.89 18.45 46.53 15.82 16.91 48.02 89.55 71.95 40.89 88.93 73.36 42.34 coo 22.84 13.44 52.91 20.84 13.18 52.38 86.09 78.56 33.43 88.06 78.13 34.12 coo 8.71 17.11 46.51 7.23 17.64 49.20 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 144 GLN~? 5.36 O1 GOL B3024 294 GLU B 106 GLU~? 14.28 O1 GOL B3024 304 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 15.89 18.45 46.53 15.82 16.91 48.02 25.23 67.97 25.00 25.82 66.20 23.96 coo 22.84 13.44 52.91 20.84 13.18 52.38 31.31 72.93 17.86 29.23 72.75 18.06 coo 8.71 17.11 46.51 7.23 17.64 49.20 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN C 144 GLN~? 12.42 O1 GOL C3036 294 GLU C 63 GLU~? 10.01 O3 GOL C3021 304 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 15.89 18.45 46.53 15.82 16.91 48.02 81.50 28.39 73.43 80.87 26.87 72.03 coo 22.84 13.44 52.91 20.84 13.18 52.38 74.66 28.22 62.99 76.28 27.57 61.69 coo 8.71 17.11 46.51 7.23 17.64 49.20 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN C 144 GLN~? 12.42 O1 GOL C3036 294 GLU C 106 GLU~? 19.79 O1 GOL C3036 304 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 15.89 18.45 46.53 15.82 16.91 48.02 81.50 28.39 73.43 80.87 26.87 72.03 coo 22.84 13.44 52.91 20.84 13.18 52.38 75.34 22.76 79.72 77.40 22.80 79.51 coo 8.71 17.11 46.51 7.23 17.64 49.20 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN D 144 GLN~? 17.30 O3 GOL D3019 294 GLU D 106 GLU~? 21.38 CL CL D2012 304 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 15.89 18.45 46.53 15.82 16.91 48.02 17.88 45.80 74.24 18.72 47.75 74.07 coo 22.84 13.44 52.91 20.84 13.18 52.38 21.11 39.74 82.39 19.19 40.22 81.74 coo 8.71 17.11 46.51 7.23 17.64 49.20 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN D 156 GLN.? -10.40 O2 GOL D3020s 294 GLU D 73 GLU~? 5.51 C2 GOL D3020 304 ARG D 155 ARG.? 13.82 O1 GOL D3020 coo 15.89 18.45 46.53 15.82 16.91 48.02 7.90 58.78 74.76 9.78 59.37 74.06 coo 22.84 13.44 52.91 20.84 13.18 52.38 12.99 58.17 82.26 12.31 59.24 83.94 coo 8.71 17.11 46.51 7.23 17.64 49.20 0.93 64.44 73.19 -0.93 62.13 72.64 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN E 144 GLN~? 13.80 O3 GOL E3002 294 GLU E 106 GLU~? 21.05 O1 GOL E3022 304 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 15.89 18.45 46.53 15.82 16.91 48.02 22.86 81.65 61.34 23.71 82.87 59.78 coo 22.84 13.44 52.91 20.84 13.18 52.38 27.90 88.73 67.36 25.90 88.59 66.70 coo 8.71 17.11 46.51 7.23 17.64 49.20 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN F 144 GLN~? 11.49 CL CL F2035 294 GLU F 106 GLU~? 12.79 CL CL F2035 304 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 15.89 18.45 46.53 15.82 16.91 48.02 86.06 33.92 35.15 85.92 35.17 33.44 coo 22.84 13.44 52.91 20.84 13.18 52.38 81.39 27.31 28.31 83.45 27.54 28.69 coo 8.71 17.11 46.51 7.23 17.64 49.20 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 9 3 # 9 111 GLN G 144 GLN~? 13.62 C3 GOL G3001 294 GLU G 106 GLU~? 21.38 C3 GOL G3001 304 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 15.89 18.45 46.53 15.82 16.91 48.02 20.40 31.78 38.43 20.75 30.54 40.14 coo 22.84 13.44 52.91 20.84 13.18 52.38 24.93 23.55 33.32 22.94 24.09 33.51 coo 8.71 17.11 46.51 7.23 17.64 49.20 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 10 3 # 10 111 GLN H 144 GLN~? 5.80 O2 GOL H3016 294 GLU H 106 GLU~? 14.51 O2 GOL H3016 304 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 15.89 18.45 46.53 15.82 16.91 48.02 84.54 66.68 78.81 83.66 65.46 80.38 coo 22.84 13.44 52.91 20.84 13.18 52.38 79.71 74.06 84.56 81.75 73.57 84.59 coo 8.71 17.11 46.51 7.23 17.64 49.20 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 11 3 # 11 111 GLN I 144 GLN~? 5.83 O1 GOL I3032 294 GLU I 106 GLU~? 14.47 O1 GOL I3032 304 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 15.89 18.45 46.53 15.82 16.91 48.02 203.35 189.41 155.57 202.68 190.98 156.90 coo 22.84 13.44 52.91 20.84 13.18 52.38 199.46 196.34 148.59 201.47 195.97 149.14 coo 8.71 17.11 46.51 7.23 17.64 49.20 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 12 3 # 12 111 GLN J 144 GLN~? 19.62 O1 GOL J3030 294 GLU J 106 GLU~? 21.26 CL CL J2016 304 ARG J 145 ARG~? 22.99 CL CL J2016 coo 15.89 18.45 46.53 15.82 16.91 48.02 138.83 183.31 142.69 139.42 181.74 141.36 coo 22.84 13.44 52.91 20.84 13.18 52.38 144.43 188.69 135.80 142.30 188.60 135.89 coo 8.71 17.11 46.51 7.23 17.64 49.20 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 13 3 # 13 111 GLN K 144 GLN~? 13.25 O3 GOL K3009 294 GLU K 106 GLU~? 21.15 O3 GOL K3009 304 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 15.89 18.45 46.53 15.82 16.91 48.02 198.77 144.45 186.07 198.16 143.26 184.38 coo 22.84 13.44 52.91 20.84 13.18 52.38 193.16 138.18 192.36 195.25 138.38 192.10 coo 8.71 17.11 46.51 7.23 17.64 49.20 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 14 3 # 14 111 GLN L 144 GLN~? 18.25 O3 GOL L3028 294 GLU L 106 GLU~? 21.37 CL CL L2009 304 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 15.89 18.45 46.53 15.82 16.91 48.02 134.07 157.87 191.59 134.72 159.48 192.82 coo 22.84 13.44 52.91 20.84 13.18 52.38 138.12 152.20 198.93 136.10 152.63 198.56 coo 8.71 17.11 46.51 7.23 17.64 49.20 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 15 3 # 15 111 GLN M 144 GLN~? 18.53 O3 GOL M3042 294 GLU M 106 GLU~? 21.48 CL CL M2017 304 ARG M 145 ARG~? 23.51 CL CL M2017 coo 15.89 18.45 46.53 15.82 16.91 48.02 137.26 195.03 179.49 137.97 196.37 178.00 coo 22.84 13.44 52.91 20.84 13.18 52.38 142.15 202.05 185.59 140.16 201.82 184.97 coo 8.71 17.11 46.51 7.23 17.64 49.20 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 16 3 # 16 111 GLN N 144 GLN~? 5.76 C1 GOL N3029 294 GLU N 106 GLU~? 14.62 O2 GOL N3029 304 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 15.89 18.45 46.53 15.82 16.91 48.02 201.39 151.74 148.20 201.01 153.17 146.62 coo 22.84 13.44 52.91 20.84 13.18 52.38 196.48 145.55 141.46 198.54 145.70 141.81 coo 8.71 17.11 46.51 7.23 17.64 49.20 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 17 3 # 17 111 GLN O 144 GLN~? 6.42 O3 GOL O3026 294 GLU O 106 GLU~? 13.74 CL CL O2036 304 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 15.89 18.45 46.53 15.82 16.91 48.02 136.08 146.43 154.31 136.54 145.45 156.17 coo 22.84 13.44 52.91 20.84 13.18 52.38 140.87 138.77 148.77 138.84 139.06 148.95 coo 8.71 17.11 46.51 7.23 17.64 49.20 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 18 3 # 18 111 GLN P 144 GLN~? 12.96 O3 GOL P3014 294 GLU P 106 GLU~? 20.67 O3 GOL P3014 304 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 15.89 18.45 46.53 15.82 16.91 48.02 200.41 182.40 193.61 199.53 181.01 194.99 coo 22.84 13.44 52.91 20.84 13.18 52.38 195.52 189.19 199.68 197.57 188.76 199.63 coo 8.71 17.11 46.51 7.23 17.64 49.20 206.30 185.90 191.05 208.78 186.92 189.45 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 18 hits 1pmi_c00 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU D 163 GLU~? 14.42 O1 GOL D3020 A 67 ARG D 155 ARG.? 13.82 O1 GOL D3020 A 86 HIS D 158 HIS.? 6.33 O1 GOL D3020 coo 18.15 3.28 18.56 20.10 2.92 19.20 0.62 54.76 72.61 1.16 56.78 72.68 coo 21.52 6.83 26.64 21.22 5.53 23.85 0.93 64.44 73.19 -0.93 62.13 72.64 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 0.86 62.48 80.06 1.83 63.91 81.27 1pyl_c00 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c00 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 68 ALA A 103 ALA.? 23.54 C1 GOL A3040 A 72 LEU A 110 LEU~? 18.41 C1 GOL A3040 coo 46.76 7.59 18.65 45.27 6.01 18.52 88.23 80.63 30.72 87.92 80.82 28.67 coo 48.88 4.35 16.59 48.73 5.09 15.20 85.79 84.63 30.26 86.09 85.81 29.49 coo 53.89 6.25 15.09 52.88 7.92 14.14 85.91 85.57 35.24 87.19 86.99 34.26 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 68 ALA A 135 ALA.? 20.01 CL CL A2020 A 72 LEU A 99 LEU.? 15.49 CL CL A2020 coo 46.76 7.59 18.65 45.27 6.01 18.52 88.23 80.63 30.72 87.92 80.82 28.67 coo 48.88 4.35 16.59 48.73 5.09 15.20 92.96 83.99 31.70 93.11 82.79 32.66 coo 53.89 6.25 15.09 52.88 7.92 14.14 96.68 83.55 35.29 98.87 83.52 34.86 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 68 ALA B 103 ALA.? 22.01 O1 GOL B3024 A 72 LEU B 110 LEU~? 17.71 O2 GOL B3024 coo 46.76 7.59 18.65 45.27 6.01 18.52 30.49 75.29 14.98 31.30 77.16 14.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 33.80 74.43 11.81 33.98 74.86 10.44 coo 53.89 6.25 15.09 52.88 7.92 14.14 32.43 69.41 11.82 31.60 70.11 9.92 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP C 102 ASP.? 24.57 CL CL C2011 A 68 ALA C 103 ALA.? 23.74 CL CL C2011 A 72 LEU C 110 LEU~? 19.25 CL CL C2011 coo 46.76 7.59 18.65 45.27 6.01 18.52 76.25 20.52 82.74 75.40 20.56 84.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 72.83 17.21 82.55 72.76 16.04 83.42 coo 53.89 6.25 15.09 52.88 7.92 14.14 74.12 15.92 77.70 74.61 14.19 78.82 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP D 102 ASP.? 24.32 CL CL D2012 A 68 ALA D 103 ALA.? 22.75 O3 GOL D3018 A 72 LEU D 110 LEU~? 18.05 O1 GOL D3018 coo 46.76 7.59 18.65 45.27 6.01 18.52 18.96 37.41 85.00 19.42 35.40 85.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 21.54 37.81 88.92 21.25 37.31 90.31 coo 53.89 6.25 15.09 52.88 7.92 14.14 21.44 42.80 88.88 20.14 42.16 90.54 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP D 102 ASP.? 24.32 CL CL D2012 A 68 ALA D 135 ALA.? 17.96 CL CL D2012 A 72 LEU D 99 LEU.? 13.98 CL CL D2012 coo 46.76 7.59 18.65 45.27 6.01 18.52 18.96 37.41 85.00 19.42 35.40 85.42 coo 48.88 4.35 16.59 48.73 5.09 15.20 14.36 39.19 88.01 14.38 39.77 86.62 coo 53.89 6.25 15.09 52.88 7.92 14.14 10.70 42.57 87.13 8.63 41.98 87.46 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP E 102 ASP.? 24.45 CL CL E2013 A 68 ALA E 103 ALA.? 22.77 O1 GOL E3022 A 72 LEU E 110 LEU~? 17.80 O1 GOL E3022 coo 46.76 7.59 18.65 45.27 6.01 18.52 26.42 91.49 69.61 27.08 91.68 71.63 coo 48.88 4.35 16.59 48.73 5.09 15.20 29.75 94.87 69.28 29.73 96.24 69.72 coo 53.89 6.25 15.09 52.88 7.92 14.14 29.73 94.82 64.20 29.03 96.70 64.87 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP E 102 ASP.? 24.45 CL CL E2013 A 68 ALA E 135 ALA.? 17.76 CL CL E2013 A 72 LEU E 99 LEU.? 14.23 CL CL E2013 coo 46.76 7.59 18.65 45.27 6.01 18.52 26.42 91.49 69.61 27.08 91.68 71.63 coo 48.88 4.35 16.59 48.73 5.09 15.20 22.68 95.82 67.83 22.19 94.52 67.17 coo 53.89 6.25 15.09 52.88 7.92 14.14 18.95 95.36 64.50 17.03 96.10 65.27 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP F 102 ASP.? 16.73 CL CL F2035 A 68 ALA F 103 ALA.? 17.16 CL CL F2035 A 72 LEU F 110 LEU~? 14.54 CL CL F2035 coo 46.76 7.59 18.65 45.27 6.01 18.52 82.74 24.28 26.35 81.91 22.30 26.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 80.38 24.48 22.19 80.56 23.71 20.93 coo 53.89 6.25 15.09 52.88 7.92 14.14 81.53 29.19 21.42 82.56 28.03 19.88 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP F 102 ASP.? 16.73 CL CL F2035 A 68 ALA F 135 ALA.? 17.61 CL CL F2034 A 72 LEU F 99 LEU.? 13.96 CL CL F2034 coo 46.76 7.59 18.65 45.27 6.01 18.52 82.74 24.28 26.35 81.91 22.30 26.35 coo 48.88 4.35 16.59 48.73 5.09 15.20 87.72 24.37 22.89 88.08 25.22 24.08 coo 53.89 6.25 15.09 52.88 7.92 14.14 92.01 27.08 23.54 93.77 25.78 23.40 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 68 ALA G 103 ALA.? 23.43 O3 GOL G3038 A 72 LEU G 110 LEU~? 18.36 O3 GOL G3038 coo 46.76 7.59 18.65 45.27 6.01 18.52 23.47 21.05 30.82 24.30 20.62 28.93 coo 48.88 4.35 16.59 48.73 5.09 15.20 25.93 17.13 31.78 25.80 15.78 31.20 coo 53.89 6.25 15.09 52.88 7.92 14.14 24.88 17.34 36.71 23.89 15.60 35.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 12 3 # 12 A 67 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 68 ALA G 135 ALA.? 19.98 C3 GOL G3038 A 72 LEU G 99 LEU.? 16.17 CL CL G2033 coo 46.76 7.59 18.65 45.27 6.01 18.52 23.47 21.05 30.82 24.30 20.62 28.93 coo 48.88 4.35 16.59 48.73 5.09 15.20 18.49 17.87 31.65 18.29 19.28 32.20 coo 53.89 6.25 15.09 52.88 7.92 14.14 14.23 19.01 34.29 12.19 18.63 33.49 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 13 3 # 13 A 67 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 68 ALA H 103 ALA.? 22.00 O2 GOL H3016 A 72 LEU H 110 LEU~? 18.30 O2 GOL H3016 coo 46.76 7.59 18.65 45.27 6.01 18.52 81.36 76.99 86.94 80.90 79.01 86.89 coo 48.88 4.35 16.59 48.73 5.09 15.20 78.03 77.34 90.28 78.09 78.05 91.59 coo 53.89 6.25 15.09 52.88 7.92 14.14 77.89 72.56 91.33 78.86 73.47 93.02 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 14 3 # 14 A 67 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 68 ALA H 135 ALA.? 17.80 CL CL H2014 A 72 LEU H 99 LEU.? 14.24 CL CL H2014 coo 46.76 7.59 18.65 45.27 6.01 18.52 81.36 76.99 86.94 80.90 79.01 86.89 coo 48.88 4.35 16.59 48.73 5.09 15.20 85.12 76.02 91.45 85.59 75.06 90.35 coo 53.89 6.25 15.09 52.88 7.92 14.14 88.74 72.63 91.84 90.81 73.32 92.17 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 15 3 # 15 A 67 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 68 ALA I 103 ALA.? 22.10 O1 GOL I3032 A 72 LEU I 110 LEU~? 17.73 O1 GOL I3031 coo 46.76 7.59 18.65 45.27 6.01 18.52 201.10 198.54 145.88 200.66 198.62 143.82 coo 48.88 4.35 16.59 48.73 5.09 15.20 198.53 202.47 145.78 198.83 203.71 144.96 coo 53.89 6.25 15.09 52.88 7.92 14.14 198.75 203.21 150.66 200.08 204.73 149.80 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 16 3 # 16 A 67 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 68 ALA I 135 ALA.? 17.77 CL CL I2015 A 72 LEU I 99 LEU.? 14.05 CL CL I2015 coo 46.76 7.59 18.65 45.27 6.01 18.52 201.10 198.54 145.88 200.66 198.62 143.82 coo 48.88 4.35 16.59 48.73 5.09 15.20 205.79 202.14 146.97 205.93 200.92 147.82 coo 53.89 6.25 15.09 52.88 7.92 14.14 209.53 201.81 150.19 211.63 201.97 149.59 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 17 3 # 17 A 67 ASP J 102 ASP.? 24.08 CL CL J2016 A 68 ALA J 103 ALA.? 22.78 O3 GOL J3030 A 72 LEU J 110 LEU~? 17.96 O1 GOL J3030 coo 46.76 7.59 18.65 45.27 6.01 18.52 143.25 191.36 132.98 143.80 193.32 132.63 coo 48.88 4.35 16.59 48.73 5.09 15.20 146.20 190.71 129.38 146.25 191.31 128.01 coo 53.89 6.25 15.09 52.88 7.92 14.14 145.43 185.75 129.18 144.50 186.56 127.41 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 18 3 # 18 A 67 ASP J 102 ASP.? 24.08 CL CL J2016 A 68 ALA J 135 ALA.? 17.65 CL CL J2016 A 72 LEU J 99 LEU.? 13.96 CL CL J2016 coo 46.76 7.59 18.65 45.27 6.01 18.52 143.25 191.36 132.98 143.80 193.32 132.63 coo 48.88 4.35 16.59 48.73 5.09 15.20 138.91 190.36 128.97 138.50 189.71 130.36 coo 53.89 6.25 15.09 52.88 7.92 14.14 134.68 187.63 129.42 132.80 188.60 128.96 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 19 3 # 19 A 67 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 68 ALA K 103 ALA.? 22.71 O1 GOL K3041 A 72 LEU K 110 LEU~? 18.09 O1 GOL K3041 coo 46.76 7.59 18.65 45.27 6.01 18.52 194.36 135.90 195.25 193.66 135.95 197.23 coo 48.88 4.35 16.59 48.73 5.09 15.20 191.37 132.16 195.10 191.41 130.94 195.93 coo 53.89 6.25 15.09 52.88 7.92 14.14 192.16 131.44 190.22 192.93 129.74 191.26 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 20 3 # 20 A 67 ASP L 102 ASP.? 24.59 CL CL L2009 A 68 ALA L 103 ALA.? 23.28 O1 GOL L3027 A 72 LEU L 110 LEU~? 17.85 O1 GOL L3027 coo 46.76 7.59 18.65 45.27 6.01 18.52 136.52 149.82 201.33 136.95 147.73 201.53 coo 48.88 4.35 16.59 48.73 5.09 15.20 139.05 149.94 205.30 138.69 149.21 206.51 coo 53.89 6.25 15.09 52.88 7.92 14.14 138.54 155.08 205.64 137.33 154.40 207.38 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 21 3 # 21 A 67 ASP M 102 ASP.? 24.52 CL CL M2017 A 68 ALA M 103 ALA.? 23.16 C1 GOL M3043 A 72 LEU M 110 LEU~? 18.24 C1 GOL M3043 coo 46.76 7.59 18.65 45.27 6.01 18.52 140.74 204.70 188.01 141.33 204.99 189.98 coo 48.88 4.35 16.59 48.73 5.09 15.20 143.77 208.24 187.66 143.68 209.57 188.29 coo 53.89 6.25 15.09 52.88 7.92 14.14 143.49 208.34 182.71 142.65 210.11 183.53 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 22 3 # 22 A 67 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 68 ALA N 103 ALA.? 21.96 O2 GOL N3029 A 72 LEU N 110 LEU~? 17.91 O2 GOL N3029 coo 46.76 7.59 18.65 45.27 6.01 18.52 197.96 142.41 139.19 197.06 140.46 139.09 coo 48.88 4.35 16.59 48.73 5.09 15.20 195.39 142.61 135.23 195.50 141.92 133.92 coo 53.89 6.25 15.09 52.88 7.92 14.14 196.19 147.56 134.49 197.22 146.48 132.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 23 3 # 23 A 67 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 68 ALA N 135 ALA.? 17.79 O2 GOL N3029 A 72 LEU N 99 LEU.? 16.24 CL CL N2030 coo 46.76 7.59 18.65 45.27 6.01 18.52 197.96 142.41 139.19 197.06 140.46 139.09 coo 48.88 4.35 16.59 48.73 5.09 15.20 202.74 142.87 135.54 203.09 143.71 136.74 coo 53.89 6.25 15.09 52.88 7.92 14.14 206.93 145.59 136.00 209.00 144.75 135.80 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 24 3 # 24 A 67 ASP O 102 ASP.? 13.16 CL CL O2036 A 68 ALA O 103 ALA.? 8.47 CL CL O2036 A 72 LEU O 110 LEU~? 6.15 CL CL O2036 coo 46.76 7.59 18.65 45.27 6.01 18.52 139.48 136.33 146.19 140.25 135.96 144.25 coo 48.88 4.35 16.59 48.73 5.09 15.20 141.96 132.42 146.77 141.81 131.11 146.18 coo 53.89 6.25 15.09 52.88 7.92 14.14 141.14 132.26 151.71 140.14 130.52 150.82 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 25 3 # 25 A 67 ASP O 102 ASP.? 13.16 CL CL O2036 A 68 ALA O 135 ALA.? 13.72 CL CL O2036 A 72 LEU O 99 LEU.? 14.37 CL CL O2018 coo 46.76 7.59 18.65 45.27 6.01 18.52 139.48 136.33 146.19 140.25 135.96 144.25 coo 48.88 4.35 16.59 48.73 5.09 15.20 134.59 132.69 147.05 134.19 133.97 147.77 coo 53.89 6.25 15.09 52.88 7.92 14.14 130.52 133.57 149.85 128.56 133.58 148.88 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 26 3 # 26 A 67 ASP P 102 ASP.? 24.26 CL CL P2019 A 68 ALA P 103 ALA.? 22.96 O2 GOL P3034 A 72 LEU P 110 LEU~? 17.88 O2 GOL P3034 coo 46.76 7.59 18.65 45.27 6.01 18.52 197.01 191.93 202.05 196.73 194.01 202.05 coo 48.88 4.35 16.59 48.73 5.09 15.20 193.97 192.06 205.68 194.07 192.84 206.95 coo 53.89 6.25 15.09 52.88 7.92 14.14 194.21 187.19 206.62 195.34 188.05 208.34 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 26 hits 1q6l_c05 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 581 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 713 ARG A 44 ARG~? 20.37 O3 GOL E3035 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 51.19 99.66 33.34 49.41 97.31 34.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 58.38 95.12 28.70 59.87 92.50 29.19 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 47.85 90.78 30.63 47.19 93.18 28.89 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 581 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 713 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 51.19 99.66 33.34 49.41 97.31 34.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 47.85 90.78 30.63 47.19 93.18 28.89 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 37 ARG~? 23.00 O3 GOL B3003 A 581 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 713 ARG A 44 ARG~? 20.37 O3 GOL E3035 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 58.38 95.12 28.70 59.87 92.50 29.19 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 51.19 99.66 33.34 49.41 97.31 34.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 47.85 90.78 30.63 47.19 93.18 28.89 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 44 ARG~? 20.37 O3 GOL E3035 A 581 ARG A 36 ARG~? 20.86 C3 GOL E3035 A 713 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 47.85 90.78 30.63 47.19 93.18 28.89 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 51.19 99.66 33.34 49.41 97.31 34.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG B 34 ARG~? 11.02 O1 GOL B3003 A 581 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 713 ARG B 36 ARG~? 18.74 O2 GOL B3003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 57.05 65.77 3.59 55.99 68.39 2.44 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 62.11 68.41 8.30 60.04 68.85 10.44 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 67.49 62.18 2.86 67.75 61.06 -0.01 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG B 37 ARG~? -4.23 C1 GOL B3003s A 581 ARG B 34 ARG~? 11.02 O1 GOL B3003 A 713 ARG B 36 ARG~? 18.74 O2 GOL B3003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 62.11 68.41 8.30 60.04 68.85 10.44 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 57.05 65.77 3.59 55.99 68.39 2.44 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 67.49 62.18 2.86 67.75 61.06 -0.01 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG C 34 ARG~? 20.14 CL CL C2004 A 581 ARG C 37 ARG~? -20.33 CL CL C2004s A 713 ARG C 36 ARG~? 17.12 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 49.42 6.75 74.39 49.90 6.28 77.46 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 44.35 12.06 77.77 46.44 14.26 77.62 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG C 36 ARG~? 17.12 CL CL C2004 A 581 ARG C 37 ARG~? -20.33 CL CL C2004s A 713 ARG C 44 ARG~? 23.41 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 37.77 8.89 71.79 36.83 11.19 70.06 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 44.35 12.06 77.77 46.44 14.26 77.62 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 35.63 18.34 73.64 34.17 16.13 75.21 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG C 36 ARG~? 17.12 CL CL C2004 A 581 ARG C 44 ARG~? 23.41 CL CL C2004 A 713 ARG C 37 ARG~? -20.33 CL CL C2004s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 37.77 8.89 71.79 36.83 11.19 70.06 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 35.63 18.34 73.64 34.17 16.13 75.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 34 ARG~? 20.14 CL CL C2004 A 713 ARG C 36 ARG~? 17.12 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 44.35 12.06 77.77 46.44 14.26 77.62 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 49.42 6.75 74.39 49.90 6.28 77.46 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG C 37 ARG~? -20.33 CL CL C2004s A 581 ARG C 36 ARG~? 17.12 CL CL C2004 A 713 ARG C 44 ARG~? 23.41 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 44.35 12.06 77.77 46.44 14.26 77.62 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 37.77 8.89 71.79 36.83 11.19 70.06 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 35.63 18.34 73.64 34.17 16.13 75.21 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG C 44 ARG~? 23.41 CL CL C2004 A 581 ARG C 36 ARG~? 17.12 CL CL C2004 A 713 ARG C 37 ARG~? -20.33 CL CL C2004s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 35.63 18.34 73.64 34.17 16.13 75.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 37.77 8.89 71.79 36.83 11.19 70.06 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 581 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 713 ARG D 44 ARG~? 13.53 C1 GOL D3005 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 55.93 43.64 102.74 57.91 43.73 100.41 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 48.82 38.28 99.42 47.22 38.23 96.82 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 59.28 39.14 94.57 59.93 38.01 97.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 34 ARG~? 12.13 O1 GOL D3005 A 713 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 48.82 38.28 99.42 47.22 38.23 96.82 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 43.70 43.25 103.08 42.03 40.72 103.99 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG D 37 ARG~? -4.25 O1 GOL D3005s A 581 ARG D 36 ARG~? 15.63 O1 GOL D3005 A 713 ARG D 44 ARG~? 13.53 C1 GOL D3005 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 48.82 38.28 99.42 47.22 38.23 96.82 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 55.93 43.64 102.74 57.91 43.73 100.41 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 59.28 39.14 94.57 59.93 38.01 97.32 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 581 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 713 ARG E 44 ARG~? 13.68 C1 GOL E3004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 66.28 100.73 63.79 67.89 98.12 63.67 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 58.59 99.11 69.23 56.48 96.91 69.19 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 67.85 92.14 68.56 69.19 94.64 69.74 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 581 ARG E 34 ARG~? 12.13 O1 GOL E3004 A 713 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 58.59 99.11 69.23 56.48 96.91 69.19 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 54.44 103.79 65.07 52.71 105.19 67.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG E 37 ARG~? -4.52 O1 GOL E3004s A 581 ARG E 36 ARG~? 16.00 C1 GOL E3004 A 713 ARG E 44 ARG~? 13.68 C1 GOL E3004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 58.59 99.11 69.23 56.48 96.91 69.19 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 66.28 100.73 63.79 67.89 98.12 63.67 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 67.85 92.14 68.56 69.19 94.64 69.74 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 581 ARG F 37 ARG~? -27.07 CL CL F2035s A 713 ARG F 44 ARG~? 19.46 O1 GOL B3017 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 47.43 34.56 6.90 45.82 36.16 8.95 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 53.50 28.70 11.30 55.02 28.89 13.93 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 43.53 32.70 15.75 42.58 31.25 13.24 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 581 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 713 ARG F 37 ARG~? -27.07 CL CL F2035s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 47.43 34.56 6.90 45.82 36.16 8.95 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 43.53 32.70 15.75 42.58 31.25 13.24 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG F 37 ARG~? -27.07 CL CL F2035s A 581 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 713 ARG F 44 ARG~? 19.46 O1 GOL B3017 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 53.50 28.70 11.30 55.02 28.89 13.93 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 47.43 34.56 6.90 45.82 36.16 8.95 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 43.53 32.70 15.75 42.58 31.25 13.24 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG F 44 ARG~? 19.46 O1 GOL B3017 A 581 ARG F 36 ARG~? 20.40 O1 GOL B3017 A 713 ARG F 37 ARG~? -27.07 CL CL F2035s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 43.53 32.70 15.75 42.58 31.25 13.24 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 47.43 34.56 6.90 45.82 36.16 8.95 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG G 34 ARG~? 20.84 CL CL C2004 A 581 ARG G 37 ARG~? 20.29 CL CL C2004 A 713 ARG G 36 ARG~? 19.13 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 46.76 3.66 41.28 45.52 3.22 38.51 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 52.62 7.45 38.03 50.95 9.97 37.63 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 57.05 1.30 44.33 57.17 -1.56 45.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG G 37 ARG~? 20.29 CL CL C2004 A 581 ARG G 34 ARG~? 20.84 CL CL C2004 A 713 ARG G 36 ARG~? 19.13 CL CL C2004 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 52.62 7.45 38.03 50.95 9.97 37.63 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 46.76 3.66 41.28 45.52 3.22 38.51 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 57.05 1.30 44.33 57.17 -1.56 45.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 25 3 # 25 A 396 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 581 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 713 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 53.27 74.94 100.30 54.87 77.69 100.34 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 49.12 78.88 94.88 51.18 78.27 92.74 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 26 3 # 26 A 396 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 581 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 713 ARG H 44 ARG~? 13.32 O2 GOL H3006 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 41.35 74.42 97.84 39.90 73.17 95.49 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 49.12 78.88 94.88 51.18 78.27 92.74 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 39.82 76.81 88.50 38.54 78.60 90.61 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 27 3 # 27 A 396 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 581 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 713 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 41.35 74.42 97.84 39.90 73.17 95.49 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 39.82 76.81 88.50 38.54 78.60 90.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 28 3 # 28 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 34 ARG~? 11.22 O3 GOL H3006 A 713 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 49.12 78.88 94.88 51.18 78.27 92.74 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 53.27 74.94 100.30 54.87 77.69 100.34 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 29 3 # 29 A 396 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 581 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 713 ARG H 44 ARG~? 13.32 O2 GOL H3006 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 49.12 78.88 94.88 51.18 78.27 92.74 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 41.35 74.42 97.84 39.90 73.17 95.49 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 39.82 76.81 88.50 38.54 78.60 90.61 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 30 3 # 30 A 396 ARG H 44 ARG~? 13.32 O2 GOL H3006 A 581 ARG H 36 ARG~? 15.68 C3 GOL H3006 A 713 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 39.82 76.81 88.50 38.54 78.60 90.61 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 41.35 74.42 97.84 39.90 73.17 95.49 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 31 3 # 31 A 396 ARG I 34 ARG~? 20.72 CL CL I2001 A 581 ARG I 37 ARG~? 20.23 CL CL I2001 A 713 ARG I 36 ARG~? 18.35 CL CL I2001 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 175.86 216.47 149.42 177.66 216.28 146.86 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 170.53 211.87 145.98 172.22 209.35 146.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 32 3 # 32 A 396 ARG I 36 ARG~? 18.35 CL CL I2001 A 581 ARG I 37 ARG~? 20.23 CL CL I2001 A 713 ARG I 44 ARG~? 23.41 CL CL I2001 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 163.77 216.28 151.02 161.75 213.99 150.84 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 170.53 211.87 145.98 172.22 209.35 146.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 160.24 207.09 148.05 159.51 209.54 146.34 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 33 3 # 33 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 34 ARG~? 20.72 CL CL I2001 A 713 ARG I 36 ARG~? 18.35 CL CL I2001 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 170.53 211.87 145.98 172.22 209.35 146.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 175.86 216.47 149.42 177.66 216.28 146.86 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 34 3 # 34 A 396 ARG I 37 ARG~? 20.23 CL CL I2001 A 581 ARG I 36 ARG~? 18.35 CL CL I2001 A 713 ARG I 44 ARG~? 23.41 CL CL I2001 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 170.53 211.87 145.98 172.22 209.35 146.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 163.77 216.28 151.02 161.75 213.99 150.84 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 160.24 207.09 148.05 159.51 209.54 146.34 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 35 3 # 35 A 396 ARG J 36 ARG~? 16.92 CL CL J2002 A 581 ARG J 37 ARG~? 20.17 CL CL J2002 A 713 ARG J 44 ARG~? 18.91 O3 GOL N3044 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 181.40 180.11 121.45 182.70 178.85 123.93 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 174.71 186.35 123.78 172.76 186.51 126.11 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 183.90 183.73 130.13 185.30 184.88 127.66 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 36 3 # 36 A 396 ARG J 36 ARG~? 16.92 CL CL J2002 A 581 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 713 ARG J 37 ARG~? 20.17 CL CL J2002 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 181.40 180.11 121.45 182.70 178.85 123.93 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 183.90 183.73 130.13 185.30 184.88 127.66 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 37 3 # 37 A 396 ARG J 37 ARG~? 20.17 CL CL J2002 A 581 ARG J 34 ARG~? 20.21 CL CL J2002 A 713 ARG J 36 ARG~? 16.92 CL CL J2002 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 174.71 186.35 123.78 172.76 186.51 126.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 169.79 183.14 118.82 167.66 185.29 119.35 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 38 3 # 38 A 396 ARG J 37 ARG~? 20.17 CL CL J2002 A 581 ARG J 36 ARG~? 16.92 CL CL J2002 A 713 ARG J 44 ARG~? 18.91 O3 GOL N3044 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 174.71 186.35 123.78 172.76 186.51 126.11 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 181.40 180.11 121.45 182.70 178.85 123.93 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 183.90 183.73 130.13 185.30 184.88 127.66 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 39 3 # 39 A 396 ARG J 44 ARG~? 18.91 O3 GOL N3044 A 581 ARG J 36 ARG~? 16.92 CL CL J2002 A 713 ARG J 37 ARG~? 20.17 CL CL J2002 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 183.90 183.73 130.13 185.30 184.88 127.66 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 181.40 180.11 121.45 182.70 178.85 123.93 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 40 3 # 40 A 396 ARG K 34 ARG~? 11.32 O1 GOL K3011 A 581 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 713 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 167.98 121.31 187.60 169.63 121.60 190.28 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 162.88 126.06 191.42 164.87 128.39 191.36 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 41 3 # 41 A 396 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 581 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 713 ARG K 44 ARG~? 13.27 C1 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 156.15 122.83 185.77 154.85 125.10 184.29 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 162.88 126.06 191.42 164.87 128.39 191.36 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 153.63 132.28 188.00 152.37 129.86 189.45 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 42 3 # 42 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 34 ARG~? 11.32 O1 GOL K3011 A 713 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 162.88 126.06 191.42 164.87 128.39 191.36 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 167.98 121.31 187.60 169.63 121.60 190.28 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 43 3 # 43 A 396 ARG K 37 ARG~? -4.30 O1 GOL K3011s A 581 ARG K 36 ARG~? 15.75 C1 GOL K3011 A 713 ARG K 44 ARG~? 13.27 C1 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 162.88 126.06 191.42 164.87 128.39 191.36 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 156.15 122.83 185.77 154.85 125.10 184.29 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 153.63 132.28 188.00 152.37 129.86 189.45 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 44 3 # 44 A 396 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 581 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 162.35 156.38 218.07 160.56 153.83 217.87 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 167.17 151.29 214.24 165.45 151.32 211.73 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 45 3 # 45 A 396 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 581 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 713 ARG L 44 ARG~? 26.02 O3 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 174.06 157.20 217.38 176.23 157.17 215.21 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 167.17 151.29 214.24 165.45 151.32 211.73 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 177.39 152.73 209.01 178.24 151.54 211.72 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 46 3 # 46 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 34 ARG~? 28.77 O3 GOL K3011 A 713 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 167.17 151.29 214.24 165.45 151.32 211.73 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 162.35 156.38 218.07 160.56 153.83 217.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 47 3 # 47 A 396 ARG L 37 ARG~? 22.34 O3 GOL K3011 A 581 ARG L 36 ARG~? 28.87 C1 GOL P3034 A 713 ARG L 44 ARG~? 26.02 O3 GOL K3011 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 167.17 151.29 214.24 165.45 151.32 211.73 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 174.06 157.20 217.38 176.23 157.17 215.21 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 177.39 152.73 209.01 178.24 151.54 211.72 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 48 3 # 48 A 396 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 581 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 713 ARG M 44 ARG~? 13.46 C1 GOL M3007 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 179.97 216.30 180.98 181.48 213.82 180.04 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 172.69 214.03 186.60 170.63 211.79 186.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 182.09 207.66 185.06 183.17 210.24 186.35 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 49 3 # 49 A 396 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 581 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 713 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 179.97 216.30 180.98 181.48 213.82 180.04 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 182.09 207.66 185.06 183.17 210.24 186.35 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 50 3 # 50 A 396 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 581 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 713 ARG M 44 ARG~? 13.46 C1 GOL M3007 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 172.69 214.03 186.60 170.63 211.79 186.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 179.97 216.30 180.98 181.48 213.82 180.04 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 182.09 207.66 185.06 183.17 210.24 186.35 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 51 3 # 51 A 396 ARG M 44 ARG~? 13.46 C1 GOL M3007 A 581 ARG M 36 ARG~? 16.07 O1 GOL M3007 A 713 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 182.09 207.66 185.06 183.17 210.24 186.35 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 179.97 216.30 180.98 181.48 213.82 180.04 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 52 3 # 52 A 396 ARG N 34 ARG~? 11.02 O3 GOL N3008 A 581 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 713 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 173.47 149.90 121.53 175.07 147.29 121.87 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 167.97 146.21 125.72 169.64 146.36 128.31 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 53 3 # 53 A 396 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 581 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 713 ARG N 44 ARG~? 12.62 O2 GOL N3008 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 161.60 152.07 121.93 160.06 153.41 124.19 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 167.97 146.21 125.72 169.64 146.36 128.31 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 157.97 149.49 130.76 157.12 148.00 128.25 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 54 3 # 54 A 396 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 581 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 713 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 161.60 152.07 121.93 160.06 153.41 124.19 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 157.97 149.49 130.76 157.12 148.00 128.25 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 55 3 # 55 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 34 ARG~? 11.02 O3 GOL N3008 A 713 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 167.97 146.21 125.72 169.64 146.36 128.31 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 173.47 149.90 121.53 175.07 147.29 121.87 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 56 3 # 56 A 396 ARG N 37 ARG~? -4.21 O3 GOL N3008s A 581 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 713 ARG N 44 ARG~? 12.62 O2 GOL N3008 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 167.97 146.21 125.72 169.64 146.36 128.31 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 161.60 152.07 121.93 160.06 153.41 124.19 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 157.97 149.49 130.76 157.12 148.00 128.25 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 57 3 # 57 A 396 ARG N 44 ARG~? 12.62 O2 GOL N3008 A 581 ARG N 36 ARG~? 15.62 C3 GOL N3008 A 713 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 157.97 149.49 130.76 157.12 148.00 128.25 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 161.60 152.07 121.93 160.06 153.41 124.19 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 58 3 # 58 A 396 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 581 ARG O 37 ARG~? 22.15 CL CL K2003 A 713 ARG O 44 ARG~? 19.56 O1 GOL K3010 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 175.82 120.47 157.52 177.72 122.75 158.28 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 169.49 123.46 151.21 167.81 125.99 151.08 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 179.51 128.71 153.87 180.36 126.03 152.63 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 59 3 # 59 A 396 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 581 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 713 ARG O 37 ARG~? 22.15 CL CL K2003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 175.82 120.47 157.52 177.72 122.75 158.28 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 179.51 128.71 153.87 180.36 126.03 152.63 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 60 3 # 60 A 396 ARG O 37 ARG~? 22.15 CL CL K2003 A 581 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 713 ARG O 44 ARG~? 19.56 O1 GOL K3010 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 169.49 123.46 151.21 167.81 125.99 151.08 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 175.82 120.47 157.52 177.72 122.75 158.28 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 179.51 128.71 153.87 180.36 126.03 152.63 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 61 3 # 61 A 396 ARG O 44 ARG~? 19.56 O1 GOL K3010 A 581 ARG O 36 ARG~? 19.89 O1 GOL K3010 A 713 ARG O 37 ARG~? 22.15 CL CL K2003 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 179.51 128.71 153.87 180.36 126.03 152.63 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 175.82 120.47 157.52 177.72 122.75 158.28 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 62 3 # 62 A 396 ARG P 34 ARG~? 27.86 O3 GOL M3007 A 581 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 713 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 169.45 187.34 216.38 171.34 189.81 216.30 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 165.27 191.94 211.53 167.28 191.57 209.25 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 63 3 # 63 A 396 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 581 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 713 ARG P 44 ARG~? 18.01 O1 GOL L3028 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 157.78 187.06 214.51 156.14 185.86 212.27 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 165.27 191.94 211.53 167.28 191.57 209.25 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 155.73 189.76 205.27 154.58 191.34 207.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 64 3 # 64 A 396 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 581 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 713 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 157.78 187.06 214.51 156.14 185.86 212.27 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 155.73 189.76 205.27 154.58 191.34 207.62 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 65 3 # 65 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 34 ARG~? 27.86 O3 GOL M3007 A 713 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 165.27 191.94 211.53 167.28 191.57 209.25 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 169.45 187.34 216.38 171.34 189.81 216.30 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 66 3 # 66 A 396 ARG P 37 ARG~? -21.37 O3 GOL M3007s A 581 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 713 ARG P 44 ARG~? 18.01 O1 GOL L3028 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 165.27 191.94 211.53 167.28 191.57 209.25 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 157.78 187.06 214.51 156.14 185.86 212.27 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 155.73 189.76 205.27 154.58 191.34 207.62 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 67 3 # 67 A 396 ARG P 44 ARG~? 18.01 O1 GOL L3028 A 581 ARG P 36 ARG~? 18.56 O1 GOL L3028 A 713 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 155.73 189.76 205.27 154.58 191.34 207.62 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 157.78 187.06 214.51 156.14 185.86 212.27 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 165.27 191.94 211.53 167.28 191.57 209.25 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 67 hits 1qb4_c01 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 83 SER~? 4.31 CL CL A2020 A 310 GLU A 93 GLU~? 8.07 CL CL A2020 A 399 HIS A 79 HIS~? -3.92 CL CL A2020s coo 2.67 37.96 55.23 1.78 40.01 56.16 109.33 86.01 47.44 108.27 87.28 49.22 coo 6.61 38.44 63.61 6.69 38.31 61.50 106.40 86.90 39.80 107.05 88.84 40.38 coo 4.95 41.82 59.53 3.85 40.70 58.14 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 81 SER~? 10.28 CL CL B2010 A 310 GLU B 93 GLU~? 9.70 CL CL B2010 A 399 HIS B 79 HIS~? 5.08 CL CL B2010 coo 2.67 37.96 55.23 1.78 40.01 56.16 8.58 59.85 12.91 9.44 59.08 15.03 coo 6.61 38.44 63.61 6.69 38.31 61.50 11.87 67.96 6.38 12.21 67.44 4.38 coo 4.95 41.82 59.53 3.85 40.70 58.14 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 3 3 # 3 A 189 SER B 83 SER~? 7.75 CL CL B2010 A 310 GLU B 93 GLU~? 9.70 CL CL B2010 A 399 HIS B 79 HIS~? 5.08 CL CL B2010 coo 2.67 37.96 55.23 1.78 40.01 56.16 7.70 61.77 7.67 8.73 59.61 7.20 coo 6.61 38.44 63.61 6.69 38.31 61.50 11.87 67.96 6.38 12.21 67.44 4.38 coo 4.95 41.82 59.53 3.85 40.70 58.14 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 4 3 # 4 A 189 SER C 81 SER~? 9.13 CL CL C2021 A 310 GLU C 93 GLU~? 8.05 CL CL C2021 A 399 HIS C 79 HIS~? -4.32 CL CL C2021s coo 2.67 37.96 55.23 1.78 40.01 56.16 97.80 14.60 67.87 97.00 16.56 66.71 coo 6.61 38.44 63.61 6.69 38.31 61.50 94.51 9.91 76.89 94.48 7.78 76.63 coo 4.95 41.82 59.53 3.85 40.70 58.14 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 5 3 # 5 A 189 SER C 83 SER~? 3.84 CL CL C2021 A 310 GLU C 93 GLU~? 8.05 CL CL C2021 A 399 HIS C 79 HIS~? -4.32 CL CL C2021s coo 2.67 37.96 55.23 1.78 40.01 56.16 99.03 9.95 70.83 97.44 9.06 69.22 coo 6.61 38.44 63.61 6.69 38.31 61.50 94.51 9.91 76.89 94.48 7.78 76.63 coo 4.95 41.82 59.53 3.85 40.70 58.14 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 6 3 # 6 A 189 SER D 81 SER~? 8.64 O1 GOL D3020 A 310 GLU D 93 GLU~? 8.23 CL CL D2022 A 399 HIS D 79 HIS~? -4.57 CL CL D2022s coo 2.67 37.96 55.23 1.78 40.01 56.16 0.59 56.62 82.32 2.14 57.19 80.58 coo 6.61 38.44 63.61 6.69 38.31 61.50 0.77 48.16 89.31 0.23 49.10 91.12 coo 4.95 41.82 59.53 3.85 40.70 58.14 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 7 3 # 7 A 189 SER D 83 SER~? 4.15 CL CL D2022 A 310 GLU D 93 GLU~? 8.23 CL CL D2022 A 399 HIS D 79 HIS~? -4.57 CL CL D2022s coo 2.67 37.96 55.23 1.78 40.01 56.16 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 6.61 38.44 63.61 6.69 38.31 61.50 0.77 48.16 89.31 0.23 49.10 91.12 coo 4.95 41.82 59.53 3.85 40.70 58.14 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 8 3 # 8 A 189 SER E 81 SER~? 9.10 CL CL E2032 A 310 GLU E 93 GLU~? 8.42 CL CL E2032 A 399 HIS E 79 HIS~? -4.18 CL CL E2032s coo 2.67 37.96 55.23 1.78 40.01 56.16 8.14 93.66 50.22 9.19 91.54 49.74 coo 6.61 38.44 63.61 6.69 38.31 61.50 9.96 100.16 58.92 10.04 102.16 58.24 coo 4.95 41.82 59.53 3.85 40.70 58.14 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 9 3 # 9 A 189 SER E 83 SER~? 3.98 CL CL E2032 A 310 GLU E 93 GLU~? 8.42 CL CL E2032 A 399 HIS E 79 HIS~? -4.18 CL CL E2032s coo 2.67 37.96 55.23 1.78 40.01 56.16 6.89 98.81 51.94 8.26 99.71 50.10 coo 6.61 38.44 63.61 6.69 38.31 61.50 9.96 100.16 58.92 10.04 102.16 58.24 coo 4.95 41.82 59.53 3.85 40.70 58.14 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 10 3 # 10 A 189 SER F 81 SER~? 9.12 CL CL F2023 A 310 GLU F 93 GLU~? 8.36 CL CL F2023 A 399 HIS F 79 HIS~? -4.63 CL CL F2023s coo 2.67 37.96 55.23 1.78 40.01 56.16 105.10 38.99 25.26 103.91 40.31 26.96 coo 6.61 38.44 63.61 6.69 38.31 61.50 102.94 29.85 20.29 103.30 29.96 18.20 coo 4.95 41.82 59.53 3.85 40.70 58.14 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 11 3 # 11 A 189 SER F 83 SER~? 4.14 CL CL F2023 A 310 GLU F 93 GLU~? 8.36 CL CL F2023 A 399 HIS F 79 HIS~? -4.63 CL CL F2023s coo 2.67 37.96 55.23 1.78 40.01 56.16 107.41 36.26 21.11 106.31 38.05 19.96 coo 6.61 38.44 63.61 6.69 38.31 61.50 102.94 29.85 20.29 103.30 29.96 18.20 coo 4.95 41.82 59.53 3.85 40.70 58.14 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 12 3 # 12 A 189 SER G 81 SER~? 9.39 CL CL G2033 A 310 GLU G 93 GLU~? 8.63 CL CL G2033 A 399 HIS G 79 HIS~? -4.46 CL CL G2033s coo 2.67 37.96 55.23 1.78 40.01 56.16 1.35 23.42 45.68 2.61 25.29 46.56 coo 6.61 38.44 63.61 6.69 38.31 61.50 3.64 16.49 37.62 3.03 14.55 38.23 coo 4.95 41.82 59.53 3.85 40.70 58.14 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 13 3 # 13 A 189 SER G 83 SER~? 4.16 CL CL G2033 A 310 GLU G 93 GLU~? 8.63 CL CL G2033 A 399 HIS G 79 HIS~? -4.46 CL CL G2033s coo 2.67 37.96 55.23 1.78 40.01 56.16 -0.88 18.73 43.69 0.20 17.85 45.68 coo 6.61 38.44 63.61 6.69 38.31 61.50 3.64 16.49 37.62 3.03 14.55 38.23 coo 4.95 41.82 59.53 3.85 40.70 58.14 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 14 3 # 14 A 189 SER H 81 SER~? 9.05 CL CL H2024 A 310 GLU H 93 GLU~? 8.72 CL CL H2024 A 399 HIS H 79 HIS~? 4.82 CL CL H2024 coo 2.67 37.96 55.23 1.78 40.01 56.16 99.24 58.01 93.04 98.20 57.10 91.00 coo 6.61 38.44 63.61 6.69 38.31 61.50 97.56 68.07 97.57 97.65 67.50 99.59 coo 4.95 41.82 59.53 3.85 40.70 58.14 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 15 3 # 15 A 189 SER H 83 SER~? 4.17 CL CL H2024 A 310 GLU H 93 GLU~? 8.72 CL CL H2024 A 399 HIS H 79 HIS~? 4.82 CL CL H2024 coo 2.67 37.96 55.23 1.78 40.01 56.16 100.86 60.76 97.52 99.44 59.04 98.47 coo 6.61 38.44 63.61 6.69 38.31 61.50 97.56 68.07 97.57 97.65 67.50 99.59 coo 4.95 41.82 59.53 3.85 40.70 58.14 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 16 3 # 16 A 189 SER I 81 SER~? 9.15 CL CL I2025 A 310 GLU I 93 GLU~? 8.40 CL CL I2025 A 399 HIS I 79 HIS~? -4.56 CL CL I2025s coo 2.67 37.96 55.23 1.78 40.01 56.16 220.47 200.38 164.21 219.13 198.61 165.10 coo 6.61 38.44 63.61 6.69 38.31 61.50 219.77 205.57 155.06 219.86 207.68 155.25 coo 4.95 41.82 59.53 3.85 40.70 58.14 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 17 3 # 17 A 189 SER I 83 SER~? 4.12 CL CL I2025 A 310 GLU I 93 GLU~? 8.40 CL CL I2025 A 399 HIS I 79 HIS~? -4.56 CL CL I2025s coo 2.67 37.96 55.23 1.78 40.01 56.16 222.83 204.85 161.89 221.39 205.66 163.52 coo 6.61 38.44 63.61 6.69 38.31 61.50 219.77 205.57 155.06 219.86 207.68 155.25 coo 4.95 41.82 59.53 3.85 40.70 58.14 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 18 3 # 18 A 189 SER J 81 SER~? 9.04 CL CL J2026 A 310 GLU J 93 GLU~? 8.18 CL CL J2026 A 399 HIS J 79 HIS~? -4.36 CL CL J2026s coo 2.67 37.96 55.23 1.78 40.01 56.16 121.87 175.35 131.02 122.76 174.32 132.99 coo 6.61 38.44 63.61 6.69 38.31 61.50 124.50 183.71 125.04 124.44 183.21 122.99 coo 4.95 41.82 59.53 3.85 40.70 58.14 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 19 3 # 19 A 189 SER J 83 SER~? 3.90 CL CL J2026 A 310 GLU J 93 GLU~? 8.18 CL CL J2026 A 399 HIS J 79 HIS~? -4.36 CL CL J2026s coo 2.67 37.96 55.23 1.78 40.01 56.16 120.35 177.35 126.19 121.76 175.49 125.60 coo 6.61 38.44 63.61 6.69 38.31 61.50 124.50 183.71 125.04 124.44 183.21 122.99 coo 4.95 41.82 59.53 3.85 40.70 58.14 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 20 3 # 20 A 189 SER K 81 SER~? 9.04 CL CL K2027 A 310 GLU K 93 GLU~? 8.22 CL CL K2027 A 399 HIS K 79 HIS~? -4.34 CL CL K2027s coo 2.67 37.96 55.23 1.78 40.01 56.16 215.63 131.69 179.58 214.60 133.54 178.42 coo 6.61 38.44 63.61 6.69 38.31 61.50 212.85 126.80 188.86 213.03 124.72 188.44 coo 4.95 41.82 59.53 3.85 40.70 58.14 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 21 3 # 21 A 189 SER K 83 SER~? 3.98 CL CL K2027 A 310 GLU K 93 GLU~? 8.22 CL CL K2027 A 399 HIS K 79 HIS~? -4.34 CL CL K2027s coo 2.67 37.96 55.23 1.78 40.01 56.16 216.96 127.03 182.22 215.88 126.06 180.30 coo 6.61 38.44 63.61 6.69 38.31 61.50 212.85 126.80 188.86 213.03 124.72 188.44 coo 4.95 41.82 59.53 3.85 40.70 58.14 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 22 3 # 22 A 189 SER L 81 SER~? 8.97 CL CL L2028 A 310 GLU L 93 GLU~? 8.05 CL CL L2028 A 399 HIS L 79 HIS~? -4.09 CL CL L2028s coo 2.67 37.96 55.23 1.78 40.01 56.16 117.25 168.62 201.10 118.49 169.09 199.06 coo 6.61 38.44 63.61 6.69 38.31 61.50 118.11 159.89 208.04 117.71 160.95 209.86 coo 4.95 41.82 59.53 3.85 40.70 58.14 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 23 3 # 23 A 189 SER L 83 SER~? 3.95 CL CL L2028 A 310 GLU L 93 GLU~? 8.05 CL CL L2028 A 399 HIS L 79 HIS~? -4.09 CL CL L2028s coo 2.67 37.96 55.23 1.78 40.01 56.16 115.00 167.12 206.00 116.47 168.85 206.74 coo 6.61 38.44 63.61 6.69 38.31 61.50 118.11 159.89 208.04 117.71 160.95 209.86 coo 4.95 41.82 59.53 3.85 40.70 58.14 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 24 3 # 24 A 189 SER M 81 SER~? 9.17 C1 GOL M3042 A 310 GLU M 93 GLU~? 8.60 CL CL M2029 A 399 HIS M 79 HIS~? -4.31 CL CL M2029s coo 2.67 37.96 55.23 1.78 40.01 56.16 121.49 206.79 169.24 122.66 204.72 168.74 coo 6.61 38.44 63.61 6.69 38.31 61.50 123.31 213.00 178.36 123.21 215.02 177.75 coo 4.95 41.82 59.53 3.85 40.70 58.14 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 25 3 # 25 A 189 SER M 83 SER~? 4.48 CL CL M2029 A 310 GLU M 93 GLU~? 8.60 CL CL M2029 A 399 HIS M 79 HIS~? -4.31 CL CL M2029s coo 2.67 37.96 55.23 1.78 40.01 56.16 119.79 211.86 171.05 121.18 212.22 169.09 coo 6.61 38.44 63.61 6.69 38.31 61.50 123.31 213.00 178.36 123.21 215.02 177.75 coo 4.95 41.82 59.53 3.85 40.70 58.14 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 26 3 # 26 A 189 SER N 81 SER~? 9.02 CL CL N2030 A 310 GLU N 93 GLU~? 8.57 CL CL N2030 A 399 HIS N 79 HIS~? -4.33 CL CL N2030s coo 2.67 37.96 55.23 1.78 40.01 56.16 219.66 158.05 137.54 218.33 159.17 139.26 coo 6.61 38.44 63.61 6.69 38.31 61.50 217.47 148.79 132.22 217.76 148.97 130.14 coo 4.95 41.82 59.53 3.85 40.70 58.14 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 27 3 # 27 A 189 SER N 83 SER~? 3.82 CL CL N2030 A 310 GLU N 93 GLU~? 8.57 CL CL N2030 A 399 HIS N 79 HIS~? -4.33 CL CL N2030s coo 2.67 37.96 55.23 1.78 40.01 56.16 221.50 155.10 133.13 220.51 157.01 132.05 coo 6.61 38.44 63.61 6.69 38.31 61.50 217.47 148.79 132.22 217.76 148.97 130.14 coo 4.95 41.82 59.53 3.85 40.70 58.14 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 28 3 # 28 A 189 SER O 81 SER~? 10.10 CL CL O2018 A 310 GLU O 93 GLU~? 9.72 CL CL O2018 A 399 HIS O 79 HIS~? 5.21 CL CL O2018 coo 2.67 37.96 55.23 1.78 40.01 56.16 117.95 136.60 162.36 119.18 138.53 163.10 coo 6.61 38.44 63.61 6.69 38.31 61.50 119.95 130.02 153.81 119.63 127.98 154.32 coo 4.95 41.82 59.53 3.85 40.70 58.14 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 29 3 # 29 A 189 SER O 83 SER~? 7.53 CL CL O2018 A 310 GLU O 93 GLU~? 9.72 CL CL O2018 A 399 HIS O 79 HIS~? 5.21 CL CL O2018 coo 2.67 37.96 55.23 1.78 40.01 56.16 115.90 131.94 160.39 117.13 130.87 162.21 coo 6.61 38.44 63.61 6.69 38.31 61.50 119.95 130.02 153.81 119.63 127.98 154.32 coo 4.95 41.82 59.53 3.85 40.70 58.14 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 30 3 # 30 A 189 SER P 81 SER~? 10.48 CL CL P2019 A 310 GLU P 93 GLU~? 9.65 CL CL P2019 A 399 HIS P 79 HIS~? 5.38 CL CL P2019 coo 2.67 37.96 55.23 1.78 40.01 56.16 216.34 173.84 206.20 215.26 172.77 204.29 coo 6.61 38.44 63.61 6.69 38.31 61.50 214.54 183.14 211.27 214.54 182.92 213.36 coo 4.95 41.82 59.53 3.85 40.70 58.14 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 31 3 # 31 A 189 SER P 83 SER~? 8.38 CL CL P2019 A 310 GLU P 93 GLU~? 9.65 CL CL P2019 A 399 HIS P 79 HIS~? 5.38 CL CL P2019 coo 2.67 37.96 55.23 1.78 40.01 56.16 218.12 176.21 210.92 216.94 174.20 211.47 coo 6.61 38.44 63.61 6.69 38.31 61.50 214.54 183.14 211.27 214.54 182.92 213.36 coo 4.95 41.82 59.53 3.85 40.70 58.14 212.25 178.47 210.26 213.09 179.27 212.01 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 31 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 A 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 55.45 46.76 42.08 57.34 46.16 42.75 106.32 81.43 56.18 105.60 83.26 56.91 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.44 78.16 48.76 91.65 76.94 50.06 coo 47.58 17.35 41.83 51.40 20.85 40.83 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 158 HIS.? 12.55 CL CL B2010 A 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 55.45 46.76 42.08 57.34 46.16 42.75 7.56 53.89 15.18 8.49 52.54 13.87 coo 48.87 29.19 44.63 49.10 27.34 43.63 23.66 59.02 20.34 21.93 58.32 21.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS C 158 HIS.? 10.62 CL CL C2021 A 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 55.45 46.76 42.08 57.34 46.16 42.75 98.99 15.14 61.83 98.04 13.53 60.88 coo 48.87 29.19 44.63 49.10 27.34 43.63 82.81 22.02 65.69 84.52 22.80 64.66 coo 47.58 17.35 41.83 51.40 20.85 40.83 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 A 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 55.45 46.76 42.08 57.34 46.16 42.75 0.86 62.48 80.06 1.83 63.91 81.27 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.94 54.59 79.01 15.65 55.42 77.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS E 158 HIS.? 10.67 CL CL E2032 A 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 55.45 46.76 42.08 57.34 46.16 42.75 8.21 91.93 44.16 9.29 93.32 43.02 coo 48.87 29.19 44.63 49.10 27.34 43.63 23.07 86.29 52.35 21.57 85.17 51.32 coo 47.58 17.35 41.83 51.40 20.85 40.83 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS F 158 HIS.? -10.90 CL CL F2023s A 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 55.45 46.76 42.08 57.34 46.16 42.75 105.92 45.34 26.29 105.13 46.33 24.62 coo 48.87 29.19 44.63 49.10 27.34 43.63 88.86 41.25 28.96 90.30 42.22 30.24 coo 47.58 17.35 41.83 51.40 20.85 40.83 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS G 158 HIS.? 10.64 CL CL G2033 A 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 55.45 46.76 42.08 57.34 46.16 42.75 0.65 25.49 51.61 1.26 23.82 52.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 17.70 27.34 47.09 16.19 28.71 47.73 coo 47.58 17.35 41.83 51.40 20.85 40.83 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS H 158 HIS.? 10.33 CL CL H2024 A 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 55.45 46.76 42.08 57.34 46.16 42.75 98.94 51.80 92.35 97.68 51.03 93.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 84.24 58.93 85.48 85.73 57.59 84.66 coo 47.58 17.35 41.83 51.40 20.85 40.83 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 155 HIS I 158 HIS.? 11.08 CL CL I2025 A 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 55.45 46.76 42.08 57.34 46.16 42.75 220.34 199.03 170.60 219.44 200.67 171.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 204.37 195.46 163.61 205.75 194.30 164.79 coo 47.58 17.35 41.83 51.40 20.85 40.83 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 A 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 55.45 46.76 42.08 57.34 46.16 42.75 121.18 169.23 132.79 122.06 167.98 131.35 coo 48.87 29.19 44.63 49.10 27.34 43.63 137.44 174.60 137.57 135.80 173.80 138.69 coo 47.58 17.35 41.83 51.40 20.85 40.83 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 155 HIS K 158 HIS.? 10.92 CL CL K2027 A 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 55.45 46.76 42.08 57.34 46.16 42.75 216.60 132.79 173.33 215.77 131.08 172.42 coo 48.87 29.19 44.63 49.10 27.34 43.63 200.17 138.24 178.11 201.77 139.28 177.19 coo 47.58 17.35 41.83 51.40 20.85 40.83 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 155 HIS L 158 HIS.? 11.11 CL CL L2028 A 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 55.45 46.76 42.08 57.34 46.16 42.75 117.45 174.63 198.96 118.55 176.04 200.05 coo 48.87 29.19 44.63 49.10 27.34 43.63 133.34 166.97 196.27 132.03 168.03 194.96 coo 47.58 17.35 41.83 51.40 20.85 40.83 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 A 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 55.45 46.76 42.08 57.34 46.16 42.75 121.40 205.18 163.43 122.55 206.46 162.23 coo 48.87 29.19 44.63 49.10 27.34 43.63 136.87 200.18 170.79 135.36 199.08 169.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 155 HIS N 158 HIS.? 10.50 CL CL N2030 A 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 55.45 46.76 42.08 57.34 46.16 42.75 220.32 164.11 138.58 219.66 165.01 136.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 203.51 159.51 142.26 205.02 160.53 143.48 coo 47.58 17.35 41.83 51.40 20.85 40.83 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 155 HIS O 158 HIS.? 12.21 CL CL O2018 A 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 55.45 46.76 42.08 57.34 46.16 42.75 117.44 138.41 168.51 118.31 136.96 169.75 coo 48.87 29.19 44.63 49.10 27.34 43.63 134.07 141.35 162.95 132.57 142.58 163.78 coo 47.58 17.35 41.83 51.40 20.85 40.83 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 A 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 55.45 46.76 42.08 57.34 46.16 42.75 216.29 167.50 205.15 215.20 166.66 206.73 coo 48.87 29.19 44.63 49.10 27.34 43.63 200.75 174.15 199.66 202.28 173.10 198.62 coo 47.58 17.35 41.83 51.40 20.85 40.83 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 B 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 106.32 81.43 56.18 105.60 83.26 56.91 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.44 78.16 48.76 91.65 76.94 50.06 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 158 HIS.? 12.55 CL CL B2010 B 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 7.56 53.89 15.18 8.49 52.54 13.87 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 23.66 59.02 20.34 21.93 58.32 21.38 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS C 158 HIS.? 10.62 CL CL C2021 B 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 98.99 15.14 61.83 98.04 13.53 60.88 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 82.81 22.02 65.69 84.52 22.80 64.66 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 0.86 62.48 80.06 1.83 63.91 81.27 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.94 54.59 79.01 15.65 55.42 77.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS E 158 HIS.? 10.67 CL CL E2032 B 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 8.21 91.93 44.16 9.29 93.32 43.02 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 23.07 86.29 52.35 21.57 85.17 51.32 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS F 158 HIS.? -10.90 CL CL F2023s B 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 105.92 45.34 26.29 105.13 46.33 24.62 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 88.86 41.25 28.96 90.30 42.22 30.24 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS G 158 HIS.? 10.64 CL CL G2033 B 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 0.65 25.49 51.61 1.26 23.82 52.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 17.70 27.34 47.09 16.19 28.71 47.73 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 155 HIS H 158 HIS.? 10.33 CL CL H2024 B 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 98.94 51.80 92.35 97.68 51.03 93.84 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 84.24 58.93 85.48 85.73 57.59 84.66 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 155 HIS I 158 HIS.? 11.08 CL CL I2025 B 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 220.34 199.03 170.60 219.44 200.67 171.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 204.37 195.46 163.61 205.75 194.30 164.79 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 B 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 121.18 169.23 132.79 122.06 167.98 131.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 137.44 174.60 137.57 135.80 173.80 138.69 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 155 HIS K 158 HIS.? 10.92 CL CL K2027 B 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 216.60 132.79 173.33 215.77 131.08 172.42 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 200.17 138.24 178.11 201.77 139.28 177.19 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 155 HIS L 158 HIS.? 11.11 CL CL L2028 B 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 117.45 174.63 198.96 118.55 176.04 200.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 133.34 166.97 196.27 132.03 168.03 194.96 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 B 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 121.40 205.18 163.43 122.55 206.46 162.23 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 136.87 200.18 170.79 135.36 199.08 169.77 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 155 HIS N 158 HIS.? 10.50 CL CL N2030 B 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 220.32 164.11 138.58 219.66 165.01 136.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 203.51 159.51 142.26 205.02 160.53 143.48 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 155 HIS O 158 HIS.? 12.21 CL CL O2018 B 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 117.44 138.41 168.51 118.31 136.96 169.75 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 134.07 141.35 162.95 132.57 142.58 163.78 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 B 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 216.29 167.50 205.15 215.20 166.66 206.73 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 200.75 174.15 199.66 202.28 173.10 198.62 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 C 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 55.11 47.10 12.61 53.44 47.85 11.58 106.32 81.43 56.18 105.60 83.26 56.91 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.44 78.16 48.76 91.65 76.94 50.06 coo 37.54 22.37 12.10 37.83 27.55 13.24 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 158 HIS.? 12.55 CL CL B2010 C 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 55.11 47.10 12.61 53.44 47.85 11.58 7.56 53.89 15.18 8.49 52.54 13.87 coo 45.78 31.11 9.51 44.25 30.06 10.53 23.66 59.02 20.34 21.93 58.32 21.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS C 158 HIS.? 10.62 CL CL C2021 C 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 55.11 47.10 12.61 53.44 47.85 11.58 98.99 15.14 61.83 98.04 13.53 60.88 coo 45.78 31.11 9.51 44.25 30.06 10.53 82.81 22.02 65.69 84.52 22.80 64.66 coo 37.54 22.37 12.10 37.83 27.55 13.24 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 C 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 55.11 47.10 12.61 53.44 47.85 11.58 0.86 62.48 80.06 1.83 63.91 81.27 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.94 54.59 79.01 15.65 55.42 77.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS E 158 HIS.? 10.67 CL CL E2032 C 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 55.11 47.10 12.61 53.44 47.85 11.58 8.21 91.93 44.16 9.29 93.32 43.02 coo 45.78 31.11 9.51 44.25 30.06 10.53 23.07 86.29 52.35 21.57 85.17 51.32 coo 37.54 22.37 12.10 37.83 27.55 13.24 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS F 158 HIS.? -10.90 CL CL F2023s C 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 55.11 47.10 12.61 53.44 47.85 11.58 105.92 45.34 26.29 105.13 46.33 24.62 coo 45.78 31.11 9.51 44.25 30.06 10.53 88.86 41.25 28.96 90.30 42.22 30.24 coo 37.54 22.37 12.10 37.83 27.55 13.24 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS G 158 HIS.? 10.64 CL CL G2033 C 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 55.11 47.10 12.61 53.44 47.85 11.58 0.65 25.49 51.61 1.26 23.82 52.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 17.70 27.34 47.09 16.19 28.71 47.73 coo 37.54 22.37 12.10 37.83 27.55 13.24 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS H 158 HIS.? 10.33 CL CL H2024 C 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 55.11 47.10 12.61 53.44 47.85 11.58 98.94 51.80 92.35 97.68 51.03 93.84 coo 45.78 31.11 9.51 44.25 30.06 10.53 84.24 58.93 85.48 85.73 57.59 84.66 coo 37.54 22.37 12.10 37.83 27.55 13.24 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 155 HIS I 158 HIS.? 11.08 CL CL I2025 C 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 55.11 47.10 12.61 53.44 47.85 11.58 220.34 199.03 170.60 219.44 200.67 171.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 204.37 195.46 163.61 205.75 194.30 164.79 coo 37.54 22.37 12.10 37.83 27.55 13.24 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 C 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 55.11 47.10 12.61 53.44 47.85 11.58 121.18 169.23 132.79 122.06 167.98 131.35 coo 45.78 31.11 9.51 44.25 30.06 10.53 137.44 174.60 137.57 135.80 173.80 138.69 coo 37.54 22.37 12.10 37.83 27.55 13.24 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 155 HIS K 158 HIS.? 10.92 CL CL K2027 C 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 55.11 47.10 12.61 53.44 47.85 11.58 216.60 132.79 173.33 215.77 131.08 172.42 coo 45.78 31.11 9.51 44.25 30.06 10.53 200.17 138.24 178.11 201.77 139.28 177.19 coo 37.54 22.37 12.10 37.83 27.55 13.24 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 155 HIS L 158 HIS.? 11.11 CL CL L2028 C 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 55.11 47.10 12.61 53.44 47.85 11.58 117.45 174.63 198.96 118.55 176.04 200.05 coo 45.78 31.11 9.51 44.25 30.06 10.53 133.34 166.97 196.27 132.03 168.03 194.96 coo 37.54 22.37 12.10 37.83 27.55 13.24 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 C 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 55.11 47.10 12.61 53.44 47.85 11.58 121.40 205.18 163.43 122.55 206.46 162.23 coo 45.78 31.11 9.51 44.25 30.06 10.53 136.87 200.18 170.79 135.36 199.08 169.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 155 HIS N 158 HIS.? 10.50 CL CL N2030 C 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 55.11 47.10 12.61 53.44 47.85 11.58 220.32 164.11 138.58 219.66 165.01 136.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 203.51 159.51 142.26 205.02 160.53 143.48 coo 37.54 22.37 12.10 37.83 27.55 13.24 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 155 HIS O 158 HIS.? 12.21 CL CL O2018 C 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 55.11 47.10 12.61 53.44 47.85 11.58 117.44 138.41 168.51 118.31 136.96 169.75 coo 45.78 31.11 9.51 44.25 30.06 10.53 134.07 141.35 162.95 132.57 142.58 163.78 coo 37.54 22.37 12.10 37.83 27.55 13.24 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 C 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 55.11 47.10 12.61 53.44 47.85 11.58 216.29 167.50 205.15 215.20 166.66 206.73 coo 45.78 31.11 9.51 44.25 30.06 10.53 200.75 174.15 199.66 202.28 173.10 198.62 coo 37.54 22.37 12.10 37.83 27.55 13.24 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 D 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 106.32 81.43 56.18 105.60 83.26 56.91 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.44 78.16 48.76 91.65 76.94 50.06 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 158 HIS.? 12.55 CL CL B2010 D 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 7.56 53.89 15.18 8.49 52.54 13.87 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 23.66 59.02 20.34 21.93 58.32 21.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS C 158 HIS.? 10.62 CL CL C2021 D 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 98.99 15.14 61.83 98.04 13.53 60.88 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 82.81 22.02 65.69 84.52 22.80 64.66 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 D 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 0.86 62.48 80.06 1.83 63.91 81.27 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.94 54.59 79.01 15.65 55.42 77.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS E 158 HIS.? 10.67 CL CL E2032 D 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 8.21 91.93 44.16 9.29 93.32 43.02 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 23.07 86.29 52.35 21.57 85.17 51.32 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS F 158 HIS.? -10.90 CL CL F2023s D 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 105.92 45.34 26.29 105.13 46.33 24.62 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 88.86 41.25 28.96 90.30 42.22 30.24 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS G 158 HIS.? 10.64 CL CL G2033 D 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 0.65 25.49 51.61 1.26 23.82 52.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 17.70 27.34 47.09 16.19 28.71 47.73 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS H 158 HIS.? 10.33 CL CL H2024 D 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 98.94 51.80 92.35 97.68 51.03 93.84 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 84.24 58.93 85.48 85.73 57.59 84.66 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 155 HIS I 158 HIS.? 11.08 CL CL I2025 D 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 220.34 199.03 170.60 219.44 200.67 171.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 204.37 195.46 163.61 205.75 194.30 164.79 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 D 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 121.18 169.23 132.79 122.06 167.98 131.35 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 137.44 174.60 137.57 135.80 173.80 138.69 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 155 HIS K 158 HIS.? 10.92 CL CL K2027 D 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 216.60 132.79 173.33 215.77 131.08 172.42 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 200.17 138.24 178.11 201.77 139.28 177.19 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 155 HIS L 158 HIS.? 11.11 CL CL L2028 D 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 117.45 174.63 198.96 118.55 176.04 200.05 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 133.34 166.97 196.27 132.03 168.03 194.96 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 D 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 121.40 205.18 163.43 122.55 206.46 162.23 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 136.87 200.18 170.79 135.36 199.08 169.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 155 HIS N 158 HIS.? 10.50 CL CL N2030 D 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 220.32 164.11 138.58 219.66 165.01 136.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 203.51 159.51 142.26 205.02 160.53 143.48 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 155 HIS O 158 HIS.? 12.21 CL CL O2018 D 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 117.44 138.41 168.51 118.31 136.96 169.75 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 134.07 141.35 162.95 132.57 142.58 163.78 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 D 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 216.29 167.50 205.15 215.20 166.66 206.73 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 200.75 174.15 199.66 202.28 173.10 198.62 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 E 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s E 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 106.32 81.43 56.18 105.60 83.26 56.91 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.44 78.16 48.76 91.65 76.94 50.06 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 158 HIS.? 12.55 CL CL B2010 E 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s E 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 7.56 53.89 15.18 8.49 52.54 13.87 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 23.66 59.02 20.34 21.93 58.32 21.38 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS C 158 HIS.? 10.62 CL CL C2021 E 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s E 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 98.99 15.14 61.83 98.04 13.53 60.88 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 82.81 22.02 65.69 84.52 22.80 64.66 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 E 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s E 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 0.86 62.48 80.06 1.83 63.91 81.27 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.94 54.59 79.01 15.65 55.42 77.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS E 158 HIS.? 10.67 CL CL E2032 E 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 E 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 8.21 91.93 44.16 9.29 93.32 43.02 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 23.07 86.29 52.35 21.57 85.17 51.32 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS F 158 HIS.? -10.90 CL CL F2023s E 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s E 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 105.92 45.34 26.29 105.13 46.33 24.62 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 88.86 41.25 28.96 90.30 42.22 30.24 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS G 158 HIS.? 10.64 CL CL G2033 E 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s E 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 0.65 25.49 51.61 1.26 23.82 52.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 17.70 27.34 47.09 16.19 28.71 47.73 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS H 158 HIS.? 10.33 CL CL H2024 E 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s E 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 98.94 51.80 92.35 97.68 51.03 93.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 84.24 58.93 85.48 85.73 57.59 84.66 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 155 HIS I 158 HIS.? 11.08 CL CL I2025 E 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s E 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 220.34 199.03 170.60 219.44 200.67 171.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 204.37 195.46 163.61 205.75 194.30 164.79 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 E 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 E 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 121.18 169.23 132.79 122.06 167.98 131.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 137.44 174.60 137.57 135.80 173.80 138.69 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 155 HIS K 158 HIS.? 10.92 CL CL K2027 E 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s E 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 216.60 132.79 173.33 215.77 131.08 172.42 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 200.17 138.24 178.11 201.77 139.28 177.19 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 155 HIS L 158 HIS.? 11.11 CL CL L2028 E 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s E 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 117.45 174.63 198.96 118.55 176.04 200.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 133.34 166.97 196.27 132.03 168.03 194.96 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 E 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s E 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 121.40 205.18 163.43 122.55 206.46 162.23 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 136.87 200.18 170.79 135.36 199.08 169.77 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 155 HIS N 158 HIS.? 10.50 CL CL N2030 E 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s E 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 220.32 164.11 138.58 219.66 165.01 136.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 203.51 159.51 142.26 205.02 160.53 143.48 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 155 HIS O 158 HIS.? 12.21 CL CL O2018 E 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s E 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 117.44 138.41 168.51 118.31 136.96 169.75 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 134.07 141.35 162.95 132.57 142.58 163.78 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 E 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 E 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 216.29 167.50 205.15 215.20 166.66 206.73 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 200.75 174.15 199.66 202.28 173.10 198.62 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 F 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s F 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 106.32 81.43 56.18 105.60 83.26 56.91 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.44 78.16 48.76 91.65 76.94 50.06 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 158 HIS.? 12.55 CL CL B2010 F 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s F 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 7.56 53.89 15.18 8.49 52.54 13.87 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 23.66 59.02 20.34 21.93 58.32 21.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS C 158 HIS.? 10.62 CL CL C2021 F 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s F 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 98.99 15.14 61.83 98.04 13.53 60.88 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 82.81 22.02 65.69 84.52 22.80 64.66 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 F 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s F 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 0.86 62.48 80.06 1.83 63.91 81.27 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.94 54.59 79.01 15.65 55.42 77.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS E 158 HIS.? 10.67 CL CL E2032 F 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 F 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 8.21 91.93 44.16 9.29 93.32 43.02 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 23.07 86.29 52.35 21.57 85.17 51.32 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS F 158 HIS.? -10.90 CL CL F2023s F 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s F 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 105.92 45.34 26.29 105.13 46.33 24.62 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 88.86 41.25 28.96 90.30 42.22 30.24 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS G 158 HIS.? 10.64 CL CL G2033 F 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s F 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 0.65 25.49 51.61 1.26 23.82 52.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 17.70 27.34 47.09 16.19 28.71 47.73 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS H 158 HIS.? 10.33 CL CL H2024 F 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s F 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 98.94 51.80 92.35 97.68 51.03 93.84 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 84.24 58.93 85.48 85.73 57.59 84.66 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 155 HIS I 158 HIS.? 11.08 CL CL I2025 F 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s F 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 220.34 199.03 170.60 219.44 200.67 171.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 204.37 195.46 163.61 205.75 194.30 164.79 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 F 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 F 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 121.18 169.23 132.79 122.06 167.98 131.35 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 137.44 174.60 137.57 135.80 173.80 138.69 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 155 HIS K 158 HIS.? 10.92 CL CL K2027 F 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s F 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 216.60 132.79 173.33 215.77 131.08 172.42 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 200.17 138.24 178.11 201.77 139.28 177.19 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 155 HIS L 158 HIS.? 11.11 CL CL L2028 F 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s F 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 117.45 174.63 198.96 118.55 176.04 200.05 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 133.34 166.97 196.27 132.03 168.03 194.96 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 F 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s F 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 121.40 205.18 163.43 122.55 206.46 162.23 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 136.87 200.18 170.79 135.36 199.08 169.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 155 HIS N 158 HIS.? 10.50 CL CL N2030 F 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s F 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 220.32 164.11 138.58 219.66 165.01 136.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 203.51 159.51 142.26 205.02 160.53 143.48 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 155 HIS O 158 HIS.? 12.21 CL CL O2018 F 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s F 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 117.44 138.41 168.51 118.31 136.96 169.75 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 134.07 141.35 162.95 132.57 142.58 163.78 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 F 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 F 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 216.29 167.50 205.15 215.20 166.66 206.73 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 200.75 174.15 199.66 202.28 173.10 198.62 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 G 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s G 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 106.32 81.43 56.18 105.60 83.26 56.91 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.44 78.16 48.76 91.65 76.94 50.06 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 158 HIS.? 12.55 CL CL B2010 G 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s G 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 7.56 53.89 15.18 8.49 52.54 13.87 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 23.66 59.02 20.34 21.93 58.32 21.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS C 158 HIS.? 10.62 CL CL C2021 G 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s G 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 98.99 15.14 61.83 98.04 13.53 60.88 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 82.81 22.02 65.69 84.52 22.80 64.66 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 G 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s G 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 0.86 62.48 80.06 1.83 63.91 81.27 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.94 54.59 79.01 15.65 55.42 77.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS E 158 HIS.? 10.67 CL CL E2032 G 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 G 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 8.21 91.93 44.16 9.29 93.32 43.02 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 23.07 86.29 52.35 21.57 85.17 51.32 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS F 158 HIS.? -10.90 CL CL F2023s G 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s G 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 105.92 45.34 26.29 105.13 46.33 24.62 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 88.86 41.25 28.96 90.30 42.22 30.24 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS G 158 HIS.? 10.64 CL CL G2033 G 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s G 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 0.65 25.49 51.61 1.26 23.82 52.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 17.70 27.34 47.09 16.19 28.71 47.73 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS H 158 HIS.? 10.33 CL CL H2024 G 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s G 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 98.94 51.80 92.35 97.68 51.03 93.84 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 84.24 58.93 85.48 85.73 57.59 84.66 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 155 HIS I 158 HIS.? 11.08 CL CL I2025 G 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s G 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 220.34 199.03 170.60 219.44 200.67 171.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 204.37 195.46 163.61 205.75 194.30 164.79 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 G 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 G 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 121.18 169.23 132.79 122.06 167.98 131.35 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 137.44 174.60 137.57 135.80 173.80 138.69 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 155 HIS K 158 HIS.? 10.92 CL CL K2027 G 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s G 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 216.60 132.79 173.33 215.77 131.08 172.42 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 200.17 138.24 178.11 201.77 139.28 177.19 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 155 HIS L 158 HIS.? 11.11 CL CL L2028 G 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s G 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 117.45 174.63 198.96 118.55 176.04 200.05 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 133.34 166.97 196.27 132.03 168.03 194.96 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 G 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s G 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 121.40 205.18 163.43 122.55 206.46 162.23 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 136.87 200.18 170.79 135.36 199.08 169.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 155 HIS N 158 HIS.? 10.50 CL CL N2030 G 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s G 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 220.32 164.11 138.58 219.66 165.01 136.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 203.51 159.51 142.26 205.02 160.53 143.48 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 155 HIS O 158 HIS.? 12.21 CL CL O2018 G 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s G 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 117.44 138.41 168.51 118.31 136.96 169.75 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 134.07 141.35 162.95 132.57 142.58 163.78 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 G 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 G 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 216.29 167.50 205.15 215.20 166.66 206.73 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 200.75 174.15 199.66 202.28 173.10 198.62 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 158 HIS.? 6.53 O1 GOL A3037 H 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s H 261 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 106.32 81.43 56.18 105.60 83.26 56.91 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.44 78.16 48.76 91.65 76.94 50.06 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 158 HIS.? 12.55 CL CL B2010 H 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s H 261 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 7.56 53.89 15.18 8.49 52.54 13.87 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 23.66 59.02 20.34 21.93 58.32 21.38 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS C 158 HIS.? 10.62 CL CL C2021 H 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s H 261 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 98.99 15.14 61.83 98.04 13.53 60.88 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 82.81 22.02 65.69 84.52 22.80 64.66 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS D 158 HIS.? 6.33 O1 GOL D3020 H 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s H 261 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 0.86 62.48 80.06 1.83 63.91 81.27 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.94 54.59 79.01 15.65 55.42 77.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS E 158 HIS.? 10.67 CL CL E2032 H 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 H 261 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 8.21 91.93 44.16 9.29 93.32 43.02 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 23.07 86.29 52.35 21.57 85.17 51.32 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS F 158 HIS.? -10.90 CL CL F2023s H 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s H 261 LYS F 61 LYS~? -5.82 CL CL F2035s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 105.92 45.34 26.29 105.13 46.33 24.62 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 88.86 41.25 28.96 90.30 42.22 30.24 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS G 158 HIS.? 10.64 CL CL G2033 H 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s H 261 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 0.65 25.49 51.61 1.26 23.82 52.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 17.70 27.34 47.09 16.19 28.71 47.73 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS H 158 HIS.? 10.33 CL CL H2024 H 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s H 261 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 98.94 51.80 92.35 97.68 51.03 93.84 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 84.24 58.93 85.48 85.73 57.59 84.66 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 155 HIS I 158 HIS.? 11.08 CL CL I2025 H 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s H 261 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 220.34 199.03 170.60 219.44 200.67 171.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 204.37 195.46 163.61 205.75 194.30 164.79 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 155 HIS J 158 HIS.? 7.50 O2 GOL J3033 H 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 H 261 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 121.18 169.23 132.79 122.06 167.98 131.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 137.44 174.60 137.57 135.80 173.80 138.69 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 155 HIS K 158 HIS.? 10.92 CL CL K2027 H 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s H 261 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 216.60 132.79 173.33 215.77 131.08 172.42 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 200.17 138.24 178.11 201.77 139.28 177.19 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 155 HIS L 158 HIS.? 11.11 CL CL L2028 H 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s H 261 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 117.45 174.63 198.96 118.55 176.04 200.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 133.34 166.97 196.27 132.03 168.03 194.96 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 155 HIS M 158 HIS.? 6.42 O1 GOL M3042 H 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s H 261 LYS M 61 LYS~? 24.74 CL CL I2007 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 121.40 205.18 163.43 122.55 206.46 162.23 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 136.87 200.18 170.79 135.36 199.08 169.77 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 155 HIS N 158 HIS.? 10.50 CL CL N2030 H 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s H 261 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 220.32 164.11 138.58 219.66 165.01 136.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 203.51 159.51 142.26 205.02 160.53 143.48 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 155 HIS O 158 HIS.? 12.21 CL CL O2018 H 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s H 261 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 117.44 138.41 168.51 118.31 136.96 169.75 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 134.07 141.35 162.95 132.57 142.58 163.78 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 H 155 HIS P 158 HIS.? 12.33 O2 GOL P3014 H 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 H 261 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 216.29 167.50 205.15 215.20 166.66 206.73 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 200.75 174.15 199.66 202.28 173.10 198.62 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 187.60 176.80 197.02 187.44 179.17 191.02 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 A 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 55.48 26.51 40.65 55.39 23.99 39.43 84.38 79.76 38.04 83.16 77.26 38.08 coo 48.87 29.19 44.63 49.10 27.34 43.63 88.23 80.63 30.72 87.92 80.82 28.67 coo 47.58 17.35 41.83 51.40 20.85 40.83 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 A 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 55.48 26.51 40.65 55.39 23.99 39.43 32.33 67.79 18.21 32.96 68.04 20.89 coo 48.87 29.19 44.63 49.10 27.34 43.63 30.49 75.29 14.98 31.30 77.16 14.42 coo 47.58 17.35 41.83 51.40 20.85 40.83 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 236 ASP C 102 ASP.? 24.57 CL CL C2011 A 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 55.48 26.51 40.65 55.39 23.99 39.43 74.32 21.96 74.78 73.58 24.65 74.54 coo 48.87 29.19 44.63 49.10 27.34 43.63 76.25 20.52 82.74 75.40 20.56 84.65 coo 47.58 17.35 41.83 51.40 20.85 40.83 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 A 236 ASP D 102 ASP.? 24.32 CL CL D2012 A 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 55.48 26.51 40.65 55.39 23.99 39.43 22.95 44.43 82.69 24.09 43.90 80.20 coo 48.87 29.19 44.63 49.10 27.34 43.63 18.96 37.41 85.00 19.42 35.40 85.42 coo 47.58 17.35 41.83 51.40 20.85 40.83 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 A 236 ASP E 102 ASP.? 24.45 CL CL E2013 A 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 55.48 26.51 40.65 55.39 23.99 39.43 29.73 88.43 62.54 30.41 85.74 63.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 26.42 91.49 69.61 27.08 91.68 71.63 coo 47.58 17.35 41.83 51.40 20.85 40.83 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR F 109 TYR~? 6.98 CL CL F2035 A 236 ASP F 102 ASP.? 16.73 CL CL F2035 A 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 55.48 26.51 40.65 55.39 23.99 39.43 80.57 32.26 27.20 79.31 32.54 29.65 coo 48.87 29.19 44.63 49.10 27.34 43.63 82.74 24.28 26.35 81.91 22.30 26.35 coo 47.58 17.35 41.83 51.40 20.85 40.83 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 A 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 55.48 26.51 40.65 55.39 23.99 39.43 25.80 23.55 38.48 27.03 26.02 38.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 23.47 21.05 30.82 24.30 20.62 28.93 coo 47.58 17.35 41.83 51.40 20.85 40.83 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 A 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 55.48 26.51 40.65 55.39 23.99 39.43 77.84 69.46 85.37 77.15 69.38 82.64 coo 48.87 29.19 44.63 49.10 27.34 43.63 81.36 76.99 86.94 80.90 79.01 86.89 coo 47.58 17.35 41.83 51.40 20.85 40.83 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 A 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 55.48 26.51 40.65 55.39 23.99 39.43 197.73 197.22 153.29 196.64 194.65 153.36 coo 48.87 29.19 44.63 49.10 27.34 43.63 201.10 198.54 145.88 200.66 198.62 143.82 coo 47.58 17.35 41.83 51.40 20.85 40.83 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 A 236 ASP J 102 ASP.? 24.08 CL CL J2016 A 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 55.48 26.51 40.65 55.39 23.99 39.43 145.48 183.77 135.57 146.27 183.96 138.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 143.25 191.36 132.98 143.80 193.32 132.63 coo 47.58 17.35 41.83 51.40 20.85 40.83 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 A 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 55.48 26.51 40.65 55.39 23.99 39.43 192.13 137.45 187.51 191.27 140.11 187.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 194.36 135.90 195.25 193.66 135.95 197.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 A 236 ASP L 102 ASP.? 24.59 CL CL L2009 A 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 55.48 26.51 40.65 55.39 23.99 39.43 139.89 156.88 199.30 141.02 156.55 196.75 coo 48.87 29.19 44.63 49.10 27.34 43.63 136.52 149.82 201.33 136.95 147.73 201.53 coo 47.58 17.35 41.83 51.40 20.85 40.83 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR M 75 TYR~? 10.36 CL CL M2017 A 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 55.48 26.51 40.65 55.39 23.99 39.43 130.62 206.12 176.17 130.27 204.76 178.58 coo 48.87 29.19 44.63 49.10 27.34 43.63 136.87 200.18 170.79 135.36 199.08 169.77 coo 47.58 17.35 41.83 51.40 20.85 40.83 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 A 236 ASP M 102 ASP.? 24.52 CL CL M2017 A 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 55.48 26.51 40.65 55.39 23.99 39.43 143.85 202.19 180.75 144.68 199.53 181.04 coo 48.87 29.19 44.63 49.10 27.34 43.63 140.74 204.70 188.01 141.33 204.99 189.98 coo 47.58 17.35 41.83 51.40 20.85 40.83 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 A 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 55.48 26.51 40.65 55.39 23.99 39.43 195.52 150.33 140.44 194.35 150.45 143.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 197.96 142.41 139.19 197.06 140.46 139.09 coo 47.58 17.35 41.83 51.40 20.85 40.83 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 163 TYR O 109 TYR~? 12.46 CL CL O2036 A 236 ASP O 102 ASP.? 13.16 CL CL O2036 A 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 55.48 26.51 40.65 55.39 23.99 39.43 141.96 138.45 153.78 143.09 141.01 153.60 coo 48.87 29.19 44.63 49.10 27.34 43.63 139.48 136.33 146.19 140.25 135.96 144.25 coo 47.58 17.35 41.83 51.40 20.85 40.83 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 A 236 ASP P 102 ASP.? 24.26 CL CL P2019 A 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 55.48 26.51 40.65 55.39 23.99 39.43 193.88 184.51 200.52 193.11 184.53 197.85 coo 48.87 29.19 44.63 49.10 27.34 43.63 197.01 191.93 202.05 196.73 194.01 202.05 coo 47.58 17.35 41.83 51.40 20.85 40.83 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 B 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 B 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 84.38 79.76 38.04 83.16 77.26 38.08 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 88.23 80.63 30.72 87.92 80.82 28.67 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 B 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 B 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 32.33 67.79 18.21 32.96 68.04 20.89 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 30.49 75.29 14.98 31.30 77.16 14.42 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 B 236 ASP C 102 ASP.? 24.57 CL CL C2011 B 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 74.32 21.96 74.78 73.58 24.65 74.54 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 76.25 20.52 82.74 75.40 20.56 84.65 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 B 236 ASP D 102 ASP.? 24.32 CL CL D2012 B 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 22.95 44.43 82.69 24.09 43.90 80.20 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 18.96 37.41 85.00 19.42 35.40 85.42 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 B 236 ASP E 102 ASP.? 24.45 CL CL E2013 B 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 29.73 88.43 62.54 30.41 85.74 63.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 26.42 91.49 69.61 27.08 91.68 71.63 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR F 109 TYR~? 6.98 CL CL F2035 B 236 ASP F 102 ASP.? 16.73 CL CL F2035 B 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 80.57 32.26 27.20 79.31 32.54 29.65 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 82.74 24.28 26.35 81.91 22.30 26.35 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 B 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 B 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 25.80 23.55 38.48 27.03 26.02 38.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 23.47 21.05 30.82 24.30 20.62 28.93 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 B 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 B 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 77.84 69.46 85.37 77.15 69.38 82.64 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 81.36 76.99 86.94 80.90 79.01 86.89 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 B 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 B 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 197.73 197.22 153.29 196.64 194.65 153.36 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 201.10 198.54 145.88 200.66 198.62 143.82 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 B 236 ASP J 102 ASP.? 24.08 CL CL J2016 B 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 145.48 183.77 135.57 146.27 183.96 138.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 143.25 191.36 132.98 143.80 193.32 132.63 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 B 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 B 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 192.13 137.45 187.51 191.27 140.11 187.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 194.36 135.90 195.25 193.66 135.95 197.23 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 B 236 ASP L 102 ASP.? 24.59 CL CL L2009 B 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 139.89 156.88 199.30 141.02 156.55 196.75 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 136.52 149.82 201.33 136.95 147.73 201.53 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 B 236 ASP M 102 ASP.? 24.52 CL CL M2017 B 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 143.85 202.19 180.75 144.68 199.53 181.04 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 140.74 204.70 188.01 141.33 204.99 189.98 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 B 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 B 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 195.52 150.33 140.44 194.35 150.45 143.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 197.96 142.41 139.19 197.06 140.46 139.09 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 163 TYR O 109 TYR~? 12.46 CL CL O2036 B 236 ASP O 102 ASP.? 13.16 CL CL O2036 B 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 141.96 138.45 153.78 143.09 141.01 153.60 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 139.48 136.33 146.19 140.25 135.96 144.25 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 B 236 ASP P 102 ASP.? 24.26 CL CL P2019 B 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 193.88 184.51 200.52 193.11 184.53 197.85 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 197.01 191.93 202.05 196.73 194.01 202.05 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 C 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 C 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 39.51 34.34 13.63 37.63 32.61 14.79 84.38 79.76 38.04 83.16 77.26 38.08 coo 45.78 31.11 9.51 44.25 30.06 10.53 88.23 80.63 30.72 87.92 80.82 28.67 coo 37.54 22.37 12.10 37.83 27.55 13.24 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 C 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 C 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 39.51 34.34 13.63 37.63 32.61 14.79 32.33 67.79 18.21 32.96 68.04 20.89 coo 45.78 31.11 9.51 44.25 30.06 10.53 30.49 75.29 14.98 31.30 77.16 14.42 coo 37.54 22.37 12.10 37.83 27.55 13.24 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 C 236 ASP C 102 ASP.? 24.57 CL CL C2011 C 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 39.51 34.34 13.63 37.63 32.61 14.79 74.32 21.96 74.78 73.58 24.65 74.54 coo 45.78 31.11 9.51 44.25 30.06 10.53 76.25 20.52 82.74 75.40 20.56 84.65 coo 37.54 22.37 12.10 37.83 27.55 13.24 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 C 236 ASP D 102 ASP.? 24.32 CL CL D2012 C 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 39.51 34.34 13.63 37.63 32.61 14.79 22.95 44.43 82.69 24.09 43.90 80.20 coo 45.78 31.11 9.51 44.25 30.06 10.53 18.96 37.41 85.00 19.42 35.40 85.42 coo 37.54 22.37 12.10 37.83 27.55 13.24 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 C 236 ASP E 102 ASP.? 24.45 CL CL E2013 C 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 39.51 34.34 13.63 37.63 32.61 14.79 29.73 88.43 62.54 30.41 85.74 63.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 26.42 91.49 69.61 27.08 91.68 71.63 coo 37.54 22.37 12.10 37.83 27.55 13.24 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR F 109 TYR~? 6.98 CL CL F2035 C 236 ASP F 102 ASP.? 16.73 CL CL F2035 C 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 39.51 34.34 13.63 37.63 32.61 14.79 80.57 32.26 27.20 79.31 32.54 29.65 coo 45.78 31.11 9.51 44.25 30.06 10.53 82.74 24.28 26.35 81.91 22.30 26.35 coo 37.54 22.37 12.10 37.83 27.55 13.24 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 C 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 C 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 39.51 34.34 13.63 37.63 32.61 14.79 25.80 23.55 38.48 27.03 26.02 38.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 23.47 21.05 30.82 24.30 20.62 28.93 coo 37.54 22.37 12.10 37.83 27.55 13.24 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 C 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 C 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 39.51 34.34 13.63 37.63 32.61 14.79 77.84 69.46 85.37 77.15 69.38 82.64 coo 45.78 31.11 9.51 44.25 30.06 10.53 81.36 76.99 86.94 80.90 79.01 86.89 coo 37.54 22.37 12.10 37.83 27.55 13.24 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 C 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 C 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 39.51 34.34 13.63 37.63 32.61 14.79 197.73 197.22 153.29 196.64 194.65 153.36 coo 45.78 31.11 9.51 44.25 30.06 10.53 201.10 198.54 145.88 200.66 198.62 143.82 coo 37.54 22.37 12.10 37.83 27.55 13.24 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 C 236 ASP J 102 ASP.? 24.08 CL CL J2016 C 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 39.51 34.34 13.63 37.63 32.61 14.79 145.48 183.77 135.57 146.27 183.96 138.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 143.25 191.36 132.98 143.80 193.32 132.63 coo 37.54 22.37 12.10 37.83 27.55 13.24 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 C 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 C 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 39.51 34.34 13.63 37.63 32.61 14.79 192.13 137.45 187.51 191.27 140.11 187.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 194.36 135.90 195.25 193.66 135.95 197.23 coo 37.54 22.37 12.10 37.83 27.55 13.24 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 C 236 ASP L 102 ASP.? 24.59 CL CL L2009 C 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 39.51 34.34 13.63 37.63 32.61 14.79 139.89 156.88 199.30 141.02 156.55 196.75 coo 45.78 31.11 9.51 44.25 30.06 10.53 136.52 149.82 201.33 136.95 147.73 201.53 coo 37.54 22.37 12.10 37.83 27.55 13.24 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 163 TYR M 75 TYR~? 10.36 CL CL M2017 C 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 39.51 34.34 13.63 37.63 32.61 14.79 130.62 206.12 176.17 130.27 204.76 178.58 coo 45.78 31.11 9.51 44.25 30.06 10.53 136.87 200.18 170.79 135.36 199.08 169.77 coo 37.54 22.37 12.10 37.83 27.55 13.24 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 C 236 ASP M 102 ASP.? 24.52 CL CL M2017 C 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 39.51 34.34 13.63 37.63 32.61 14.79 143.85 202.19 180.75 144.68 199.53 181.04 coo 45.78 31.11 9.51 44.25 30.06 10.53 140.74 204.70 188.01 141.33 204.99 189.98 coo 37.54 22.37 12.10 37.83 27.55 13.24 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 C 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 C 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 C 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 39.51 34.34 13.63 37.63 32.61 14.79 195.52 150.33 140.44 194.35 150.45 143.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 197.96 142.41 139.19 197.06 140.46 139.09 coo 37.54 22.37 12.10 37.83 27.55 13.24 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 C 163 TYR O 109 TYR~? 12.46 CL CL O2036 C 236 ASP O 102 ASP.? 13.16 CL CL O2036 C 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 39.51 34.34 13.63 37.63 32.61 14.79 141.96 138.45 153.78 143.09 141.01 153.60 coo 45.78 31.11 9.51 44.25 30.06 10.53 139.48 136.33 146.19 140.25 135.96 144.25 coo 37.54 22.37 12.10 37.83 27.55 13.24 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 C 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 C 236 ASP P 102 ASP.? 24.26 CL CL P2019 C 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 39.51 34.34 13.63 37.63 32.61 14.79 193.88 184.51 200.52 193.11 184.53 197.85 coo 45.78 31.11 9.51 44.25 30.06 10.53 197.01 191.93 202.05 196.73 194.01 202.05 coo 37.54 22.37 12.10 37.83 27.55 13.24 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 D 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 D 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 84.38 79.76 38.04 83.16 77.26 38.08 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 88.23 80.63 30.72 87.92 80.82 28.67 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 D 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 D 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 32.33 67.79 18.21 32.96 68.04 20.89 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 30.49 75.29 14.98 31.30 77.16 14.42 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 D 236 ASP C 102 ASP.? 24.57 CL CL C2011 D 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 74.32 21.96 74.78 73.58 24.65 74.54 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 76.25 20.52 82.74 75.40 20.56 84.65 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 D 236 ASP D 102 ASP.? 24.32 CL CL D2012 D 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 22.95 44.43 82.69 24.09 43.90 80.20 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 18.96 37.41 85.00 19.42 35.40 85.42 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 D 236 ASP E 102 ASP.? 24.45 CL CL E2013 D 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 29.73 88.43 62.54 30.41 85.74 63.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 26.42 91.49 69.61 27.08 91.68 71.63 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR F 109 TYR~? 6.98 CL CL F2035 D 236 ASP F 102 ASP.? 16.73 CL CL F2035 D 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 80.57 32.26 27.20 79.31 32.54 29.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 82.74 24.28 26.35 81.91 22.30 26.35 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 D 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 D 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 25.80 23.55 38.48 27.03 26.02 38.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 23.47 21.05 30.82 24.30 20.62 28.93 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 D 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 D 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 77.84 69.46 85.37 77.15 69.38 82.64 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 81.36 76.99 86.94 80.90 79.01 86.89 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 D 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 D 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 197.73 197.22 153.29 196.64 194.65 153.36 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 201.10 198.54 145.88 200.66 198.62 143.82 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 D 236 ASP J 102 ASP.? 24.08 CL CL J2016 D 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 145.48 183.77 135.57 146.27 183.96 138.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 143.25 191.36 132.98 143.80 193.32 132.63 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 D 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 D 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 192.13 137.45 187.51 191.27 140.11 187.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 194.36 135.90 195.25 193.66 135.95 197.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 D 236 ASP L 102 ASP.? 24.59 CL CL L2009 D 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 139.89 156.88 199.30 141.02 156.55 196.75 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 136.52 149.82 201.33 136.95 147.73 201.53 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 D 163 TYR M 75 TYR~? 10.36 CL CL M2017 D 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 130.62 206.12 176.17 130.27 204.76 178.58 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 136.87 200.18 170.79 135.36 199.08 169.77 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 D 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 D 236 ASP M 102 ASP.? 24.52 CL CL M2017 D 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 143.85 202.19 180.75 144.68 199.53 181.04 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 140.74 204.70 188.01 141.33 204.99 189.98 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 D 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 D 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 D 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 195.52 150.33 140.44 194.35 150.45 143.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 197.96 142.41 139.19 197.06 140.46 139.09 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 D 163 TYR O 109 TYR~? 12.46 CL CL O2036 D 236 ASP O 102 ASP.? 13.16 CL CL O2036 D 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 141.96 138.45 153.78 143.09 141.01 153.60 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 139.48 136.33 146.19 140.25 135.96 144.25 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 D 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 D 236 ASP P 102 ASP.? 24.26 CL CL P2019 D 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 193.88 184.51 200.52 193.11 184.53 197.85 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 197.01 191.93 202.05 196.73 194.01 202.05 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 E 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 E 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 84.38 79.76 38.04 83.16 77.26 38.08 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 88.23 80.63 30.72 87.92 80.82 28.67 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 E 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 E 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 32.33 67.79 18.21 32.96 68.04 20.89 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 30.49 75.29 14.98 31.30 77.16 14.42 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 E 236 ASP C 102 ASP.? 24.57 CL CL C2011 E 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 74.32 21.96 74.78 73.58 24.65 74.54 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 76.25 20.52 82.74 75.40 20.56 84.65 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 E 236 ASP D 102 ASP.? 24.32 CL CL D2012 E 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 22.95 44.43 82.69 24.09 43.90 80.20 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 18.96 37.41 85.00 19.42 35.40 85.42 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 E 236 ASP E 102 ASP.? 24.45 CL CL E2013 E 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 29.73 88.43 62.54 30.41 85.74 63.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 26.42 91.49 69.61 27.08 91.68 71.63 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR F 109 TYR~? 6.98 CL CL F2035 E 236 ASP F 102 ASP.? 16.73 CL CL F2035 E 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 80.57 32.26 27.20 79.31 32.54 29.65 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 82.74 24.28 26.35 81.91 22.30 26.35 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 E 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 E 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 25.80 23.55 38.48 27.03 26.02 38.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 23.47 21.05 30.82 24.30 20.62 28.93 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 E 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 E 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 77.84 69.46 85.37 77.15 69.38 82.64 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 81.36 76.99 86.94 80.90 79.01 86.89 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 E 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 E 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 197.73 197.22 153.29 196.64 194.65 153.36 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 201.10 198.54 145.88 200.66 198.62 143.82 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 E 236 ASP J 102 ASP.? 24.08 CL CL J2016 E 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 145.48 183.77 135.57 146.27 183.96 138.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 143.25 191.36 132.98 143.80 193.32 132.63 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 E 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 192.13 137.45 187.51 191.27 140.11 187.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 194.36 135.90 195.25 193.66 135.95 197.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 E 236 ASP L 102 ASP.? 24.59 CL CL L2009 E 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 139.89 156.88 199.30 141.02 156.55 196.75 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 136.52 149.82 201.33 136.95 147.73 201.53 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 236 ASP M 102 ASP.? 24.52 CL CL M2017 E 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 143.85 202.19 180.75 144.68 199.53 181.04 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 140.74 204.70 188.01 141.33 204.99 189.98 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 E 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 E 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 195.52 150.33 140.44 194.35 150.45 143.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 197.96 142.41 139.19 197.06 140.46 139.09 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 163 TYR O 109 TYR~? 12.46 CL CL O2036 E 236 ASP O 102 ASP.? 13.16 CL CL O2036 E 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 141.96 138.45 153.78 143.09 141.01 153.60 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 139.48 136.33 146.19 140.25 135.96 144.25 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 E 236 ASP P 102 ASP.? 24.26 CL CL P2019 E 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 193.88 184.51 200.52 193.11 184.53 197.85 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 197.01 191.93 202.05 196.73 194.01 202.05 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 F 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 F 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 84.38 79.76 38.04 83.16 77.26 38.08 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 88.23 80.63 30.72 87.92 80.82 28.67 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 F 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 F 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 32.33 67.79 18.21 32.96 68.04 20.89 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 30.49 75.29 14.98 31.30 77.16 14.42 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 F 236 ASP C 102 ASP.? 24.57 CL CL C2011 F 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 74.32 21.96 74.78 73.58 24.65 74.54 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 76.25 20.52 82.74 75.40 20.56 84.65 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 F 236 ASP D 102 ASP.? 24.32 CL CL D2012 F 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 22.95 44.43 82.69 24.09 43.90 80.20 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 18.96 37.41 85.00 19.42 35.40 85.42 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 F 236 ASP E 102 ASP.? 24.45 CL CL E2013 F 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 29.73 88.43 62.54 30.41 85.74 63.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 26.42 91.49 69.61 27.08 91.68 71.63 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR F 109 TYR~? 6.98 CL CL F2035 F 236 ASP F 102 ASP.? 16.73 CL CL F2035 F 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 80.57 32.26 27.20 79.31 32.54 29.65 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 82.74 24.28 26.35 81.91 22.30 26.35 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 F 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 F 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 25.80 23.55 38.48 27.03 26.02 38.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 23.47 21.05 30.82 24.30 20.62 28.93 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 F 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 F 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 77.84 69.46 85.37 77.15 69.38 82.64 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 81.36 76.99 86.94 80.90 79.01 86.89 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 F 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 F 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 197.73 197.22 153.29 196.64 194.65 153.36 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 201.10 198.54 145.88 200.66 198.62 143.82 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 F 236 ASP J 102 ASP.? 24.08 CL CL J2016 F 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 145.48 183.77 135.57 146.27 183.96 138.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 143.25 191.36 132.98 143.80 193.32 132.63 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 F 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 F 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 192.13 137.45 187.51 191.27 140.11 187.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 194.36 135.90 195.25 193.66 135.95 197.23 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 F 236 ASP L 102 ASP.? 24.59 CL CL L2009 F 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 139.89 156.88 199.30 141.02 156.55 196.75 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 136.52 149.82 201.33 136.95 147.73 201.53 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR M 75 TYR~? 10.36 CL CL M2017 F 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s F 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 130.62 206.12 176.17 130.27 204.76 178.58 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 136.87 200.18 170.79 135.36 199.08 169.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 F 236 ASP M 102 ASP.? 24.52 CL CL M2017 F 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 143.85 202.19 180.75 144.68 199.53 181.04 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 140.74 204.70 188.01 141.33 204.99 189.98 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 F 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 F 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 195.52 150.33 140.44 194.35 150.45 143.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 197.96 142.41 139.19 197.06 140.46 139.09 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 163 TYR O 109 TYR~? 12.46 CL CL O2036 F 236 ASP O 102 ASP.? 13.16 CL CL O2036 F 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 141.96 138.45 153.78 143.09 141.01 153.60 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 139.48 136.33 146.19 140.25 135.96 144.25 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 F 236 ASP P 102 ASP.? 24.26 CL CL P2019 F 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 193.88 184.51 200.52 193.11 184.53 197.85 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 197.01 191.93 202.05 196.73 194.01 202.05 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 G 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 G 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 84.38 79.76 38.04 83.16 77.26 38.08 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 88.23 80.63 30.72 87.92 80.82 28.67 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 G 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 G 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 32.33 67.79 18.21 32.96 68.04 20.89 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 30.49 75.29 14.98 31.30 77.16 14.42 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 G 236 ASP C 102 ASP.? 24.57 CL CL C2011 G 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 74.32 21.96 74.78 73.58 24.65 74.54 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 76.25 20.52 82.74 75.40 20.56 84.65 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 G 236 ASP D 102 ASP.? 24.32 CL CL D2012 G 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 22.95 44.43 82.69 24.09 43.90 80.20 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 18.96 37.41 85.00 19.42 35.40 85.42 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 G 236 ASP E 102 ASP.? 24.45 CL CL E2013 G 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 29.73 88.43 62.54 30.41 85.74 63.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 26.42 91.49 69.61 27.08 91.68 71.63 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR F 109 TYR~? 6.98 CL CL F2035 G 236 ASP F 102 ASP.? 16.73 CL CL F2035 G 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 80.57 32.26 27.20 79.31 32.54 29.65 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 82.74 24.28 26.35 81.91 22.30 26.35 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 G 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 G 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 25.80 23.55 38.48 27.03 26.02 38.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 23.47 21.05 30.82 24.30 20.62 28.93 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 G 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 G 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 77.84 69.46 85.37 77.15 69.38 82.64 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 81.36 76.99 86.94 80.90 79.01 86.89 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 G 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 G 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 197.73 197.22 153.29 196.64 194.65 153.36 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 201.10 198.54 145.88 200.66 198.62 143.82 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 G 236 ASP J 102 ASP.? 24.08 CL CL J2016 G 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 145.48 183.77 135.57 146.27 183.96 138.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 143.25 191.36 132.98 143.80 193.32 132.63 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 G 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 G 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 192.13 137.45 187.51 191.27 140.11 187.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 194.36 135.90 195.25 193.66 135.95 197.23 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 G 236 ASP L 102 ASP.? 24.59 CL CL L2009 G 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 139.89 156.88 199.30 141.02 156.55 196.75 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 136.52 149.82 201.33 136.95 147.73 201.53 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 163 TYR M 75 TYR~? 10.36 CL CL M2017 G 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s G 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 130.62 206.12 176.17 130.27 204.76 178.58 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 136.87 200.18 170.79 135.36 199.08 169.77 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 G 236 ASP M 102 ASP.? 24.52 CL CL M2017 G 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 143.85 202.19 180.75 144.68 199.53 181.04 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 140.74 204.70 188.01 141.33 204.99 189.98 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 G 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 G 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 G 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 195.52 150.33 140.44 194.35 150.45 143.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 197.96 142.41 139.19 197.06 140.46 139.09 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 G 163 TYR O 109 TYR~? 12.46 CL CL O2036 G 236 ASP O 102 ASP.? 13.16 CL CL O2036 G 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 141.96 138.45 153.78 143.09 141.01 153.60 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 139.48 136.33 146.19 140.25 135.96 144.25 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 G 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 G 236 ASP P 102 ASP.? 24.26 CL CL P2019 G 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 193.88 184.51 200.52 193.11 184.53 197.85 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 197.01 191.93 202.05 196.73 194.01 202.05 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 17 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 109 TYR~? 19.57 O1 GOL A3040 H 236 ASP A 102 ASP.? 25.18 C1 GOL A3040 H 261 LYS A 142 LYS~? 20.36 CL CL A2020 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 84.38 79.76 38.04 83.16 77.26 38.08 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 88.23 80.63 30.72 87.92 80.82 28.67 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 109 TYR~? 11.52 O1 GOL B3024 H 236 ASP B 102 ASP.? 20.31 O1 GOL B3024 H 261 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 32.33 67.79 18.21 32.96 68.04 20.89 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 30.49 75.29 14.98 31.30 77.16 14.42 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR C 109 TYR~? 17.83 O1 GOL C3036 H 236 ASP C 102 ASP.? 24.57 CL CL C2011 H 261 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 74.32 21.96 74.78 73.58 24.65 74.54 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 76.25 20.52 82.74 75.40 20.56 84.65 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR D 109 TYR~? 18.34 O3 GOL D3019 H 236 ASP D 102 ASP.? 24.32 CL CL D2012 H 261 LYS D 142 LYS~? 18.65 CL CL D2012 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 22.95 44.43 82.69 24.09 43.90 80.20 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 18.96 37.41 85.00 19.42 35.40 85.42 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR E 109 TYR~? 18.10 O1 GOL E3035 H 236 ASP E 102 ASP.? 24.45 CL CL E2013 H 261 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 29.73 88.43 62.54 30.41 85.74 63.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 26.42 91.49 69.61 27.08 91.68 71.63 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR F 109 TYR~? 6.98 CL CL F2035 H 236 ASP F 102 ASP.? 16.73 CL CL F2035 H 261 LYS F 142 LYS~? 19.20 CL CL F2034 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 80.57 32.26 27.20 79.31 32.54 29.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 82.74 24.28 26.35 81.91 22.30 26.35 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR G 109 TYR~? 19.47 O2 GOL G3001 H 236 ASP G 102 ASP.? 25.30 O3 GOL G3038 H 261 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 25.80 23.55 38.48 27.03 26.02 38.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 23.47 21.05 30.82 24.30 20.62 28.93 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR H 109 TYR~? 11.76 O2 GOL H3016 H 236 ASP H 102 ASP.? 20.45 O2 GOL H3016 H 261 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 77.84 69.46 85.37 77.15 69.38 82.64 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 81.36 76.99 86.94 80.90 79.01 86.89 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR I 109 TYR~? 11.79 O1 GOL I3032 H 236 ASP I 102 ASP.? 20.44 O1 GOL I3032 H 261 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 197.73 197.22 153.29 196.64 194.65 153.36 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 201.10 198.54 145.88 200.66 198.62 143.82 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 163 TYR J 109 TYR~? 19.91 O1 GOL J3030 H 236 ASP J 102 ASP.? 24.08 CL CL J2016 H 261 LYS J 142 LYS~? 19.62 CL CL J2016 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 145.48 183.77 135.57 146.27 183.96 138.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 143.25 191.36 132.98 143.80 193.32 132.63 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 163 TYR K 109 TYR~? 18.63 O3 GOL K3010 H 236 ASP K 102 ASP.? 24.81 O1 GOL K3041 H 261 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 192.13 137.45 187.51 191.27 140.11 187.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 194.36 135.90 195.25 193.66 135.95 197.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 163 TYR L 109 TYR~? 18.94 O3 GOL L3028 H 236 ASP L 102 ASP.? 24.59 CL CL L2009 H 261 LYS L 142 LYS~? 23.18 CL CL L2009 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 139.89 156.88 199.30 141.02 156.55 196.75 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 136.52 149.82 201.33 136.95 147.73 201.53 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 H 163 TYR M 109 TYR~? 20.13 O1 GOL M3043 H 236 ASP M 102 ASP.? 24.52 CL CL M2017 H 261 LYS M 142 LYS~? 19.90 CL CL M2017 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 143.85 202.19 180.75 144.68 199.53 181.04 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 140.74 204.70 188.01 141.33 204.99 189.98 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 H 163 TYR N 109 TYR~? 12.25 C2 GOL N3029 H 236 ASP N 102 ASP.? 20.60 O2 GOL N3029 H 261 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 195.52 150.33 140.44 194.35 150.45 143.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 197.96 142.41 139.19 197.06 140.46 139.09 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 H 163 TYR O 109 TYR~? 12.46 CL CL O2036 H 236 ASP O 102 ASP.? 13.16 CL CL O2036 H 261 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 141.96 138.45 153.78 143.09 141.01 153.60 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 139.48 136.33 146.19 140.25 135.96 144.25 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 H 163 TYR P 109 TYR~? 18.49 O3 GOL P3014 H 236 ASP P 102 ASP.? 24.26 CL CL P2019 H 261 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 193.88 184.51 200.52 193.11 184.53 197.85 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 197.01 191.93 202.05 196.73 194.01 202.05 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 204.59 186.28 195.60 209.96 186.96 196.62 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 16 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 C 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 C 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 39.01 29.77 22.02 37.48 31.30 19.84 51.19 99.66 33.34 49.41 97.31 34.21 coo 39.51 34.34 13.63 37.63 32.61 14.79 59.25 100.54 36.63 61.78 101.51 37.35 coo 45.78 31.11 9.51 44.25 30.06 10.53 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 C 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 C 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 39.01 29.77 22.02 37.48 31.30 19.84 58.38 95.12 28.70 59.87 92.50 29.19 coo 39.51 34.34 13.63 37.63 32.61 14.79 59.25 100.54 36.63 61.78 101.51 37.35 coo 45.78 31.11 9.51 44.25 30.06 10.53 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 C 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 C 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 39.01 29.77 22.02 37.48 31.30 19.84 94.33 67.29 39.79 97.00 65.79 39.32 coo 39.51 34.34 13.63 37.63 32.61 14.79 92.99 77.44 39.76 93.75 79.76 38.42 coo 45.78 31.11 9.51 44.25 30.06 10.53 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 C 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 C 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 39.01 29.77 22.02 37.48 31.30 19.84 19.64 71.23 27.64 22.06 69.48 28.42 coo 39.51 34.34 13.63 37.63 32.61 14.79 23.25 68.41 18.58 23.33 69.19 15.92 coo 45.78 31.11 9.51 44.25 30.06 10.53 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG C 36 ARG~? 17.12 CL CL C2004 C 163 TYR C 35 TYR~? 12.95 CL CL C2004 C 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 39.01 29.77 22.02 37.48 31.30 19.84 37.77 8.89 71.79 36.83 11.19 70.06 coo 39.51 34.34 13.63 37.63 32.61 14.79 45.94 6.51 69.90 48.30 5.07 69.65 coo 45.78 31.11 9.51 44.25 30.06 10.53 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG C 37 ARG~? -20.33 CL CL C2004s C 163 TYR C 35 TYR~? 12.95 CL CL C2004 C 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 39.01 29.77 22.02 37.48 31.30 19.84 44.35 12.06 77.77 46.44 14.26 77.62 coo 39.51 34.34 13.63 37.63 32.61 14.79 45.94 6.51 69.90 48.30 5.07 69.65 coo 45.78 31.11 9.51 44.25 30.06 10.53 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG C 95 ARG~? 15.71 CL CL C2031 C 163 TYR C 75 TYR~? 10.50 CL CL C2011 C 236 ASP C 127 ASP.? 10.87 CL CL C2011 coo 39.01 29.77 22.02 37.48 31.30 19.84 94.96 18.62 81.47 95.21 21.64 80.86 coo 39.51 34.34 13.63 37.63 32.61 14.79 87.86 16.77 72.91 87.86 18.43 75.14 coo 45.78 31.11 9.51 44.25 30.06 10.53 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 C 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 C 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 39.01 29.77 22.02 37.48 31.30 19.84 85.99 31.07 76.22 83.80 32.01 74.28 coo 39.51 34.34 13.63 37.63 32.61 14.79 83.34 22.31 75.20 83.28 19.92 76.54 coo 45.78 31.11 9.51 44.25 30.06 10.53 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 C 163 TYR D 35 TYR~? 13.02 CL CL H2005 C 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 39.01 29.77 22.02 37.48 31.30 19.84 55.93 43.64 102.74 57.91 43.73 100.41 coo 39.51 34.34 13.63 37.63 32.61 14.79 48.27 47.24 102.95 45.77 48.18 103.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s C 163 TYR D 35 TYR~? 13.02 CL CL H2005 C 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 39.01 29.77 22.02 37.48 31.30 19.84 48.82 38.28 99.42 47.22 38.23 96.82 coo 39.51 34.34 13.63 37.63 32.61 14.79 48.27 47.24 102.95 45.77 48.18 103.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 C 163 TYR D 143 TYR~? 15.16 CL CL D2012 C 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 39.01 29.77 22.02 37.48 31.30 19.84 12.08 41.78 71.45 11.86 39.69 73.74 coo 39.51 34.34 13.63 37.63 32.61 14.79 14.34 45.54 80.17 13.57 44.79 82.74 coo 45.78 31.11 9.51 44.25 30.06 10.53 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 C 163 TYR E 143 TYR~? 15.23 CL CL E2013 C 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 39.01 29.77 22.02 37.48 31.30 19.84 16.30 80.38 65.14 17.26 82.53 67.17 coo 39.51 34.34 13.63 37.63 32.61 14.79 20.79 87.99 61.33 20.74 90.64 62.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 C 163 TYR F 35 TYR~? 30.41 CL CL F2035 C 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 39.01 29.77 22.02 37.48 31.30 19.84 47.43 34.56 6.90 45.82 36.16 8.95 coo 39.51 34.34 13.63 37.63 32.61 14.79 55.89 36.47 6.05 58.49 36.69 5.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 110 ARG F 37 ARG~? -27.07 CL CL F2035s C 163 TYR F 35 TYR~? 30.41 CL CL F2035 C 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 39.01 29.77 22.02 37.48 31.30 19.84 53.50 28.70 11.30 55.02 28.89 13.93 coo 39.51 34.34 13.63 37.63 32.61 14.79 55.89 36.47 6.05 58.49 36.69 5.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 110 ARG F 95 ARG~? 18.18 CL CL F2034 C 163 TYR F 75 TYR~? 9.99 CL CL F2034 C 236 ASP F 127 ASP.? 10.85 CL CL F2034 coo 39.01 29.77 22.02 37.48 31.30 19.84 101.23 25.44 29.03 100.92 26.10 32.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 95.01 33.97 25.26 94.64 31.83 27.03 coo 45.78 31.11 9.51 44.25 30.06 10.53 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 C 163 TYR F 143 TYR~? 15.09 CL CL F2034 C 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 39.01 29.77 22.02 37.48 31.30 19.84 91.49 29.42 38.83 93.62 28.28 40.76 coo 39.51 34.34 13.63 37.63 32.61 14.79 89.42 31.84 29.55 89.79 30.44 27.17 coo 45.78 31.11 9.51 44.25 30.06 10.53 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 110 ARG G 37 ARG~? 20.29 CL CL C2004 C 163 TYR G 35 TYR~? 13.11 CL CL C2004 C 236 ASP G 28 ASP~? 15.85 CL CL C2004 coo 39.01 29.77 22.02 37.48 31.30 19.84 52.62 7.45 38.03 50.95 9.97 37.63 coo 39.51 34.34 13.63 37.63 32.61 14.79 50.35 3.70 46.66 47.74 2.77 47.00 coo 45.78 31.11 9.51 44.25 30.06 10.53 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 C 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 C 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 39.01 29.77 22.02 37.48 31.30 19.84 15.17 34.68 33.42 15.78 32.53 31.28 coo 39.51 34.34 13.63 37.63 32.61 14.79 16.97 25.90 37.77 16.51 23.33 36.84 coo 45.78 31.11 9.51 44.25 30.06 10.53 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 A 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 C 163 TYR H 35 TYR~? 13.05 CL CL H2005 C 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 39.01 29.77 22.02 37.48 31.30 19.84 41.35 74.42 97.84 39.90 73.17 95.49 coo 39.51 34.34 13.63 37.63 32.61 14.79 48.71 70.98 100.43 50.94 70.32 101.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 A 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s C 163 TYR H 35 TYR~? 13.05 CL CL H2005 C 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 39.01 29.77 22.02 37.48 31.30 19.84 49.12 78.88 94.88 51.18 78.27 92.74 coo 39.51 34.34 13.63 37.63 32.61 14.79 48.71 70.98 100.43 50.94 70.32 101.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 A 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 C 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 C 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 39.01 29.77 22.02 37.48 31.30 19.84 91.20 69.90 76.54 91.87 72.67 77.80 coo 39.51 34.34 13.63 37.63 32.61 14.79 86.77 67.99 85.16 86.88 69.36 87.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 A 110 ARG I 36 ARG~? 18.35 CL CL I2001 C 163 TYR I 35 TYR~? 13.03 CL CL I2001 C 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 163.77 216.28 151.02 161.75 213.99 150.84 coo 39.51 34.34 13.63 37.63 32.61 14.79 171.46 216.91 154.12 173.98 218.04 154.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 A 110 ARG I 37 ARG~? 20.23 CL CL I2001 C 163 TYR I 35 TYR~? 13.03 CL CL I2001 C 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 170.53 211.87 145.98 172.22 209.35 146.21 coo 39.51 34.34 13.63 37.63 32.61 14.79 171.46 216.91 154.12 173.98 218.04 154.69 coo 45.78 31.11 9.51 44.25 30.06 10.53 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 A 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 C 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 C 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 39.01 29.77 22.02 37.48 31.30 19.84 209.45 186.59 151.83 209.12 188.26 149.20 coo 39.51 34.34 13.63 37.63 32.61 14.79 206.55 195.37 154.41 207.09 197.83 153.23 coo 45.78 31.11 9.51 44.25 30.06 10.53 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 A 110 ARG J 36 ARG~? 16.92 CL CL J2002 C 163 TYR J 35 TYR~? 13.02 CL CL J2002 C 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 181.40 180.11 121.45 182.70 178.85 123.93 coo 39.51 34.34 13.63 37.63 32.61 14.79 173.30 177.82 119.58 170.88 177.40 118.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 A 110 ARG J 37 ARG~? 20.17 CL CL J2002 C 163 TYR J 35 TYR~? 13.02 CL CL J2002 C 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 174.71 186.35 123.78 172.76 186.51 126.11 coo 39.51 34.34 13.63 37.63 32.61 14.79 173.30 177.82 119.58 170.88 177.40 118.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 A 110 ARG J 145 ARG~? 22.99 CL CL J2016 C 163 TYR J 143 TYR~? 15.18 CL CL J2016 C 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 39.01 29.77 22.02 37.48 31.30 19.84 132.84 187.86 144.62 133.71 189.96 142.45 coo 39.51 34.34 13.63 37.63 32.61 14.79 136.50 183.91 136.49 136.50 184.93 133.88 coo 45.78 31.11 9.51 44.25 30.06 10.53 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 A 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 C 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 C 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 39.01 29.77 22.02 37.48 31.30 19.84 156.15 122.83 185.77 154.85 125.10 184.29 coo 39.51 34.34 13.63 37.63 32.61 14.79 164.29 120.92 183.43 166.71 119.58 183.22 coo 45.78 31.11 9.51 44.25 30.06 10.53 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 A 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s C 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 C 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 39.01 29.77 22.02 37.48 31.30 19.84 162.88 126.06 191.42 164.87 128.39 191.36 coo 39.51 34.34 13.63 37.63 32.61 14.79 164.29 120.92 183.43 166.71 119.58 183.22 coo 45.78 31.11 9.51 44.25 30.06 10.53 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 A 110 ARG K 95 ARG~? 18.15 CL CL K2027 C 163 TYR K 75 TYR~? 12.36 CL CL K2027 C 236 ASP K 127 ASP.? 12.37 CL CL K2027 coo 39.01 29.77 22.02 37.48 31.30 19.84 211.85 134.99 193.85 212.13 138.00 193.03 coo 39.51 34.34 13.63 37.63 32.61 14.79 205.79 133.16 185.06 205.81 134.80 187.34 coo 45.78 31.11 9.51 44.25 30.06 10.53 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 A 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 C 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 C 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 39.01 29.77 22.02 37.48 31.30 19.84 204.60 147.17 190.28 202.10 146.29 191.85 coo 39.51 34.34 13.63 37.63 32.61 14.79 201.16 138.32 187.50 201.22 135.84 188.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 A 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 C 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 C 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 39.01 29.77 22.02 37.48 31.30 19.84 174.06 157.20 217.38 176.23 157.17 215.21 coo 39.51 34.34 13.63 37.63 32.61 14.79 166.36 159.94 218.26 163.88 160.60 219.34 coo 45.78 31.11 9.51 44.25 30.06 10.53 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 A 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 C 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 C 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 39.01 29.77 22.02 37.48 31.30 19.84 167.17 151.29 214.24 165.45 151.32 211.73 coo 39.51 34.34 13.63 37.63 32.61 14.79 166.36 159.94 218.26 163.88 160.60 219.34 coo 45.78 31.11 9.51 44.25 30.06 10.53 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 A 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 C 163 TYR L 143 TYR~? 15.30 CL CL L2009 C 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 39.01 29.77 22.02 37.48 31.30 19.84 129.45 155.66 188.12 131.98 157.11 187.19 coo 39.51 34.34 13.63 37.63 32.61 14.79 131.10 157.77 197.34 130.52 156.95 199.97 coo 45.78 31.11 9.51 44.25 30.06 10.53 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 A 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 C 163 TYR M 35 TYR~? 13.00 CL CL I2001 C 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 179.97 216.30 180.98 181.48 213.82 180.04 coo 39.51 34.34 13.63 37.63 32.61 14.79 172.26 218.21 177.69 169.95 219.60 176.96 coo 45.78 31.11 9.51 44.25 30.06 10.53 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 A 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s C 163 TYR M 35 TYR~? 13.00 CL CL I2001 C 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 39.01 29.77 22.02 37.48 31.30 19.84 172.69 214.03 186.60 170.63 211.79 186.52 coo 39.51 34.34 13.63 37.63 32.61 14.79 172.26 218.21 177.69 169.95 219.60 176.96 coo 45.78 31.11 9.51 44.25 30.06 10.53 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 A 110 ARG M 145 ARG~? 23.51 CL CL M2017 C 163 TYR M 143 TYR~? 15.40 CL CL M2017 C 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 39.01 29.77 22.02 37.48 31.30 19.84 131.12 192.72 183.38 131.87 195.02 185.33 coo 39.51 34.34 13.63 37.63 32.61 14.79 134.88 201.35 179.85 134.66 203.97 180.76 coo 45.78 31.11 9.51 44.25 30.06 10.53 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 A 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 C 163 TYR N 35 TYR~? 13.09 CL CL J2002 C 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 161.60 152.07 121.93 160.06 153.41 124.19 coo 39.51 34.34 13.63 37.63 32.61 14.79 169.83 154.24 120.71 172.41 154.64 119.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 A 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s C 163 TYR N 35 TYR~? 13.09 CL CL J2002 C 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 39.01 29.77 22.02 37.48 31.30 19.84 167.97 146.21 125.72 169.64 146.36 128.31 coo 39.51 34.34 13.63 37.63 32.61 14.79 169.83 154.24 120.71 172.41 154.64 119.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 A 110 ARG N 95 ARG~? 18.49 CL CL N2030 C 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 C 236 ASP N 127 ASP.? 12.60 CL CL N2030 coo 39.01 29.77 22.02 37.48 31.30 19.84 215.46 144.14 140.72 215.90 144.66 143.75 coo 39.51 34.34 13.63 37.63 32.61 14.79 209.71 152.64 137.80 209.50 150.35 139.41 coo 45.78 31.11 9.51 44.25 30.06 10.53 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 A 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 C 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 C 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 39.01 29.77 22.02 37.48 31.30 19.84 206.36 147.54 151.55 205.74 145.29 149.50 coo 39.51 34.34 13.63 37.63 32.61 14.79 204.41 150.24 142.39 204.78 148.95 139.97 coo 45.78 31.11 9.51 44.25 30.06 10.53 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 A 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 C 163 TYR O 35 TYR~? 20.32 CL CL K2003 C 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 39.01 29.77 22.02 37.48 31.30 19.84 175.82 120.47 157.52 177.72 122.75 158.28 coo 39.51 34.34 13.63 37.63 32.61 14.79 167.80 119.41 159.74 165.27 118.34 160.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 A 110 ARG O 37 ARG~? 22.15 CL CL K2003 C 163 TYR O 35 TYR~? 20.32 CL CL K2003 C 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 39.01 29.77 22.02 37.48 31.30 19.84 169.49 123.46 151.21 167.81 125.99 151.08 coo 39.51 34.34 13.63 37.63 32.61 14.79 167.80 119.41 159.74 165.27 118.34 160.26 coo 45.78 31.11 9.51 44.25 30.06 10.53 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 A 110 ARG O 95 ARG~? 18.05 CL CL O2018 C 163 TYR O 75 TYR~? 10.24 CL CL O2018 C 236 ASP O 127 ASP.? 11.33 CL CL O2018 coo 39.01 29.77 22.02 37.48 31.30 19.84 121.75 137.79 148.01 121.99 140.87 148.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 127.87 136.17 156.70 127.95 137.50 154.23 coo 45.78 31.11 9.51 44.25 30.06 10.53 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 A 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 C 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 C 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 39.01 29.77 22.02 37.48 31.30 19.84 130.60 149.22 149.86 131.12 146.92 147.82 coo 39.51 34.34 13.63 37.63 32.61 14.79 133.04 140.38 153.60 132.61 137.79 152.63 coo 45.78 31.11 9.51 44.25 30.06 10.53 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 A 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 C 163 TYR P 143 TYR~? 15.20 CL CL P2019 C 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 39.01 29.77 22.02 37.48 31.30 19.84 206.30 185.90 191.05 208.78 186.92 189.45 coo 39.51 34.34 13.63 37.63 32.61 14.79 202.86 183.43 199.65 203.11 184.67 202.14 coo 45.78 31.11 9.51 44.25 30.06 10.53 200.75 174.15 199.66 202.28 173.10 198.62 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 D 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 D 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 51.19 99.66 33.34 49.41 97.31 34.21 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 59.25 100.54 36.63 61.78 101.51 37.35 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 D 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 D 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 58.38 95.12 28.70 59.87 92.50 29.19 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 59.25 100.54 36.63 61.78 101.51 37.35 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 D 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 D 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 94.33 67.29 39.79 97.00 65.79 39.32 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 92.99 77.44 39.76 93.75 79.76 38.42 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 D 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 D 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 19.64 71.23 27.64 22.06 69.48 28.42 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 23.25 68.41 18.58 23.33 69.19 15.92 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG C 36 ARG~? 17.12 CL CL C2004 D 163 TYR C 35 TYR~? 12.95 CL CL C2004 D 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 37.77 8.89 71.79 36.83 11.19 70.06 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 45.94 6.51 69.90 48.30 5.07 69.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG C 37 ARG~? -20.33 CL CL C2004s D 163 TYR C 35 TYR~? 12.95 CL CL C2004 D 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 44.35 12.06 77.77 46.44 14.26 77.62 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 45.94 6.51 69.90 48.30 5.07 69.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG C 95 ARG~? 15.71 CL CL C2031 D 163 TYR C 75 TYR~? 10.50 CL CL C2011 D 236 ASP C 127 ASP.? 10.87 CL CL C2011 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 94.96 18.62 81.47 95.21 21.64 80.86 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 87.86 16.77 72.91 87.86 18.43 75.14 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 D 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 D 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 85.99 31.07 76.22 83.80 32.01 74.28 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 83.34 22.31 75.20 83.28 19.92 76.54 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 D 163 TYR D 35 TYR~? 13.02 CL CL H2005 D 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 55.93 43.64 102.74 57.91 43.73 100.41 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 48.27 47.24 102.95 45.77 48.18 103.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s D 163 TYR D 35 TYR~? 13.02 CL CL H2005 D 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 48.82 38.28 99.42 47.22 38.23 96.82 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 48.27 47.24 102.95 45.77 48.18 103.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 D 163 TYR D 143 TYR~? 15.16 CL CL D2012 D 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 12.08 41.78 71.45 11.86 39.69 73.74 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 14.34 45.54 80.17 13.57 44.79 82.74 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 D 163 TYR E 143 TYR~? 15.23 CL CL E2013 D 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 16.30 80.38 65.14 17.26 82.53 67.17 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 20.79 87.99 61.33 20.74 90.64 62.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 D 163 TYR F 35 TYR~? 30.41 CL CL F2035 D 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 47.43 34.56 6.90 45.82 36.16 8.95 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 55.89 36.47 6.05 58.49 36.69 5.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 110 ARG F 37 ARG~? -27.07 CL CL F2035s D 163 TYR F 35 TYR~? 30.41 CL CL F2035 D 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 53.50 28.70 11.30 55.02 28.89 13.93 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 55.89 36.47 6.05 58.49 36.69 5.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 110 ARG F 95 ARG~? 18.18 CL CL F2034 D 163 TYR F 75 TYR~? 9.99 CL CL F2034 D 236 ASP F 127 ASP.? 10.85 CL CL F2034 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 101.23 25.44 29.03 100.92 26.10 32.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 95.01 33.97 25.26 94.64 31.83 27.03 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 D 163 TYR F 143 TYR~? 15.09 CL CL F2034 D 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 91.49 29.42 38.83 93.62 28.28 40.76 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 89.42 31.84 29.55 89.79 30.44 27.17 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 110 ARG G 37 ARG~? 20.29 CL CL C2004 D 163 TYR G 35 TYR~? 13.11 CL CL C2004 D 236 ASP G 28 ASP~? 15.85 CL CL C2004 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 52.62 7.45 38.03 50.95 9.97 37.63 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 50.35 3.70 46.66 47.74 2.77 47.00 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 D 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 D 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 15.17 34.68 33.42 15.78 32.53 31.28 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 16.97 25.90 37.77 16.51 23.33 36.84 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 B 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 D 163 TYR H 35 TYR~? 13.05 CL CL H2005 D 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 41.35 74.42 97.84 39.90 73.17 95.49 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 48.71 70.98 100.43 50.94 70.32 101.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 B 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s D 163 TYR H 35 TYR~? 13.05 CL CL H2005 D 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 49.12 78.88 94.88 51.18 78.27 92.74 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 48.71 70.98 100.43 50.94 70.32 101.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 B 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 D 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 D 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 91.20 69.90 76.54 91.87 72.67 77.80 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 86.77 67.99 85.16 86.88 69.36 87.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 B 110 ARG I 36 ARG~? 18.35 CL CL I2001 D 163 TYR I 35 TYR~? 13.03 CL CL I2001 D 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 163.77 216.28 151.02 161.75 213.99 150.84 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 171.46 216.91 154.12 173.98 218.04 154.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 B 110 ARG I 37 ARG~? 20.23 CL CL I2001 D 163 TYR I 35 TYR~? 13.03 CL CL I2001 D 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 170.53 211.87 145.98 172.22 209.35 146.21 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 171.46 216.91 154.12 173.98 218.04 154.69 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 B 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 D 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 D 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 209.45 186.59 151.83 209.12 188.26 149.20 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 206.55 195.37 154.41 207.09 197.83 153.23 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 B 110 ARG J 36 ARG~? 16.92 CL CL J2002 D 163 TYR J 35 TYR~? 13.02 CL CL J2002 D 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 181.40 180.11 121.45 182.70 178.85 123.93 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 173.30 177.82 119.58 170.88 177.40 118.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 B 110 ARG J 37 ARG~? 20.17 CL CL J2002 D 163 TYR J 35 TYR~? 13.02 CL CL J2002 D 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 174.71 186.35 123.78 172.76 186.51 126.11 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 173.30 177.82 119.58 170.88 177.40 118.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 B 110 ARG J 145 ARG~? 22.99 CL CL J2016 D 163 TYR J 143 TYR~? 15.18 CL CL J2016 D 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 132.84 187.86 144.62 133.71 189.96 142.45 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 136.50 183.91 136.49 136.50 184.93 133.88 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 B 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 D 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 D 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 156.15 122.83 185.77 154.85 125.10 184.29 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 164.29 120.92 183.43 166.71 119.58 183.22 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 B 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s D 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 D 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 162.88 126.06 191.42 164.87 128.39 191.36 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 164.29 120.92 183.43 166.71 119.58 183.22 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 B 110 ARG K 95 ARG~? 18.15 CL CL K2027 D 163 TYR K 75 TYR~? 12.36 CL CL K2027 D 236 ASP K 127 ASP.? 12.37 CL CL K2027 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 211.85 134.99 193.85 212.13 138.00 193.03 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 205.79 133.16 185.06 205.81 134.80 187.34 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 B 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 D 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 D 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 204.60 147.17 190.28 202.10 146.29 191.85 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 201.16 138.32 187.50 201.22 135.84 188.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 B 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 D 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 D 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 174.06 157.20 217.38 176.23 157.17 215.21 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 166.36 159.94 218.26 163.88 160.60 219.34 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 B 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 D 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 D 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 167.17 151.29 214.24 165.45 151.32 211.73 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 166.36 159.94 218.26 163.88 160.60 219.34 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 B 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 D 163 TYR L 143 TYR~? 15.30 CL CL L2009 D 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 129.45 155.66 188.12 131.98 157.11 187.19 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 131.10 157.77 197.34 130.52 156.95 199.97 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 B 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 D 163 TYR M 35 TYR~? 13.00 CL CL I2001 D 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 179.97 216.30 180.98 181.48 213.82 180.04 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 172.26 218.21 177.69 169.95 219.60 176.96 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 B 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s D 163 TYR M 35 TYR~? 13.00 CL CL I2001 D 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 172.69 214.03 186.60 170.63 211.79 186.52 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 172.26 218.21 177.69 169.95 219.60 176.96 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 B 110 ARG M 145 ARG~? 23.51 CL CL M2017 D 163 TYR M 143 TYR~? 15.40 CL CL M2017 D 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 131.12 192.72 183.38 131.87 195.02 185.33 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 134.88 201.35 179.85 134.66 203.97 180.76 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 B 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 D 163 TYR N 35 TYR~? 13.09 CL CL J2002 D 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 161.60 152.07 121.93 160.06 153.41 124.19 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 169.83 154.24 120.71 172.41 154.64 119.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 B 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s D 163 TYR N 35 TYR~? 13.09 CL CL J2002 D 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 167.97 146.21 125.72 169.64 146.36 128.31 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 169.83 154.24 120.71 172.41 154.64 119.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 B 110 ARG N 95 ARG~? 18.49 CL CL N2030 D 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 D 236 ASP N 127 ASP.? 12.60 CL CL N2030 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 215.46 144.14 140.72 215.90 144.66 143.75 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 209.71 152.64 137.80 209.50 150.35 139.41 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 B 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 D 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 D 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 206.36 147.54 151.55 205.74 145.29 149.50 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 204.41 150.24 142.39 204.78 148.95 139.97 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 B 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 D 163 TYR O 35 TYR~? 20.32 CL CL K2003 D 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 175.82 120.47 157.52 177.72 122.75 158.28 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 167.80 119.41 159.74 165.27 118.34 160.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 B 110 ARG O 37 ARG~? 22.15 CL CL K2003 D 163 TYR O 35 TYR~? 20.32 CL CL K2003 D 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 169.49 123.46 151.21 167.81 125.99 151.08 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 167.80 119.41 159.74 165.27 118.34 160.26 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 B 110 ARG O 95 ARG~? 18.05 CL CL O2018 D 163 TYR O 75 TYR~? 10.24 CL CL O2018 D 236 ASP O 127 ASP.? 11.33 CL CL O2018 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 121.75 137.79 148.01 121.99 140.87 148.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 127.87 136.17 156.70 127.95 137.50 154.23 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 B 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 D 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 D 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 130.60 149.22 149.86 131.12 146.92 147.82 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 133.04 140.38 153.60 132.61 137.79 152.63 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 B 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 D 163 TYR P 143 TYR~? 15.20 CL CL P2019 D 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 206.30 185.90 191.05 208.78 186.92 189.45 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 202.86 183.43 199.65 203.11 184.67 202.14 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 200.75 174.15 199.66 202.28 173.10 198.62 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 C 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 55.48 26.51 40.65 55.39 23.99 39.43 59.25 100.54 36.63 61.78 101.51 37.35 coo 48.87 29.19 44.63 49.10 27.34 43.63 62.23 105.49 38.88 63.59 105.50 37.26 coo 52.39 23.42 32.10 54.51 23.27 34.29 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 A 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 C 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 55.48 26.51 40.65 55.39 23.99 39.43 59.25 100.54 36.63 61.78 101.51 37.35 coo 48.87 29.19 44.63 49.10 27.34 43.63 62.23 105.49 38.88 63.59 105.50 37.26 coo 52.39 23.42 32.10 54.51 23.27 34.29 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 A 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 55.48 26.51 40.65 55.39 23.99 39.43 92.99 77.44 39.76 93.75 79.76 38.42 coo 48.87 29.19 44.63 49.10 27.34 43.63 90.44 78.16 48.76 91.65 76.94 50.06 coo 52.39 23.42 32.10 54.51 23.27 34.29 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 A 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 55.48 26.51 40.65 55.39 23.99 39.43 23.25 68.41 18.58 23.33 69.19 15.92 coo 48.87 29.19 44.63 49.10 27.34 43.63 23.66 59.02 20.34 21.93 58.32 21.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 35 TYR~? 12.95 CL CL C2004 A 236 ASP C 28 ASP~? 15.70 CL CL C2004 C 110 ARG C 36 ARG~? 17.12 CL CL C2004 coo 55.48 26.51 40.65 55.39 23.99 39.43 45.94 6.51 69.90 48.30 5.07 69.65 coo 48.87 29.19 44.63 49.10 27.34 43.63 48.49 0.93 68.23 49.38 0.74 70.13 coo 52.39 23.42 32.10 54.51 23.27 34.29 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR C 35 TYR~? 12.95 CL CL C2004 A 236 ASP C 28 ASP~? 15.70 CL CL C2004 C 110 ARG C 37 ARG~? -20.33 CL CL C2004s coo 55.48 26.51 40.65 55.39 23.99 39.43 45.94 6.51 69.90 48.30 5.07 69.65 coo 48.87 29.19 44.63 49.10 27.34 43.63 48.49 0.93 68.23 49.38 0.74 70.13 coo 52.39 23.42 32.10 54.51 23.27 34.29 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 75 TYR~? 10.50 CL CL C2011 A 236 ASP C 127 ASP.? 10.87 CL CL C2011 C 110 ARG C 95 ARG~? 15.71 CL CL C2031 coo 55.48 26.51 40.65 55.39 23.99 39.43 87.86 16.77 72.91 87.86 18.43 75.14 coo 48.87 29.19 44.63 49.10 27.34 43.63 86.95 7.50 76.71 86.89 6.71 78.70 coo 52.39 23.42 32.10 54.51 23.27 34.29 94.96 18.62 81.47 95.21 21.64 80.86 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 A 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 55.48 26.51 40.65 55.39 23.99 39.43 83.34 22.31 75.20 83.28 19.92 76.54 coo 48.87 29.19 44.63 49.10 27.34 43.63 82.81 22.02 65.69 84.52 22.80 64.66 coo 52.39 23.42 32.10 54.51 23.27 34.29 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR D 35 TYR~? 13.02 CL CL H2005 A 236 ASP D 28 ASP~? 15.80 CL CL H2005 C 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 55.48 26.51 40.65 55.39 23.99 39.43 48.27 47.24 102.95 45.77 48.18 103.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 45.36 50.43 107.49 43.88 48.98 107.89 coo 52.39 23.42 32.10 54.51 23.27 34.29 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR D 35 TYR~? 13.02 CL CL H2005 A 236 ASP D 28 ASP~? 15.80 CL CL H2005 C 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 55.48 26.51 40.65 55.39 23.99 39.43 48.27 47.24 102.95 45.77 48.18 103.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 45.36 50.43 107.49 43.88 48.98 107.89 coo 52.39 23.42 32.10 54.51 23.27 34.29 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR D 143 TYR~? 15.16 CL CL D2012 A 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 55.48 26.51 40.65 55.39 23.99 39.43 14.34 45.54 80.17 13.57 44.79 82.74 coo 48.87 29.19 44.63 49.10 27.34 43.63 16.94 54.59 79.01 15.65 55.42 77.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR E 143 TYR~? 15.23 CL CL E2013 A 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 55.48 26.51 40.65 55.39 23.99 39.43 20.79 87.99 61.33 20.74 90.64 62.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 23.07 86.29 52.35 21.57 85.17 51.32 coo 52.39 23.42 32.10 54.51 23.27 34.29 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR F 35 TYR~? 30.41 CL CL F2035 A 236 ASP F 28 ASP~? 32.62 CL CL F2035 C 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 55.48 26.51 40.65 55.39 23.99 39.43 55.89 36.47 6.05 58.49 36.69 5.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 59.39 38.13 1.08 60.39 36.31 1.06 coo 52.39 23.42 32.10 54.51 23.27 34.29 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 A 163 TYR F 35 TYR~? 30.41 CL CL F2035 A 236 ASP F 28 ASP~? 32.62 CL CL F2035 C 110 ARG F 37 ARG~? -27.07 CL CL F2035s coo 55.48 26.51 40.65 55.39 23.99 39.43 55.89 36.47 6.05 58.49 36.69 5.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 59.39 38.13 1.08 60.39 36.31 1.06 coo 52.39 23.42 32.10 54.51 23.27 34.29 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 A 163 TYR F 75 TYR~? 9.99 CL CL F2034 A 236 ASP F 127 ASP.? 10.85 CL CL F2034 C 110 ARG F 95 ARG~? 18.18 CL CL F2034 coo 55.48 26.51 40.65 55.39 23.99 39.43 95.01 33.97 25.26 94.64 31.83 27.03 coo 48.87 29.19 44.63 49.10 27.34 43.63 96.13 30.12 15.93 96.25 28.10 15.23 coo 52.39 23.42 32.10 54.51 23.27 34.29 101.23 25.44 29.03 100.92 26.10 32.03 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 A 163 TYR F 143 TYR~? 15.09 CL CL F2034 A 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 55.48 26.51 40.65 55.39 23.99 39.43 89.42 31.84 29.55 89.79 30.44 27.17 coo 48.87 29.19 44.63 49.10 27.34 43.63 88.86 41.25 28.96 90.30 42.22 30.24 coo 52.39 23.42 32.10 54.51 23.27 34.29 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 A 163 TYR G 35 TYR~? 13.11 CL CL C2004 A 236 ASP G 28 ASP~? 15.85 CL CL C2004 C 110 ARG G 37 ARG~? 20.29 CL CL C2004 coo 55.48 26.51 40.65 55.39 23.99 39.43 50.35 3.70 46.66 47.74 2.77 47.00 coo 48.87 29.19 44.63 49.10 27.34 43.63 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 A 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 A 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 55.48 26.51 40.65 55.39 23.99 39.43 16.97 25.90 37.77 16.51 23.33 36.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 17.70 27.34 47.09 16.19 28.71 47.73 coo 52.39 23.42 32.10 54.51 23.27 34.29 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 A 163 TYR H 35 TYR~? 13.05 CL CL H2005 A 236 ASP H 28 ASP~? 15.80 CL CL H2005 C 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 55.48 26.51 40.65 55.39 23.99 39.43 48.71 70.98 100.43 50.94 70.32 101.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 50.63 68.82 106.06 51.93 70.45 106.39 coo 52.39 23.42 32.10 54.51 23.27 34.29 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 A 163 TYR H 35 TYR~? 13.05 CL CL H2005 A 236 ASP H 28 ASP~? 15.80 CL CL H2005 C 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 55.48 26.51 40.65 55.39 23.99 39.43 48.71 70.98 100.43 50.94 70.32 101.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 50.63 68.82 106.06 51.93 70.45 106.39 coo 52.39 23.42 32.10 54.51 23.27 34.29 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 A 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 A 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 55.48 26.51 40.65 55.39 23.99 39.43 86.77 67.99 85.16 86.88 69.36 87.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 84.24 58.93 85.48 85.73 57.59 84.66 coo 52.39 23.42 32.10 54.51 23.27 34.29 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 A 163 TYR I 35 TYR~? 13.03 CL CL I2001 A 236 ASP I 28 ASP~? 15.71 CL CL I2001 C 110 ARG I 36 ARG~? 18.35 CL CL I2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 171.46 216.91 154.12 173.98 218.04 154.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 174.34 221.90 156.42 175.71 222.11 154.83 coo 52.39 23.42 32.10 54.51 23.27 34.29 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 A 163 TYR I 35 TYR~? 13.03 CL CL I2001 A 236 ASP I 28 ASP~? 15.71 CL CL I2001 C 110 ARG I 37 ARG~? 20.23 CL CL I2001 coo 55.48 26.51 40.65 55.39 23.99 39.43 171.46 216.91 154.12 173.98 218.04 154.69 coo 48.87 29.19 44.63 49.10 27.34 43.63 174.34 221.90 156.42 175.71 222.11 154.83 coo 52.39 23.42 32.10 54.51 23.27 34.29 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 A 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 A 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 55.48 26.51 40.65 55.39 23.99 39.43 206.55 195.37 154.41 207.09 197.83 153.23 coo 48.87 29.19 44.63 49.10 27.34 43.63 204.37 195.46 163.61 205.75 194.30 164.79 coo 52.39 23.42 32.10 54.51 23.27 34.29 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 A 163 TYR J 35 TYR~? 13.02 CL CL J2002 A 236 ASP J 28 ASP~? 15.67 CL CL J2002 C 110 ARG J 36 ARG~? 16.92 CL CL J2002 coo 55.48 26.51 40.65 55.39 23.99 39.43 173.30 177.82 119.58 170.88 177.40 118.29 coo 48.87 29.19 44.63 49.10 27.34 43.63 170.87 175.19 114.50 169.74 176.91 114.00 coo 52.39 23.42 32.10 54.51 23.27 34.29 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 A 163 TYR J 35 TYR~? 13.02 CL CL J2002 A 236 ASP J 28 ASP~? 15.67 CL CL J2002 C 110 ARG J 37 ARG~? 20.17 CL CL J2002 coo 55.48 26.51 40.65 55.39 23.99 39.43 173.30 177.82 119.58 170.88 177.40 118.29 coo 48.87 29.19 44.63 49.10 27.34 43.63 170.87 175.19 114.50 169.74 176.91 114.00 coo 52.39 23.42 32.10 54.51 23.27 34.29 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 A 163 TYR J 143 TYR~? 15.18 CL CL J2016 A 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 110 ARG J 145 ARG~? 22.99 CL CL J2016 coo 55.48 26.51 40.65 55.39 23.99 39.43 136.50 183.91 136.49 136.50 184.93 133.88 coo 48.87 29.19 44.63 49.10 27.34 43.63 137.44 174.60 137.57 135.80 173.80 138.69 coo 52.39 23.42 32.10 54.51 23.27 34.29 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 A 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 C 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 55.48 26.51 40.65 55.39 23.99 39.43 164.29 120.92 183.43 166.71 119.58 183.22 coo 48.87 29.19 44.63 49.10 27.34 43.63 166.96 115.59 181.42 167.86 115.34 183.30 coo 52.39 23.42 32.10 54.51 23.27 34.29 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 A 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 A 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 C 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 55.48 26.51 40.65 55.39 23.99 39.43 164.29 120.92 183.43 166.71 119.58 183.22 coo 48.87 29.19 44.63 49.10 27.34 43.63 166.96 115.59 181.42 167.86 115.34 183.30 coo 52.39 23.42 32.10 54.51 23.27 34.29 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 A 163 TYR K 75 TYR~? 12.36 CL CL K2027 A 236 ASP K 127 ASP.? 12.37 CL CL K2027 C 110 ARG K 95 ARG~? 18.15 CL CL K2027 coo 55.48 26.51 40.65 55.39 23.99 39.43 205.79 133.16 185.06 205.81 134.80 187.34 coo 48.87 29.19 44.63 49.10 27.34 43.63 205.42 123.70 188.60 205.51 122.74 190.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 211.85 134.99 193.85 212.13 138.00 193.03 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 A 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 A 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 55.48 26.51 40.65 55.39 23.99 39.43 201.16 138.32 187.50 201.22 135.84 188.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 200.17 138.24 178.11 201.77 139.28 177.19 coo 52.39 23.42 32.10 54.51 23.27 34.29 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 A 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 A 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 C 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 55.48 26.51 40.65 55.39 23.99 39.43 166.36 159.94 218.26 163.88 160.60 219.34 coo 48.87 29.19 44.63 49.10 27.34 43.63 163.49 162.78 223.08 162.21 161.15 223.46 coo 52.39 23.42 32.10 54.51 23.27 34.29 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 A 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 A 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 C 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 55.48 26.51 40.65 55.39 23.99 39.43 166.36 159.94 218.26 163.88 160.60 219.34 coo 48.87 29.19 44.63 49.10 27.34 43.63 163.49 162.78 223.08 162.21 161.15 223.46 coo 52.39 23.42 32.10 54.51 23.27 34.29 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 A 163 TYR L 143 TYR~? 15.30 CL CL L2009 A 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 55.48 26.51 40.65 55.39 23.99 39.43 131.10 157.77 197.34 130.52 156.95 199.97 coo 48.87 29.19 44.63 49.10 27.34 43.63 133.34 166.97 196.27 132.03 168.03 194.96 coo 52.39 23.42 32.10 54.51 23.27 34.29 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 A 163 TYR M 35 TYR~? 13.00 CL CL I2001 A 236 ASP M 28 ASP~? 15.52 CL CL I2001 C 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 55.48 26.51 40.65 55.39 23.99 39.43 172.26 218.21 177.69 169.95 219.60 176.96 coo 48.87 29.19 44.63 49.10 27.34 43.63 170.27 223.20 174.57 168.89 223.83 176.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 A 163 TYR M 35 TYR~? 13.00 CL CL I2001 A 236 ASP M 28 ASP~? 15.52 CL CL I2001 C 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 55.48 26.51 40.65 55.39 23.99 39.43 172.26 218.21 177.69 169.95 219.60 176.96 coo 48.87 29.19 44.63 49.10 27.34 43.63 170.27 223.20 174.57 168.89 223.83 176.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 A 163 TYR M 143 TYR~? 15.40 CL CL M2017 A 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 110 ARG M 145 ARG~? 23.51 CL CL M2017 coo 55.48 26.51 40.65 55.39 23.99 39.43 134.88 201.35 179.85 134.66 203.97 180.76 coo 48.87 29.19 44.63 49.10 27.34 43.63 136.87 200.18 170.79 135.36 199.08 169.77 coo 52.39 23.42 32.10 54.51 23.27 34.29 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 A 163 TYR N 35 TYR~? 13.09 CL CL J2002 A 236 ASP N 28 ASP~? 15.68 CL CL J2002 C 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 55.48 26.51 40.65 55.39 23.99 39.43 169.83 154.24 120.71 172.41 154.64 119.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 173.04 156.37 115.74 174.12 154.54 115.64 coo 52.39 23.42 32.10 54.51 23.27 34.29 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 A 163 TYR N 35 TYR~? 13.09 CL CL J2002 A 236 ASP N 28 ASP~? 15.68 CL CL J2002 C 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 55.48 26.51 40.65 55.39 23.99 39.43 169.83 154.24 120.71 172.41 154.64 119.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 173.04 156.37 115.74 174.12 154.54 115.64 coo 52.39 23.42 32.10 54.51 23.27 34.29 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 A 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 236 ASP N 127 ASP.? 12.60 CL CL N2030 C 110 ARG N 95 ARG~? 18.49 CL CL N2030 coo 55.48 26.51 40.65 55.39 23.99 39.43 209.71 152.64 137.80 209.50 150.35 139.41 coo 48.87 29.19 44.63 49.10 27.34 43.63 210.39 149.08 128.41 210.51 147.14 127.55 coo 52.39 23.42 32.10 54.51 23.27 34.29 215.46 144.14 140.72 215.90 144.66 143.75 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 A 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 A 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 55.48 26.51 40.65 55.39 23.99 39.43 204.41 150.24 142.39 204.78 148.95 139.97 coo 48.87 29.19 44.63 49.10 27.34 43.63 203.51 159.51 142.26 205.02 160.53 143.48 coo 52.39 23.42 32.10 54.51 23.27 34.29 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 A 163 TYR O 35 TYR~? 20.32 CL CL K2003 A 236 ASP O 28 ASP~? 23.95 CL CL O2036 C 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 55.48 26.51 40.65 55.39 23.99 39.43 167.80 119.41 159.74 165.27 118.34 160.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 164.72 114.57 162.31 163.52 114.24 160.62 coo 52.39 23.42 32.10 54.51 23.27 34.29 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 A 163 TYR O 35 TYR~? 20.32 CL CL K2003 A 236 ASP O 28 ASP~? 23.95 CL CL O2036 C 110 ARG O 37 ARG~? 22.15 CL CL K2003 coo 55.48 26.51 40.65 55.39 23.99 39.43 167.80 119.41 159.74 165.27 118.34 160.26 coo 48.87 29.19 44.63 49.10 27.34 43.63 164.72 114.57 162.31 163.52 114.24 160.62 coo 52.39 23.42 32.10 54.51 23.27 34.29 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 A 163 TYR O 75 TYR~? 10.24 CL CL O2018 A 236 ASP O 127 ASP.? 11.33 CL CL O2018 C 110 ARG O 95 ARG~? 18.05 CL CL O2018 coo 55.48 26.51 40.65 55.39 23.99 39.43 127.87 136.17 156.70 127.95 137.50 154.23 coo 48.87 29.19 44.63 49.10 27.34 43.63 127.12 126.29 154.29 127.00 125.34 152.37 coo 52.39 23.42 32.10 54.51 23.27 34.29 121.75 137.79 148.01 121.99 140.87 148.18 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 A 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 A 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 55.48 26.51 40.65 55.39 23.99 39.43 133.04 140.38 153.60 132.61 137.79 152.63 coo 48.87 29.19 44.63 49.10 27.34 43.63 134.07 141.35 162.95 132.57 142.58 163.78 coo 52.39 23.42 32.10 54.51 23.27 34.29 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 A 163 TYR P 143 TYR~? 15.20 CL CL P2019 A 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 55.48 26.51 40.65 55.39 23.99 39.43 202.86 183.43 199.65 203.11 184.67 202.14 coo 48.87 29.19 44.63 49.10 27.34 43.63 200.75 174.15 199.66 202.28 173.10 198.62 coo 52.39 23.42 32.10 54.51 23.27 34.29 206.30 185.90 191.05 208.78 186.92 189.45 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 B 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 D 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 59.25 100.54 36.63 61.78 101.51 37.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 62.23 105.49 38.88 63.59 105.50 37.26 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 B 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 D 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 59.25 100.54 36.63 61.78 101.51 37.35 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 62.23 105.49 38.88 63.59 105.50 37.26 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 B 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s D 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 92.99 77.44 39.76 93.75 79.76 38.42 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 90.44 78.16 48.76 91.65 76.94 50.06 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 35 TYR~? 15.50 C1 GOL B3003 B 236 ASP B 28 ASP~? 19.20 C1 GOL B3003 D 110 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 60.35 59.88 4.36 57.88 59.60 3.08 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 B 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s D 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 23.25 68.41 18.58 23.33 69.19 15.92 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 23.66 59.02 20.34 21.93 58.32 21.38 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 35 TYR~? 12.95 CL CL C2004 B 236 ASP C 28 ASP~? 15.70 CL CL C2004 D 110 ARG C 36 ARG~? 17.12 CL CL C2004 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 45.94 6.51 69.90 48.30 5.07 69.65 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 48.49 0.93 68.23 49.38 0.74 70.13 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR C 35 TYR~? 12.95 CL CL C2004 B 236 ASP C 28 ASP~? 15.70 CL CL C2004 D 110 ARG C 37 ARG~? -20.33 CL CL C2004s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 45.94 6.51 69.90 48.30 5.07 69.65 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 48.49 0.93 68.23 49.38 0.74 70.13 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR C 75 TYR~? 10.50 CL CL C2011 B 236 ASP C 127 ASP.? 10.87 CL CL C2011 D 110 ARG C 95 ARG~? 15.71 CL CL C2031 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 87.86 16.77 72.91 87.86 18.43 75.14 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 86.95 7.50 76.71 86.89 6.71 78.70 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 94.96 18.62 81.47 95.21 21.64 80.86 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 B 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s D 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 83.34 22.31 75.20 83.28 19.92 76.54 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 82.81 22.02 65.69 84.52 22.80 64.66 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR D 35 TYR~? 13.02 CL CL H2005 B 236 ASP D 28 ASP~? 15.80 CL CL H2005 D 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 48.27 47.24 102.95 45.77 48.18 103.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 45.36 50.43 107.49 43.88 48.98 107.89 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR D 35 TYR~? 13.02 CL CL H2005 B 236 ASP D 28 ASP~? 15.80 CL CL H2005 D 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 48.27 47.24 102.95 45.77 48.18 103.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 45.36 50.43 107.49 43.88 48.98 107.89 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR D 143 TYR~? 15.16 CL CL D2012 B 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s D 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 14.34 45.54 80.17 13.57 44.79 82.74 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 16.94 54.59 79.01 15.65 55.42 77.54 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 B 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 D 110 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 58.94 102.78 60.36 56.69 104.19 59.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 57.09 107.82 57.29 55.83 108.40 58.91 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 B 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 D 110 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 58.94 102.78 60.36 56.69 104.19 59.52 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 57.09 107.82 57.29 55.83 108.40 58.91 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 B 163 TYR E 143 TYR~? 15.23 CL CL E2013 B 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 D 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 20.79 87.99 61.33 20.74 90.64 62.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 23.07 86.29 52.35 21.57 85.17 51.32 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 B 163 TYR F 35 TYR~? 30.41 CL CL F2035 B 236 ASP F 28 ASP~? 32.62 CL CL F2035 D 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 55.89 36.47 6.05 58.49 36.69 5.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 59.39 38.13 1.08 60.39 36.31 1.06 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 B 163 TYR F 35 TYR~? 30.41 CL CL F2035 B 236 ASP F 28 ASP~? 32.62 CL CL F2035 D 110 ARG F 37 ARG~? -27.07 CL CL F2035s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 55.89 36.47 6.05 58.49 36.69 5.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 59.39 38.13 1.08 60.39 36.31 1.06 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 B 163 TYR F 143 TYR~? 15.09 CL CL F2034 B 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s D 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 89.42 31.84 29.55 89.79 30.44 27.17 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 88.86 41.25 28.96 90.30 42.22 30.24 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 B 163 TYR G 35 TYR~? 13.11 CL CL C2004 B 236 ASP G 28 ASP~? 15.85 CL CL C2004 D 110 ARG G 37 ARG~? 20.29 CL CL C2004 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 50.35 3.70 46.66 47.74 2.77 47.00 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 B 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 B 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s D 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 16.97 25.90 37.77 16.51 23.33 36.84 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 17.70 27.34 47.09 16.19 28.71 47.73 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 B 163 TYR H 35 TYR~? 13.05 CL CL H2005 B 236 ASP H 28 ASP~? 15.80 CL CL H2005 D 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 48.71 70.98 100.43 50.94 70.32 101.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 50.63 68.82 106.06 51.93 70.45 106.39 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 B 163 TYR H 35 TYR~? 13.05 CL CL H2005 B 236 ASP H 28 ASP~? 15.80 CL CL H2005 D 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 48.71 70.98 100.43 50.94 70.32 101.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 50.63 68.82 106.06 51.93 70.45 106.39 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 B 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 B 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s D 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 86.77 67.99 85.16 86.88 69.36 87.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 84.24 58.93 85.48 85.73 57.59 84.66 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 B 163 TYR I 35 TYR~? 13.03 CL CL I2001 B 236 ASP I 28 ASP~? 15.71 CL CL I2001 D 110 ARG I 36 ARG~? 18.35 CL CL I2001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 171.46 216.91 154.12 173.98 218.04 154.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 174.34 221.90 156.42 175.71 222.11 154.83 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 B 163 TYR I 35 TYR~? 13.03 CL CL I2001 B 236 ASP I 28 ASP~? 15.71 CL CL I2001 D 110 ARG I 37 ARG~? 20.23 CL CL I2001 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 171.46 216.91 154.12 173.98 218.04 154.69 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 174.34 221.90 156.42 175.71 222.11 154.83 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 B 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 B 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s D 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 206.55 195.37 154.41 207.09 197.83 153.23 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 204.37 195.46 163.61 205.75 194.30 164.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 B 163 TYR J 35 TYR~? 13.02 CL CL J2002 B 236 ASP J 28 ASP~? 15.67 CL CL J2002 D 110 ARG J 36 ARG~? 16.92 CL CL J2002 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 173.30 177.82 119.58 170.88 177.40 118.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 170.87 175.19 114.50 169.74 176.91 114.00 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 B 163 TYR J 35 TYR~? 13.02 CL CL J2002 B 236 ASP J 28 ASP~? 15.67 CL CL J2002 D 110 ARG J 37 ARG~? 20.17 CL CL J2002 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 173.30 177.82 119.58 170.88 177.40 118.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 170.87 175.19 114.50 169.74 176.91 114.00 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 B 163 TYR J 143 TYR~? 15.18 CL CL J2016 B 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 D 110 ARG J 145 ARG~? 22.99 CL CL J2016 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 136.50 183.91 136.49 136.50 184.93 133.88 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 137.44 174.60 137.57 135.80 173.80 138.69 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 B 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 B 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 D 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 164.29 120.92 183.43 166.71 119.58 183.22 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 166.96 115.59 181.42 167.86 115.34 183.30 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 B 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 B 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 D 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 164.29 120.92 183.43 166.71 119.58 183.22 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 166.96 115.59 181.42 167.86 115.34 183.30 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 B 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 B 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s D 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 201.16 138.32 187.50 201.22 135.84 188.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 200.17 138.24 178.11 201.77 139.28 177.19 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 B 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 B 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 D 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 166.36 159.94 218.26 163.88 160.60 219.34 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 163.49 162.78 223.08 162.21 161.15 223.46 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 B 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 B 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 D 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 166.36 159.94 218.26 163.88 160.60 219.34 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 163.49 162.78 223.08 162.21 161.15 223.46 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 B 163 TYR L 143 TYR~? 15.30 CL CL L2009 B 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s D 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 131.10 157.77 197.34 130.52 156.95 199.97 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 133.34 166.97 196.27 132.03 168.03 194.96 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 B 163 TYR M 35 TYR~? 13.00 CL CL I2001 B 236 ASP M 28 ASP~? 15.52 CL CL I2001 D 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 172.26 218.21 177.69 169.95 219.60 176.96 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 170.27 223.20 174.57 168.89 223.83 176.08 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 B 163 TYR M 35 TYR~? 13.00 CL CL I2001 B 236 ASP M 28 ASP~? 15.52 CL CL I2001 D 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 172.26 218.21 177.69 169.95 219.60 176.96 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 170.27 223.20 174.57 168.89 223.83 176.08 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 B 163 TYR M 143 TYR~? 15.40 CL CL M2017 B 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s D 110 ARG M 145 ARG~? 23.51 CL CL M2017 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 134.88 201.35 179.85 134.66 203.97 180.76 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 136.87 200.18 170.79 135.36 199.08 169.77 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 B 163 TYR N 35 TYR~? 13.09 CL CL J2002 B 236 ASP N 28 ASP~? 15.68 CL CL J2002 D 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 169.83 154.24 120.71 172.41 154.64 119.66 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 173.04 156.37 115.74 174.12 154.54 115.64 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 B 163 TYR N 35 TYR~? 13.09 CL CL J2002 B 236 ASP N 28 ASP~? 15.68 CL CL J2002 D 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 169.83 154.24 120.71 172.41 154.64 119.66 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 173.04 156.37 115.74 174.12 154.54 115.64 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 B 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 B 236 ASP N 127 ASP.? 12.60 CL CL N2030 D 110 ARG N 95 ARG~? 18.49 CL CL N2030 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 209.71 152.64 137.80 209.50 150.35 139.41 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 210.39 149.08 128.41 210.51 147.14 127.55 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 215.46 144.14 140.72 215.90 144.66 143.75 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 B 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 B 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s D 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 204.41 150.24 142.39 204.78 148.95 139.97 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 203.51 159.51 142.26 205.02 160.53 143.48 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 B 163 TYR O 35 TYR~? 20.32 CL CL K2003 B 236 ASP O 28 ASP~? 23.95 CL CL O2036 D 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 167.80 119.41 159.74 165.27 118.34 160.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 164.72 114.57 162.31 163.52 114.24 160.62 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 B 163 TYR O 35 TYR~? 20.32 CL CL K2003 B 236 ASP O 28 ASP~? 23.95 CL CL O2036 D 110 ARG O 37 ARG~? 22.15 CL CL K2003 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 167.80 119.41 159.74 165.27 118.34 160.26 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 164.72 114.57 162.31 163.52 114.24 160.62 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 B 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 B 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s D 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 133.04 140.38 153.60 132.61 137.79 152.63 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 134.07 141.35 162.95 132.57 142.58 163.78 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 B 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 B 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 D 110 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 165.51 183.94 216.71 167.90 183.49 218.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 167.75 181.83 222.09 168.94 183.53 222.37 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 47 3 # 47 B 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 B 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 D 110 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 165.51 183.94 216.71 167.90 183.49 218.05 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 167.75 181.83 222.09 168.94 183.53 222.37 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 48 3 # 48 B 163 TYR P 143 TYR~? 15.20 CL CL P2019 B 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 D 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 202.86 183.43 199.65 203.11 184.67 202.14 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 200.75 174.15 199.66 202.28 173.10 198.62 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 206.30 185.90 191.05 208.78 186.92 189.45 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 48 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 G 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 G 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 51.19 99.66 33.34 49.41 97.31 34.21 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 59.25 100.54 36.63 61.78 101.51 37.35 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 G 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 G 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 58.38 95.12 28.70 59.87 92.50 29.19 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 59.25 100.54 36.63 61.78 101.51 37.35 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 G 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 G 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 94.33 67.29 39.79 97.00 65.79 39.32 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 92.99 77.44 39.76 93.75 79.76 38.42 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 G 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 G 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 19.64 71.23 27.64 22.06 69.48 28.42 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 23.25 68.41 18.58 23.33 69.19 15.92 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG C 36 ARG~? 17.12 CL CL C2004 G 163 TYR C 35 TYR~? 12.95 CL CL C2004 G 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 37.77 8.89 71.79 36.83 11.19 70.06 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 45.94 6.51 69.90 48.30 5.07 69.65 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG C 37 ARG~? -20.33 CL CL C2004s G 163 TYR C 35 TYR~? 12.95 CL CL C2004 G 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 44.35 12.06 77.77 46.44 14.26 77.62 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 45.94 6.51 69.90 48.30 5.07 69.65 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG C 95 ARG~? 15.71 CL CL C2031 G 163 TYR C 75 TYR~? 10.50 CL CL C2011 G 236 ASP C 127 ASP.? 10.87 CL CL C2011 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 94.96 18.62 81.47 95.21 21.64 80.86 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 87.86 16.77 72.91 87.86 18.43 75.14 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 G 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 G 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 85.99 31.07 76.22 83.80 32.01 74.28 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 83.34 22.31 75.20 83.28 19.92 76.54 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 G 163 TYR D 35 TYR~? 13.02 CL CL H2005 G 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 55.93 43.64 102.74 57.91 43.73 100.41 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 48.27 47.24 102.95 45.77 48.18 103.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s G 163 TYR D 35 TYR~? 13.02 CL CL H2005 G 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 48.82 38.28 99.42 47.22 38.23 96.82 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 48.27 47.24 102.95 45.77 48.18 103.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 G 163 TYR D 143 TYR~? 15.16 CL CL D2012 G 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 12.08 41.78 71.45 11.86 39.69 73.74 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 14.34 45.54 80.17 13.57 44.79 82.74 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 G 163 TYR E 143 TYR~? 15.23 CL CL E2013 G 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 16.30 80.38 65.14 17.26 82.53 67.17 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 20.79 87.99 61.33 20.74 90.64 62.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 G 163 TYR F 35 TYR~? 30.41 CL CL F2035 G 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 47.43 34.56 6.90 45.82 36.16 8.95 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 55.89 36.47 6.05 58.49 36.69 5.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 110 ARG F 37 ARG~? -27.07 CL CL F2035s G 163 TYR F 35 TYR~? 30.41 CL CL F2035 G 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 53.50 28.70 11.30 55.02 28.89 13.93 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 55.89 36.47 6.05 58.49 36.69 5.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 110 ARG F 95 ARG~? 18.18 CL CL F2034 G 163 TYR F 75 TYR~? 9.99 CL CL F2034 G 236 ASP F 127 ASP.? 10.85 CL CL F2034 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 101.23 25.44 29.03 100.92 26.10 32.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 95.01 33.97 25.26 94.64 31.83 27.03 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 G 163 TYR F 143 TYR~? 15.09 CL CL F2034 G 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 91.49 29.42 38.83 93.62 28.28 40.76 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 89.42 31.84 29.55 89.79 30.44 27.17 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 E 110 ARG G 37 ARG~? 20.29 CL CL C2004 G 163 TYR G 35 TYR~? 13.11 CL CL C2004 G 236 ASP G 28 ASP~? 15.85 CL CL C2004 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 52.62 7.45 38.03 50.95 9.97 37.63 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 50.35 3.70 46.66 47.74 2.77 47.00 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 E 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 G 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 G 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 15.17 34.68 33.42 15.78 32.53 31.28 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 16.97 25.90 37.77 16.51 23.33 36.84 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 E 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 G 163 TYR H 35 TYR~? 13.05 CL CL H2005 G 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 41.35 74.42 97.84 39.90 73.17 95.49 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 48.71 70.98 100.43 50.94 70.32 101.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 E 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s G 163 TYR H 35 TYR~? 13.05 CL CL H2005 G 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 49.12 78.88 94.88 51.18 78.27 92.74 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 48.71 70.98 100.43 50.94 70.32 101.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 E 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 G 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 G 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 91.20 69.90 76.54 91.87 72.67 77.80 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 86.77 67.99 85.16 86.88 69.36 87.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 E 110 ARG I 36 ARG~? 18.35 CL CL I2001 G 163 TYR I 35 TYR~? 13.03 CL CL I2001 G 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 163.77 216.28 151.02 161.75 213.99 150.84 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 171.46 216.91 154.12 173.98 218.04 154.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 E 110 ARG I 37 ARG~? 20.23 CL CL I2001 G 163 TYR I 35 TYR~? 13.03 CL CL I2001 G 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 170.53 211.87 145.98 172.22 209.35 146.21 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 171.46 216.91 154.12 173.98 218.04 154.69 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 E 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 G 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 G 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 209.45 186.59 151.83 209.12 188.26 149.20 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 206.55 195.37 154.41 207.09 197.83 153.23 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 E 110 ARG J 36 ARG~? 16.92 CL CL J2002 G 163 TYR J 35 TYR~? 13.02 CL CL J2002 G 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 181.40 180.11 121.45 182.70 178.85 123.93 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 173.30 177.82 119.58 170.88 177.40 118.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 E 110 ARG J 37 ARG~? 20.17 CL CL J2002 G 163 TYR J 35 TYR~? 13.02 CL CL J2002 G 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 174.71 186.35 123.78 172.76 186.51 126.11 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 173.30 177.82 119.58 170.88 177.40 118.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 E 110 ARG J 145 ARG~? 22.99 CL CL J2016 G 163 TYR J 143 TYR~? 15.18 CL CL J2016 G 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 132.84 187.86 144.62 133.71 189.96 142.45 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 136.50 183.91 136.49 136.50 184.93 133.88 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 E 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 G 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 G 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 156.15 122.83 185.77 154.85 125.10 184.29 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 164.29 120.92 183.43 166.71 119.58 183.22 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 E 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s G 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 G 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 162.88 126.06 191.42 164.87 128.39 191.36 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 164.29 120.92 183.43 166.71 119.58 183.22 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 E 110 ARG K 95 ARG~? 18.15 CL CL K2027 G 163 TYR K 75 TYR~? 12.36 CL CL K2027 G 236 ASP K 127 ASP.? 12.37 CL CL K2027 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 211.85 134.99 193.85 212.13 138.00 193.03 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 205.79 133.16 185.06 205.81 134.80 187.34 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 E 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 G 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 G 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 204.60 147.17 190.28 202.10 146.29 191.85 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 201.16 138.32 187.50 201.22 135.84 188.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 E 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 G 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 G 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 174.06 157.20 217.38 176.23 157.17 215.21 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 166.36 159.94 218.26 163.88 160.60 219.34 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 E 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 G 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 G 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 167.17 151.29 214.24 165.45 151.32 211.73 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 166.36 159.94 218.26 163.88 160.60 219.34 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 E 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 G 163 TYR L 143 TYR~? 15.30 CL CL L2009 G 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 129.45 155.66 188.12 131.98 157.11 187.19 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 131.10 157.77 197.34 130.52 156.95 199.97 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 E 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 G 163 TYR M 35 TYR~? 13.00 CL CL I2001 G 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 179.97 216.30 180.98 181.48 213.82 180.04 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 172.26 218.21 177.69 169.95 219.60 176.96 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 E 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s G 163 TYR M 35 TYR~? 13.00 CL CL I2001 G 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 172.69 214.03 186.60 170.63 211.79 186.52 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 172.26 218.21 177.69 169.95 219.60 176.96 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 E 110 ARG M 145 ARG~? 23.51 CL CL M2017 G 163 TYR M 143 TYR~? 15.40 CL CL M2017 G 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 131.12 192.72 183.38 131.87 195.02 185.33 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 134.88 201.35 179.85 134.66 203.97 180.76 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 E 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 G 163 TYR N 35 TYR~? 13.09 CL CL J2002 G 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 161.60 152.07 121.93 160.06 153.41 124.19 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 169.83 154.24 120.71 172.41 154.64 119.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 E 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s G 163 TYR N 35 TYR~? 13.09 CL CL J2002 G 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 167.97 146.21 125.72 169.64 146.36 128.31 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 169.83 154.24 120.71 172.41 154.64 119.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 E 110 ARG N 95 ARG~? 18.49 CL CL N2030 G 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 G 236 ASP N 127 ASP.? 12.60 CL CL N2030 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 215.46 144.14 140.72 215.90 144.66 143.75 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 209.71 152.64 137.80 209.50 150.35 139.41 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 E 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 G 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 G 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 206.36 147.54 151.55 205.74 145.29 149.50 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 204.41 150.24 142.39 204.78 148.95 139.97 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 E 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 G 163 TYR O 35 TYR~? 20.32 CL CL K2003 G 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 175.82 120.47 157.52 177.72 122.75 158.28 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 167.80 119.41 159.74 165.27 118.34 160.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 E 110 ARG O 37 ARG~? 22.15 CL CL K2003 G 163 TYR O 35 TYR~? 20.32 CL CL K2003 G 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 169.49 123.46 151.21 167.81 125.99 151.08 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 167.80 119.41 159.74 165.27 118.34 160.26 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 E 110 ARG O 95 ARG~? 18.05 CL CL O2018 G 163 TYR O 75 TYR~? 10.24 CL CL O2018 G 236 ASP O 127 ASP.? 11.33 CL CL O2018 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 121.75 137.79 148.01 121.99 140.87 148.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 127.87 136.17 156.70 127.95 137.50 154.23 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 E 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 G 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 G 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 130.60 149.22 149.86 131.12 146.92 147.82 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 133.04 140.38 153.60 132.61 137.79 152.63 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 E 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 G 163 TYR P 143 TYR~? 15.20 CL CL P2019 G 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 206.30 185.90 191.05 208.78 186.92 189.45 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 202.86 183.43 199.65 203.11 184.67 202.14 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 200.75 174.15 199.66 202.28 173.10 198.62 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 H 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 H 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 51.19 99.66 33.34 49.41 97.31 34.21 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 59.25 100.54 36.63 61.78 101.51 37.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 H 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 H 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 58.38 95.12 28.70 59.87 92.50 29.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 59.25 100.54 36.63 61.78 101.51 37.35 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 62.23 105.49 38.88 63.59 105.50 37.26 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 H 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 H 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 94.33 67.29 39.79 97.00 65.79 39.32 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 92.99 77.44 39.76 93.75 79.76 38.42 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 37 ARG~? -4.23 C1 GOL B3003s H 163 TYR B 35 TYR~? 15.50 C1 GOL B3003 H 236 ASP B 28 ASP~? 19.20 C1 GOL B3003 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 62.11 68.41 8.30 60.04 68.85 10.44 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 60.35 59.88 4.36 57.88 59.60 3.08 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 57.70 57.51 -0.61 56.74 59.29 -1.16 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 H 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 H 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 19.64 71.23 27.64 22.06 69.48 28.42 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 23.25 68.41 18.58 23.33 69.19 15.92 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG C 36 ARG~? 17.12 CL CL C2004 H 163 TYR C 35 TYR~? 12.95 CL CL C2004 H 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 37.77 8.89 71.79 36.83 11.19 70.06 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 45.94 6.51 69.90 48.30 5.07 69.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG C 37 ARG~? -20.33 CL CL C2004s H 163 TYR C 35 TYR~? 12.95 CL CL C2004 H 236 ASP C 28 ASP~? 15.70 CL CL C2004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 44.35 12.06 77.77 46.44 14.26 77.62 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 45.94 6.51 69.90 48.30 5.07 69.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 48.49 0.93 68.23 49.38 0.74 70.13 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG C 95 ARG~? 15.71 CL CL C2031 H 163 TYR C 75 TYR~? 10.50 CL CL C2011 H 236 ASP C 127 ASP.? 10.87 CL CL C2011 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 94.96 18.62 81.47 95.21 21.64 80.86 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 87.86 16.77 72.91 87.86 18.43 75.14 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 H 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 H 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 85.99 31.07 76.22 83.80 32.01 74.28 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 83.34 22.31 75.20 83.28 19.92 76.54 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 H 163 TYR D 35 TYR~? 13.02 CL CL H2005 H 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 55.93 43.64 102.74 57.91 43.73 100.41 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 48.27 47.24 102.95 45.77 48.18 103.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s H 163 TYR D 35 TYR~? 13.02 CL CL H2005 H 236 ASP D 28 ASP~? 15.80 CL CL H2005 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 48.82 38.28 99.42 47.22 38.23 96.82 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 48.27 47.24 102.95 45.77 48.18 103.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 45.36 50.43 107.49 43.88 48.98 107.89 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 H 163 TYR D 143 TYR~? 15.16 CL CL D2012 H 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 12.08 41.78 71.45 11.86 39.69 73.74 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 14.34 45.54 80.17 13.57 44.79 82.74 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 110 ARG E 36 ARG~? 16.00 C1 GOL E3004 H 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 H 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 66.28 100.73 63.79 67.89 98.12 63.67 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 58.94 102.78 60.36 56.69 104.19 59.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 110 ARG E 37 ARG~? -4.52 O1 GOL E3004s H 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 H 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 58.59 99.11 69.23 56.48 96.91 69.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 58.94 102.78 60.36 56.69 104.19 59.52 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 57.09 107.82 57.29 55.83 108.40 58.91 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 H 163 TYR E 143 TYR~? 15.23 CL CL E2013 H 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 16.30 80.38 65.14 17.26 82.53 67.17 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 20.79 87.99 61.33 20.74 90.64 62.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 H 163 TYR F 35 TYR~? 30.41 CL CL F2035 H 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 47.43 34.56 6.90 45.82 36.16 8.95 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 55.89 36.47 6.05 58.49 36.69 5.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 110 ARG F 37 ARG~? -27.07 CL CL F2035s H 163 TYR F 35 TYR~? 30.41 CL CL F2035 H 236 ASP F 28 ASP~? 32.62 CL CL F2035 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 53.50 28.70 11.30 55.02 28.89 13.93 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 55.89 36.47 6.05 58.49 36.69 5.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 59.39 38.13 1.08 60.39 36.31 1.06 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 F 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 H 163 TYR F 143 TYR~? 15.09 CL CL F2034 H 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 91.49 29.42 38.83 93.62 28.28 40.76 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 89.42 31.84 29.55 89.79 30.44 27.17 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 F 110 ARG G 37 ARG~? 20.29 CL CL C2004 H 163 TYR G 35 TYR~? 13.11 CL CL C2004 H 236 ASP G 28 ASP~? 15.85 CL CL C2004 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 52.62 7.45 38.03 50.95 9.97 37.63 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 50.35 3.70 46.66 47.74 2.77 47.00 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 47.14 -0.91 49.29 46.12 -1.37 47.54 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 F 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 H 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 H 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 15.17 34.68 33.42 15.78 32.53 31.28 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 16.97 25.90 37.77 16.51 23.33 36.84 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 F 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 H 163 TYR H 35 TYR~? 13.05 CL CL H2005 H 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 41.35 74.42 97.84 39.90 73.17 95.49 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 48.71 70.98 100.43 50.94 70.32 101.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 F 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s H 163 TYR H 35 TYR~? 13.05 CL CL H2005 H 236 ASP H 28 ASP~? 15.80 CL CL H2005 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 49.12 78.88 94.88 51.18 78.27 92.74 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 48.71 70.98 100.43 50.94 70.32 101.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 50.63 68.82 106.06 51.93 70.45 106.39 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 F 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 H 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 H 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 91.20 69.90 76.54 91.87 72.67 77.80 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 86.77 67.99 85.16 86.88 69.36 87.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 F 110 ARG I 36 ARG~? 18.35 CL CL I2001 H 163 TYR I 35 TYR~? 13.03 CL CL I2001 H 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 163.77 216.28 151.02 161.75 213.99 150.84 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 171.46 216.91 154.12 173.98 218.04 154.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 F 110 ARG I 37 ARG~? 20.23 CL CL I2001 H 163 TYR I 35 TYR~? 13.03 CL CL I2001 H 236 ASP I 28 ASP~? 15.71 CL CL I2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 170.53 211.87 145.98 172.22 209.35 146.21 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 171.46 216.91 154.12 173.98 218.04 154.69 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 174.34 221.90 156.42 175.71 222.11 154.83 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 F 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 H 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 H 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 209.45 186.59 151.83 209.12 188.26 149.20 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 206.55 195.37 154.41 207.09 197.83 153.23 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 F 110 ARG J 36 ARG~? 16.92 CL CL J2002 H 163 TYR J 35 TYR~? 13.02 CL CL J2002 H 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 181.40 180.11 121.45 182.70 178.85 123.93 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 173.30 177.82 119.58 170.88 177.40 118.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 F 110 ARG J 37 ARG~? 20.17 CL CL J2002 H 163 TYR J 35 TYR~? 13.02 CL CL J2002 H 236 ASP J 28 ASP~? 15.67 CL CL J2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 174.71 186.35 123.78 172.76 186.51 126.11 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 173.30 177.82 119.58 170.88 177.40 118.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 170.87 175.19 114.50 169.74 176.91 114.00 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 F 110 ARG J 145 ARG~? 22.99 CL CL J2016 H 163 TYR J 143 TYR~? 15.18 CL CL J2016 H 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 132.84 187.86 144.62 133.71 189.96 142.45 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 136.50 183.91 136.49 136.50 184.93 133.88 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 F 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 H 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 H 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 156.15 122.83 185.77 154.85 125.10 184.29 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 164.29 120.92 183.43 166.71 119.58 183.22 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 F 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s H 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 H 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 162.88 126.06 191.42 164.87 128.39 191.36 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 164.29 120.92 183.43 166.71 119.58 183.22 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 166.96 115.59 181.42 167.86 115.34 183.30 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 F 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 H 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 H 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 204.60 147.17 190.28 202.10 146.29 191.85 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 201.16 138.32 187.50 201.22 135.84 188.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 F 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 H 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 H 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 174.06 157.20 217.38 176.23 157.17 215.21 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 166.36 159.94 218.26 163.88 160.60 219.34 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 F 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 H 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 H 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 167.17 151.29 214.24 165.45 151.32 211.73 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 166.36 159.94 218.26 163.88 160.60 219.34 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 163.49 162.78 223.08 162.21 161.15 223.46 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 F 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 H 163 TYR L 143 TYR~? 15.30 CL CL L2009 H 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 129.45 155.66 188.12 131.98 157.11 187.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 131.10 157.77 197.34 130.52 156.95 199.97 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 F 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 H 163 TYR M 35 TYR~? 13.00 CL CL I2001 H 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 179.97 216.30 180.98 181.48 213.82 180.04 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 172.26 218.21 177.69 169.95 219.60 176.96 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 F 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s H 163 TYR M 35 TYR~? 13.00 CL CL I2001 H 236 ASP M 28 ASP~? 15.52 CL CL I2001 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 172.69 214.03 186.60 170.63 211.79 186.52 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 172.26 218.21 177.69 169.95 219.60 176.96 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 170.27 223.20 174.57 168.89 223.83 176.08 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 F 110 ARG M 145 ARG~? 23.51 CL CL M2017 H 163 TYR M 143 TYR~? 15.40 CL CL M2017 H 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 131.12 192.72 183.38 131.87 195.02 185.33 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 134.88 201.35 179.85 134.66 203.97 180.76 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 F 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 H 163 TYR N 35 TYR~? 13.09 CL CL J2002 H 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 161.60 152.07 121.93 160.06 153.41 124.19 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 169.83 154.24 120.71 172.41 154.64 119.66 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 F 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s H 163 TYR N 35 TYR~? 13.09 CL CL J2002 H 236 ASP N 28 ASP~? 15.68 CL CL J2002 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 167.97 146.21 125.72 169.64 146.36 128.31 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 169.83 154.24 120.71 172.41 154.64 119.66 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 173.04 156.37 115.74 174.12 154.54 115.64 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 F 110 ARG N 95 ARG~? 18.49 CL CL N2030 H 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 H 236 ASP N 127 ASP.? 12.60 CL CL N2030 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 215.46 144.14 140.72 215.90 144.66 143.75 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 209.71 152.64 137.80 209.50 150.35 139.41 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 F 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 H 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 H 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 206.36 147.54 151.55 205.74 145.29 149.50 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 204.41 150.24 142.39 204.78 148.95 139.97 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 F 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 H 163 TYR O 35 TYR~? 20.32 CL CL K2003 H 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 175.82 120.47 157.52 177.72 122.75 158.28 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 167.80 119.41 159.74 165.27 118.34 160.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 F 110 ARG O 37 ARG~? 22.15 CL CL K2003 H 163 TYR O 35 TYR~? 20.32 CL CL K2003 H 236 ASP O 28 ASP~? 23.95 CL CL O2036 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 169.49 123.46 151.21 167.81 125.99 151.08 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 167.80 119.41 159.74 165.27 118.34 160.26 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 164.72 114.57 162.31 163.52 114.24 160.62 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 F 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 H 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 H 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 130.60 149.22 149.86 131.12 146.92 147.82 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 133.04 140.38 153.60 132.61 137.79 152.63 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 F 110 ARG P 36 ARG~? 18.56 O1 GOL L3028 H 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 H 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 157.78 187.06 214.51 156.14 185.86 212.27 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 165.51 183.94 216.71 167.90 183.49 218.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 167.75 181.83 222.09 168.94 183.53 222.37 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 47 3 # 47 F 110 ARG P 37 ARG~? -21.37 O3 GOL M3007s H 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 H 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 165.27 191.94 211.53 167.28 191.57 209.25 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 165.51 183.94 216.71 167.90 183.49 218.05 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 167.75 181.83 222.09 168.94 183.53 222.37 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 48 3 # 48 F 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 H 163 TYR P 143 TYR~? 15.20 CL CL P2019 H 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 206.30 185.90 191.05 208.78 186.92 189.45 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 202.86 183.43 199.65 203.11 184.67 202.14 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 200.75 174.15 199.66 202.28 173.10 198.62 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 48 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 E 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 G 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 59.25 100.54 36.63 61.78 101.51 37.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 62.23 105.49 38.88 63.59 105.50 37.26 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 E 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 G 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 59.25 100.54 36.63 61.78 101.51 37.35 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 62.23 105.49 38.88 63.59 105.50 37.26 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 E 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s G 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 92.99 77.44 39.76 93.75 79.76 38.42 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 90.44 78.16 48.76 91.65 76.94 50.06 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 35 TYR~? 15.50 C1 GOL B3003 E 236 ASP B 28 ASP~? 19.20 C1 GOL B3003 G 110 ARG B 37 ARG~? -4.23 C1 GOL B3003s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 60.35 59.88 4.36 57.88 59.60 3.08 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 57.70 57.51 -0.61 56.74 59.29 -1.16 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 62.11 68.41 8.30 60.04 68.85 10.44 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 E 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s G 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 23.25 68.41 18.58 23.33 69.19 15.92 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 23.66 59.02 20.34 21.93 58.32 21.38 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 35 TYR~? 12.95 CL CL C2004 E 236 ASP C 28 ASP~? 15.70 CL CL C2004 G 110 ARG C 36 ARG~? 17.12 CL CL C2004 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 45.94 6.51 69.90 48.30 5.07 69.65 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 48.49 0.93 68.23 49.38 0.74 70.13 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 35 TYR~? 12.95 CL CL C2004 E 236 ASP C 28 ASP~? 15.70 CL CL C2004 G 110 ARG C 37 ARG~? -20.33 CL CL C2004s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 45.94 6.51 69.90 48.30 5.07 69.65 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 48.49 0.93 68.23 49.38 0.74 70.13 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR C 75 TYR~? 10.50 CL CL C2011 E 236 ASP C 127 ASP.? 10.87 CL CL C2011 G 110 ARG C 95 ARG~? 15.71 CL CL C2031 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 87.86 16.77 72.91 87.86 18.43 75.14 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 86.95 7.50 76.71 86.89 6.71 78.70 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 94.96 18.62 81.47 95.21 21.64 80.86 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 E 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s G 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 83.34 22.31 75.20 83.28 19.92 76.54 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 82.81 22.02 65.69 84.52 22.80 64.66 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR D 35 TYR~? 13.02 CL CL H2005 E 236 ASP D 28 ASP~? 15.80 CL CL H2005 G 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 48.27 47.24 102.95 45.77 48.18 103.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.36 50.43 107.49 43.88 48.98 107.89 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR D 35 TYR~? 13.02 CL CL H2005 E 236 ASP D 28 ASP~? 15.80 CL CL H2005 G 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 48.27 47.24 102.95 45.77 48.18 103.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 45.36 50.43 107.49 43.88 48.98 107.89 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR D 143 TYR~? 15.16 CL CL D2012 E 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s G 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 14.34 45.54 80.17 13.57 44.79 82.74 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 16.94 54.59 79.01 15.65 55.42 77.54 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 G 110 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 58.94 102.78 60.36 56.69 104.19 59.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 57.09 107.82 57.29 55.83 108.40 58.91 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 E 163 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 236 ASP E 28 ASP~? 19.58 O1 GOL E3004 G 110 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 58.94 102.78 60.36 56.69 104.19 59.52 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 57.09 107.82 57.29 55.83 108.40 58.91 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 E 163 TYR E 143 TYR~? 15.23 CL CL E2013 E 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 G 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 20.79 87.99 61.33 20.74 90.64 62.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 23.07 86.29 52.35 21.57 85.17 51.32 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 E 163 TYR F 35 TYR~? 30.41 CL CL F2035 E 236 ASP F 28 ASP~? 32.62 CL CL F2035 G 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 55.89 36.47 6.05 58.49 36.69 5.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 59.39 38.13 1.08 60.39 36.31 1.06 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 E 163 TYR F 35 TYR~? 30.41 CL CL F2035 E 236 ASP F 28 ASP~? 32.62 CL CL F2035 G 110 ARG F 37 ARG~? -27.07 CL CL F2035s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 55.89 36.47 6.05 58.49 36.69 5.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 59.39 38.13 1.08 60.39 36.31 1.06 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 E 163 TYR F 143 TYR~? 15.09 CL CL F2034 E 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s G 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 89.42 31.84 29.55 89.79 30.44 27.17 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 88.86 41.25 28.96 90.30 42.22 30.24 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 E 163 TYR G 35 TYR~? 13.11 CL CL C2004 E 236 ASP G 28 ASP~? 15.85 CL CL C2004 G 110 ARG G 37 ARG~? 20.29 CL CL C2004 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 50.35 3.70 46.66 47.74 2.77 47.00 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 E 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 E 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s G 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 16.97 25.90 37.77 16.51 23.33 36.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 17.70 27.34 47.09 16.19 28.71 47.73 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 E 163 TYR H 35 TYR~? 13.05 CL CL H2005 E 236 ASP H 28 ASP~? 15.80 CL CL H2005 G 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 48.71 70.98 100.43 50.94 70.32 101.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 50.63 68.82 106.06 51.93 70.45 106.39 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 E 163 TYR H 35 TYR~? 13.05 CL CL H2005 E 236 ASP H 28 ASP~? 15.80 CL CL H2005 G 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 48.71 70.98 100.43 50.94 70.32 101.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 50.63 68.82 106.06 51.93 70.45 106.39 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 E 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 E 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s G 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 86.77 67.99 85.16 86.88 69.36 87.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 84.24 58.93 85.48 85.73 57.59 84.66 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 E 163 TYR I 35 TYR~? 13.03 CL CL I2001 E 236 ASP I 28 ASP~? 15.71 CL CL I2001 G 110 ARG I 36 ARG~? 18.35 CL CL I2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 171.46 216.91 154.12 173.98 218.04 154.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 174.34 221.90 156.42 175.71 222.11 154.83 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 E 163 TYR I 35 TYR~? 13.03 CL CL I2001 E 236 ASP I 28 ASP~? 15.71 CL CL I2001 G 110 ARG I 37 ARG~? 20.23 CL CL I2001 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 171.46 216.91 154.12 173.98 218.04 154.69 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 174.34 221.90 156.42 175.71 222.11 154.83 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 E 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 E 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s G 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 206.55 195.37 154.41 207.09 197.83 153.23 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 204.37 195.46 163.61 205.75 194.30 164.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 E 163 TYR J 35 TYR~? 13.02 CL CL J2002 E 236 ASP J 28 ASP~? 15.67 CL CL J2002 G 110 ARG J 36 ARG~? 16.92 CL CL J2002 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 173.30 177.82 119.58 170.88 177.40 118.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 170.87 175.19 114.50 169.74 176.91 114.00 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 E 163 TYR J 35 TYR~? 13.02 CL CL J2002 E 236 ASP J 28 ASP~? 15.67 CL CL J2002 G 110 ARG J 37 ARG~? 20.17 CL CL J2002 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 173.30 177.82 119.58 170.88 177.40 118.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 170.87 175.19 114.50 169.74 176.91 114.00 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 E 163 TYR J 143 TYR~? 15.18 CL CL J2016 E 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 G 110 ARG J 145 ARG~? 22.99 CL CL J2016 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 136.50 183.91 136.49 136.50 184.93 133.88 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 137.44 174.60 137.57 135.80 173.80 138.69 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 E 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 G 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 164.29 120.92 183.43 166.71 119.58 183.22 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 166.96 115.59 181.42 167.86 115.34 183.30 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 E 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 G 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 164.29 120.92 183.43 166.71 119.58 183.22 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 166.96 115.59 181.42 167.86 115.34 183.30 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 E 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 E 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s G 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 201.16 138.32 187.50 201.22 135.84 188.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 200.17 138.24 178.11 201.77 139.28 177.19 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 E 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 E 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 G 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 166.36 159.94 218.26 163.88 160.60 219.34 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 163.49 162.78 223.08 162.21 161.15 223.46 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 E 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 E 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 G 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 166.36 159.94 218.26 163.88 160.60 219.34 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 163.49 162.78 223.08 162.21 161.15 223.46 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 E 163 TYR L 143 TYR~? 15.30 CL CL L2009 E 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s G 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 131.10 157.77 197.34 130.52 156.95 199.97 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 133.34 166.97 196.27 132.03 168.03 194.96 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 E 163 TYR M 35 TYR~? 13.00 CL CL I2001 E 236 ASP M 28 ASP~? 15.52 CL CL I2001 G 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 172.26 218.21 177.69 169.95 219.60 176.96 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 170.27 223.20 174.57 168.89 223.83 176.08 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 E 163 TYR M 35 TYR~? 13.00 CL CL I2001 E 236 ASP M 28 ASP~? 15.52 CL CL I2001 G 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 172.26 218.21 177.69 169.95 219.60 176.96 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 170.27 223.20 174.57 168.89 223.83 176.08 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 E 163 TYR M 143 TYR~? 15.40 CL CL M2017 E 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s G 110 ARG M 145 ARG~? 23.51 CL CL M2017 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 134.88 201.35 179.85 134.66 203.97 180.76 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 136.87 200.18 170.79 135.36 199.08 169.77 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 E 163 TYR N 35 TYR~? 13.09 CL CL J2002 E 236 ASP N 28 ASP~? 15.68 CL CL J2002 G 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 169.83 154.24 120.71 172.41 154.64 119.66 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 173.04 156.37 115.74 174.12 154.54 115.64 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 E 163 TYR N 35 TYR~? 13.09 CL CL J2002 E 236 ASP N 28 ASP~? 15.68 CL CL J2002 G 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 169.83 154.24 120.71 172.41 154.64 119.66 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 173.04 156.37 115.74 174.12 154.54 115.64 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 E 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 E 236 ASP N 127 ASP.? 12.60 CL CL N2030 G 110 ARG N 95 ARG~? 18.49 CL CL N2030 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 209.71 152.64 137.80 209.50 150.35 139.41 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 210.39 149.08 128.41 210.51 147.14 127.55 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 215.46 144.14 140.72 215.90 144.66 143.75 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 E 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 E 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s G 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 204.41 150.24 142.39 204.78 148.95 139.97 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 203.51 159.51 142.26 205.02 160.53 143.48 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 E 163 TYR O 35 TYR~? 20.32 CL CL K2003 E 236 ASP O 28 ASP~? 23.95 CL CL O2036 G 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 167.80 119.41 159.74 165.27 118.34 160.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 164.72 114.57 162.31 163.52 114.24 160.62 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 E 163 TYR O 35 TYR~? 20.32 CL CL K2003 E 236 ASP O 28 ASP~? 23.95 CL CL O2036 G 110 ARG O 37 ARG~? 22.15 CL CL K2003 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 167.80 119.41 159.74 165.27 118.34 160.26 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 164.72 114.57 162.31 163.52 114.24 160.62 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 E 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 E 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s G 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 133.04 140.38 153.60 132.61 137.79 152.63 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 134.07 141.35 162.95 132.57 142.58 163.78 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 E 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 E 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 G 110 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 165.51 183.94 216.71 167.90 183.49 218.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 167.75 181.83 222.09 168.94 183.53 222.37 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 47 3 # 47 E 163 TYR P 35 TYR~? 28.94 O1 GOL L3028 E 236 ASP P 28 ASP~? 33.76 O1 GOL L3028 G 110 ARG P 37 ARG~? -21.37 O3 GOL M3007s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 165.51 183.94 216.71 167.90 183.49 218.05 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 167.75 181.83 222.09 168.94 183.53 222.37 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 165.27 191.94 211.53 167.28 191.57 209.25 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 48 3 # 48 E 163 TYR P 143 TYR~? 15.20 CL CL P2019 E 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 G 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 202.86 183.43 199.65 203.11 184.67 202.14 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 200.75 174.15 199.66 202.28 173.10 198.62 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 206.30 185.90 191.05 208.78 186.92 189.45 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 48 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 F 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 H 110 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 59.25 100.54 36.63 61.78 101.51 37.35 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 62.23 105.49 38.88 63.59 105.50 37.26 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 35 TYR~? 31.11 O2 GOL E3035 F 236 ASP A 28 ASP~? 35.69 O2 GOL E3035 H 110 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 59.25 100.54 36.63 61.78 101.51 37.35 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 62.23 105.49 38.88 63.59 105.50 37.26 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 143 TYR~? 16.38 O1 GOL A3040 F 236 ASP A 70 ASP~? -9.95 O3 GOL A3037s H 110 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 92.99 77.44 39.76 93.75 79.76 38.42 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 90.44 78.16 48.76 91.65 76.94 50.06 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 143 TYR~? 10.77 O2 GOL B3024 F 236 ASP B 70 ASP~? -3.24 O2 GOL B3024s H 110 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 23.25 68.41 18.58 23.33 69.19 15.92 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 23.66 59.02 20.34 21.93 58.32 21.38 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR C 35 TYR~? 12.95 CL CL C2004 F 236 ASP C 28 ASP~? 15.70 CL CL C2004 H 110 ARG C 36 ARG~? 17.12 CL CL C2004 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 45.94 6.51 69.90 48.30 5.07 69.65 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 48.49 0.93 68.23 49.38 0.74 70.13 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 35 TYR~? 12.95 CL CL C2004 F 236 ASP C 28 ASP~? 15.70 CL CL C2004 H 110 ARG C 37 ARG~? -20.33 CL CL C2004s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 45.94 6.51 69.90 48.30 5.07 69.65 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 48.49 0.93 68.23 49.38 0.74 70.13 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 75 TYR~? 10.50 CL CL C2011 F 236 ASP C 127 ASP.? 10.87 CL CL C2011 H 110 ARG C 95 ARG~? 15.71 CL CL C2031 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 87.86 16.77 72.91 87.86 18.43 75.14 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 86.95 7.50 76.71 86.89 6.71 78.70 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 94.96 18.62 81.47 95.21 21.64 80.86 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR C 143 TYR~? 14.40 O1 GOL C3036 F 236 ASP C 70 ASP~? 3.38 O1 GOL C3036s H 110 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 83.34 22.31 75.20 83.28 19.92 76.54 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 82.81 22.02 65.69 84.52 22.80 64.66 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 35 TYR~? 13.02 CL CL H2005 F 236 ASP D 28 ASP~? 15.80 CL CL H2005 H 110 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 48.27 47.24 102.95 45.77 48.18 103.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 45.36 50.43 107.49 43.88 48.98 107.89 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR D 35 TYR~? 13.02 CL CL H2005 F 236 ASP D 28 ASP~? 15.80 CL CL H2005 H 110 ARG D 37 ARG~? -4.25 O1 GOL D3005s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 48.27 47.24 102.95 45.77 48.18 103.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 45.36 50.43 107.49 43.88 48.98 107.89 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 48.82 38.28 99.42 47.22 38.23 96.82 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR D 143 TYR~? 15.16 CL CL D2012 F 236 ASP D 70 ASP~? -11.51 O3 GOL D3019s H 110 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 14.34 45.54 80.17 13.57 44.79 82.74 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 16.94 54.59 79.01 15.65 55.42 77.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR E 143 TYR~? 15.23 CL CL E2013 F 236 ASP E 70 ASP~? 5.56 O3 GOL E3002 H 110 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 20.79 87.99 61.33 20.74 90.64 62.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 23.07 86.29 52.35 21.57 85.17 51.32 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR F 35 TYR~? 30.41 CL CL F2035 F 236 ASP F 28 ASP~? 32.62 CL CL F2035 H 110 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 55.89 36.47 6.05 58.49 36.69 5.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 59.39 38.13 1.08 60.39 36.31 1.06 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 F 163 TYR F 35 TYR~? 30.41 CL CL F2035 F 236 ASP F 28 ASP~? 32.62 CL CL F2035 H 110 ARG F 37 ARG~? -27.07 CL CL F2035s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 55.89 36.47 6.05 58.49 36.69 5.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 59.39 38.13 1.08 60.39 36.31 1.06 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 15 3 # 15 F 163 TYR F 75 TYR~? 9.99 CL CL F2034 F 236 ASP F 127 ASP.? 10.85 CL CL F2034 H 110 ARG F 95 ARG~? 18.18 CL CL F2034 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 95.01 33.97 25.26 94.64 31.83 27.03 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 96.13 30.12 15.93 96.25 28.10 15.23 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 101.23 25.44 29.03 100.92 26.10 32.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 16 3 # 16 F 163 TYR F 143 TYR~? 15.09 CL CL F2034 F 236 ASP F 70 ASP~? -11.57 O3 GOL F3039s H 110 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 89.42 31.84 29.55 89.79 30.44 27.17 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 88.86 41.25 28.96 90.30 42.22 30.24 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 17 3 # 17 F 163 TYR G 35 TYR~? 13.11 CL CL C2004 F 236 ASP G 28 ASP~? 15.85 CL CL C2004 H 110 ARG G 37 ARG~? 20.29 CL CL C2004 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 50.35 3.70 46.66 47.74 2.77 47.00 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 47.14 -0.91 49.29 46.12 -1.37 47.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 52.62 7.45 38.03 50.95 9.97 37.63 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 18 3 # 18 F 163 TYR G 143 TYR~? 15.53 C3 GOL G3001 F 236 ASP G 70 ASP~? -5.29 C3 GOL G3001s H 110 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 16.97 25.90 37.77 16.51 23.33 36.84 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 17.70 27.34 47.09 16.19 28.71 47.73 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 19 3 # 19 F 163 TYR H 35 TYR~? 13.05 CL CL H2005 F 236 ASP H 28 ASP~? 15.80 CL CL H2005 H 110 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 48.71 70.98 100.43 50.94 70.32 101.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 50.63 68.82 106.06 51.93 70.45 106.39 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 20 3 # 20 F 163 TYR H 35 TYR~? 13.05 CL CL H2005 F 236 ASP H 28 ASP~? 15.80 CL CL H2005 H 110 ARG H 37 ARG~? -4.44 O3 GOL H3006s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 48.71 70.98 100.43 50.94 70.32 101.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 50.63 68.82 106.06 51.93 70.45 106.39 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 49.12 78.88 94.88 51.18 78.27 92.74 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 21 3 # 21 F 163 TYR H 143 TYR~? 11.30 O2 GOL H3016 F 236 ASP H 70 ASP~? -4.05 C3 GOL H3016s H 110 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 86.77 67.99 85.16 86.88 69.36 87.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 84.24 58.93 85.48 85.73 57.59 84.66 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 22 3 # 22 F 163 TYR I 35 TYR~? 13.03 CL CL I2001 F 236 ASP I 28 ASP~? 15.71 CL CL I2001 H 110 ARG I 36 ARG~? 18.35 CL CL I2001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 171.46 216.91 154.12 173.98 218.04 154.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 174.34 221.90 156.42 175.71 222.11 154.83 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 23 3 # 23 F 163 TYR I 35 TYR~? 13.03 CL CL I2001 F 236 ASP I 28 ASP~? 15.71 CL CL I2001 H 110 ARG I 37 ARG~? 20.23 CL CL I2001 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 171.46 216.91 154.12 173.98 218.04 154.69 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 174.34 221.90 156.42 175.71 222.11 154.83 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 24 3 # 24 F 163 TYR I 143 TYR~? 11.25 C1 GOL I3032 F 236 ASP I 70 ASP~? -3.65 C2 GOL I3032s H 110 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 206.55 195.37 154.41 207.09 197.83 153.23 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 204.37 195.46 163.61 205.75 194.30 164.79 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 25 3 # 25 F 163 TYR J 35 TYR~? 13.02 CL CL J2002 F 236 ASP J 28 ASP~? 15.67 CL CL J2002 H 110 ARG J 36 ARG~? 16.92 CL CL J2002 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 173.30 177.82 119.58 170.88 177.40 118.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 170.87 175.19 114.50 169.74 176.91 114.00 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 26 3 # 26 F 163 TYR J 35 TYR~? 13.02 CL CL J2002 F 236 ASP J 28 ASP~? 15.67 CL CL J2002 H 110 ARG J 37 ARG~? 20.17 CL CL J2002 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 173.30 177.82 119.58 170.88 177.40 118.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 170.87 175.19 114.50 169.74 176.91 114.00 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 27 3 # 27 F 163 TYR J 143 TYR~? 15.18 CL CL J2016 F 236 ASP J 70 ASP~? 11.68 O1 GOL J3033 H 110 ARG J 145 ARG~? 22.99 CL CL J2016 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 136.50 183.91 136.49 136.50 184.93 133.88 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 137.44 174.60 137.57 135.80 173.80 138.69 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 28 3 # 28 F 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 F 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 H 110 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 164.29 120.92 183.43 166.71 119.58 183.22 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 166.96 115.59 181.42 167.86 115.34 183.30 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 29 3 # 29 F 163 TYR K 35 TYR~? 15.70 O1 GOL K3011 F 236 ASP K 28 ASP~? 19.61 O1 GOL K3011 H 110 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 164.29 120.92 183.43 166.71 119.58 183.22 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 166.96 115.59 181.42 167.86 115.34 183.30 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 30 3 # 30 F 163 TYR K 75 TYR~? 12.36 CL CL K2027 F 236 ASP K 127 ASP.? 12.37 CL CL K2027 H 110 ARG K 95 ARG~? 18.15 CL CL K2027 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 205.79 133.16 185.06 205.81 134.80 187.34 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 205.42 123.70 188.60 205.51 122.74 190.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 211.85 134.99 193.85 212.13 138.00 193.03 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 31 3 # 31 F 163 TYR K 143 TYR~? 15.99 O3 GOL K3009 F 236 ASP K 70 ASP~? -4.89 O3 GOL K3009s H 110 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 201.16 138.32 187.50 201.22 135.84 188.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 200.17 138.24 178.11 201.77 139.28 177.19 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 32 3 # 32 F 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 F 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 H 110 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 166.36 159.94 218.26 163.88 160.60 219.34 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 163.49 162.78 223.08 162.21 161.15 223.46 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 33 3 # 33 F 163 TYR L 35 TYR~? 33.75 O3 GOL K3011 F 236 ASP L 28 ASP~? 34.50 O1 GOL L3028 H 110 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 166.36 159.94 218.26 163.88 160.60 219.34 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 163.49 162.78 223.08 162.21 161.15 223.46 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 167.17 151.29 214.24 165.45 151.32 211.73 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 34 3 # 34 F 163 TYR L 143 TYR~? 15.30 CL CL L2009 F 236 ASP L 70 ASP~? -12.27 O3 GOL L3028s H 110 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 131.10 157.77 197.34 130.52 156.95 199.97 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 133.34 166.97 196.27 132.03 168.03 194.96 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 35 3 # 35 F 163 TYR M 35 TYR~? 13.00 CL CL I2001 F 236 ASP M 28 ASP~? 15.52 CL CL I2001 H 110 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 172.26 218.21 177.69 169.95 219.60 176.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 170.27 223.20 174.57 168.89 223.83 176.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 36 3 # 36 F 163 TYR M 35 TYR~? 13.00 CL CL I2001 F 236 ASP M 28 ASP~? 15.52 CL CL I2001 H 110 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 172.26 218.21 177.69 169.95 219.60 176.96 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 170.27 223.20 174.57 168.89 223.83 176.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 37 3 # 37 F 163 TYR M 143 TYR~? 15.40 CL CL M2017 F 236 ASP M 70 ASP~? -9.98 O3 GOL M3042s H 110 ARG M 145 ARG~? 23.51 CL CL M2017 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 134.88 201.35 179.85 134.66 203.97 180.76 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 136.87 200.18 170.79 135.36 199.08 169.77 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 38 3 # 38 F 163 TYR N 35 TYR~? 13.09 CL CL J2002 F 236 ASP N 28 ASP~? 15.68 CL CL J2002 H 110 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 169.83 154.24 120.71 172.41 154.64 119.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 173.04 156.37 115.74 174.12 154.54 115.64 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 39 3 # 39 F 163 TYR N 35 TYR~? 13.09 CL CL J2002 F 236 ASP N 28 ASP~? 15.68 CL CL J2002 H 110 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 169.83 154.24 120.71 172.41 154.64 119.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 173.04 156.37 115.74 174.12 154.54 115.64 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 40 3 # 40 F 163 TYR N 75 TYR~? 12.44 O2 GOL N3029 F 236 ASP N 127 ASP.? 12.60 CL CL N2030 H 110 ARG N 95 ARG~? 18.49 CL CL N2030 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 209.71 152.64 137.80 209.50 150.35 139.41 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 210.39 149.08 128.41 210.51 147.14 127.55 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 215.46 144.14 140.72 215.90 144.66 143.75 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 41 3 # 41 F 163 TYR N 143 TYR~? 10.73 O2 GOL N3029 F 236 ASP N 70 ASP~? -3.26 O2 GOL N3029s H 110 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 204.41 150.24 142.39 204.78 148.95 139.97 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 203.51 159.51 142.26 205.02 160.53 143.48 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 42 3 # 42 F 163 TYR O 35 TYR~? 20.32 CL CL K2003 F 236 ASP O 28 ASP~? 23.95 CL CL O2036 H 110 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 167.80 119.41 159.74 165.27 118.34 160.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 164.72 114.57 162.31 163.52 114.24 160.62 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 43 3 # 43 F 163 TYR O 35 TYR~? 20.32 CL CL K2003 F 236 ASP O 28 ASP~? 23.95 CL CL O2036 H 110 ARG O 37 ARG~? 22.15 CL CL K2003 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 167.80 119.41 159.74 165.27 118.34 160.26 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 164.72 114.57 162.31 163.52 114.24 160.62 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 169.49 123.46 151.21 167.81 125.99 151.08 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 44 3 # 44 F 163 TYR O 75 TYR~? 10.24 CL CL O2018 F 236 ASP O 127 ASP.? 11.33 CL CL O2018 H 110 ARG O 95 ARG~? 18.05 CL CL O2018 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 127.87 136.17 156.70 127.95 137.50 154.23 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 127.12 126.29 154.29 127.00 125.34 152.37 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 121.75 137.79 148.01 121.99 140.87 148.18 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 45 3 # 45 F 163 TYR O 143 TYR~? 11.76 C3 GOL O3026 F 236 ASP O 70 ASP~? 3.30 O1 GOL O3013s H 110 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 133.04 140.38 153.60 132.61 137.79 152.63 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 134.07 141.35 162.95 132.57 142.58 163.78 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 46 3 # 46 F 163 TYR P 143 TYR~? 15.20 CL CL P2019 F 236 ASP P 70 ASP~? 4.30 O3 GOL P3014 H 110 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 202.86 183.43 199.65 203.11 184.67 202.14 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 200.75 174.15 199.66 202.28 173.10 198.62 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 206.30 185.90 191.05 208.78 186.92 189.45 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 46 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 127 ASP.? 12.37 CL CL A2020 A 147 THR A 97 THR~? 9.81 CL CL A2020 A 294 ASP A 92 ASP~? 15.30 CL CL A2020 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 99.76 91.11 38.83 100.13 91.74 36.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 100.83 84.52 39.91 101.55 86.37 38.97 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 108.94 81.51 35.78 108.70 83.14 34.47 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 127 ASP.? 11.35 CL CL B2010 A 147 THR B 97 THR~? 8.84 CL CL B2010 A 294 ASP B 92 ASP~? 16.05 CL CL B2010 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 19.74 66.97 3.53 20.01 68.79 2.38 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 17.05 67.62 9.77 17.03 68.13 7.64 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 9.78 73.89 9.95 11.15 74.42 8.49 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP D 127 ASP.? 11.17 CL CL D2012 A 147 THR D 97 THR~? 8.97 CL CL D2012 A 294 ASP D 92 ASP~? 15.62 CL CL D2022 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 7.65 47.79 93.97 7.18 46.10 95.19 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 6.41 47.42 87.31 5.66 46.88 89.28 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -1.67 42.91 85.09 -1.08 41.92 86.85 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP E 127 ASP.? 11.39 CL CL E2013 A 147 THR E 97 THR~? 8.92 CL CL E2013 A 294 ASP E 92 ASP~? 15.39 CL CL E2032 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 17.80 103.20 59.40 17.93 103.89 61.44 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 14.93 96.69 59.62 14.80 98.78 60.10 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 6.40 96.69 64.15 7.81 98.00 64.97 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP G 127 ASP.? 12.80 CL CL G2033 A 147 THR G 97 THR~? 10.45 CL CL G2033 A 294 ASP G 92 ASP~? 15.60 CL CL G2033 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 10.22 12.11 38.73 10.33 11.10 36.86 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 9.13 18.78 38.11 8.58 16.78 37.47 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 2.22 20.23 31.66 3.30 18.41 31.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP H 127 ASP.? 11.27 CL CL H2014 A 147 THR H 97 THR~? 9.01 CL CL H2014 A 294 ASP H 92 ASP~? 15.85 CL CL H2024 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 90.18 69.09 100.25 90.25 71.19 100.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 92.70 68.03 93.96 92.81 68.94 95.96 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 101.24 72.29 93.07 100.11 73.39 94.44 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP I 127 ASP.? 10.93 CL CL I2015 A 147 THR I 97 THR~? 8.89 CL CL I2015 A 294 ASP I 92 ASP~? 15.56 CL CL I2025 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 212.49 209.49 154.15 212.74 210.27 152.16 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 214.00 203.11 154.73 214.55 205.07 153.95 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 222.01 200.70 150.15 220.98 202.18 149.11 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP J 127 ASP.? 11.08 CL CL J2016 A 147 THR J 97 THR~? 8.85 CL CL J2016 A 294 ASP J 92 ASP~? 15.35 CL CL J2026 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 132.13 183.26 121.62 132.41 185.18 120.66 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 129.88 183.52 128.01 129.69 184.25 125.95 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 122.14 189.51 128.78 123.73 190.15 127.54 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP M 127 ASP.? 9.06 CL CL M2017 A 147 THR M 97 THR~? 8.90 CL CL M2017 A 294 ASP M 92 ASP~? 15.40 CL CL M2029 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 130.79 216.32 178.32 129.76 218.07 177.66 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 128.36 209.80 178.57 127.99 211.95 179.07 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 120.06 209.18 183.48 121.50 210.55 184.17 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP N 127 ASP.? 12.60 CL CL N2030 A 147 THR N 97 THR~? 10.31 CL CL N2030 A 294 ASP N 92 ASP~? 15.48 CL CL N2030 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 210.39 149.08 128.41 210.51 147.14 127.55 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 211.93 149.52 134.75 212.27 148.66 132.76 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 219.13 143.58 136.78 218.22 142.74 135.01 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP P 127 ASP.? 11.05 CL CL P2019 A 147 THR P 97 THR~? 9.06 CL CL P2019 A 294 ASP P 92 ASP~? 16.23 CL CL P2019 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 207.19 183.81 214.61 207.22 185.89 215.11 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 209.41 183.26 208.09 209.69 184.17 210.04 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 217.62 187.96 206.84 216.52 189.08 208.26 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 11 hits 1qgx_c02 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 25 THR~? 27.96 O2 GOL E3035 A 182 TYR A 21 TYR~? 26.32 C3 GOL E3035 A 186 LYS A 22 LYS~? 17.94 O2 GOL E3035 coo 69.38 87.38 24.64 71.11 88.47 25.40 56.92 104.13 38.66 55.44 103.64 37.18 coo 73.61 90.42 31.12 71.36 89.66 29.64 56.96 96.11 38.73 58.94 94.19 38.55 coo 73.54 84.00 28.64 69.01 86.68 29.71 53.67 100.75 40.87 47.74 98.27 41.17 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 25 THR~? 18.37 C1 GOL B3003 A 182 TYR B 21 TYR~? 13.85 C1 GOL B3003 A 186 LYS B 22 LYS~? 21.36 O2 GOL B3003 coo 69.38 87.38 24.64 71.11 88.47 25.40 62.90 57.03 1.60 64.66 58.25 2.10 coo 73.61 90.42 31.12 71.36 89.66 29.64 61.46 58.47 9.41 59.23 59.36 10.88 coo 73.54 84.00 28.64 69.01 86.68 29.71 65.01 54.92 6.02 70.07 53.87 9.73 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 25 THR~? 14.08 CL CL C2004 A 182 TYR C 21 TYR~? 10.49 CL CL C2004 A 186 LYS C 22 LYS~? 13.40 CL CL C2004 coo 69.38 87.38 24.64 71.11 88.47 25.40 43.51 3.31 67.24 41.79 4.10 68.28 coo 73.61 90.42 31.12 71.36 89.66 29.64 45.13 11.15 67.52 47.31 12.70 68.21 coo 73.54 84.00 28.64 69.01 86.68 29.71 41.54 7.20 64.53 36.41 10.79 63.02 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR D 25 THR~? 14.25 CL CL H2005 A 182 TYR D 21 TYR~? 10.58 CL CL H2005 A 186 LYS D 22 LYS~? 13.25 CL CL H2005 coo 69.38 87.38 24.64 71.11 88.47 25.40 50.68 49.91 106.11 52.11 48.30 105.88 coo 73.61 90.42 31.12 71.36 89.66 29.64 50.45 48.27 98.24 48.40 47.71 96.43 coo 73.54 84.00 28.64 69.01 86.68 29.71 53.93 51.31 102.22 59.63 51.16 99.48 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 3 # 5 A 145 THR E 25 THR~? 18.78 O1 GOL E3004 A 182 TYR E 21 TYR~? 14.13 O1 GOL E3004 A 186 LYS E 22 LYS~? 21.81 O1 GOL E3004 coo 69.38 87.38 24.64 71.11 88.47 25.40 62.03 105.38 57.79 63.36 104.90 59.41 coo 73.61 90.42 31.12 71.36 89.66 29.64 60.20 97.64 59.27 57.81 96.28 59.79 coo 73.54 84.00 28.64 69.01 86.68 29.71 64.37 100.86 56.32 69.54 97.12 56.69 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 6 3 # 6 A 145 THR F 25 THR~? 27.97 O1 GOL B3017 A 182 TYR F 21 TYR~? 26.08 O1 GOL B3017 A 186 LYS F 22 LYS~? 18.36 O1 GOL B3017 coo 69.38 87.38 24.64 71.11 88.47 25.40 54.15 39.09 2.51 52.43 37.89 3.01 coo 73.61 90.42 31.12 71.36 89.66 29.64 54.13 38.92 10.51 56.02 38.27 12.47 coo 73.54 84.00 28.64 69.01 86.68 29.71 51.36 41.84 5.91 45.78 43.39 8.51 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 7 3 # 7 A 145 THR G 25 THR~? 14.27 CL CL C2004 A 182 TYR G 21 TYR~? 10.57 CL CL C2004 A 186 LYS G 22 LYS~? 13.25 CL CL C2004 coo 69.38 87.38 24.64 71.11 88.47 25.40 52.38 0.78 49.71 54.12 1.05 48.47 coo 73.61 90.42 31.12 71.36 89.66 29.64 52.17 8.74 48.00 50.23 10.55 47.07 coo 73.54 84.00 28.64 69.01 86.68 29.71 55.06 4.83 51.67 60.67 7.73 52.68 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 8 3 # 8 A 145 THR H 25 THR~? 14.27 CL CL H2005 A 182 TYR H 21 TYR~? 10.50 CL CL H2005 A 186 LYS H 22 LYS~? 13.32 CL CL H2005 coo 69.38 87.38 24.64 71.11 88.47 25.40 45.72 68.93 103.47 44.39 70.46 102.71 coo 73.61 90.42 31.12 71.36 89.66 29.64 47.46 68.84 95.61 49.74 68.96 94.05 coo 73.54 84.00 28.64 69.01 86.68 29.71 43.36 66.64 99.44 38.17 66.18 95.68 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 9 3 # 9 A 145 THR I 25 THR~? 14.23 CL CL I2001 A 182 TYR I 21 TYR~? 10.49 CL CL I2001 A 186 LYS I 22 LYS~? 13.37 CL CL I2001 coo 69.38 87.38 24.64 71.11 88.47 25.40 169.12 220.33 156.43 167.59 219.85 154.97 coo 73.61 90.42 31.12 71.36 89.66 29.64 169.47 212.28 156.01 171.53 210.49 155.65 coo 73.54 84.00 28.64 69.01 86.68 29.71 166.16 216.63 158.59 160.45 213.84 159.02 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 10 3 # 10 A 145 THR J 25 THR~? 14.26 CL CL J2002 A 182 TYR J 21 TYR~? 10.46 CL CL J2002 A 186 LYS J 22 LYS~? 13.36 CL CL J2002 coo 69.38 87.38 24.64 71.11 88.47 25.40 175.93 174.96 116.91 177.46 176.37 117.35 coo 73.61 90.42 31.12 71.36 89.66 29.64 174.52 176.28 124.74 172.25 177.04 126.20 coo 73.54 84.00 28.64 69.01 86.68 29.71 178.14 172.91 121.18 183.42 172.10 124.71 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 11 3 # 11 A 145 THR K 25 THR~? 18.58 O1 GOL K3011 A 182 TYR K 21 TYR~? 13.85 O1 GOL K3011 A 186 LYS K 22 LYS~? 17.74 CL CL K2003 coo 69.38 87.38 24.64 71.11 88.47 25.40 161.90 117.78 180.76 160.33 118.46 182.04 coo 73.61 90.42 31.12 71.36 89.66 29.64 163.15 125.72 181.32 165.33 127.37 181.87 coo 73.54 84.00 28.64 69.01 86.68 29.71 159.62 121.79 178.29 154.49 125.24 177.13 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 12 3 # 12 A 145 THR L 25 THR~? 33.96 O2 GOL P3034 A 182 TYR L 21 TYR~? 30.92 O3 GOL K3011 A 186 LYS L 22 LYS~? 25.13 O2 GOL P3034 coo 69.38 87.38 24.64 71.11 88.47 25.40 168.68 162.71 221.40 170.17 161.25 221.10 coo 73.61 90.42 31.12 71.36 89.66 29.64 168.26 161.38 213.44 166.20 160.80 211.67 coo 73.54 84.00 28.64 69.01 86.68 29.71 171.60 164.44 217.42 177.37 164.59 214.60 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 13 3 # 13 A 145 THR M 25 THR~? 14.08 CL CL I2001 A 182 TYR M 21 TYR~? 10.54 CL CL I2001 A 186 LYS M 22 LYS~? 13.38 CL CL I2001 coo 69.38 87.38 24.64 71.11 88.47 25.40 175.23 220.80 175.01 176.64 220.29 176.54 coo 73.61 90.42 31.12 71.36 89.66 29.64 173.68 213.02 176.47 171.32 211.57 177.01 coo 73.54 84.00 28.64 69.01 86.68 29.71 177.61 216.43 173.42 182.96 212.88 173.24 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 14 3 # 14 A 145 THR N 25 THR~? 14.22 CL CL J2002 A 182 TYR N 21 TYR~? 10.52 CL CL J2002 A 186 LYS N 22 LYS~? 13.40 CL CL J2002 coo 69.38 87.38 24.64 71.11 88.47 25.40 167.79 156.87 117.26 166.11 155.65 117.82 coo 73.61 90.42 31.12 71.36 89.66 29.64 168.15 156.47 125.36 170.14 155.81 127.21 coo 73.54 84.00 28.64 69.01 86.68 29.71 165.10 159.41 121.05 159.46 160.48 123.77 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 15 3 # 15 A 145 THR O 25 THR~? 22.04 CL CL K2003 A 182 TYR O 21 TYR~? 14.79 CL CL K2003 A 186 LYS O 22 LYS~? 17.69 O3 GOL K3010 coo 69.38 87.38 24.64 71.11 88.47 25.40 169.91 116.29 162.69 171.58 116.71 161.35 coo 73.61 90.42 31.12 71.36 89.66 29.64 169.50 124.29 161.32 167.44 126.02 160.55 coo 73.54 84.00 28.64 69.01 86.68 29.71 172.63 120.27 164.76 178.18 123.25 165.65 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 16 3 # 16 A 145 THR P 25 THR~? 25.98 O1 GOL L3028 A 182 TYR P 21 TYR~? 24.07 O1 GOL L3028 A 186 LYS P 22 LYS~? 16.49 O1 GOL L3028 coo 69.38 87.38 24.64 71.11 88.47 25.40 162.77 181.61 219.73 161.27 183.01 219.06 coo 73.61 90.42 31.12 71.36 89.66 29.64 164.13 181.87 211.82 166.34 182.20 210.17 coo 73.54 84.00 28.64 69.01 86.68 29.71 160.29 179.27 215.80 155.06 178.69 212.33 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 16 hits 1qrr_c01 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 101 PHE.? 16.29 O1 GOL A3040 A 201 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 227 LYS A 142 LYS~? 20.36 CL CL A2020 coo 23.39 49.81 32.16 21.33 51.68 32.26 88.47 81.56 37.13 88.90 80.34 39.61 coo 25.52 45.12 37.98 23.98 46.65 37.85 88.23 80.63 30.72 87.92 80.82 28.67 coo 12.68 46.83 36.69 18.26 48.67 34.51 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE B 101 PHE.? 11.70 O2 GOL B3024 A 201 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 227 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 23.39 49.81 32.16 21.33 51.68 32.26 28.89 69.07 15.24 27.85 67.09 16.93 coo 25.52 45.12 37.98 23.98 46.65 37.85 30.49 75.29 14.98 31.30 77.16 14.42 coo 12.68 46.83 36.69 18.26 48.67 34.51 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE C 101 PHE.? 16.02 O1 GOL C3036 A 201 ASP C 102 ASP.? 24.57 CL CL C2011 A 227 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 23.39 49.81 32.16 21.33 51.68 32.26 77.63 19.27 76.58 78.76 20.45 74.32 coo 25.52 45.12 37.98 23.98 46.65 37.85 76.25 20.52 82.74 75.40 20.56 84.65 coo 12.68 46.83 36.69 18.26 48.67 34.51 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE D 101 PHE.? 16.52 O1 GOL D3018 A 201 ASP D 102 ASP.? 24.32 CL CL D2012 A 227 LYS D 142 LYS~? 18.65 CL CL D2012 coo 23.39 49.81 32.16 21.33 51.68 32.26 18.72 43.85 84.71 18.50 46.02 82.98 coo 25.52 45.12 37.98 23.98 46.65 37.85 18.96 37.41 85.00 19.42 35.40 85.42 coo 12.68 46.83 36.69 18.26 48.67 34.51 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE E 101 PHE.? 16.02 O1 GOL E3022 A 201 ASP E 102 ASP.? 24.45 CL CL E2013 A 227 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 23.39 49.81 32.16 21.33 51.68 32.26 26.26 91.40 63.08 25.56 89.78 60.94 coo 25.52 45.12 37.98 23.98 46.65 37.85 26.42 91.49 69.61 27.08 91.68 71.63 coo 12.68 46.83 36.69 18.26 48.67 34.51 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE F 101 PHE.? 12.00 CL CL F2035 A 201 ASP F 102 ASP.? 16.73 CL CL F2035 A 227 LYS F 142 LYS~? 19.20 CL CL F2034 coo 23.39 49.81 32.16 21.33 51.68 32.26 84.48 30.46 25.35 85.33 32.81 26.63 coo 25.52 45.12 37.98 23.98 46.65 37.85 82.74 24.28 26.35 81.91 22.30 26.35 coo 12.68 46.83 36.69 18.26 48.67 34.51 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE G 101 PHE.? 16.70 O3 GOL G3038 A 201 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 227 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 23.39 49.81 32.16 21.33 51.68 32.26 21.93 21.41 37.11 21.15 23.14 39.18 coo 25.52 45.12 37.98 23.98 46.65 37.85 23.47 21.05 30.82 24.30 20.62 28.93 coo 12.68 46.83 36.69 18.26 48.67 34.51 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE H 101 PHE.? 12.01 O2 GOL H3016 A 201 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 227 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 23.39 49.81 32.16 21.33 51.68 32.26 81.37 70.59 88.12 82.00 68.03 87.14 coo 25.52 45.12 37.98 23.98 46.65 37.85 81.36 76.99 86.94 80.90 79.01 86.89 coo 12.68 46.83 36.69 18.26 48.67 34.51 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE I 101 PHE.? 11.99 O1 GOL I3032 A 201 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 227 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 23.39 49.81 32.16 21.33 51.68 32.26 201.72 199.29 152.26 202.23 197.96 154.63 coo 25.52 45.12 37.98 23.98 46.65 37.85 201.10 198.54 145.88 200.66 198.62 143.82 coo 12.68 46.83 36.69 18.26 48.67 34.51 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE J 101 PHE.? 16.46 O1 GOL J3030 A 201 ASP J 102 ASP.? 24.08 CL CL J2016 A 227 LYS J 142 LYS~? 19.62 CL CL J2016 coo 23.39 49.81 32.16 21.33 51.68 32.26 141.95 185.09 132.92 141.02 182.89 134.35 coo 25.52 45.12 37.98 23.98 46.65 37.85 143.25 191.36 132.98 143.80 193.32 132.63 coo 12.68 46.83 36.69 18.26 48.67 34.51 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE K 101 PHE.? 16.66 O2 GOL K3041 A 201 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 227 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 23.39 49.81 32.16 21.33 51.68 32.26 195.66 134.79 189.08 196.68 136.09 186.76 coo 25.52 45.12 37.98 23.98 46.65 37.85 194.36 135.90 195.25 193.66 135.95 197.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE L 101 PHE.? 16.46 O1 GOL L3027 A 201 ASP L 102 ASP.? 24.59 CL CL L2009 A 227 LYS L 142 LYS~? 23.18 CL CL L2009 coo 23.39 49.81 32.16 21.33 51.68 32.26 135.84 156.17 201.54 135.43 158.30 199.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 136.52 149.82 201.33 136.95 147.73 201.53 coo 12.68 46.83 36.69 18.26 48.67 34.51 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE M 101 PHE.? 16.71 C1 GOL M3043 A 201 ASP M 102 ASP.? 24.52 CL CL M2017 A 227 LYS M 142 LYS~? 19.90 CL CL M2017 coo 23.39 49.81 32.16 21.33 51.68 32.26 140.23 204.88 181.56 139.51 203.37 179.33 coo 25.52 45.12 37.98 23.98 46.65 37.85 140.74 204.70 188.01 141.33 204.99 189.98 coo 12.68 46.83 36.69 18.26 48.67 34.51 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE N 101 PHE.? 11.69 O2 GOL N3029 A 201 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 227 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 23.39 49.81 32.16 21.33 51.68 32.26 199.31 148.71 138.37 200.16 151.05 139.65 coo 25.52 45.12 37.98 23.98 46.65 37.85 197.96 142.41 139.19 197.06 140.46 139.09 coo 12.68 46.83 36.69 18.26 48.67 34.51 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE O 101 PHE.? 12.02 CL CL O2036 A 201 ASP O 102 ASP.? 13.16 CL CL O2036 A 227 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 23.39 49.81 32.16 21.33 51.68 32.26 138.04 136.16 152.49 137.26 137.85 154.61 coo 25.52 45.12 37.98 23.98 46.65 37.85 139.48 136.33 146.19 140.25 135.96 144.25 coo 12.68 46.83 36.69 18.26 48.67 34.51 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 1qz9_c02 KYNURENINASE user 16 3 # 16 A 129 PHE P 101 PHE.? 16.12 O1 GOL P3034 A 201 ASP P 102 ASP.? 24.26 CL CL P2019 A 227 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 23.39 49.81 32.16 21.33 51.68 32.26 197.59 185.62 203.03 198.21 183.20 201.89 coo 25.52 45.12 37.98 23.98 46.65 37.85 197.01 191.93 202.05 196.73 194.01 202.05 coo 12.68 46.83 36.69 18.26 48.67 34.51 204.59 186.28 195.60 209.96 186.96 196.62 1qz9_c02 source 1qz9 KYNURENINASE : 16 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 186 ASN A 134 ASN.? 22.60 O2 GOL A3040 A 260 ALA A 128 ALA.? 13.36 O2 GOL A3040 coo 11.81 33.10 11.71 13.07 31.45 11.40 88.23 80.63 30.72 87.92 80.82 28.67 coo 11.43 26.53 7.41 13.01 27.56 8.43 89.85 87.69 31.14 89.29 86.47 29.46 coo 21.53 26.33 6.96 20.26 25.69 7.52 95.27 91.54 37.35 94.22 92.64 37.53 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 186 ASN B 134 ASN.? 21.61 CL CL B2010 A 260 ALA B 128 ALA.? 12.65 CL CL B2010 coo 11.81 33.10 11.71 13.07 31.45 11.40 30.49 75.29 14.98 31.30 77.16 14.42 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.08 73.64 8.08 31.06 75.15 9.33 coo 21.53 26.33 6.96 20.26 25.69 7.52 24.45 67.55 4.22 25.71 67.00 3.59 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP D 102 ASP.? 24.32 CL CL D2012 A 186 ASN D 134 ASN.? 21.42 O3 GOL D3018 A 260 ALA D 128 ALA.? 11.58 O3 GOL D3018 coo 11.81 33.10 11.71 13.07 31.45 11.40 18.96 37.41 85.00 19.42 35.40 85.42 coo 11.43 26.53 7.41 13.01 27.56 8.43 17.21 39.17 91.82 18.06 37.43 90.85 coo 21.53 26.33 6.96 20.26 25.69 7.52 12.19 46.30 94.61 13.15 46.51 95.73 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP E 102 ASP.? 24.45 CL CL E2013 A 186 ASN E 134 ASN.? 21.44 CL CL E2013 A 260 ALA E 128 ALA.? 12.84 CL CL E2013 coo 11.81 33.10 11.71 13.07 31.45 11.40 26.42 91.49 69.61 27.08 91.68 71.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 26.64 98.55 67.66 26.91 97.58 69.55 coo 21.53 26.33 6.96 20.26 25.69 7.52 22.28 102.43 60.93 23.57 103.26 60.70 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP F 102 ASP.? 16.73 CL CL F2035 A 186 ASN F 134 ASN.? 19.08 CL CL F2035 A 260 ALA F 128 ALA.? 12.59 CL CL F2034 coo 11.81 33.10 11.71 13.07 31.45 11.40 82.74 24.28 26.35 81.91 22.30 26.35 coo 11.43 26.53 7.41 13.01 27.56 8.43 84.48 24.50 19.28 83.57 23.00 20.51 coo 21.53 26.33 6.96 20.26 25.69 7.52 91.36 29.40 15.50 90.29 29.73 14.45 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 186 ASN H 134 ASN.? 21.68 CL CL H2014 A 260 ALA H 128 ALA.? 12.60 CL CL H2014 coo 11.81 33.10 11.71 13.07 31.45 11.40 81.36 76.99 86.94 80.90 79.01 86.89 coo 11.43 26.53 7.41 13.01 27.56 8.43 81.15 76.65 94.15 80.84 78.27 92.76 coo 21.53 26.33 6.96 20.26 25.69 7.52 85.67 70.52 99.37 84.40 70.42 100.15 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 186 ASN I 134 ASN.? 21.46 CL CL I2015 A 260 ALA I 128 ALA.? 12.51 CL CL I2015 coo 11.81 33.10 11.71 13.07 31.45 11.40 201.10 198.54 145.88 200.66 198.62 143.82 coo 11.43 26.53 7.41 13.01 27.56 8.43 202.50 205.66 146.54 201.90 204.42 144.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 207.93 209.75 152.71 206.86 210.81 152.79 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 186 ASN N 134 ASN.? 22.01 O2 GOL N3029 A 260 ALA N 128 ALA.? 15.61 CL CL N2030 coo 11.81 33.10 11.71 13.07 31.45 11.40 197.96 142.41 139.19 197.06 140.46 139.09 coo 11.43 26.53 7.41 13.01 27.56 8.43 199.33 142.96 132.06 198.55 141.35 133.25 coo 21.53 26.33 6.96 20.26 25.69 7.52 205.73 148.25 128.07 204.65 148.66 127.07 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP O 102 ASP.? 13.16 CL CL O2036 A 186 ASN O 134 ASN.? 10.04 CL CL O2036 A 260 ALA O 128 ALA.? 12.41 CL CL O2036 coo 11.81 33.10 11.71 13.07 31.45 11.40 139.48 136.33 146.19 140.25 135.96 144.25 coo 11.43 26.53 7.41 13.01 27.56 8.43 138.05 129.32 147.60 138.80 130.30 145.81 coo 21.53 26.33 6.96 20.26 25.69 7.52 131.83 126.01 153.49 132.92 125.04 153.92 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 9 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 610 HIS A 151 HIS~? -11.70 O3 GOL A3037s A 661 HIS A 76 HIS~? -4.53 C1 GOL A3037s coo 75.99 81.56 1.86 73.91 81.34 2.28 90.44 78.16 48.76 91.65 76.94 50.06 coo 71.04 78.84 0.46 71.54 76.90 1.02 94.27 72.58 51.14 93.29 74.44 51.00 coo 75.40 81.38 12.06 74.88 79.42 12.63 98.60 85.60 50.46 99.38 86.61 52.13 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 610 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 661 HIS B 76 HIS~? 4.58 CL CL B2010s coo 75.99 81.56 1.86 73.91 81.34 2.28 23.66 59.02 20.34 21.93 58.32 21.38 coo 71.04 78.84 0.46 71.54 76.90 1.02 18.48 59.01 25.15 19.77 58.54 23.56 coo 75.40 81.38 12.06 74.88 79.42 12.63 17.08 57.14 11.39 16.06 55.49 10.59 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 610 HIS C 151 HIS~? -4.28 C2 GOL C3036s A 661 HIS C 76 HIS~? -4.98 CL CL C2011s coo 75.99 81.56 1.86 73.91 81.34 2.28 82.81 22.02 65.69 84.52 22.80 64.66 coo 71.04 78.84 0.46 71.54 76.90 1.02 88.24 26.50 64.44 86.75 25.04 64.52 coo 75.40 81.38 12.06 74.88 79.42 12.63 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 610 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 661 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo 75.99 81.56 1.86 73.91 81.34 2.28 16.94 54.59 79.01 15.65 55.42 77.54 coo 71.04 78.84 0.46 71.54 76.90 1.02 13.06 55.69 73.24 14.03 55.94 75.08 coo 75.40 81.38 12.06 74.88 79.42 12.63 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 5 3 # 5 A 608 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 610 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 661 HIS E 76 HIS~? -4.87 CL CL E2013s coo 75.99 81.56 1.86 73.91 81.34 2.28 23.07 86.29 52.35 21.57 85.17 51.32 coo 71.04 78.84 0.46 71.54 76.90 1.02 17.87 81.44 51.19 19.31 82.95 50.96 coo 75.40 81.38 12.06 74.88 79.42 12.63 16.97 95.07 49.08 16.37 95.97 47.28 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 6 3 # 6 A 608 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 610 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 661 HIS F 76 HIS~? -4.65 CL CL F2034s coo 75.99 81.56 1.86 73.91 81.34 2.28 88.86 41.25 28.96 90.30 42.22 30.24 coo 71.04 78.84 0.46 71.54 76.90 1.02 93.09 42.58 34.58 92.14 42.76 32.71 coo 75.40 81.38 12.06 74.88 79.42 12.63 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 7 3 # 7 A 608 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 610 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 661 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo 75.99 81.56 1.86 73.91 81.34 2.28 17.70 27.34 47.09 16.19 28.71 47.73 coo 71.04 78.84 0.46 71.54 76.90 1.02 13.55 33.19 47.26 14.46 31.35 47.64 coo 75.40 81.38 12.06 74.88 79.42 12.63 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 8 3 # 8 A 608 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 610 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 661 HIS H 76 HIS~? 4.68 CL CL H2014s coo 75.99 81.56 1.86 73.91 81.34 2.28 84.24 58.93 85.48 85.73 57.59 84.66 coo 71.04 78.84 0.46 71.54 76.90 1.02 89.33 56.65 80.95 87.93 56.76 82.51 coo 75.40 81.38 12.06 74.88 79.42 12.63 90.35 57.57 94.69 91.06 55.99 95.89 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 9 3 # 9 A 608 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 610 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 661 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo 75.99 81.56 1.86 73.91 81.34 2.28 204.37 195.46 163.61 205.75 194.30 164.79 coo 71.04 78.84 0.46 71.54 76.90 1.02 208.71 190.07 165.44 207.65 191.87 165.52 coo 75.40 81.38 12.06 74.88 79.42 12.63 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 10 3 # 10 A 608 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 610 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 661 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo 75.99 81.56 1.86 73.91 81.34 2.28 137.44 174.60 137.57 135.80 173.80 138.69 coo 71.04 78.84 0.46 71.54 76.90 1.02 132.36 173.99 142.63 133.63 173.58 141.01 coo 75.40 81.38 12.06 74.88 79.42 12.63 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 11 3 # 11 A 608 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 610 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 661 HIS K 76 HIS~? -6.12 C3 GOL K3041s coo 75.99 81.56 1.86 73.91 81.34 2.28 200.17 138.24 178.11 201.77 139.28 177.19 coo 71.04 78.84 0.46 71.54 76.90 1.02 205.25 143.04 176.89 203.95 141.38 176.70 coo 75.40 81.38 12.06 74.88 79.42 12.63 207.10 129.51 177.50 208.14 128.55 175.95 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 12 3 # 12 A 608 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 610 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 661 HIS L 76 HIS~? 4.00 O3 GOL L3027s coo 75.99 81.56 1.86 73.91 81.34 2.28 133.34 166.97 196.27 132.03 168.03 194.96 coo 71.04 78.84 0.46 71.54 76.90 1.02 129.06 168.07 190.57 130.17 168.32 192.34 coo 75.40 81.38 12.06 74.88 79.42 12.63 125.69 169.77 203.98 124.79 171.51 204.73 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 13 3 # 13 A 608 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 610 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 661 HIS M 76 HIS~? 4.78 C1 GOL M3042s coo 75.99 81.56 1.86 73.91 81.34 2.28 136.87 200.18 170.79 135.36 199.08 169.77 coo 71.04 78.84 0.46 71.54 76.90 1.02 131.91 195.13 169.59 133.22 196.76 169.40 coo 75.40 81.38 12.06 74.88 79.42 12.63 130.15 208.85 168.09 129.36 209.65 166.31 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 14 3 # 14 A 608 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 610 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 661 HIS N 76 HIS~? -6.89 CL CL N2030s coo 75.99 81.56 1.86 73.91 81.34 2.28 203.51 159.51 142.26 205.02 160.53 143.48 coo 71.04 78.84 0.46 71.54 76.90 1.02 207.96 160.84 147.59 206.93 161.03 145.77 coo 75.40 81.38 12.06 74.88 79.42 12.63 211.54 160.16 134.29 212.67 161.69 133.40 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 15 3 # 15 A 608 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 610 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 661 HIS O 76 HIS~? 4.51 CL CL O2018s coo 75.99 81.56 1.86 73.91 81.34 2.28 134.07 141.35 162.95 132.57 142.58 163.78 coo 71.04 78.84 0.46 71.54 76.90 1.02 129.65 146.92 163.60 130.73 145.15 163.91 coo 75.40 81.38 12.06 74.88 79.42 12.63 126.10 133.61 164.62 125.01 132.87 166.26 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 16 3 # 16 A 608 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 610 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 661 HIS P 76 HIS~? 4.69 CL CL P2019s coo 75.99 81.56 1.86 73.91 81.34 2.28 200.75 174.15 199.66 202.28 173.10 198.62 coo 71.04 78.84 0.46 71.54 76.90 1.02 205.70 172.52 194.71 204.41 172.45 196.35 coo 75.40 81.38 12.06 74.88 79.42 12.63 207.59 172.73 208.38 208.33 171.09 209.49 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 16 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 610 HIS A 151 HIS~? -11.70 O3 GOL A3037s C 661 HIS A 76 HIS~? -4.53 C1 GOL A3037s coo -17.65 80.52 58.00 -16.23 80.79 56.41 90.44 78.16 48.76 91.65 76.94 50.06 coo -16.56 83.18 53.03 -16.33 85.18 53.60 94.27 72.58 51.14 93.29 74.44 51.00 coo -8.38 80.78 62.24 -7.53 82.67 62.02 98.60 85.60 50.46 99.38 86.61 52.13 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 610 HIS B 151 HIS~? -4.11 O3 GOL B3015s C 661 HIS B 76 HIS~? 4.58 CL CL B2010s coo -17.65 80.52 58.00 -16.23 80.79 56.41 23.66 59.02 20.34 21.93 58.32 21.38 coo -16.56 83.18 53.03 -16.33 85.18 53.60 18.48 59.01 25.15 19.77 58.54 23.56 coo -8.38 80.78 62.24 -7.53 82.67 62.02 17.08 57.14 11.39 16.06 55.49 10.59 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 610 HIS C 151 HIS~? -4.28 C2 GOL C3036s C 661 HIS C 76 HIS~? -4.98 CL CL C2011s coo -17.65 80.52 58.00 -16.23 80.79 56.41 82.81 22.02 65.69 84.52 22.80 64.66 coo -16.56 83.18 53.03 -16.33 85.18 53.60 88.24 26.50 64.44 86.75 25.04 64.52 coo -8.38 80.78 62.24 -7.53 82.67 62.02 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 610 HIS D 151 HIS~? -13.00 O2 GOL D3020s C 661 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo -17.65 80.52 58.00 -16.23 80.79 56.41 16.94 54.59 79.01 15.65 55.42 77.54 coo -16.56 83.18 53.03 -16.33 85.18 53.60 13.06 55.69 73.24 14.03 55.94 75.08 coo -8.38 80.78 62.24 -7.53 82.67 62.02 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 5 3 # 5 C 608 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 610 HIS E 151 HIS~? -4.12 O1 GOL E3002s C 661 HIS E 76 HIS~? -4.87 CL CL E2013s coo -17.65 80.52 58.00 -16.23 80.79 56.41 23.07 86.29 52.35 21.57 85.17 51.32 coo -16.56 83.18 53.03 -16.33 85.18 53.60 17.87 81.44 51.19 19.31 82.95 50.96 coo -8.38 80.78 62.24 -7.53 82.67 62.02 16.97 95.07 49.08 16.37 95.97 47.28 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 6 3 # 6 C 608 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 610 HIS F 151 HIS~? 14.76 O3 GOL F3039s C 661 HIS F 76 HIS~? -4.65 CL CL F2034s coo -17.65 80.52 58.00 -16.23 80.79 56.41 88.86 41.25 28.96 90.30 42.22 30.24 coo -16.56 83.18 53.03 -16.33 85.18 53.60 93.09 42.58 34.58 92.14 42.76 32.71 coo -8.38 80.78 62.24 -7.53 82.67 62.02 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 7 3 # 7 C 608 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 610 HIS G 151 HIS~? -4.14 C3 GOL G3001s C 661 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo -17.65 80.52 58.00 -16.23 80.79 56.41 17.70 27.34 47.09 16.19 28.71 47.73 coo -16.56 83.18 53.03 -16.33 85.18 53.60 13.55 33.19 47.26 14.46 31.35 47.64 coo -8.38 80.78 62.24 -7.53 82.67 62.02 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 8 3 # 8 C 608 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 610 HIS H 151 HIS~? 4.32 C1 GOL H3016s C 661 HIS H 76 HIS~? 4.68 CL CL H2014s coo -17.65 80.52 58.00 -16.23 80.79 56.41 84.24 58.93 85.48 85.73 57.59 84.66 coo -16.56 83.18 53.03 -16.33 85.18 53.60 89.33 56.65 80.95 87.93 56.76 82.51 coo -8.38 80.78 62.24 -7.53 82.67 62.02 90.35 57.57 94.69 91.06 55.99 95.89 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 9 3 # 9 C 608 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 610 HIS I 151 HIS~? 3.98 O3 GOL I3032s C 661 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo -17.65 80.52 58.00 -16.23 80.79 56.41 204.37 195.46 163.61 205.75 194.30 164.79 coo -16.56 83.18 53.03 -16.33 85.18 53.60 208.71 190.07 165.44 207.65 191.87 165.52 coo -8.38 80.78 62.24 -7.53 82.67 62.02 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 10 3 # 10 C 608 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 610 HIS J 151 HIS~? -12.73 O1 GOL J3033s C 661 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo -17.65 80.52 58.00 -16.23 80.79 56.41 137.44 174.60 137.57 135.80 173.80 138.69 coo -16.56 83.18 53.03 -16.33 85.18 53.60 132.36 173.99 142.63 133.63 173.58 141.01 coo -8.38 80.78 62.24 -7.53 82.67 62.02 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 11 3 # 11 C 608 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 610 HIS K 151 HIS~? -4.18 C2 GOL K3009s C 661 HIS K 76 HIS~? -6.12 C3 GOL K3041s coo -17.65 80.52 58.00 -16.23 80.79 56.41 200.17 138.24 178.11 201.77 139.28 177.19 coo -16.56 83.18 53.03 -16.33 85.18 53.60 205.25 143.04 176.89 203.95 141.38 176.70 coo -8.38 80.78 62.24 -7.53 82.67 62.02 207.10 129.51 177.50 208.14 128.55 175.95 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 12 3 # 12 C 608 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 610 HIS L 151 HIS~? -15.32 O3 GOL L3028s C 661 HIS L 76 HIS~? 4.00 O3 GOL L3027s coo -17.65 80.52 58.00 -16.23 80.79 56.41 133.34 166.97 196.27 132.03 168.03 194.96 coo -16.56 83.18 53.03 -16.33 85.18 53.60 129.06 168.07 190.57 130.17 168.32 192.34 coo -8.38 80.78 62.24 -7.53 82.67 62.02 125.69 169.77 203.98 124.79 171.51 204.73 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 13 3 # 13 C 608 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 610 HIS M 151 HIS~? -11.81 O3 GOL M3042s C 661 HIS M 76 HIS~? 4.78 C1 GOL M3042s coo -17.65 80.52 58.00 -16.23 80.79 56.41 136.87 200.18 170.79 135.36 199.08 169.77 coo -16.56 83.18 53.03 -16.33 85.18 53.60 131.91 195.13 169.59 133.22 196.76 169.40 coo -8.38 80.78 62.24 -7.53 82.67 62.02 130.15 208.85 168.09 129.36 209.65 166.31 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 14 3 # 14 C 608 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 610 HIS N 151 HIS~? 3.39 O2 GOL N3012s C 661 HIS N 76 HIS~? -6.89 CL CL N2030s coo -17.65 80.52 58.00 -16.23 80.79 56.41 203.51 159.51 142.26 205.02 160.53 143.48 coo -16.56 83.18 53.03 -16.33 85.18 53.60 207.96 160.84 147.59 206.93 161.03 145.77 coo -8.38 80.78 62.24 -7.53 82.67 62.02 211.54 160.16 134.29 212.67 161.69 133.40 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 15 3 # 15 C 608 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 610 HIS O 151 HIS~? 4.32 O2 GOL O3026s C 661 HIS O 76 HIS~? 4.51 CL CL O2018s coo -17.65 80.52 58.00 -16.23 80.79 56.41 134.07 141.35 162.95 132.57 142.58 163.78 coo -16.56 83.18 53.03 -16.33 85.18 53.60 129.65 146.92 163.60 130.73 145.15 163.91 coo -8.38 80.78 62.24 -7.53 82.67 62.02 126.10 133.61 164.62 125.01 132.87 166.26 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 16 3 # 16 C 608 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 610 HIS P 151 HIS~? -4.15 C3 GOL P3014s C 661 HIS P 76 HIS~? 4.69 CL CL P2019s coo -17.65 80.52 58.00 -16.23 80.79 56.41 200.75 174.15 199.66 202.28 173.10 198.62 coo -16.56 83.18 53.03 -16.33 85.18 53.60 205.70 172.52 194.71 204.41 172.45 196.35 coo -8.38 80.78 62.24 -7.53 82.67 62.02 207.59 172.73 208.38 208.33 171.09 209.49 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 16 hits 1req_c11 naa= 3 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 1 3 # 1 A 39 HIS A 79 HIS~? -3.92 CL CL A2020s A 43 TRP A 82 TRP~? 8.67 CL CL A2020 A 108 GLU A 93 GLU~? 8.07 CL CL A2020 coo 33.67 25.97 25.39 31.70 26.60 25.75 103.72 86.36 44.76 104.87 88.01 44.15 coo 29.43 26.12 28.46 27.08 29.25 29.01 109.14 82.09 43.02 109.21 85.94 42.13 coo 29.13 31.14 24.26 29.28 29.08 24.66 106.40 86.90 39.80 107.05 88.84 40.38 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 2 3 # 2 A 39 HIS B 79 HIS~? 5.08 CL CL B2010 A 43 TRP B 82 TRP~? 10.92 CL CL B2010 A 108 GLU B 93 GLU~? 9.70 CL CL B2010 coo 33.67 25.97 25.39 31.70 26.60 25.75 13.46 62.96 8.26 12.78 63.30 6.30 coo 29.43 26.12 28.46 27.08 29.25 29.01 8.01 66.64 10.60 8.71 66.44 6.72 coo 29.13 31.14 24.26 29.28 29.08 24.66 11.87 67.96 6.38 12.21 67.44 4.38 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 3 3 # 3 A 39 HIS C 79 HIS~? -4.32 CL CL C2021s A 43 TRP C 82 TRP~? 8.71 CL CL C2021 A 108 GLU C 93 GLU~? 8.05 CL CL C2021 coo 33.67 25.97 25.39 31.70 26.60 25.75 92.85 10.89 71.99 93.43 9.18 73.06 coo 29.43 26.12 28.46 27.08 29.25 29.01 98.75 13.72 74.76 97.71 10.01 75.57 coo 29.13 31.14 24.26 29.28 29.08 24.66 94.51 9.91 76.89 94.48 7.78 76.63 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 4 3 # 4 A 39 HIS D 79 HIS~? -4.57 CL CL D2022s A 43 TRP D 82 TRP~? 8.88 CL CL D2022 A 108 GLU D 93 GLU~? 8.23 CL CL D2022 coo 33.67 25.97 25.39 31.70 26.60 25.75 3.57 52.49 87.96 2.52 51.97 89.71 coo 29.43 26.12 28.46 27.08 29.25 29.01 -2.00 50.10 84.15 -2.01 50.58 88.03 coo 29.13 31.14 24.26 29.28 29.08 24.66 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 5 3 # 5 A 39 HIS E 79 HIS~? -4.18 CL CL E2032s A 43 TRP E 82 TRP~? 8.95 CL CL E2032 A 108 GLU E 93 GLU~? 8.42 CL CL E2032 coo 33.67 25.97 25.39 31.70 26.60 25.75 12.36 98.35 54.34 11.69 100.32 54.60 coo 29.43 26.12 28.46 27.08 29.25 29.01 6.15 95.71 56.78 6.86 99.58 56.84 coo 29.13 31.14 24.26 29.28 29.08 24.66 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 6 3 # 6 A 39 HIS F 79 HIS~? -4.63 CL CL F2023s A 43 TRP F 82 TRP~? 9.00 CL CL F2023 A 108 GLU F 93 GLU~? 8.36 CL CL F2023 coo 33.67 25.97 25.39 31.70 26.60 25.75 101.04 34.65 20.79 101.93 33.69 19.16 coo 29.43 26.12 28.46 27.08 29.25 29.01 106.15 31.91 24.85 106.17 31.15 20.99 coo 29.13 31.14 24.26 29.28 29.08 24.66 102.94 29.85 20.29 103.30 29.96 18.20 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 7 3 # 7 A 39 HIS G 79 HIS~? -4.46 CL CL G2033s A 43 TRP G 82 TRP~? 9.22 CL CL G2033 A 108 GLU G 93 GLU~? 8.63 CL CL G2033 coo 33.67 25.97 25.39 31.70 26.60 25.75 5.20 17.85 42.65 4.12 16.10 42.26 coo 29.43 26.12 28.46 27.08 29.25 29.01 0.44 21.52 38.76 0.42 17.60 39.04 coo 29.13 31.14 24.26 29.28 29.08 24.66 3.64 16.49 37.62 3.03 14.55 38.23 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 8 3 # 8 A 39 HIS H 79 HIS~? 4.82 CL CL H2024 A 43 TRP H 82 TRP~? 9.25 CL CL H2024 A 108 GLU H 93 GLU~? 8.72 CL CL H2024 coo 33.67 25.97 25.39 31.70 26.60 25.75 95.19 63.20 96.60 95.96 63.87 98.43 coo 29.43 26.12 28.46 27.08 29.25 29.01 101.51 64.78 93.60 100.79 65.58 97.38 coo 29.13 31.14 24.26 29.28 29.08 24.66 97.56 68.07 97.57 97.65 67.50 99.59 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 9 3 # 9 A 39 HIS I 79 HIS~? -4.56 CL CL I2025s A 43 TRP I 82 TRP~? 8.94 CL CL I2025 A 108 GLU I 93 GLU~? 8.40 CL CL I2025 coo 33.67 25.97 25.39 31.70 26.60 25.75 216.99 204.94 159.50 218.07 206.60 158.77 coo 29.43 26.12 28.46 27.08 29.25 29.01 222.70 201.25 157.47 222.56 205.13 157.06 coo 29.13 31.14 24.26 29.28 29.08 24.66 219.77 205.57 155.06 219.86 207.68 155.25 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 10 3 # 10 A 39 HIS J 79 HIS~? -4.36 CL CL J2026s A 43 TRP J 82 TRP~? 8.74 CL CL J2026 A 108 GLU J 93 GLU~? 8.18 CL CL J2026 coo 33.67 25.97 25.39 31.70 26.60 25.75 126.45 179.07 126.46 125.69 179.71 124.61 coo 29.43 26.12 28.46 27.08 29.25 29.01 120.81 182.25 129.28 121.40 182.19 125.39 coo 29.13 31.14 24.26 29.28 29.08 24.66 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 11 3 # 11 A 39 HIS L 79 HIS~? -4.09 CL CL L2028s A 43 TRP L 82 TRP~? 8.52 CL CL L2028 A 108 GLU L 93 GLU~? 8.05 CL CL L2028 coo 33.67 25.97 25.39 31.70 26.60 25.75 120.65 164.52 206.19 119.64 164.06 207.98 coo 29.43 26.12 28.46 27.08 29.25 29.01 114.77 162.30 202.99 115.21 162.18 206.89 coo 29.13 31.14 24.26 29.28 29.08 24.66 118.11 159.89 208.04 117.71 160.95 209.86 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 12 3 # 12 A 39 HIS M 79 HIS~? -4.31 CL CL M2029s A 43 TRP M 82 TRP~? 8.91 CL CL M2029 A 108 GLU M 93 GLU~? 8.60 CL CL M2029 coo 33.67 25.97 25.39 31.70 26.60 25.75 125.50 211.59 173.52 124.72 213.49 173.99 coo 29.43 26.12 28.46 27.08 29.25 29.01 119.56 208.61 175.82 120.25 212.49 175.98 coo 29.13 31.14 24.26 29.28 29.08 24.66 123.31 213.00 178.36 123.21 215.02 177.75 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 13 3 # 13 A 39 HIS N 79 HIS~? -4.33 CL CL N2030s A 43 TRP N 82 TRP~? 8.80 CL CL N2030 A 108 GLU N 93 GLU~? 8.57 CL CL N2030 coo 33.67 25.97 25.39 31.70 26.60 25.75 215.64 153.98 132.96 216.60 153.22 131.26 coo 29.43 26.12 28.46 27.08 29.25 29.01 220.77 150.98 136.79 220.56 150.52 132.88 coo 29.13 31.14 24.26 29.28 29.08 24.66 217.47 148.79 132.22 217.76 148.97 130.14 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 14 3 # 14 A 39 HIS O 79 HIS~? 5.21 CL CL O2018 A 43 TRP O 82 TRP~? 10.82 CL CL O2018 A 108 GLU O 93 GLU~? 9.72 CL CL O2018 coo 33.67 25.97 25.39 31.70 26.60 25.75 121.98 131.53 158.56 121.09 129.74 157.92 coo 29.43 26.12 28.46 27.08 29.25 29.01 116.65 134.94 155.50 116.94 131.00 155.50 coo 29.13 31.14 24.26 29.28 29.08 24.66 119.95 130.02 153.81 119.63 127.98 154.32 ULMN 3 1rhc_c00 F420-DEPENDENT ALCOHOL DEHYDROGENASEuser 15 3 # 15 A 39 HIS P 79 HIS~? 5.38 CL CL P2019 A 43 TRP P 82 TRP~? 11.18 CL CL P2019 A 108 GLU P 93 GLU~? 9.65 CL CL P2019 coo 33.67 25.97 25.39 31.70 26.60 25.75 212.25 178.47 210.26 213.09 179.27 212.01 coo 29.43 26.12 28.46 27.08 29.25 29.01 218.35 180.63 207.32 217.67 181.08 211.18 coo 29.13 31.14 24.26 29.28 29.08 24.66 214.54 183.14 211.27 214.54 182.92 213.36 1rhc_c00 source 1rhc F420-DEPENDENT ALCOHOL DEHYDROGENASE : 15 hits 1rhc_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 102 ASP.? 25.18 C1 GOL A3040 595 GLU A 141 GLU~? 27.05 O1 GOL A3040 713 TYR A 143 TYR~? 16.38 O1 GOL A3040 coo 5.64 2.82 38.49 4.59 4.19 37.25 88.23 80.63 30.72 87.92 80.82 28.67 coo 4.35 13.73 37.63 3.39 12.18 36.55 89.05 70.31 35.51 89.11 68.84 33.95 coo 3.76 10.25 31.38 3.16 9.87 34.10 92.99 77.44 39.76 93.75 79.76 38.42 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP C 102 ASP.? 24.57 CL CL C2011 595 GLU C 141 GLU~? 19.53 O2 GOL H3025 713 TYR C 143 TYR~? 14.40 O1 GOL C3036 coo 5.64 2.82 38.49 4.59 4.19 37.25 76.25 20.52 82.74 75.40 20.56 84.65 coo 4.35 13.73 37.63 3.39 12.18 36.55 80.37 30.30 78.61 80.09 31.65 80.29 coo 3.76 10.25 31.38 3.16 9.87 34.10 83.34 22.31 75.20 83.28 19.92 76.54 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP D 102 ASP.? 24.32 CL CL D2012 595 GLU D 141 GLU~? 22.23 O1 GOL G3001 713 TYR D 143 TYR~? 15.16 CL CL D2012 coo 5.64 2.82 38.49 4.59 4.19 37.25 18.96 37.41 85.00 19.42 35.40 85.42 coo 4.35 13.73 37.63 3.39 12.18 36.55 17.13 41.08 72.88 18.91 42.32 72.55 coo 3.76 10.25 31.38 3.16 9.87 34.10 14.34 45.54 80.17 13.57 44.79 82.74 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP E 102 ASP.? 24.45 CL CL E2013 595 GLU E 141 GLU~? 19.75 O1 GOL D3019 713 TYR E 143 TYR~? 15.23 CL CL E2013 coo 5.64 2.82 38.49 4.59 4.19 37.25 26.42 91.49 69.61 27.08 91.68 71.63 coo 4.35 13.73 37.63 3.39 12.18 36.55 21.80 82.16 67.66 21.51 80.62 69.17 coo 3.76 10.25 31.38 3.16 9.87 34.10 20.79 87.99 61.33 20.74 90.64 62.13 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP F 102 ASP.? 16.73 CL CL F2035 595 GLU F 141 GLU~? 15.85 CL CL F2035 713 TYR F 143 TYR~? 15.09 CL CL F2034 coo 5.64 2.82 38.49 4.59 4.19 37.25 82.74 24.28 26.35 81.91 22.30 26.35 coo 4.35 13.73 37.63 3.39 12.18 36.55 84.56 28.39 36.54 84.29 26.85 38.03 coo 3.76 10.25 31.38 3.16 9.87 34.10 89.42 31.84 29.55 89.79 30.44 27.17 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP H 102 ASP.? 20.45 O2 GOL H3016 595 GLU H 141 GLU~? 14.58 O1 GOL H3016 713 TYR H 143 TYR~? 11.30 O2 GOL H3016 coo 5.64 2.82 38.49 4.59 4.19 37.25 81.36 76.99 86.94 80.90 79.01 86.89 coo 4.35 13.73 37.63 3.39 12.18 36.55 84.42 72.24 77.39 84.86 73.57 75.76 coo 3.76 10.25 31.38 3.16 9.87 34.10 86.77 67.99 85.16 86.88 69.36 87.57 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP I 102 ASP.? 20.44 O1 GOL I3032 595 GLU I 141 GLU~? 15.06 O1 GOL I3032 713 TYR I 143 TYR~? 11.25 C1 GOL I3032 coo 5.64 2.82 38.49 4.59 4.19 37.25 201.10 198.54 145.88 200.66 198.62 143.82 coo 4.35 13.73 37.63 3.39 12.18 36.55 203.00 188.32 149.96 202.87 186.91 148.25 coo 3.76 10.25 31.38 3.16 9.87 34.10 206.55 195.37 154.41 207.09 197.83 153.23 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP J 102 ASP.? 24.08 CL CL J2016 595 GLU J 141 GLU~? 24.92 O2 GOL M3042 713 TYR J 143 TYR~? 15.18 CL CL J2016 coo 5.64 2.82 38.49 4.59 4.19 37.25 143.25 191.36 132.98 143.80 193.32 132.63 coo 4.35 13.73 37.63 3.39 12.18 36.55 139.93 188.85 143.36 139.82 190.60 144.63 coo 3.76 10.25 31.38 3.16 9.87 34.10 136.50 183.91 136.49 136.50 184.93 133.88 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP K 102 ASP.? 24.81 O1 GOL K3041 595 GLU K 141 GLU~? 22.10 C1 GOL P3014 713 TYR K 143 TYR~? 15.99 O3 GOL K3009 coo 5.64 2.82 38.49 4.59 4.19 37.25 194.36 135.90 195.25 193.66 135.95 197.23 coo 4.35 13.73 37.63 3.39 12.18 36.55 197.75 145.77 191.54 197.42 146.88 193.40 coo 3.76 10.25 31.38 3.16 9.87 34.10 201.16 138.32 187.50 201.22 135.84 188.82 ULMN 3 1sll_c00 SIALIDASE L user 10 3 # 10 318 ASP L 102 ASP.? 24.59 CL CL L2009 595 GLU L 141 GLU~? 22.39 C3 GOL O3013 713 TYR L 143 TYR~? 15.30 CL CL L2009 coo 5.64 2.82 38.49 4.59 4.19 37.25 136.52 149.82 201.33 136.95 147.73 201.53 coo 4.35 13.73 37.63 3.39 12.18 36.55 132.89 153.36 189.75 130.85 152.81 189.78 coo 3.76 10.25 31.38 3.16 9.87 34.10 131.10 157.77 197.34 130.52 156.95 199.97 ULMN 3 1sll_c00 SIALIDASE L user 11 3 # 11 318 ASP N 102 ASP.? 20.60 O2 GOL N3029 595 GLU N 141 GLU~? 10.16 C1 GOL N3029 713 TYR N 143 TYR~? 10.73 O2 GOL N3029 coo 5.64 2.82 38.49 4.59 4.19 37.25 197.96 142.41 139.19 197.06 140.46 139.09 coo 4.35 13.73 37.63 3.39 12.18 36.55 199.85 147.19 149.72 199.65 149.31 150.43 coo 3.76 10.25 31.38 3.16 9.87 34.10 204.41 150.24 142.39 204.78 148.95 139.97 ULMN 3 1sll_c00 SIALIDASE L user 12 3 # 12 318 ASP O 102 ASP.? 13.16 CL CL O2036 595 GLU O 141 GLU~? 15.58 O3 GOL O3026 713 TYR O 143 TYR~? 11.76 C3 GOL O3026 coo 5.64 2.82 38.49 4.59 4.19 37.25 139.48 136.33 146.19 140.25 135.96 144.25 coo 4.35 13.73 37.63 3.39 12.18 36.55 137.18 147.02 148.83 137.46 148.02 146.94 coo 3.76 10.25 31.38 3.16 9.87 34.10 133.04 140.38 153.60 132.61 137.79 152.63 ULMN 3 1sll_c00 SIALIDASE L user 13 3 # 13 318 ASP P 102 ASP.? 24.26 CL CL P2019 595 GLU P 141 GLU~? 21.95 O3 GOL P3014 713 TYR P 143 TYR~? 15.20 CL CL P2019 coo 5.64 2.82 38.49 4.59 4.19 37.25 197.01 191.93 202.05 196.73 194.01 202.05 coo 4.35 13.73 37.63 3.39 12.18 36.55 200.04 187.90 192.14 200.20 189.50 190.73 coo 3.76 10.25 31.38 3.16 9.87 34.10 202.86 183.43 199.65 203.11 184.67 202.14 1sll_c00 source 1sll SIALIDASE L : 13 hits 1sll_c00 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 58 GLY.? 25.44 O1 GOL A3040 B 17 GLN A 3 GLN.? 27.97 O3 GOL B3003 B 140 GLU A 59 GLU.? 24.46 O1 GOL A3040 coo 61.49 19.86 5.96 61.52 19.46 5.16 72.01 82.97 38.85 71.63 83.18 39.53 coo 63.76 11.90 7.93 65.18 13.07 6.77 67.67 79.07 42.08 68.64 80.37 40.66 coo 66.44 19.00 7.38 67.69 17.67 8.37 73.55 78.44 42.57 74.34 76.74 41.50 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY D 58 GLY.? 18.13 O1 GOL D3005 B 17 GLN D 3 GLN.? 15.68 CL CL D2008 B 140 GLU D 59 GLU.? 17.18 O2 GOL D3019 coo 61.49 19.86 5.96 61.52 19.46 5.16 35.29 45.78 85.57 35.70 46.47 85.60 coo 63.76 11.90 7.93 65.18 13.07 6.77 40.42 47.66 81.61 38.75 46.94 82.74 coo 66.44 19.00 7.38 67.69 17.67 8.37 34.38 48.89 80.62 34.75 48.54 78.54 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY H 58 GLY.? 17.64 O3 GOL H3006 B 17 GLN H 3 GLN.? 13.91 CL CL D2008 B 140 GLU H 59 GLU.? 16.22 O2 GOL H3016 coo 61.49 19.86 5.96 61.52 19.46 5.16 65.05 68.68 85.82 64.63 67.97 85.93 coo 63.76 11.90 7.93 65.18 13.07 6.77 60.52 62.00 79.39 60.48 60.97 77.46 coo 66.44 19.00 7.38 67.69 17.67 8.37 68.06 65.41 81.65 68.51 66.61 79.97 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY I 58 GLY.? 18.81 CL CL I2007 B 17 GLN I 3 GLN.? 15.83 CL CL I2007 B 140 GLU I 59 GLU.? 16.14 O2 GOL I3032 coo 61.49 19.86 5.96 61.52 19.46 5.16 185.16 199.62 154.81 184.82 199.83 155.56 coo 63.76 11.90 7.93 65.18 13.07 6.77 180.34 195.70 156.97 181.98 197.09 156.54 coo 66.44 19.00 7.38 67.69 17.67 8.37 186.59 195.61 159.01 186.55 193.49 159.24 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY J 58 GLY.? 21.75 CL CL J2002 B 17 GLN J 3 GLN.? 20.77 CL CL J2002 B 140 GLU J 59 GLU.? 24.47 CL CL J2002 coo 61.49 19.86 5.96 61.52 19.46 5.16 157.87 180.66 134.88 158.15 179.86 134.79 coo 63.76 11.90 7.93 65.18 13.07 6.77 161.15 178.34 140.07 160.70 179.03 138.08 coo 66.44 19.00 7.38 67.69 17.67 8.37 155.32 177.68 139.49 156.41 177.56 141.35 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY K 58 GLY.? 18.35 O1 GOL K3011 B 17 GLN K 3 GLN.? 17.70 CL CL K2003 B 140 GLU K 59 GLU.? 18.15 O3 GOL K3010 coo 61.49 19.86 5.96 61.52 19.46 5.16 179.79 136.37 184.44 179.50 136.20 183.68 coo 63.76 11.90 7.93 65.18 13.07 6.77 176.80 144.66 180.27 177.41 146.72 180.36 coo 66.44 19.00 7.38 67.69 17.67 8.37 181.67 140.70 183.14 183.47 141.86 183.25 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 7 3 # 7 A 261 GLY N 58 GLY.? 17.87 O3 GOL N3008 B 17 GLN N 3 GLN.? 18.78 C1 GOL N3044 B 140 GLU N 59 GLU.? 17.47 C1 GOL N3044 coo 61.49 19.86 5.96 61.52 19.46 5.16 183.43 153.24 137.84 183.14 154.05 137.70 coo 63.76 11.90 7.93 65.18 13.07 6.77 179.96 158.79 143.19 179.96 160.86 143.77 coo 66.44 19.00 7.38 67.69 17.67 8.37 185.19 157.06 142.09 184.04 157.69 143.79 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 8 3 # 8 A 261 GLY P 58 GLY.? 25.31 O1 GOL P3034 B 17 GLN P 3 GLN.? 26.90 O3 GOL M3007 B 140 GLU P 59 GLU.? 23.07 O3 GOL P3014 coo 61.49 19.86 5.96 61.52 19.46 5.16 181.27 182.97 201.43 180.87 182.24 201.54 coo 63.76 11.90 7.93 65.18 13.07 6.77 177.35 179.53 197.40 178.32 181.29 198.18 coo 66.44 19.00 7.38 67.69 17.67 8.37 183.91 180.18 196.89 184.59 182.10 196.19 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 8 hits 1t4c_c02 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 83 SER~? 4.31 CL CL A2020 354 GLU A 93 GLU~? 8.07 CL CL A2020 463 HIS A 79 HIS~? -3.92 CL CL A2020s coo 48.87 13.74 2.81 48.49 11.54 3.93 109.33 86.01 47.44 108.27 87.28 49.22 coo 39.95 14.43 3.01 41.55 14.10 1.63 106.40 86.90 39.80 107.05 88.84 40.38 coo 43.90 10.50 2.81 45.63 11.48 3.27 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 83 SER~? 7.75 CL CL B2010 354 GLU B 93 GLU~? 9.70 CL CL B2010 463 HIS B 79 HIS~? 5.08 CL CL B2010 coo 48.87 13.74 2.81 48.49 11.54 3.93 7.70 61.77 7.67 8.73 59.61 7.20 coo 39.95 14.43 3.01 41.55 14.10 1.63 11.87 67.96 6.38 12.21 67.44 4.38 coo 43.90 10.50 2.81 45.63 11.48 3.27 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 3 3 # 3 217 SER C 81 SER~? 9.13 CL CL C2021 354 GLU C 93 GLU~? 8.05 CL CL C2021 463 HIS C 79 HIS~? -4.32 CL CL C2021s coo 48.87 13.74 2.81 48.49 11.54 3.93 97.80 14.60 67.87 97.00 16.56 66.71 coo 39.95 14.43 3.01 41.55 14.10 1.63 94.51 9.91 76.89 94.48 7.78 76.63 coo 43.90 10.50 2.81 45.63 11.48 3.27 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 4 3 # 4 217 SER C 83 SER~? 3.84 CL CL C2021 354 GLU C 93 GLU~? 8.05 CL CL C2021 463 HIS C 79 HIS~? -4.32 CL CL C2021s coo 48.87 13.74 2.81 48.49 11.54 3.93 99.03 9.95 70.83 97.44 9.06 69.22 coo 39.95 14.43 3.01 41.55 14.10 1.63 94.51 9.91 76.89 94.48 7.78 76.63 coo 43.90 10.50 2.81 45.63 11.48 3.27 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 5 3 # 5 217 SER D 83 SER~? 4.15 CL CL D2022 354 GLU D 93 GLU~? 8.23 CL CL D2022 463 HIS D 79 HIS~? -4.57 CL CL D2022s coo 48.87 13.74 2.81 48.49 11.54 3.93 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 39.95 14.43 3.01 41.55 14.10 1.63 0.77 48.16 89.31 0.23 49.10 91.12 coo 43.90 10.50 2.81 45.63 11.48 3.27 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 6 3 # 6 217 SER E 83 SER~? 3.98 CL CL E2032 354 GLU E 93 GLU~? 8.42 CL CL E2032 463 HIS E 79 HIS~? -4.18 CL CL E2032s coo 48.87 13.74 2.81 48.49 11.54 3.93 6.89 98.81 51.94 8.26 99.71 50.10 coo 39.95 14.43 3.01 41.55 14.10 1.63 9.96 100.16 58.92 10.04 102.16 58.24 coo 43.90 10.50 2.81 45.63 11.48 3.27 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 7 3 # 7 217 SER F 81 SER~? 9.12 CL CL F2023 354 GLU F 93 GLU~? 8.36 CL CL F2023 463 HIS F 79 HIS~? -4.63 CL CL F2023s coo 48.87 13.74 2.81 48.49 11.54 3.93 105.10 38.99 25.26 103.91 40.31 26.96 coo 39.95 14.43 3.01 41.55 14.10 1.63 102.94 29.85 20.29 103.30 29.96 18.20 coo 43.90 10.50 2.81 45.63 11.48 3.27 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 8 3 # 8 217 SER F 83 SER~? 4.14 CL CL F2023 354 GLU F 93 GLU~? 8.36 CL CL F2023 463 HIS F 79 HIS~? -4.63 CL CL F2023s coo 48.87 13.74 2.81 48.49 11.54 3.93 107.41 36.26 21.11 106.31 38.05 19.96 coo 39.95 14.43 3.01 41.55 14.10 1.63 102.94 29.85 20.29 103.30 29.96 18.20 coo 43.90 10.50 2.81 45.63 11.48 3.27 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 9 3 # 9 217 SER G 81 SER~? 9.39 CL CL G2033 354 GLU G 93 GLU~? 8.63 CL CL G2033 463 HIS G 79 HIS~? -4.46 CL CL G2033s coo 48.87 13.74 2.81 48.49 11.54 3.93 1.35 23.42 45.68 2.61 25.29 46.56 coo 39.95 14.43 3.01 41.55 14.10 1.63 3.64 16.49 37.62 3.03 14.55 38.23 coo 43.90 10.50 2.81 45.63 11.48 3.27 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 10 3 # 10 217 SER G 83 SER~? 4.16 CL CL G2033 354 GLU G 93 GLU~? 8.63 CL CL G2033 463 HIS G 79 HIS~? -4.46 CL CL G2033s coo 48.87 13.74 2.81 48.49 11.54 3.93 -0.88 18.73 43.69 0.20 17.85 45.68 coo 39.95 14.43 3.01 41.55 14.10 1.63 3.64 16.49 37.62 3.03 14.55 38.23 coo 43.90 10.50 2.81 45.63 11.48 3.27 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 11 3 # 11 217 SER H 83 SER~? 4.17 CL CL H2024 354 GLU H 93 GLU~? 8.72 CL CL H2024 463 HIS H 79 HIS~? 4.82 CL CL H2024 coo 48.87 13.74 2.81 48.49 11.54 3.93 100.86 60.76 97.52 99.44 59.04 98.47 coo 39.95 14.43 3.01 41.55 14.10 1.63 97.56 68.07 97.57 97.65 67.50 99.59 coo 43.90 10.50 2.81 45.63 11.48 3.27 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 12 3 # 12 217 SER I 81 SER~? 9.15 CL CL I2025 354 GLU I 93 GLU~? 8.40 CL CL I2025 463 HIS I 79 HIS~? -4.56 CL CL I2025s coo 48.87 13.74 2.81 48.49 11.54 3.93 220.47 200.38 164.21 219.13 198.61 165.10 coo 39.95 14.43 3.01 41.55 14.10 1.63 219.77 205.57 155.06 219.86 207.68 155.25 coo 43.90 10.50 2.81 45.63 11.48 3.27 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 13 3 # 13 217 SER I 83 SER~? 4.12 CL CL I2025 354 GLU I 93 GLU~? 8.40 CL CL I2025 463 HIS I 79 HIS~? -4.56 CL CL I2025s coo 48.87 13.74 2.81 48.49 11.54 3.93 222.83 204.85 161.89 221.39 205.66 163.52 coo 39.95 14.43 3.01 41.55 14.10 1.63 219.77 205.57 155.06 219.86 207.68 155.25 coo 43.90 10.50 2.81 45.63 11.48 3.27 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 14 3 # 14 217 SER J 81 SER~? 9.04 CL CL J2026 354 GLU J 93 GLU~? 8.18 CL CL J2026 463 HIS J 79 HIS~? -4.36 CL CL J2026s coo 48.87 13.74 2.81 48.49 11.54 3.93 121.87 175.35 131.02 122.76 174.32 132.99 coo 39.95 14.43 3.01 41.55 14.10 1.63 124.50 183.71 125.04 124.44 183.21 122.99 coo 43.90 10.50 2.81 45.63 11.48 3.27 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 15 3 # 15 217 SER J 83 SER~? 3.90 CL CL J2026 354 GLU J 93 GLU~? 8.18 CL CL J2026 463 HIS J 79 HIS~? -4.36 CL CL J2026s coo 48.87 13.74 2.81 48.49 11.54 3.93 120.35 177.35 126.19 121.76 175.49 125.60 coo 39.95 14.43 3.01 41.55 14.10 1.63 124.50 183.71 125.04 124.44 183.21 122.99 coo 43.90 10.50 2.81 45.63 11.48 3.27 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 16 3 # 16 217 SER K 81 SER~? 9.04 CL CL K2027 354 GLU K 93 GLU~? 8.22 CL CL K2027 463 HIS K 79 HIS~? -4.34 CL CL K2027s coo 48.87 13.74 2.81 48.49 11.54 3.93 215.63 131.69 179.58 214.60 133.54 178.42 coo 39.95 14.43 3.01 41.55 14.10 1.63 212.85 126.80 188.86 213.03 124.72 188.44 coo 43.90 10.50 2.81 45.63 11.48 3.27 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 17 3 # 17 217 SER K 83 SER~? 3.98 CL CL K2027 354 GLU K 93 GLU~? 8.22 CL CL K2027 463 HIS K 79 HIS~? -4.34 CL CL K2027s coo 48.87 13.74 2.81 48.49 11.54 3.93 216.96 127.03 182.22 215.88 126.06 180.30 coo 39.95 14.43 3.01 41.55 14.10 1.63 212.85 126.80 188.86 213.03 124.72 188.44 coo 43.90 10.50 2.81 45.63 11.48 3.27 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 18 3 # 18 217 SER L 83 SER~? 3.95 CL CL L2028 354 GLU L 93 GLU~? 8.05 CL CL L2028 463 HIS L 79 HIS~? -4.09 CL CL L2028s coo 48.87 13.74 2.81 48.49 11.54 3.93 115.00 167.12 206.00 116.47 168.85 206.74 coo 39.95 14.43 3.01 41.55 14.10 1.63 118.11 159.89 208.04 117.71 160.95 209.86 coo 43.90 10.50 2.81 45.63 11.48 3.27 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 19 3 # 19 217 SER M 83 SER~? 4.48 CL CL M2029 354 GLU M 93 GLU~? 8.60 CL CL M2029 463 HIS M 79 HIS~? -4.31 CL CL M2029s coo 48.87 13.74 2.81 48.49 11.54 3.93 119.79 211.86 171.05 121.18 212.22 169.09 coo 39.95 14.43 3.01 41.55 14.10 1.63 123.31 213.00 178.36 123.21 215.02 177.75 coo 43.90 10.50 2.81 45.63 11.48 3.27 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 20 3 # 20 217 SER N 83 SER~? 3.82 CL CL N2030 354 GLU N 93 GLU~? 8.57 CL CL N2030 463 HIS N 79 HIS~? -4.33 CL CL N2030s coo 48.87 13.74 2.81 48.49 11.54 3.93 221.50 155.10 133.13 220.51 157.01 132.05 coo 39.95 14.43 3.01 41.55 14.10 1.63 217.47 148.79 132.22 217.76 148.97 130.14 coo 43.90 10.50 2.81 45.63 11.48 3.27 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 21 3 # 21 217 SER O 83 SER~? 7.53 CL CL O2018 354 GLU O 93 GLU~? 9.72 CL CL O2018 463 HIS O 79 HIS~? 5.21 CL CL O2018 coo 48.87 13.74 2.81 48.49 11.54 3.93 115.90 131.94 160.39 117.13 130.87 162.21 coo 39.95 14.43 3.01 41.55 14.10 1.63 119.95 130.02 153.81 119.63 127.98 154.32 coo 43.90 10.50 2.81 45.63 11.48 3.27 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 22 3 # 22 217 SER P 81 SER~? 10.48 CL CL P2019 354 GLU P 93 GLU~? 9.65 CL CL P2019 463 HIS P 79 HIS~? 5.38 CL CL P2019 coo 48.87 13.74 2.81 48.49 11.54 3.93 216.34 173.84 206.20 215.26 172.77 204.29 coo 39.95 14.43 3.01 41.55 14.10 1.63 214.54 183.14 211.27 214.54 182.92 213.36 coo 43.90 10.50 2.81 45.63 11.48 3.27 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 23 3 # 23 217 SER P 83 SER~? 8.38 CL CL P2019 354 GLU P 93 GLU~? 9.65 CL CL P2019 463 HIS P 79 HIS~? 5.38 CL CL P2019 coo 48.87 13.74 2.81 48.49 11.54 3.93 218.12 176.21 210.92 216.94 174.20 211.47 coo 39.95 14.43 3.01 41.55 14.10 1.63 214.54 183.14 211.27 214.54 182.92 213.36 coo 43.90 10.50 2.81 45.63 11.48 3.27 212.25 178.47 210.26 213.09 179.27 212.01 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 23 hits 1thg_c00 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 128 ALA.? 13.36 O2 GOL A3040 A 251 GLY A 129 GLY.? 16.08 CL CL A2020 A 252 ASP A 127 ASP.? 12.37 CL CL A2020 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 95.27 91.54 37.35 94.22 92.64 37.53 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 96.95 90.98 33.96 96.57 91.66 34.21 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 128 ALA.? 12.65 CL CL B2010 A 251 GLY B 129 GLY.? 14.26 CL CL B2010 A 252 ASP B 127 ASP.? 11.35 CL CL B2010 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 24.45 67.55 4.22 25.71 67.00 3.59 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 23.38 70.92 2.96 23.93 70.32 2.60 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA C 128 ALA.? 12.39 CL CL C2011 A 251 GLY C 129 GLY.? 14.69 CL CL C2011 A 252 ASP C 127 ASP.? 10.87 CL CL C2011 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 82.17 7.76 77.14 80.94 6.87 76.93 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 81.78 8.76 80.79 81.72 8.03 80.50 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA D 128 ALA.? 11.58 O3 GOL D3018 A 251 GLY D 129 GLY.? 14.02 CL CL D2012 A 252 ASP D 127 ASP.? 11.17 CL CL D2012 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 12.19 46.30 94.61 13.15 46.51 95.73 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 10.05 43.17 94.83 10.56 43.50 95.44 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 5 3 # 5 A 250 ALA E 128 ALA.? 12.84 CL CL E2013 A 251 GLY E 129 GLY.? 14.25 CL CL E2013 A 252 ASP E 127 ASP.? 11.39 CL CL E2013 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 22.28 102.43 60.93 23.57 103.26 60.70 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 20.44 102.98 64.21 20.96 103.48 63.67 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 6 3 # 6 A 250 ALA F 128 ALA.? 12.59 CL CL F2034 A 251 GLY F 129 GLY.? 14.09 CL CL F2034 A 252 ASP F 127 ASP.? 10.85 CL CL F2034 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 91.36 29.40 15.50 90.29 29.73 14.45 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 92.60 25.79 15.59 92.12 26.16 15.04 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 7 3 # 7 A 250 ALA G 128 ALA.? 13.29 C3 GOL G3038 A 251 GLY G 129 GLY.? 16.82 C3 GOL G3038 A 252 ASP G 127 ASP.? 12.80 CL CL G2033 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 14.98 11.60 38.42 15.98 10.56 38.85 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 15.32 11.77 34.67 15.32 11.08 35.12 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 8 3 # 8 A 250 ALA H 128 ALA.? 12.60 CL CL H2014 A 251 GLY H 129 GLY.? 14.25 CL CL H2014 A 252 ASP H 127 ASP.? 11.27 CL CL H2014 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 85.67 70.52 99.37 84.40 70.42 100.15 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 87.45 73.88 99.29 86.89 73.62 99.80 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 9 3 # 9 A 250 ALA I 128 ALA.? 12.51 CL CL I2015 A 251 GLY I 129 GLY.? 13.91 CL CL I2015 A 252 ASP I 127 ASP.? 10.93 CL CL I2015 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 207.93 209.75 152.71 206.86 210.81 152.79 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 209.85 209.51 149.43 209.30 210.08 149.73 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 10 3 # 10 A 250 ALA J 128 ALA.? 11.61 O3 GOL J3030 A 251 GLY J 129 GLY.? 13.90 CL CL J2016 A 252 ASP J 127 ASP.? 11.08 CL CL J2016 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 136.84 183.95 121.83 137.97 183.60 120.89 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 135.43 187.49 121.46 135.94 187.11 120.95 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 11 3 # 11 A 250 ALA K 128 ALA.? 11.56 O1 GOL K3041 A 251 GLY K 129 GLY.? 14.73 O1 GOL K3041 A 252 ASP K 127 ASP.? 12.37 CL CL K2027 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 200.65 123.83 189.34 199.48 122.89 189.03 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 202.21 123.63 192.85 201.55 123.47 192.72 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 12 3 # 12 A 250 ALA L 128 ALA.? 12.59 CL CL L2009 A 251 GLY L 129 GLY.? 13.94 CL CL L2009 A 252 ASP L 127 ASP.? 11.05 CL CL L2009 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 129.58 158.29 211.87 130.69 158.48 212.90 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 127.66 155.03 212.10 128.14 155.43 212.70 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 13 3 # 13 A 250 ALA M 128 ALA.? 12.66 CL CL M2017 A 251 GLY M 129 GLY.? 14.05 CL CL M2017 A 252 ASP M 127 ASP.? 9.06 CL CL M2017 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 135.37 215.97 179.88 136.60 216.85 179.62 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 133.41 216.38 183.16 134.04 216.71 183.09 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 14 3 # 14 A 250 ALA N 128 ALA.? 15.61 CL CL N2030 A 251 GLY N 129 GLY.? 16.53 CL CL N2030 A 252 ASP N 127 ASP.? 12.60 CL CL N2030 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 205.73 148.25 128.07 204.65 148.66 127.07 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 206.92 144.66 128.10 206.47 145.04 127.54 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 15 3 # 15 A 250 ALA O 128 ALA.? 12.41 CL CL O2036 A 251 GLY O 129 GLY.? 14.42 CL CL O2018 A 252 ASP O 127 ASP.? 11.33 CL CL O2018 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 131.83 126.01 153.49 132.92 125.04 153.92 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 130.49 125.78 149.93 130.89 125.19 150.35 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 16 3 # 16 A 250 ALA P 128 ALA.? 12.43 CL CL P2019 A 251 GLY P 129 GLY.? 13.95 CL CL P2019 A 252 ASP P 127 ASP.? 11.05 CL CL P2019 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 202.58 185.14 214.18 201.42 184.99 215.13 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 204.46 188.51 214.20 203.84 188.48 214.51 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 207.19 183.81 214.61 207.22 185.89 215.11 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 16 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 128 ALA.? 13.36 O2 GOL A3040 B 251 GLY A 129 GLY.? 16.08 CL CL A2020 B 252 ASP A 127 ASP.? 12.37 CL CL A2020 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 95.27 91.54 37.35 94.22 92.64 37.53 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 96.95 90.98 33.96 96.57 91.66 34.21 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 99.76 91.11 38.83 100.13 91.74 36.79 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 128 ALA.? 12.65 CL CL B2010 B 251 GLY B 129 GLY.? 14.26 CL CL B2010 B 252 ASP B 127 ASP.? 11.35 CL CL B2010 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 24.45 67.55 4.22 25.71 67.00 3.59 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 23.38 70.92 2.96 23.93 70.32 2.60 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 19.74 66.97 3.53 20.01 68.79 2.38 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA C 128 ALA.? 12.39 CL CL C2011 B 251 GLY C 129 GLY.? 14.69 CL CL C2011 B 252 ASP C 127 ASP.? 10.87 CL CL C2011 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 82.17 7.76 77.14 80.94 6.87 76.93 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 81.78 8.76 80.79 81.72 8.03 80.50 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 86.95 7.50 76.71 86.89 6.71 78.70 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA D 128 ALA.? 11.58 O3 GOL D3018 B 251 GLY D 129 GLY.? 14.02 CL CL D2012 B 252 ASP D 127 ASP.? 11.17 CL CL D2012 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 12.19 46.30 94.61 13.15 46.51 95.73 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 10.05 43.17 94.83 10.56 43.50 95.44 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 7.65 47.79 93.97 7.18 46.10 95.19 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 5 3 # 5 B 250 ALA E 128 ALA.? 12.84 CL CL E2013 B 251 GLY E 129 GLY.? 14.25 CL CL E2013 B 252 ASP E 127 ASP.? 11.39 CL CL E2013 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 22.28 102.43 60.93 23.57 103.26 60.70 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 20.44 102.98 64.21 20.96 103.48 63.67 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 17.80 103.20 59.40 17.93 103.89 61.44 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 6 3 # 6 B 250 ALA F 128 ALA.? 12.59 CL CL F2034 B 251 GLY F 129 GLY.? 14.09 CL CL F2034 B 252 ASP F 127 ASP.? 10.85 CL CL F2034 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 91.36 29.40 15.50 90.29 29.73 14.45 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 92.60 25.79 15.59 92.12 26.16 15.04 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 96.13 30.12 15.93 96.25 28.10 15.23 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 7 3 # 7 B 250 ALA G 128 ALA.? 13.29 C3 GOL G3038 B 251 GLY G 129 GLY.? 16.82 C3 GOL G3038 B 252 ASP G 127 ASP.? 12.80 CL CL G2033 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 14.98 11.60 38.42 15.98 10.56 38.85 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 15.32 11.77 34.67 15.32 11.08 35.12 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 10.22 12.11 38.73 10.33 11.10 36.86 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 8 3 # 8 B 250 ALA H 128 ALA.? 12.60 CL CL H2014 B 251 GLY H 129 GLY.? 14.25 CL CL H2014 B 252 ASP H 127 ASP.? 11.27 CL CL H2014 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 85.67 70.52 99.37 84.40 70.42 100.15 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 87.45 73.88 99.29 86.89 73.62 99.80 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 90.18 69.09 100.25 90.25 71.19 100.79 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 9 3 # 9 B 250 ALA I 128 ALA.? 12.51 CL CL I2015 B 251 GLY I 129 GLY.? 13.91 CL CL I2015 B 252 ASP I 127 ASP.? 10.93 CL CL I2015 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 207.93 209.75 152.71 206.86 210.81 152.79 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 209.85 209.51 149.43 209.30 210.08 149.73 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 212.49 209.49 154.15 212.74 210.27 152.16 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 10 3 # 10 B 250 ALA J 128 ALA.? 11.61 O3 GOL J3030 B 251 GLY J 129 GLY.? 13.90 CL CL J2016 B 252 ASP J 127 ASP.? 11.08 CL CL J2016 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 136.84 183.95 121.83 137.97 183.60 120.89 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 135.43 187.49 121.46 135.94 187.11 120.95 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 132.13 183.26 121.62 132.41 185.18 120.66 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 11 3 # 11 B 250 ALA K 128 ALA.? 11.56 O1 GOL K3041 B 251 GLY K 129 GLY.? 14.73 O1 GOL K3041 B 252 ASP K 127 ASP.? 12.37 CL CL K2027 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 200.65 123.83 189.34 199.48 122.89 189.03 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 202.21 123.63 192.85 201.55 123.47 192.72 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 205.42 123.70 188.60 205.51 122.74 190.54 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 12 3 # 12 B 250 ALA L 128 ALA.? 12.59 CL CL L2009 B 251 GLY L 129 GLY.? 13.94 CL CL L2009 B 252 ASP L 127 ASP.? 11.05 CL CL L2009 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 129.58 158.29 211.87 130.69 158.48 212.90 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 127.66 155.03 212.10 128.14 155.43 212.70 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 124.97 159.68 211.55 124.68 157.87 212.62 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 13 3 # 13 B 250 ALA M 128 ALA.? 12.66 CL CL M2017 B 251 GLY M 129 GLY.? 14.05 CL CL M2017 B 252 ASP M 127 ASP.? 9.06 CL CL M2017 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 135.37 215.97 179.88 136.60 216.85 179.62 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 133.41 216.38 183.16 134.04 216.71 183.09 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 130.79 216.32 178.32 129.76 218.07 177.66 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 14 3 # 14 B 250 ALA N 128 ALA.? 15.61 CL CL N2030 B 251 GLY N 129 GLY.? 16.53 CL CL N2030 B 252 ASP N 127 ASP.? 12.60 CL CL N2030 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 205.73 148.25 128.07 204.65 148.66 127.07 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 206.92 144.66 128.10 206.47 145.04 127.54 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 210.39 149.08 128.41 210.51 147.14 127.55 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 15 3 # 15 B 250 ALA O 128 ALA.? 12.41 CL CL O2036 B 251 GLY O 129 GLY.? 14.42 CL CL O2018 B 252 ASP O 127 ASP.? 11.33 CL CL O2018 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 131.83 126.01 153.49 132.92 125.04 153.92 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 130.49 125.78 149.93 130.89 125.19 150.35 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 127.12 126.29 154.29 127.00 125.34 152.37 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 16 3 # 16 B 250 ALA P 128 ALA.? 12.43 CL CL P2019 B 251 GLY P 129 GLY.? 13.95 CL CL P2019 B 252 ASP P 127 ASP.? 11.05 CL CL P2019 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 202.58 185.14 214.18 201.42 184.99 215.13 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 204.46 188.51 214.20 203.84 188.48 214.51 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 207.19 183.81 214.61 207.22 185.89 215.11 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 16 hits 1tz3_c03 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 79 HIS~? -3.92 CL CL A2020s 89 GLU A 93 GLU~? 8.07 CL CL A2020 243 ASN A 162 ASN~? 20.80 CL CL A2020 coo 5.83 15.74 17.38 6.41 17.70 17.86 103.72 86.36 44.76 104.87 88.01 44.15 coo 3.11 16.19 13.44 4.96 17.09 13.42 106.40 86.90 39.80 107.05 88.84 40.38 coo 0.53 21.81 31.33 1.05 20.47 29.70 110.86 71.03 47.42 111.08 69.19 46.38 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 79 HIS~? 5.08 CL CL B2010 89 GLU B 93 GLU~? 9.70 CL CL B2010 243 ASN B 162 ASN~? 18.91 O3 GOL B3015 coo 5.83 15.74 17.38 6.41 17.70 17.86 13.46 62.96 8.26 12.78 63.30 6.30 coo 3.11 16.19 13.44 4.96 17.09 13.42 11.87 67.96 6.38 12.21 67.44 4.38 coo 0.53 21.81 31.33 1.05 20.47 29.70 3.18 65.96 21.79 2.54 67.75 22.68 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS C 76 HIS~? -4.98 CL CL C2011s 89 GLU C 73 GLU~? 6.99 O1 GOL C3036 243 ASN C 118 ASN~? 16.04 CL CL C2011 coo 5.83 15.74 17.38 6.41 17.70 17.86 89.28 12.80 65.47 90.23 11.67 63.98 coo 3.11 16.19 13.44 4.96 17.09 13.42 86.57 17.41 63.72 86.98 15.43 63.06 coo 0.53 21.81 31.33 1.05 20.47 29.70 73.44 6.07 71.04 74.54 6.27 72.84 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS C 79 HIS~? -4.32 CL CL C2021s 89 GLU C 93 GLU~? 8.05 CL CL C2021 243 ASN C 162 ASN~? -4.56 CL CL C2031s coo 5.83 15.74 17.38 6.41 17.70 17.86 92.85 10.89 71.99 93.43 9.18 73.06 coo 3.11 16.19 13.44 4.96 17.09 13.42 94.51 9.91 76.89 94.48 7.78 76.63 coo 0.53 21.81 31.33 1.05 20.47 29.70 103.70 24.43 71.40 105.80 24.17 71.94 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS D 76 HIS~? 4.24 O2 GOL D3018s 89 GLU D 73 GLU~? 5.51 C2 GOL D3020 243 ASN D 118 ASN~? 12.14 O3 GOL D3018 coo 5.83 15.74 17.38 6.41 17.70 17.86 8.84 57.69 86.26 7.93 59.46 86.93 coo 3.11 16.19 13.44 4.96 17.09 13.42 12.99 58.17 82.26 12.31 59.24 83.94 coo 0.53 21.81 31.33 1.05 20.47 29.70 21.36 51.13 97.39 19.90 49.65 97.18 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS D 79 HIS~? -4.57 CL CL D2022s 89 GLU D 93 GLU~? 8.23 CL CL D2022 243 ASN D 162 ASN~? 20.95 CL CL D2022 coo 5.83 15.74 17.38 6.41 17.70 17.86 3.57 52.49 87.96 2.52 51.97 89.71 coo 3.11 16.19 13.44 4.96 17.09 13.42 0.77 48.16 89.31 0.23 49.10 91.12 coo 0.53 21.81 31.33 1.05 20.47 29.70 -3.53 51.75 71.97 -5.56 51.21 71.39 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 7 3 # 7 86 HIS E 79 HIS~? -4.18 CL CL E2032s 89 GLU E 93 GLU~? 8.42 CL CL E2032 243 ASN E 162 ASN~? 18.79 O1 GOL E3002 coo 5.83 15.74 17.38 6.41 17.70 17.86 12.36 98.35 54.34 11.69 100.32 54.60 coo 3.11 16.19 13.44 4.96 17.09 13.42 9.96 100.16 58.92 10.04 102.16 58.24 coo 0.53 21.81 31.33 1.05 20.47 29.70 1.60 84.75 54.79 0.68 83.54 56.28 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 8 3 # 8 86 HIS F 76 HIS~? -4.65 CL CL F2034s 89 GLU F 73 GLU~? 5.19 O3 GOL F3039 243 ASN F 118 ASN~? 12.37 O2 GOL F3039 coo 5.83 15.74 17.38 6.41 17.70 17.86 97.24 41.20 21.57 98.43 42.65 20.63 coo 3.11 16.19 13.44 4.96 17.09 13.42 93.55 43.24 25.35 94.46 43.89 23.55 coo 0.53 21.81 31.33 1.05 20.47 29.70 83.29 35.61 11.58 84.35 33.80 11.95 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 9 3 # 9 86 HIS F 79 HIS~? -4.63 CL CL F2023s 89 GLU F 93 GLU~? 8.36 CL CL F2023 243 ASN F 162 ASN~? 20.44 CL CL F2023 coo 5.83 15.74 17.38 6.41 17.70 17.86 101.04 34.65 20.79 101.93 33.69 19.16 coo 3.11 16.19 13.44 4.96 17.09 13.42 102.94 29.85 20.29 103.30 29.96 18.20 coo 0.53 21.81 31.33 1.05 20.47 29.70 108.49 35.42 36.44 110.53 34.82 36.67 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 10 3 # 10 86 HIS G 76 HIS~? -3.85 O1 GOL G3038s 89 GLU G 73 GLU~? 5.63 O1 GOL G3038 243 ASN G 118 ASN~? 13.16 O3 GOL G3038 coo 5.83 15.74 17.38 6.41 17.70 17.86 9.26 20.10 48.62 8.05 19.49 50.22 coo 3.11 16.19 13.44 4.96 17.09 13.42 12.93 24.13 49.80 12.04 22.49 50.80 coo 0.53 21.81 31.33 1.05 20.47 29.70 23.11 9.07 44.97 21.97 9.06 43.17 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 11 3 # 11 86 HIS G 79 HIS~? -4.46 CL CL G2033s 89 GLU G 93 GLU~? 8.63 CL CL G2033 243 ASN G 162 ASN~? 17.59 O3 GOL G3001 coo 5.83 15.74 17.38 6.41 17.70 17.86 5.20 17.85 42.65 4.12 16.10 42.26 coo 3.11 16.19 13.44 4.96 17.09 13.42 3.64 16.49 37.62 3.03 14.55 38.23 coo 0.53 21.81 31.33 1.05 20.47 29.70 -1.80 33.61 39.96 -0.92 35.33 39.04 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 12 3 # 12 86 HIS H 76 HIS~? 4.68 CL CL H2014s 89 GLU H 73 GLU~? -8.72 CL CL H2014s 243 ASN H 118 ASN~? 16.13 CL CL H2014 coo 5.83 15.74 17.38 6.41 17.70 17.86 90.35 57.57 94.69 91.06 55.99 95.89 coo 3.11 16.19 13.44 4.96 17.09 13.42 87.54 56.19 90.14 87.78 55.44 92.11 coo 0.53 21.81 31.33 1.05 20.47 29.70 76.05 66.21 101.09 77.62 67.71 101.06 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 13 3 # 13 86 HIS H 79 HIS~? 4.82 CL CL H2024 89 GLU H 93 GLU~? 8.72 CL CL H2024 243 ASN H 162 ASN~? 19.79 CL CL H2024 coo 5.83 15.74 17.38 6.41 17.70 17.86 95.19 63.20 96.60 95.96 63.87 98.43 coo 3.11 16.19 13.44 4.96 17.09 13.42 97.56 68.07 97.57 97.65 67.50 99.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 105.86 60.31 83.22 107.86 60.06 84.05 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 14 3 # 14 86 HIS I 76 HIS~? 4.17 O3 GOL I3031s 89 GLU I 73 GLU~? -6.03 O3 GOL I3031s 243 ASN I 118 ASN~? 12.95 O1 GOL I3031 coo 5.83 15.74 17.38 6.41 17.70 17.86 212.11 203.51 165.19 213.01 204.42 166.85 coo 3.11 16.19 13.44 4.96 17.09 13.42 208.30 199.46 166.53 209.06 201.27 167.27 coo 0.53 21.81 31.33 1.05 20.47 29.70 198.78 212.90 157.53 200.20 212.55 155.97 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 15 3 # 15 86 HIS I 79 HIS~? -4.56 CL CL I2025s 89 GLU I 93 GLU~? 8.40 CL CL I2025 243 ASN I 162 ASN~? 21.04 CL CL I2025 coo 5.83 15.74 17.38 6.41 17.70 17.86 216.99 204.94 159.50 218.07 206.60 158.77 coo 3.11 16.19 13.44 4.96 17.09 13.42 219.77 205.57 155.06 219.86 207.68 155.25 coo 0.53 21.81 31.33 1.05 20.47 29.70 225.18 189.96 161.14 225.82 188.37 160.00 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 16 3 # 16 86 HIS J 76 HIS~? 4.19 O2 GOL J3033s 89 GLU J 73 GLU~? 5.06 O1 GOL J3033 243 ASN J 118 ASN~? 12.66 O3 GOL J3030 coo 5.83 15.74 17.38 6.41 17.70 17.86 130.51 172.99 128.94 129.60 171.33 128.01 coo 3.11 16.19 13.44 4.96 17.09 13.42 133.49 171.70 133.63 132.81 170.83 131.84 coo 0.53 21.81 31.33 1.05 20.47 29.70 145.50 177.92 120.49 144.26 179.66 120.53 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 17 3 # 17 86 HIS J 79 HIS~? -4.36 CL CL J2026s 89 GLU J 93 GLU~? 8.18 CL CL J2026 243 ASN J 162 ASN~? 20.00 CL CL J2026 coo 5.83 15.74 17.38 6.41 17.70 17.86 126.45 179.07 126.46 125.69 179.71 124.61 coo 3.11 16.19 13.44 4.96 17.09 13.42 124.50 183.71 125.04 124.44 183.21 122.99 coo 0.53 21.81 31.33 1.05 20.47 29.70 116.58 180.36 140.72 114.44 180.36 140.30 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 18 3 # 18 86 HIS K 76 HIS~? -6.12 C3 GOL K3041s 89 GLU K 73 GLU~? 7.36 C3 GOL K3041 243 ASN K 118 ASN~? 12.53 O1 GOL K3041 coo 5.83 15.74 17.38 6.41 17.70 17.86 207.10 129.51 177.50 208.14 128.55 175.95 coo 3.11 16.19 13.44 4.96 17.09 13.42 204.07 133.93 175.85 204.65 132.02 175.03 coo 0.53 21.81 31.33 1.05 20.47 29.70 191.94 121.64 183.31 193.08 121.89 185.10 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 19 3 # 19 86 HIS K 79 HIS~? -4.34 CL CL K2027s 89 GLU K 93 GLU~? 8.22 CL CL K2027 243 ASN K 162 ASN~? 20.55 CL CL K2027 coo 5.83 15.74 17.38 6.41 17.70 17.86 211.01 127.65 183.80 211.70 125.86 184.65 coo 3.11 16.19 13.44 4.96 17.09 13.42 212.85 126.80 188.86 213.03 124.72 188.44 coo 0.53 21.81 31.33 1.05 20.47 29.70 220.99 141.86 183.52 222.93 141.99 184.43 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 20 3 # 20 86 HIS L 76 HIS~? 4.00 O3 GOL L3027s 89 GLU L 73 GLU~? 5.94 O3 GOL L3027 243 ASN L 118 ASN~? 12.89 O1 GOL L3027 coo 5.83 15.74 17.38 6.41 17.70 17.86 125.69 169.77 203.98 124.79 171.51 204.73 coo 3.11 16.19 13.44 4.96 17.09 13.42 129.44 170.32 199.72 128.69 171.38 201.39 coo 0.53 21.81 31.33 1.05 20.47 29.70 138.94 163.13 214.22 137.52 161.58 214.01 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 21 3 # 21 86 HIS L 79 HIS~? -4.09 CL CL L2028s 89 GLU L 93 GLU~? 8.05 CL CL L2028 243 ASN L 162 ASN~? 19.26 CL CL L2028 coo 5.83 15.74 17.38 6.41 17.70 17.86 120.65 164.52 206.19 119.64 164.06 207.98 coo 3.11 16.19 13.44 4.96 17.09 13.42 118.11 159.89 208.04 117.71 160.95 209.86 coo 0.53 21.81 31.33 1.05 20.47 29.70 112.25 163.92 191.15 110.27 164.53 191.77 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 22 3 # 22 86 HIS M 76 HIS~? 4.78 C1 GOL M3042s 89 GLU M 73 GLU~? -3.31 O3 GOL M3042s 243 ASN M 118 ASN~? 11.47 O3 GOL M3043 coo 5.83 15.74 17.38 6.41 17.70 17.86 130.15 208.85 168.09 129.36 209.65 166.31 coo 3.11 16.19 13.44 4.96 17.09 13.42 133.35 204.22 167.43 132.84 205.99 166.43 coo 0.53 21.81 31.33 1.05 20.47 29.70 144.69 217.23 174.75 143.27 217.31 176.29 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 23 3 # 23 86 HIS M 79 HIS~? -4.31 CL CL M2029s 89 GLU M 93 GLU~? 8.60 CL CL M2029 243 ASN M 162 ASN~? 21.06 CL CL M2029 coo 5.83 15.74 17.38 6.41 17.70 17.86 125.50 211.59 173.52 124.72 213.49 173.99 coo 3.11 16.19 13.44 4.96 17.09 13.42 123.31 213.00 178.36 123.21 215.02 177.75 coo 0.53 21.81 31.33 1.05 20.47 29.70 115.58 197.49 173.95 115.83 195.56 174.88 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 24 3 # 24 86 HIS N 79 HIS~? -4.33 CL CL N2030s 89 GLU N 93 GLU~? 8.57 CL CL N2030 243 ASN N 162 ASN~? 20.47 O1 GOL N3012 coo 5.83 15.74 17.38 6.41 17.70 17.86 215.64 153.98 132.96 216.60 153.22 131.26 coo 3.11 16.19 13.44 4.96 17.09 13.42 217.47 148.79 132.22 217.76 148.97 130.14 coo 0.53 21.81 31.33 1.05 20.47 29.70 223.57 153.98 148.46 225.62 153.32 148.64 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 25 3 # 25 86 HIS O 76 HIS~? 4.51 CL CL O2018s 89 GLU O 73 GLU~? 6.85 O1 GOL O3013 243 ASN O 118 ASN~? 8.57 CL CL O2036 coo 5.83 15.74 17.38 6.41 17.70 17.86 126.10 133.61 164.62 125.01 132.87 166.26 coo 3.11 16.19 13.44 4.96 17.09 13.42 129.73 137.78 165.68 128.97 136.10 166.67 coo 0.53 21.81 31.33 1.05 20.47 29.70 140.29 123.54 159.68 139.14 123.57 157.91 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 26 3 # 26 86 HIS O 79 HIS~? 5.21 CL CL O2018 89 GLU O 93 GLU~? 9.72 CL CL O2018 243 ASN O 162 ASN~? 20.65 O3 GOL O3013 coo 5.83 15.74 17.38 6.41 17.70 17.86 121.98 131.53 158.56 121.09 129.74 157.92 coo 3.11 16.19 13.44 4.96 17.09 13.42 119.95 130.02 153.81 119.63 127.98 154.32 coo 0.53 21.81 31.33 1.05 20.47 29.70 113.68 146.60 157.20 111.65 146.01 156.91 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 27 3 # 27 86 HIS P 76 HIS~? 4.69 CL CL P2019s 89 GLU P 73 GLU~? 5.04 O1 GOL P3034 243 ASN P 118 ASN~? 12.47 O2 GOL P3034 coo 5.83 15.74 17.38 6.41 17.70 17.86 207.59 172.73 208.38 208.33 171.09 209.49 coo 3.11 16.19 13.44 4.96 17.09 13.42 204.36 171.43 203.90 204.84 170.63 205.81 coo 0.53 21.81 31.33 1.05 20.47 29.70 193.17 180.34 216.14 194.59 181.90 215.93 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 28 3 # 28 86 HIS P 79 HIS~? 5.38 CL CL P2019 89 GLU P 93 GLU~? 9.65 CL CL P2019 243 ASN P 162 ASN~? 19.02 O2 GOL P3014 coo 5.83 15.74 17.38 6.41 17.70 17.86 212.25 178.47 210.26 213.09 179.27 212.01 coo 3.11 16.19 13.44 4.96 17.09 13.42 214.54 183.14 211.27 214.54 182.92 213.36 coo 0.53 21.81 31.33 1.05 20.47 29.70 222.14 176.71 196.35 222.77 177.56 194.52 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 28 hits 1ula_c00 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU D 93 GLU~? 8.23 CL CL D2022 A 596 ARG D 94 ARG~? 15.71 CL CL D2012 A 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo 69.13 32.20 28.58 68.39 32.96 30.44 0.77 48.16 89.31 0.23 49.10 91.12 coo 70.89 37.31 29.70 69.54 36.29 32.39 3.39 42.85 90.39 4.96 40.19 90.49 coo 66.09 40.54 34.70 66.92 37.69 35.49 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 A 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s A 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 69.13 32.20 28.58 68.39 32.96 30.44 48.05 79.48 100.95 48.41 81.47 101.74 coo 70.89 37.31 29.70 69.54 36.29 32.39 49.12 78.88 94.88 51.18 78.27 92.74 coo 66.09 40.54 34.70 66.92 37.69 35.49 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 A 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s A 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 69.13 32.20 28.58 68.39 32.96 30.44 173.63 220.13 185.95 172.97 221.25 187.66 coo 70.89 37.31 29.70 69.54 36.29 32.39 172.69 214.03 186.60 170.63 211.79 186.52 coo 66.09 40.54 34.70 66.92 37.69 35.49 179.97 216.30 180.98 181.48 213.82 180.04 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU D 93 GLU~? 8.23 CL CL D2022 B 596 ARG D 94 ARG~? 15.71 CL CL D2012 B 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo 38.22 57.83 70.36 36.82 56.74 69.18 0.77 48.16 89.31 0.23 49.10 91.12 coo 34.24 60.89 68.08 33.31 57.93 67.63 3.39 42.85 90.39 4.96 40.19 90.49 coo 31.43 57.38 61.97 31.90 55.58 64.41 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 B 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s B 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 38.22 57.83 70.36 36.82 56.74 69.18 48.05 79.48 100.95 48.41 81.47 101.74 coo 34.24 60.89 68.08 33.31 57.93 67.63 49.12 78.88 94.88 51.18 78.27 92.74 coo 31.43 57.38 61.97 31.90 55.58 64.41 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 B 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s B 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 38.22 57.83 70.36 36.82 56.74 69.18 173.63 220.13 185.95 172.97 221.25 187.66 coo 34.24 60.89 68.08 33.31 57.93 67.63 172.69 214.03 186.60 170.63 211.79 186.52 coo 31.43 57.38 61.97 31.90 55.58 64.41 179.97 216.30 180.98 181.48 213.82 180.04 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU D 93 GLU~? 8.23 CL CL D2022 C 596 ARG D 94 ARG~? 15.71 CL CL D2012 C 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo 11.31 31.26 27.00 13.31 30.71 26.58 0.77 48.16 89.31 0.23 49.10 91.12 coo 13.44 32.78 22.07 15.56 30.91 23.37 3.39 42.85 90.39 4.96 40.19 90.49 coo 21.00 33.35 22.82 19.83 30.82 24.09 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 C 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s C 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 11.31 31.26 27.00 13.31 30.71 26.58 48.05 79.48 100.95 48.41 81.47 101.74 coo 13.44 32.78 22.07 15.56 30.91 23.37 49.12 78.88 94.88 51.18 78.27 92.74 coo 21.00 33.35 22.82 19.83 30.82 24.09 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 C 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s C 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 11.31 31.26 27.00 13.31 30.71 26.58 173.63 220.13 185.95 172.97 221.25 187.66 coo 13.44 32.78 22.07 15.56 30.91 23.37 172.69 214.03 186.60 170.63 211.79 186.52 coo 21.00 33.35 22.82 19.83 30.82 24.09 179.97 216.30 180.98 181.48 213.82 180.04 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU D 93 GLU~? 8.23 CL CL D2022 D 596 ARG D 94 ARG~? 15.71 CL CL D2012 D 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 0.77 48.16 89.31 0.23 49.10 91.12 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 3.39 42.85 90.39 4.96 40.19 90.49 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 D 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s D 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 48.05 79.48 100.95 48.41 81.47 101.74 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 49.12 78.88 94.88 51.18 78.27 92.74 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 D 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s D 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 173.63 220.13 185.95 172.97 221.25 187.66 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 172.69 214.03 186.60 170.63 211.79 186.52 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 179.97 216.30 180.98 181.48 213.82 180.04 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU D 93 GLU~? 8.23 CL CL D2022 E 596 ARG D 94 ARG~? 15.71 CL CL D2012 E 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 0.77 48.16 89.31 0.23 49.10 91.12 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 3.39 42.85 90.39 4.96 40.19 90.49 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 E 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s E 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 48.05 79.48 100.95 48.41 81.47 101.74 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 49.12 78.88 94.88 51.18 78.27 92.74 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU J 33 GLU~? 23.63 CL CL J2002 E 596 ARG J 37 ARG~? 20.17 CL CL J2002 E 647 ARG J 36 ARG~? 16.92 CL CL J2002 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 176.38 185.90 117.21 176.25 187.26 115.55 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 174.71 186.35 123.78 172.76 186.51 126.11 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 E 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s E 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 173.63 220.13 185.95 172.97 221.25 187.66 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 172.69 214.03 186.60 170.63 211.79 186.52 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU O 33 GLU~? 27.49 CL CL O2036 E 596 ARG O 37 ARG~? 22.15 CL CL K2003 E 647 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 170.20 117.15 151.62 169.74 115.90 149.90 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 169.49 123.46 151.21 167.81 125.99 151.08 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 175.82 120.47 157.52 177.72 122.75 158.28 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 5 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU D 93 GLU~? 8.23 CL CL D2022 F 596 ARG D 94 ARG~? 15.71 CL CL D2012 F 647 ARG D 95 ARG~? 18.32 CL CL D2012 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 0.77 48.16 89.31 0.23 49.10 91.12 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 3.39 42.85 90.39 4.96 40.19 90.49 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU H 33 GLU~? 12.50 C3 GOL H3006 F 596 ARG H 37 ARG~? -4.44 O3 GOL H3006s F 647 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 48.05 79.48 100.95 48.41 81.47 101.74 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 49.12 78.88 94.88 51.18 78.27 92.74 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU J 33 GLU~? 23.63 CL CL J2002 F 596 ARG J 37 ARG~? 20.17 CL CL J2002 F 647 ARG J 36 ARG~? 16.92 CL CL J2002 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 176.38 185.90 117.21 176.25 187.26 115.55 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 174.71 186.35 123.78 172.76 186.51 126.11 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU M 33 GLU~? 12.64 O1 GOL M3007 F 596 ARG M 37 ARG~? -4.64 O1 GOL M3007s F 647 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 173.63 220.13 185.95 172.97 221.25 187.66 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 172.69 214.03 186.60 170.63 211.79 186.52 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 5 3 # 5 F 581 GLU O 33 GLU~? 27.49 CL CL O2036 F 596 ARG O 37 ARG~? 22.15 CL CL K2003 F 647 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 170.20 117.15 151.62 169.74 115.90 149.90 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 169.49 123.46 151.21 167.81 125.99 151.08 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 175.82 120.47 157.52 177.72 122.75 158.28 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 5 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 11 ASN~? 13.90 C3 GOL E3035 457 GLY A 45 GLY~? 19.51 C3 GOL E3035 459 GLU A 43 GLU~? 17.96 C3 GOL E3035 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 47.69 85.14 44.28 46.82 84.21 42.52 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 50.95 85.70 34.39 50.82 86.05 33.63 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 49.19 92.81 37.46 48.57 94.78 37.27 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 118 ASN~? 12.89 O2 GOL A3040 457 GLY A 121 GLY.? 7.05 O2 GOL A3040 459 GLU A 120 GLU.? -11.73 C1 GOL A3040s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 86.19 95.46 41.69 87.65 94.96 40.21 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 88.39 94.99 48.45 88.29 94.18 48.53 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 83.52 91.40 48.59 81.73 92.29 49.38 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 11 ASN~? 20.64 CL CL F2035 457 GLY B 45 GLY~? 12.70 O2 GOL B3003 459 GLU B 43 GLU~? 16.83 O2 GOL B3003 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 67.09 53.72 23.05 68.24 55.42 23.61 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 66.43 63.77 19.85 66.74 64.36 19.39 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 68.56 58.79 14.03 69.54 58.38 12.22 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN C 11 ASN~? 13.02 CL CL C2006 457 GLY C 45 GLY~? 17.00 CL CL C2006 459 GLU C 43 GLU~? 15.46 CL CL C2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 39.48 23.73 60.48 38.53 24.80 62.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 40.48 22.75 70.83 40.13 22.40 71.51 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 38.06 16.03 67.09 37.03 14.19 67.14 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN D 11 ASN~? 12.70 O3 GOL H3025 457 GLY D 45 GLY~? 12.67 C1 GOL D3005 459 GLU D 43 GLU~? 15.38 CL CL H2005 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 59.63 51.24 86.13 60.38 49.29 85.64 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 56.08 41.63 88.81 56.21 40.99 89.32 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 58.07 46.43 95.03 58.79 46.64 97.07 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN E 11 ASN~? 21.92 C1 GOL E3004 457 GLY E 45 GLY~? 12.80 C1 GOL E3004 459 GLU E 43 GLU~? 17.32 C1 GOL E3004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 66.56 84.05 56.14 67.19 83.33 58.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 63.63 87.21 65.85 63.80 87.67 66.48 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 66.77 92.95 61.24 67.88 94.70 61.00 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN E 118 ASN~? 11.51 O3 GOL E3022 457 GLY E 121 GLY.? -5.18 O3 GOL E3022s 459 GLU E 120 GLU.? -9.65 O2 GOL E3035s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 31.70 103.14 55.93 30.26 103.25 57.51 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 29.14 101.88 49.37 29.06 101.07 49.43 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 33.01 97.18 49.59 34.45 97.37 48.08 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN F 11 ASN~? 13.91 O1 GOL B3017 457 GLY F 45 GLY~? 18.91 O1 GOL B3017 459 GLU F 43 GLU~? 17.56 O1 GOL B3017 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 46.13 46.06 21.64 44.92 44.52 22.55 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 47.24 35.61 20.99 47.06 34.90 20.57 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 46.38 39.16 13.84 45.66 39.18 11.88 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN G 11 ASN~? 12.45 O1 GOL C3021 457 GLY G 45 GLY~? 16.95 O1 GOL C3021 459 GLU G 43 GLU~? 15.32 CL CL C2004 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 60.32 20.98 52.71 61.40 21.45 50.92 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 59.08 17.96 42.67 59.32 17.47 42.06 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 59.87 11.86 47.66 60.57 9.92 48.07 ULMN 3 1vom_c00 MYOSIN user 10 3 # 10 233 ASN G 118 ASN~? 13.16 O3 GOL G3038 457 GLY G 121 GLY.? 7.09 O3 GOL G3038 459 GLU G 120 GLU.? -11.42 O3 GOL G3038s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 23.11 9.07 44.97 21.97 9.06 43.17 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 19.46 10.82 50.81 19.56 11.63 50.72 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 24.27 14.49 51.28 25.51 14.14 52.97 ULMN 3 1vom_c00 MYOSIN user 11 3 # 11 233 ASN H 11 ASN~? 13.03 CL CL D2008 457 GLY H 45 GLY~? 12.88 C3 GOL H3006 459 GLU H 43 GLU~? 15.40 CL CL H2005 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 40.80 62.96 83.01 40.13 64.68 81.92 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 43.89 73.11 84.12 43.73 73.84 84.49 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 40.68 69.93 90.74 39.73 70.17 92.61 ULMN 3 1vom_c00 MYOSIN user 12 3 # 12 233 ASN I 11 ASN~? 13.03 CL CL I2007 457 GLY I 45 GLY~? 17.06 CL CL I2007 459 GLU I 43 GLU~? 15.44 CL CL I2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 161.01 200.49 161.41 160.17 199.75 159.57 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 163.74 201.85 151.32 163.59 202.25 150.62 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 161.95 208.67 154.98 161.14 210.63 154.95 ULMN 3 1vom_c00 MYOSIN user 13 3 # 13 233 ASN I 118 ASN~? 12.95 O1 GOL I3031 457 GLY I 121 GLY.? 7.09 C1 GOL I3031 459 GLU I 120 GLU.? -11.94 O1 GOL I3031s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 198.78 212.90 157.53 200.20 212.55 155.97 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 201.38 212.19 164.10 201.27 211.38 164.18 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 196.64 208.29 164.24 194.84 208.90 165.25 ULMN 3 1vom_c00 MYOSIN user 14 3 # 14 233 ASN J 11 ASN~? 12.94 O2 GOL N3044 457 GLY J 45 GLY~? 18.52 O2 GOL N3044 459 GLU J 43 GLU~? 15.36 CL CL J2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 180.98 171.30 137.88 181.93 173.10 138.53 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 179.59 181.42 135.19 179.83 182.04 134.73 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 181.82 176.83 128.99 182.77 176.54 127.14 ULMN 3 1vom_c00 MYOSIN user 15 3 # 15 233 ASN K 11 ASN~? 12.99 CL CL K2003 457 GLY K 45 GLY~? 12.40 C1 GOL K3011 459 GLU K 43 GLU~? 16.84 C1 GOL K3011 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 156.74 138.31 174.91 155.83 139.22 176.64 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 158.16 136.87 185.20 157.90 136.49 185.89 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 155.84 130.25 181.35 154.86 128.33 181.37 ULMN 3 1vom_c00 MYOSIN user 16 3 # 16 233 ASN L 11 ASN~? 26.76 O3 GOL P3014 457 GLY L 45 GLY~? 23.68 O3 GOL K3011 459 GLU L 43 GLU~? 27.03 C1 GOL P3034 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 176.63 165.37 201.14 177.48 163.54 200.51 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 173.88 155.42 203.48 174.00 154.76 203.97 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 175.92 159.97 209.77 176.60 160.07 211.76 ULMN 3 1vom_c00 MYOSIN user 17 3 # 17 233 ASN M 11 ASN~? 13.05 CL CL I2007 457 GLY M 45 GLY~? 13.07 O1 GOL M3007 459 GLU M 43 GLU~? 15.49 CL CL I2001 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 180.57 199.77 172.35 181.29 199.01 174.20 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 177.90 202.61 182.31 178.11 203.05 182.95 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 180.74 208.70 177.96 181.77 210.50 177.78 ULMN 3 1vom_c00 MYOSIN user 18 3 # 18 233 ASN N 11 ASN~? 18.16 CL CL J2002 457 GLY N 45 GLY~? 12.51 C3 GOL N3008 459 GLU N 43 GLU~? 15.48 CL CL J2002 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 160.32 162.66 137.06 159.27 161.03 137.96 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 161.92 152.32 135.85 161.69 151.66 135.48 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 160.49 156.26 129.04 159.76 156.26 127.05 ULMN 3 1vom_c00 MYOSIN user 19 3 # 19 233 ASN O 11 ASN~? 13.05 CL CL K2003 457 GLY O 45 GLY~? 17.06 CL CL K2003 459 GLU O 43 GLU~? 17.17 O1 GOL K3010 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 177.30 136.62 166.28 178.38 137.16 164.50 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 175.59 134.16 156.16 175.85 133.73 155.53 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 177.14 127.85 160.77 177.95 125.93 161.03 ULMN 3 1vom_c00 MYOSIN user 20 3 # 20 233 ASN P 11 ASN~? 12.58 O1 GOL L3028 457 GLY P 45 GLY~? 17.57 O1 GOL L3028 459 GLU P 43 GLU~? 15.67 O1 GOL L3028 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 157.20 176.23 199.28 156.46 178.04 198.37 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 159.87 186.40 200.77 159.64 187.12 201.08 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 157.04 182.77 207.26 156.16 182.81 209.15 1vom_c00 source 1vom MYOSIN : 20 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 317 GLU C 106 GLU~? 19.79 O1 GOL C3036 A 365 ARG C 114 ARG~? 19.78 CL CL C2011 coo 1.77 6.56 57.05 3.05 7.44 59.37 74.32 21.96 74.78 73.58 24.65 74.54 coo 3.06 2.85 52.79 4.83 3.89 53.24 75.34 22.76 79.72 77.40 22.80 79.51 coo 3.82 17.09 49.56 4.09 14.32 50.84 73.29 10.73 76.57 73.51 10.59 79.63 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 317 GLU C 106 GLU~? 19.79 O1 GOL C3036 A 365 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 1.77 6.56 57.05 3.05 7.44 59.37 74.32 21.96 74.78 73.58 24.65 74.54 coo 3.06 2.85 52.79 4.83 3.89 53.24 75.34 22.76 79.72 77.40 22.80 79.51 coo 3.82 17.09 49.56 4.09 14.32 50.84 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR F 109 TYR~? 6.98 CL CL F2035 A 317 GLU F 106 GLU~? 12.79 CL CL F2035 A 365 ARG F 114 ARG~? 18.29 CL CL F2035 coo 1.77 6.56 57.05 3.05 7.44 59.37 80.57 32.26 27.20 79.31 32.54 29.65 coo 3.06 2.85 52.79 4.83 3.89 53.24 81.39 27.31 28.31 83.45 27.54 28.69 coo 3.82 17.09 49.56 4.09 14.32 50.84 81.94 30.32 15.98 81.85 27.28 16.31 1vzx_c02 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR C 109 TYR~? 17.83 O1 GOL C3036 B1317 GLU C 106 GLU~? 19.79 O1 GOL C3036 B1365 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 74.32 21.96 74.78 73.58 24.65 74.54 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 75.34 22.76 79.72 77.40 22.80 79.51 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR F 109 TYR~? 6.98 CL CL F2035 B1317 GLU F 106 GLU~? 12.79 CL CL F2035 B1365 ARG F 114 ARG~? 18.29 CL CL F2035 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 80.57 32.26 27.20 79.31 32.54 29.65 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 81.39 27.31 28.31 83.45 27.54 28.69 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 81.94 30.32 15.98 81.85 27.28 16.31 1vzx_c03 source 1vzx 2.04.01.0087 : 2 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 75 TYR~? 11.96 CL CL A2020 A 40 ASP A 127 ASP.? 12.37 CL CL A2020 A 103 LEU A 99 LEU.? 15.49 CL CL A2020 coo 12.09 16.13 10.57 11.28 18.80 10.73 97.97 81.77 42.85 98.10 80.04 40.64 coo 7.55 25.51 14.34 9.65 25.73 14.24 99.76 91.11 38.83 100.13 91.74 36.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.68 83.55 35.29 98.87 83.52 34.86 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 143 TYR~? 16.38 O1 GOL A3040 A 40 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 103 LEU A 99 LEU.? 15.49 CL CL A2020 coo 12.09 16.13 10.57 11.28 18.80 10.73 92.99 77.44 39.76 93.75 79.76 38.42 coo 7.55 25.51 14.34 9.65 25.73 14.24 88.23 80.63 30.72 87.92 80.82 28.67 coo 11.83 18.73 16.99 10.99 19.71 15.26 96.68 83.55 35.29 98.87 83.52 34.86 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 75 TYR~? 10.15 CL CL B2010 A 40 ASP B 127 ASP.? 11.35 CL CL B2010 A 103 LEU B 99 LEU.? 13.87 CL CL B2010 coo 12.09 16.13 10.57 11.28 18.80 10.73 18.67 65.14 13.86 18.80 67.67 14.99 coo 7.55 25.51 14.34 9.65 25.73 14.24 19.74 66.97 3.53 20.01 68.79 2.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.93 71.67 10.80 20.15 72.56 9.78 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 143 TYR~? 10.77 O2 GOL B3024 A 40 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 103 LEU B 99 LEU.? 13.87 CL CL B2010 coo 12.09 16.13 10.57 11.28 18.80 10.73 23.25 68.41 18.58 23.33 69.19 15.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 30.49 75.29 14.98 31.30 77.16 14.42 coo 11.83 18.73 16.99 10.99 19.71 15.26 21.93 71.67 10.80 20.15 72.56 9.78 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 75 TYR~? 10.50 CL CL C2011 A 40 ASP C 127 ASP.? 10.87 CL CL C2011 A 103 LEU C 99 LEU.? 14.27 CL CL C2011 coo 12.09 16.13 10.57 11.28 18.80 10.73 87.86 16.77 72.91 87.86 18.43 75.14 coo 7.55 25.51 14.34 9.65 25.73 14.24 86.95 7.50 76.71 86.89 6.71 78.70 coo 11.83 18.73 16.99 10.99 19.71 15.26 84.64 15.71 79.79 86.53 15.48 80.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 143 TYR~? 14.40 O1 GOL C3036 A 40 ASP C 102 ASP.? 24.57 CL CL C2011 A 103 LEU C 99 LEU.? 14.27 CL CL C2011 coo 12.09 16.13 10.57 11.28 18.80 10.73 83.34 22.31 75.20 83.28 19.92 76.54 coo 7.55 25.51 14.34 9.65 25.73 14.24 76.25 20.52 82.74 75.40 20.56 84.65 coo 11.83 18.73 16.99 10.99 19.71 15.26 84.64 15.71 79.79 86.53 15.48 80.91 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 75 TYR~? 10.03 CL CL D2012 A 40 ASP D 127 ASP.? 11.17 CL CL D2012 A 103 LEU D 99 LEU.? 13.98 CL CL D2012 coo 12.09 16.13 10.57 11.28 18.80 10.73 9.41 49.60 83.94 9.22 47.13 82.70 coo 7.55 25.51 14.34 9.65 25.73 14.24 7.65 47.79 93.97 7.18 46.10 95.19 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.70 42.57 87.13 8.63 41.98 87.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR D 143 TYR~? 15.16 CL CL D2012 A 40 ASP D 102 ASP.? 24.32 CL CL D2012 A 103 LEU D 99 LEU.? 13.98 CL CL D2012 coo 12.09 16.13 10.57 11.28 18.80 10.73 14.34 45.54 80.17 13.57 44.79 82.74 coo 7.55 25.51 14.34 9.65 25.73 14.24 18.96 37.41 85.00 19.42 35.40 85.42 coo 11.83 18.73 16.99 10.99 19.71 15.26 10.70 42.57 87.13 8.63 41.98 87.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR E 75 TYR~? 10.13 CL CL E2013 A 40 ASP E 127 ASP.? 11.39 CL CL E2013 A 103 LEU E 99 LEU.? 14.23 CL CL E2013 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.89 92.83 57.30 16.35 91.61 59.76 coo 7.55 25.51 14.34 9.65 25.73 14.24 17.80 103.20 59.40 17.93 103.89 61.44 coo 11.83 18.73 16.99 10.99 19.71 15.26 18.95 95.36 64.50 17.03 96.10 65.27 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR E 143 TYR~? 15.23 CL CL E2013 A 40 ASP E 102 ASP.? 24.45 CL CL E2013 A 103 LEU E 99 LEU.? 14.23 CL CL E2013 coo 12.09 16.13 10.57 11.28 18.80 10.73 20.79 87.99 61.33 20.74 90.64 62.13 coo 7.55 25.51 14.34 9.65 25.73 14.24 26.42 91.49 69.61 27.08 91.68 71.63 coo 11.83 18.73 16.99 10.99 19.71 15.26 18.95 95.36 64.50 17.03 96.10 65.27 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR F 75 TYR~? 9.99 CL CL F2034 A 40 ASP F 127 ASP.? 10.85 CL CL F2034 A 103 LEU F 99 LEU.? 13.96 CL CL F2034 coo 12.09 16.13 10.57 11.28 18.80 10.73 95.01 33.97 25.26 94.64 31.83 27.03 coo 7.55 25.51 14.34 9.65 25.73 14.24 96.13 30.12 15.93 96.25 28.10 15.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 92.01 27.08 23.54 93.77 25.78 23.40 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR F 143 TYR~? 15.09 CL CL F2034 A 40 ASP F 102 ASP.? 16.73 CL CL F2035 A 103 LEU F 99 LEU.? 13.96 CL CL F2034 coo 12.09 16.13 10.57 11.28 18.80 10.73 89.42 31.84 29.55 89.79 30.44 27.17 coo 7.55 25.51 14.34 9.65 25.73 14.24 82.74 24.28 26.35 81.91 22.30 26.35 coo 11.83 18.73 16.99 10.99 19.71 15.26 92.01 27.08 23.54 93.77 25.78 23.40 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR G 75 TYR~? 12.69 CL CL G2033 A 40 ASP G 127 ASP.? 12.80 CL CL G2033 A 103 LEU G 99 LEU.? 16.17 CL CL G2033 coo 12.09 16.13 10.57 11.28 18.80 10.73 11.49 22.21 40.76 11.82 23.42 38.24 coo 7.55 25.51 14.34 9.65 25.73 14.24 10.22 12.11 38.73 10.33 11.10 36.86 coo 11.83 18.73 16.99 10.99 19.71 15.26 14.23 19.01 34.29 12.19 18.63 33.49 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR G 143 TYR~? 15.53 C3 GOL G3001 A 40 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 103 LEU G 99 LEU.? 16.17 CL CL G2033 coo 12.09 16.13 10.57 11.28 18.80 10.73 16.97 25.90 37.77 16.51 23.33 36.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 23.47 21.05 30.82 24.30 20.62 28.93 coo 11.83 18.73 16.99 10.99 19.71 15.26 14.23 19.01 34.29 12.19 18.63 33.49 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR H 75 TYR~? 10.27 CL CL H2014 A 40 ASP H 127 ASP.? 11.27 CL CL H2014 A 103 LEU H 99 LEU.? 14.24 CL CL H2014 coo 12.09 16.13 10.57 11.28 18.80 10.73 90.64 65.09 90.65 91.11 67.21 88.98 coo 7.55 25.51 14.34 9.65 25.73 14.24 90.18 69.09 100.25 90.25 71.19 100.79 coo 11.83 18.73 16.99 10.99 19.71 15.26 88.74 72.63 91.84 90.81 73.32 92.17 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR H 143 TYR~? 11.30 O2 GOL H3016 A 40 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 103 LEU H 99 LEU.? 14.24 CL CL H2014 coo 12.09 16.13 10.57 11.28 18.80 10.73 86.77 67.99 85.16 86.88 69.36 87.57 coo 7.55 25.51 14.34 9.65 25.73 14.24 81.36 76.99 86.94 80.90 79.01 86.89 coo 11.83 18.73 16.99 10.99 19.71 15.26 88.74 72.63 91.84 90.81 73.32 92.17 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 17 3 # 17 A 16 TYR I 75 TYR~? 10.32 CL CL I2015 A 40 ASP I 127 ASP.? 10.93 CL CL I2015 A 103 LEU I 99 LEU.? 14.05 CL CL I2015 coo 12.09 16.13 10.57 11.28 18.80 10.73 211.34 199.93 157.52 211.50 198.33 155.24 coo 7.55 25.51 14.34 9.65 25.73 14.24 212.49 209.49 154.15 212.74 210.27 152.16 coo 11.83 18.73 16.99 10.99 19.71 15.26 209.53 201.81 150.19 211.63 201.97 149.59 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 18 3 # 18 A 16 TYR I 143 TYR~? 11.25 C1 GOL I3032 A 40 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 103 LEU I 99 LEU.? 14.05 CL CL I2015 coo 12.09 16.13 10.57 11.28 18.80 10.73 206.55 195.37 154.41 207.09 197.83 153.23 coo 7.55 25.51 14.34 9.65 25.73 14.24 201.10 198.54 145.88 200.66 198.62 143.82 coo 11.83 18.73 16.99 10.99 19.71 15.26 209.53 201.81 150.19 211.63 201.97 149.59 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 19 3 # 19 A 16 TYR J 75 TYR~? 10.17 CL CL J2016 A 40 ASP J 127 ASP.? 11.08 CL CL J2016 A 103 LEU J 99 LEU.? 13.96 CL CL J2016 coo 12.09 16.13 10.57 11.28 18.80 10.73 131.82 180.89 131.78 131.82 183.34 133.12 coo 7.55 25.51 14.34 9.65 25.73 14.24 132.13 183.26 121.62 132.41 185.18 120.66 coo 11.83 18.73 16.99 10.99 19.71 15.26 134.68 187.63 129.42 132.80 188.60 128.96 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 20 3 # 20 A 16 TYR J 143 TYR~? 15.18 CL CL J2016 A 40 ASP J 102 ASP.? 24.08 CL CL J2016 A 103 LEU J 99 LEU.? 13.96 CL CL J2016 coo 12.09 16.13 10.57 11.28 18.80 10.73 136.50 183.91 136.49 136.50 184.93 133.88 coo 7.55 25.51 14.34 9.65 25.73 14.24 143.25 191.36 132.98 143.80 193.32 132.63 coo 11.83 18.73 16.99 10.99 19.71 15.26 134.68 187.63 129.42 132.80 188.60 128.96 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 21 3 # 21 A 16 TYR K 75 TYR~? 12.36 CL CL K2027 A 40 ASP K 127 ASP.? 12.37 CL CL K2027 A 103 LEU K 99 LEU.? 15.90 CL CL K2027 coo 12.09 16.13 10.57 11.28 18.80 10.73 205.79 133.16 185.06 205.81 134.80 187.34 coo 7.55 25.51 14.34 9.65 25.73 14.24 205.42 123.70 188.60 205.51 122.74 190.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 202.94 131.53 192.10 204.93 130.90 192.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 22 3 # 22 A 16 TYR K 143 TYR~? 15.99 O3 GOL K3009 A 40 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 103 LEU K 99 LEU.? 15.90 CL CL K2027 coo 12.09 16.13 10.57 11.28 18.80 10.73 201.16 138.32 187.50 201.22 135.84 188.82 coo 7.55 25.51 14.34 9.65 25.73 14.24 194.36 135.90 195.25 193.66 135.95 197.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 202.94 131.53 192.10 204.93 130.90 192.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 23 3 # 23 A 16 TYR L 75 TYR~? 10.07 CL CL L2009 A 40 ASP L 127 ASP.? 11.05 CL CL L2009 A 103 LEU L 99 LEU.? 13.85 CL CL L2009 coo 12.09 16.13 10.57 11.28 18.80 10.73 126.23 161.73 201.55 126.10 159.32 200.24 coo 7.55 25.51 14.34 9.65 25.73 14.24 124.97 159.68 211.55 124.68 157.87 212.62 coo 11.83 18.73 16.99 10.99 19.71 15.26 127.71 154.64 204.45 125.47 154.23 204.74 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 24 3 # 24 A 16 TYR M 75 TYR~? 10.36 CL CL M2017 A 40 ASP M 127 ASP.? 9.06 CL CL M2017 A 103 LEU M 99 LEU.? 13.91 CL CL M2017 coo 12.09 16.13 10.57 11.28 18.80 10.73 130.62 206.12 176.17 130.27 204.76 178.58 coo 7.55 25.51 14.34 9.65 25.73 14.24 130.79 216.32 178.32 129.76 218.07 177.66 coo 11.83 18.73 16.99 10.99 19.71 15.26 132.61 208.78 183.22 130.76 209.95 183.74 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 25 3 # 25 A 16 TYR M 143 TYR~? 15.40 CL CL M2017 A 40 ASP M 102 ASP.? 24.52 CL CL M2017 A 103 LEU M 99 LEU.? 13.91 CL CL M2017 coo 12.09 16.13 10.57 11.28 18.80 10.73 134.88 201.35 179.85 134.66 203.97 180.76 coo 7.55 25.51 14.34 9.65 25.73 14.24 140.74 204.70 188.01 141.33 204.99 189.98 coo 11.83 18.73 16.99 10.99 19.71 15.26 132.61 208.78 183.22 130.76 209.95 183.74 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 26 3 # 26 A 16 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 40 ASP N 127 ASP.? 12.60 CL CL N2030 A 103 LEU N 99 LEU.? 16.24 CL CL N2030 coo 12.09 16.13 10.57 11.28 18.80 10.73 209.71 152.64 137.80 209.50 150.35 139.41 coo 7.55 25.51 14.34 9.65 25.73 14.24 210.39 149.08 128.41 210.51 147.14 127.55 coo 11.83 18.73 16.99 10.99 19.71 15.26 206.93 145.59 136.00 209.00 144.75 135.80 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 27 3 # 27 A 16 TYR N 143 TYR~? 10.73 O2 GOL N3029 A 40 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 103 LEU N 99 LEU.? 16.24 CL CL N2030 coo 12.09 16.13 10.57 11.28 18.80 10.73 204.41 150.24 142.39 204.78 148.95 139.97 coo 7.55 25.51 14.34 9.65 25.73 14.24 197.96 142.41 139.19 197.06 140.46 139.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 206.93 145.59 136.00 209.00 144.75 135.80 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 28 3 # 28 A 16 TYR O 75 TYR~? 10.24 CL CL O2018 A 40 ASP O 127 ASP.? 11.33 CL CL O2018 A 103 LEU O 99 LEU.? 14.37 CL CL O2018 coo 12.09 16.13 10.57 11.28 18.80 10.73 127.87 136.17 156.70 127.95 137.50 154.23 coo 7.55 25.51 14.34 9.65 25.73 14.24 127.12 126.29 154.29 127.00 125.34 152.37 coo 11.83 18.73 16.99 10.99 19.71 15.26 130.52 133.57 149.85 128.56 133.58 148.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 29 3 # 29 A 16 TYR O 143 TYR~? 11.76 C3 GOL O3026 A 40 ASP O 102 ASP.? 13.16 CL CL O2036 A 103 LEU O 99 LEU.? 14.37 CL CL O2018 coo 12.09 16.13 10.57 11.28 18.80 10.73 133.04 140.38 153.60 132.61 137.79 152.63 coo 7.55 25.51 14.34 9.65 25.73 14.24 139.48 136.33 146.19 140.25 135.96 144.25 coo 11.83 18.73 16.99 10.99 19.71 15.26 130.52 133.57 149.85 128.56 133.58 148.88 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 30 3 # 30 A 16 TYR P 75 TYR~? 10.23 CL CL P2019 A 40 ASP P 127 ASP.? 11.05 CL CL P2019 A 103 LEU P 99 LEU.? 13.98 CL CL P2019 coo 12.09 16.13 10.57 11.28 18.80 10.73 207.22 180.36 204.70 207.43 182.65 203.13 coo 7.55 25.51 14.34 9.65 25.73 14.24 207.19 183.81 214.61 207.22 185.89 215.11 coo 11.83 18.73 16.99 10.99 19.71 15.26 205.13 187.68 206.38 207.13 188.38 206.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 31 3 # 31 A 16 TYR P 143 TYR~? 15.20 CL CL P2019 A 40 ASP P 102 ASP.? 24.26 CL CL P2019 A 103 LEU P 99 LEU.? 13.98 CL CL P2019 coo 12.09 16.13 10.57 11.28 18.80 10.73 202.86 183.43 199.65 203.11 184.67 202.14 coo 7.55 25.51 14.34 9.65 25.73 14.24 197.01 191.93 202.05 196.73 194.01 202.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 205.13 187.68 206.38 207.13 188.38 206.85 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 31 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 75 TYR~? 11.96 CL CL A2020 B 40 ASP A 127 ASP.? 12.37 CL CL A2020 B 103 LEU A 99 LEU.? 15.49 CL CL A2020 coo 14.25 20.09 37.35 13.48 17.40 37.38 97.97 81.77 42.85 98.10 80.04 40.64 coo 9.39 10.77 34.53 11.50 10.63 34.41 99.76 91.11 38.83 100.13 91.74 36.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.68 83.55 35.29 98.87 83.52 34.86 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 143 TYR~? 16.38 O1 GOL A3040 B 40 ASP A 102 ASP.? 25.18 C1 GOL A3040 B 103 LEU A 99 LEU.? 15.49 CL CL A2020 coo 14.25 20.09 37.35 13.48 17.40 37.38 92.99 77.44 39.76 93.75 79.76 38.42 coo 9.39 10.77 34.53 11.50 10.63 34.41 88.23 80.63 30.72 87.92 80.82 28.67 coo 12.89 17.60 31.13 12.34 16.51 32.90 96.68 83.55 35.29 98.87 83.52 34.86 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 75 TYR~? 10.15 CL CL B2010 B 40 ASP B 127 ASP.? 11.35 CL CL B2010 B 103 LEU B 99 LEU.? 13.87 CL CL B2010 coo 14.25 20.09 37.35 13.48 17.40 37.38 18.67 65.14 13.86 18.80 67.67 14.99 coo 9.39 10.77 34.53 11.50 10.63 34.41 19.74 66.97 3.53 20.01 68.79 2.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.93 71.67 10.80 20.15 72.56 9.78 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 143 TYR~? 10.77 O2 GOL B3024 B 40 ASP B 102 ASP.? 20.31 O1 GOL B3024 B 103 LEU B 99 LEU.? 13.87 CL CL B2010 coo 14.25 20.09 37.35 13.48 17.40 37.38 23.25 68.41 18.58 23.33 69.19 15.92 coo 9.39 10.77 34.53 11.50 10.63 34.41 30.49 75.29 14.98 31.30 77.16 14.42 coo 12.89 17.60 31.13 12.34 16.51 32.90 21.93 71.67 10.80 20.15 72.56 9.78 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 75 TYR~? 10.50 CL CL C2011 B 40 ASP C 127 ASP.? 10.87 CL CL C2011 B 103 LEU C 99 LEU.? 14.27 CL CL C2011 coo 14.25 20.09 37.35 13.48 17.40 37.38 87.86 16.77 72.91 87.86 18.43 75.14 coo 9.39 10.77 34.53 11.50 10.63 34.41 86.95 7.50 76.71 86.89 6.71 78.70 coo 12.89 17.60 31.13 12.34 16.51 32.90 84.64 15.71 79.79 86.53 15.48 80.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 143 TYR~? 14.40 O1 GOL C3036 B 40 ASP C 102 ASP.? 24.57 CL CL C2011 B 103 LEU C 99 LEU.? 14.27 CL CL C2011 coo 14.25 20.09 37.35 13.48 17.40 37.38 83.34 22.31 75.20 83.28 19.92 76.54 coo 9.39 10.77 34.53 11.50 10.63 34.41 76.25 20.52 82.74 75.40 20.56 84.65 coo 12.89 17.60 31.13 12.34 16.51 32.90 84.64 15.71 79.79 86.53 15.48 80.91 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR D 75 TYR~? 10.03 CL CL D2012 B 40 ASP D 127 ASP.? 11.17 CL CL D2012 B 103 LEU D 99 LEU.? 13.98 CL CL D2012 coo 14.25 20.09 37.35 13.48 17.40 37.38 9.41 49.60 83.94 9.22 47.13 82.70 coo 9.39 10.77 34.53 11.50 10.63 34.41 7.65 47.79 93.97 7.18 46.10 95.19 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.70 42.57 87.13 8.63 41.98 87.46 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR D 143 TYR~? 15.16 CL CL D2012 B 40 ASP D 102 ASP.? 24.32 CL CL D2012 B 103 LEU D 99 LEU.? 13.98 CL CL D2012 coo 14.25 20.09 37.35 13.48 17.40 37.38 14.34 45.54 80.17 13.57 44.79 82.74 coo 9.39 10.77 34.53 11.50 10.63 34.41 18.96 37.41 85.00 19.42 35.40 85.42 coo 12.89 17.60 31.13 12.34 16.51 32.90 10.70 42.57 87.13 8.63 41.98 87.46 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR E 75 TYR~? 10.13 CL CL E2013 B 40 ASP E 127 ASP.? 11.39 CL CL E2013 B 103 LEU E 99 LEU.? 14.23 CL CL E2013 coo 14.25 20.09 37.35 13.48 17.40 37.38 16.89 92.83 57.30 16.35 91.61 59.76 coo 9.39 10.77 34.53 11.50 10.63 34.41 17.80 103.20 59.40 17.93 103.89 61.44 coo 12.89 17.60 31.13 12.34 16.51 32.90 18.95 95.36 64.50 17.03 96.10 65.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR E 143 TYR~? 15.23 CL CL E2013 B 40 ASP E 102 ASP.? 24.45 CL CL E2013 B 103 LEU E 99 LEU.? 14.23 CL CL E2013 coo 14.25 20.09 37.35 13.48 17.40 37.38 20.79 87.99 61.33 20.74 90.64 62.13 coo 9.39 10.77 34.53 11.50 10.63 34.41 26.42 91.49 69.61 27.08 91.68 71.63 coo 12.89 17.60 31.13 12.34 16.51 32.90 18.95 95.36 64.50 17.03 96.10 65.27 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR F 75 TYR~? 9.99 CL CL F2034 B 40 ASP F 127 ASP.? 10.85 CL CL F2034 B 103 LEU F 99 LEU.? 13.96 CL CL F2034 coo 14.25 20.09 37.35 13.48 17.40 37.38 95.01 33.97 25.26 94.64 31.83 27.03 coo 9.39 10.77 34.53 11.50 10.63 34.41 96.13 30.12 15.93 96.25 28.10 15.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 92.01 27.08 23.54 93.77 25.78 23.40 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR F 143 TYR~? 15.09 CL CL F2034 B 40 ASP F 102 ASP.? 16.73 CL CL F2035 B 103 LEU F 99 LEU.? 13.96 CL CL F2034 coo 14.25 20.09 37.35 13.48 17.40 37.38 89.42 31.84 29.55 89.79 30.44 27.17 coo 9.39 10.77 34.53 11.50 10.63 34.41 82.74 24.28 26.35 81.91 22.30 26.35 coo 12.89 17.60 31.13 12.34 16.51 32.90 92.01 27.08 23.54 93.77 25.78 23.40 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR G 75 TYR~? 12.69 CL CL G2033 B 40 ASP G 127 ASP.? 12.80 CL CL G2033 B 103 LEU G 99 LEU.? 16.17 CL CL G2033 coo 14.25 20.09 37.35 13.48 17.40 37.38 11.49 22.21 40.76 11.82 23.42 38.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 10.22 12.11 38.73 10.33 11.10 36.86 coo 12.89 17.60 31.13 12.34 16.51 32.90 14.23 19.01 34.29 12.19 18.63 33.49 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR G 143 TYR~? 15.53 C3 GOL G3001 B 40 ASP G 102 ASP.? 25.30 O3 GOL G3038 B 103 LEU G 99 LEU.? 16.17 CL CL G2033 coo 14.25 20.09 37.35 13.48 17.40 37.38 16.97 25.90 37.77 16.51 23.33 36.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 23.47 21.05 30.82 24.30 20.62 28.93 coo 12.89 17.60 31.13 12.34 16.51 32.90 14.23 19.01 34.29 12.19 18.63 33.49 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR H 75 TYR~? 10.27 CL CL H2014 B 40 ASP H 127 ASP.? 11.27 CL CL H2014 B 103 LEU H 99 LEU.? 14.24 CL CL H2014 coo 14.25 20.09 37.35 13.48 17.40 37.38 90.64 65.09 90.65 91.11 67.21 88.98 coo 9.39 10.77 34.53 11.50 10.63 34.41 90.18 69.09 100.25 90.25 71.19 100.79 coo 12.89 17.60 31.13 12.34 16.51 32.90 88.74 72.63 91.84 90.81 73.32 92.17 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 16 3 # 16 B 16 TYR H 143 TYR~? 11.30 O2 GOL H3016 B 40 ASP H 102 ASP.? 20.45 O2 GOL H3016 B 103 LEU H 99 LEU.? 14.24 CL CL H2014 coo 14.25 20.09 37.35 13.48 17.40 37.38 86.77 67.99 85.16 86.88 69.36 87.57 coo 9.39 10.77 34.53 11.50 10.63 34.41 81.36 76.99 86.94 80.90 79.01 86.89 coo 12.89 17.60 31.13 12.34 16.51 32.90 88.74 72.63 91.84 90.81 73.32 92.17 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 17 3 # 17 B 16 TYR I 75 TYR~? 10.32 CL CL I2015 B 40 ASP I 127 ASP.? 10.93 CL CL I2015 B 103 LEU I 99 LEU.? 14.05 CL CL I2015 coo 14.25 20.09 37.35 13.48 17.40 37.38 211.34 199.93 157.52 211.50 198.33 155.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 212.49 209.49 154.15 212.74 210.27 152.16 coo 12.89 17.60 31.13 12.34 16.51 32.90 209.53 201.81 150.19 211.63 201.97 149.59 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 18 3 # 18 B 16 TYR I 143 TYR~? 11.25 C1 GOL I3032 B 40 ASP I 102 ASP.? 20.44 O1 GOL I3032 B 103 LEU I 99 LEU.? 14.05 CL CL I2015 coo 14.25 20.09 37.35 13.48 17.40 37.38 206.55 195.37 154.41 207.09 197.83 153.23 coo 9.39 10.77 34.53 11.50 10.63 34.41 201.10 198.54 145.88 200.66 198.62 143.82 coo 12.89 17.60 31.13 12.34 16.51 32.90 209.53 201.81 150.19 211.63 201.97 149.59 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 19 3 # 19 B 16 TYR J 75 TYR~? 10.17 CL CL J2016 B 40 ASP J 127 ASP.? 11.08 CL CL J2016 B 103 LEU J 99 LEU.? 13.96 CL CL J2016 coo 14.25 20.09 37.35 13.48 17.40 37.38 131.82 180.89 131.78 131.82 183.34 133.12 coo 9.39 10.77 34.53 11.50 10.63 34.41 132.13 183.26 121.62 132.41 185.18 120.66 coo 12.89 17.60 31.13 12.34 16.51 32.90 134.68 187.63 129.42 132.80 188.60 128.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 20 3 # 20 B 16 TYR J 143 TYR~? 15.18 CL CL J2016 B 40 ASP J 102 ASP.? 24.08 CL CL J2016 B 103 LEU J 99 LEU.? 13.96 CL CL J2016 coo 14.25 20.09 37.35 13.48 17.40 37.38 136.50 183.91 136.49 136.50 184.93 133.88 coo 9.39 10.77 34.53 11.50 10.63 34.41 143.25 191.36 132.98 143.80 193.32 132.63 coo 12.89 17.60 31.13 12.34 16.51 32.90 134.68 187.63 129.42 132.80 188.60 128.96 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 21 3 # 21 B 16 TYR K 75 TYR~? 12.36 CL CL K2027 B 40 ASP K 127 ASP.? 12.37 CL CL K2027 B 103 LEU K 99 LEU.? 15.90 CL CL K2027 coo 14.25 20.09 37.35 13.48 17.40 37.38 205.79 133.16 185.06 205.81 134.80 187.34 coo 9.39 10.77 34.53 11.50 10.63 34.41 205.42 123.70 188.60 205.51 122.74 190.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 202.94 131.53 192.10 204.93 130.90 192.94 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 22 3 # 22 B 16 TYR K 143 TYR~? 15.99 O3 GOL K3009 B 40 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 103 LEU K 147 LEU~? 9.19 O3 GOL K3009 coo 14.25 20.09 37.35 13.48 17.40 37.38 201.16 138.32 187.50 201.22 135.84 188.82 coo 9.39 10.77 34.53 11.50 10.63 34.41 200.17 138.24 178.11 201.77 139.28 177.19 coo 12.89 17.60 31.13 12.34 16.51 32.90 203.33 142.40 181.83 202.00 140.72 181.37 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 23 3 # 23 B 16 TYR K 143 TYR~? 15.99 O3 GOL K3009 B 40 ASP K 102 ASP.? 24.81 O1 GOL K3041 B 103 LEU K 99 LEU.? 15.90 CL CL K2027 coo 14.25 20.09 37.35 13.48 17.40 37.38 201.16 138.32 187.50 201.22 135.84 188.82 coo 9.39 10.77 34.53 11.50 10.63 34.41 194.36 135.90 195.25 193.66 135.95 197.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 202.94 131.53 192.10 204.93 130.90 192.94 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 24 3 # 24 B 16 TYR L 75 TYR~? 10.07 CL CL L2009 B 40 ASP L 127 ASP.? 11.05 CL CL L2009 B 103 LEU L 99 LEU.? 13.85 CL CL L2009 coo 14.25 20.09 37.35 13.48 17.40 37.38 126.23 161.73 201.55 126.10 159.32 200.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 124.97 159.68 211.55 124.68 157.87 212.62 coo 12.89 17.60 31.13 12.34 16.51 32.90 127.71 154.64 204.45 125.47 154.23 204.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 25 3 # 25 B 16 TYR L 143 TYR~? 15.30 CL CL L2009 B 40 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 103 LEU L 147 LEU~? -16.60 CL CL L2009s coo 14.25 20.09 37.35 13.48 17.40 37.38 131.10 157.77 197.34 130.52 156.95 199.97 coo 9.39 10.77 34.53 11.50 10.63 34.41 133.34 166.97 196.27 132.03 168.03 194.96 coo 12.89 17.60 31.13 12.34 16.51 32.90 130.20 163.09 192.22 131.33 163.62 193.98 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 26 3 # 26 B 16 TYR M 75 TYR~? 10.36 CL CL M2017 B 40 ASP M 127 ASP.? 9.06 CL CL M2017 B 103 LEU M 99 LEU.? 13.91 CL CL M2017 coo 14.25 20.09 37.35 13.48 17.40 37.38 130.62 206.12 176.17 130.27 204.76 178.58 coo 9.39 10.77 34.53 11.50 10.63 34.41 130.79 216.32 178.32 129.76 218.07 177.66 coo 12.89 17.60 31.13 12.34 16.51 32.90 132.61 208.78 183.22 130.76 209.95 183.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 27 3 # 27 B 16 TYR M 143 TYR~? 15.40 CL CL M2017 B 40 ASP M 102 ASP.? 24.52 CL CL M2017 B 103 LEU M 99 LEU.? 13.91 CL CL M2017 coo 14.25 20.09 37.35 13.48 17.40 37.38 134.88 201.35 179.85 134.66 203.97 180.76 coo 9.39 10.77 34.53 11.50 10.63 34.41 140.74 204.70 188.01 141.33 204.99 189.98 coo 12.89 17.60 31.13 12.34 16.51 32.90 132.61 208.78 183.22 130.76 209.95 183.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 28 3 # 28 B 16 TYR N 75 TYR~? 12.44 O2 GOL N3029 B 40 ASP N 127 ASP.? 12.60 CL CL N2030 B 103 LEU N 99 LEU.? 16.24 CL CL N2030 coo 14.25 20.09 37.35 13.48 17.40 37.38 209.71 152.64 137.80 209.50 150.35 139.41 coo 9.39 10.77 34.53 11.50 10.63 34.41 210.39 149.08 128.41 210.51 147.14 127.55 coo 12.89 17.60 31.13 12.34 16.51 32.90 206.93 145.59 136.00 209.00 144.75 135.80 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 29 3 # 29 B 16 TYR N 143 TYR~? 10.73 O2 GOL N3029 B 40 ASP N 102 ASP.? 20.60 O2 GOL N3029 B 103 LEU N 99 LEU.? 16.24 CL CL N2030 coo 14.25 20.09 37.35 13.48 17.40 37.38 204.41 150.24 142.39 204.78 148.95 139.97 coo 9.39 10.77 34.53 11.50 10.63 34.41 197.96 142.41 139.19 197.06 140.46 139.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 206.93 145.59 136.00 209.00 144.75 135.80 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 30 3 # 30 B 16 TYR O 75 TYR~? 10.24 CL CL O2018 B 40 ASP O 127 ASP.? 11.33 CL CL O2018 B 103 LEU O 99 LEU.? 14.37 CL CL O2018 coo 14.25 20.09 37.35 13.48 17.40 37.38 127.87 136.17 156.70 127.95 137.50 154.23 coo 9.39 10.77 34.53 11.50 10.63 34.41 127.12 126.29 154.29 127.00 125.34 152.37 coo 12.89 17.60 31.13 12.34 16.51 32.90 130.52 133.57 149.85 128.56 133.58 148.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 31 3 # 31 B 16 TYR O 143 TYR~? 11.76 C3 GOL O3026 B 40 ASP O 102 ASP.? 13.16 CL CL O2036 B 103 LEU O 99 LEU.? 14.37 CL CL O2018 coo 14.25 20.09 37.35 13.48 17.40 37.38 133.04 140.38 153.60 132.61 137.79 152.63 coo 9.39 10.77 34.53 11.50 10.63 34.41 139.48 136.33 146.19 140.25 135.96 144.25 coo 12.89 17.60 31.13 12.34 16.51 32.90 130.52 133.57 149.85 128.56 133.58 148.88 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 32 3 # 32 B 16 TYR P 75 TYR~? 10.23 CL CL P2019 B 40 ASP P 127 ASP.? 11.05 CL CL P2019 B 103 LEU P 99 LEU.? 13.98 CL CL P2019 coo 14.25 20.09 37.35 13.48 17.40 37.38 207.22 180.36 204.70 207.43 182.65 203.13 coo 9.39 10.77 34.53 11.50 10.63 34.41 207.19 183.81 214.61 207.22 185.89 215.11 coo 12.89 17.60 31.13 12.34 16.51 32.90 205.13 187.68 206.38 207.13 188.38 206.85 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 33 3 # 33 B 16 TYR P 143 TYR~? 15.20 CL CL P2019 B 40 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 103 LEU P 147 LEU~? 8.50 O3 GOL P3014 coo 14.25 20.09 37.35 13.48 17.40 37.38 202.86 183.43 199.65 203.11 184.67 202.14 coo 9.39 10.77 34.53 11.50 10.63 34.41 200.75 174.15 199.66 202.28 173.10 198.62 coo 12.89 17.60 31.13 12.34 16.51 32.90 204.30 177.55 195.43 203.04 177.22 197.15 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 34 3 # 34 B 16 TYR P 143 TYR~? 15.20 CL CL P2019 B 40 ASP P 102 ASP.? 24.26 CL CL P2019 B 103 LEU P 99 LEU.? 13.98 CL CL P2019 coo 14.25 20.09 37.35 13.48 17.40 37.38 202.86 183.43 199.65 203.11 184.67 202.14 coo 9.39 10.77 34.53 11.50 10.63 34.41 197.01 191.93 202.05 196.73 194.01 202.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 205.13 187.68 206.38 207.13 188.38 206.85 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 34 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 131 HIS.? 23.28 O2 GOL A3040 A 169 ASP A 127 ASP.? 12.37 CL CL A2020 A 288 GLU A 93 GLU~? 8.07 CL CL A2020 coo 67.72 35.99 30.87 69.77 36.13 31.33 92.67 90.69 28.54 93.68 90.74 26.70 coo 73.17 30.66 22.56 72.87 30.30 20.46 99.76 91.11 38.83 100.13 91.74 36.79 coo 74.06 28.51 15.92 73.77 29.56 17.73 106.40 86.90 39.80 107.05 88.84 40.38 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 131 HIS.? 20.97 CL CL B2010 A 169 ASP B 127 ASP.? 11.35 CL CL B2010 A 288 GLU B 93 GLU~? 9.70 CL CL B2010 coo 67.72 35.99 30.87 69.77 36.13 31.33 28.04 75.38 3.45 27.81 77.14 2.33 coo 73.17 30.66 22.56 72.87 30.30 20.46 19.74 66.97 3.53 20.01 68.79 2.38 coo 74.06 28.51 15.92 73.77 29.56 17.73 11.87 67.96 6.38 12.21 67.44 4.38 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS C 131 HIS.? 21.65 CL CL C2011 A 169 ASP C 127 ASP.? 10.87 CL CL C2011 A 288 GLU C 93 GLU~? 8.05 CL CL C2021 coo 67.72 35.99 30.87 69.77 36.13 31.33 77.67 9.26 85.52 77.97 8.68 87.52 coo 73.17 30.66 22.56 72.87 30.30 20.46 86.95 7.50 76.71 86.89 6.71 78.70 coo 74.06 28.51 15.92 73.77 29.56 17.73 94.51 9.91 76.89 94.48 7.78 76.63 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS D 131 HIS.? 21.16 CL CL D2012 A 169 ASP D 127 ASP.? 11.17 CL CL D2012 A 288 GLU D 93 GLU~? 8.23 CL CL D2022 coo 67.72 35.99 30.87 69.77 36.13 31.33 14.37 37.50 95.10 13.27 35.76 95.49 coo 73.17 30.66 22.56 72.87 30.30 20.46 7.65 47.79 93.97 7.18 46.10 95.19 coo 74.06 28.51 15.92 73.77 29.56 17.73 0.77 48.16 89.31 0.23 49.10 91.12 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS E 131 HIS.? 21.62 CL CL E2013 A 169 ASP E 127 ASP.? 11.39 CL CL E2013 A 288 GLU E 93 GLU~? 8.42 CL CL E2032 coo 67.72 35.99 30.87 69.77 36.13 31.33 25.00 102.72 69.75 24.26 103.67 71.48 coo 73.17 30.66 22.56 72.87 30.30 20.46 17.80 103.20 59.40 17.93 103.89 61.44 coo 74.06 28.51 15.92 73.77 29.56 17.73 9.96 100.16 58.92 10.04 102.16 58.24 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS F 131 HIS.? 21.33 CL CL F2034 A 169 ASP F 127 ASP.? 10.85 CL CL F2034 A 288 GLU F 93 GLU~? 8.36 CL CL F2023 coo 67.72 35.99 30.87 69.77 36.13 31.33 86.97 21.37 16.19 87.42 19.33 15.94 coo 73.17 30.66 22.56 72.87 30.30 20.46 96.13 30.12 15.93 96.25 28.10 15.23 coo 74.06 28.51 15.92 73.77 29.56 17.73 102.94 29.85 20.29 103.30 29.96 18.20 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS G 131 HIS.? 23.01 C3 GOL G3038 A 169 ASP G 127 ASP.? 12.80 CL CL G2033 A 288 GLU G 93 GLU~? 8.63 CL CL G2033 coo 67.72 35.99 30.87 69.77 36.13 31.33 19.23 10.55 30.25 18.64 9.92 28.33 coo 73.17 30.66 22.56 72.87 30.30 20.46 10.22 12.11 38.73 10.33 11.10 36.86 coo 74.06 28.51 15.92 73.77 29.56 17.73 3.64 16.49 37.62 3.03 14.55 38.23 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS H 131 HIS.? 21.54 CL CL H2014 A 169 ASP H 127 ASP.? 11.27 CL CL H2014 A 288 GLU H 93 GLU~? 8.72 CL CL H2024 coo 67.72 35.99 30.87 69.77 36.13 31.33 83.28 79.38 97.87 84.13 81.25 98.32 coo 73.17 30.66 22.56 72.87 30.30 20.46 90.18 69.09 100.25 90.25 71.19 100.79 coo 74.06 28.51 15.92 73.77 29.56 17.73 97.56 68.07 97.57 97.65 67.50 99.59 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 9 3 # 9 A 105 HIS I 131 HIS.? 21.12 CL CL I2015 A 169 ASP I 127 ASP.? 10.93 CL CL I2015 A 288 GLU I 93 GLU~? 8.40 CL CL I2025 coo 67.72 35.99 30.87 69.77 36.13 31.33 205.05 208.81 144.12 206.00 208.92 142.25 coo 73.17 30.66 22.56 72.87 30.30 20.46 212.49 209.49 154.15 212.74 210.27 152.16 coo 74.06 28.51 15.92 73.77 29.56 17.73 219.77 205.57 155.06 219.86 207.68 155.25 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 10 3 # 10 A 105 HIS J 131 HIS.? 21.32 CL CL J2016 A 169 ASP J 127 ASP.? 11.08 CL CL J2016 A 288 GLU J 93 GLU~? 8.18 CL CL J2026 coo 67.72 35.99 30.87 69.77 36.13 31.33 140.93 192.25 121.78 140.50 194.18 121.08 coo 73.17 30.66 22.56 72.87 30.30 20.46 132.13 183.26 121.62 132.41 185.18 120.66 coo 74.06 28.51 15.92 73.77 29.56 17.73 124.50 183.71 125.04 124.44 183.21 122.99 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 11 3 # 11 A 105 HIS K 131 HIS.? 21.27 O1 GOL K3041 A 169 ASP K 127 ASP.? 12.37 CL CL K2027 A 288 GLU K 93 GLU~? 8.22 CL CL K2027 coo 67.72 35.99 30.87 69.77 36.13 31.33 196.99 124.95 197.52 197.50 124.37 199.47 coo 73.17 30.66 22.56 72.87 30.30 20.46 205.42 123.70 188.60 205.51 122.74 190.54 coo 74.06 28.51 15.92 73.77 29.56 17.73 212.85 126.80 188.86 213.03 124.72 188.44 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 12 3 # 12 A 105 HIS L 131 HIS.? 20.79 CL CL L2009 A 169 ASP L 127 ASP.? 11.05 CL CL L2009 A 288 GLU L 93 GLU~? 8.05 CL CL L2028 coo 67.72 35.99 30.87 69.77 36.13 31.33 131.63 149.73 212.78 130.46 148.21 213.64 coo 73.17 30.66 22.56 72.87 30.30 20.46 124.97 159.68 211.55 124.68 157.87 212.62 coo 74.06 28.51 15.92 73.77 29.56 17.73 118.11 159.89 208.04 117.71 160.95 209.86 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 13 3 # 13 A 105 HIS M 131 HIS.? 21.22 CL CL M2017 A 169 ASP M 127 ASP.? 9.06 CL CL M2017 A 288 GLU M 93 GLU~? 8.60 CL CL M2029 coo 67.72 35.99 30.87 69.77 36.13 31.33 137.94 216.13 188.51 137.11 217.01 190.24 coo 73.17 30.66 22.56 72.87 30.30 20.46 130.79 216.32 178.32 129.76 218.07 177.66 coo 74.06 28.51 15.92 73.77 29.56 17.73 123.31 213.00 178.36 123.21 215.02 177.75 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 14 3 # 14 A 105 HIS N 131 HIS.? 24.11 CL CL N2030 A 169 ASP N 127 ASP.? 12.60 CL CL N2030 A 288 GLU N 93 GLU~? 8.57 CL CL N2030 coo 67.72 35.99 30.87 69.77 36.13 31.33 201.51 139.96 128.80 202.02 137.96 128.37 coo 73.17 30.66 22.56 72.87 30.30 20.46 210.39 149.08 128.41 210.51 147.14 127.55 coo 74.06 28.51 15.92 73.77 29.56 17.73 217.47 148.79 132.22 217.76 148.97 130.14 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 15 3 # 15 A 105 HIS O 131 HIS.? 12.83 CL CL O2036 A 169 ASP O 127 ASP.? 11.33 CL CL O2018 A 288 GLU O 93 GLU~? 9.72 CL CL O2018 coo 67.72 35.99 30.87 69.77 36.13 31.33 136.08 125.57 145.21 136.18 124.88 143.24 coo 73.17 30.66 22.56 72.87 30.30 20.46 127.12 126.29 154.29 127.00 125.34 152.37 coo 74.06 28.51 15.92 73.77 29.56 17.73 119.95 130.02 153.81 119.63 127.98 154.32 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 16 3 # 16 A 105 HIS P 131 HIS.? 21.18 CL CL P2019 A 169 ASP P 127 ASP.? 11.05 CL CL P2019 A 288 GLU P 93 GLU~? 9.65 CL CL P2019 coo 67.72 35.99 30.87 69.77 36.13 31.33 199.94 193.83 213.04 200.54 195.72 213.71 coo 73.17 30.66 22.56 72.87 30.30 20.46 207.19 183.81 214.61 207.22 185.89 215.11 coo 74.06 28.51 15.92 73.77 29.56 17.73 214.54 183.14 211.27 214.54 182.92 213.36 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 16 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 135 ALA.? 20.01 CL CL A2020 B 182 GLY A 129 GLY.? 16.08 CL CL A2020 B 183 GLY A 132 GLY.? 16.45 O2 GOL A3040 coo 38.36-101.47-135.52 39.62-101.29-136.35 92.96 83.99 31.70 93.11 82.79 32.66 coo 41.93-102.35-126.87 41.52-101.89-126.30 96.95 90.98 33.96 96.57 91.66 34.21 coo 38.37-101.99-128.11 38.63-102.24-127.37 91.45 91.87 34.64 91.64 91.15 34.23 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 135 ALA.? 20.01 CL CL A2020 B 182 GLY A 132 GLY.? 16.45 O2 GOL A3040 B 183 GLY A 129 GLY.? 16.08 CL CL A2020 coo 38.36-101.47-135.52 39.62-101.29-136.35 92.96 83.99 31.70 93.11 82.79 32.66 coo 41.93-102.35-126.87 41.52-101.89-126.30 91.45 91.87 34.64 91.64 91.15 34.23 coo 38.37-101.99-128.11 38.63-102.24-127.37 96.95 90.98 33.96 96.57 91.66 34.21 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA C 135 ALA.? 18.18 CL CL C2011 B 182 GLY C 129 GLY.? 14.69 CL CL C2011 B 183 GLY C 132 GLY.? 16.13 CL CL C2011 coo 38.36-101.47-135.52 39.62-101.29-136.35 80.29 16.27 82.51 80.76 17.49 81.72 coo 41.93-102.35-126.87 41.52-101.89-126.30 81.78 8.76 80.79 81.72 8.03 80.50 coo 38.37-101.99-128.11 38.63-102.24-127.37 77.75 8.57 79.24 77.97 9.20 79.71 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA C 135 ALA.? 18.18 CL CL C2011 B 182 GLY C 132 GLY.? 16.13 CL CL C2011 B 183 GLY C 129 GLY.? 14.69 CL CL C2011 coo 38.36-101.47-135.52 39.62-101.29-136.35 80.29 16.27 82.51 80.76 17.49 81.72 coo 41.93-102.35-126.87 41.52-101.89-126.30 77.75 8.57 79.24 77.97 9.20 79.71 coo 38.37-101.99-128.11 38.63-102.24-127.37 81.78 8.76 80.79 81.72 8.03 80.50 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA G 135 ALA.? 19.98 C3 GOL G3038 B 182 GLY G 129 GLY.? 16.82 C3 GOL G3038 B 183 GLY G 132 GLY.? 16.31 C3 GOL G3038 coo 38.36-101.47-135.52 39.62-101.29-136.35 18.49 17.87 31.65 18.29 19.28 32.20 coo 41.93-102.35-126.87 41.52-101.89-126.30 15.32 11.77 34.67 15.32 11.08 35.12 coo 38.37-101.99-128.11 38.63-102.24-127.37 19.28 10.80 36.53 19.22 11.38 35.96 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA G 135 ALA.? 19.98 C3 GOL G3038 B 182 GLY G 132 GLY.? 16.31 C3 GOL G3038 B 183 GLY G 129 GLY.? 16.82 C3 GOL G3038 coo 38.36-101.47-135.52 39.62-101.29-136.35 18.49 17.87 31.65 18.29 19.28 32.20 coo 41.93-102.35-126.87 41.52-101.89-126.30 19.28 10.80 36.53 19.22 11.38 35.96 coo 38.37-101.99-128.11 38.63-102.24-127.37 15.32 11.77 34.67 15.32 11.08 35.12 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA H 135 ALA.? 17.80 CL CL H2014 B 182 GLY H 129 GLY.? 14.25 CL CL H2014 B 183 GLY H 132 GLY.? 16.30 CL CL H2014 coo 38.36-101.47-135.52 39.62-101.29-136.35 85.12 76.02 91.45 85.59 75.06 90.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 87.45 73.88 99.29 86.89 73.62 99.80 coo 38.37-101.99-128.11 38.63-102.24-127.37 81.84 73.30 98.81 82.16 73.70 98.17 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA H 135 ALA.? 17.80 CL CL H2014 B 182 GLY H 132 GLY.? 16.30 CL CL H2014 B 183 GLY H 129 GLY.? 14.25 CL CL H2014 coo 38.36-101.47-135.52 39.62-101.29-136.35 85.12 76.02 91.45 85.59 75.06 90.35 coo 41.93-102.35-126.87 41.52-101.89-126.30 81.84 73.30 98.81 82.16 73.70 98.17 coo 38.37-101.99-128.11 38.63-102.24-127.37 87.45 73.88 99.29 86.89 73.62 99.80 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA O 135 ALA.? 13.72 CL CL O2036 B 182 GLY O 129 GLY.? 14.42 CL CL O2018 B 183 GLY O 132 GLY.? 9.54 CL CL O2036 coo 38.36-101.47-135.52 39.62-101.29-136.35 134.59 132.69 147.05 134.19 133.97 147.77 coo 41.93-102.35-126.87 41.52-101.89-126.30 130.49 125.78 149.93 130.89 125.19 150.35 coo 38.37-101.99-128.11 38.63-102.24-127.37 135.90 125.45 151.48 135.82 126.02 150.88 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA O 135 ALA.? 13.72 CL CL O2036 B 182 GLY O 132 GLY.? 9.54 CL CL O2036 B 183 GLY O 129 GLY.? 14.42 CL CL O2018 coo 38.36-101.47-135.52 39.62-101.29-136.35 134.59 132.69 147.05 134.19 133.97 147.77 coo 41.93-102.35-126.87 41.52-101.89-126.30 135.90 125.45 151.48 135.82 126.02 150.88 coo 38.37-101.99-128.11 38.63-102.24-127.37 130.49 125.78 149.93 130.89 125.19 150.35 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 10 hits 1xny_c01 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA F 103 ALA.? 17.16 CL CL F2035 C 126 ARG F 114 ARG~? 18.29 CL CL F2035 C 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 80.38 24.48 22.19 80.56 23.71 20.93 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 81.94 30.32 15.98 81.85 27.28 16.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA F 107 ALA~? 11.99 CL CL F2035 C 126 ARG F 114 ARG~? 18.29 CL CL F2035 C 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 77.64 28.24 23.39 76.33 27.50 23.08 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 81.94 30.32 15.98 81.85 27.28 16.31 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 81.39 27.31 28.31 83.45 27.54 28.69 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA F 103 ALA.? 17.16 CL CL F2035 D 126 ARG F 114 ARG~? 18.29 CL CL F2035 D 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 80.38 24.48 22.19 80.56 23.71 20.93 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 81.94 30.32 15.98 81.85 27.28 16.31 coo 6.23 0.50 57.10 5.93 0.72 59.19 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA F 107 ALA~? 11.99 CL CL F2035 D 126 ARG F 114 ARG~? 18.29 CL CL F2035 D 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 77.64 28.24 23.39 76.33 27.50 23.08 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 81.94 30.32 15.98 81.85 27.28 16.31 coo 6.23 0.50 57.10 5.93 0.72 59.19 81.39 27.31 28.31 83.45 27.54 28.69 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA F 103 ALA.? 17.16 CL CL F2035 E 126 ARG F 114 ARG~? 18.29 CL CL F2035 E 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -4.56 10.03 62.36 -4.38 11.31 61.55 80.38 24.48 22.19 80.56 23.71 20.93 coo -3.02 12.00 70.07 -1.94 13.84 67.82 81.94 30.32 15.98 81.85 27.28 16.31 coo -8.67 12.22 56.54 -8.68 12.09 58.65 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA F 107 ALA~? 11.99 CL CL F2035 E 126 ARG F 114 ARG~? 18.29 CL CL F2035 E 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -4.56 10.03 62.36 -4.38 11.31 61.55 77.64 28.24 23.39 76.33 27.50 23.08 coo -3.02 12.00 70.07 -1.94 13.84 67.82 81.94 30.32 15.98 81.85 27.28 16.31 coo -8.67 12.22 56.54 -8.68 12.09 58.65 81.39 27.31 28.31 83.45 27.54 28.69 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA F 103 ALA.? 17.16 CL CL F2035 F 126 ARG F 114 ARG~? 18.29 CL CL F2035 F 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 80.38 24.48 22.19 80.56 23.71 20.93 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 81.94 30.32 15.98 81.85 27.28 16.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA F 107 ALA~? 11.99 CL CL F2035 F 126 ARG F 114 ARG~? 18.29 CL CL F2035 F 138 GLU F 106 GLU~? 12.79 CL CL F2035 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 77.64 28.24 23.39 76.33 27.50 23.08 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 81.94 30.32 15.98 81.85 27.28 16.31 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 81.39 27.31 28.31 83.45 27.54 28.69 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 100 GLY.? 15.80 C1 GOL A3040 B 175 ARG A 114 ARG~? 18.99 O2 GOL A3040 B 242 TYR A 112 TYR~? 13.10 O1 GOL A3040 coo 99.45 58.28 3.33 99.57 58.61 4.10 92.24 84.14 36.91 92.61 83.48 36.62 coo 106.37 63.53 0.89 108.02 63.40 -1.62 86.11 90.82 36.33 86.92 90.68 33.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 82.86 85.03 43.55 82.36 85.03 46.30 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 100 GLY.? 14.32 CL CL B2010 B 175 ARG B 114 ARG~? 18.19 O1 GOL B3023 B 242 TYR B 112 TYR~? 11.41 O3 GOL B3017 coo 99.45 58.28 3.33 99.57 58.61 4.10 25.80 69.23 11.98 25.39 69.78 12.33 coo 106.37 63.53 0.89 108.02 63.40 -1.62 33.27 67.19 7.11 33.19 70.17 6.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 33.54 61.27 14.83 33.38 58.57 15.48 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 121 GLY.? -5.20 O1 GOL B3023s B 175 ARG B 122 ARG.? -6.42 O2 GOL B3023s B 242 TYR B 112 TYR~? 11.41 O3 GOL B3017 coo 99.45 58.28 3.33 99.57 58.61 4.10 29.25 55.24 4.83 29.16 55.30 5.64 coo 106.37 63.53 0.89 108.02 63.40 -1.62 26.34 54.66 11.25 25.32 53.82 13.99 coo 100.93 69.04 4.38 99.52 68.48 2.09 33.54 61.27 14.83 33.38 58.57 15.48 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY C 100 GLY.? 14.66 CL CL C2011 B 175 ARG C 114 ARG~? 19.78 CL CL C2011 B 242 TYR C 112 TYR~? 12.57 O3 GOL C3021 coo 99.45 58.28 3.33 99.57 58.61 4.10 80.63 15.92 77.56 81.07 16.49 77.86 coo 106.37 63.53 0.89 108.02 63.40 -1.62 73.29 10.73 76.57 73.51 10.59 79.63 coo 100.93 69.04 4.38 99.52 68.48 2.09 72.92 17.11 69.08 73.05 17.20 66.28 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY C 121 GLY.? 13.36 CL CL C2011 B 175 ARG C 122 ARG.? -9.05 O1 GOL C3036s B 242 TYR C 112 TYR~? 12.57 O3 GOL C3021 coo 99.45 58.28 3.33 99.57 58.61 4.10 77.11 6.14 65.07 77.19 6.93 64.98 coo 106.37 63.53 0.89 108.02 63.40 -1.62 80.03 12.35 63.23 81.23 14.78 61.83 coo 100.93 69.04 4.38 99.52 68.48 2.09 72.92 17.11 69.08 73.05 17.20 66.28 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY D 100 GLY.? 14.37 CL CL D2012 B 175 ARG D 114 ARG~? 18.11 O3 GOL D3018 B 242 TYR D 112 TYR~? 11.57 O3 GOL D3019 coo 99.45 58.28 3.33 99.57 58.61 4.10 15.06 44.22 87.32 14.69 43.84 86.72 coo 106.37 63.53 0.89 108.02 63.40 -1.62 21.28 44.89 93.84 20.52 41.96 94.27 coo 100.93 69.04 4.38 99.52 68.48 2.09 24.56 50.70 86.69 25.05 53.37 86.07 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY D 121 GLY.? 7.20 O1 GOL D3018 B 175 ARG D 122 ARG.? -6.47 O1 GOL D3018s B 242 TYR D 112 TYR~? 11.57 O3 GOL D3019 coo 99.45 58.28 3.33 99.57 58.61 4.10 19.20 57.54 95.55 19.31 57.48 94.76 coo 106.37 63.53 0.89 108.02 63.40 -1.62 18.06 58.51 88.62 17.90 59.58 85.74 coo 100.93 69.04 4.38 99.52 68.48 2.09 24.56 50.70 86.69 25.05 53.37 86.07 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY E 100 GLY.? 14.41 CL CL E2013 B 175 ARG E 114 ARG~? 18.39 O3 GOL E3022 B 242 TYR E 112 TYR~? 11.16 O2 GOL E3035 coo 99.45 58.28 3.33 99.57 58.61 4.10 23.21 94.72 62.80 22.71 94.23 63.20 coo 106.37 63.53 0.89 108.02 63.40 -1.62 31.03 99.62 62.12 30.45 100.18 65.09 coo 100.93 69.04 4.38 99.52 68.48 2.09 32.26 92.00 56.29 32.65 91.34 53.61 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 9 3 # 9 B 137 GLY E 121 GLY.? -5.18 O3 GOL E3022s B 175 ARG E 122 ARG.? -5.69 O1 GOL E3022s B 242 TYR E 112 TYR~? 11.16 O2 GOL E3035 coo 99.45 58.28 3.33 99.57 58.61 4.10 29.14 101.88 49.37 29.06 101.07 49.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 26.42 95.37 48.46 25.62 92.61 47.34 coo 100.93 69.04 4.38 99.52 68.48 2.09 32.26 92.00 56.29 32.65 91.34 53.61 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 10 3 # 10 B 137 GLY F 58 GLY.? 9.01 CL CL F2035 B 175 ARG F 108 ARG~? -3.40 CL CL F2035s B 242 TYR F 109 TYR~? 6.98 CL CL F2035 coo 99.45 58.28 3.33 99.57 58.61 4.10 68.80 35.71 23.84 68.57 36.47 23.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 74.01 31.91 26.65 74.85 33.96 28.84 coo 100.93 69.04 4.38 99.52 68.48 2.09 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 11 3 # 11 B 137 GLY F 58 GLY.? 9.01 CL CL F2035 B 175 ARG F 108 ARG~? -3.40 CL CL F2035s B 242 TYR F 112 TYR~? 9.99 CL CL F2035 coo 99.45 58.28 3.33 99.57 58.61 4.10 68.80 35.71 23.84 68.57 36.47 23.65 coo 106.37 63.53 0.89 108.02 63.40 -1.62 74.01 31.91 26.65 74.85 33.96 28.84 coo 100.93 69.04 4.38 99.52 68.48 2.09 80.32 37.88 21.99 80.47 40.63 22.04 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 12 3 # 12 B 137 GLY F 100 GLY.? 14.35 CL CL F2034 B 175 ARG F 114 ARG~? 18.29 CL CL F2035 B 242 TYR F 112 TYR~? 9.99 CL CL F2035 coo 99.45 58.28 3.33 99.57 58.61 4.10 88.10 29.47 22.82 88.41 29.13 23.45 coo 106.37 63.53 0.89 108.02 63.40 -1.62 81.94 30.32 15.98 81.85 27.28 16.31 coo 100.93 69.04 4.38 99.52 68.48 2.09 80.32 37.88 21.99 80.47 40.63 22.04 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 13 3 # 13 B 137 GLY F 121 GLY.? 6.26 O2 GOL F3039 B 175 ARG F 122 ARG.? -4.08 O3 GOL F3039s B 242 TYR F 112 TYR~? 9.99 CL CL F2035 coo 99.45 58.28 3.33 99.57 58.61 4.10 86.99 41.57 12.14 86.85 41.72 12.88 coo 106.37 63.53 0.89 108.02 63.40 -1.62 88.42 43.62 18.77 88.84 45.09 21.41 coo 100.93 69.04 4.38 99.52 68.48 2.09 80.32 37.88 21.99 80.47 40.63 22.04 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 14 3 # 14 B 137 GLY G 100 GLY.? 15.63 C3 GOL G3038 B 175 ARG G 114 ARG~? 19.08 O3 GOL G3038 B 242 TYR G 112 TYR~? 13.62 O3 GOL G3038 coo 99.45 58.28 3.33 99.57 58.61 4.10 18.20 18.81 36.73 17.92 19.38 36.23 coo 106.37 63.53 0.89 108.02 63.40 -1.62 24.45 12.48 38.95 24.54 11.96 35.94 coo 100.93 69.04 4.38 99.52 68.48 2.09 26.10 19.68 45.15 26.07 20.41 47.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 15 3 # 15 B 137 GLY G 121 GLY.? 7.09 O3 GOL G3038 B 175 ARG G 122 ARG.? -6.12 O3 GOL G3038s B 242 TYR G 112 TYR~? 13.62 O3 GOL G3038 coo 99.45 58.28 3.33 99.57 58.61 4.10 19.46 10.82 50.81 19.56 11.63 50.72 coo 106.37 63.53 0.89 108.02 63.40 -1.62 18.11 17.77 51.41 17.63 20.64 52.34 coo 100.93 69.04 4.38 99.52 68.48 2.09 26.10 19.68 45.15 26.07 20.41 47.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 16 3 # 16 B 137 GLY H 100 GLY.? 14.46 CL CL H2014 B 175 ARG H 114 ARG~? 20.07 CL CL H2014 B 242 TYR H 112 TYR~? 11.95 O3 GOL H3016 coo 99.45 58.28 3.33 99.57 58.61 4.10 84.43 70.85 91.47 84.93 71.17 90.93 coo 106.37 63.53 0.89 108.02 63.40 -1.62 76.88 71.50 96.54 77.56 74.47 96.38 coo 100.93 69.04 4.38 99.52 68.48 2.09 75.20 64.22 90.27 74.79 61.48 90.12 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 17 3 # 17 B 137 GLY H 121 GLY.? 13.59 CL CL H2014 B 175 ARG H 122 ARG.? -8.72 O1 GOL H3025s B 242 TYR H 112 TYR~? 11.95 O3 GOL H3016 coo 99.45 58.28 3.33 99.57 58.61 4.10 78.44 59.63 101.34 78.49 59.47 100.54 coo 106.37 63.53 0.89 108.02 63.40 -1.62 80.95 57.12 95.14 81.70 55.44 92.71 coo 100.93 69.04 4.38 99.52 68.48 2.09 75.20 64.22 90.27 74.79 61.48 90.12 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 18 3 # 18 B 137 GLY I 100 GLY.? 14.37 CL CL I2015 B 175 ARG I 114 ARG~? 18.68 O1 GOL I3031 B 242 TYR I 112 TYR~? 12.20 O2 GOL I3032 coo 99.45 58.28 3.33 99.57 58.61 4.10 205.29 202.15 152.01 205.70 201.55 151.69 coo 106.37 63.53 0.89 108.02 63.40 -1.62 198.65 208.42 151.97 199.12 208.35 148.94 coo 100.93 69.04 4.38 99.52 68.48 2.09 196.16 202.11 159.00 195.80 201.93 161.71 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 19 3 # 19 B 137 GLY I 121 GLY.? 7.09 C1 GOL I3031 B 175 ARG I 122 ARG.? -5.95 O1 GOL I3031s B 242 TYR I 112 TYR~? 12.20 O2 GOL I3032 coo 99.45 58.28 3.33 99.57 58.61 4.10 201.38 212.19 164.10 201.27 211.38 164.18 coo 106.37 63.53 0.89 108.02 63.40 -1.62 202.92 205.52 166.02 203.30 202.90 167.57 coo 100.93 69.04 4.38 99.52 68.48 2.09 196.16 202.11 159.00 195.80 201.93 161.71 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 20 3 # 20 B 137 GLY J 100 GLY.? 14.25 CL CL J2016 B 175 ARG J 114 ARG~? 18.34 O3 GOL J3030 B 242 TYR J 112 TYR~? 13.43 O1 GOL J3030 coo 99.45 58.28 3.33 99.57 58.61 4.10 138.71 185.34 129.72 138.30 185.82 130.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 145.85 183.80 124.31 145.72 186.84 123.92 coo 100.93 69.04 4.38 99.52 68.48 2.09 146.80 177.39 131.57 146.79 174.66 132.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 21 3 # 21 B 137 GLY J 121 GLY.? 7.12 O1 GOL J3030 B 175 ARG J 122 ARG.? -6.11 O1 GOL J3030s B 242 TYR J 112 TYR~? 13.43 O1 GOL J3030 coo 99.45 58.28 3.33 99.57 58.61 4.10 142.11 171.84 121.56 142.12 171.82 122.36 coo 106.37 63.53 0.89 108.02 63.40 -1.62 139.69 170.93 128.19 138.90 169.62 130.85 coo 100.93 69.04 4.38 99.52 68.48 2.09 146.80 177.39 131.57 146.79 174.66 132.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 22 3 # 22 B 137 GLY K 100 GLY.? 14.95 O1 GOL K3041 B 175 ARG K 114 ARG~? 18.18 O1 GOL K3041 B 242 TYR K 112 TYR~? 10.80 O3 GOL K3010 coo 99.45 58.28 3.33 99.57 58.61 4.10 198.88 131.68 189.78 199.27 132.26 190.18 coo 106.37 63.53 0.89 108.02 63.40 -1.62 191.56 126.17 188.91 191.90 126.17 191.97 coo 100.93 69.04 4.38 99.52 68.48 2.09 190.77 132.67 181.60 190.81 132.90 178.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 23 3 # 23 B 137 GLY K 121 GLY.? 7.06 O2 GOL K3041 B 175 ARG K 122 ARG.? -6.46 O2 GOL K3041s B 242 TYR K 112 TYR~? 10.80 O3 GOL K3010 coo 99.45 58.28 3.33 99.57 58.61 4.10 195.43 121.96 177.23 195.45 122.78 177.16 coo 106.37 63.53 0.89 108.02 63.40 -1.62 197.94 128.45 175.54 198.81 130.96 174.01 coo 100.93 69.04 4.38 99.52 68.48 2.09 190.77 132.67 181.60 190.81 132.90 178.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 24 3 # 24 B 137 GLY L 100 GLY.? 14.34 CL CL L2009 B 175 ARG L 114 ARG~? 18.80 O1 GOL L3027 B 242 TYR L 112 TYR~? 12.13 O3 GOL L3028 coo 99.45 58.28 3.33 99.57 58.61 4.10 132.17 156.37 204.50 131.77 155.97 203.90 coo 106.37 63.53 0.89 108.02 63.40 -1.62 138.87 157.00 210.52 138.32 154.00 210.96 coo 100.93 69.04 4.38 99.52 68.48 2.09 141.53 163.06 203.38 141.93 165.73 202.75 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 25 3 # 25 B 137 GLY L 121 GLY.? 7.11 C1 GOL L3027 B 175 ARG L 122 ARG.? -6.18 O1 GOL L3027s B 242 TYR L 112 TYR~? 12.13 O3 GOL L3028 coo 99.45 58.28 3.33 99.57 58.61 4.10 136.45 169.43 212.70 136.52 169.43 211.87 coo 106.37 63.53 0.89 108.02 63.40 -1.62 134.93 170.64 205.87 134.58 171.85 203.07 coo 100.93 69.04 4.38 99.52 68.48 2.09 141.53 163.06 203.38 141.93 165.73 202.75 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 26 3 # 26 B 137 GLY L 129 GLY.? 13.94 CL CL L2009 B 175 ARG L 94 ARG~? 15.79 CL CL L2009 B 242 TYR L 75 TYR~? 10.07 CL CL L2009 coo 99.45 58.28 3.33 99.57 58.61 4.10 127.66 155.03 212.10 128.14 155.43 212.70 coo 106.37 63.53 0.89 108.02 63.40 -1.62 121.28 153.19 204.82 123.22 151.93 206.95 coo 100.93 69.04 4.38 99.52 68.48 2.09 126.23 161.73 201.55 126.10 159.32 200.24 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 27 3 # 27 B 137 GLY M 100 GLY.? 14.53 CL CL M2017 B 175 ARG M 114 ARG~? 18.40 O3 GOL M3043 B 242 TYR M 112 TYR~? 13.51 O1 GOL M3043 coo 99.45 58.28 3.33 99.57 58.61 4.10 136.99 208.10 181.48 136.55 207.56 181.91 coo 106.37 63.53 0.89 108.02 63.40 -1.62 144.35 213.37 180.84 143.79 213.88 183.80 coo 100.93 69.04 4.38 99.52 68.48 2.09 145.86 206.20 174.56 146.17 205.67 171.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 28 3 # 28 B 137 GLY M 121 GLY.? -5.10 O3 GOL M3043s B 175 ARG M 122 ARG.? -5.48 O1 GOL M3043s B 242 TYR M 112 TYR~? 13.51 O1 GOL M3043 coo 99.45 58.28 3.33 99.57 58.61 4.10 141.94 216.17 168.34 141.94 215.38 168.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 139.60 209.60 166.99 138.90 206.81 165.93 coo 100.93 69.04 4.38 99.52 68.48 2.09 145.86 206.20 174.56 146.17 205.67 171.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 29 3 # 29 B 137 GLY N 58 GLY.? 17.87 O3 GOL N3008 B 175 ARG N 108 ARG~? 14.89 C2 GOL N3029 B 242 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo 99.45 58.28 3.33 99.57 58.61 4.10 183.43 153.24 137.84 183.14 154.05 137.70 coo 106.37 63.53 0.89 108.02 63.40 -1.62 189.02 149.68 140.15 189.67 151.62 142.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 30 3 # 30 B 137 GLY N 58 GLY.? 17.87 O3 GOL N3008 B 175 ARG N 108 ARG~? 14.89 C2 GOL N3029 B 242 TYR N 112 TYR~? 12.42 O1 GOL N3044 coo 99.45 58.28 3.33 99.57 58.61 4.10 183.43 153.24 137.84 183.14 154.05 137.70 coo 106.37 63.53 0.89 108.02 63.40 -1.62 189.02 149.68 140.15 189.67 151.62 142.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 194.78 156.07 135.52 194.77 158.81 135.67 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 31 3 # 31 B 137 GLY N 100 GLY.? 15.00 O2 GOL N3029 B 175 ARG N 114 ARG~? 21.90 O2 GOL N3029 B 242 TYR N 112 TYR~? 12.42 O1 GOL N3044 coo 99.45 58.28 3.33 99.57 58.61 4.10 202.89 147.88 135.58 203.22 147.52 136.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 196.45 148.76 129.28 196.55 145.72 129.25 coo 100.93 69.04 4.38 99.52 68.48 2.09 194.78 156.07 135.52 194.77 158.81 135.67 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 32 3 # 32 B 137 GLY N 121 GLY.? 16.46 O1 GOL N3044 B 175 ARG N 122 ARG.? -8.98 O1 GOL N3044s B 242 TYR N 112 TYR~? 12.42 O1 GOL N3044 coo 99.45 58.28 3.33 99.57 58.61 4.10 200.70 160.34 125.46 200.61 160.47 126.26 coo 106.37 63.53 0.89 108.02 63.40 -1.62 202.43 162.21 132.12 202.95 163.61 134.81 coo 100.93 69.04 4.38 99.52 68.48 2.09 194.78 156.07 135.52 194.77 158.81 135.67 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 33 3 # 33 B 137 GLY O 100 GLY.? 12.06 CL CL O2036 B 175 ARG O 114 ARG~? 4.95 CL CL O2036 B 242 TYR O 112 TYR~? 11.14 CL CL O2036 coo 99.45 58.28 3.33 99.57 58.61 4.10 134.51 133.33 152.18 134.16 133.89 151.73 coo 106.37 63.53 0.89 108.02 63.40 -1.62 141.08 127.21 153.72 140.82 126.86 150.69 coo 100.93 69.04 4.38 99.52 68.48 2.09 142.72 134.33 160.12 142.81 134.85 162.82 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 34 3 # 34 B 137 GLY O 121 GLY.? 13.81 CL CL O2018 B 175 ARG O 122 ARG.? -8.86 O1 GOL O3013s B 242 TYR O 112 TYR~? 11.14 CL CL O2036 coo 99.45 58.28 3.33 99.57 58.61 4.10 136.95 124.83 165.80 137.02 125.67 165.76 coo 106.37 63.53 0.89 108.02 63.40 -1.62 135.19 131.73 166.81 134.71 134.57 167.84 coo 100.93 69.04 4.38 99.52 68.48 2.09 142.72 134.33 160.12 142.81 134.85 162.82 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 35 3 # 35 B 137 GLY P 100 GLY.? 14.36 CL CL P2019 B 175 ARG P 114 ARG~? 18.57 O2 GOL P3034 B 242 TYR P 112 TYR~? 13.01 O1 GOL P3034 coo 99.45 58.28 3.33 99.57 58.61 4.10 200.81 185.95 206.27 201.28 186.23 205.69 coo 106.37 63.53 0.89 108.02 63.40 -1.62 193.59 185.96 211.51 194.17 188.98 211.79 coo 100.93 69.04 4.38 99.52 68.48 2.09 191.84 178.79 205.19 191.53 176.04 204.95 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 36 3 # 36 B 137 GLY P 121 GLY.? 6.50 O2 GOL P3034 B 175 ARG P 122 ARG.? -4.11 O1 GOL P3034s B 242 TYR P 112 TYR~? 13.01 O1 GOL P3034 coo 99.45 58.28 3.33 99.57 58.61 4.10 195.91 173.94 215.78 195.91 173.79 214.98 coo 106.37 63.53 0.89 108.02 63.40 -1.62 198.11 171.86 209.38 198.78 170.26 206.84 coo 100.93 69.04 4.38 99.52 68.48 2.09 191.84 178.79 205.19 191.53 176.04 204.95 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 36 hits 1xva_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 150 TRP~? 9.40 O3 GOL A3037 223 ASP A 70 ASP~? -9.95 O3 GOL A3037s 258 ALA A 170 ALA.? 20.53 O3 GOL A3037 coo 128.40 33.01 26.67 128.12 36.28 28.81 99.61 75.57 49.87 96.34 77.60 50.68 coo 127.91 41.73 23.55 129.18 40.35 24.44 90.44 78.16 48.76 91.65 76.94 50.06 coo 141.00 37.49 25.74 139.80 37.53 24.78 100.22 69.47 39.87 99.41 69.91 41.08 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP B 150 TRP~? 6.74 O3 GOL B3015 223 ASP B 70 ASP~? -3.24 O2 GOL B3024s 258 ALA B 170 ALA~? 13.58 O2 GOL B3024 coo 128.40 33.01 26.67 128.12 36.28 28.81 14.34 60.39 20.70 17.67 58.57 19.72 coo 127.91 41.73 23.55 129.18 40.35 24.44 23.66 59.02 20.34 21.93 58.32 21.38 coo 141.00 37.49 25.74 139.80 37.53 24.78 14.77 71.56 24.13 15.26 70.13 24.43 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP D 150 TRP~? 10.12 O2 GOL D3020 223 ASP D 70 ASP~? -11.51 O3 GOL D3019s 258 ALA D 170 ALA~? 19.68 CL CL D2012 coo 128.40 33.01 26.67 128.12 36.28 28.81 7.58 55.02 76.49 10.84 56.37 78.24 coo 127.91 41.73 23.55 129.18 40.35 24.44 16.94 54.59 79.01 15.65 55.42 77.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 6.93 44.07 72.75 7.76 45.36 72.93 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP E 150 TRP~? 6.44 C3 GOL E3002 223 ASP E 70 ASP~? 5.56 O3 GOL E3002 258 ALA E 170 ALA.? 14.63 O1 GOL E3002 coo 128.40 33.01 26.67 128.12 36.28 28.81 13.53 85.96 51.70 17.23 86.80 50.63 coo 127.91 41.73 23.55 129.18 40.35 24.44 23.07 86.29 52.35 21.57 85.17 51.32 coo 141.00 37.49 25.74 139.80 37.53 24.78 11.76 82.55 62.69 12.60 82.37 61.38 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP F 150 TRP~? 12.61 CL CL F2034 223 ASP F 70 ASP~? -11.57 O3 GOL F3039s 258 ALA F 170 ALA~? 19.53 CL CL F2034 coo 128.40 33.01 26.67 128.12 36.28 28.81 98.06 40.24 31.68 95.06 41.77 29.63 coo 127.91 41.73 23.55 129.18 40.35 24.44 88.86 41.25 28.96 90.30 42.22 30.24 coo 141.00 37.49 25.74 139.80 37.53 24.78 96.41 30.37 37.19 95.95 31.80 36.85 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP G 150 TRP~? 4.79 O3 GOL G3001 223 ASP G 70 ASP~? -5.29 C3 GOL G3001s 258 ALA G 170 ALA.? 15.18 O3 GOL G3001 coo 128.40 33.01 26.67 128.12 36.28 28.81 8.65 29.73 45.56 11.64 28.04 47.47 coo 127.91 41.73 23.55 129.18 40.35 24.44 17.70 27.34 47.09 16.19 28.71 47.73 coo 141.00 37.49 25.74 139.80 37.53 24.78 10.14 33.28 34.54 10.49 33.27 36.03 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP H 150 TRP~? 9.03 C1 GOL H3016 223 ASP H 70 ASP~? -4.05 C3 GOL H3016s 258 ALA H 170 ALA.? 11.39 O1 GOL H3016 coo 128.40 33.01 26.67 128.12 36.28 28.81 93.76 57.94 85.12 90.09 57.13 86.33 coo 127.91 41.73 23.55 129.18 40.35 24.44 84.24 58.93 85.48 85.73 57.59 84.66 coo 141.00 37.49 25.74 139.80 37.53 24.78 95.42 68.01 79.25 94.50 66.81 79.47 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP I 150 TRP~? 8.45 O3 GOL I3032 223 ASP I 70 ASP~? -3.65 C2 GOL I3032s 258 ALA I 170 ALA~? 13.63 C1 GOL I3032 coo 128.40 33.01 26.67 128.12 36.28 28.81 213.69 193.51 164.07 210.33 195.28 165.13 coo 127.91 41.73 23.55 129.18 40.35 24.44 204.37 195.46 163.61 205.75 194.30 164.79 coo 141.00 37.49 25.74 139.80 37.53 24.78 214.24 188.20 153.84 213.48 188.46 155.16 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 9 3 # 9 142 TRP J 150 TRP~? 9.82 O1 GOL J3033 223 ASP J 70 ASP~? 11.68 O1 GOL J3033 258 ALA J 170 ALA.? 20.08 CL CL J2016 coo 128.40 33.01 26.67 128.12 36.28 28.81 127.85 175.49 138.51 131.22 173.81 137.27 coo 127.91 41.73 23.55 129.18 40.35 24.44 137.44 174.60 137.57 135.80 173.80 138.69 coo 141.00 37.49 25.74 139.80 37.53 24.78 128.19 186.40 142.63 128.67 184.98 142.77 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 10 3 # 10 142 TRP K 150 TRP~? 6.22 O2 GOL K3009 223 ASP K 70 ASP~? -4.89 O3 GOL K3009s 258 ALA K 170 ALA~? 15.83 C2 GOL K3009 coo 128.40 33.01 26.67 128.12 36.28 28.81 209.66 139.23 178.83 206.28 137.79 177.39 coo 127.91 41.73 23.55 129.18 40.35 24.44 200.17 138.24 178.11 201.77 139.28 177.19 coo 141.00 37.49 25.74 139.80 37.53 24.78 209.50 144.80 189.17 208.76 144.59 187.81 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 11 3 # 11 142 TRP L 150 TRP~? 12.70 CL CL L2009 223 ASP L 70 ASP~? -12.27 O3 GOL L3028s 258 ALA L 170 ALA.? 19.71 CL CL L2009 coo 128.40 33.01 26.67 128.12 36.28 28.81 124.03 167.33 194.23 127.41 168.49 195.83 coo 127.91 41.73 23.55 129.18 40.35 24.44 133.34 166.97 196.27 132.03 168.03 194.96 coo 141.00 37.49 25.74 139.80 37.53 24.78 123.01 156.39 190.65 123.83 157.72 190.60 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 12 3 # 12 142 TRP M 150 TRP~? 9.50 O3 GOL M3042 223 ASP M 70 ASP~? -9.98 O3 GOL M3042s 258 ALA M 170 ALA.? 20.25 CL CL M2017 coo 128.40 33.01 26.67 128.12 36.28 28.81 127.35 199.32 170.42 130.91 200.46 169.17 coo 127.91 41.73 23.55 129.18 40.35 24.44 136.87 200.18 170.79 135.36 199.08 169.77 coo 141.00 37.49 25.74 139.80 37.53 24.78 126.38 195.21 181.34 127.27 195.23 180.08 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 13 3 # 13 142 TRP N 150 TRP~? 6.52 O2 GOL N3012 223 ASP N 70 ASP~? -3.26 O2 GOL N3029s 258 ALA N 170 ALA~? 12.36 O1 GOL N3029 coo 128.40 33.01 26.67 128.12 36.28 28.81 212.92 158.88 144.19 209.70 160.35 142.44 coo 127.91 41.73 23.55 129.18 40.35 24.44 203.51 159.51 142.26 205.02 160.53 143.48 coo 141.00 37.49 25.74 139.80 37.53 24.78 212.01 148.38 149.74 211.51 149.84 149.62 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 14 3 # 14 142 TRP O 150 TRP~? 6.10 O1 GOL O3013 223 ASP O 70 ASP~? 3.30 O1 GOL O3013s 258 ALA O 170 ALA.? 12.82 O3 GOL O3026 coo 128.40 33.01 26.67 128.12 36.28 28.81 124.79 143.29 162.05 128.01 141.74 163.72 coo 127.91 41.73 23.55 129.18 40.35 24.44 134.07 141.35 162.95 132.57 142.58 163.78 coo 141.00 37.49 25.74 139.80 37.53 24.78 125.43 147.48 151.25 125.99 147.40 152.63 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 15 3 # 15 142 TRP P 150 TRP~? 5.47 O2 GOL P3014 223 ASP P 70 ASP~? 4.30 O3 GOL P3014 258 ALA P 170 ALA~? 15.54 O1 GOL P3014 coo 128.40 33.01 26.67 128.12 36.28 28.81 210.27 173.82 198.63 206.78 172.70 200.12 coo 127.91 41.73 23.55 129.18 40.35 24.44 200.75 174.15 199.66 202.28 173.10 198.62 coo 141.00 37.49 25.74 139.80 37.53 24.78 211.39 184.06 193.31 210.59 182.76 193.44 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 15 hits 2aat_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 83 SER~? 4.31 CL CL A2020 327 GLU A 93 GLU~? 8.07 CL CL A2020 440 HIS A 79 HIS~? -3.92 CL CL A2020s coo 6.96 64.04 57.84 6.74 63.69 60.26 109.33 86.01 47.44 108.27 87.28 49.22 coo 14.82 64.63 62.37 13.47 65.72 61.17 106.40 86.90 39.80 107.05 88.84 40.38 coo 9.52 66.51 63.07 8.75 65.02 61.81 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 81 SER~? 10.28 CL CL B2010 327 GLU B 93 GLU~? 9.70 CL CL B2010 440 HIS B 79 HIS~? 5.08 CL CL B2010 coo 6.96 64.04 57.84 6.74 63.69 60.26 8.58 59.85 12.91 9.44 59.08 15.03 coo 14.82 64.63 62.37 13.47 65.72 61.17 11.87 67.96 6.38 12.21 67.44 4.38 coo 9.52 66.51 63.07 8.75 65.02 61.81 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 3 3 # 3 200 SER B 83 SER~? 7.75 CL CL B2010 327 GLU B 93 GLU~? 9.70 CL CL B2010 440 HIS B 79 HIS~? 5.08 CL CL B2010 coo 6.96 64.04 57.84 6.74 63.69 60.26 7.70 61.77 7.67 8.73 59.61 7.20 coo 14.82 64.63 62.37 13.47 65.72 61.17 11.87 67.96 6.38 12.21 67.44 4.38 coo 9.52 66.51 63.07 8.75 65.02 61.81 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 4 3 # 4 200 SER C 81 SER~? 9.13 CL CL C2021 327 GLU C 93 GLU~? 8.05 CL CL C2021 440 HIS C 79 HIS~? -4.32 CL CL C2021s coo 6.96 64.04 57.84 6.74 63.69 60.26 97.80 14.60 67.87 97.00 16.56 66.71 coo 14.82 64.63 62.37 13.47 65.72 61.17 94.51 9.91 76.89 94.48 7.78 76.63 coo 9.52 66.51 63.07 8.75 65.02 61.81 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 5 3 # 5 200 SER C 83 SER~? 3.84 CL CL C2021 327 GLU C 93 GLU~? 8.05 CL CL C2021 440 HIS C 79 HIS~? -4.32 CL CL C2021s coo 6.96 64.04 57.84 6.74 63.69 60.26 99.03 9.95 70.83 97.44 9.06 69.22 coo 14.82 64.63 62.37 13.47 65.72 61.17 94.51 9.91 76.89 94.48 7.78 76.63 coo 9.52 66.51 63.07 8.75 65.02 61.81 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 6 3 # 6 200 SER D 81 SER~? 8.64 O1 GOL D3020 327 GLU D 93 GLU~? 8.23 CL CL D2022 440 HIS D 79 HIS~? -4.57 CL CL D2022s coo 6.96 64.04 57.84 6.74 63.69 60.26 0.59 56.62 82.32 2.14 57.19 80.58 coo 14.82 64.63 62.37 13.47 65.72 61.17 0.77 48.16 89.31 0.23 49.10 91.12 coo 9.52 66.51 63.07 8.75 65.02 61.81 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 7 3 # 7 200 SER D 83 SER~? 4.15 CL CL D2022 327 GLU D 93 GLU~? 8.23 CL CL D2022 440 HIS D 79 HIS~? -4.57 CL CL D2022s coo 6.96 64.04 57.84 6.74 63.69 60.26 -2.16 54.95 86.89 -0.79 56.60 88.02 coo 14.82 64.63 62.37 13.47 65.72 61.17 0.77 48.16 89.31 0.23 49.10 91.12 coo 9.52 66.51 63.07 8.75 65.02 61.81 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 8 3 # 8 200 SER E 81 SER~? 9.10 CL CL E2032 327 GLU E 93 GLU~? 8.42 CL CL E2032 440 HIS E 79 HIS~? -4.18 CL CL E2032s coo 6.96 64.04 57.84 6.74 63.69 60.26 8.14 93.66 50.22 9.19 91.54 49.74 coo 14.82 64.63 62.37 13.47 65.72 61.17 9.96 100.16 58.92 10.04 102.16 58.24 coo 9.52 66.51 63.07 8.75 65.02 61.81 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 9 3 # 9 200 SER E 83 SER~? 3.98 CL CL E2032 327 GLU E 93 GLU~? 8.42 CL CL E2032 440 HIS E 79 HIS~? -4.18 CL CL E2032s coo 6.96 64.04 57.84 6.74 63.69 60.26 6.89 98.81 51.94 8.26 99.71 50.10 coo 14.82 64.63 62.37 13.47 65.72 61.17 9.96 100.16 58.92 10.04 102.16 58.24 coo 9.52 66.51 63.07 8.75 65.02 61.81 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 10 3 # 10 200 SER F 81 SER~? 9.12 CL CL F2023 327 GLU F 93 GLU~? 8.36 CL CL F2023 440 HIS F 79 HIS~? -4.63 CL CL F2023s coo 6.96 64.04 57.84 6.74 63.69 60.26 105.10 38.99 25.26 103.91 40.31 26.96 coo 14.82 64.63 62.37 13.47 65.72 61.17 102.94 29.85 20.29 103.30 29.96 18.20 coo 9.52 66.51 63.07 8.75 65.02 61.81 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 11 3 # 11 200 SER F 83 SER~? 4.14 CL CL F2023 327 GLU F 93 GLU~? 8.36 CL CL F2023 440 HIS F 79 HIS~? -4.63 CL CL F2023s coo 6.96 64.04 57.84 6.74 63.69 60.26 107.41 36.26 21.11 106.31 38.05 19.96 coo 14.82 64.63 62.37 13.47 65.72 61.17 102.94 29.85 20.29 103.30 29.96 18.20 coo 9.52 66.51 63.07 8.75 65.02 61.81 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 12 3 # 12 200 SER G 81 SER~? 9.39 CL CL G2033 327 GLU G 93 GLU~? 8.63 CL CL G2033 440 HIS G 79 HIS~? -4.46 CL CL G2033s coo 6.96 64.04 57.84 6.74 63.69 60.26 1.35 23.42 45.68 2.61 25.29 46.56 coo 14.82 64.63 62.37 13.47 65.72 61.17 3.64 16.49 37.62 3.03 14.55 38.23 coo 9.52 66.51 63.07 8.75 65.02 61.81 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 13 3 # 13 200 SER G 83 SER~? 4.16 CL CL G2033 327 GLU G 93 GLU~? 8.63 CL CL G2033 440 HIS G 79 HIS~? -4.46 CL CL G2033s coo 6.96 64.04 57.84 6.74 63.69 60.26 -0.88 18.73 43.69 0.20 17.85 45.68 coo 14.82 64.63 62.37 13.47 65.72 61.17 3.64 16.49 37.62 3.03 14.55 38.23 coo 9.52 66.51 63.07 8.75 65.02 61.81 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 14 3 # 14 200 SER H 83 SER~? 4.17 CL CL H2024 327 GLU H 93 GLU~? 8.72 CL CL H2024 440 HIS H 79 HIS~? 4.82 CL CL H2024 coo 6.96 64.04 57.84 6.74 63.69 60.26 100.86 60.76 97.52 99.44 59.04 98.47 coo 14.82 64.63 62.37 13.47 65.72 61.17 97.56 68.07 97.57 97.65 67.50 99.59 coo 9.52 66.51 63.07 8.75 65.02 61.81 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 15 3 # 15 200 SER I 81 SER~? 9.15 CL CL I2025 327 GLU I 93 GLU~? 8.40 CL CL I2025 440 HIS I 79 HIS~? -4.56 CL CL I2025s coo 6.96 64.04 57.84 6.74 63.69 60.26 220.47 200.38 164.21 219.13 198.61 165.10 coo 14.82 64.63 62.37 13.47 65.72 61.17 219.77 205.57 155.06 219.86 207.68 155.25 coo 9.52 66.51 63.07 8.75 65.02 61.81 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 16 3 # 16 200 SER I 83 SER~? 4.12 CL CL I2025 327 GLU I 93 GLU~? 8.40 CL CL I2025 440 HIS I 79 HIS~? -4.56 CL CL I2025s coo 6.96 64.04 57.84 6.74 63.69 60.26 222.83 204.85 161.89 221.39 205.66 163.52 coo 14.82 64.63 62.37 13.47 65.72 61.17 219.77 205.57 155.06 219.86 207.68 155.25 coo 9.52 66.51 63.07 8.75 65.02 61.81 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 17 3 # 17 200 SER J 81 SER~? 9.04 CL CL J2026 327 GLU J 93 GLU~? 8.18 CL CL J2026 440 HIS J 79 HIS~? -4.36 CL CL J2026s coo 6.96 64.04 57.84 6.74 63.69 60.26 121.87 175.35 131.02 122.76 174.32 132.99 coo 14.82 64.63 62.37 13.47 65.72 61.17 124.50 183.71 125.04 124.44 183.21 122.99 coo 9.52 66.51 63.07 8.75 65.02 61.81 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 18 3 # 18 200 SER J 83 SER~? 3.90 CL CL J2026 327 GLU J 93 GLU~? 8.18 CL CL J2026 440 HIS J 79 HIS~? -4.36 CL CL J2026s coo 6.96 64.04 57.84 6.74 63.69 60.26 120.35 177.35 126.19 121.76 175.49 125.60 coo 14.82 64.63 62.37 13.47 65.72 61.17 124.50 183.71 125.04 124.44 183.21 122.99 coo 9.52 66.51 63.07 8.75 65.02 61.81 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 19 3 # 19 200 SER K 81 SER~? 9.04 CL CL K2027 327 GLU K 93 GLU~? 8.22 CL CL K2027 440 HIS K 79 HIS~? -4.34 CL CL K2027s coo 6.96 64.04 57.84 6.74 63.69 60.26 215.63 131.69 179.58 214.60 133.54 178.42 coo 14.82 64.63 62.37 13.47 65.72 61.17 212.85 126.80 188.86 213.03 124.72 188.44 coo 9.52 66.51 63.07 8.75 65.02 61.81 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 20 3 # 20 200 SER K 83 SER~? 3.98 CL CL K2027 327 GLU K 93 GLU~? 8.22 CL CL K2027 440 HIS K 79 HIS~? -4.34 CL CL K2027s coo 6.96 64.04 57.84 6.74 63.69 60.26 216.96 127.03 182.22 215.88 126.06 180.30 coo 14.82 64.63 62.37 13.47 65.72 61.17 212.85 126.80 188.86 213.03 124.72 188.44 coo 9.52 66.51 63.07 8.75 65.02 61.81 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 21 3 # 21 200 SER L 83 SER~? 3.95 CL CL L2028 327 GLU L 93 GLU~? 8.05 CL CL L2028 440 HIS L 79 HIS~? -4.09 CL CL L2028s coo 6.96 64.04 57.84 6.74 63.69 60.26 115.00 167.12 206.00 116.47 168.85 206.74 coo 14.82 64.63 62.37 13.47 65.72 61.17 118.11 159.89 208.04 117.71 160.95 209.86 coo 9.52 66.51 63.07 8.75 65.02 61.81 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 22 3 # 22 200 SER M 83 SER~? 4.48 CL CL M2029 327 GLU M 93 GLU~? 8.60 CL CL M2029 440 HIS M 79 HIS~? -4.31 CL CL M2029s coo 6.96 64.04 57.84 6.74 63.69 60.26 119.79 211.86 171.05 121.18 212.22 169.09 coo 14.82 64.63 62.37 13.47 65.72 61.17 123.31 213.00 178.36 123.21 215.02 177.75 coo 9.52 66.51 63.07 8.75 65.02 61.81 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 23 3 # 23 200 SER N 81 SER~? 9.02 CL CL N2030 327 GLU N 93 GLU~? 8.57 CL CL N2030 440 HIS N 79 HIS~? -4.33 CL CL N2030s coo 6.96 64.04 57.84 6.74 63.69 60.26 219.66 158.05 137.54 218.33 159.17 139.26 coo 14.82 64.63 62.37 13.47 65.72 61.17 217.47 148.79 132.22 217.76 148.97 130.14 coo 9.52 66.51 63.07 8.75 65.02 61.81 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 24 3 # 24 200 SER N 83 SER~? 3.82 CL CL N2030 327 GLU N 93 GLU~? 8.57 CL CL N2030 440 HIS N 79 HIS~? -4.33 CL CL N2030s coo 6.96 64.04 57.84 6.74 63.69 60.26 221.50 155.10 133.13 220.51 157.01 132.05 coo 14.82 64.63 62.37 13.47 65.72 61.17 217.47 148.79 132.22 217.76 148.97 130.14 coo 9.52 66.51 63.07 8.75 65.02 61.81 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 25 3 # 25 200 SER O 81 SER~? 10.10 CL CL O2018 327 GLU O 93 GLU~? 9.72 CL CL O2018 440 HIS O 79 HIS~? 5.21 CL CL O2018 coo 6.96 64.04 57.84 6.74 63.69 60.26 117.95 136.60 162.36 119.18 138.53 163.10 coo 14.82 64.63 62.37 13.47 65.72 61.17 119.95 130.02 153.81 119.63 127.98 154.32 coo 9.52 66.51 63.07 8.75 65.02 61.81 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 26 3 # 26 200 SER O 83 SER~? 7.53 CL CL O2018 327 GLU O 93 GLU~? 9.72 CL CL O2018 440 HIS O 79 HIS~? 5.21 CL CL O2018 coo 6.96 64.04 57.84 6.74 63.69 60.26 115.90 131.94 160.39 117.13 130.87 162.21 coo 14.82 64.63 62.37 13.47 65.72 61.17 119.95 130.02 153.81 119.63 127.98 154.32 coo 9.52 66.51 63.07 8.75 65.02 61.81 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 27 3 # 27 200 SER P 81 SER~? 10.48 CL CL P2019 327 GLU P 93 GLU~? 9.65 CL CL P2019 440 HIS P 79 HIS~? 5.38 CL CL P2019 coo 6.96 64.04 57.84 6.74 63.69 60.26 216.34 173.84 206.20 215.26 172.77 204.29 coo 14.82 64.63 62.37 13.47 65.72 61.17 214.54 183.14 211.27 214.54 182.92 213.36 coo 9.52 66.51 63.07 8.75 65.02 61.81 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 28 3 # 28 200 SER P 83 SER~? 8.38 CL CL P2019 327 GLU P 93 GLU~? 9.65 CL CL P2019 440 HIS P 79 HIS~? 5.38 CL CL P2019 coo 6.96 64.04 57.84 6.74 63.69 60.26 218.12 176.21 210.92 216.94 174.20 211.47 coo 14.82 64.63 62.37 13.47 65.72 61.17 214.54 183.14 211.27 214.54 182.92 213.36 coo 9.52 66.51 63.07 8.75 65.02 61.81 212.25 178.47 210.26 213.09 179.27 212.01 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 28 hits 2ace_c00 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS G 151 HIS~? -4.14 C3 GOL G3001s B 50 GLU G 163 GLU~? 11.22 O3 GOL G3001 B 113 GLN G 156 GLN.? -2.79 O3 GOL G3001s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 13.55 33.19 47.26 14.46 31.35 47.64 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 1.42 33.23 43.78 1.39 32.97 45.86 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 8.33 31.51 50.57 9.87 32.77 49.98 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS J 151 HIS~? -12.73 O1 GOL J3033s B 50 GLU J 163 GLU~? 14.80 O1 GOL J3033 B 113 GLN J 156 GLN.? -9.65 O1 GOL J3033s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 132.36 173.99 142.63 133.63 173.58 141.01 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 120.24 176.69 140.95 120.35 174.56 140.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 128.06 171.27 140.20 130.09 170.91 140.43 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS N 151 HIS~? 3.39 O2 GOL N3012s B 50 GLU N 163 GLU~? 12.29 O1 GOL N3012 B 113 GLN N 156 GLN.? -2.65 O1 GOL N3012s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 207.96 160.84 147.59 206.93 161.03 145.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 220.21 157.81 147.58 220.09 159.81 146.98 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 212.49 162.95 145.52 210.46 163.61 145.52 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS G 151 HIS~? -4.14 C3 GOL G3001s B 50 GLU G 163 GLU~? 11.22 O3 GOL G3001 B 113 GLN G 156 GLN.? -2.79 O3 GOL G3001s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 13.55 33.19 47.26 14.46 31.35 47.64 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 1.42 33.23 43.78 1.39 32.97 45.86 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 8.33 31.51 50.57 9.87 32.77 49.98 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS J 151 HIS~? -12.73 O1 GOL J3033s B 50 GLU J 163 GLU~? 14.80 O1 GOL J3033 B 113 GLN J 156 GLN.? -9.65 O1 GOL J3033s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 132.36 173.99 142.63 133.63 173.58 141.01 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 120.24 176.69 140.95 120.35 174.56 140.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 128.06 171.27 140.20 130.09 170.91 140.43 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS N 151 HIS~? 3.39 O2 GOL N3012s B 50 GLU N 163 GLU~? 12.29 O1 GOL N3012 B 113 GLN N 156 GLN.? -2.65 O1 GOL N3012s coo 37.74 -17.01 11.59 38.11 -17.83 13.49 207.96 160.84 147.59 206.93 161.03 145.77 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 220.21 157.81 147.58 220.09 159.81 146.98 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 212.49 162.95 145.52 210.46 163.61 145.52 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 50 GLU G 163 GLU~? 11.22 O3 GOL G3001 A 113 GLN G 156 GLN.? -2.79 O3 GOL G3001s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 13.55 33.19 47.26 14.46 31.35 47.64 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 1.42 33.23 43.78 1.39 32.97 45.86 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 8.33 31.51 50.57 9.87 32.77 49.98 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 50 GLU J 163 GLU~? 14.80 O1 GOL J3033 A 113 GLN J 156 GLN.? -9.65 O1 GOL J3033s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 132.36 173.99 142.63 133.63 173.58 141.01 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 120.24 176.69 140.95 120.35 174.56 140.67 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 128.06 171.27 140.20 130.09 170.91 140.43 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 50 GLU N 163 GLU~? 12.29 O1 GOL N3012 A 113 GLN N 156 GLN.? -2.65 O1 GOL N3012s coo 73.37 -13.43 4.64 73.06 -11.77 3.39 207.96 160.84 147.59 206.93 161.03 145.77 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 220.21 157.81 147.58 220.09 159.81 146.98 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 212.49 162.95 145.52 210.46 163.61 145.52 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS G 151 HIS~? -4.14 C3 GOL G3001s C 50 GLU G 163 GLU~? 11.22 O3 GOL G3001 C 113 GLN G 156 GLN.? -2.79 O3 GOL G3001s coo 74.92 8.52 28.42 74.88 6.86 29.70 13.55 33.19 47.26 14.46 31.35 47.64 coo 65.25 15.95 28.73 65.73 15.63 30.78 1.42 33.23 43.78 1.39 32.97 45.86 coo 70.80 6.73 32.72 71.88 8.55 32.53 8.33 31.51 50.57 9.87 32.77 49.98 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS J 151 HIS~? -12.73 O1 GOL J3033s C 50 GLU J 163 GLU~? 14.80 O1 GOL J3033 C 113 GLN J 156 GLN.? -9.65 O1 GOL J3033s coo 74.92 8.52 28.42 74.88 6.86 29.70 132.36 173.99 142.63 133.63 173.58 141.01 coo 65.25 15.95 28.73 65.73 15.63 30.78 120.24 176.69 140.95 120.35 174.56 140.67 coo 70.80 6.73 32.72 71.88 8.55 32.53 128.06 171.27 140.20 130.09 170.91 140.43 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS N 151 HIS~? 3.39 O2 GOL N3012s C 50 GLU N 163 GLU~? 12.29 O1 GOL N3012 C 113 GLN N 156 GLN.? -2.65 O1 GOL N3012s coo 74.92 8.52 28.42 74.88 6.86 29.70 207.96 160.84 147.59 206.93 161.03 145.77 coo 65.25 15.95 28.73 65.73 15.63 30.78 220.21 157.81 147.58 220.09 159.81 146.98 coo 70.80 6.73 32.72 71.88 8.55 32.53 212.49 162.95 145.52 210.46 163.61 145.52 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS G 151 HIS~? -4.14 C3 GOL G3001s D 50 GLU G 163 GLU~? 11.22 O3 GOL G3001 D 113 GLN G 156 GLN.? -2.79 O3 GOL G3001s coo 38.66 11.31 27.15 38.67 12.13 25.22 13.55 33.19 47.26 14.46 31.35 47.64 coo 48.72 12.85 33.83 48.36 14.77 32.95 1.42 33.23 43.78 1.39 32.97 45.86 coo 42.85 14.77 24.15 41.85 15.11 26.02 8.33 31.51 50.57 9.87 32.77 49.98 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS J 151 HIS~? -12.73 O1 GOL J3033s D 50 GLU J 163 GLU~? 14.80 O1 GOL J3033 D 113 GLN J 156 GLN.? -9.65 O1 GOL J3033s coo 38.66 11.31 27.15 38.67 12.13 25.22 132.36 173.99 142.63 133.63 173.58 141.01 coo 48.72 12.85 33.83 48.36 14.77 32.95 120.24 176.69 140.95 120.35 174.56 140.67 coo 42.85 14.77 24.15 41.85 15.11 26.02 128.06 171.27 140.20 130.09 170.91 140.43 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS N 151 HIS~? 3.39 O2 GOL N3012s D 50 GLU N 163 GLU~? 12.29 O1 GOL N3012 D 113 GLN N 156 GLN.? -2.65 O1 GOL N3012s coo 38.66 11.31 27.15 38.67 12.13 25.22 207.96 160.84 147.59 206.93 161.03 145.77 coo 48.72 12.85 33.83 48.36 14.77 32.95 220.21 157.81 147.58 220.09 159.81 146.98 coo 42.85 14.77 24.15 41.85 15.11 26.02 212.49 162.95 145.52 210.46 163.61 145.52 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 3 hits 2ag0_c11 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 79 HIS~? -3.92 CL CL A2020s B 163 ALA A 77 ALA~? 7.34 O2 GOL A3037 B 182 SER A 81 SER~? 8.94 O1 GOL A3037 coo 30.42 1.98 4.36 29.07 0.41 4.68 103.72 86.36 44.76 104.87 88.01 44.15 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 100.75 81.76 50.18 100.07 80.47 50.63 coo 24.00 -0.17 2.07 24.51 1.00 0.04 106.79 81.80 49.88 105.31 80.20 50.94 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 158 HIS.? 6.53 O1 GOL A3037 B 163 ALA A 77 ALA~? 7.34 O2 GOL A3037 B 182 SER A 81 SER~? 8.94 O1 GOL A3037 coo 30.42 1.98 4.36 29.07 0.41 4.68 106.32 81.43 56.18 105.60 83.26 56.91 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 100.75 81.76 50.18 100.07 80.47 50.63 coo 24.00 -0.17 2.07 24.51 1.00 0.04 106.79 81.80 49.88 105.31 80.20 50.94 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 79 HIS~? 5.08 CL CL B2010 B 163 ALA B 77 ALA~? 8.79 CL CL B2010 B 182 SER B 81 SER~? 10.28 CL CL B2010 coo 30.42 1.98 4.36 29.07 0.41 4.68 13.46 62.96 8.26 12.78 63.30 6.30 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 14.35 58.87 14.63 14.64 58.71 16.11 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.58 59.85 12.91 9.44 59.08 15.03 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS B 158 HIS.? 12.55 CL CL B2010 B 163 ALA B 77 ALA~? 8.79 CL CL B2010 B 182 SER B 81 SER~? 10.28 CL CL B2010 coo 30.42 1.98 4.36 29.07 0.41 4.68 7.56 53.89 15.18 8.49 52.54 13.87 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 14.35 58.87 14.63 14.64 58.71 16.11 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.58 59.85 12.91 9.44 59.08 15.03 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS C 79 HIS~? -4.32 CL CL C2021s B 163 ALA C 77 ALA~? 8.49 O1 GOL C3036 B 182 SER C 81 SER~? 9.13 CL CL C2021 coo 30.42 1.98 4.36 29.07 0.41 4.68 92.85 10.89 71.99 93.43 9.18 73.06 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 92.17 16.11 66.53 91.99 17.53 65.96 coo 24.00 -0.17 2.07 24.51 1.00 0.04 97.80 14.60 67.87 97.00 16.56 66.71 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 6 3 # 6 B 46 HIS C 158 HIS.? 10.62 CL CL C2021 B 163 ALA C 77 ALA~? 8.49 O1 GOL C3036 B 182 SER C 81 SER~? 9.13 CL CL C2021 coo 30.42 1.98 4.36 29.07 0.41 4.68 98.99 15.14 61.83 98.04 13.53 60.88 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 92.17 16.11 66.53 91.99 17.53 65.96 coo 24.00 -0.17 2.07 24.51 1.00 0.04 97.80 14.60 67.87 97.00 16.56 66.71 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 7 3 # 7 B 46 HIS D 79 HIS~? -4.57 CL CL D2022s B 163 ALA D 77 ALA~? 7.20 C1 GOL D3020 B 182 SER D 81 SER~? 8.64 O1 GOL D3020 coo 30.42 1.98 4.36 29.07 0.41 4.68 3.57 52.49 87.96 2.52 51.97 89.71 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 6.55 56.57 82.37 7.24 56.79 81.03 coo 24.00 -0.17 2.07 24.51 1.00 0.04 0.59 56.62 82.32 2.14 57.19 80.58 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 8 3 # 8 B 46 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 163 ALA D 77 ALA~? 7.20 C1 GOL D3020 B 182 SER D 81 SER~? 8.64 O1 GOL D3020 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.86 62.48 80.06 1.83 63.91 81.27 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 6.55 56.57 82.37 7.24 56.79 81.03 coo 24.00 -0.17 2.07 24.51 1.00 0.04 0.59 56.62 82.32 2.14 57.19 80.58 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 9 3 # 9 B 46 HIS E 79 HIS~? -4.18 CL CL E2032s B 163 ALA E 77 ALA~? 8.91 CL CL E2013 B 182 SER E 81 SER~? 9.10 CL CL E2032 coo 30.42 1.98 4.36 29.07 0.41 4.68 12.36 98.35 54.34 11.69 100.32 54.60 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 13.89 92.05 50.21 14.20 90.55 50.08 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.14 93.66 50.22 9.19 91.54 49.74 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 10 3 # 10 B 46 HIS E 158 HIS.? 10.67 CL CL E2032 B 163 ALA E 77 ALA~? 8.91 CL CL E2013 B 182 SER E 81 SER~? 9.10 CL CL E2032 coo 30.42 1.98 4.36 29.07 0.41 4.68 8.21 91.93 44.16 9.29 93.32 43.02 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 13.89 92.05 50.21 14.20 90.55 50.08 coo 24.00 -0.17 2.07 24.51 1.00 0.04 8.14 93.66 50.22 9.19 91.54 49.74 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 11 3 # 11 B 46 HIS F 79 HIS~? -4.63 CL CL F2023s B 163 ALA F 77 ALA~? 8.70 CL CL F2034 B 182 SER F 81 SER~? 9.12 CL CL F2023 coo 30.42 1.98 4.36 29.07 0.41 4.68 101.04 34.65 20.79 101.93 33.69 19.16 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 99.32 40.41 25.48 98.76 40.99 26.78 coo 24.00 -0.17 2.07 24.51 1.00 0.04 105.10 38.99 25.26 103.91 40.31 26.96 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 12 3 # 12 B 46 HIS F 158 HIS.? -10.90 CL CL F2023s B 163 ALA F 77 ALA~? 8.70 CL CL F2034 B 182 SER F 81 SER~? 9.12 CL CL F2023 coo 30.42 1.98 4.36 29.07 0.41 4.68 105.92 45.34 26.29 105.13 46.33 24.62 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 99.32 40.41 25.48 98.76 40.99 26.78 coo 24.00 -0.17 2.07 24.51 1.00 0.04 105.10 38.99 25.26 103.91 40.31 26.96 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 13 3 # 13 B 46 HIS G 79 HIS~? -4.46 CL CL G2033s B 163 ALA G 77 ALA~? 7.25 O3 GOL G3001 B 182 SER G 81 SER~? 9.39 CL CL G2033 coo 30.42 1.98 4.36 29.07 0.41 4.68 5.20 17.85 42.65 4.12 16.10 42.26 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 7.15 23.73 47.01 7.71 25.14 47.31 coo 24.00 -0.17 2.07 24.51 1.00 0.04 1.35 23.42 45.68 2.61 25.29 46.56 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 14 3 # 14 B 46 HIS G 158 HIS.? 10.64 CL CL G2033 B 163 ALA G 77 ALA~? 7.25 O3 GOL G3001 B 182 SER G 81 SER~? 9.39 CL CL G2033 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.65 25.49 51.61 1.26 23.82 52.74 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 7.15 23.73 47.01 7.71 25.14 47.31 coo 24.00 -0.17 2.07 24.51 1.00 0.04 1.35 23.42 45.68 2.61 25.29 46.56 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 15 3 # 15 B 46 HIS H 79 HIS~? 4.82 CL CL H2024 B 163 ALA H 77 ALA~? 8.84 CL CL H2014 B 182 SER H 81 SER~? 9.05 CL CL H2024 coo 30.42 1.98 4.36 29.07 0.41 4.68 95.19 63.20 96.60 95.96 63.87 98.43 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 93.56 57.80 91.48 93.28 57.22 90.10 coo 24.00 -0.17 2.07 24.51 1.00 0.04 99.24 58.01 93.04 98.20 57.10 91.00 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 16 3 # 16 B 46 HIS H 158 HIS.? 10.33 CL CL H2024 B 163 ALA H 77 ALA~? 8.84 CL CL H2014 B 182 SER H 81 SER~? 9.05 CL CL H2024 coo 30.42 1.98 4.36 29.07 0.41 4.68 98.94 51.80 92.35 97.68 51.03 93.84 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 93.56 57.80 91.48 93.28 57.22 90.10 coo 24.00 -0.17 2.07 24.51 1.00 0.04 99.24 58.01 93.04 98.20 57.10 91.00 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 17 3 # 17 B 46 HIS I 79 HIS~? -4.56 CL CL I2025s B 163 ALA I 77 ALA~? 9.03 CL CL I2015 B 182 SER I 81 SER~? 9.15 CL CL I2025 coo 30.42 1.98 4.36 29.07 0.41 4.68 216.99 204.94 159.50 218.07 206.60 158.77 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 214.62 199.75 164.52 214.07 198.37 164.98 coo 24.00 -0.17 2.07 24.51 1.00 0.04 220.47 200.38 164.21 219.13 198.61 165.10 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 18 3 # 18 B 46 HIS I 158 HIS.? 11.08 CL CL I2025 B 163 ALA I 77 ALA~? 9.03 CL CL I2015 B 182 SER I 81 SER~? 9.15 CL CL I2025 coo 30.42 1.98 4.36 29.07 0.41 4.68 220.34 199.03 170.60 219.44 200.67 171.57 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 214.62 199.75 164.52 214.07 198.37 164.98 coo 24.00 -0.17 2.07 24.51 1.00 0.04 220.47 200.38 164.21 219.13 198.61 165.10 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 19 3 # 19 B 46 HIS J 79 HIS~? -4.36 CL CL J2026s B 163 ALA J 77 ALA~? 7.22 O2 GOL J3033 B 182 SER J 81 SER~? 9.04 CL CL J2026 coo 30.42 1.98 4.36 29.07 0.41 4.68 126.45 179.07 126.46 125.69 179.71 124.61 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 127.70 174.36 132.33 128.03 174.02 133.80 coo 24.00 -0.17 2.07 24.51 1.00 0.04 121.87 175.35 131.02 122.76 174.32 132.99 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 20 3 # 20 B 46 HIS J 158 HIS.? 7.50 O2 GOL J3033 B 163 ALA J 77 ALA~? 7.22 O2 GOL J3033 B 182 SER J 81 SER~? 9.04 CL CL J2026 coo 30.42 1.98 4.36 29.07 0.41 4.68 121.18 169.23 132.79 122.06 167.98 131.35 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 127.70 174.36 132.33 128.03 174.02 133.80 coo 24.00 -0.17 2.07 24.51 1.00 0.04 121.87 175.35 131.02 122.76 174.32 132.99 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 21 3 # 21 B 46 HIS K 79 HIS~? -4.34 CL CL K2027s B 163 ALA K 77 ALA~? 8.79 O2 GOL K3009 B 182 SER K 81 SER~? 9.04 CL CL K2027 coo 30.42 1.98 4.36 29.07 0.41 4.68 211.01 127.65 183.80 211.70 125.86 184.65 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 209.89 132.99 178.48 209.55 134.39 178.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 215.63 131.69 179.58 214.60 133.54 178.42 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 22 3 # 22 B 46 HIS K 158 HIS.? 10.92 CL CL K2027 B 163 ALA K 77 ALA~? 8.79 O2 GOL K3009 B 182 SER K 81 SER~? 9.04 CL CL K2027 coo 30.42 1.98 4.36 29.07 0.41 4.68 216.60 132.79 173.33 215.77 131.08 172.42 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 209.89 132.99 178.48 209.55 134.39 178.02 coo 24.00 -0.17 2.07 24.51 1.00 0.04 215.63 131.69 179.58 214.60 133.54 178.42 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 23 3 # 23 B 46 HIS L 79 HIS~? -4.09 CL CL L2028s B 163 ALA L 77 ALA~? 8.83 CL CL L2009 B 182 SER L 81 SER~? 8.97 CL CL L2028 coo 30.42 1.98 4.36 29.07 0.41 4.68 120.65 164.52 206.19 119.64 164.06 207.98 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 123.16 168.73 200.29 123.66 168.91 198.87 coo 24.00 -0.17 2.07 24.51 1.00 0.04 117.25 168.62 201.10 118.49 169.09 199.06 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 24 3 # 24 B 46 HIS L 158 HIS.? 11.11 CL CL L2028 B 163 ALA L 77 ALA~? 8.83 CL CL L2009 B 182 SER L 81 SER~? 8.97 CL CL L2028 coo 30.42 1.98 4.36 29.07 0.41 4.68 117.45 174.63 198.96 118.55 176.04 200.05 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 123.16 168.73 200.29 123.66 168.91 198.87 coo 24.00 -0.17 2.07 24.51 1.00 0.04 117.25 168.62 201.10 118.49 169.09 199.06 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 25 3 # 25 B 46 HIS M 79 HIS~? -4.31 CL CL M2029s B 163 ALA M 77 ALA~? 6.98 C2 GOL M3042 B 182 SER M 81 SER~? 9.17 C1 GOL M3042 coo 30.42 1.98 4.36 29.07 0.41 4.68 125.50 211.59 173.52 124.72 213.49 173.99 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 127.30 205.48 169.06 127.68 204.04 168.84 coo 24.00 -0.17 2.07 24.51 1.00 0.04 121.49 206.79 169.24 122.66 204.72 168.74 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 26 3 # 26 B 46 HIS M 158 HIS.? 6.42 O1 GOL M3042 B 163 ALA M 77 ALA~? 6.98 C2 GOL M3042 B 182 SER M 81 SER~? 9.17 C1 GOL M3042 coo 30.42 1.98 4.36 29.07 0.41 4.68 121.40 205.18 163.43 122.55 206.46 162.23 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 127.30 205.48 169.06 127.68 204.04 168.84 coo 24.00 -0.17 2.07 24.51 1.00 0.04 121.49 206.79 169.24 122.66 204.72 168.74 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 27 3 # 27 B 46 HIS N 79 HIS~? -4.33 CL CL N2030s B 163 ALA N 77 ALA~? 9.77 O2 GOL N3012 B 182 SER N 81 SER~? 9.02 CL CL N2030 coo 30.42 1.98 4.36 29.07 0.41 4.68 215.64 153.98 132.96 216.60 153.22 131.26 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 213.79 159.16 138.04 213.32 159.76 139.40 coo 24.00 -0.17 2.07 24.51 1.00 0.04 219.66 158.05 137.54 218.33 159.17 139.26 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 28 3 # 28 B 46 HIS N 158 HIS.? 10.50 CL CL N2030 B 163 ALA N 77 ALA~? 9.77 O2 GOL N3012 B 182 SER N 81 SER~? 9.02 CL CL N2030 coo 30.42 1.98 4.36 29.07 0.41 4.68 220.32 164.11 138.58 219.66 165.01 136.80 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 213.79 159.16 138.04 213.32 159.76 139.40 coo 24.00 -0.17 2.07 24.51 1.00 0.04 219.66 158.05 137.54 218.33 159.17 139.26 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 29 3 # 29 B 46 HIS O 79 HIS~? 5.21 CL CL O2018 B 163 ALA O 77 ALA~? 8.55 O1 GOL O3013 B 182 SER O 81 SER~? 10.10 CL CL O2018 coo 30.42 1.98 4.36 29.07 0.41 4.68 121.98 131.53 158.56 121.09 129.74 157.92 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 123.76 137.25 163.23 124.22 138.65 163.60 coo 24.00 -0.17 2.07 24.51 1.00 0.04 117.95 136.60 162.36 119.18 138.53 163.10 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 30 3 # 30 B 46 HIS O 158 HIS.? 12.21 CL CL O2018 B 163 ALA O 77 ALA~? 8.55 O1 GOL O3013 B 182 SER O 81 SER~? 10.10 CL CL O2018 coo 30.42 1.98 4.36 29.07 0.41 4.68 117.44 138.41 168.51 118.31 136.96 169.75 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 123.76 137.25 163.23 124.22 138.65 163.60 coo 24.00 -0.17 2.07 24.51 1.00 0.04 117.95 136.60 162.36 119.18 138.53 163.10 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 31 3 # 31 B 46 HIS P 79 HIS~? 5.38 CL CL P2019 B 163 ALA P 77 ALA~? 8.06 O2 GOL P3014 B 182 SER P 81 SER~? 10.48 CL CL P2019 coo 30.42 1.98 4.36 29.07 0.41 4.68 212.25 178.47 210.26 213.09 179.27 212.01 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 210.48 173.29 204.91 210.13 172.95 203.48 coo 24.00 -0.17 2.07 24.51 1.00 0.04 216.34 173.84 206.20 215.26 172.77 204.29 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 32 3 # 32 B 46 HIS P 158 HIS.? 12.33 O2 GOL P3014 B 163 ALA P 77 ALA~? 8.06 O2 GOL P3014 B 182 SER P 81 SER~? 10.48 CL CL P2019 coo 30.42 1.98 4.36 29.07 0.41 4.68 216.29 167.50 205.15 215.20 166.66 206.73 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 210.48 173.29 204.91 210.13 172.95 203.48 coo 24.00 -0.17 2.07 24.51 1.00 0.04 216.34 173.84 206.20 215.26 172.77 204.29 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 32 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 145 ARG~? 24.46 O3 GOL A3037 A 161 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 174 TYR A 109 TYR~? 19.57 O1 GOL A3040 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 94.33 67.29 39.79 97.00 65.79 39.32 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 88.23 80.63 30.72 87.92 80.82 28.67 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 84.38 79.76 38.04 83.16 77.26 38.08 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 145 ARG~? 9.64 O1 GOL B3024 A 161 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 174 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 19.64 71.23 27.64 22.06 69.48 28.42 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 30.49 75.29 14.98 31.30 77.16 14.42 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG C 145 ARG~? 15.99 O1 GOL C3036 A 161 ASP C 102 ASP.? 24.57 CL CL C2011 A 174 TYR C 109 TYR~? 17.83 O1 GOL C3036 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 85.99 31.07 76.22 83.80 32.01 74.28 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 76.25 20.52 82.74 75.40 20.56 84.65 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 74.32 21.96 74.78 73.58 24.65 74.54 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG D 145 ARG~? 21.40 O1 GOL G3001 A 161 ASP D 102 ASP.? 24.32 CL CL D2012 A 174 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 12.08 41.78 71.45 11.86 39.69 73.74 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 18.96 37.41 85.00 19.42 35.40 85.42 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG E 145 ARG~? 19.70 O1 GOL E3002 A 161 ASP E 102 ASP.? 24.45 CL CL E2013 A 174 TYR E 109 TYR~? 18.10 O1 GOL E3035 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 16.30 80.38 65.14 17.26 82.53 67.17 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 26.42 91.49 69.61 27.08 91.68 71.63 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 29.73 88.43 62.54 30.41 85.74 63.01 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG F 145 ARG~? 19.97 O3 GOL C3036 A 161 ASP F 102 ASP.? 16.73 CL CL F2035 A 174 TYR F 109 TYR~? 6.98 CL CL F2035 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 91.49 29.42 38.83 93.62 28.28 40.76 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 82.74 24.28 26.35 81.91 22.30 26.35 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG G 145 ARG~? 20.03 C3 GOL G3001 A 161 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 174 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 15.17 34.68 33.42 15.78 32.53 31.28 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 23.47 21.05 30.82 24.30 20.62 28.93 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG H 145 ARG~? 14.63 O1 GOL H3016 A 161 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 174 TYR H 109 TYR~? 11.76 O2 GOL H3016 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 91.20 69.90 76.54 91.87 72.67 77.80 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 81.36 76.99 86.94 80.90 79.01 86.89 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 77.84 69.46 85.37 77.15 69.38 82.64 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG I 145 ARG~? 15.37 O1 GOL I3032 A 161 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 174 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 209.45 186.59 151.83 209.12 188.26 149.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 201.10 198.54 145.88 200.66 198.62 143.82 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG J 145 ARG~? 22.99 CL CL J2016 A 161 ASP J 102 ASP.? 24.08 CL CL J2016 A 174 TYR J 109 TYR~? 19.91 O1 GOL J3030 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 132.84 187.86 144.62 133.71 189.96 142.45 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 143.25 191.36 132.98 143.80 193.32 132.63 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 145.48 183.77 135.57 146.27 183.96 138.21 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 11 3 # 11 A 14 ARG K 145 ARG~? 19.97 C2 GOL K3009 A 161 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 174 TYR K 109 TYR~? 18.63 O3 GOL K3010 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 204.60 147.17 190.28 202.10 146.29 191.85 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 194.36 135.90 195.25 193.66 135.95 197.23 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 192.13 137.45 187.51 191.27 140.11 187.32 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 12 3 # 12 A 14 ARG L 145 ARG~? 21.94 C3 GOL O3013 A 161 ASP L 102 ASP.? 24.59 CL CL L2009 A 174 TYR L 109 TYR~? 18.94 O3 GOL L3028 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 129.45 155.66 188.12 131.98 157.11 187.19 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 136.52 149.82 201.33 136.95 147.73 201.53 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 139.89 156.88 199.30 141.02 156.55 196.75 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 13 3 # 13 A 14 ARG M 145 ARG~? 23.51 CL CL M2017 A 161 ASP M 102 ASP.? 24.52 CL CL M2017 A 174 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 131.12 192.72 183.38 131.87 195.02 185.33 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 140.74 204.70 188.01 141.33 204.99 189.98 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 14 3 # 14 A 14 ARG N 145 ARG~? 14.05 C1 GOL N3029 A 161 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 174 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 206.36 147.54 151.55 205.74 145.29 149.50 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 197.96 142.41 139.19 197.06 140.46 139.09 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 15 3 # 15 A 14 ARG O 145 ARG~? 14.75 O3 GOL O3026 A 161 ASP O 102 ASP.? 13.16 CL CL O2036 A 174 TYR O 109 TYR~? 12.46 CL CL O2036 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 130.60 149.22 149.86 131.12 146.92 147.82 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 139.48 136.33 146.19 140.25 135.96 144.25 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 141.96 138.45 153.78 143.09 141.01 153.60 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 16 3 # 16 A 14 ARG P 145 ARG~? 19.93 O1 GOL P3014 A 161 ASP P 102 ASP.? 24.26 CL CL P2019 A 174 TYR P 109 TYR~? 18.49 O3 GOL P3014 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 206.30 185.90 191.05 208.78 186.92 189.45 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 197.01 191.93 202.05 196.73 194.01 202.05 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 193.88 184.51 200.52 193.11 184.53 197.85 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 145 ARG~? 24.46 O3 GOL A3037 B 161 ASP A 102 ASP.? 25.18 C1 GOL A3040 B 174 TYR A 109 TYR~? 19.57 O1 GOL A3040 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 94.33 67.29 39.79 97.00 65.79 39.32 coo -14.86 10.19 8.14 -14.82 12.31 8.42 88.23 80.63 30.72 87.92 80.82 28.67 coo -21.46 12.70 8.53 -19.04 12.30 7.24 84.38 79.76 38.04 83.16 77.26 38.08 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 145 ARG~? 9.64 O1 GOL B3024 B 161 ASP B 102 ASP.? 20.31 O1 GOL B3024 B 174 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 19.64 71.23 27.64 22.06 69.48 28.42 coo -14.86 10.19 8.14 -14.82 12.31 8.42 30.49 75.29 14.98 31.30 77.16 14.42 coo -21.46 12.70 8.53 -19.04 12.30 7.24 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG C 145 ARG~? 15.99 O1 GOL C3036 B 161 ASP C 102 ASP.? 24.57 CL CL C2011 B 174 TYR C 109 TYR~? 17.83 O1 GOL C3036 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 85.99 31.07 76.22 83.80 32.01 74.28 coo -14.86 10.19 8.14 -14.82 12.31 8.42 76.25 20.52 82.74 75.40 20.56 84.65 coo -21.46 12.70 8.53 -19.04 12.30 7.24 74.32 21.96 74.78 73.58 24.65 74.54 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG D 145 ARG~? 21.40 O1 GOL G3001 B 161 ASP D 102 ASP.? 24.32 CL CL D2012 B 174 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 12.08 41.78 71.45 11.86 39.69 73.74 coo -14.86 10.19 8.14 -14.82 12.31 8.42 18.96 37.41 85.00 19.42 35.40 85.42 coo -21.46 12.70 8.53 -19.04 12.30 7.24 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG E 145 ARG~? 19.70 O1 GOL E3002 B 161 ASP E 102 ASP.? 24.45 CL CL E2013 B 174 TYR E 109 TYR~? 18.10 O1 GOL E3035 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 16.30 80.38 65.14 17.26 82.53 67.17 coo -14.86 10.19 8.14 -14.82 12.31 8.42 26.42 91.49 69.61 27.08 91.68 71.63 coo -21.46 12.70 8.53 -19.04 12.30 7.24 29.73 88.43 62.54 30.41 85.74 63.01 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG F 145 ARG~? 19.97 O3 GOL C3036 B 161 ASP F 102 ASP.? 16.73 CL CL F2035 B 174 TYR F 109 TYR~? 6.98 CL CL F2035 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 91.49 29.42 38.83 93.62 28.28 40.76 coo -14.86 10.19 8.14 -14.82 12.31 8.42 82.74 24.28 26.35 81.91 22.30 26.35 coo -21.46 12.70 8.53 -19.04 12.30 7.24 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG G 145 ARG~? 20.03 C3 GOL G3001 B 161 ASP G 102 ASP.? 25.30 O3 GOL G3038 B 174 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 15.17 34.68 33.42 15.78 32.53 31.28 coo -14.86 10.19 8.14 -14.82 12.31 8.42 23.47 21.05 30.82 24.30 20.62 28.93 coo -21.46 12.70 8.53 -19.04 12.30 7.24 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG H 145 ARG~? 14.63 O1 GOL H3016 B 161 ASP H 102 ASP.? 20.45 O2 GOL H3016 B 174 TYR H 109 TYR~? 11.76 O2 GOL H3016 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 91.20 69.90 76.54 91.87 72.67 77.80 coo -14.86 10.19 8.14 -14.82 12.31 8.42 81.36 76.99 86.94 80.90 79.01 86.89 coo -21.46 12.70 8.53 -19.04 12.30 7.24 77.84 69.46 85.37 77.15 69.38 82.64 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG I 145 ARG~? 15.37 O1 GOL I3032 B 161 ASP I 102 ASP.? 20.44 O1 GOL I3032 B 174 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 209.45 186.59 151.83 209.12 188.26 149.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 201.10 198.54 145.88 200.66 198.62 143.82 coo -21.46 12.70 8.53 -19.04 12.30 7.24 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG J 145 ARG~? 22.99 CL CL J2016 B 161 ASP J 102 ASP.? 24.08 CL CL J2016 B 174 TYR J 109 TYR~? 19.91 O1 GOL J3030 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 132.84 187.86 144.62 133.71 189.96 142.45 coo -14.86 10.19 8.14 -14.82 12.31 8.42 143.25 191.36 132.98 143.80 193.32 132.63 coo -21.46 12.70 8.53 -19.04 12.30 7.24 145.48 183.77 135.57 146.27 183.96 138.21 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 11 3 # 11 B 14 ARG K 145 ARG~? 19.97 C2 GOL K3009 B 161 ASP K 102 ASP.? 24.81 O1 GOL K3041 B 174 TYR K 109 TYR~? 18.63 O3 GOL K3010 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 204.60 147.17 190.28 202.10 146.29 191.85 coo -14.86 10.19 8.14 -14.82 12.31 8.42 194.36 135.90 195.25 193.66 135.95 197.23 coo -21.46 12.70 8.53 -19.04 12.30 7.24 192.13 137.45 187.51 191.27 140.11 187.32 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 12 3 # 12 B 14 ARG L 145 ARG~? 21.94 C3 GOL O3013 B 161 ASP L 102 ASP.? 24.59 CL CL L2009 B 174 TYR L 109 TYR~? 18.94 O3 GOL L3028 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 129.45 155.66 188.12 131.98 157.11 187.19 coo -14.86 10.19 8.14 -14.82 12.31 8.42 136.52 149.82 201.33 136.95 147.73 201.53 coo -21.46 12.70 8.53 -19.04 12.30 7.24 139.89 156.88 199.30 141.02 156.55 196.75 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 13 3 # 13 B 14 ARG M 145 ARG~? 23.51 CL CL M2017 B 161 ASP M 102 ASP.? 24.52 CL CL M2017 B 174 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 131.12 192.72 183.38 131.87 195.02 185.33 coo -14.86 10.19 8.14 -14.82 12.31 8.42 140.74 204.70 188.01 141.33 204.99 189.98 coo -21.46 12.70 8.53 -19.04 12.30 7.24 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 14 3 # 14 B 14 ARG N 145 ARG~? 14.05 C1 GOL N3029 B 161 ASP N 102 ASP.? 20.60 O2 GOL N3029 B 174 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 206.36 147.54 151.55 205.74 145.29 149.50 coo -14.86 10.19 8.14 -14.82 12.31 8.42 197.96 142.41 139.19 197.06 140.46 139.09 coo -21.46 12.70 8.53 -19.04 12.30 7.24 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 15 3 # 15 B 14 ARG O 145 ARG~? 14.75 O3 GOL O3026 B 161 ASP O 102 ASP.? 13.16 CL CL O2036 B 174 TYR O 109 TYR~? 12.46 CL CL O2036 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 130.60 149.22 149.86 131.12 146.92 147.82 coo -14.86 10.19 8.14 -14.82 12.31 8.42 139.48 136.33 146.19 140.25 135.96 144.25 coo -21.46 12.70 8.53 -19.04 12.30 7.24 141.96 138.45 153.78 143.09 141.01 153.60 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 16 3 # 16 B 14 ARG P 145 ARG~? 19.93 O1 GOL P3014 B 161 ASP P 102 ASP.? 24.26 CL CL P2019 B 174 TYR P 109 TYR~? 18.49 O3 GOL P3014 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 206.30 185.90 191.05 208.78 186.92 189.45 coo -14.86 10.19 8.14 -14.82 12.31 8.42 197.01 191.93 202.05 196.73 194.01 202.05 coo -21.46 12.70 8.53 -19.04 12.30 7.24 193.88 184.51 200.52 193.11 184.53 197.85 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 16 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG B 145 ARG~? 9.64 O1 GOL B3024 C 161 ASP B 102 ASP.? 20.31 O1 GOL B3024 C 174 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo 2.84 19.43 40.34 1.59 20.35 37.65 19.64 71.23 27.64 22.06 69.48 28.42 coo -0.62 11.10 28.05 -0.65 13.15 27.46 30.49 75.29 14.98 31.30 77.16 14.42 coo 5.94 13.28 27.17 3.53 13.05 28.58 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG C 145 ARG~? 15.99 O1 GOL C3036 C 161 ASP C 102 ASP.? 24.57 CL CL C2011 C 174 TYR C 109 TYR~? 17.83 O1 GOL C3036 coo 2.84 19.43 40.34 1.59 20.35 37.65 85.99 31.07 76.22 83.80 32.01 74.28 coo -0.62 11.10 28.05 -0.65 13.15 27.46 76.25 20.52 82.74 75.40 20.56 84.65 coo 5.94 13.28 27.17 3.53 13.05 28.58 74.32 21.96 74.78 73.58 24.65 74.54 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG D 145 ARG~? 21.40 O1 GOL G3001 C 161 ASP D 102 ASP.? 24.32 CL CL D2012 C 174 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo 2.84 19.43 40.34 1.59 20.35 37.65 12.08 41.78 71.45 11.86 39.69 73.74 coo -0.62 11.10 28.05 -0.65 13.15 27.46 18.96 37.41 85.00 19.42 35.40 85.42 coo 5.94 13.28 27.17 3.53 13.05 28.58 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG E 145 ARG~? 19.70 O1 GOL E3002 C 161 ASP E 102 ASP.? 24.45 CL CL E2013 C 174 TYR E 109 TYR~? 18.10 O1 GOL E3035 coo 2.84 19.43 40.34 1.59 20.35 37.65 16.30 80.38 65.14 17.26 82.53 67.17 coo -0.62 11.10 28.05 -0.65 13.15 27.46 26.42 91.49 69.61 27.08 91.68 71.63 coo 5.94 13.28 27.17 3.53 13.05 28.58 29.73 88.43 62.54 30.41 85.74 63.01 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG F 145 ARG~? 19.97 O3 GOL C3036 C 161 ASP F 102 ASP.? 16.73 CL CL F2035 C 174 TYR F 109 TYR~? 6.98 CL CL F2035 coo 2.84 19.43 40.34 1.59 20.35 37.65 91.49 29.42 38.83 93.62 28.28 40.76 coo -0.62 11.10 28.05 -0.65 13.15 27.46 82.74 24.28 26.35 81.91 22.30 26.35 coo 5.94 13.28 27.17 3.53 13.05 28.58 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG G 145 ARG~? 20.03 C3 GOL G3001 C 161 ASP G 102 ASP.? 25.30 O3 GOL G3038 C 174 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo 2.84 19.43 40.34 1.59 20.35 37.65 15.17 34.68 33.42 15.78 32.53 31.28 coo -0.62 11.10 28.05 -0.65 13.15 27.46 23.47 21.05 30.82 24.30 20.62 28.93 coo 5.94 13.28 27.17 3.53 13.05 28.58 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG H 145 ARG~? 14.63 O1 GOL H3016 C 161 ASP H 102 ASP.? 20.45 O2 GOL H3016 C 174 TYR H 109 TYR~? 11.76 O2 GOL H3016 coo 2.84 19.43 40.34 1.59 20.35 37.65 91.20 69.90 76.54 91.87 72.67 77.80 coo -0.62 11.10 28.05 -0.65 13.15 27.46 81.36 76.99 86.94 80.90 79.01 86.89 coo 5.94 13.28 27.17 3.53 13.05 28.58 77.84 69.46 85.37 77.15 69.38 82.64 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG I 145 ARG~? 15.37 O1 GOL I3032 C 161 ASP I 102 ASP.? 20.44 O1 GOL I3032 C 174 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo 2.84 19.43 40.34 1.59 20.35 37.65 209.45 186.59 151.83 209.12 188.26 149.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 201.10 198.54 145.88 200.66 198.62 143.82 coo 5.94 13.28 27.17 3.53 13.05 28.58 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG J 145 ARG~? 22.99 CL CL J2016 C 161 ASP J 102 ASP.? 24.08 CL CL J2016 C 174 TYR J 109 TYR~? 19.91 O1 GOL J3030 coo 2.84 19.43 40.34 1.59 20.35 37.65 132.84 187.86 144.62 133.71 189.96 142.45 coo -0.62 11.10 28.05 -0.65 13.15 27.46 143.25 191.36 132.98 143.80 193.32 132.63 coo 5.94 13.28 27.17 3.53 13.05 28.58 145.48 183.77 135.57 146.27 183.96 138.21 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG K 145 ARG~? 19.97 C2 GOL K3009 C 161 ASP K 102 ASP.? 24.81 O1 GOL K3041 C 174 TYR K 109 TYR~? 18.63 O3 GOL K3010 coo 2.84 19.43 40.34 1.59 20.35 37.65 204.60 147.17 190.28 202.10 146.29 191.85 coo -0.62 11.10 28.05 -0.65 13.15 27.46 194.36 135.90 195.25 193.66 135.95 197.23 coo 5.94 13.28 27.17 3.53 13.05 28.58 192.13 137.45 187.51 191.27 140.11 187.32 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 11 3 # 11 C 14 ARG L 145 ARG~? 21.94 C3 GOL O3013 C 161 ASP L 102 ASP.? 24.59 CL CL L2009 C 174 TYR L 109 TYR~? 18.94 O3 GOL L3028 coo 2.84 19.43 40.34 1.59 20.35 37.65 129.45 155.66 188.12 131.98 157.11 187.19 coo -0.62 11.10 28.05 -0.65 13.15 27.46 136.52 149.82 201.33 136.95 147.73 201.53 coo 5.94 13.28 27.17 3.53 13.05 28.58 139.89 156.88 199.30 141.02 156.55 196.75 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 12 3 # 12 C 14 ARG M 145 ARG~? 23.51 CL CL M2017 C 161 ASP M 102 ASP.? 24.52 CL CL M2017 C 174 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo 2.84 19.43 40.34 1.59 20.35 37.65 131.12 192.72 183.38 131.87 195.02 185.33 coo -0.62 11.10 28.05 -0.65 13.15 27.46 140.74 204.70 188.01 141.33 204.99 189.98 coo 5.94 13.28 27.17 3.53 13.05 28.58 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 13 3 # 13 C 14 ARG N 145 ARG~? 14.05 C1 GOL N3029 C 161 ASP N 102 ASP.? 20.60 O2 GOL N3029 C 174 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo 2.84 19.43 40.34 1.59 20.35 37.65 206.36 147.54 151.55 205.74 145.29 149.50 coo -0.62 11.10 28.05 -0.65 13.15 27.46 197.96 142.41 139.19 197.06 140.46 139.09 coo 5.94 13.28 27.17 3.53 13.05 28.58 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 14 3 # 14 C 14 ARG O 145 ARG~? 14.75 O3 GOL O3026 C 161 ASP O 102 ASP.? 13.16 CL CL O2036 C 174 TYR O 109 TYR~? 12.46 CL CL O2036 coo 2.84 19.43 40.34 1.59 20.35 37.65 130.60 149.22 149.86 131.12 146.92 147.82 coo -0.62 11.10 28.05 -0.65 13.15 27.46 139.48 136.33 146.19 140.25 135.96 144.25 coo 5.94 13.28 27.17 3.53 13.05 28.58 141.96 138.45 153.78 143.09 141.01 153.60 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 15 3 # 15 C 14 ARG P 145 ARG~? 19.93 O1 GOL P3014 C 161 ASP P 102 ASP.? 24.26 CL CL P2019 C 174 TYR P 109 TYR~? 18.49 O3 GOL P3014 coo 2.84 19.43 40.34 1.59 20.35 37.65 206.30 185.90 191.05 208.78 186.92 189.45 coo -0.62 11.10 28.05 -0.65 13.15 27.46 197.01 191.93 202.05 196.73 194.01 202.05 coo 5.94 13.28 27.17 3.53 13.05 28.58 193.88 184.51 200.52 193.11 184.53 197.85 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 15 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG B 145 ARG~? 9.64 O1 GOL B3024 D 161 ASP B 102 ASP.? 20.31 O1 GOL B3024 D 174 TYR B 109 TYR~? 11.52 O1 GOL B3024 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 19.64 71.23 27.64 22.06 69.48 28.42 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 30.49 75.29 14.98 31.30 77.16 14.42 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 32.33 67.79 18.21 32.96 68.04 20.89 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG C 145 ARG~? 15.99 O1 GOL C3036 D 161 ASP C 102 ASP.? 24.57 CL CL C2011 D 174 TYR C 109 TYR~? 17.83 O1 GOL C3036 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 85.99 31.07 76.22 83.80 32.01 74.28 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 76.25 20.52 82.74 75.40 20.56 84.65 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 74.32 21.96 74.78 73.58 24.65 74.54 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG D 145 ARG~? 21.40 O1 GOL G3001 D 161 ASP D 102 ASP.? 24.32 CL CL D2012 D 174 TYR D 109 TYR~? 18.34 O3 GOL D3019 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 12.08 41.78 71.45 11.86 39.69 73.74 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 18.96 37.41 85.00 19.42 35.40 85.42 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 22.95 44.43 82.69 24.09 43.90 80.20 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG E 145 ARG~? 19.70 O1 GOL E3002 D 161 ASP E 102 ASP.? 24.45 CL CL E2013 D 174 TYR E 109 TYR~? 18.10 O1 GOL E3035 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 16.30 80.38 65.14 17.26 82.53 67.17 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 26.42 91.49 69.61 27.08 91.68 71.63 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 29.73 88.43 62.54 30.41 85.74 63.01 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG F 145 ARG~? 19.97 O3 GOL C3036 D 161 ASP F 102 ASP.? 16.73 CL CL F2035 D 174 TYR F 109 TYR~? 6.98 CL CL F2035 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 91.49 29.42 38.83 93.62 28.28 40.76 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 82.74 24.28 26.35 81.91 22.30 26.35 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 80.57 32.26 27.20 79.31 32.54 29.65 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG G 145 ARG~? 20.03 C3 GOL G3001 D 161 ASP G 102 ASP.? 25.30 O3 GOL G3038 D 174 TYR G 109 TYR~? 19.47 O2 GOL G3001 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 15.17 34.68 33.42 15.78 32.53 31.28 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 23.47 21.05 30.82 24.30 20.62 28.93 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 25.80 23.55 38.48 27.03 26.02 38.21 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG H 145 ARG~? 14.63 O1 GOL H3016 D 161 ASP H 102 ASP.? 20.45 O2 GOL H3016 D 174 TYR H 109 TYR~? 11.76 O2 GOL H3016 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 91.20 69.90 76.54 91.87 72.67 77.80 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 81.36 76.99 86.94 80.90 79.01 86.89 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 77.84 69.46 85.37 77.15 69.38 82.64 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG I 145 ARG~? 15.37 O1 GOL I3032 D 161 ASP I 102 ASP.? 20.44 O1 GOL I3032 D 174 TYR I 109 TYR~? 11.79 O1 GOL I3032 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 209.45 186.59 151.83 209.12 188.26 149.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 201.10 198.54 145.88 200.66 198.62 143.82 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 197.73 197.22 153.29 196.64 194.65 153.36 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG J 145 ARG~? 22.99 CL CL J2016 D 161 ASP J 102 ASP.? 24.08 CL CL J2016 D 174 TYR J 109 TYR~? 19.91 O1 GOL J3030 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 132.84 187.86 144.62 133.71 189.96 142.45 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 143.25 191.36 132.98 143.80 193.32 132.63 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 145.48 183.77 135.57 146.27 183.96 138.21 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG K 145 ARG~? 19.97 C2 GOL K3009 D 161 ASP K 102 ASP.? 24.81 O1 GOL K3041 D 174 TYR K 109 TYR~? 18.63 O3 GOL K3010 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 204.60 147.17 190.28 202.10 146.29 191.85 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 194.36 135.90 195.25 193.66 135.95 197.23 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 192.13 137.45 187.51 191.27 140.11 187.32 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 11 3 # 11 D 14 ARG L 145 ARG~? 21.94 C3 GOL O3013 D 161 ASP L 102 ASP.? 24.59 CL CL L2009 D 174 TYR L 109 TYR~? 18.94 O3 GOL L3028 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 129.45 155.66 188.12 131.98 157.11 187.19 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 136.52 149.82 201.33 136.95 147.73 201.53 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 139.89 156.88 199.30 141.02 156.55 196.75 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 12 3 # 12 D 14 ARG M 145 ARG~? 23.51 CL CL M2017 D 161 ASP M 102 ASP.? 24.52 CL CL M2017 D 174 TYR M 109 TYR~? 20.13 O1 GOL M3043 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 131.12 192.72 183.38 131.87 195.02 185.33 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 140.74 204.70 188.01 141.33 204.99 189.98 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 143.85 202.19 180.75 144.68 199.53 181.04 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 13 3 # 13 D 14 ARG N 145 ARG~? 14.05 C1 GOL N3029 D 161 ASP N 102 ASP.? 20.60 O2 GOL N3029 D 174 TYR N 109 TYR~? 12.25 C2 GOL N3029 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 206.36 147.54 151.55 205.74 145.29 149.50 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 197.96 142.41 139.19 197.06 140.46 139.09 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 195.52 150.33 140.44 194.35 150.45 143.01 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 14 3 # 14 D 14 ARG O 145 ARG~? 14.75 O3 GOL O3026 D 161 ASP O 102 ASP.? 13.16 CL CL O2036 D 174 TYR O 109 TYR~? 12.46 CL CL O2036 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 130.60 149.22 149.86 131.12 146.92 147.82 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 139.48 136.33 146.19 140.25 135.96 144.25 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 141.96 138.45 153.78 143.09 141.01 153.60 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 15 3 # 15 D 14 ARG P 145 ARG~? 19.93 O1 GOL P3014 D 161 ASP P 102 ASP.? 24.26 CL CL P2019 D 174 TYR P 109 TYR~? 18.49 O3 GOL P3014 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 206.30 185.90 191.05 208.78 186.92 189.45 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 197.01 191.93 202.05 196.73 194.01 202.05 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 193.88 184.51 200.52 193.11 184.53 197.85 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 15 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU I 62 GLU~? 9.77 O2 GOL I3032 A 156 GLU I 59 GLU.? 16.14 O2 GOL I3032 A 194 ASN M 11 ASN~? 13.05 CL CL I2007 coo 74.14 15.91 8.55 72.08 15.36 8.63 193.02 195.43 166.68 192.61 194.52 168.53 coo 67.47 20.07 1.34 65.99 20.06 2.88 186.59 195.61 159.01 186.55 193.49 159.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 180.57 199.77 172.35 181.29 199.01 174.20 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU N 62 GLU~? 6.38 C1 GOL N3044 A 156 GLU N 59 GLU.? 17.47 C1 GOL N3044 A 194 ASN J 11 ASN~? 12.94 O2 GOL N3044 coo 74.14 15.91 8.55 72.08 15.36 8.63 192.80 164.06 142.20 192.44 166.06 142.86 coo 67.47 20.07 1.34 65.99 20.06 2.88 185.19 157.06 142.09 184.04 157.69 143.79 coo 67.44 25.26 13.91 67.54 23.65 15.28 180.98 171.30 137.88 181.93 173.10 138.53 2dbt_c00 source 2dbt CHITINASE C : 2 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU D 62 GLU~? 6.84 O2 GOL D3019 C 156 GLU D 59 GLU.? 17.18 O2 GOL D3019 C 194 ASN H 11 ASN~? 13.03 CL CL D2008 coo 41.23 29.31 13.28 43.03 29.85 12.29 28.24 57.03 78.84 28.94 58.69 77.75 coo 44.75 23.09 5.51 46.77 22.91 6.12 34.38 48.89 80.62 34.75 48.54 78.54 coo 49.75 21.00 18.12 50.45 23.02 18.26 40.80 62.96 83.01 40.13 64.68 81.92 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU I 62 GLU~? 9.77 O2 GOL I3032 C 156 GLU I 59 GLU.? 16.14 O2 GOL I3032 C 194 ASN M 11 ASN~? 13.05 CL CL I2007 coo 41.23 29.31 13.28 43.03 29.85 12.29 193.02 195.43 166.68 192.61 194.52 168.53 coo 44.75 23.09 5.51 46.77 22.91 6.12 186.59 195.61 159.01 186.55 193.49 159.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 180.57 199.77 172.35 181.29 199.01 174.20 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU L 62 GLU~? 6.90 C3 GOL L3028 C 156 GLU L 59 GLU.? 17.63 O3 GOL L3028 C 194 ASN P 11 ASN~? 12.58 O1 GOL L3028 coo 41.23 29.31 13.28 43.03 29.85 12.29 144.62 169.85 195.72 145.14 171.64 194.63 coo 44.75 23.09 5.51 46.77 22.91 6.12 151.12 161.98 196.76 151.01 161.70 194.66 coo 49.75 21.00 18.12 50.45 23.02 18.26 157.20 176.23 199.28 156.46 178.04 198.37 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU N 62 GLU~? 6.38 C1 GOL N3044 C 156 GLU N 59 GLU.? 17.47 C1 GOL N3044 C 194 ASN J 11 ASN~? 12.94 O2 GOL N3044 coo 41.23 29.31 13.28 43.03 29.85 12.29 192.80 164.06 142.20 192.44 166.06 142.86 coo 44.75 23.09 5.51 46.77 22.91 6.12 185.19 157.06 142.09 184.04 157.69 143.79 coo 49.75 21.00 18.12 50.45 23.02 18.26 180.98 171.30 137.88 181.93 173.10 138.53 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 109 TYR~? 19.57 O1 GOL A3040 A 245 ASP A 102 ASP.? 25.18 C1 GOL A3040 A 273 LYS A 142 LYS~? 20.36 CL CL A2020 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 84.38 79.76 38.04 83.16 77.26 38.08 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 88.23 80.63 30.72 87.92 80.82 28.67 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR B 75 TYR~? 10.15 CL CL B2010 A 245 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 18.67 65.14 13.86 18.80 67.67 14.99 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 23.66 59.02 20.34 21.93 58.32 21.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 109 TYR~? 11.52 O1 GOL B3024 A 245 ASP B 102 ASP.? 20.31 O1 GOL B3024 A 273 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 32.33 67.79 18.21 32.96 68.04 20.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 30.49 75.29 14.98 31.30 77.16 14.42 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR C 75 TYR~? 10.50 CL CL C2011 A 245 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 87.86 16.77 72.91 87.86 18.43 75.14 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 82.81 22.02 65.69 84.52 22.80 64.66 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR C 109 TYR~? 17.83 O1 GOL C3036 A 245 ASP C 102 ASP.? 24.57 CL CL C2011 A 273 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 74.32 21.96 74.78 73.58 24.65 74.54 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 76.25 20.52 82.74 75.40 20.56 84.65 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR D 109 TYR~? 18.34 O3 GOL D3019 A 245 ASP D 102 ASP.? 24.32 CL CL D2012 A 273 LYS D 142 LYS~? 18.65 CL CL D2012 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 22.95 44.43 82.69 24.09 43.90 80.20 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 18.96 37.41 85.00 19.42 35.40 85.42 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR E 75 TYR~? 10.13 CL CL E2013 A 245 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 16.89 92.83 57.30 16.35 91.61 59.76 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 23.07 86.29 52.35 21.57 85.17 51.32 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR E 109 TYR~? 18.10 O1 GOL E3035 A 245 ASP E 102 ASP.? 24.45 CL CL E2013 A 273 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 29.73 88.43 62.54 30.41 85.74 63.01 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 26.42 91.49 69.61 27.08 91.68 71.63 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 150 TYR F 75 TYR~? 9.99 CL CL F2034 A 245 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 95.01 33.97 25.26 94.64 31.83 27.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 88.86 41.25 28.96 90.30 42.22 30.24 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 150 TYR F 109 TYR~? 6.98 CL CL F2035 A 245 ASP F 102 ASP.? 16.73 CL CL F2035 A 273 LYS F 142 LYS~? 19.20 CL CL F2034 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 80.57 32.26 27.20 79.31 32.54 29.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 82.74 24.28 26.35 81.91 22.30 26.35 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 150 TYR G 109 TYR~? 19.47 O2 GOL G3001 A 245 ASP G 102 ASP.? 25.30 O3 GOL G3038 A 273 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 25.80 23.55 38.48 27.03 26.02 38.21 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 23.47 21.05 30.82 24.30 20.62 28.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 150 TYR H 75 TYR~? 10.27 CL CL H2014 A 245 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 90.64 65.09 90.65 91.11 67.21 88.98 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 84.24 58.93 85.48 85.73 57.59 84.66 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 150 TYR H 109 TYR~? 11.76 O2 GOL H3016 A 245 ASP H 102 ASP.? 20.45 O2 GOL H3016 A 273 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 77.84 69.46 85.37 77.15 69.38 82.64 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 81.36 76.99 86.94 80.90 79.01 86.89 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 150 TYR I 109 TYR~? 11.79 O1 GOL I3032 A 245 ASP I 102 ASP.? 20.44 O1 GOL I3032 A 273 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 197.73 197.22 153.29 196.64 194.65 153.36 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 201.10 198.54 145.88 200.66 198.62 143.82 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 150 TYR J 109 TYR~? 19.91 O1 GOL J3030 A 245 ASP J 102 ASP.? 24.08 CL CL J2016 A 273 LYS J 142 LYS~? 19.62 CL CL J2016 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 145.48 183.77 135.57 146.27 183.96 138.21 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 143.25 191.36 132.98 143.80 193.32 132.63 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 150 TYR K 75 TYR~? 12.36 CL CL K2027 A 245 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 205.79 133.16 185.06 205.81 134.80 187.34 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 200.17 138.24 178.11 201.77 139.28 177.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 17 3 # 17 A 150 TYR K 109 TYR~? 18.63 O3 GOL K3010 A 245 ASP K 102 ASP.? 24.81 O1 GOL K3041 A 273 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 192.13 137.45 187.51 191.27 140.11 187.32 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 194.36 135.90 195.25 193.66 135.95 197.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 18 3 # 18 A 150 TYR L 75 TYR~? 10.07 CL CL L2009 A 245 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 126.23 161.73 201.55 126.10 159.32 200.24 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 133.34 166.97 196.27 132.03 168.03 194.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 19 3 # 19 A 150 TYR L 109 TYR~? 18.94 O3 GOL L3028 A 245 ASP L 102 ASP.? 24.59 CL CL L2009 A 273 LYS L 142 LYS~? 23.18 CL CL L2009 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 139.89 156.88 199.30 141.02 156.55 196.75 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 136.52 149.82 201.33 136.95 147.73 201.53 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 20 3 # 20 A 150 TYR M 75 TYR~? 10.36 CL CL M2017 A 245 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 130.62 206.12 176.17 130.27 204.76 178.58 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 136.87 200.18 170.79 135.36 199.08 169.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 21 3 # 21 A 150 TYR M 109 TYR~? 20.13 O1 GOL M3043 A 245 ASP M 102 ASP.? 24.52 CL CL M2017 A 273 LYS M 142 LYS~? 19.90 CL CL M2017 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 143.85 202.19 180.75 144.68 199.53 181.04 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 140.74 204.70 188.01 141.33 204.99 189.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 22 3 # 22 A 150 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 245 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 209.71 152.64 137.80 209.50 150.35 139.41 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 203.51 159.51 142.26 205.02 160.53 143.48 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 23 3 # 23 A 150 TYR N 109 TYR~? 12.25 C2 GOL N3029 A 245 ASP N 102 ASP.? 20.60 O2 GOL N3029 A 273 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 195.52 150.33 140.44 194.35 150.45 143.01 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 197.96 142.41 139.19 197.06 140.46 139.09 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 24 3 # 24 A 150 TYR O 75 TYR~? 10.24 CL CL O2018 A 245 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 127.87 136.17 156.70 127.95 137.50 154.23 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 134.07 141.35 162.95 132.57 142.58 163.78 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 25 3 # 25 A 150 TYR O 109 TYR~? 12.46 CL CL O2036 A 245 ASP O 102 ASP.? 13.16 CL CL O2036 A 273 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 141.96 138.45 153.78 143.09 141.01 153.60 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 139.48 136.33 146.19 140.25 135.96 144.25 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 26 3 # 26 A 150 TYR P 109 TYR~? 18.49 O3 GOL P3014 A 245 ASP P 102 ASP.? 24.26 CL CL P2019 A 273 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 193.88 184.51 200.52 193.11 184.53 197.85 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 197.01 191.93 202.05 196.73 194.01 202.05 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 204.59 186.28 195.60 209.96 186.96 196.62 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 26 hits 2gsa_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 81 SER~? 8.94 O1 GOL A3037 B 158 HIS A 158 HIS.? 6.53 O1 GOL A3037 B 208 ASN A 84 ASN~? 7.41 CL CL A2020 coo 50.29 50.10 71.46 47.85 50.06 71.46 106.79 81.80 49.88 105.31 80.20 50.94 coo 48.67 45.40 71.68 47.67 46.90 70.60 106.32 81.43 56.18 105.60 83.26 56.91 coo 48.91 49.12 65.17 47.29 49.14 66.54 110.27 84.71 52.14 109.25 86.35 53.07 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER B 81 SER~? 10.28 CL CL B2010 B 158 HIS B 158 HIS.? 12.55 CL CL B2010 B 208 ASN B 84 ASN~? 10.19 CL CL B2010 coo 50.29 50.10 71.46 47.85 50.06 71.46 8.58 59.85 12.91 9.44 59.08 15.03 coo 48.67 45.40 71.68 47.67 46.90 70.60 7.56 53.89 15.18 8.49 52.54 13.87 coo 48.91 49.12 65.17 47.29 49.14 66.54 5.47 57.99 9.65 6.63 56.79 8.31 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER C 81 SER~? 9.13 CL CL C2021 B 158 HIS C 158 HIS.? 10.62 CL CL C2021 B 208 ASN C 84 ASN~? 7.25 CL CL C2021 coo 50.29 50.10 71.46 47.85 50.06 71.46 97.80 14.60 67.87 97.00 16.56 66.71 coo 48.67 45.40 71.68 47.67 46.90 70.60 98.99 15.14 61.83 98.04 13.53 60.88 coo 48.91 49.12 65.17 47.29 49.14 66.54 100.78 11.44 66.55 99.89 10.02 65.23 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER D 81 SER~? 8.64 O1 GOL D3020 B 158 HIS D 158 HIS.? 6.33 O1 GOL D3020 B 208 ASN D 84 ASN~? 7.04 CL CL D2022 coo 50.29 50.10 71.46 47.85 50.06 71.46 0.59 56.62 82.32 2.14 57.19 80.58 coo 48.67 45.40 71.68 47.67 46.90 70.60 0.86 62.48 80.06 1.83 63.91 81.27 coo 48.91 49.12 65.17 47.29 49.14 66.54 -3.16 59.10 84.71 -2.15 60.07 86.28 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 5 3 # 5 B 137 SER E 81 SER~? 9.10 CL CL E2032 B 158 HIS E 158 HIS.? 10.67 CL CL E2032 B 208 ASN E 84 ASN~? 6.86 CL CL E2032 coo 50.29 50.10 71.46 47.85 50.06 71.46 8.14 93.66 50.22 9.19 91.54 49.74 coo 48.67 45.40 71.68 47.67 46.90 70.60 8.21 91.93 44.16 9.29 93.32 43.02 coo 48.91 49.12 65.17 47.29 49.14 66.54 5.48 96.99 47.72 6.68 98.41 46.68 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 6 3 # 6 B 137 SER F 81 SER~? 9.12 CL CL F2023 B 158 HIS F 158 HIS.? -10.90 CL CL F2023s B 208 ASN F 84 ASN.? 7.11 CL CL F2023 coo 50.29 50.10 71.46 47.85 50.06 71.46 105.10 38.99 25.26 103.91 40.31 26.96 coo 48.67 45.40 71.68 47.67 46.90 70.60 105.92 45.34 26.29 105.13 46.33 24.62 coo 48.91 49.12 65.17 47.29 49.14 66.54 109.54 40.13 22.81 108.36 41.04 21.28 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 7 3 # 7 B 137 SER G 81 SER~? 9.39 CL CL G2033 B 158 HIS G 158 HIS.? 10.64 CL CL G2033 B 208 ASN G 84 ASN~? 7.24 CL CL G2033 coo 50.29 50.10 71.46 47.85 50.06 71.46 1.35 23.42 45.68 2.61 25.29 46.56 coo 48.67 45.40 71.68 47.67 46.90 70.60 0.65 25.49 51.61 1.26 23.82 52.74 coo 48.91 49.12 65.17 47.29 49.14 66.54 -2.25 21.18 47.67 -1.73 19.89 49.31 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 8 3 # 8 B 137 SER H 81 SER~? 9.05 CL CL H2024 B 158 HIS H 158 HIS.? 10.33 CL CL H2024 B 208 ASN H 84 ASN~? 6.41 CL CL H2024 coo 50.29 50.10 71.46 47.85 50.06 71.46 99.24 58.01 93.04 98.20 57.10 91.00 coo 48.67 45.40 71.68 47.67 46.90 70.60 98.94 51.80 92.35 97.68 51.03 93.84 coo 48.91 49.12 65.17 47.29 49.14 66.54 102.16 56.25 96.45 100.56 55.72 97.69 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 9 3 # 9 B 137 SER I 81 SER~? 9.15 CL CL I2025 B 158 HIS I 158 HIS.? 11.08 CL CL I2025 B 208 ASN I 84 ASN~? 7.02 CL CL I2025 coo 50.29 50.10 71.46 47.85 50.06 71.46 220.47 200.38 164.21 219.13 198.61 165.10 coo 48.67 45.40 71.68 47.67 46.90 70.60 220.34 199.03 170.60 219.44 200.67 171.57 coo 48.91 49.12 65.17 47.29 49.14 66.54 223.75 203.10 166.30 222.73 204.63 167.34 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 10 3 # 10 B 137 SER J 81 SER~? 9.04 CL CL J2026 B 158 HIS J 158 HIS.? 7.50 O2 GOL J3033 B 208 ASN J 84 ASN~? 7.23 CL CL J2026 coo 50.29 50.10 71.46 47.85 50.06 71.46 121.87 175.35 131.02 122.76 174.32 132.99 coo 48.67 45.40 71.68 47.67 46.90 70.60 121.18 169.23 132.79 122.06 167.98 131.35 coo 48.91 49.12 65.17 47.29 49.14 66.54 118.44 173.52 128.48 119.65 172.15 127.42 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 11 3 # 11 B 137 SER K 81 SER~? 9.04 CL CL K2027 B 158 HIS K 158 HIS.? 10.92 CL CL K2027 B 208 ASN K 84 ASN~? 7.12 CL CL K2027 coo 50.29 50.10 71.46 47.85 50.06 71.46 215.63 131.69 179.58 214.60 133.54 178.42 coo 48.67 45.40 71.68 47.67 46.90 70.60 216.60 132.79 173.33 215.77 131.08 172.42 coo 48.91 49.12 65.17 47.29 49.14 66.54 218.95 128.67 178.13 217.92 127.23 176.93 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 12 3 # 12 B 137 SER L 81 SER~? 8.97 CL CL L2028 B 158 HIS L 158 HIS.? 11.11 CL CL L2028 B 208 ASN L 84 ASN~? 6.99 CL CL L2028 coo 50.29 50.10 71.46 47.85 50.06 71.46 117.25 168.62 201.10 118.49 169.09 199.06 coo 48.67 45.40 71.68 47.67 46.90 70.60 117.45 174.63 198.96 118.55 176.04 200.05 coo 48.91 49.12 65.17 47.29 49.14 66.54 114.19 171.29 203.61 115.33 172.43 205.02 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 13 3 # 13 B 137 SER M 81 SER~? 9.17 C1 GOL M3042 B 158 HIS M 158 HIS.? 6.42 O1 GOL M3042 B 208 ASN M 84 ASN~? 7.69 CL CL M2029 coo 50.29 50.10 71.46 47.85 50.06 71.46 121.49 206.79 169.24 122.66 204.72 168.74 coo 48.67 45.40 71.68 47.67 46.90 70.60 121.40 205.18 163.43 122.55 206.46 162.23 coo 48.91 49.12 65.17 47.29 49.14 66.54 118.35 209.44 167.10 119.51 210.52 165.71 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 14 3 # 14 B 137 SER N 81 SER~? 9.02 CL CL N2030 B 158 HIS N 158 HIS.? 10.50 CL CL N2030 B 208 ASN N 84 ASN~? 6.35 CL CL N2030 coo 50.29 50.10 71.46 47.85 50.06 71.46 219.66 158.05 137.54 218.33 159.17 139.26 coo 48.67 45.40 71.68 47.67 46.90 70.60 220.32 164.11 138.58 219.66 165.01 136.80 coo 48.91 49.12 65.17 47.29 49.14 66.54 223.39 159.28 134.52 222.37 160.07 132.83 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 15 3 # 15 B 137 SER O 81 SER~? 10.10 CL CL O2018 B 158 HIS O 158 HIS.? 12.21 CL CL O2018 B 208 ASN O 84 ASN.? 10.27 CL CL O2018 coo 50.29 50.10 71.46 47.85 50.06 71.46 117.95 136.60 162.36 119.18 138.53 163.10 coo 48.67 45.40 71.68 47.67 46.90 70.60 117.44 138.41 168.51 118.31 136.96 169.75 coo 48.91 49.12 65.17 47.29 49.14 66.54 113.86 134.05 164.18 115.11 132.69 165.22 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 16 3 # 16 B 137 SER P 81 SER~? 10.48 CL CL P2019 B 158 HIS P 158 HIS.? 12.33 O2 GOL P3014 B 208 ASN P 84 ASN~? 10.96 CL CL P2019 coo 50.29 50.10 71.46 47.85 50.06 71.46 216.34 173.84 206.20 215.26 172.77 204.29 coo 48.67 45.40 71.68 47.67 46.90 70.60 216.29 167.50 205.15 215.20 166.66 206.73 coo 48.91 49.12 65.17 47.29 49.14 66.54 219.43 171.97 209.05 218.45 170.73 210.43 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 16 hits 2hdh_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 341 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 356 HIS A 79 HIS~? -3.92 CL CL A2020s coo 121.00 36.37 19.26 121.57 38.37 19.56 98.60 85.60 50.46 99.38 86.61 52.13 coo 125.72 32.70 19.75 124.44 34.16 18.84 94.58 81.89 51.70 95.31 83.75 52.44 coo 124.34 41.73 25.55 123.79 42.60 23.72 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 76 HIS~? -4.53 C1 GOL A3037s A 341 GLU A 73 GLU~? -3.07 O3 GOL A3037s A 356 HIS A 158 HIS.? 6.53 O1 GOL A3037 coo 121.00 36.37 19.26 121.57 38.37 19.56 98.60 85.60 50.46 99.38 86.61 52.13 coo 125.72 32.70 19.75 124.44 34.16 18.84 94.58 81.89 51.70 95.31 83.75 52.44 coo 124.34 41.73 25.55 123.79 42.60 23.72 106.32 81.43 56.18 105.60 83.26 56.91 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS B 76 HIS~? 4.58 CL CL B2010s A 341 GLU B 73 GLU~? 6.38 O3 GOL B3023 A 356 HIS B 79 HIS~? 5.08 CL CL B2010 coo 121.00 36.37 19.26 121.57 38.37 19.56 17.08 57.14 11.39 16.06 55.49 10.59 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.80 56.19 16.30 19.32 55.14 14.52 coo 124.34 41.73 25.55 123.79 42.60 23.72 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS B 76 HIS~? 4.58 CL CL B2010s A 341 GLU B 73 GLU~? 6.38 O3 GOL B3023 A 356 HIS B 158 HIS.? 12.55 CL CL B2010 coo 121.00 36.37 19.26 121.57 38.37 19.56 17.08 57.14 11.39 16.06 55.49 10.59 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.80 56.19 16.30 19.32 55.14 14.52 coo 124.34 41.73 25.55 123.79 42.60 23.72 7.56 53.89 15.18 8.49 52.54 13.87 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS C 76 HIS~? -4.98 CL CL C2011s A 341 GLU C 73 GLU~? 6.99 O1 GOL C3036 A 356 HIS C 79 HIS~? -4.32 CL CL C2021s coo 121.00 36.37 19.26 121.57 38.37 19.56 89.28 12.80 65.47 90.23 11.67 63.98 coo 125.72 32.70 19.75 124.44 34.16 18.84 86.57 17.41 63.72 86.98 15.43 63.06 coo 124.34 41.73 25.55 123.79 42.60 23.72 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 A 311 HIS C 76 HIS~? -4.98 CL CL C2011s A 341 GLU C 73 GLU~? 6.99 O1 GOL C3036 A 356 HIS C 158 HIS.? 10.62 CL CL C2021 coo 121.00 36.37 19.26 121.57 38.37 19.56 89.28 12.80 65.47 90.23 11.67 63.98 coo 125.72 32.70 19.75 124.44 34.16 18.84 86.57 17.41 63.72 86.98 15.43 63.06 coo 124.34 41.73 25.55 123.79 42.60 23.72 98.99 15.14 61.83 98.04 13.53 60.88 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 A 311 HIS D 76 HIS~? 4.24 O2 GOL D3018s A 341 GLU D 73 GLU~? 5.51 C2 GOL D3020 A 356 HIS D 79 HIS~? -4.57 CL CL D2022s coo 121.00 36.37 19.26 121.57 38.37 19.56 8.84 57.69 86.26 7.93 59.46 86.93 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.99 58.17 82.26 12.31 59.24 83.94 coo 124.34 41.73 25.55 123.79 42.60 23.72 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 A 311 HIS E 76 HIS~? -4.87 CL CL E2013s A 341 GLU E 73 GLU~? -6.85 O1 GOL E3022s A 356 HIS E 79 HIS~? -4.18 CL CL E2032s coo 121.00 36.37 19.26 121.57 38.37 19.56 16.97 95.07 49.08 16.37 95.97 47.28 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.82 90.31 48.74 19.50 92.07 47.58 coo 124.34 41.73 25.55 123.79 42.60 23.72 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 9 3 # 9 A 311 HIS E 76 HIS~? -4.87 CL CL E2013s A 341 GLU E 73 GLU~? -6.85 O1 GOL E3022s A 356 HIS E 158 HIS.? 10.67 CL CL E2032 coo 121.00 36.37 19.26 121.57 38.37 19.56 16.97 95.07 49.08 16.37 95.97 47.28 coo 125.72 32.70 19.75 124.44 34.16 18.84 19.82 90.31 48.74 19.50 92.07 47.58 coo 124.34 41.73 25.55 123.79 42.60 23.72 8.21 91.93 44.16 9.29 93.32 43.02 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 10 3 # 10 A 311 HIS F 76 HIS~? -4.65 CL CL F2034s A 341 GLU F 73 GLU~? 5.19 O3 GOL F3039 A 356 HIS F 79 HIS~? -4.63 CL CL F2023s coo 121.00 36.37 19.26 121.57 38.37 19.56 97.24 41.20 21.57 98.43 42.65 20.63 coo 125.72 32.70 19.75 124.44 34.16 18.84 93.55 43.24 25.35 94.46 43.89 23.55 coo 124.34 41.73 25.55 123.79 42.60 23.72 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 11 3 # 11 A 311 HIS F 76 HIS~? -4.65 CL CL F2034s A 341 GLU F 73 GLU~? 5.19 O3 GOL F3039 A 356 HIS F 158 HIS.? -10.90 CL CL F2023s coo 121.00 36.37 19.26 121.57 38.37 19.56 97.24 41.20 21.57 98.43 42.65 20.63 coo 125.72 32.70 19.75 124.44 34.16 18.84 93.55 43.24 25.35 94.46 43.89 23.55 coo 124.34 41.73 25.55 123.79 42.60 23.72 105.92 45.34 26.29 105.13 46.33 24.62 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 12 3 # 12 A 311 HIS F 79 HIS~? -4.63 CL CL F2023s A 341 GLU F 93 GLU~? 8.36 CL CL F2023 A 356 HIS F 76 HIS~? -4.65 CL CL F2034s coo 121.00 36.37 19.26 121.57 38.37 19.56 101.04 34.65 20.79 101.93 33.69 19.16 coo 125.72 32.70 19.75 124.44 34.16 18.84 102.94 29.85 20.29 103.30 29.96 18.20 coo 124.34 41.73 25.55 123.79 42.60 23.72 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 13 3 # 13 A 311 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 341 GLU G 73 GLU~? 5.63 O1 GOL G3038 A 356 HIS G 79 HIS~? -4.46 CL CL G2033s coo 121.00 36.37 19.26 121.57 38.37 19.56 9.26 20.10 48.62 8.05 19.49 50.22 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.93 24.13 49.80 12.04 22.49 50.80 coo 124.34 41.73 25.55 123.79 42.60 23.72 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 14 3 # 14 A 311 HIS G 76 HIS~? -3.85 O1 GOL G3038s A 341 GLU G 73 GLU~? 5.63 O1 GOL G3038 A 356 HIS G 158 HIS.? 10.64 CL CL G2033 coo 121.00 36.37 19.26 121.57 38.37 19.56 9.26 20.10 48.62 8.05 19.49 50.22 coo 125.72 32.70 19.75 124.44 34.16 18.84 12.93 24.13 49.80 12.04 22.49 50.80 coo 124.34 41.73 25.55 123.79 42.60 23.72 0.65 25.49 51.61 1.26 23.82 52.74 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 15 3 # 15 A 311 HIS H 76 HIS~? 4.68 CL CL H2014s A 341 GLU H 73 GLU~? -8.72 CL CL H2014s A 356 HIS H 79 HIS~? 4.82 CL CL H2024 coo 121.00 36.37 19.26 121.57 38.37 19.56 90.35 57.57 94.69 91.06 55.99 95.89 coo 125.72 32.70 19.75 124.44 34.16 18.84 87.54 56.19 90.14 87.78 55.44 92.11 coo 124.34 41.73 25.55 123.79 42.60 23.72 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 16 3 # 16 A 311 HIS H 76 HIS~? 4.68 CL CL H2014s A 341 GLU H 73 GLU~? -8.72 CL CL H2014s A 356 HIS H 158 HIS.? 10.33 CL CL H2024 coo 121.00 36.37 19.26 121.57 38.37 19.56 90.35 57.57 94.69 91.06 55.99 95.89 coo 125.72 32.70 19.75 124.44 34.16 18.84 87.54 56.19 90.14 87.78 55.44 92.11 coo 124.34 41.73 25.55 123.79 42.60 23.72 98.94 51.80 92.35 97.68 51.03 93.84 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 17 3 # 17 A 311 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 341 GLU I 73 GLU~? -6.03 O3 GOL I3031s A 356 HIS I 79 HIS~? -4.56 CL CL I2025s coo 121.00 36.37 19.26 121.57 38.37 19.56 212.11 203.51 165.19 213.01 204.42 166.85 coo 125.72 32.70 19.75 124.44 34.16 18.84 208.30 199.46 166.53 209.06 201.27 167.27 coo 124.34 41.73 25.55 123.79 42.60 23.72 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 18 3 # 18 A 311 HIS I 76 HIS~? 4.17 O3 GOL I3031s A 341 GLU I 73 GLU~? -6.03 O3 GOL I3031s A 356 HIS I 158 HIS.? 11.08 CL CL I2025 coo 121.00 36.37 19.26 121.57 38.37 19.56 212.11 203.51 165.19 213.01 204.42 166.85 coo 125.72 32.70 19.75 124.44 34.16 18.84 208.30 199.46 166.53 209.06 201.27 167.27 coo 124.34 41.73 25.55 123.79 42.60 23.72 220.34 199.03 170.60 219.44 200.67 171.57 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 19 3 # 19 A 311 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 341 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 356 HIS J 79 HIS~? -4.36 CL CL J2026s coo 121.00 36.37 19.26 121.57 38.37 19.56 130.51 172.99 128.94 129.60 171.33 128.01 coo 125.72 32.70 19.75 124.44 34.16 18.84 133.49 171.70 133.63 132.81 170.83 131.84 coo 124.34 41.73 25.55 123.79 42.60 23.72 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 20 3 # 20 A 311 HIS J 76 HIS~? 4.19 O2 GOL J3033s A 341 GLU J 73 GLU~? 5.06 O1 GOL J3033 A 356 HIS J 158 HIS.? 7.50 O2 GOL J3033 coo 121.00 36.37 19.26 121.57 38.37 19.56 130.51 172.99 128.94 129.60 171.33 128.01 coo 125.72 32.70 19.75 124.44 34.16 18.84 133.49 171.70 133.63 132.81 170.83 131.84 coo 124.34 41.73 25.55 123.79 42.60 23.72 121.18 169.23 132.79 122.06 167.98 131.35 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 21 3 # 21 A 311 HIS K 76 HIS~? -6.12 C3 GOL K3041s A 341 GLU K 73 GLU~? 7.36 C3 GOL K3041 A 356 HIS K 79 HIS~? -4.34 CL CL K2027s coo 121.00 36.37 19.26 121.57 38.37 19.56 207.10 129.51 177.50 208.14 128.55 175.95 coo 125.72 32.70 19.75 124.44 34.16 18.84 204.07 133.93 175.85 204.65 132.02 175.03 coo 124.34 41.73 25.55 123.79 42.60 23.72 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 22 3 # 22 A 311 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 341 GLU L 73 GLU~? 5.94 O3 GOL L3027 A 356 HIS L 79 HIS~? -4.09 CL CL L2028s coo 121.00 36.37 19.26 121.57 38.37 19.56 125.69 169.77 203.98 124.79 171.51 204.73 coo 125.72 32.70 19.75 124.44 34.16 18.84 129.44 170.32 199.72 128.69 171.38 201.39 coo 124.34 41.73 25.55 123.79 42.60 23.72 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 23 3 # 23 A 311 HIS L 76 HIS~? 4.00 O3 GOL L3027s A 341 GLU L 73 GLU~? 5.94 O3 GOL L3027 A 356 HIS L 158 HIS.? 11.11 CL CL L2028 coo 121.00 36.37 19.26 121.57 38.37 19.56 125.69 169.77 203.98 124.79 171.51 204.73 coo 125.72 32.70 19.75 124.44 34.16 18.84 129.44 170.32 199.72 128.69 171.38 201.39 coo 124.34 41.73 25.55 123.79 42.60 23.72 117.45 174.63 198.96 118.55 176.04 200.05 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 24 3 # 24 A 311 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 341 GLU M 73 GLU~? -3.31 O3 GOL M3042s A 356 HIS M 79 HIS~? -4.31 CL CL M2029s coo 121.00 36.37 19.26 121.57 38.37 19.56 130.15 208.85 168.09 129.36 209.65 166.31 coo 125.72 32.70 19.75 124.44 34.16 18.84 133.35 204.22 167.43 132.84 205.99 166.43 coo 124.34 41.73 25.55 123.79 42.60 23.72 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 25 3 # 25 A 311 HIS M 76 HIS~? 4.78 C1 GOL M3042s A 341 GLU M 73 GLU~? -3.31 O3 GOL M3042s A 356 HIS M 158 HIS.? 6.42 O1 GOL M3042 coo 121.00 36.37 19.26 121.57 38.37 19.56 130.15 208.85 168.09 129.36 209.65 166.31 coo 125.72 32.70 19.75 124.44 34.16 18.84 133.35 204.22 167.43 132.84 205.99 166.43 coo 124.34 41.73 25.55 123.79 42.60 23.72 121.40 205.18 163.43 122.55 206.46 162.23 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 26 3 # 26 A 311 HIS N 76 HIS~? -6.89 CL CL N2030s A 341 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 356 HIS N 79 HIS~? -4.33 CL CL N2030s coo 121.00 36.37 19.26 121.57 38.37 19.56 211.54 160.16 134.29 212.67 161.69 133.40 coo 125.72 32.70 19.75 124.44 34.16 18.84 207.93 161.92 138.37 208.75 162.64 136.53 coo 124.34 41.73 25.55 123.79 42.60 23.72 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 27 3 # 27 A 311 HIS N 76 HIS~? -6.89 CL CL N2030s A 341 GLU N 73 GLU~? -8.02 O3 GOL N3012s A 356 HIS N 158 HIS.? 10.50 CL CL N2030 coo 121.00 36.37 19.26 121.57 38.37 19.56 211.54 160.16 134.29 212.67 161.69 133.40 coo 125.72 32.70 19.75 124.44 34.16 18.84 207.93 161.92 138.37 208.75 162.64 136.53 coo 124.34 41.73 25.55 123.79 42.60 23.72 220.32 164.11 138.58 219.66 165.01 136.80 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 28 3 # 28 A 311 HIS O 76 HIS~? 4.51 CL CL O2018s A 341 GLU O 73 GLU~? 6.85 O1 GOL O3013 A 356 HIS O 79 HIS~? 5.21 CL CL O2018 coo 121.00 36.37 19.26 121.57 38.37 19.56 126.10 133.61 164.62 125.01 132.87 166.26 coo 125.72 32.70 19.75 124.44 34.16 18.84 129.73 137.78 165.68 128.97 136.10 166.67 coo 124.34 41.73 25.55 123.79 42.60 23.72 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 29 3 # 29 A 311 HIS O 76 HIS~? 4.51 CL CL O2018s A 341 GLU O 73 GLU~? 6.85 O1 GOL O3013 A 356 HIS O 158 HIS.? 12.21 CL CL O2018 coo 121.00 36.37 19.26 121.57 38.37 19.56 126.10 133.61 164.62 125.01 132.87 166.26 coo 125.72 32.70 19.75 124.44 34.16 18.84 129.73 137.78 165.68 128.97 136.10 166.67 coo 124.34 41.73 25.55 123.79 42.60 23.72 117.44 138.41 168.51 118.31 136.96 169.75 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 30 3 # 30 A 311 HIS P 76 HIS~? 4.69 CL CL P2019s A 341 GLU P 73 GLU~? 5.04 O1 GOL P3034 A 356 HIS P 79 HIS~? 5.38 CL CL P2019 coo 121.00 36.37 19.26 121.57 38.37 19.56 207.59 172.73 208.38 208.33 171.09 209.49 coo 125.72 32.70 19.75 124.44 34.16 18.84 204.36 171.43 203.90 204.84 170.63 205.81 coo 124.34 41.73 25.55 123.79 42.60 23.72 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 31 3 # 31 A 311 HIS P 76 HIS~? 4.69 CL CL P2019s A 341 GLU P 73 GLU~? 5.04 O1 GOL P3034 A 356 HIS P 158 HIS.? 12.33 O2 GOL P3014 coo 121.00 36.37 19.26 121.57 38.37 19.56 207.59 172.73 208.38 208.33 171.09 209.49 coo 125.72 32.70 19.75 124.44 34.16 18.84 204.36 171.43 203.90 204.84 170.63 205.81 coo 124.34 41.73 25.55 123.79 42.60 23.72 216.29 167.50 205.15 215.20 166.66 206.73 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 31 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 76 HIS~? -4.53 C1 GOL A3037s B 341 GLU A 73 GLU~? -3.07 O3 GOL A3037s B 356 HIS A 79 HIS~? -3.92 CL CL A2020s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 98.60 85.60 50.46 99.38 86.61 52.13 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 94.58 81.89 51.70 95.31 83.75 52.44 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 103.72 86.36 44.76 104.87 88.01 44.15 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 76 HIS~? -4.53 C1 GOL A3037s B 341 GLU A 73 GLU~? -3.07 O3 GOL A3037s B 356 HIS A 158 HIS.? 6.53 O1 GOL A3037 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 98.60 85.60 50.46 99.38 86.61 52.13 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 94.58 81.89 51.70 95.31 83.75 52.44 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 106.32 81.43 56.18 105.60 83.26 56.91 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS B 76 HIS~? 4.58 CL CL B2010s B 341 GLU B 73 GLU~? 6.38 O3 GOL B3023 B 356 HIS B 79 HIS~? 5.08 CL CL B2010 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 17.08 57.14 11.39 16.06 55.49 10.59 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.80 56.19 16.30 19.32 55.14 14.52 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 13.46 62.96 8.26 12.78 63.30 6.30 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS B 76 HIS~? 4.58 CL CL B2010s B 341 GLU B 73 GLU~? 6.38 O3 GOL B3023 B 356 HIS B 158 HIS.? 12.55 CL CL B2010 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 17.08 57.14 11.39 16.06 55.49 10.59 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.80 56.19 16.30 19.32 55.14 14.52 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 7.56 53.89 15.18 8.49 52.54 13.87 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS C 76 HIS~? -4.98 CL CL C2011s B 341 GLU C 73 GLU~? 6.99 O1 GOL C3036 B 356 HIS C 79 HIS~? -4.32 CL CL C2021s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 89.28 12.80 65.47 90.23 11.67 63.98 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 86.57 17.41 63.72 86.98 15.43 63.06 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 92.85 10.89 71.99 93.43 9.18 73.06 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 B 311 HIS C 76 HIS~? -4.98 CL CL C2011s B 341 GLU C 73 GLU~? 6.99 O1 GOL C3036 B 356 HIS C 158 HIS.? 10.62 CL CL C2021 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 89.28 12.80 65.47 90.23 11.67 63.98 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 86.57 17.41 63.72 86.98 15.43 63.06 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 98.99 15.14 61.83 98.04 13.53 60.88 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 B 311 HIS C 79 HIS~? -4.32 CL CL C2021s B 341 GLU C 93 GLU~? 8.05 CL CL C2021 B 356 HIS C 76 HIS~? -4.98 CL CL C2011s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 92.85 10.89 71.99 93.43 9.18 73.06 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 94.51 9.91 76.89 94.48 7.78 76.63 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 89.28 12.80 65.47 90.23 11.67 63.98 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 B 311 HIS D 76 HIS~? 4.24 O2 GOL D3018s B 341 GLU D 73 GLU~? 5.51 C2 GOL D3020 B 356 HIS D 79 HIS~? -4.57 CL CL D2022s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 8.84 57.69 86.26 7.93 59.46 86.93 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.99 58.17 82.26 12.31 59.24 83.94 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 3.57 52.49 87.96 2.52 51.97 89.71 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 9 3 # 9 B 311 HIS D 79 HIS~? -4.57 CL CL D2022s B 341 GLU D 93 GLU~? 8.23 CL CL D2022 B 356 HIS D 76 HIS~? 4.24 O2 GOL D3018s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 3.57 52.49 87.96 2.52 51.97 89.71 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 0.77 48.16 89.31 0.23 49.10 91.12 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 8.84 57.69 86.26 7.93 59.46 86.93 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 10 3 # 10 B 311 HIS E 76 HIS~? -4.87 CL CL E2013s B 341 GLU E 73 GLU~? -6.85 O1 GOL E3022s B 356 HIS E 79 HIS~? -4.18 CL CL E2032s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 16.97 95.07 49.08 16.37 95.97 47.28 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.82 90.31 48.74 19.50 92.07 47.58 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 12.36 98.35 54.34 11.69 100.32 54.60 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 11 3 # 11 B 311 HIS E 76 HIS~? -4.87 CL CL E2013s B 341 GLU E 73 GLU~? -6.85 O1 GOL E3022s B 356 HIS E 158 HIS.? 10.67 CL CL E2032 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 16.97 95.07 49.08 16.37 95.97 47.28 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 19.82 90.31 48.74 19.50 92.07 47.58 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 8.21 91.93 44.16 9.29 93.32 43.02 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 12 3 # 12 B 311 HIS F 76 HIS~? -4.65 CL CL F2034s B 341 GLU F 73 GLU~? 5.19 O3 GOL F3039 B 356 HIS F 79 HIS~? -4.63 CL CL F2023s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 97.24 41.20 21.57 98.43 42.65 20.63 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 93.55 43.24 25.35 94.46 43.89 23.55 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 101.04 34.65 20.79 101.93 33.69 19.16 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 13 3 # 13 B 311 HIS F 76 HIS~? -4.65 CL CL F2034s B 341 GLU F 73 GLU~? 5.19 O3 GOL F3039 B 356 HIS F 158 HIS.? -10.90 CL CL F2023s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 97.24 41.20 21.57 98.43 42.65 20.63 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 93.55 43.24 25.35 94.46 43.89 23.55 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 105.92 45.34 26.29 105.13 46.33 24.62 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 14 3 # 14 B 311 HIS F 79 HIS~? -4.63 CL CL F2023s B 341 GLU F 93 GLU~? 8.36 CL CL F2023 B 356 HIS F 76 HIS~? -4.65 CL CL F2034s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 101.04 34.65 20.79 101.93 33.69 19.16 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 102.94 29.85 20.29 103.30 29.96 18.20 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 97.24 41.20 21.57 98.43 42.65 20.63 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 15 3 # 15 B 311 HIS G 76 HIS~? -3.85 O1 GOL G3038s B 341 GLU G 73 GLU~? 5.63 O1 GOL G3038 B 356 HIS G 79 HIS~? -4.46 CL CL G2033s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 9.26 20.10 48.62 8.05 19.49 50.22 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.93 24.13 49.80 12.04 22.49 50.80 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 5.20 17.85 42.65 4.12 16.10 42.26 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 16 3 # 16 B 311 HIS G 76 HIS~? -3.85 O1 GOL G3038s B 341 GLU G 73 GLU~? 5.63 O1 GOL G3038 B 356 HIS G 158 HIS.? 10.64 CL CL G2033 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 9.26 20.10 48.62 8.05 19.49 50.22 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 12.93 24.13 49.80 12.04 22.49 50.80 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 0.65 25.49 51.61 1.26 23.82 52.74 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 17 3 # 17 B 311 HIS G 79 HIS~? -4.46 CL CL G2033s B 341 GLU G 93 GLU~? 8.63 CL CL G2033 B 356 HIS G 76 HIS~? -3.85 O1 GOL G3038s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 5.20 17.85 42.65 4.12 16.10 42.26 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 3.64 16.49 37.62 3.03 14.55 38.23 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 9.26 20.10 48.62 8.05 19.49 50.22 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 18 3 # 18 B 311 HIS H 76 HIS~? 4.68 CL CL H2014s B 341 GLU H 73 GLU~? -8.72 CL CL H2014s B 356 HIS H 79 HIS~? 4.82 CL CL H2024 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 90.35 57.57 94.69 91.06 55.99 95.89 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 87.54 56.19 90.14 87.78 55.44 92.11 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 95.19 63.20 96.60 95.96 63.87 98.43 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 19 3 # 19 B 311 HIS H 76 HIS~? 4.68 CL CL H2014s B 341 GLU H 73 GLU~? -8.72 CL CL H2014s B 356 HIS H 158 HIS.? 10.33 CL CL H2024 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 90.35 57.57 94.69 91.06 55.99 95.89 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 87.54 56.19 90.14 87.78 55.44 92.11 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 98.94 51.80 92.35 97.68 51.03 93.84 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 20 3 # 20 B 311 HIS I 76 HIS~? 4.17 O3 GOL I3031s B 341 GLU I 73 GLU~? -6.03 O3 GOL I3031s B 356 HIS I 79 HIS~? -4.56 CL CL I2025s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 212.11 203.51 165.19 213.01 204.42 166.85 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 208.30 199.46 166.53 209.06 201.27 167.27 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 216.99 204.94 159.50 218.07 206.60 158.77 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 21 3 # 21 B 311 HIS I 79 HIS~? -4.56 CL CL I2025s B 341 GLU I 93 GLU~? 8.40 CL CL I2025 B 356 HIS I 76 HIS~? 4.17 O3 GOL I3031s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 216.99 204.94 159.50 218.07 206.60 158.77 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 219.77 205.57 155.06 219.86 207.68 155.25 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 212.11 203.51 165.19 213.01 204.42 166.85 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 22 3 # 22 B 311 HIS J 76 HIS~? 4.19 O2 GOL J3033s B 341 GLU J 73 GLU~? 5.06 O1 GOL J3033 B 356 HIS J 79 HIS~? -4.36 CL CL J2026s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 130.51 172.99 128.94 129.60 171.33 128.01 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 133.49 171.70 133.63 132.81 170.83 131.84 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 126.45 179.07 126.46 125.69 179.71 124.61 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 23 3 # 23 B 311 HIS J 76 HIS~? 4.19 O2 GOL J3033s B 341 GLU J 73 GLU~? 5.06 O1 GOL J3033 B 356 HIS J 158 HIS.? 7.50 O2 GOL J3033 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 130.51 172.99 128.94 129.60 171.33 128.01 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 133.49 171.70 133.63 132.81 170.83 131.84 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 121.18 169.23 132.79 122.06 167.98 131.35 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 24 3 # 24 B 311 HIS J 79 HIS~? -4.36 CL CL J2026s B 341 GLU J 93 GLU~? 8.18 CL CL J2026 B 356 HIS J 76 HIS~? 4.19 O2 GOL J3033s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 126.45 179.07 126.46 125.69 179.71 124.61 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 124.50 183.71 125.04 124.44 183.21 122.99 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 130.51 172.99 128.94 129.60 171.33 128.01 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 25 3 # 25 B 311 HIS K 76 HIS~? -6.12 C3 GOL K3041s B 341 GLU K 73 GLU~? 7.36 C3 GOL K3041 B 356 HIS K 79 HIS~? -4.34 CL CL K2027s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 207.10 129.51 177.50 208.14 128.55 175.95 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 204.07 133.93 175.85 204.65 132.02 175.03 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 211.01 127.65 183.80 211.70 125.86 184.65 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 26 3 # 26 B 311 HIS L 76 HIS~? 4.00 O3 GOL L3027s B 341 GLU L 73 GLU~? 5.94 O3 GOL L3027 B 356 HIS L 79 HIS~? -4.09 CL CL L2028s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 125.69 169.77 203.98 124.79 171.51 204.73 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 129.44 170.32 199.72 128.69 171.38 201.39 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 120.65 164.52 206.19 119.64 164.06 207.98 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 27 3 # 27 B 311 HIS M 76 HIS~? 4.78 C1 GOL M3042s B 341 GLU M 73 GLU~? -3.31 O3 GOL M3042s B 356 HIS M 79 HIS~? -4.31 CL CL M2029s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 130.15 208.85 168.09 129.36 209.65 166.31 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 133.35 204.22 167.43 132.84 205.99 166.43 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 125.50 211.59 173.52 124.72 213.49 173.99 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 28 3 # 28 B 311 HIS M 76 HIS~? 4.78 C1 GOL M3042s B 341 GLU M 73 GLU~? -3.31 O3 GOL M3042s B 356 HIS M 158 HIS.? 6.42 O1 GOL M3042 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 130.15 208.85 168.09 129.36 209.65 166.31 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 133.35 204.22 167.43 132.84 205.99 166.43 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 121.40 205.18 163.43 122.55 206.46 162.23 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 29 3 # 29 B 311 HIS N 76 HIS~? -6.89 CL CL N2030s B 341 GLU N 73 GLU~? -8.02 O3 GOL N3012s B 356 HIS N 79 HIS~? -4.33 CL CL N2030s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 211.54 160.16 134.29 212.67 161.69 133.40 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 207.93 161.92 138.37 208.75 162.64 136.53 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 215.64 153.98 132.96 216.60 153.22 131.26 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 30 3 # 30 B 311 HIS N 76 HIS~? -6.89 CL CL N2030s B 341 GLU N 73 GLU~? -8.02 O3 GOL N3012s B 356 HIS N 158 HIS.? 10.50 CL CL N2030 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 211.54 160.16 134.29 212.67 161.69 133.40 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 207.93 161.92 138.37 208.75 162.64 136.53 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 220.32 164.11 138.58 219.66 165.01 136.80 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 31 3 # 31 B 311 HIS O 76 HIS~? 4.51 CL CL O2018s B 341 GLU O 73 GLU~? 6.85 O1 GOL O3013 B 356 HIS O 79 HIS~? 5.21 CL CL O2018 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 126.10 133.61 164.62 125.01 132.87 166.26 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 129.73 137.78 165.68 128.97 136.10 166.67 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 121.98 131.53 158.56 121.09 129.74 157.92 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 32 3 # 32 B 311 HIS O 76 HIS~? 4.51 CL CL O2018s B 341 GLU O 73 GLU~? 6.85 O1 GOL O3013 B 356 HIS O 158 HIS.? 12.21 CL CL O2018 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 126.10 133.61 164.62 125.01 132.87 166.26 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 129.73 137.78 165.68 128.97 136.10 166.67 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 117.44 138.41 168.51 118.31 136.96 169.75 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 33 3 # 33 B 311 HIS P 76 HIS~? 4.69 CL CL P2019s B 341 GLU P 73 GLU~? 5.04 O1 GOL P3034 B 356 HIS P 79 HIS~? 5.38 CL CL P2019 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 207.59 172.73 208.38 208.33 171.09 209.49 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 204.36 171.43 203.90 204.84 170.63 205.81 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 212.25 178.47 210.26 213.09 179.27 212.01 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 34 3 # 34 B 311 HIS P 76 HIS~? 4.69 CL CL P2019s B 341 GLU P 73 GLU~? 5.04 O1 GOL P3034 B 356 HIS P 158 HIS.? 12.33 O2 GOL P3014 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 207.59 172.73 208.38 208.33 171.09 209.49 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 204.36 171.43 203.90 204.84 170.63 205.81 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 216.29 167.50 205.15 215.20 166.66 206.73 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 35 3 # 35 B 311 HIS P 79 HIS~? 5.38 CL CL P2019 B 341 GLU P 93 GLU~? 9.65 CL CL P2019 B 356 HIS P 76 HIS~? 4.69 CL CL P2019s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 212.25 178.47 210.26 213.09 179.27 212.01 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 214.54 183.14 211.27 214.54 182.92 213.36 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 207.59 172.73 208.38 208.33 171.09 209.49 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 35 hits 2isd_c01 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 98 PHE.? 12.32 O1 GOL A3040 A 263 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 292 LYS A 142 LYS~? 20.36 CL CL A2020 coo 51.51 50.32 16.39 52.13 49.68 13.75 94.73 84.25 40.94 92.04 83.71 40.47 coo 54.43 44.82 23.74 55.21 45.06 21.80 90.44 78.16 48.76 91.65 76.94 50.06 coo 63.95 45.30 16.71 59.11 49.15 16.05 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 98 PHE.? 11.15 CL CL B2010 A 263 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 292 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 51.51 50.32 16.39 52.13 49.68 13.75 22.68 65.92 11.87 25.22 66.01 13.02 coo 54.43 44.82 23.74 55.21 45.06 21.80 23.66 59.02 20.34 21.93 58.32 21.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE C 98 PHE.? 11.39 CL CL C2011 A 263 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 292 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 51.51 50.32 16.39 52.13 49.68 13.75 83.86 15.19 74.07 81.38 16.44 74.03 coo 54.43 44.82 23.74 55.21 45.06 21.80 82.81 22.02 65.69 84.52 22.80 64.66 coo 63.95 45.30 16.71 59.11 49.15 16.05 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE D 98 PHE.? 11.07 CL CL D2012 A 263 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 292 LYS D 142 LYS~? 18.65 CL CL D2012 coo 51.51 50.32 16.39 52.13 49.68 13.75 12.59 48.19 86.72 15.29 47.64 86.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 16.94 54.59 79.01 15.65 55.42 77.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE E 98 PHE.? 11.20 CL CL E2013 A 263 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 292 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 51.51 50.32 16.39 52.13 49.68 13.75 20.72 94.66 58.85 23.24 93.53 59.37 coo 54.43 44.82 23.74 55.21 45.06 21.80 23.07 86.29 52.35 21.57 85.17 51.32 coo 63.95 45.30 16.71 59.11 49.15 16.05 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE F 98 PHE.? 11.09 CL CL F2034 A 263 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 292 LYS F 142 LYS~? 19.20 CL CL F2034 coo 51.51 50.32 16.39 52.13 49.68 13.75 91.41 32.84 22.80 88.70 32.93 23.40 coo 54.43 44.82 23.74 55.21 45.06 21.80 88.86 41.25 28.96 90.30 42.22 30.24 coo 63.95 45.30 16.71 59.11 49.15 16.05 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE G 98 PHE.? 12.40 C3 GOL G3038 A 263 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 292 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 51.51 50.32 16.39 52.13 49.68 13.75 15.02 19.56 40.09 17.78 20.04 40.01 coo 54.43 44.82 23.74 55.21 45.06 21.80 17.70 27.34 47.09 16.19 28.71 47.73 coo 63.95 45.30 16.71 59.11 49.15 16.05 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE H 98 PHE.? 11.23 CL CL H2014 A 263 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 292 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 51.51 50.32 16.39 52.13 49.68 13.75 86.83 66.96 92.26 84.37 67.28 91.08 coo 54.43 44.82 23.74 55.21 45.06 21.80 84.24 58.93 85.48 85.73 57.59 84.66 coo 63.95 45.30 16.71 59.11 49.15 16.05 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE I 98 PHE.? 11.14 CL CL I2015 A 263 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 292 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 51.51 50.32 16.39 52.13 49.68 13.75 207.94 202.24 155.85 205.25 201.61 155.56 coo 54.43 44.82 23.74 55.21 45.06 21.80 204.37 195.46 163.61 205.75 194.30 164.79 coo 63.95 45.30 16.71 59.11 49.15 16.05 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE J 98 PHE.? 11.05 CL CL J2016 A 263 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 292 LYS J 142 LYS~? 19.62 CL CL J2016 coo 51.51 50.32 16.39 52.13 49.68 13.75 135.63 181.85 129.67 138.24 181.95 130.69 coo 54.43 44.82 23.74 55.21 45.06 21.80 137.44 174.60 137.57 135.80 173.80 138.69 coo 63.95 45.30 16.71 59.11 49.15 16.05 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE K 98 PHE.? 11.99 O1 GOL K3041 A 263 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 292 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 51.51 50.32 16.39 52.13 49.68 13.75 201.94 131.33 186.30 199.31 132.28 186.27 coo 54.43 44.82 23.74 55.21 45.06 21.80 200.17 138.24 178.11 201.77 139.28 177.19 coo 63.95 45.30 16.71 59.11 49.15 16.05 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE L 98 PHE.? 11.24 CL CL L2009 A 263 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 292 LYS L 142 LYS~? 23.18 CL CL L2009 coo 51.51 50.32 16.39 52.13 49.68 13.75 129.72 160.22 203.93 132.34 159.70 203.19 coo 54.43 44.82 23.74 55.21 45.06 21.80 133.34 166.97 196.27 132.03 168.03 194.96 coo 63.95 45.30 16.71 59.11 49.15 16.05 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE M 98 PHE.? 11.28 CL CL M2017 A 263 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 292 LYS M 142 LYS~? 19.90 CL CL M2017 coo 51.51 50.32 16.39 52.13 49.68 13.75 134.29 208.09 177.60 136.84 206.99 178.00 coo 54.43 44.82 23.74 55.21 45.06 21.80 136.87 200.18 170.79 135.36 199.08 169.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE N 98 PHE.? 12.51 O2 GOL N3029 A 263 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 292 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 51.51 50.32 16.39 52.13 49.68 13.75 205.99 151.41 135.45 203.31 151.41 136.18 coo 54.43 44.82 23.74 55.21 45.06 21.80 203.51 159.51 142.26 205.02 160.53 143.48 coo 63.95 45.30 16.71 59.11 49.15 16.05 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE O 98 PHE.? 11.35 CL CL O2018 A 263 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 292 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 51.51 50.32 16.39 52.13 49.68 13.75 131.45 133.74 155.71 134.18 134.46 155.64 coo 54.43 44.82 23.74 55.21 45.06 21.80 134.07 141.35 162.95 132.57 142.58 163.78 coo 63.95 45.30 16.71 59.11 49.15 16.05 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE P 98 PHE.? 11.01 CL CL P2019 A 263 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 292 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 51.51 50.32 16.39 52.13 49.68 13.75 203.50 182.03 206.67 200.90 182.30 205.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 200.75 174.15 199.66 202.28 173.10 198.62 coo 63.95 45.30 16.71 59.11 49.15 16.05 204.59 186.28 195.60 209.96 186.96 196.62 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 98 PHE.? 12.32 O1 GOL A3040 B 263 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 292 LYS A 142 LYS~? 20.36 CL CL A2020 coo 49.99 26.05 6.28 51.46 26.87 8.49 94.73 84.25 40.94 92.04 83.71 40.47 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 90.44 78.16 48.76 91.65 76.94 50.06 coo 60.53 31.67 0.97 57.79 27.51 3.63 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 98 PHE.? 11.15 CL CL B2010 B 263 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 292 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 49.99 26.05 6.28 51.46 26.87 8.49 22.68 65.92 11.87 25.22 66.01 13.02 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 23.66 59.02 20.34 21.93 58.32 21.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE C 98 PHE.? 11.39 CL CL C2011 B 263 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 292 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 49.99 26.05 6.28 51.46 26.87 8.49 83.86 15.19 74.07 81.38 16.44 74.03 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 82.81 22.02 65.69 84.52 22.80 64.66 coo 60.53 31.67 0.97 57.79 27.51 3.63 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE D 98 PHE.? 11.07 CL CL D2012 B 263 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 292 LYS D 142 LYS~? 18.65 CL CL D2012 coo 49.99 26.05 6.28 51.46 26.87 8.49 12.59 48.19 86.72 15.29 47.64 86.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 16.94 54.59 79.01 15.65 55.42 77.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE E 98 PHE.? 11.20 CL CL E2013 B 263 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 292 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 49.99 26.05 6.28 51.46 26.87 8.49 20.72 94.66 58.85 23.24 93.53 59.37 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 23.07 86.29 52.35 21.57 85.17 51.32 coo 60.53 31.67 0.97 57.79 27.51 3.63 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE F 98 PHE.? 11.09 CL CL F2034 B 263 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 292 LYS F 142 LYS~? 19.20 CL CL F2034 coo 49.99 26.05 6.28 51.46 26.87 8.49 91.41 32.84 22.80 88.70 32.93 23.40 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 88.86 41.25 28.96 90.30 42.22 30.24 coo 60.53 31.67 0.97 57.79 27.51 3.63 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE G 98 PHE.? 12.40 C3 GOL G3038 B 263 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 292 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 49.99 26.05 6.28 51.46 26.87 8.49 15.02 19.56 40.09 17.78 20.04 40.01 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 17.70 27.34 47.09 16.19 28.71 47.73 coo 60.53 31.67 0.97 57.79 27.51 3.63 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE H 98 PHE.? 11.23 CL CL H2014 B 263 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 292 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 49.99 26.05 6.28 51.46 26.87 8.49 86.83 66.96 92.26 84.37 67.28 91.08 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 84.24 58.93 85.48 85.73 57.59 84.66 coo 60.53 31.67 0.97 57.79 27.51 3.63 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE I 98 PHE.? 11.14 CL CL I2015 B 263 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 292 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 49.99 26.05 6.28 51.46 26.87 8.49 207.94 202.24 155.85 205.25 201.61 155.56 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 204.37 195.46 163.61 205.75 194.30 164.79 coo 60.53 31.67 0.97 57.79 27.51 3.63 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE J 98 PHE.? 11.05 CL CL J2016 B 263 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 292 LYS J 142 LYS~? 19.62 CL CL J2016 coo 49.99 26.05 6.28 51.46 26.87 8.49 135.63 181.85 129.67 138.24 181.95 130.69 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 137.44 174.60 137.57 135.80 173.80 138.69 coo 60.53 31.67 0.97 57.79 27.51 3.63 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE K 98 PHE.? 11.99 O1 GOL K3041 B 263 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 292 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 49.99 26.05 6.28 51.46 26.87 8.49 201.94 131.33 186.30 199.31 132.28 186.27 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 200.17 138.24 178.11 201.77 139.28 177.19 coo 60.53 31.67 0.97 57.79 27.51 3.63 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE L 98 PHE.? 11.24 CL CL L2009 B 263 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 292 LYS L 142 LYS~? 23.18 CL CL L2009 coo 49.99 26.05 6.28 51.46 26.87 8.49 129.72 160.22 203.93 132.34 159.70 203.19 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 133.34 166.97 196.27 132.03 168.03 194.96 coo 60.53 31.67 0.97 57.79 27.51 3.63 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE M 98 PHE.? 11.28 CL CL M2017 B 263 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 292 LYS M 142 LYS~? 19.90 CL CL M2017 coo 49.99 26.05 6.28 51.46 26.87 8.49 134.29 208.09 177.60 136.84 206.99 178.00 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 136.87 200.18 170.79 135.36 199.08 169.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE N 98 PHE.? 12.51 O2 GOL N3029 B 263 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 292 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 49.99 26.05 6.28 51.46 26.87 8.49 205.99 151.41 135.45 203.31 151.41 136.18 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 203.51 159.51 142.26 205.02 160.53 143.48 coo 60.53 31.67 0.97 57.79 27.51 3.63 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 177 PHE O 98 PHE.? 11.35 CL CL O2018 B 263 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 292 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 49.99 26.05 6.28 51.46 26.87 8.49 131.45 133.74 155.71 134.18 134.46 155.64 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 134.07 141.35 162.95 132.57 142.58 163.78 coo 60.53 31.67 0.97 57.79 27.51 3.63 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 177 PHE P 98 PHE.? 11.01 CL CL P2019 B 263 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 292 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 49.99 26.05 6.28 51.46 26.87 8.49 203.50 182.03 206.67 200.90 182.30 205.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 200.75 174.15 199.66 202.28 173.10 198.62 coo 60.53 31.67 0.97 57.79 27.51 3.63 204.59 186.28 195.60 209.96 186.96 196.62 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 98 PHE.? 12.32 O1 GOL A3040 C 263 ASP A 70 ASP~? -9.95 O3 GOL A3037s C 292 LYS A 142 LYS~? 20.36 CL CL A2020 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 94.73 84.25 40.94 92.04 83.71 40.47 coo 19.84 12.02 9.33 18.68 11.23 7.75 90.44 78.16 48.76 91.65 76.94 50.06 coo 12.82 3.49 4.98 17.80 5.59 1.90 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 98 PHE.? 11.15 CL CL B2010 C 263 ASP B 70 ASP~? -3.24 O2 GOL B3024s C 292 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 22.68 65.92 11.87 25.22 66.01 13.02 coo 19.84 12.02 9.33 18.68 11.23 7.75 23.66 59.02 20.34 21.93 58.32 21.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE C 98 PHE.? 11.39 CL CL C2011 C 263 ASP C 70 ASP~? 3.38 O1 GOL C3036s C 292 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 83.86 15.19 74.07 81.38 16.44 74.03 coo 19.84 12.02 9.33 18.68 11.23 7.75 82.81 22.02 65.69 84.52 22.80 64.66 coo 12.82 3.49 4.98 17.80 5.59 1.90 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE D 98 PHE.? 11.07 CL CL D2012 C 263 ASP D 70 ASP~? -11.51 O3 GOL D3019s C 292 LYS D 142 LYS~? 18.65 CL CL D2012 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 12.59 48.19 86.72 15.29 47.64 86.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 16.94 54.59 79.01 15.65 55.42 77.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE E 98 PHE.? 11.20 CL CL E2013 C 263 ASP E 70 ASP~? 5.56 O3 GOL E3002 C 292 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 20.72 94.66 58.85 23.24 93.53 59.37 coo 19.84 12.02 9.33 18.68 11.23 7.75 23.07 86.29 52.35 21.57 85.17 51.32 coo 12.82 3.49 4.98 17.80 5.59 1.90 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE F 98 PHE.? 11.09 CL CL F2034 C 263 ASP F 70 ASP~? -11.57 O3 GOL F3039s C 292 LYS F 142 LYS~? 19.20 CL CL F2034 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 91.41 32.84 22.80 88.70 32.93 23.40 coo 19.84 12.02 9.33 18.68 11.23 7.75 88.86 41.25 28.96 90.30 42.22 30.24 coo 12.82 3.49 4.98 17.80 5.59 1.90 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE G 98 PHE.? 12.40 C3 GOL G3038 C 263 ASP G 70 ASP~? -5.29 C3 GOL G3001s C 292 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 15.02 19.56 40.09 17.78 20.04 40.01 coo 19.84 12.02 9.33 18.68 11.23 7.75 17.70 27.34 47.09 16.19 28.71 47.73 coo 12.82 3.49 4.98 17.80 5.59 1.90 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE H 98 PHE.? 11.23 CL CL H2014 C 263 ASP H 70 ASP~? -4.05 C3 GOL H3016s C 292 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 86.83 66.96 92.26 84.37 67.28 91.08 coo 19.84 12.02 9.33 18.68 11.23 7.75 84.24 58.93 85.48 85.73 57.59 84.66 coo 12.82 3.49 4.98 17.80 5.59 1.90 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE I 98 PHE.? 11.14 CL CL I2015 C 263 ASP I 70 ASP~? -3.65 C2 GOL I3032s C 292 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 207.94 202.24 155.85 205.25 201.61 155.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 204.37 195.46 163.61 205.75 194.30 164.79 coo 12.82 3.49 4.98 17.80 5.59 1.90 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE J 98 PHE.? 11.05 CL CL J2016 C 263 ASP J 70 ASP~? 11.68 O1 GOL J3033 C 292 LYS J 142 LYS~? 19.62 CL CL J2016 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 135.63 181.85 129.67 138.24 181.95 130.69 coo 19.84 12.02 9.33 18.68 11.23 7.75 137.44 174.60 137.57 135.80 173.80 138.69 coo 12.82 3.49 4.98 17.80 5.59 1.90 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE K 98 PHE.? 11.99 O1 GOL K3041 C 263 ASP K 70 ASP~? -4.89 O3 GOL K3009s C 292 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 201.94 131.33 186.30 199.31 132.28 186.27 coo 19.84 12.02 9.33 18.68 11.23 7.75 200.17 138.24 178.11 201.77 139.28 177.19 coo 12.82 3.49 4.98 17.80 5.59 1.90 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE L 98 PHE.? 11.24 CL CL L2009 C 263 ASP L 70 ASP~? -12.27 O3 GOL L3028s C 292 LYS L 142 LYS~? 23.18 CL CL L2009 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 129.72 160.22 203.93 132.34 159.70 203.19 coo 19.84 12.02 9.33 18.68 11.23 7.75 133.34 166.97 196.27 132.03 168.03 194.96 coo 12.82 3.49 4.98 17.80 5.59 1.90 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE M 98 PHE.? 11.28 CL CL M2017 C 263 ASP M 70 ASP~? -9.98 O3 GOL M3042s C 292 LYS M 142 LYS~? 19.90 CL CL M2017 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 134.29 208.09 177.60 136.84 206.99 178.00 coo 19.84 12.02 9.33 18.68 11.23 7.75 136.87 200.18 170.79 135.36 199.08 169.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE N 98 PHE.? 12.51 O2 GOL N3029 C 263 ASP N 70 ASP~? -3.26 O2 GOL N3029s C 292 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 205.99 151.41 135.45 203.31 151.41 136.18 coo 19.84 12.02 9.33 18.68 11.23 7.75 203.51 159.51 142.26 205.02 160.53 143.48 coo 12.82 3.49 4.98 17.80 5.59 1.90 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE O 98 PHE.? 11.35 CL CL O2018 C 263 ASP O 70 ASP~? 3.30 O1 GOL O3013s C 292 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 131.45 133.74 155.71 134.18 134.46 155.64 coo 19.84 12.02 9.33 18.68 11.23 7.75 134.07 141.35 162.95 132.57 142.58 163.78 coo 12.82 3.49 4.98 17.80 5.59 1.90 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE P 98 PHE.? 11.01 CL CL P2019 C 263 ASP P 70 ASP~? 4.30 O3 GOL P3014 C 292 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 203.50 182.03 206.67 200.90 182.30 205.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 200.75 174.15 199.66 202.28 173.10 198.62 coo 12.82 3.49 4.98 17.80 5.59 1.90 204.59 186.28 195.60 209.96 186.96 196.62 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c05 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 148 ASN~? 19.52 O3 GOL A3037 20 HIS A 151 HIS~? -11.70 O3 GOL A3037s 93 ASP A 70 ASP~? -9.95 O3 GOL A3037s coo 45.21 45.27 48.24 46.79 44.92 46.88 94.75 68.19 45.57 92.70 67.63 45.54 coo 47.05 39.55 45.24 48.99 39.30 44.46 94.27 72.58 51.14 93.29 74.44 51.00 coo 46.96 34.22 47.29 47.91 35.95 46.52 90.44 78.16 48.76 91.65 76.94 50.06 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN B 148 ASN~? 9.53 C1 GOL B3024 20 HIS B 151 HIS~? -4.11 O3 GOL B3015s 93 ASP B 70 ASP~? -3.24 O2 GOL B3024s coo 45.21 45.27 48.24 46.79 44.92 46.88 18.41 65.45 28.07 17.76 65.23 30.07 coo 47.05 39.55 45.24 48.99 39.30 44.46 18.48 59.01 25.15 19.77 58.54 23.56 coo 46.96 34.22 47.29 47.91 35.95 46.52 23.66 59.02 20.34 21.93 58.32 21.38 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN C 148 ASN~? 11.79 O3 GOL C3036 20 HIS C 151 HIS~? -4.28 C2 GOL C3036s 93 ASP C 70 ASP~? 3.38 O1 GOL C3036s coo 45.21 45.27 48.24 46.79 44.92 46.88 88.30 30.82 70.17 86.43 31.75 69.70 coo 47.05 39.55 45.24 48.99 39.30 44.46 88.24 26.50 64.44 86.75 25.04 64.52 coo 46.96 34.22 47.29 47.91 35.95 46.52 82.81 22.02 65.69 84.52 22.80 64.66 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 4 3 # 4 10 ASN D 148 ASN~? 21.41 O2 GOL D3020 20 HIS D 151 HIS~? -13.00 O2 GOL D3020s 93 ASP D 70 ASP~? -11.51 O3 GOL D3019s coo 45.21 45.27 48.24 46.79 44.92 46.88 12.38 49.18 69.99 12.27 49.48 67.83 coo 47.05 39.55 45.24 48.99 39.30 44.46 13.06 55.69 73.24 14.03 55.94 75.08 coo 46.96 34.22 47.29 47.91 35.95 46.52 16.94 54.59 79.01 15.65 55.42 77.54 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 5 3 # 5 10 ASN E 148 ASN~? 10.65 O1 GOL E3002 20 HIS E 151 HIS~? -4.12 O1 GOL E3002s 93 ASP E 70 ASP~? 5.56 O3 GOL E3002 coo 45.21 45.27 48.24 46.79 44.92 46.88 16.50 78.61 57.58 15.95 76.60 57.32 coo 47.05 39.55 45.24 48.99 39.30 44.46 17.87 81.44 51.19 19.31 82.95 50.96 coo 46.96 34.22 47.29 47.91 35.95 46.52 23.07 86.29 52.35 21.57 85.17 51.32 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 6 3 # 6 10 ASN F 148 ASN~? 20.16 CL CL F2035 20 HIS F 151 HIS~? 14.76 O3 GOL F3039s 93 ASP F 70 ASP~? -11.57 O3 GOL F3039s coo 45.21 45.27 48.24 46.79 44.92 46.88 92.36 36.84 38.84 92.17 37.47 40.85 coo 47.05 39.55 45.24 48.99 39.30 44.46 93.09 42.58 34.58 92.14 42.76 32.71 coo 46.96 34.22 47.29 47.91 35.95 46.52 88.86 41.25 28.96 90.30 42.22 30.24 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 7 3 # 7 10 ASN G 148 ASN~? 12.10 C1 GOL G3001 20 HIS G 151 HIS~? -4.14 C3 GOL G3001s 93 ASP G 70 ASP~? -5.29 C3 GOL G3001s coo 45.21 45.27 48.24 46.79 44.92 46.88 14.30 36.21 40.84 16.27 36.90 41.19 coo 47.05 39.55 45.24 48.99 39.30 44.46 13.55 33.19 47.26 14.46 31.35 47.64 coo 46.96 34.22 47.29 47.91 35.95 46.52 17.70 27.34 47.09 16.19 28.71 47.73 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 8 3 # 8 10 ASN H 148 ASN~? 6.95 O1 GOL H3016 20 HIS H 151 HIS~? 4.32 C1 GOL H3016s 93 ASP H 70 ASP~? -4.05 C3 GOL H3016s coo 45.21 45.27 48.24 46.79 44.92 46.88 90.74 62.26 76.80 90.93 61.43 74.87 coo 47.05 39.55 45.24 48.99 39.30 44.46 89.33 56.65 80.95 87.93 56.76 82.51 coo 46.96 34.22 47.29 47.91 35.95 46.52 84.24 58.93 85.48 85.73 57.59 84.66 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 9 3 # 9 10 ASN I 148 ASN~? 10.15 O1 GOL I3032 20 HIS I 151 HIS~? 3.98 O3 GOL I3032s 93 ASP I 70 ASP~? -3.65 C2 GOL I3032s coo 45.21 45.27 48.24 46.79 44.92 46.88 209.21 186.01 159.54 209.28 184.02 160.30 coo 47.05 39.55 45.24 48.99 39.30 44.46 208.71 190.07 165.44 207.65 191.87 165.52 coo 46.96 34.22 47.29 47.91 35.95 46.52 204.37 195.46 163.61 205.75 194.30 164.79 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 10 3 # 10 10 ASN J 148 ASN~? 20.55 O1 GOL J3033 20 HIS J 151 HIS~? -12.73 O1 GOL J3033s 93 ASP J 70 ASP~? 11.68 O1 GOL J3033 coo 45.21 45.27 48.24 46.79 44.92 46.88 132.19 180.35 145.70 132.98 179.70 147.44 coo 47.05 39.55 45.24 48.99 39.30 44.46 132.36 173.99 142.63 133.63 173.58 141.01 coo 46.96 34.22 47.29 47.91 35.95 46.52 137.44 174.60 137.57 135.80 173.80 138.69 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 11 3 # 11 10 ASN K 148 ASN~? 12.08 C1 GOL K3009 20 HIS K 151 HIS~? -4.18 C2 GOL K3009s 93 ASP K 70 ASP~? -4.89 O3 GOL K3009s coo 45.21 45.27 48.24 46.79 44.92 46.88 205.46 147.19 182.80 205.92 149.13 182.14 coo 47.05 39.55 45.24 48.99 39.30 44.46 205.25 143.04 176.89 203.95 141.38 176.70 coo 46.96 34.22 47.29 47.91 35.95 46.52 200.17 138.24 178.11 201.77 139.28 177.19 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 12 3 # 12 10 ASN L 148 ASN~? 21.20 O3 GOL L3028 20 HIS L 151 HIS~? -15.32 O3 GOL L3028s 93 ASP L 70 ASP~? -12.27 O3 GOL L3028s coo 45.21 45.27 48.24 46.79 44.92 46.88 128.43 161.78 187.33 130.41 161.66 186.63 coo 47.05 39.55 45.24 48.99 39.30 44.46 129.06 168.07 190.57 130.17 168.32 192.34 coo 46.96 34.22 47.29 47.91 35.95 46.52 133.34 166.97 196.27 132.03 168.03 194.96 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 13 3 # 13 10 ASN M 148 ASN~? 20.35 O3 GOL M3042 20 HIS M 151 HIS~? -11.81 O3 GOL M3042s 93 ASP M 70 ASP~? -9.98 O3 GOL M3042s coo 45.21 45.27 48.24 46.79 44.92 46.88 131.01 191.89 175.87 130.74 189.82 175.52 coo 47.05 39.55 45.24 48.99 39.30 44.46 131.91 195.13 169.59 133.22 196.76 169.40 coo 46.96 34.22 47.29 47.91 35.95 46.52 136.87 200.18 170.79 135.36 199.08 169.77 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 14 3 # 14 10 ASN N 148 ASN~? 8.14 O1 GOL N3029 20 HIS N 151 HIS~? 3.39 O2 GOL N3012s 93 ASP N 70 ASP~? -3.26 O2 GOL N3029s coo 45.21 45.27 48.24 46.79 44.92 46.88 207.66 155.05 151.71 208.13 155.55 153.68 coo 47.05 39.55 45.24 48.99 39.30 44.46 207.96 160.84 147.59 206.93 161.03 145.77 coo 46.96 34.22 47.29 47.91 35.95 46.52 203.51 159.51 142.26 205.02 160.53 143.48 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 15 3 # 15 10 ASN O 148 ASN~? 8.79 O3 GOL O3026 20 HIS O 151 HIS~? 4.32 O2 GOL O3026s 93 ASP O 70 ASP~? 3.30 O1 GOL O3013s coo 45.21 45.27 48.24 46.79 44.92 46.88 129.87 150.23 157.24 129.64 152.28 157.66 coo 47.05 39.55 45.24 48.99 39.30 44.46 129.65 146.92 163.60 130.73 145.15 163.91 coo 46.96 34.22 47.29 47.91 35.95 46.52 134.07 141.35 162.95 132.57 142.58 163.78 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 16 3 # 16 10 ASN P 148 ASN~? 11.59 O1 GOL P3014 20 HIS P 151 HIS~? -4.15 C3 GOL P3014s 93 ASP P 70 ASP~? 4.30 O3 GOL P3014 coo 45.21 45.27 48.24 46.79 44.92 46.88 206.51 178.28 190.78 206.84 177.74 188.77 coo 47.05 39.55 45.24 48.99 39.30 44.46 205.70 172.52 194.71 204.41 172.45 196.35 coo 46.96 34.22 47.29 47.91 35.95 46.52 200.75 174.15 199.66 202.28 173.10 198.62 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 16 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 92 ASP~? 15.30 CL CL A2020 166 GLY A 100 GLY.? 15.80 C1 GOL A3040 169 GLU A 106 GLU~? 21.37 O1 GOL A3040 coo 8.28 6.87 1.62 10.08 5.77 1.34 108.94 81.51 35.78 108.70 83.14 34.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 92.24 84.14 36.91 92.61 83.48 36.62 coo -16.67 7.89 2.78 -17.65 6.56 1.49 86.09 78.56 33.43 88.06 78.13 34.12 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 102 ASP.? 25.18 C1 GOL A3040 166 GLY A 58 GLY.? 25.44 O1 GOL A3040 169 GLU A 56 GLU.? 25.60 O3 GOL B3003 coo 8.28 6.87 1.62 10.08 5.77 1.34 88.23 80.63 30.72 87.92 80.82 28.67 coo -8.58 13.22 3.21 -8.90 13.15 4.05 72.01 82.97 38.85 71.63 83.18 39.53 coo -16.67 7.89 2.78 -17.65 6.56 1.49 66.40 88.57 34.15 65.18 90.26 34.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 102 ASP.? 20.31 O1 GOL B3024 166 GLY B 58 GLY.? 18.09 O1 GOL B3003 169 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo 8.28 6.87 1.62 10.08 5.77 1.34 30.49 75.29 14.98 31.30 77.16 14.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 44.56 63.99 18.46 44.83 63.17 18.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP C 54 ASP~? 14.99 CL CL C2006 166 GLY D 47 GLY~? 9.88 C1 GOL D3005 169 GLU D 52 GLU~? 2.84 O1 GOL D3005s coo 8.28 6.87 1.62 10.08 5.77 1.34 53.32 23.86 72.39 51.93 24.66 71.07 coo -8.58 13.22 3.21 -8.90 13.15 4.05 52.47 37.92 86.43 52.30 37.49 87.09 coo -16.67 7.89 2.78 -17.65 6.56 1.49 44.94 36.04 90.12 45.74 34.99 91.77 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP C 92 ASP~? 15.08 CL CL C2021 166 GLY C 100 GLY.? 14.66 CL CL C2011 169 GLU C 106 GLU~? 19.79 O1 GOL C3036 coo 8.28 6.87 1.62 10.08 5.77 1.34 96.74 14.44 81.93 95.51 12.97 82.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 80.63 15.92 77.56 81.07 16.49 77.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 75.34 22.76 79.72 77.40 22.80 79.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP C 102 ASP.? 24.57 CL CL C2011 166 GLY C 58 GLY.? 18.89 CL CL C2006 169 GLU C 56 GLU~? 17.52 CL CL C2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 76.25 20.52 82.74 75.40 20.56 84.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 61.95 21.22 71.14 61.69 21.11 70.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 54.66 16.88 74.36 53.19 15.44 73.98 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP D 54 ASP~? 13.05 O1 GOL D3005 166 GLY C 47 GLY~? 18.58 O3 GOL D3005 169 GLU C 52 GLU~? -16.46 O3 GOL D3005s coo 8.28 6.87 1.62 10.08 5.77 1.34 43.67 42.20 85.12 45.49 43.03 84.45 coo -8.58 13.22 3.21 -8.90 13.15 4.05 43.81 25.26 74.77 43.75 24.69 75.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 49.96 20.70 78.97 48.54 19.65 80.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP D 92 ASP~? 15.62 CL CL D2022 166 GLY D 100 GLY.? 14.37 CL CL D2012 169 GLU D 106 GLU~? 21.38 CL CL D2012 coo 8.28 6.87 1.62 10.08 5.77 1.34 -1.67 42.91 85.09 -1.08 41.92 86.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.06 44.22 87.32 14.69 43.84 86.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 21.11 39.74 82.39 19.19 40.22 81.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP D 102 ASP.? 24.32 CL CL D2012 166 GLY D 58 GLY.? 18.13 O1 GOL D3005 169 GLU D 56 GLU~? 9.22 O1 GOL D3005 coo 8.28 6.87 1.62 10.08 5.77 1.34 18.96 37.41 85.00 19.42 35.40 85.42 coo -8.58 13.22 3.21 -8.90 13.15 4.05 35.29 45.78 85.57 35.70 46.47 85.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 40.62 42.19 92.06 41.92 42.65 93.65 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP E 54 ASP~? 13.23 O1 GOL E3004 166 GLY H 47 GLY~? 10.10 C2 GOL H3006 169 GLU H 52 GLU~? -2.46 O3 GOL H3006s coo 8.28 6.87 1.62 10.08 5.77 1.34 50.61 86.23 65.01 52.31 85.22 64.30 coo -8.58 13.22 3.21 -8.90 13.15 4.05 48.04 76.16 81.66 48.12 76.70 82.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 54.90 78.91 86.42 53.66 80.21 87.52 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP E 92 ASP~? 15.39 CL CL E2032 166 GLY E 100 GLY.? 14.41 CL CL E2013 169 GLU E 106 GLU~? 21.05 O1 GOL E3022 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.40 96.69 64.15 7.81 98.00 64.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 23.21 94.72 62.80 22.71 94.23 63.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 27.90 88.73 67.36 25.90 88.59 66.70 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP E 102 ASP.? 24.45 CL CL E2013 166 GLY E 58 GLY.? 18.36 O1 GOL E3004 169 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo 8.28 6.87 1.62 10.08 5.77 1.34 26.42 91.49 69.61 27.08 91.68 71.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 42.49 88.38 61.38 42.87 88.40 60.61 coo -16.67 7.89 2.78 -17.65 6.56 1.49 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP F 54 ASP~? 17.55 CL CL F2035 166 GLY F 111 GLY~? 12.31 CL CL F2035 169 GLU F 120 GLU.? -11.16 O2 GOL F3039s coo 8.28 6.87 1.62 10.08 5.77 1.34 59.85 34.12 24.67 58.32 35.47 25.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 79.06 32.44 19.50 79.67 32.75 19.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 82.16 42.76 15.61 80.62 43.81 14.61 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP F 92 ASP~? 15.33 CL CL F2023 166 GLY F 100 GLY.? 14.35 CL CL F2034 169 GLU F 106 GLU~? 12.79 CL CL F2035 coo 8.28 6.87 1.62 10.08 5.77 1.34 104.11 24.69 25.10 103.20 23.88 23.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 88.10 29.47 22.82 88.41 29.13 23.45 coo -16.67 7.89 2.78 -17.65 6.56 1.49 81.39 27.31 28.31 83.45 27.54 28.69 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP F 102 ASP.? 16.73 CL CL F2035 166 GLY F 58 GLY.? 9.01 CL CL F2035 169 GLU F 56 GLU~? 19.98 CL CL F2035 coo 8.28 6.87 1.62 10.08 5.77 1.34 82.74 24.28 26.35 81.91 22.30 26.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 68.80 35.71 23.84 68.57 36.47 23.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP G 54 ASP~? 15.07 CL CL C2006 166 GLY F 47 GLY~? 23.85 O1 GOL B3017 169 GLU F 52 GLU~? -24.25 CL CL F2035s coo 8.28 6.87 1.62 10.08 5.77 1.34 46.65 21.52 40.60 48.29 22.27 41.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 50.15 31.83 24.18 50.23 31.30 23.58 coo -16.67 7.89 2.78 -17.65 6.56 1.49 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP G 92 ASP~? 15.60 CL CL G2033 166 GLY G 100 GLY.? 15.63 C3 GOL G3038 169 GLU G 106 GLU~? 21.38 C3 GOL G3001 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.22 20.23 31.66 3.30 18.41 31.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 18.20 18.81 36.73 17.92 19.38 36.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 24.93 23.55 33.32 22.94 24.09 33.51 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP G 102 ASP.? 25.30 O3 GOL G3038 166 GLY G 58 GLY.? 18.83 CL CL C2006 169 GLU G 56 GLU.? 17.83 CL CL C2004 coo 8.28 6.87 1.62 10.08 5.77 1.34 23.47 21.05 30.82 24.30 20.62 28.93 coo -8.58 13.22 3.21 -8.90 13.15 4.05 37.54 20.92 42.39 37.85 20.95 43.17 coo -16.67 7.89 2.78 -17.65 6.56 1.49 43.97 14.81 40.22 44.85 13.00 40.58 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP H 92 ASP~? 15.85 CL CL H2024 166 GLY H 100 GLY.? 14.46 CL CL H2014 169 GLU H 106 GLU~? 14.51 O2 GOL H3016 coo 8.28 6.87 1.62 10.08 5.77 1.34 101.24 72.29 93.07 100.11 73.39 94.44 coo -8.58 13.22 3.21 -8.90 13.15 4.05 84.43 70.85 91.47 84.93 71.17 90.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 79.71 74.06 84.56 81.75 73.57 84.59 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP H 102 ASP.? 20.45 O2 GOL H3016 166 GLY H 58 GLY.? 17.64 O3 GOL H3006 169 GLU H 56 GLU.? 8.74 O3 GOL H3006 coo 8.28 6.87 1.62 10.08 5.77 1.34 81.36 76.99 86.94 80.90 79.01 86.89 coo -8.58 13.22 3.21 -8.90 13.15 4.05 65.05 68.68 85.82 64.63 67.97 85.93 coo -16.67 7.89 2.78 -17.65 6.56 1.49 58.45 73.39 90.18 56.86 73.32 91.53 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP I 92 ASP~? 15.56 CL CL I2025 166 GLY I 100 GLY.? 14.37 CL CL I2015 169 GLU I 106 GLU~? 14.47 O1 GOL I3032 coo 8.28 6.87 1.62 10.08 5.77 1.34 222.01 200.70 150.15 220.98 202.18 149.11 coo -8.58 13.22 3.21 -8.90 13.15 4.05 205.29 202.15 152.01 205.70 201.55 151.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 199.46 196.34 148.59 201.47 195.97 149.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP I 102 ASP.? 20.44 O1 GOL I3032 166 GLY I 58 GLY.? 18.81 CL CL I2007 169 GLU I 56 GLU.? 17.30 CL CL I2001 coo 8.28 6.87 1.62 10.08 5.77 1.34 201.10 198.54 145.88 200.66 198.62 143.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 185.16 199.62 154.81 184.82 199.83 155.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 178.97 205.20 150.86 177.96 206.96 151.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP J 92 ASP~? 15.35 CL CL J2026 166 GLY J 100 GLY.? 14.25 CL CL J2016 169 GLU J 106 GLU~? 21.26 CL CL J2016 coo 8.28 6.87 1.62 10.08 5.77 1.34 122.14 189.51 128.78 123.73 190.15 127.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 138.71 185.34 129.72 138.30 185.82 130.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 144.43 188.69 135.80 142.30 188.60 135.89 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP J 102 ASP.? 24.08 CL CL J2016 166 GLY J 58 GLY.? 21.75 CL CL J2002 169 GLU J 56 GLU.? 17.48 CL CL J2002 coo 8.28 6.87 1.62 10.08 5.77 1.34 143.25 191.36 132.98 143.80 193.32 132.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 157.87 180.66 134.88 158.15 179.86 134.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 164.69 183.53 129.34 166.31 182.92 128.17 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP K 102 ASP.? 24.81 O1 GOL K3041 166 GLY K 58 GLY.? 18.35 O1 GOL K3011 169 GLU K 56 GLU~? 9.32 O1 GOL K3011 coo 8.28 6.87 1.62 10.08 5.77 1.34 194.36 135.90 195.25 193.66 135.95 197.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.79 136.37 184.44 179.50 136.20 183.68 coo -16.67 7.89 2.78 -17.65 6.56 1.49 172.89 131.40 187.88 171.30 130.10 187.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP L 54 ASP~? 22.45 O3 GOL K3011 166 GLY K 47 GLY~? 9.64 C1 GOL K3011 169 GLU K 52 GLU~? -2.85 O1 GOL K3011s coo 8.28 6.87 1.62 10.08 5.77 1.34 161.13 155.54 200.38 162.83 156.50 199.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 161.61 139.29 189.10 161.60 138.74 189.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 168.06 134.81 192.85 166.74 133.62 193.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP L 92 ASP~? 15.46 CL CL L2028 166 GLY L 100 GLY.? 14.34 CL CL L2009 169 GLU L 106 GLU~? 21.37 CL CL L2009 coo 8.28 6.87 1.62 10.08 5.77 1.34 115.70 154.99 203.31 116.12 153.70 204.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 132.17 156.37 204.50 131.77 155.97 203.90 coo -16.67 7.89 2.78 -17.65 6.56 1.49 138.12 152.20 198.93 136.10 152.63 198.56 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP L 102 ASP.? 24.59 CL CL L2009 166 GLY L 58 GLY.? 20.77 O3 GOL L3028 169 GLU L 56 GLU.? 24.71 O3 GOL K3011 coo 8.28 6.87 1.62 10.08 5.77 1.34 136.52 149.82 201.33 136.95 147.73 201.53 coo -8.58 13.22 3.21 -8.90 13.15 4.05 152.51 158.63 201.46 152.89 159.37 201.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 158.53 155.21 207.26 159.92 155.54 208.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP M 54 ASP~? 13.03 O2 GOL M3007 166 GLY M 111 GLY~? 17.25 C1 GOL M3043 169 GLU M 106 GLU~? 21.48 CL CL M2017 coo 8.28 6.87 1.62 10.08 5.77 1.34 164.95 201.02 181.99 166.71 200.19 181.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 146.83 209.40 179.72 146.17 209.01 179.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP M 54 ASP~? 13.03 O2 GOL M3007 166 GLY M 111 GLY~? 17.25 C1 GOL M3043 169 GLU M 120 GLU.? -11.44 O3 GOL M3043s coo 8.28 6.87 1.62 10.08 5.77 1.34 164.95 201.02 181.99 166.71 200.19 181.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 146.83 209.40 179.72 146.17 209.01 179.39 coo -16.67 7.89 2.78 -17.65 6.56 1.49 146.06 211.81 168.53 147.94 211.97 167.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP M 54 ASP~? 13.03 O2 GOL M3007 166 GLY P 47 GLY~? 17.92 O3 GOL M3007 169 GLU P 52 GLU~? -15.89 O3 GOL M3007s coo 8.28 6.87 1.62 10.08 5.77 1.34 164.95 201.02 181.99 166.71 200.19 181.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 163.80 189.86 198.22 163.85 190.37 198.81 coo -16.67 7.89 2.78 -17.65 6.56 1.49 170.60 192.65 202.74 169.53 193.98 203.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP M 92 ASP~? 15.40 CL CL M2029 166 GLY M 100 GLY.? 14.53 CL CL M2017 169 GLU M 106 GLU~? 21.48 CL CL M2017 coo 8.28 6.87 1.62 10.08 5.77 1.34 120.06 209.18 183.48 121.50 210.55 184.17 coo -8.58 13.22 3.21 -8.90 13.15 4.05 136.99 208.10 181.48 136.55 207.56 181.91 coo -16.67 7.89 2.78 -17.65 6.56 1.49 142.15 202.05 185.59 140.16 201.82 184.97 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP M 102 ASP.? 24.52 CL CL M2017 166 GLY M 58 GLY.? 18.41 O2 GOL M3007 169 GLU M 56 GLU~? 9.79 O1 GOL M3007 coo 8.28 6.87 1.62 10.08 5.77 1.34 140.74 204.70 188.01 141.33 204.99 189.98 coo -8.58 13.22 3.21 -8.90 13.15 4.05 156.56 202.96 179.07 156.91 202.98 178.30 coo -16.67 7.89 2.78 -17.65 6.56 1.49 163.29 208.10 182.55 164.69 209.62 182.16 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP N 54 ASP~? 13.04 O3 GOL N3008 166 GLY N 111 GLY~? 17.59 O2 GOL N3029 169 GLU N 120 GLU.? -11.11 O2 GOL N3044s coo 8.28 6.87 1.62 10.08 5.77 1.34 174.60 151.44 139.08 172.92 152.56 139.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 193.65 150.74 132.84 194.28 151.05 133.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 196.16 161.38 129.21 195.01 163.08 128.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 35 3 # 35 141 ASP N 54 ASP~? 13.04 O3 GOL N3008 166 GLY O 47 GLY~? 19.05 O1 GOL N3008 169 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo 8.28 6.87 1.62 10.08 5.77 1.34 174.60 151.44 139.08 172.92 152.56 139.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 172.47 136.75 151.98 172.39 136.07 151.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 36 3 # 36 141 ASP N 92 ASP~? 15.48 CL CL N2030 166 GLY N 100 GLY.? 15.00 O2 GOL N3029 169 GLU N 106 GLU~? 14.62 O2 GOL N3029 coo 8.28 6.87 1.62 10.08 5.77 1.34 219.13 143.58 136.78 218.22 142.74 135.01 coo -8.58 13.22 3.21 -8.90 13.15 4.05 202.89 147.88 135.58 203.22 147.52 136.22 coo -16.67 7.89 2.78 -17.65 6.56 1.49 196.48 145.55 141.46 198.54 145.70 141.81 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 37 3 # 37 141 ASP N 102 ASP.? 20.60 O2 GOL N3029 166 GLY N 58 GLY.? 17.87 O3 GOL N3008 169 GLU N 56 GLU.? 8.85 O3 GOL N3008 coo 8.28 6.87 1.62 10.08 5.77 1.34 197.96 142.41 139.19 197.06 140.46 139.09 coo -8.58 13.22 3.21 -8.90 13.15 4.05 183.43 153.24 137.84 183.14 154.05 137.70 coo -16.67 7.89 2.78 -17.65 6.56 1.49 177.02 149.87 132.23 175.77 150.16 130.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 38 3 # 38 141 ASP O 54 ASP~? 15.16 CL CL K2003 166 GLY N 47 GLY~? 9.71 O1 GOL N3008 169 GLU N 52 GLU~? -2.84 O3 GOL N3008s coo 8.28 6.87 1.62 10.08 5.77 1.34 162.95 137.35 154.91 164.67 137.97 155.90 coo -8.58 13.22 3.21 -8.90 13.15 4.05 165.04 148.45 138.73 165.12 147.95 138.15 coo -16.67 7.89 2.78 -17.65 6.56 1.49 171.98 144.88 135.10 170.87 143.79 133.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 39 3 # 39 141 ASP O 92 ASP~? 15.96 CL CL O2018 166 GLY O 100 GLY.? 12.06 CL CL O2036 169 GLU O 106 GLU~? 13.74 CL CL O2036 coo 8.28 6.87 1.62 10.08 5.77 1.34 118.21 134.06 148.13 119.12 132.25 147.57 coo -8.58 13.22 3.21 -8.90 13.15 4.05 134.51 133.33 152.18 134.16 133.89 151.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 140.87 138.77 148.77 138.84 139.06 148.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 40 3 # 40 141 ASP O 102 ASP.? 13.16 CL CL O2036 166 GLY O 58 GLY.? 13.15 CL CL O2036 169 GLU O 4 GLU.? 15.52 CL CL K2003 coo 8.28 6.87 1.62 10.08 5.77 1.34 139.48 136.33 146.19 140.25 135.96 144.25 coo -8.58 13.22 3.21 -8.90 13.15 4.05 154.09 136.29 157.02 154.38 136.21 157.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 160.46 142.68 161.06 159.04 143.89 159.95 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 41 3 # 41 141 ASP O 102 ASP.? 13.16 CL CL O2036 166 GLY O 58 GLY.? 13.15 CL CL O2036 169 GLU O 56 GLU.? 16.78 CL CL O2036 coo 8.28 6.87 1.62 10.08 5.77 1.34 139.48 136.33 146.19 140.25 135.96 144.25 coo -8.58 13.22 3.21 -8.90 13.15 4.05 154.09 136.29 157.02 154.38 136.21 157.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 42 3 # 42 141 ASP P 54 ASP~? 21.88 O3 GOL M3007 166 GLY M 47 GLY~? 10.19 O2 GOL M3007 169 GLU M 52 GLU~? 2.53 O2 GOL M3007s coo 8.28 6.87 1.62 10.08 5.77 1.34 172.77 185.90 199.12 171.10 184.95 198.29 coo -8.58 13.22 3.21 -8.90 13.15 4.05 173.95 200.63 186.00 173.90 201.28 186.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 167.24 205.49 188.41 168.46 206.85 189.44 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 43 3 # 43 141 ASP P 92 ASP~? 16.23 CL CL P2019 166 GLY P 100 GLY.? 14.36 CL CL P2019 169 GLU P 106 GLU~? 20.67 O3 GOL P3014 coo 8.28 6.87 1.62 10.08 5.77 1.34 217.62 187.96 206.84 216.52 189.08 208.26 coo -8.58 13.22 3.21 -8.90 13.15 4.05 200.81 185.95 206.27 201.28 186.23 205.69 coo -16.67 7.89 2.78 -17.65 6.56 1.49 195.52 189.19 199.68 197.57 188.76 199.63 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 44 3 # 44 141 ASP P 102 ASP.? 24.26 CL CL P2019 166 GLY P 58 GLY.? 25.31 O1 GOL P3034 169 GLU P 56 GLU.? 24.16 O3 GOL M3007 coo 8.28 6.87 1.62 10.08 5.77 1.34 197.01 191.93 202.05 196.73 194.01 202.05 coo -8.58 13.22 3.21 -8.90 13.15 4.05 181.27 182.97 201.43 180.87 182.24 201.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 174.58 187.04 206.13 173.17 186.75 207.60 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 44 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 75 TYR~? 11.96 CL CL A2020 A 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 256 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 97.97 81.77 42.85 98.10 80.04 40.64 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 90.44 78.16 48.76 91.65 76.94 50.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 123 TYR.? -4.01 O1 GOL A3040s A 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 256 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 92.97 88.22 47.49 92.65 86.11 49.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 90.44 78.16 48.76 91.65 76.94 50.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 123 TYR.? -4.01 O1 GOL A3040s A 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 256 LYS A 142 LYS~? 20.36 CL CL A2020 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 92.97 88.22 47.49 92.65 86.11 49.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 90.44 78.16 48.76 91.65 76.94 50.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 157 TYR.? -3.90 O2 GOL A3037s A 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s A 256 LYS A 142 LYS~? 20.36 CL CL A2020 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 100.57 80.52 55.08 97.88 80.73 54.34 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 90.44 78.16 48.76 91.65 76.94 50.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR B 75 TYR~? 10.15 CL CL B2010 A 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 256 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 18.67 65.14 13.86 18.80 67.67 14.99 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.66 59.02 20.34 21.93 58.32 21.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 123 TYR.? -4.36 O2 GOL B3023s A 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 256 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.54 58.32 9.82 22.98 57.14 12.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.66 59.02 20.34 21.93 58.32 21.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR B 123 TYR.? -4.36 O2 GOL B3023s A 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 256 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.54 58.32 9.82 22.98 57.14 12.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.66 59.02 20.34 21.93 58.32 21.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR B 157 TYR.? 7.53 O1 GOL B3015 A 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s A 256 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.23 54.49 17.04 16.01 54.48 17.30 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.66 59.02 20.34 21.93 58.32 21.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR C 75 TYR~? 10.50 CL CL C2011 A 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 256 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 87.86 16.77 72.91 87.86 18.43 75.14 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR C 112 TYR~? 12.57 O3 GOL C3021 A 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 256 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 72.92 17.11 69.08 73.05 17.20 66.28 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR C 123 TYR.? -8.00 CL CL C2011s A 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 256 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 82.73 11.63 67.15 83.32 13.82 65.52 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR C 123 TYR.? -8.00 CL CL C2011s A 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 256 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 82.73 11.63 67.15 83.32 13.82 65.52 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR C 157 TYR.? 7.25 O1 GOL C3036 A 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s A 256 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 93.23 17.43 61.74 90.40 17.73 61.84 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 82.81 22.02 65.69 84.52 22.80 64.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR D 75 TYR~? 10.03 CL CL D2012 A 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 256 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.41 49.60 83.94 9.22 47.13 82.70 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 15 3 # 15 A 122 TYR D 112 TYR~? 11.57 O3 GOL D3019 A 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 256 LYS D 142 LYS~? 18.65 CL CL D2012 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 24.56 50.70 86.69 25.05 53.37 86.07 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 16 3 # 16 A 122 TYR D 123 TYR.? -4.29 O1 GOL D3018s A 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 256 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 14.40 55.37 89.22 14.73 56.67 86.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 17 3 # 17 A 122 TYR D 123 TYR.? -4.29 O1 GOL D3018s A 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 256 LYS D 142 LYS~? 18.65 CL CL D2012 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 14.40 55.37 89.22 14.73 56.67 86.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 18 3 # 18 A 122 TYR D 157 TYR.? 4.28 O2 GOL D3020 A 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s A 256 LYS D 142 LYS~? 18.65 CL CL D2012 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 6.86 61.00 80.62 9.60 60.40 80.64 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 16.94 54.59 79.01 15.65 55.42 77.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 19 3 # 19 A 122 TYR E 75 TYR~? 10.13 CL CL E2013 A 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 256 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 16.89 92.83 57.30 16.35 91.61 59.76 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.07 86.29 52.35 21.57 85.17 51.32 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 20 3 # 20 A 122 TYR E 123 TYR.? -3.70 O1 GOL E3022s A 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 256 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.00 96.79 51.50 22.74 94.30 50.21 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.07 86.29 52.35 21.57 85.17 51.32 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 21 3 # 21 A 122 TYR E 123 TYR.? -3.70 O1 GOL E3022s A 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 256 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 23.00 96.79 51.50 22.74 94.30 50.21 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.07 86.29 52.35 21.57 85.17 51.32 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 22 3 # 22 A 122 TYR E 157 TYR.? -7.44 C3 GOL E3002s A 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 A 256 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 13.76 89.62 45.68 16.45 89.35 46.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 23.07 86.29 52.35 21.57 85.17 51.32 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 23 3 # 23 A 122 TYR F 75 TYR~? 9.99 CL CL F2034 A 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 256 LYS F 61 LYS~? -5.82 CL CL F2035s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 95.01 33.97 25.26 94.64 31.83 27.03 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 24 3 # 24 A 122 TYR F 112 TYR~? 9.99 CL CL F2035 A 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 256 LYS F 142 LYS~? 19.20 CL CL F2034 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 80.32 37.88 21.99 80.47 40.63 22.04 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 25 3 # 25 A 122 TYR F 123 TYR.? -3.90 O3 GOL F3039s A 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 256 LYS F 61 LYS~? -5.82 CL CL F2035s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 91.29 39.67 18.85 91.31 41.46 21.04 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 26 3 # 26 A 122 TYR F 123 TYR.? -3.90 O3 GOL F3039s A 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 256 LYS F 142 LYS~? 19.20 CL CL F2034 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 91.29 39.67 18.85 91.31 41.46 21.04 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 27 3 # 27 A 122 TYR F 157 TYR.? -10.36 O3 GOL F3039s A 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s A 256 LYS F 142 LYS~? 19.20 CL CL F2034 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 100.15 45.18 26.97 97.32 45.17 26.68 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 88.86 41.25 28.96 90.30 42.22 30.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 28 3 # 28 A 122 TYR G 75 TYR~? 12.69 CL CL G2033 A 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 256 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 11.49 22.21 40.76 11.82 23.42 38.24 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 29 3 # 29 A 122 TYR G 112 TYR~? 13.62 O3 GOL G3038 A 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 256 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 26.10 19.68 45.15 26.07 20.41 47.86 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 30 3 # 30 A 122 TYR G 123 TYR.? -4.47 O3 GOL G3038s A 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 256 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 15.30 16.99 47.49 15.28 19.49 48.80 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 31 3 # 31 A 122 TYR G 123 TYR.? -4.47 O3 GOL G3038s A 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 256 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 15.30 16.99 47.49 15.28 19.49 48.80 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 32 3 # 32 A 122 TYR G 157 TYR.? 5.49 O3 GOL G3001 A 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s A 256 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 6.53 26.08 51.42 9.33 25.84 51.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 17.70 27.34 47.09 16.19 28.71 47.73 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 33 3 # 33 A 122 TYR H 75 TYR~? 10.27 CL CL H2014 A 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 256 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 90.64 65.09 90.65 91.11 67.21 88.98 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 34 3 # 34 A 122 TYR H 112 TYR~? 11.95 O3 GOL H3016 A 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 256 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 75.20 64.22 90.27 74.79 61.48 90.12 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 35 3 # 35 A 122 TYR H 123 TYR.? -7.93 CL CL H2014s A 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 256 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 84.40 60.41 95.89 84.67 58.62 93.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 36 3 # 36 A 122 TYR H 123 TYR.? -7.93 CL CL H2014s A 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 256 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 84.40 60.41 95.89 84.67 58.62 93.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 37 3 # 37 A 122 TYR H 157 TYR.? -11.04 CL CL H2014s A 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s A 256 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 93.68 52.87 90.01 90.96 53.43 89.67 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 84.24 58.93 85.48 85.73 57.59 84.66 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 38 3 # 38 A 122 TYR I 75 TYR~? 10.32 CL CL I2015 A 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 256 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 211.34 199.93 157.52 211.50 198.33 155.24 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 39 3 # 39 A 122 TYR I 112 TYR~? 12.20 O2 GOL I3032 A 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 256 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 196.16 202.11 159.00 195.80 201.93 161.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 40 3 # 40 A 122 TYR I 123 TYR.? -3.81 O1 GOL I3031s A 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 256 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 206.34 205.79 162.64 206.20 203.62 164.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 41 3 # 41 A 122 TYR I 123 TYR.? -3.81 O1 GOL I3031s A 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 256 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 206.34 205.79 162.64 206.20 203.62 164.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 42 3 # 42 A 122 TYR I 157 TYR.? -10.00 O3 GOL I3031s A 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s A 256 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 214.62 198.06 169.41 211.87 198.21 168.94 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 204.37 195.46 163.61 205.75 194.30 164.79 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 43 3 # 43 A 122 TYR J 75 TYR~? 10.17 CL CL J2016 A 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 256 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 131.82 180.89 131.78 131.82 183.34 133.12 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 44 3 # 44 A 122 TYR J 112 TYR~? 13.43 O1 GOL J3030 A 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 256 LYS J 142 LYS~? 19.62 CL CL J2016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 146.80 177.39 131.57 146.79 174.66 132.11 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 45 3 # 45 A 122 TYR J 123 TYR.? -4.20 O1 GOL J3030s A 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 256 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 136.67 174.46 127.10 136.30 173.08 129.51 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 46 3 # 46 A 122 TYR J 123 TYR.? -4.20 O1 GOL J3030s A 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 256 LYS J 142 LYS~? 19.62 CL CL J2016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 136.67 174.46 127.10 136.30 173.08 129.51 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 47 3 # 47 A 122 TYR J 157 TYR.? 4.16 O1 GOL J3033 A 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 A 256 LYS J 142 LYS~? 19.62 CL CL J2016 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 126.93 169.72 134.52 129.73 169.94 134.63 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 137.44 174.60 137.57 135.80 173.80 138.69 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 48 3 # 48 A 122 TYR K 75 TYR~? 12.36 CL CL K2027 A 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 256 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 205.79 133.16 185.06 205.81 134.80 187.34 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 49 3 # 49 A 122 TYR K 112 TYR~? 10.80 O3 GOL K3010 A 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 256 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 190.77 132.67 181.60 190.81 132.90 178.83 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 50 3 # 50 A 122 TYR K 123 TYR.? -4.42 O2 GOL K3041s A 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 256 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 200.86 127.71 179.28 201.20 129.91 177.64 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 51 3 # 51 A 122 TYR K 123 TYR.? -4.42 O2 GOL K3041s A 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 256 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 200.86 127.71 179.28 201.20 129.91 177.64 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 52 3 # 52 A 122 TYR K 157 TYR.? 6.79 O2 GOL K3009 A 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s A 256 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 210.77 134.37 173.74 207.96 134.59 173.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.17 138.24 178.11 201.77 139.28 177.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 53 3 # 53 A 122 TYR L 75 TYR~? 10.07 CL CL L2009 A 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 256 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 126.23 161.73 201.55 126.10 159.32 200.24 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 54 3 # 54 A 122 TYR L 112 TYR~? 12.13 O3 GOL L3028 A 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 256 LYS L 142 LYS~? 23.18 CL CL L2009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 141.53 163.06 203.38 141.93 165.73 202.75 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 55 3 # 55 A 122 TYR L 123 TYR.? -4.18 O1 GOL L3027s A 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 256 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 131.49 167.37 206.62 131.53 168.77 204.19 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 56 3 # 56 A 122 TYR L 123 TYR.? -4.18 O1 GOL L3027s A 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 256 LYS L 142 LYS~? 23.18 CL CL L2009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 131.49 167.37 206.62 131.53 168.77 204.19 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 57 3 # 57 A 122 TYR L 157 TYR.? 9.71 O3 GOL L3027 A 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s A 256 LYS L 142 LYS~? 23.18 CL CL L2009 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 123.19 173.24 198.15 125.89 172.62 198.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 133.34 166.97 196.27 132.03 168.03 194.96 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 58 3 # 58 A 122 TYR M 75 TYR~? 10.36 CL CL M2017 A 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 256 LYS M 61 LYS~? 24.74 CL CL I2007 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 130.62 206.12 176.17 130.27 204.76 178.58 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 136.87 200.18 170.79 135.36 199.08 169.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 59 3 # 59 A 122 TYR M 123 TYR.? -4.30 O1 GOL M3043s A 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 256 LYS M 61 LYS~? 24.74 CL CL I2007 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 136.30 210.69 170.36 136.06 208.30 168.99 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 136.87 200.18 170.79 135.36 199.08 169.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 60 3 # 60 A 122 TYR M 123 TYR.? -4.30 O1 GOL M3043s A 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 256 LYS M 142 LYS~? 19.90 CL CL M2017 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 136.30 210.69 170.36 136.06 208.30 168.99 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 136.87 200.18 170.79 135.36 199.08 169.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 61 3 # 61 A 122 TYR M 157 TYR.? -4.16 C2 GOL M3042s A 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s A 256 LYS M 142 LYS~? 19.90 CL CL M2017 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 127.03 203.34 164.58 129.75 203.18 165.07 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 136.87 200.18 170.79 135.36 199.08 169.77 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 62 3 # 62 A 122 TYR N 75 TYR~? 12.44 O2 GOL N3029 A 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 256 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 209.71 152.64 137.80 209.50 150.35 139.41 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 63 3 # 63 A 122 TYR N 112 TYR~? 12.42 O1 GOL N3044 A 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 256 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 194.78 156.07 135.52 194.77 158.81 135.67 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 64 3 # 64 A 122 TYR N 123 TYR.? -12.00 CL CL N2030s A 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 256 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 205.39 158.43 131.87 205.49 160.09 134.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 65 3 # 65 A 122 TYR N 123 TYR.? -12.00 CL CL N2030s A 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 256 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 205.39 158.43 131.87 205.49 160.09 134.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 66 3 # 66 A 122 TYR N 157 TYR.? 7.89 C1 GOL N3012 A 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s A 256 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 214.45 164.07 139.74 211.68 163.84 139.51 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 203.51 159.51 142.26 205.02 160.53 143.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 67 3 # 67 A 122 TYR O 75 TYR~? 10.24 CL CL O2018 A 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 256 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 127.87 136.17 156.70 127.95 137.50 154.23 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 68 3 # 68 A 122 TYR O 112 TYR~? 11.14 CL CL O2036 A 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 256 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 142.72 134.33 160.12 142.81 134.85 162.82 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 69 3 # 69 A 122 TYR O 123 TYR.? -7.90 CL CL O2018s A 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 256 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 132.12 130.96 163.05 132.10 133.32 164.44 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 70 3 # 70 A 122 TYR O 123 TYR.? -7.90 CL CL O2018s A 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 256 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 132.12 130.96 163.05 132.10 133.32 164.44 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 71 3 # 71 A 122 TYR O 157 TYR.? 6.41 O2 GOL O3013 A 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s A 256 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 123.23 139.38 167.80 126.05 139.22 167.65 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 134.07 141.35 162.95 132.57 142.58 163.78 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 72 3 # 72 A 122 TYR P 75 TYR~? 10.23 CL CL P2019 A 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 256 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 207.22 180.36 204.70 207.43 182.65 203.13 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 73 3 # 73 A 122 TYR P 112 TYR~? 13.01 O1 GOL P3034 A 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 256 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 191.84 178.79 205.19 191.53 176.04 204.95 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 74 3 # 74 A 122 TYR P 123 TYR.? -3.93 O1 GOL P3034s A 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 256 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 201.57 175.22 210.06 201.77 173.54 207.86 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 75 3 # 75 A 122 TYR P 123 TYR.? -3.93 O1 GOL P3034s A 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 256 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 201.57 175.22 210.06 201.77 173.54 207.86 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 76 3 # 76 A 122 TYR P 157 TYR.? 6.12 O2 GOL P3014 A 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 A 256 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 210.70 168.63 203.45 207.96 169.02 203.20 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 200.75 174.15 199.66 202.28 173.10 198.62 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 204.59 186.28 195.60 209.96 186.96 196.62 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 76 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 75 TYR~? 11.96 CL CL A2020 B 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 256 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -32.67 22.74 10.17 -32.85 23.98 7.70 97.97 81.77 42.85 98.10 80.04 40.64 coo -26.88 17.61 16.89 -26.08 17.11 15.00 90.44 78.16 48.76 91.65 76.94 50.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 123 TYR.? -4.01 O1 GOL A3040s B 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 256 LYS A 61 LYS~? 25.67 O1 GOL A3040 coo -32.67 22.74 10.17 -32.85 23.98 7.70 92.97 88.22 47.49 92.65 86.11 49.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 90.44 78.16 48.76 91.65 76.94 50.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 77.17 77.82 45.44 75.12 71.91 44.01 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 123 TYR.? -4.01 O1 GOL A3040s B 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 256 LYS A 142 LYS~? 20.36 CL CL A2020 coo -32.67 22.74 10.17 -32.85 23.98 7.70 92.97 88.22 47.49 92.65 86.11 49.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 90.44 78.16 48.76 91.65 76.94 50.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 157 TYR.? -3.90 O2 GOL A3037s B 214 ASP A 70 ASP~? -9.95 O3 GOL A3037s B 256 LYS A 142 LYS~? 20.36 CL CL A2020 coo -32.67 22.74 10.17 -32.85 23.98 7.70 100.57 80.52 55.08 97.88 80.73 54.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 90.44 78.16 48.76 91.65 76.94 50.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 94.05 73.09 37.15 99.40 72.43 37.04 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR B 75 TYR~? 10.15 CL CL B2010 B 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 256 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -32.67 22.74 10.17 -32.85 23.98 7.70 18.67 65.14 13.86 18.80 67.67 14.99 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.66 59.02 20.34 21.93 58.32 21.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR B 123 TYR.? -4.36 O2 GOL B3023s B 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 256 LYS B 61 LYS~? 13.21 O1 GOL B3024 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.54 58.32 9.82 22.98 57.14 12.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.66 59.02 20.34 21.93 58.32 21.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 37.08 59.90 23.39 37.89 62.97 28.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR B 123 TYR.? -4.36 O2 GOL B3023s B 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 256 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.54 58.32 9.82 22.98 57.14 12.28 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.66 59.02 20.34 21.93 58.32 21.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR B 157 TYR.? 7.53 O1 GOL B3015 B 214 ASP B 70 ASP~? -3.24 O2 GOL B3024s B 256 LYS B 142 LYS~? 15.72 O2 GOL B3024 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.23 54.49 17.04 16.01 54.48 17.30 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.66 59.02 20.34 21.93 58.32 21.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 21.85 72.06 22.17 16.34 73.26 20.39 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR C 75 TYR~? 10.50 CL CL C2011 B 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 256 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -32.67 22.74 10.17 -32.85 23.98 7.70 87.86 16.77 72.91 87.86 18.43 75.14 coo -26.88 17.61 16.89 -26.08 17.11 15.00 82.81 22.02 65.69 84.52 22.80 64.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR C 123 TYR.? -8.00 CL CL C2011s B 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 256 LYS C 61 LYS~? 16.19 O3 GOL C3021 coo -32.67 22.74 10.17 -32.85 23.98 7.70 82.73 11.63 67.15 83.32 13.82 65.52 coo -26.88 17.61 16.89 -26.08 17.11 15.00 82.81 22.02 65.69 84.52 22.80 64.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 69.46 25.25 66.14 70.83 29.06 67.88 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR C 123 TYR.? -8.00 CL CL C2011s B 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 256 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -32.67 22.74 10.17 -32.85 23.98 7.70 82.73 11.63 67.15 83.32 13.82 65.52 coo -26.88 17.61 16.89 -26.08 17.11 15.00 82.81 22.02 65.69 84.52 22.80 64.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR C 157 TYR.? 7.25 O1 GOL C3036 B 214 ASP C 70 ASP~? 3.38 O1 GOL C3036s B 256 LYS C 142 LYS~? 17.22 O1 GOL C3036 coo -32.67 22.74 10.17 -32.85 23.98 7.70 93.23 17.43 61.74 90.40 17.73 61.84 coo -26.88 17.61 16.89 -26.08 17.11 15.00 82.81 22.02 65.69 84.52 22.80 64.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 84.87 26.44 78.04 89.10 24.68 78.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR D 75 TYR~? 10.03 CL CL D2012 B 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 256 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.41 49.60 83.94 9.22 47.13 82.70 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.94 54.59 79.01 15.65 55.42 77.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR D 123 TYR.? -4.29 O1 GOL D3018s B 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 256 LYS D 61 LYS~? 17.13 O3 GOL D3019 coo -32.67 22.74 10.17 -32.85 23.98 7.70 14.40 55.37 89.22 14.73 56.67 86.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.94 54.59 79.01 15.65 55.42 77.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 30.16 51.15 79.13 28.89 47.78 74.43 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR D 123 TYR.? -4.29 O1 GOL D3018s B 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 256 LYS D 142 LYS~? 18.65 CL CL D2012 coo -32.67 22.74 10.17 -32.85 23.98 7.70 14.40 55.37 89.22 14.73 56.67 86.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.94 54.59 79.01 15.65 55.42 77.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 16 3 # 16 B 122 TYR D 157 TYR.? 4.28 O2 GOL D3020 B 214 ASP D 70 ASP~? -11.51 O3 GOL D3019s B 256 LYS D 142 LYS~? 18.65 CL CL D2012 coo -32.67 22.74 10.17 -32.85 23.98 7.70 6.86 61.00 80.62 9.60 60.40 80.64 coo -26.88 17.61 16.89 -26.08 17.11 15.00 16.94 54.59 79.01 15.65 55.42 77.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 13.01 42.17 76.46 7.83 42.85 76.18 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 17 3 # 17 B 122 TYR E 75 TYR~? 10.13 CL CL E2013 B 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 256 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -32.67 22.74 10.17 -32.85 23.98 7.70 16.89 92.83 57.30 16.35 91.61 59.76 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.07 86.29 52.35 21.57 85.17 51.32 coo -16.04 12.06 11.09 -17.97 10.54 5.71 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 18 3 # 18 B 122 TYR E 123 TYR.? -3.70 O1 GOL E3022s B 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 256 LYS E 61 LYS~? 18.09 C2 GOL E3035 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.00 96.79 51.50 22.74 94.30 50.21 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.07 86.29 52.35 21.57 85.17 51.32 coo -16.04 12.06 11.09 -17.97 10.54 5.71 36.09 83.48 55.83 38.22 79.83 59.29 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 19 3 # 19 B 122 TYR E 123 TYR.? -3.70 O1 GOL E3022s B 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 256 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 23.00 96.79 51.50 22.74 94.30 50.21 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.07 86.29 52.35 21.57 85.17 51.32 coo -16.04 12.06 11.09 -17.97 10.54 5.71 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 20 3 # 20 B 122 TYR E 157 TYR.? -7.44 C3 GOL E3002s B 214 ASP E 70 ASP~? 5.56 O3 GOL E3002 B 256 LYS E 142 LYS~? 18.17 O1 GOL E3002 coo -32.67 22.74 10.17 -32.85 23.98 7.70 13.76 89.62 45.68 16.45 89.35 46.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 23.07 86.29 52.35 21.57 85.17 51.32 coo -16.04 12.06 11.09 -17.97 10.54 5.71 18.76 84.43 64.64 13.52 85.68 64.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 21 3 # 21 B 122 TYR F 75 TYR~? 9.99 CL CL F2034 B 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 256 LYS F 61 LYS~? -5.82 CL CL F2035s coo -32.67 22.74 10.17 -32.85 23.98 7.70 95.01 33.97 25.26 94.64 31.83 27.03 coo -26.88 17.61 16.89 -26.08 17.11 15.00 88.86 41.25 28.96 90.30 42.22 30.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 22 3 # 22 B 122 TYR F 123 TYR.? -3.90 O3 GOL F3039s B 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 256 LYS F 61 LYS~? -5.82 CL CL F2035s coo -32.67 22.74 10.17 -32.85 23.98 7.70 91.29 39.67 18.85 91.31 41.46 21.04 coo -26.88 17.61 16.89 -26.08 17.11 15.00 88.86 41.25 28.96 90.30 42.22 30.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 75.18 41.05 29.20 73.13 39.59 35.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 23 3 # 23 B 122 TYR F 123 TYR.? -3.90 O3 GOL F3039s B 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 256 LYS F 142 LYS~? 19.20 CL CL F2034 coo -32.67 22.74 10.17 -32.85 23.98 7.70 91.29 39.67 18.85 91.31 41.46 21.04 coo -26.88 17.61 16.89 -26.08 17.11 15.00 88.86 41.25 28.96 90.30 42.22 30.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 24 3 # 24 B 122 TYR F 157 TYR.? -10.36 O3 GOL F3039s B 214 ASP F 70 ASP~? -11.57 O3 GOL F3039s B 256 LYS F 142 LYS~? 19.20 CL CL F2034 coo -32.67 22.74 10.17 -32.85 23.98 7.70 100.15 45.18 26.97 97.32 45.17 26.68 coo -26.88 17.61 16.89 -26.08 17.11 15.00 88.86 41.25 28.96 90.30 42.22 30.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 89.94 29.13 34.00 95.25 27.31 34.06 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 25 3 # 25 B 122 TYR G 75 TYR~? 12.69 CL CL G2033 B 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 256 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 11.49 22.21 40.76 11.82 23.42 38.24 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.70 27.34 47.09 16.19 28.71 47.73 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 26 3 # 26 B 122 TYR G 123 TYR.? -4.47 O3 GOL G3038s B 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 256 LYS G 61 LYS~? 18.93 O2 GOL G3001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 15.30 16.99 47.49 15.28 19.49 48.80 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.70 27.34 47.09 16.19 28.71 47.73 coo -16.04 12.06 11.09 -17.97 10.54 5.71 31.38 27.35 46.57 31.17 32.58 43.56 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 27 3 # 27 B 122 TYR G 123 TYR.? -4.47 O3 GOL G3038s B 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 256 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 15.30 16.99 47.49 15.28 19.49 48.80 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.70 27.34 47.09 16.19 28.71 47.73 coo -16.04 12.06 11.09 -17.97 10.54 5.71 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 28 3 # 28 B 122 TYR G 157 TYR.? 5.49 O3 GOL G3001 B 214 ASP G 70 ASP~? -5.29 C3 GOL G3001s B 256 LYS G 142 LYS~? 22.79 C3 GOL G3001 coo -32.67 22.74 10.17 -32.85 23.98 7.70 6.53 26.08 51.42 9.33 25.84 51.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 17.70 27.34 47.09 16.19 28.71 47.73 coo -16.04 12.06 11.09 -17.97 10.54 5.71 16.44 29.60 34.10 15.26 26.17 28.78 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 29 3 # 29 B 122 TYR H 75 TYR~? 10.27 CL CL H2014 B 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 256 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 90.64 65.09 90.65 91.11 67.21 88.98 coo -26.88 17.61 16.89 -26.08 17.11 15.00 84.24 58.93 85.48 85.73 57.59 84.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 30 3 # 30 B 122 TYR H 123 TYR.? -7.93 CL CL H2014s B 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 256 LYS H 61 LYS~? 14.53 O2 GOL H3016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 84.40 60.41 95.89 84.67 58.62 93.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 84.24 58.93 85.48 85.73 57.59 84.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 71.37 62.08 82.00 69.43 63.00 77.17 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 31 3 # 31 B 122 TYR H 123 TYR.? -7.93 CL CL H2014s B 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 256 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 84.40 60.41 95.89 84.67 58.62 93.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 84.24 58.93 85.48 85.73 57.59 84.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 32 3 # 32 B 122 TYR H 157 TYR.? -11.04 CL CL H2014s B 214 ASP H 70 ASP~? -4.05 C3 GOL H3016s B 256 LYS H 142 LYS~? 14.79 O1 GOL H3016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 93.68 52.87 90.01 90.96 53.43 89.67 coo -26.88 17.61 16.89 -26.08 17.11 15.00 84.24 58.93 85.48 85.73 57.59 84.66 coo -16.04 12.06 11.09 -17.97 10.54 5.71 88.83 70.49 80.96 94.32 71.20 82.05 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 33 3 # 33 B 122 TYR I 75 TYR~? 10.32 CL CL I2015 B 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 256 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -32.67 22.74 10.17 -32.85 23.98 7.70 211.34 199.93 157.52 211.50 198.33 155.24 coo -26.88 17.61 16.89 -26.08 17.11 15.00 204.37 195.46 163.61 205.75 194.30 164.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 34 3 # 34 B 122 TYR I 123 TYR.? -3.81 O1 GOL I3031s B 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 256 LYS I 61 LYS~? 10.96 O1 GOL I3032 coo -32.67 22.74 10.17 -32.85 23.98 7.70 206.34 205.79 162.64 206.20 203.62 164.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 204.37 195.46 163.61 205.75 194.30 164.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 190.91 194.56 160.97 192.19 189.31 159.02 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 35 3 # 35 B 122 TYR I 123 TYR.? -3.81 O1 GOL I3031s B 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 256 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -32.67 22.74 10.17 -32.85 23.98 7.70 206.34 205.79 162.64 206.20 203.62 164.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 204.37 195.46 163.61 205.75 194.30 164.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 36 3 # 36 B 122 TYR I 157 TYR.? -10.00 O3 GOL I3031s B 214 ASP I 70 ASP~? -3.65 C2 GOL I3032s B 256 LYS I 142 LYS~? 14.36 O1 GOL I3032 coo -32.67 22.74 10.17 -32.85 23.98 7.70 214.62 198.06 169.41 211.87 198.21 168.94 coo -26.88 17.61 16.89 -26.08 17.11 15.00 204.37 195.46 163.61 205.75 194.30 164.79 coo -16.04 12.06 11.09 -17.97 10.54 5.71 208.03 191.18 151.66 205.16 191.96 148.66 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 37 3 # 37 B 122 TYR J 75 TYR~? 10.17 CL CL J2016 B 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 256 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -32.67 22.74 10.17 -32.85 23.98 7.70 131.82 180.89 131.78 131.82 183.34 133.12 coo -26.88 17.61 16.89 -26.08 17.11 15.00 137.44 174.60 137.57 135.80 173.80 138.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 38 3 # 38 B 122 TYR J 123 TYR.? -4.20 O1 GOL J3030s B 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 256 LYS J 61 LYS~? 25.33 O1 GOL J3030 coo -32.67 22.74 10.17 -32.85 23.98 7.70 136.67 174.46 127.10 136.30 173.08 129.51 coo -26.88 17.61 16.89 -26.08 17.11 15.00 137.44 174.60 137.57 135.80 173.80 138.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 150.81 175.94 139.88 149.98 178.29 145.35 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 39 3 # 39 B 122 TYR J 123 TYR.? -4.20 O1 GOL J3030s B 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 256 LYS J 142 LYS~? 19.62 CL CL J2016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 136.67 174.46 127.10 136.30 173.08 129.51 coo -26.88 17.61 16.89 -26.08 17.11 15.00 137.44 174.60 137.57 135.80 173.80 138.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 40 3 # 40 B 122 TYR J 157 TYR.? 4.16 O1 GOL J3033 B 214 ASP J 70 ASP~? 11.68 O1 GOL J3033 B 256 LYS J 142 LYS~? 19.62 CL CL J2016 coo -32.67 22.74 10.17 -32.85 23.98 7.70 126.93 169.72 134.52 129.73 169.94 134.63 coo -26.88 17.61 16.89 -26.08 17.11 15.00 137.44 174.60 137.57 135.80 173.80 138.69 coo -16.04 12.06 11.09 -17.97 10.54 5.71 135.12 187.43 140.16 132.76 191.26 136.26 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 41 3 # 41 B 122 TYR K 75 TYR~? 12.36 CL CL K2027 B 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 256 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -32.67 22.74 10.17 -32.85 23.98 7.70 205.79 133.16 185.06 205.81 134.80 187.34 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.17 138.24 178.11 201.77 139.28 177.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 42 3 # 42 B 122 TYR K 123 TYR.? -4.42 O2 GOL K3041s B 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 256 LYS K 61 LYS~? 17.02 C3 GOL K3010 coo -32.67 22.74 10.17 -32.85 23.98 7.70 200.86 127.71 179.28 201.20 129.91 177.64 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.17 138.24 178.11 201.77 139.28 177.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 186.73 140.78 179.08 183.84 145.13 179.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 43 3 # 43 B 122 TYR K 123 TYR.? -4.42 O2 GOL K3041s B 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 256 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -32.67 22.74 10.17 -32.85 23.98 7.70 200.86 127.71 179.28 201.20 129.91 177.64 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.17 138.24 178.11 201.77 139.28 177.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 44 3 # 44 B 122 TYR K 157 TYR.? 6.79 O2 GOL K3009 B 214 ASP K 70 ASP~? -4.89 O3 GOL K3009s B 256 LYS K 142 LYS~? 19.15 C2 GOL K3009 coo -32.67 22.74 10.17 -32.85 23.98 7.70 210.77 134.37 173.74 207.96 134.59 173.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.17 138.24 178.11 201.77 139.28 177.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 202.52 142.42 190.46 207.82 141.83 191.71 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 45 3 # 45 B 122 TYR L 75 TYR~? 10.07 CL CL L2009 B 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 256 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -32.67 22.74 10.17 -32.85 23.98 7.70 126.23 161.73 201.55 126.10 159.32 200.24 coo -26.88 17.61 16.89 -26.08 17.11 15.00 133.34 166.97 196.27 132.03 168.03 194.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 46 3 # 46 B 122 TYR L 123 TYR.? -4.18 O1 GOL L3027s B 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 256 LYS L 61 LYS~? 18.93 O3 GOL L3028 coo -32.67 22.74 10.17 -32.85 23.98 7.70 131.49 167.37 206.62 131.53 168.77 204.19 coo -26.88 17.61 16.89 -26.08 17.11 15.00 133.34 166.97 196.27 132.03 168.03 194.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 146.71 163.98 195.55 147.88 159.76 190.94 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 47 3 # 47 B 122 TYR L 123 TYR.? -4.18 O1 GOL L3027s B 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 256 LYS L 142 LYS~? 23.18 CL CL L2009 coo -32.67 22.74 10.17 -32.85 23.98 7.70 131.49 167.37 206.62 131.53 168.77 204.19 coo -26.88 17.61 16.89 -26.08 17.11 15.00 133.34 166.97 196.27 132.03 168.03 194.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 48 3 # 48 B 122 TYR L 157 TYR.? 9.71 O3 GOL L3027 B 214 ASP L 70 ASP~? -12.27 O3 GOL L3028s B 256 LYS L 142 LYS~? 23.18 CL CL L2009 coo -32.67 22.74 10.17 -32.85 23.98 7.70 123.19 173.24 198.15 125.89 172.62 198.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 133.34 166.97 196.27 132.03 168.03 194.96 coo -16.04 12.06 11.09 -17.97 10.54 5.71 129.76 154.52 193.42 128.34 149.37 194.11 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 49 3 # 49 B 122 TYR M 75 TYR~? 10.36 CL CL M2017 B 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 256 LYS M 61 LYS~? 24.74 CL CL I2007 coo -32.67 22.74 10.17 -32.85 23.98 7.70 130.62 206.12 176.17 130.27 204.76 178.58 coo -26.88 17.61 16.89 -26.08 17.11 15.00 136.87 200.18 170.79 135.36 199.08 169.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 50 3 # 50 B 122 TYR M 123 TYR.? -4.30 O1 GOL M3043s B 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 256 LYS M 61 LYS~? 24.74 CL CL I2007 coo -32.67 22.74 10.17 -32.85 23.98 7.70 136.30 210.69 170.36 136.06 208.30 168.99 coo -26.88 17.61 16.89 -26.08 17.11 15.00 136.87 200.18 170.79 135.36 199.08 169.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 150.09 197.87 173.54 150.10 192.15 176.50 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 51 3 # 51 B 122 TYR M 123 TYR.? -4.30 O1 GOL M3043s B 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 256 LYS M 142 LYS~? 19.90 CL CL M2017 coo -32.67 22.74 10.17 -32.85 23.98 7.70 136.30 210.69 170.36 136.06 208.30 168.99 coo -26.88 17.61 16.89 -26.08 17.11 15.00 136.87 200.18 170.79 135.36 199.08 169.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 52 3 # 52 B 122 TYR M 157 TYR.? -4.16 C2 GOL M3042s B 214 ASP M 70 ASP~? -9.98 O3 GOL M3042s B 256 LYS M 142 LYS~? 19.90 CL CL M2017 coo -32.67 22.74 10.17 -32.85 23.98 7.70 127.03 203.34 164.58 129.75 203.18 165.07 coo -26.88 17.61 16.89 -26.08 17.11 15.00 136.87 200.18 170.79 135.36 199.08 169.77 coo -16.04 12.06 11.09 -17.97 10.54 5.71 133.20 197.60 183.11 127.92 198.39 183.89 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 53 3 # 53 B 122 TYR N 75 TYR~? 12.44 O2 GOL N3029 B 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 256 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -32.67 22.74 10.17 -32.85 23.98 7.70 209.71 152.64 137.80 209.50 150.35 139.41 coo -26.88 17.61 16.89 -26.08 17.11 15.00 203.51 159.51 142.26 205.02 160.53 143.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 54 3 # 54 B 122 TYR N 123 TYR.? -12.00 CL CL N2030s B 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 256 LYS N 61 LYS~? 14.04 C2 GOL N3029 coo -32.67 22.74 10.17 -32.85 23.98 7.70 205.39 158.43 131.87 205.49 160.09 134.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 203.51 159.51 142.26 205.02 160.53 143.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 189.87 158.70 143.06 188.28 156.08 148.60 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 55 3 # 55 B 122 TYR N 123 TYR.? -12.00 CL CL N2030s B 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 256 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -32.67 22.74 10.17 -32.85 23.98 7.70 205.39 158.43 131.87 205.49 160.09 134.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 203.51 159.51 142.26 205.02 160.53 143.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 56 3 # 56 B 122 TYR N 157 TYR.? 7.89 C1 GOL N3012 B 214 ASP N 70 ASP~? -3.26 O2 GOL N3029s B 256 LYS N 142 LYS~? 14.74 O1 GOL N3029 coo -32.67 22.74 10.17 -32.85 23.98 7.70 214.45 164.07 139.74 211.68 163.84 139.51 coo -26.88 17.61 16.89 -26.08 17.11 15.00 203.51 159.51 142.26 205.02 160.53 143.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 205.28 147.20 146.57 210.60 146.27 146.55 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 57 3 # 57 B 122 TYR O 75 TYR~? 10.24 CL CL O2018 B 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 256 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -32.67 22.74 10.17 -32.85 23.98 7.70 127.87 136.17 156.70 127.95 137.50 154.23 coo -26.88 17.61 16.89 -26.08 17.11 15.00 134.07 141.35 162.95 132.57 142.58 163.78 coo -16.04 12.06 11.09 -17.97 10.54 5.71 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 58 3 # 58 B 122 TYR O 123 TYR.? -7.90 CL CL O2018s B 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 256 LYS O 61 LYS~? 15.34 C1 GOL O3026 coo -32.67 22.74 10.17 -32.85 23.98 7.70 132.12 130.96 163.05 132.10 133.32 164.44 coo -26.88 17.61 16.89 -26.08 17.11 15.00 134.07 141.35 162.95 132.57 142.58 163.78 coo -16.04 12.06 11.09 -17.97 10.54 5.71 147.78 142.16 161.70 150.96 146.03 160.29 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 59 3 # 59 B 122 TYR O 123 TYR.? -7.90 CL CL O2018s B 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 256 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -32.67 22.74 10.17 -32.85 23.98 7.70 132.12 130.96 163.05 132.10 133.32 164.44 coo -26.88 17.61 16.89 -26.08 17.11 15.00 134.07 141.35 162.95 132.57 142.58 163.78 coo -16.04 12.06 11.09 -17.97 10.54 5.71 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 60 3 # 60 B 122 TYR O 157 TYR.? 6.41 O2 GOL O3013 B 214 ASP O 70 ASP~? 3.30 O1 GOL O3013s B 256 LYS O 142 LYS~? 15.43 O3 GOL O3026 coo -32.67 22.74 10.17 -32.85 23.98 7.70 123.23 139.38 167.80 126.05 139.22 167.65 coo -26.88 17.61 16.89 -26.08 17.11 15.00 134.07 141.35 162.95 132.57 142.58 163.78 coo -16.04 12.06 11.09 -17.97 10.54 5.71 132.09 144.26 150.20 126.63 143.20 149.32 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 61 3 # 61 B 122 TYR P 75 TYR~? 10.23 CL CL P2019 B 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 256 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -32.67 22.74 10.17 -32.85 23.98 7.70 207.22 180.36 204.70 207.43 182.65 203.13 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.75 174.15 199.66 202.28 173.10 198.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 62 3 # 62 B 122 TYR P 123 TYR.? -3.93 O1 GOL P3034s B 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 256 LYS P 61 LYS~? 20.24 O3 GOL P3014 coo -32.67 22.74 10.17 -32.85 23.98 7.70 201.57 175.22 210.06 201.77 173.54 207.86 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.75 174.15 199.66 202.28 173.10 198.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 187.60 176.80 197.02 187.44 179.17 191.02 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 63 3 # 63 B 122 TYR P 123 TYR.? -3.93 O1 GOL P3034s B 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 256 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -32.67 22.74 10.17 -32.85 23.98 7.70 201.57 175.22 210.06 201.77 173.54 207.86 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.75 174.15 199.66 202.28 173.10 198.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 204.59 186.28 195.60 209.96 186.96 196.62 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 64 3 # 64 B 122 TYR P 157 TYR.? 6.12 O2 GOL P3014 B 214 ASP P 70 ASP~? 4.30 O3 GOL P3014 B 256 LYS P 142 LYS~? 18.94 O2 GOL P3014 coo -32.67 22.74 10.17 -32.85 23.98 7.70 210.70 168.63 203.45 207.96 169.02 203.20 coo -26.88 17.61 16.89 -26.08 17.11 15.00 200.75 174.15 199.66 202.28 173.10 198.62 coo -16.04 12.06 11.09 -17.97 10.54 5.71 204.59 186.28 195.60 209.96 186.96 196.62 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 64 hits 2tpl_c05 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 34 ARG~? 29.77 O3 GOL B3003 127 ARG A 37 ARG~? 23.00 O3 GOL B3003 270 GLU A 56 GLU.? 25.60 O3 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 63.78 99.32 32.06 65.50 99.77 29.57 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 58.38 95.12 28.70 59.87 92.50 29.19 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 66.40 88.57 34.15 65.18 90.26 34.28 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 37 ARG~? 23.00 O3 GOL B3003 127 ARG A 34 ARG~? 29.77 O3 GOL B3003 270 GLU A 52 GLU~? -17.57 O3 GOL B3003s coo -1.14 25.72 1.64 0.76 28.10 1.50 58.38 95.12 28.70 59.87 92.50 29.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 63.78 99.32 32.06 65.50 99.77 29.57 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 62.12 85.51 28.52 61.28 86.90 27.21 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 37 ARG~? 23.00 O3 GOL B3003 127 ARG A 34 ARG~? 29.77 O3 GOL B3003 270 GLU A 56 GLU.? 25.60 O3 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 58.38 95.12 28.70 59.87 92.50 29.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 63.78 99.32 32.06 65.50 99.77 29.57 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 66.40 88.57 34.15 65.18 90.26 34.28 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 51 ARG~? 16.54 O3 GOL B3003 127 ARG A 55 ARG~? 19.31 O3 GOL B3003 270 GLU A 4 GLU.? 26.76 C3 GOL E3035 coo -1.14 25.72 1.64 0.76 28.10 1.50 61.69 79.67 29.64 62.00 76.91 30.99 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 66.98 80.93 31.90 64.74 79.05 32.90 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 59.22 77.78 43.29 58.16 77.76 45.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 55 ARG~? 19.31 O3 GOL B3003 127 ARG A 51 ARG~? 16.54 O3 GOL B3003 270 GLU A 4 GLU.? 26.76 C3 GOL E3035 coo -1.14 25.72 1.64 0.76 28.10 1.50 66.98 80.93 31.90 64.74 79.05 32.90 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 61.69 79.67 29.64 62.00 76.91 30.99 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 59.22 77.78 43.29 58.16 77.76 45.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG B 34 ARG~? 11.02 O1 GOL B3003 127 ARG B 37 ARG~? -4.23 C1 GOL B3003s 270 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 57.05 65.77 3.59 55.99 68.39 2.44 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 62.11 68.41 8.30 60.04 68.85 10.44 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG B 37 ARG~? -4.23 C1 GOL B3003s 127 ARG B 34 ARG~? 11.02 O1 GOL B3003 270 GLU B 56 GLU.? 9.23 C1 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 62.11 68.41 8.30 60.04 68.85 10.44 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 57.05 65.77 3.59 55.99 68.39 2.44 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 52.16 66.04 13.94 53.39 65.68 12.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG B 51 ARG~? 11.52 O3 GOL B3003 127 ARG B 55 ARG~? -14.24 O1 GOL B3003s 270 GLU B 4 GLU.? 22.11 C1 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 56.02 71.46 21.90 55.03 71.54 24.81 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 50.06 69.68 20.36 47.07 69.49 19.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 54.73 58.55 26.68 55.86 57.12 27.84 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG B 51 ARG~? 11.52 O3 GOL B3003 127 ARG B 55 ARG~? -14.24 O1 GOL B3003s 270 GLU B 8 GLU~? 20.28 O3 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 56.02 71.46 21.90 55.03 71.54 24.81 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 50.06 69.68 20.36 47.07 69.49 19.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 58.16 61.18 28.15 56.55 61.04 29.52 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG B 55 ARG~? -14.24 O1 GOL B3003s 127 ARG B 51 ARG~? 11.52 O3 GOL B3003 270 GLU B 4 GLU.? 22.11 C1 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 50.06 69.68 20.36 47.07 69.49 19.37 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 56.02 71.46 21.90 55.03 71.54 24.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 54.73 58.55 26.68 55.86 57.12 27.84 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG B 55 ARG~? -14.24 O1 GOL B3003s 127 ARG B 51 ARG~? 11.52 O3 GOL B3003 270 GLU B 8 GLU~? 20.28 O3 GOL B3003 coo -1.14 25.72 1.64 0.76 28.10 1.50 50.06 69.68 20.36 47.07 69.49 19.37 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 56.02 71.46 21.90 55.03 71.54 24.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 58.16 61.18 28.15 56.55 61.04 29.52 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 12 3 # 12 71 ARG C 51 ARG~? 15.50 O3 GOL D3005 127 ARG C 55 ARG~? 19.41 CL CL C2006 270 GLU C 8 GLU~? 14.15 CL CL C2006 coo -1.14 25.72 1.64 0.76 28.10 1.50 50.80 26.41 78.15 53.63 27.50 78.75 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 55.97 24.40 76.93 55.45 26.29 74.49 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 48.33 30.34 66.47 50.23 31.23 66.45 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 13 3 # 13 71 ARG D 51 ARG~? -12.62 C3 GOL D3005s 127 ARG D 55 ARG~? 14.96 O1 GOL D3005 270 GLU D 4 GLU.? 10.36 CL CL D2008 coo -1.14 25.72 1.64 0.76 28.10 1.50 44.97 36.17 83.73 45.77 36.49 80.75 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 39.97 38.45 84.97 39.00 40.64 83.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 47.42 48.67 79.11 48.78 50.16 78.53 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 14 3 # 14 71 ARG D 51 ARG~? -12.62 C3 GOL D3005s 127 ARG D 55 ARG~? 14.96 O1 GOL D3005 270 GLU D 8 GLU~? 14.61 CL CL D2008 coo -1.14 25.72 1.64 0.76 28.10 1.50 44.97 36.17 83.73 45.77 36.49 80.75 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 39.97 38.45 84.97 39.00 40.64 83.01 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 51.06 45.29 79.18 49.57 45.21 77.73 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 15 3 # 15 71 ARG D 55 ARG~? 14.96 O1 GOL D3005 127 ARG D 51 ARG~? -12.62 C3 GOL D3005s 270 GLU D 4 GLU.? 10.36 CL CL D2008 coo -1.14 25.72 1.64 0.76 28.10 1.50 39.97 38.45 84.97 39.00 40.64 83.01 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 44.97 36.17 83.73 45.77 36.49 80.75 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 47.42 48.67 79.11 48.78 50.16 78.53 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 16 3 # 16 71 ARG E 34 ARG~? 12.13 O1 GOL E3004 127 ARG E 37 ARG~? -4.52 O1 GOL E3004s 270 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo -1.14 25.72 1.64 0.76 28.10 1.50 54.44 103.79 65.07 52.71 105.19 67.23 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 58.59 99.11 69.23 56.48 96.91 69.19 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 17 3 # 17 71 ARG E 37 ARG~? -4.52 O1 GOL E3004s 127 ARG E 34 ARG~? 12.13 O1 GOL E3004 270 GLU E 52 GLU~? -2.93 O1 GOL E3004s coo -1.14 25.72 1.64 0.76 28.10 1.50 58.59 99.11 69.23 56.48 96.91 69.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 54.44 103.79 65.07 52.71 105.19 67.23 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 52.85 90.79 71.14 54.01 92.22 72.22 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 18 3 # 18 71 ARG E 37 ARG~? -4.52 O1 GOL E3004s 127 ARG E 34 ARG~? 12.13 O1 GOL E3004 270 GLU E 56 GLU~? 9.34 O1 GOL E3004 coo -1.14 25.72 1.64 0.76 28.10 1.50 58.59 99.11 69.23 56.48 96.91 69.19 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 54.44 103.79 65.07 52.71 105.19 67.23 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 49.08 93.57 65.06 50.69 94.83 64.79 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 19 3 # 19 71 ARG E 51 ARG~? 12.86 C3 GOL E3004 127 ARG E 55 ARG~? 13.47 C3 GOL E3004 270 GLU E 8 GLU~? 20.37 C3 GOL E3004 coo -1.14 25.72 1.64 0.76 28.10 1.50 51.65 84.19 70.80 51.43 81.15 70.20 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 47.24 86.77 68.80 48.11 84.54 66.77 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 56.40 79.00 61.68 54.75 77.83 61.13 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 20 3 # 20 71 ARG E 55 ARG~? 13.47 C3 GOL E3004 127 ARG E 51 ARG~? 12.86 C3 GOL E3004 270 GLU E 8 GLU~? 20.37 C3 GOL E3004 coo -1.14 25.72 1.64 0.76 28.10 1.50 47.24 86.77 68.80 48.11 84.54 66.77 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 51.65 84.19 70.80 51.43 81.15 70.20 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 56.40 79.00 61.68 54.75 77.83 61.13 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 21 3 # 21 71 ARG F 34 ARG~? 28.76 CL CL F2035 127 ARG F 37 ARG~? -27.07 CL CL F2035s 270 GLU F 56 GLU~? 19.98 CL CL F2035 coo -1.14 25.72 1.64 0.76 28.10 1.50 59.52 30.90 7.26 60.86 28.10 6.84 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 53.50 28.70 11.30 55.02 28.89 13.93 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 22 3 # 22 71 ARG F 37 ARG~? -27.07 CL CL F2035s 127 ARG F 34 ARG~? 28.76 CL CL F2035 270 GLU F 52 GLU~? -24.25 CL CL F2035s coo -1.14 25.72 1.64 0.76 28.10 1.50 53.50 28.70 11.30 55.02 28.89 13.93 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 59.52 30.90 7.26 60.86 28.10 6.84 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 57.13 27.62 20.93 55.96 26.54 19.60 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 23 3 # 23 71 ARG F 37 ARG~? -27.07 CL CL F2035s 127 ARG F 34 ARG~? 28.76 CL CL F2035 270 GLU F 56 GLU~? 19.98 CL CL F2035 coo -1.14 25.72 1.64 0.76 28.10 1.50 53.50 28.70 11.30 55.02 28.89 13.93 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 59.52 30.90 7.26 60.86 28.10 6.84 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 62.56 32.21 18.10 61.29 32.37 16.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 24 3 # 24 71 ARG F 51 ARG~? 18.26 CL CL F2035 127 ARG F 55 ARG~? 14.19 CL CL F2035 270 GLU F 4 GLU.? 20.54 CL CL F2035 coo -1.14 25.72 1.64 0.76 28.10 1.50 56.56 29.17 27.33 58.39 29.67 29.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 62.56 29.89 25.65 64.18 28.30 27.76 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 56.74 42.66 28.58 56.05 44.66 28.52 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 25 3 # 25 71 ARG F 51 ARG~? 18.26 CL CL F2035 127 ARG F 55 ARG~? 14.19 CL CL F2035 270 GLU F 8 GLU~? 22.40 CL CL F2035 coo -1.14 25.72 1.64 0.76 28.10 1.50 56.56 29.17 27.33 58.39 29.67 29.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 62.56 29.89 25.65 64.18 28.30 27.76 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 54.32 40.00 29.52 52.85 39.83 30.97 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 26 3 # 26 71 ARG F 55 ARG~? 14.19 CL CL F2035 127 ARG F 51 ARG~? 18.26 CL CL F2035 270 GLU F 8 GLU~? 22.40 CL CL F2035 coo -1.14 25.72 1.64 0.76 28.10 1.50 62.56 29.89 25.65 64.18 28.30 27.76 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 56.56 29.17 27.33 58.39 29.67 29.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 54.32 40.00 29.52 52.85 39.83 30.97 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 27 3 # 27 71 ARG G 34 ARG~? 20.84 CL CL C2004 127 ARG G 37 ARG~? 20.29 CL CL C2004 270 GLU G 56 GLU.? 17.83 CL CL C2004 coo -1.14 25.72 1.64 0.76 28.10 1.50 46.76 3.66 41.28 45.52 3.22 38.51 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 52.62 7.45 38.03 50.95 9.97 37.63 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 43.97 14.81 40.22 44.85 13.00 40.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 28 3 # 28 71 ARG G 37 ARG~? 20.29 CL CL C2004 127 ARG G 34 ARG~? 20.84 CL CL C2004 270 GLU G 56 GLU.? 17.83 CL CL C2004 coo -1.14 25.72 1.64 0.76 28.10 1.50 52.62 7.45 38.03 50.95 9.97 37.63 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 46.76 3.66 41.28 45.52 3.22 38.51 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 43.97 14.81 40.22 44.85 13.00 40.58 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 29 3 # 29 71 ARG H 51 ARG~? -11.05 O1 GOL H3006s 127 ARG H 55 ARG~? 13.48 O3 GOL H3006 270 GLU H 8 GLU~? 14.54 CL CL D2008 coo -1.14 25.72 1.64 0.76 28.10 1.50 55.75 78.18 80.83 58.67 78.05 79.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 60.33 75.55 82.58 59.37 73.14 80.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 50.67 67.41 76.56 52.70 67.57 75.98 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 30 3 # 30 71 ARG H 55 ARG~? 13.48 O3 GOL H3006 127 ARG H 51 ARG~? -11.05 O1 GOL H3006s 270 GLU H 8 GLU~? 14.54 CL CL D2008 coo -1.14 25.72 1.64 0.76 28.10 1.50 60.33 75.55 82.58 59.37 73.14 80.81 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 55.75 78.18 80.83 58.67 78.05 79.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 50.67 67.41 76.56 52.70 67.57 75.98 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 31 3 # 31 71 ARG I 51 ARG~? 21.58 CL CL I2007 127 ARG I 55 ARG~? 19.02 CL CL I2007 270 GLU I 4 GLU.? 9.55 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 174.23 196.17 146.19 174.71 193.30 147.29 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 179.74 197.90 148.59 178.27 195.79 150.32 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 172.87 194.13 159.37 171.68 193.98 161.14 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 32 3 # 32 71 ARG I 51 ARG~? 21.58 CL CL I2007 127 ARG I 55 ARG~? 19.02 CL CL I2007 270 GLU I 8 GLU~? 13.89 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 174.23 196.17 146.19 174.71 193.30 147.29 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 179.74 197.90 148.59 178.27 195.79 150.32 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 170.22 193.07 156.46 171.58 191.67 157.15 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 33 3 # 33 71 ARG I 55 ARG~? 19.02 CL CL I2007 127 ARG I 51 ARG~? 21.58 CL CL I2007 270 GLU I 4 GLU.? 9.55 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 179.74 197.90 148.59 178.27 195.79 150.32 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 174.23 196.17 146.19 174.71 193.30 147.29 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 172.87 194.13 159.37 171.68 193.98 161.14 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 34 3 # 34 71 ARG I 55 ARG~? 19.02 CL CL I2007 127 ARG I 51 ARG~? 21.58 CL CL I2007 270 GLU I 8 GLU~? 13.89 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 179.74 197.90 148.59 178.27 195.79 150.32 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 174.23 196.17 146.19 174.71 193.30 147.29 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 170.22 193.07 156.46 171.58 191.67 157.15 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 35 3 # 35 71 ARG J 34 ARG~? 20.21 CL CL J2002 127 ARG J 37 ARG~? 20.17 CL CL J2002 270 GLU J 56 GLU.? 17.48 CL CL J2002 coo -1.14 25.72 1.64 0.76 28.10 1.50 169.79 183.14 118.82 167.66 185.29 119.35 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 174.71 186.35 123.78 172.76 186.51 126.11 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 164.69 183.53 129.34 166.31 182.92 128.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 36 3 # 36 71 ARG J 37 ARG~? 20.17 CL CL J2002 127 ARG J 34 ARG~? 20.21 CL CL J2002 270 GLU J 56 GLU.? 17.48 CL CL J2002 coo -1.14 25.72 1.64 0.76 28.10 1.50 174.71 186.35 123.78 172.76 186.51 126.11 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 169.79 183.14 118.82 167.66 185.29 119.35 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 164.69 183.53 129.34 166.31 182.92 128.17 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 37 3 # 37 71 ARG J 51 ARG~? 27.44 CL CL J2002 127 ARG J 55 ARG~? 24.05 CL CL J2002 270 GLU J 8 GLU~? 22.39 CL CL J2002 coo -1.14 25.72 1.64 0.76 28.10 1.50 168.80 189.12 137.91 166.15 189.45 139.46 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 163.85 187.29 136.52 164.25 185.16 138.77 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 171.86 178.07 143.57 170.28 177.54 144.90 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 38 3 # 38 71 ARG J 55 ARG~? 24.05 CL CL J2002 127 ARG J 51 ARG~? 27.44 CL CL J2002 270 GLU J 8 GLU~? 22.39 CL CL J2002 coo -1.14 25.72 1.64 0.76 28.10 1.50 163.85 187.29 136.52 164.25 185.16 138.77 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 168.80 189.12 137.91 166.15 189.45 139.46 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 171.86 178.07 143.57 170.28 177.54 144.90 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 39 3 # 39 71 ARG K 51 ARG~? -10.79 O3 GOL K3011s 127 ARG K 55 ARG~? 13.86 O3 GOL K3011 270 GLU K 8 GLU~? 14.31 CL CL K2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 168.73 140.32 192.51 171.31 141.97 192.79 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 173.95 138.80 190.43 173.34 140.90 188.20 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 166.29 144.34 181.01 165.98 146.34 180.71 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 40 3 # 40 71 ARG K 55 ARG~? 13.86 O3 GOL K3011 127 ARG K 51 ARG~? -10.79 O3 GOL K3011s 270 GLU K 8 GLU~? 14.31 CL CL K2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 173.95 138.80 190.43 173.34 140.90 188.20 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 168.73 140.32 192.51 171.31 141.97 192.79 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 166.29 144.34 181.01 165.98 146.34 180.71 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 41 3 # 41 71 ARG L 51 ARG~? 16.39 O3 GOL K3011 127 ARG L 55 ARG~? 21.00 O3 GOL K3011 270 GLU L 4 GLU.? 26.61 O1 GOL L3028 coo -1.14 25.72 1.64 0.76 28.10 1.50 163.01 149.53 198.74 162.90 150.47 195.82 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 158.05 151.49 200.24 157.97 153.99 198.35 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 164.36 162.97 195.39 165.70 164.44 194.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 42 3 # 42 71 ARG L 51 ARG~? 16.39 O3 GOL K3011 127 ARG L 55 ARG~? 21.00 O3 GOL K3011 270 GLU L 8 GLU~? 26.30 O3 GOL K3011 coo -1.14 25.72 1.64 0.76 28.10 1.50 163.01 149.53 198.74 162.90 150.47 195.82 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 158.05 151.49 200.24 157.97 153.99 198.35 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 167.69 159.47 194.26 167.52 160.00 192.23 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 43 3 # 43 71 ARG L 55 ARG~? 21.00 O3 GOL K3011 127 ARG L 51 ARG~? 16.39 O3 GOL K3011 270 GLU L 4 GLU.? 26.61 O1 GOL L3028 coo -1.14 25.72 1.64 0.76 28.10 1.50 158.05 151.49 200.24 157.97 153.99 198.35 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 163.01 149.53 198.74 162.90 150.47 195.82 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 164.36 162.97 195.39 165.70 164.44 194.50 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 44 3 # 44 71 ARG L 55 ARG~? 21.00 O3 GOL K3011 127 ARG L 51 ARG~? 16.39 O3 GOL K3011 270 GLU L 8 GLU~? 26.30 O3 GOL K3011 coo -1.14 25.72 1.64 0.76 28.10 1.50 158.05 151.49 200.24 157.97 153.99 198.35 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 163.01 149.53 198.74 162.90 150.47 195.82 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 167.69 159.47 194.26 167.52 160.00 192.23 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 45 3 # 45 71 ARG M 51 ARG~? -9.68 O2 GOL M3007s 127 ARG M 55 ARG~? 12.49 O2 GOL M3007 270 GLU M 4 GLU.? 9.58 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 166.66 199.07 188.11 163.90 199.62 189.28 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 162.29 201.15 185.73 159.83 200.25 187.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 168.05 195.36 174.90 169.23 194.67 173.26 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 46 3 # 46 71 ARG M 51 ARG~? -9.68 O2 GOL M3007s 127 ARG M 55 ARG~? 12.49 O2 GOL M3007 270 GLU M 8 GLU~? 14.09 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 166.66 199.07 188.11 163.90 199.62 189.28 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 162.29 201.15 185.73 159.83 200.25 187.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 170.87 194.05 178.21 169.19 192.83 177.76 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 47 3 # 47 71 ARG M 55 ARG~? 12.49 O2 GOL M3007 127 ARG M 51 ARG~? -9.68 O2 GOL M3007s 270 GLU M 4 GLU.? 9.58 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 162.29 201.15 185.73 159.83 200.25 187.37 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 166.66 199.07 188.11 163.90 199.62 189.28 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 168.05 195.36 174.90 169.23 194.67 173.26 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 48 3 # 48 71 ARG M 55 ARG~? 12.49 O2 GOL M3007 127 ARG M 51 ARG~? -9.68 O2 GOL M3007s 270 GLU M 8 GLU~? 14.09 CL CL I2007 coo -1.14 25.72 1.64 0.76 28.10 1.50 162.29 201.15 185.73 159.83 200.25 187.37 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 166.66 199.07 188.11 163.90 199.62 189.28 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 170.87 194.05 178.21 169.19 192.83 177.76 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 49 3 # 49 71 ARG N 51 ARG~? 10.93 O1 GOL N3008 127 ARG N 55 ARG~? 13.92 O1 GOL N3008 270 GLU N 8 GLU~? 19.42 O1 GOL N3008 coo -1.14 25.72 1.64 0.76 28.10 1.50 172.16 145.36 140.78 174.78 144.98 142.37 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 177.28 147.38 139.71 179.40 146.33 141.72 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 168.83 156.63 144.46 167.27 156.30 145.82 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 50 3 # 50 71 ARG N 55 ARG~? 13.92 O1 GOL N3008 127 ARG N 51 ARG~? 10.93 O1 GOL N3008 270 GLU N 4 GLU.? 18.86 CL CL J2002 coo -1.14 25.72 1.64 0.76 28.10 1.50 177.28 147.38 139.71 179.40 146.33 141.72 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 172.16 145.36 140.78 174.78 144.98 142.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 171.67 159.43 143.17 170.71 161.26 143.65 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 51 3 # 51 71 ARG N 55 ARG~? 13.92 O1 GOL N3008 127 ARG N 51 ARG~? 10.93 O1 GOL N3008 270 GLU N 8 GLU~? 19.42 O1 GOL N3008 coo -1.14 25.72 1.64 0.76 28.10 1.50 177.28 147.38 139.71 179.40 146.33 141.72 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 172.16 145.36 140.78 174.78 144.98 142.37 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 168.83 156.63 144.46 167.27 156.30 145.82 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 52 3 # 52 71 ARG O 34 ARG~? 19.49 CL CL O2036 127 ARG O 37 ARG~? 22.15 CL CL K2003 270 GLU O 56 GLU.? 16.78 CL CL O2036 coo -1.14 25.72 1.64 0.76 28.10 1.50 163.83 119.56 154.44 162.36 118.67 151.85 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 169.49 123.46 151.21 167.81 125.99 151.08 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 53 3 # 53 71 ARG O 37 ARG~? 22.15 CL CL K2003 127 ARG O 34 ARG~? 19.49 CL CL O2036 270 GLU O 52 GLU~? 17.58 O1 GOL N3008s coo -1.14 25.72 1.64 0.76 28.10 1.50 169.49 123.46 151.21 167.81 125.99 151.08 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 163.83 119.56 154.44 162.36 118.67 151.85 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 165.51 132.62 148.90 166.63 131.12 147.92 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 54 3 # 54 71 ARG O 37 ARG~? 22.15 CL CL K2003 127 ARG O 34 ARG~? 19.49 CL CL O2036 270 GLU O 56 GLU.? 16.78 CL CL O2036 coo -1.14 25.72 1.64 0.76 28.10 1.50 169.49 123.46 151.21 167.81 125.99 151.08 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 163.83 119.56 154.44 162.36 118.67 151.85 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 160.60 130.40 154.07 161.73 128.68 154.54 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 55 3 # 55 71 ARG O 51 ARG~? 16.43 O1 GOL N3008 127 ARG O 55 ARG~? 19.37 CL CL K2003 270 GLU O 4 GLU.? 15.52 CL CL K2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 165.78 138.84 148.96 164.30 141.49 149.44 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 159.96 137.60 150.54 160.85 139.64 152.73 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 160.46 142.68 161.06 159.04 143.89 159.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 56 3 # 56 71 ARG O 51 ARG~? 16.43 O1 GOL N3008 127 ARG O 55 ARG~? 19.37 CL CL K2003 270 GLU O 8 GLU~? 14.62 CL CL K2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 165.78 138.84 148.96 164.30 141.49 149.44 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 159.96 137.60 150.54 160.85 139.64 152.73 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 169.51 143.54 159.40 167.68 144.45 158.79 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 57 3 # 57 71 ARG O 55 ARG~? 19.37 CL CL K2003 127 ARG O 51 ARG~? 16.43 O1 GOL N3008 270 GLU O 4 GLU.? 15.52 CL CL K2003 coo -1.14 25.72 1.64 0.76 28.10 1.50 159.96 137.60 150.54 160.85 139.64 152.73 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 165.78 138.84 148.96 164.30 141.49 149.44 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 160.46 142.68 161.06 159.04 143.89 159.95 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 58 3 # 58 71 ARG P 51 ARG~? 14.75 O3 GOL M3007 127 ARG P 55 ARG~? 20.09 O3 GOL M3007 270 GLU P 8 GLU~? 25.06 O3 GOL M3007 coo -1.14 25.72 1.64 0.76 28.10 1.50 171.10 192.14 197.11 173.97 192.46 196.07 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 176.25 189.61 198.56 175.31 187.31 196.65 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 166.50 181.50 192.72 168.30 181.40 191.65 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 59 3 # 59 71 ARG P 55 ARG~? 20.09 O3 GOL M3007 127 ARG P 51 ARG~? 14.75 O3 GOL M3007 270 GLU P 4 GLU.? 25.05 O1 GOL L3028 coo -1.14 25.72 1.64 0.76 28.10 1.50 176.25 189.61 198.56 175.31 187.31 196.65 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 171.10 192.14 197.11 173.97 192.46 196.07 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 169.41 178.25 194.54 168.21 176.56 193.99 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 60 3 # 60 71 ARG P 55 ARG~? 20.09 O3 GOL M3007 127 ARG P 51 ARG~? 14.75 O3 GOL M3007 270 GLU P 8 GLU~? 25.06 O3 GOL M3007 coo -1.14 25.72 1.64 0.76 28.10 1.50 176.25 189.61 198.56 175.31 187.31 196.65 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 171.10 192.14 197.11 173.97 192.46 196.07 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 166.50 181.50 192.72 168.30 181.40 191.65 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 60 hits 5cpa_c01 naa= 3 ULMN 3 8pch_c00 CATHEPSIN H user 1 3 # 1 A 25 CYH A 153 CYH.? 14.43 O2 GOL A3037 A 159 HIS A 151 HIS~? -11.70 O3 GOL A3037s A 175 ASN A 148 ASN~? 19.52 O3 GOL A3037 coo 17.05 13.18 22.45 14.62 11.74 22.22 101.61 70.42 52.87 102.62 71.46 50.52 coo 11.41 9.68 19.45 11.30 7.64 19.91 94.27 72.58 51.14 93.29 74.44 51.00 coo 18.02 12.10 14.04 16.52 11.22 15.25 94.75 68.19 45.57 92.70 67.63 45.54 ULMN 3 8pch_c00 CATHEPSIN H user 2 3 # 2 A 25 CYH B 153 CYH~? 8.68 O3 GOL B3015 A 159 HIS B 151 HIS~? -4.11 O3 GOL B3015s A 175 ASN B 148 ASN~? 9.53 C1 GOL B3024 coo 17.05 13.18 22.45 14.62 11.74 22.22 10.51 59.26 25.83 10.35 61.25 24.02 coo 11.41 9.68 19.45 11.30 7.64 19.91 18.48 59.01 25.15 19.77 58.54 23.56 coo 18.02 12.10 14.04 16.52 11.22 15.25 18.41 65.45 28.07 17.76 65.23 30.07 ULMN 3 8pch_c00 CATHEPSIN H user 3 3 # 3 A 25 CYH C 153 CYH.? 7.56 CL CL C2031 A 159 HIS C 151 HIS~? -4.28 C2 GOL C3036s A 175 ASN C 148 ASN~? 11.79 O3 GOL C3036 coo 17.05 13.18 22.45 14.62 11.74 22.22 96.07 27.08 64.55 96.20 25.81 66.95 coo 11.41 9.68 19.45 11.30 7.64 19.91 88.24 26.50 64.44 86.75 25.04 64.52 coo 18.02 12.10 14.04 16.52 11.22 15.25 88.30 30.82 70.17 86.43 31.75 69.70 ULMN 3 8pch_c00 CATHEPSIN H user 4 3 # 4 A 25 CYH D 153 CYH.? 14.75 O1 GOL D3020 A 159 HIS D 151 HIS~? -13.00 O2 GOL D3020s A 175 ASN D 148 ASN~? 21.41 O2 GOL D3020 coo 17.05 13.18 22.45 14.62 11.74 22.22 5.67 57.11 70.86 4.62 54.95 72.38 coo 11.41 9.68 19.45 11.30 7.64 19.91 13.06 55.69 73.24 14.03 55.94 75.08 coo 18.02 12.10 14.04 16.52 11.22 15.25 12.38 49.18 69.99 12.27 49.48 67.83 ULMN 3 8pch_c00 CATHEPSIN H user 5 3 # 5 A 25 CYH E 153 CYH~? 8.85 O1 GOL E3002 A 159 HIS E 151 HIS~? -4.12 O1 GOL E3002s A 175 ASN E 148 ASN~? 10.65 O1 GOL E3002 coo 17.05 13.18 22.45 14.62 11.74 22.22 10.10 80.75 49.90 9.59 82.62 51.85 coo 11.41 9.68 19.45 11.30 7.64 19.91 17.87 81.44 51.19 19.31 82.95 50.96 coo 18.02 12.10 14.04 16.52 11.22 15.25 16.50 78.61 57.58 15.95 76.60 57.32 ULMN 3 8pch_c00 CATHEPSIN H user 6 3 # 6 A 25 CYH F 153 CYH~? 17.48 CL CL F2034 A 159 HIS F 151 HIS~? 14.76 O3 GOL F3039s A 175 ASN F 148 ASN~? 20.16 CL CL F2035 coo 17.05 13.18 22.45 14.62 11.74 22.22 100.56 42.65 36.94 101.15 40.25 35.75 coo 11.41 9.68 19.45 11.30 7.64 19.91 93.09 42.58 34.58 92.14 42.76 32.71 coo 18.02 12.10 14.04 16.52 11.22 15.25 92.36 36.84 38.84 92.17 37.47 40.85 ULMN 3 8pch_c00 CATHEPSIN H user 7 3 # 7 A 25 CYH G 153 CYH~? 9.03 O3 GOL G3001 A 159 HIS G 151 HIS~? -4.14 C3 GOL G3001s A 175 ASN G 148 ASN~? 12.10 C1 GOL G3001 coo 17.05 13.18 22.45 14.62 11.74 22.22 6.06 35.44 46.92 5.44 33.82 44.74 coo 11.41 9.68 19.45 11.30 7.64 19.91 13.55 33.19 47.26 14.46 31.35 47.64 coo 18.02 12.10 14.04 16.52 11.22 15.25 14.30 36.21 40.84 16.27 36.90 41.19 ULMN 3 8pch_c00 CATHEPSIN H user 8 3 # 8 A 25 CYH H 153 CYH.? 12.27 O1 GOL H3016 A 159 HIS H 151 HIS~? 4.32 C1 GOL H3016s A 175 ASN H 148 ASN~? 6.95 O1 GOL H3016 coo 17.05 13.18 22.45 14.62 11.74 22.22 97.03 55.04 80.47 97.67 57.42 81.76 coo 11.41 9.68 19.45 11.30 7.64 19.91 89.33 56.65 80.95 87.93 56.76 82.51 coo 18.02 12.10 14.04 16.52 11.22 15.25 90.74 62.26 76.80 90.93 61.43 74.87 ULMN 3 8pch_c00 CATHEPSIN H user 9 3 # 9 A 25 CYH I 153 CYH~? 13.03 O3 GOL I3032 A 159 HIS I 151 HIS~? 3.98 O3 GOL I3032s A 175 ASN I 148 ASN~? 10.15 O1 GOL I3032 coo 17.05 13.18 22.45 14.62 11.74 22.22 216.28 188.21 166.60 217.09 189.60 164.27 coo 11.41 9.68 19.45 11.30 7.64 19.91 208.71 190.07 165.44 207.65 191.87 165.52 coo 18.02 12.10 14.04 16.52 11.22 15.25 209.21 186.01 159.54 209.28 184.02 160.30 ULMN 3 8pch_c00 CATHEPSIN H user 10 3 # 10 A 25 CYH J 153 CYH.? 14.69 O1 GOL J3033 A 159 HIS J 151 HIS~? -12.73 O1 GOL J3033s A 175 ASN J 148 ASN~? 20.55 O1 GOL J3033 coo 17.05 13.18 22.45 14.62 11.74 22.22 124.53 173.82 143.70 124.14 176.01 142.05 coo 11.41 9.68 19.45 11.30 7.64 19.91 132.36 173.99 142.63 133.63 173.58 141.01 coo 18.02 12.10 14.04 16.52 11.22 15.25 132.19 180.35 145.70 132.98 179.70 147.44 ULMN 3 8pch_c00 CATHEPSIN H user 11 3 # 11 A 25 CYH K 153 CYH.? 10.08 C1 GOL K3009 A 159 HIS K 151 HIS~? -4.18 C2 GOL K3009s A 175 ASN K 148 ASN~? 12.08 C1 GOL K3009 coo 17.05 13.18 22.45 14.62 11.74 22.22 213.02 144.07 176.61 213.41 142.76 178.95 coo 11.41 9.68 19.45 11.30 7.64 19.91 205.25 143.04 176.89 203.95 141.38 176.70 coo 18.02 12.10 14.04 16.52 11.22 15.25 205.46 147.19 182.80 205.92 149.13 182.14 ULMN 3 8pch_c00 CATHEPSIN H user 12 3 # 12 A 25 CYH L 153 CYH.? 17.58 CL CL L2028 A 159 HIS L 151 HIS~? -15.32 O3 GOL L3028s A 175 ASN L 148 ASN~? 21.20 O3 GOL L3028 coo 17.05 13.18 22.45 14.62 11.74 22.22 121.51 169.13 188.69 120.63 167.06 190.29 coo 11.41 9.68 19.45 11.30 7.64 19.91 129.06 168.07 190.57 130.17 168.32 192.34 coo 18.02 12.10 14.04 16.52 11.22 15.25 128.43 161.78 187.33 130.41 161.66 186.63 ULMN 3 8pch_c00 CATHEPSIN H user 13 3 # 13 A 25 CYH M 153 CYH~? 14.73 C2 GOL M3042 A 159 HIS M 151 HIS~? -11.81 O3 GOL M3042s A 175 ASN M 148 ASN~? 20.35 O3 GOL M3042 coo 17.05 13.18 22.45 14.62 11.74 22.22 124.18 194.08 168.46 123.60 195.77 170.58 coo 11.41 9.68 19.45 11.30 7.64 19.91 131.91 195.13 169.59 133.22 196.76 169.40 coo 18.02 12.10 14.04 16.52 11.22 15.25 131.01 191.89 175.87 130.74 189.82 175.52 ULMN 3 8pch_c00 CATHEPSIN H user 14 3 # 14 A 25 CYH N 153 CYH.? 9.71 O1 GOL N3012 A 159 HIS N 151 HIS~? 3.39 O2 GOL N3012s A 175 ASN N 148 ASN~? 8.14 O1 GOL N3029 coo 17.05 13.18 22.45 14.62 11.74 22.22 215.62 161.14 149.48 216.18 158.76 148.20 coo 11.41 9.68 19.45 11.30 7.64 19.91 207.96 160.84 147.59 206.93 161.03 145.77 coo 18.02 12.10 14.04 16.52 11.22 15.25 207.66 155.05 151.71 208.13 155.55 153.68 ULMN 3 8pch_c00 CATHEPSIN H user 15 3 # 15 A 25 CYH O 153 CYH.? 10.07 O3 GOL O3013 A 159 HIS O 151 HIS~? 4.32 O2 GOL O3026s A 175 ASN O 148 ASN~? 8.79 O3 GOL O3026 coo 17.05 13.18 22.45 14.62 11.74 22.22 121.90 148.90 163.71 121.42 147.29 161.55 coo 11.41 9.68 19.45 11.30 7.64 19.91 129.65 146.92 163.60 130.73 145.15 163.91 coo 18.02 12.10 14.04 16.52 11.22 15.25 129.87 150.23 157.24 129.64 152.28 157.66 ULMN 3 8pch_c00 CATHEPSIN H user 16 3 # 16 A 25 CYH P 153 CYH.? 9.50 O2 GOL P3014 A 159 HIS P 151 HIS~? -4.15 C3 GOL P3014s A 175 ASN P 148 ASN~? 11.59 O1 GOL P3014 coo 17.05 13.18 22.45 14.62 11.74 22.22 213.41 171.20 193.92 214.01 173.48 195.24 coo 11.41 9.68 19.45 11.30 7.64 19.91 205.70 172.52 194.71 204.41 172.45 196.35 coo 18.02 12.10 14.04 16.52 11.22 15.25 206.51 178.28 190.78 206.84 177.74 188.77 8pch_c00 source 8pch CATHEPSIN H : 16 hits 8pch_c00 naa= 3 ULMN 3 9pap_c00 PAPAIN user 1 3 # 1 25 CYH A 153 CYH.? 14.43 O2 GOL A3037 159 HIS A 151 HIS~? -11.70 O3 GOL A3037s 175 ASN A 148 ASN~? 19.52 O3 GOL A3037 coo 28.80 72.58 20.00 27.22 70.79 21.44 101.61 70.42 52.87 102.62 71.46 50.52 coo 29.11 66.58 21.75 30.70 67.95 21.84 94.27 72.58 51.14 93.29 74.44 51.00 coo 35.92 67.06 19.69 34.35 66.95 21.23 94.75 68.19 45.57 92.70 67.63 45.54 ULMN 3 9pap_c00 PAPAIN user 2 3 # 2 25 CYH B 153 CYH~? 8.68 O3 GOL B3015 159 HIS B 151 HIS~? -4.11 O3 GOL B3015s 175 ASN B 148 ASN~? 9.53 C1 GOL B3024 coo 28.80 72.58 20.00 27.22 70.79 21.44 10.51 59.26 25.83 10.35 61.25 24.02 coo 29.11 66.58 21.75 30.70 67.95 21.84 18.48 59.01 25.15 19.77 58.54 23.56 coo 35.92 67.06 19.69 34.35 66.95 21.23 18.41 65.45 28.07 17.76 65.23 30.07 ULMN 3 9pap_c00 PAPAIN user 3 3 # 3 25 CYH C 153 CYH.? 7.56 CL CL C2031 159 HIS C 151 HIS~? -4.28 C2 GOL C3036s 175 ASN C 148 ASN~? 11.79 O3 GOL C3036 coo 28.80 72.58 20.00 27.22 70.79 21.44 96.07 27.08 64.55 96.20 25.81 66.95 coo 29.11 66.58 21.75 30.70 67.95 21.84 88.24 26.50 64.44 86.75 25.04 64.52 coo 35.92 67.06 19.69 34.35 66.95 21.23 88.30 30.82 70.17 86.43 31.75 69.70 ULMN 3 9pap_c00 PAPAIN user 4 3 # 4 25 CYH D 153 CYH.? 14.75 O1 GOL D3020 159 HIS D 151 HIS~? -13.00 O2 GOL D3020s 175 ASN D 148 ASN~? 21.41 O2 GOL D3020 coo 28.80 72.58 20.00 27.22 70.79 21.44 5.67 57.11 70.86 4.62 54.95 72.38 coo 29.11 66.58 21.75 30.70 67.95 21.84 13.06 55.69 73.24 14.03 55.94 75.08 coo 35.92 67.06 19.69 34.35 66.95 21.23 12.38 49.18 69.99 12.27 49.48 67.83 ULMN 3 9pap_c00 PAPAIN user 5 3 # 5 25 CYH E 153 CYH~? 8.85 O1 GOL E3002 159 HIS E 151 HIS~? -4.12 O1 GOL E3002s 175 ASN E 148 ASN~? 10.65 O1 GOL E3002 coo 28.80 72.58 20.00 27.22 70.79 21.44 10.10 80.75 49.90 9.59 82.62 51.85 coo 29.11 66.58 21.75 30.70 67.95 21.84 17.87 81.44 51.19 19.31 82.95 50.96 coo 35.92 67.06 19.69 34.35 66.95 21.23 16.50 78.61 57.58 15.95 76.60 57.32 ULMN 3 9pap_c00 PAPAIN user 6 3 # 6 25 CYH F 153 CYH~? 17.48 CL CL F2034 159 HIS F 151 HIS~? 14.76 O3 GOL F3039s 175 ASN F 148 ASN~? 20.16 CL CL F2035 coo 28.80 72.58 20.00 27.22 70.79 21.44 100.56 42.65 36.94 101.15 40.25 35.75 coo 29.11 66.58 21.75 30.70 67.95 21.84 93.09 42.58 34.58 92.14 42.76 32.71 coo 35.92 67.06 19.69 34.35 66.95 21.23 92.36 36.84 38.84 92.17 37.47 40.85 ULMN 3 9pap_c00 PAPAIN user 7 3 # 7 25 CYH G 153 CYH~? 9.03 O3 GOL G3001 159 HIS G 151 HIS~? -4.14 C3 GOL G3001s 175 ASN G 148 ASN~? 12.10 C1 GOL G3001 coo 28.80 72.58 20.00 27.22 70.79 21.44 6.06 35.44 46.92 5.44 33.82 44.74 coo 29.11 66.58 21.75 30.70 67.95 21.84 13.55 33.19 47.26 14.46 31.35 47.64 coo 35.92 67.06 19.69 34.35 66.95 21.23 14.30 36.21 40.84 16.27 36.90 41.19 ULMN 3 9pap_c00 PAPAIN user 8 3 # 8 25 CYH H 153 CYH.? 12.27 O1 GOL H3016 159 HIS H 151 HIS~? 4.32 C1 GOL H3016s 175 ASN H 148 ASN~? 6.95 O1 GOL H3016 coo 28.80 72.58 20.00 27.22 70.79 21.44 97.03 55.04 80.47 97.67 57.42 81.76 coo 29.11 66.58 21.75 30.70 67.95 21.84 89.33 56.65 80.95 87.93 56.76 82.51 coo 35.92 67.06 19.69 34.35 66.95 21.23 90.74 62.26 76.80 90.93 61.43 74.87 ULMN 3 9pap_c00 PAPAIN user 9 3 # 9 25 CYH I 153 CYH~? 13.03 O3 GOL I3032 159 HIS I 151 HIS~? 3.98 O3 GOL I3032s 175 ASN I 148 ASN~? 10.15 O1 GOL I3032 coo 28.80 72.58 20.00 27.22 70.79 21.44 216.28 188.21 166.60 217.09 189.60 164.27 coo 29.11 66.58 21.75 30.70 67.95 21.84 208.71 190.07 165.44 207.65 191.87 165.52 coo 35.92 67.06 19.69 34.35 66.95 21.23 209.21 186.01 159.54 209.28 184.02 160.30 ULMN 3 9pap_c00 PAPAIN user 10 3 # 10 25 CYH J 153 CYH.? 14.69 O1 GOL J3033 159 HIS J 151 HIS~? -12.73 O1 GOL J3033s 175 ASN J 148 ASN~? 20.55 O1 GOL J3033 coo 28.80 72.58 20.00 27.22 70.79 21.44 124.53 173.82 143.70 124.14 176.01 142.05 coo 29.11 66.58 21.75 30.70 67.95 21.84 132.36 173.99 142.63 133.63 173.58 141.01 coo 35.92 67.06 19.69 34.35 66.95 21.23 132.19 180.35 145.70 132.98 179.70 147.44 ULMN 3 9pap_c00 PAPAIN user 11 3 # 11 25 CYH K 153 CYH.? 10.08 C1 GOL K3009 159 HIS K 151 HIS~? -4.18 C2 GOL K3009s 175 ASN K 148 ASN~? 12.08 C1 GOL K3009 coo 28.80 72.58 20.00 27.22 70.79 21.44 213.02 144.07 176.61 213.41 142.76 178.95 coo 29.11 66.58 21.75 30.70 67.95 21.84 205.25 143.04 176.89 203.95 141.38 176.70 coo 35.92 67.06 19.69 34.35 66.95 21.23 205.46 147.19 182.80 205.92 149.13 182.14 ULMN 3 9pap_c00 PAPAIN user 12 3 # 12 25 CYH L 153 CYH.? 17.58 CL CL L2028 159 HIS L 151 HIS~? -15.32 O3 GOL L3028s 175 ASN L 148 ASN~? 21.20 O3 GOL L3028 coo 28.80 72.58 20.00 27.22 70.79 21.44 121.51 169.13 188.69 120.63 167.06 190.29 coo 29.11 66.58 21.75 30.70 67.95 21.84 129.06 168.07 190.57 130.17 168.32 192.34 coo 35.92 67.06 19.69 34.35 66.95 21.23 128.43 161.78 187.33 130.41 161.66 186.63 ULMN 3 9pap_c00 PAPAIN user 13 3 # 13 25 CYH M 153 CYH~? 14.73 C2 GOL M3042 159 HIS M 151 HIS~? -11.81 O3 GOL M3042s 175 ASN M 148 ASN~? 20.35 O3 GOL M3042 coo 28.80 72.58 20.00 27.22 70.79 21.44 124.18 194.08 168.46 123.60 195.77 170.58 coo 29.11 66.58 21.75 30.70 67.95 21.84 131.91 195.13 169.59 133.22 196.76 169.40 coo 35.92 67.06 19.69 34.35 66.95 21.23 131.01 191.89 175.87 130.74 189.82 175.52 ULMN 3 9pap_c00 PAPAIN user 14 3 # 14 25 CYH N 153 CYH.? 9.71 O1 GOL N3012 159 HIS N 151 HIS~? 3.39 O2 GOL N3012s 175 ASN N 148 ASN~? 8.14 O1 GOL N3029 coo 28.80 72.58 20.00 27.22 70.79 21.44 215.62 161.14 149.48 216.18 158.76 148.20 coo 29.11 66.58 21.75 30.70 67.95 21.84 207.96 160.84 147.59 206.93 161.03 145.77 coo 35.92 67.06 19.69 34.35 66.95 21.23 207.66 155.05 151.71 208.13 155.55 153.68 ULMN 3 9pap_c00 PAPAIN user 15 3 # 15 25 CYH O 153 CYH.? 10.07 O3 GOL O3013 159 HIS O 151 HIS~? 4.32 O2 GOL O3026s 175 ASN O 148 ASN~? 8.79 O3 GOL O3026 coo 28.80 72.58 20.00 27.22 70.79 21.44 121.90 148.90 163.71 121.42 147.29 161.55 coo 29.11 66.58 21.75 30.70 67.95 21.84 129.65 146.92 163.60 130.73 145.15 163.91 coo 35.92 67.06 19.69 34.35 66.95 21.23 129.87 150.23 157.24 129.64 152.28 157.66 ULMN 3 9pap_c00 PAPAIN user 16 3 # 16 25 CYH P 153 CYH.? 9.50 O2 GOL P3014 159 HIS P 151 HIS~? -4.15 C3 GOL P3014s 175 ASN P 148 ASN~? 11.59 O1 GOL P3014 coo 28.80 72.58 20.00 27.22 70.79 21.44 213.41 171.20 193.92 214.01 173.48 195.24 coo 29.11 66.58 21.75 30.70 67.95 21.84 205.70 172.52 194.71 204.41 172.45 196.35 coo 35.92 67.06 19.69 34.35 66.95 21.23 206.51 178.28 190.78 206.84 177.74 188.77 9pap_c00 source 9pap PAPAIN : 16 hits 9pap_c00 naa= 3 ULMN 3 9pap_c01 PAPAIN user 1 3 # 1 19 GLN D 156 GLN.? -10.40 O2 GOL D3020s 25 CYH D 153 CYH.? 14.75 O1 GOL D3020 159 HIS D 151 HIS~? -13.00 O2 GOL D3020s coo 32.31 73.73 23.96 30.81 72.30 23.25 7.90 58.78 74.76 9.78 59.37 74.06 coo 28.80 72.58 20.00 27.22 70.79 21.44 5.67 57.11 70.86 4.62 54.95 72.38 coo 29.11 66.58 21.75 30.70 67.95 21.84 13.06 55.69 73.24 14.03 55.94 75.08 ULMN 3 9pap_c01 PAPAIN user 2 3 # 2 19 GLN G 156 GLN.? -2.79 O3 GOL G3001s 25 CYH G 153 CYH~? 9.03 O3 GOL G3001 159 HIS G 151 HIS~? -4.14 C3 GOL G3001s coo 32.31 73.73 23.96 30.81 72.30 23.25 8.33 31.51 50.57 9.87 32.77 49.98 coo 28.80 72.58 20.00 27.22 70.79 21.44 6.06 35.44 46.92 5.44 33.82 44.74 coo 29.11 66.58 21.75 30.70 67.95 21.84 13.55 33.19 47.26 14.46 31.35 47.64 9pap_c01 source 9pap PAPAIN : 2 hits 9pap_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 11 ASN~? 13.90 C3 GOL E3035 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.69 85.14 44.28 46.82 84.21 42.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 19 ASN~? 19.18 O2 GOL E3035 coo 5.80 63.03 55.85 5.52 65.03 56.45 52.52 96.60 45.55 50.48 96.15 45.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 31 ASN~? 35.25 O3 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.40 103.46 34.22 64.32 104.05 33.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 84 ASN~? 7.41 CL CL A2020 coo 5.80 63.03 55.85 5.52 65.03 56.45 110.27 84.71 52.14 109.25 86.35 53.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 118 ASN~? 12.89 O2 GOL A3040 coo 5.80 63.03 55.85 5.52 65.03 56.45 86.19 95.46 41.69 87.65 94.96 40.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 134 ASN.? 22.60 O2 GOL A3040 coo 5.80 63.03 55.85 5.52 65.03 56.45 89.85 87.69 31.14 89.29 86.47 29.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 148 ASN~? 19.52 O3 GOL A3037 coo 5.80 63.03 55.85 5.52 65.03 56.45 94.75 68.19 45.57 92.70 67.63 45.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 162 ASN~? 20.80 CL CL A2020 coo 5.80 63.03 55.85 5.52 65.03 56.45 110.86 71.03 47.42 111.08 69.19 46.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 165 ASN~? 16.94 CL CL A2020 coo 5.80 63.03 55.85 5.52 65.03 56.45 108.75 72.77 42.41 110.07 74.24 41.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 169 ASN~? 19.90 CL CL A2020 coo 5.80 63.03 55.85 5.52 65.03 56.45 104.72 70.61 38.69 106.25 71.83 37.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 11 ASN~? 20.64 CL CL F2035 coo 5.80 63.03 55.85 5.52 65.03 56.45 67.09 53.72 23.05 68.24 55.42 23.61 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 19 ASN~? 23.26 C1 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.37 50.97 10.93 66.09 50.23 11.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 31 ASN~? 16.07 O1 GOL B3003 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.08 62.28 0.56 56.41 63.22 -0.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 84 ASN~? 10.19 CL CL B2010 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.47 57.99 9.65 6.63 56.79 8.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 118 ASN~? 11.46 O1 GOL B3023 coo 5.80 63.03 55.85 5.52 65.03 56.45 33.03 60.93 3.68 31.91 62.70 3.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 134 ASN.? 21.61 CL CL B2010 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.08 73.64 8.08 31.06 75.15 9.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 148 ASN~? 9.53 C1 GOL B3024 coo 5.80 63.03 55.85 5.52 65.03 56.45 18.41 65.45 28.07 17.76 65.23 30.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 162 ASN~? 18.91 O3 GOL B3015 coo 5.80 63.03 55.85 5.52 65.03 56.45 3.18 65.96 21.79 2.54 67.75 22.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 165 ASN~? 18.31 CL CL B2010 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.70 69.75 19.58 5.86 70.24 17.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 169 ASN~? 19.72 O3 GOL B3015 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.89 72.68 22.09 9.26 73.23 20.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 11 ASN~? 13.02 CL CL C2006 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.48 23.73 60.48 38.53 24.80 62.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN C 19 ASN~? 8.68 CL CL C2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 42.15 11.55 59.90 40.37 12.31 59.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN C 31 ASN~? 18.06 CL CL C2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.83 2.95 72.82 49.52 2.14 73.82 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 84 ASN~? 7.25 CL CL C2021 coo 5.80 63.03 55.85 5.52 65.03 56.45 100.78 11.44 66.55 99.89 10.02 65.23 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN C 118 ASN~? 16.04 CL CL C2011 coo 5.80 63.03 55.85 5.52 65.03 56.45 73.44 6.07 71.04 74.54 6.27 72.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN C 134 ASN.? 21.68 CL CL C2011 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.46 13.23 82.50 75.64 14.68 83.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN C 148 ASN~? 11.79 O3 GOL C3036 coo 5.80 63.03 55.85 5.52 65.03 56.45 88.30 30.82 70.17 86.43 31.75 69.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN C 162 ASN~? -4.56 CL CL C2031s coo 5.80 63.03 55.85 5.52 65.03 56.45 103.70 24.43 71.40 105.80 24.17 71.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN C 165 ASN~? 10.20 CL CL C2031 coo 5.80 63.03 55.85 5.52 65.03 56.45 100.01 23.07 75.97 100.77 21.38 76.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN C 169 ASN~? 12.67 CL CL C2031 coo 5.80 63.03 55.85 5.52 65.03 56.45 95.89 26.30 78.61 97.43 24.97 79.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN D 11 ASN~? 12.70 O3 GOL H3025 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.63 51.24 86.13 60.38 49.29 85.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN D 19 ASN~? 8.55 CL CL H2005 coo 5.80 63.03 55.85 5.52 65.03 56.45 54.92 54.97 97.12 56.98 55.32 96.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN D 31 ASN~? 16.80 O1 GOL D3005 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.01 45.50 106.50 43.03 45.09 107.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN D 84 ASN~? 7.04 CL CL D2022 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.16 59.10 84.71 -2.15 60.07 86.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN D 118 ASN~? 12.14 O3 GOL D3018 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.36 51.13 97.39 19.90 49.65 97.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN D 134 ASN.? 21.42 O3 GOL D3018 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.21 39.17 91.82 18.06 37.43 90.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN D 148 ASN~? 21.41 O2 GOL D3020 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.38 49.18 69.99 12.27 49.48 67.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN D 162 ASN~? 20.95 CL CL D2022 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.53 51.75 71.97 -5.56 51.21 71.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN D 165 ASN~? 17.10 CL CL D2022 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.38 47.13 75.34 -2.60 46.72 77.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN D 169 ASN~? 20.20 CL CL D2022 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.51 43.08 73.92 0.74 42.93 75.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN E 11 ASN~? 21.92 C1 GOL E3004 coo 5.80 63.03 55.85 5.52 65.03 56.45 66.56 84.05 56.14 67.19 83.33 58.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN E 19 ASN~? 23.49 O1 GOL E3004 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.46 95.79 52.63 66.34 94.87 52.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN E 31 ASN~? 16.68 O1 GOL E3004 coo 5.80 63.03 55.85 5.52 65.03 56.45 56.53 106.82 62.15 54.79 107.93 62.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN E 84 ASN~? 6.86 CL CL E2032 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.48 96.99 47.72 6.68 98.41 46.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN E 118 ASN~? 11.51 O3 GOL E3022 coo 5.80 63.03 55.85 5.52 65.03 56.45 31.70 103.14 55.93 30.26 103.25 57.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN E 134 ASN.? 21.44 CL CL E2013 coo 5.80 63.03 55.85 5.52 65.03 56.45 26.64 98.55 67.66 26.91 97.58 69.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 47 1 # 47 A 461 ASN E 148 ASN~? 10.65 O1 GOL E3002 coo 5.80 63.03 55.85 5.52 65.03 56.45 16.50 78.61 57.58 15.95 76.60 57.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 48 1 # 48 A 461 ASN E 162 ASN~? 18.79 O1 GOL E3002 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.60 84.75 54.79 0.68 83.54 56.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 49 1 # 49 A 461 ASN E 165 ASN~? 16.84 CL CL E2032 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.18 87.03 59.16 3.30 89.01 59.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 50 1 # 50 A 461 ASN E 169 ASN~? 20.11 CL CL E2032 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.68 84.72 63.04 6.24 86.17 63.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 51 1 # 51 A 461 ASN F 11 ASN~? 13.91 O1 GOL B3017 coo 5.80 63.03 55.85 5.52 65.03 56.45 46.13 46.06 21.64 44.92 44.52 22.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 52 1 # 52 A 461 ASN F 19 ASN~? 19.88 O2 GOL B3017 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.22 46.49 10.14 49.31 47.27 10.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 53 1 # 53 A 461 ASN F 31 ASN~? 31.62 CL CL F2035 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.51 33.50 3.06 60.38 32.61 2.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 54 1 # 54 A 461 ASN F 84 ASN.? 7.11 CL CL F2023 coo 5.80 63.03 55.85 5.52 65.03 56.45 109.54 40.13 22.81 108.36 41.04 21.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 55 1 # 55 A 461 ASN F 118 ASN~? 12.37 O2 GOL F3039 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.29 35.61 11.58 84.35 33.80 11.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 56 1 # 56 A 461 ASN F 134 ASN.? 19.08 CL CL F2035 coo 5.80 63.03 55.85 5.52 65.03 56.45 84.48 24.50 19.28 83.57 23.00 20.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 57 1 # 57 A 461 ASN F 148 ASN~? 20.16 CL CL F2035 coo 5.80 63.03 55.85 5.52 65.03 56.45 92.36 36.84 38.84 92.17 37.47 40.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 58 1 # 58 A 461 ASN F 162 ASN~? 20.44 CL CL F2023 coo 5.80 63.03 55.85 5.52 65.03 56.45 108.49 35.42 36.44 110.53 34.82 36.67 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 59 1 # 59 A 461 ASN F 165 ASN~? 17.23 CL CL F2023 coo 5.80 63.03 55.85 5.52 65.03 56.45 105.13 30.81 34.30 106.23 29.87 32.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 60 1 # 60 A 461 ASN F 169 ASN~? 20.12 CL CL F2034 coo 5.80 63.03 55.85 5.52 65.03 56.45 100.53 28.30 36.27 102.02 27.22 35.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 61 1 # 61 A 461 ASN G 11 ASN~? 12.45 O1 GOL C3021 coo 5.80 63.03 55.85 5.52 65.03 56.45 60.32 20.98 52.71 61.40 21.45 50.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 62 1 # 62 A 461 ASN G 19 ASN~? 8.62 CL CL C2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 55.28 9.85 55.47 57.22 10.47 56.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 63 1 # 63 A 461 ASN G 31 ASN~? 18.27 CL CL C2004 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.68 0.09 44.37 45.83 -0.65 43.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 64 1 # 64 A 461 ASN G 84 ASN~? 7.24 CL CL G2033 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.25 21.18 47.67 -1.73 19.89 49.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 65 1 # 65 A 461 ASN G 118 ASN~? 13.16 O3 GOL G3038 coo 5.80 63.03 55.85 5.52 65.03 56.45 23.11 9.07 44.97 21.97 9.06 43.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 66 1 # 66 A 461 ASN G 134 ASN.? 22.43 C3 GOL G3038 coo 5.80 63.03 55.85 5.52 65.03 56.45 21.73 14.27 32.50 22.54 15.11 30.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 67 1 # 67 A 461 ASN G 148 ASN~? 12.10 C1 GOL G3001 coo 5.80 63.03 55.85 5.52 65.03 56.45 14.30 36.21 40.84 16.27 36.90 41.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 68 1 # 68 A 461 ASN G 162 ASN~? 17.59 O3 GOL G3001 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.80 33.61 39.96 -0.92 35.33 39.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 69 1 # 69 A 461 ASN G 165 ASN~? 17.67 CL CL G2033 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.33 30.61 35.97 0.19 28.96 35.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 70 1 # 70 A 461 ASN G 169 ASN~? 19.61 O3 GOL G3001 coo 5.80 63.03 55.85 5.52 65.03 56.45 5.90 31.93 32.74 4.21 30.61 32.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 71 1 # 71 A 461 ASN H 11 ASN~? 13.03 CL CL D2008 coo 5.80 63.03 55.85 5.52 65.03 56.45 40.80 62.96 83.01 40.13 64.68 81.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 72 1 # 72 A 461 ASN H 19 ASN~? 8.65 CL CL H2005 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.13 61.95 95.23 41.19 61.49 94.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 73 1 # 73 A 461 ASN H 31 ASN~? 16.72 O3 GOL H3006 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.10 73.51 104.06 52.89 74.15 105.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 74 1 # 74 A 461 ASN H 84 ASN~? 6.41 CL CL H2024 coo 5.80 63.03 55.85 5.52 65.03 56.45 102.16 56.25 96.45 100.56 55.72 97.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 75 1 # 75 A 461 ASN H 118 ASN~? 16.13 CL CL H2014 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.05 66.21 101.09 77.62 67.71 101.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 76 1 # 76 A 461 ASN H 134 ASN.? 21.68 CL CL H2014 coo 5.80 63.03 55.85 5.52 65.03 56.45 81.15 76.65 94.15 80.84 78.27 92.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 77 1 # 77 A 461 ASN H 148 ASN~? 6.95 O1 GOL H3016 coo 5.80 63.03 55.85 5.52 65.03 56.45 90.74 62.26 76.80 90.93 61.43 74.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 78 1 # 78 A 461 ASN H 162 ASN~? 19.79 CL CL H2024 coo 5.80 63.03 55.85 5.52 65.03 56.45 105.86 60.31 83.22 107.86 60.06 84.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 79 1 # 79 A 461 ASN H 165 ASN~? 17.68 CL CL H2024 coo 5.80 63.03 55.85 5.52 65.03 56.45 103.12 65.63 84.35 103.98 66.71 85.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 80 1 # 80 A 461 ASN H 169 ASN~? 18.72 O1 GOL H3016 coo 5.80 63.03 55.85 5.52 65.03 56.45 99.54 69.25 81.25 100.84 70.03 82.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 81 1 # 81 A 461 ASN I 11 ASN~? 13.03 CL CL I2007 coo 5.80 63.03 55.85 5.52 65.03 56.45 161.01 200.49 161.41 160.17 199.75 159.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 82 1 # 82 A 461 ASN I 19 ASN~? 8.69 CL CL I2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 165.40 212.09 163.02 163.35 211.60 163.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 83 1 # 83 A 461 ASN I 31 ASN~? 18.18 CL CL I2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 174.31 220.26 151.67 176.20 220.84 150.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 84 1 # 84 A 461 ASN I 84 ASN~? 7.02 CL CL I2025 coo 5.80 63.03 55.85 5.52 65.03 56.45 223.75 203.10 166.30 222.73 204.63 167.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 85 1 # 85 A 461 ASN I 118 ASN~? 12.95 O1 GOL I3031 coo 5.80 63.03 55.85 5.52 65.03 56.45 198.78 212.90 157.53 200.20 212.55 155.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 86 1 # 86 A 461 ASN I 134 ASN.? 21.46 CL CL I2015 coo 5.80 63.03 55.85 5.52 65.03 56.45 202.50 205.66 146.54 201.90 204.42 144.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 87 1 # 87 A 461 ASN I 148 ASN~? 10.15 O1 GOL I3032 coo 5.80 63.03 55.85 5.52 65.03 56.45 209.21 186.01 159.54 209.28 184.02 160.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 88 1 # 88 A 461 ASN I 162 ASN~? 21.04 CL CL I2025 coo 5.80 63.03 55.85 5.52 65.03 56.45 225.18 189.96 161.14 225.82 188.37 160.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 89 1 # 89 A 461 ASN I 165 ASN~? 17.28 CL CL I2025 coo 5.80 63.03 55.85 5.52 65.03 56.45 222.61 191.79 155.96 223.80 193.47 155.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 90 1 # 90 A 461 ASN I 169 ASN~? 20.31 CL CL I2025 coo 5.80 63.03 55.85 5.52 65.03 56.45 218.60 189.48 152.52 220.34 190.74 152.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 91 1 # 91 A 461 ASN J 11 ASN~? 12.94 O2 GOL N3044 coo 5.80 63.03 55.85 5.52 65.03 56.45 180.98 171.30 137.88 181.93 173.10 138.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 92 1 # 92 A 461 ASN J 19 ASN~? 8.56 CL CL J2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 177.77 168.91 125.99 179.61 168.23 126.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 93 1 # 93 A 461 ASN J 31 ASN~? 18.09 CL CL J2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 171.02 180.04 115.82 169.37 180.80 114.74 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 94 1 # 94 A 461 ASN J 84 ASN~? 7.23 CL CL J2026 coo 5.80 63.03 55.85 5.52 65.03 56.45 118.44 173.52 128.48 119.65 172.15 127.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 95 1 # 95 A 461 ASN J 118 ASN~? 12.66 O3 GOL J3030 coo 5.80 63.03 55.85 5.52 65.03 56.45 145.50 177.92 120.49 144.26 179.66 120.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 96 1 # 96 A 461 ASN J 134 ASN.? 21.36 CL CL J2016 coo 5.80 63.03 55.85 5.52 65.03 56.45 142.59 189.93 125.86 143.30 191.66 127.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 97 1 # 97 A 461 ASN J 148 ASN~? 20.55 O1 GOL J3033 coo 5.80 63.03 55.85 5.52 65.03 56.45 132.19 180.35 145.70 132.98 179.70 147.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 98 1 # 98 A 461 ASN J 162 ASN~? 20.00 CL CL J2026 coo 5.80 63.03 55.85 5.52 65.03 56.45 116.58 180.36 140.72 114.44 180.36 140.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 99 1 # 99 A 461 ASN J 165 ASN~? 17.02 CL CL J2026 coo 5.80 63.03 55.85 5.52 65.03 56.45 119.99 184.59 138.50 118.95 185.04 136.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 100 1 # 100 A 461 ASN J 169 ASN~? 19.84 CL CL J2026 coo 5.80 63.03 55.85 5.52 65.03 56.45 124.16 188.01 140.62 122.87 188.45 138.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 101 1 # 101 A 461 ASN K 11 ASN~? 12.99 CL CL K2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 156.74 138.31 174.91 155.83 139.22 176.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 102 1 # 102 A 461 ASN K 19 ASN~? 12.99 CL CL K2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 159.95 126.22 173.79 158.08 126.91 172.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 103 1 # 103 A 461 ASN K 31 ASN~? 16.74 O1 GOL K3011 coo 5.80 63.03 55.85 5.52 65.03 56.45 166.35 117.31 186.12 168.04 116.44 187.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 104 1 # 104 A 461 ASN K 84 ASN~? 7.12 CL CL K2027 coo 5.80 63.03 55.85 5.52 65.03 56.45 218.95 128.67 178.13 217.92 127.23 176.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 105 1 # 105 A 461 ASN K 118 ASN~? 12.53 O1 GOL K3041 coo 5.80 63.03 55.85 5.52 65.03 56.45 191.94 121.64 183.31 193.08 121.89 185.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 106 1 # 106 A 461 ASN K 134 ASN.? 21.40 O1 GOL K3041 coo 5.80 63.03 55.85 5.52 65.03 56.45 194.99 128.59 194.84 194.18 129.99 196.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 107 1 # 107 A 461 ASN K 148 ASN~? 12.08 C1 GOL K3009 coo 5.80 63.03 55.85 5.52 65.03 56.45 205.46 147.19 182.80 205.92 149.13 182.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 108 1 # 108 A 461 ASN K 162 ASN~? 20.55 CL CL K2027 coo 5.80 63.03 55.85 5.52 65.03 56.45 220.99 141.86 183.52 222.93 141.99 184.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 109 1 # 109 A 461 ASN K 165 ASN~? 17.10 CL CL K2027 coo 5.80 63.03 55.85 5.52 65.03 56.45 217.62 140.29 187.92 218.57 138.50 188.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 110 1 # 110 A 461 ASN K 169 ASN~? 20.23 CL CL K2027 coo 5.80 63.03 55.85 5.52 65.03 56.45 213.36 143.00 190.89 214.89 141.65 191.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 111 1 # 111 A 461 ASN L 11 ASN~? 26.76 O3 GOL P3014 coo 5.80 63.03 55.85 5.52 65.03 56.45 176.63 165.37 201.14 177.48 163.54 200.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 112 1 # 112 A 461 ASN L 19 ASN~? 27.25 O2 GOL P3034 coo 5.80 63.03 55.85 5.52 65.03 56.45 172.29 168.28 212.49 174.30 168.74 211.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 113 1 # 113 A 461 ASN L 31 ASN~? 34.54 O3 GOL K3011 coo 5.80 63.03 55.85 5.52 65.03 56.45 163.63 157.90 222.01 161.73 157.29 222.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 114 1 # 114 A 461 ASN L 84 ASN~? 6.99 CL CL L2028 coo 5.80 63.03 55.85 5.52 65.03 56.45 114.19 171.29 203.61 115.33 172.43 205.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 115 1 # 115 A 461 ASN L 118 ASN~? 12.89 O1 GOL L3027 coo 5.80 63.03 55.85 5.52 65.03 56.45 138.94 163.13 214.22 137.52 161.58 214.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 116 1 # 116 A 461 ASN L 134 ASN.? 21.61 CL CL L2009 coo 5.80 63.03 55.85 5.52 65.03 56.45 134.78 151.23 208.60 135.91 149.70 207.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 117 1 # 117 A 461 ASN L 148 ASN~? 21.20 O3 GOL L3028 coo 5.80 63.03 55.85 5.52 65.03 56.45 128.43 161.78 187.33 130.41 161.66 186.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 118 1 # 118 A 461 ASN L 162 ASN~? 19.26 CL CL L2028 coo 5.80 63.03 55.85 5.52 65.03 56.45 112.25 163.92 191.15 110.27 164.53 191.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 119 1 # 119 A 461 ASN L 165 ASN~? 16.81 CL CL L2028 coo 5.80 63.03 55.85 5.52 65.03 56.45 114.71 159.55 193.76 113.48 159.11 195.49 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 120 1 # 120 A 461 ASN L 169 ASN~? 19.82 CL CL L2028 coo 5.80 63.03 55.85 5.52 65.03 56.45 118.50 155.71 192.04 116.85 155.24 193.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 121 1 # 121 A 461 ASN M 11 ASN~? 13.05 CL CL I2007 coo 5.80 63.03 55.85 5.52 65.03 56.45 180.57 199.77 172.35 181.29 199.01 174.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 122 1 # 122 A 461 ASN M 19 ASN~? 8.72 CL CL I2001 coo 5.80 63.03 55.85 5.52 65.03 56.45 177.80 211.54 169.57 179.70 210.70 169.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 123 1 # 123 A 461 ASN M 31 ASN~? 17.43 O1 GOL M3007 coo 5.80 63.03 55.85 5.52 65.03 56.45 169.82 222.03 179.48 168.08 223.12 179.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 124 1 # 124 A 461 ASN M 84 ASN~? 7.69 CL CL M2029 coo 5.80 63.03 55.85 5.52 65.03 56.45 118.35 209.44 167.10 119.51 210.52 165.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 125 1 # 125 A 461 ASN M 118 ASN~? 11.47 O3 GOL M3043 coo 5.80 63.03 55.85 5.52 65.03 56.45 144.69 217.23 174.75 143.27 217.31 176.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 126 1 # 126 A 461 ASN M 134 ASN.? 21.64 CL CL M2017 coo 5.80 63.03 55.85 5.52 65.03 56.45 140.32 211.77 186.52 140.85 210.60 188.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 127 1 # 127 A 461 ASN M 148 ASN~? 20.35 O3 GOL M3042 coo 5.80 63.03 55.85 5.52 65.03 56.45 131.01 191.89 175.87 130.74 189.82 175.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 128 1 # 128 A 461 ASN M 162 ASN~? 21.06 CL CL M2029 coo 5.80 63.03 55.85 5.52 65.03 56.45 115.58 197.49 173.95 115.83 195.56 174.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 129 1 # 129 A 461 ASN M 165 ASN~? 17.33 CL CL M2029 coo 5.80 63.03 55.85 5.52 65.03 56.45 118.38 199.68 178.54 117.52 201.51 179.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 130 1 # 130 A 461 ASN M 169 ASN~? 20.21 CL CL M2029 coo 5.80 63.03 55.85 5.52 65.03 56.45 122.14 197.16 182.25 120.57 198.65 182.36 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 131 1 # 131 A 461 ASN N 11 ASN~? 18.16 CL CL J2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.32 162.66 137.06 159.27 161.03 137.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 132 1 # 132 A 461 ASN N 19 ASN~? 8.64 CL CL J2002 coo 5.80 63.03 55.85 5.52 65.03 56.45 164.88 163.88 125.50 162.92 164.59 126.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 133 1 # 133 A 461 ASN N 31 ASN~? 16.42 O3 GOL N3008 coo 5.80 63.03 55.85 5.52 65.03 56.45 172.40 151.59 117.56 174.20 150.72 116.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 134 1 # 134 A 461 ASN N 84 ASN~? 6.35 CL CL N2030 coo 5.80 63.03 55.85 5.52 65.03 56.45 223.39 159.28 134.52 222.37 160.07 132.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 135 1 # 135 A 461 ASN N 118 ASN~? 20.12 CL CL N2030 coo 5.80 63.03 55.85 5.52 65.03 56.45 197.21 154.22 124.75 198.31 152.47 125.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 136 1 # 136 A 461 ASN N 134 ASN.? 22.01 O2 GOL N3029 coo 5.80 63.03 55.85 5.52 65.03 56.45 199.33 142.96 132.06 198.55 141.35 133.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 137 1 # 137 A 461 ASN N 148 ASN~? 8.14 O1 GOL N3029 coo 5.80 63.03 55.85 5.52 65.03 56.45 207.66 155.05 151.71 208.13 155.55 153.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 138 1 # 138 A 461 ASN N 162 ASN~? 20.47 O1 GOL N3012 coo 5.80 63.03 55.85 5.52 65.03 56.45 223.57 153.98 148.46 225.62 153.32 148.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 139 1 # 139 A 461 ASN N 165 ASN~? 17.23 CL CL N2030 coo 5.80 63.03 55.85 5.52 65.03 56.45 220.62 149.73 146.26 221.75 148.90 144.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 140 1 # 140 A 461 ASN N 169 ASN~? 19.21 O1 GOL N3029 coo 5.80 63.03 55.85 5.52 65.03 56.45 216.18 147.01 148.49 217.97 146.49 147.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 141 1 # 141 A 461 ASN O 11 ASN~? 13.05 CL CL K2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 177.30 136.62 166.28 178.38 137.16 164.50 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 142 1 # 142 A 461 ASN O 19 ASN~? 12.94 CL CL K2003 coo 5.80 63.03 55.85 5.52 65.03 56.45 172.82 125.20 168.77 174.75 125.83 169.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 143 1 # 143 A 461 ASN O 31 ASN~? 22.31 CL CL O2036 coo 5.80 63.03 55.85 5.52 65.03 56.45 165.12 115.88 157.47 163.27 115.16 156.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 144 1 # 144 A 461 ASN O 84 ASN.? 10.27 CL CL O2018 coo 5.80 63.03 55.85 5.52 65.03 56.45 113.86 134.05 164.18 115.11 132.69 165.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 145 1 # 145 A 461 ASN O 118 ASN~? 8.57 CL CL O2036 coo 5.80 63.03 55.85 5.52 65.03 56.45 140.29 123.54 159.68 139.14 123.57 157.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 146 1 # 146 A 461 ASN O 134 ASN.? 10.04 CL CL O2036 coo 5.80 63.03 55.85 5.52 65.03 56.45 138.05 129.32 147.60 138.80 130.30 145.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 147 1 # 147 A 461 ASN O 148 ASN~? 8.79 O3 GOL O3026 coo 5.80 63.03 55.85 5.52 65.03 56.45 129.87 150.23 157.24 129.64 152.28 157.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 148 1 # 148 A 461 ASN O 162 ASN~? 20.65 O3 GOL O3013 coo 5.80 63.03 55.85 5.52 65.03 56.45 113.68 146.60 157.20 111.65 146.01 156.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 149 1 # 149 A 461 ASN O 165 ASN~? 18.23 CL CL O2018 coo 5.80 63.03 55.85 5.52 65.03 56.45 116.66 144.08 153.13 115.47 142.38 152.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 150 1 # 150 A 461 ASN O 169 ASN~? 19.84 O3 GOL O3026 coo 5.80 63.03 55.85 5.52 65.03 56.45 121.26 145.80 149.68 119.81 144.33 149.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 151 1 # 151 A 461 ASN P 11 ASN~? 12.58 O1 GOL L3028 coo 5.80 63.03 55.85 5.52 65.03 56.45 157.20 176.23 199.28 156.46 178.04 198.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 152 1 # 152 A 461 ASN P 19 ASN~? 18.28 O1 GOL L3028 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.18 174.82 211.39 158.25 174.28 210.61 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 153 1 # 153 A 461 ASN P 31 ASN~? 33.36 O3 GOL M3007 coo 5.80 63.03 55.85 5.52 65.03 56.45 167.75 186.44 220.46 169.52 187.23 221.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 154 1 # 154 A 461 ASN P 84 ASN~? 10.96 CL CL P2019 coo 5.80 63.03 55.85 5.52 65.03 56.45 219.43 171.97 209.05 218.45 170.73 210.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 155 1 # 155 A 461 ASN P 118 ASN~? 12.47 O2 GOL P3034 coo 5.80 63.03 55.85 5.52 65.03 56.45 193.17 180.34 216.14 194.59 181.90 215.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 156 1 # 156 A 461 ASN P 134 ASN.? 21.42 CL CL P2019 coo 5.80 63.03 55.85 5.52 65.03 56.45 197.55 191.31 209.34 197.08 192.94 207.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 157 1 # 157 A 461 ASN P 148 ASN~? 11.59 O1 GOL P3014 coo 5.80 63.03 55.85 5.52 65.03 56.45 206.51 178.28 190.78 206.84 177.74 188.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 158 1 # 158 A 461 ASN P 162 ASN~? 19.02 O2 GOL P3014 coo 5.80 63.03 55.85 5.52 65.03 56.45 222.14 176.71 196.35 222.77 177.56 194.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 159 1 # 159 A 461 ASN P 165 ASN~? 18.52 CL CL P2019 coo 5.80 63.03 55.85 5.52 65.03 56.45 219.28 181.89 197.79 220.29 182.63 199.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 160 1 # 160 A 461 ASN P 169 ASN~? 20.57 CL CL P2019 coo 5.80 63.03 55.85 5.52 65.03 56.45 215.43 185.33 195.20 216.81 186.25 196.56 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 160 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE B 168 ILE~? 14.82 CL CL B2010 A 52 ASN E 148 ASN~? 10.65 O1 GOL E3002 A 53 VAL E 149 VAL~? 10.46 O1 GOL E3002 A 78 ASN B 165 ASN~? 18.31 CL CL B2010 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 12.56 70.10 17.52 11.51 69.53 16.51 coo 81.20 29.47 37.49 79.47 28.44 38.24 16.50 78.61 57.58 15.95 76.60 57.32 coo 82.17 24.86 36.27 81.03 23.67 37.80 12.80 80.51 55.94 11.22 80.83 57.47 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 6.70 69.75 19.58 5.86 70.24 17.69 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE L 168 ILE~? 14.57 CL CL L2028 A 52 ASN O 148 ASN~? 8.79 O3 GOL O3026 A 53 VAL O 149 VAL~? 10.94 O3 GOL O3026 A 78 ASN L 165 ASN~? 16.81 CL CL L2028 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 120.18 158.16 196.71 119.15 158.68 197.57 coo 81.20 29.47 37.49 79.47 28.44 38.24 129.87 150.23 157.24 129.64 152.28 157.66 coo 82.17 24.86 36.27 81.03 23.67 37.80 125.65 148.90 158.13 124.39 148.96 156.41 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 114.71 159.55 193.76 113.48 159.11 195.49 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 2 hits 1qfw_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 14 ARG~? 17.33 C3 GOL E3035 A 188 TYR A 21 TYR~? 26.32 C3 GOL E3035 A 190 SER A 18 SER~? 19.06 O2 GOL E3035 coo 37.69 7.64 13.51 38.82 8.84 16.11 51.58 86.56 39.71 49.78 85.03 37.73 coo 47.14 12.10 13.73 48.75 12.33 16.01 56.96 96.11 38.73 58.94 94.19 38.55 coo 43.77 6.93 15.46 45.49 7.21 17.11 52.83 94.35 41.19 50.56 94.79 40.50 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG D 14 ARG~? 14.52 CL CL D2008 A 188 TYR D 21 TYR~? 10.58 CL CL H2005 A 190 SER D 18 SER~? 11.82 CL CL H2005 coo 37.69 7.64 13.51 38.82 8.84 16.11 55.60 47.14 88.58 57.38 44.84 87.47 coo 47.14 12.10 13.73 48.75 12.33 16.01 50.45 48.27 98.24 48.40 47.71 96.43 coo 43.77 6.93 15.46 45.49 7.21 17.11 54.66 50.25 95.98 56.94 49.72 96.72 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG E 14 ARG~? 16.26 C1 GOL E3004 A 188 TYR E 21 TYR~? 14.13 O1 GOL E3004 A 190 SER E 18 SER~? 18.57 O1 GOL E3004 coo 37.69 7.64 13.51 38.82 8.84 16.11 63.05 87.03 60.24 64.56 85.62 62.59 coo 47.14 12.10 13.73 48.75 12.33 16.01 60.20 97.64 59.27 57.81 96.28 59.79 coo 43.77 6.93 15.46 45.49 7.21 17.11 63.74 94.63 57.27 66.09 94.75 57.93 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG F 14 ARG~? 16.88 O1 GOL B3017 A 188 TYR F 21 TYR~? 26.08 O1 GOL B3017 A 190 SER F 18 SER~? 18.98 O1 GOL B3017 coo 37.69 7.64 13.51 38.82 8.84 16.11 49.17 40.62 20.09 46.79 39.22 21.58 coo 47.14 12.10 13.73 48.75 12.33 16.01 54.13 38.92 10.51 56.02 38.27 12.47 coo 43.77 6.93 15.46 45.49 7.21 17.11 50.60 42.15 12.28 48.22 42.09 11.72 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG G 14 ARG~? 14.57 CL CL C2006 A 188 TYR G 21 TYR~? 10.57 CL CL C2004 A 190 SER G 18 SER~? 11.79 CL CL C2004 coo 37.69 7.64 13.51 38.82 8.84 16.11 57.32 18.45 47.88 59.70 19.45 46.16 coo 47.14 12.10 13.73 48.75 12.33 16.01 52.17 8.74 48.00 50.23 10.55 47.07 coo 43.77 6.93 15.46 45.49 7.21 17.11 55.84 11.08 50.81 58.15 10.49 50.68 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG H 14 ARG~? 14.44 CL CL D2008 A 188 TYR H 21 TYR~? 10.50 CL CL H2005 A 190 SER H 18 SER~? 11.79 CL CL H2005 coo 37.69 7.64 13.51 38.82 8.84 16.11 44.51 67.63 85.23 43.02 69.63 83.32 coo 47.14 12.10 13.73 48.75 12.33 16.01 47.46 68.84 95.61 49.74 68.96 94.05 coo 43.77 6.93 15.46 45.49 7.21 17.11 43.82 66.34 93.10 41.47 66.92 93.11 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG J 14 ARG~? 16.47 O2 GOL N3044 A 188 TYR J 21 TYR~? 10.46 CL CL J2002 A 190 SER J 18 SER~? 11.71 CL CL J2002 coo 37.69 7.64 13.51 38.82 8.84 16.11 178.00 176.13 135.20 179.89 178.17 136.63 coo 47.14 12.10 13.73 48.75 12.33 16.01 174.52 176.28 124.74 172.25 177.04 126.20 coo 43.77 6.93 15.46 45.49 7.21 17.11 177.96 173.57 127.53 180.33 173.72 127.25 ULMN 3 2p3i_p00 VP4 user 8 3 # 8 A 101 ARG K 14 ARG~? 14.49 CL CL K2003 A 188 TYR K 21 TYR~? 13.85 O1 GOL K3011 A 190 SER K 18 SER~? 14.77 CL CL K2003 coo 37.69 7.64 13.51 38.82 8.84 16.11 159.72 136.15 179.98 157.68 137.80 181.74 coo 47.14 12.10 13.73 48.75 12.33 16.01 163.15 125.72 181.32 165.33 127.37 181.87 coo 43.77 6.93 15.46 45.49 7.21 17.11 159.74 128.20 178.19 157.36 127.88 178.37 ULMN 3 2p3i_p00 VP4 user 9 3 # 9 A 101 ARG L 14 ARG~? 26.83 O3 GOL K3011 A 188 TYR L 21 TYR~? 30.92 O3 GOL K3011 A 190 SER L 18 SER~? 28.19 C1 GOL P3034 coo 37.69 7.64 13.51 38.82 8.84 16.11 172.85 160.87 203.42 174.90 158.78 202.32 coo 47.14 12.10 13.73 48.75 12.33 16.01 168.26 161.38 213.44 166.20 160.80 211.67 coo 43.77 6.93 15.46 45.49 7.21 17.11 172.12 163.66 211.09 174.33 163.17 211.65 ULMN 3 2p3i_p00 VP4 user 10 3 # 10 A 101 ARG M 14 ARG~? 14.61 CL CL I2007 A 188 TYR M 21 TYR~? 10.54 CL CL I2001 A 190 SER M 18 SER~? 11.79 CL CL I2001 coo 37.69 7.64 13.51 38.82 8.84 16.11 177.02 202.54 176.79 178.85 201.28 179.05 coo 47.14 12.10 13.73 48.75 12.33 16.01 173.68 213.02 176.47 171.32 211.57 177.01 coo 43.77 6.93 15.46 45.49 7.21 17.11 177.31 210.15 174.21 179.68 210.41 174.63 ULMN 3 2p3i_p00 VP4 user 11 3 # 11 A 101 ARG N 14 ARG~? 15.89 C3 GOL N3008 A 188 TYR N 21 TYR~? 10.52 CL CL J2002 A 190 SER N 18 SER~? 11.82 CL CL J2002 coo 37.69 7.64 13.51 38.82 8.84 16.11 163.48 157.63 135.35 161.30 155.86 136.73 coo 47.14 12.10 13.73 48.75 12.33 16.01 168.15 156.47 125.36 170.14 155.81 127.21 coo 43.77 6.93 15.46 45.49 7.21 17.11 164.52 159.39 127.36 162.12 159.15 126.89 ULMN 3 2p3i_p00 VP4 user 12 3 # 12 A 101 ARG O 14 ARG~? 14.59 CL CL K2003 A 188 TYR O 21 TYR~? 14.79 CL CL K2003 A 190 SER O 18 SER~? 14.85 CL CL K2003 coo 37.69 7.64 13.51 38.82 8.84 16.11 174.25 134.10 161.46 176.22 135.49 159.49 coo 47.14 12.10 13.73 48.75 12.33 16.01 169.50 124.29 161.32 167.44 126.02 160.55 coo 43.77 6.93 15.46 45.49 7.21 17.11 173.20 126.61 164.13 175.55 126.05 163.98 ULMN 3 2p3i_p00 VP4 user 13 3 # 13 A 101 ARG P 14 ARG~? 15.62 O1 GOL L3028 A 188 TYR P 21 TYR~? 24.07 O1 GOL L3028 A 190 SER P 18 SER~? 17.05 O1 GOL L3028 coo 37.69 7.64 13.51 38.82 8.84 16.11 160.23 180.86 201.41 159.06 183.03 199.69 coo 47.14 12.10 13.73 48.75 12.33 16.01 164.13 181.87 211.82 166.34 182.20 210.17 coo 43.77 6.93 15.46 45.49 7.21 17.11 160.57 179.24 209.35 158.22 179.71 209.48 2p3i_p00 source 2p3i VP4 : 13 hits 2p3i_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 108 ARG~? 22.68 O1 GOL A3040 B 6 THR A 64 THR~? 18.85 O1 GOL A3040 B 8 THR A 67 THR~? -15.67 O1 GOL A3040s coo 40.52 16.08 100.90 37.97 16.41 102.60 77.54 80.61 37.36 78.31 77.83 38.52 coo 36.11 13.64 95.03 34.54 14.86 95.91 82.36 77.26 44.89 81.47 76.71 42.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 87.07 77.47 46.60 86.90 75.54 45.71 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG B 108 ARG~? 14.18 O1 GOL B3024 B 6 THR B 105 THR.? 19.41 O1 GOL B3024 B 8 THR B 137 THR.? 20.12 O1 GOL B3024 coo 40.52 16.08 100.90 37.97 16.41 102.60 39.05 68.00 18.82 37.75 66.74 21.38 coo 36.11 13.64 95.03 34.54 14.86 95.91 34.49 75.75 17.47 33.13 77.30 18.07 coo 32.72 8.05 92.39 31.25 9.11 91.35 27.20 77.94 14.81 25.17 78.51 15.30 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG E 108 ARG~? 18.65 O1 GOL E3035 B 6 THR E 105 THR.? 24.42 O1 GOL D3019 B 8 THR E 137 THR.? 22.17 CL CL E2013 coo 40.52 16.08 100.90 37.97 16.41 102.60 36.12 87.73 64.17 35.30 85.24 62.51 coo 36.11 13.64 95.03 34.54 14.86 95.91 30.57 89.23 70.86 28.85 88.51 71.92 coo 32.72 8.05 92.39 31.25 9.11 91.35 22.70 91.77 71.51 20.53 91.40 71.47 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG F 108 ARG~? -3.40 CL CL F2035s B 6 THR F 105 THR.? 14.75 CL CL F2035 B 8 THR F 137 THR.? 20.15 CL CL F2035 coo 40.52 16.08 100.90 37.97 16.41 102.60 74.01 31.91 26.65 74.85 33.96 28.84 coo 36.11 13.64 95.03 34.54 14.86 95.91 78.18 24.30 27.70 79.35 23.01 28.98 coo 32.72 8.05 92.39 31.25 9.11 91.35 85.93 21.84 27.36 87.79 21.55 28.39 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG G 108 ARG~? 22.05 O2 GOL G3001 B 6 THR G 105 THR.? 24.65 O1 GOL B3017 B 8 THR G 137 THR.? 24.74 CL CL G2033 coo 40.52 16.08 100.90 37.97 16.41 102.60 32.32 22.84 38.36 31.62 25.53 39.73 coo 36.11 13.64 95.03 34.54 14.86 95.91 28.24 22.56 30.52 26.99 23.47 29.06 coo 32.72 8.05 92.39 31.25 9.11 91.35 20.34 21.70 28.27 18.47 22.70 27.98 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG I 108 ARG~? 14.30 O1 GOL I3032 B 6 THR I 105 THR.? 19.75 O1 GOL I3032 B 8 THR I 137 THR.? 20.08 O1 GOL I3032 coo 40.52 16.08 100.90 37.97 16.41 102.60 191.22 197.47 152.14 191.76 195.04 153.98 coo 36.11 13.64 95.03 34.54 14.86 95.91 196.67 196.85 145.06 198.08 195.68 144.00 coo 32.72 8.05 92.39 31.25 9.11 91.35 204.82 197.76 143.86 206.74 196.81 144.00 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG J 108 ARG~? 23.02 O1 GOL J3030 B 6 THR J 105 THR.? 26.65 CL CL J2016 B 8 THR J 137 THR.? 22.19 CL CL J2016 coo 40.52 16.08 100.90 37.97 16.41 102.60 152.38 184.27 135.62 151.05 183.00 138.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 147.52 191.90 135.01 146.15 193.36 135.77 coo 32.72 8.05 92.39 31.25 9.11 91.35 139.81 193.84 133.00 137.76 194.24 133.58 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG K 108 ARG~? 18.77 O3 GOL K3010 B 6 THR K 105 THR.? 26.54 O3 GOL K3011 B 8 THR K 137 THR.? 24.14 O1 GOL K3041 coo 40.52 16.08 100.90 37.97 16.41 102.60 185.36 137.67 187.99 186.54 140.01 186.30 coo 36.11 13.64 95.03 34.54 14.86 95.91 189.99 137.92 195.49 191.30 139.02 196.78 coo 32.72 8.05 92.39 31.25 9.11 91.35 197.75 136.25 197.75 199.78 136.83 197.91 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG M 108 ARG~? 23.14 O1 GOL M3043 B 6 THR M 105 THR.? 24.57 C1 GOL L3028 B 8 THR M 137 THR.? 22.49 CL CL M2017 coo 40.52 16.08 100.90 37.97 16.41 102.60 150.62 202.12 182.01 149.56 199.68 180.53 coo 36.11 13.64 95.03 34.54 14.86 95.91 145.11 202.54 189.01 143.57 201.62 190.19 coo 32.72 8.05 92.39 31.25 9.11 91.35 137.14 204.63 190.01 135.11 203.99 190.03 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG N 108 ARG~? 14.89 C2 GOL N3029 B 6 THR N 105 THR.? 20.04 C1 GOL N3029 B 8 THR N 137 THR.? 20.02 O2 GOL N3029 coo 40.52 16.08 100.90 37.97 16.41 102.60 189.02 149.68 140.15 189.67 151.62 142.49 coo 36.11 13.64 95.03 34.54 14.86 95.91 193.42 142.19 140.79 194.84 140.97 141.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 201.34 139.99 139.99 203.29 139.79 140.87 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG P 108 ARG~? 21.30 O3 GOL P3014 B 6 THR P 105 THR.? 26.53 O3 GOL P3014 B 8 THR P 137 THR.? 22.56 CL CL P2019 coo 40.52 16.08 100.90 37.97 16.41 102.60 187.53 185.71 199.97 188.17 183.79 197.64 coo 36.11 13.64 95.03 34.54 14.86 95.91 192.76 192.82 199.88 194.36 193.92 198.88 coo 32.72 8.05 92.39 31.25 9.11 91.35 200.99 193.88 201.82 203.01 194.45 201.35 1b01_d00 source 1b01 GENE REGULATION/DNA : 11 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN D 166 GLN~? 21.13 O1 GOL D3020 A 11 ASN D 169 ASN~? 20.20 CL CL D2022 A 13 ARG D 95 ARG~? 18.32 CL CL D2012 coo 33.45 2.10 7.21 34.51 1.09 5.67 2.69 48.18 70.17 3.26 49.63 68.68 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 2.51 43.08 73.92 0.74 42.93 75.11 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 1.08 42.29 81.69 1.93 41.79 78.81 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN E 166 GLN~? 14.31 O1 GOL E3002 A 11 ASN E 169 ASN~? 20.11 CL CL E2032 A 13 ARG E 95 ARG~? 18.33 CL CL E2013 coo 33.45 2.10 7.21 34.51 1.09 5.67 5.52 81.96 57.48 5.30 80.80 55.69 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 7.68 84.72 63.04 6.24 86.17 63.59 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 8.24 92.43 64.58 8.56 89.36 64.86 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 3 3 # 3 A 9 GLN F 166 GLN~? 21.12 CL CL F2023 A 11 ASN F 169 ASN~? 20.12 CL CL F2034 A 13 ARG F 95 ARG~? 18.18 CL CL F2034 coo 33.45 2.10 7.21 34.51 1.09 5.67 103.62 34.05 38.32 104.43 35.87 39.06 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 100.53 28.30 36.27 102.02 27.22 35.16 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 101.23 25.44 29.03 100.92 26.10 32.03 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 4 3 # 4 A 9 GLN I 166 GLN~? 17.50 O3 GOL I3032 A 11 ASN I 169 ASN~? 20.31 CL CL I2025 A 13 ARG I 95 ARG~? 18.52 CL CL I2015 coo 33.45 2.10 7.21 34.51 1.09 5.67 220.47 187.37 158.82 220.07 186.40 160.66 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 218.60 189.48 152.52 220.34 190.74 152.17 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 219.42 197.06 150.20 219.02 193.99 150.58 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 5 3 # 5 A 9 GLN L 166 GLN~? 20.21 CL CL L2028 A 11 ASN L 169 ASN~? 19.82 CL CL L2028 A 13 ARG L 95 ARG~? 18.19 CL CL L2028 coo 33.45 2.10 7.21 34.51 1.09 5.67 116.52 161.43 189.18 115.71 163.43 188.74 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 118.50 155.71 192.04 116.85 155.24 193.31 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 118.02 154.26 199.66 118.36 154.13 196.59 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 6 3 # 6 A 9 GLN P 166 GLN~? 15.12 O1 GOL P3014 A 11 ASN P 169 ASN~? 20.57 CL CL P2019 A 13 ARG P 95 ARG~? 18.58 CL CL P2019 coo 33.45 2.10 7.21 34.51 1.09 5.67 217.71 179.11 193.44 217.65 177.49 192.12 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 215.43 185.33 195.20 216.81 186.25 196.56 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 215.71 187.54 202.72 215.66 187.33 199.63 1bdv_d00 source 1bdv GENE REGULATION/DNA : 6 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 75 TYR~? 11.96 CL CL A2020 I 306 VAL A 96 VAL~? 9.04 CL CL A2020 I 308 VAL A 80 VAL~? 4.13 CL CL A2020 coo 26.18 35.24 6.87 24.33 35.18 8.97 97.97 81.77 42.85 98.10 80.04 40.64 coo 23.55 29.53 9.81 23.15 27.39 10.24 103.28 81.80 41.19 104.76 82.51 42.67 coo 16.43 30.18 9.35 15.05 30.67 11.01 104.92 85.12 49.55 104.04 85.91 51.40 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 112 TYR~? 13.10 O1 GOL A3040 I 306 VAL A 113 VAL~? 12.12 C1 GOL A3040 I 308 VAL A 117 VAL~? 8.45 O2 GOL A3040 coo 26.18 35.24 6.87 24.33 35.18 8.97 82.86 85.03 43.55 82.36 85.03 46.30 coo 23.55 29.53 9.81 23.15 27.39 10.24 87.01 87.16 41.47 88.85 86.31 40.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 88.68 92.37 44.41 90.46 92.02 43.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 123 TYR.? -4.01 O1 GOL A3040s I 306 VAL A 117 VAL~? 8.45 O2 GOL A3040 I 308 VAL A 119 VAL~? 13.24 C1 GOL A3040 coo 26.18 35.24 6.87 24.33 35.18 8.97 92.97 88.22 47.49 92.65 86.11 49.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 88.68 92.37 44.41 90.46 92.02 43.20 coo 16.43 30.18 9.35 15.05 30.67 11.01 83.70 95.31 45.51 81.61 94.94 45.00 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 75 TYR~? 10.15 CL CL B2010 I 306 VAL B 96 VAL~? 9.65 CL CL B2010 I 308 VAL B 80 VAL~? 5.84 CL CL B2010 coo 26.18 35.24 6.87 24.33 35.18 8.97 18.67 65.14 13.86 18.80 67.67 14.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 13.95 67.43 12.03 11.82 66.79 11.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 11.18 58.98 10.24 11.78 56.84 10.20 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR B 112 TYR~? 11.41 O3 GOL B3017 I 306 VAL B 113 VAL~? 12.01 O2 GOL B3023 I 308 VAL B 117 VAL~? 7.38 O1 GOL B3023 coo 26.18 35.24 6.87 24.33 35.18 8.97 33.54 61.27 14.83 33.38 58.57 15.48 coo 23.55 29.53 9.81 23.15 27.39 10.24 30.48 63.35 11.24 28.73 64.73 11.33 coo 16.43 30.18 9.35 15.05 30.67 11.01 29.36 59.48 6.45 27.80 60.95 6.12 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 123 TYR.? -4.36 O2 GOL B3023s I 306 VAL B 117 VAL~? 7.38 O1 GOL B3023 I 308 VAL B 119 VAL~? 11.62 O1 GOL B3023 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.54 58.32 9.82 22.98 57.14 12.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 29.36 59.48 6.45 27.80 60.95 6.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 34.41 56.92 5.13 36.44 57.17 5.94 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR C 75 TYR~? 10.50 CL CL C2011 I 306 VAL C 96 VAL~? 9.27 CL CL C2021 I 308 VAL C 80 VAL~? 4.09 CL CL C2021 coo 26.18 35.24 6.87 24.33 35.18 8.97 87.86 16.77 72.91 87.86 18.43 75.14 coo 23.55 29.53 9.81 23.15 27.39 10.24 92.79 15.47 75.54 94.53 14.67 74.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 95.17 11.84 67.49 94.46 11.27 65.48 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR C 112 TYR~? 12.57 O3 GOL C3021 I 306 VAL C 113 VAL~? 14.48 CL CL C2011 I 308 VAL C 117 VAL~? 12.02 CL CL C2011 coo 26.18 35.24 6.87 24.33 35.18 8.97 72.92 17.11 69.08 73.05 17.20 66.28 coo 23.55 29.53 9.81 23.15 27.39 10.24 76.03 14.06 71.86 77.77 14.49 73.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 77.06 8.59 69.17 78.59 8.56 70.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR C 123 TYR.? -8.00 CL CL C2011s I 306 VAL C 117 VAL~? 12.02 CL CL C2011 I 308 VAL C 119 VAL~? 17.48 O3 GOL C3021 coo 26.18 35.24 6.87 24.33 35.18 8.97 82.73 11.63 67.15 83.32 13.82 65.52 coo 23.55 29.53 9.81 23.15 27.39 10.24 77.06 8.59 69.17 78.59 8.56 70.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 71.94 6.77 66.91 69.92 7.59 67.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR D 75 TYR~? 10.03 CL CL D2012 I 306 VAL D 96 VAL~? 9.29 CL CL D2012 I 308 VAL D 80 VAL~? -3.98 CL CL D2022s coo 26.18 35.24 6.87 24.33 35.18 8.97 9.41 49.60 83.94 9.22 47.13 82.70 coo 23.55 29.53 9.81 23.15 27.39 10.24 4.00 48.12 84.43 2.43 49.66 84.55 coo 16.43 30.18 9.35 15.05 30.67 11.01 2.32 56.98 85.67 3.21 58.91 86.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR D 112 TYR~? 11.57 O3 GOL D3019 I 306 VAL D 113 VAL~? 11.95 O1 GOL D3018 I 308 VAL D 117 VAL~? 8.09 O3 GOL D3018 coo 26.18 35.24 6.87 24.33 35.18 8.97 24.56 50.70 86.69 25.05 53.37 86.07 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.33 49.20 89.32 18.51 48.16 88.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 18.86 53.22 93.85 17.06 52.06 93.78 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR D 123 TYR.? -4.29 O1 GOL D3018s I 306 VAL D 117 VAL~? 8.09 O3 GOL D3018 I 308 VAL D 119 VAL~? 13.05 O1 GOL D3018 coo 26.18 35.24 6.87 24.33 35.18 8.97 14.40 55.37 89.22 14.73 56.67 86.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 18.86 53.22 93.85 17.06 52.06 93.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 23.85 54.83 96.42 25.94 54.25 96.24 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR E 75 TYR~? 10.13 CL CL E2013 I 306 VAL E 96 VAL~? 9.65 CL CL E2032 I 308 VAL E 80 VAL~? 4.03 CL CL E2032 coo 26.18 35.24 6.87 24.33 35.18 8.97 16.89 92.83 57.30 16.35 91.61 59.76 coo 23.55 29.53 9.81 23.15 27.39 10.24 11.95 94.47 58.76 10.06 94.79 57.70 coo 16.43 30.18 9.35 15.05 30.67 11.01 10.81 96.40 49.90 11.82 96.49 47.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR E 112 TYR~? 11.16 O2 GOL E3035 I 306 VAL E 113 VAL~? 11.63 O1 GOL E3022 I 308 VAL E 117 VAL~? 7.40 O3 GOL E3022 coo 26.18 35.24 6.87 24.33 35.18 8.97 32.26 92.00 56.29 32.65 91.34 53.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.81 95.51 57.83 26.89 95.31 58.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 28.38 100.28 53.79 26.55 100.65 54.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR E 123 TYR.? -3.70 O1 GOL E3022s I 306 VAL E 117 VAL~? 7.40 O3 GOL E3022 I 308 VAL E 119 VAL~? 11.62 O3 GOL E3022 coo 26.18 35.24 6.87 24.33 35.18 8.97 23.00 96.79 51.50 22.74 94.30 50.21 coo 23.55 29.53 9.81 23.15 27.39 10.24 28.38 100.28 53.79 26.55 100.65 54.99 coo 16.43 30.18 9.35 15.05 30.67 11.01 33.78 101.64 52.28 35.79 101.01 52.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR F 75 TYR~? 9.99 CL CL F2034 I 306 VAL F 96 VAL~? 9.51 CL CL F2034 I 308 VAL F 80 VAL~? -3.94 CL CL F2023s coo 26.18 35.24 6.87 24.33 35.18 8.97 95.01 33.97 25.26 94.64 31.83 27.03 coo 23.55 29.53 9.81 23.15 27.39 10.24 99.78 31.35 25.17 101.87 32.03 25.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 103.23 39.13 21.93 102.76 41.19 21.29 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR F 112 TYR~? 9.99 CL CL F2035 I 306 VAL F 113 VAL~? 11.67 O2 GOL F3039 I 308 VAL F 117 VAL~? 7.69 O2 GOL F3039 coo 26.18 35.24 6.87 24.33 35.18 8.97 80.32 37.88 21.99 80.47 40.63 22.04 coo 23.55 29.53 9.81 23.15 27.39 10.24 84.04 35.03 19.80 85.59 33.70 20.68 coo 16.43 30.18 9.35 15.05 30.67 11.01 86.33 37.65 14.71 87.76 36.03 15.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR F 123 TYR.? -3.90 O3 GOL F3039s I 306 VAL F 117 VAL~? 7.69 O2 GOL F3039 I 308 VAL F 119 VAL~? 12.29 O2 GOL F3039 coo 26.18 35.24 6.87 24.33 35.18 8.97 91.29 39.67 18.85 91.31 41.46 21.04 coo 23.55 29.53 9.81 23.15 27.39 10.24 86.33 37.65 14.71 87.76 36.03 15.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 81.70 39.77 11.69 79.47 39.61 11.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR G 112 TYR~? 13.62 O3 GOL G3038 I 306 VAL G 113 VAL~? 12.24 O3 GOL G3038 I 308 VAL G 117 VAL~? 8.40 O3 GOL G3038 coo 26.18 35.24 6.87 24.33 35.18 8.97 26.10 19.68 45.15 26.07 20.41 47.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 22.40 17.00 42.69 20.87 17.65 41.28 coo 16.43 30.18 9.35 15.05 30.67 11.01 20.07 12.50 46.43 18.60 12.55 44.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR G 123 TYR.? -4.47 O3 GOL G3038s I 306 VAL G 117 VAL~? 8.40 O3 GOL G3038 I 308 VAL G 119 VAL~? 13.00 O3 GOL G3038 coo 26.18 35.24 6.87 24.33 35.18 8.97 15.30 16.99 47.49 15.28 19.49 48.80 coo 23.55 29.53 9.81 23.15 27.39 10.24 20.07 12.50 46.43 18.60 12.55 44.85 coo 16.43 30.18 9.35 15.05 30.67 11.01 24.69 9.99 49.12 26.87 10.23 48.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR H 75 TYR~? 10.27 CL CL H2014 I 306 VAL H 96 VAL~? 9.76 CL CL H2014 I 308 VAL H 80 VAL~? -3.72 CL CL H2024s coo 26.18 35.24 6.87 24.33 35.18 8.97 90.64 65.09 90.65 91.11 67.21 88.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 95.72 66.67 92.03 97.59 65.63 92.40 coo 16.43 30.18 9.35 15.05 30.67 11.01 96.53 58.45 95.73 95.40 56.64 96.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR H 112 TYR~? 11.95 O3 GOL H3016 I 306 VAL H 113 VAL~? 14.47 O3 GOL H3016 I 308 VAL H 117 VAL~? 12.21 CL CL H2014 coo 26.18 35.24 6.87 24.33 35.18 8.97 75.20 64.22 90.27 74.79 61.48 90.12 coo 23.55 29.53 9.81 23.15 27.39 10.24 78.77 66.34 93.31 80.67 67.25 92.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 79.22 63.46 98.82 80.94 64.77 98.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR H 123 TYR.? -7.93 CL CL H2014s I 306 VAL H 117 VAL~? 12.21 CL CL H2014 I 308 VAL H 119 VAL~? 16.89 O1 GOL H3025 coo 26.18 35.24 6.87 24.33 35.18 8.97 84.40 60.41 95.89 84.67 58.62 93.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 79.22 63.46 98.82 80.94 64.77 98.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 73.73 62.40 100.55 71.77 62.88 99.68 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR I 75 TYR~? 10.32 CL CL I2015 I 306 VAL I 96 VAL~? 9.78 CL CL I2015 I 308 VAL I 80 VAL~? 4.00 CL CL I2025 coo 26.18 35.24 6.87 24.33 35.18 8.97 211.34 199.93 157.52 211.50 198.33 155.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 216.51 200.50 155.85 218.48 200.49 156.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 218.34 203.57 164.17 217.45 204.22 166.05 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR I 112 TYR~? 12.20 O2 GOL I3032 I 306 VAL I 113 VAL~? 11.68 O1 GOL I3031 I 308 VAL I 117 VAL~? 8.16 O1 GOL I3031 coo 26.18 35.24 6.87 24.33 35.18 8.97 196.16 202.11 159.00 195.80 201.93 161.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 200.11 204.66 156.86 201.91 203.95 155.80 coo 16.43 30.18 9.35 15.05 30.67 11.01 201.59 209.80 160.01 203.36 209.62 158.71 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR I 123 TYR.? -3.81 O1 GOL I3031s I 306 VAL I 117 VAL~? 8.16 O1 GOL I3031 I 308 VAL I 119 VAL~? 13.05 O1 GOL I3031 coo 26.18 35.24 6.87 24.33 35.18 8.97 206.34 205.79 162.64 206.20 203.62 164.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 201.59 209.80 160.01 203.36 209.62 158.71 coo 16.43 30.18 9.35 15.05 30.67 11.01 196.51 212.39 161.44 194.42 211.91 160.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR J 75 TYR~? 10.17 CL CL J2016 I 306 VAL J 96 VAL~? 9.32 CL CL J2026 I 308 VAL J 80 VAL~? 3.94 CL CL J2026 coo 26.18 35.24 6.87 24.33 35.18 8.97 131.82 180.89 131.78 131.82 183.34 133.12 coo 23.55 29.53 9.81 23.15 27.39 10.24 126.84 183.23 130.31 125.13 181.83 130.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 124.29 174.79 128.10 124.92 172.71 127.83 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR J 112 TYR~? 13.43 O1 GOL J3030 I 306 VAL J 113 VAL~? 11.86 O1 GOL J3030 I 308 VAL J 117 VAL~? 8.21 O1 GOL J3030 coo 26.18 35.24 6.87 24.33 35.18 8.97 146.80 177.39 131.57 146.79 174.66 132.11 coo 23.55 29.53 9.81 23.15 27.39 10.24 143.46 179.67 128.40 141.63 180.84 128.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 142.11 176.08 123.51 140.52 177.64 123.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR J 123 TYR.? -4.20 O1 GOL J3030s I 306 VAL J 117 VAL~? 8.21 O1 GOL J3030 I 308 VAL J 119 VAL~? 12.91 O1 GOL J3030 coo 26.18 35.24 6.87 24.33 35.18 8.97 136.67 174.46 127.10 136.30 173.08 129.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 142.11 176.08 123.51 140.52 177.64 123.39 coo 16.43 30.18 9.35 15.05 30.67 11.01 147.21 173.81 121.66 149.31 174.02 122.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 30 3 # 30 I 303 TYR K 75 TYR~? 12.36 CL CL K2027 I 306 VAL K 96 VAL~? 9.74 CL CL K2027 I 308 VAL K 80 VAL~? -3.85 CL CL K2027s coo 26.18 35.24 6.87 24.33 35.18 8.97 205.79 133.16 185.06 205.81 134.80 187.34 coo 23.55 29.53 9.81 23.15 27.39 10.24 210.69 132.15 187.63 212.44 132.18 186.29 coo 16.43 30.18 9.35 15.05 30.67 11.01 213.19 128.75 179.46 212.35 128.08 177.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 31 3 # 31 I 303 TYR K 112 TYR~? 10.80 O3 GOL K3010 I 306 VAL K 113 VAL~? 12.08 O2 GOL K3041 I 308 VAL K 117 VAL~? 8.24 O2 GOL K3041 coo 26.18 35.24 6.87 24.33 35.18 8.97 190.77 132.67 181.60 190.81 132.90 178.83 coo 23.55 29.53 9.81 23.15 27.39 10.24 194.12 129.71 184.26 195.83 130.19 185.47 coo 16.43 30.18 9.35 15.05 30.67 11.01 195.36 124.43 181.23 196.93 124.37 182.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 32 3 # 32 I 303 TYR K 123 TYR.? -4.42 O2 GOL K3041s I 306 VAL K 117 VAL~? 8.24 O2 GOL K3041 I 308 VAL K 119 VAL~? 12.97 O2 GOL K3041 coo 26.18 35.24 6.87 24.33 35.18 8.97 200.86 127.71 179.28 201.20 129.91 177.64 coo 23.55 29.53 9.81 23.15 27.39 10.24 195.36 124.43 181.23 196.93 124.37 182.79 coo 16.43 30.18 9.35 15.05 30.67 11.01 190.28 122.41 179.20 188.21 123.10 179.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 33 3 # 33 I 303 TYR L 75 TYR~? 10.07 CL CL L2009 I 306 VAL L 96 VAL~? 9.12 CL CL L2028 I 308 VAL L 80 VAL~? -3.76 CL CL L2028s coo 26.18 35.24 6.87 24.33 35.18 8.97 126.23 161.73 201.55 126.10 159.32 200.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 120.83 160.23 202.38 119.21 161.78 202.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 119.43 168.99 204.21 120.36 170.93 204.70 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 34 3 # 34 I 303 TYR L 112 TYR~? 12.13 O3 GOL L3028 I 306 VAL L 113 VAL~? 11.97 O1 GOL L3027 I 308 VAL L 117 VAL~? 8.22 O1 GOL L3027 coo 26.18 35.24 6.87 24.33 35.18 8.97 141.53 163.06 203.38 141.93 165.73 202.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 137.57 161.30 206.14 135.70 160.24 205.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 136.20 165.21 210.80 134.41 163.91 210.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 35 3 # 35 I 303 TYR L 123 TYR.? -4.18 O1 GOL L3027s I 306 VAL L 117 VAL~? 8.22 O1 GOL L3027 I 308 VAL L 119 VAL~? 13.02 O1 GOL L3027 coo 26.18 35.24 6.87 24.33 35.18 8.97 131.49 167.37 206.62 131.53 168.77 204.19 coo 23.55 29.53 9.81 23.15 27.39 10.24 136.20 165.21 210.80 134.41 163.91 210.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 141.31 166.86 213.23 143.38 166.27 212.85 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 36 3 # 36 I 303 TYR M 112 TYR~? 13.51 O1 GOL M3043 I 306 VAL M 113 VAL~? 12.06 C1 GOL M3043 I 308 VAL M 117 VAL~? 7.45 O3 GOL M3043 coo 26.18 35.24 6.87 24.33 35.18 8.97 145.86 206.20 174.56 146.17 205.67 171.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 142.36 209.43 176.39 140.47 209.10 177.38 coo 16.43 30.18 9.35 15.05 30.67 11.01 141.50 214.29 172.60 139.69 214.40 173.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 37 3 # 37 I 303 TYR M 123 TYR.? -4.30 O1 GOL M3043s I 306 VAL M 117 VAL~? 7.45 O3 GOL M3043 I 308 VAL M 119 VAL~? 11.54 O3 GOL M3043 coo 26.18 35.24 6.87 24.33 35.18 8.97 136.30 210.69 170.36 136.06 208.30 168.99 coo 23.55 29.53 9.81 23.15 27.39 10.24 141.50 214.29 172.60 139.69 214.40 173.82 coo 16.43 30.18 9.35 15.05 30.67 11.01 146.80 216.10 170.85 148.81 215.45 171.39 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 38 3 # 38 I 303 TYR N 112 TYR~? 12.42 O1 GOL N3044 I 306 VAL N 113 VAL~? 13.97 O2 GOL N3029 I 308 VAL N 117 VAL~? 16.27 CL CL N2030 coo 26.18 35.24 6.87 24.33 35.18 8.97 194.78 156.07 135.52 194.77 158.81 135.67 coo 23.55 29.53 9.81 23.15 27.39 10.24 198.46 153.48 133.03 200.18 152.22 133.71 coo 16.43 30.18 9.35 15.05 30.67 11.01 200.32 156.31 127.87 201.88 154.79 128.10 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 39 3 # 39 I 303 TYR N 123 TYR.? -12.00 CL CL N2030s I 306 VAL N 117 VAL~? 16.27 CL CL N2030 I 308 VAL N 119 VAL~? 16.82 O2 GOL N3044 coo 26.18 35.24 6.87 24.33 35.18 8.97 205.39 158.43 131.87 205.49 160.09 134.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 200.32 156.31 127.87 201.88 154.79 128.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 195.57 158.42 125.25 193.41 158.26 125.62 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 40 3 # 40 I 303 TYR O 75 TYR~? 10.24 CL CL O2018 I 306 VAL O 96 VAL~? 9.82 CL CL O2018 I 308 VAL O 80 VAL~? 5.47 CL CL O2018 coo 26.18 35.24 6.87 24.33 35.18 8.97 127.87 136.17 156.70 127.95 137.50 154.23 coo 23.55 29.53 9.81 23.15 27.39 10.24 122.87 135.46 154.41 120.76 135.56 155.05 coo 16.43 30.18 9.35 15.05 30.67 11.01 120.06 133.48 162.85 120.79 133.02 164.86 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 41 3 # 41 I 303 TYR O 112 TYR~? 11.14 CL CL O2036 I 306 VAL O 113 VAL~? 9.06 CL CL O2036 I 308 VAL O 117 VAL~? 11.48 CL CL O2036 coo 26.18 35.24 6.87 24.33 35.18 8.97 142.72 134.33 160.12 142.81 134.85 162.82 coo 23.55 29.53 9.81 23.15 27.39 10.24 139.02 131.48 157.88 137.29 132.03 156.62 coo 16.43 30.18 9.35 15.05 30.67 11.01 137.20 126.80 161.42 135.62 126.81 159.90 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 42 3 # 42 I 303 TYR O 123 TYR.? -7.90 CL CL O2018s I 306 VAL O 117 VAL~? 11.48 CL CL O2036 I 308 VAL O 119 VAL~? 11.02 CL CL O2036 coo 26.18 35.24 6.87 24.33 35.18 8.97 132.12 130.96 163.05 132.10 133.32 164.44 coo 23.55 29.53 9.81 23.15 27.39 10.24 137.20 126.80 161.42 135.62 126.81 159.90 coo 16.43 30.18 9.35 15.05 30.67 11.01 142.01 124.37 163.71 144.18 124.69 163.43 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 43 3 # 43 I 303 TYR P 75 TYR~? 10.23 CL CL P2019 I 306 VAL P 96 VAL~? 9.69 CL CL P2019 I 308 VAL P 80 VAL~? 6.02 CL CL P2019 coo 26.18 35.24 6.87 24.33 35.18 8.97 207.22 180.36 204.70 207.43 182.65 203.13 coo 23.55 29.53 9.81 23.15 27.39 10.24 212.38 182.24 205.89 213.92 180.66 205.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 213.81 173.77 209.07 212.90 171.82 209.48 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 44 3 # 44 I 303 TYR P 112 TYR~? 13.01 O1 GOL P3034 I 306 VAL P 113 VAL~? 11.89 O2 GOL P3034 I 308 VAL P 117 VAL~? 7.86 O2 GOL P3034 coo 26.18 35.24 6.87 24.33 35.18 8.97 191.84 178.79 205.19 191.53 176.04 204.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 195.43 180.97 208.15 197.33 181.97 207.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 196.30 177.85 213.38 198.05 179.19 213.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 45 3 # 45 I 303 TYR P 123 TYR.? -3.93 O1 GOL P3034s I 306 VAL P 117 VAL~? 7.86 O2 GOL P3034 I 308 VAL P 119 VAL~? 12.54 O2 GOL P3034 coo 26.18 35.24 6.87 24.33 35.18 8.97 201.57 175.22 210.06 201.77 173.54 207.86 coo 23.55 29.53 9.81 23.15 27.39 10.24 196.30 177.85 213.38 198.05 179.19 213.37 coo 16.43 30.18 9.35 15.05 30.67 11.01 191.00 176.41 215.48 188.94 176.86 214.78 1cqt_d00 source 1cqt GENE REGULATION/DNA : 45 hits 1cqt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG A 34 ARG~? 29.77 O3 GOL B3003 E 41 TYR A 35 TYR~? 31.11 O2 GOL E3035 E 83 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 63.78 99.32 32.06 65.50 99.77 29.57 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 59.25 100.54 36.63 61.78 101.51 37.35 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG A 36 ARG~? 20.86 C3 GOL E3035 E 41 TYR A 21 TYR~? 26.32 C3 GOL E3035 E 83 ARG B 36 ARG~? 18.74 O2 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 51.19 99.66 33.34 49.41 97.31 34.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 56.96 96.11 38.73 58.94 94.19 38.55 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 67.49 62.18 2.86 67.75 61.06 -0.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG A 36 ARG~? 20.86 C3 GOL E3035 E 41 TYR A 21 TYR~? 26.32 C3 GOL E3035 E 83 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 51.19 99.66 33.34 49.41 97.31 34.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 56.96 96.11 38.73 58.94 94.19 38.55 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG A 36 ARG~? 20.86 C3 GOL E3035 E 41 TYR A 35 TYR~? 31.11 O2 GOL E3035 E 83 ARG H 51 ARG~? -11.05 O1 GOL H3006s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 51.19 99.66 33.34 49.41 97.31 34.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 59.25 100.54 36.63 61.78 101.51 37.35 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 55.75 78.18 80.83 58.67 78.05 79.79 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG A 108 ARG~? 22.68 O1 GOL A3040 E 41 TYR A 109 TYR~? 19.57 O1 GOL A3040 E 83 ARG F 108 ARG~? -3.40 CL CL F2035s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 77.54 80.61 37.36 78.31 77.83 38.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 84.38 79.76 38.04 83.16 77.26 38.08 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 74.01 31.91 26.65 74.85 33.96 28.84 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG A 108 ARG~? 22.68 O1 GOL A3040 E 41 TYR A 109 TYR~? 19.57 O1 GOL A3040 E 83 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 77.54 80.61 37.36 78.31 77.83 38.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 84.38 79.76 38.04 83.16 77.26 38.08 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG A 108 ARG~? 22.68 O1 GOL A3040 E 41 TYR A 112 TYR~? 13.10 O1 GOL A3040 E 83 ARG E 108 ARG~? 18.65 O1 GOL E3035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 77.54 80.61 37.36 78.31 77.83 38.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 82.86 85.03 43.55 82.36 85.03 46.30 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 36.12 87.73 64.17 35.30 85.24 62.51 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG A 108 ARG~? 22.68 O1 GOL A3040 E 41 TYR A 112 TYR~? 13.10 O1 GOL A3040 E 83 ARG H 66 ARG~? -3.23 O1 GOL H3025s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 77.54 80.61 37.36 78.31 77.83 38.52 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 82.86 85.03 43.55 82.36 85.03 46.30 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 77.19 55.44 84.09 76.02 53.18 85.87 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG A 155 ARG.? 9.00 O2 GOL A3037 E 41 TYR A 157 TYR.? -3.90 O2 GOL A3037s E 83 ARG E 37 ARG~? -4.52 O1 GOL E3004s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 105.02 75.56 59.01 104.52 78.07 60.78 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 100.57 80.52 55.08 97.88 80.73 54.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 58.59 99.11 69.23 56.48 96.91 69.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 10 3 # 10 E 40 ARG A 155 ARG.? 9.00 O2 GOL A3037 E 41 TYR A 157 TYR.? -3.90 O2 GOL A3037s E 83 ARG H 55 ARG~? 13.48 O3 GOL H3006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 105.02 75.56 59.01 104.52 78.07 60.78 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 100.57 80.52 55.08 97.88 80.73 54.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 60.33 75.55 82.58 59.37 73.14 80.81 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 11 3 # 11 E 40 ARG B 34 ARG~? 11.02 O1 GOL B3003 E 41 TYR B 35 TYR~? 15.50 C1 GOL B3003 E 83 ARG A 114 ARG~? 18.99 O2 GOL A3040 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 57.05 65.77 3.59 55.99 68.39 2.44 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.35 59.88 4.36 57.88 59.60 3.08 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 86.11 90.82 36.33 86.92 90.68 33.36 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 12 3 # 12 E 40 ARG B 34 ARG~? 11.02 O1 GOL B3003 E 41 TYR B 35 TYR~? 15.50 C1 GOL B3003 E 83 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 57.05 65.77 3.59 55.99 68.39 2.44 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.35 59.88 4.36 57.88 59.60 3.08 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 13 3 # 13 E 40 ARG B 36 ARG~? 18.74 O2 GOL B3003 E 41 TYR B 35 TYR~? 15.50 C1 GOL B3003 E 83 ARG A 36 ARG~? 20.86 C3 GOL E3035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.49 62.18 2.86 67.75 61.06 -0.01 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.35 59.88 4.36 57.88 59.60 3.08 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 51.19 99.66 33.34 49.41 97.31 34.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 14 3 # 14 E 40 ARG B 108 ARG~? 14.18 O1 GOL B3024 E 41 TYR B 109 TYR~? 11.52 O1 GOL B3024 E 83 ARG E 108 ARG~? 18.65 O1 GOL E3035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 39.05 68.00 18.82 37.75 66.74 21.38 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 32.33 67.79 18.21 32.96 68.04 20.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 36.12 87.73 64.17 35.30 85.24 62.51 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 15 3 # 15 E 40 ARG B 108 ARG~? 14.18 O1 GOL B3024 E 41 TYR B 109 TYR~? 11.52 O1 GOL B3024 E 83 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 39.05 68.00 18.82 37.75 66.74 21.38 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 32.33 67.79 18.21 32.96 68.04 20.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 16 3 # 16 E 40 ARG B 108 ARG~? 14.18 O1 GOL B3024 E 41 TYR B 109 TYR~? 11.52 O1 GOL B3024 E 83 ARG G 55 ARG~? 22.00 CL CL C2006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 39.05 68.00 18.82 37.75 66.74 21.38 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 32.33 67.79 18.21 32.96 68.04 20.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 44.23 21.19 35.75 42.00 23.24 36.25 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 17 3 # 17 E 40 ARG B 108 ARG~? 14.18 O1 GOL B3024 E 41 TYR B 109 TYR~? 11.52 O1 GOL B3024 E 83 ARG G 108 ARG~? 22.05 O2 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 39.05 68.00 18.82 37.75 66.74 21.38 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 32.33 67.79 18.21 32.96 68.04 20.89 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 32.32 22.84 38.36 31.62 25.53 39.73 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 18 3 # 18 E 40 ARG B 155 ARG.? 12.69 O3 GOL B3015 E 41 TYR B 157 TYR.? 7.53 O1 GOL B3015 E 83 ARG F 37 ARG~? -27.07 CL CL F2035s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 7.18 53.45 20.49 4.91 55.44 21.24 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.23 54.49 17.04 16.01 54.48 17.30 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 53.50 28.70 11.30 55.02 28.89 13.93 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 19 3 # 19 E 40 ARG B 155 ARG.? 12.69 O3 GOL B3015 E 41 TYR B 157 TYR.? 7.53 O1 GOL B3015 E 83 ARG G 55 ARG~? 22.00 CL CL C2006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 7.18 53.45 20.49 4.91 55.44 21.24 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.23 54.49 17.04 16.01 54.48 17.30 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 44.23 21.19 35.75 42.00 23.24 36.25 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 20 3 # 20 E 40 ARG C 34 ARG~? 20.14 CL CL C2004 E 41 TYR C 21 TYR~? 10.49 CL CL C2004 E 83 ARG D 114 ARG~? 18.11 O3 GOL D3018 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 49.42 6.75 74.39 49.90 6.28 77.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.13 11.15 67.52 47.31 12.70 68.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 21.28 44.89 93.84 20.52 41.96 94.27 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 21 3 # 21 E 40 ARG C 34 ARG~? 20.14 CL CL C2004 E 41 TYR C 35 TYR~? 12.95 CL CL C2004 E 83 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 49.42 6.75 74.39 49.90 6.28 77.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.94 6.51 69.90 48.30 5.07 69.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 22 3 # 22 E 40 ARG C 34 ARG~? 20.14 CL CL C2004 E 41 TYR C 35 TYR~? 12.95 CL CL C2004 E 83 ARG F 51 ARG~? 18.26 CL CL F2035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 49.42 6.75 74.39 49.90 6.28 77.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.94 6.51 69.90 48.30 5.07 69.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 23 3 # 23 E 40 ARG C 36 ARG~? 17.12 CL CL C2004 E 41 TYR C 21 TYR~? 10.49 CL CL C2004 E 83 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 37.77 8.89 71.79 36.83 11.19 70.06 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.13 11.15 67.52 47.31 12.70 68.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 24 3 # 24 E 40 ARG C 36 ARG~? 17.12 CL CL C2004 E 41 TYR C 21 TYR~? 10.49 CL CL C2004 E 83 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 37.77 8.89 71.79 36.83 11.19 70.06 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.13 11.15 67.52 47.31 12.70 68.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 25 3 # 25 E 40 ARG C 36 ARG~? 17.12 CL CL C2004 E 41 TYR C 35 TYR~? 12.95 CL CL C2004 E 83 ARG D 36 ARG~? 15.63 O1 GOL D3005 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 37.77 8.89 71.79 36.83 11.19 70.06 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.94 6.51 69.90 48.30 5.07 69.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 55.93 43.64 102.74 57.91 43.73 100.41 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 26 3 # 26 E 40 ARG C 36 ARG~? 17.12 CL CL C2004 E 41 TYR C 35 TYR~? 12.95 CL CL C2004 E 83 ARG F 51 ARG~? 18.26 CL CL F2035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 37.77 8.89 71.79 36.83 11.19 70.06 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 45.94 6.51 69.90 48.30 5.07 69.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 56.56 29.17 27.33 58.39 29.67 29.78 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 27 3 # 27 E 40 ARG C 108 ARG~? 20.30 O3 GOL C3021 E 41 TYR C 109 TYR~? 17.83 O1 GOL C3036 E 83 ARG F 55 ARG~? 14.19 CL CL F2035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.42 22.77 74.41 69.21 25.29 74.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 74.32 21.96 74.78 73.58 24.65 74.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 28 3 # 28 E 40 ARG C 108 ARG~? 20.30 O3 GOL C3021 E 41 TYR C 109 TYR~? 17.83 O1 GOL C3036 E 83 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 67.42 22.77 74.41 69.21 25.29 74.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 74.32 21.96 74.78 73.58 24.65 74.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 29 3 # 29 E 40 ARG C 145 ARG~? 15.99 O1 GOL C3036 E 41 TYR C 143 TYR~? 14.40 O1 GOL C3036 E 83 ARG C 36 ARG~? 17.12 CL CL C2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 85.99 31.07 76.22 83.80 32.01 74.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.34 22.31 75.20 83.28 19.92 76.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 30 3 # 30 E 40 ARG C 145 ARG~? 15.99 O1 GOL C3036 E 41 TYR C 143 TYR~? 14.40 O1 GOL C3036 E 83 ARG C 44 ARG~? 23.41 CL CL C2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 85.99 31.07 76.22 83.80 32.01 74.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.34 22.31 75.20 83.28 19.92 76.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 35.63 18.34 73.64 34.17 16.13 75.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 31 3 # 31 E 40 ARG C 145 ARG~? 15.99 O1 GOL C3036 E 41 TYR C 143 TYR~? 14.40 O1 GOL C3036 E 83 ARG F 95 ARG~? 18.18 CL CL F2034 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 85.99 31.07 76.22 83.80 32.01 74.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.34 22.31 75.20 83.28 19.92 76.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 101.23 25.44 29.03 100.92 26.10 32.03 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 32 3 # 32 E 40 ARG C 145 ARG~? 15.99 O1 GOL C3036 E 41 TYR C 143 TYR~? 14.40 O1 GOL C3036 E 83 ARG F 108 ARG~? -3.40 CL CL F2035s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 85.99 31.07 76.22 83.80 32.01 74.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 83.34 22.31 75.20 83.28 19.92 76.54 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 74.01 31.91 26.65 74.85 33.96 28.84 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 33 3 # 33 E 40 ARG C 155 ARG.? 9.50 CL CL C2031 E 41 TYR C 157 TYR.? 7.25 O1 GOL C3036 E 83 ARG F 55 ARG~? 14.19 CL CL F2035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 100.04 20.62 60.58 101.89 22.90 59.46 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 93.23 17.43 61.74 90.40 17.73 61.84 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 62.56 29.89 25.65 64.18 28.30 27.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 34 3 # 34 E 40 ARG D 34 ARG~? 12.13 O1 GOL D3005 E 41 TYR D 35 TYR~? 13.02 CL CL H2005 E 83 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 43.70 43.25 103.08 42.03 40.72 103.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.27 47.24 102.95 45.77 48.18 103.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 35 3 # 35 E 40 ARG D 34 ARG~? 12.13 O1 GOL D3005 E 41 TYR D 35 TYR~? 13.02 CL CL H2005 E 83 ARG E 51 ARG~? 12.86 C3 GOL E3004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 43.70 43.25 103.08 42.03 40.72 103.99 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.27 47.24 102.95 45.77 48.18 103.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 51.65 84.19 70.80 51.43 81.15 70.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 36 3 # 36 E 40 ARG D 36 ARG~? 15.63 O1 GOL D3005 E 41 TYR D 21 TYR~? 10.58 CL CL H2005 E 83 ARG C 36 ARG~? 17.12 CL CL C2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 55.93 43.64 102.74 57.91 43.73 100.41 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 50.45 48.27 98.24 48.40 47.71 96.43 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 37 3 # 37 E 40 ARG D 36 ARG~? 15.63 O1 GOL D3005 E 41 TYR D 21 TYR~? 10.58 CL CL H2005 E 83 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 55.93 43.64 102.74 57.91 43.73 100.41 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 50.45 48.27 98.24 48.40 47.71 96.43 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 38 3 # 38 E 40 ARG D 36 ARG~? 15.63 O1 GOL D3005 E 41 TYR D 35 TYR~? 13.02 CL CL H2005 E 83 ARG C 36 ARG~? 17.12 CL CL C2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 55.93 43.64 102.74 57.91 43.73 100.41 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.27 47.24 102.95 45.77 48.18 103.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 37.77 8.89 71.79 36.83 11.19 70.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 39 3 # 39 E 40 ARG D 36 ARG~? 15.63 O1 GOL D3005 E 41 TYR D 35 TYR~? 13.02 CL CL H2005 E 83 ARG E 51 ARG~? 12.86 C3 GOL E3004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 55.93 43.64 102.74 57.91 43.73 100.41 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.27 47.24 102.95 45.77 48.18 103.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 51.65 84.19 70.80 51.43 81.15 70.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 40 3 # 40 E 40 ARG D 108 ARG~? 19.71 O3 GOL D3019 E 41 TYR D 109 TYR~? 18.34 O3 GOL D3019 E 83 ARG G 108 ARG~? 22.05 O2 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 29.84 43.62 83.53 28.05 43.26 81.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 22.95 44.43 82.69 24.09 43.90 80.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 32.32 22.84 38.36 31.62 25.53 39.73 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 41 3 # 41 E 40 ARG D 108 ARG~? 19.71 O3 GOL D3019 E 41 TYR D 109 TYR~? 18.34 O3 GOL D3019 E 83 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 29.84 43.62 83.53 28.05 43.26 81.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 22.95 44.43 82.69 24.09 43.90 80.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 42 3 # 42 E 40 ARG D 108 ARG~? 19.71 O3 GOL D3019 E 41 TYR D 112 TYR~? 11.57 O3 GOL D3019 E 83 ARG E 66 ARG~? -3.03 O1 GOL E3035s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 29.84 43.62 83.53 28.05 43.26 81.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 24.56 50.70 86.69 25.05 53.37 86.07 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 30.02 84.01 49.15 31.09 85.25 46.47 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 43 3 # 43 E 40 ARG D 108 ARG~? 19.71 O3 GOL D3019 E 41 TYR D 112 TYR~? 11.57 O3 GOL D3019 E 83 ARG H 108 ARG~? 14.48 O2 GOL H3016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 29.84 43.62 83.53 28.05 43.26 81.00 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 24.56 50.70 86.69 25.05 53.37 86.07 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 71.22 70.92 84.57 72.18 68.95 82.36 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 44 3 # 44 E 40 ARG E 34 ARG~? 12.13 O1 GOL E3004 E 41 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 83 ARG H 114 ARG~? 20.07 CL CL H2014 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 54.44 103.79 65.07 52.71 105.19 67.23 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 58.94 102.78 60.36 56.69 104.19 59.52 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 76.88 71.50 96.54 77.56 74.47 96.38 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 45 3 # 45 E 40 ARG E 34 ARG~? 12.13 O1 GOL E3004 E 41 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 83 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 54.44 103.79 65.07 52.71 105.19 67.23 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 58.94 102.78 60.36 56.69 104.19 59.52 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 46 3 # 46 E 40 ARG E 36 ARG~? 16.00 C1 GOL E3004 E 41 TYR E 21 TYR~? 14.13 O1 GOL E3004 E 83 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 66.28 100.73 63.79 67.89 98.12 63.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.20 97.64 59.27 57.81 96.28 59.79 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 47 3 # 47 E 40 ARG E 36 ARG~? 16.00 C1 GOL E3004 E 41 TYR E 21 TYR~? 14.13 O1 GOL E3004 E 83 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 66.28 100.73 63.79 67.89 98.12 63.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 60.20 97.64 59.27 57.81 96.28 59.79 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 48 3 # 48 E 40 ARG E 36 ARG~? 16.00 C1 GOL E3004 E 41 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 83 ARG B 51 ARG~? 11.52 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 66.28 100.73 63.79 67.89 98.12 63.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 58.94 102.78 60.36 56.69 104.19 59.52 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 56.02 71.46 21.90 55.03 71.54 24.81 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 49 3 # 49 E 40 ARG E 36 ARG~? 16.00 C1 GOL E3004 E 41 TYR E 35 TYR~? 15.88 O1 GOL E3004 E 83 ARG H 36 ARG~? 15.68 C3 GOL H3006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 66.28 100.73 63.79 67.89 98.12 63.67 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 58.94 102.78 60.36 56.69 104.19 59.52 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 41.35 74.42 97.84 39.90 73.17 95.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 50 3 # 50 E 40 ARG E 108 ARG~? 18.65 O1 GOL E3035 E 41 TYR E 109 TYR~? 18.10 O1 GOL E3035 E 83 ARG B 51 ARG~? 11.52 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 36.12 87.73 64.17 35.30 85.24 62.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 29.73 88.43 62.54 30.41 85.74 63.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 56.02 71.46 21.90 55.03 71.54 24.81 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 51 3 # 51 E 40 ARG E 108 ARG~? 18.65 O1 GOL E3035 E 41 TYR E 109 TYR~? 18.10 O1 GOL E3035 E 83 ARG B 108 ARG~? 14.18 O1 GOL B3024 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 36.12 87.73 64.17 35.30 85.24 62.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 29.73 88.43 62.54 30.41 85.74 63.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 39.05 68.00 18.82 37.75 66.74 21.38 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 52 3 # 52 E 40 ARG E 108 ARG~? 18.65 O1 GOL E3035 E 41 TYR E 109 TYR~? 18.10 O1 GOL E3035 E 83 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 36.12 87.73 64.17 35.30 85.24 62.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 29.73 88.43 62.54 30.41 85.74 63.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 53 3 # 53 E 40 ARG E 155 ARG.? 13.04 O1 GOL E3002 E 41 TYR E 157 TYR.? -7.44 C3 GOL E3002s E 83 ARG A 37 ARG~? 23.00 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 7.91 86.02 43.52 5.22 85.54 45.07 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.76 89.62 45.68 16.45 89.35 46.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 58.38 95.12 28.70 59.87 92.50 29.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 54 3 # 54 E 40 ARG E 155 ARG.? 13.04 O1 GOL E3002 E 41 TYR E 157 TYR.? -7.44 C3 GOL E3002s E 83 ARG B 55 ARG~? -14.24 O1 GOL B3003s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 7.91 86.02 43.52 5.22 85.54 45.07 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 13.76 89.62 45.68 16.45 89.35 46.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 50.06 69.68 20.36 47.07 69.49 19.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 55 3 # 55 E 40 ARG F 34 ARG~? 28.76 CL CL F2035 E 41 TYR F 35 TYR~? 30.41 CL CL F2035 E 83 ARG G 114 ARG~? 19.08 O3 GOL G3038 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 59.52 30.90 7.26 60.86 28.10 6.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 55.89 36.47 6.05 58.49 36.69 5.11 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 24.45 12.48 38.95 24.54 11.96 35.94 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 56 3 # 56 E 40 ARG F 34 ARG~? 28.76 CL CL F2035 E 41 TYR F 35 TYR~? 30.41 CL CL F2035 E 83 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 59.52 30.90 7.26 60.86 28.10 6.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 55.89 36.47 6.05 58.49 36.69 5.11 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 57 3 # 57 E 40 ARG F 36 ARG~? 20.40 O1 GOL B3017 E 41 TYR F 21 TYR~? 26.08 O1 GOL B3017 E 83 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 47.43 34.56 6.90 45.82 36.16 8.95 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 54.13 38.92 10.51 56.02 38.27 12.47 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 58 3 # 58 E 40 ARG F 36 ARG~? 20.40 O1 GOL B3017 E 41 TYR F 21 TYR~? 26.08 O1 GOL B3017 E 83 ARG G 36 ARG~? 19.13 CL CL C2004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 47.43 34.56 6.90 45.82 36.16 8.95 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 54.13 38.92 10.51 56.02 38.27 12.47 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 57.05 1.30 44.33 57.17 -1.56 45.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 59 3 # 59 E 40 ARG F 36 ARG~? 20.40 O1 GOL B3017 E 41 TYR F 35 TYR~? 30.41 CL CL F2035 E 83 ARG A 51 ARG~? 16.54 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 47.43 34.56 6.90 45.82 36.16 8.95 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 55.89 36.47 6.05 58.49 36.69 5.11 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 61.69 79.67 29.64 62.00 76.91 30.99 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 60 3 # 60 E 40 ARG F 108 ARG~? -3.40 CL CL F2035s E 41 TYR F 109 TYR~? 6.98 CL CL F2035 E 83 ARG A 51 ARG~? 16.54 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 74.01 31.91 26.65 74.85 33.96 28.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 80.57 32.26 27.20 79.31 32.54 29.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 61.69 79.67 29.64 62.00 76.91 30.99 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 61 3 # 61 E 40 ARG F 108 ARG~? -3.40 CL CL F2035s E 41 TYR F 109 TYR~? 6.98 CL CL F2035 E 83 ARG A 55 ARG~? 19.31 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 74.01 31.91 26.65 74.85 33.96 28.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 80.57 32.26 27.20 79.31 32.54 29.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 66.98 80.93 31.90 64.74 79.05 32.90 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 62 3 # 62 E 40 ARG F 108 ARG~? -3.40 CL CL F2035s E 41 TYR F 109 TYR~? 6.98 CL CL F2035 E 83 ARG A 108 ARG~? 22.68 O1 GOL A3040 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 74.01 31.91 26.65 74.85 33.96 28.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 80.57 32.26 27.20 79.31 32.54 29.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 77.54 80.61 37.36 78.31 77.83 38.52 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 63 3 # 63 E 40 ARG F 108 ARG~? -3.40 CL CL F2035s E 41 TYR F 109 TYR~? 6.98 CL CL F2035 E 83 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 74.01 31.91 26.65 74.85 33.96 28.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 80.57 32.26 27.20 79.31 32.54 29.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 64 3 # 64 E 40 ARG F 155 ARG.? 16.94 CL CL F2023 E 41 TYR F 157 TYR.? -10.36 O3 GOL F3039s E 83 ARG A 55 ARG~? 19.31 O3 GOL B3003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 105.33 46.75 31.26 107.63 45.25 32.77 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 100.15 45.18 26.97 97.32 45.17 26.68 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 66.98 80.93 31.90 64.74 79.05 32.90 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 65 3 # 65 E 40 ARG G 34 ARG~? 20.84 CL CL C2004 E 41 TYR G 35 TYR~? 13.11 CL CL C2004 E 83 ARG F 114 ARG~? 18.29 CL CL F2035 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 46.76 3.66 41.28 45.52 3.22 38.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 50.35 3.70 46.66 47.74 2.77 47.00 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 81.94 30.32 15.98 81.85 27.28 16.31 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 66 3 # 66 E 40 ARG G 34 ARG~? 20.84 CL CL C2004 E 41 TYR G 35 TYR~? 13.11 CL CL C2004 E 83 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 46.76 3.66 41.28 45.52 3.22 38.51 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 50.35 3.70 46.66 47.74 2.77 47.00 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 67 3 # 67 E 40 ARG G 36 ARG~? 19.13 CL CL C2004 E 41 TYR G 35 TYR~? 13.11 CL CL C2004 E 83 ARG F 36 ARG~? 20.40 O1 GOL B3017 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 57.05 1.30 44.33 57.17 -1.56 45.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 50.35 3.70 46.66 47.74 2.77 47.00 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 47.43 34.56 6.90 45.82 36.16 8.95 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 68 3 # 68 E 40 ARG G 108 ARG~? 22.05 O2 GOL G3001 E 41 TYR G 109 TYR~? 19.47 O2 GOL G3001 E 83 ARG B 108 ARG~? 14.18 O1 GOL B3024 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 32.32 22.84 38.36 31.62 25.53 39.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 25.80 23.55 38.48 27.03 26.02 38.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 39.05 68.00 18.82 37.75 66.74 21.38 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 69 3 # 69 E 40 ARG G 108 ARG~? 22.05 O2 GOL G3001 E 41 TYR G 109 TYR~? 19.47 O2 GOL G3001 E 83 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 32.32 22.84 38.36 31.62 25.53 39.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 25.80 23.55 38.48 27.03 26.02 38.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 70 3 # 70 E 40 ARG G 108 ARG~? 22.05 O2 GOL G3001 E 41 TYR G 109 TYR~? 19.47 O2 GOL G3001 E 83 ARG D 55 ARG~? 14.96 O1 GOL D3005 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 32.32 22.84 38.36 31.62 25.53 39.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 25.80 23.55 38.48 27.03 26.02 38.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 39.97 38.45 84.97 39.00 40.64 83.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 71 3 # 71 E 40 ARG G 108 ARG~? 22.05 O2 GOL G3001 E 41 TYR G 109 TYR~? 19.47 O2 GOL G3001 E 83 ARG D 108 ARG~? 19.71 O3 GOL D3019 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 32.32 22.84 38.36 31.62 25.53 39.73 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 25.80 23.55 38.48 27.03 26.02 38.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 29.84 43.62 83.53 28.05 43.26 81.00 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 72 3 # 72 E 40 ARG G 155 ARG.? 12.01 O3 GOL G3001 E 41 TYR G 157 TYR.? 5.49 O3 GOL G3001 E 83 ARG C 37 ARG~? -20.33 CL CL C2004s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 1.41 31.05 53.14 0.04 33.40 54.68 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 6.53 26.08 51.42 9.33 25.84 51.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 44.35 12.06 77.77 46.44 14.26 77.62 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 73 3 # 73 E 40 ARG G 155 ARG.? 12.01 O3 GOL G3001 E 41 TYR G 157 TYR.? 5.49 O3 GOL G3001 E 83 ARG D 55 ARG~? 14.96 O1 GOL D3005 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 1.41 31.05 53.14 0.04 33.40 54.68 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 6.53 26.08 51.42 9.33 25.84 51.41 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 39.97 38.45 84.97 39.00 40.64 83.01 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 74 3 # 74 E 40 ARG H 34 ARG~? 11.22 O3 GOL H3006 E 41 TYR H 35 TYR~? 13.05 CL CL H2005 E 83 ARG E 114 ARG~? 18.39 O3 GOL E3022 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 53.27 74.94 100.30 54.87 77.69 100.34 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.71 70.98 100.43 50.94 70.32 101.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 31.03 99.62 62.12 30.45 100.18 65.09 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 75 3 # 75 E 40 ARG H 34 ARG~? 11.22 O3 GOL H3006 E 41 TYR H 35 TYR~? 13.05 CL CL H2005 E 83 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 53.27 74.94 100.30 54.87 77.69 100.34 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.71 70.98 100.43 50.94 70.32 101.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 76 3 # 76 E 40 ARG H 36 ARG~? 15.68 C3 GOL H3006 E 41 TYR H 21 TYR~? 10.50 CL CL H2005 E 83 ARG D 94 ARG~? 15.71 CL CL D2012 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.35 74.42 97.84 39.90 73.17 95.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 47.46 68.84 95.61 49.74 68.96 94.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 3.39 42.85 90.39 4.96 40.19 90.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 77 3 # 77 E 40 ARG H 36 ARG~? 15.68 C3 GOL H3006 E 41 TYR H 21 TYR~? 10.50 CL CL H2005 E 83 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.35 74.42 97.84 39.90 73.17 95.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 47.46 68.84 95.61 49.74 68.96 94.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 78 3 # 78 E 40 ARG H 36 ARG~? 15.68 C3 GOL H3006 E 41 TYR H 21 TYR~? 10.50 CL CL H2005 E 83 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.35 74.42 97.84 39.90 73.17 95.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 47.46 68.84 95.61 49.74 68.96 94.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 79 3 # 79 E 40 ARG H 36 ARG~? 15.68 C3 GOL H3006 E 41 TYR H 35 TYR~? 13.05 CL CL H2005 E 83 ARG C 51 ARG~? 15.50 O3 GOL D3005 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.35 74.42 97.84 39.90 73.17 95.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.71 70.98 100.43 50.94 70.32 101.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 50.80 26.41 78.15 53.63 27.50 78.75 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 80 3 # 80 E 40 ARG H 36 ARG~? 15.68 C3 GOL H3006 E 41 TYR H 35 TYR~? 13.05 CL CL H2005 E 83 ARG E 36 ARG~? 16.00 C1 GOL E3004 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 41.35 74.42 97.84 39.90 73.17 95.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 48.71 70.98 100.43 50.94 70.32 101.95 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 66.28 100.73 63.79 67.89 98.12 63.67 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 81 3 # 81 E 40 ARG H 108 ARG~? 14.48 O2 GOL H3016 E 41 TYR H 109 TYR~? 11.76 O2 GOL H3016 E 83 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 71.22 70.92 84.57 72.18 68.95 82.36 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 77.84 69.46 85.37 77.15 69.38 82.64 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 82 3 # 82 E 40 ARG H 108 ARG~? 14.48 O2 GOL H3016 E 41 TYR H 109 TYR~? 11.76 O2 GOL H3016 E 83 ARG C 55 ARG~? 19.41 CL CL C2006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 71.22 70.92 84.57 72.18 68.95 82.36 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 77.84 69.46 85.37 77.15 69.38 82.64 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 55.97 24.40 76.93 55.45 26.29 74.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 83 3 # 83 E 40 ARG H 155 ARG.? 17.02 CL CL H2024 E 41 TYR H 157 TYR.? -11.04 CL CL H2014s E 83 ARG C 55 ARG~? 19.41 CL CL C2006 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 99.48 50.13 87.00 102.10 51.31 85.80 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 93.68 52.87 90.01 90.96 53.43 89.67 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 55.97 24.40 76.93 55.45 26.29 74.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 84 3 # 84 E 40 ARG I 34 ARG~? 20.72 CL CL I2001 E 41 TYR I 35 TYR~? 13.03 CL CL I2001 E 83 ARG J 114 ARG~? 18.34 O3 GOL J3030 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.86 216.47 149.42 177.66 216.28 146.86 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 171.46 216.91 154.12 173.98 218.04 154.69 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 145.85 183.80 124.31 145.72 186.84 123.92 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 85 3 # 85 E 40 ARG I 34 ARG~? 20.72 CL CL I2001 E 41 TYR I 35 TYR~? 13.03 CL CL I2001 E 83 ARG J 145 ARG~? 22.99 CL CL J2016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.86 216.47 149.42 177.66 216.28 146.86 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 171.46 216.91 154.12 173.98 218.04 154.69 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 86 3 # 86 E 40 ARG I 36 ARG~? 18.35 CL CL I2001 E 41 TYR I 21 TYR~? 10.49 CL CL I2001 E 83 ARG J 36 ARG~? 16.92 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.77 216.28 151.02 161.75 213.99 150.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.47 212.28 156.01 171.53 210.49 155.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 87 3 # 87 E 40 ARG I 36 ARG~? 18.35 CL CL I2001 E 41 TYR I 21 TYR~? 10.49 CL CL I2001 E 83 ARG M 145 ARG~? 23.51 CL CL M2017 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.77 216.28 151.02 161.75 213.99 150.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.47 212.28 156.01 171.53 210.49 155.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 88 3 # 88 E 40 ARG I 36 ARG~? 18.35 CL CL I2001 E 41 TYR I 35 TYR~? 13.03 CL CL I2001 E 83 ARG J 36 ARG~? 16.92 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.77 216.28 151.02 161.75 213.99 150.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 171.46 216.91 154.12 173.98 218.04 154.69 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 181.40 180.11 121.45 182.70 178.85 123.93 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 89 3 # 89 E 40 ARG I 36 ARG~? 18.35 CL CL I2001 E 41 TYR I 35 TYR~? 13.03 CL CL I2001 E 83 ARG P 51 ARG~? 14.75 O3 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.77 216.28 151.02 161.75 213.99 150.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 171.46 216.91 154.12 173.98 218.04 154.69 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 171.10 192.14 197.11 173.97 192.46 196.07 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 90 3 # 90 E 40 ARG I 108 ARG~? 14.30 O1 GOL I3032 E 41 TYR I 109 TYR~? 11.79 O1 GOL I3032 E 83 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 191.22 197.47 152.14 191.76 195.04 153.98 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 197.73 197.22 153.29 196.64 194.65 153.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 91 3 # 91 E 40 ARG I 108 ARG~? 14.30 O1 GOL I3032 E 41 TYR I 109 TYR~? 11.79 O1 GOL I3032 E 83 ARG P 55 ARG~? 20.09 O3 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 191.22 197.47 152.14 191.76 195.04 153.98 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 197.73 197.22 153.29 196.64 194.65 153.36 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 176.25 189.61 198.56 175.31 187.31 196.65 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 92 3 # 92 E 40 ARG I 155 ARG.? 16.75 CL CL I2025 E 41 TYR I 157 TYR.? -10.00 O3 GOL I3031s E 83 ARG M 37 ARG~? -4.64 O1 GOL M3007s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 219.78 193.99 171.61 222.12 192.73 169.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 214.62 198.06 169.41 211.87 198.21 168.94 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 172.69 214.03 186.60 170.63 211.79 186.52 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 93 3 # 93 E 40 ARG I 155 ARG.? 16.75 CL CL I2025 E 41 TYR I 157 TYR.? -10.00 O3 GOL I3031s E 83 ARG P 55 ARG~? 20.09 O3 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 219.78 193.99 171.61 222.12 192.73 169.97 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 214.62 198.06 169.41 211.87 198.21 168.94 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 176.25 189.61 198.56 175.31 187.31 196.65 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 94 3 # 94 E 40 ARG J 34 ARG~? 20.21 CL CL J2002 E 41 TYR J 35 TYR~? 13.02 CL CL J2002 E 83 ARG I 114 ARG~? 18.68 O1 GOL I3031 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 169.79 183.14 118.82 167.66 185.29 119.35 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.30 177.82 119.58 170.88 177.40 118.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 198.65 208.42 151.97 199.12 208.35 148.94 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 95 3 # 95 E 40 ARG J 34 ARG~? 20.21 CL CL J2002 E 41 TYR J 35 TYR~? 13.02 CL CL J2002 E 83 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 169.79 183.14 118.82 167.66 185.29 119.35 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.30 177.82 119.58 170.88 177.40 118.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 96 3 # 96 E 40 ARG J 36 ARG~? 16.92 CL CL J2002 E 41 TYR J 21 TYR~? 10.46 CL CL J2002 E 83 ARG I 36 ARG~? 18.35 CL CL I2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 181.40 180.11 121.45 182.70 178.85 123.93 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 174.52 176.28 124.74 172.25 177.04 126.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 97 3 # 97 E 40 ARG J 36 ARG~? 16.92 CL CL J2002 E 41 TYR J 21 TYR~? 10.46 CL CL J2002 E 83 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 181.40 180.11 121.45 182.70 178.85 123.93 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 174.52 176.28 124.74 172.25 177.04 126.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 98 3 # 98 E 40 ARG J 36 ARG~? 16.92 CL CL J2002 E 41 TYR J 35 TYR~? 13.02 CL CL J2002 E 83 ARG I 36 ARG~? 18.35 CL CL I2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 181.40 180.11 121.45 182.70 178.85 123.93 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.30 177.82 119.58 170.88 177.40 118.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 163.77 216.28 151.02 161.75 213.99 150.84 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 99 3 # 99 E 40 ARG J 36 ARG~? 16.92 CL CL J2002 E 41 TYR J 35 TYR~? 13.02 CL CL J2002 E 83 ARG O 51 ARG~? 16.43 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 181.40 180.11 121.45 182.70 178.85 123.93 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.30 177.82 119.58 170.88 177.40 118.29 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 165.78 138.84 148.96 164.30 141.49 149.44 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 100 3 # 100 E 40 ARG J 108 ARG~? 23.02 O1 GOL J3030 E 41 TYR J 109 TYR~? 19.91 O1 GOL J3030 E 83 ARG M 108 ARG~? 23.14 O1 GOL M3043 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 152.38 184.27 135.62 151.05 183.00 138.10 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 145.48 183.77 135.57 146.27 183.96 138.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 150.62 202.12 182.01 149.56 199.68 180.53 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 101 3 # 101 E 40 ARG J 108 ARG~? 23.02 O1 GOL J3030 E 41 TYR J 109 TYR~? 19.91 O1 GOL J3030 E 83 ARG M 145 ARG~? 23.51 CL CL M2017 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 152.38 184.27 135.62 151.05 183.00 138.10 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 145.48 183.77 135.57 146.27 183.96 138.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 102 3 # 102 E 40 ARG J 108 ARG~? 23.02 O1 GOL J3030 E 41 TYR J 109 TYR~? 19.91 O1 GOL J3030 E 83 ARG O 55 ARG~? 19.37 CL CL K2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 152.38 184.27 135.62 151.05 183.00 138.10 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 145.48 183.77 135.57 146.27 183.96 138.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 159.96 137.60 150.54 160.85 139.64 152.73 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 103 3 # 103 E 40 ARG J 108 ARG~? 23.02 O1 GOL J3030 E 41 TYR J 109 TYR~? 19.91 O1 GOL J3030 E 83 ARG O 108 ARG~? 13.39 CL CL O2036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 152.38 184.27 135.62 151.05 183.00 138.10 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 145.48 183.77 135.57 146.27 183.96 138.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 148.81 138.28 154.16 147.06 140.78 153.42 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 104 3 # 104 E 40 ARG J 155 ARG.? 11.80 O1 GOL J3033 E 41 TYR J 157 TYR.? 4.16 O1 GOL J3033 E 83 ARG N 37 ARG~? -4.21 O3 GOL N3008s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 121.13 167.88 138.18 121.17 165.29 139.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 126.93 169.72 134.52 129.73 169.94 134.63 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 167.97 146.21 125.72 169.64 146.36 128.31 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 105 3 # 105 E 40 ARG J 155 ARG.? 11.80 O1 GOL J3033 E 41 TYR J 157 TYR.? 4.16 O1 GOL J3033 E 83 ARG O 55 ARG~? 19.37 CL CL K2003 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 121.13 167.88 138.18 121.17 165.29 139.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 126.93 169.72 134.52 129.73 169.94 134.63 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 159.96 137.60 150.54 160.85 139.64 152.73 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 106 3 # 106 E 40 ARG K 34 ARG~? 11.32 O1 GOL K3011 E 41 TYR K 21 TYR~? 13.85 O1 GOL K3011 E 83 ARG L 114 ARG~? 18.80 O1 GOL L3027 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 167.98 121.31 187.60 169.63 121.60 190.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 163.15 125.72 181.32 165.33 127.37 181.87 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 138.87 157.00 210.52 138.32 154.00 210.96 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 107 3 # 107 E 40 ARG K 34 ARG~? 11.32 O1 GOL K3011 E 41 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 83 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 167.98 121.31 187.60 169.63 121.60 190.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.29 120.92 183.43 166.71 119.58 183.22 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 108 3 # 108 E 40 ARG K 34 ARG~? 11.32 O1 GOL K3011 E 41 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 83 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 167.98 121.31 187.60 169.63 121.60 190.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.29 120.92 183.43 166.71 119.58 183.22 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 109 3 # 109 E 40 ARG K 36 ARG~? 15.75 C1 GOL K3011 E 41 TYR K 21 TYR~? 13.85 O1 GOL K3011 E 83 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 156.15 122.83 185.77 154.85 125.10 184.29 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 163.15 125.72 181.32 165.33 127.37 181.87 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 110 3 # 110 E 40 ARG K 36 ARG~? 15.75 C1 GOL K3011 E 41 TYR K 21 TYR~? 13.85 O1 GOL K3011 E 83 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 156.15 122.83 185.77 154.85 125.10 184.29 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 163.15 125.72 181.32 165.33 127.37 181.87 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 111 3 # 111 E 40 ARG K 36 ARG~? 15.75 C1 GOL K3011 E 41 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 83 ARG L 36 ARG~? 28.87 C1 GOL P3034 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 156.15 122.83 185.77 154.85 125.10 184.29 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.29 120.92 183.43 166.71 119.58 183.22 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 174.06 157.20 217.38 176.23 157.17 215.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 112 3 # 112 E 40 ARG K 36 ARG~? 15.75 C1 GOL K3011 E 41 TYR K 35 TYR~? 15.70 O1 GOL K3011 E 83 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 156.15 122.83 185.77 154.85 125.10 184.29 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.29 120.92 183.43 166.71 119.58 183.22 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 113 3 # 113 E 40 ARG K 108 ARG~? 18.77 O3 GOL K3010 E 41 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 83 ARG N 51 ARG~? 10.93 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 185.36 137.67 187.99 186.54 140.01 186.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 192.13 137.45 187.51 191.27 140.11 187.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 172.16 145.36 140.78 174.78 144.98 142.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 114 3 # 114 E 40 ARG K 108 ARG~? 18.77 O3 GOL K3010 E 41 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 83 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 185.36 137.67 187.99 186.54 140.01 186.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 192.13 137.45 187.51 191.27 140.11 187.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 115 3 # 115 E 40 ARG K 108 ARG~? 18.77 O3 GOL K3010 E 41 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 83 ARG N 108 ARG~? 14.89 C2 GOL N3029 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 185.36 137.67 187.99 186.54 140.01 186.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 192.13 137.45 187.51 191.27 140.11 187.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 189.02 149.68 140.15 189.67 151.62 142.49 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 116 3 # 116 E 40 ARG K 108 ARG~? 18.77 O3 GOL K3010 E 41 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 83 ARG P 108 ARG~? 21.30 O3 GOL P3014 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 185.36 137.67 187.99 186.54 140.01 186.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 192.13 137.45 187.51 191.27 140.11 187.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 187.53 185.71 199.97 188.17 183.79 197.64 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 117 3 # 117 E 40 ARG K 108 ARG~? 18.77 O3 GOL K3010 E 41 TYR K 109 TYR~? 18.63 O3 GOL K3010 E 83 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 185.36 137.67 187.99 186.54 140.01 186.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 192.13 137.45 187.51 191.27 140.11 187.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.30 185.90 191.05 208.78 186.92 189.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 118 3 # 118 E 40 ARG K 155 ARG.? 13.03 O2 GOL K3009 E 41 TYR K 157 TYR.? 6.79 O2 GOL K3009 E 83 ARG N 55 ARG~? 13.92 O1 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 216.54 137.96 172.21 218.86 139.31 173.84 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 210.77 134.37 173.74 207.96 134.59 173.91 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 177.28 147.38 139.71 179.40 146.33 141.72 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 119 3 # 119 E 40 ARG L 34 ARG~? 28.77 O3 GOL K3011 E 41 TYR L 21 TYR~? 30.92 O3 GOL K3011 E 83 ARG K 114 ARG~? 18.18 O1 GOL K3041 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 162.35 156.38 218.07 160.56 153.83 217.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.26 161.38 213.44 166.20 160.80 211.67 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 191.56 126.17 188.91 191.90 126.17 191.97 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 120 3 # 120 E 40 ARG L 36 ARG~? 28.87 C1 GOL P3034 E 41 TYR L 21 TYR~? 30.92 O3 GOL K3011 E 83 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 174.06 157.20 217.38 176.23 157.17 215.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.26 161.38 213.44 166.20 160.80 211.67 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 121 3 # 121 E 40 ARG L 36 ARG~? 28.87 C1 GOL P3034 E 41 TYR L 21 TYR~? 30.92 O3 GOL K3011 E 83 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 174.06 157.20 217.38 176.23 157.17 215.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.26 161.38 213.44 166.20 160.80 211.67 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.30 185.90 191.05 208.78 186.92 189.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 122 3 # 122 E 40 ARG L 36 ARG~? 28.87 C1 GOL P3034 E 41 TYR L 35 TYR~? 33.75 O3 GOL K3011 E 83 ARG K 36 ARG~? 15.75 C1 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 174.06 157.20 217.38 176.23 157.17 215.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 166.36 159.94 218.26 163.88 160.60 219.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 156.15 122.83 185.77 154.85 125.10 184.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 123 3 # 123 E 40 ARG L 36 ARG~? 28.87 C1 GOL P3034 E 41 TYR L 35 TYR~? 33.75 O3 GOL K3011 E 83 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 174.06 157.20 217.38 176.23 157.17 215.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 166.36 159.94 218.26 163.88 160.60 219.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 124 3 # 124 E 40 ARG L 36 ARG~? 28.87 C1 GOL P3034 E 41 TYR L 35 TYR~? 33.75 O3 GOL K3011 E 83 ARG M 51 ARG~? -9.68 O2 GOL M3007s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 174.06 157.20 217.38 176.23 157.17 215.21 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 166.36 159.94 218.26 163.88 160.60 219.34 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 166.66 199.07 188.11 163.90 199.62 189.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 125 3 # 125 E 40 ARG L 108 ARG~? 19.25 O3 GOL L3028 E 41 TYR L 109 TYR~? 18.94 O3 GOL L3028 E 83 ARG M 55 ARG~? 12.49 O2 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 146.49 155.54 199.73 145.94 157.11 197.11 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 139.89 156.88 199.30 141.02 156.55 196.75 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 162.29 201.15 185.73 159.83 200.25 187.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 126 3 # 126 E 40 ARG L 108 ARG~? 19.25 O3 GOL L3028 E 41 TYR L 109 TYR~? 18.94 O3 GOL L3028 E 83 ARG M 108 ARG~? 23.14 O1 GOL M3043 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 146.49 155.54 199.73 145.94 157.11 197.11 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 139.89 156.88 199.30 141.02 156.55 196.75 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 150.62 202.12 182.01 149.56 199.68 180.53 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 127 3 # 127 E 40 ARG L 108 ARG~? 19.25 O3 GOL L3028 E 41 TYR L 109 TYR~? 18.94 O3 GOL L3028 E 83 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 146.49 155.54 199.73 145.94 157.11 197.11 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 139.89 156.88 199.30 141.02 156.55 196.75 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 128 3 # 128 E 40 ARG L 155 ARG.? 15.58 CL CL L2028 E 41 TYR L 157 TYR.? 9.71 O3 GOL L3027 E 83 ARG M 55 ARG~? 12.49 O2 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 117.81 174.80 193.27 115.12 175.12 194.77 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 123.19 173.24 198.15 125.89 172.62 198.32 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 162.29 201.15 185.73 159.83 200.25 187.37 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 129 3 # 129 E 40 ARG M 34 ARG~? 12.31 O1 GOL M3007 E 41 TYR M 35 TYR~? 13.00 CL CL I2001 E 83 ARG P 114 ARG~? 18.57 O2 GOL P3034 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 167.85 218.77 182.40 165.86 219.39 184.74 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 172.26 218.21 177.69 169.95 219.60 176.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 193.59 185.96 211.51 194.17 188.98 211.79 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 130 3 # 130 E 40 ARG M 34 ARG~? 12.31 O1 GOL M3007 E 41 TYR M 35 TYR~? 13.00 CL CL I2001 E 83 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 167.85 218.77 182.40 165.86 219.39 184.74 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 172.26 218.21 177.69 169.95 219.60 176.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.30 185.90 191.05 208.78 186.92 189.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 131 3 # 131 E 40 ARG M 36 ARG~? 16.07 O1 GOL M3007 E 41 TYR M 21 TYR~? 10.54 CL CL I2001 E 83 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 179.97 216.30 180.98 181.48 213.82 180.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.68 213.02 176.47 171.32 211.57 177.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 132 3 # 132 E 40 ARG M 36 ARG~? 16.07 O1 GOL M3007 E 41 TYR M 21 TYR~? 10.54 CL CL I2001 E 83 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 179.97 216.30 180.98 181.48 213.82 180.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 173.68 213.02 176.47 171.32 211.57 177.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 133 3 # 133 E 40 ARG M 36 ARG~? 16.07 O1 GOL M3007 E 41 TYR M 35 TYR~? 13.00 CL CL I2001 E 83 ARG J 51 ARG~? 27.44 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 179.97 216.30 180.98 181.48 213.82 180.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 172.26 218.21 177.69 169.95 219.60 176.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 168.80 189.12 137.91 166.15 189.45 139.46 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 134 3 # 134 E 40 ARG M 36 ARG~? 16.07 O1 GOL M3007 E 41 TYR M 35 TYR~? 13.00 CL CL I2001 E 83 ARG P 36 ARG~? 18.56 O1 GOL L3028 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 179.97 216.30 180.98 181.48 213.82 180.04 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 172.26 218.21 177.69 169.95 219.60 176.96 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 157.78 187.06 214.51 156.14 185.86 212.27 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 135 3 # 135 E 40 ARG M 108 ARG~? 23.14 O1 GOL M3043 E 41 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 83 ARG J 51 ARG~? 27.44 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 150.62 202.12 182.01 149.56 199.68 180.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 143.85 202.19 180.75 144.68 199.53 181.04 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 168.80 189.12 137.91 166.15 189.45 139.46 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 136 3 # 136 E 40 ARG M 108 ARG~? 23.14 O1 GOL M3043 E 41 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 83 ARG J 55 ARG~? 24.05 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 150.62 202.12 182.01 149.56 199.68 180.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 143.85 202.19 180.75 144.68 199.53 181.04 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 163.85 187.29 136.52 164.25 185.16 138.77 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 137 3 # 137 E 40 ARG M 108 ARG~? 23.14 O1 GOL M3043 E 41 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 83 ARG J 108 ARG~? 23.02 O1 GOL J3030 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 150.62 202.12 182.01 149.56 199.68 180.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 143.85 202.19 180.75 144.68 199.53 181.04 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 152.38 184.27 135.62 151.05 183.00 138.10 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 138 3 # 138 E 40 ARG M 108 ARG~? 23.14 O1 GOL M3043 E 41 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 83 ARG L 108 ARG~? 19.25 O3 GOL L3028 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 150.62 202.12 182.01 149.56 199.68 180.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 143.85 202.19 180.75 144.68 199.53 181.04 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 146.49 155.54 199.73 145.94 157.11 197.11 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 139 3 # 139 E 40 ARG M 108 ARG~? 23.14 O1 GOL M3043 E 41 TYR M 109 TYR~? 20.13 O1 GOL M3043 E 83 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 150.62 202.12 182.01 149.56 199.68 180.53 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 143.85 202.19 180.75 144.68 199.53 181.04 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 140 3 # 140 E 40 ARG M 155 ARG.? 12.99 O1 GOL M3042 E 41 TYR M 157 TYR.? -4.16 C2 GOL M3042s E 83 ARG I 37 ARG~? 20.23 CL CL I2001 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 121.45 199.58 162.40 118.88 198.67 163.91 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 127.03 203.34 164.58 129.75 203.18 165.07 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 170.53 211.87 145.98 172.22 209.35 146.21 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 141 3 # 141 E 40 ARG M 155 ARG.? 12.99 O1 GOL M3042 E 41 TYR M 157 TYR.? -4.16 C2 GOL M3042s E 83 ARG J 55 ARG~? 24.05 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 121.45 199.58 162.40 118.88 198.67 163.91 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 127.03 203.34 164.58 129.75 203.18 165.07 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 163.85 187.29 136.52 164.25 185.16 138.77 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 142 3 # 142 E 40 ARG N 34 ARG~? 11.02 O3 GOL N3008 E 41 TYR N 21 TYR~? 10.52 CL CL J2002 E 83 ARG O 114 ARG~? 4.95 CL CL O2036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 173.47 149.90 121.53 175.07 147.29 121.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.15 156.47 125.36 170.14 155.81 127.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 141.08 127.21 153.72 140.82 126.86 150.69 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 143 3 # 143 E 40 ARG N 34 ARG~? 11.02 O3 GOL N3008 E 41 TYR N 35 TYR~? 13.09 CL CL J2002 E 83 ARG I 51 ARG~? 21.58 CL CL I2007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 173.47 149.90 121.53 175.07 147.29 121.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.83 154.24 120.71 172.41 154.64 119.66 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 144 3 # 144 E 40 ARG N 34 ARG~? 11.02 O3 GOL N3008 E 41 TYR N 35 TYR~? 13.09 CL CL J2002 E 83 ARG O 114 ARG~? 4.95 CL CL O2036 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 173.47 149.90 121.53 175.07 147.29 121.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.83 154.24 120.71 172.41 154.64 119.66 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 141.08 127.21 153.72 140.82 126.86 150.69 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 145 3 # 145 E 40 ARG N 34 ARG~? 11.02 O3 GOL N3008 E 41 TYR N 35 TYR~? 13.09 CL CL J2002 E 83 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 173.47 149.90 121.53 175.07 147.29 121.87 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.83 154.24 120.71 172.41 154.64 119.66 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 146 3 # 146 E 40 ARG N 36 ARG~? 15.62 C3 GOL N3008 E 41 TYR N 21 TYR~? 10.52 CL CL J2002 E 83 ARG J 145 ARG~? 22.99 CL CL J2016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 161.60 152.07 121.93 160.06 153.41 124.19 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.15 156.47 125.36 170.14 155.81 127.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 147 3 # 147 E 40 ARG N 36 ARG~? 15.62 C3 GOL N3008 E 41 TYR N 21 TYR~? 10.52 CL CL J2002 E 83 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 161.60 152.07 121.93 160.06 153.41 124.19 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 168.15 156.47 125.36 170.14 155.81 127.21 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 148 3 # 148 E 40 ARG N 36 ARG~? 15.62 C3 GOL N3008 E 41 TYR N 35 TYR~? 13.09 CL CL J2002 E 83 ARG I 51 ARG~? 21.58 CL CL I2007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 161.60 152.07 121.93 160.06 153.41 124.19 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.83 154.24 120.71 172.41 154.64 119.66 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 174.23 196.17 146.19 174.71 193.30 147.29 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 149 3 # 149 E 40 ARG N 36 ARG~? 15.62 C3 GOL N3008 E 41 TYR N 35 TYR~? 13.09 CL CL J2002 E 83 ARG O 36 ARG~? 19.89 O1 GOL K3010 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 161.60 152.07 121.93 160.06 153.41 124.19 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.83 154.24 120.71 172.41 154.64 119.66 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 175.82 120.47 157.52 177.72 122.75 158.28 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 150 3 # 150 E 40 ARG N 108 ARG~? 14.89 C2 GOL N3029 E 41 TYR N 109 TYR~? 12.25 C2 GOL N3029 E 83 ARG I 55 ARG~? 19.02 CL CL I2007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 189.02 149.68 140.15 189.67 151.62 142.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 195.52 150.33 140.44 194.35 150.45 143.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 179.74 197.90 148.59 178.27 195.79 150.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 151 3 # 151 E 40 ARG N 108 ARG~? 14.89 C2 GOL N3029 E 41 TYR N 109 TYR~? 12.25 C2 GOL N3029 E 83 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 189.02 149.68 140.15 189.67 151.62 142.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 195.52 150.33 140.44 194.35 150.45 143.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 152 3 # 152 E 40 ARG N 108 ARG~? 14.89 C2 GOL N3029 E 41 TYR N 109 TYR~? 12.25 C2 GOL N3029 E 83 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 189.02 149.68 140.15 189.67 151.62 142.49 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 195.52 150.33 140.44 194.35 150.45 143.01 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 153 3 # 153 E 40 ARG N 155 ARG.? 11.80 C1 GOL N3012 E 41 TYR N 157 TYR.? 7.89 C1 GOL N3012 E 83 ARG I 55 ARG~? 19.02 CL CL I2007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 219.49 166.94 144.14 219.55 170.01 143.56 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 214.45 164.07 139.74 211.68 163.84 139.51 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 179.74 197.90 148.59 178.27 195.79 150.32 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 154 3 # 154 E 40 ARG N 155 ARG.? 11.80 C1 GOL N3012 E 41 TYR N 157 TYR.? 7.89 C1 GOL N3012 E 83 ARG J 37 ARG~? 20.17 CL CL J2002 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 219.49 166.94 144.14 219.55 170.01 143.56 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 214.45 164.07 139.74 211.68 163.84 139.51 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 174.71 186.35 123.78 172.76 186.51 126.11 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 155 3 # 155 E 40 ARG O 34 ARG~? 19.49 CL CL O2036 E 41 TYR O 35 TYR~? 20.32 CL CL K2003 E 83 ARG N 114 ARG~? 21.90 O2 GOL N3029 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.83 119.56 154.44 162.36 118.67 151.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 167.80 119.41 159.74 165.27 118.34 160.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 196.45 148.76 129.28 196.55 145.72 129.25 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 156 3 # 156 E 40 ARG O 34 ARG~? 19.49 CL CL O2036 E 41 TYR O 35 TYR~? 20.32 CL CL K2003 E 83 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 163.83 119.56 154.44 162.36 118.67 151.85 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 167.80 119.41 159.74 165.27 118.34 160.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 157 3 # 157 E 40 ARG O 36 ARG~? 19.89 O1 GOL K3010 E 41 TYR O 21 TYR~? 14.79 CL CL K2003 E 83 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.82 120.47 157.52 177.72 122.75 158.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.50 124.29 161.32 167.44 126.02 160.55 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 158 3 # 158 E 40 ARG O 36 ARG~? 19.89 O1 GOL K3010 E 41 TYR O 21 TYR~? 14.79 CL CL K2003 E 83 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.82 120.47 157.52 177.72 122.75 158.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 169.50 124.29 161.32 167.44 126.02 160.55 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 159 3 # 159 E 40 ARG O 36 ARG~? 19.89 O1 GOL K3010 E 41 TYR O 35 TYR~? 20.32 CL CL K2003 E 83 ARG L 51 ARG~? 16.39 O3 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.82 120.47 157.52 177.72 122.75 158.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 167.80 119.41 159.74 165.27 118.34 160.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 163.01 149.53 198.74 162.90 150.47 195.82 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 160 3 # 160 E 40 ARG O 36 ARG~? 19.89 O1 GOL K3010 E 41 TYR O 35 TYR~? 20.32 CL CL K2003 E 83 ARG N 36 ARG~? 15.62 C3 GOL N3008 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 175.82 120.47 157.52 177.72 122.75 158.28 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 167.80 119.41 159.74 165.27 118.34 160.26 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 161.60 152.07 121.93 160.06 153.41 124.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 161 3 # 161 E 40 ARG O 108 ARG~? 13.39 CL CL O2036 E 41 TYR O 109 TYR~? 12.46 CL CL O2036 E 83 ARG J 108 ARG~? 23.02 O1 GOL J3030 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 148.81 138.28 154.16 147.06 140.78 153.42 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 141.96 138.45 153.78 143.09 141.01 153.60 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 152.38 184.27 135.62 151.05 183.00 138.10 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 162 3 # 162 E 40 ARG O 108 ARG~? 13.39 CL CL O2036 E 41 TYR O 109 TYR~? 12.46 CL CL O2036 E 83 ARG J 145 ARG~? 22.99 CL CL J2016 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 148.81 138.28 154.16 147.06 140.78 153.42 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 141.96 138.45 153.78 143.09 141.01 153.60 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 163 3 # 163 E 40 ARG O 108 ARG~? 13.39 CL CL O2036 E 41 TYR O 112 TYR~? 11.14 CL CL O2036 E 83 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 148.81 138.28 154.16 147.06 140.78 153.42 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 142.72 134.33 160.12 142.81 134.85 162.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 164 3 # 164 E 40 ARG O 108 ARG~? 13.39 CL CL O2036 E 41 TYR O 112 TYR~? 11.14 CL CL O2036 E 83 ARG L 66 ARG~? -3.01 O3 GOL L3028s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 148.81 138.28 154.16 147.06 140.78 153.42 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 142.72 134.33 160.12 142.81 134.85 162.82 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 140.51 170.53 195.42 141.23 173.15 196.90 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 165 3 # 165 E 40 ARG O 155 ARG.? 13.45 O3 GOL O3013 E 41 TYR O 157 TYR.? 6.41 O2 GOL O3013 E 83 ARG K 37 ARG~? -4.30 O1 GOL K3011s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 117.87 143.72 169.20 115.63 144.83 167.33 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 123.23 139.38 167.80 126.05 139.22 167.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 162.88 126.06 191.42 164.87 128.39 191.36 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 166 3 # 166 E 40 ARG O 155 ARG.? 13.45 O3 GOL O3013 E 41 TYR O 157 TYR.? 6.41 O2 GOL O3013 E 83 ARG L 55 ARG~? 21.00 O3 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 117.87 143.72 169.20 115.63 144.83 167.33 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 123.23 139.38 167.80 126.05 139.22 167.65 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 158.05 151.49 200.24 157.97 153.99 198.35 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 167 3 # 167 E 40 ARG P 34 ARG~? 27.86 O3 GOL M3007 E 41 TYR P 21 TYR~? 24.07 O1 GOL L3028 E 83 ARG M 114 ARG~? 18.40 O3 GOL M3043 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 169.45 187.34 216.38 171.34 189.81 216.30 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.13 181.87 211.82 166.34 182.20 210.17 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 144.35 213.37 180.84 143.79 213.88 183.80 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 168 3 # 168 E 40 ARG P 36 ARG~? 18.56 O1 GOL L3028 E 41 TYR P 21 TYR~? 24.07 O1 GOL L3028 E 83 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 157.78 187.06 214.51 156.14 185.86 212.27 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.13 181.87 211.82 166.34 182.20 210.17 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 169 3 # 169 E 40 ARG P 36 ARG~? 18.56 O1 GOL L3028 E 41 TYR P 21 TYR~? 24.07 O1 GOL L3028 E 83 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 157.78 187.06 214.51 156.14 185.86 212.27 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 164.13 181.87 211.82 166.34 182.20 210.17 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 170 3 # 170 E 40 ARG P 36 ARG~? 18.56 O1 GOL L3028 E 41 TYR P 35 TYR~? 28.94 O1 GOL L3028 E 83 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 157.78 187.06 214.51 156.14 185.86 212.27 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 165.51 183.94 216.71 167.90 183.49 218.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 171 3 # 171 E 40 ARG P 36 ARG~? 18.56 O1 GOL L3028 E 41 TYR P 35 TYR~? 28.94 O1 GOL L3028 E 83 ARG M 36 ARG~? 16.07 O1 GOL M3007 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 157.78 187.06 214.51 156.14 185.86 212.27 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 165.51 183.94 216.71 167.90 183.49 218.05 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 179.97 216.30 180.98 181.48 213.82 180.04 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 172 3 # 172 E 40 ARG P 108 ARG~? 21.30 O3 GOL P3014 E 41 TYR P 109 TYR~? 18.49 O3 GOL P3014 E 83 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 187.53 185.71 199.97 188.17 183.79 197.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 193.88 184.51 200.52 193.11 184.53 197.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 173 3 # 173 E 40 ARG P 108 ARG~? 21.30 O3 GOL P3014 E 41 TYR P 109 TYR~? 18.49 O3 GOL P3014 E 83 ARG K 51 ARG~? -10.79 O3 GOL K3011s coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 187.53 185.71 199.97 188.17 183.79 197.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 193.88 184.51 200.52 193.11 184.53 197.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 168.73 140.32 192.51 171.31 141.97 192.79 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 174 3 # 174 E 40 ARG P 108 ARG~? 21.30 O3 GOL P3014 E 41 TYR P 109 TYR~? 18.49 O3 GOL P3014 E 83 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 187.53 185.71 199.97 188.17 183.79 197.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 193.88 184.51 200.52 193.11 184.53 197.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 175 3 # 175 E 40 ARG P 108 ARG~? 21.30 O3 GOL P3014 E 41 TYR P 109 TYR~? 18.49 O3 GOL P3014 E 83 ARG K 108 ARG~? 18.77 O3 GOL K3010 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 187.53 185.71 199.97 188.17 183.79 197.64 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 193.88 184.51 200.52 193.11 184.53 197.85 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 185.36 137.67 187.99 186.54 140.01 186.30 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 176 3 # 176 E 40 ARG P 155 ARG.? 12.61 O2 GOL P3014 E 41 TYR P 157 TYR.? 6.12 O2 GOL P3014 E 83 ARG K 55 ARG~? 13.86 O3 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 216.42 165.88 200.05 218.98 167.31 198.98 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 210.70 168.63 203.45 207.96 169.02 203.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 173.95 138.80 190.43 173.34 140.90 188.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 177 3 # 177 E 40 ARG P 155 ARG.? 12.61 O2 GOL P3014 E 41 TYR P 157 TYR.? 6.12 O2 GOL P3014 E 83 ARG L 37 ARG~? 22.34 O3 GOL K3011 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 216.42 165.88 200.05 218.98 167.31 198.98 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 210.70 168.63 203.45 207.96 169.02 203.20 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 167.17 151.29 214.24 165.45 151.32 211.73 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 177 hits 1id3_d00 naa= 3 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 1 5 # 1 C 111 ARG A 36 ARG~? 20.86 C3 GOL E3035 C 115 THR A 40 THR~? 22.15 C3 GOL E3035 C 117 ARG A 44 ARG~? 20.37 O3 GOL E3035 C 118 GLU A 43 GLU~? 17.96 C3 GOL E3035 C 121 ARG A 14 ARG~? 17.33 C3 GOL E3035 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 51.19 99.66 33.34 49.41 97.31 34.21 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 51.54 93.42 33.02 50.86 94.28 31.14 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 47.85 90.78 30.63 47.19 93.18 28.89 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 49.19 92.81 37.46 48.57 94.78 37.27 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 51.58 86.56 39.71 49.78 85.03 37.73 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 2 5 # 2 C 111 ARG E 36 ARG~? 16.00 C1 GOL E3004 C 115 THR E 40 THR~? 11.68 C1 GOL E3004 C 117 ARG E 44 ARG~? 13.68 C1 GOL E3004 C 118 GLU E 43 GLU~? 17.32 C1 GOL E3004 C 121 ARG E 14 ARG~? 16.26 C1 GOL E3004 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 66.28 100.73 63.79 67.89 98.12 63.67 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 64.85 95.00 65.57 65.64 96.04 67.25 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 67.85 92.14 68.56 69.19 94.64 69.74 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 66.77 92.95 61.24 67.88 94.70 61.00 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 63.05 87.03 60.24 64.56 85.62 62.59 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 3 5 # 3 C 111 ARG F 36 ARG~? 20.40 O1 GOL B3017 C 115 THR F 40 THR~? 21.55 O1 GOL B3017 C 117 ARG F 44 ARG~? 19.46 O1 GOL B3017 C 118 GLU F 43 GLU~? 17.56 O1 GOL B3017 C 121 ARG F 14 ARG~? 16.88 O1 GOL B3017 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 47.43 34.56 6.90 45.82 36.16 8.95 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 47.69 34.31 13.13 46.73 32.65 12.19 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 43.53 32.70 15.75 42.58 31.25 13.24 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 46.38 39.16 13.84 45.66 39.18 11.88 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 49.17 40.62 20.09 46.79 39.22 21.58 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 4 5 # 4 C 111 ARG K 36 ARG~? 15.75 C1 GOL K3011 C 115 THR K 40 THR~? 11.40 C1 GOL K3011 C 117 ARG K 44 ARG~? 13.27 C1 GOL K3011 C 118 GLU K 43 GLU~? 16.84 C1 GOL K3011 C 121 ARG K 14 ARG~? 14.49 CL CL K2003 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 156.15 122.83 185.77 154.85 125.10 184.29 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 157.32 128.98 186.14 156.19 128.19 187.79 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 153.63 132.28 188.00 152.37 129.86 189.45 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 155.84 130.25 181.35 154.86 128.33 181.37 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 159.72 136.15 179.98 157.68 137.80 181.74 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 5 5 # 5 C 111 ARG L 36 ARG~? 28.87 C1 GOL P3034 C 115 THR L 40 THR~? 26.45 O3 GOL K3011 C 117 ARG L 44 ARG~? 26.02 O3 GOL K3011 C 118 GLU L 43 GLU~? 27.03 C1 GOL P3034 C 121 ARG L 14 ARG~? 26.83 O3 GOL K3011 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 174.06 157.20 217.38 176.23 157.17 215.21 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 173.59 155.39 211.40 174.45 153.80 212.54 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 177.39 152.73 209.01 178.24 151.54 211.72 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 175.92 159.97 209.77 176.60 160.07 211.76 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 172.85 160.87 203.42 174.90 158.78 202.32 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 6 5 # 6 C 111 ARG M 36 ARG~? 16.07 O1 GOL M3007 C 115 THR M 40 THR~? 11.81 O1 GOL M3007 C 117 ARG M 44 ARG~? 13.46 C1 GOL M3007 C 118 GLU M 43 GLU~? 15.49 CL CL I2001 C 121 ARG M 14 ARG~? 14.61 CL CL I2007 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 179.97 216.30 180.98 181.48 213.82 180.04 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 178.75 210.50 182.26 179.67 211.49 183.92 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 182.09 207.66 185.06 183.17 210.24 186.35 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 180.74 208.70 177.96 181.77 210.50 177.78 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 177.02 202.54 176.79 178.85 201.28 179.05 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 7 5 # 7 C 111 ARG N 36 ARG~? 15.62 C3 GOL N3008 C 115 THR N 40 THR~? 11.37 O2 GOL N3008 C 117 ARG N 44 ARG~? 12.62 O2 GOL N3008 C 118 GLU N 43 GLU~? 15.48 CL CL J2002 C 121 ARG N 14 ARG~? 15.89 C3 GOL N3008 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 161.60 152.07 121.93 160.06 153.41 124.19 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 162.07 151.44 128.00 161.12 149.77 127.03 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 157.97 149.49 130.76 157.12 148.00 128.25 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 160.49 156.26 129.04 159.76 156.26 127.05 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 163.48 157.63 135.35 161.30 155.86 136.73 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 8 5 # 8 C 111 ARG O 36 ARG~? 19.89 O1 GOL K3010 C 115 THR O 40 THR~? 21.43 O1 GOL K3010 C 117 ARG O 44 ARG~? 19.56 O1 GOL K3010 C 118 GLU O 43 GLU~? 17.17 O1 GOL K3010 C 121 ARG O 14 ARG~? 14.59 CL CL K2003 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 175.82 120.47 157.52 177.72 122.75 158.28 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 175.50 126.36 156.13 176.43 125.18 154.53 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 179.51 128.71 153.87 180.36 126.03 152.63 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 177.14 127.85 160.77 177.95 125.93 161.03 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 174.25 134.10 161.46 176.22 135.49 159.49 ULMN 5 1mdy_d00 TRANSCRIPTION/DNA user 9 5 # 9 C 111 ARG P 36 ARG~? 18.56 O1 GOL L3028 C 115 THR P 40 THR~? 19.80 O1 GOL L3028 C 117 ARG P 44 ARG~? 18.01 O1 GOL L3028 C 118 GLU P 43 GLU~? 15.67 O1 GOL L3028 C 121 ARG P 14 ARG~? 15.62 O1 GOL L3028 coo 116.41 -10.73 -3.45 115.85 -13.35 -1.93 157.78 187.06 214.51 156.14 185.86 212.27 coo 113.36 -15.21 -5.01 112.66 -13.15 -5.07 159.06 187.40 208.46 158.17 189.22 209.24 coo 116.65 -21.40 -5.98 118.43 -20.27 -3.72 155.73 189.76 205.27 154.58 191.34 207.62 coo 109.69 -17.53 -1.81 109.75 -18.92 -0.21 157.04 182.77 207.26 156.16 182.81 209.15 coo 109.84 -22.92 -0.22 107.84 -21.87 1.85 160.23 180.86 201.41 159.06 183.03 199.69 1mdy_d00 source 1mdy TRANSCRIPTION/DNA : 9 hits 1mdy_d00 naa= 5 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN A 144 GLN~? 18.34 O3 GOL A3037 C 44 LYS A 142 LYS~? 20.36 CL CL A2020 C 75 ARG A 145 ARG~? 24.46 O3 GOL A3037 coo 34.33 34.01 1.06 32.24 34.35 1.22 89.55 71.95 40.89 88.93 73.36 42.34 coo 36.27 30.15 5.40 32.93 24.83 5.96 94.05 73.09 37.15 99.40 72.43 37.04 coo 30.88 29.31 6.12 29.39 29.02 3.47 94.33 67.29 39.79 97.00 65.79 39.32 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 2 3 # 2 C 43 GLN B 144 GLN~? 5.36 O1 GOL B3024 C 44 LYS B 142 LYS~? 15.72 O2 GOL B3024 C 75 ARG B 145 ARG~? 9.64 O1 GOL B3024 coo 34.33 34.01 1.06 32.24 34.35 1.22 25.23 67.97 25.00 25.82 66.20 23.96 coo 36.27 30.15 5.40 32.93 24.83 5.96 21.85 72.06 22.17 16.34 73.26 20.39 coo 30.88 29.31 6.12 29.39 29.02 3.47 19.64 71.23 27.64 22.06 69.48 28.42 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 3 3 # 3 C 43 GLN C 144 GLN~? 12.42 O1 GOL C3036 C 44 LYS C 142 LYS~? 17.22 O1 GOL C3036 C 75 ARG C 145 ARG~? 15.99 O1 GOL C3036 coo 34.33 34.01 1.06 32.24 34.35 1.22 81.50 28.39 73.43 80.87 26.87 72.03 coo 36.27 30.15 5.40 32.93 24.83 5.96 84.87 26.44 78.04 89.10 24.68 78.66 coo 30.88 29.31 6.12 29.39 29.02 3.47 85.99 31.07 76.22 83.80 32.01 74.28 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 4 3 # 4 C 43 GLN D 144 GLN~? 17.30 O3 GOL D3019 C 44 LYS D 142 LYS~? 18.65 CL CL D2012 C 75 ARG D 145 ARG~? 21.40 O1 GOL G3001 coo 34.33 34.01 1.06 32.24 34.35 1.22 17.88 45.80 74.24 18.72 47.75 74.07 coo 36.27 30.15 5.40 32.93 24.83 5.96 13.01 42.17 76.46 7.83 42.85 76.18 coo 30.88 29.31 6.12 29.39 29.02 3.47 12.08 41.78 71.45 11.86 39.69 73.74 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 5 3 # 5 C 43 GLN E 144 GLN~? 13.80 O3 GOL E3002 C 44 LYS E 142 LYS~? 18.17 O1 GOL E3002 C 75 ARG E 145 ARG~? 19.70 O1 GOL E3002 coo 34.33 34.01 1.06 32.24 34.35 1.22 22.86 81.65 61.34 23.71 82.87 59.78 coo 36.27 30.15 5.40 32.93 24.83 5.96 18.76 84.43 64.64 13.52 85.68 64.66 coo 30.88 29.31 6.12 29.39 29.02 3.47 16.30 80.38 65.14 17.26 82.53 67.17 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 6 3 # 6 C 43 GLN F 144 GLN~? 11.49 CL CL F2035 C 44 LYS F 142 LYS~? 19.20 CL CL F2034 C 75 ARG F 145 ARG~? 19.97 O3 GOL C3036 coo 34.33 34.01 1.06 32.24 34.35 1.22 86.06 33.92 35.15 85.92 35.17 33.44 coo 36.27 30.15 5.40 32.93 24.83 5.96 89.94 29.13 34.00 95.25 27.31 34.06 coo 30.88 29.31 6.12 29.39 29.02 3.47 91.49 29.42 38.83 93.62 28.28 40.76 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 7 3 # 7 C 43 GLN G 144 GLN~? 13.62 C3 GOL G3001 C 44 LYS G 142 LYS~? 22.79 C3 GOL G3001 C 75 ARG G 145 ARG~? 20.03 C3 GOL G3001 coo 34.33 34.01 1.06 32.24 34.35 1.22 20.40 31.78 38.43 20.75 30.54 40.14 coo 36.27 30.15 5.40 32.93 24.83 5.96 16.44 29.60 34.10 15.26 26.17 28.78 coo 30.88 29.31 6.12 29.39 29.02 3.47 15.17 34.68 33.42 15.78 32.53 31.28 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 8 3 # 8 C 43 GLN H 144 GLN~? 5.80 O2 GOL H3016 C 44 LYS H 142 LYS~? 14.79 O1 GOL H3016 C 75 ARG H 145 ARG~? 14.63 O1 GOL H3016 coo 34.33 34.01 1.06 32.24 34.35 1.22 84.54 66.68 78.81 83.66 65.46 80.38 coo 36.27 30.15 5.40 32.93 24.83 5.96 88.83 70.49 80.96 94.32 71.20 82.05 coo 30.88 29.31 6.12 29.39 29.02 3.47 91.20 69.90 76.54 91.87 72.67 77.80 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 9 3 # 9 C 43 GLN I 144 GLN~? 5.83 O1 GOL I3032 C 44 LYS I 142 LYS~? 14.36 O1 GOL I3032 C 75 ARG I 145 ARG~? 15.37 O1 GOL I3032 coo 34.33 34.01 1.06 32.24 34.35 1.22 203.35 189.41 155.57 202.68 190.98 156.90 coo 36.27 30.15 5.40 32.93 24.83 5.96 208.03 191.18 151.66 205.16 191.96 148.66 coo 30.88 29.31 6.12 29.39 29.02 3.47 209.45 186.59 151.83 209.12 188.26 149.20 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 10 3 # 10 C 43 GLN J 144 GLN~? 19.62 O1 GOL J3030 C 44 LYS J 142 LYS~? 19.62 CL CL J2016 C 75 ARG J 145 ARG~? 22.99 CL CL J2016 coo 34.33 34.01 1.06 32.24 34.35 1.22 138.83 183.31 142.69 139.42 181.74 141.36 coo 36.27 30.15 5.40 32.93 24.83 5.96 135.12 187.43 140.16 132.76 191.26 136.26 coo 30.88 29.31 6.12 29.39 29.02 3.47 132.84 187.86 144.62 133.71 189.96 142.45 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 11 3 # 11 C 43 GLN K 144 GLN~? 13.25 O3 GOL K3009 C 44 LYS K 142 LYS~? 19.15 C2 GOL K3009 C 75 ARG K 145 ARG~? 19.97 C2 GOL K3009 coo 34.33 34.01 1.06 32.24 34.35 1.22 198.77 144.45 186.07 198.16 143.26 184.38 coo 36.27 30.15 5.40 32.93 24.83 5.96 202.52 142.42 190.46 207.82 141.83 191.71 coo 30.88 29.31 6.12 29.39 29.02 3.47 204.60 147.17 190.28 202.10 146.29 191.85 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 12 3 # 12 C 43 GLN L 144 GLN~? 18.25 O3 GOL L3028 C 44 LYS L 142 LYS~? 23.18 CL CL L2009 C 75 ARG L 145 ARG~? 21.94 C3 GOL O3013 coo 34.33 34.01 1.06 32.24 34.35 1.22 134.07 157.87 191.59 134.72 159.48 192.82 coo 36.27 30.15 5.40 32.93 24.83 5.96 129.76 154.52 193.42 128.34 149.37 194.11 coo 30.88 29.31 6.12 29.39 29.02 3.47 129.45 155.66 188.12 131.98 157.11 187.19 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 13 3 # 13 C 43 GLN M 144 GLN~? 18.53 O3 GOL M3042 C 44 LYS M 142 LYS~? 19.90 CL CL M2017 C 75 ARG M 145 ARG~? 23.51 CL CL M2017 coo 34.33 34.01 1.06 32.24 34.35 1.22 137.26 195.03 179.49 137.97 196.37 178.00 coo 36.27 30.15 5.40 32.93 24.83 5.96 133.20 197.60 183.11 127.92 198.39 183.89 coo 30.88 29.31 6.12 29.39 29.02 3.47 131.12 192.72 183.38 131.87 195.02 185.33 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 14 3 # 14 C 43 GLN N 144 GLN~? 5.76 C1 GOL N3029 C 44 LYS N 142 LYS~? 14.74 O1 GOL N3029 C 75 ARG N 145 ARG~? 14.05 C1 GOL N3029 coo 34.33 34.01 1.06 32.24 34.35 1.22 201.39 151.74 148.20 201.01 153.17 146.62 coo 36.27 30.15 5.40 32.93 24.83 5.96 205.28 147.20 146.57 210.60 146.27 146.55 coo 30.88 29.31 6.12 29.39 29.02 3.47 206.36 147.54 151.55 205.74 145.29 149.50 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 15 3 # 15 C 43 GLN O 144 GLN~? 6.42 O3 GOL O3026 C 44 LYS O 142 LYS~? 15.43 O3 GOL O3026 C 75 ARG O 145 ARG~? 14.75 O3 GOL O3026 coo 34.33 34.01 1.06 32.24 34.35 1.22 136.08 146.43 154.31 136.54 145.45 156.17 coo 36.27 30.15 5.40 32.93 24.83 5.96 132.09 144.26 150.20 126.63 143.20 149.32 coo 30.88 29.31 6.12 29.39 29.02 3.47 130.60 149.22 149.86 131.12 146.92 147.82 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 16 3 # 16 C 43 GLN P 144 GLN~? 12.96 O3 GOL P3014 C 44 LYS P 142 LYS~? 18.94 O2 GOL P3014 C 75 ARG P 145 ARG~? 19.93 O1 GOL P3014 coo 34.33 34.01 1.06 32.24 34.35 1.22 200.41 182.40 193.61 199.53 181.01 194.99 coo 36.27 30.15 5.40 32.93 24.83 5.96 204.59 186.28 195.60 209.96 186.96 196.62 coo 30.88 29.31 6.12 29.39 29.02 3.47 206.30 185.90 191.05 208.78 186.92 189.45 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 16 hits 2er8_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 14 ARG~? 17.33 C3 GOL E3035 A 50 LYS A 22 LYS~? 17.94 O2 GOL E3035 A 51 ASN A 19 ASN~? 19.18 O2 GOL E3035 coo 28.68 23.77 42.74 27.76 26.72 42.93 51.58 86.56 39.71 49.78 85.03 37.73 coo 14.40 30.33 40.28 14.25 28.31 45.36 53.67 100.75 40.87 47.74 98.27 41.17 coo 19.09 30.55 41.51 19.09 28.89 42.82 52.52 96.60 45.55 50.48 96.15 45.93 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 14 ARG~? 16.53 O2 GOL B3003 A 50 LYS B 22 LYS~? 21.36 O2 GOL B3003 A 51 ASN B 19 ASN~? 23.26 C1 GOL B3003 coo 28.68 23.77 42.74 27.76 26.72 42.93 64.80 58.15 20.85 67.08 60.03 21.17 coo 14.40 30.33 40.28 14.25 28.31 45.36 65.01 54.92 6.02 70.07 53.87 9.73 coo 19.09 30.55 41.51 19.09 28.89 42.82 64.37 50.97 10.93 66.09 50.23 11.96 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG C 14 ARG~? 14.47 CL CL C2006 A 50 LYS C 22 LYS~? 13.40 CL CL C2004 A 51 ASN C 19 ASN~? 8.68 CL CL C2004 coo 28.68 23.77 42.74 27.76 26.72 42.93 42.37 22.00 65.55 40.14 23.31 67.25 coo 14.40 30.33 40.28 14.25 28.31 45.36 41.54 7.20 64.53 36.41 10.79 63.02 coo 19.09 30.55 41.51 19.09 28.89 42.82 42.15 11.55 59.90 40.37 12.31 59.05 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG D 14 ARG~? 14.52 CL CL D2008 A 50 LYS D 22 LYS~? 13.25 CL CL H2005 A 51 ASN D 19 ASN~? 8.55 CL CL H2005 coo 28.68 23.77 42.74 27.76 26.72 42.93 55.60 47.14 88.58 57.38 44.84 87.47 coo 14.40 30.33 40.28 14.25 28.31 45.36 53.93 51.31 102.22 59.63 51.16 99.48 coo 19.09 30.55 41.51 19.09 28.89 42.82 54.92 54.97 97.12 56.98 55.32 96.56 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 5 ARG E 14 ARG~? 16.26 C1 GOL E3004 A 50 LYS E 22 LYS~? 21.81 O1 GOL E3004 A 51 ASN E 19 ASN~? 23.49 O1 GOL E3004 coo 28.68 23.77 42.74 27.76 26.72 42.93 63.05 87.03 60.24 64.56 85.62 62.59 coo 14.40 30.33 40.28 14.25 28.31 45.36 64.37 100.86 56.32 69.54 97.12 56.69 coo 19.09 30.55 41.51 19.09 28.89 42.82 64.46 95.79 52.63 66.34 94.87 52.29 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 5 ARG F 14 ARG~? 16.88 O1 GOL B3017 A 50 LYS F 22 LYS~? 18.36 O1 GOL B3017 A 51 ASN F 19 ASN~? 19.88 O2 GOL B3017 coo 28.68 23.77 42.74 27.76 26.72 42.93 49.17 40.62 20.09 46.79 39.22 21.58 coo 14.40 30.33 40.28 14.25 28.31 45.36 51.36 41.84 5.91 45.78 43.39 8.51 coo 19.09 30.55 41.51 19.09 28.89 42.82 51.22 46.49 10.14 49.31 47.27 10.65 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 5 ARG G 14 ARG~? 14.57 CL CL C2006 A 50 LYS G 22 LYS~? 13.25 CL CL C2004 A 51 ASN G 19 ASN~? 8.62 CL CL C2004 coo 28.68 23.77 42.74 27.76 26.72 42.93 57.32 18.45 47.88 59.70 19.45 46.16 coo 14.40 30.33 40.28 14.25 28.31 45.36 55.06 4.83 51.67 60.67 7.73 52.68 coo 19.09 30.55 41.51 19.09 28.89 42.82 55.28 9.85 55.47 57.22 10.47 56.18 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 5 ARG H 14 ARG~? 14.44 CL CL D2008 A 50 LYS H 22 LYS~? 13.32 CL CL H2005 A 51 ASN H 19 ASN~? 8.65 CL CL H2005 coo 28.68 23.77 42.74 27.76 26.72 42.93 44.51 67.63 85.23 43.02 69.63 83.32 coo 14.40 30.33 40.28 14.25 28.31 45.36 43.36 66.64 99.44 38.17 66.18 95.68 coo 19.09 30.55 41.51 19.09 28.89 42.82 43.13 61.95 95.23 41.19 61.49 94.39 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 9 3 # 9 A 5 ARG I 14 ARG~? 14.48 CL CL I2007 A 50 LYS I 22 LYS~?